PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bhat, AA; Lu, H; Soutto, M; Capobianco, A; Rai, P; Zaika, A; El-Rifai, W				Bhat, Ajaz A.; Lu, Heng; Soutto, Mohammed; Capobianco, Anthony; Rai, Priyamvada; Zaika, Alexander; El-Rifai, Wael			Exposure of Barrett's and esophageal adenocarcinoma cells to bile acids activates EGFR-STAT3 signaling axis via induction of APE1	ONCOGENE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; OXIDATIVE DNA-DAMAGE; KAPPA-B ACTIVATION; GENE-EXPRESSION; CONSTITUTIVE ACTIVATION; CONFERS RESISTANCE; NUCLEAR EGFR-STAT3; PROTEIN APE1/REF-1; UNITED-STATES; LOW PH	The development of Barrett's esophagus (BE) and its progression to esophageal adenocarcinoma (EAC) is highly linked to exposure to acidic bile salts due to chronic gastroesophageal reflux disease (GERD). In this study, we investigated the role of Apurinic/apyrimidinic endonuclease 1/redox effector factor-1 (APE1/REF-1) in STAT3 activation in response to acidic bile salts. Our results indicate that APE1 is constitutively overexpressed in EAC, whereas its expression is transiently induced in response to acidic bile salts in non-neoplastic BE. Using overexpression or shRNA knockdown of APE1, we found that APE1 is required for phosphorylation, nuclear localization, and transcriptional activation of STAT3. By using an APE1 redox-specific mutant (C65A) and APE1 redox inhibitor (E3330), we demonstrate that APE1 activates STAT3 in a redox-dependent manner. By using pharmacologic inhibitors and genetic knockdown systems, we found that EGFR is a required link between APE1 and STAT3. EGFR phosphorylation (Y1068) was directly associated with APE1 levels and redox function. Co-immunoprecipitation and proximity ligation assays indicated that APE1 coexists and interacts with the EGFR-STAT3 protein complex. Consistent with these findings, we demonstrated a significant induction in mRNA expression levels of STAT3 target genes (IL-6, IL-17A, BCL-xL, Survivin, and c-MYC) in BE and EAC cells, following acidic bile salts treatment. ChIP assays indicated that acidic bile salts treatment enhances binding of STAT3 to the promoter of its target genes, Survivin and BCL-xL. Inhibition of APE1/REF-1 redox activity using E3330 abrogated STAT3 DNA binding and transcriptional activity. The induction of APE1-STAT3 axis in acidic bile salts conditions provided a survival advantage and promoted cellular proliferation. In summary, our study provides multiple pieces of evidence supporting a critical role for APE1 induction in activating the EGFR-STAT3 signaling axis in response to acidic bile salts, the main risk factor for Barrett's carcinogenesis.	[Bhat, Ajaz A.; Lu, Heng; Soutto, Mohammed; Capobianco, Anthony; Zaika, Alexander; El-Rifai, Wael] Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA; [Bhat, Ajaz A.] Sidra Med, Div Translat Med, Res Branch, Doha, Qatar; [Rai, Priyamvada] Univ Miami, Miller Sch Med, Div Med Oncol, Dept Med, Miami, FL 33136 USA; [Zaika, Alexander; El-Rifai, Wael] Miami Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA	University of Miami; Sidra Medical & Research Center; University of Miami	El-Rifai, W (corresponding author), Univ Miami, Miller Sch Med, Dept Surg, Miami, FL 33136 USA.; El-Rifai, W (corresponding author), Miami Healthcare Syst, Dept Vet Affairs, Miami, FL 33125 USA.	welrifai@med.miami.edu	Bhat, Ajaz/V-3642-2019	Bhat, Ajaz/0000-0003-3640-6275; Rai, Priyamvada/0000-0001-7822-7553	U.S. National Institutes of Health [R01CA206563]; U.S. Department of Veterans affairs [1IK6BX003787, I01BX001179]; NATIONAL CANCER INSTITUTE [R01CA206564, R01CA206563] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002115, IK6BX003787, I01BX001179] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by grants from the U.S. National Institutes of Health (R01CA206563) and the U.S. Department of Veterans affairs (1IK6BX003787 and I01BX001179). The content of this work is solely the responsibility of the authors and do not necessarily represent the official views of the Department of Veterans Affairs, National Institutes of Health, or the University of Miami.	Abdel-Latif MMM, 2004, ANN SURG, V239, P491, DOI 10.1097/01.sla.0000118751.95179.c6; Bernstein H, 1999, TOXICOL LETT, V108, P37, DOI 10.1016/S0378-4274(99)00113-7; Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Biswas A, 2015, AM J PHYSIOL-CELL PH, V309, pC296, DOI 10.1152/ajpcell.00022.2015; Bobola MS, 2005, CLIN CANCER RES, V11, P7405, DOI 10.1158/1078-0432.CCR-05-1068; Cardoso AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047462; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Chua CY, 2016, ONCOGENE, V35, P738, DOI 10.1038/onc.2015.131; COFFER PJ, 1995, BIOCHEM BIOPH RES CO, V210, P74, DOI 10.1006/bbrc.1995.1629; Cook MB, 2009, BRIT J CANCER, V101, P855, DOI 10.1038/sj.bjc.6605246; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Di Maso V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143289; Dossa AY, 2016, AM J PHYSIOL-GASTR L, V310, pG81, DOI 10.1152/ajpgi.00065.2015; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Dvorak K, 2007, CLIN CANCER RES, V13, P5305, DOI 10.1158/1078-0432.CCR-07-0483; Dvorak K, 2007, GUT, V56, P763, DOI 10.1136/gut.2006.103697; Dvorakova K, 2004, CLIN CANCER RES, V10, P2020, DOI 10.1158/1078-0432.CCR-0437-03; Eloubeidi MA, 2003, AM J GASTROENTEROL, V98, P1627, DOI 10.1016/S0002-9270(03)00228-4; Farhadi A, 2002, AM J GASTROENTEROL, V97, P22; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fishel ML, 2010, EXP HEMATOL, V38, P1178, DOI 10.1016/j.exphem.2010.08.011; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Gritsko T, 2006, CLIN CANCER RES, V12, P11, DOI 10.1158/1078-0432.CCR-04-1752; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; Hong J, 2016, ONCOTARGET, V7, P16688, DOI 10.18632/oncotarget.7696; Hoshino M, 2007, PATHOBIOLOGY, V74, P15, DOI 10.1159/000101047; IFTIKHAR SY, 1993, ANN ROY COLL SURG, V75, P411; Inayama M, 2007, HEPATO-GASTROENTEROL, V54, P761; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jenkins GJS, 2008, MUTAGENESIS, V23, P399, DOI 10.1093/mutage/gen029; Jolly AJ, 2004, MUTAGENESIS, V19, P319, DOI 10.1093/mutage/geh035; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kauer WKH, 1997, SURGERY, V122, P874, DOI 10.1016/S0039-6060(97)90327-5; Kelley MR, 2011, ANTIOXID REDOX SIGN, V14, P1387, DOI 10.1089/ars.2010.3410; Kim JS, 2012, INT J RADIAT ONCOL, V82, P130, DOI 10.1016/j.ijrobp.2010.09.037; Lagergren J, 2005, GUT, V54, pI1, DOI 10.1136/gut.2004.041517; Le Bras GF, 2014, LAB INVEST, V94, P1134, DOI 10.1038/labinvest.2014.97; Leaman DW, 1996, MOL CELL BIOL, V16, P369; Lechner S, 2002, CARCINOGENESIS, V23, P1281, DOI 10.1093/carcin/23.8.1281; Lee JS, 2001, MUTAT RES-FUND MOL M, V480, P189, DOI 10.1016/S0027-5107(01)00199-3; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Nehra D, 1999, GUT, V44, P598, DOI 10.1136/gut.44.5.598; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Park OK, 1996, P NATL ACAD SCI USA, V93, P13704, DOI 10.1073/pnas.93.24.13704; Peng DF, 2014, J CANCER, V5, P510, DOI 10.7150/jca.9215; Peng DF, 2012, GUT, V61, P1250, DOI 10.1136/gutjnl-2011-301078; Pera M, 2005, J SURG ONCOL, V92, P151, DOI 10.1002/jso.20357; Picardo SL, 2012, DIGEST SURG, V29, P251, DOI 10.1159/000341498; Poehlmann A, 2012, PATHOL RES PRACT, V208, P269, DOI 10.1016/j.prp.2012.03.007; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Shao H, 2003, CANCER RES, V63, P3923; Sital RR, 2006, SCAND J GASTROENTERO, V41, P11, DOI 10.1080/00365520600664219; SOKOL RJ, 1995, GASTROENTEROLOGY, V109, P1249, DOI 10.1016/0016-5085(95)90585-5; Sommerfeld A, 2009, J BIOL CHEM, V284, P22173, DOI 10.1074/jbc.M109.005355; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Thakur S, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.42; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Vigneron A, 2008, CANCER RES, V68, P815, DOI 10.1158/0008-5472.CAN-07-5115; Yang Z, 2014, INT J ONCOL, V45, P1820, DOI 10.3892/ijo.2014.2589; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Yu XT, 2007, J CANCER RES CLIN, V133, P145, DOI 10.1007/s00432-006-0139-z; Zhang F, 2015, J TOXICOL PATHOL, V28, P79, DOI 10.1293/tox.2014-0047; Zhang HY, 2009, CANCER RES, V69, P9083, DOI 10.1158/0008-5472.CAN-09-2518; Zhang R, 2005, WORLD J GASTROENTERO, V11, P6466, DOI 10.3748/wjg.v11.i41.6466	75	32	33	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6011	6024		10.1038/s41388-018-0388-8	http://dx.doi.org/10.1038/s41388-018-0388-8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29991802	Green Accepted			2022-12-26	WOS:000450175900001
J	Smith, HK; Pasmans, F; Dhaenens, M; Deforce, D; Bonte, D; Verheyen, K; Lens, L; Martel, A				Smith, Hannah Keely; Pasmans, Frank; Dhaenens, Maarten; Deforce, Dieter; Bonte, Dries; Verheyen, Kris; Lens, Luc; Martel, An			Skin mucosome activity as an indicator of Batrachochytrium salamandrivorans susceptibility in salamanders	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE DEFENSES; EMERGING INFECTIOUS-DISEASE; FROG RANA-MUSCOSA; CHYTRID FUNGUS; AMPHIBIAN SKIN; CUTANEOUS BACTERIA; CHYTRIDIOMYCOSIS; SECRETIONS; DENDROBATIDIS; TETRODOTOXIN	Recently emerged fungal diseases, Batrachochytrium dendrobatidis (Bd) and Batrachochytrium salamandrivorans (Bsal) are an increasing threat to amphibians worldwide. In Europe, the threat of Bsal to salamander populations is demonstrated by the rapid decline of fire salamander populations in Germany, the Netherlands and Belgium. Although most European urodelans are susceptible to infection in infection trials, recent evidence suggests marked interspecific differences in the course of infection, with potentially far reaching implications for salamander conservation. As a salamander's skin is the first line of defense against such pathogens, interspecific differences in innate immune function of the skin may explain differential susceptibility. Here we investigate if compounds present on a salamander's skin can kill Bsa/spores and if there is variation among species. We used a non-invasive assay to compare killing ability of salamander mucosomes of four different species (captive and wild Salamandra salamandra and captive Ichtyosaura alpestris, Cynops pyrrhogaster and Lissotriton helveticus) by exposing Bsa/zoospores to salamander mucosomes and determining spore survival. In all samples, zoospores were killed when exposed to mucosomes. Moreover, we saw a significant variation in this Bsal killing ability of mucosomes between different salamander host species. Our results indicate that mucosomes of salamanders might provide crucial skin protection against Bsal, and could explain why some species are more susceptible than others. This study represents a step towards better understanding host species variation in innate immune function and disease susceptibility in amphibians.	[Smith, Hannah Keely; Pasmans, Frank; Martel, An] Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Wildlife Hlth Ghent, Ghent, Belgium; [Dhaenens, Maarten; Deforce, Dieter] Univ Ghent, Fac Pharmaceut Sci, Lab Pharmaceut Biotechnol, Ghent, Belgium; [Bonte, Dries; Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit TEREC, KL Ledeganckstr, Ghent, Belgium; [Verheyen, Kris] Univ Ghent, Dept Environm, Forest & Nat Lab, Gontrode, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	Martel, A (corresponding author), Univ Ghent, Dept Pathol Bacteriol & Avian Dis, Wildlife Hlth Ghent, Ghent, Belgium.	An.Martel@ugent.be	Deforce, Dieter LD/J-4725-2013; Dhaenens, Maarten/AAE-5694-2020; Bonte, Dries/AAH-3913-2021; Pasmans, Frank/D-3667-2014	Deforce, Dieter LD/0000-0002-0635-661X; Dhaenens, Maarten/0000-0002-9801-3509; Bonte, Dries/0000-0002-3320-7505; Verheyen, Kris/0000-0002-2067-9108; Lens, Luc/0000-0002-0241-2215; Smith, Hannah/0000-0001-9895-4184	University of Ghent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB); UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB)	University of Ghent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB); UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB)	Financial support for this research was provided via the University of Ghent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB) to Hannah Keely Smith.; Financial support for this research was provided via the UGent GOA project Scaling up Functional Biodiversity Research: from Individuals to Landscapes and Back (TREEWEB). We would like to thank Tijn Raaymakers for suggestions during early version of this manuscript and Alex Laking and Elin Verbrugghe for help during experiments. We are grateful to the three anonymous reviewers whose comments greatly improved the initial manuscript.	Becker MH, 2015, MOL ECOL, V24, P1628, DOI 10.1111/mec.13135; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bletz MC, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170107; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2006, ORYX, V40, P84, DOI 10.1017/S0030605306000093; BRODIE ED, 1990, HERPETOLOGICA, V46, P1; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; Cheng YK, 2011, P NATL ACAD SCI USA, V108, pE16, DOI 10.1073/pnas.1018584108; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; Conlon JM, 2011, CELL MOL LIFE SCI, V68, P2303, DOI 10.1007/s00018-011-0720-8; Daly JW, 2005, J NAT PROD, V68, P1556, DOI 10.1021/np0580560; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Duellman W. E., 1986, BIOL AMPHIBIANS; Farrer RA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14742; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Grant EHC, 2017, FRONT ECOL ENVIRON, V15, P214, DOI 10.1002/fee.1481; HABERMEHL G, 1967, LIEBIGS ANN CHEM, V706, P213; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; Heatwhole H, 1994, AMPHIBIAN BIOL, V1; Laking AE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44443; Lam BA, 2011, ECOHEALTH, V8, P36, DOI 10.1007/s10393-011-0689-7; Lauer A, COPEIA, V200, P630; Lauer A, 2008, ISME J, V2, P145, DOI 10.1038/ismej.2007.110; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lotters S, 2009, ECOHEALTH, V6, P358, DOI 10.1007/s10393-010-0281-6; Loudon AH, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00441; Lu J, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053317, 10.1371/journal.pone.0070827]; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; MASTROMEI G, 1991, TOXICON, V29, P321, DOI 10.1016/0041-0101(91)90285-Y; McMahon TA, 2014, ECOHEALTH, V11, P164, DOI 10.1007/s10393-014-0908-0; Mebs D, 2005, TOXICON, V45, P603, DOI 10.1016/j.toxicon.2005.01.001; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Myers JM, 2012, J CHEM ECOL, V38, P958, DOI 10.1007/s10886-012-0170-2; Pask JD, 2012, GLOBAL CHANGE BIOL, V18, P1231, DOI 10.1111/j.1365-2486.2011.02622.x; Pasmans F., 2013, PLOS ONE, V8, P1; Qian JQ, 2008, TOXICON, V52, P22, DOI 10.1016/j.toxicon.2008.05.007; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Riera AS, 2003, BIOCELL, V27, P37; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2006, DEV COMP IMMUNOL, V30, P831, DOI 10.1016/j.dci.2005.10.005; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; ROSEGHINI M, 1989, COMP BIOCHEM PHYS C, V94, P455, DOI 10.1016/0742-8413(89)90097-2; Rosenthal M, 2011, INFECT GENET EVOL, V11, P839, DOI 10.1016/j.meegid.2011.03.022; Sabino-Pinto J, 2016, MICROB ECOL, V72, P460, DOI 10.1007/s00248-016-0797-6; Sanchez E, 2017, MICROB ECOL, V73, P455, DOI 10.1007/s00248-016-0863-0; Savage AE, 2016, ROYAL SOC P BIOL SCI, V283, P2015; SCHOEPF C, 1961, EXPERIENTIA, V17, P285, DOI 10.1007/BF02158158; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Sheafor B, 2008, J WILDLIFE DIS, V44, P226, DOI 10.7589/0090-3558-44.2.226; SPIGHT TM, 1967, COMP BIOCHEM PHYSIOL, V20, P767, DOI 10.1016/0010-406X(67)90050-3; Spitzen-der Sluijs A, 2013, AMPHIBIA-REPTILIA, V34, DOI [10.1038/nature22059, DOI 10.1038/NATURE22059]; Spitzen-van der Sluijs A, 2016, EMERG INFECT DIS, V22, P1286, DOI 10.3201/eid2207.160109; Stegen G, 2017, NATURE, V544, P353, DOI 10.1038/nature22059; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927; TOLEDO RC, 1995, COMP BIOCHEM PHYS A, V111, P1, DOI 10.1016/0300-9629(95)98515-I; Tsuruda K, 2002, TOXICON, V40, P131, DOI 10.1016/S0041-0101(01)00198-2; Van Rooij P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0266-0; Vences M, 2014, MOL PHYLOGENET EVOL, V73, P208, DOI 10.1016/j.ympev.2013.12.009; von Byern J, 2017, TOXICON, V135, P24, DOI 10.1016/j.toxicon.2017.05.021; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, HOST PATHOGEN DYNAMI; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Woodhams DC, 2007, ANIM CONSERV, V10, P425, DOI 10.1111/j.1469-1795.2007.00150.x; Woodhams D. C., 2014, PLOS ONE, V9; Yap TA, 2017, ECOHEALTH, P1, DOI [10.1007/s10393-017-1220-6, DOI 10.1007/S10393-017-1220-6]; Yotsu-Yamashita M, 2007, TOXICON, V50, P306, DOI 10.1016/j.toxicon.2007.03.019; Yotsu-Yamashita M, 2017, TOXICON, V134, P14, DOI 10.1016/j.toxicon.2017.05.014; Zhao Y, 2006, COMP BIOCHEM PHYS C, V142, P46, DOI 10.1016/j.cbpc.2005.10.001	78	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199295	10.1371/journal.pone.0199295	http://dx.doi.org/10.1371/journal.pone.0199295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020936	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400011
J	Liu, LS; Firrman, J; Tanes, C; Bittinger, K; Thomas-Gahring, A; Wu, GD; Van den Abbeele, P; Tomasula, PM				Liu, LinShu; Firrman, Jenni; Tanes, Ceylan; Bittinger, Kyle; Thomas-Gahring, Audrey; Wu, Gary D.; Van den Abbeele, Pieter; Tomasula, Peggy M.			Establishing a mucosal gut microbial community in vitro using an artificial simulator	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; HUMAN LARGE-INTESTINE; DIVERSITY; FERMENTATION; BACTERIA; SYSTEM; DIET; METABOLISM; COLON	The Twin Simulator of the Human Intestinal Microbial Ecosystem (TWINSHIME (R)) was initially developed to study the luminal gut microbiota of the ascending (AC), transverse (TC), and descending (DC) colon regions. Given the unique composition and potential importance of the mucosal microbiota for human health, the TWINSHIME was recently adapted to simulate the mucosal microbiota as well as the luminal community. It has been previously demonstrated that the luminal community in the TWINSHIME reaches a steady state within two weeks post inoculation, and is able to differentiate into region specific communities. However, less is known regarding the mucosal community structure and dynamics. During the current study, the luminal and mucosal communities in each region of the TWINSHIME were evaluated over the course of six weeks. Based on 16S rRNA gene sequencing and short chain fatty acid analysis, it was determined that both the luminal and mucosal communities reached stability 10-20 days after inoculation, and remained stable until the end of the experiment. Bioinformatics analysis revealed the formation of unique community structures between the mucosal and luminal phases in all three colon regions, yet these communities were similar to the inoculum. Specific colonizers of the mucus mainly belonged to the Firmicutes phylum and included Lachnospiraceae (AC/TC/DC), Ruminococcaceaeand Eubacteriaceae (AC), Lactobacillaceae (AC/TC), Clostridiaceaeand Erysipeiotrichaceae (TC/DC). In contrast, Bacteroidaceae were enriched in the gut lumen of all three colon regions. The unique profile of short chain fatty acid (SCFA) production further demonstrated system stability, but also proved to be an area of marked differences between the in vitro system and in vivo reports. Results of this study demonstrate that it is possible to replicate the community structure and composition of the gut microbiota in vitro. Through implementation of this system, the human gut microbiota can be studied in a dynamic and continuous fashion.	[Liu, LinShu; Firrman, Jenni; Thomas-Gahring, Audrey; Tomasula, Peggy M.] ARS, Dairy & Funct Foods Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA; [Tanes, Ceylan; Bittinger, Kyle] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Wu, Gary D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Van den Abbeele, Pieter] ProDigest, Ghent, Belgium	United States Department of Agriculture (USDA); University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Liu, LS (corresponding author), ARS, Dairy & Funct Foods Res Unit, Eastern Reg Res Ctr, USDA, Wyndmoor, PA 19038 USA.	LinShu.Liu@ars.usda.gov	Bittinger, Kyle/ABG-2342-2020	Liu, LinShu/0000-0003-3962-290X	US Congress; company ProDigest	US Congress; company ProDigest	This work was supported by funds from the US Congress. The company ProDigest provided support in the form of salary for author Pieter Van den Abbeele. The specific role of author Pieter Van den Abbeele is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Baumgartner A, 2012, J MED MICROBIOL, V61, P1600, DOI 10.1099/jmm.0.047456-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhandari V, 2012, ANTON LEEUW INT J G, V102, P517, DOI 10.1007/s10482-012-9759-2; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davis CK, 2012, FEMS MICROBIOL ECOL, V80, P671, DOI 10.1111/j.1574-6941.2012.01338.x; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fan PX, 2015, CURR PROTEIN PEPT SC, V16, P646, DOI 10.2174/1389203716666150630133657; Feria-Gervasio D, 2014, J MICROBIOL METH, V96, P111, DOI 10.1016/j.mimet.2013.11.015; Garcia-Villalba R, 2012, J SEP SCI, V35, P1906, DOI 10.1002/jssc.201101121; Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164; Guerra A, 2012, TRENDS BIOTECHNOL, V30, P591, DOI 10.1016/j.tibtech.2012.08.001; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jumas-Bilak E, 2009, INT J SYST EVOL MICR, V59, P1028, DOI 10.1099/ijs.0.006718-0; Kato LM, 2014, IMMUNOL REV, V260, P67, DOI 10.1111/imr.12185; Konturek PC, 2015, J PHYSIOL PHARMACOL, V66, P483; Krishnan S, 2015, CURR OPIN BIOTECH, V36, P137, DOI 10.1016/j.copbio.2015.08.015; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; MACFARLANE GT, 1989, J APPL BACTERIOL, V67, P521, DOI 10.1111/j.1365-2672.1989.tb02524.x; Maga EA, 2013, GUT MICROBES, V4, P136, DOI 10.4161/gmic.23188; Marchandin H, 2010, RES MICROBIOL, V161, P91, DOI 10.1016/j.resmic.2009.12.008; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MILLER TL, 1981, APPL ENVIRON MICROB, V42, P400, DOI 10.1128/AEM.42.3.400-407.1981; Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622; Molly K, 1996, MICROB ECOL HEALTH D, V9, P79, DOI 10.1002/(SICI)1234-987X(199603)9:2<79::AID-MEH415>3.3.CO;2-V; MOLLY K, 1994, MICROB ECOL HEALTH D, V7, P191, DOI 10.3109/08910609409141354; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Possemiers S, 2004, FEMS MICROBIOL ECOL, V49, P495, DOI 10.1016/j.femsec.2004.05.002; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Van de Wiele T, 2015, IMPACT FOOD BIOACTIV, P3005; Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; Van Herreweghen F, 2017, BENEF MICROBES, V8, P81, DOI 10.3920/BM2016.0013; Vartoukian SR, 2010, ENVIRON MICROBIOL, V12, P916, DOI 10.1111/j.1462-2920.2009.02135.x; Vigsnaes LK, 2012, SCI REP, V3, pe1; Wang M, 2017, MOLECULES, V22, pe1; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	46	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0197692	10.1371/journal.pone.0197692	http://dx.doi.org/10.1371/journal.pone.0197692			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016326	Green Submitted, gold, Green Published			2022-12-26	WOS:000438866600003
J	Nieto, NC; Porter, WT; Wachara, JC; Lowrey, TJ; Martin, L; Motyka, PJ; Salkeld, DJ				Nieto, Nathan C.; Porter, W. Tanner; Wachara, Julie C.; Lowrey, Thomas J.; Martin, Luke; Motyka, Peter J.; Salkeld, Daniel J.			Using citizen science to describe the prevalence and distribution of tick bite and exposure to tick-borne diseases in the United States	PLOS ONE			English	Article							LYME-DISEASE; DERMACENTOR-VARIABILIS; IXODES-PACIFICUS; ANAPLASMA-PHAGOCYTOPHILUM; BORRELIA-MIYAMOTOI; GEOGRAPHIC-DISTRIBUTION; AMBLYOMMA-AMERICANUM; ACARI IXODIDAE; PATHOGENS; RISK	Tick-borne pathogens are increasing their range and incidence in North America as a consequence of numerous factors including improvements in diagnostics and diagnosis, range expansion of primary vectors, changes in human behavior, and an increasing understanding of the diversity of species of pathogens that cause human disease. Public health agencies have access to human incidence data on notifiable diseases e.g., Borrelia burgdorferi, the causative agent of Lyme disease, and often local pathogen prevalence in vector populations. However, data on exposure to vectors and pathogens can be difficult to determine e.g., if disease does not occur. We report on an investigation of exposure to ticks and tick-borne bacteria, conducted at a national scale, using citizen science participation. 16,080 ticks were submitted between January 2016 and August 2017, and screened for B. burgdorferi, B. miyamotoi, Anaplasma phagocytophilum, and Babesia microti. These data corroborate entomologic investigations of tick distributions in North America, but also identify patterns of local disease risk and tick contact with humans throughout the year in numerous species of ticks and associated pathogens.	[Nieto, Nathan C.; Porter, W. Tanner; Wachara, Julie C.; Lowrey, Thomas J.; Motyka, Peter J.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Martin, Luke; Salkeld, Daniel J.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Northern Arizona University; Colorado State University	Nieto, NC (corresponding author), No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA.	nathan.nieto@nau.edu	Porter, William Tanner/V-5593-2019	Porter, William Tanner/0000-0002-2611-0924	Bay Area Lyme Foundation	Bay Area Lyme Foundation	Our research was supported by a grant to NC Nieto from the Bay Area Lyme Foundation (https://www.bayarealyme.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Dahlgren FS, 2011, AM J TROP MED HYG, V85, P124, DOI 10.4269/ajtmh.2011.10-0613; Dergousoff SJ, 2007, MOL CELL PROBE, V21, P343, DOI 10.1016/j.mcp.2007.04.003; Dergousoff SJ, 2013, J MED ENTOMOL, V50, P510, DOI 10.1603/ME12193; Drazenovich N, 2006, VECTOR-BORNE ZOONOT, V6, P83, DOI 10.1089/vbz.2006.6.83; EASTON ER, 1977, J MED ENTOMOL, V13, P501, DOI 10.1093/jmedent/13.4-5.501; Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092; Eisen RJ, 2017, ILAR J, V58, P319, DOI 10.1093/ilar/ilx005; Eisen RJ, 2016, J MED ENTOMOL, V53, P349, DOI 10.1093/jme/tjv237; Foley JE, 2010, VET MICROBIOL, V140, P332, DOI 10.1016/j.vetmic.2009.07.017; Forrester JD, 2015, TICKS TICK-BORNE DIS, V6, P721, DOI 10.1016/j.ttbdis.2015.06.005; Freifeld CC, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000376; Furman D.P., 1984, Bulletin of the California Insect Survey, V25, P1; Gasmi S, 2016, TICKS TICK-BORNE DIS, V7, P1075, DOI 10.1016/j.ttbdis.2016.09.006; Hai VV, 2014, TICKS TICK-BORNE DIS, V5, P607, DOI 10.1016/j.ttbdis.2014.07.022; Hall JL, 2017, EMERG INFECT DIS, V23, P463, DOI 10.3201/eid2303.161397; Hamer SA, 2013, AM J TROP MED HYG, V89, P924, DOI 10.4269/ajtmh.13-0081; Herwaldt Barbara L., 2012, Morbidity and Mortality Weekly Report, V61, P505; James AM, 2015, MED VET ENTOMOL, V29, P178, DOI 10.1111/mve.12099; James AM, 2006, J MED ENTOMOL, V43, P17, DOI 10.1603/0022-2585(2006)043[0017:DSAHOT]2.0.CO;2; Kilpatrick AM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0117; Kjemtrup AM, 2006, VET PARASITOL, V138, P103, DOI 10.1016/j.vetpar.2006.01.044; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Laaksonen M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.17; LANE RS, 1994, J MED ENTOMOL, V31, P417, DOI 10.1093/jmedent/31.3.417; Lane RS, 2004, J MED ENTOMOL, V41, P239, DOI 10.1603/0022-2585-41.2.239; Mani RJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130513; Mani RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035441; Meentemeyer RK, 2015, FRONT ECOL ENVIRON, V13, P189, DOI 10.1890/140299; Nelson CA, 2015, EMERG INFECT DIS, V21, P1625, DOI 10.3201/eid2109.150417; Nieto NC, 2016, AM J TROP MED HYG, V95, P50, DOI 10.4269/ajtmh.15-0707; Padgett K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110853; Palmer JRB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00914-9; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8; Ripoche M, 2018, J MED ENTOMOL, V55, P1016, DOI 10.1093/jme/tjy030; Salkeld DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134812; Scott JD, 2001, J MED ENTOMOL, V38, P493, DOI 10.1603/0022-2585-38.4.493; Scott JD, 2015, SYST APPL ACAROL-UK, V20, P155, DOI 10.11158/saa.20.2.1; Shock BC, 2014, TICKS TICK-BORNE DIS, V5, P373, DOI 10.1016/j.ttbdis.2014.01.003; Sonenshine D. E., 1979, INSECTS VIRGINIA NO; Springer YP, 2015, AM J TROP MED HYG, V93, P875, DOI 10.4269/ajtmh.15-0330; Stromdahl EY, 2018, J MED ENTOMOL, V55, P501, DOI 10.1093/jme/tjx250; Teal AE, 2012, J CLIN MICROBIOL, V50, P903, DOI 10.1128/JCM.05848-11; Walter KS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0834; Xu G, 2016, VECTOR-BORNE ZOONOT, V16, P520, DOI 10.1089/vbz.2015.1912	49	58	59	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199644	10.1371/journal.pone.0199644	http://dx.doi.org/10.1371/journal.pone.0199644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001350	Green Submitted, gold, Green Published			2022-12-26	WOS:000438457400016
J	Xie, A; Zhou, AY; Liu, H; Shi, GB; Liu, M; Boheler, KR; Dudley, SC				Xie, An; Zhou, Anyu; Liu, Hong; Shi, Guangbin; Liu, Man; Boheler, Kenneth R.; Dudley, Samuel C., Jr.			Mitochondrial Ca2+ flux modulates spontaneous electrical activity in ventricular cardiomyocytes	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; CARDIAC MYOCYTES; RYANODINE RECEPTOR; CALCIUM UNIPORTER; ATRIAL MYOCYTES; HEART; ARRHYTHMIAS; CONTRIBUTES; MECHANISMS; EXCHANGER	Introduction Ca2+ release from sarcoplasmic reticulum (SR) is known to contribute to automaticity via the cytoplasmic Na+-Ca2+ exchanger (NCX). Mitochondria participate in Ca2+ cycling. We studied the role of mitochondrial Ca2+ flux in ventricular spontaneous electrical activity. Methods Spontaneously contracting mouse embryonic stem cells (ESC)-derived ventricular cardiomyocytes (CMs) were differentiated from wild type and ryanodine receptor type 2 (RYR2) knockout mouse ESCs and differentiated for 19-21 days. Automaticity was also observed in human induced pluripotent stem cell (hiPSC)-derived ventricular CMs differentiated for 30 days, and acute isolated adult mouse ventricular cells in ischemic simulated buffer. Action potentials (APs) were recorded by perforated whole cell current-clamp. Cytoplasmic and mitochondrial Ca2+ transients were determined by fluorescent imaging. Results In mouse ESC-derived ventricular CMs, spontaneous beating was dependent on the L-type Ca2+ channel, cytoplasmic NCX and mitochondrial NCX. Spontaneous beating was modulated by SR Ca2+ release from RYR2 or inositol trisphosphate receptors (IP3R), the pacemaker current (I-f) and mitochondrial Ca2+ uptake by the mitochondrial Ca2+ uniporter (MCU). In RYR2 knockout mouse ESC-derived ventricular CMs, mitochondrial Ca2+ flux influenced spontaneous beating independently of the SR Ca(2+ )release from RYR2, and the mitochondrial effect was dependent on IP3R SR Ca2+ release. Depolarization of mitochondria and preservation of ATP could terminate spontaneous beating. A contribution of mitochondrial Ca2+ flux to automaticity was confirmed in hiPSC-derived ventricular CMs and ischemic adult mouse ventricular CMs, confirming the findings across species and cell maturity levels. Conclusions Mitochondrial and sarcolemma NCX fluxes are required for ventricular automaticity. Mitochondrial Ca2+ uptake plays a modulatory role. Mitochondrial Ca2+ uptake through MCU is influenced by IP3R-dependent SR Ca2+ release.	[Xie, An; Zhou, Anyu; Liu, Hong; Shi, Guangbin; Liu, Man; Dudley, Samuel C., Jr.] Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA; [Boheler, Kenneth R.] Univ Hong Kong, LKS Fac Med, Stem Cell & Regenerat Med Consortium, Hong Kong, Hong Kong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong	Dudley, SC (corresponding author), Univ Minnesota, Dept Med, Lillehei Heart Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	sdudley@umn.edu	Dudley, Samuel C/A-7085-2009; Liu, Man/GXH-3184-2022; Dudley, Samuel/AAR-7950-2021	Liu, Man/0000-0002-1390-7862; Dudley, Samuel/0000-0001-5843-5961; Zhou, Anyu/0000-0003-3041-5701	NIH [R01 HL104025, HL106592]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104025, R01HL106592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH grants R01 HL104025 and HL106592 to SCD.; Supported by the NIH grants R01 HL104025 and HL106592.	Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Bouchard S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011911; Brennan JP, 2006, CARDIOVASC RES, V72, P322, DOI 10.1016/j.cardiores.2006.08.006; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Bucchi A, 2002, J GEN PHYSIOL, V120, P1, DOI 10.1085/jgp.20028593; Campanella M, 2004, BIOL RES, V37, P653; Collins S, 2010, NATURE, V467, P283, DOI 10.1038/467283a; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Di Diego JM, 2011, HEART RHYTHM, V8, P1963, DOI 10.1016/j.hrthm.2011.06.036; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; Drago I, 2012, P NATL ACAD SCI USA, V109, P12986, DOI 10.1073/pnas.1210718109; Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x; Joiner MLA, 2012, NATURE, V491, P269, DOI 10.1038/nature11444; Kapur N, 2007, J PHYSIOL-LONDON, V581, P1113, DOI 10.1113/jphysiol.2006.125955; Kohlhaas M, 2010, CIRCULATION, V121, P1606, DOI 10.1161/CIRCULATIONAHA.109.914911; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Kwong JQ, 2015, CELL REP, V12, P15, DOI 10.1016/j.celrep.2015.06.002; Li L, 1998, AM J PHYSIOL-HEART C, V274, pH1335, DOI 10.1152/ajpheart.1998.274.4.H1335; Liao SY, 2010, HEART RHYTHM, V7, P1852, DOI 10.1016/j.hrthm.2010.09.006; Lieu DK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P191, DOI 10.1161/CIRCEP.111.973420; Louch WE, 2010, BIOPHYS J, V99, P1377, DOI 10.1016/j.bpj.2010.06.055; Luo M, 2013, CIRC RES, V113, P690, DOI 10.1161/CIRCRESAHA.113.301651; Ma JY, 2011, AM J PHYSIOL-HEART C, V301, pH2006, DOI 10.1152/ajpheart.00694.2011; Maack C, 2006, CIRC RES, V99, P172, DOI 10.1161/01.RES.0000232546.92777.05; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Saotome M, 2005, AM J PHYSIOL-HEART C, V288, pH1820, DOI 10.1152/ajpheart.00589.2004; SATOH H, 1993, EUR J PHARMACOL, V240, P283; Shigekawa M, 2001, CIRC RES, V88, P864, DOI 10.1161/hh0901.090298; Takeuchi A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02766; Wang JX, 1997, EUR J PHARMACOL, V320, P241, DOI 10.1016/S0014-2999(96)00901-6; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Yang KC, 2014, FREE RADICAL BIO MED, V71, P351, DOI 10.1016/j.freeradbiomed.2014.03.033; Yaniv Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00047; Yaniv Y, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00028; Yaniv Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037582; Zahanich I, 2011, J MOL CELL CARDIOL, V50, P66, DOI 10.1016/j.yjmcc.2010.09.018; Zhang YM, 2003, AM J PHYSIOL-HEART C, V285, pH2770, DOI 10.1152/ajpheart.01114.2002; Zhang YM, 2002, CIRCULATION, V106, P1294, DOI 10.1161/01.CIR.0000027585.05868.67; Zhao ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080574; Zima AV, 2013, AM J PHYSIOL-HEART C, V304, pH983, DOI 10.1152/ajpheart.00932.2012	44	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200448	10.1371/journal.pone.0200448	http://dx.doi.org/10.1371/journal.pone.0200448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001390	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400057
J	Pappas, MA; Vijan, S; Rothberg, MB; Singer, DE				Pappas, Matthew A.; Vijan, Sandeep; Rothberg, Michael B.; Singer, Daniel E.			Reducing age bias in decision analyses of anticoagulation for patients with nonvalvular atrial fibrillation - A microsimulation study	PLOS ONE			English	Article							NET CLINICAL BENEFIT; ISCHEMIC-STROKE; INTRACRANIAL HEMORRHAGE; WARFARIN; PREVENTION; GUIDELINES; OUTCOMES; RIVAROXABAN; MORTALITY; THERAPY	Background Anticoagulation decreases a patient's risk of ischemic stroke and increases the risk of hemorrhage. Decision analyses regarding anticoagulation therefore require that different outcomes be weighted in comparison to one another. Most decision analyses to date have weighted intracranial hemorrhage (ICH) as 1.5 times worse than ischemic stroke, but because death and disability have lifelong impact, the expected impact should vary by life expectancy. Therefore, a fixed weighting ratio leads to age-related bias decision analyses of anticoagulation. We aimed to quantify the relative impact of ICH and ischemic stroke and derive a ratio that allows decision analysis without microsimulation. Methods We created a microsimulation model to predict QALYs lost due to ICH and ischemic stroke. We then applied a meta-model to predict the ratio of QALYs lost from ICH relative to ischemic stroke. Results Previously-used weighting ratios (1.5) are close to our derived mean weighting ratio (1.60). However, the weighting ratio of QALYs lost from ICH relative to ischemic stroke is sensitive to age and discount rate. Patients at younger ages have higher mean weighting ratios, as do patients with higher discount rates. Conclusions The ratio of QALYs lost to ICH relative to ischemic stroke varies with age and discount rate. We present a set of such ratios here for use in decision analyses that do not incorporate full microsimulation models. Use of weighting ratios that vary with age, rather than the current fixed ratios, has the potential to reduce age-based bias in decision-making regarding events with lifelong implications. In this case, use of dynamic ratios may change anticoagulation recommendations for patients with nonvalvular atrial fibrillation at relatively low stroke risk.	[Pappas, Matthew A.; Rothberg, Michael B.] Cleveland Clin, Med Inst, Ctr Value Based Care Res, Cleveland, OH 44106 USA; [Vijan, Sandeep] Univ Michigan Hlth Syst, Dept Internal Med, Div Gen Internal Med, Ann Arbor, MI USA; [Singer, Daniel E.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Singer, Daniel E.] Harvard Med Sch, Boston, MA 02114 USA	Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pappas, MA (corresponding author), Cleveland Clin, Med Inst, Ctr Value Based Care Res, Cleveland, OH 44106 USA.	pappasm@ccf.org						Andrade AA, 2015, J GEN INTERN MED, V30, P777, DOI 10.1007/s11606-015-3201-1; [Anonymous], 2012, HEALTHC COST UT PROJ; Azoulay L, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-49; Banerjee A, 2014, THROMB HAEMOSTASIS, V111, P549, DOI 10.1160/TH13-12-1033; Banerjee A, 2012, THROMB HAEMOSTASIS, V107, P584, DOI 10.1160/TH11-11-0784; Blann Andrew D, 2016, JACC Clin Electrophysiol, V2, P47, DOI 10.1016/j.jacep.2015.09.015; Bohula EA, 2016, CIRCULATION, V134, P24, DOI 10.1161/CIRCULATIONAHA.116.022361; Busl KM, 2013, J NEUROSURG, V119, P1296, DOI 10.3171/2013.4.JNS122236; Camm AJ, 2012, EUR HEART J, V33; Chan P-H, 2016, CAN J CARDIOL; Chit A, 2015, LANCET INFECT DIS, V15, P1459, DOI 10.1016/S1473-3099(15)00249-2; Connolly SJ, 2011, ANN INTERN MED, V155, P579, DOI 10.7326/0003-4819-155-9-201111010-00004; Dachs RJ, 2008, PLOS MED, V5, P705, DOI 10.1371/journal.pmed.0050113; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Fang MC, 2015, JAMA INTERN MED, V175, P850, DOI 10.1001/jamainternmed.2015.20; Fang MC, 2014, NEUROLOGY, V82, P1033, DOI 10.1212/WNL.0000000000000248; Friberg L, 2012, EUR HEART J, V33, P1500, DOI 10.1093/eurheartj/ehr488; Friberg L, 2012, CIRCULATION, V125, P2298, DOI 10.1161/CIRCULATIONAHA.111.055079; Gangireddy SR, 2012, EUR HEART J, V33, P2700, DOI 10.1093/eurheartj/ehs292; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; January CT, 2014, J AM COLL CARDIOL, V64, pE1, DOI [10.1161/CIR.0000000000000041, 10.1016/j.jacc.2014.03.022, 10.1161/CIR.0000000000000142, 10.1016/j.jacc.2014.03.021]; Lip GYH, 2015, J AM COLL CARDIOL, V65, P1385, DOI 10.1016/j.jacc.2015.01.044; McPhail S, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-65; Murphy SL, 2015, NATL VITAL STAT REP; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Olesen JB, 2011, THROMB HAEMOSTASIS, V106, P739, DOI 10.1160/TH11-05-0364; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Shewale AR, 2015, J STROKE CEREBROVASC, V24, P2845, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.019; Singer DE, 2009, ANN INTERN MED, V151, P297, DOI 10.7326/0003-4819-151-5-200909010-00003; Smith EE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005207; Smith EE, 2010, CIRCULATION, V122, P1496, DOI 10.1161/CIRCULATIONAHA.109.932822; US Census Bureau Application Services Division W, US CENS BUR POP EST; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	35	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199593	10.1371/journal.pone.0199593	http://dx.doi.org/10.1371/journal.pone.0199593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995900	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800026
J	Xu, MZ; Wu, YC; Shroff, H; Wu, M; Mani, M				Xu, Muzhi; Wu, Yicong; Shroff, Hari; Wu, Min; Mani, Madhav			A scheme for 3-dimensional morphological reconstruction and force inference in the early C. elegans embryo	PLOS ONE			English	Article							CELL; TENSION; MECHANOTRANSDUCTION; MORPHOGENESIS	In this study, we present a scheme for the reconstruction of cellular morphology and the inference of mechanical forces in the early C. elegans embryo. We have developed and bench-marked a morphological reconstruction scheme that transforms flourescence-based in vivo images of membranes into a point cloud of smoothed surface patches, which facilitates an accurate estimation of membrane curvatures and the angles between membranes. Assuming an isotropic and homogeneous distribution of tensions along individual membranes, we infer a pattern of forces that are 7% deviated from force balance at edges, and 10% deviated from the Young-Laplace relation across membranes. We demonstrate the stability of our inference scheme via a sensitivity analysis, and the reproducibility of our image-analysis and force inference pipelines.	[Xu, Muzhi; Wu, Min; Mani, Madhav] Northwestern Univ, Engn Sci & Appl Math, Evanston, IL 60208 USA; [Wu, Yicong; Shroff, Hari] NIBIB, Sect High Resolut Opt Imaging, NIH, Bethesda, MD 20892 USA; [Wu, Min] Worcester Polytech Inst, Math Sci, Worcester, MA 01609 USA; [Mani, Madhav] Northwestern Univ, Mol Biosci, Evanston, IL 60208 USA	Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Worcester Polytechnic Institute; Northwestern University	Wu, M; Mani, M (corresponding author), Northwestern Univ, Engn Sci & Appl Math, Evanston, IL 60208 USA.; Wu, M (corresponding author), Worcester Polytech Inst, Math Sci, Worcester, MA 01609 USA.; Mani, M (corresponding author), Northwestern Univ, Mol Biosci, Evanston, IL 60208 USA.	englier@gmail.com; madhav.mani@gmail.com	Mani, Madhav/I-2269-2015	Wu, Min/0000-0003-4728-6475; Wu, Yicong/0000-0002-8819-7527	Engineering Science and Applied Mathematics at Northwestern University; Simons foundation Mathematical Modeling of Living Systems; National Institute of Biomedical Imaging and Bioengineering; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000074] Funding Source: NIH RePORTER	Engineering Science and Applied Mathematics at Northwestern University; Simons foundation Mathematical Modeling of Living Systems; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by Engineering Science and Applied Mathematics at Northwestern University; Simons foundation Mathematical Modeling of Living Systems (https://www.simonsfoundation.org/mathematics-physical-sciences/simons-investigators/simons-investigators-awardees/); and Intramural Research Programs of the National Institute of Biomedical Imaging and Bioengineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brodland GW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099116; Castillo E, 2013, INNOVATIONS SHAPE AN, P283, DOI DOI 10.1007/978-3-642-34141-0_13; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Farge E, 2011, CURR TOP DEV BIOL, V95, P243, DOI 10.1016/B978-0-12-385065-2.00008-6; Fujita M, 2012, PLOS ONE, V7, P463, DOI 10.1371/journal.pone.0030224; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hoppe Hugues, 1992, SURFACE RECONSTRUCTI, V26; Ishihara S, 2013, ARXIV13014298; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Kale GR, 2018, BIORXIV, DOI [10.1101/255158, DOI 10.1101/255158]; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Liang J., 2012, SOLVING PARTIAL DIFF; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Noll N, 2017, NAT PHYS, V13, P1221, DOI [10.1038/nphys4219, 10.1038/NPHYS4219]; Streichan S. J., 2017, ARXIV170107100; Veldhuis JH, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0261; Veldhuis JH, 2015, METHOD CELL BIOL, V125, P331, DOI 10.1016/bs.mcb.2014.10.010; Wang D, 2013, J COMPUT PHYS, V233, P449, DOI 10.1016/j.jcp.2012.09.001; WormBook, C ELEGANS RES COMMUN; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Wu Y., 2011, PNAS, V109, P17708; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713	25	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199151	10.1371/journal.pone.0199151	http://dx.doi.org/10.1371/journal.pone.0199151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990323	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300005
J	Yang, BR; Choi, NK; Kim, MS; Chun, J; Joo, SH; Kim, H; Lee, J				Yang, Bo Ram; Choi, Nam-Kyong; Kim, Mi-Sook; Chun, Jaeyoung; Joo, Sang Hyun; Kim, Hyesung; Lee, Joongyub			Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; POPULATION-BASED COHORT; CROHNS-DISEASE; ULCERATIVE-COLITIS; PYODERMA-GANGRENOSUM; NATURAL-HISTORY; ACUTE-PANCREATITIS; ERYTHEMA-NODOSUM; SWEETS-SYNDROME; RISK-FACTORS	Background The prevalence of inflammatory bowel disease (IBD) in South Korea is increasing. Although extraintestinal manifestations (EIMs) are an important factor in the clinical outcomes of IBD patients, EIMs have not yet been investigated in Korea. Thus, we conducted a cross-sectional study to assess the prevalence of EIMs in Korean IBD patients. Methods The 2014 claims data from the National Health Insurance System (NHIS) of Korea were used. IBD patients were identified by codes for Crohn disease (CD) and ulcerative colitis (UC) in the NHIS registration system for rare or intractable diseases. International Classification of Diseases, Tenth Edition codes were used to identify EIM cases. To estimate the prevalence of EIMs in the general population of Korea, we used national sample data. Standardized prevalence ratios (SPRs) were calculated to compare the prevalence rates of EIMs among IBD patients to those among the general population of Korea. Results A total of 13,925 CD patients and 29,356 UC patients were identified. CD and UC patients were different in terms of demographics and utilization of medication. Among the 17 EIMs investigated, pyoderma gangrenosum, osteomalacia, Sweet syndrome, and scleritis were observed in very few patients. The SPRs were greater than 1 for all EIMs. Aphthous stomatitis, rheumatoid arthritis, and osteoporosis were highly prevalent in both CD and UC patients, but the SPRs of the EIMs were not high. Conclusion The study confirmed that EIMs are more prevalent among IBD patients than among the general population of Korea. The prevalence of ElMs in IBD patients suggests the need for greater attention and effort in clinical practice.	[Yang, Bo Ram; Kim, Mi-Sook] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Choi, Nam-Kyong] Ewha Womans Univ, Dept Hlth Convergence, Seoul, South Korea; [Kim, Mi-Sook] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Chun, Jaeyoung] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Chun, Jaeyoung] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Joo, Sang Hyun] Seoul Natl Univ Hosp, Div Rheumatol, Dept Internal Med, Seoul, South Korea; [Kim, Hyesung] Janssen Korea, Med Affairs, Seoul, South Korea; [Lee, Joongyub] Inha Univ, Sch Med, Incheon, South Korea; [Lee, Joongyub] Inha Univ Hosp, Dept Prevent & Management, Incheon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Johnson & Johnson; Inha University; Inha University; Inha University Hospital	Lee, J (corresponding author), Inha Univ, Sch Med, Incheon, South Korea.; Lee, J (corresponding author), Inha Univ Hosp, Dept Prevent & Management, Incheon, South Korea.	tp240@naver.com	Chun, Jaeyoung/G-2921-2015	Chun, Jaeyoung/0000-0002-4212-0380; Yang, Bo Ram/0000-0002-8771-8829	Janssen Korea [RRA-16010]	Janssen Korea(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This study was funded by Janssen Korea (http://www.janssen.com/korea/company), RRA-16010 (JL). The funder provided support in the form of salaries for HK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ICD 10 VERS 2016; Ardizzone S, 2000, J INTERN MED, V247, P63, DOI 10.1046/j.1365-2796.2000.00582.x; Bandyopadhyay D, 2015, INDIAN J GASTROENTER, V34, P387, DOI 10.1007/s12664-015-0598-8; Bennett ML, 2000, MEDICINE, V79, P37, DOI 10.1097/00005792-200001000-00004; BENTON EC, 1985, ACTA DERM-VENEREOL, V65, P77; Bermejo F, 2008, ALIMENT PHARM THER, V28, P623, DOI 10.1111/j.1365-2036.2008.03746.x; Bernstein CN, 2001, AM J GASTROENTEROL, V96, P1116; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; CHAN CK, 1988, J CLIN EPIDEMIOL, V41, P1125, DOI 10.1016/0895-4356(88)90082-0; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Danese S, 2005, WORLD J GASTROENTERO, V11, P7227, DOI 10.3748/wjg.v11.i46.7227; DAVIS P, 1978, ARTHRITIS RHEUM, V21, P234, DOI 10.1002/art.1780210210; Evans Paul E, 2007, MedGenMed, V9, P55; Farhi D, 2008, MEDICINE, V87, P281, DOI 10.1097/MD.0b013e318187cc9c; Freeman HJ, 2005, CAN J GASTROENTEROL, V19, P603, DOI 10.1155/2005/323914; Hsu YC, 2017, J CHIN MED ASSOC, V80, P56, DOI 10.1016/j.jcma.2016.08.009; Karmiris K, 2016, J CROHNS COLITIS, V10, P429, DOI 10.1093/ecco-jcc/jjv232; KEMMETT D, 1988, BMJ-BRIT MED J, V297, P1513, DOI 10.1136/bmj.297.6662.1513-a; Kim HJ, 2015, INFLAMM BOWEL DIS, V21, P623, DOI 10.1097/MIB.0000000000000313; Kim JA, 2017, J KOREAN MED SCI, V32, P718, DOI 10.3346/jkms.2017.32.5.718; Lapidus A, 1999, AM J GASTROENTEROL, V94, P1261, DOI 10.1111/j.1572-0241.1999.01076.x; Larsen S, 2010, ANN MED, V42, P97, DOI 10.3109/07853890903559724; Lebwohl M, 1998, INFLAMM BOWEL DIS, V4, P142, DOI 10.1002/ibd.3780040209; LEE YM, 1995, NEW ENGL J MED, V332, P924, DOI 10.1056/NEJM199504063321406; Levine Jonathan S, 2011, Gastroenterol Hepatol (N Y), V7, P235; Mendoza JL, 2005, MED CLIN-BARCELONA, V125, P297; MONSEN U, 1990, AM J GASTROENTEROL, V85, P711; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Nguyen GC, 2006, AM J GASTROENTEROL, V101, P1012, DOI 10.1111/j.1572-0241.2006.00504.x; Orchard TR, 1998, GUT, V42, P387, DOI 10.1136/gut.42.3.387; Ramadas AV, 2010, GUT, V59, P1200, DOI 10.1136/gut.2009.202101; Rasmussen HH, 1999, SCAND J GASTROENTERO, V34, P199; Ricart E, 2004, INFLAMM BOWEL DIS, V10, P207, DOI 10.1097/00054725-200405000-00005; Rothfuss KS, 2006, WORLD J GASTROENTERO, V12, P4819; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Siffledeen JS, 2004, INFLAMM BOWEL DIS, V10, P220, DOI 10.1097/00054725-200405000-00007; Singla MB, 2017, INFLAMM BOWEL DIS, V23, P1637, DOI 10.1097/MIB.0000000000001187; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Souissi Amel, 2007, Tunis Med, V85, P49; Su CYG, 2002, GASTROENTEROL CLIN N, V31, P307, DOI 10.1016/S0889-8553(01)00019-X; Tripepi G, 2010, NEPHRON CLIN PRACT, V116, pC322, DOI 10.1159/000319591; Turkcapar N, 2006, RHEUMATOL INT, V26, P663, DOI 10.1007/s00296-005-0044-9; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1982, DOI 10.1097/MIB.0000000000000392; Vavricka SR, 2015, INFLAMM BOWEL DIS, V21, P1794, DOI 10.1097/MIB.0000000000000429; Vavricka SR, 2013, INFLAMM BOWEL DIS, V19, P2768, DOI 10.1097/01.MIB.0000438356.84263.3b; Vavricka SR, 2011, AM J GASTROENTEROL, V106, P110, DOI 10.1038/ajg.2010.343; Veloso FT, 2004, ALIMENT PHARM THER, V20, P50, DOI 10.1111/j.1365-2036.2004.02055.x; Veloso FT, 1996, J CLIN GASTROENTEROL, V23, P29, DOI 10.1097/00004836-199607000-00009; Von Tirpitz Ch., 1999, Zeitschrift fuer Gastroenterologie, V37, P5; WIESNER RH, 1980, GASTROENTEROLOGY, V79, P200; Winther KV, 2003, GASTROENTEROLOGY, V125, P1576, DOI 10.1053/j.gastro.2003.09.036; Ye BD, 2011, INFLAMM BOWEL DIS, V17, P1901, DOI 10.1002/ibd.21569; Yuksel I, 2009, INFLAMM BOWEL DIS, V15, P546, DOI 10.1002/ibd.20807	54	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200363	10.1371/journal.pone.0200363	http://dx.doi.org/10.1371/journal.pone.0200363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990326	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300041
J	Zhao, Y; Li, X; Wang, F; Zhao, XC; Gao, YQ; Zhao, CJ; He, L; Li, ZT; Xu, JY				Zhao, Ying; Li, Xin; Wang, Feng; Zhao, Xunchao; Gao, Yuqiao; Zhao, Changjiang; He, Lin; Li, Zuotong; Xu, Jingyu			Glycerol-3-phosphate dehydrogenase (GPDH) gene family in Zea mays L.: Identification, subcellular localization, and transcriptional responses to abiotic stresses	PLOS ONE			English	Article							BRASSICA-NAPUS L.; OVER-EXPRESSION; GLYCEROL METABOLISM; CHLAMYDOMONAS; CLONING; YEAST; SHUTTLE; PROTEIN; ENZYME; SEEDS	Glycerol-3-phosphate dehydrogenase (GPDH) catalyzes the formation of glycerol-3-phosphate, and plays an essential role in glycerolipid metabolism and in response to various stresses in different species. In this study, six ZmGPDH genes were obtained by a thorough search against maize genome, and designated as ZmGPDH1-6, respectively. The structural and evolutionary analyses showed that the ZmGPDHs family had typical conserved domains and similar protein structures as the known GPDHs from other plant species. ZmGPDHs were divided into NAD(+)-dependent type A form (ZmGPDH1-5) and FAD-dependent type B form (ZmGPDH6) based on their N-terminal sequences. Four full length ZmGPDHs were fused with GFP fusion proteins, and their subcellular localization was determined. ZmGPDH1 and ZmGPDH3 were located to the cytosol and mainly recruited to the surface of endoplasmic reticulum (ER), whereas ZmGPDH4 and ZmGPDH5 were located in the chloroplast. The transcriptional analysis of the ZmGPDHs in different maize tissues revealed relatively high level of transcripts accumulation of ZmGPDHs in roots and early stage developing seeds. Furthermore, we examined the transcriptional responses of the six GPDH genes in maize under various abiotic stresses, including salt, drought, alkali and cold, and significant induction of ZmGPDHs under osmotic stresses was observed. Together, this work will provide useful information for deciphering the roles of GPDHs in plant development and abiotic stress responses.	[Zhao, Ying; Wang, Feng; Zhao, Xunchao; Gao, Yuqiao; Zhao, Changjiang; He, Lin; Li, Zuotong; Xu, Jingyu] Heilongjiang Bayi Agr Univ, Coll Agr, Daqing Key Lab Straw Reclamat Technol Res & Dev, Key Lab Modern Agr Cultivat & Crop Germplasm Impr, Daqing, Peoples R China; [Li, Xin] Heilongjiang Acad Agr Sci, Harbin, Heilongjiang, Peoples R China	Heilongjiang Bayi Agricultural University; Heilongjiang Academy of Agricultural Sciences	Li, ZT; Xu, JY (corresponding author), Heilongjiang Bayi Agr Univ, Coll Agr, Daqing Key Lab Straw Reclamat Technol Res & Dev, Key Lab Modern Agr Cultivat & Crop Germplasm Impr, Daqing, Peoples R China.	lxg6401999@163.com; xujingyu2003@hotmail.com			National Key Research and Development Program of China [2016YFD0101002]; Heilongjiang Bayi Agricultural University Scientific Start-up Found for the Returned Overseas Chinese Scholar [2031011047]; Heilongjiang Bayi Agricultural University Key Cultivateing Program [XA2014-01]; Heilongjiang Bayi Agricultural University Graduate Student Innovation Fund Projects [YJSCX 2017-Z01]	National Key Research and Development Program of China; Heilongjiang Bayi Agricultural University Scientific Start-up Found for the Returned Overseas Chinese Scholar; Heilongjiang Bayi Agricultural University Key Cultivateing Program; Heilongjiang Bayi Agricultural University Graduate Student Innovation Fund Projects	This work was supported by National Key Research and Development Program of China (2016YFD0101002); Heilongjiang Bayi Agricultural University Scientific Start-up Found for the Returned Overseas Chinese Scholar (2031011047); Heilongjiang Bayi Agricultural University Key Cultivateing Program (XA2014-01); Heilongjiang Bayi Agricultural University Graduate Student Innovation Fund Projects (YJSCX 2017-Z01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Cai M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062287; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037578; Cho JI, 2014, BIOTECHNOL LETT, V36, P1641, DOI 10.1007/s10529-014-1522-5; Driver T, 2017, PLANT PHYSIOL, V174, P2083, DOI 10.1104/pp.17.00491; Eastmond PJ, 2004, PLANT J, V37, P617, DOI 10.1111/j.1365-313X.2003.01989.x; GENG MT, 2017, INT J MOL SCI, V18; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Guadalupe-Medina V, 2014, MICROB BIOTECHNOL, V7, P44, DOI 10.1111/1751-7915.12080; Haslam RP, 2016, PLANT J, V87, P76, DOI 10.1111/tpj.13172; He QH, 2007, J PLANT PHYSIOL, V164, P214, DOI 10.1016/j.jplph.2006.04.004; He YX, 2009, PLANT MOL BIOL, V71, P193, DOI 10.1007/s11103-009-9517-7; Herrera-Valencia VA, 2012, CURR MICROBIOL, V64, P477, DOI 10.1007/s00284-012-0095-6; Klein M, 2017, ENVIRON MICROBIOL, V19, P878, DOI 10.1111/1462-2920.13617; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Casais-Molina ML, 2016, J APPL PHYCOL, V28, P219, DOI 10.1007/s10811-015-0588-3; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; Lobell DB, 2013, NAT CLIM CHANGE, V3, P497, DOI [10.1038/nclimate1832, 10.1038/NCLIMATE1832]; Morales-Sanchez D, 2017, PLANT J, V90, P1079, DOI 10.1111/tpj.13530; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; Oren A, 2017, ENVIRON MICROBIOL, V19, P851, DOI 10.1111/1462-2920.13493; Ou XJ, 2006, J MOL BIOL, V357, P858, DOI 10.1016/j.jmb.2005.12.074; Petrovic U, 2002, MOL MICROBIOL, V45, P665, DOI 10.1046/j.1365-2958.2002.03021.x; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Raymond JA, 2015, FISH PHYSIOL BIOCHEM, V41, P811, DOI 10.1007/s10695-015-0048-7; Sharma N, 2001, PLANT SCI, V160, P603, DOI 10.1016/S0168-9452(00)00421-0; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shen WY, 2006, PLANT CELL, V18, P422, DOI 10.1105/tpc.105.039750; Shen WY, 2003, FEBS LETT, V536, P92, DOI 10.1016/S0014-5793(03)00033-4; Singh V, 2016, J PLANT RES, V129, P285, DOI 10.1007/s10265-015-0781-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toepfer R, 1996, International Patent Application, Patent No. [PCT/EP 94/02936, 9402936]; Vigeolas H, 2004, PLANTA, V219, P827, DOI 10.1007/s00425-004-1273-y; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wei YD, 2001, PLANT PHYSIOL BIOCH, V39, P841, DOI 10.1016/S0981-9428(01)01308-0; Yang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081756; Yao Y, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-110; Yeh JI, 2008, P NATL ACAD SCI USA, V105, P3280, DOI 10.1073/pnas.0712331105; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604; Zhang ZB, 2014, MOL BIOL REP, V41, P6157, DOI 10.1007/s11033-014-3495-9	43	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200357	10.1371/journal.pone.0200357	http://dx.doi.org/10.1371/journal.pone.0200357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990328	gold, Green Submitted, Green Published			2022-12-26	WOS:000438170300040
J	Kunz, M; Loffler-Wirth, H; Dannemann, M; Willscher, E; Doose, G; Kelso, J; Kottek, T; Nickel, B; Hopp, L; Landsberg, J; Hoffmann, S; Tuting, T; Zigrino, P; Mauch, C; Utikal, J; Ziemer, M; Schulze, HJ; Holzel, M; Roesch, A; Kneitz, S; Meierjohann, S; Bosserhoff, A; Binder, H; Schartl, M				Kunz, Manfred; Loeffler-Wirth, Henry; Dannemann, Michael; Willscher, Edith; Doose, Gero; Kelso, Janet; Kottek, Tina; Nickel, Birgit; Hopp, Lydia; Landsberg, Jenny; Hoffmann, Steve; Tueting, Thomas; Zigrino, Paola; Mauch, Cornelia; Utikal, Jochen; Ziemer, Mirjana; Schulze, Hans-Joachim; Holzel, Michael; Roesch, Alexander; Kneitz, Susanne; Meierjohann, Svenja; Bosserhoff, Anja; Binder, Hans; Schartl, Manfred			RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas	ONCOGENE			English	Article							GENE-EXPRESSION SIGNATURE; METASTATIC MELANOMA; CUTANEOUS MELANOMA; PROGRESSION; VALIDATION; EVOLUTION; THICKNESS; THERAPY	Recent studies revealed trajectories of mutational events in early melanomagenesis, but the accompanying changes in gene expression are far less understood. Therefore, we performed a comprehensive RNA-seq analysis of laser-microdissected melanocytic nevi (n = 23) and primary melanoma samples (n = 57) and characterized the molecular mechanisms of early melanoma development. Using self-organizing maps, unsupervised clustering, and analysis of pseudotime (PT) dynamics to identify evolutionary trajectories, we describe here two transcriptomic types of melanocytic nevi (N1 and N2) and primary melanomas (M1 and M2). N1/M1 lesions are characterized by pigmentation-type and MITF gene signatures, and a high prevalence of NRAS mutations in M1 melanomas. N2/M2 lesions are characterized by inflammatory-type and AXL gene signatures with an equal distribution of wild-type and mutated BRAF and low prevalence of NRAS mutations in M2 melanomas. Interestingly, N1 nevi and M1 melanomas and N2 nevi and M2 melanomas, respectively, cluster together, but there is no clustering in a stage-dependent manner. Transcriptional signatures of M1 melanomas harbor signatures of BRAF/MEK inhibitor resistance and M2 melanomas harbor signatures of anti-PD-1 antibody treatment resistance. Pseudotime dynamics of nevus and melanoma samples are suggestive for a switch-like immune-escape mechanism in melanoma development with downregulation of immune genes paralleled by an increasing expression of a cell cycle signature in late-stage melanomas. Taken together, the transcriptome analysis identifies gene signatures and mechanisms underlying development of melanoma in early and late stages with relevance for diagnostics and therapy.	[Kunz, Manfred; Kottek, Tina; Ziemer, Mirjana] Univ Leipzig, Dept Dermatol Venereol & Allergol, Philipp Rosenthal Str 23-25, D-04103 Leipzig, Germany; [Loeffler-Wirth, Henry; Willscher, Edith; Doose, Gero; Hopp, Lydia; Hoffmann, Steve; Binder, Hans] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Hartelstra 16-18, D-04107 Leipzig, Germany; [Dannemann, Michael; Kelso, Janet; Nickel, Birgit] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Deutsch Pl 6, D-04103 Leipzig, Germany; [Doose, Gero; Hoffmann, Steve] Univ Leipzig, Bioinformat Grp, Fac Math & Comp Sci, Hartelstr 16-18, D-04107 Leipzig, Germany; [Landsberg, Jenny] Univ Bonn, Dept Dermatol & Allergy, Sigmund Freud Str 25, D-53127 Bonn, Germany; [Tueting, Thomas] Univ Magdeburg, Dept Dermatol, Leipziger Str 44, D-39120 Magdeburg, Germany; [Zigrino, Paola; Mauch, Cornelia] Univ Cologne, Dept Dermatol Venereol & Allergol, D-50937 Cologne, Germany; [Utikal, Jochen] German Canc Res Ctr, Skin Canc Unit, Heidelberg, Germany; [Utikal, Jochen] Ruprecht Karl Univ Heidelberg, Dept Dermatol Venereol & Allergol, Univ Med Ctr Mannheim, D-68167 Mannheim, Germany; [Schulze, Hans-Joachim] Fachklin Hornheide, Dept Dermatol, Dorbaumstr 300, D-48157 Munster, Germany; [Holzel, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53127 Bonn, Germany; [Roesch, Alexander] Univ Duisburg Essen, West German Canc Ctr, Dept Dermatol, Univ Hosp Essen, D-45122 Essen, Germany; [Roesch, Alexander] Univ Duisburg Essen, German Canc Consortium DKTK, D-45122 Essen, Germany; [Kneitz, Susanne; Meierjohann, Svenja; Schartl, Manfred] Univ Wurzburg, Dept Physiol Chem, Biozentrum, D-97074 Wurzburg, Germany; [Kneitz, Susanne; Meierjohann, Svenja; Schartl, Manfred] Univ Clin Wurzburg, Comprehens Canc Ctr Mainfranken, D-97080 Wurzburg, Germany; [Bosserhoff, Anja] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Zentrum, Fahrstr 17, D-91054 Erlangen, Germany; [Schartl, Manfred] Texas A&M Univ, Hagler Inst Adv Study, College Stn, TX 77843 USA; [Schartl, Manfred] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Leipzig University; Leipzig University; Max Planck Society; Leipzig University; University of Bonn; Otto von Guericke University; University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Bonn; University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; University of Wurzburg; University of Wurzburg; University of Erlangen Nuremberg; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kunz, M (corresponding author), Univ Leipzig, Dept Dermatol Venereol & Allergol, Philipp Rosenthal Str 23-25, D-04103 Leipzig, Germany.	Manfred.kunz@medizin.uni-leipzig.de	Tüting, Thomas/AAJ-3610-2021; Landsberg, Jennifer/AAF-5113-2019; Landsberg, Jenny/AGI-0216-2022; Bosserhoff, Anja/GNH-4801-2022; Hoffmann, Steve/E-1438-2013; Binder, Hans/U-5519-2018	Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Utikal, Jochen/0000-0001-5316-0241; Binder, Hans/0000-0002-2242-4678; Loeffler-Wirth, Henry/0000-0001-8239-440X; Zigrino, Paola/0000-0002-7470-0064	Deutsche Krebshilfe, Melanomverbund [109716]	Deutsche Krebshilfe, Melanomverbund	MK, MD, AB, SM, and MS were supported by funding of the Deutsche Krebshilfe, Melanomverbund, grant number 109716.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Binder H, 2015, ENCY INFORM SCI TECH, V3rd, P1642, DOI [DOI 10.4018/978-1-4666-5888-2.CH157, 10.4018/978-1-4666-5888-2.ch157]; Binder H., 2013, SYST BIOMED, V1, P99, DOI [10.4161/sysb.25897, DOI 10.4161/SYSB.25897]; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Campbell KR, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005212; Chen PL, 2016, CANCER DISCOV, V6, P827, DOI 10.1158/2159-8290.CD-15-1545; Cirenajwis H, 2015, ONCOTARGET, V6, P12297, DOI 10.18632/oncotarget.3655; Clarke LE, 2017, CANCER-AM CANCER SOC, V123, P617, DOI 10.1002/cncr.30385; Clarke LE, 2015, J CUTAN PATHOL, V42, P244, DOI 10.1111/cup.12475; Gerber T, 2017, ONCOTARGET, V8, P846, DOI 10.18632/oncotarget.13666; Haqq C, 2005, P NATL ACAD SCI USA, V102, P6092, DOI 10.1073/pnas.0501564102; Harbst K, 2012, CLIN CANCER RES, V18, P4026, DOI 10.1158/1078-0432.CCR-12-0343; Haymaker C, 2012, ONCOIMMUNOLOGY, V1, P735, DOI 10.4161/onci.20823; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Hulstaert E, 2017, ONCOTARGET, V8, P43470, DOI 10.18632/oncotarget.16478; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Jonsson G, 2010, CLIN CANCER RES, V16, P3356, DOI 10.1158/1078-0432.CCR-09-2509; Kauffmann A, 2008, ONCOGENE, V27, P565, DOI 10.1038/sj.onc.1210700; Keenen B, 2010, ONCOGENE, V29, P81, DOI 10.1038/onc.2009.304; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Loffler-Wirth H, 2015, BIOINFORMATICS, V31, P3225, DOI 10.1093/bioinformatics/btv342; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maurus K, 2017, ONCOGENE, V36, P5110, DOI 10.1038/onc.2017.135; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Reid JE, 2016, BIOINFORMATICS, V32, P2973, DOI 10.1093/bioinformatics/btw372; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Saladi SV, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-280; Schadendorf D, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.3; Shain AH, 2015, NEW ENGL J MED, V373, P1926, DOI 10.1056/NEJMoa1502583; Shen H, 2008, CANCER RES, V68, P10154, DOI 10.1158/0008-5472.CAN-08-1794; Solus JF, 2013, ADV ANAT PATHOL, V20, P217, DOI 10.1097/PAP.0b013e3182976c94; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan RJ, 2015, CLIN CANCER RES, V21, P2424, DOI 10.1158/1078-0432.CCR-14-1650; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Toronen P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-307; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; Wirth H, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-18; Wirth H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-306; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057	51	50	50	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 22	2018	37	47					6136	6151		10.1038/s41388-018-0385-y	http://dx.doi.org/10.1038/s41388-018-0385-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HB2PG	29995873				2022-12-26	WOS:000450883000003
J	Kotelevets, L; Walker, F; Mamadou, G; Lehy, T; Jordan, P; Chastre, E				Kotelevets, Larissa; Walker, Francine; Mamadou, Godefroy; Lehy, Therese; Jordan, Peter; Chastre, Eric			The Rac1 splice form Rac1b favors mouse colonic mucosa regeneration and contributes to intestinal cancer progression	ONCOGENE			English	Article							TUMOR-RELATED RAC1B; COLORECTAL-CANCER; CELL-SURVIVAL; OVEREXPRESSION; ACTIVATION; EXPRESSION; COLITIS; CATENIN; VARIANT; DIFFERENTIATION	We previously have identified the ectopic expression of Rac1b, an activated and novel splice variant of Rac1, in a subset of human colorectal adenocarcinomas, as well as in inflammatory bowel diseases and in colitis mouse model. Rac1b overexpression has been further evidenced in breast, pancreatic, thyroid, ovarian, and lung cancers. In this context, the aim of our study was to investigate the physiopathological implications of Rac1b in intestinal inflammation and carcinogenesis in vivo. The ectopic expression of Rac1b was induced in mouse intestinal epithelial cells after crossing Rosa26-LSL-Rac1b and villin-Cre mice. These animals were let to age or were challenged with dextran sulfate sodium (DSS) to induce experimental colitis, or either received azoxymethane (AOM)/DSS treatment, or were bred with Apc(Min/+) or II10(-/-) mice to trigger intestinal tumors. Rac1b ectopic expression increased the intestinal epithelial cell proliferation and migration, enhanced the production of reactive oxygen species, and promoted the Paneth cell lineage. Although Rac1b overexpression alone was not sufficient to drive intestinal neoplasia, it enhanced Apc-dependent intestinal tumorigenesis. In the context of II10 knockout, the Rac1b transgene strengthened colonic inflammation due to induced intestinal mucosa permeability and promoted cecum and proximal colon carcinogenesis. In contrast, Rac1b alleviated carcinogen/acute inflammation-associated colon carcinogenesis (AOM/DSS). This resulted at least partly from the early mucosal repair after resolution of inflammation. Our data highlight the critical role of Rac1b in driving wound-healing after resolution of intestinal inflammation, and in cooperating with Wnt pathway dysregulation and chronic inflammation to promote intestinal carcinogenesis.	[Kotelevets, Larissa; Chastre, Eric] INSERM, Ctr Rech St Antoine, UMR S 938, Paris, France; [Kotelevets, Larissa; Chastre, Eric] Univ Pierre & Marie Curie Paris 6, Hop St Antoine, Site Batiment Kourilsky, Paris, France; [Walker, Francine; Lehy, Therese] INSERM, U1149, Ctr Rech Inflammat, CNRS,ERL8252, Paris, France; [Walker, Francine] Hop Univ Paris Nord Val de Seine Bichat Claude Be, AP HP, Dept Pathol, Paris, France; [Mamadou, Godefroy] Univ Paris Diderot Paris7, TransCell Lab Lab, Fac Med Xavier Bichat, Paris, France; [Jordan, Peter] Natl Hlth Inst, Dept Human Genet, Lisbon, Portugal	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Kotelevets, L; Chastre, E (corresponding author), INSERM, Ctr Rech St Antoine, UMR S 938, Paris, France.; Kotelevets, L; Chastre, E (corresponding author), Univ Pierre & Marie Curie Paris 6, Hop St Antoine, Site Batiment Kourilsky, Paris, France.	larissa.kotelevets@inserm.fr; eric.chastre@inserm.fr	Jordan, Peter/G-9335-2012; CHASTRE, Eric/L-8446-2018	Jordan, Peter/0000-0002-1425-9211; CHASTRE, Eric/0000-0002-8993-1228	University Paris Diderot; INSERM	University Paris Diderot; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The authors acknowledge Dr. Sylvie Robine (Institut Curie, Paris, France) for her donation of the villin-Cre (B6-Tg (Vil-cre) 20Sy/Nci) mice. The authors greatly thank Valerie Gratio of the CRI cytometry facility. The authors are indebted to Dr. Samira Benadda (INSERM U1149) for her assistance in confocal microscopy, and Olivier Thibaudeau (INSERM U1152) for help in histologic experiments. This work was supported by French minister of higher education and research, INSERM, and University Paris Diderot.	Alonso-Espinaco V, 2014, EUR J CANCER, V50, P1973, DOI 10.1016/j.ejca.2014.04.019; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Cole AM, 2010, EMBO MOL MED, V2, P472, DOI 10.1002/emmm.201000101; Curtis KM, 2012, MOL CELL NEUROSCI, V49, P138, DOI 10.1016/j.mcn.2011.10.008; Espinha G, 2015, MOL CELL BIOCHEM, V404, P281, DOI 10.1007/s11010-015-2388-0; Esufali S, 2007, CANCER RES, V67, P2469, DOI 10.1158/0008-5472.CAN-06-2843; Farin HF, 2016, NATURE, V530, P340, DOI 10.1038/nature16937; Goncalves V, 2009, HUM MOL GENET, V18, P3696, DOI 10.1093/hmg/ddp317; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Guo YN, 2015, MOL CANCER THER, V14, P2215, DOI 10.1158/1535-7163.MCT-15-0419; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kang HT, 2017, AGING CELL, V16, P541, DOI 10.1111/acel.12584; Kato M, 2016, EXP ANIM TOKYO, V65, P197, DOI 10.1538/expanim.15-0127; Kazanietz MG, 2017, CANCER RES, V77, P5445, DOI 10.1158/0008-5472.CAN-17-1456; Kotelevets L, 2017, CANCER RES, V77, P2964, DOI 10.1158/0008-5472.CAN-16-1741; Kotelevets L, 2016, INT J PHARMACEUT, V514, P24, DOI 10.1016/j.ijpharm.2016.06.005; Lee K, 2012, MOL BIOL CELL, V23, P4097, DOI 10.1091/mbc.E12-02-0166; Lessel W, 2017, CARCINOGENESIS, V38, P559, DOI 10.1093/carcin/bgx032; Li G, 2016, ONCOTARGET, V7, P17970, DOI 10.18632/oncotarget.7602; Mahler JF, 1996, TOXICOL PATHOL, V24, P710, DOI 10.1177/019262339602400606; Matos P, 2006, J BIOL CHEM, V281, P13724, DOI 10.1074/jbc.M513243200; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2008, GASTROENTEROLOGY, V135, P899, DOI 10.1053/j.gastro.2008.05.052; Matos P, 2008, MOL CANCER RES, V6, P1178, DOI 10.1158/1541-7786.MCR-08-0008; Matos P, 2013, NEOPLASIA, V15, P102, DOI 10.1593/neo.121890; Mehner Christine, 2015, Genes Cancer, V6, P480; Mori Yoshifumi, 2013, Small GTPases, V4, P9, DOI 10.4161/sgtp.23311; Myant KB, 2013, CELL STEM CELL, V12, P761, DOI 10.1016/j.stem.2013.04.006; Orlichenko L, 2010, J BIOL CHEM, V285, P19153, DOI 10.1074/jbc.M109.099382; Pethe VV, 2011, INT J ONCOL, V39, P805, DOI 10.3892/ijo.2011.1066; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rodriguez-Colman MJ, 2017, NATURE, V543, P424, DOI 10.1038/nature21673; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schnelzer A, 2000, ONCOGENE, V19, P3013, DOI 10.1038/sj.onc.1203621; Silva AL, 2013, EUR J ENDOCRINOL, V168, P795, DOI 10.1530/EJE-12-0960; Singh A, 2004, ONCOGENE, V23, P9369, DOI 10.1038/sj.onc.1208182; SOBHANI I, 1993, GASTROENTEROLOGY, V105, P22; Stallings-Mann ML, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004062; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Ungefroren H, 2014, ONCOTARGET, V5, P277, DOI 10.18632/oncotarget.1696; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wang F, 2017, CELL RES, V27, P540, DOI 10.1038/cr.2017.7; Zhou C, 2013, ONCOGENE, V32, P903, DOI 10.1038/onc.2012.99	44	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6054	6068		10.1038/s41388-018-0389-7	http://dx.doi.org/10.1038/s41388-018-0389-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29985482	Green Submitted			2022-12-26	WOS:000450175900004
J	Bhowmick, DC; Jeremic, A				Bhowmick, Diti Chatterjee; Jeremic, Aleksandar			Functional proteasome complex is required for turnover of islet amyloid polypeptide in pancreatic -cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; insulin; secretion; proteasome; transcription; type 2 diabetes; FoxA2; hyperglycemia; Islet amyloid polypeptide	ENDOPLASMIC-RETICULUM STRESS; INSULIN GENE-EXPRESSION; MESSENGER-RNA STABILITY; CHROMOSOMAL LOCALIZATION; DIABETES-MELLITUS; BETA-CELLS; AMYLIN; PROTEIN; TRANSCRIPTION; SECRETION	Human islet amyloid polypeptide (hIAPP) is the principal constituent of amyloid deposits and toxic oligomers in the pancreatic islets. Together with hyperglycemia, hIAPP-derived oligomers and aggregates are important culprits in type 2 diabetes mellitus (T2DM). Here, we explored the role of the cell's main proteolytic complex, the proteasome, in hIAPP turnover in normal and stressed -cells evoked by chronic hyperglycemia. Moderate inhibition (10-35%) of proteasome activity/function in cultured human islets by the proteasome inhibitor lactacystin enhanced intracellular accumulation of hIAPP. Unexpectedly, prolonged (>1 h) and marked (>50%) impairment of proteasome activity/function had a strong inhibitory effect on hIAPP transcription and secretion from normal and stressed -cells. This negative compensatory feedback mechanism for controlling IAPP turnover was also observed in the lactacystin-treated rat insulinoma -cell line (INS 832/13), demonstrating the presence of an evolutionarily conserved mechanism for IAPP production. In line with these in situ studies, our current ex vivo data showed that proteasome activity and hIAPP expression are also down-regulated in islets isolated from T2DM subjects. Gene expression and promoter activity studies demonstrated that the functional proteasome complex is required for efficient activation of the hIAPP promoter and for full expression of IAPP's essential transcription factor, FOXA2. ChIP studies revealed that promoter occupancy of FoxA2 at the rat IAPP promoter region is an important and limiting factor for amylin expression in proteasome-impaired murine cells. This study suggests a novel regulatory pathway in -cells involving proteasome, FOXA2, and IAPP, which can be possibly targeted to regulate hIAPP levels and islet amyloidosis in T2DM.	[Bhowmick, Diti Chatterjee; Jeremic, Aleksandar] George Washington Univ, Dept Biol Sci, 800 22nd St NW, Washington, DC 20052 USA; [Bhowmick, Diti Chatterjee; Jeremic, Aleksandar] George Washington Univ, Dept Biomed Sci, Washington, DC 20052 USA	George Washington University; George Washington University	Jeremic, A (corresponding author), George Washington Univ, Dept Biol Sci, 800 22nd St NW, Washington, DC 20052 USA.	jerema@gwu.edu			NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091845] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Christopher Day and Meghana Keswani for preparation of hIAPP promoter plasmid. We thank our colleagues Rob Donaldson and Anne Chiaramello for critical reading of the manuscript and stimulating discussions on the subject. We thank NIDDK-supported Integrated Islet Distribution Program at City of Hope for making human islets available for this study.	Alarcon C, 2012, ENDOCRINOLOGY, V153, P2082, DOI 10.1210/en.2011-2019; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Baranello RJ, 2015, CURR ALZHEIMER RES, V12, P32, DOI 10.2174/1567205012666141218140953; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Bhaumik SR, 2008, CRIT REV BIOCHEM MOL, V43, P419, DOI 10.1080/10409230802605914 ; Brender JR, 2015, J PHYS CHEM B, V119, P2886, DOI 10.1021/jp511758w; Broca C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092066; Brooks SA, 2010, WIRES RNA, V1, P240, DOI 10.1002/wrna.11; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; GERMAN MS, 1992, MOL CELL BIOL, V12, P1777, DOI 10.1128/MCB.12.4.1777; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hwang JJ, 2008, DIABETES CARE, V31, P945, DOI 10.2337/dc07-2433; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jaisson S, 2014, DIABETOLOGIA, V57, P1517, DOI 10.1007/s00125-014-3257-1; Jing G, 2014, J BIOL CHEM, V289, P11807, DOI 10.1074/jbc.M113.525022; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kitiphongspattana K, 2005, J BIOL CHEM, V280, P15727, DOI 10.1074/jbc.M410876200; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Kwak J, 2011, BBA-GENE REGUL MECH, V1809, P88, DOI 10.1016/j.bbagrm.2010.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz TA, 2006, PHYSIOL BEHAV, V89, P465, DOI 10.1016/j.physbeh.2006.04.001; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; Marques O, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.94; Martin C, 2006, DIABETES EDUCATOR, V32, p101S, DOI 10.1177/0145721706288237; Mather KJ, 2002, DIABETES-METAB RES, V18, P118, DOI 10.1002/dmrr.263; MOSSELMAN S, 1988, FEBS LETT, V239, P227, DOI 10.1016/0014-5793(88)80922-0; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; Mulder H, 1996, AM J PHYSIOL-ENDOC M, V271, pE1008, DOI 10.1152/ajpendo.1996.271.6.E1008; NAKAZATO M, 1990, REGUL PEPTIDES, V31, P179, DOI 10.1016/0167-0115(90)90004-G; NISHI M, 1989, MOL ENDOCRINOL, V3, P1775, DOI 10.1210/mend-3-11-1775; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Pillay K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/826706; Scherbaum WA, 1998, EXP CLIN ENDOCR DIAB, V106, P97, DOI 10.1055/s-0029-1211958; Schwarz K, 2000, J IMMUNOL, V164, P6147, DOI 10.4049/jimmunol.164.12.6147; Shepherd LMA, 2004, BBA-GENE STRUCT EXPR, V1681, P28, DOI 10.1016/j.bbaexp.2004.09.009; Singh S, 2016, BIOCHEM J, V473, P2655, DOI 10.1042/BCJ20160026; Tarcsa E, 2000, J BIOL CHEM, V275, P20295, DOI 10.1074/jbc.M001555200; Trikha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073080; WAGONER PK, 1993, P NATL ACAD SCI USA, V90, P9145, DOI 10.1073/pnas.90.19.9145; Wang M, 1996, MOL ENDOCRINOL, V10, P243, DOI 10.1210/me.10.3.243; WELSH M, 1985, J BIOL CHEM, V260, P3590; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287	51	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14210	14223		10.1074/jbc.RA118.002414	http://dx.doi.org/10.1074/jbc.RA118.002414			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30012886	Green Published, hybrid			2022-12-26	WOS:000444671500003
J	Ishikawa, Y; Rubin, K; Bachinger, HP; Kalamajski, S				Ishikawa, Yoshihiro; Rubin, Kristofer; Baechinger, Hans Peter; Kalamajski, Sebastian			The endoplasmic reticulum-resident collagen chaperone Hsp47 interacts with and promotes the secretion of decorin, fibromodulin, and lumican	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); collagen; small leucine-rich proteoglycan (SLRP); protein secretion; protein-protein interaction; chaperone; decorin; fibromodulin; heat shock protein (HSP); extracellular matrix; Hsp47; lumican; small leucine-rich protein	LEUCINE-RICH PROTEOGLYCANS; HEAT-SHOCK-PROTEIN; I COLLAGEN; NULL MICE; OSTEOGENESIS IMPERFECTA; TENDON FIBROBLASTS; CORNEAL OPACITY; SKIN FRAGILITY; DEFICIENT MICE; CROSS-LINKING	The build-up of diversified and tissue-specific assemblies of extracellular matrix (ECM) proteins depends on secreted and cell surface-located molecular arrays that coordinate ECM proteins into discrete designs. The family of small leucine-rich proteins (SLRPs) associates with and dictates the structure of fibrillar collagens, which form the backbone of most ECM types. However, whether SLRPs form complexes with proteins other than collagens is unclear. Here, we demonstrate that heat shock protein 47 (Hsp47), a well-established endoplasmic reticulum-resident collagen chaperone, also binds the SLRPs decorin, lumican, and fibromodulin with affinities comparable with that in the Hsp47-type I collagen interaction. Furthermore, we show that a lack of Hsp47 inhibits the cellular secretion of decorin and lumican. Our results expand the understanding of the concerted molecular interactions that control the secretion and organization of a functional collagenous ECM.	[Ishikawa, Yoshihiro; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ishikawa, Yoshihiro; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA; [Rubin, Kristofer; Kalamajski, Sebastian] Uppsala Univ, Dept Med Biochem & Microbiol, S-75237 Uppsala, Sweden	Oregon Health & Science University; Uppsala University	Kalamajski, S (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, S-75237 Uppsala, Sweden.	sebastian.kalamajski@imbim.uu.se	Rubin, Kristofer/AAC-1810-2020	Rubin, Kristofer/0000-0003-2789-6276; Ishikawa, Yoshihiro/0000-0003-2013-0518; Kalamajski, Sebastian/0000-0002-6600-9302	Science for Life Laboratory (Solna, Sweden)	Science for Life Laboratory (Solna, Sweden)	In situ PLA was performed by the PLA Proteomics Facility (Uppsala, Sweden), which is supported by Science for Life Laboratory (Solna, Sweden).	Canty-Laird EG, 2012, BIOCHEM J, V441, P707, DOI 10.1042/BJ20111379; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Christiansen HE, 2010, AM J HUM GENET, V86, P389, DOI 10.1016/j.ajhg.2010.01.034; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Drogemuller C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000579; Eyre DR, 2013, CALCIFIED TISSUE INT, V93, P338, DOI 10.1007/s00223-013-9723-9; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Gomez-Navarro N, 2016, J CELL BIOL, V215, P769, DOI 10.1083/jcb.201610031; Gorur A, 2017, J CELL BIOL, V216, P1745, DOI 10.1083/jcb.201702135; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Humphries SM, 2008, J BIOL CHEM, V283, P12129, DOI 10.1074/jbc.M708198200; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishikawa Y, 2017, J BIOL CHEM, V292, P17216, DOI 10.1074/jbc.M117.802298; Ishikawa Y, 2016, P NATL ACAD SCI USA, V113, pE6036, DOI 10.1073/pnas.1609571113; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Jonsson M, 2003, J BIOL CHEM, V278, P21415, DOI 10.1074/jbc.M210977200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2016, J BIOL CHEM, V291, P7951, DOI 10.1074/jbc.M115.693408; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Liu M, 2017, J CELL BIOL, V216, P1035, DOI 10.1083/jcb.201611088; Ma WF, 2016, P NATL ACAD SCI USA, V113, P10061, DOI 10.1073/pnas.1605916113; Macdonald JR, 2001, J BIOL CHEM, V276, P25399, DOI 10.1074/jbc.M102471200; Maeda M, 2017, J CELL BIOL, V216, P1731, DOI 10.1083/jcb.201703084; Malhotra V, 2015, ANNU REV CELL DEV BI, V31, P109, DOI 10.1146/annurev-cellbio-100913-013002; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Matsuoka Y, 2004, MOL BIOL CELL, V15, P4467, DOI 10.1091/mbc.E04-01-0050; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; NAKAI A, 1992, J CELL BIOL, V117, P903, DOI 10.1083/jcb.117.4.903; Olsson PO, 2016, MOL CANCER THER, V15, P2455, DOI 10.1158/1535-7163.MCT-16-0026; Pokidysheva E, 2013, J BIOL CHEM, V288, P24742, DOI 10.1074/jbc.M113.464156; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Schmidt K, 2013, BIOL OPEN, V2, P256, DOI 10.1242/bio.20133251; Sepulveda D, 2018, MOL CELL, V69, P238, DOI 10.1016/j.molcel.2017.12.028; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Tanabe T, 2016, MOL BIOL CELL, V27, P2008, DOI 10.1091/mbc.E16-03-0180; Venditti R, 2012, SCIENCE, V337, P1668, DOI 10.1126/science.1224947; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Vranka J, 2001, MATRIX BIOL, V20, P439, DOI 10.1016/S0945-053X(01)00148-2; Wilson DG, 2011, J CELL BIOL, V194, P347, DOI 10.1083/jcb.2010071621942c; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	46	15	16	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13707	13716		10.1074/jbc.RA117.000758	http://dx.doi.org/10.1074/jbc.RA117.000758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30002123	Green Published, hybrid			2022-12-26	WOS:000443375500029
J	Huo, H; Fryatt, AG; Farmer, LK; Schmid, R; Evans, RJ				Huo, Hong; Fryatt, Alistair G.; Farmer, Louise K.; Schmid, Ralf; Evans, Richard J.			Mapping the binding site of the P2X receptor antagonist PPADS reveals the importance of orthosteric site charge and the cysteine-rich head region	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						purinergic receptor; mutagenesis; ion channel; oocyte; molecular docking; antagonist; cysteine; orthosteric site; P2XR; PPADS	AGONIST BINDING; CONFORMATIONAL-CHANGES; EXTRACELLULAR LOOP; ATP BINDING; ACTIVATION; RESIDUES; MUTANTS; INSIGHT	ATP is the native agonist for cell-surface ligand-gated P2X receptor (P2XR) cation channels. The seven mammalian subunits (P2X1-7) form homo- and heterotrimeric P2XRs having significant physiological and pathophysiological roles. Pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid (PPADS) is an effective antagonist at most mammalian P2XRs. Lys-249 in the extracellular domain of P2XR has previously been shown to contribute to PPADS action. To map this antagonist site, we generated human P2X1R cysteine substitutions within a circle centered at Lys-249 (with a radius of 13 equal to the length of PPADS). We hypothesized that cysteine substitutions of residues involved in PPADS binding would (i) reduce cysteine accessibility (measured by MTSEA-biotinylation), (ii) exhibit altered PPADS affinity, and (iii) quench the fluorescence of cysteine residues modified with MTS-TAMRA. Of the 26 residues tested, these criteria were met by only four (Lys-70, Asp-170, Lys-190, and Lys-249), defining the antagonist site, validating molecular docking results, and thereby providing the first experimentally supported model of PPADS binding. This binding site overlapped with the ATP-binding site, indicating that PPADS sterically blocks agonist access. Moreover, PPADS induced a conformational change at the cysteine-rich head (CRH) region adjacent to the orthosteric ATP-binding pocket. The importance of this movement was confirmed by demonstrating that substitution introducing positive charge present in the CRH of the hP2X1R causes PPADS sensitivity at the normally insensitive rat P2X4R. This study provides a template for developing P2XR subtype selectivity based on the differences among the mammalian subunits around the orthosteric P2XR-binding site and the CRH.	[Huo, Hong; Fryatt, Alistair G.; Farmer, Louise K.; Schmid, Ralf; Evans, Richard J.] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England; [Schmid, Ralf] Univ Leicester, Leicester Inst Struct & Chem Biol, Leicester, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England.	rje6@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023; Farmer, Louise/0000-0002-9462-2606	British Heart Foundation [FS/09/059/27972, PG/11/64/28772]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Studentship FS/09/059/27972 (to L.F.) and project Grant PG/11/64/28772. The authors declare that they have no conflicts of interest with the contents of this article.	Allsopp RC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00732-5; Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Chessell IP, 1998, BRIT J PHARMACOL, V124, P1314, DOI 10.1038/sj.bjp.0701958; Davis IW, 2009, J MOL BIOL, V385, P381, DOI 10.1016/j.jmb.2008.11.010; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Farmer LK, 2015, J BIOL CHEM, V290, P1559, DOI 10.1074/jbc.M114.592246; Fryatt AG, 2016, SCI REP-UK, V6, DOI 10.1038/srep32918; Fryatt AG, 2014, MOL PHARMACOL, V86, P707, DOI 10.1124/mol.114.095307; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Karasawa A, 2016, ELIFE, V5, DOI 10.7554/eLife.22153; Kasuya G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00887-9; Kim YC, 1998, DRUG DEVELOP RES, V45, P52, DOI 10.1002/(SICI)1098-2299(199810)45:2<52::AID-DDR2>3.0.CO;2-V; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Lorinczi E, 2012, P NATL ACAD SCI USA, V109, P11396, DOI 10.1073/pnas.1118759109; Mansoor SE, 2016, NATURE, V538, P66, DOI 10.1038/nature19367; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Mulryan K, 2000, NATURE, V403, P86, DOI 10.1038/47495; Ralevic V, 1998, PHARMACOL REV, V50, P413; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]	28	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 17	2018	293	33					12820	12831		10.1074/jbc.RA118.003737	http://dx.doi.org/10.1074/jbc.RA118.003737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR0KC	29997254	hybrid, Green Published			2022-12-26	WOS:000442203500015
J	Shelley, SL; Williamson, TE; Brusatte, SL				Shelley, Sarah L.; Williamson, Thomas E.; Brusatte, Stephen L.			The osteology of Periptychus carinidens: A robust, ungulate-like placental mammal (Mammalia: Periptychidae) from the Paleocene of North America	PLOS ONE			English	Article							EUTHERIAN MAMMALS; EOCENE BOUNDARY; HORN FORMATION; CENTRAL UTAH; PHYLOGENY; CLASSIFICATION; TEMPERATURE; ADAPTATIONS; GRADIENTS; EVOLUTION	Periptychus is the archetypal genus of Periptychidae, a Glade of prolific Paleocene `condylarth' mammals from North America that were among the first placental mammals to radiate after the end-Cretaceous extinction, remarkable for their distinctive dental anatomy. A comprehensive understanding of the anatomy of Periptychus has been hindered by a lack of cranial and postcranial material and only cursory description of existing material. We comprehensively describe the cranial, dental and postcranial anatomy of Periptychus carinidens based on new fossil material from the early Paleocene (Torrejonian) of New Mexico, USA. The cranial anatomy of Periptychus is broadly concurrent with the inferred plesiomorphic eutherian condition, albeit more robust in overall construction. The rostrum is moderately elongate with no constriction, the facial region is broad, and the braincase is small with a well-exposed mastoid on the posterolateral corner and tall sagittal and nuchal crests. The dentition of Periptychus is characterized by strongly crenulated enamel, enlarged upper and lower premolars with a tall centralised paracone/protoconid. The postcranial skeleton of Periptychus is that of a robust, medium-sized (similar to 20 Kg) stout-limbed animal that was incipiently mediportal and adopted a plantigrade stance. The structure of the fore- and hindlimb of Periptychus corresponds to that of a typically terrestrial mammal, while morphological features of the forelimb such as the low tubercles of the humerus, long and prominent deltopectoral crest, pronounced medial epicondyle, and hemispherical capitulum indicate some scansorial and/or fossorial ability. Most striking is the strongly dorso-plantarly compressed astragalus of Periptychus, which in combination with the distal crus and calcaneal morphology indicates a moderately mobile cruropedal joint. The anatomy of Periptychus is unique and lacks any extant analogue; it combines a basic early placental body plan with numerous unique specializations in its dental, cranial and postcranial anatomy that exemplify the ability of mammals to adapt and evolve following catastrophic environmental upheaval.	[Shelley, Sarah L.; Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Williamson, Thomas E.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM USA; [Shelley, Sarah L.] Edward Oneil Res Ctr, Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA	University of Edinburgh	Shelley, SL (corresponding author), Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland.; Shelley, SL (corresponding author), Edward Oneil Res Ctr, Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	shelleyS@carnegiemnh.org	Williamson, Thomas/AAW-9320-2020	Shelley, Sarah/0000-0001-6628-0226	Natural Environment Research Council; National Science Foundation [EAR 0207750, EAR 1325544, DEB 1654952]; European Research Council Starting Grant (PalM); Marie Curie Career Integration Grant [CIG 630652]; NSF [DEB 1654949]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Science Foundation(National Science Foundation (NSF)); European Research Council Starting Grant (PalM); Marie Curie Career Integration Grant; NSF(National Science Foundation (NSF))	SLS was funded by a Natural Environment Research Council PhD studentship (www.nerc.ac.uk/) administered through the School of Geosciences, University of Edinburgh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TEW was supported by National Science Foundation EAR 0207750 (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Both TEW and SLB were supported by National Science Foundation EAR 1325544 and DEB 1654952 (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SLB is also supported by an European Research Council Starting Grant (PalM) (erc.europa.eu/funding/starting-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SLB and SLS were supported by a Marie Curie Career Integration Grant (CIG 630652) (ec.europa.eu/research/mariecurieactions/funded-projects/careerintegration-grants_en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SLS, TEW and SLB were also supported by NSF DEB 1654949 (www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald J.D., 1987, P24; Archibald J. D., 1998, EVOLUTION TERTIARY M, P292; Archibald JD, 2011, J MAMM EVOL, V18, P153, DOI 10.1007/s10914-011-9162-1; ARCHIBALD JD, 1993, PALEOBIOLOGY, V19, P1; Argot C, 2013, J MAMM EVOL, V20, P83, DOI 10.1007/s10914-012-9198-x; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; CIFELLI RL, 1982, J PALEONTOL, V56, P795; CIFELLI RL, 1995, GREAT BASIN NAT, V55, P304; Cope E. D., 1881, Proceedings of the American Philosophical Society, Vxix, P484; Cope E. D., 1884, American Naturalist, Vxviii, P892; Cope E. D., 1888, Transactions of the American Philosophical Society, Vxvi, P298; Cope E.D., 1880, P AM PHILOS SOC, V18, P452; Cope E.D., 1883, P ACAD NAT SCI PHILA, V35, P168; Cope E. D., 1881, AM NAT, V15, P1017; Cope E.D., 1882, AM PHILOS P, V20, P461; Cope ED, 1882, AM NAT, V16, P832; Cope ED, AM NAT, V84, P892; Cope ED., 1881, AM NAT, V15, P337, DOI 10.1086/272809; Cope ED, 1897, AM NAT, V31, P335; d'Europe, 1964, MEMOIRES MUSEE NAT C, V13, P1; de Muizon C, 2015, GEODIVERSITAS, V37, P397, DOI 10.5252/g2015n4a1; Evans H.E., 2013, MILLERS ANATOMY DOG; EVANS P, 1979, ANN ROY COLL SURG, V61, P271; Fricke HC, 2004, AM J SCI, V304, P612, DOI 10.2475/ajs.304.7.612; GAZIN C. LEWIS, 1938, JOUR WASHINGTON ACAD SCI, V28, P271; Gazin CL, 1941, P US NATL MUS; Gebo Daniel L., 1993, Journal of Vertebrate Paleontology, V13, P125; Geisler JH, 1998, ADV VERT PALEOBIOL, P163; Gill, 1872, ARRANGEMENT FAMILIES; Gould FDH, 2014, J VERTEBR PALEONTOL, V34, P1180, DOI 10.1080/02724634.2014.841707; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Gregory W. K., 1910, B AM MUS NAT HIST, V27, P1, DOI DOI 10.1007/S13364-013-0165-6; Halliday TJD, 2017, BIOL REV, V92, P521, DOI 10.1111/brv.12242; Head JJ, 2009, NATURE, V457, P715, DOI 10.1038/nature07671; Hobbs K, 2012, PALEOCENE CLIMATE CH, P2022; Hogan C.M., 2011, RESPIRATION ENCY EAR; Hunter JP, 1995, J VERT PALEONTOL SVP, p36A; Jaramillo C, 2010, SCIENCE, V330, P957, DOI 10.1126/science.1193833; Kondrashov PE, 2012, J PALEONTOL, V86, P25, DOI 10.1666/11-009.1; Kondrashov Peter E., 2004, Bulletin of the New Mexico Museum of Natural History and Science, V26, P11; Linnaeus C V, 1758, HOLMIAE SALVII, V1; Lofgren D, 2014, AM MUS NOVIT, P1; Lofgren Donald L., 2004, P43; LUCAS S. G., 1993, MAMMAL PHYLOGENY, V2, P182; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo Zhe-Xi, 2004, Bulletin of Carnegie Museum of Natural History, V36, P159, DOI 10.2992/0145-9058(2004)36[159:EODRIM]2.0.CO;2; MacIntyre GT., 1972, EVOLUTIONARY BIOL, P275, DOI [10.1007/978-1-4684-9063-3_9, DOI 10.1007/978-1-4684-9063-3_9]; MacPhee R.D.E., 1981, Contributions to Primatology, V18, P1; MACPHEE RDE, 1994, B AM MUS NAT HIST, P1; Markwick PJ, 1998, PALAEOGEOGR PALAEOCL, V137, P205, DOI 10.1016/S0031-0182(97)00108-9; MARKWICK PJ, 1994, GEOLOGY, V22, P613, DOI 10.1130/0091-7613(1994)022<0613:ECATCT>2.3.CO;2; Matthew W. D., 1897, Bulletin of the American Museum, Vxxii, P259; Matthew W. D., 1937, Transactions of the American Philosophical Society Philadelphia NS, V30, P1; Matthew W.D., 1909, MEMOIRS AM MUSEUM NA, V9, P289; MCDOWELL SAMUEL BOOKER, 1958, BULL AMER MUS NAT HIST, V115, P113; McKenna M. C., 1975, PHYLOGENY PRIMATES, P21, DOI DOI 10.1007/978-1-4684-2166-8_2; McKenna MC, 1997, CLASSIFICATION MAMMA; NOVACEK MJ, 1986, B AM MUS NAT HIST, V183, P1; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; O'Leary MA, 2010, B AM MUS NAT HIST, P4; Osborn HF, 1895, B AM MUS NAT HIST, V7, P1; Osborn HF., 1898, B AM MUS NAT HIST, V10, P169; Prothero D.R., 1988, Systematics Association Special Volume Series, P201; RADINSKY LB, 1966, EVOLUTION, V20, P408, DOI 10.1111/j.1558-5646.1966.tb03375.x; Rigby J.K. Jr, 1980, Evolutionary Monographs, V3, P1; Rigby J.K. Jr, 1981, P89; Robison SF, 1986, PALEOCENE PUERCAN TO; ROSE KD, 2006, BEGINNING AGE MAMMAL; Schaeffer Bobb, 1947, AMER MUS NOVITATES, V1356, P1; SCHIEBOUT JA, 1974, TEXAS MEMORIAL MUSEU, V24, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Secord R, 2015, J VERT PALEONTOL SVP; Simons EL., 1960, T AM PHILOS SOC, V50, P3, DOI [10.2307/1005810, DOI 10.2307/1005810]; SIMPSON GEORGE GAYLORD, 1936, AMER MUS NOVITATES, V849, P1; SIMPSON GEORGE GAYLORD, 1935, AMER MUS NOVITATES, V795-816-817, P1; SIMPSON GEORGE GAYLORD, 1959, AMER MUS NOVITATES 1950, P1; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Slatter D, 2003, TXB SMALL ANIMAL SUR; SLOAN RE, 1965, SCIENCE, V148, P220, DOI 10.1126/science.148.3667.220; Standhardt B. R., 1986, VERTEBRATE PALEONTOL; Szalay F.S., 1974, P223; SZALAY FS, 1980, FOLIA PRIMATOL, V34, P1, DOI 10.1159/000155946; SZALAY FS, 1968, EVOLUTION, V22, P19, DOI 10.1111/j.1558-5646.1968.tb03445.x; Szalay FS, 2006, EVOLUTIONARY HIST MA; Szalay FS., 1996, NEW MEX MUS NAT HIST, V7, P1; Tidwell W.D., 1981, ADV SAN JUAN BASIN P, P307; TOMIDA Y, 1980, AM J SCI, V280, P787, DOI 10.2475/ajs.280.8.787; Tomida Y, ADV SAN JUAN BASIN P; Turnbull W. D., 1970, FIELDIANA GEOLOGY, V18, P149; van Valen L., 1978, Evolutionary Theory, V4, P45; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; WIBLE J R, 1983, Acta Palaeontologica Polonica, V28, P281; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wible John R., 2000, Bulletin of the American Museum of Natural History, V247, P1, DOI 10.1206/0003-0090(2000)247<0001:CAOKDM>2.0.CO;2; Wible JR, 2008, ANN CARNEGIE MUS, V77, P321, DOI 10.2992/0097-4463-77.3.321; WIBLE JR, 1993, MAMMAL PHYLOGENY, P45; WIBLE JR, 1987, ZOOL J LINN SOC-LOND, V91, P107, DOI 10.1111/j.1096-3642.1987.tb01725.x; Wible JR., 1984, THESIS; Williamson T. E., 1992, B NEW MEXICO MUSEUM, V1, P1; Williamson TE, 1996, B NEW MEXICO MUSEUM, V8, P1; Williamson Thomas E., 1992, New Mexico Geological Society Field Conference Guidebook, V43, P265; Wilson Greg, 1999, Journal of Vertebrate Paleontology, V19, p85A; Wilson J.A., 1967, GEOLOGY BIG BEND NAT, P157; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913; Wood HE, 1941, BULL GEOL SOC AM, V52, P1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zack SP, 2005, ACTA PALAEONTOL POL, V50, P809; ZIEGLER AC, 1971, Q REV BIOL, V46, P226, DOI 10.1086/406897	108	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200132	10.1371/journal.pone.0200132	http://dx.doi.org/10.1371/journal.pone.0200132			139	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020948	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400040
J	Li, J; Zhang, S; Liu, XX; Han, D; Xu, JQ; Ma, YF				Li, Jiao; Zhang, Shuang; Liu, Xiaoxi; Han, Deping; Xu, Jianqin; Ma, Yunfei			Neuroprotective effects of leonurine against oxygen-glucose deprivation by targeting Cx36/CaMKII in PC12 cells	PLOS ONE			English	Article							GAP-JUNCTIONS; SHORT-TERM; BRAIN; DEATH; CONNEXIN36; GLUTAMATE; ISCHEMIA; PROTECTS; STROKE; INJURY	Leonurine has been reported to play an important role in ameliorating cognitive dysfunction, inhibiting ischemic stroke, and attenuating perihematomal edema and neuroinflammation in intracerebral hemorrhage. However, the exact mechanism and potential molecular targets of this effect remain unclear. Thus, in this study we investigated the neuroprotective effects of leonurine on hypoxia ischemia injury and explored the underlying mechanisms. An in vitro model of oxygen-glucose deprivation (OGD)-induced PC12 cells was established to mimic ischemic-like conditions. Cell viability, apoptosis, Cx36 and pCaMKII/CaMKII expression levels were evaluated after treatment with leonurine. The Cx36-selective antagonist mefloquine and CaMKII Inhibitor KN-93 were used to investigate the neuroprotective effect of leonurine on and the involvement of Cx36/CaMKII in this process. The results revealed that cell viability decreased and cell apoptosis and the protein expression of Cx36 and pCaMKII/CaMKII increased in the OGD-induced PC12 cells. Leonurine significantly increased cell viability and decreased cell apoptosis and the protein expression of Cx36 and pCaMKII/CaMKII in the OGD-induced PC12 cells. The specific inhibitor of Cx36 and CaMKII displayed similar protective effects. Moreover, the inhibition of Cx36 reduced pCaMKII levels and the ratio of pCaMKII/CaMKII in the OGD-induced PC12 cells, and vice versa. Taken together, these results suggest that leonurine might have a protective effect on OGD-induced PC12 cells through targeting the Cx36/CaMKII pathway. Thus, leonurine appears to have potential as a preventive or therapeutic drug against ischemic-induced neuronal injury.	[Li, Jiao; Zhang, Shuang; Liu, Xiaoxi; Han, Deping; Xu, Jianqin; Ma, Yunfei] China Agr Univ, Coll Vet Med, Beijing, Peoples R China; [Liu, Xiaoxi] Guangdong Ocean Univ, Dept Vet Med, Zhanjiang, Peoples R China	China Agricultural University; Guangdong Ocean University	Ma, YF (corresponding author), China Agr Univ, Coll Vet Med, Beijing, Peoples R China.	yunfeima@cau.edu.cn		MA, Yunfei/0000-0002-6176-3496	National Natural Science Foundation of China [31502025, 31772686]; Public Service Sectors Agriculture Research Projects of Ministry of Agriculture of China [201403051-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Sectors Agriculture Research Projects of Ministry of Agriculture of China	This work was supported by grants from the National Natural Science Foundation of China (No. 31502025, No. 31772686) to YM and the Public Service Sectors Agriculture Research Projects of Ministry of Agriculture of China (No. 201403051-07) to JX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Alluri H, 2015, JOVE-J VIS EXP, V2015; Belluardo N, 2000, BRAIN RES, V865, P121, DOI 10.1016/S0006-8993(00)02300-3; Belousov AB, 2013, TRENDS NEUROSCI, V36, P227, DOI 10.1016/j.tins.2012.11.001; Chen ZH, 2017, NEUROEPIDEMIOLOGY, V48, P95, DOI 10.1159/000477494; de Pina-Benabou MH, 2005, STROKE, V36, P2232, DOI 10.1161/01.STR.0000182239.75969.d8; Decrock E, 2009, CELL DEATH DIFFER, V16, P524, DOI 10.1038/cdd.2008.196; Frantseva MV, 2002, J NEUROSCI, V22, P644, DOI 10.1523/JNEUROSCI.22-03-00644.2002; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Jivad Nahid, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P789, DOI 10.1016/j.apjtb.2015.07.015; Lin SZ, 2016, PHARMAZIE, V71, P644, DOI 10.1691/ph.2016.6692; Liu CH, 2016, PHYTOMEDICINE, V23, P1638, DOI 10.1016/j.phymed.2016.10.005; Liu HC, 2012, BRAIN RES, V1474, P73, DOI 10.1016/j.brainres.2012.07.028; Liu XH, 2010, PHYTOMEDICINE, V17, P753, DOI 10.1016/j.phymed.2010.01.018; Liu XH, 2013, FREE RADICAL BIO MED, V54, P93, DOI 10.1016/j.freeradbiomed.2012.10.555; Liu XH, 2012, ATHEROSCLEROSIS, V222, P34, DOI 10.1016/j.atherosclerosis.2011.04.027; Loh KP, 2010, STROKE, V41, P2661, DOI 10.1161/STROKEAHA.110.589895; Mukherjee D, 2011, WORLD NEUROSURG, V76, pS85, DOI 10.1016/j.wneu.2011.07.023; Oguro K, 2001, J NEUROSCI, V21, P7534, DOI 10.1523/JNEUROSCI.21-19-07534.2001; Ohsumi A, 2006, ACTA NEUROCHIR SUPPL, V96, P148; Park WM, 2011, J NEUROSCI, V31, P5909, DOI 10.1523/JNEUROSCI.6787-10.2011; Qi J, 2010, BIOL PHARM BULL, V33, P1958, DOI 10.1248/bpb.33.1958; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rowley HA, 2005, NEUROIMAG CLIN N AM, V15, P575, DOI 10.1016/j.nic.2005.08.002; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; Sharma J, 2011, ASN NEURO, V3, DOI 10.1042/AN20100032; SILVER IA, 1992, J CEREBR BLOOD F MET, V12, P759, DOI 10.1038/jcbfm.1992.107; SIMS NR, 1995, INT J BIOCHEM CELL B, V27, P531, DOI 10.1016/1357-2725(95)00026-L; Vest RS, 2010, J BIOL CHEM, V285, P20675, DOI 10.1074/jbc.M109.088617; Wang YF, 2012, J NEUROSCI, V32, P713, DOI 10.1523/JNEUROSCI.3872-11.2012; Zemke D, 2004, NEUROTOXICOLOGY, V25, P895, DOI 10.1016/j.neuro.2004.03.009; Zhang QY, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7150376; Zlomuzica A, 2012, BEHAV BRAIN RES, V226, P293, DOI 10.1016/j.bbr.2011.08.028; Zundorf G, 2007, J NEUROCHEM, V102, P508, DOI 10.1111/j.1471-4159.2007.04509.x	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200705	10.1371/journal.pone.0200705	http://dx.doi.org/10.1371/journal.pone.0200705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016355	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600037
J	Weydert, C; van Heertum, B; Dirix, L; De Houwer, S; De Wit, F; Mast, J; Husson, SJ; Busschots, K; Konig, R; Gijsbers, R; De Rijck, J; Debyser, Z				Weydert, Caroline; van Heertum, Bart; Dirix, Lieve; De Houwer, Stephanie; De Wit, Flore; Mast, Jan; Husson, Steven J.; Busschots, Katrien; Koenig, Renate; Gijsbers, Rik; De Rijck, Jan; Debyser, Zeger			Y-box-binding protein 1 supports the early and late steps of HIV replication	PLOS ONE			English	Article							STAGE EMBRYONIC-DEVELOPMENT; LEUKEMIA-VIRUS INTEGRATION; NUCLEAR EXPRESSION; YB-1; TRANSCRIPTION; RNA; GENE; PROMOTER; CELLS; ENTRY	The human immunodeficiency virus (HIV) depends on cellular proteins, so-called cofactors, to complete its replication cycle. In search for new therapeutic targets we identified the DNA and RNA binding protein Y-box-binding Protein 1 (YB-1) as a cofactor supporting early and late steps of HIV replication. YB-1 depletion resulted in a 10-fold decrease in HIV-1 replication in different cell lines. Dissection of the replication defects revealed that knockdown of YB-1 is associated with a 2- to 5-fold decrease in virion production due to interference with the viral RNA metabolism. Using single-round virus infection experiments we demonstrated that early HIV-1 replication also depends on the cellular YB-1 levels. More precisely, using quantitative PCR and an in vivo nuclear import assay with fluorescently labeled viral particles, we showed that YB-1 knockdown leads to a block between reverse transcription and nuclear import of HIV-1. Interaction studies revealed that YB-1 associates with integrase, although a direct interaction with HIV integrase could not be unambiguously proven. In conclusion, our results indicate that YB-1 affects multiple stages of HIV replication. Future research on the interaction between YB-1 and the virus will reveal whether this protein qualifies as a new antiviral target.	[Weydert, Caroline; van Heertum, Bart; Dirix, Lieve; De Houwer, Stephanie; De Wit, Flore; Busschots, Katrien; Gijsbers, Rik; De Rijck, Jan; Debyser, Zeger] Katholieke Univ Leuven, Div Mol Virol & Gene Therapy, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Dirix, Lieve] Katholieke Univ Leuven, Lab Photochem & Spect, Dept Chem, Leuven, Belgium; [Mast, Jan] VAR CODA CERVA, Vet & Agrochem Res Ctr, Brussels, Belgium; [Husson, Steven J.] Katholieke Univ Leuven, Dept Biol, Funct Genom & Prote, B-3000 Leuven, Belgium; [Husson, Steven J.] Univ Antwerp, Dept Biol, Syst Physiol & Ecotoxicol Res SPHERE, B-2000 Antwerp, Belgium; [Koenig, Renate] Paul Ehrlich Inst, Host Pathogen Interact, D-63225 Langen, Germany; [Weydert, Caroline] Katholieke Univ Leuven, Lab Gynecol Pediat & Urol, Dept Dev & Regenerat, PKD Grp, Leuven, Belgium; [Busschots, Katrien] European Commiss, DG Joint Res Ctr, Directorate F Hlth Consumer & Reference Mat, Geel, Belgium	KU Leuven; KU Leuven; KU Leuven; University of Antwerp; Paul Ehrlich Institute; KU Leuven	Debyser, Z (corresponding author), Katholieke Univ Leuven, Div Mol Virol & Gene Therapy, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium.	Zager.debyser@kuleuven.be	König, Renate/AAB-8918-2019	König, Renate/0000-0003-4882-9179; Mast, Jan/0000-0002-4879-3367; Weydert, Caroline/0000-0001-6598-4395	Flemish Fund for Scientific Research (FWO; Fonds voor Wetenschappelijk Onderzoek); IWT fellowships; KU Leuven IDO; Belgian IAP Belvir; ERA-NET EURECA; OT program	Flemish Fund for Scientific Research (FWO; Fonds voor Wetenschappelijk Onderzoek)(FWO); IWT fellowships; KU Leuven IDO; Belgian IAP Belvir; ERA-NET EURECA; OT program	CW and LD were supported by the Flemish Fund for Scientific Research (FWO; Fonds voor Wetenschappelijk Onderzoek). FDW is an FWO-fellow. BvH and SDH were supported by IWT fellowships. Research was supported by the KU Leuven IDO and OT program, the Belgian IAP Belvir and the ERA-NET EURECA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002413; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Ambrose Z, 2014, VIROLOGY, V454, P371, DOI 10.1016/j.virol.2014.02.004; Ansari SA, 1999, J GEN VIROL, V80, P2629, DOI 10.1099/0022-1317-80-10-2629; Bann DV, 2014, J VIROL, V88, P4434, DOI 10.1128/JVI.02607-13; Barre-Sinoussi F, 2013, NAT REV MICROBIOL, V11, P877, DOI 10.1038/nrmicro3132; Bin Hamid F, 2016, CAN J MICROBIOL, V62, P1, DOI 10.1139/cjm-2015-0350; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chatel-Chaix L, 2011, J VIROL, V85, P11022, DOI 10.1128/JVI.00719-11; Chen HB, 2011, J CLIN INVEST, V121, P1549, DOI 10.1172/JCI44539; Cherepanov P, 2000, FASEB J, V14, P1389, DOI 10.1096/fj.14.10.1389; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Houwer S, 2014, J BIOL CHEM, V289, P25351, DOI 10.1074/jbc.M113.533281; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Demeulemeester J, 2012, J BIOMOL SCREEN, V17, P618, DOI 10.1177/1087057111436343; Desimmie BA, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-014-0134-4; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; DIDIER DK, 1988, P NATL ACAD SCI USA, V85, P7322, DOI 10.1073/pnas.85.19.7322; Dolfini D, 2013, ONCOGENE, V32, P4189, DOI 10.1038/onc.2012.521; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fenwick C, 2014, ANTIMICROB AGENTS CH, V58, P3233, DOI 10.1128/AAC.02719-13; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Holm PS, 2002, J BIOL CHEM, V277, P10427, DOI 10.1074/jbc.M106955200; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Kamura T, 1999, CANCER, V85, P2450, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2450::AID-CNCR21>3.0.CO;2-U; Kappes J, 2005, CELL BASED METHOD AN; KASHANCHI F, 1994, J VIROL, V68, P561, DOI 10.1128/JVI.68.1.561-565.1994; Kawaguchi A, 2012, J VIROL, V86, P11086, DOI 10.1128/JVI.00453-12; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; KERR D, 1994, J VIROL, V68, P7637, DOI 10.1128/JVI.68.11.7637-7643.1994; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kosnopfel C, 2014, EUR J CELL BIOL, V93, P61, DOI 10.1016/j.ejcb.2013.11.007; Krishnamoorthy G, 2003, NUCLEIC ACIDS RES, V31, P5425, DOI 10.1093/nar/gkg738; LEWIS PF, 1994, J VIROL, V68, P510, DOI 10.1128/JVI.68.1.510-516.1994; Li W, 2012, PROTEIN CELL, V3, P943, DOI 10.1007/s13238-012-2090-x; LI Y, 2015, COCHRANE DB SYST REV, DOI DOI 10.1002/PRCA.201400189; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Lyonnais S, 2013, VIRUS RES, V171, P287, DOI 10.1016/j.virusres.2012.09.008; Mast J, 2005, VET PATHOL, V42, P559, DOI 10.1354/vp.42-5-559; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; MINICH WB, 1992, BIOCHIMIE, V74, P477, DOI 10.1016/0300-9084(92)90088-V; Mu X, 2013, PROTEIN CELL, V4, P591, DOI 10.1007/s13238-013-3011-3; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Neville M, 1997, CURR BIOL, V7, P767, DOI 10.1016/S0960-9822(06)00335-6; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Osorio L, 2014, J BIOTECHNOL, V169, P71, DOI 10.1016/j.jbiotec.2013.11.004; OZER J, 1990, J BIOL CHEM, V265, P22143; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Pisarev AV, 2002, J BIOL CHEM, V277, P15445, DOI 10.1074/jbc.M111954200; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Sawaya BE, 1998, J GEN VIROL, V79, P239, DOI 10.1099/0022-1317-79-2-239; Schambach A, 2006, GENE THER, V13, P1524, DOI 10.1038/sj.gt.3302807; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Shibao K, 1999, INT J CANCER, V83, P732; Sun DQ, 2006, BIOTECHNIQUES, V41, P59, DOI 10.2144/000112203; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Tesina P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8968; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; U. S. Food and Drug Administration, 2015, DRUGS FDA 2015; Uchiumi T, 2006, J BIOL CHEM, V281, P40440, DOI 10.1074/jbc.M605948200; Weydert C, 2015, CURR TOP MED CHEM; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407	73	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200080	10.1371/journal.pone.0200080	http://dx.doi.org/10.1371/journal.pone.0200080			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995936	Green Published, gold			2022-12-26	WOS:000438388800041
J	Chrispijn, ND; Andralojc, KM; Castenmiller, C; Kamminga, LM				Chrispijn, Naomi D.; Andralojc, Karolina M.; Castenmiller, Charlotte; Kamminga, Leonie M.			Gene expression profile of a selection of Polycomb Group genes during zebrafish embryonic and germ line development	PLOS ONE			English	Article							GROUP PROTEINS; CELL IDENTITY; STEM-CELLS; EZH2; DROSOPHILA; FATE; SPECIFICATION; MAINTENANCE; METHYLATION; PERSPECTIVE	Polycomb Group (PcG) genes are transcriptional repressors that are described to be important during development and differentiation. There is significant interest in PcGs proteins because of their role in stem cell biology and tumorigenesis. In this study we characterize the expression of a selection of PcG genes in the adult germline of zebrafish and during embryogenesis. In adults, expression of selected PcG genes is found to be enriched in germ line over somatic tissues. Therefore, the germ line of adult zebrafish was analyzed for the expression pattern of a selection of PcG genes by whole mount in situ hybridization. We detected presence of the tested PcG gene transcripts at early stages of both oogenesis and spermatogenesis. This enriched expression for early stages of gametogenesis is also observed in developing gonads at 4 and 5 weeks post fertilization. Additionally, zebrafish embryos were used to study the spatio-temporal expression patterns of a selection of PcG genes during development. The PcG genes that we tested are maternally loaded and ubiquitously expressed at early developmental stages, except of ezhl. The expression of the PcG genes that were assessed becomes enriched anteriorly and is more defined during tissue specification. The data shown here is an important resource for functional PcG gene studies in vivo.	[Chrispijn, Naomi D.; Andralojc, Karolina M.; Castenmiller, Charlotte; Kamminga, Leonie M.] Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Dept Mol Biol, Nijmegen, Netherlands; [Kamminga, Leonie M.] Radboud Univ Nijmegen, Dept Mol Biol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Kamminga, LM (corresponding author), Radboud Univ Nijmegen, Fac Sci, Radboud Inst Mol Life Sci, Dept Mol Biol, Nijmegen, Netherlands.; Kamminga, LM (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Med Ctr, Nijmegen, Netherlands.	l.Kamminga@science.ru.nl	Kamminga, Leonie M/E-1771-2012; Kamminga, Leonie/O-5722-2019; Andralojc, Karolina KM/I-4307-2016	Kamminga, Leonie M/0000-0002-0508-7796; Castenmiler, Charlotte/0000-0001-7608-7390	Innovative Research Scheme of the Netherlands Organisation for Scientific Research [NWO-Veni 916.96.021, NWO-Vidi 864.12.009, NWO-Meervoud 836.13.003]; Radboud University Nijmegen Medical Centre tenure track fellowship; European Union's Horizon 2020 research and innovation programme under the Marie Skoodowska-Curie Grant [705939]	Innovative Research Scheme of the Netherlands Organisation for Scientific Research; Radboud University Nijmegen Medical Centre tenure track fellowship; European Union's Horizon 2020 research and innovation programme under the Marie Skoodowska-Curie Grant	The work was funded by the Innovative Research Scheme of the Netherlands Organisation for Scientific Research (www.nwo.nl, NWO-Veni 916.96.021, NWO-Vidi 864.12.009, NWO-Meervoud 836.13.003, L.M.K.), the Radboud University Nijmegen Medical Centre tenure track fellowship (www.radboudumc.nl, L.M.K.), and the European Union's Horizon 2020 research and innovation programme under the Marie Skoodowska-Curie Grant Agreement No. 705939 (K.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON AC, 1964, LIFE SCI, V3, P1407, DOI 10.1016/0024-3205(64)90082-7; Ata H, 2016, METHOD CELL BIOL, V135, P149, DOI 10.1016/bs.mcb.2016.04.023; Bender LB, 2004, CURR BIOL, V14, P1639, DOI 10.1016/j.cub.2004.08.062; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Chambers EL, 2010, HUM REPROD, V25, P2559, DOI 10.1093/humrep/deq192; Draper BW, 2017, METHODS MOL BIOL, V1463, P103, DOI 10.1007/978-1-4939-4017-2_8; Dupret B, 2017, BBA-GENE REGUL MECH, V1860, P1079, DOI 10.1016/j.bbagrm.2017.08.011; Dupret B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158700; Gupta Tripti, 2010, J Vis Exp, DOI 10.3791/1717; Holdeman R, 1998, DEVELOPMENT, V125, P2457; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Iovino N, 2013, DEV CELL, V26, P431, DOI 10.1016/j.devcel.2013.06.021; Juan AH, 2016, CELL REP, V17, P1369, DOI 10.1016/j.celrep.2016.09.087; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Koudijs MJ, 2005, PLOS GENET, V1, P223, DOI 10.1371/journal.pgen.0010019; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Le Faou P, 2011, GENE, V475, P10, DOI 10.1016/j.gene.2010.12.012; Leal MC, 2009, BIOL REPROD, V81, P177, DOI 10.1095/biolreprod.109.076299; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Posfai E, 2012, GENE DEV, V26, P920, DOI 10.1101/gad.188094.112; Prokopuk L, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0465-4; Prokopuk L, 2017, EPIGENET CHROMATIN, V10, P1, DOI 10.1186/s13072-017-0113-9; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; San B, 2016, SCI REP-UK, V6, DOI 10.1038/srep24658; SELMAN K, 1993, J MORPHOL, V218, P203, DOI 10.1002/jmor.1052180209; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sowpati DT, 2015, MECH DEVELOP, V138, P97, DOI 10.1016/j.mod.2015.07.013; Strome S, 2015, NAT REV MOL CELL BIO, V16, P406, DOI 10.1038/nrm4009; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; van der Velden YU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073997; van der Velden YU, 2012, DEVELOPMENT, V139, P2210, DOI 10.1242/dev.077156; Volkel P, 2012, EPIGENETICS-US, V7, P482, DOI 10.4161/epi.19741; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; White RJ, 2017, ELIFE, V6, DOI [10.7554/eLife.30860.001, 10.7554/eLife.30860]	42	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200316	10.1371/journal.pone.0200316	http://dx.doi.org/10.1371/journal.pone.0200316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985950	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500032
J	Bielicki, JA; Sharland, M; Versporten, A; Goossens, H; Cromwell, DA				Bielicki, Julia A.; Sharland, Mike; Versporten, Ann; Goossens, Herman; Cromwell, David A.			Using risk adjustment to improve the interpretation of global inpatient pediatric antibiotic prescribing	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CASE-MIX ADJUSTMENT; ANTIMICROBIAL STEWARDSHIP; EUROPEAN CHILDREN; UNITED-STATES; HOSPITALS; SURVEILLANCE; RESISTANCE; PREVALENCE; TRENDS	Objectives Assessment of regional pediatric last-resort antibiotic utilization patterns is hampered by potential confounding from population differences. We developed a risk-adjustment model from readily available, internationally used survey data and a simple patient classification to aid such comparisons. Design We investigated the association between pediatric conserve antibiotic (pCA) exposure and patient / treatment characteristics derived from global point prevalence surveys of antibiotic prescribing, and developed a risk-adjustment model using multivariable logistic regression. The performance of a simple patient classification of groups with different expected pCA exposure levels was compared to the risk model. Setting 226 centers in 41 countries across 5 continents. Participants Neonatal and pediatric inpatient antibiotic prescriptions for sepsis/bloodstream infection for 1281 patients. Results Overall pCA exposure was high (35%), strongly associated with each variable (patient age, ward, underlying disease, community acquisition or nosocomial infection and empiric or targeted treatment), and all were included in the final risk-adjustment model. The model demonstrated good discrimination (c-statistic = 0.83) and calibration (p = 0.38). The simple classification model demonstrated similar discrimination and calibration to the risk model. The crude regional pCA exposure rates ranged from 10.3% (Africa) to 67.4% (Latin America). Risk adjustment substantially reduced the regional variation, the adjusted rates ranging from 17.1% (Africa) to 42.8% (Latin America). Conclusions Greater comparability of pCA exposure rates can be achieved by using a few easily collected variables to produce risk-adjusted rates.	[Bielicki, Julia A.; Sharland, Mike] St Georges Univ London, Paediat Infect Dis Res Grp, Infect & Immun, London, England; [Bielicki, Julia A.; Cromwell, David A.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England; [Bielicki, Julia A.] Univ Basel, Paediat Pharmacol Grp, Childrens Hosp, Basel, Switzerland; [Versporten, Ann; Goossens, Herman] Univ Antwerp, Lab Med Microbiol, Vaccine & Infect Dis Inst VAXINFECTIO, Fac Med & Hlth Sci, Antwerp, Belgium	St Georges University London; University of London; London School of Hygiene & Tropical Medicine; University of Basel; University of Antwerp	Bielicki, JA (corresponding author), St Georges Univ London, Paediat Infect Dis Res Grp, Infect & Immun, London, England.; Bielicki, JA (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London, England.; Bielicki, JA (corresponding author), Univ Basel, Paediat Pharmacol Grp, Childrens Hosp, Basel, Switzerland.	jbielick@sgul.ac.uk	Cromwell, David/AAD-6519-2019	Versporten, Ann/0000-0002-3551-6643; sharland, mike/0000-0001-8626-8291	Directorate General for Health and Consumer Protection (DG SANCO) through the Executive Agency for Health and Consumers (ARPEC Project) [A 2009-11-01]	Directorate General for Health and Consumer Protection (DG SANCO) through the Executive Agency for Health and Consumers (ARPEC Project)	The ARPEC project was co-funded by the Directorate General for Health and Consumer Protection (DG SANCO) through the Executive Agency for Health and Consumers (grant number ARPEC Project A 2009-11-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadeo B, 2010, CLIN MICROBIOL INFEC, V16, P735, DOI 10.1111/j.1469-0691.2009.02920.x; Bielicki JA, 2015, J ANTIMICROBIAL CHEM; Bielicki J, 2015, PEDIATR INFECT DIS J, V34, P311, DOI 10.1097/INF.0000000000000621; Bragg F, 2010, BMJ, V341; Downie L, 2012, ARCH DIS CHILD; Feudtner C, 2012, ARCH PEDIAT ADOL MED, V166, P9, DOI 10.1001/archpediatrics.2011.161; Harris AD, 2008, INFECT CONT HOSP EP, V29, P693, DOI 10.1086/590471; Haug JB, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/s13756-014-0040-5; Hebert C, 2012, INFECT CONT HOSP EP, V33, P381, DOI 10.1086/664768; Hersh AL, 2015, PEDIATRICS, V135, P33, DOI 10.1542/peds.2014-2579; Hyun DY, 2013, JAMA PEDIATR, V167, P859, DOI 10.1001/jamapediatrics.2013.2241; Kanerva M, 2011, J ANTIMICROB CHEMOTH, V66, P2651, DOI 10.1093/jac/dkr333; Kritsotakis EI, 2006, CLIN MICROBIOL INFEC, V12, P701, DOI 10.1111/j.1469-0691.2006.01415.x; Laupland KB, 2009, PEDIATR INFECT DIS J, V28, P114, DOI 10.1097/INF.0b013e318187ad5a; Le Doare K, 2015, J PEDIAT INF DIS SOC, V4, P11, DOI 10.1093/jpids/piu014; Llata E, 2009, CLIN INFECT DIS, V48, P1434, DOI 10.1086/598328; MacDougall C, 2008, INFECT CONT HOSP EP, V29, P203, DOI 10.1086/528810; Muller-Pebody B, 2011, ARCH DIS CHILD-FETAL, V96, pF4, DOI 10.1136/adc.2009.178483; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Polk RE, 2011, CLIN INFECT DIS, V53, P1100, DOI 10.1093/cid/cir672; Raymond J, 2000, INFECT CONT HOSP EP, V21, P260, DOI 10.1086/501755; Robson MS, 2001, FETAL MATERN MED REV, V12, P23, DOI [DOI 10.1017/S0965539501000122, 10.1017/S0965539501000122]; Tokars JI, 2004, CLIN INFECT DIS, V39, P1347, DOI 10.1086/425000; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; Versporten A, 2016, J ANTIMICROB CHEMOTH, V71, P1106, DOI 10.1093/jac/dkv418; Versporten A, 2013, PEDIATR INFECT DIS J, V32, pE242, DOI 10.1097/INF.0b013e318286c612; WHO Collaborating Centre for Drug Statistics Methodology, 2015, ATC DDD IND 2015; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; World Health Organization, 2017, ESSE MED LIST; Zarb P, 2012, EURO SURVEILL, P17	30	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199878	10.1371/journal.pone.0199878	http://dx.doi.org/10.1371/journal.pone.0199878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979795	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000437809500038
J	Ramunke, S; Borges, FD; von Son-de Fernex, E; von Samson-Himmelstjerna, G; Krucken, J				Ramuenke, Sabrina; Borges, Fernando de Almeida; von Son-de Fernex, Elke; von Samson-Himmelstjerna, Georg; Kruecken, Jurgen			Molecular marker sequences of cattle Cooperia species identify Cooperia spatulata as a morphotype of Cooperia punctata	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; GASTROINTESTINAL NEMATODES; ANTHELMINTIC RESISTANCE; ONCHOCERCA-OCHENGI; GENETIC-EVIDENCE; RIBOSOMAL DNA; RUMINANTS; CALVES; IDENTIFICATION; INFECTIONS	The genus Cooperia includes important parasites of ruminants and currently contains 34 accepted species. However, even for those species infecting livestock, there is a considerable lack of molecular information and many species are only identifiable using subtle morphological traits. The present study aimed to provide molecular data to allow diagnosis of Cooperia species infecting cattle. Partial sequences of two mitochondrial (cytochrome oxidase 2, 12S rRNA gene) and two nuclear genes (isotype 1 beta tubulin gene including two introns, internal transcribed spacers (ITS) were obtained from morphologically identified specimens of Cooperia pectinata, Cooperia punctata and Cooperia spatulata as well as from larvae of pure Cooperia oncophora and C. punctata laboratory isolates. Pairwise identity of ITS-2 sequences was very high and it was the only region able to identify a specimen as Cooperia sp. However, the ITS-2 was unreliable for diagnosis at the species level. All other marker sequences could not unequivocally be allocated to the genus Cooperia but allowed clear species identification with the exception of the pair C. punctata/C. spatulata for which no significant differences were found for any marker sequence. Maximum-likelihood phylogenetic analyses of individual genes as well as a multi-locus analysis covering all four sequences confirmed that specimen identified as C. spatulata were randomly distributed throughout the C. punctata cluster and formed no group of their own. In contrast, the other Cooperia species formed clearly separated and statistically supported clusters. These data indicate that C. spatulata is most likely only a morphotype of C. punctata and the name should be considered a synonym. Combinations of nuclear and mitochondrial markers should be used to identify morphotypes or cryptic species to benefit from excellent barcoding properties of the latter but allowing proper phylogenetic analyses and controlling for lineage sorting that might occur for mitochondrial genotypes within a species.	[Ramuenke, Sabrina; von Samson-Himmelstjerna, Georg; Kruecken, Jurgen] Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany; [Borges, Fernando de Almeida] Univ Fed Mato Grosso Sul UFMS, Campo Grande, Brazil; [von Son-de Fernex, Elke] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Ctr Ensenanza Invest & Extens Ganaderia Trop, H Tlapacoyan, Veracruz, Mexico	Free University of Berlin; Universidade Federal de Mato Grosso do Sul; Universidad Nacional Autonoma de Mexico	Krucken, J (corresponding author), Free Univ Berlin, Inst Parasitol & Trop Vet Med, Berlin, Germany.	juergen.kruecken@fu-berlin.de	Krücken, Jürgen/AAE-3133-2021; Krücken, Jürgen/B-6794-2009; Borges, Fernando/T-6717-2019; Krücken, Jürgen/CAF-6903-2022	Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Krücken, Jürgen/0000-0002-2842-8100; Borges, Fernando/0000-0002-8888-6269				AlGusbi S, 2014, INT J PARASITOL, V44, P647, DOI 10.1016/j.ijpara.2014.04.007; ALLEN RW, 1958, J PARASITOL, V44, P503, DOI 10.2307/3274416; [Anonymous], 2010, GATEWAY COMPUTING EN; Arantes IG, 1938, REV CTR CIENCIAS RUR, V3, P265; Ault CN, 1931, DEUT TIERARZTL WCHR, V39, P469; Avramenko RW, 2017, INT J PARASITOL, V47, P893, DOI 10.1016/j.ijpara.2017.06.006; Avramenko RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143559; Baylis H. A., 1938, Veterinary Record London, V50, P283; Bennema SC, 2010, VET PARASITOL, V173, P247, DOI 10.1016/j.vetpar.2010.07.002; Beveridge I, 2014, HBK ZOOL, P557; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Chaudhry U, 2015, INT J PARASITOL, V45, P149, DOI 10.1016/j.ijpara.2014.09.002; Chilton Neil B., 2004, Animal Health Research Reviews, V5, P173, DOI 10.1079/AHR200497; Coles GC, 1998, VET REC, V142, P255; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070212; Demeler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061285; DROZDZ J, 1995, SYST PARASITOL, V32, P91, DOI 10.1007/BF00009507; Eisenbarth A, 2013, ACTA TROP, V127, P261, DOI 10.1016/j.actatropica.2013.05.011; Epe C, 1997, RES VET SCI, V62, P17, DOI 10.1016/S0034-5288(97)90173-9; GASSER RB, 1993, NUCLEIC ACIDS RES, V21, P2525, DOI 10.1093/nar/21.10.2525; GIBBONS LM, 1981, SYST PARASITOL, V2, P219, DOI 10.1007/BF00009344; Heise M, 1999, J PARASITOL, V85, P431, DOI 10.2307/3285774; Hildebrandt JC, 2014, VET PARASITOL, V205, P318, DOI 10.1016/j.vetpar.2014.06.006; HUMBERT JF, 1995, PARASITOL RES, V81, P1, DOI 10.1007/BF00932409; ISENSTEI.RS, 1971, J PARASITOL, V57, P316, DOI 10.2307/3278034; Jaleta TG, 2018, PARASITOL RES, V117, P1069, DOI 10.1007/s00436-018-5783-0; KARAMENDIN O. S., 1967, Helminthologia, V7, P81; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEJAMBRE LF, 1993, ACTA TROP, V53, P331, DOI 10.1016/0001-706X(93)90038-D; LEROUX P. L., 1936, JOUR HELMINTHOL, V14, P113, DOI 10.1017/S0022149X00030595; LICHTENFELS JR, 1977, P HELM SOC WASH, V44, P111; Lichtenfels JR, 1997, VET PARASITOL, V72, P225, DOI 10.1016/S0304-4017(97)00099-X; Lichtenfels JR, 1997, VET PARASITOL, V72; Linstow O.F.B.von, 1907, CENTRALBLATT BAKTERI, V1, P708; Louvandini H, 2009, VET PARASITOL, V163, P47, DOI 10.1016/j.vetpar.2009.04.021; Nagaraj SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S10; Newton LA, 1998, INT J PARASITOL, V28, P331, DOI 10.1016/S0020-7519(97)00149-5; Oliveira MCS, 2013, VET PARASITOL, V197, P168, DOI 10.1016/j.vetpar.2013.06.021; PALOSCHI CG, 1982, PESQUI AGROPECU BRAS, V17, P1515; PLOEGER HW, 1990, VET PARASITOL, V36, P71, DOI 10.1016/0304-4017(90)90095-S; Popescu AA, 2012, BIOINFORMATICS, V28, P1536, DOI 10.1093/bioinformatics/bts184; Rees T., 2017, INTERIM REGISTER MAR; Rees T, 2017, BIODIVERSITY INFORM, DOI [10.17161/bi.v12i0.6522, DOI 10.17161/BI.V12I0.6522]; Schnieder T, 1999, PARASITOL RES, V85, P895, DOI 10.1007/s004360050654; Schwartz B., 1928, Proceedings of the United States National Museum, V74, P1; Skrjabin KI, 1953, TRICHOSTRONGYLOIDEA; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STRINGFE.F, 1970, J PARASITOL, V56, P1189, DOI 10.2307/3277566; Stromberg BE, 2012, VET PARASITOL, V183, P284, DOI 10.1016/j.vetpar.2011.07.030; Sweeny JPA, 2012, VET PARASITOL, V187, P227, DOI 10.1016/j.vetpar.2012.01.007; Sweeny JPA, 2012, VET PARASITOL, V184, P298, DOI 10.1016/j.vetpar.2011.08.016; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; TRAVASSOS L, 1937, REVISAO FAMILIA TRIC; van Wyk JA, 2004, VET PARASITOL, V119, P277, DOI 10.1016/j.vetpar.2003.11.012; von Son-de Fernex E, 2017, EXP PARASITOL, V178, P1, DOI 10.1016/j.exppara.2017.04.013; WALKER ML, 1968, P HELM SOC WASH, V35, P49; Walker ML, 1968, HELMINTHOLOGICAL SOC, V35, P3; Xia X., 2009, ASSESSING SUBSTITUTI; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Zarlenga D.S., 1990, Revue Scientifique et Technique Office International des Epizooties, V9, P533; Zhu XQ, 1998, ELECTROPHORESIS, V19, P1366, DOI 10.1002/elps.1150190828	62	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200390	10.1371/journal.pone.0200390	http://dx.doi.org/10.1371/journal.pone.0200390			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979783	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500105
J	Jeon, HY; Lee, YJ; Kim, YS; Kim, SY; Han, ET; Park, WS; Hong, SH; Kim, YM; Ha, KS				Jeon, Hye-Yoon; Lee, Yeon-Ju; Kim, You-Sun; Kim, Soo-Youl; Han, Eun-Taek; Park, Won Sun; Hong, Seok-Ho; Kim, Young-Myeong; Ha, Kwon-Soo			Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice	FASEB JOURNAL			English	Article						transglutaminase 2; VEGF; adherens junction	TISSUE TRANSGLUTAMINASE; MESENCHYMAL TRANSITION; ENDOTHELIAL APOPTOSIS; PERMEABILITY; REPLACEMENT; ACTIVATION; THERAPY	C-peptide has a beneficial effect against diabetic complications, but its role in hyperglycemia-induced metastasis is unknown. We investigated hyperglycemia-mediated pulmonary vascular leakage and metastasis and C-peptide inhibition of these molecular events using human pulmonary microvascular endothelial cells (HPMVECs) and streptozotocin-induced diabetic mice. VEGF, which is elevated in the lungs of diabetic mice, activated transglutaminase 2 (TGase2) in HPMVECs by sequential elevation of intracellular Ca2+ and reactive oxygen species (ROS) levels. VEGF also induced vascular endothelial (VE)-cadherin disruption and increased the permeability of endothelial cells, both of which were prevented by the TGase inhibitors monodansylcadaverine and cystamine or TGM2-specific small interfering RNA. C-peptide prevented VEGF-induced VE-cadherin disruption and endothelial cell permeability through inhibiting ROS-mediated activation of TGase2. C-peptide supplementation inhibited hyperglycemia-induced ROS generation and TGase2 activation and prevented vascular leakage and metastasis in the lungs of diabetic mice. The role of TGase2 in hyperglycemia-induced pulmonary vascular leakage and metastasis was further demonstrated in diabetic Tgm2(-/-) mice. These findings demonstrate that hyperglycemia induces metastasis, and C-peptide prevents the hyperglycemia-induced metastasis in the lungs of diabetic mice by inhibiting VEGF-induced TGase2 activation and subsequent vascular leakage.Jeon, H.-Y., Lee, Y.-J., Kim, Y.-S., Kim, S.-Y., Han, E.-T., Park, W. S., Hong, S.-H., Kim, Y.-M., Ha, K.-S. Proinsulin C-peptide prevents hyperglycemia-induced vascular leakage and metastasis of melanoma cells in the lungs of diabetic mice.	[Jeon, Hye-Yoon; Lee, Yeon-Ju; Kim, Young-Myeong; Ha, Kwon-Soo] Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea; [Han, Eun-Taek] Kangwon Natl Univ, Sch Med, Dept Med Environm Biol & Trop Med, Chunchon, South Korea; [Park, Won Sun] Kangwon Natl Univ, Sch Med, Dept Physiol, Chunchon, South Korea; [Hong, Seok-Ho] Kangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea; [Kim, You-Sun] Ajou Univ, Sch Med, Dept Biochem, Suwon, South Korea; [Kim, Soo-Youl] Natl Canc Ctr, Canc Cell & Mol Biol Branch, Goyang, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University; Ajou University; National Cancer Center - Korea (NCC)	Ha, KS (corresponding author), Kangwon Natl Univ, Sch Med, Dept Mol & Cellular Biochem, Kangwondaehak Gil 1, Chunchon 24341, Kangwon Do, South Korea.	ksha@kangwon.ac.kr	Ha, Kwon-Soo/AAU-4417-2020	Ha, Kwon-Soo/0000-0002-4219-1787	National Research Foundation of Korea [2015R1A4A1038666, 2016R1A2A1A05004975]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation of Korea grants 2015R1A4A1038666 and 2016R1A2A1A05004975 (to K.-S.H.). The authors declare no conflicts of interest.	Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Ayinde O, 2017, ONCOTARGET, V8, P20025, DOI 10.18632/oncotarget.15370; Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Bhatt MP, 2016, J ENDOCRINOL, V231, P97, DOI 10.1530/JOE-16-0349; Bhatt MP, 2014, CARDIOVASC RES, V104, P234, DOI 10.1093/cvr/cvu211; Bhatt MP, 2013, DIABETES, V62, P3851, DOI 10.2337/db13-0039; Bhatt MP, 2013, DIABETES, V62, P243, DOI 10.2337/db12-0293; Cao L, 2012, ONCOGENE, V31, P2521, DOI 10.1038/onc.2011.429; Di Giacomo G, 2009, AMINO ACIDS, V36, P717, DOI 10.1007/s00726-008-0119-5; Di Sabatino A, 2012, AUTOIMMUN REV, V11, P746, DOI 10.1016/j.autrev.2012.01.007; Hanbali A, 2007, ARCH INTERN MED, V167, P513, DOI 10.1001/archinte.167.5.513-a; Hills CE, 2010, AM J NEPHROL, V31, P389, DOI 10.1159/000289864; Ido Y, 1997, SCIENCE, V277, P563, DOI 10.1126/science.277.5325.563; Kronig M, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1117-4; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lee K, 2013, J BIOTECHNOL, V168, P324, DOI 10.1016/j.jbiotec.2013.10.007; Lee YJ, 2017, J ENDOCRINOL, V235, P39, DOI 10.1530/JOE-17-0109; Lee YJ, 2016, DIABETES, V65, P2414, DOI 10.2337/db15-1594; Li W, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5190314; Lim Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145004; Lim YC, 2015, J INVEST DERMATOL, V135, P269, DOI 10.1038/jid.2014.285; Lim YC, 2014, CARDIOVASC RES, V101, P155, DOI 10.1093/cvr/cvt238; Meadows KL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006577; Nadalutti C, 2011, CELL PROLIFERAT, V44, P49, DOI 10.1111/j.1365-2184.2010.00716.x; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Ozer Kutan, 2016, Asian Pac J Cancer Prev, V17, P105; Park D, 2010, AMINO ACIDS, V39, P619, DOI 10.1007/s00726-010-0500-z; Park MK, 2013, EUR J CANCER, V49, P1692, DOI 10.1016/j.ejca.2012.11.036; Phoomak C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43842; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Ruan QM, 2007, FRONT BIOSCI-LANDMRK, V12, P891, DOI 10.2741/2111; Sane DC, 2007, FRONT BIOSCI-LANDMRK, V12, P2530, DOI 10.2741/2253; Seyfried Thomas N., 2013, Critical Reviews in Oncogenesis, V18, P43; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Takatani-Nakase T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090136; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Vasconcelos-dos-Santos A, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.2; Wahren J, 2016, DIABETES CARE, V39, P596, DOI 10.2337/dc15-2068; Wahren J, 2012, DIABETES, V61, P761, DOI 10.2337/db11-1423; Wu FTH, 2015, EMBO MOL MED, V7, P770, DOI 10.15252/emmm.201404193; Ye WL, 2016, DEV CELL, V37, P114, DOI 10.1016/j.devcel.2016.03.015	41	15	15	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					750	762		10.1096/fj.201800723R	http://dx.doi.org/10.1096/fj.201800723R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020832				2022-12-26	WOS:000457401500058
J	Meng, QC; Shi, S; Liang, C; Liang, DK; Hua, J; Zhang, B; Xu, J; Yu, XJ				Meng, Qingcai; Shi, Si; Liang, Chen; Liang, Dingkong; Hua, Jie; Zhang, Bo; Xu, Jin; Yu, Xianjun			Abrogation of glutathione peroxidase-1 drives EMT and chemoresistance in pancreatic cancer by activating ROS-mediated Akt/GSK3 beta/Snail signaling	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; TAMOXIFEN RESISTANCE; CELLS; SNAIL; EXPRESSION; SURVIVAL; RISK; OVEREXPRESSION; POLYMORPHISM; GEMCITABINE	The devastating prognosis of pancreatic ductal adenocarcinoma (PDAC) is partially attributed to chemotherapy resistance. Glutathione peroxidase-1 (GPx1) plays various roles in the development and progression of multiple tumors, with the exception of pancreatic cancer. Here, we tentatively explored the role of GPx1 in the malignant biological behavior and gemcitabine (GEM) resistance of PDAC. GPx1 levels were detected using tissue microarrays and were negatively correlated with the overall survival of patients with PDAC. GPx1 silencing induced a mesenchymal transition phenotype and increased GEM resistance in vitro and in vivo. Additionally, the activation of reactive oxygen species (ROS)-mediated Akt/glycogen synthase kinase 3 beta (GSK3 beta)/Snail signaling was involved in this process, as determined by RNA sequencing. Moreover, low GPx1 expression correlated with a worse survival rate in patients with PDAC who received GEM adjuvant chemotherapy, whereas this correlation was not detected in patients receiving fluoropyrimidine. Based on our results, GPx1 inhibits the epithelial-mesenchymal transition (EMT) and chemoresistance by regulating the Akt/GSK3 beta/Snail signaling axis in PDAC. Furthermore, GPx1 may be a potential predictive biomarker in GEM-treated PDAC patients.	[Meng, Qingcai; Shi, Si; Liang, Chen; Liang, Dingkong; Hua, Jie; Zhang, Bo; Xu, Jin; Yu, Xianjun] Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China; [Meng, Qingcai; Shi, Si; Liang, Chen; Liang, Dingkong; Hua, Jie; Zhang, Bo; Xu, Jin; Yu, Xianjun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Meng, Qingcai; Shi, Si; Liang, Chen; Liang, Dingkong; Hua, Jie; Zhang, Bo; Xu, Jin; Yu, Xianjun] Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China; [Meng, Qingcai; Shi, Si; Liang, Chen; Liang, Dingkong; Hua, Jie; Zhang, Bo; Xu, Jin; Yu, Xianjun] Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Yu, XJ (corresponding author), Fudan Univ, Dept Pancreat Surg, Shanghai Canc Ctr, Shanghai 200032, Peoples R China.; Yu, XJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China.; Yu, XJ (corresponding author), Shanghai Pancreat Canc Inst, Shanghai 200032, Peoples R China.; Yu, XJ (corresponding author), Fudan Univ, Pancreat Canc Inst, Shanghai 200032, Peoples R China.	yuxianjun@fudanpci.org		Liang, Chen/0000-0003-0578-7589; Shi, Si/0000-0002-6652-0629; yu, xianjun/0000-0002-6697-7143	National Science Foundation for Distinguished Young Scholars of China [81625016]; Shanghai Sailing Program [17YF1402500]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Shanghai Sailing Program	We thank Professor Daming Gao (Institutes for Biological Sciences, Chinese Academy of Sciences) and Professor Yi Qin (Cancer Research Institute, Fudan University) for providing critical comments. This study was supported by grants from the National Science Foundation for Distinguished Young Scholars of China (no. 81625016) and the Shanghai Sailing Program (no. 17YF1402500).	Arsova-Sarafinovska Z, 2009, INT UROL NEPHROL, V41, P63, DOI 10.1007/s11255-008-9407-y; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Chao W, 2017, MOLECULES, V22, DOI 10.3390/molecules22040537; Cullen JJ, 2003, PANCREAS, V26, P23, DOI 10.1097/00006676-200301000-00005; Faucher K, 2005, MOL CELL BIOCHEM, V277, P81, DOI 10.1007/s11010-005-5075-8; FLOHE L, 1973, FEBS LETT, V32, P132, DOI 10.1016/0014-5793(73)80755-0; Gao X, 2017, ONCOTARGET, V8, P51888, DOI 10.18632/oncotarget.17128; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Hiscox S, 2004, CLIN EXP METASTAS, V21, P201, DOI 10.1023/B:CLIN.0000037697.76011.1d; Hoos WA, 2013, J CLIN ONCOL, V31, P3432, DOI 10.1200/JCO.2013.49.4823; Ichimura Y, 2004, J UROLOGY, V172, P728, DOI 10.1097/01.ju.0000130942.40597.9d; Ji SR, 2016, CLIN CANCER RES, V22, P3950, DOI 10.1158/1078-0432.CCR-15-2380; Kodydkova J, 2013, PANCREAS, V42, P614, DOI 10.1097/MPA.0b013e318288360a; Kourie HR, 2016, WORLD J GASTRO ONCOL, V8, P297, DOI 10.4251/wjgo.v8.i3.297; Kulak MV, 2013, ONCOGENE, V32, P4043, DOI 10.1038/onc.2012.400; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li SJ, 2000, CANCER RES, V60, P3927; Liang C, 2015, ONCOTARGET, V6, P14440, DOI 10.18632/oncotarget.3885; Marechal R, 2012, GASTROENTEROLOGY, V143, P664, DOI 10.1053/j.gastro.2012.06.006; Maseki S, 2012, BRIT J CANCER, V106, P1196, DOI 10.1038/bjc.2012.24; Midha S, 2016, CANCER LETT, V381, P269, DOI 10.1016/j.canlet.2016.07.022; Miething C, 2014, NATURE, V510, P402, DOI 10.1038/nature13239; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Namba T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.172; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; Ratnasinghe D, 2000, CANCER RES, V60, P6381; Ravn-Haren G, 2006, CARCINOGENESIS, V27, P820, DOI 10.1093/carcin/bgi267; Rho JK, 2009, LUNG CANCER, V63, P219, DOI 10.1016/j.lungcan.2008.05.017; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Soltysova A, 2005, NEOPLASMA, V52, P435; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Sun SB, 2017, CELL BIOL INT, V41, P842, DOI 10.1002/cbin.10792; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xiong GB, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0739-x; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173; Zhu LF, 2012, LAB INVEST, V92, P744, DOI 10.1038/labinvest.2012.8	50	72	76	1	26	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 1	2018	37	44					5843	5857		10.1038/s41388-018-0392-z	http://dx.doi.org/10.1038/s41388-018-0392-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GY9EX	29980787				2022-12-26	WOS:000448943100003
J	Ballak, DB; Li, SZ; Cavalli, G; Stahl, JL; Tengesdal, IW; van Diepen, JA; Kluck, V; Swartzwelter, B; Azam, T; Tack, CJ; Stienstra, R; Mandrup-Poulsen, T; Seals, DR; Dinarello, CA				Ballak, Dov B.; Li, Suzhao; Cavalli, Giulio; Stahl, Jonathan L.; Tengesdal, Isak W.; van Diepen, Janna A.; Kluck, Viola; Swartzwelter, Benjamin; Azam, Tania; Tack, Cees J.; Stienstra, Rinke; Mandrup-Poulsen, Thomas; Seals, Douglas R.; Dinarello, Charles A.			Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; inflammation; cytokine; drug development; insulin resistance; glucose metabolism; mouse; type 2 diabetes; cellular research; mouse model	HIGH-FAT DIET; TYPE-2 DIABETES-MELLITUS; BETA-CELL PROLIFERATION; PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; RECEPTOR ANTAGONIST; INNATE INFLAMMATION; FAMILY-MEMBERS; IL-37 REQUIRES; FOOD-INTAKE	Obesity and the metabolic syndrome are characterized by chronic, low-grade inflammation mainly originating from expanding adipose tissue and resulting in inhibition of insulin signaling and disruption of glycemic control. Transgenic mice expressing human interleukin 37 (IL-37), an anti-inflammatory cytokine of the IL-1 family, are protected against metabolic syndrome when fed a high-fat diet (HFD) containing 45% fat. Here, we examined whether treatment with recombinant IL-37 ameliorates established insulin resistance and obesity-induced inflammation. WT mice were fed a HFD for 22 weeks and then treated daily with IL-37 (1 g/mouse) during the last 2 weeks. Compared with vehicle only-treated mice, IL-37-treated mice exhibited reduced insulin in the plasma and had significant improvements in glucose tolerance and in insulin content of the islets. The IL-37 treatment also increased the levels of circulating IL-1 receptor antagonist. Cultured adipose tissues revealed that IL-37 treatment significantly decreases spontaneous secretions of IL-1, tumor necrosis factor (TNF), and CXC motif chemokine ligand 1 (CXCL-1). We also fed mice a 60% fat diet with concomitant daily IL-37 for 2 weeks and observed decreased secretion of IL-1, TNF, and IL-6 and reduced intracellular levels of IL-1 in the liver and adipose tissue, along with improved plasma glucose clearance. Compared with vehicle treatment, these IL-37-treated mice had no apparent weight gain. In human adipose tissue cultures, the presence of 50 pm IL-37 reduced spontaneous release of TNF and 50% of lipopolysaccharide-induced TNF. These findings indicate that IL-37's anti-inflammatory effects can ameliorate established metabolic disturbances during obesity.	[Ballak, Dov B.; Li, Suzhao; Cavalli, Giulio; Tengesdal, Isak W.; Kluck, Viola; Swartzwelter, Benjamin; Azam, Tania; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Ballak, Dov B.; Seals, Douglas R.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Stahl, Jonathan L.; Mandrup-Poulsen, Thomas] Univ Copenhagen, Dept Biomed Sci, DK-1165 Copenhagen, Denmark; [van Diepen, Janna A.; Tack, Cees J.; Stienstra, Rinke; Dinarello, Charles A.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 Nijmegen, Netherlands; [Stienstra, Rinke] Wageningen Univ, Div Human Nutr, NL-6525 Wageningen, Netherlands	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Copenhagen; Radboud University Nijmegen; Wageningen University & Research	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.	cdinare333@aol.com	van Diepen, Janna/ABG-9508-2021; Tack, Cees J/A-2368-2014; Ballak, Dov B/E-1188-2017; Kluck, Viola/H-3768-2017	van Diepen, Janna/0000-0001-9091-1075; Swartzwelter, Benjamin/0000-0002-6283-5199; Stahl-Meyer, Jonathan/0000-0002-9476-5455; Kluck, Viola/0000-0003-2802-2239	National Institutes of Health (NIH) [AI-15614]; Interleukin Foundation; Glenn/AFAR postdoctoral fellowship; Prof. Dr. Terpstra Award from the Dutch Union of Diabetes Research; American Heart Association postdoctoral fellowship; Colorado Clinical and Translational Sciences Institute (CCTSI) CO-Pilot Mentored Faculty award; NIH [AI128443]; MSD/EFSD program; VIDI grant from the Netherlands Organization for Scientific Research; NIH Grants [AG-013038, RO1 HL107120]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R56AI015614] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interleukin Foundation; Glenn/AFAR postdoctoral fellowship; Prof. Dr. Terpstra Award from the Dutch Union of Diabetes Research; American Heart Association postdoctoral fellowship(American Heart Association); Colorado Clinical and Translational Sciences Institute (CCTSI) CO-Pilot Mentored Faculty award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSD/EFSD program; VIDI grant from the Netherlands Organization for Scientific Research; NIH Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies are supported by National Institutes of Health (NIH) Grant AI-15614 (to C. A. D.) and the Interleukin Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Glenn/AFAR postdoctoral fellowship, the Interleukin Foundation, and the Prof. Dr. Terpstra Award from the Dutch Union of Diabetes Research.; Supported by an American Heart Association postdoctoral fellowship, a Colorado Clinical and Translational Sciences Institute (CCTSI) CO-Pilot Mentored Faculty award, and NIH Grant AI128443.; Supported by the Interleukin Foundation.; Supported by a grant from the MSD/EFSD program and a VIDI grant from the Netherlands Organization for Scientific Research.; Supported by NIH Grants AG-013038 and RO1 HL107120.	Abdullah A, 2011, INT J EPIDEMIOL, V40, P985, DOI 10.1093/ije/dyr018; Ballak DB, 2015, CYTOKINE, V75, P280, DOI 10.1016/j.cyto.2015.05.005; Ballak DB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5711; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Boni-Schnetzler M, 2018, CELL REP, V22, P1774, DOI 10.1016/j.celrep.2018.01.063; Boon MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074083; Cavalli G, 2017, P NATL ACAD SCI USA, V114, P2313, DOI 10.1073/pnas.1619011114; Cavalli G, 2016, RHEUMATOLOGY, V55, P2220, DOI 10.1093/rheumatology/kew325; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Dinarello CA, 2016, EUR J IMMUNOL, V46, P1067, DOI 10.1002/eji.201545828; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Ehses JA, 2009, P NATL ACAD SCI USA, V106, P13998, DOI 10.1073/pnas.0810087106; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Gao D, 2014, AM J PHYSIOL-ENDOC M, V307, pE289, DOI 10.1152/ajpendo.00430.2013; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; He M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014205; Hensen J, 2013, DIABETES METAB, V39, P524, DOI 10.1016/j.diabet.2013.07.003; Hong TP, 2000, EUR CYTOKINE NETW, V11, P193; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Juge-Aubry CE, 2003, DIABETES, V52, P1104, DOI 10.2337/diabetes.52.5.1104; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee Y, 2010, MAGN RESON MED, V64, P72, DOI 10.1002/mrm.22409; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Leontieva OV, 2014, AGING CELL, V13, P616, DOI 10.1111/acel.12211; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Li SZ, 2015, P NATL ACAD SCI USA, V112, P2497, DOI 10.1073/pnas.1424626112; Lunding L, 2015, ALLERGY, V70, P366, DOI 10.1111/all.12566; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Moretti S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004462; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Nold-Petry CA, 2015, NAT IMMUNOL, V16, P354, DOI 10.1038/ni.3103; Nov O, 2010, ENDOCRINOLOGY, V151, P4247, DOI 10.1210/en.2010-0340; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ridker PM, 2012, CIRCULATION, V126, P2739, DOI 10.1161/CIRCULATIONAHA.112.122556; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Shiwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135554; Somm E, 2005, DIABETES, V54, P3503, DOI 10.2337/diabetes.54.12.3503; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; ter Horst KW, 2015, INT J OBESITY, V39, P1703, DOI 10.1038/ijo.2015.125; Timper K, 2015, J DIABETES COMPLICAT, V29, P955, DOI 10.1016/j.jdiacomp.2015.05.019; Tynan GA, 2014, DIABETES, V63, P2037, DOI 10.2337/db13-1476; Um JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029524; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wiedemann MSF, 2013, AM J PHYSIOL-ENDOC M, V305, pE388, DOI 10.1152/ajpendo.00179.2013; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zeng QC, 2017, P NATL ACAD SCI USA, V114, P1631, DOI 10.1073/pnas.1619667114; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	65	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14224	14236		10.1074/jbc.RA118.003698	http://dx.doi.org/10.1074/jbc.RA118.003698			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30006351	hybrid, Green Published			2022-12-26	WOS:000444671500004
J	Mangione, PP; Verona, G; Corazza, A; Marcoux, J; Canetti, D; Giorgetti, S; Raimondi, S; Stoppini, M; Esposito, M; Relini, A; Canale, C; Valli, M; Marchese, L; Faravelli, G; Obici, L; Hawkins, PN; Taylor, GW; Gillmore, JD; Pepys, MB; Bellotti, V				Mangione, P. Patrizia; Verona, Guglielmo; Corazza, Alessandra; Marcoux, Julien; Canetti, Diana; Giorgetti, Sofia; Raimondi, Sara; Stoppini, Monica; Esposito, Marilena; Relini, Annalisa; Canale, Claudio; Valli, Maurizia; Marchese, Loredana; Faravelli, Giulia; Obici, Laura; Hawkins, Philip N.; Taylor, Graham W.; Gillmore, Julian D.; Pepys, Mark B.; Bellotti, Vittorio			Plasminogen activation triggers transthyretin amyloidogenesis in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; protein aggregation; protease; tissue plasminogen activator (tPA); fibril; amyloid fibrillogenesis; amyloidogenesis; mechano-enzymatic mechanism; systemic amyloidosis; transthyretin	FAMILIAL AMYLOID POLYNEUROPATHY; CARDIAC AMYLOIDOSIS; FIBRIL FORMATION; TAFAMIDIS; CLEAVAGE; TRIAL	Systemic amyloidosis is a usually fatal disease caused by extracellular accumulation of abnormal protein fibers, amyloid fibrils, derived by misfolding and aggregation of soluble globular plasma protein precursors. Both WT and genetic variants of the normal plasma protein transthyretin (TTR) form amyloid, but neither the misfolding leading to fibrillogenesis nor the anatomical localization of TTR amyloid deposition are understood. We have previously shown that, under physiological conditions, trypsin cleaves human TTR in a mechano-enzymatic mechanism that generates abundant amyloid fibrils in vitro. In sharp contrast, the widely used in vitro model of denaturation and aggregation of TTR by prolonged exposure to pH 4.0 yields almost no clearly defined amyloid fibrils. However, the exclusive duodenal location of trypsin means that this enzyme cannot contribute to systemic extracellular TTR amyloid deposition in vivo. Here, we therefore conducted a bioinformatics search for systemically active tryptic proteases with appropriate tissue distribution, which unexpectedly identified plasmin as the leading candidate. We confirmed that plasmin, just as trypsin, selectively cleaves human TTR between residues 48 and 49 under physiological conditions in vitro. Truncated and full-length protomers are then released from the native homotetramer and rapidly aggregate into abundant fibrils indistinguishable from ex vivo TTR amyloid. Our findings suggest that physiological fibrinolysis is likely to play a critical role in TTR amyloid formation in vivo. Identification of this surprising intersection between two hitherto unrelated pathways opens new avenues for elucidating the mechanisms of TTR amyloidosis, for seeking susceptibility risk factors, and for therapeutic innovation.	[Mangione, P. Patrizia; Verona, Guglielmo; Corazza, Alessandra; Canetti, Diana; Esposito, Marilena; Taylor, Graham W.; Pepys, Mark B.; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Mangione, P. Patrizia; Giorgetti, Sofia; Raimondi, Sara; Stoppini, Monica; Valli, Maurizia; Marchese, Loredana; Faravelli, Giulia; Bellotti, Vittorio] Univ Pavia, Inst Biochem, Dept Mol Med, I-27100 Pavia, Italy; [Corazza, Alessandra] Univ Udine, Dept Med DAME, I-33100 Udine, Italy; [Corazza, Alessandra] Ist Nazl Biostrutture & Biosistemi, I-00136 Rome, Italy; [Marcoux, Julien] Univ Toulouse, CNRS, UPS, Inst Pharmacol & Biol Struct, F-31000 Toulouse, France; [Relini, Annalisa] Univ Genoa, Dept Chem & Ind Chem, I-16146 Genoa, Italy; [Canale, Claudio] Univ Genoa, Dept Phys, I-16146 Genoa, Italy; [Obici, Laura] Fdn IRCCS Policlin San Matteo, Amyloidosis Res & Treatment Ctr, I-27100 Pavia, Italy; [Hawkins, Philip N.; Gillmore, Julian D.; Pepys, Mark B.] UCL, Natl Amyloidosis Ctr, London NW3 2PF, England; [Hawkins, Philip N.; Gillmore, Julian D.; Pepys, Mark B.] Royal Free Hosp, London NW3 2PF, England; [Esposito, Marilena] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy	University of London; University College London; University of Pavia; University of Udine; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); University of Genoa; University of Genoa; IRCCS Fondazione San Matteo; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Naples Federico II	Bellotti, V (corresponding author), Rowland Hill St, London NW3 2PF, England.	v.bellotti@ucl.ac.uk	Relini, Annalisa/AHC-3105-2022; Corazza, Alessandra/AGB-1457-2022; Giorgetti, Sofia/AAD-4341-2019; Verona, Guglielmo/AAH-9802-2019; Taylor, Graham Walter/R-4811-2019; Obici, Laura/AAC-3060-2019; Bellotti, Vittorio/A-6201-2014	Corazza, Alessandra/0000-0003-2272-1928; Giorgetti, Sofia/0000-0001-9438-6511; Verona, Guglielmo/0000-0001-8100-3876; Taylor, Graham Walter/0000-0002-9672-8463; Obici, Laura/0000-0001-7468-700X; Canale, Claudio/0000-0002-7582-6849; CANETTI, DIANA/0000-0001-5292-8124; RELINI, ANNALISA/0000-0002-4040-9279; Mangione, Palma/0000-0003-0260-1400; Marcoux, Julien/0000-0001-7321-7436; Bellotti, Vittorio/0000-0001-8678-662X; Faravelli, Giulia/0000-0002-7348-9404	University College London Technology Fund; University College London Amyloidosis Research Fund; United Kingdom Medical Research Council [MR/K000187/1]; Rosetrees Trust/Royal Free Charity PhD programme [M427]; Cariplo Foundation [2013 0964, 2014 0700]; Italian Ministry of Health Ricerca Finalizzata [RF 2013 02355259]; Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022 grant; Istituto Nazionale di Biostrutture e Biosistemi; MRC [MR/K000187/1, G0901596, G7900510] Funding Source: UKRI	University College London Technology Fund; University College London Amyloidosis Research Fund; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rosetrees Trust/Royal Free Charity PhD programme; Cariplo Foundation(Fondazione Cariplo); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy); Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022 grant; Istituto Nazionale di Biostrutture e Biosistemi; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by investment from the University College London Technology Fund and by the University College London Amyloidosis Research Fund, the United Kingdom Medical Research Council Grant MR/K000187/1, the Rosetrees Trust/Royal Free Charity PhD programme M427, the Cariplo Foundation Projects 2013 0964 and 2014 0700, the Italian Ministry of Health Ricerca Finalizzata RF 2013 02355259, the Italian Ministry of Research and University Dipartimenti di Eccellenza 2018-2022 grant to the Molecular Medicine Department (University of Pavia), and the Istituto Nazionale di Biostrutture e Biosistemi. Core support for the Wolfson Drug Discovery Unit is provided by the United Kingdom National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme via the UCLH/UCL Biomedical Research Centre. The authors declare that they have no conflicts of interest with the contents of this article.	Adams D, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0948-5; Benson M. D., 2017, ORPHANET J RARE D S1, V12, P165; Benson MD, 2003, BEST PRACT RES CL RH, V17, P909, DOI 10.1016/j.berh.2003.09.001; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Gillmore JD, 2016, CIRCULATION, V133, P2404, DOI 10.1161/CIRCULATIONAHA.116.021612; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Klimtchuk ES, 2018, P NATL ACAD SCI USA, V115, pE6428, DOI 10.1073/pnas.1802977115; Liu CZ, 2008, PROTEIN EXPRES PURIF, V61, P31, DOI 10.1016/j.pep.2008.05.007; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Pepys MB, 2009, J PATHOL, V217, P1, DOI 10.1002/path.2467; Plante-Bordeneuve V, 2017, J NEUROL, V264, P268, DOI 10.1007/s00415-016-8337-3; PUCHTLER H, 1985, Applied Pathology, V3, P5; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tucker HM, 2000, J NEUROSCI, V20, P3937; Verona G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00338-x; Weiss C, 1998, MED SCI SPORT EXER, V30, P246, DOI 10.1097/00005768-199802000-00012	26	45	45	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14192	14199		10.1074/jbc.RA118.003990	http://dx.doi.org/10.1074/jbc.RA118.003990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30018138	Green Published, hybrid			2022-12-26	WOS:000444671500001
J	Quinn, SM; Howsmon, DP; Hahn, J; Gilbert, SP				Quinn, Sean M.; Howsmon, Daniel P.; Hahn, Juergen; Gilbert, Susan P.			Kinesin-2 heterodimerization alters entry into a processive run along the microtubule but not stepping within the run	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computational biology; intracellular trafficking; microtubule; neuron; mathematical modeling; ATPase; pre-steady-state kinetics; processivity; ciliogenesis; intraflagellar transport	LEFT-RIGHT ASYMMETRY; HAND-OVER-HAND; SUPERFAMILY PROTEIN; ORGANELLE TRANSPORT; NEURONAL POLARITY; ACCESSORY SUBUNIT; KIF3A SUBUNIT; COILED-COIL; MOTOR; MOUSE	Heterodimeric KIF3AC and KIF3AB, two members of the mammalian kinesin-2 family, generate force for microtubule plus end-directed cargo transport. However, the advantage of heterodimeric kinesins over homodimeric ones is not well-understood. We showed previously that microtubule association for entry into a processive run was similar in rate for KIF3AC and KIF3AB at approximate to 7.0 m(-1) s(-1). Yet, for engineered homodimers of KIF3AA and KIF3BB, this constant is significantly faster at 11 m(-1) s(-1) and much slower for KIF3CC at 2.1 m(-1) s(-1). These results led us to hypothesize that heterodimerization of KIF3A with KIF3C and KIF3A with KIF3B altered the intrinsic catalytic properties of each motor domain. Here, we tested this hypothesis by using presteady-state stopped-flow kinetics and mathematical modeling. Surprisingly, the modeling revealed that the catalytic properties of KIF3A and KIF3B/C were altered upon microtubule binding, yet each motor domain retained its relative intrinsic kinetics for ADP release and subsequent ATP binding and the nucleotide-promoted transitions thereafter. These results are consistent with the interpretation that for KIF3AB, each motor head is catalytically similar and therefore each step is approximately equivalent. In contrast, for KIF3AC the results predict that the processive steps will alternate between a fast step for KIF3A followed by a slow step for KIF3C resulting in asymmetric stepping during a processive run. This study reveals the impact of heterodimerization of the motor polypeptides for microtubule association to start the processive run and the fundamental differences in the motile properties of KIF3C compared with KIF3A and KIF3B.	[Quinn, Sean M.; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol Sci, Troy, NY 12180 USA; [Howsmon, Daniel P.; Hahn, Juergen] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Hahn, Juergen] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA; [Howsmon, Daniel P.] Univ Texas Austin, 201 East 24th St,Stop C0200, Austin, TX 78712 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Texas System; University of Texas Austin	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol Sci, Troy, NY 12180 USA.; Hahn, J (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Biol Engn, Troy, NY 12180 USA.; Hahn, J (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biomed Engn, Troy, NY 12180 USA.	hahnj@rpi.edu; sgilbert@rpi.edu	Hahn, Juergen/H-8025-2019	Hahn, Juergen/0000-0002-1078-4203	NIGMS, National Institutes of Health [R01-AI110642, R37-GM054141]; Rensselaer Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054141] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Rensselaer Presidential Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grants R01-AI110642 (to J.H.) and R37-GM054141 (to S.P.G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Rensselaer Presidential Fellowship.	Albracht CD, 2016, J BIOL CHEM, V291, P23248, DOI 10.1074/jbc.M116.752196; Albracht CD, 2014, J BIOL CHEM, V289, P27836, DOI 10.1074/jbc.M114.583914; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Bentley M, 2016, NAT REV NEUROSCI, V17, P611, DOI 10.1038/nrn.2016.100; Brunnbauer M, 2010, P NATL ACAD SCI USA, V107, P10460, DOI 10.1073/pnas.1005177107; Carpenter BS, 2015, J CELL SCI, V128, P1034, DOI 10.1242/jcs.162552; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Chien A, 2017, ELIFE, V6, DOI 10.7554/eLife.28606; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; Doodhi H, 2009, BIOCHEMISTRY-US, V48, P2248, DOI 10.1021/bi8018338; Drummond IA, 2012, CURR OPIN CELL BIOL, V24, P24, DOI 10.1016/j.ceb.2011.12.007; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gilbert SP, 2018, J BIOL CHEM, V293, P4510, DOI 10.1074/jbc.R117.001324; Gindhart JG, 1996, TRENDS CELL BIOL, V6, P415, DOI 10.1016/S0962-8924(96)20037-6; Gumy LF, 2013, J NEUROSCI, V33, P11329, DOI 10.1523/JNEUROSCI.5221-12.2013; Guzik-Lendrum S, 2017, BIOPHYS J, V113, P1845, DOI 10.1016/j.bpj.2017.09.015; Guzik-Lendrum S, 2015, BIOPHYS J, V109, P1472, DOI 10.1016/j.bpj.2015.08.004; Hirokawa N, 2012, CURR OPIN CELL BIOL, V24, P31, DOI 10.1016/j.ceb.2012.01.002; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; Huang CF, 2012, TRAFFIC, V13, P549, DOI 10.1111/j.1600-0854.2011.01325.x; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ichinose S, 2015, NEURON, V87, P1022, DOI 10.1016/j.neuron.2015.08.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Lindhout DA, 2004, BIOPOLYMERS, V75, P367, DOI 10.1002/bip.20150; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Milic B, 2017, P NATL ACAD SCI USA, V114, pE6830, DOI 10.1073/pnas.1708157114; Muresan V, 1998, MOL BIOL CELL, V9, P637, DOI 10.1091/mbc.9.3.637; Nakagawa T, 1997, P NATL ACAD SCI USA, V94, P9654, DOI 10.1073/pnas.94.18.9654; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Park JH, 2018, CURR OPIN NEUROBIOL, V51, P95, DOI 10.1016/j.conb.2018.03.001; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Ruane PT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27456; Sardella M, 1998, GENOMICS, V47, P405, DOI 10.1006/geno.1997.5123; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Scholey JM, 2013, ANNU REV CELL DEV BI, V29, P443, DOI 10.1146/annurev-cellbio-101512-122335; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Shimizu K, 1998, J BIOL CHEM, V273, P6591, DOI 10.1074/jbc.273.12.6591; Stepp WL, 2017, EMBO REP, V18, P1947, DOI 10.15252/embr.201744097; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tas RP, 2017, NEURON, V96, P1264, DOI 10.1016/j.neuron.2017.11.018; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Wedaman KP, 1996, J CELL BIOL, V132, P371, DOI 10.1083/jcb.132.3.371; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Yang ZH, 1998, MOL BIOL CELL, V9, P249, DOI 10.1091/mbc.9.2.249; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Zhang PW, 2016, J BIOL CHEM, V291, P4407, DOI 10.1074/jbc.M115.705970; Zhao CT, 2012, P NATL ACAD SCI USA, V109, P2388, DOI 10.1073/pnas.1116035109	58	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13389	13400		10.1074/jbc.RA118.002767	http://dx.doi.org/10.1074/jbc.RA118.002767			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991594	Green Published, hybrid			2022-12-26	WOS:000443375500004
J	Agundez, L; Zarate-Perez, F; Meier, AF; Bardelli, M; Llosa, M; Escalante, CR; Linden, RM; Henckaerts, E				Agundez, Leticia; Zarate-Perez, Francisco; Meier, Anita F.; Bardelli, Martino; Llosa, Matxalen; Escalante, Carlos R.; Linden, R. Michael; Henckaerts, Els			Exchange of functional domains between a bacterial conjugative relaxase and the integrase of the human adeno-associated virus	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; SINGLE-STRANDED-DNA; ROLLING-CIRCLE REPLICATION; GRAM-NEGATIVE BACTERIA; TYPE-2 REP68 PROTEIN; MAMMALIAN-CELLS; PLASMID R388; WILD-TYPE; GENE-PRODUCT; BIOCHEMICAL-CHARACTERIZATION	Endonucleases of the HUH family are specialized in processing single-stranded DNA in a variety of evolutionarily highly conserved biological processes related to mobile genetic elements. They share a structurally defined catalytic domain for site-specific nicking and strand-transfer reactions, which is often linked to the activities of additional functional domains, contributing to their overall versatility. To assess if these HUH domains could be interchanged, we created a chimeric protein from two distantly related HUH endonucleases, containing the N-terminal HUH domain of the bacterial conjugative relaxase TrwC and the C-terminal DNA helicase domain of the human adeno-associated virus (AAV) replicase and site-specific integrase. The purified chimeric protein retained oligomerization properties and DNA helicase activities similar to Rep68, while its DNA binding specificity and cleaving-joining activity at oriT was similar to TrwC. Interestingly, the chimeric protein could catalyse site-specific integration in bacteria with an efficiency comparable to that of TrwC, while the HUH domain of TrwC alone was unable to catalyze this reaction, implying that the Rep68 C-terminal helicase domain is complementing the TrwC HUH domain to achieve site-specific integration into TrwC targets in bacteria. Our results illustrate how HUH domains could have acquired through evolution other domains in order to attain new roles, contributing to the functional flexibility observed in this protein superfamily.	[Agundez, Leticia; Meier, Anita F.; Bardelli, Martino; Linden, R. Michael; Henckaerts, Els] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Zarate-Perez, Francisco; Escalante, Carlos R.] Virginia Commonwealth Univ, Sch Med, Dept Physiol & Biophys, Richmond, VA USA; [Llosa, Matxalen] Univ Cantabria CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain; [Agundez, Leticia] UCL, Inst Ophthalmol, Dept Genet, London, England; [Zarate-Perez, Francisco] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA USA; [Bardelli, Martino] Univ Oxford, Jenner Inst, Oxford, England	University of London; King's College London; Virginia Commonwealth University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); University of London; University College London; Virginia Commonwealth University; University of Oxford; Jenner Institute	Henckaerts, E (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England.; Llosa, M (corresponding author), Univ Cantabria CSIC SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain.	llosam@unican.es; els.henckaerts@kcl.ac.uk	ZARATE PEREZ, FRANCISCO/ABF-1106-2021; Henckaerts, Els/S-2727-2018; , matxalen/ABG-5541-2020; Meier, Anita/AAP-5484-2020	ZARATE PEREZ, FRANCISCO/0000-0001-7014-6804; , matxalen/0000-0002-4826-2240; Meier, Anita/0000-0002-7691-0735; Henckaerts, Els Jeanny V/0000-0002-4624-7856	Medical Research Council (MRC) [MR/N022890/1, 1001764]; National Institutes of Health (NIH) [RO1-GM09285]; Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2013-46414-P]; Swiss National Science Foundation; MRC [MR/N022890/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness (MINECO); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC) grant MR/N022890/1 to EH and grant 1001764 to RML; National Institutes of Health (NIH) grant RO1-GM09285 to CRE; Spanish Ministry of Economy and Competitiveness (MINECO) grant BIO2013-46414-P to ML and AFM is supported by a Doc.Mobility fellowship from the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031047; Agundez L, 2011, APPL ENVIRON MICROB, V77, P201, DOI 10.1128/AEM.01371-10; Allan GM, 2000, J VET DIAGN INVEST, V12, P3, DOI 10.1177/104063870001200102; BAAS PD, 1988, CURR TOP MICROBIOL, V136, P31; Bardelli M, 2016, J VIROL, V90, P6612, DOI 10.1128/JVI.00356-16; CANFIELD V, 1990, MOL CELL BIOL, V10, P1367, DOI 10.1128/MCB.10.4.1367; Carraro N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005298; Cassell GD, 2004, VIROLOGY, V327, P206, DOI 10.1016/j.virol.2004.06.034; Cesar CE, 2006, MOL MICROBIOL, V62, P984, DOI 10.1111/j.1365-2958.2006.05437.x; Chandler M, 2013, NAT REV MICROBIOL, V11, P525, DOI 10.1038/nrmicro3067; CHEJANOVSKY N, 1989, VIROLOGY, V171, P239, DOI 10.1016/0042-6822(89)90531-X; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; Di Pasquale G, 1998, J VIROL, V72, P7916, DOI 10.1128/JVI.72.10.7916-7925.1998; Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102; Dutheil N, 2014, J VIROL, V88, P8227, DOI 10.1128/JVI.00412-14; Dyda F, 2003, STRUCTURE, V11, P1310, DOI 10.1016/j.str.2003.10.010; Garcillan-Barcia MD, 2001, MOL MICROBIOL, V39, P494, DOI 10.1046/j.1365-2958.2001.02261.x; GIRAUD C, 1994, P NATL ACAD SCI USA, V91, P10039, DOI 10.1073/pnas.91.21.10039; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; Gonzalez-Prieto C, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00207-17; Gonzalez-Prieto C, 2013, TRENDS BIOTECHNOL, V31, P41, DOI 10.1016/j.tibtech.2013.02.002; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; HERMONAT PL, 1984, J VIROL, V51, P329, DOI 10.1128/JVI.51.2.329-339.1984; Hickman AB, 2002, MOL CELL, V10, P327, DOI 10.1016/S1097-2765(02)00592-0; Hickman AB, 2004, MOL CELL, V13, P403, DOI 10.1016/S1097-2765(04)00023-1; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Huser D, 2014, J VIROL, V88, P11253, DOI 10.1128/JVI.01356-14; ILYINA TV, 1992, NUCLEIC ACIDS RES, V20, P3279, DOI 10.1093/nar/20.13.3279; IM DS, 1992, J VIROL, V66, P1119, DOI 10.1128/JVI.66.2.1119-1128.1992; IM DS, 1990, CELL, V61, P447, DOI 10.1016/0092-8674(90)90526-K; James JA, 2003, STRUCTURE, V11, P1025, DOI 10.1016/S0969-2126(03)00152-7; Janovitz T, 2014, J VIROL, V88, P2481, DOI 10.1128/JVI.03419-13; Kazlauskas D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040187; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; Khan SA, 2000, MOL MICROBIOL, V37, P477, DOI 10.1046/j.1365-2958.2000.02001.x; KOONIN EV, 1993, BIOSYSTEMS, V30, P241, DOI 10.1016/0303-2647(93)90074-M; KOTIN RM, 1992, EMBO J, V11, P5071, DOI 10.1002/j.1460-2075.1992.tb05614.x; Lamartina S, 2000, J VIROL, V74, P8831, DOI 10.1128/JVI.74.19.8831-8842.2000; Lee CA, 2012, J BACTERIOL, V194, P3165, DOI 10.1128/JB.00301-12; Linden RM, 1996, P NATL ACAD SCI USA, V93, P7966, DOI 10.1073/pnas.93.15.7966; LLOSA M, 1995, J MOL BIOL, V246, P54, DOI 10.1006/jmbi.1994.0065; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; Lucas M, 2010, J BIOL CHEM, V285, P8918, DOI 10.1074/jbc.M109.057539; Mansilla-Soto J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000513; MARTINEZ E, 1988, MOL GEN GENET, V211, P320, DOI 10.1007/BF00330610; MCCARTY DM, 1994, J VIROL, V68, P4988, DOI 10.1128/JVI.68.8.4988-4997.1994; MENDIOLA MV, 1992, J BACTERIOL, V174, P1345, DOI 10.1128/jb.174.4.1345-1351.1992; MENDIOLA MV, 1992, NUCLEIC ACIDS RES, V20, P3521, DOI 10.1093/nar/20.13.3521; Musayev FN, 2015, J BIOL CHEM, V290, P27487, DOI 10.1074/jbc.M115.669960; Petri K, 2015, J VIROL, V89, P7428, DOI 10.1128/JVI.00426-15; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Ryan JH, 1996, J VIROL, V70, P1542, DOI 10.1128/JVI.70.3.1542-1553.1996; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Smith DH, 1999, J VIROL, V73, P2930, DOI 10.1128/JVI.73.4.2930-2937.1999; Smith RH, 2000, J VIROL, V74, P3122, DOI 10.1128/JVI.74.7.3122-3129.2000; Smith RH, 1998, J VIROL, V72, P4874, DOI 10.1128/JVI.72.6.4874-4881.1998; Smith RH, 1997, J VIROL, V71, P4461, DOI 10.1128/JVI.71.6.4461-4471.1997; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Ton-Hoang B, 2012, NUCLEIC ACIDS RES, V40, P3596, DOI 10.1093/nar/gkr1198; TRATSCHIN JD, 1986, MOL CELL BIOL, V6, P2884, DOI 10.1128/MCB.6.8.2884; Uliel S, 2001, PROTEIN ENG, V14, P533, DOI 10.1093/protein/14.8.533; Ward P., 2006, PARVOVIRUSES, P189, DOI [10.1201/b13393-20, DOI 10.1201/B13393-20]; Weitzman MD, 1996, J VIROL, V70, P2440, DOI 10.1128/JVI.70.4.2440-2448.1996; WEITZMAN MD, 1994, P NATL ACAD SCI USA, V91, P5808, DOI 10.1073/pnas.91.13.5808; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Yoon M, 2001, J VIROL, V75, P3230, DOI 10.1128/JVI.75.7.3230-3239.2001; Yoon-Robarts M, 2004, J BIOL CHEM, V279, P50472, DOI 10.1074/jbc.M403900200; Zarate-Perez F, 2017, BIO PROTOC, V7; Zarate-Perez F, 2013, J VIROL, V87, P1232, DOI 10.1128/JVI.02441-12; Zarate-Perez F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002764; Zeltner N, 2010, GENE THER, V17, P872, DOI 10.1038/gt.2010.27; Zolotukhin S, 1996, J VIROL, V70, P4646, DOI 10.1128/JVI.70.7.4646-4654.1996	79	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200841	10.1371/journal.pone.0200841	http://dx.doi.org/10.1371/journal.pone.0200841			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016371	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600046
J	Sandoval-Molina, MA; Zavaleta-Mancera, HA; Leon-Solano, HJ; Solache-Ramos, LT; Jenner, B; Morales-Rodriguez, S; Patron-Soberano, A; Janczur, MK				Alberto Sandoval-Molina, Mario; Araceli Zavaleta-Mancera, Hilda; Javier Leon-Solano, Hector; Tzenyatze Solache-Ramos, Lupita; Jenner, Bartosz; Morales-Rodriguez, Simon; Patron-Soberano, Araceli; Krzysztof Janczur, Mariusz			First description of extrafloral nectaries in Opuntia robusta (Cactaceae): Anatomy and ultrastructure	PLOS ONE			English	Article							EXTRA-FLORAL NECTARIES; YOUNG LEAVES; RAIN-FOREST; HOST-PLANT; ANTS; PATTERNS; SECRETION; DEFENSE; LEAF; PREFERENCES	To our knowledge, there are no studies about the structure and ecological function of extrafloral nectaries (EFNs) in Opuntia robusta. This is the first description of EFNs in O. robusta, where young spines have an interesting structure and a secreting function, which are different from EFNs described in other Cactaceae species. We used light, scanning-electron, and transmission-electron microscopy to examine morphology, anatomy, and ultrastructure of the secretory spines in areoles in female and hermaphrodite individuals of O. robusta. Young cladodes develop areoles with modified and secretory spines as EFNs only active during the early growth phase. EFNs are non-vascularized structures, with no stomata, that consist of a basal meristematic tissue, a middle elongation region, and an apical secretory cone formed by large globular epidermal cells, containing nectar and medullar elongated cells. We observed the presence of Golgi apparatus, vesicles and plastids in the medullar and sup-epidermal cells of the spine. We propose that the nectar is stored in the globular cells at the apex of the spine and secreted by breaking through the globular cells or by pores. We recorded a more frequent presence of ants on younger cladode sprouts producing young secreting spines: this result is parallel with the predictions of Optimal Defense Hypothesis, which states that younger plant organs should be better defended than older ones because their loss produces a higher fitness impairment. Although Diaz-Castelazo's hypothesis states that a more complex structure of EFNs correlates with their lower among-organs dispersion, comparing to less complex EFNs, non-vascularized structure of EFNs in O. robusta is not associated with their higher among-organs dispersion likened to O. stricta, which produces vascularized EFNs. We provide evidence that this characteristic is not a good taxonomic feature of Opuntia genus. Moreover, the comparison of EFNs of O. robusta and O. stricta suggests that the hypothesis of Diaz-Castelazo should be revised: it is rather a rule but not a law.	[Alberto Sandoval-Molina, Mario; Javier Leon-Solano, Hector; Tzenyatze Solache-Ramos, Lupita; Krzysztof Janczur, Mariusz] Autonomous Univ State Mexico, Dept Nat Sci, Res Grp Ecol & Evolutionary Biol, Toluca, Estado De Mexic, Mexico; [Alberto Sandoval-Molina, Mario] Inst Ecol, Xalapa, Veracruz, Mexico; [Araceli Zavaleta-Mancera, Hilda; Morales-Rodriguez, Simon] Colegio Postgrad, Postgrad Bot, Unidad Microscopia Elect, Campus Montecillo, Texcoco, Estado De Mexic, Mexico; [Javier Leon-Solano, Hector; Tzenyatze Solache-Ramos, Lupita; Krzysztof Janczur, Mariusz] Autonomous Univ State Mexico, Grad Program Agr Sci & Nat Resources PCARN, Toluca, Estado De Mexic, Mexico; [Jenner, Bartosz] Evidence Generat & Clin Res RB, Kingston Upon Hull, N Humberside, England; [Patron-Soberano, Araceli] Inst Potosino Invest Cient & Tecnol, San Luis Potosi, Mexico	Universidad Autonoma del Estado de Mexico; Instituto de Ecologia - Mexico; Colegio de Postgraduados - Mexico; Universidad Autonoma del Estado de Mexico; Instituto Potosino Investigacion Cientifica y Tecnologica	Janczur, MK (corresponding author), Autonomous Univ State Mexico, Dept Nat Sci, Res Grp Ecol & Evolutionary Biol, Toluca, Estado De Mexic, Mexico.; Janczur, MK (corresponding author), Autonomous Univ State Mexico, Grad Program Agr Sci & Nat Resources PCARN, Toluca, Estado De Mexic, Mexico.	majmx@interia.pl	Janczur, Mariusz K/A-3964-2012	Sandoval Molina, Mario Alberto/0000-0002-8536-6006; Zavaleta-Mancera, Hilda Araceli/0000-0003-1092-6299; Janczur, Mariusz Krzysztof/0000-0002-3886-6710	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT) [180694/2012]	Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was funded by Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT), award number 180694/2012, to MKJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini M, 2013, PLANT SPEC BIOL, V28, P185, DOI 10.1111/j.1442-1984.2012.00371.x; AIDE TM, 1993, ECOLOGY, V74, P455, DOI 10.2307/1939307; Anderson R.S., 2002, AM BEETLES, V2, P722; Apple JL, 2001, OECOLOGIA, V127, P409, DOI 10.1007/s004420000605; Aranda-Rickert A, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu068; BAZZAZ FA, 1984, PERSPECTIVES PLANT P, P324; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; BENNER U, 1975, PROTOPLASMA, V85, P337, DOI 10.1007/BF01567958; BENTLEY BL, 1977, J ECOL, V65, P27, DOI 10.2307/2259060; BENTLEY BL, 1977, ANNU REV ECOL SYST, V8, P407, DOI 10.1146/annurev.es.08.110177.002203; BERTSCH A, 1983, OECOLOGIA, V59, P40, DOI 10.1007/BF00388069; BLOM P E, 1980, Southwestern Naturalist, V25, P181, DOI 10.2307/3671240; Bluthgen N, 2004, J ANIM ECOL, V73, P155, DOI 10.1111/j.1365-2656.2004.00789.x; Bluthgen N, 2003, AUST J BOT, V51, P515, DOI 10.1071/BT02108; Boke NH, 1944, AM J BOT, V31, P299, DOI 10.2307/2437195; BOKE NH, 1961, AM J BOT, V48, P593, DOI 10.2307/2439372; BOWDEN BN, 1970, PHYTOCHEMISTRY, V9, P2315, DOI 10.1016/S0031-9422(00)85731-3; BUCKLEY R, 1991, BIOTROPICA, V23, P282, DOI 10.2307/2388205; Chamberlain SA, 2010, OECOLOGIA, V164, P741, DOI 10.1007/s00442-010-1673-6; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; CORBET SA, 1979, ECOL ENTOMOL, V4, P9, DOI 10.1111/j.1365-2311.1979.tb00557.x; Coutinho IAC, 2015, BOTANY, V93, P379, DOI 10.1139/cjb-2014-0227; del Castillo R.F., 1988, AGROCIENCIA-MEXICO, V71, P185; del Castillo R.F., 1996, CACT SUCULENT MEX, V41, P3; del Castillo RF, 2009, AM J BOT, V96, P1148, DOI 10.3732/ajb.0800301; delsCastillo R. F., 1986, THESIS; Diaz-Castelazo C, 2005, ANN BOT-LONDON, V96, P1175, DOI 10.1093/aob/mci270; Diaz-Castelazo C., 2017, ANT PLANT INTERACTIO, P179; Diaz-Castelazo Cecilia, 1998, Acta Zoologica Mexicana Nueva Serie, V73, P45; ELEFTHERIOU EP, 1983, J EXP BOT, V34, P103, DOI 10.1093/jxb/34.2.103; Elias T. S., 1983, The biology of nectaries, P174; Estrada-Alvarez JC, 2016, COLEOPTS BULL, V70, P814, DOI 10.1649/0010-065X-70.4.814; EVERT RF, 1964, AM J BOT, V51, P552, DOI 10.2307/2440286; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; FAHN A, 1988, NEW PHYTOL, V108, P229, DOI 10.1111/j.1469-8137.1988.tb04159.x; FAHN A, 1979, AM J BOT, V66, P977, DOI 10.2307/2442240; FAHN A, 1979, ANN BOT-LONDON, V44, P85, DOI 10.1093/oxfordjournals.aob.a085710; Fahn A., 1979, SECRETORY TISSUES PL; Fahn A., 1970, BOT J LINN SOC    S1, P51; Felger R.S., 2014, PHYTONEURON, V2014-69, P1; FINDLAY N, 1971, AUST J BIOL SCI, V24, P647, DOI 10.1071/BI9710647; Fisher B. L., 2007, ANTS N AM GUIDE GENE; Galen C, 2005, OECOLOGIA, V144, P80, DOI 10.1007/s00442-005-0042-3; GALETTO L, 1992, CAN J BOT, V70, P1101, DOI 10.1139/b92-136; de Almeida OJG, 2012, FLORA, V207, P119, DOI 10.1016/j.flora.2011.11.004; Garcia-Sanchez R., 1984, THESIS; GIAQUINTA RT, 1979, PLANT PHYSIOL, V63, P744, DOI 10.1104/pp.63.4.744; Gibson A. C., 1990, CACTUS PRIMER; Gonzalez-Camarena E., 2018, THESIS; Gonzalez-Elizondo M.S., 2003, ACTA BOT MEX, V64, P45, DOI DOI 10.21829/ABM64.2003.928; Gonzalez-Teuber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046598; Gulmon SL, 1986, COSTS DEFENCE THEIR, P681; Hamlin J. C., 1924, Annals of the Entomological Society of America, V17, P193, DOI 10.1093/aesa/17.2.193; Heil M, 2015, ANNU REV ENTOMOL, V60, P213, DOI 10.1146/annurev-ento-010814-020753; Hernandez HM, 2013, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2013-1.RLTS.T152874A689177.en, DOI 10.2305/IUCN.UK.2013-1.RLTS.T152874A689177.EN]; Holland JN, 2010, J ARID ENVIRON, V74, P712, DOI 10.1016/j.jaridenv.2009.10.008; Hunt D., 2006, NEW CACTUS LEXICON; Kadochova Stepanka, 2013, F1000Res, V2, P280, DOI 10.12688/f1000research.2-280.v1; Koptur S, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P75, DOI 10.1017/CBO9780511542220.004; KOPTUR S, 1992, FLA ENTOMOL, V75, P38, DOI 10.2307/3495479; KRONESTEDT EC, 1986, NORD J BOT, V6, P627; Janczur MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089535; Janczur MK, 2009, EVOL ECOL RES, V11, P447; KURSAR TA, 1991, BIOTROPICA, V23, P141, DOI 10.2307/2388299; Kursar TA, 2003, BIOCHEM SYST ECOL, V31, P929, DOI 10.1016/S0305-1978(03)00087-5; LANZA J, 1988, BIOTROPICA, V20, P341, DOI 10.2307/2388328; LERSTEN NR, 1994, PLANT SYST EVOL, V192, P231, DOI 10.1007/BF00986254; LIEBERMAN D, 1984, BIOTROPICA, V16, P193, DOI 10.2307/2388052; Lloyd F.E., 1912, PLANT WORLD, V15, P145; LOVETT A, 1989, PROF GEOGR, V41, P190, DOI 10.1111/j.0033-0124.1989.00190.x; Mackay WP, 1989, 2 S NAC INS SOC MEM; MADDEN D, 1992, OECOLOGIA, V91, P235, DOI 10.1007/BF00317789; Marroquin J. S., 1964, ESTUDIO ECOLOGICO DA; Mauseth JD, 2006, ANN BOT-LONDON, V98, P901, DOI 10.1093/aob/mcl133; MAUSETH JD, 1982, BOT GAZ, V143, P273, DOI 10.1086/337300; MAUSETH JD, 1975, AM J BOT, V62, P869, DOI 10.2307/2441899; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; McKey DD, HERBIVORES THEIR INT; Microsoft Corporation, 2010, MICR EXC MAC V 14 7, V14; Morris WF, 2005, ECOLOGY, V86, P3190, DOI 10.1890/05-0465; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Ness JH, 2006, ECOLOGY, V87, P912, DOI 10.1890/0012-9658(2006)87[912:IQAQOM]2.0.CO;2; Ness JH, 2006, OIKOS, V113, P506, DOI 10.1111/j.2006.0030-1299.14143.x; Novoa S, 2005, ECOL APL, V4, P83, DOI 10.21704/rea.v4i1-2.302; Offenberg J, 2004, P ROY SOC B-BIOL SCI, V271, pS433, DOI 10.1098/rsbl.2004.0210; Ohm JR, 2014, ECOLOGY, V95, P2924, DOI 10.1890/13-2309.1; Oldroyd BP, 2009, CURR BIOL, V19, pR1035, DOI 10.1016/j.cub.2009.09.038; Oliveira PS, 1999, FUNCT ECOL, V13, P623, DOI 10.1046/j.1365-2435.1999.00360.x; Orozco J, 2012, COLEOPTS BULL, V66, P1, DOI 10.1649/0010-066X-66.mo4.1; Pacini E, 2003, PLANT SYST EVOL, V238, P7, DOI 10.1007/s00606-002-0277-y; Pacini Ettore, 2007, P167, DOI 10.1007/978-1-4020-5937-7_4; Palmer A., 2007, METHODOLOGY-EUR, V3, P89, DOI DOI 10.1027/1614-2241.3.3.89; PICKETT CH, 1979, AM J BOT, V66, P618, DOI 10.2307/2442406; RACHMILEVITZ T, 1973, ANN BOT-LONDON, V37, P1; Robbins M, 2009, FLA ENTOMOL, V92, P391, DOI 10.1653/024.092.0231; RUFFNER GA, 1986, AM J BOT, V73, P185, DOI 10.2307/2444171; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Rzedowski J., 1978, VEGETACION MEXICO; Samah S, 2015, P IEEE GLOB COMM C G, P1, DOI [10.1007/s11105-015-0908-4, DOI 10.1007/S11105-015-0908-4]; Sandoval-Molina MA, LIGHT MICROSCOPY PRO, DOI [10.17504/protocols.io.kzrcx56, DOI 10.17504/PROTOCOLS.IO.KZRCX56]; Sandoval-Molina MA, TRANSMISSION ELECT M, DOI [10.17504/protocols.io.k3xcypn, DOI 10.17504/PROTOCOLS.IO.K3XCYPN]; Sandoval-Molina MA, FIXATION DEHYDRATATI, DOI [10.17504/protocols.io.k3vcyn6, DOI 10.17504/PROTOCOLS.IO.K3VCYN6]; Sandoval-Molina MA, REPLICATION DATA 1 D, DOI [10.7910/DVN/ULQKVX, DOI 10.7910/DVN/ULQKVX]; SAS Institute Inc, 2017, SAS SYST WIND V 9 4, V9; SAWIDIS T, 1987, ANN BOT-LONDON, V59, P643; Schatten H., 2012, SCANNING ELECT MICRO; Seeber H., 2014, POISSON REGRESSION B; SEMARNAT, 2013, AR NAT PROT DIAGN FI; SEMARNAT, 2010, NOM059SEMARNAT2010 S; Solache Ramos LT, 2014, HIST VIDA FORMAS SEX; TARKOWSKA JA, 1981, ACTA SOC BOT POL, V50, P391, DOI 10.5586/asbp.1981.061; Traw MB, 2008, ECOLOGY, V89, P763, DOI 10.1890/07-0729.1; VanDam NM, 1996, FUNCT ECOL, V10, P128, DOI 10.2307/2390271; VANDAM NM, 1995, J CHEM ECOL, V21, P507, DOI 10.1007/BF02033698; Vila R., 2006, REV PERU ENTOMOL, V13, P125; Wackers FL, 2005, PLANT-PROVIDED FOOD FOR CARNIVOROUS INSECTS: PROTECTIVE MUTUALISM AND ITS APPLICATIONS, P17, DOI 10.1017/CBO9780511542220.003; Wagner D, 2002, EVOL ECOL RES, V4, P293; Wagner D, 2010, J ECOL, V98, P614, DOI 10.1111/j.1365-2745.2010.01640.x; WAY MJ, 1992, ANNU REV ENTOMOL, V37, P479, DOI 10.1146/annurev.en.37.010192.002403; Weber MG, 2013, ANN BOT-LONDON, V111, P1251, DOI 10.1093/aob/mcs225; Weidenmuller A, 2009, CURR BIOL, V19, P1897, DOI 10.1016/j.cub.2009.08.059; Wilder SM, 2010, BIOL LETTERS, V6, P177, DOI 10.1098/rsbl.2009.0736; ZANDONELLA P, 1982, B SOC BOT FR-ACTUAL, V129, P109, DOI 10.1080/01811789.1982.10826555; Zangerl A. R., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P363; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868; Zavaleta Mancera HA, FLUORESCENT STAINING, DOI [10.17504/protocols.io.q83dzyn, DOI 10.17504/PROTOCOLS.IO.Q83DZYN]; Zavaleta-Mancera HA, 1999, J EXP BOT, V50, P1683, DOI 10.1093/jexbot/50.340.1683; Zavaleta-Mancera Hilda-Araceli, 2003, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Botanica, V74, P17	128	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200422	10.1371/journal.pone.0200422	http://dx.doi.org/10.1371/journal.pone.0200422			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016339	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600024
J	Gazibara, T; Milic, M; Parlic, M; Stevanovic, J; Lazic, D; Maric, G; Kisic-Tepavcevic, D; Pekmezovic, T				Gazibara, Tatjana; Milic, Marija; Parlic, Milan; Stevanovic, Jasmina; Lazic, Dragoslav; Maric, Gorica; Kisic-Tepavcevic, Darija; Pekmezovic, Tatjana			Illict drug use and academia in North Kosovo: Prevalence, patterns, predictors and health-related quality of life	PLOS ONE			English	Article							MALE COLLEGE-STUDENTS; UNIVERSITY-STUDENTS; GENDER-DIFFERENCES; SUBSTANCE-ABUSE; MARIJUANA USE; ALCOHOL; INITIATION; BEHAVIORS; COCAINE; MISUSE	Purpose The purpose of this study were to estimate the prevalence and patterns of illicit drug use in a sample of University students from North Kosovo, to assess factors associated with illicit drug use and to assess health-related quality of life (HRQoL) among students according to illicit drug use. Methods A cross-sectional study was conducted at the Student Public Health Center, where 514 University students were enrolled from April to June 2015 in North Kosovo. Participants completed the general socio-demographic and behavioral questionnaire, Beck Depression Inventory (BDI) and the SF-36 questionnaire for HRQoL assessment. Data on lifetime illicit drug use were self-reported. Results As much as 16.0% of students reported ever illicit drug use. The most frequently used drugs were marijuana (9.3%) and bromazepam (7.6%). Factors associated with ever illicit drug use were: being smoker and alcohol user, having chronic diseases and having higher depressive symptoms score. Ever illicit drug users reported all domains of HRQoL as worse. Conclusion These results could serve as a tool for implementation of preventive strategies and University policies to promote healthy lifestyles and behaviors. Measurement of HRQoL could also be used as indicator of the effect of interventions designed to reduce and/or prevent illicit drug use at institutions of higher education.	[Gazibara, Tatjana; Maric, Gorica; Kisic-Tepavcevic, Darija; Pekmezovic, Tatjana] Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia; [Milic, Marija; Parlic, Milan; Stevanovic, Jasmina] Univ Pristina, Fac Med, Dept Epidemiol, Kosovska Mitrovica, Kosovo, Kosovo; [Lazic, Dragoslav] Univ Pristina, Fac Dent, Kosovska Mitrovica, Kosovo, Kosovo	University of Belgrade	Pekmezovic, T (corresponding author), Univ Belgrade, Inst Epidemiol, Fac Med, Belgrade, Serbia.	pekmezovic@sezampro.rs		Gazibara, Tatjana/0000-0002-9621-8375; Milic, Marija/0000-0001-5575-0587; Maric, Gorica/0000-0003-2739-142X; Pekmezovic, Tatjana/0000-0001-7978-1409	Ministry of Education, Science and Technological Development of Republic of Serbia [175087]	Ministry of Education, Science and Technological Development of Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	This work was supported by Ministry of Education, Science and Technological Development of Republic of Serbia (grant no. 175087). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari El, 2015, GLOB J HLTH SCI, V7, P18; Atwoli L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-34; Babor T., 2010, DRUG POLICY PUBLIC G; BECK AT, 1972, POSTGRAD MED, V52, P81, DOI 10.1080/00325481.1972.11713319; Caldeira KM, 2012, DRUG ALCOHOL DEPEN, V125, P267, DOI 10.1016/j.drugalcdep.2012.02.022; Davies J, 2000, J AM COLL HEALTH, V48, P259, DOI 10.1080/07448480009596267; Degenhardt L, 2012, LANCET, V379, P55, DOI 10.1016/S0140-6736(11)61138-0; El Ansari W, 2013, INT J PREVENTIVE MED, V4, P293; Ford JA, 2008, ADDICT BEHAV, V33, P934, DOI 10.1016/j.addbeh.2008.02.016; Gupta S, 2013, J CLIN DIAGN RES, V7, P1632, DOI 10.7860/JCDR/2013/6441.3215; Institute of Public Health of Serbia, AN STUD 1997 2007; Jones SE, 2006, J ADOLESCENT HEALTH, V39, P291, DOI 10.1016/j.jadohealth.2005.12.003; Kasperski SJ, 2011, ADDICT BEHAV, V36, P408, DOI 10.1016/j.addbeh.2010.12.002; Kassa A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1044; Kisic-Tepavcevic D, 2013, AM J DRUG ALCOHOL AB, V39, P130, DOI 10.3109/00952990.2012.746348; Klemenc-Ketis Z, 2011, SRP ARK CELOK LEK, V139, P197, DOI 10.2298/SARH1104197K; Lev-Ran S, 2012, DRUG ALCOHOL DEPEN, V123, P190, DOI 10.1016/j.drugalcdep.2011.11.010; McCabe SE, 2009, DRUG ALCOHOL DEPEN, V102, P63, DOI 10.1016/j.drugalcdep.2009.01.007; Meisel MK, 2015, ADDICT BEHAV, V45, P110, DOI 10.1016/j.addbeh.2015.01.025; Mohammadpoorasl A, 2014, ASIAN J PSYCHIATR, V9, P41, DOI 10.1016/j.ajp.2013.12.015; Mohammadpoorasl A, 2013, AM J MENS HEALTH, V7, P475, DOI 10.1177/1557988313483540; Ott R, 2014, PHARMACOPSYCHIATRY, V47, P22, DOI 10.1055/s-0033-1358682; Palmer RS, 2012, J COLL STUDENT DEV, V53, P124, DOI 10.1353/csd.2012.0014; Pekmezovic T, 2011, QUAL LIFE RES, V20, P391, DOI 10.1007/s11136-010-9754-x; Pinchevsky GM, 2012, PREV SCI, V13, P43, DOI 10.1007/s11121-011-0243-4; Randolph ME, 2009, AM J DRUG ALCOHOL AB, V35, P80, DOI 10.1080/00952990802585422; Rimsza ME, 2005, PEDIATR CLIN N AM, V52, P307, DOI 10.1016/j.pcl.2004.10.008; Shamsipour M, 2014, SUBST USE MISUSE, V49, P1303, DOI 10.3109/10826084.2014.897730; Sim T, 2005, J AM COLL HEALTH, V54, P25, DOI 10.3200/JACH.54.1.25-29; Suerken CK, 2014, ADDICT BEHAV, V39, P302, DOI 10.1016/j.addbeh.2013.10.018; Topolski TD, 2001, J ADOLESCENT HEALTH, V29, P426, DOI 10.1016/S1054-139X(01)00305-6; Toprak S, 2010, J ADDICT MED, V4, P93, DOI 10.1097/ADM.0b013e3181b246c5; Unwin BK, 2013, AM FAM PHYSICIAN, V88, P596; Wagner GA, 2007, REV BRAS PSIQUIATR, V29, P123, DOI 10.1590/S1516-44462006005000033; Williams J, 2006, SUBST USE MISUSE, V41, P489, DOI 10.1080/10826080500521755	35	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199921	10.1371/journal.pone.0199921	http://dx.doi.org/10.1371/journal.pone.0199921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2LQ	30011284	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800007
J	Rakotonirainy, NH; Razafindratovo, V; Remonja, CR; Rasoloarijaona, R; Piola, P; Raharintsoa, C; Randremanana, RV				Rakotonirainy, Nivo Heritiana; Razafindratovo, Valerie; Remonja, Chitale Rabaoarisoa; Rasoloarijaona, Randza; Piola, Patrice; Raharintsoa, Charlotte; Randremanana, Rindra Vatosoa			Dietary diversity of 6-to 59-month-old children in rural areas of Moramanga and Morondava districts, Madagascar	PLOS ONE			English	Article							COMPLEMENTARY FEEDING PRACTICES; AGED 6-23 MONTHS; FOOD VARIETY; DETERMINANTS; ADEQUACY; INCOME; INDICATORS; MALI	Background A dietary imbalance or a disregard for the nutritional needs of children during early childhood can affect their growth. From the age of six months, breast milk is no longer able to meet the energy and micronutrient needs of children; the consumption of adequate complementary foods is therefore essential. Various indicators have been used to assess the quality of children's diets, and the dietary diversity score is a good indicator of children's diets. The objective of this study was to describe the dietary practices of children in rural areas of Moramanga and Morondava, Madagascar, and to identify the determinants of low dietary diversity to prioritize nutritional interventions. Methods We collected dietary data in 2014 on children aged 6-59 months in a study on the determinants of chronic malnutrition using the 24-hour recall method. Data on the characteristics of households and mothers were also collected. We carried out bivariate and multivariate analyses to identify the determinants of low dietary diversity scores for children. Results We included 1824 children: 893 from Moramanga and 931 from Morondava. Approximately 42.1% [95% CI: 39.0-45.4] of the children from Moramanga and 47.6% [95% CI: 44.4-50.8] of those from Morondava had a poorly diversified diet, consisting mainly of foods rich in carbohydrates and poor in meat products. Poor maternal education was associated with a high likelihood of having a non-varied diet in both study areas; the adjusted odds ratios were 2.2 [95% CI: 1.3-3.8] and 4.0 [95% CI: 2.5-6.4] for children from mothers with lower education levels for Moramanga and Morondava, respectively. For children recruited in Morondava, having low household socioeconomic status (adjusted OR: 1.8, 95% CI: 1.2-2.8) and belonging to a household without livestock was associated with a low dietary diversity score (adjusted OR: 1.8, 95% CI 1.2-2.7). Conclusion Our results show the need to improve girls' education, adapt nutrition education programs for mothers based on their level of education, and strengthen poverty reduction programs.	[Rakotonirainy, Nivo Heritiana; Remonja, Chitale Rabaoarisoa; Randremanana, Rindra Vatosoa] Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar; [Razafindratovo, Valerie; Rasoloarijaona, Randza; Raharintsoa, Charlotte] Univ Antananarivo, Fac Sci, Lab Biochim Appl Sci Alimentat & Nutr, Antananarivo, Madagascar; [Piola, Patrice] Inst Pasteur Cambodge, Epidemiol & Publ Hlth Unit, Phnom Penh, Cambodia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; University Antananarivo; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia	Randremanana, RV (corresponding author), Inst Pasteur Madagascar, Epidemiol Unit, Antananarivo, Madagascar.	rrandrem@pasteur.mg			United States Agency for International Development [AID-687-G-13-00003]	United States Agency for International Development(United States Agency for International Development (USAID))	This work was funded by the United States Agency for International Development, grant reference number: AID-687-G-13-00003. The Institut Pasteur de Madagascar received the funding. The funding agency had no role in study design, data collection or analysis, decision to publish, or preparation of this manuscript.	Aemro M, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/782931; [Anonymous], 2013, GUIDE MEASURING DIET; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Biro G, 2002, EUR J CLIN NUTR, V56, pS25, DOI 10.1038/sj.ejcn.1601426; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; de l'Economie et du plan Madagascar, ACT EC REG AL MANG; FAO, 2013, FAOSTAT DAT; Gillespie S, 2012, IFPRI DISCUSS PAP; Goudet S., 2005, DIAGNOSTIC ETAT NUTR; GRET WFP, 2015, PERC DYN SOC CULT RE; HADDAD L, 1994, WORLD DEV, V22, P543, DOI 10.1016/0305-750X(94)90110-4; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; INSTAT, 2014, ENQ NAT SUIV IND OBJ; Issaka AI, 2015, MATERN CHILD NUTR, V11, P14, DOI 10.1111/mcn.12194; Jones AD, 2015, PUBLIC HEALTH NUTR, V18, P329, DOI 10.1017/S1368980014000123; Joshi N, 2012, MATERN CHILD NUTR, V8, P45, DOI 10.1111/j.1740-8709.2011.00384.x; Kennedy G., 2011, GUID MEAS HOUS IND D; Mayen AL, 2014, AM J CLIN NUTR, V100, P1520, DOI 10.3945/ajcn.114.089029; Miller LC, 2014, FOOD NUTR BULL, V35, P312, DOI 10.1177/156482651403500304; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; ONU, OBJ DEV DUR 2015; Rabaoarisoa CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186493; Rakotomanana H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4835-1; Ramirez-Luzuriaga MJ, 2016, J NUTR, V146, P107, DOI 10.3945/jn.115.215962; Senarath U, 2012, MATERN CHILD NUTR, V8, P89, DOI 10.1111/j.1740-8709.2011.00370.x; Sibhatu KT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186406; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; Steyn NP, 2014, NUTRITION, V30, P55, DOI 10.1016/j.nut.2013.06.002; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; UNICEF PAM ONN MSP, 2011, AN GLOB SEC AL NUTR; UNICEF WHO, 2014, WORLD BANK GROUP 201; World Health Organization, 2007, P CONCL CONS M WASH; World Health Organization (WHO), 2004, GUID PRINC FEED INF	33	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200235	10.1371/journal.pone.0200235	http://dx.doi.org/10.1371/journal.pone.0200235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005067	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200008
J	Wilson, KR; Liu, H; Healey, G; Vuong, V; Ishido, S; Herold, MJ; Villadangos, JA; Mintern, JD				Wilson, Kayla R.; Liu, Haiyin; Healey, Geraldine; Vuong, Vivian; Ishido, Satoshi; Herold, Marco J.; Villadangos, Jose A.; Mintern, Justine D.			MARCH1-mediated ubiquitination of MHC II impacts the MHC I antigen presentation pathway	PLOS ONE			English	Article							DENDRITIC CELLS; SURFACE EXPRESSION; PLASMA-MEMBRANE; LIPID RAFTS; MOLECULES; SELECTION; TURNOVER; IDENTIFICATION; STABILIZATION; MATURATION	Major histocompatibility complex class II (MHC II) expression and turn-over are regulated via its ubiquitination by the membrane associated RING-CH 1 (MARCH1) E3 ligase. Unexpectedly, we show that MHC II ubiquitination also impacts MHC I. Lack of MARCH1 in B cells and dendritic cells (DCs) resulted in a significant reduction in surface MHC I expression. This decrease was not directly caused by changes in MARCH1 ubiquitination of MHC I but indirectly by altered MHC II trafficking in the absence of its ubiquitination. Deletion of MHC II in March 1(-/-) cells restored normal MHC I surface expression and replacement of wild type MHC II by a variant that could not be ubiquitinated caused a reduction in MHC I expression. Furthermore, these cells displayed inefficient presentation of peptide and protein antigen via MHC I to CD8(+) T cells. In summary, we describe an unexpected intersection between MHC I and MHC II such that the surface expression of both molecules are indirectly and directly regulated by MARCH1 ubiquitination, respectively.	[Wilson, Kayla R.; Liu, Haiyin; Healey, Geraldine; Vuong, Vivian; Villadangos, Jose A.; Mintern, Justine D.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Ishido, Satoshi] Hyogo Coll Med, Dept Microbiol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo, Japan; [Herold, Marco J.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Herold, Marco J.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Villadangos, Jose A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia	University of Melbourne; Hyogo College of Medicine; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Villadangos, JA; Mintern, JD (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic, Australia.; Villadangos, JA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia.	j.villadangos@unimelb.edu.au; jmintern@unimelb.edu.au	Herold, Marco J/C-8039-2013; Villadangos, Jose A/AAU-1404-2020	Herold, Marco J/0000-0001-7539-7581; Villadangos, Jose A/0000-0001-6771-8891; Wilson, Kayla/0000-0003-2023-7964; Mintern, Justine/0000-0002-3797-8577; Liu, Haiyin/0000-0003-3103-6949				Anderson HA, 2015, BBA-MOL CELL RES, V1853, P775, DOI 10.1016/j.bbamcr.2014.09.019; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Baravalle G, 2015, J IMMUNOL, V187, P2966, DOI [10.1037/emo0000122.Do, DOI 10.1037/EMO0000122.DO]; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cho KJ, 2015, P NATL ACAD SCI USA, V112, P10449, DOI 10.1073/pnas.1507981112; Cho KJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00369; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; De Angelis Rigotti F, 2017, IMMUNOL CELL BIOL, P1, DOI [10.1038/icb.2016.103, DOI 10.1038/ICB.2016.103]; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x; Eyster CA, 2011, MOL BIOL CELL, V22, P3218, DOI 10.1091/mbc.E10-11-0874; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Ishikawa R, 2014, INT IMMUNOL, V26, P283, DOI 10.1093/intimm/dxt066; Jenei A, 1997, P NATL ACAD SCI USA, V94, P7269, DOI 10.1073/pnas.94.14.7269; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Liu HY, 2016, METHODS MOL BIOL, V1423, P199, DOI 10.1007/978-1-4939-3606-9_15; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Malynn BA, 2010, IMMUNITY, V33, P843, DOI 10.1016/j.immuni.2010.12.007; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; McGehee AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018817; Moffat JM, 2013, CURR OPIN IMMUNOL, V25, P109, DOI 10.1016/j.coi.2012.10.008; Oh J, 2013, J EXP MED, V210, P1069, DOI 10.1084/jem.20122695; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Ohmura-Hoshino M, 2009, J IMMUNOL, V183, P6893, DOI 10.4049/jimmunol.0902178; Poloso NJ, 2004, J IMMUNOL, V173, P4539, DOI 10.4049/jimmunol.173.7.4539; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Reuter A, 2015, J IMMUNOL, V194, P2696, DOI 10.4049/jimmunol.1402535; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Steiner OG, 2008, BLOOD, V111, P2073, DOI 10.1182/blood-2007-06-097576; Szollosi J, 1996, J IMMUNOL, V157, P2939; Tze LE, 2011, J EXP MED, V208, P149, DOI 10.1084/jem.20092203; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; Vremec D, 2010, METHODS MOL BIOL, V595, P205, DOI 10.1007/978-1-60761-421-0_14; Walseng E, 2010, P NATL ACAD SCI USA, V107, P20465, DOI 10.1073/pnas.1010990107; Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665	42	19	19	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200540	10.1371/journal.pone.0200540	http://dx.doi.org/10.1371/journal.pone.0200540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001419	Green Published, gold			2022-12-26	WOS:000438457400075
J	Basiita, RK; Zenger, KR; Mwanja, MT; Jerry, DR				Basiita, Rose K.; Zenger, Kyall R.; Mwanja, Matthew T.; Jerry, Dean R.			Gene flow and genetic structure in Nile perch, Lates niloticus, from African freshwater rivers and lakes	PLOS ONE			English	Article							SPATIAL AUTOCORRELATION ANALYSIS; KYOGA EAST-AFRICA; OREOCHROMIS-NILOTICUS; POPULATION-STRUCTURE; CICHLID FISHES; PLEISTOCENE DESICCATION; RE-IMPLEMENTATION; DNA ANALYSES; KAINJI LAKE; VICTORIA	Background Geological evolution of the African continent has been subject to complex processes including uplift, volcanism, desert formation and tectonic rifting. This complex geology has created substantial biogeographical barriers, and coupled with anthropogenic introductions of freshwater fishes, has influenced the genetic diversity, connectivity and sub-structuring of the teleost fauna. Nile perch, Lates niloticus, is an iconic fish in Africa and is of high commercial importance, both in the species' native range and where it has been translocated. However, the species is in decline and there is a need to understand its population genetic structure to facilitate sustainable management of the fishery and aquaculture development. Methodology Nile perch tissue samples were acquired from two West and four East (Lakes; Albert, Kyoga, Victoria and Turkana) African locations. Nineteen polymorphic microsatellite loci were used to study the genetic variation among populations across regions (West and East Africa), as well as between native and introduced environments within East Africa. Principal findings and their significance Results revealed strong and significant genetic structuring among populations across the sampled distribution (divergence across regions, F-CT = 0.26, P = 0.000). STRUCTURE analysis at a broad scale revealed K = 2 clusters, the West African individuals were assigned to one cluster, while all individuals from the East African region, regardless of whether native or introduced, were assigned to another cluster. The distinct genetic clusters identified in the current study between the West and East African Nile perch, appear to have been maintained by presence of biogeographic barriers and restricted gene flow between the two regions. Therefore, any translocations of Nile perch should be carefully considered across the regions of West and East Africa. Further analysis at a regional scale revealed further structuring of up to K = 3 genetic clusters in East African Nile perch. Significantly (P < 0.05) lower genetic diversity based on analysis of allelic richness (A(R)) was obtained for the two translocated populations of Lake Kyoga (A(R) = 3.61) and Lake Victoria (A(R) = 3.52), compared to Nile perch populations from their putative origins of Lakes Albert (A(R) = 4.12) and Turkana (A(R) = 4.43). The lower genetic diversity in the translocated populations may be an indication of previous bottlenecks and may also indicate a difficulty for these populations to persist and adapt to climatic changes and anthropogenic pressures that are currently present in the East African region.	[Basiita, Rose K.; Zenger, Kyall R.; Jerry, Dean R.] James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia; [Basiita, Rose K.; Mwanja, Matthew T.] Natl Agr Res Org, Natl Fisheries Resources Res Inst, Aquaculture Res & Dev Ctr Kajjansi, Kampala, Uganda; [Basiita, Rose K.] WorldFish Zambia Off, Ridgeway Lusaka, Zambia	James Cook University; CGIAR; Worldfish	Basiita, RK (corresponding author), James Cook Univ, Coll Sci & Engn, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld, Australia.; Basiita, RK (corresponding author), Natl Agr Res Org, Natl Fisheries Resources Res Inst, Aquaculture Res & Dev Ctr Kajjansi, Kampala, Uganda.; Basiita, RK (corresponding author), WorldFish Zambia Off, Ridgeway Lusaka, Zambia.	Basiitarose@gmail.com	Jerry, Dean R/B-3053-2012; Zenger, Kyall R/ABD-2101-2020; Basiita, Rose Komugisha/C-6112-2016	Zenger, Kyall R/0000-0001-6817-8786; Jerry, Dean/0000-0003-3735-1798; Basiita, Rose Komugisha/0000-0002-7257-0286	James Cook University; AusAID PhD scholarship; Uganda Government	James Cook University; AusAID PhD scholarship; Uganda Government	We acknowledge funding contribution from James Cook University through the competitive research grant scheme for post graduates awarded to RKB. We also recognize the AusAID PhD scholarship awarded to RKB. All the Samples used in the study from East African sites were availed through Funding by the Uganda Government. DRJ secured all resources required for lab analysis, manuscript preparation and publication costs. We declare the funders had no role in the study design, data analysis, decision to publish and preparation of the manuscript.	Agnese JF, 1997, HEREDITY, V79, P88, DOI 10.1038/hdy.1997.126; Amos B, 1991, LONG TERM PRESERVATI; Arnoux E, 2014, HEREDITY, V113, P514, DOI 10.1038/hdy.2014.56; Balirwa JS, 2003, BIOSCIENCE, V53, P703, DOI 10.1641/0006-3568(2003)053[0703:BAFSIT]2.0.CO;2; Ball MC, 2011, FORENSIC SCI INT-GEN, V5, P50, DOI 10.1016/j.fsigen.2010.02.002; BALOGUN JK, 1986, J FISH BIOL, V29, P489, DOI 10.1111/j.1095-8649.1986.tb04964.x; Basiita RK, 2011, AFR J AQUAT SCI, V36, P89, DOI 10.2989/16085914.2011.559694; Basiita RK, 2015, ANIMAL GENETICS, V46; BEADLE LC, 1981, INLAND WATERS AFRICA; Belkhir K, 2004, GENETIX 4 05 2, P55; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuning KRM, 1997, PALAEOGEOGR PALAEOCL, V136, P259, DOI 10.1016/S0031-0182(97)00034-5; Bishop W., 1965, Geological Society of America Special Paper, V84, P293; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caballero A, 2013, GENETICS, V195, P1373, DOI 10.1534/genetics.113.158410; Chapman L., 2007, INT ASS THEORETICAL, V30, P16; CHAPMAN LJ, 1995, CONSERV BIOL, V9, P1274, DOI 10.1046/j.1523-1739.1995.9051262.x-i1; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Danley PD, 2012, INT J EVOLUTIONARY B, V2012; Dawson MN, 1998, MOL MAR BIOL BIOTECH, V7, P145; DGEBUADZE YY, 1994, HYDROBIOLOGIA, V286, P125, DOI 10.1007/BF00008502; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Eknath A., 1998, 6 WORLD C GEN APPL L; EKNATH AE, 1993, AQUACULTURE, V111, P171, DOI 10.1016/0044-8486(93)90035-W; Elmer KR, 2009, P NATL ACAD SCI USA, V106, P13404, DOI 10.1073/pnas.0902299106; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L., 2010, MOL ECOLOGY RESOURCE, V10, P464; Ferguson A, 1995, J FISH BIOL, V47, P103, DOI 10.1111/j.1095-8649.1995.tb06048.x; FishBase, 2009, WORLD WID WEB EL PUB; Goudet J, 2002, FSTAT 2 9 3 2; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Hardy OJ, 1999, HEREDITY, V83, P145, DOI 10.1046/j.1365-2540.1999.00558.x; HARGREAVES GL, 1985, J IRRIG DRAIN ENG, V111, P265, DOI 10.1061/(ASCE)0733-9437(1985)111:3(265); HARRISON K, 1991, J FISH BIOL, V38, P175, DOI 10.1111/j.1095-8649.1991.tb03104.x; Hauser L, 1998, MOL ECOL, V7, P849, DOI 10.1046/j.1365-294x.1998.00399.x; HOLDEN MJ, 1967, J ZOOL, V151, P329; Hopson AJ, 1972, STUDY NILE PERCH LAT; ITA EO, 1978, HYDROBIOLOGIA, V58, P233, DOI 10.1007/BF02346958; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson TC, 2000, AMBIO, V29, P2, DOI 10.1639/0044-7447(2000)029[0002:THHOLV]2.0.CO;2; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kenchington F, 1939, P ZOOLOGICAL SOC LON; Kinziger AP, 2011, ECOL EVOL, V1, P73, DOI 10.1002/ece3.8; Kolding J., 1995, IMPACT SPECIES CHANG, P335, DOI 10.1007/978-94-011-0563-7_16; KUDHONGANIA AW, 1992, HYDROBIOLOGIA, V232, P1, DOI 10.1007/BF00014605; Lowe-McConnell Rosemary, 2009, Freshwater Reviews, V2, P131, DOI 10.1608/FRJ-2.2.2; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; McGlynn G, 2013, QUATERNARY SCI REV, V61, P32, DOI 10.1016/j.quascirev.2012.11.008; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221; Mkumbo OC, 2015, FISHERIES MANAG ECOL, V22, P56, DOI 10.1111/fme.12084; Mwanja MT, 2014, AFR ZOOL, V49, P181, DOI 10.3377/004.049.0213; Mwanja MT, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-59; Mwanja Matthew Tenywa, 2012, Management of Biological Invasions, V3, P77; Mwanja MT, 2008, AFRICAN J BIOTECHNOL, V7; Mwanja TM, 2013, EVOLUTIONARY HIST NI; Odada EO, 2003, AQUAT SCI, V65, P254, DOI 10.1007/s00027-003-0638-9; Odada EO, 2006, E AFRICAN GREAT LAKE; Ogutu-Ohwayo R., 1994, THESIS; OGUTUOHWAYO R, 1993, CONSERV BIOL, V7, P701, DOI 10.1046/j.1523-1739.1993.07030701.x; OGUTUOHWAYO R, 1990, ENVIRON BIOL FISH, V27, P81, DOI 10.1007/BF00001938; OGUTUOHWAYO R, 1988, HYDROBIOLOGIA, V162, P193, DOI 10.1007/BF00016667; OGUTUOHWAYO R, 1990, J FISH BIOL, V37, P207, DOI 10.1111/j.1095-8649.1990.tb05040.x; Olowo JP, 1999, AFR J ECOL, V37, P457, DOI 10.1046/j.1365-2028.1999.00203.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pickford M, 1993, GEOLOGY PALAEOBIOLOG; Pringle RM, 2005, BIOSCIENCE, V55, P780, DOI 10.1641/0006-3568(2005)055[0780:TOOTNP]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Reynolds J., 1988, SOCIOECONOMIC EFFECT; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rutz C, 2012, NATURWISSENSCHAFTEN, V99, P313, DOI 10.1007/s00114-012-0904-6; Seehausen O, 2002, P ROY SOC B-BIOL SCI, V269, P491, DOI 10.1098/rspb.2001.1906; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; SOKAL RR, 1983, GENETICS, V105, P219; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Taabu-Munyaho A, 2014, AQUAT ECOSYST HEALTH, V17, P52, DOI 10.1080/14634988.2014.876886; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varis O, 2002, INT J WATER RESOUR D, V18, P245, DOI 10.1080/07900620220135085; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; Ward RD, 2006, FISH RES, V80, P9, DOI 10.1016/j.fishres.2006.03.009; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1943, GENETICS, V28, P114; Zhu ZY, 2006, GENOME, V49, P969, DOI 10.1139/G06-080	91	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200001	10.1371/journal.pone.0200001	http://dx.doi.org/10.1371/journal.pone.0200001			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995906	Green Published, gold, Green Accepted			2022-12-26	WOS:000438388800039
J	Knechtle, B; Nikolaidis, PT; Valeri, F				Knechtle, Beat; Nikolaidis, Pantelis Theodoros; Valeri, Fabio			When conflict influences liking: The case of the Stroop task	PLOS ONE			English	Article							EAST-AFRICAN RUNNERS; DEMOGRAPHIC CHARACTERISTICS; RUNNING PERFORMANCE; ENDURANCE RUNNERS; MARATHON; RACE; GENOTYPES; KENYAN; TIME	Research suggests that cognitive conflict is accompanied by a negative signal. Building on the demonstrated role of negative affect in attitude formation and change, the present research investigated whether the experience of cognitive conflict negatively influences subsequent evaluations of neutral stimuli. Relying on the emergence of conflict in the Stroop task, participants were presented with compatible (non-conflict) and incompatible (conflict) Stroop color words that were each followed by a neutral visual stimulus. In general, participants liked stimuli following incompatible Stroop words less than stimuli following compatible Stroop words. The results revealed similar compatibility effects in tasks in which participants actively responded to the Stroop words and in tasks in which they passively observed them. Furthermore, these effects emerged in offline and online measures of evaluation. Interestingly, the results also suggest that the compatibility effect on liking observed in the present research was to some degree driven by the positivity associated with the compatible Stroop words, and not just by the negativity associated with the incompatible Stroop words. We discuss the present findings in the context of how and when conflicting responses to events (such as in the Stroop task) can influence evaluations of stimuli associated with the conflicting events.	[Knechtle, Beat] Medbase St Gallen Vadianpl, St Gallen, Switzerland; [Knechtle, Beat; Valeri, Fabio] Univ Zurich, Inst Primary Care, Zurich, Switzerland; [Nikolaidis, Pantelis Theodoros] Exercise Physiol Lab, Nikaia, Greece	University of Zurich	Knechtle, B (corresponding author), Medbase St Gallen Vadianpl, St Gallen, Switzerland.; Knechtle, B (corresponding author), Univ Zurich, Inst Primary Care, Zurich, Switzerland.	beat.knechtle@hispeed.ch	Knechtle, Beat/ABC-5529-2020; Nikolaidis, Pantelis Theodoros/K-8664-2017	Knechtle, Beat/0000-0002-2412-9103; Nikolaidis, Pantelis Theodoros/0000-0001-8030-7122				Bairner A, 2015, INT REV SOCIOL SPORT, V50, P375, DOI 10.1177/1012690214538863; Cejka N, 2014, J SPORT SCI, V32, P354, DOI 10.1080/02640414.2013.825729; Collins M, 2004, MED SCI SPORT EXER, V36, P1314, DOI 10.1249/01.MSS.0000135779.41475.42; Cona G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132943; de Hon O, 2015, SPORTS MED, V45, P57, DOI 10.1007/s40279-014-0247-x; Hallmann K, 2015, RUNNING EUROPE RISE; Houlihan B, 2006, HDB SPORTS STUDIES; Irving R, 2013, SCI WORLD J, DOI 10.1155/2013/670217; Knechtle B, 2012, INT J SPORT PHYSIOL, V7, P310, DOI 10.1123/ijspp.7.4.310; Knechtle B, 2010, PERCEPT MOTOR SKILL, V111, P681, DOI 10.2466/05.25.PMS.111.6.681-693; Knechtle B, 2010, J STRENGTH COND RES, V24, P604, DOI 10.1519/JSC.0b013e3181c7b406; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Marc A, 2017, J SPORT MED PHYS FIT, V57, P418, DOI 10.23736/S0022-4707.16.06019-9; Marc A, 2014, J SPORT SCI, V32, P524, DOI 10.1080/02640414.2013.835436; Mooses M, 2017, INT J SPORT PHYSIOL, V12, P422, DOI 10.1123/ijspp.2016-0408; Nikolaidis PT, 2017, J STRENGTH COND RES, V31, P2189, DOI 10.1519/JSC.0000000000001687; Nikolaidis PT, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9821757; Noakes TD, 1990, J SPORT SCI, V8, P35, DOI 10.1080/02640419008732129; Ntoumanis N, 1999, SCAND J MED SCI SPOR, V9, P315; Onywera VO, 2009, MED SPORT SCI, V54, P102, DOI 10.1159/000235699; Onywera VO, 2006, J SPORT SCI, V24, P415, DOI 10.1080/02640410500189033; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rupert JL, 2003, COMP BIOCHEM PHYS A, V136, P191, DOI 10.1016/S1095-6433(02)00349-5; Scott RA, 2003, MED SCI SPORT EXER, V35, P1727, DOI 10.1249/01.MSS.0000089335.85254.89; Scott RA, 2007, SPORTS MED, V37, P424, DOI 10.2165/00007256-200737040-00039; Tanda G, 2015, OPEN ACCESS J SPORTS, V6, P129, DOI 10.2147/OAJSM.S80637; Wilber RL, 2012, INT J SPORT PHYSIOL, V7, P92, DOI 10.1123/ijspp.7.2.92	27	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199701	10.1371/journal.pone.0199701	http://dx.doi.org/10.1371/journal.pone.0199701			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995926	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000438388800032
J	Si, B; Dumkrieger, G; Wu, T; Zafonte, R; Valadka, AB; Okonkwo, DO; Manley, GT; Wang, LJ; Dodick, DW; Schwedt, TJ; Li, J				Si, Bing; Dumkrieger, Gina; Wu, Teresa; Zafonte, Ross; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.; Wang, Lujia; Dodick, David W.; Schwedt, Todd J.; Li, Jing			Sub-classifying patients with mild traumatic brain injury: A clustering approach based on baseline clinical characteristics and 90-day and 180-day outcomes	PLOS ONE			English	Article							POST-CONCUSSION SYMPTOMS; HEAD-INJURY; PREDICTION; POLYMORPHISM; SELECTION; SCALE	Background The current classification of traumatic brain injury (TBI) into "mild", "moderate", or "severe" does not adequately account for the patient heterogeneity that still exists within each of these categories. The objective of this study was to identify "sub-groups" of mild TBI (mTBI) patients based on data available at the time of the initial post-TBI patient evaluation and to determine if the sub-grouping correlates with patient outcomes at 90 and 180 days post-TBI. Methods Data from patients in the TRACK-TBI Pilot dataset who had a Glasgow Coma Scale (GCS) score of 13 to 15 at arrival to the Emergency Department and a closed head injury were included. Considering 53 clinical variables that are typically available during the initial evaluation of the patient with mild TBI, sparse heirarchial clustering with cluster quality assessment was used to identify the optimal number of patient sub-groups. Patient sub-groups were then compared for ten outcomes measured at 90 or 180 days post-TBI. Results Amongst the 485 patients with mTBI, optimal clustering was based on the inclusion of 12 clinical variables that divided the patients into 5 mild TBI sub-groups. Clinical variables driving the sub-clustering included: gender, employment status, marital status, TBI due to falling, brain CT scan result, systolic blood pressure, diastolic blood pressure, administration of IV fluids in the Emergency Department, alcohol use, tobacco use, history of neurologic disease, and history of psychiatric disease. These 5 mild TBI sub-groups differed in their 90 day and 180 day outcomes within several domains including global outcomes, persistence of TBI-related symptoms, and neuropsychological impairment. Conclusions Sub-groups of patients with mTBI can be identified according to clinical variables that are relatively easy to obtain at the time of initial patient evaluation. A patient's sub-group assignment is associated with multidimensional patient outcomes at 90 and 180 days. These findings support the notion that there are clinically meaningful subgroups of patients amongst those currently classified as having mTBI.	[Si, Bing; Dumkrieger, Gina; Wu, Teresa; Wang, Lujia; Li, Jing] Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ 85287 USA; [Dumkrieger, Gina; Dodick, David W.; Schwedt, Todd J.] Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA; [Zafonte, Ross] Harvard Med Sch, Dept Phys Med & Rehabil, Spaulding Rehabil Hosp, Massachusetts Gen Hosp,Brigham & Womens Hosp, Boston, MA USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Spaulding Rehabilitation Hospital; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Li, J (corresponding author), Arizona State Univ, Sch Comp Informat & Decis Syst Engn, Tempe, AZ 85287 USA.; Schwedt, TJ (corresponding author), Mayo Clin, Dept Neurol, Phoenix, AZ 85054 USA.	schwedt.todd@mayo.edu; jing.li.8@asu.edu	Wang, Lujia/ACO-4039-2022	Wang, Lujia/0000-0002-0475-004X; Dumkrieger, Gina/0000-0001-9519-5370; Schwedt, Todd/0000-0002-7780-7086	Eunice Kennedy Shriver National Institute of Child Health and Human Development [NIHR21HD089035, NIH R21HD089035]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD089035] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	TJS JL, DWD, TW, and RZ received funding for this research from NIHR21HD089035 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NIH R21HD089035 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cnossen M.C., 2017, J NEUROTRAUMA; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Derogatis L.R., 1993, BRIEF SYMPTOM INVENT, V18; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; HAMILITON BB, 1994, PHYS THER, V74, P494, DOI 10.1093/ptj/74.5.494; Hamilton B. B., 1987, REHABILITATION OUTCO, P137; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2016, J NEUROTRAUM, V33, P215, DOI 10.1089/neu.2015.3949; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Mitrishina MB, 2005, HDB NORMATIVE DATA N; Nelson L.D., 2017, J NEUROTRAUMA, V34; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Reitan R.M., 1992, TRAIL MAKING TEST MA; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; TEASDALE G, 1974, LANCET, V2, P81; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Buuren S, 2011, J STAT SOFTW, V45, P1; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Winkler EA, 2017, J CLIN NEUROSCI, V35, P109, DOI 10.1016/j.jocn.2016.09.017; Witten DM, 2010, J AM STAT ASSOC, V105, P713, DOI 10.1198/jasa.2010.tm09415; Yue JK, 2017, NEUROGENETICS, V18, P29, DOI 10.1007/s10048-016-0500-6; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zabora J, 2001, PSYCHOSOMATICS, V42, P241, DOI 10.1176/appi.psy.42.3.241	32	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0198741	10.1371/journal.pone.0198741	http://dx.doi.org/10.1371/journal.pone.0198741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995912	Green Submitted, gold, Green Published			2022-12-26	WOS:000438388800012
J	Li, K; Zhang, JH; Yang, YJ; Hang, W; Yin, H				Li, Ke; Zhang, Jin-Hui; Yang, Yu-Jing; Hang, Wei; Yin, Huan			Morphology and fine organization of the midgut of Gampsocleis gratiosa (Orthoptera: Tettigoniidae)	PLOS ONE			English	Article							LIPID BODIES; AUTOPHAGY; ULTRASTRUCTURE; BIOGENESIS; LYSOSOME	The morphology and ultrastructure of the midgut of Gampsocleis gratiosa (Orthoptera: Tettigoniidae) was examined by light and electron microscopy. The midgut consists of two bulbous gastric caeca and a tubular ventriculus. The general organization of the gastric caeca is similar to that of the ventriculus. They are composed of a peritrophic membrane, an epithelium, a basal lamina and muscle layer from the inside to outside. Three types of cells were identified: regenerative, principal, and endocrine. Regenerative cells occur in groups (called nidi) at the base of principal cells. Principal cells grow from regenerative cells. Rare endocrine cells are scattered throughout the epithelium. Principal cells exhibit intense secretory activity, and regional differences in their ultrastructure were observed along the entire midgut. The microvilli are longer than those in any other region in the posterior region of the midgut. Lysosomes, multivesicular bodies (MVBs), autophagosomes, abundant Golgi apparatuses and lipid droplets primarily occur in the gastric caeca. Three pathways of secretion (merocrine, apocrine and holocrine) occur within the midgut epithelium, and a distinctive type of apocrine bleb was found in the gastric caeca. Therefore, these gastric caeca may be evolving toward a special type of gland.	[Li, Ke; Zhang, Jin-Hui; Yang, Yu-Jing; Yin, Huan] Shanxi Normal Univ, Coll Life Sci, Linfen, Shanxi, Peoples R China; [Li, Ke; Hang, Wei] Shanxi Normal Univ, Modern Coll Humanities & Sci, Linfen, Shanxi, Peoples R China	Shanxi Normal University; Shanxi Normal University	Yin, H (corresponding author), Shanxi Normal Univ, Coll Life Sci, Linfen, Shanxi, Peoples R China.	80831227@qq.com	zhang, jinhui/GXF-6528-2022; zhang, jin/GXV-9154-2022; yang, yujing/GXF-6999-2022	Yin, Huan/0000-0001-8755-3350; yang, yujing/0000-0002-1995-4029	Shanxi Province of China [2015540]	Shanxi Province of China	The undergraduate innovative experiment project of Shanxi Province of China (2015540) provided the funding to support this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTEE JH, 1977, J INSECT PHYSIOL, V23, P965, DOI 10.1016/0022-1910(77)90124-X; Biagio FP, 2009, J INSECT PHYSIOL, V55, P1125, DOI 10.1016/j.jinsphys.2009.08.015; Cakici Ozlem, 2012, Biharean Biologist, V6, P108; Chapman R.F., 1998, INSECT STRUCTRE FUNC, V4th Edn, DOI [10.1017/CBO9780511818202, DOI 10.1017/CBO9780511818202]; DROSTE HJ, 1974, J INSECT PHYSIOL, V20, P2385, DOI 10.1016/0022-1910(74)90025-0; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fialho MDCQ, 2009, ANN ENTOMOL SOC AM, V102, P119, DOI 10.1603/008.102.0113; Happ GM, 1984, INSECT ULTRASTRUCTUR, DOI [10.2307/1309435, DOI 10.2307/1309435]; Kadandale P, 2010, P NATL ACAD SCI USA, V107, P10502, DOI 10.1073/pnas.0914168107; Landim C, 1985, ZOOLOGIA, V3, P181; Li KX, 2016, ADVANCED MATERIAL ENGINEERING (AME 2015), P523; Li Zhao-Ying, 2004, Entomological Knowledge, V41, P244; Marana SR, 1997, J INSECT PHYSIOL, V43, P465, DOI 10.1016/S0022-1910(96)00117-5; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martin S, 2005, SEMIN CELL DEV BIOL, V16, P163, DOI 10.1016/j.semcdb.2005.01.007; Murphy DJ, 2001, PROG LIPID RES, V40, P325, DOI 10.1016/S0163-7827(01)00013-3; Nardi JB, 2009, ARTHROPOD STRUCT DEV, V38, P377, DOI 10.1016/j.asd.2009.04.003; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Roelfstra L, 2010, MED VET ENTOMOL, V24, P236, DOI 10.1111/j.1365-2915.2010.00881.x; Rost-Roszkowska MM, 2007, J MORPHOL, V268, P224, DOI 10.1002/jmor.10513; ROTHMAN JE, 1992, NATURE, V355, P409, DOI 10.1038/355409a0; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; SMITH RE, 1966, J CELL BIOL, V31, P319, DOI 10.1083/jcb.31.2.319; Terra, 2005, COMPREHENSIVE MOL IN, P171, DOI [10.1016/B0-44-451924-6/00053-3, DOI 10.1016/B0-44-451924-6/00053-3]; TERRA WR, 1990, ANNU REV ENTOMOL, V35, P181, DOI 10.1146/annurev.en.35.010190.001145; TERRA WR, 1988, J INSECT PHYSIOL, V34, P463, DOI 10.1016/0022-1910(88)90187-4; Waltermann M, 2005, J BACTERIOL, V187, P3607, DOI 10.1128/JB.187.11.3607-3619.2005; Wanderley-Teixeira V., 2006, Braz. J. Biol., V66, P1045, DOI 10.1590/S1519-69842006000600011; Wegener C, 2015, CURR OPIN INSECT SCI, V11, P8, DOI 10.1016/j.cois.2015.07.003; Xu HX, 2015, ANNU REV PHYSIOL, V77, P57, DOI 10.1146/annurev-physiol-021014-071649; Zhang FM, 2012, MICRON, V43, P725, DOI 10.1016/j.micron.2012.01.004	33	2	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200405	10.1371/journal.pone.0200405	http://dx.doi.org/10.1371/journal.pone.0200405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985965	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500041
J	Chen, ST; Kuo, TC; Liao, YY; Lin, MC; Tien, YW; Huang, MC				Chen, Syue-Ting; Kuo, Ting-Chun; Liao, Ying-Yu; Lin, Mei-Chun; Tien, Yu-Wen; Huang, Min-Chuan			Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; PHASE-I; CANCER-CELLS; EXPRESSION; MET; FIBROBLASTS; ACTIVATION; PROGNOSIS; STROMA; PHENOTYPES	Mucins are heavily glycosylated proteins that play critical roles in the pathogenesis of tumour malignancies. Pancreatic ductal adenocarcinoma (PDAC) is characterised by the aberrant expression of mucins. However, the role of mucin (MUC) 20 in PDAC remains unclear. PDAC is usually surrounded by a dense fibrotic stroma consisting of an extracellular matrix and pancreatic stellate cells (PSCs). The stroma creates a nutrient-deprived, hypoxic, and acidic microenvironment, and promotes the malignant behaviours of PDAC cells. In this study, immunohistochemical staining demonstrated that high MUC20 expression correlated with poor progression-free survival and high local recurrence rate of PDAC patients (n = 61). The expression of MUC20 was induced by serum deprivation, hypoxia, and acidic pH in PDAC cells. MUC20 knockdown with siRNA decreased cell viability, as well as migration and invasion induced by PSCs in HPAC and HPAF-II cells. In intraperitoneal, subcutaneous, and orthotopic injection models, MUC20 knockdown decreased tumour growth in immunodeficient mice. Phospho-RTK array and western blot analysis indicated that MUC20 knockdown decreased HGF-mediated phosphorylation of MET in PDAC cells. Moreover, HGF-induced malignant phenotypes could be suppressed by MUC20 knockdown. Co-immunoprecipitation revealed the physical association of MUC20 and MET. These findings suggest that MUC20 knockdown suppresses the malignant phenotypes of PDAC cells at least partially through the inhibition of the HGF/MET pathway and that MUC20 could act as a potential therapeutic target.	[Chen, Syue-Ting; Liao, Ying-Yu; Huang, Min-Chuan] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Kuo, Ting-Chun; Tien, Yu-Wen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Lin, Mei-Chun] Natl Taiwan Univ Hosp, Dept Otolaryngol, Hsinchu, Hsinchu, Taiwan; [Lin, Mei-Chun] Natl Taiwan Univ, Canc Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, MC (corresponding author), Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan.; Tien, YW (corresponding author), Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan.	ywtien5106@ntu.edu.tw; mchuang@ntu.edu.tw		TIEN, YU-WEN/0000-0002-9126-2705; HUANG, MIN-CHUAN/0000-0002-0704-3447; KUO, TING-CHUN/0000-0003-1960-1423	National Taiwan University Hospital [106-N3608]; Translational Research Program of National Taiwan University Hospital; National Taiwan University College of Medicine [107C101-B2, NSC-83]; Ministry of Science and Technology, Taiwan [104-2320-B-002-068-MY3, 106-2321-B-002-034]	National Taiwan University Hospital(National Taiwan University); Translational Research Program of National Taiwan University Hospital; National Taiwan University College of Medicine(National Taiwan University); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by National Taiwan University Hospital (106-N3608 to Dr. TCK), Translational Research Program of National Taiwan University Hospital and National Taiwan University College of Medicine (107C101-B2 and NSC-83 to Dr. MCH), and Ministry of Science and Technology, Taiwan (104-2320-B-002-068-MY3 to Dr. MCH and 106-2321-B-002-034 to Dr. YWT). In addition, we are grateful to Dr. WH Lee (Genomics Research Center, Academia Sinica, Taiwan) for providing human PDAC and PSC cell lines. We are grateful to Dr. SH Wang (Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taiwan) for providing reagents and technical assistance during revision process.	Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Chauhan SC, 2012, MOL CANCER THER, V11, P24, DOI 10.1158/1535-7163.MCT-11-0598; Chen CH, 2016, GYNECOL ONCOL, V140, P131, DOI 10.1016/j.ygyno.2015.11.025; Chen CH, 2013, GYNECOL ONCOL, V128, P560, DOI 10.1016/j.ygyno.2012.12.012; Erkan M, 2012, NAT REV GASTRO HEPAT, V9, P454, DOI 10.1038/nrgastro.2012.115; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Garajova Ingrid, 2015, Transl Oncogenomics, V7, P13, DOI 10.4137/TOG.S30534; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Goydos JS, 1996, J SURG RES, V63, P298, DOI 10.1006/jsre.1996.0264; Gulec SA, 2011, CLIN CANCER RES, V17, P4091, DOI 10.1158/1078-0432.CCR-10-2579; Haridas D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026839; Higuchi T, 2004, MOL CELL BIOL, V24, P7456, DOI 10.1128/MCB.24.17.7456-7468.2004; Higuchi T, 2004, J BIOL CHEM, V279, P1968, DOI 10.1074/jbc.M304558200; Kaur S, 2013, NAT REV GASTRO HEPAT, V10, P607, DOI 10.1038/nrgastro.2013.120; Kitajima Y, 2008, CANCER SCI, V99, P1341, DOI 10.1111/j.1349-7006.2008.00828.x; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Maitra A, 2008, ANNU REV PATHOL-MECH, V3, P157, DOI 10.1146/annurev.pathmechdis.3.121806.154305; Mei L, 2016, J GASTROINTEST ONCOL, V7, P487, DOI 10.21037/jgo.2016.03.03; Molina V, 2012, TUMOR BIOL, V33, P799, DOI 10.1007/s13277-011-0297-8; Moniaux N, 2006, J BIOL CHEM, V281, P23676, DOI 10.1074/jbc.M600302200; Nielsen MFB, 2016, WORLD J GASTROENTERO, V22, P2678, DOI 10.3748/wjg.v22.i9.2678; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Patel MB, 2014, CARCINOGENESIS, V35, P1891, DOI 10.1093/carcin/bgu122; Paulson AS, 2013, GASTROENTEROLOGY, V144, P1316, DOI 10.1053/j.gastro.2013.01.078; Pennacchietti S, 2003, CANCER CELL, V3, P347, DOI 10.1016/S1535-6108(03)00085-0; Pothula SP, 2016, BRIT J CANCER, V114, P269, DOI 10.1038/bjc.2015.478; Qian LW, 2003, CANCER LETT, V190, P105, DOI 10.1016/S0304-3835(02)00517-7; Ramanathan RK, 2005, CANCER IMMUNOL IMMUN, V54, P254, DOI 10.1007/s00262-004-0581-1; Rizwani W, 2015, CANCERS, V7, P1785, DOI 10.3390/cancers7030861; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Takikita M, 2009, CANCER RES, V69, P2950, DOI 10.1158/0008-5472.CAN-08-3879; Tanaka S, 2016, ANN SURG ONCOL, V23, P197, DOI 10.1245/s10434-015-4463-x; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Yamasaki H, 2004, INT J ONCOL, V24, P107; Yauch RL, 2012, CURR OPIN GENET DEV, V22, P45, DOI 10.1016/j.gde.2012.01.003	38	27	27	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6041	6053		10.1038/s41388-018-0403-0	http://dx.doi.org/10.1038/s41388-018-0403-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29993037	Green Published, hybrid			2022-12-26	WOS:000450175900003
J	Li, A; Chen, P; Leng, Y; Kang, JH				Li, Ang; Chen, Ping; Leng, Ye; Kang, Jiuhong			Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway	ONCOGENE			English	Article							TUMOR-STROMA; HDAC6; MICROENVIRONMENT; CELLS; INFLAMMATION; INHIBITORS; CHEMOTHERAPY; METASTASES; PROMOTION; FIBROSIS	Cancer-associated fibroblasts (CAFs) are important components in breast tumors and essential for tumor progression and metastasis. However, the role of epigenetic modification in driving the function of CAFs within breast tumors is only marginally known. Herein, we reported that histone deacetylase 6 (HDAC6), one of class II histone deacetylases, was frequently upregulated in the CAFs of breast tumor and promotes an immunosuppressive microenvironment. The genetic or pharmacologic disruption of HDAC6 in CAFs delays tumor growth, inhibits the tumor recruitment of myeloid-derived suppressor cells and regulatory T cells, alters the macrophage phenotype switch, and increases the CD8+ and CD4+ T-cell activation in vivo. Mechanistically, we identified prostaglandin E2/cyclooxygenase-2 (COX2) as a major target of HDAC6 in CAFs by regulating STAT3 activation. Overexpressing COX2 in HDAC6-knockdown CAFs can completely restore the immunosuppressive properties of the fibroblasts. Clinically, a positive correlation among the stromal expression levels of HDAC6, p-STAT3, and COX2 in human breast cancer was observed. High-stromal expression of HDAC6 was markedly associated with poor survival outcome. Overall, our findings indicated that fibroblastic HDAC6 was a vital epigenetic mediator involved in programming an immunosuppressive tumor microenvironment that dampens antitumor immunity. Thus, HDAC6 may be a good potential target to improve breast cancer immunotherapy.	[Li, Ang; Chen, Ping; Leng, Ye; Kang, Jiuhong] Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, 1239 Siping Rd, Shanghai 200092, Peoples R China	Tongji University	Kang, JH (corresponding author), Tongji Univ, Clin & Translat Res Ctr, Shanghai Matern & Infant Hlth Hosp 1, Shanghai Key Lab Signaling & Dis Res,Sch Life Sci, 1239 Siping Rd, Shanghai 200092, Peoples R China.	jhkang@tongji.edu.cn			Ministry of Science and Technology of China [2016YFA0101300]; Science and Technology Commission of Shanghai Municipality [16PJ1410200]; Fundamental Research Funds for the Central Universities [1501219171, 22120170068]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants obtained from the Ministry of Science and Technology of China (grant #2016YFA0101300), Science and Technology Commission of Shanghai Municipality (grant #16PJ1410200), and the Fundamental Research Funds for the Central Universities (grant #1501219171, 22120170068).	Chang AL, 2016, CANCER RES, V76, P5671, DOI 10.1158/0008-5472.CAN-16-0144; Cheng F, 2014, J IMMUNOL, V193, P2850, DOI 10.4049/jimmunol.1302778; Cheng F, 2014, MOL IMMUNOL, V60, P44, DOI 10.1016/j.molimm.2014.02.019; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cohen N, 2017, ONCOGENE, V36, P4457, DOI 10.1038/onc.2017.65; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fanelli A, 2017, THER ADV DRUG SAF, V8, P173, DOI 10.1177/2042098617690485; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Frangogiannis NG, 2017, J CLIN INVEST, V127, P1600, DOI 10.1172/JCI87491; Fulton AM, 2006, CANCER RES, V66, P9794, DOI 10.1158/0008-5472.CAN-06-2067; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karavitis J, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23129; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Lee HJ, 2017, CELL SIGNAL, V38, P1, DOI 10.1016/j.cellsig.2017.06.012; Li L, 2016, ONCOGENE, V35, P4048, DOI 10.1038/onc.2015.476; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; Marsh T, 2013, BBA-MOL BASIS DIS, V1832, P1070, DOI 10.1016/j.bbadis.2012.10.013; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Putcha P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0658-0; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Reader J, 2011, CANCER METAST REV, V30, P449, DOI 10.1007/s10555-011-9303-2; Regulski M, 2016, DRUG DISCOV TODAY, V21, P598, DOI 10.1016/j.drudis.2015.12.003; Scherz-Shouval R, 2014, CELL, V158, P564, DOI 10.1016/j.cell.2014.05.045; Schoepp M, 2017, CANCERS, V9, DOI 10.3390/cancers9060054; Schuetze KB, 2014, J MOL CELL CARDIOL, V70, P100, DOI 10.1016/j.yjmcc.2014.02.015; Schwartz H, 2016, CANCER RES, V76, P4359, DOI 10.1158/0008-5472.CAN-16-0485; Shalapour S, 2015, NATURE, V521, P94, DOI 10.1038/nature14395; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sharon Y, 2015, CANCER RES, V75, P963, DOI 10.1158/0008-5472.CAN-14-1990; Smith MP, 2016, CLIN CANCER RES, V22, P5966, DOI 10.1158/1078-0432.CCR-16-0954; Su CW, 2016, CRIT REV ONCOL HEMAT, V107, P33, DOI 10.1016/j.critrevonc.2016.08.010; Terranova-Barberio M, 2016, IMMUNOTHERAPY-UK, V8, P705, DOI 10.2217/imt-2016-0014; Wang HP, 2017, TRENDS CANCER, V3, P583, DOI 10.1016/j.trecan.2017.06.005; Wang SL, 2009, CELL MOL IMMUNOL, V6, P327, DOI 10.1038/cmi.2009.43; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Yan HL, 2012, CELL SIGNAL, V24, P961, DOI 10.1016/j.cellsig.2011.12.019; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Youn GS, 2015, GLIA, V63, P1953, DOI 10.1002/glia.22865; Zheng H, 2016, CLIN CANCER RES, V22, P4119, DOI 10.1158/1078-0432.CCR-15-2584	50	44	47	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5952	5966		10.1038/s41388-018-0379-9	http://dx.doi.org/10.1038/s41388-018-0379-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29980788				2022-12-26	WOS:000449562500004
J	Ivanov, IV; Kuester, S; MacKeben, M; Krumm, A; Haaga, M; Staudt, M; Cordey, A; Gehrlich, C; Martus, P; Trauzettel-Klosinski, S				Ivanov, Iliya V.; Kuester, Stephan; MacKeben, Manfred; Krumm, Anna; Haaga, Manja; Staudt, Martin; Cordey, Angelika; Gehrlich, Claudia; Martus, Peter; Trauzettel-Klosinski, Susanne			Effects of visual search training in children with hemianopia	PLOS ONE			English	Article							QUALITY-OF-LIFE; HOMONYMOUS HEMIANOPIA; FIELD DEFECTS; EYE-MOVEMENTS; T-TEST; STRATEGIES; REHABILITATION; IMPAIRMENT; EXOTROPIA; VISION	Background This study investigates the effect of a new computer-based visual search training (VST) that was adapted for children with homonymous hemianopia (HH). Methods 22 children with HH (median age 11 years, 8 months: 6y6m-19y2m) trained at home for 15 minutes twice/day, 5 days/week, for 6 weeks. To assess performance before training (T1), directly after training (T2) and 6 weeks after the end of training (T3), we measured search times (STs) during on-screen search (with eye tracking), and in a real life search task. Additional variables analyzed during on-screen search were numbers, amplitudes, and durations of saccades, their directional patterns and the proportional number of saccades into the non-seeing field. The latter was the main variable during free viewing. Sixteen healthy age-matched children, who did not undergo the training, served as comparison group. Quality of Life (QoL)-questionnaires were also applied. Results STs of the patients decreased significantly during the training and all search performance tests. This improvement persisted 6 weeks after the end of the training. Saccade amplitudes increased, total number of saccades to find the target decreased, and the proportional number of saccades to the non-seeing side increased. These changes were maintained at T3. Saccade durations did not change. During free viewing, saccades were equally distributed to both sides before and after training. Patients reported improvements in QoL and activities of daily living. Performance in the healthy children did not change by simply repeating the visual search test. Conclusions The improvement in STs in all search tasks, larger and fewer saccades, and an improved search strategy after VST suggests that the children with HH benefited from the training. The maintained improvement at T3 and the improvement in the real life search task indicate that the newly developed search strategy persists and can be applied to everyday life.	[Ivanov, Iliya V.; Kuester, Stephan; Krumm, Anna; Cordey, Angelika; Gehrlich, Claudia; Trauzettel-Klosinski, Susanne] Univ Tubingen, Vis Rehabil Res Unit, Ctr Ophthalmol, Tubingen, Germany; [Ivanov, Iliya V.] Univ Tubingen, Inst Ophthalm Res, ZEISS Vis Sci Lab, Ctr Ophthalmol, Tubingen, Germany; [MacKeben, Manfred] Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA; [Haaga, Manja; Staudt, Martin] Univ Childrens Hosp Tubingen, Pediat Neurol, Tubingen, Germany; [Staudt, Martin] Schon Klin Vogtareuth, Clin Neuropediat & Neurorehabil, Vogtareuth, Germany; [Martus, Peter] Univ Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; The Smith-Kettlewell Eye Research Institute; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen	Kuester, S (corresponding author), Univ Tubingen, Vis Rehabil Res Unit, Ctr Ophthalmol, Tubingen, Germany.	stephan.kuester@uni-tuebingen.de			Brunenbusch-Stein Foundation [T 093-22.758]; Herbert Funke Foundation [D.30.09599]; Kerstan Foundation [D.30.18776]; Kossmann Foundation [D.30.11453]; Niethammer Foundation	Brunenbusch-Stein Foundation; Herbert Funke Foundation; Kerstan Foundation(European Commission); Kossmann Foundation; Niethammer Foundation	This work was supported by Brunenbusch-Stein Foundation, T 093-22.758 to II; the Herbert Funke Foundation, D.30.09599 to MH; the Kerstan Foundation, D.30.18776 to STK; the Kossmann Foundation, D.30.11453 to AK; The Niethammer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brehmer Y, 2007, DEV PSYCHOL, V43, P465, DOI 10.1037/0012-1649.43.2.465; Brehmer Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00063; Cochrane GM, 2011, INVEST OPHTH VIS SCI, V52, P1632, DOI 10.1167/iovs.10-6079; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Haan GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166310; Donahue SP, 2007, J NEURO-OPHTHALMOL, V27, P304, DOI 10.1097/WNO.0b013e31815b9c2a; Dutton GN, 2004, EYE, V18, P27, DOI 10.1038/sj.eye.6700541; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fayel A, 2014, EXP BRAIN RES, V232, P903, DOI 10.1007/s00221-013-3803-y; Haaga M, 2018, NEUROPEDIATRICS; Harbert MJ, 2012, J NEURO-ONCOL, V107, P545, DOI 10.1007/s11060-011-0774-3; HERZAU V, 1988, GRAEF ARCH CLIN EXP, V226, P148, DOI 10.1007/BF02173304; Horton JC, GRAEFES ARCH CL 0114; HOYT CS, 1987, AUST NZ J OPHTHALMOL, V15, P57, DOI 10.1111/j.1442-9071.1987.tb00305.x; Huo R, 1999, BRIT J OPHTHALMOL, V83, P670, DOI 10.1136/bjo.83.6.670; Ivanov IV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157825; KERKHOFF G, 1992, RESTOR NEUROL NEUROS, V4, P245, DOI 10.3233/RNN-1992-4402; Khadka J, 2010, BRIT J OPHTHALMOL, V94, P730, DOI 10.1136/bjo.2009.171181; Koenraads Y, 2014, EPILEPSIA, V55, P909, DOI 10.1111/epi.12615; LEVY Y, 1995, J PEDIATR OPHTHALMOL, V32, P236; Machner B, 2009, ANN NY ACAD SCI, V1164, P419, DOI 10.1111/j.1749-6632.2009.03769.x; Mannan SK, 2010, J NEUROL, V257, P1812, DOI 10.1007/s00415-010-5615-3; MEIENBERG O, 1981, ANN NEUROL, V9, P537, DOI 10.1002/ana.410090605; Mezey LE, 1998, DEV MED CHILD NEUROL, V40, P626; Murray IC, 2009, OPHTHALMOLOGY, V116, P2017, DOI 10.1016/j.ophtha.2009.03.015; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Nyquist JB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37431; Pambakian ALM, 2000, J NEUROL NEUROSUR PS, V69, P751, DOI 10.1136/jnnp.69.6.751; Pambakian ALM, 2004, J NEUROL NEUROSUR PS, V75, P1443, DOI 10.1136/jnnp.2003.025957; Papageorgiou E, 2007, GRAEF ARCH CLIN EXP, V245, P1749, DOI 10.1007/s00417-007-0644-z; Paysse E A, 1997, J AAPOS, V1, P209, DOI 10.1016/S1091-8531(97)90039-2; Philip SS, 2014, CLIN EXP OPTOM, V97, P196, DOI 10.1111/cxo.12155; Pollock A, 2012, STROKE, V43, pE37, DOI 10.1161/STROKEAHA.111.639815; Porro G, 1998, NEURO-OPHTHALMOLOGY, V19, P205, DOI 10.1076/noph.19.4.205.3939; Rasch D, 2011, STAT PAP, V52, P219, DOI 10.1007/s00362-009-0224-x; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P148, DOI 10.1007/s00787-008-1016-x; Raz N, 2017, J NEUROL, V264, P1051, DOI 10.1007/s00415-016-8291-0; Reinhard J, 2005, BRIT J OPHTHALMOL, V89, P30, DOI 10.1136/bjo.2003.040543; Reinhard JI, 2014, J NEURO-OPHTHALMOL, V34, P354, DOI 10.1097/WNO.0000000000000146; Rosenholtz R, 2007, J VISION, V7, DOI 10.1167/7.2.17; Roth T, 2009, NEUROLOGY, V72, P324, DOI 10.1212/01.wnl.0000341276.65721.f2; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Tinelli F, 2015, MULTISENS RES, V28, P153, DOI 10.1163/22134808-00002484; Tinelli F, 2011, NEUROREHAB NEURAL RE, V25, P721, DOI 10.1177/1545968311407780; Tinga AM, 2016, NEUROPSYCHOL REV, V26, P73, DOI 10.1007/s11065-015-9301-1; Trauzettel-Klosinski S., 2017, HOMONYMOUS VISUAL FI, P121; Trauzettel-Klosinski S, 2010, J NEURO-OPHTHALMOL, V30, P73, DOI 10.1097/WNO.0b013e3181ce7e8f; TrauzettelKlosinski S, 1997, NEURO-OPHTHALMOLOGY, V18, P117, DOI 10.3109/01658109709044129; van Waveren M, 2013, GRAEF ARCH CLIN EXP, V251, P575, DOI 10.1007/s00417-012-2045-1; Vervloed MPJ, 2006, J DEV BEHAV PEDIATR, V27, P493, DOI 10.1097/00004703-200612000-00008; Waddington J, 2017, BRIT J VISUAL IMPA, V35, P197, DOI 10.1177/0264619617706100; Werth R, 1999, RESTOR NEUROL NEUROS, V15, P229; Werth R, 2005, NEUROPSYCHOLOGIA, V43, P2011, DOI 10.1016/j.neuropsychologia.2005.03.023; ZANGEMEISTER WH, 1995, OPTOMETRY VISION SCI, V72, P467, DOI 10.1097/00006324-199507000-00006; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.38; ZIHL J, 1995, NEUROPSYCHOLOGIA, V33, P287, DOI 10.1016/0028-3932(94)00119-A	56	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0197285	10.1371/journal.pone.0197285	http://dx.doi.org/10.1371/journal.pone.0197285			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020930	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400002
J	Nicolas, G; Apolloni, A; Coste, C; Wint, GRW; Lancelot, R; Gilbert, M				Nicolas, Gaelle; Apolloni, Andrea; Coste, Caroline; Wint, G. R. William; Lancelot, Renaud; Gilbert, Marius			Predictive gravity models of livestock mobility in Mauritania: The effects of supply, demand and cultural factors	PLOS ONE			English	Article							NETWORK; MOVEMENTS; OUTBREAK; SPREAD	Animal movements are typically driven by areas of supply and demand for animal products and by the seasonality of production and demand. As animals can potentially spread infectious diseases, disease prevention can benefit from a better understanding of the factors influencing movements patterns in space and time. In Mauritania, an important cultural event, called the Tabaski (Aid el Kebir) strongly affects timing and structure of movements, and due to the arid and semi-arid climatic conditions, the season can also influence movement patterns. In order to better characterize the animal movements patterns, a survey was carried out in 2014, and those data were analysed here using social network analysis (SNA) metrics and used to train predictive gravity models. More specifically, we aimed to contrast the movements structure by ruminant species, season (Tabaski vs. Non-Tabaski) and mode of transport (truck vs. foot). The networks differed according to the species, and to the season, with a changed proportion of truck vs. foot movements. The gravity models were able to predict the probability of a movement link between two locations with moderate to good accuracy (AUC ranging from 0.76 to 0.97), according to species, seasons, and mode of transport, but we failed to predict the traded volume of those trade links. The significant predictor variables of a movement link were the human and sheep population at the source and origin, and the distance separating the locations. Though some improvements would be needed to predict traded volumes and better account for the barriers to mobility, the results provide useful predictions to inform epidemiological models in space and time, and, upon external validation, could be useful to predict movements at a larger regional scale.	[Nicolas, Gaelle; Gilbert, Marius] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium; [Apolloni, Andrea; Lancelot, Renaud] CIRAD, Int Ctr Agron Res & Dev, Montpellier, France; [Coste, Caroline; Gilbert, Marius] Fonds Natl Rech Sci, Brussels, Belgium; [Wint, G. R. William] Univ Oxford, Dept Zool, ERGO, Oxford, England	Universite Libre de Bruxelles; CIRAD; Fonds de la Recherche Scientifique - FNRS; University of Oxford	Nicolas, G (corresponding author), Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium.	gaelle.nicolas6@gmail.com	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; Nicolas, Gaelle/0000-0002-7116-2811	EU [FP7-613996]; VMERGE Steering Committee as VMERGE000	EU(European Commission); VMERGE Steering Committee as VMERGE000	This study was funded by EU grant FP7-613996 VMERGE and is catalogued by the VMERGE Steering Committee as VMERGE000 (http://www.vmerge.eu). The contents of this publication are the sole responsibility of the authors and don't necessarily reflect the views of the European Commission.	Apolloni A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191565; Auguie B, 2017, GRIDEXTRA MISCELLANE; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barrios JM, 2012, INT J ENV RES PUB HE, V9, P4346, DOI 10.3390/ijerph9124346; Beaunee G, 2015, VET RES, V46, DOI [10.1186/s13567-015-0247-3, 10.1186/s13567-015-0218-8]; Biteye B, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2591-9; Black P, 2009, C OIE, P15; Chapman M, 2013, CIRCULATION POPULATI; Clarkson L, 2001, FEAST FAMINEFOOD NUT, DOI [10.1093/acprof:oso/9780198227519.001.0001/acprof-9780198227519, DOI 10.1093/ACPROF:OSO/9780198227519.001.0001/ACPROF-9780198227519]; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, CR BIOL, V330, P364, DOI 10.1016/j.crvi.2007.02.014; Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111; El Mamy AB, 2014, VECTOR-BORNE ZOONOT, V14, P856, DOI 10.1089/vbz.2014.1605; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; Fevre EM, 2006, TRENDS MICROBIOL, V14, P125, DOI 10.1016/j.tim.2006.01.004; Grace D., 2012, MAPPING POVERTY LIKE; Hammami P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161769; Ibra T, 2012, ATLAS TRENDS PASTORA; Jones BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149982; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kiss IZ, 2006, J R SOC INTERFACE, V3, P669, DOI 10.1098/rsif.2006.0129; L'Hote Y, 2002, HYDROLOG SCI J, V47, P563, DOI 10.1080/02626660209492960; Lancelot R, 2017, P NATL ACAD SCI USA, V114, P938, DOI 10.1073/pnas.1607948114; Lichoti JK, 2016, PREV VET MED, V126, P1, DOI 10.1016/j.prevetmed.2016.01.019; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; Moritz M., 2017, NETWORKS HAZARD ADAP, P193; Moslonka-Lefebvre M, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1099; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nicolas G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003346; Nicolas G, 2013, ACTA TROP, V126, P19, DOI 10.1016/j.actatropica.2012.12.013; Nicolas G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150424; Relun A, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00027; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Sarzynska M, 2013, ARXIV13084589QBIOSTA; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Wang X., 2014, PHYSICS, V11; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	41	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199547	10.1371/journal.pone.0199547	http://dx.doi.org/10.1371/journal.pone.0199547			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020968	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400017
J	Guyet, A; Dade-Robertson, M; Wipat, A; Casement, J; Smith, W; Mitrani, H; Zhang, M				Guyet, Aurelie; Dade-Robertson, Martyn; Wipat, Anil; Casement, John; Smith, Wendy; Mitrani, Helen; Zhang, Meng			Mild hydrostatic pressure triggers oxidative responses in Escherichia coli	PLOS ONE			English	Article							FE-S CLUSTER; GENE-EXPRESSION; IN-VIVO; HYDROGEN-PEROXIDE; CYSTEINE DESULFURASE; ASSEMBLY PROTEINS; IRON HOMEOSTASIS; SOS RESPONSE; SUF OPERON; STRESS	Hydrostatic pressure is an important physical stimulus which can cause various responses in bacterial cells. The survival and cellular processes of Escherichia coli under hydrostatic pressures between 10 MPaand 110 MPa have been studied. However, understanding bacterial responses to moderately elevated pressure of up to 10 MPa is useful for a range of different applications including for example in smart and responsive materials. In this study, the genetic responses of E. coli K-12 MG1655 to 1 MPa pressure was examined using transcriptomic analysis by RNA-Seq. The results show that 101 genes were differentially expressed under 1 MPa pressure in E. coli cells, with 85 of them up-regulated. The analysis suggested that some genes were over expressed to adapt the increase of oxygen levels in our system, and several functional categories are involved including oxidative stress responses, Fe-S cluster assembly and iron acquisition. Two differentially expressed genes azuCand entC were further investigated using RT-qPCR, and GFP reported strains of those two genes were created, AG1319 (P-azuC azuC-msfgfp) and AG1321 (P-entC entC-msfgfp). A linear response of azuC expression was observed between 0 MPa to 1 MPa by monitoring the fluorescence signal of strain AG1319 (P(azuC)azuC-msfgfp). This study is the first report to demonstrate the genetic response of bacterial cells under 1 MPa hydrostatic pressure, and provides preliminary data for creating pressure sensing bacterial strains for a wide range of applications.	[Guyet, Aurelie] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Dade-Robertson, Martyn; Wipat, Anil; Smith, Wendy] Newcastle Univ, Sch Comp, Newcastle Upon Tyne, Tyne & Wear, England; [Dade-Robertson, Martyn] Newcastle Univ, Sch Architecture Planning & Landscape, Newcastle Upon Tyne, Tyne & Wear, England; [Casement, John] Newcastle Univ, Fac Med Sci, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Mitrani, Helen] Newcastle Univ, Sch Engn, Newcastle Upon Tyne, Tyne & Wear, England; [Zhang, Meng] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Northumbria University	Zhang, M (corresponding author), Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England.	meng.zhang@northumbria.ac.uk	ZHANG, MENG/AAB-8613-2020	ZHANG, MENG/0000-0003-1089-6464; Wipat, Anil/0000-0001-7310-4191; Guyet, Aurelie/0000-0001-8971-7013; Casement, John/0000-0003-3514-7259	Engineering and Physical Sciences Research Council;  [EP/N005791/1];  [EP/R003629/1]; EPSRC [EP/R003777/1, EP/J02175X/1, EP/R003629/1, EP/N005791/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ; ; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was funded by the Engineering and Physical Sciences Research Council (https://www.epsrc.ac.uk/default.htm). Partially from fund reference NO. EP/N005791/1 and EP/R003629/1 and the recipients are MDR (PI), AW (CoI), HM (CoI) and MZ (CoI). Another part was fund by same funder and reference No. is EP/J02175X/1. AW is recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertsen A, 2005, MOL MICROBIOL, V58, P1381, DOI 10.1111/j.1365-2958.2005.04903.x; Aertsen A, 2005, APPL ENVIRON MICROB, V71, P2226, DOI 10.1128/AEM.71.5.2226-2231.2005; Aertsen A, 2004, J BACTERIOL, V186, P6133, DOI 10.1128/jb.186.18.6133-6141.2004; Aertsen A, 2008, HIGH-PRESSURE MICROBIOLOGY, P87; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Baez A, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-23; Bowman JP, 2008, MICROBIOL-SGM, V154, P462, DOI 10.1099/mic.0.2007/010314-0; Braun V, 1997, BIOL CHEM, V378, P779; Cabiscol Elisa, 2000, International Microbiology, V3, P3; COTTER PA, 1990, J BACTERIOL, V172, P6333, DOI 10.1128/jb.172.11.6333-6338.1990; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; Dade-Robertson M, 2016, ACADIA 2016 C 27 29; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Fang JS, 2010, TRENDS MICROBIOL, V18, P413, DOI 10.1016/j.tim.2010.06.006; Fernandez-Rodriguez J, 2017, NAT CHEM BIOL, V13, P706, DOI 10.1038/nchembio.2390; Follonier S, 2012, APPL MICROBIOL BIOT, V93, P1805, DOI 10.1007/s00253-011-3854-6; Giel JL, 2013, MOL MICROBIOL, V87, P478, DOI 10.1111/mmi.12052; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hantke K, 1997, J BACTERIOL, V179, P6201, DOI 10.1128/jb.179.19.6201-6204.1997; Hanzelmann P, 2004, J BIOL CHEM, V279, P34721, DOI 10.1074/jbc.M313398200; Hemm MR, 2010, J BACTERIOL, V192, P46, DOI 10.1128/JB.00872-09; Hesterkamp T, 1998, EMBO J, V17, P4818, DOI 10.1093/emboj/17.16.4818; Hidese R, 2014, J BACTERIOL, V196, P1238, DOI 10.1128/JB.01160-13; Ishii A, 2005, EXTREMOPHILES, V9, P65, DOI 10.1007/s00792-004-0414-3; Ishii A, 2004, MICROBIOL-SGM, V150, P1965, DOI 10.1099/mic.0.26962-0; Jahn N, 2015, MOL MICROBIOL, V98, P651, DOI 10.1111/mmi.13146; Jang SJ, 2010, MOL MICROBIOL, V78, P1448, DOI 10.1111/j.1365-2958.2010.07418.x; Lau CKY, 2016, FEMS MICROBIOL REV, V40, P273, DOI 10.1093/femsre/fuv049; Lee JH, 2004, MOL MICROBIOL, V51, P1745, DOI 10.1111/j.1365-2958.2003.03946.x; Lee KC, 2008, J BACTERIOL, V190, P8244, DOI 10.1128/JB.01161-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loiseau L, 2003, J BIOL CHEM, V278, P38352, DOI 10.1074/jbc.M305953200; Malone AS, 2006, APPL ENVIRON MICROB, V72, P2661, DOI 10.1128/AEM.72.4.2661-2671.2006; Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Oger PM, 2010, RES MICROBIOL, V161, P799, DOI 10.1016/j.resmic.2010.09.017; Ouzounov N, 2016, BIOPHYS J, V111, P1035, DOI 10.1016/j.bpj.2016.07.017; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; PARK SJ, 1995, MOL MICROBIOL, V15, P473, DOI 10.1111/j.1365-2958.1995.tb02261.x; PIERCE JR, 1986, J BACTERIOL, V166, P930, DOI 10.1128/jb.166.3.930-936.1986; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Raulfs EC, 2008, P NATL ACAD SCI USA, V105, P8591, DOI 10.1073/pnas.0803173105; Roche B, 2015, MOL MICROBIOL, V95, P605, DOI 10.1111/mmi.12888; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Sato T, 1996, FEMS MICROBIOL LETT, V135, P111; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Schwartz CJ, 2000, P NATL ACAD SCI USA, V97, P9009, DOI 10.1073/pnas.160261497; Seo SW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5910; Sutton VR, 2004, BIOCHEMISTRY-US, V43, P791, DOI 10.1021/bi0357053; Sutton VR, 2004, J BACTERIOL, V186, P8018, DOI 10.1128/JB.186.23.8018-8025.2004; Tao K, 1997, J BACTERIOL, V179, P5967, DOI 10.1128/jb.179.18.5967-5970.1997; Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; WELCH TJ, 1993, J BACTERIOL, V175, P7170, DOI 10.1128/JB.175.22.7170-7177.1993; YAYANOS AA, 1969, BIOPHYS J, V9, P1464, DOI 10.1016/S0006-3495(69)86466-0; Yeo WS, 2006, MOL MICROBIOL, V61, P206, DOI 10.1111/j.1365-2958.2006.05220.x; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; ZOBELL CE, 1962, J BACTERIOL, V84, P1228, DOI 10.1128/JB.84.6.1228-1236.1962	60	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200660	10.1371/journal.pone.0200660	http://dx.doi.org/10.1371/journal.pone.0200660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016375	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000438866600032
J	Chiang, TY; Fan, SY; Jou, RW				Chiang, Ting-Yi; Fan, Shin-Yuan; Jou, Ruwen			Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MULTIDRUG-RESISTANCE; MTB/RIF ASSAY; TRANSMISSION; DNA	Timely diagnosis of drug-resistant tuberculosis (DR-TB) is beneficial for case treatment and management. We implemented an algorithm to improve molecular diagnostic utilization to intensify DR-TB case findings. The GeneXpert MTB/RIF (Xpert) test was used for initial diagnosis. Samples with Mycobacterium tuberculosis complex (MTBC)-positive and rifampicin resistance (RR) results were subsequently and simultaneously tested using the GenoType MTBDRp/us (DRplus) and MTBDRs/(DRs/) tests. This prospective cohort study enrolled 2957 high-risk DR-TB cases. We tested sputum specimens using conventional mycobacteriological and molecular tests. Gene sequencing was performed to resolve discordant results. According to the Xpert test, 33.6% of specimens were MTBC-positive and 5.1% were RR. RR specimens were further analyzed in the DRplus and DRs/tests. We identified 1 extensively drug-resistant (XDR), 8 pre-XDR, 18 simple multidrug-resistant (MDR), 22 mono-RR, and 2 RR cases with concurrent second-line injection DR-TB. Of these, 25 (49%) were relapses, 13 (25.5%) were treatment failures, 10 (19.6%) were from MDR-TB high-incidence areas/countries, 1 was from MDR-TB contact and 2 were unknown. Among culture-positive TB cases, the sensitivities, specificities, and positive predictive values (PPVs) of the Xpert test and RR cases were 73.6% and 100.0%, 85.7% and 98.6%, and 73.5% and 80.0%, respectively. Gene sequencing of discordant results revealed 7 disputed rpoB mutations and 2 silent mutations for RIF, 1 ahpC mutation for isoniazid and 1 gyrA mutation for fluoroquinolone. The algorithm effectively identified approximately 23% of annual MDR-/XDR-TB and 37.5% of RR-TB cases that were enrolled in our DR-TB treatment and management program within 3 days.	[Chiang, Ting-Yi; Fan, Shin-Yuan; Jou, Ruwen] Ctr Dis Control, TB Res Ctr, Taipei, Taiwan; [Chiang, Ting-Yi; Fan, Shin-Yuan; Jou, Ruwen] Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan; [Jou, Ruwen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University	Jou, RW (corresponding author), Ctr Dis Control, TB Res Ctr, Taipei, Taiwan.; Jou, RW (corresponding author), Ctr Dis Control, Res & Diagnost Ctr, Taipei, Taiwan.; Jou, RW (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan.	rwj@cdc.gov.tw			Taiwan CDC, Ministry of Health and Welfare [MOHW105-CDC-C-315-123104, MOHW106-CDC-C-315-113701]	Taiwan CDC, Ministry of Health and Welfare	This research was supported by grants from Taiwan CDC, Ministry of Health and Welfare (Grant number: MOHW105-CDC-C-315-123104 and MOHW106-CDC-C-315-113701 to RJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1981, AM REV RESPIR DIS, V123, P343; Aung WW, 2015, ANN LAB MED, V35, P494, DOI 10.3343/alm.2015.35.5.494; Bai YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150321; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Cepheid, 2013, XPERT MTB RIF ASS PA; Chang CW, 2011, INFECT GENET EVOL, V11, P633, DOI 10.1016/j.meegid.2011.01.021; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Chuang PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165222; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Georghiou SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033275; Hain Life Sciences, 2012, GEN MTBDRPLUS VER 2; Hain Life Sciences, 2015, GENOTYPE MTBDRS VER; Heyckendorf J, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01550-17; Ho J, 2013, J ANTIMICROB CHEMOTH, V68, P2915, DOI 10.1093/jac/dkt284; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Huang WL, 2009, J CLIN MICROBIOL, V47, P2520, DOI 10.1128/JCM.02499-08; Jo KW, 2017, TUBERC RESPIR DIS, V80, P270, DOI 10.4046/trd.2017.80.3.270; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lin HC, 2017, EUR J CLIN MICROBIOL, V36, P2431, DOI 10.1007/s10096-017-3082-9; Mboowa G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-481; Ochang Ernest A, 2016, Int J Mycobacteriol, V5 Suppl 1, pS145, DOI 10.1016/j.ijmyco.2016.09.007; Pai M, 2015, J INFECT DIS, V211, pS21, DOI 10.1093/infdis/jiu803; Rahman A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152694; Rice JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186139; Tagliani E, 2015, J CLIN MICROBIOL, V53, P2961, DOI 10.1128/JCM.01257-15; Taiwan CDC, 2017, TAIWAN GUIDELINES TB; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Traore H, 2006, J CLIN MICROBIOL, V44, P4384, DOI 10.1128/JCM.01332-06; Trauner A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1196-0; Van Deun A, 2015, INT J TUBERC LUNG D, V19, P185, DOI 10.5588/ijtld.14.0651; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; van Ingen J, 2011, INT J TUBERC LUNG D, V15, P990, DOI 10.5588/ijtld.10.0127; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; WHO, 2003, GUID SURV DRUG RES T; WHO, 2017, GLOB TUB REP 2017; World Health Organization, 2016, US MOL LIN PROB ASS; World Health Organization, 2015, IMPL TUB DIAGN POL F; World Health Organization, 2015, GLOB TUB REP 2015; Yu MC, 2015, EUR RESPIR J, V45, P272, DOI 10.1183/09031936.00080614; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200755	10.1371/journal.pone.0200755	http://dx.doi.org/10.1371/journal.pone.0200755			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011319	Green Published, gold			2022-12-26	WOS:000438829800049
J	Liao, CS; Chen, SB; Guo, ZQ; Ye, SW; Zhang, TL; Li, ZJ; Murphy, BR; Liu, JS				Liao, Chuansong; Chen, Sibao; Guo, Zhiqiang; Ye, Shaowen; Zhang, Tanglin; Li, Zhongjie; Murphy, Brian R.; Liu, Jiashou			Species-specific variations in reproductive traits of three yellow catfish species (Pelteobagrus spp.) in relation to habitats in the Three Gorges Reservoir, China	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; YANGTZE-RIVER; PHENOTYPIC PLASTICITY; ENVIRONMENTAL-FACTORS; SEX-DIFFERENTIATION; EGG SIZE; FISH; FECUNDITY; POPULATION; DAMS	The reproductive biology of three yellow catfish congeners was studied in the Three Gorges Reservoir of the Yangtze River, China. We compared reproductive traits among the lentic, transitional, and lotic zones. A total of 4502 individuals of the three species was collected, and the sex ratio, size at 50% maturity, spawning season, fecundity, and egg size were determined. Results showed that populations inhabiting the lotic zone spawned earlier than those inhabiting the lentic zone. For the three species, fecundities were significantly higher for populations in the lotic zone than for those in the lentic and transitional zones (P < 0.05). Pelteobagrus vachelli (Richardson) and P. fulvidraco (Richardson) displayed an obvious trade-off between egg size and fecundity, whereas P. nitidus (Sauvage et Dabry) produced the largest eggs in the lotic zone. Sex ratios were significantly different among zones (P < 0.05, for each species), but the bias patterns were different. Sizes at 50% maturity of female P. nitidus and P. vachelli were the largest in the lotic zone and the smallest in the transitional zone, but was similar among zones for P. fulvidraco. Overall results suggest that the three yellow catfish species developed different reproductive traits among the three habitats in the TGR, whereas the variations reflected further interspecific differences. Our study indicates the importance of riverine habitats for the conservation of species of fish, even for species such as these eurytopic catfish inhabiting the upper reach of the Yangtze River. This study further suggests that species-specific responses should be considered when evaluating the influences of new hydropower projects, even for such closely related species of fish.	[Liao, Chuansong; Chen, Sibao; Ye, Shaowen; Zhang, Tanglin; Li, Zhongjie; Liu, Jiashou] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China; [Liao, Chuansong; Chen, Sibao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Guo, Zhiqiang] Hainan Univ, Haikou, Hainan, Peoples R China; [Murphy, Brian R.] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hainan University; Virginia Polytechnic Institute & State University	Liu, JS (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Hubei, Peoples R China.	jsliu@ihb.ac.cn		Ye, Shaowen/0000-0003-3932-8401	Earmarked Fund for China Agriculture Research System [CARS-45]; National Science and Technology Supporting Program of China [2012BAD25B08]; China Three Gorges Corporation Project [CT-12-08-01]; State Key Laboratory of Freshwater Ecology and Biotechnology [2014FBZ04]; USDA National Institute of Food and Agriculture (Hatch Project) [230537]; Acorn Alcinda Foundation, Lewes, Delaware, USA	Earmarked Fund for China Agriculture Research System; National Science and Technology Supporting Program of China; China Three Gorges Corporation Project; State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); USDA National Institute of Food and Agriculture (Hatch Project); Acorn Alcinda Foundation, Lewes, Delaware, USA	This work was funded by (1) The Earmarked Fund for China Agriculture Research System (CARS-45), http://www.moa.gov.cn/zwllm/tzgg/tz/201703/t20170320_5530342.htm, Jiashou Liu; (2) The National Science and Technology Supporting Program of China (2012BAD25B08), http://program.most.gov.cn/, Jiashou Liu; (3) The China Three Gorges Corporation Project (CT-12-08-01), http://www.ctg.com.cn/sxjt/kjcx/_301965/index.html, Zhongjie Li and Jiashou Liu; (4) The State Key Laboratory of Freshwater Ecology and Biotechnology (2014FBZ04), http://febl.ihb.cas.cn/, Jiashou Liu and Zhongjie Li; (5) USDA National Institute of Food and Agriculture (Hatch Project 230537), Brian R. Murphy; and (6) The Acorn Alcinda Foundation, Lewes, Delaware, USA, Brian R Murphy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MP, 2009, HYDROBIOLOGIA, V627, P181, DOI 10.1007/s10750-009-9727-7; Allan JD, 2013, P NATL ACAD SCI USA, V110, P372, DOI 10.1073/pnas.1213841110; Baker JA, 2002, ECOL FRESHW FISH, V11, P20, DOI 10.1034/j.1600-0633.2002.110104.x; Baroiller JF, 2009, SEX DEV, V3, P118, DOI 10.1159/000223077; BAXTER RM, 1977, ANNU REV ECOL SYST, V8, P255, DOI 10.1146/annurev.es.08.110177.001351; Cao L, 2009, ENVIRON BIOL FISH, V86, P75, DOI 10.1007/s10641-008-9342-x; Cheng F, 2015, REV FISH BIOL FISHER, V25, P569, DOI 10.1007/s11160-015-9395-9; Cheng Xiao-chun, 2007, Zoological Research, V28, P73; Closs GP, 2013, FRESHWATER BIOL, V58, P1162, DOI 10.1111/fwb.12116; de Merona B, 2009, NEOTROP ICHTHYOL, V7, P683, DOI 10.1590/S1679-62252009000400018; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Duan Z., 1999, ACTA HYDR SIN, V23, P610; Franchi E, 2014, J LIMNOL, V73, P203, DOI 10.4081/jlimnol.2014.876; Fu BJ, 2010, PROG PHYS GEOG, V34, P741, DOI 10.1177/0309133310370286; Gao X, 2010, ENVIRON BIOL FISH, V87, P163, DOI 10.1007/s10641-009-9577-1; Godinho AL, 2010, ENVIRON BIOL FISH, V87, P143, DOI 10.1007/s10641-009-9574-4; Gois KS, 2015, HYDROBIOLOGIA, V746, P401, DOI 10.1007/s10750-014-2061-8; Gong WB, 2009, J FRESHWATER ECOL, V24, P529, DOI 10.1080/02705060.2009.9664329; Hassel K, 2005, ECOGRAPHY, V28, P71, DOI 10.1111/j.0906-7590.2005.03910.x; Jigyasu HV, 2010, J WATER HEALTH, V8, P109, DOI 10.2166/wh.2009.035; Jones PE, 2016, ECOL FRESHW FISH, V25, P174, DOI 10.1111/eff.12200; Kendall NW, 2013, OIKOS, V122, P411, DOI 10.1111/j.1600-0706.2012.20319.x; Korta M, 2010, FISH RES, V104, P64, DOI 10.1016/j.fishres.2009.03.007; Le Bris A, 2017, FISH RES, V186, P397, DOI 10.1016/j.fishres.2016.09.008; Li J, 2013, J HYDROL ENG, V18, P1563, DOI 10.1061/(ASCE)HE.1943-5584.0000759; Lima AC, 2016, HYDROBIOLOGIA, V763, P207, DOI 10.1007/s10750-015-2377-z; Liu HQ, 2013, MAR BIOTECHNOL, V15, P321, DOI 10.1007/s10126-012-9487-7; Lopez-Pujol J, 2009, J NAT HIST, V43, P2765, DOI 10.1080/00222930903220010; Mazzoni R, 2002, J FISH BIOL, V61, P1606, DOI 10.1006/jfbi.2002.2178; McCully P, 1995, SILENCED RIVERS ECOL; MEP (Ministry of Environmental Protection of People's Republic of China), 1997, EC ENV B 3 GORG PROJ; Meurer S, 2012, NEOTROP ICHTHYOL, V10, P159, DOI 10.1590/S1679-62252012000100015; MILTON DA, 1995, ICES J MAR SCI, V52, P111, DOI 10.1016/1054-3139(95)80020-4; Pelicice FM, 2015, FISH FISH, V16, P697, DOI 10.1111/faf.12089; Perera HACC, 2013, J APPL ICHTHYOL, V29, P1061, DOI 10.1111/jai.12261; Perkin JS, 2017, CAN J FISH AQUAT SCI, V74, P228, DOI 10.1139/cjfas-2015-0593; Qiu CG, 2000, FISHERY SCI, V19, P28, DOI [10.16378/j.cnki.1003-1111.2000.02.016, DOI 10.16378/J.CNKI.1003-1111.2000.02.016]; Robinson BW, 1996, EVOL ECOL, V10, P631, DOI 10.1007/BF01237711; Shao ML, 2008, INT REV HYDROBIOL, V93, P175, DOI 10.1002/iroh.200710971; Siddiqui AQ, 1997, AQUAC RES, V28, P341; Sinovcic G, 2008, ESTUAR COAST SHELF S, V76, P739, DOI 10.1016/j.ecss.2007.07.037; Stauffer JR, 2004, ANIM BIOL, V54, P137, DOI 10.1163/1570756041445191; STEARNS SC, 1983, EVOLUTION, V37, P601, DOI [10.2307/2408273, 10.1111/j.1558-5646.1983.tb05577.x]; Tagliaferro M, 2017, HYDROBIOLOGIA, V784, P35, DOI 10.1007/s10750-016-2850-3; Takasuka A, 2005, FISH RES, V76, P475, DOI 10.1016/j.fishres.2005.07.003; Terossi M, 2010, MAR ECOL-EVOL PERSP, V31, P584, DOI 10.1111/j.1439-0485.2010.00387.x; THORPE JE, 1984, AQUACULTURE, V43, P289, DOI 10.1016/0044-8486(84)90030-9; Thorsen A, 2010, FISH RES, V104, P45, DOI 10.1016/j.fishres.2010.03.020; Vrtilek M, 2015, ECOL FRESHW FISH, V24, P616, DOI 10.1111/eff.12175; Wang BaoQiang, 2015, Acta Hydrobiologica Sinica, V39, P965; Wang JN, 2014, FRESHWATER BIOL, V59, P1343, DOI 10.1111/fwb.12348; Wang N, 2010, REV AQUACULT, V2, P209, DOI 10.1111/j.1753-5131.2010.01037.x; Wang QG, 2013, CLEAN-SOIL AIR WATER, V41, P1039, DOI 10.1002/clen.201200066; Wang Y, 2011, YANGTZE RIVER, V42, P5, DOI [10.16232/j.cnki.1001-4179.2011.15.022, DOI 10.16232/J.CNKI.1001-4179.2011.15.022]; Wang ZW, 2004, BIOCHEM GENET, V42, P391, DOI 10.1023/B:BIGI.0000043951.30411.7a; WCD-World Comission on Dams, 2000, DAMS DEV NEW FRAM DE; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199; WINEMILLER KO, 1989, OECOLOGIA, V81, P225, DOI 10.1007/BF00379810; Wooton R.J., 2015, REPROD BIOL TELEOST; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2; Wu Q., 2007, FRESHWATER FISHERIES, V37, P70, DOI DOI 10.3969/J.ISSN.1000-6907.2007.02.018; Xia YG, 2016, CHIN J OCEANOL LIMN, V34, P19, DOI 10.1007/s00343-015-4214-7; Xiao Tiao-Yi, 2003, Chinese Journal of Zoology, V38, P83; Xiong Fei, 2015, Acta Ecologica Sinica, V35, P7320; Yang G, 2005, FRESHWATER FISHERIES, V35, P31, DOI [10.3969/j.issn.1000-6907.2005.06.009, DOI 10.3969/J.ISSN.1000-6907.2005.06.009]; Yang Jiayun, 1994, Journal of Southwest China Normal University Natural Science, V19, P639; Ye C, 2011, J HAZARD MATER, V191, P366, DOI 10.1016/j.jhazmat.2011.04.090; Yi YJ, 2010, J HYDROL, V387, P283, DOI 10.1016/j.jhydrol.2010.04.018; Zhang GS, 2016, AQUACULT REP, V3, P115, DOI 10.1016/j.aqrep.2016.01.001; Zhang L, 2012, ANHUI AGR SCI B, V18, P164, DOI [10.16377/j.cnki.issn1007-7731.2012.11.087, DOI 10.16377/J.CNKI.ISSN1007-7731.2012.11.087]; Zhang Xiong, 2014, Changjiang Liuyu Ziyuan Yu Huanjing, V23, P496; [赵莎莎 Zhao Shasha], 2015, [水生生物学报, Acta Hydrobiologica Sinica], V39, P973; Zhou JZ, 2014, ECOL INFORM, V20, P33, DOI 10.1016/j.ecoinf.2014.01.008; Zhu FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088033; 2004, KOREAN J APPL ENTOMO, V43, P211	75	4	6	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199990	10.1371/journal.pone.0199990	http://dx.doi.org/10.1371/journal.pone.0199990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011287	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800009
J	Lee, MS; Moon, MH; Woo, H; Sung, CK; Oh, S; Jeon, HW; Lee, TS				Lee, Myoung Seok; Moon, Min Hoan; Woo, Hyunsik; Sung, Chang Kyu; Oh, Sohee; Jeon, Hye Won; Lee, Taek Sang			CT findings of adnexal torsion: A matched case-control study	PLOS ONE			English	Article							OVARIAN TORSION; FEATURES; PAIN; DEPICTION; DIAGNOSIS; MRI	Objective The purpose of our study was to assess computed tomographic (CT) findings of adnexal torsion through a matched case-control analysis. Materials and methods This retrospective, single-institution case-control study included 43 women with adnexal torsion and 43 age- and ovarian mass-matched control women. CT images were evaluated independently by two readers for the following: prominent peripheral follicles, uterine deviation, thickened pedicles, a whirl sign, and a navel sign. Comparisons of CT findings were performed using the Chi square test and receiver operating characteristic (ROC) curves were obtained to assess the diagnostic performance. Differences between the areas under the ROC curves (AUCs) were compared by using a Delong test. Results The CT findings significant for adnexal torsion were uterine deviation toward the side of the affected ovary (P= < .01 for reader 1 and P= .02 for reader 2) and thickened pedicles with ancillary findings including a whirl sign, a navel sign, and uterine deviation facing thickened pedicles (P < .01 for both readers). Thickened pedicles with ancillary findings had the highest diagnostic accuracy, as measured with ROC curves (AUC, 0.86 in reader 1 and 0.85 in reader 2). Combining uterine deviation toward the side of the affected ovary with thickened pedicles with ancillary findings did not increase the performance relative to that of thickened pedicles with ancillary findings alone. Conclusions Thickened pedicles with ancillary findings including a whirl sign, a navel sign, and uterine deviation facing thickened pedicles could be helpful for the diagnosis of adnexal torsion.	[Lee, Myoung Seok; Moon, Min Hoan; Woo, Hyunsik; Sung, Chang Kyu] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea; [Oh, Sohee] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Biostat, Coll Med, Seoul, South Korea; [Jeon, Hye Won; Lee, Taek Sang] Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Moon, MH (corresponding author), Seoul Natl Univ, SMG SNU Boramae Med Ctr, Dept Radiol, Coll Med, Seoul, South Korea.	mmhoan@gmail.com		Moon, Min Hoan/0000-0003-2448-2895				Breivik EK, 2000, CLIN J PAIN, V16, P22, DOI 10.1097/00002508-200003000-00005; Chang HC, 2008, RADIOGRAPHICS, V28, P1355, DOI 10.1148/rg.285075130; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duigenan S, 2012, AM J ROENTGENOL, V198, pW122, DOI 10.2214/AJR.10.7293; Fleischer AC, 2001, J ULTRAS MED, V20, P241; HIBBARD LT, 1985, AM J OBSTET GYNECOL, V152, P456, DOI 10.1016/S0002-9378(85)80157-5; Hiller N, 2007, AM J ROENTGENOL, V189, P124, DOI 10.2214/AJR.06.0073; Houry D, 2001, ANN EMERG MED, V38, P156, DOI 10.1067/mem.2001.114303; Il Jung S, 2011, J OBSTET GYNAECOL RE, V37, P228, DOI 10.1111/j.1447-0756.2010.01380.x; Jung SI, 2015, KOREAN J RADIOL, V16, P835, DOI 10.3348/kjr.2015.16.4.835; Katz J, 1999, SURG CLIN N AM, V79, P231, DOI 10.1016/S0039-6109(05)70381-9; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lee EJ, 1998, J ULTRAS MED, V17, P83; Lee MH, 2014, ABDOM IMAGING, V39, P1350, DOI 10.1007/s00261-014-0158-1; Lee SL, 2016, DIAGN INTERV IMAG, V97, P899, DOI 10.1016/j.diii.2016.03.004; Lourenco AP, 2014, EMERG RADIOL, V21, P179, DOI 10.1007/s10140-013-1163-3; Moore C, 2009, EMERG RADIOL, V16, P115, DOI 10.1007/s10140-008-0754-x; Pedrosa I, 2007, RADIOGRAPHICS, V27, P721, DOI 10.1148/rg.273065116; Rha SE, 2002, RADIOGRAPHICS, V22, P283, DOI 10.1148/radiographics.22.2.g02mr02283; Sasaki KJ, 2014, J MINIM INVAS GYN, V21, P196, DOI 10.1016/j.jmig.2013.09.010; WARNER MA, 1985, RADIOLOGY, V154, P773, DOI 10.1148/radiology.154.3.3881798; White Melissa, 2005, Emerg Med Australas, V17, P231	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200190	10.1371/journal.pone.0200190	http://dx.doi.org/10.1371/journal.pone.0200190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995921	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800045
J	Pereira, FB; Luque, JL; Tavares, LER				Pereira, Felipe Bisaggio; Luque, Jose Luis; Roland Tavares, Luiz Eduardo			Integrative approach on Pharyngodonidae (Nematoda: Oxyuroidea) parasitic in reptiles: Relationship among its genera, importance of their diagnostic features, and new data on Parapharyngodon bainae	PLOS ONE			English	Article							OXYURIDA PHARYNGODONIDAE; MEXICO; DIVERSITY; EVOLUTION; FISHES; SPP.	The first integrative approach using sequences of two genes (18S and 28S rRNA) plus morphological and life history traits, was explored in Pharyngodonidae nematodes parasitic in reptiles. Additionally, first genetic characterization of Parapharyngodon bainae and new data on its morphology are given. This approach evaluated the phylogenetic relationships among genera within Pharyngodonidae, as well as the importance of their diagnostic morphological features. Specimens of P. bainae were collected from faecal pellets of the lizard Tropidurus torquatus in the State of Minas Gerais, Brazil. Nematodes were fixed for scanning electron microscopy and molecular procedures. Morphological observations revealed the accurate structures of cephalic end, of cloacal region in males, of vulva and eggs. Phylogenetic reconstructions were based upon four datasets: aligned sequences of the 18S, of the 28S, of both concatenated genes and of combined morphological and molecular datasets. Bayesian inference and maximum likelihood were performed to infer the phylogenies of molecular datasets and maximum parsimony to infer that of all-combined data. Pharyngodonid parasites of reptiles seem to configure two general monophyletic lineages, as previously assertions. Results also showed the monophyly of Spauligodon, Skrjabinodon and Parapharyngodon, as well as the clear separation between the latter and Thelandros. Combination of datasets improved nodal supports. Analysis of the all-combined datasets revealed the importance of vulval position and egg morphology as phylogenetic informative traits. However, characters of male caudal morphology appear as are highly homoplastic, and seem to be product of convergent evolution or multiple losses of ancestral traits. The closely-related Thelandros and Parapharyngodon are kept valid and their diagnosis should be based upon the position of the operculum in eggs (terminal or subterminal, respectively). Some inconsistencies in the scarce molecular and morphological databases were noted. Thus, new genetic data is required for further conclusions and current database must be evaluated with attention.	[Pereira, Felipe Bisaggio; Roland Tavares, Luiz Eduardo] Univ Fed Mato Grosso do Sul, Programa Posgrad Biol Anim, Inst Biociencias, Campo Grande, Brazil; [Luque, Jose Luis] Univ Fed Rural Rio de Janeiro, Inst Vet, Dept Parasitol Anim, Seropedica, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Pereira, FB (corresponding author), Univ Fed Mato Grosso do Sul, Programa Posgrad Biol Anim, Inst Biociencias, Campo Grande, Brazil.	felipebisaggiop@hotmail.com	Pereira, Felipe Bisaggio/D-6289-2015; Tavares, Luiz ER/H-9909-2012; Luque, Jose L/C-9767-2014	Pereira, Felipe Bisaggio/0000-0002-7921-5965; Tavares, Luiz ER/0000-0001-6522-3633; Luque, Jose/0000-0003-3515-1127	Post-doctoral fellowship PNPD-CAPES (Programa Nacional de Pos-Doutorado-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil) [474077/2011-0, 304254/2011-8, 402665/2012-0, 311567/2013-4]; Czech Academy of Sciences (IPCAS) [RVO: 60077344]; Czech Science Foundation [P505/12/G112]	Post-doctoral fellowship PNPD-CAPES (Programa Nacional de Pos-Doutorado-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brazil); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Czech Academy of Sciences (IPCAS); Czech Science Foundation(Grant Agency of the Czech Republic)	FBP was supported by a Post-doctoral fellowship PNPD-CAPES (Programa Nacional de Pos-Doutorado-Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-CAPES, Brazil), JLL (Nos. 474077/2011-0, 304254/2011-8, 402665/2012-0) and LERT (No 311567/2013-4) were supported by a Research fellowship from CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico do Brasil). SEM observations and molecular procedures were supported by the Czech Academy of Sciences (IPCAS; RVO: 60077344) and the Czech Science Foundation (Project No. P505/12/G112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank MSc Philippe Vieira Alves from the Universidade Federal Rurual do Rio de Janeiro and Dr. Bernadete Maria de Sousa form the Universidade Federal de Juiz de Fora for the support in field collections. Thanks are also due to Dr. Tomas Scholz, Dr. Jan Babec and the staff of the Laboratory of Electron Microscopy from the Institute of Parasitology, Biology Centre of the Czech Academy of Sciences (IPCAS; RVO: 60077344) and the Czech Science Foundation (Project No. P505/12/G112) for the support and covering costs of SEM observations and molecular procedures at the IPCAS.	Adamson M. L., 1989, Advances in Parasitology, V28, P175, DOI 10.1016/S0065-308X(08)60333-4; ADAMSON ML, 1981, SYST PARASITOL, V3, P105, DOI 10.1007/BF00012216; AINSWORTH R, 1990, J PARASITOL, V76, P812, DOI 10.2307/3282799; Anderson R. C., 2009, Keys to the nematode parasites of vertebrates: archival volume, P30, DOI [10.1079/9781845935726.0000, 10.1079/9781845935726.0030]; Bursey C, 2013, J PARASITOL, V99, P475, DOI 10.1645/GE-3235.1; Bursey CR, 2015, J PARASITOL, V101, P374, DOI 10.1645/13-460.1; Cernotikova E, 2011, FOLIA PARASIT, V58, P135, DOI 10.14411/fp.2011.013; Chabaud A. G., 1962, Deuxieme note Ann Parasit hum comp, V37, P569; Chang JM, 2014, MOL BIOL EVOL, V31, P1625, DOI 10.1093/molbev/msu117; Chitwood BG, 1975, INTRO NEMATOLOGY; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Falk BG, 2013, MOL ECOL, V22, P4576, DOI 10.1111/mec.12410; FREITAS JFT, 1957, MEMORIAS I O CRUZ, V55, P21, DOI DOI 10.1590/S0074-02761957000100003; GARCIACALVENTE I, 1948, REV IBERICA PARASITO, V8, P367; de Oca EUGM, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.559.6842; Gibbons L. M., 2009, Keys to the nematode parasites of vertebrates: supplementary volume, pv, DOI 10.1079/9781845935719.0000; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hugot JP, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0486-6; Jorge F, 2014, J EVOLUTION BIOL, V27, P1631, DOI 10.1111/jeb.12430; Jorge F, 2013, J ZOOL SYST EVOL RES, V51, P187, DOI 10.1111/jzs.12019; Jorge F, 2012, J PARASITOL, V98, P160, DOI 10.1645/GE-2856.1; Jorge F, 2011, SYST PARASITOL, V80, P53, DOI 10.1007/s11230-011-9311-1; Maddison WP., 2019, CHROMASEQ MESQUITE P; Malysheva SV, 2016, J HELMINTHOL, V90, P186, DOI 10.1017/S0022149X15000061; Masova S, 2008, ACTA PARASITOL, V53, P274, DOI 10.2478/s11686-008-0039-2; Mockett S, 2017, PARASITOLOGY, V144, P680, DOI 10.1017/S0031182016002365; MORAVEC F, 1987, FOLIA PARASIT, V34, P269; Nadler SA, 2011, PARASITOLOGY, V138, P1688, DOI 10.1017/S003118201000168X; Notredame C, 2003, BIOINFORMATICS AND GENOMES: CURRENT PERSPECTIVES, P27; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nunn GB, 1992, NEMATODE MOL EVALUTI; Pereira FB, 2017, SYST PARASITOL, V94, P599, DOI 10.1007/s11230-017-9725-5; Pereira FB, 2017, PARASITOL INT, V66, P898, DOI 10.1016/j.parint.2016.10.012; Pereira FB, 2011, J PARASITOL, V97, P311, DOI 10.1645/GE-2579.1; Petter A. J., 1976, CIH Keys to the nematode parasites of vertebrates, Commonwealth Agricultural Bureaux, Farnham Royal, Bucks, England.; Planet PJ, 2006, J BIOMED INFORM, V39, P86, DOI 10.1016/j.jbi.2005.08.008; ROCA V, 1988, Parassitologia (Rome), V30, P197; Seurat L. G., 1917, Archives de Zoologie Experimentale, V56; Sharpilo V. P., 1976, PARASITIC WORMS REPT; SOLERA-PUERTAS M A, 1988, Revista Iberica de Parasitologia, V48, P33; Solorzano-Garcia B, 2017, J PARASITOL, V103, P404, DOI 10.1645/17-8; Solorzano-Garcia B, 2016, PARASITOL INT, V65, P401, DOI 10.1016/j.parint.2016.05.016; Swofford DL, PHYLOGENETIC ANAL US; Velarde-Aguilar MG, 2015, J PARASITOL, V101, P212, DOI 10.1645/13-328.1; Vicente Joaquim Julio, 1993, Revista Brasileira de Zoologia, V10, P19, DOI 10.1590/S0101-81751993000100003; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200494	10.1371/journal.pone.0200494	http://dx.doi.org/10.1371/journal.pone.0200494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995964	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800074
J	Anjana, RM; Unnikrishnan, R; Mugilan, P; Jagdish, PS; Parthasarathy, B; Deepa, M; Loganathan, G; Kumar, RA; Rahulashankiruthiyayan, T; Sankari, GU; Venkatesan, U; Mohan, V; Rani, CSS				Anjana, Ranjit Mohan; Unnikrishnan, Ranjit; Mugilan, Poongkunran; Jagdish, Padoor Sethuraman; Parthasarathy, Balasubramanian; Deepa, Mohan; Loganathan, Geetha; Kumar, Rajendran Ashok; Rahulashankiruthiyayan, Thangarajan; Sankari, Ganesan Uma; Venkatesan, Ulagamathesan; Mohan, Viswanathan; Rani, Coimbatore Subramanian Shanthi			Causes and predictors of mortality in Asian Indians with and without diabetes-10 year follow-up of the Chennai Urban Rural Epidemiology Study (CURES-150)	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ALL-CAUSE MORTALITY; BODY-MASS INDEX; RISK-FACTORS; EXCESS MORTALITY; LIFE-STYLE; POPULATION; PREVALENCE; MELLITUS; DISEASE	Background The incidence and prevalence of diabetes is increasing worldwide and it is the fifth leading cause of mortality accounting for over 3.8 million deaths annually. Despite the enormity of the diabetes-related health burdens, very few studies have evaluated the factors associated with mortality among people with diabetes in India. We sought to study the causes and predictors of mortality among urban Asian Indians with and without diabetes. Methods and findings Of 2273 adults (27,850 person-years of follow-up) from the 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES), the cause of death could be ascertained in 552 individuals out of the 671 who had died (response rate 82.3%). Verbal autopsy was obtained from the family members of the deceased and this was adjudicated by trained physicians. The age-standardized mortality rate was 28.2 (95% CI 25.9-30.6) per 100,000 population. Mortality rates were significantly higher in individuals with diabetes compared to those without [27.9(95% CI 25.5-30.6) vs. 8.0 (6.6-9.9) per 1000 person years]. Compared to individuals of normal body mass index, underweight individuals had higher risk of mortality (Hazard ratio 1.49; 95% CI 1.11-2.0), whereas overweight and obese individuals did not show a higher risk. The population-attributable risk for all-cause mortality in the entire study cohort was highest for ischemic heart disease and diabetes. The excess mortality attributable to diabetes was highest in the age group of 51 to 70 years, and was mostly accounted for by renal disease (Rate ratio 5.68, 95% CI 2.43-6.23), ischemic heart disease (4.23,2.78-6.67), and cerebrovascular disease (4.00,1.87-9.81). Conclusion Underweight (but not overweight or obesity) was strongly associated with mortality in this Asian Indian population. lschemic heart disease and diabetes contributed the most to risk for all cause mortality. Excess mortality due to diabetes was higher in relatively younger individuals and was mostly accounted for by renal disease.	[Anjana, Ranjit Mohan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; Dr Mohans Diabet Special Ctr, WHO Collaborating Ctr Noncommunicable Dis Prevent, Madras, Tamil Nadu, India; ICMR Ctr Adv Res Diabet, Madras, Tamil Nadu, India	Madras Diabetes Research Foundation	Anjana, RM (corresponding author), Madras Diabet Res Fdn, Madras, Tamil Nadu, India.	dranjana@drmohans.com						Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Alegre-Diaz J, 2016, NEW ENGL J MED, V375, P1961, DOI 10.1056/NEJMoa1605368; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; An YL, 2015, DIABETES CARE, V38, P1365, DOI 10.2337/dc14-2498; Anjana RM, 2015, DIABETES CARE, V38, P1441, DOI 10.2337/dc14-2814; [Anonymous], 2010, AS PAC PERSP RED OB; Ballotari P, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/914057; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bruno G, 2007, DIABETOLOGIA, V50, P941, DOI 10.1007/s00125-007-0616-1; Deepa M, 2003, J Assoc Physicians India, V51, P863; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gregg EW, 2007, ANN INTERN MED, V147, P149, DOI 10.7326/0003-4819-147-3-200708070-00167; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; KNUIMAN MW, 1992, AM J EPIDEMIOL, V135, P638, DOI 10.1093/oxfordjournals.aje.a116343; LENNER P, 1990, ACTA ONCOL, V29, P573, DOI 10.3109/02841869009090053; Lowe LP, 1997, DIABETES CARE, V20, P163, DOI 10.2337/diacare.20.2.163; Ma S, 1998, ASSOCIATIONS DIABETE, V105, P470; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mohan V, 2006, J Assoc Physicians India, V54, P113; Mohan V, 2001, J AM COLL CARDIOL, V38, P682, DOI 10.1016/S0735-1097(01)01415-2; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; PANZRAM G, 1981, DIABETOLOGIA, V20, P587; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Pradeepa R, 2008, DIABETIC MED, V25, P407, DOI 10.1111/j.1464-5491.2008.02397.x; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Premalatha G, 2000, DIABETES CARE, V23, P1295, DOI 10.2337/diacare.23.9.1295; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Roper NA, 2001, BRIT MED J, V322, P1389, DOI 10.1136/bmj.322.7299.1389; Salles GF, 2004, DIABETES CARE, V27, P1299, DOI 10.2337/diacare.27.6.1299; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Svensson MK, 2013, DIABETES VASC DIS RE, V10, P520, DOI 10.1177/1479164113500798; Unnikrishnan R, 2007, DIABETES CARE, V30, P2019, DOI 10.2337/dc06-2554; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xiao H., 2015, PLOS ONE, V10; Yoon U, 2013, METABOLISM, V62, P303, DOI 10.1016/j.metabol.2012.07.009; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zargar AH, 1999, DIABETES RES CLIN PR, V43, P67; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	42	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0197376	10.1371/journal.pone.0197376	http://dx.doi.org/10.1371/journal.pone.0197376			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985959	gold, Green Submitted, Green Published			2022-12-26	WOS:000438035500004
J	Lu, XD; Gao, J; Zhang, Y; Zhao, T; Cai, HC; Zhang, TR				Lu, Xiangdong; Gao, Juan; Zhang, Yao; Zhao, Tao; Cai, Hongchuan; Zhang, Tingrong			CTEN induces epithelial-mesenchymal transition (EMT) and metastasis in non small cell lung cancer cells	PLOS ONE			English	Article							PROSTATE-CANCER; TGF-BETA; TENSIN; PROGRESSION; EXPRESSION; MOTILITY; TUMORS	To explore the effects and mechanism of CTEN (COOH-terminus tensin-like molecule) on EMT, cell migration and invasion of Human lung adenocarcinoma cells. The pCMV-vector, pCMV-CTEN, Control-shRNA, and CTEN-shRNA were transfected into A549 and NCI-H1299 cells by Lipofectamine 2000. Transforming growth factor-beta 1(TGF-beta 1)and epithelial-mesenchymal transition (EMT) -related biomarkers were detected by eliseand western blot. The migration and invasion ability of A549 cells and NCI-H1299 were examined by scratch-wound assay and transwell assay respectively. We found compare with control group, the expression of TGF-beta and mesenchymal markers in CTEN overexpression group were increased, and the epithelial marker was decreased, which induced the EMT process. Mean-while, scratch-woundassay showed that the migration efficiency of A549 and NCI-H1299 cells in CTEN overexpression group were higher than that in control group.Transwell assay demonstrated that the number of cells that migrated and invaded through the membrane were obviously more than those in control group.Furthermore, Knockdown of CTEN partially reversed transforming growth factor-beta 1(TGF-beta 1)-induced changes in EMT markers. In conclusion, CTEN activated the expression of TGF-beta 1, thereby prompting EMT in lung adenocareinma cancer cells.	[Lu, Xiangdong; Zhang, Yao; Zhao, Tao; Zhang, Tingrong] Southeast Univ, Med Coll, Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China; [Gao, Juan] Jiangyin Hosp Tradit Chinese Med, Dept Obstet & Gynecol, Jiangyin, Peoples R China; [Cai, Hongchuan] 515th Hosp PLA, Jiangyin, Peoples R China	Southeast University - China	Zhang, TR (corresponding author), Southeast Univ, Med Coll, Jiangyin Hosp, Dept Oncol, Jiangyin, Peoples R China.	zhangtingrong1967@126.com			Jiangyin social development science and technology plan project	Jiangyin social development science and technology plan project	This study was supported by the 2015 Jiangyin social development science and technology plan project to Tingrong Zhang.	Albasri A, 2011, BREAST CANCER RES TR, V126, P47, DOI 10.1007/s10549-010-0890-3; Albasri A, 2009, J PATHOL, V218, P57, DOI 10.1002/path.2508; Barbieri I, 2010, CANCER RES, V70, P2558, DOI 10.1158/0008-5472.CAN-09-2840; GAO X, 1995, ONCOGENE, V11, P1241; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Lo SH, 2004, INT J BIOCHEM CELL B, V36, P31, DOI 10.1016/S1357-2725(03)00171-7; Lo SH, 2002, CANCER RES, V62, P4217; Sasaki H, 2003, LUNG CANCER, V40, P151, DOI 10.1016/S0169-5002(03)00037-0; Shimizu H, 2016, ADV CLIN EXP MED, V25, P117, DOI 10.17219/acem/60715; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tanoue LT, 2015, AM J RESP CRIT CARE, V191, P19, DOI 10.1164/rccm.201410-1777CI; Usami Y, 2008, J PATHOL, V215, P330, DOI 10.1002/path.2365; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	15	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0198823	10.1371/journal.pone.0198823	http://dx.doi.org/10.1371/journal.pone.0198823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985912	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500007
J	Park, IY; Cho, NH; Lim, SH; Kim, HA				Park, In Young; Cho, Nam Han; Lim, Seung Hun; Kim, Hyun Ah			Gender-specific associations between fat mass, metabolic syndrome and musculoskeletal pain in community residents: A three-year longitudinal study	PLOS ONE			English	Article							GENERAL-POPULATION; KNEE PAIN; OBESITY; OSTEOARTHRITIS; INFLAMMATION; PREVALENCE; DISABILITY; MORTALITY; DISEASES; COHORT	Increase in fat mass is correlated with musculoskeletal pain. The aim of this study was to examine the relationship between fat mass and the musculoskeletal pain prospectively in Korean community residents. In the Korean Health and Genome Study, participants (mean age 60.2 years, 56.2% women) completed pain questionnaires and underwent dual x-ray absorptiometry to calculate body composition. Three-year follow-up data on pain was available for 1,325 participants. Pain was categorized according to number of pain regions. At three years of follow-up, participants were classified as follows: 1) no pain both at baseline and at three years (no pain), 2) any pain (one, two or more, or widespread regions) at baseline and no pain at three years (transient pain), 3) no pain at baseline and any pain at three years (new pain) 4) any pain both at baseline and at 3 years (persistent pain). 1) and 2) were grouped as no/transient pain group (no pain) and 3) and 4) as new/persistent pain group (pain). Female gender and obesity were two significant factors associated with the persistence or development of pain. Total fat mass and fat:muscle mass ratio were associated with pain among female participants only, and the odds ratios for pain were significantly increased in female participants in the highest quartile of total fat mass and fat muscle ratio after adjustment. In conclusion, both female gender and obesity were two significant factors associated with pain. Fat mass parameters and pain were significantly associated only among females.	[Park, In Young; Kim, Hyun Ah] Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea; [Cho, Nam Han; Lim, Seung Hun] Ajou Univ, Dept Prevent Med, Sch Med, Suwon, South Korea; [Kim, Hyun Ah] Hallym Univ, Inst Skeletal Aging, Chunchon, South Korea	Hallym University; Ajou University; Hallym University	Kim, HA (corresponding author), Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea.; Kim, HA (corresponding author), Hallym Univ, Inst Skeletal Aging, Chunchon, South Korea.	kimha@hallym.ac.kr	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	Korea Health Industry Development Institute [HI14C2248, HI16C0287]; Korea Centers for Disease Control and Prevention [20012003-348-6111-221, 2004-347-6111-213, 2005-347-2400-2440-215]; Hallym University Research Fund	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Korea Centers for Disease Control and Prevention; Hallym University Research Fund	Kim HA and Park IY are supported by grants (grant numbers: HI14C2248 and HI16C0287) from Korea Health Industry Development Institute (https://www.khidi.or.kr/). Cho NH and Lim SH are supported by grants (grant numbers: 20012003-348-6111-221, 2004-347-6111-213, and 2005-347-2400-2440-215) from Korea Centers for Disease Control and Prevention (http://cdc.go.kr/CDC/intro.html). This study was supported in part by Hallym University Research Fund.	Allen KD, 2009, OSTEOARTHR CARTILAGE, V17, P1275, DOI 10.1016/j.joca.2009.03.021; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Brady SRE, 2015, J PAIN, V16, P700, DOI 10.1016/j.jpain.2015.04.006; Ding C, 2016, CURR OPIN CLIN NUTR, V19, P408, DOI 10.1097/MCO.0000000000000317; Docking RE, 2015, BRIT J PAIN, V9, P86, DOI 10.1177/2049463714527438; Federation ID, 2006, IDF CONS WORLDW DEF; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Griffin TM, 2008, BIORHEOLOGY, V45, P387, DOI 10.3233/BIR-2008-0485; Hassan S, 2014, PAIN, V155, P2448, DOI 10.1016/j.pain.2014.08.027; Haukka E, 2012, OCCUP ENVIRON MED, V69, P485, DOI 10.1136/oemed-2011-100453; Hitt HC, 2007, J PAIN, V8, P430, DOI 10.1016/j.jpain.2006.12.003; Jin XZ, 2016, SEMIN ARTHRITIS RHEU, V45, P564, DOI 10.1016/j.semarthrit.2015.10.006; Kim IJ, 2011, J KOREAN MED SCI, V26, P1140, DOI 10.3346/jkms.2011.26.9.1140; Leveille SG, 2005, PAIN, V116, P332, DOI 10.1016/j.pain.2005.05.002; Macfarlane GJ, 2001, BRIT MED J, V323, P662, DOI 10.1136/bmj.323.7314.662; Mundal I, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-213; Nedungadi TP, 2009, J CARDIOVASC TRANSL, V2, P321, DOI 10.1007/s12265-009-9101-1; Niu JB, 2017, ARTHRITIS RHEUMATOL, V69, P1194, DOI 10.1002/art.40087; Office KNS, KOR STAT INF SERV; Pan F, 2017, ARTHRIT CARE RES, V69, P509, DOI 10.1002/acr.22963; Panagiotakos DB, 2005, ATHEROSCLEROSIS, V183, P308, DOI 10.1016/j.atherosclerosis.2005.03.010; Peltonen M, 2003, PAIN, V104, P549, DOI 10.1016/S0304-3959(03)00091-5; Scudds RJ, 1998, PAIN, V75, P229, DOI 10.1016/S0304-3959(97)00224-8; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walsh TP, 2016, ARTHRIT CARE RES, V68, P526, DOI 10.1002/acr.22719; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Yoo JJ, 2014, ARTHRITIS RHEUMATOL, V66, P3511, DOI 10.1002/art.38861	28	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200138	10.1371/journal.pone.0200138	http://dx.doi.org/10.1371/journal.pone.0200138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985938	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500024
J	Yan, FH; Shi, MY; He, ZY; Wu, LH; Xu, XH; He, M; Chen, JJ; Deng, XX; Cheng, YJ; Xu, J				Yan, Fuhua; Shi, Meiyan; He, Zhenyu; Wu, Lianhai; Xu, Xianghua; He, Min; Chen, Jiajing; Deng, Xiuxin; Cheng, Yunjiang; Xu, Juan			Largely different carotenogenesis in two pummelo fruits with different flesh colors	PLOS ONE			English	Article							LYCOPENE BETA-CYCLASE; CAROTENOID BIOSYNTHESIS; CITRUS-SINENSIS; FUNCTIONAL-CHARACTERIZATION; RIPENING PROCESSES; EPSILON-CYCLASE; ACCUMULATION; EXPRESSION; MUTANT; SYNTHASE	Carotenoids in citrus fruits have health benefits and make the fruits visually attractive. Red-fleshed 'Chuhong' ('CH') and pale green-fleshed Feicur ('FC') pummelo (Citrus maxima (Burm) Merr.) fruits are interesting materials for studying the mechanisms of carotenoid accumulation. In this study, particularly high contents of linear carotenes were observed in the albedo tissue, segment membranes and juice sacs of 'CH'. However, carotenoids, especially beta-carotene and xanthophylls, accumulated more in the flavedo tissue of 'FC' than in that of 'CH'. Additionally, the contents of other terpenoids such as limonin, nomilin and abscisic acid significantly differed in the juice sacs at 150 days postanthesis. A dramatic increase in carotenoid production was observed at 45 to 75 days postanthesis in the segment membranes and juice sacs of 'CH'. Different expression levels of carotenogenesis genes, especially the zeta-carotene desaturase (CmZDS), beta-carotenoid hydroxylase (CmBCH) and zeaxanthin epoxidase (CmZEP) genes, in combination are directly responsible for the largely different carotenoid profiles between these two pummelo fruits. The sequences of eleven genes involved in carotenoid synthesis were investigated; different alleles of seven of eleven genes might also explain the largely different carotenogenesis observed between 'CH' and 'FC'. These results enhance our understanding of carotenogenesis in pummelo fruits.	[Yan, Fuhua; Shi, Meiyan; He, Zhenyu; He, Min; Chen, Jiajing; Deng, Xiuxin; Cheng, Yunjiang; Xu, Juan] Minist Educ, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China; [Yan, Fuhua; Wu, Lianhai; Xu, Xianghua] Forestry Sci Acad Lishui, Lishui, Zhejiang, Peoples R China		Xu, J (corresponding author), Minist Educ, Key Lab Hort Plant Biol, Wuhan, Hubei, Peoples R China.	xujuan@mail.hzau.edu.cn		Xiuxin, Deng/0000-0003-4490-4514	Special Fund for Agro-scientific Research in the Public Interest [201303093]; National Natural Science Foundation of China (NSFC) [31672102, 31521092]; Science and Technology Cooperation Project, Healthy fruit tourism orchard development and demonstration, Lishui City, Zhejiang Province [20100411, 2013C02004]; Science and Technology Cooperation Project; Healthy Fruit Tourism Orchard Development and Demonstration, Lishui City, Zhejiang Province [20100411, 2013C02004]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Science and Technology Cooperation Project, Healthy fruit tourism orchard development and demonstration, Lishui City, Zhejiang Province; Science and Technology Cooperation Project; Healthy Fruit Tourism Orchard Development and Demonstration, Lishui City, Zhejiang Province	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303093) and the National Natural Science Foundation of China (NSFC Nos. of 31672102 and 31521092), and Science and Technology Cooperation Project, Healthy fruit tourism orchard development and demonstration, Lishui City, Zhejiang Province (Grant Nos. 20100411 and 2013C02004).; This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201303093), the National Natural Science Foundation of China (NSFC Nos. of 31672102 and 31521092), the Science and Technology Cooperation Project, and the Healthy Fruit Tourism Orchard Development and Demonstration, Lishui City, Zhejiang Province (Grant Nos. 20100411, 2013C02004). We thank Prof. Zuoxiong Liu for editing the English language of the manuscript.	Alquezar B, 2008, PHYTOCHEMISTRY, V69, P1997, DOI 10.1016/j.phytochem.2008.04.020; Alquezar B, 2013, TREE GENET GENOMES, V9, P1257, DOI 10.1007/s11295-013-0635-7; Alquezar B, 2009, J EXP BOT, V60, P1783, DOI 10.1093/jxb/erp048; Alvarez D, 2016, PLANT PHYSIOL, V172, P2314, DOI 10.1104/pp.16.01262; Bai L, 2009, PLANT J, V59, P588, DOI 10.1111/j.1365-313X.2009.03899.x; Baranska M, 2006, PLANTA, V224, P1028, DOI 10.1007/s00425-006-0289-x; Blas AL, 2010, PLANT PHYSIOL, V152, P2013, DOI 10.1104/pp.109.152298; Bouvier F, 2000, EUR J BIOCHEM, V267, P6346, DOI 10.1046/j.1432-1327.2000.01722.x; Cazzonelli CI, 2009, PLANT CELL, V21, P39, DOI 10.1105/tpc.108.063131; Chen JJ, 2015, FOOD CHEM, V184, P238, DOI 10.1016/j.foodchem.2015.03.087; Devitt LC, 2010, J EXP BOT, V61, P33, DOI 10.1093/jxb/erp284; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Du H, 2013, PLANT MOL BIOL, V83, P475, DOI 10.1007/s11103-013-0103-7; Farre G, 2011, TRENDS PLANT SCI, V16, P532, DOI 10.1016/j.tplants.2011.08.001; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Gao HJ, 2011, ACTA PHYSIOL PLANT, V33, P2485, DOI 10.1007/s11738-011-0793-x; Giuliano G, 2014, CURR OPIN PLANT BIOL, V19, P111, DOI 10.1016/j.pbi.2014.05.006; Gonzalez-Jorge S, 2016, PLANT PHYSIOL, V171, P1837, DOI 10.1104/pp.16.00604; Iorizzo M, 2016, NAT GENET, V48, P657, DOI 10.1038/ng.3565; Kato M, 2004, PLANT PHYSIOL, V134, P824, DOI 10.1104/pp.103.031104; Kubola J, 2013, FOOD RES INT, V50, P664, DOI 10.1016/j.foodres.2011.07.004; Latari K, 2015, PLANT PHYSIOL, V168, P1550, DOI 10.1104/pp.15.00243; Lee HS, 2001, J AGR FOOD CHEM, V49, P2563, DOI 10.1021/jf001313g; Li SJ, 2014, FOOD CHEM, V145, P963, DOI 10.1016/j.foodchem.2013.09.040; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Liu CH, 2015, J SCI FOOD AGR, V95, P111, DOI 10.1002/jsfa.6689; Liu CH, 2012, FOOD SCI BIOTECHNOL, V21, P531, DOI 10.1007/s10068-012-0068-3; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Liu LH, 2012, J EXP BOT, V63, P5751, DOI 10.1093/jxb/ers224; Liu Q, 2007, J EXP BOT, V58, P4161, DOI 10.1093/jxb/erm273; Liu WN, 2016, SCI HORTIC-AMSTERDAM, V198, P379, DOI 10.1016/j.scienta.2015.09.050; Lu PJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00898-y; Lu SW, 2018, PLANT PHYSIOL, V176, P2657, DOI 10.1104/pp.17.01830; Lu SW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01367; Luo T, 2015, J AGR FOOD CHEM, V63, P8601, DOI 10.1021/acs.jafc.5b02807; Luo ZD, 2013, NEW PHYTOL, V198, P442, DOI 10.1111/nph.12175; Lv FF, 2015, J EXP BOT, V66, P4719, DOI 10.1093/jxb/erv231; Ma QL, 2014, J EXP BOT, V65, P61, DOI 10.1093/jxb/ert344; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Mills JP, 2007, J NUTR, V137, P1395, DOI 10.1093/jn/137.6.1395; Pan XQ, 2010, NAT PROTOC, V5, P986, DOI 10.1038/nprot.2010.37; Pankratov I, 2016, PLANT J, V88, P82, DOI 10.1111/tpj.13232; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Pasupuleti V, 2014, J FOOD SCI TECH MYS, V51, P4126, DOI 10.1007/s13197-013-0932-z; Ronen G, 2000, P NATL ACAD SCI USA, V97, P11102, DOI 10.1073/pnas.190177497; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Sagawa JM, 2016, NEW PHYTOL, V209, P1049, DOI 10.1111/nph.13647; Santos CAF, 2005, GENET MOL BIOL, V28, P287, DOI 10.1590/S1415-47572005000200019; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu CJ, 2006, J AGR FOOD CHEM, V54, P5474, DOI 10.1021/jf060702t; Xu J, 2006, SCI HORTIC-AMSTERDAM, V108, P181, DOI 10.1016/j.scienta.2006.01.032; Xu JA, 2011, ACTA PHYSIOL PLANT, V33, P745, DOI 10.1007/s11738-010-0599-2; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Zeng WF, 2013, PLANT CELL TISS ORG, V113, P449, DOI 10.1007/s11240-012-0285-8; Zhang JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194835; Zhang JC, 2013, J INTEGR AGR, V12, P1731, DOI 10.1016/S2095-3119(13)60366-4; Zhang JC, 2009, PLANT CELL REP, V28, P1737, DOI 10.1007/s00299-009-0774-3; Zhu F, 2017, NEW PHYTOL, V216, P178, DOI 10.1111/nph.14684	60	9	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200320	10.1371/journal.pone.0200320	http://dx.doi.org/10.1371/journal.pone.0200320			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985936	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500033
J	Bar Shira, E; Friedman, A				Bar Shira, Enav; Friedman, Aharon			Innate immune functions of avian intestinal epithelial cells: Response to bacterial stimuli and localization of responding cells in the developing avian digestive tract	PLOS ONE			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; GOBLET CELLS; ANTIMICROBIAL PEPTIDES; SECRETORY COMPONENT; ESCHERICHIA-COLI; PANETH CELLS; EXPRESSION; CHICK; AVIDIN; IGA	Intestinal epithelial cells are multi-tasked cells that participate in digestion and absorption as well as in protection of the digestive tract. While information on the physiology and immune functions of intestinal epithelial cells in mammals is abundant, little is known of their immune function in birds and other species. Our main objectives were to study the development of antibacterial innate immune functions in the rapidly developing gut of the pre- and post-hatch chick and to determine the functional diversity of epithelial cells. After establishing primary intestinal epithelial cell cultures, we demonstrated their capacity to uptake and process bacteria. The response to bacterial products, LPS and LTA, induced expression of pro-inflammatory cytokine genes (IL-6, IL-18) as well as the expression of the acute phase proteins avidin, lysozyme and the secretory component derived from the polymeric immunoglobulin receptor. These proteins were then localized in gut sections, and the goblet cell was shown to store avidin, lysozyme as well as secretory component. Lysozyme staining was also located in a novel rod-shaped intestinal cell, situated at different loci along the villus, thus deviating from the classical Paneth cell in the mammal, that is restricted to crypts. Thus, in the chicken, the intestinal epithelium, and particularly goblet cells, are committed to innate immune protection. The unique role of the goblet cell in chicken intestinal immunity, as well as the unique distribution of lysozyme-positive cells highlight alternative solutions of gut protection in the bird.	[Bar Shira, Enav; Friedman, Aharon] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel	Hebrew University of Jerusalem	Friedman, A (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel.	ronnie.friedman@mail.huji.ac.il	Friedman, Ronnie/GNM-8589-2022	Friedman, Aharon/0000-0002-5968-0667	Israel Science Foundation [45/10]	Israel Science Foundation(Israel Science Foundation)	The work was funded by the Israel Science Foundation (grant number 45/10)(AF and EB-S), web site: https://www.isf.org.il/#/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Allaire JM, 2017, AM J PHYSL GASTROINT; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Asano Masatake, 2011, J Oral Sci, V53, P147; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Bar-Shira E, 2014, DEV COMP IMMUNOL, V44, P186, DOI 10.1016/j.dci.2013.12.010; Barbara PD, 2003, CELL MOL LIFE SCI, V60, P1322, DOI 10.1007/s00018-003-2289-3; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Cakebread JA, 2017, INT DAIRY J, V68, P32, DOI 10.1016/j.idairyj.2016.12.011; Caldwell DJ, 2004, POULTRY SCI, V83, P591, DOI 10.1093/ps/83.4.591; Caldwell DJ, 2001, DEV COMP IMMUNOL, V25, P169, DOI 10.1016/S0145-305X(00)00055-0; Chen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187880; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Cuperus T, 2016, DEV COMP IMMUNOL, V61, P48, DOI 10.1016/j.dci.2016.03.008; Dahan S, 2007, IMMUNOL REV, V215, P243, DOI 10.1111/j.1600-065X.2006.00484.x; Deguine Jacques, 2014, F1000Prime Rep, V6, P97, DOI 10.12703/P6-97; Derache C, 2009, DEV COMP IMMUNOL, V33, P959, DOI 10.1016/j.dci.2009.03.005; Dubin RF, 2004, AM J PHYSIOL-LUNG C, V286, pL750, DOI 10.1152/ajplung.00326.2003; Duerr CU, 2012, SEMIN IMMUNOL, V24, P25, DOI 10.1016/j.smim.2011.11.002; ELO HA, 1979, COMP BIOCHEM PHYS B, V62, P237, DOI 10.1016/0305-0491(79)90205-0; ELO HA, 1980, EXPERIENTIA, V36, P312, DOI 10.1007/BF01952296; ELO HA, 1984, COMP BIOCHEM PHYS B, V78, P15, DOI 10.1016/0305-0491(84)90137-8; Eren U, 2016, MICROSC RES TECHNIQ, V79, P604, DOI 10.1002/jemt.22674; Friedman A, 2003, WORLD POULTRY SCI J, V59, P209, DOI 10.1079/WPS20030013; Goitsuka R, 2007, P NATL ACAD SCI USA, V104, P15063, DOI 10.1073/pnas.0707037104; GRONE HJ, 1986, AM J PATHOL, V124, P294; Johansen FE, 2011, MUCOSAL IMMUNOL, V4, P598, DOI 10.1038/mi.2011.37; Kaetzel CS, 2017, J IMMUNOL, V198, P1765, DOI 10.4049/jimmunol.1700025; Knoop K, 2014, J IMMUNOL, V192; Knoop KA, 2015, MUCOSAL IMMUNOL, V8, P198, DOI 10.1038/mi.2014.58; KOHLER PO, 1968, SCIENCE, V160, P86, DOI 10.1126/science.160.3823.86; Luton F, 2009, TRAFFIC, V10, P1128, DOI 10.1111/j.1600-0854.2009.00941.x; Maldonado-Contreras AL, 2011, CELL TISSUE RES, V343, P5, DOI 10.1007/s00441-010-1082-5; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; McGuckin MA, 2017, MUCOSAL IMMUNOL, V10, P1118, DOI 10.1038/mi.2016.132; MEDDINGS JB, 1990, J CLIN INVEST, V85, P1099, DOI 10.1172/JCI114541; Nile CJ, 2004, CELL MOL LIFE SCI, V61, P2760, DOI 10.1007/s00018-004-4345-z; Ragland SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006512; Rumbo M, 2005, CELL MOL LIFE SCI, V62, P1288, DOI 10.1007/s00018-005-5033-3; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Smirnov A, 2006, POULTRY SCI, V85, P669, DOI 10.1093/ps/85.4.669; Stadtmueller BM, 2016, J IMMUNOL, V197, P1408, DOI 10.4049/jimmunol.1600463; Stadtmueller BM, 2016, ELIFE, V5, DOI 10.7554/eLife.10640; Su S, 2017, POULTRY SCI, V96, P2421, DOI 10.3382/ps/pew468; Sugiarto H, 2004, BIOCHEM BIOPH RES CO, V323, P721, DOI 10.1016/j.bbrc.2004.08.162; Vermeer PD, 2003, AM J RESP CELL MOL, V28, P286, DOI 10.1165/rcmb.4887; Walton KD, 2016, DEVELOPMENT, V143, P2261, DOI 10.1242/dev.135400; Wang DH, 2011, P NATL ACAD SCI USA, V108, P10272, DOI 10.1073/pnas.1017668108; Wang L, 2016, POULTRY SCI, V95, P1631, DOI 10.3382/ps/pew079; Xu S, 2013, J CELL SCI, V126, P2704, DOI 10.1242/jcs.122242; Zerega B, 2001, J CELL SCI, V114, P1473; Zhang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154546	54	30	30	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200393	10.1371/journal.pone.0200393	http://dx.doi.org/10.1371/journal.pone.0200393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979771	Green Submitted, gold, Green Published			2022-12-26	WOS:000437809500107
J	Wang, ZK; Zeng, SK; Guo, JB; Qin, TC				Wang, Zengkai; Zeng, Shengkui; Guo, Jianbin; Qin, Taichun			Remaining capacity estimation of lithium-ion batteries based on the constant voltage charging profile	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; STATE-OF-CHARGE; COULOMB COUNTING METHOD; USEFUL LIFE ESTIMATION; ELECTRIC VEHICLES; HEALTH ESTIMATION; VECTOR MACHINE; FILTER; MODEL; PREDICTION	Estimation of remaining capacity is essential for ensuring the safety and reliability of lithium-ion batteries. In actual operation, batteries are seldom fully discharged. For a constant current-constant voltage charging mode, the incomplete discharging process affects not only the initial state but also processed variables of the subsequent charging profile, thereby mainly limiting the applications of many feature-based capacity estimation methods which rely on a whole cycling process. Since the charging information of the constant voltage profile can be completely saved whether the battery is fully discharged or not, a geometrical feature of the constant voltage charging profile is extracted to be a new aging feature of lithium-ion batteries under the incomplete discharging situation in this work. By introducing the quantum computing theory into the classical machine learning technique, an integrated quantum particle swarm optimization-based support vector regression estimation framework, as well as its application to characterize the relationship between extracted feature and battery remaining capacity, are presented and illustrated in detail. With the lithium-ion battery data provided by NASA, experiment and comparison results demonstrate the effectiveness, accuracy, and superiority of the proposed battery capacity estimation framework for the not entirely discharged condition.	[Wang, Zengkai; Zeng, Shengkui; Guo, Jianbin; Qin, Taichun] Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China; [Zeng, Shengkui; Guo, Jianbin] Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China	Beihang University	Guo, JB (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing, Peoples R China.; Guo, JB (corresponding author), Sci & Technol Reliabil & Environm Engn Lab, Beijing, Peoples R China.	guojianbin@buaa.edu.cn						[Anonymous], P IEEE C CYB INT SYS, DOI [10.1109/ICCIS.2004.1460396, DOI 10.1109/ICCIS.2004.1460396]; Ashwin TR, 2016, J POWER SOURCES, V328, P586, DOI 10.1016/j.jpowsour.2016.08.054; Berecibar M, 2016, RENEW SUST ENERG REV, V56, P572, DOI 10.1016/j.rser.2015.11.042; Cao GH, 2016, ENERGY, V115, P734, DOI 10.1016/j.energy.2016.09.065; Chen ZY, 2018, APPL ENERG, V213, P375, DOI 10.1016/j.apenergy.2018.01.068; Cheng CT, 2015, WATER-SUI, V7, P4232, DOI 10.3390/w7084232; Cheng YJ, 2017, COMPLEXITY, DOI 10.1155/2017/6342170; Deng ZW, 2016, ENERGY, V112, P469, DOI 10.1016/j.energy.2016.06.130; Dong GZ, 2017, J POWER SOURCES, V364, P316, DOI 10.1016/j.jpowsour.2017.08.040; Farmann A, 2015, J POWER SOURCES, V281, P114, DOI 10.1016/j.jpowsour.2015.01.129; Goh T, 2017, ENERGY, V135, P257, DOI 10.1016/j.energy.2017.06.141; Guo Z, 2014, J POWER SOURCES, V249, P457, DOI 10.1016/j.jpowsour.2013.10.114; Hu C, 2014, APPL ENERG, V129, P49, DOI 10.1016/j.apenergy.2014.04.077; Hu XS, 2014, ENERGY, V64, P953, DOI 10.1016/j.energy.2013.11.061; Kang LW, 2014, APPL ENERG, V121, P20, DOI 10.1016/j.apenergy.2014.01.066; Li JF, 2015, ENERGY, V86, P638, DOI 10.1016/j.energy.2015.04.021; Li XS, 2017, DATA, V2, DOI 10.3390/data2030027; Liu DT, 2015, IEEE T SYST MAN CY-S, V45, P915, DOI 10.1109/TSMC.2015.2389757; Liu DT, 2015, IEEE T INSTRUM MEAS, V64, P660, DOI 10.1109/TIM.2014.2348613; Liu ZB, 2017, IEEE T INSTRUM MEAS, V66, P280, DOI 10.1109/TIM.2016.2622838; Ning G, 2006, ELECTROCHIM ACTA, V51, P2012, DOI 10.1016/j.electacta.2005.06.033; Qin TC, 2015, MICROELECTRON RELIAB, V55, P1280, DOI 10.1016/j.microrel.2015.06.133; Ren C, 2014, KNOWL-BASED SYST, V56, P226, DOI 10.1016/j.knosys.2013.11.015; Saha B., 2009, P ANN C PROGN HLTH M; Sepasi S, 2015, ENERGIES, V8, P5217, DOI 10.3390/en8065217; Sheng HM, 2015, J POWER SOURCES, V281, P131, DOI 10.1016/j.jpowsour.2015.01.145; Sukawattanavijit C, 2017, IEEE GEOSCI REMOTE S, V14, P284, DOI 10.1109/LGRS.2016.2628406; Sun J, 2004, IEEE C EVOL COMPUTAT, P325; Sun J, 2012, INFORM SCIENCES, V193, P81, DOI 10.1016/j.ins.2012.01.005; Tulsyan A, 2016, J POWER SOURCES, V331, P208, DOI 10.1016/j.jpowsour.2016.08.113; Wang YJ, 2016, J POWER SOURCES, V315, P199, DOI 10.1016/j.jpowsour.2016.03.054; Wu J, 2016, J POWER SOURCES, V327, P457, DOI 10.1016/j.jpowsour.2016.07.065; Wu J, 2016, APPL ENERG, V173, P134, DOI 10.1016/j.apenergy.2016.04.057; Xie JL, 2018, J POWER ELECTRON, V18, P910, DOI 10.6113/JPE.2018.18.3.910; Yu JS, 2017, QUAL ENG, V29, P536, DOI 10.1080/08982112.2017.1322210; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang XC, 2017, SHOCK VIB, V2017, DOI 10.1155/2017/9581379; Zhang Y, 2015, ENERGIES, V8, P12439, DOI 10.3390/en81112320; Zhao L, 2016, INT J ENERG RES, V40, P1389, DOI 10.1002/er.3530; Zheng LF, 2016, APPL ENERG, V180, P424, DOI 10.1016/j.apenergy.2016.08.016; Zhu Q, 2017, IEEE T VEH TECHNOL, V66, P10853, DOI 10.1109/TVT.2017.2723522; Zou CF, 2018, J POWER SOURCES, V390, P286, DOI 10.1016/j.jpowsour.2018.04.033; Zou CF, 2018, IEEE T IND ELECTRON, V65, P5951, DOI 10.1109/TIE.2017.2782691	43	22	22	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200169	10.1371/journal.pone.0200169	http://dx.doi.org/10.1371/journal.pone.0200169			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979778	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500072
J	Slaughter, MJ; Shanle, EK; McFadden, AW; Hollis, ES; Suttle, LE; Strahl, BD; Davis, IJ				Slaughter, Mariesa J.; Shanle, Erin K.; McFadden, Andrew W.; Hollis, Emily S.; Suttle, Lindsey E.; Strahl, Brian D.; Davis, Ian J.			PBRM1 bromodomains variably influence nucleosome interactions and cellular function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; chromatin; chromatin regulation; chromatin structure; histones; histone acetylation; histone methylation; histone modification; bromodomain; PBRM1; BAF180	RENAL-CARCINOMA; HISTONE MODIFICATIONS; PROTEIN BRD4; CHROMATIN; ACETYLATION; RECOGNITION; TARGETS; FAMILY; LIGAND; DOMAIN	Chromatin remodelers use bromodomains (BDs) to recognize histones. Polybromo 1 (PBRM1 or BAF180) is hypothesized to function as the nucleosome-recognition subunit of the PBAF chromatin-remodeling complex and is frequently mutated in clear cell renal cell carcinoma (ccRCC). Previous studies have applied in vitro methods to explore the binding specificities of the six individual PBRM1 BDs. However, BD targeting to histones and the influence of neighboring BD on nucleosome recognition have not been well characterized. Here, using histone microarrays and intact nucleosomes to investigate the histone-binding characteristics of the six PBRM1 BDs individually and combined, we demonstrate that BD2 and BD4 of PBRM1 mediate binding to acetylated histone peptides and to modified recombinant and cellular nucleosomes. Moreover, we show that neighboring BDs variably modulate these chromatin interactions, with BD1 and BD5 enhancing nucleosome interactions of BD2 and BD4, respectively, whereas BD3 attenuated these interactions. We also found that binding pocket missense mutations in BD4 observed in ccRCC disrupt PBRM1-chromatin interactions and that these mutations in BD4, but not similar mutations in BD2, in the context of full-length PBRM1, accelerate ccRCC cell proliferation. Taken together, our biochemical and mutational analyses have identified BD4 as being critically important for maintaining proper PBRM1 function and demonstrate that BD4 mutations increase ccRCC cell growth. Because of the link between PBRM1 status and sensitivity to immune checkpoint inhibitor treatment, these data also suggest the relevance of BD4 as a potential clinical target.	[Slaughter, Mariesa J.; Strahl, Brian D.; Davis, Ian J.] Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Slaughter, Mariesa J.; McFadden, Andrew W.; Hollis, Emily S.; Suttle, Lindsey E.; Strahl, Brian D.; Davis, Ian J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Shanle, Erin K.; Strahl, Brian D.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Davis, IJ (corresponding author), Univ N Carolina, Dept Genet, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Davis, IJ (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Davis, IJ (corresponding author), Univ N Carolina, Dept Pediat, Chapel Hill, NC 27514 USA.	ian_davis@med.unc.edu		Davis, Ian/0000-0002-1552-0960; Suttle, Lindsey/0000-0002-5870-4479	National Institutes of Health [CA166447, CA198482, GM126900]; CornHammond Fund for Pediatric Oncology; University of North Carolina Lineberger Developmental Grants; Institutional Research and Academic Career Development Award - National Institute of General Medical Sciences, division of Training, Workforce Development, and Diversity [GM000678]; NATIONAL CANCER INSTITUTE [R01CA198482, R01CA166447, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678, R35GM126900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CornHammond Fund for Pediatric Oncology; University of North Carolina Lineberger Developmental Grants; Institutional Research and Academic Career Development Award - National Institute of General Medical Sciences, division of Training, Workforce Development, and Diversity; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA166447 (I.J.D.), CA198482 (I.J.D. and B.D.S.), and GM126900 (B.D.S.); the CornHammond Fund for Pediatric Oncology (I.J.D.) and a University of North Carolina Lineberger Developmental Grants. This work was also supported by Institutional Research and Academic Career Development Award GM000678 (to E.K.S.) granted by the National Institute of General Medical Sciences, division of Training, Workforce Development, and Diversity. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chandrasekaran R, 2007, BIOCHEM BIOPH RES CO, V355, P661, DOI 10.1016/j.bbrc.2007.01.193; Charlop-Powers Z, 2010, CELL RES, V20, P529, DOI 10.1038/cr.2010.43; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153718; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durinck S, 2015, NAT GENET, V47, P13, DOI 10.1038/ng.3146; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Miao D, 2018, SCIENCE, V359, P801, DOI 10.1126/science.aan5951; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Porter EG, 2017, J BIOL CHEM, V292, P2601, DOI 10.1074/jbc.M116.746875; Rothbart SB, 2012, METHOD ENZYMOL, V512, P107, DOI 10.1016/B978-0-12-391940-3.00006-8; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taverna SD, 2007, P NATL ACAD SCI USA, V104, P2086, DOI 10.1073/pnas.0610993104; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	34	19	19	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13592	13603		10.1074/jbc.RA118.003381	http://dx.doi.org/10.1074/jbc.RA118.003381			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986887	Green Published, hybrid			2022-12-26	WOS:000443375500019
J	Rimer, JM; Lee, J; Holley, CL; Crowder, RJ; Chen, DL; Hanson, PI; Ory, DS; Schaffer, JE				Rimer, Jamie M.; Lee, Jiyeon; Holley, Christopher L.; Crowder, Robert J.; Chen, Delphine L.; Hanson, Phyllis, I; Ory, Daniel S.; Schaffer, Jean E.			Long-range function of secreted small nucleolar RNAs that direct 2 '-O-methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFECTED MACROPHAGES; NUCLEAR IMPORT; IN-VITRO; CELLS; MICRORNAS; MICROPARTICLES; EXPRESSION; MECHANISM; SNORNP; SNRNA	Small nucleolar RNAs (snoRNAs) are noncoding RNAs that guide chemical modifications of structural RNAs. Whereas snoRNAs primarily localize in the nucleolus, where their canonical function is to target nascent ribosomal RNAs for 2'-O-methylation, recent studies provide evidence that snoRNAs traffic out of the nucleus. Furthermore, RNA-Seq data indicate that extracellular vesicles released from cells contain snoRNAs. However, it is not known whether snoRNA secretion is regulated or whether secreted snoRNAs are functional. Here, we show that inflammation stimulates secretion of Rpl13a snoRNAs U32a (SNORD32a), U33 (SNORD33), U34 (SNORD34), and U35a (SNORD35a) from cultured macrophages, in mice, and in human subjects. Secreted snoRNAs co-fractionate with extracellular vesicles and are taken up by recipient cells. In a murine parabiosis model, we demonstrate that snoRNAs travel through the circulation to function in distant tissues. These findings support a previously unappreciated link between inflammation and snoRNA secretion in mice and humans and uncover a potential role for secreted snoRNAs in cell-cell communication.	[Rimer, Jamie M.; Lee, Jiyeon; Holley, Christopher L.; Crowder, Robert J.; Chen, Delphine L.; Ory, Daniel S.; Schaffer, Jean E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Chen, Delphine L.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Hanson, Phyllis, I] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schaffer, JE (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Campus Box 8086, St Louis, MO 63110 USA.	jschaff@wustl.edu	Holley, Christopher/T-1312-2019; Holley, Christopher/ABB-6677-2020	Holley, Christopher/0000-0002-2870-3352; Lee, Jiyeon/0000-0002-8952-7938	National Institutes of Health [R01 DK064989, P30 DK020579, T32 HL007081]; Fondation Leducq [12CVD04]; Doris Duke Clinical Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK108357, R01DK064989, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM122434] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); Doris Duke Clinical Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 DK064989, P30 DK020579, and T32 HL007081 and Fondation Leducq Grant 12CVD04. The clinical trial supporting this work was funded by a Doris Duke Clinical Investigator Award (to D. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; BASERGA SJ, 1992, GENE DEV, V6, P1120, DOI 10.1101/gad.6.6.1120; Berardocco M, 2017, ONCOTARGET, V8, P82920, DOI 10.18632/oncotarget.20503; Brandis KA, 2013, J BIOL CHEM, V288, P35703, DOI 10.1074/jbc.M113.488577; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen DL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191783; Chen FW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015054; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Darwich AS, 2014, DRUG METAB DISPOS, V42, P2016, DOI 10.1124/dmd.114.058404; Dong ZW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks698; Dupuis-Sandoval F, 2015, WIRES RNA, V6, P381, DOI 10.1002/wrna.1284; Feng JL, 2009, GENE, V437, P14, DOI 10.1016/j.gene.2009.01.017; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Helwa I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170628; HEUSER J, 1980, J CELL BIOL, V84, P560, DOI 10.1083/jcb.84.3.560; Holley CL, 2015, J BIOL CHEM, V290, P11741, DOI 10.1074/jbc.M115.637413; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jinn S, 2015, CELL METAB, V21, P855, DOI 10.1016/j.cmet.2015.04.010; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kaur S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20936-7; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Lee JY, 2016, J CLIN INVEST, V126, P4616, DOI 10.1172/JCI88069; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Li MW, 2017, J BIOL CHEM, V292, P20228, DOI 10.1074/jbc.M117.818146; Magami Y, 2002, LIVER, V22, P419, DOI 10.1034/j.1600-0676.2002.01702.x; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Saha S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13096; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Scruggs BS, 2012, MOL CELL BIOL, V32, P4092, DOI 10.1128/MCB.00022-12; Shi MM, 1999, IMMUNOLOGY, V97, P309; Sienna N, 1996, EXP CELL RES, V227, P98, DOI 10.1006/excr.1996.0254; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Singh PP, 2012, J IMMUNOL, V189, P777, DOI 10.4049/jimmunol.1103638; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Terns MP, 2002, GENE EXPRESSION, V10, P17; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valleron W, 2012, BLOOD, V120, P3997, DOI 10.1182/blood-2012-06-438135; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856; Watkins NJ, 2007, MOL CELL BIOL, V27, P7018, DOI 10.1128/MCB.00516-07; Watkins NJ, 2004, MOL CELL, V16, P789, DOI 10.1016/j.molcel.2004.11.012; Wei ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01196-x; Yang LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115293; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zhang Y, 2012, CELL MOL IMMUNOL, V9, P489, DOI 10.1038/cmi.2012.33; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	49	28	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13284	13296		10.1074/jbc.RA118.003410	http://dx.doi.org/10.1074/jbc.RA118.003410			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29980600	Green Published, hybrid			2022-12-26	WOS:000442730200026
J	Chao, YS; Wu, HC; Wu, CJ; Chen, WC				Chao, Yi-Sheng; Wu, Hsing-Chien; Wu, Chao-Jung; Chen, Wei-Chih			Index or illusion: The case of frailty indices in the Health and Retirement Study	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ELDERLY-PEOPLE; MODELS; RISK; PREVALENCE; DISABILITY; MORTALITY; DESIGN; ADULTS	Introduction Frailty is a geriatric syndrome that has been defined differently with various indices. Without a uniform definition, it remains unclear how to interpret and compare different frailty indices (Fls). With the advances in index mining, we find it necessary to review the implicit assumptions about the creation of Fls. We are concerned the processing of frailty data may introduce measurement error and bias. We aim to review the assumptions, interpretability and predictive power of Fls regarding mortality. Methods Three Fls, the Functional Domains Model proposed by Strawbridge et al. (1998), the Burden Model by Rockwood et al. (2007) and the Biologic Syndrome Model by Fried et al. (2004), were directly compared using the data from the Health and Retirement Study (HRS), a longitudinal study since 1996 mainly following up Americans aged 50 years and over. The Fls were reproduced according to Cigolle et al. (2009) and interpreted with their input variables through forward-stepwise regression. Biases were the residuals of the Fls that could not be explained by own input variables. Any four of the input variables were used to create alternative indices. Discrete-time survival analysis was conducted to compare the predictive power of Fls, input variables and alternative indices on mortality. Results We found frailty a syndrome not unique to the elderly. The Fls were produced with different degrees of bias. The Fls could not be fully interpreted with the theory-based input variables. The bias induced by the Biological Syndrome Model better predicted mortality than frailty status. A complicated FI, the Burden Model, could be simplified. The input variables better predicted mortality than the Fls. The continuous Fls predicted mortality better than the frailty statuses. At least 6865 alternative indices better predicted mortality than the Fls. Conclusion Fls have been used as outcome in clinical trials and need to be reviewed for adequacy based on our findings. The three Fls are not closely linked to the theories because of bias introduced by data manipulation and excessive numbers of input variables. We are developing new algorithms to develop and validate innovative indices.	[Chao, Yi-Sheng] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Wu, Hsing-Chien] Taipei Hosp, Minist Hlth & Welf, New Taipei, Taiwan; [Wu, Chao-Jung] Univ Quebec Montreal, Dept Informat, Montreal, PQ, Canada; [Chen, Wei-Chih] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Chen, Wei-Chih] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan; [Chao, Yi-Sheng] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada	Universite de Montreal; University of Quebec; University of Quebec Montreal; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, WC (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.; Chen, WC (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei, Taiwan.	wiji.chen@gmail.com		Wu, Hsing-Chien/0000-0002-1762-5774; Wu, Chao-Jung/0000-0002-8270-5498	Fonds de recherche du Quebec - Sante (FRQS) fellowship; NATIONAL INSTITUTE ON AGING [U01AG009740] Funding Source: NIH RePORTER	Fonds de recherche du Quebec - Sante (FRQS) fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YSC is financed by the Fonds de recherche du Quebec - Sante (FRQS) fellowship. The granting agencies had no role in this study.	Babbie E., 2012, RES METHODS SOCIOLOG; Barnwell-Menard JL, 2015, STAT MED, V34, P936, DOI 10.1002/sim.6387; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cesari M, 2014, CONTEMP CLIN TRIALS, V38, P145, DOI 10.1016/j.cct.2014.04.006; Chao YS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183997; Cigolle CT, 2009, J AM GERIATR SOC, V57, P830, DOI 10.1111/j.1532-5415.2009.02225.x; Dorner TE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1232; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Fedarko NS, 2011, CLIN GERIATR MED, V27, P27, DOI 10.1016/j.cger.2010.08.006; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Harris J., 2016, CARING AGES, V17, P15, DOI [10.1016/j.carage.2016.09.012, DOI 10.1016/J.CARAGE.2016.09.012]; Hasson D., 2005, International Electronic Journal of Health Education, V8, P178; Hastie T., 2009, UNSUPERVISED LEARNIN; Health and Retirement Study RAND HRS Data File (v.P) public use dataset, 2016, U01AG009740 PADBTUOM; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Kahn R, 2008, LANCET, V371, P1892, DOI 10.1016/S0140-6736(08)60731-X; Kehler DS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0423-6; Kirn DR, 2015, CONTEMP CLIN TRIALS, V43, P164, DOI 10.1016/j.cct.2015.06.001; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Moon JR, 2012, SOC SCI MED, V75, P526, DOI 10.1016/j.socscimed.2012.04.004; R Development Core Team, 2016, R LANG ENV STAT COMP; RAND Corporation, 2016, RAND HRS DAT FIL SUP; Ravindrarajah R, 2013, ARCH GERONTOL GERIAT, V57, P360, DOI 10.1016/j.archger.2013.06.010; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P738, DOI 10.1093/gerona/62.7.738; Rockwood K, 2007, J AM MED DIR ASSOC, V8, P595, DOI 10.1016/j.jamda.2007.07.012; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sattar N, 2008, LANCET, V371, P1927, DOI 10.1016/S0140-6736(08)60602-9; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Smets IHGJ, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-26; Song XW, 2004, J AM GERIATR SOC, V52, P1180, DOI 10.1111/j.1532-5415.2004.52319.x; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS9, DOI 10.1093/geronb/53B.1.S9; Team RStudio, 2016, RSTUDIO INT DEV R; Therneau T, 2014, PACKAGE SURVIVAL ANA; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; van Buuren S, 2011, J STAT SOFTW, V45, P1	41	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0197859	10.1371/journal.pone.0197859	http://dx.doi.org/10.1371/journal.pone.0197859			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020923	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400003
J	Wang, Y; Geng, CA; Yuan, XL; Hua, M; Tian, FH; Li, CT				Wang, Yi; Geng, Changan; Yuan, Xiaolong; Hua, Mei; Tian, Fenghua; Li, Changtian			Identification of a putative polyketide synthase gene involved in usnic acid biosynthesis in the lichen Nephromopsis pallescens	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; ASPERGILLUS-NIDULANS; FORMING FUNGUS; CLUSTER; GENOME; TRANSCRIPTION; METABOLITE; MYCOBIONT; COMPOUND; CITRININ	Usnic acid is a unique polyketide produced by lichens. To characterize usnic acid biosynthesis, the transcriptome of the usnic-acid-producing lichen-forming fungus Nephromopsis pallescens was sequenced using Illumina NextSeq technology. Seven complete non-reducing polyketide synthase genes and nine highly-reducing polyketide synthase genes were obtained through transcriptome analysis. Gene expression results obtained by qPCR and usnic acid detection with LCMS-IT-TOF showed that Nppks7 is probably involved in usnic acid biosynthesis in N. pallescens. Nppks7 is a non-reducing polyketide synthase with a MeT domain that also possesses beta-ketoacyl-ACP synthase, acyl transferase, product template, acyl carrier protein, C-methyltransferase, and Claisen cyclase domains. Phylogenetic analysis shows that Nppks7 and other polyketide synthases from lichens form a unique monophyletic Glade. Taken together, our data indicate that Nppks7 is a novel PKS in N. pallescens that is likely involved in usnic acid biosynthesis.	[Wang, Yi; Yuan, Xiaolong; Hua, Mei] Yunnan Acad Forestry, Key Lab Forest Plant Cultivat & Utilizat, Kunming, Yunnan, Peoples R China; [Wang, Yi; Tian, Fenghua; Li, Changtian] Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun, Jilin, Peoples R China; [Geng, Changan] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China	Jilin Agricultural University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Li, CT (corresponding author), Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun, Jilin, Peoples R China.	lct@jlau.edu.cn		Wang, Yi/0000-0003-3089-8184; Li, Chang-Tian/0000-0001-6498-8642	National Natural Science Foundation of China [31400488]; Applied Basic Research Project of Yunnan Province Grant [2016FB055]; Yunnan Academy of Forestry Innovation Fund Project [QN2018-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Project of Yunnan Province Grant; Yunnan Academy of Forestry Innovation Fund Project	This work was supported by a grant from National Natural Science Foundation of China (31400488), by the Applied Basic Research Project of Yunnan Province Grant (2016FB055) and by the Yunnan Academy of Forestry Innovation Fund Project, Grant (QN2018-01).	Abdel-Hameed M, 2016, FUNGAL BIOL-UK, V120, P306, DOI 10.1016/j.funbio.2015.10.009; Armaleo D, 2011, MYCOLOGIA, V103, P741, DOI 10.3852/10-335; Backorova M, 2012, TOXICOL IN VITRO, V26, P462, DOI 10.1016/j.tiv.2012.01.017; Brunauer G, 2009, MYCOL RES, V113, P82, DOI 10.1016/j.mycres.2008.08.007; Campanella L, 2002, BIOCHIMIE, V84, P329, DOI 10.1016/S0300-9084(02)01386-X; Chiang YM, 2013, J AM CHEM SOC, V135, P7720, DOI 10.1021/ja401945a; Chooi YH, 2008, MYCOL RES, V112, P147, DOI 10.1016/j.mycres.2007.08.022; Cocchietto M, 2002, NATURWISSENSCHAFTEN, V89, P137, DOI 10.1007/s00114-002-0305-3; Francolini I, 2004, ANTIMICROB AGENTS CH, V48, P4360, DOI 10.1128/AAC.48.11.4360-4365.2004; Gagunashvili AN, 2009, MYCOL RES, V113, P354, DOI 10.1016/j.mycres.2008.11.011; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo L, 2008, J ENVIRON SCI HEAL C, V26, P317, DOI 10.1080/10590500802533392; Hametner C., 2015, RECENT ADV LICHENOLO, V2, P95; Hashimoto M, 2015, BIOORG MED CHEM LETT, V25, P1381, DOI 10.1016/j.bmcl.2015.02.057; Hawranik DJ, 2009, BIOORG MED CHEM LETT, V19, P2383, DOI 10.1016/j.bmcl.2009.03.087; Helfrich EJN, 2014, CURR OPIN BIOTECH, V29, P107, DOI 10.1016/j.copbio.2014.03.004; HONEGGER R, 1984, LICHENOLOGIST, V16, P111, DOI 10.1017/S0024282984000293; Ingolfsdottir K, 2002, PHYTOCHEMISTRY, V61, P729, DOI 10.1016/S0031-9422(02)00383-7; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Luo H, 2011, J MICROBIOL, V49, P66, DOI 10.1007/s12275-011-0289-9; Mardis ER, 2013, ANNU REV ANAL CHEM, V6, P287, DOI 10.1146/annurev-anchem-062012-092628; Mayer M, 2005, ANTI-CANCER DRUG, V16, P805, DOI 10.1097/01.cad.0000175588.09070.77; Miao V, 2001, TRENDS BIOTECHNOL, V19, P349, DOI 10.1016/S0167-7799(01)01700-0; Molina MC, 2003, PLANT PHYSIOL BIOCH, V41, P175, DOI 10.1016/S0981-9428(02)00017-7; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pang F, 2018, GENOMICS, V110, P162, DOI 10.1016/j.ygeno.2017.09.008; Park SY, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01065-13; Park SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083896; Park SY, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00678-13; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Reeves CD, APPL ENV MICROBIOLOG, V74, P5121; Sakai K, 2008, J BIOSCI BIOENG, V106, P466, DOI 10.1263/jbb.106.466; Sanchez JF, 2010, MOL BIOSYST, V6, P587, DOI 10.1039/b904541d; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; Stocker WE, 2013, STUDIES NATURAL PROD, P337; Stocker-Worgotter E, 2008, NAT PROD REP, V25, P188, DOI 10.1039/b606983p; Storm PA, 2017, CELL CHEM BIOL, V24, P316, DOI 10.1016/j.chembiol.2017.01.008; Wang SH, 2008, CHEM BIOL, V15, P1328, DOI 10.1016/j.chembiol.2008.10.006; Wang Y, 2016, RES J BIOTECHNOL, V11, P16; [王毅 WANG Yi], 2015, [菌物学报, Mygosystema], V34, P246; Wang Y, 2014, MYCOBIOLOGY, V42, P34, DOI 10.5941/MYCO.2014.42.1.34; Wang Y, 2012, MYCOL PROG, V11, P75, DOI 10.1007/s11557-010-0730-1; Wei XL, 2008, PLANT PATHOLOGY J, V24, P202, DOI 10.5423/PPJ.2008.24.2.202	43	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199110	10.1371/journal.pone.0199110	http://dx.doi.org/10.1371/journal.pone.0199110			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020937	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400009
J	Cornara, D; Garzo, E; Morente, M; Moreno, A; Alba-Tercedor, J; Fereres, A				Cornara, Daniele; Garzo, Elisa; Morente, Marina; Moreno, Aranzazu; Alba-Tercedor, Javier; Fereres, Alberto			EPG combined with micro-CT and video recording reveals new insights on the feeding behavior of Philaenus spumarius	PLOS ONE			English	Article							HOMALODISCA-VITRIPENNIS HEMIPTERA; GLASSY-WINGED SHARPSHOOTER; WAVE-FORM CHARACTERIZATION; XYLELLA-FASTIDIOSA; TRANSPIRATION STREAM; STYLET PENETRATION; INSECT VECTORS; COAGULATA SAY; PLANT-VIRUS; CICADELLIDAE	The meadow spittlebug Philaenus spumarius plays a key role in the transmission of the bacterium Xylella fastidiosa to olive in Apulia (South Italy). Currently, available data on P. spumarius feeding behavior is limited, and a real-time observation of the different steps involved in stylet insertion, exploratory probes, and ingestion, has never been carried out. Therefore, we performed an EPG-assisted characterization of P. spumarius female feeding behavior on olive, in order to detect and analyze the main EPG waveforms describing their amplitude, frequency, voltage level, and electrical origin of the traces during stylet penetration in plant tissues. Thereafter, each of the main waveforms was correlated with specific biological activities, through video recording and analysis of excretion by adults and excretion/secretion by nymphs. Furthermore, the specific stylet tips position within the plant tissues during each of the waveforms observed was assessed by microcomputer tomography (micro-CT). Additional EPG-recordings were carried out with males of P. spumarius on olive, in order to assess possible sex-related differences. P. spumarius feeding behavior can be described by five main distinct waveforms: C (pathway), Xc (xylem contact/preingestion), Xi(xylem sap ingestion), R (resting), N (interruption within xylem phase). Compared to males, females require shorter time to begin the first probe, and their Xi phase is significantly longer. Furthermore, considering the single waveform events, males on olive exhibit longer np and R compared to females.	[Cornara, Daniele; Garzo, Elisa; Morente, Marina; Moreno, Aranzazu; Fereres, Alberto] CSIC, ICA, Madrid, Spain; [Alba-Tercedor, Javier] Univ Granada, Fac Sci, Dept Zool, Campus Fuentenueva, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Agrarias (ICA); University of Granada	Fereres, A (corresponding author), CSIC, ICA, Madrid, Spain.	a.fereres@csic.es	Fereres, Alberto/F-2990-2011; cornara, daniele/AAN-2685-2020; Fereres, Alberto/GZG-4690-2022; Morente, Marina/T-5752-2019; Alba-Tercedor, Javier/C-3679-2015; Moreno, Aránzazu/F-9309-2015; Garzo, Elisa/G-3047-2015	Fereres, Alberto/0000-0001-6012-3270; cornara, daniele/0000-0001-8258-2291; Moreno, Aránzazu/0000-0003-1394-3123; Alba-Tercedor, Javier/0000-0002-3461-5340; Garzo, Elisa/0000-0001-8626-5832	European Union Horizon 2020 research and innovation program [635646, 727987]; USDA NIFA Award [2015-70016-23028]	European Union Horizon 2020 research and innovation program; USDA NIFA Award	This work has been financially supported by European Union Horizon 2020 research and innovation program under grant agreements no. 635646 POnTE (Pest Organisms Threatening Europe), and no. 727987 XF-ACTORS (Xylella Fastidiosa Active Containment Through a multidisciplinary-Oriented Research Strategy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the micro-CT, the work benefited of the project: "Developing an Infrastructure and Product Test Pipeline to Deliver Novel Therapies for Citrus Greening Disease", USDA NIFA Award No.2015-70016-23028.	Alba-Tercedor J., 2017, BRUK MICR CT US M 20, P270; Alba-Tercedor J, 2014, BRUKER MICROCT USERS, P260; Almeida RP, 2016, XYLELLA FASTIDIOSA V, V144, P235; Almeida RPP, 2004, ANN ENTOMOL SOC AM, V97, P838, DOI 10.1603/0013-8746(2004)097[0838:SPBOGA]2.0.CO;2; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; [Anonymous], 2017, R LANG ENV STAT COMP; Antolinez CA, ENTOMOL EXP APPL, DOI [10.1111/eea.12565/full, DOI 10.1111/EEA.12565/FULL]; Backus E.A., 1985, P163; Backus EA, 2005, ANN ENTOMOL SOC AM, V98, P787, DOI 10.1603/0013-8746(2005)098[0787:SPBAHC]2.0.CO;2; BACKUS EA, 2016, VECTOR MEDIATED TRAN, P173; Backus EA, 2015, PHYTOPATHOLOGY, V105, P608, DOI 10.1094/PHYTO-09-14-0258-R; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Backus Elaine A., 1994, P1; Backus EA, 2009, J INSECT PHYSIOL, V55, P869, DOI 10.1016/j.jinsphys.2009.05.007; Backus EA, 2009, ANN ENTOMOL SOC AM, V102, P847, DOI 10.1603/008.102.0512; Cid M, 2010, ANN ENTOMOL SOC AM, V103, P404, DOI 10.1603/AN09079; Cornara D, 2018, J PEST SCI, V91, P957, DOI 10.1007/s10340-018-0966-0; Cornara D, 2017, J APPL ENTOMOL, V141, P80, DOI 10.1111/jen.12365; Cornara D, 2016, PHYTOPATHOLOGY, V106, P1285, DOI 10.1094/PHYTO-05-16-0202-R; Cornara D, 2017, J PEST SCI, V90, P521, DOI 10.1007/s10340-016-0793-0; Crane PS, 1970, THESIS; Crews LJ, 1998, AM J BOT, V85, P449, DOI 10.2307/2446427; Daugherty MP, 2009, ANN APPL BIOL, V155, P361, DOI 10.1111/j.1744-7348.2009.00346.x; Dolezal P, 2004, ANN ENTOMOL SOC AM, V97, P1055, DOI 10.1603/0013-8746(2004)097[1055:NMOMTF]2.0.CO;2; Dugravot S, 2008, J INSECT PHYSIOL, V54, P1467, DOI 10.1016/j.jinsphys.2008.05.008; Eigenbrode SD, 2017, ANN REV ENTOMOL; Fereres A, 2015, CURR OPIN VIROL, V10, P42, DOI 10.1016/j.coviro.2014.12.008; Frazier N. W., 1965, P INT C VIR VECT PER, P91; Gergerich RC, 2015, PLANT DIS, V99, P176, DOI 10.1094/PDIS-07-14-0762-FE; Harris Kerry F., 2001, P111, DOI 10.1016/B978-012327681-0/50009-1; HORSFIELD D, 1978, ENTOMOL EXP APPL, V24, P95, DOI 10.1007/BF00334176; Jackson BC, 2008, J ECON ENTOMOL, V101, P1122, DOI 10.1603/0022-0493(2008)101[1122:IODVFO]2.0.CO;2; Joost PH, 2006, J INSECT PHYSIOL, V52, P327, DOI 10.1016/j.jinsphys.2005.11.012; Koga R, 2013, ENVIRON MICROBIOL, V15, P2073, DOI 10.1111/1462-2920.12121; Krugner R, 2012, ANN ENTOMOL SOC AM, V105, P280, DOI 10.1603/AN11117; Lei H, 1997, BEMISIA 1996 TAXONOM, P53; Llewellyn M., 1982, Proceedings of the International Symposium on Insect-Plant Relationships, V5, P243; Malone M, 1999, NEW PHYTOL, V143, P261, DOI 10.1046/j.1469-8137.1999.00448.x; Marcone C, 2017, FOREST PATHOL, V47, DOI 10.1111/efp.12324; Matteoni JA, 1988, ELM YELLOWS ASH YELL, P19; MCLEAN DL, 1964, NATURE, V202, P1358, DOI 10.1038/2021358a0; Miranda MP, 2009, ENTOMOL EXP APPL, V130, P35, DOI 10.1111/j.1570-7458.2008.00794.x; Moreno A, 2012, J GEN VIROL, V93, P662, DOI 10.1099/vir.0.037887-0; Novotny V, 1997, EVOL ECOL, V11, P419, DOI 10.1023/A:1018432807165; Pautasso M., 2015, CAB Reviews, V10, P1, DOI 10.1079/PAVSNNR201510021; Pompon J, 2011, J INSECT PHYSIOL, V57, P1317, DOI 10.1016/j.jinsphys.2011.06.007; Ponder KL, 2002, NEW PHYTOL, V153, P237, DOI 10.1046/j.0028-646X.2001.00314.x; POWELL G, 1993, ENTOMOL EXP APPL, V68, P193, DOI 10.1007/BF02380538; PURCELL AH, 1979, PHYTOPATHOLOGY, V69, P393, DOI 10.1094/Phyto-69-393; PURCELL AH, 1980, J ECON ENTOMOL, V73, P834, DOI 10.1093/jee/73.6.834; RAPUSAS HR, 1990, ENVIRON ENTOMOL, V19, P594, DOI 10.1093/ee/19.3.594; RAVEN JA, 1983, ADV ECOL RES, V13, P135, DOI 10.1016/S0065-2504(08)60109-9; Ruiz N, 2006, J HORTIC SCI BIOTECH, V81, P783, DOI 10.1080/14620316.2006.11512138; Saguez J, 2015, ENTOMOL EXP APPL, DOI [10.1111/eea.12353/full, DOI 10.1111/EEA.12353/FULL]; Sandanayaka W. R. M., 2017, New Zealand Plant Protection, V70, P31, DOI 10.30843/nzpp.2017.70.23; Sandanayaka WRM, 2013, J APPL ENTOMOL, V137, P519, DOI 10.1111/jen.12025; Thompson V, 2004, B ENTOMOL RES, V94, P189, DOI 10.1079/BER2004293; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187, DOI 10.1007/BF00361931; Walker G.P., 2000, P14; Watson R, 2001, J EXP BOT, V52, P1873, DOI 10.1093/jexbot/52.362.1873; Wayadande AC, 1996, J INSECT BEHAV, V9, P3, DOI 10.1007/BF02213720; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; WIEGERT RG, 1964, ECOL MONOGR, V34, P217, DOI 10.2307/1948501	64	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0199154	10.1371/journal.pone.0199154	http://dx.doi.org/10.1371/journal.pone.0199154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016320	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600006
J	Ibrahim, A; Harrison, M; Meinke, H; Fan, Y; Johnson, P; Zhou, MX				Ibrahim, Ahmed; Harrison, Matthew; Meinke, Holger; Fan, Yun; Johnson, Peter; Zhou, Meixue			A regulator of early flowering in barley (Hordeum vulgare L.)	PLOS ONE			English	Article							SPRING GROWTH HABIT; ENVIRONMENTAL-CONTROL; PASTING PROPERTIES; CIRCADIAN CLOCK; LOW-TEMPERATURE; HEADING DATE; SE GENE; WHEAT; TIME; EARLINESS	Heading date (HD) of cereals is an important trait for adaptation to diverse environments and is critical for determining yield and quality and the number of genes and gene combinations that confer earliness in barley under short days is limited. In our study, a QTL for early flowering was identified from the cross between an Australian malting barley cultivar and a Chinese landrace. Four sets of near isogenic lines (NILs) were developed with a QTL located on chromosome 5H at the interval of 122.0-129.0 cM. Further experiments were conducted to investigate how this gene was regulated by photoperiod using the NILs with three sowing dates from autumn to summer. The NILs carrying the earliness allele were significantly earlier than the late genotype at all sowing dates. This gene was different from previously reported vernalisation genes that are located at a similar position as no vernalisation was required for all the NILs. The difference between this gene and Eam5 (HvPHYC) locus which also located between two co-segregated markers (3398516S5, 122.5 cM, and 4014046D5, 126.1 cM), is that with the existence of Ppd-H1 (Eam1), Eam5 has no effect on ear emergence under long days while the gene from TX9425 still reduced the time to ear emergency. The locus showed no pleiotropic effects on grain pasting properties and agronomic traits except for spike length and number of spikelets per spike, and thus can be effectively used in breeding programs. The array of early heading dates caused by interactions of Eam5 gene with other maturity genes provides an opportunity to better fine tune heading dates with production environments, which can be critical factor in barley breeding.	[Ibrahim, Ahmed; Harrison, Matthew; Meinke, Holger; Fan, Yun; Johnson, Peter; Zhou, Meixue] Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia; [Ibrahim, Ahmed] Ahmadu Bello Univ, Inst Agr Res, Dept Plant Sci, Zaria, Nigeria	University of Tasmania; Ahmadu Bello University; Institute for Agricultural Research, Samaru, Zaria	Zhou, MX (corresponding author), Univ Tasmania, Tasmanian Inst Agr, Hobart, Tas, Australia.	Meixue.Zhou@utas.edu.au	Harrison, Matthew/AAH-8915-2020; Harrison, Matthew Tom/C-2434-2014; Meinke, Holger/GRS-6385-2022; Meinke, Holger/C-7215-2013; , Meixue/C-2387-2014	Harrison, Matthew/0000-0001-7425-452X; Harrison, Matthew Tom/0000-0001-7425-452X; Meinke, Holger/0000-0003-2657-3264; , Meixue/0000-0003-3009-7854	Grains Research and Development Corporation; Grains Research & Development Corporation (GRDC) of Australia	Grains Research and Development Corporation(Grains R&D Corp); Grains Research & Development Corporation (GRDC) of Australia(Grains R&D Corp)	This work was supported by the Grains Research and Development Corporation funded the project (AI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Grains Research & Development Corporation (GRDC) of Australia.	Akbar Hossain, 2012, Journal of Plant Breeding and Crop Science, V4, P184; Alqudah AM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00896; Alqudah AM, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00117; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; [Anonymous], 2015, ABIOTIC STRESS AGRON; Appendino ML, 2003, J AGR SCI-CAMBRIDGE, V141, P149, DOI 10.1017/S0021859603003472; Barley' Franklin, DEP PRIMARY IND TASM, V2; BARUA UM, 1993, GENOME, V36, P1080, DOI 10.1139/g93-143; Biyashev RM, 1997, J HERED, V88, P21, DOI 10.1093/oxfordjournals.jhered.a023050; Boden SA, 2014, PLANT CELL, V26, P1557, DOI 10.1105/tpc.114.123794; Borner A, 2002, PLANT BREEDING, V121, P129, DOI 10.1046/j.1439-0523.2002.00691.x; Boyd WJR, 2003, AUST J AGR RES, V54, P1277, DOI 10.1071/AR03014; Boyd WJR, 2007, 13 AUSTR BARL TECHN; Bullrich L, 2002, THEOR APPL GENET, V105, P585, DOI 10.1007/s00122-002-0982-5; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cuesta-Marcos A, 2008, MOL BREEDING, V21, P455, DOI 10.1007/s11032-007-9145-3; Cuesta-Marcos A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-707; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; ELLIS RH, 1988, ANN BOT-LONDON, V62, P145, DOI 10.1093/oxfordjournals.aob.a087645; Fan Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1243-8; Faricelli ME, 2010, FUNCT INTEGR GENOMIC, V10, P293, DOI 10.1007/s10142-009-0146-7; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Fox G, 2009, J I BREWING, V115, P95, DOI 10.1002/j.2050-0416.2009.tb00352.x; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; Fujita M, 2003, P 10 INT WHEAT GEN S, V3, P971; Gawronski P, 2012, MOL BREEDING, V30, P1097, DOI 10.1007/s11032-011-9697-0; Gonzalez FG, 2003, FIELD CROP RES, V81, P29, DOI 10.1016/S0378-4290(02)00196-X; Griffiths S, 2009, THEOR APPL GENET, V119, P383, DOI 10.1007/s00122-009-1046-x; Gupta M, 2010, COMPR REV FOOD SCI F, V9, P318, DOI 10.1111/j.1541-4337.2010.00112.x; Harrison MT, 2014, GLOBAL CHANGE BIOL, V20, P867, DOI 10.1111/gcb.12381; Hay RKM, 1998, ANN BOT-LONDON, V82, P541, DOI 10.1006/anbo.1998.0733; HAY RKM, 1991, AUST J AGR RES, V42, P661, DOI 10.1071/AR9910661; Hemming MN, 2009, MOL GENET GENOMICS, V282, P107, DOI 10.1007/s00438-009-0449-3; Herndl M, 2008, EUPHYTICA, V163, P309, DOI 10.1007/s10681-008-9671-z; Hills CB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01906; Juskiw PE, 2001, AGRON J, V93, P370, DOI 10.2134/agronj2001.932370x; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Kippes N, 2016, THEOR APPL GENET, V129, P1417, DOI 10.1007/s00122-016-2713-3; Kippes N, 2015, P NATL ACAD SCI USA, V112, pE5401, DOI 10.1073/pnas.1514883112; Kiss T, 2014, CEREAL RES COMMUN, V42, P239, DOI 10.1556/CRC.2013.0064; Kuchel H, 2006, THEOR APPL GENET, V113, P1103, DOI 10.1007/s00122-006-0370-7; Laurie AD, 1994, GENETIC ANAL PHOTOPE, V72, P619; Laurie DA, RFLP MAPPING 5 MAJOR; Lewis S, 2008, J EXP BOT, V59, P3595, DOI 10.1093/jxb/ern209; Li HB, 2010, MOL GENET GENOMICS, V284, P319, DOI 10.1007/s00438-010-0570-3; Li HB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-401; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Mathews S, 2010, PLANT CELL, V22, P4, DOI 10.1105/tpc.109.072280; McMaster GS, 2003, J AGR SCI, V141, P129, DOI 10.1017/S0021859603003460; MEINKE H, 1993, AGRON J, V85, P735, DOI 10.2134/agronj1993.00021962008500030039x; Mizuno N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165618; Nilan RA, 1971, P388; Nishida H, 2013, PLANT PHYSIOL, V163, P804, DOI 10.1104/pp.113.222570; Nuttonson MY, 1956, COMP STUDY LOWER UPP, V18, P1; Pang JY, 2004, AUST J AGR RES, V55, P895, DOI 10.1071/AR03097; Pankin A, 2014, GENETICS, V198, P383, DOI 10.1534/genetics.114.165613; Pourkheirandish M, 2007, ANN BOT-LONDON, V100, P999, DOI 10.1093/aob/mcm139; Ren XF, 2012, MOL BREEDING, V30, P1121, DOI 10.1007/s11032-012-9700-4; Ren XF, 2010, CROP PASTURE SCI, V61, P145, DOI 10.1071/CP09187; ROBERTS EH, 1988, ANN BOT-LONDON, V62, P127, DOI 10.1093/oxfordjournals.aob.a087644; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Singh S, 2010, FOOD CHEM, V122, P559, DOI 10.1016/j.foodchem.2010.03.010; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Snape JW, 2001, EUPHYTICA, V119, P185, DOI 10.1023/A:1017594422176; Stell R., 1980, PRINCIPLES PROCEDURE; Swiecka S, 2014, J APPL GENET, V55, P469, DOI 10.1007/s13353-014-0223-z; Szucs P, 2006, THEOR APPL GENET, V112, P1277, DOI 10.1007/s00122-006-0229-y; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Valarik M, 2006, THEOR APPL GENET, V112, P945, DOI 10.1007/s00122-005-0198-6; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Wang JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090144; Wang JM, 2010, GENETICA, V138, P1191, DOI 10.1007/s10709-010-9511-7; Wang JM, 2010, EUPHYTICA, V175, P331, DOI 10.1007/s10681-010-0175-2; WENT FW, 1953, ANNU REV PLANT PHYS, V4, P347, DOI 10.1146/annurev.pp.04.060153.002023; Wexelsen H, 1933, HEREDITAS, V18, P307; Xu RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043079; Yin XY, 1997, FIELD CROP RES, V51, P189, DOI 10.1016/S0378-4290(96)03456-9; Zhou M, 2005, J CEREAL SCI, V41, P31, DOI 10.1016/j.jcs.2004.04.003; Zhou MX, 2008, J CEREAL SCI, V48, P789, DOI 10.1016/j.jcs.2008.05.006; Zhou MX, 2000, J SCI FOOD AGR, V80, P1486, DOI 10.1002/1097-0010(200008)80:10<1486::AID-JSFA668>3.3.CO;2-R; Zhou MX, 1999, AUST J AGR RES, V50, P1409, DOI 10.1071/AR99025; Zhou MX, 1998, CEREAL CHEM, V75, P273, DOI 10.1094/CCHEM.1998.75.3.273; Zikhali M., 2015, ADV WHEAT GENETICS G, P339, DOI [10.1007/978-4-431-55675-6_39, DOI 10.1007/978-4-431-55675-6_39]; Zikhali M, 2014, MOL BREEDING, V34, P1023, DOI 10.1007/s11032-014-0094-3	87	16	17	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200722	10.1371/journal.pone.0200722	http://dx.doi.org/10.1371/journal.pone.0200722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016338	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000438866600038
J	Schley, G; Jordan, J; Ellmann, S; Rosen, S; Eckardt, KU; Uder, M; Willam, C; Bauerle, T				Schley, Gunnar; Jordan, Jutta; Ellmann, Stephan; Rosen, Seymour; Eckardt, Kai-Uwe; Uder, Michael; Willam, Carsten; Baeuerle, Tobias			Multiparametric magnetic resonance imaging of experimental chronic kidney disease: A quantitative correlation study with histology	PLOS ONE			English	Article							RENAL FIBROSIS; RAT MODEL; INTERSTITIAL FIBROSIS; FUNCTIONAL ASSESSMENT; MURINE MODEL; DIFFUSION; MRI; INJURY; MECHANISMS; TRANSPLANTATION	Objectives In human chronic kidney disease (CKD) the extent of renal tubulointerstitial fibrosis correlates with progressive loss of renal function. However, fibrosis can so far only be assessed by histology of kidney biopsies. Magnetic resonance imaging (MRI) can provide information about tissue architecture, but its potential to assess fibrosis and inflammation in diseased kidneys remains poorly defined. Materials and methods We evaluated excised kidneys in a murine adenine-induced nephropathy model for CKD by MRI and correlated quantitative MRI parameters (T1, 12, and T2* relaxation times, apparent diffusion coefficient and fractional anisotropy) with histological hallmarks of progressive CKD, including renal fibrosis, inflammation, and microvascular rarefaction. Furthermore, we analyzed the effects of paraformaldehyde fixation on MRI parameters by comparing kidney samples before and after fixation with paraformaldehyde. Results In diseased kidneys T2 and T2* relaxation times, apparent diffusion coefficient and fractional anisotropy in the renal cortex and/or outer medulla were significantly different from those in control kidneys. In particular, T2 relaxation time was the best parameter to distinguish control and CKD groups and correlated very well with the extent of fibrosis, inflammatory infiltrates, tubular dilation, crystal deposition, and loss of peritubular capillaries and normal tubules in the renal cortex and outer medulla. Fixation with paraformaldehyde had no impact on T2 relaxation time and fractional anisotropy, whereas T1 times significantly decreased and T2* times and apparent diffusion coefficients increased in fixed kidney tissue. Conclusions MRI parameters provide a promising approach to quantitatively assess renal fibrosis and inflammation in CKD. Especially T2 relaxation time correlates well with histological features of CKD and is not influenced by paraformaldehyde fixation of kidney samples. Thus, T2 relaxation time might be a candidate parameter for non-invasive assessment of renal fibrosis in human patients.	[Schley, Gunnar; Eckardt, Kai-Uwe; Willam, Carsten] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Nephrol & Hypertens, Erlangen, Germany; [Schley, Gunnar; Jordan, Jutta; Ellmann, Stephan; Eckardt, Kai-Uwe; Uder, Michael; Willam, Carsten; Baeuerle, Tobias] Univ Hosp Erlangen, Erlangen, Germany; [Jordan, Jutta; Ellmann, Stephan; Uder, Michael; Baeuerle, Tobias] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Radiol, Erlangen, Germany; [Rosen, Seymour] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; [Eckardt, Kai-Uwe] Charite Univ Med Berlin, Dept Nephrol & Med Intens Care, Berlin, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Harvard University; Beth Israel Deaconess Medical Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schley, G (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Nephrol & Hypertens, Erlangen, Germany.; Schley, G (corresponding author), Univ Hosp Erlangen, Erlangen, Germany.	gunnar.schley@uk-erlangen.de	Ellmann, Stephan/P-3824-2016	Ellmann, Stephan/0000-0003-2737-5526; Schley, Gunnar/0000-0001-9929-5854; Bauerle, Tobias/0000-0002-0206-6199	Departments of Nephrology and Hypertension and Radiology; Friedrich-Alexander University Erlangen-Nurnberg (FAU); University Hospital Erlangen; Deutsche Forschungsgemeinschaft within Collaborative Research Centre [1181]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander University Erlangen-NOrnberg (FAU)	Departments of Nephrology and Hypertension and Radiology; Friedrich-Alexander University Erlangen-Nurnberg (FAU); University Hospital Erlangen; Deutsche Forschungsgemeinschaft within Collaborative Research Centre; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander University Erlangen-NOrnberg (FAU)	This study was supported by internal institutional funds from the Departments of Nephrology and Hypertension and Radiology, Friedrich-Alexander University Erlangen-Nurnberg (FAU) and University Hospital Erlangen, and by Deutsche Forschungsgemeinschaft within Collaborative Research Centre 1181 (project Z02). We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander University Erlangen-NOrnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boor P, 2015, J MAGN RESON IMAGING, V42, P990, DOI 10.1002/jmri.24853; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Cai XR, 2016, J MAGN RESON IMAGING, V44, P698, DOI 10.1002/jmri.25172; Cheung JS, 2010, NMR BIOMED, V23, P496, DOI 10.1002/nbm.1486; DEMIGUEL MH, 1994, J AM SOC NEPHROL, V4, P1861; Diwan V, 2018, NEPHROLOGY, V23, P5, DOI 10.1111/nep.13180; Ebrahimi B, 2014, CLIN J AM SOC NEPHRO, V9, P395, DOI 10.2215/CJN.02900313; Fan WJ, 2016, EUR RADIOL, V26, P567, DOI 10.1007/s00330-015-3841-x; Farris AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161019; Farris AB, 2012, CURR OPIN NEPHROL HY, V21, P289, DOI 10.1097/MNH.0b013e3283521cfa; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Friedli I, 2016, SCI REP-UK, V6, DOI 10.1038/srep30088; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hennedige T, 2015, MAGN RESON IMAGING, V33, P1324, DOI 10.1016/j.mri.2015.07.012; Hueper K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162705; Hueper K, 2016, J MAGN RESON IMAGING, V44, P112, DOI 10.1002/jmri.25158; Hueper K, 2016, INVEST RADIOL, V51, P58, DOI 10.1097/RLI.0000000000000205; Hueper K, 2014, EUR RADIOL, V24, P2252, DOI 10.1007/s00330-014-3250-6; Hueper K, 2013, AM J PHYSIOL-RENAL, V305, pF1428, DOI 10.1152/ajprenal.00123.2013; Hueper K, 2013, INVEST RADIOL, V48, P834, DOI 10.1097/RLI.0b013e31829d0414; Hueper K, 2012, INVEST RADIOL, V47, P430, DOI 10.1097/RLI.0b013e31824f272d; Hueper K, 2011, EUR RADIOL, V21, P2427, DOI 10.1007/s00330-011-2189-0; Inoue T, 2011, J AM SOC NEPHROL, V22, P1429, DOI 10.1681/ASN.2010111143; Kiernan J, 2008, HISTOLOGICAL HISTOCH; Lanzman RS, 2013, RADIOLOGY, V266, P218, DOI 10.1148/radiol.12112522; Leung G, 2017, CLIN J AM SOC NEPHRO, V12, P1019, DOI 10.2215/CJN.07900716; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Li J, 2017, ADV CHRONIC KIDNEY D, V24, P150, DOI 10.1053/j.ackd.2017.03.005; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu ZL, 2015, EUR RADIOL, V25, P652, DOI 10.1007/s00330-014-3461-x; Milman Z, 2014, AM J NEPHROL, V39, P268, DOI 10.1159/000360093; Morrell GR, 2017, J AM SOC NEPHROL, V28, P2565, DOI 10.1681/ASN.2016101089; Mulay SR, 2016, AM J PHYSIOL-RENAL, V310, pF785, DOI 10.1152/ajprenal.00488.2015; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Peyronnet R, 2012, CELL REP, V1, P241, DOI 10.1016/j.celrep.2012.01.006; Ries M, 2003, J MAGN RESON IMAGING, V17, P104, DOI 10.1002/jmri.10224; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schley G, 2011, J AM SOC NEPHROL, V22, P2004, DOI 10.1681/ASN.2010121249; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; Swinscow T.D.V., 1997, STAT SQUARE ONE, DOI 10.1136/bmj.2.6042.1008; Tamura M, 2009, HISTOCHEM CELL BIOL, V131, P483, DOI 10.1007/s00418-009-0557-5; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Thoeny HC, 2006, RADIOLOGY, V241, P812, DOI 10.1148/radiol.2413060103; Thoeny HC, 2011, RADIOLOGY, V259, P25, DOI 10.1148/radiol.10092419; Thomsen HS, 2006, EUR RADIOL, V16, P2619, DOI 10.1007/s00330-006-0495-8; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Visconti Luca, 2016, World J Nephrol, V5, P321, DOI 10.5527/wjn.v5.i4.321; Wang F, 2014, MAGN RESON IMAGING, V32, P1125, DOI 10.1016/j.mri.2014.07.012; Xie L, 2016, AM J PHYSIOL-RENAL, V311, pF1109, DOI 10.1152/ajprenal.00134.2016; Zhang JL, 2014, KIDNEY INT, V85, P768, DOI 10.1038/ki.2013.361	52	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200259	10.1371/journal.pone.0200259	http://dx.doi.org/10.1371/journal.pone.0200259			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011301	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800016
J	Santoro, C; Giugliano, T; Kraemer, M; Torella, A; Schwitalla, JC; Cirillo, M; Melis, D; Berlit, P; Nigro, V; Perrotta, S; Piluso, G				Santoro, Claudia; Giugliano, Teresa; Kraemer, Markus; Torella, Annalaura; Schwitalla, Jan Claudius; Cirillo, Mario; Melis, Daniela; Berlit, Peter; Nigro, Vincenzo; Perrotta, Silverio; Piluso, Giulio			Whole exome sequencing identifies MRVI1 as a susceptibility gene for moyamoya syndrome in neurofibromatosis type 1	PLOS ONE			English	Article							DISEASE; IRAG; RECEPTOR; LINKAGE; VARIANTS; DATABASE; LEADS; LOCI	Background and purpose Moyamoya angiopathy is a progressive cerebral vasculopathy. The p.R4810K substitution in RNF213 has previously been linked to moyamoya disease in Asian populations. When associated with other medical conditions, such as neurofibromatosis type 1, this vasculopathy is frequently reported as moyamoya syndrome. Intriguingly, most cases of moyamoya-complicated neurofibromatosis type 1 have been described in Caucasians, inverting the population ratio observed in Asians, although prevalence of neurofibromatosis type 1 is constant worldwide. Our aim was to investigate whether, among Caucasians, additive genetic factors may contribute to the occurrence of moyamoya in neurofibromatosis type 1. Methods Whole exome sequencing was carried out on an Italian family with moyamoya-complicated neurofibromatosis type 1 to identify putative genetic modifiers independent of the NF1 locus and potentially involved in moyamoya pathogenesis. Results were validated in an unrelated family of German ancestry. Results We identified the p.P186S substitution (rs35857561) in MRVI1 that segregated with moyamoya syndrome in both the Italian and German family. Conclusions The rs35857561 polymorphism in MRVI1 may be a genetic susceptibility factor for moyamoya in European patients with neurofibromatosis type 1. MRVI1 is a functional partner of ITPR1, PRKG1 and GUCY1A3, which are involved in response to nitric oxide. Mutations in GUCY1A3 have been recently linked to a recessive syndromic form of moyamoya with esophageal achalasia.	[Santoro, Claudia; Perrotta, Silverio] Univ Campania Luigi Vanvitelli, Dipartimento Donna Bambino & Chirurg Gen Speciali, Naples, Italy; [Giugliano, Teresa; Torella, Annalaura; Nigro, Vincenzo; Piluso, Giulio] Univ Campania Luigi Vanvitelli, Dipartimento Med Precis, Naples, Italy; [Kraemer, Markus; Schwitalla, Jan Claudius; Berlit, Peter] Alfried Krupp Hosp, Dept Neurol, Essen, Germany; [Kraemer, Markus] Heinrich Heine Univ, Med Fac, Dept Neurol, Dusseldorf, Germany; [Torella, Annalaura; Nigro, Vincenzo] Telethon Inst Genet & Med TIGEM, Pozzuoli, Italy; [Cirillo, Mario] Univ Campania Luigi Vanvitelli, Dipartimento Sci Med Chirurg Neurol Metabol & Inv, Naples, Italy; [Melis, Daniela] Univ Napoli Federico II, Dipartimento Pediat, Naples, Italy	IRCCS Bambino Gesu; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; Alfried Krupp Hospital; Heinrich Heine University Dusseldorf; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Universita della Campania Vanvitelli; University of Naples Federico II	Piluso, G (corresponding author), Univ Campania Luigi Vanvitelli, Dipartimento Med Precis, Naples, Italy.	giulio.piluso@unicampania.it	PILUSO, Giulio/AAA-3400-2019; Schwitalla, Jan Claudius/AHA-6947-2022; Nigro, Vincenzo/AAB-2274-2022; Piluso, Giulio/AAA-3661-2019; Melis, Daniela/AAD-3623-2019; santoro, claudia/V-8578-2019	PILUSO, Giulio/0000-0001-9418-125X; Melis, Daniela/0000-0002-9458-3926; santoro, claudia/0000-0003-4547-0500; CIRILLO, MARIO/0000-0001-5350-7700; Torella, Annalaura/0000-0003-2479-6018; Perrotta, Silverio/0000-0001-6149-6845				Achrol AS, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.1.FOCUS08302; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ammendola A, 2001, J BIOL CHEM, V276, P24153, DOI 10.1074/jbc.M101530200; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Bessler WK, 2016, FREE RADICAL BIO MED, V97, P212, DOI 10.1016/j.freeradbiomed.2016.06.002; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duan L, 2018, STROKE, V49, P11, DOI [10.1161/STROKEAHA.117.017430, 10.1161/strokeaha.117.017430]; Duat-Rodriguez A, 2014, PEDIATR NEUROL, V50, P96, DOI 10.1016/j.pediatrneurol.2013.04.007; Friedman JM, 2002, GENET MED, V4, P105, DOI 10.1097/00125817-200205000-00002; Friedman JM, 1999, CLIN EPIDEMIOLOGICAL; Friedman JM, 1993, GENEREVIEWS R; Geiselhoringer A, 2004, EMBO J, V23, P4222, DOI 10.1038/sj.emboj.7600440; Guey S, 2017, EUR J HUM GENET, V25, P995, DOI 10.1038/ejhg.2017.92; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Han C, 2015, J CLIN NEUROSCI, V22, P286, DOI 10.1016/j.jocn.2014.05.046; Herve D, 2014, AM J HUM GENET, V94, P385, DOI 10.1016/j.ajhg.2014.01.018; Ikeda H, 1999, AM J HUM GENET, V64, P533, DOI 10.1086/302243; Inoue TK, 2000, J CHILD NEUROL, V15, P179, DOI 10.1177/088307380001500307; Johnson AD, 2010, NAT GENET, V42, P608, DOI 10.1038/ng.604; Kraemer M, 2008, STROKE, V39, P3193, DOI 10.1161/STROKEAHA.107.513408; Kuriyama S, 2008, STROKE, V39, P42, DOI 10.1161/STROKEAHA.107.490714; Liu WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022542; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Mayes DA, 2013, CELL REP, V4, P1197, DOI 10.1016/j.celrep.2013.08.011; Miskinyte S, 2011, AM J HUM GENET, V88, P718, DOI 10.1016/j.ajhg.2011.04.017; Mukawa M, 2017, J STROKE CEREBROVASC, V26, P150, DOI 10.1016/j.jstrokecerebrovasdis.2016.09.003; Mutarelli M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S3-S5; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Sakurai K, 2004, J HUM GENET, V49, P278, DOI 10.1007/s10038-004-0143-6; Santoro C, 2017, AM J MED GENET A, V173, P1521, DOI 10.1002/ajmg.a.38212; Schlossmann J, 2011, AM J PHYSIOL-HEART C, V301, pH672, DOI 10.1152/ajpheart.00198.2011; Scott RM, 2009, NEW ENGL J MED, V360, P1226, DOI 10.1056/NEJMra0804622; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SUZUKI J, 1983, STROKE, V14, P104, DOI 10.1161/01.STR.14.1.104; SUZUKI J, 1969, ARCH NEUROL-CHICAGO, V20, P288, DOI 10.1001/archneur.1969.00480090076012; Uchino K, 2005, NEUROLOGY, V65, P956, DOI 10.1212/01.wnl.0000176066.33797.82; von Werder A, 2011, AM J PHYSIOL-CELL PH, V301, pC1445, DOI 10.1152/ajpcell.00304.2010; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xing C, 2006, HYPERTENSION, V47, P797, DOI 10.1161/01.HYP.0000208330.68355.72; Yamauchi T, 2000, STROKE, V31, P930, DOI 10.1161/01.STR.31.4.930	41	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200446	10.1371/journal.pone.0200446	http://dx.doi.org/10.1371/journal.pone.0200446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001348	gold, Green Submitted, Green Published			2022-12-26	WOS:000438457400055
J	Young, SD; Zhang, QP				Young, Sean D.; Zhang, Qingpeng			Using search engine big data for predicting new HIV diagnoses	PLOS ONE			English	Article								Background A large and growing body of "big data" is generated by internet search engines, such as Google. Because people often search for information about public health and medical issues, researchers may be able to use search engine data to monitor and predict public health problems, such as HIV. We sought to assess the feasibility of using Google search data to analyze and predict new HIV diagnoses cases in the United States. Methods and findings From 2007 to 2014, we collected search volume data on HIV-related Google search keywords across the United States. State-level new HIV diagnoses data were collected from the Centers for Disease Control and Prevention (CDC) and AIDSVu.org. We developed a negative binomial model to predict HIV cases using a subset of significant predictor keywords identified by LASSO. The Google search data were combined with state-level HIV case reports provided by the CDC. We use historical data to train the model and predict new HIV diagnoses from 2011 to 2014, with an average R-2 value of 0.99 between predicted versus actual cases, and average root-mean-square error (RMSE) of 108.75. Conclusions Results indicate that Google Trends is a feasible tool to predict new cases of HIV at the state level. We discuss the implications of integrating visualization maps and tools based on these models into public health and HIV monitoring and surveillance.	[Young, Sean D.] Univ Calif Los Angeles, Dept Family Med, Univ Calif Inst Predict Technol, Los Angeles, CA 90095 USA; [Zhang, Qingpeng] City Univ Hong Kong, Dept Syst Engn & Engn Management, Kowloon, Hong Kong, Peoples R China	University of California System; University of California Los Angeles; City University of Hong Kong	Young, SD (corresponding author), Univ Calif Los Angeles, Dept Family Med, Univ Calif Inst Predict Technol, Los Angeles, CA 90095 USA.	sdyoung@mednet.ucla.edu	Zhang, Qingpeng/D-4682-2011; PAN, ZEQIANG/X-6341-2018	Zhang, Qingpeng/0000-0002-6819-0686; Young, Sean D./0000-0001-6052-4875	National Institute of Allergy and Infectious Diseases grants [R56 AI125105, R01 AI132030]; National Institute of Mental Health [5R01MH106415]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132030, R56AI125105] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases grants; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases grants R56 AI125105 and R01 AI132030 and the National Institute of Mental Health (5R01MH106415).	AIDSVu-FAQs, AIDSVU FAQS; [Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; [Anonymous], SURVEILLANCE OVERVIE; [Anonymous], AIDSVU UND HIV YOU L; [Anonymous], 2017, BASIC STAT HIV BASIC; Aslam AA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3532; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Desai R, 2012, CLIN INFECT DIS, V55, pE75, DOI 10.1093/cid/cis579; Desai R, 2012, CLIN INFECT DIS, V54, pCP8, DOI 10.1093/cid/cis121; Fox S, 2013, HLTH ONLINE 2013, DOI DOI 10.1186/1471-244X-10-113; Ireland ME, 2015, HEALTH PSYCHOL, V34, P1252, DOI 10.1037/hea0000279; Jena AB, 2013, CLIN INFECT DIS, V56, P1352, DOI 10.1093/cid/cit022; Milinovich GJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0690-1; Palella FJ, 2003, ANN INTERN MED, V138, P620, DOI 10.7326/0003-4819-138-8-200304150-00007; Polgreen PM, 2008, CLIN INFECT DIS, V47, P1443, DOI 10.1086/593098; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; Weaver JB, 2010, AM J PUBLIC HEALTH, V100, P1520, DOI 10.2105/AJPH.2009.180521; Yang SH, 2015, P NATL ACAD SCI USA, V112, P14473, DOI 10.1073/pnas.1515373112; Young S. D., DRUG ALCOHOL DEPENDE; Young SD, 2014, PREV MED, V63, P112, DOI 10.1016/j.ypmed.2014.01.024	23	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199527	10.1371/journal.pone.0199527	http://dx.doi.org/10.1371/journal.pone.0199527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001360	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400011
J	Binder-Heschl, C; Crossley, K; te Pas, A; Polglase, G; Blank, D; Zahra, V; Moxham, A; Rodgers, K; Hooper, S				Binder-Heschl, Corinna; Crossley, Kelly; te Pas, Arjan; Polglase, Graeme; Blank, Douglas; Zahra, Valerie; Moxham, Alison; Rodgers, Karyn; Hooper, Stuart			Haemodynamic effects of prenatal caffeine on the cardiovascular transition in ventilated preterm lambs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BLOOD-FLOW-VELOCITY; PREMATURE-INFANTS; ADENOSINE RECEPTORS; CLINICAL-OUTCOMES; DUCTUS-ARTERIOSUS; DOSE CAFFEINE; THERAPY; APNEA; BIRTH	Background Caffeine is routinely given to preterm infants hours after birth to treat apnea of prematurity. In view of it's success, earlier administration in the delivery room is being considered, but little is known about how caffeine may effect the cardiovascular changes during the fetal to neonatal transition. Our aim was to determine the effect of prenatal caffeine administration on haemodynamic parameters in ventilated preterm lambs immediately after birth. Methods Catheters (carotid artery and jugular vein) and ultrasonic flow probes (pulmonary artery and carotid artery) were implanted in preterm lambs (similar to 126 +/- 2 days of gestation; term is 147 days), immediately before delivery by caesarean section. Before the cord was clamped, lambs were intubated and a caffeine (10mg/kg caffeine-base; n = 9) or saline (n = 5) infusion was given intravenously to the ewe and lamb over a 15-minute period. Two minutes after clamping the cord, ventilation commenced with a sustained inflation (35 cm H2O for 30 seconds) followed by ventilation for 30 minutes (target tidal volume of 6-8ml/kg). Results Blood gas parameters and rectal body temperature were not different between the two groups. Changes in pulmonary blood flow (PBF) and carotid blood flow (CBF) did not differ significantly between groups. PBF increased significantly after ventilation onset in both groups (caffeine p = 0.022, saline p <0.001) and remained elevated thereafter. CBF did not increase but decreased after SI in the caffeine group. Blood pressure, heart rate, and peripheral oxygen saturation did not differ between groups at any stage of the study. Conclusion Prenatal caffeine infusion had no significant effect on acute haemodynamic parameters in ventilated preterm lambs during the cardiorespiratory transition.	[Binder-Heschl, Corinna] Med Univ Graz, Graz, Austria; [Binder-Heschl, Corinna; Crossley, Kelly; Polglase, Graeme; Blank, Douglas; Zahra, Valerie; Moxham, Alison; Rodgers, Karyn; Hooper, Stuart] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [te Pas, Arjan] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands; [Blank, Douglas] Royal Womens Hosp, Newborn Res Ctr, Melbourne, Vic, Australia	Medical University of Graz; Hudson Institute of Medical Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Hooper, S (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	stuart.hooper@monash.edu	pas, arjan te/AAA-9019-2020; Crossley, Kelly J/I-7407-2013	pas, arjan te/0000-0001-7831-8797; Crossley, Kelly J/0000-0002-1580-1156; Blank, Douglas/0000-0002-6711-5799; Hooper, Stuart/0000-0003-1676-4825	Corinna Binder-Heschl - Austrian Science Fund (FWF) [J 3595-B19]	Corinna Binder-Heschl - Austrian Science Fund (FWF)	This work was supported by Corinna Binder-Heschl is supported by the Austrian Science Fund (FWF): J 3595-B19 (https://www.fwf.ac.at). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aden Ulrika, 2011, Handb Exp Pharmacol, P373, DOI 10.1007/978-3-642-13443-2_14; Aguar M, 2014, ACTA PAEDIATR, V103, pE229, DOI 10.1111/apa.12611; ARANDA JV, 1977, J PEDIATR-US, V90, P467, DOI 10.1016/S0022-3476(77)80718-X; Bancalari E, 2006, NEW ENGL J MED, V354, P2179, DOI 10.1056/NEJMe068028; Banerjee P, 2014, J FORENSIC SCI, V59, P865, DOI 10.1111/1556-4029.12387; Bhatt S, 2013, J PHYSIOL-LONDON, V591, P2113, DOI 10.1113/jphysiol.2012.250084; Clyman RI, 2007, PEDIATR RES, V62, P167, DOI 10.1203/PDR.0b013e3180a725b1; Comer A M, 2001, Paediatr Drugs, V3, P61, DOI 10.2165/00128072-200103010-00005; Crossley KJ, 2012, PEDIATR RES, V72, P19, DOI 10.1038/pr.2012.49; Crossley KJ, 2009, J PHYSIOL-LONDON, V587, P4695, DOI 10.1113/jphysiol.2009.174870; Dekker J, 2017, PEDIATR RES, V82, P290, DOI 10.1038/pr.2017.45; Doerner JM, 2015, INT J CARDIOVAS IMAG, V31, P595, DOI 10.1007/s10554-014-0577-7; Echeverri D, 2010, INT J VASC MED, V2010, DOI 10.1155/2010/834060; Francart Suzanne J, 2013, J Pediatr Pharmacol Ther, V18, P45, DOI 10.5863/1551-6776-18.1.45; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hoecker C, 2006, ARCH DIS CHILD-FETAL, V91, pF61, DOI 10.1136/adc.2005.073866; Hoecker C, 2002, PEDIATRICS, V109, P784, DOI 10.1542/peds.109.5.784; Katheria AC, 2015, AM J PERINAT, V32, P879, DOI 10.1055/s-0034-1543981; Kua KP, 2017, BRIT J CLIN PHARMACO, V83, P180, DOI 10.1111/bcp.13089; Martin Richard J, 2004, Paediatr Respir Rev, V5 Suppl A, pS377, DOI 10.1016/S1526-0542(04)90067-X; Mohammed S, 2015, EUR J PEDIATR, V174, P949, DOI 10.1007/s00431-015-2494-8; MURAT I, 1981, J PEDIATR-US, V99, P984, DOI 10.1016/S0022-3476(81)80038-8; Natarajan G, 2007, PEDIATRICS, V119, P936, DOI 10.1542/peds.2006-2986; Patel RM, 2013, J PERINATOL, V33, P134, DOI 10.1038/jp.2012.52; PINCOMB GA, 1985, AM J CARDIOL, V56, P119, DOI 10.1016/0002-9149(85)90578-8; Polglase GR, 2004, PEDIATR RES, V56, P932, DOI 10.1203/01.PDR.0000145254.66447.C0; Polglase GR, 2009, J APPL PHYSIOL, V106, P1347, DOI 10.1152/japplphysiol.91445.2008; ROSENKRANTZ TS, 1984, AM J DIS CHILD, V138, P489, DOI 10.1001/archpedi.1984.02140430065017; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Soloveychik V, 2009, J PERINATOL, V29, P205, DOI 10.1038/jp.2008.193; Steer P, 2004, ARCH DIS CHILD-FETAL, V89, pF499, DOI 10.1136/adc.2002.023432; Steer PA, 2003, J PAEDIATR CHILD H, V39, P511, DOI 10.1046/j.1440-1754.2003.00207.x; Taha D, 2014, J MATERN-FETAL NEO M, V27, P1698, DOI 10.3109/14767058.2014.885941; Tracy MB, 2010, ACTA PAEDIATR, V99, P1319, DOI 10.1111/j.1651-2227.2010.01828.x	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200572	10.1371/journal.pone.0200572	http://dx.doi.org/10.1371/journal.pone.0200572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995944	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800084
J	Gyawali, P; Martin, SA; Heilbronn, LK; Vincent, AD; Jenkins, AJ; Januszewski, AS; Taylor, AW; Adams, RJT; O'Loughlin, PD; Wittert, GA				Gyawali, Prabin; Martin, Sean A.; Heilbronn, Leonie K.; Vincent, Andrew D.; Jenkins, Alicia J.; Januszewski, Andrzej S.; Taylor, Anne W.; Adams, Robert J. T.; O'Loughlin, Peter D.; Wittert, Gary A.			Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men	PLOS ONE			English	Article							STEROID-HORMONES; BODY-COMPOSITION; US MEN; YOUNG MEN; INSULIN-RESISTANCE; CLINICAL MEDICINE; THYROID-HORMONES; RISK-FACTORS; OLDER MEN; TESTOSTERONE	Despite its widespread clinical use, there is little data available from population-based studies on the determinants of serum sex hormone binding globulin (SHBG). We aimed to examine multifactorial determinants of circulating SHBG levels in community-dwelling men. Study participants comprised randomly selected 35-80 y.o. men (n = 2563) prospectively-followed for 5 years (n = 2038) in the Men Androgen Inflammation Lifestyle Environment and Stress (MAILES) study. After excluding men with illness or medications known to affect SHBG (n = 172), data from 1786 men were available at baseline, and 1476 at follow-up. The relationship between baseline body composition (DXA), serum glucose, insulin, triglycerides, thyroxine (fT4), sex steroids (total testosterone (TT), oestradiol (E2)), and pro-inflammatory cytokines and serum SHBG level at both baseline & follow-up was determined by linear and penalized logistic regression models adjusting for age, lifestyle & demographic, body composition, metabolic, and hormonal factors. Restricted cubic spline analyses was also conducted to capture possible non-linear relationships. At baseline there were positive cross-sectional associations between age (beta = 0.409, p<0.001), TT (beta = 0.560, p<0.001), fT4 (beta = 0.067, p = 0.019) and SHBG, and negative associations between triglycerides (beta = -0.112, p<0.001), abdominal fat mass (beta = -0.068, p = 0.032) and E2 (beta = -0.058, p = 0.050) and SHBG. In longitudinal analysis the positive determinants of SHBG at 4.9 years were age (beta = 0.406, p = <0.001), TT (beta = 0.461, p = < 0.001), and fT4 (beta = 0.040, p = 0.034) and negative determinants were triglycerides (beta = -0.065, p = 0.027) and abdominal fat mass (beta = -0.078, p = 0.032). Taken together these data suggest low SHBG is a marker of abdominal obesity and increased serum triglycerides, conditions which are known to have been associated with low testosterone and low T4.	[Gyawali, Prabin; Martin, Sean A.; Heilbronn, Leonie K.; Vincent, Andrew D.; Wittert, Gary A.] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Gyawali, Prabin; Martin, Sean A.; Vincent, Andrew D.; Wittert, Gary A.] Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia; [Gyawali, Prabin; Martin, Sean A.; Heilbronn, Leonie K.; Taylor, Anne W.; Adams, Robert J. T.; Wittert, Gary A.] SAHMRI, Adelaide, SA, Australia; [Jenkins, Alicia J.; Januszewski, Andrzej S.] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia; [Taylor, Anne W.] Univ Adelaide, Populat Res & Outcomes Studies, Adelaide, SA, Australia; [Adams, Robert J. T.] Univ Adelaide, Queen Elizabeth Hosp, Hlth Observ, Woodville, SA, Australia; [O'Loughlin, Peter D.] SA Pathol, Chem Pathol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI); University of Sydney; University of Adelaide; University of Adelaide; SA Pathology	Gyawali, P; Wittert, GA (corresponding author), Univ Adelaide, Sch Med, Adelaide, SA, Australia.; Gyawali, P; Wittert, GA (corresponding author), Univ Adelaide, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA, Australia.; Gyawali, P; Wittert, GA (corresponding author), SAHMRI, Adelaide, SA, Australia.	prabin.gyawali@adelaide.edu.au; gary.wittert@adelaide.edu.au	Adams, Robert/Z-3197-2019; wittert, gary/AAE-2398-2019; Heilbronn, Leonie/H-1874-2013; Taylor, Anne/F-5708-2010	Heilbronn, Leonie/0000-0003-2106-7303; Wittert, Gary/0000-0001-6818-6065; Taylor, Anne/0000-0002-4422-7974; Jenkins, Alicia/0000-0003-0583-3717; Gyawali, Prabin/0000-0002-0855-3326	National Health and Medical Research Council of Australia (NHMRC) [627227]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHMRC Project Grant 627227).	Abdella NA, 2017, DIABETES RES CLIN PR, V133, P159, DOI 10.1016/j.diabres.2017.08.024; ANDERSON DC, 1974, CLIN ENDOCRINOL, V3, P69, DOI 10.1111/j.1365-2265.1974.tb03298.x; Antonio L, 2015, J CLIN ENDOCR METAB, V100, P1396, DOI 10.1210/jc.2014-4184; Bonnet F, 2013, CLIN ENDOCRINOL, V79, P517, DOI 10.1111/cen.12089; Brand JS, 2012, MATURITAS, V71, P274, DOI 10.1016/j.maturitas.2011.12.007; Caldwell JD, 2009, HORM METAB RES, V41, P173, DOI 10.1055/s-0028-1093351; Canoy D, 2014, EUR J ENDOCRINOL, V170, P863, DOI 10.1530/EJE-13-1046; Cooper LA, 2015, CLIN ENDOCRINOL, V83, P828, DOI 10.1111/cen.12768; Cuhadar S, 2013, BIOCHEM MEDICA, V23, P70, DOI 10.11613/BM.2013.009; Daka B, 2011, DIABETOLOGIA, V54, pS219; Danielson KK, 2008, DIABETES CARE, V31, P1207, DOI 10.2337/dc07-2169; de Ronde W, 2005, J CLIN ENDOCR METAB, V90, P157, DOI 10.1210/jc.2004-0422; DUMOULIN SC, 1995, EUR J ENDOCRINOL, V132, P594, DOI 10.1530/eje.0.1320594; Firtser S, 2012, ATHEROSCLEROSIS, V222, P257, DOI 10.1016/j.atherosclerosis.2012.02.020; Flechtner-Mors M, 2014, HORM METAB RES, V46, P287, DOI 10.1055/s-0033-1354369; GAFNY M, 1994, CLIN ENDOCRINOL, V41, P169, DOI 10.1111/j.1365-2265.1994.tb02526.x; Gapstur SM, 2002, CANCER EPIDEM BIOMAR, V11, P1041; Gates MA, 2013, J CLIN ENDOCR METAB, V98, P2442, DOI 10.1210/jc.2012-2582; Gautier A, 2013, CLIN ENDOCRINOL, V78, P373, DOI 10.1111/j.1365-2265.2012.04401.x; Goto A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-130; Grant JF, 2014, INT J EPIDEMIOL, V43, P1040, DOI 10.1093/ije/dyt064; Gyawali P, 2018, ACTA DIABETOL, V55, P861, DOI 10.1007/s00592-018-1163-6; Hammond GL, 2012, CURR OPIN ENDOCRINOL, V19, P183, DOI 10.1097/MED.0b013e328353732f; Hammond GL, 2011, BIOL REPROD, V85, P431, DOI 10.1095/biolreprod.111.092593; Hammond GL, 1996, HORM RES, V45, P197, DOI 10.1159/000184787; Hammond GL, 2017, MALE HYPOGONADISM, P305, DOI DOI 10.1007/978-3-319-53298-1_15; Handelsman DJ, 2016, ANN CLIN BIOCHEM, V53, P377, DOI 10.1177/0004563215610589; He ZH, 2018, INT J OBESITY, V42, P1366, DOI 10.1038/s41366-018-0033-1; Hsu B, 2014, J CLIN ENDOCR METAB, V99, P1638, DOI 10.1210/jc.2013-3984; Janne M, 1998, J BIOL CHEM, V273, P34105, DOI 10.1074/jbc.273.51.34105; Kim C, 2017, J CLIN ENDOCR METAB, V102, P3381, DOI 10.1210/jc.2017-00967; Kopper NW, 2008, DRUG DES DEV THER, V2, P193; LEE IR, 1987, J CLIN ENDOCR METAB, V64, P825, DOI 10.1210/jcem-64-4-825; Lee K, 2015, CLIN ENDOCRINOL, V83, P236, DOI 10.1111/cen.12722; Liu PY, 2007, J CLIN ENDOCR METAB, V92, P3599, DOI 10.1210/jc.2007-0862; LONGCOPE C, 1990, J CLIN ENDOCR METAB, V71, P1442, DOI 10.1210/jcem-71-6-1442; LOUKOVAARA M, 1995, J CLIN ENDOCR METAB, V80, P160, DOI 10.1210/jc.80.1.160; Mazess RB, 2000, CALCIFIED TISSUE INT, V67, P291, DOI 10.1007/s002230001147; Papatheodorou SI, 2014, CANCER CAUSE CONTROL, V25, P353, DOI 10.1007/s10552-013-0336-4; Pascual-Figal DA, 2009, REV ESP CARDIOL, V62, P1381, DOI 10.1016/S0300-8932(09)73123-9; Peter A, 2010, DIABETES, V59, P3167, DOI 10.2337/db10-0179; PLYMATE SR, 1988, J CLIN ENDOCR METAB, V67, P460, DOI 10.1210/jcem-67-3-460; PLYMATE SR, 1983, J CLIN ENDOCR METAB, V57, P645, DOI 10.1210/jcem-57-3-645; Pugeat M, 2010, MOL CELL ENDOCRINOL, V316, P53, DOI 10.1016/j.mce.2009.09.020; Roberts CK, 2013, METABOLISM, V62, P725, DOI 10.1016/j.metabol.2012.12.004; Rosner W, 2015, STEROIDS, V99, P113, DOI 10.1016/j.steroids.2014.08.005; Saez-Lopez C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12509-x; Saez-Lopez C, 2015, ENDOCRINOLOGY, V156, P4571, DOI 10.1210/en.2015-1677; Saez-Lopez C, 2014, MOL NUTR FOOD RES, V58, P760, DOI 10.1002/mnfr.201300304; Selva DM, 2007, J CLIN INVEST, V117, P3979, DOI 10.1172/JCI32249; Selva DM, 2009, J MOL ENDOCRINOL, V43, P19, DOI 10.1677/JME-09-0025; Selva DM, 2009, ENDOCRINOLOGY, V150, P2183, DOI 10.1210/en.2008-1289; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Simo R, 2015, TRENDS ENDOCRIN MET, V26, P376, DOI 10.1016/j.tem.2015.05.001; Simo R, 2014, ENDOCRINOLOGY, V155, P2820, DOI 10.1210/en.2014-1072; Simo R, 2012, MOL ENDOCRINOL, V26, P438, DOI 10.1210/me.2011-1321; Thaler MA, 2015, BEST PRACT RES CL EN, V29, P749, DOI 10.1016/j.beem.2015.06.005; Tong GY, 2014, EUR J ENDOCRINOL, V170, P237, DOI 10.1530/EJE-13-0557; Trabert B, 2012, CANCER CAUSE CONTROL, V23, P1881, DOI 10.1007/s10552-012-0024-9; Tsilidis KK, 2013, ANDROLOGY-US, V1, P919, DOI 10.1111/j.2047-2927.2013.00129.x; Vanbillemont G, 2012, CLIN ENDOCRINOL, V76, P111, DOI 10.1111/j.1365-2265.2011.04155.x; Vermeulen A, 1996, J CLIN ENDOCR METAB, V81, P1821, DOI 10.1210/jc.81.5.1821; Wallace IR, 2013, CLIN ENDOCRINOL, V78, P321, DOI 10.1111/cen.12086; Wang NJ, 2017, ENDOCRINE, V56, P649, DOI 10.1007/s12020-017-1272-y; Wang Q, 2015, INT J EPIDEMIOL, V44, P623, DOI 10.1093/ije/dyv093; Winters SJ, 2014, J CLIN ENDOCR METAB, V99, pE2780, DOI 10.1210/jc.2014-2640; Wu A, 2015, M END SOC AUSTR SOC; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Yeap BB, 2014, CLIN ENDOCRINOL, V81, P100, DOI 10.1111/cen.12407; Zhang YJ, 2013, CLIN ENDOCRINOL, V78, P60, DOI 10.1111/j.1365-2265.2012.04359.x	70	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200078	10.1371/journal.pone.0200078	http://dx.doi.org/10.1371/journal.pone.0200078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995902	Green Published, gold			2022-12-26	WOS:000438388800040
J	Stomp, M; Leroux, M; Cellier, M; Henry, S; Lemasson, A; Hausberger, M				Stomp, Mathilde; Leroux, Mael; Cellier, Marjorie; Henry, Severine; Lemasson, Alban; Hausberger, Martine			An unexpected acoustic indicator of positive emotions in horses	PLOS ONE			English	Article							ANTICIPATORY BEHAVIOR; VOCAL REPERTOIRE; COGNITIVE BIAS; ENVIRONMENTAL ENRICHMENT; STEREOTYPICAL BEHAVIOR; DOMESTIC HORSE; YOUNG HORSES; HEART-RATE; RESPONSES; WELFARE	Indicators of positive emotions are still scarce and many proposed behavioural markers have proven ambiguous. Studies established a link between acoustic signals and emitter's internal state, but few related to positive emotions and still fewer considered non-vocal sounds. One of them, the snort, is shared by several perrisodactyls and has been associated to positive contexts in these species. We hypothesized that this could be also the case in horses. In this species, there is a clear need for a thorough description of non-vocal acoustic signals (snorts, snores or blows are often used interchangeably) but overall this sound produced by nostrils during expiration has up to now been mostly considered as having a hygienic function. However, observations revealed that snorts were produced more in some individuals than in others, without relationship with air conditions. We observed 48 horses living in two "extreme" conditions: restricted conditions (single stall, low roughage diet) and naturalistic conditions (stable groups in pasture). The immediate place (e.g. stall/pasture) and the behavioural/postural (behaviour performed/ears positions) contexts of snort production were observed. We additionally performed an evaluation of the welfare state, using validated behavioural (e.g. stereotypies) and postural (e.g. overall ears positions) welfare indicators. The results show that 1) snort production was significantly associated with situations known to be positive for horses (e.g. feeding in pasture) and with a positive internal state (ears in forward or sidewards positions), 2) the riding school horses produced twice as many snorts when in pasture than in stall, 3) the naturalistic population emitted significantly more snorts than riding school ones in comparable contexts, 4) the frequency of snorts was negatively correlated with the composite total chronic stress score (TCSS, reflecting compromised welfare based on the horse's rank on the different indicators): the lower the TCSS, the higher the snort rate. Snorts therefore appear as reliable indicators of positive emotions.	[Stomp, Mathilde; Leroux, Mael; Cellier, Marjorie; Henry, Severine; Lemasson, Alban] Univ Rennes 1, CNRS Ethol Anim & Humaine, Univ Caen Normandie, Stn Biol Paimpont,CNRS,UMR 6552, Paimpont, France; [Hausberger, Martine] Univ Rennes 1, Univ Caen Normandie, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie; Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie; Universite de Rennes	Stomp, M (corresponding author), Univ Rennes 1, CNRS Ethol Anim & Humaine, Univ Caen Normandie, Stn Biol Paimpont,CNRS,UMR 6552, Paimpont, France.	mathilde.stomp@univ-rennes1.fr	Leroux, Maël/GVS-1622-2022	Leroux, Maël/0000-0001-7087-449X	IFCE (Institut francais du cheval et de l'equitation); Fonds eperons; University of Rennes; CNRS	IFCE (Institut francais du cheval et de l'equitation); Fonds eperons; University of Rennes; CNRS(Centre National de la Recherche Scientifique (CNRS))	This study was funded by IFCE (Institut francais du cheval et de l'equitation) (http://www.ifce.fr/), the Fonds eperons (https://www.fondseperon.com/), the University of Rennes (https://www.univ-rennes1.fr/), and the CNRS (http://www.cnrs.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ABA, 2016, APPL ANIM BEHAV SCI, V176, P52, DOI 10.1016/j.applanim.2015.12.001; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson C, 2015, BEHAV PROCESS, V113, P152, DOI 10.1016/j.beproc.2015.02.003; Anikin A.R., 2017, J NONVERBAL BEHAV, P1, DOI [10.1007/s10919-017-0268-x, DOI 10.1007/S10919-017-0268-X]; Arnaud MG., 1997, NOTATION ETAT CORPOR, V1, P40; Ashley FH, 2005, EQUINE VET J, V37, P565, DOI 10.2746/042516405775314826; Bachmann I, 2003, EQUINE VET J, V35, P158, DOI 10.2746/042516403776114216; Barlow G. W., 1968, P217; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Benhajali H, 2014, APPL ANIM BEHAV SCI, V153, P36, DOI 10.1016/j.applanim.2014.01.002; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; Blois-Heulin C., 2015, ANIM BEHAV COG, V2, P156, DOI DOI 10.12966/ABC.05.04.2015; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bradshaw J., 2012, BEHAV DOMESTIC CAT, Vsecond; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Briefer EF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09989; Burgdorf J, 2011, NEUROSCI BIOBEHAV R, V35, P1831, DOI 10.1016/j.neubiorev.2010.11.011; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Christensen JW, 2013, EQUINE VET J, V45, P298, DOI [10.1111/j.2042-3306.2012.00629.x, 10.1111/j.20]; Cooper JJ, 2005, LIVEST PROD SCI, V92, P177, DOI 10.1016/j.livprodsci.2004.11.017; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V69, P67, DOI 10.1016/S0168-1591(00)00115-5; Dantzer R., 1988, LES EMOTIONS, P121; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Durier Virginie, 2012, Front Psychol, V3, P442, DOI 10.3389/fpsyg.2012.00442; FEH C, 1993, ANIM BEHAV, V46, P1191, DOI 10.1006/anbe.1993.1309; FEIST JD, 1976, Z TIERPSYCHOL, V41, P337; Finlayson K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166446; Fontaine R., 1981, CIENCIAS, P443; Freymond SB, 2014, APPL ANIM BEHAV SCI, V158, P34, DOI 10.1016/j.applanim.2014.06.006; Fureix C., 2011, ISRN Zoology, V2011, P271209, DOI 10.5402/2011/271209; Fureix C, 2010, LES HARAS NATIONAUX, P111; Fureix C, 2012, APPL ANIM BEHAV SCI, V138, P216, DOI 10.1016/j.applanim.2012.02.009; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Fureix C, 2009, ANIM COGN, V12, P643, DOI 10.1007/s10071-009-0223-2; GILLHAM SB, 1994, APPL ANIM BEHAV SCI, V41, P147, DOI 10.1016/0168-1591(94)90019-1; Gleerup KB, 2016, EQUINE VET EDUC, V28, P47, DOI 10.1111/eve.12383; Gogoleva SS, 2010, BEHAVIOUR, V147, P1713, DOI 10.1163/000579510X528242; Hafez ESE, 1962, BEHAV DOMEST ANIM; Hausberger A, 2002, APPL ANIM BEHAV SCI, V76, P339, DOI 10.1016/S0168-1591(02)00016-3; HAUSBERGER M, 2012, SIGNIFICANCE ADULT P, DOI DOI 10.1007/S00114-012-0902-8; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; Hemsworth PH, 2011, APPL ANIM BEHAV SCI, V135, P24, DOI 10.1016/j.applanim.2011.09.007; Henry S, 2006, DEV PSYCHOBIOL, V48, P712, DOI 10.1002/dev.20189; Henry S, 2005, APPL ANIM BEHAV SCI, V93, P341, DOI 10.1016/j.applanim.2005.01.008; Henry S, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1429-1; HUNSAKER D, 1965, ANIM BEHAV, V13, P69, DOI 10.1016/0003-3472(65)90073-4; KILEY M, 1972, Zeitschrift fuer Tierpsychologie, V31, P171; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lee J, 2011, APPL ANIM BEHAV SCI, V130, P91, DOI 10.1016/j.applanim.2011.01.001; Leliveld LMC, 2016, PHYSIOL BEHAV, V157, P116, DOI 10.1016/j.physbeh.2016.02.002; Lemasson A, 2015, J COMP PSYCHOL, V129, P311, DOI 10.1037/a0039032; Lemasson A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118468; Lesimple C, 2016, APPL ANIM BEHAV SCI, V181, P105, DOI 10.1016/j.applanim.2016.04.015; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00021; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Li P, 2016, NATURE, V530, P293, DOI 10.1038/nature16964; Linn SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192166; Lockener S, 2016, J VET BEHAV, V11, P50, DOI 10.1016/j.jveb.2015.11.005; MACEDONIA JM, 1993, FOLIA PRIMATOL, V61, P186, DOI 10.1159/000156749; Maigrot AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09437-1; Marx G, 2001, APPL ANIM BEHAV SCI, V75, P61, DOI 10.1016/S0168-1591(01)00180-0; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G, 2008, STEROTYPIC ANIMAL BE, DOI [10.1079/9780851990040.0000, DOI 10.1079/9780851990040.0000]; MCCALL CA, 1985, APPL ANIM BEHAV SCI, V14, P27, DOI 10.1016/0168-1591(85)90035-8; McClernon FJ, 2004, ADDICT BEHAV, V29, P765, DOI 10.1016/j.addbeh.2004.02.005; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Mills Daniel, 2005, DOMESTIC HORSE ORIGI; Moe RO, 2006, APPL ANIM BEHAV SCI, V101, P362, DOI 10.1016/j.applanim.2006.02.004; Montenegro O. L., 1998, BEHAV LOWLAND TAPIR; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Nicol C, 1999, Equine Vet J Suppl, P20; Normando S, 2003, VET RES COMMUN, V27, P615, DOI 10.1023/B:VERC.0000014230.52006.df; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Pawluski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182257; Peters G, 2002, MAMMAL REV, V32, P245, DOI 10.1046/j.1365-2907.2002.00113.x; Peters SM, 2012, APPL ANIM BEHAV SCI, V138, P60, DOI 10.1016/j.applanim.2012.01.018; Policht R, 2008, BIOACOUSTICS, V18, P69, DOI 10.1080/09524622.2008.9753591; Quirke T, 2012, APPL ANIM BEHAV SCI, V142, P189, DOI 10.1016/j.applanim.2012.09.007; Raabymagle P, 2006, J EQUINE VET SCI, V26, P11, DOI 10.1016/j.jevs.2005.11.015; Redbo I, 1998, ANIM SCI, V66, P475, DOI 10.1017/S1357729800009644; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Rees Paul A., 2004, Journal of Applied Animal Welfare Science, V7, P49, DOI 10.1207/s15327604jaws0701_3; Reimert I, 2013, PHYSIOL BEHAV, V109, P42, DOI 10.1016/j.physbeh.2012.11.002; Rivera E, 2002, APPL ANIM BEHAV SCI, V78, P235, DOI 10.1016/S0168-1591(02)00091-6; Rochais C, 2018, APPL ANIM BEHAV SCI, V198, P52, DOI 10.1016/j.applanim.2017.09.019; Rochais C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20117; Salmeto AL, 2011, BRAIN RES, V1373, P124, DOI 10.1016/j.brainres.2010.12.007; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SISSOM DEF, 1991, J ZOOL, V223, P67, DOI 10.1111/j.1469-7998.1991.tb04749.x; Soltis J, 2011, J ACOUST SOC AM, V129, P1059, DOI 10.1121/1.3531798; Soltysik S, 2005, PHYSIOL BEHAV, V85, P598, DOI 10.1016/j.physbeh.2005.06.008; Sondergaard E, 2011, APPL ANIM BEHAV SCI, V132, P131, DOI 10.1016/j.applanim.2011.04.007; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Tallet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071841; Tyler S., 1972, ANIM BEHAV MONOGR, V5, P87, DOI [DOI 10.1016/0003-3472(72)90003-6, 10.1016/0003-3472(72)90003-6]; Vinke CM, 2004, APPL ANIM BEHAV SCI, V89, P145, DOI 10.1016/j.applanim.2004.06.002; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; Visser EK, 2009, VET J, V181, P48, DOI 10.1016/j.tvjl.2009.03.009; Waring G.H., 2003, HORSE BEHAV BEHAV TR; Waters AJ, 2002, EQUINE VET J, V34, P572, DOI 10.2746/042516402776180241; Wichman A, 2012, APPL ANIM BEHAV SCI, V140, P62, DOI 10.1016/j.applanim.2012.05.006; WINTER P, 1966, EXP BRAIN RES, V1, P359; Wolff A, 1997, BEHAV PROCESS, V40, P209, DOI 10.1016/S0376-6357(97)00784-5; Yeon SC, 2012, J VET BEHAV, V7, P179, DOI 10.1016/j.jveb.2011.08.004; Zimmermann E, 1995, ACOUSTIC COMMUNICATI, P311, DOI DOI 10.1007/978-1-4757-2405-9_19	116	31	31	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0197898	10.1371/journal.pone.0197898	http://dx.doi.org/10.1371/journal.pone.0197898			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM7QQ	29995876	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800006
J	Zeng, YS; Zeng, WS; Zhang, Y; Ye, W; Cheng, DM; Kanzaki, N; Giblin-Davis, RM				Zeng, Yongsan; Zeng, Wensheng; Zhang, Yuan; Ye, Weimin; Cheng, Dongmei; Kanzaki, Natsumi; Giblin-Davis, Robin M.			Morphological and molecular characteristics of Parasitodiplogaster religiosae n. sp (Nematoda: Diplogastrina) associated with Ficus religiosa in China	PLOS ONE			English	Article							N. SP NEMATODA; PHYLOGENETIC-RELATIONSHIPS; AGAONIDAE; PARASITE; FIGS	A new nematode species of the genus Parasitodiplogaster was recovered from syconia of Ficus religiosa at the Guangxiao Temple, Guangzhou, China. It is described herein as P. religiosae n. sp. and is characterised by possessing the longest and thinnest spicule of all currently described males in the genus, an elongated laterally "epsilon-shaped" and ventrally rhomboid-like gubernaculum, a stoma without teeth, consisting of a ring-like cheilostom with indistinct anteriolateral projections, a tube-like gymnostom and a funnel-like stegostom, monodelphic with a mean vulval position of 66%. There are three pre-cloacal and six postcloacal male genital papillae with the arrangement P1, P2, P3, (C, P4), P5, P6d, P7, P8, P9d, Ph. This new species was easily differentiated from other members of the genus by DNA sequences of partial small subunit rRNA gene (SSU) and the D2-D3 expansion segments of the large subunit rRNA gene (LSU). Phylogenetic analysis also corroborated its reasonable placement within a well-supported monophyletic Glade with other Parasitodiplogaster species and within the australis-group that includes P. australis and P. salicifoliae that are all associates of fig wasp pollinators (Platyscapa sp.) of figs of the subsection Urostigma.	[Zeng, Yongsan; Zeng, Wensheng; Zhang, Yuan; Cheng, Dongmei] Zhongkai Univ Agr & Engn, Dept Plant Protect, Guangzhou, Guangdong, Peoples R China; [Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Agron Div, Nematode Assay Sect, Raleigh, NC USA; [Kanzaki, Natsumi] Kansai Res Ctr, Forestry & Forest Prod Res Inst, Kyoto, Japan; [Giblin-Davis, Robin M.] Univ Florida, Ft Lauderdale Res & Educ Ctr, Dept Entomol & Nematol, IFAS, Ft Lauderdale, FL 33314 USA	Zhongkai University of Agriculture & Engineering; Forestry & Forest Products Research Institute - Japan; State University System of Florida; University of Florida	Zeng, YS (corresponding author), Zhongkai Univ Agr & Engn, Dept Plant Protect, Guangzhou, Guangdong, Peoples R China.	zys65@163.com		zeng, yongsan/0000-0002-2609-1807; Giblin-Davis, Robin/0000-0002-8861-8678	National Natural Science Foundation of China [31572252]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No. 31572252) to YZ.; We thank Ms. Yun Ye for assistance of collecting samples. This study was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No. 31572252) to YZ.	ANDRASSY I, 1964, OPUSCULA ZOOL, V5, P9; [Anonymous], 1992, THESIS; Bartholomaeus F, 2009, NEMATOLOGY, V11, P583, DOI 10.1163/138855409X12465362560638; Giblin-Davis RM, 2006, J NEMATOL, V38, P137; GIBLINDAVIS RM, 1995, J NEMATOL, V27, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kanzaki N, 2016, NEMATOLOGY, V18, P417, DOI 10.1163/15685411-00002967; Kanzaki N, 2015, NEMATOLOGY, V17, P831, DOI 10.1163/15685411-00002908; Kanzaki N, 2014, ZOOKEYS, P17, DOI 10.3897/zookeys.442.7459; Kanzaki N, 2014, NEMATOLOGY, V16, P607, DOI 10.1163/15685411-00002791; Kanzaki N, 2013, NEMATOLOGY, V15, P957, DOI 10.1163/15685411-00002735; Kanzaki N, 2012, NEMATOLOGY, V14, P529, DOI 10.1163/156854111X612216; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Mullin PG, 2005, NEMATOLOGY, V7, P59, DOI 10.1163/1568541054192199; POINAR G O JR, 1991, Revue de Nematologie, V14, P361; POINAR GO, 1979, P K NED AKAD C BIOL, V82, P375; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Singh D, 2011, J ETHNOPHARMACOL, V134, P565, DOI 10.1016/j.jep.2011.01.046; Southey JF., 1970, LAB METHODS WORK PLA; Sudhaus W., 2003, Journal of Nematode Morphology and Systematics, V6, P43; Susoy V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501031; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WILLIAMS BD, 1992, GENETICS, V131, P609; Wohr M, 2015, NEMATOLOGY, V17, P301, DOI 10.1163/15685411-00002868; Wohr M, 2014, NEMATOLOGY, V16, P453, DOI 10.1163/15685411-00002777; Ye WM, 2007, MOL PHYLOGENET EVOL, V43, P1185, DOI 10.1016/j.ympev.2007.02.006; Ye Weimin, 1996, Afro-Asian Journal of Nematology, V6, P203	27	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199417	10.1371/journal.pone.0199417	http://dx.doi.org/10.1371/journal.pone.0199417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995895	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800023
J	Alcantar-Fernandez, J; Navarro, RE; Salazar-Martinez, AM; Perez-Andrade, ME; Miranda-Rios, J				Alcantar-Fernandez, Jonathan; Navarro, Rosa E.; Maria Salazar-Martinez, Ana; Elva Perez-Andrade, Martha; Miranda-Rios, Juan			Caenorhabditis elegans respond to high-glucose diets through a network of stress-responsive transcription factors	PLOS ONE			English	Article							LIFE-SPAN; C. ELEGANS; OXIDATIVE STRESS; MODEL; GENETICS; INSULIN; PROTEIN; QUANTIFICATION; DAF-16/FOXO; LONGEVITY	High-glycemic-index diets, as well as a sedentary lifestyle are considered as determinant factors for the development of obesity, type 2 diabetes, and cardiovascular diseases in humans. These diets have been shown to shorten the life span of C. elegans in a manner that is dependent on insulin signaling, but the participation of other signaling pathways have not been addressed. In this study, we have determined that worms fed with high-glucose diets show alterations in glucose content and uptake, triglyceride content, body size, number of eggs laid, egg-laying defects, and signs of oxidative stress and accelerated aging. Additionally, we analyzed the participation of different key regulators of carbohydrate and lipid metabolism, oxidative stress and longevity such as SKN-1/NRF2, HIF-1/HIF1 alpha, SBP-1/SREBP, CRH-1/CREB, CEP-1/p53, and DAF-16/FOXO, in the reduction of lifespan in glucose-fed worms.	[Alcantar-Fernandez, Jonathan] Univ Nacl Autonoma Mexico, Programa Doctorado Ciencias Biomed, Mexico City, DF, Mexico; [Alcantar-Fernandez, Jonathan; Elva Perez-Andrade, Martha; Miranda-Rios, Juan] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Unidad Genet Nutr, Mexico City, DF, Mexico; [Alcantar-Fernandez, Jonathan; Elva Perez-Andrade, Martha; Miranda-Rios, Juan] Inst Nacl Pediat, Mexico City, DF, Mexico; [Navarro, Rosa E.] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City, DF, Mexico; [Maria Salazar-Martinez, Ana] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Miranda-Rios, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Unidad Genet Nutr, Mexico City, DF, Mexico.; Miranda-Rios, J (corresponding author), Inst Nacl Pediat, Mexico City, DF, Mexico.	riosjuanm@biomedicas.unam.mx	Fernández, Jonathan Alcántar/AAP-9407-2020; Miranda Ríos, Juan/ABB-7767-2021	Fernández, Jonathan Alcántar/0000-0001-5302-4223; Navarro, Rosa/0000-0003-4992-4450	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico UNAM [IN205818]; Fondos Federales Secretaria de Salud, Instituto Nacional de Pediatria [036/2015]; CONACyT; PAPIIT-UNAM; NIH Office of Research Infra-structure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico UNAM; Fondos Federales Secretaria de Salud, Instituto Nacional de Pediatria; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); NIH Office of Research Infra-structure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT), Direccion General de Asuntos del Personal Academico UNAM (IN205818) and Fondos Federales Secretaria de Salud, Instituto Nacional de Pediatria (036/2015) to J.M-R. J. A-F. is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowships from CONACyT and PAPIIT-UNAM. Some strains were provided by CGC, which is funded by NIH Office of Research Infra-structure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas O, 2016, BMB REP, V49, P81, DOI 10.5483/BMBRep.2016.49.2.261; Bonomini F, 2015, AGING DIS, V6, P109, DOI 10.14336/AD.2014.0305; BRENNER S, 1974, GENETICS, V77, P71; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Chang HW, 2017, AGING CELL, V16, P814, DOI 10.1111/acel.12619; Chen JJ, 2004, J NEMATOL, V36, P107; Choi SS, 2011, NUTR RES PRACT, V5, P214, DOI 10.4162/nrp.2011.5.3.214; Cox-Paulson EA, 2012, CBE-LIFE SCI EDUC, V11, P165, DOI 10.1187/cbe-11-06-0045; Davies SK, 2012, MECH AGEING DEV, V133, P46, DOI 10.1016/j.mad.2011.11.002; Depuydt G, 2014, J PROTEOME RES, V13, P1938, DOI 10.1021/pr401081b; Derry WB, 2001, SCIENCE, V294, P591, DOI 10.1126/science.1065486; DRAPER HH, 1990, METHOD ENZYMOL, V186, P421; Feldman N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085964; Garcia-Segura L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142262; Garigan D, 2002, GENETICS, V161, P1101; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Gusarov I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15868; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huelgas-Morales G, 2016, G3-GENES GENOM GENET, V6, P1031, DOI 10.1534/g3.115.026815; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kitaoka S, 2016, FEBS OPEN BIO, V6, P576, DOI 10.1002/2211-5463.12068; Kubagawa HM, 2006, NAT CELL BIOL, V8, P1143, DOI 10.1038/ncb1476; Labuschagne CF, 2013, AGING CELL, V12, P214, DOI 10.1111/acel.12043; Lee D, 2015, GENE DEV, V29, P2490, DOI 10.1101/gad.266304.115; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Lempradl A, 2015, NAT REV GENET, V16, P665, DOI 10.1038/nrg3941; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li J, 2009, PROTEOMICS, V9, P4539, DOI 10.1002/pmic.200900101; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Luersen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060731; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Markaki M, 2010, BIOTECHNOL J, V5, P1261, DOI 10.1002/biot.201000183; Mendler M, 2012, EXP CLIN ENDOCR DIAB, V120, P182, DOI 10.1055/s-0032-1304570; Mendler M, 2015, DIABETOLOGIA, V58, P393, DOI 10.1007/s00125-014-3415-5; Mondoux MA, 2011, GENETICS, V188, P369, DOI 10.1534/genetics.111.126490; Petrascheck Michael, 2017, Front Genet, V8, P92, DOI 10.3389/fgene.2017.00092; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reisner K, 2011, J BIOCHEM MOL TOXIC, V25, P269, DOI 10.1002/jbt.20386; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Saito K, 2011, ANAL BIOCHEM, V412, P9, DOI 10.1016/j.ab.2011.01.022; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; So Shuhei, 2012, Worm, V1, P93, DOI 10.4161/worm.20175; Svensk E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005982; Tain LS, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-28; Tauffenberger A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004346; Tauffenberger A, 2012, AGING CELL, V11, P856, DOI 10.1111/j.1474-9726.2012.00855.x; Teshiba E, 2016, BIOSCI BIOTECH BIOCH, V80, P1436, DOI 10.1080/09168451.2016.1158634; TRUSWELL AS, 1994, AM J CLIN NUTR, V59, p710S, DOI 10.1093/ajcn/59.3.710S; Tullet JMA, 2017, AGING CELL, V16, P1191, DOI 10.1111/acel.12627; Van Raamsdonk JM, 2011, MECH AGEING DEV, V132, P519, DOI 10.1016/j.mad.2011.08.006; VANFLETEREN JR, 1995, FASEB J, V9, P1355, DOI 10.1096/fasebj.9.13.7557026; Vanfleteren JR, 1998, J GERONTOL A-BIOL, V53, pB380, DOI 10.1093/gerona/53A.5.B380; Villanueva-Chimal E, 2017, GENESIS, V55, DOI 10.1002/dvg.23072; Wood W, 1998, NEMATODE CAENORHABDI, V17, P667; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103	66	27	27	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199888	10.1371/journal.pone.0199888	http://dx.doi.org/10.1371/journal.pone.0199888			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990370	gold, Green Submitted, Green Published			2022-12-26	WOS:000438170300019
J	Faustmann, G; Meinitzer, A; Magnes, C; Tiran, B; Obermayer-Pietsch, B; Gruber, HJ; Ribalta, J; Rock, E; Roob, JM; Winklhofer-Roob, BM				Faustmann, Gernot; Meinitzer, Andreas; Magnes, Christoph; Tiran, Beate; Obermayer-Pietsch, Barbara; Gruber, Hans-Juergen; Ribalta, Josep; Rock, Edmond; Roob, Johannes M.; Winklhofer-Roob, Brigitte M.			Progesterone-associated arginine decline at luteal phase of menstrual cycle and associations with related amino acids and nuclear factor kB activation	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; KAPPA-B ACTIVATION; HUMAN CORPUS-LUTEUM; NITRIC-OXIDE; IMMUNE-RESPONSE; MASS-SPECTROMETRY; EARLY-PREGNANCY; DOWN-REGULATION; IN-VITRO; PLASMA	Background/Objectives Given their role in female reproduction, the effects of progesterone on arginine and related amino acids, polyamines and NF-kappa B p65 activation were studied across the menstrual cycle. Methods Arginine, ornithine and citrulline as well as putrescine, spermidine, spermine, and N-acetylputrescine were determined in plasma, NF-kappa B p65 activation in peripheral blood mononuclear cells and progesterone in serum of 28 women at early (T1) and late follicular (T2) and mid (T3) and late (T4) luteal phase. Results Arginine and related amino acids declined from T1 and T2 to T3 and T4, while progesterone increased. At T3, arginine, ornithine, and citrulline were inversely related with progesterone. Changes (Delta T3-T2) in arginine, ornithine, and citrulline were inversely related with changes (Delta T3-T2) in progesterone. Ornithine and citrulline were positively related with arginine, as were changes (Delta T3-T2) in ornithine and citrulline with changes (Delta T3-T2) in arginine. At T2, NF-kappa B p65 activation was positively related with arginine. Polyamines did not change and were not related to progesterone. All results described were significant at P < 0.001. Conclusions This study for the first time provides data, at the plasma and PBMC level, supporting a proposed regulatory node of arginine and related amino acids, progesterone and NF-kappa B p65 at luteal phase of the menstrual cycle, aimed at successful preparation of pregnancy.	[Faustmann, Gernot; Winklhofer-Roob, Brigitte M.] Karl Franzens Univ Graz, Inst Mol Biosci, Human Nutr & Metab Res & Training Ctr, Graz, Austria; [Faustmann, Gernot; Roob, Johannes M.] Med Univ, Dept Internal Med, Clin Div Nephrol, Graz, Austria; [Meinitzer, Andreas; Tiran, Beate; Gruber, Hans-Juergen] Med Univ, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Magnes, Christoph] Joanneum Res Forsch Gesellschaft mbH, HLTH, Inst Biomed & Hlth Sci, Graz, Austria; [Obermayer-Pietsch, Barbara] Med Univ, Dept Internal Med, Div Endocrinol, Graz, Austria; [Ribalta, Josep] Univ Rovira & Virgili, Fac Med, Fac Med & Ciencies Salut, Unitat Recerca Lipids & Arteriosclerosi, Reus, Spain; [Rock, Edmond] INRA, Ctr Auvergne Rhone Alpes, Unite Nutr Humaine, St Genes Champanelle, France	University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz; Universitat Rovira i Virgili; INRAE	Winklhofer-Roob, BM (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Human Nutr & Metab Res & Training Ctr, Graz, Austria.	brigitte.winklhoferroob@uni-graz.at	Ribalta, Josep/AAD-4859-2020; Winklhofer-Roob, Brigitte M/L-7899-2015	Ribalta, Josep/0000-0002-8879-4719; Winklhofer-Roob, Brigitte M/0000-0002-2021-2137; Magnes, Christoph/0000-0002-5153-7444; Faustmann, Gernot/0000-0003-2184-0175	European Union's 7th Framework Programme FP7 [244995]; Medical University, Graz, Austria; Federal Ministry of Science, Research and Economy of Austria [GZ 651.483/0001-II/2/2010, GZ 651.484/0001-II/2/2010, GZ 650.874/1-VI/2/2003]; European Union's 5th Framework Programme [QLK1-CT-1999-00830]; Universitat Rovira I Virgili, Tarragona, Spain	European Union's 7th Framework Programme FP7; Medical University, Graz, Austria; Federal Ministry of Science, Research and Economy of Austria; European Union's 5th Framework Programme; Universitat Rovira I Virgili, Tarragona, Spain	This work was carried out with financial support of the European Union's 7th Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS Project) to Karl-Franzens University, Graz, Austria (BWR), and Medical University, Graz, Austria (JMR) and of the Federal Ministry of Science, Research and Economy of Austria under grant agreement GZ 651.483/0001-II/2/2010 to Karl-Franzens University, Graz, Austria (BWR), and grant agreement GZ 651.484/0001-II/2/2010 to Medical University, Graz, Austria (JMR) for the BIOCLAIMS Project, and of the European Union's 5th Framework Programme under grant agreement no QLK1-CT-1999-00830 (VITAGE Project) to Karl-Franzens University, Graz, Austria (BWR), Institut National de la Recherch Agronomique, Clermont-Ferrand, France (ER), and Universitat Rovira I Virgili, Tarragona, Spain (JR), and of the Federal Ministry of Science, Research and Economy of Austria under grant agreement GZ 650.874/1-VI/2/2003 to Karl-Franzens University, Graz, Austria (BWR), for the VITAGE Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baniyash M, 2004, NAT REV IMMUNOL, V4, P675, DOI 10.1038/nri1434; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; CALLOWAY DH, 1982, J NUTR, V112, P356, DOI 10.1093/jn/112.2.356; Castillo L, 1996, P NATL ACAD SCI USA, V93, P11460, DOI 10.1073/pnas.93.21.11460; CHAISIRI P, 1980, CLIN CHIM ACTA, V104, P367, DOI 10.1016/0009-8981(80)90395-2; Chwalisz K, 2000, HUM REPROD, V15, P96, DOI 10.1093/humrep/15.suppl_3.96; COX BD, 1978, HORM METAB RES, V10, P428, DOI 10.1055/s-0028-1093407; Davis JS, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-10; DHANAKOTI SN, 1990, AM J PHYSIOL, V259, pE437, DOI 10.1152/ajpendo.1990.259.3.E437; Dulak J, 2000, ARTERIOSCL THROM VAS, V20, P659, DOI 10.1161/01.ATV.20.3.659; Faas M, 2000, FERTIL STERIL, V74, P1008, DOI 10.1016/S0015-0282(00)01553-3; Faustmann G, 2016, BIOFACTORS, V42, P376, DOI 10.1002/biof.1281; Friden BE, 2000, MOL HUM REPROD, V6, P397, DOI 10.1093/molehr/6.5.397; Fujiwara H, 2009, MOL HUM REPROD, V15, P335, DOI 10.1093/molehr/gap027; Gilad VH, 2002, LIFE SCI, V72, P135, DOI 10.1016/S0024-3205(02)02202-6; Gonzalez-Ramos R, 2012, FERTIL STERIL, V97, P645, DOI 10.1016/j.fertnstert.2011.12.006; Greene JM, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-15; Hashii K, 1998, HUM REPROD, V13, P2738, DOI 10.1093/humrep/13.10.2738; HRABAK A, 1994, BIOCHEM BIOPH RES CO, V198, P206, DOI 10.1006/bbrc.1994.1029; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; KEGG: Kyoto Encyclopedia of Genes and Genomes, ARG PROL MET; Khorram O, 1999, J CLIN ENDOCR METAB, V84, P2226, DOI 10.1210/jc.84.6.2226; Khorram O, 2009, FERTIL STERIL, V91, P2157, DOI 10.1016/j.fertnstert.2008.05.019; Kropf P, 2007, EUR J IMMUNOL, V37, P935, DOI 10.1002/eji.200636542; LARIVIERE F, 1994, AM J PHYSIOL, V267, pE422, DOI 10.1152/ajpendo.1994.267.3.E422; Lee KY, 2005, SCIENCE, V308, P114, DOI 10.1126/science.1107107; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Liu R, 2012, J MASS SPECTROM, V47, P1341, DOI 10.1002/jms.3084; LUNDGREN DW, 1976, P SOC EXP BIOL MED, V152, P81; Magnes C, 2014, J CHROMATOGR A, V1331, P44, DOI 10.1016/j.chroma.2013.12.061; McCracken SA, 2004, J IMMUNOL, V172, P4583, DOI 10.4049/jimmunol.172.7.4583; McCracken SA, 2003, J REPROD IMMUNOL, V58, P27, DOI 10.1016/S0165-0378(02)00081-5; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Mitsube K, 2002, HUM REPROD, V17, P2509, DOI 10.1093/humrep/17.10.2509; Moali C, 1998, BIOCHEMISTRY-US, V37, P10453, DOI 10.1021/bi980742t; Moller SE, 1996, EUR J CLIN PHARMACOL, V50, P179, DOI 10.1007/s002280050089; Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64; Morris SM, 2007, J NUTR, V137, p1602S, DOI 10.1093/jn/137.6.1602S; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Paul S, 2013, TRENDS IMMUNOL, V34, P269, DOI 10.1016/j.it.2013.02.002; Reynolds LP, 2000, ENDOCRINE, V12, P1, DOI 10.1385/ENDO:12:1:1; Rodriguez PC, 2003, J IMMUNOL, V171, P1232, DOI 10.4049/jimmunol.171.3.1232; ROTH M, 1971, ANAL CHEM, V43, P880, DOI 10.1021/ac60302a020; Schwarz EL, 2005, CLIN CHIM ACTA, V354, P83, DOI 10.1016/j.cccn.2004.11.016; SOLOMON SJ, 1982, AM J CLIN NUTR, V36, P611, DOI 10.1093/ajcn/36.4.611; Su L, 2009, IMMUNOL LETT, V125, P151, DOI 10.1016/j.imlet.2009.07.003; Tajima Makiko, 2012, J Med Dent Sci, V59, P75; Tamura H, 2008, FERTIL STERIL, V90, P2334, DOI 10.1016/j.fertnstert.2007.10.056; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026; Vega M, 1998, ENDOCRINE, V8, P185, DOI 10.1385/ENDO:8:2:185; Yeung EH, 2013, INT J OBESITY, V37, P237, DOI 10.1038/ijo.2012.9; Yoshioka S, 2006, HUM REPROD, V21, P3290, DOI 10.1093/humrep/del312	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200489	10.1371/journal.pone.0200489	http://dx.doi.org/10.1371/journal.pone.0200489			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990354	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300056
J	Silva, WTAF				Silva, Willian T. A. F.			Methylation dynamics during the maternal-to-zygotic genome transition in dioecious species	PLOS ONE			English	Article							DNA METHYLATION; GENE-EXPRESSION; MAMMALIAN DEVELOPMENT; PREIMPLANTATION EMBRYOS; MIDBLASTULA TRANSITION; TRANSCRIPTOME ANALYSIS; CELL-LINES; DEMETHYLATION; DROSOPHILA; ZEBRAFISH	The starting point of a new generation in sexually reproducing species is fertilization. In many species, fertilization is followed by cell divisions controlled primarily by maternal transcripts, with little to no zygotic transcription. The activation of the zygotic genome (ZGA) is part of a process called maternal-to-zygotic transition (MZT), during which transcripts from the zygotic genome take control of development, setting the conditions for cellular specialization. While we know that epigenetic processes (e.g. methylation) are involved in the MZT, their roles and interplay in the transition are largely unknown. I developed a model and used simulations to elucidate the interaction between possible epigenetic processes, namely methylation processes, involved in the MZT. The model focuses on the dynamics of global methylation levels and how these interact with factors such as a parental repressor and the nucleocytoplasmic ratio to trigger the ZGA, followed by development from fertilization to adulthood. In addition, I included transgenerational effects transmitted to the zygote from both parents through their gametes to show that these may set the stage for plastic developmental processes. I demonstrate that the rates of maintenance methylation and demethylation, which are important for the achievement of the final methylation levels of an individual, exhibit a certain level of flexibility in terms of parameter values. I find that high final methylation levels require more restricted combinations of parameter values. The model is discussed in the context of the current empirical knowledge and provide suggestions for directions of future empirical and theoretical studies.	[Silva, Willian T. A. F.] Uppsala Univ, Dept Evolutionary Biol, Norbyvagen 18D, S-75310 Uppsala, Sweden	Uppsala University	Silva, WTAF (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Norbyvagen 18D, S-75310 Uppsala, Sweden.	willian.silva@evobiolab.com		Silva, Willian/0000-0002-9517-485X	Sven and Lilly Lawski's Foundation for Science Research	Sven and Lilly Lawski's Foundation for Science Research	WTAFS received funding from the Sven and Lilly Lawski's Foundation for Science Research during 2014 and 2015 in the form of a stipend for postgraduate studies.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Baroux C, 2008, COLD SH Q B, V73, P89, DOI 10.1101/sqb.2008.73.053; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; Choi M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007060; Collart C, 2013, SCIENCE, V341, P893, DOI 10.1126/science.1241530; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; Day T, 2004, GENETICS, V167, P1537, DOI 10.1534/genetics.103.026211; Dean W, 2014, MOL REPROD DEV, V81, P113, DOI 10.1002/mrd.22280; Doerksen T, 1996, BIOL REPROD, V55, P1155, DOI 10.1095/biolreprod55.5.1155; Dumollard R, 2013, DEV BIOL, V384, P331, DOI 10.1016/j.ydbio.2013.10.007; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Farrell JA, 2014, ANNU REV GENET, V48, P269, DOI 10.1146/annurev-genet-111212-133531; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Guo F, 2014, CELL STEM CELL, V15, P447, DOI 10.1016/j.stem.2014.08.003; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Langley AR, 2014, DEVELOPMENT, V141, P3834, DOI 10.1242/dev.102368; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Mathavan S, 2005, PLOS GENET, V1, P260, DOI 10.1371/journal.pgen.0010029; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Mommer BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098564; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Mychasiuk R, 2013, NEUROSCIENCE, V241, P100, DOI 10.1016/j.neuroscience.2013.03.025; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NOTHIAS JY, 1995, J BIOL CHEM, V270, P22077, DOI 10.1074/jbc.270.38.22077; Ogushi S, 2008, SCIENCE, V319, P613, DOI 10.1126/science.1151276; OHKUMA Y, 1990, CELL, V61, P475, DOI 10.1016/0092-8674(90)90529-N; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; OTTO SP, 1990, GENETICS, V124, P429; Park SJ, 2013, GENE DEV, V27, P2736, DOI 10.1101/gad.227926.113; Peshkin L, 2015, DEV CELL, V35, P383, DOI 10.1016/j.devcel.2015.10.010; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Pritchard DK, 1996, GENE DEV, V10, P1131, DOI 10.1101/gad.10.9.1131; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; ROTT NN, 1968, J EMBRYOL EXP MORPH, V20, P141; Ruzov A, 2004, DEVELOPMENT, V131, P6185, DOI 10.1242/dev.01549; SANFORD JP, 1987, GENE DEV, V1, P1039, DOI 10.1101/gad.1.10.1039; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Sutovsky P., 1999, INT REV CYTOL, V195, P1; SZE LC, 1953, J EXP ZOOL, V122, P577, DOI 10.1002/jez.1401220311; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tsuji-Takayama K, 2004, BIOCHEM BIOPH RES CO, V323, P86, DOI 10.1016/j.bbrc.2004.08.052; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; Wagner DS, 2004, DEV CELL, V6, P781, DOI 10.1016/j.devcel.2004.04.001; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu CH, 2018, SCIENCE, V359, P1166, DOI 10.1126/science.aan5480; Yang XF, 2015, HUM MOL GENET, V24, P4374, DOI 10.1093/hmg/ddv172; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	67	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200028	10.1371/journal.pone.0200028	http://dx.doi.org/10.1371/journal.pone.0200028			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990374	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300026
J	Tits, M; Tilmanne, J; Dutoit, T				Tits, Mickael; Tilmanne, Joelle; Dutoit, Thierry			Robust and automatic motion-capture data recovery using soft skeleton constraints and model averaging	PLOS ONE			English	Article							MICROSOFT KINECT; MISSING MARKERS; ANIMATION	Motion capture allows accurate recording of human motion, with applications in many fields, including entertainment, medicine, sports science and human computer interaction. A common difficulty with this technology is the occurrence of missing data, due to occlusions, or recording conditions. Various models have been proposed to estimate missing data. Some are based on interpolation, low-rank properties or inter-correlations. Others involve dataset matching or skeleton constraints. While the latter have the advantage of promoting a realistic motion estimation, they require prior knowledge of skeleton constraints, or the availability of a prerecorded dataset. In this article, we propose a probabilistic averaging method of several recovery models (referred to as Probabilistic Model Averaging (PMA) in this paper), based on the likelihoods of the distances between body points. This method has the advantage of being automatic, while allowing an efficient gap data recovery. To support and validate the proposed method, we use a set of four individual recovery models, based on linear/ nonlinear regression in local coordinate systems. Finally, we propose two heuristic algorithms to enforce skeleton constraints in the reconstructed motion, which can be used on any individual recovery model. For validation purposes, random gaps were introduced into motion-capture sequences, and the effects of factors such as the number of simultaneous gaps, gap length and sequence duration were analyzed. Results show that the proposed probabilistic averaging method yields better recovery than (i) each of the four individual models and (ii) two recent state-of-the-art models, regardless of gap length, sequence duration and number of simultaneous gaps. Moreover, both of our heuristic skeleton-constraint algorithms significantly improve the recovery for 7 out of 8 tested motion-capture sequences (p < 0.05), for 10 simultaneous gaps of 5 seconds. The code is available for free download at:https://github.com/numediart/MocapRecovery.	[Tits, Mickael; Tilmanne, Joelle; Dutoit, Thierry] Univ Mons, Numediart Inst, Mons, Belgium	University of Mons	Tits, M (corresponding author), Univ Mons, Numediart Inst, Mons, Belgium.	mickael.tits@umons.ac.be		Tits, Mickael/0000-0003-1769-9295	Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (FRIA, FRS-FNRS), Belgium [FC 005499]; Fonds de la Recherche Scientifique (FRS-FNRS), Belgium [EQP U.N041.13]; European Regional Development Fund [ETR 1212 0000 3303]	Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (FRIA, FRS-FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); Fonds de la Recherche Scientifique (FRS-FNRS), Belgium(Fonds de la Recherche Scientifique - FNRS); European Regional Development Fund(European Commission)	Mickael Tits is funded through a PHD grant from the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture (FRIA, FRS-FNRS, FC 005499), Belgium, http://www.fnrs.be/en/. The Qualisys motion capture equipment was funded by the Fonds de la Recherche Scientifique (FRS-FNRS, EQP U.N041.13), Belgium. This research project is supported by the European Regional Development Fund (ETR 1212 0000 3303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristidou A, 2008, LECT NOTES COMPUT SC, V5098, P238, DOI 10.1007/978-3-540-70517-8_23; Bates DM, NONLINEAR REGRESSION, V2; Burger B, 2013, 10TH SOUND AND MUSIC; Ceseracciu E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087640; Chai JX, 2005, ACM T GRAPHIC, V24, P686, DOI 10.1145/1073204.1073248; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Cigizoglu HK, 2006, ADV ENG SOFTW, V37, P63, DOI 10.1016/j.advengsoft.2005.05.002; de Aguiar E, 2006, LECT NOTES COMPUT SC, V4291, P485; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Federolf PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078689; Feng YF, 2014, INFORM SCIENCES, V277, P777, DOI 10.1016/j.ins.2014.03.013; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; Gloersen O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152616; Hodgins J. K, CMU GRAPHICS LAB MOT; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Howarth SJ, 2010, COMPUT METHOD BIOMEC, V13, P847, DOI 10.1080/10255841003664701; Jaimes A, 2007, COMPUT VIS IMAGE UND, V108, P116, DOI 10.1016/j.cviu.2006.10.019; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kirk AG, 2005, PROC CVPR IEEE, P782; Lai RY, 2011, COMPUT GRAPH FORUM; Li L., 2010, P 2010 ACM SIGGRAPH, P179; Li L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P507; Liu GD, 2006, VISUAL COMPUT, V22, P721, DOI 10.1007/s00371-006-0080-9; Moeslund TB, 2001, COMPUT VIS IMAGE UND, V81, P231, DOI 10.1006/cviu.2000.0897; Moeslund TB, 2006, COMPUT VIS IMAGE UND, V104, P90, DOI 10.1016/j.cviu.2006.08.002; Muller M., 2007, DOCUMENTATION MOCAP; Multon F, 1999, J VISUAL COMP ANIMAT, V10, P39, DOI 10.1002/(SICI)1099-1778(199901/03)10:1<39::AID-VIS195>3.0.CO;2-2; Mundermann L, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-6; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Peng SJ, 2015, COMPUT GRAPH-UK, V49, P10, DOI 10.1016/j.cag.2015.04.004; Rego P, 2010, INF SYST TECHN CISTI; Seber G., 2003, LINEAR REGRESSION AN; Silverman B. W., 1986, DENSITY ESTIMATION F, V26; SPECHT DF, 1991, IEEE T NEURAL NETWOR, V2, P568, DOI 10.1109/72.97934; Tan CH, 2015, VISUAL COMPUT, V31, P1521, DOI 10.1007/s00371-014-1031-5; Tan CH, 2013, ELECTRON LETT, V49, P752, DOI 10.1049/el.2013.0442; Wang JM, 2008, IEEE T PATTERN ANAL, V30, P283, DOI 10.1109/TPAMI.2007.1167; Zhang ZY, 2012, IEEE MULTIMEDIA, V19, P4, DOI 10.1109/MMUL.2012.24; Zhou HY, 2008, BIOMED SIGNAL PROCES, V3, P1, DOI 10.1016/j.bspc.2007.09.001	40	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199744	10.1371/journal.pone.0199744	http://dx.doi.org/10.1371/journal.pone.0199744			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990367	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300015
J	Leung, CS; Li, JT; Xu, F; Wong, ASL; Lui, KO				Leung, Cherry S.; Li, Jiatao; Xu, Feng; Wong, Alan S. L.; Lui, Kathy O.			Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants	FASEB JOURNAL			English	Article						ESCs; phagocytosis; endothelial cells; immune tolerance; xenotransplantation	REGULATORY PROTEIN ALPHA; TOLERANCE INDUCTION; ALLOGRAFT-REJECTION; SIRP-ALPHA; IN-VITRO; PHAGOCYTOSIS; ENGRAFTMENT; RECEPTOR; PROGENITORS; GENERATION	Like conventional transplants, immunosuppression is required to facilitate survival and function of human embryonic stem cell (hESC) derivatives after implantation into xenogeneic recipients. We have previously reported that T cells alone are sufficient to reject allogeneic murine ESC derivatives; and strategies that inhibit T-cell activation, including coreceptor and costimulation blockade, prevent hESC derivatives from being rejected. This study aimed to investigate, in addition to T cells, whether macrophages contribute to transplant rejection of hESC xenografts with nonobese diabetic (NOD)/SCID mice that lack functional T and B cells but have macrophages. We show that acute rejection against hESC-derived endothelial cells (hESC-ECs) was mediated, to some degree, by infiltrating macrophages that phagocytosed them. Transgenic expression of murine CD47 on cell surface of hESC-ECs mitigates macrophage-mediated phagocytosis and improves their survival after transplantation. Our results highlight that innate immune cells, such as macrophages, can reject hESC derivatives, raising concern against the use of NOD/SCID as transplant recipients for testing in vivo function of hESC-derived tissues. Augmenting CD47 signaling promotes survival and function of hESC derivatives after xenogeneic transplantation.Leung, C. S., Li, J., Xu, F., Wong, A. S. L., Lui, K. O. Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants.	[Leung, Cherry S.; Li, Jiatao; Lui, Kathy O.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Chem Pathol, Hong Kong, Peoples R China; [Li, Jiatao; Lui, Kathy O.] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Xu, Feng; Wong, Alan S. L.] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Wong, Alan S. L.] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; University of Hong Kong; University of Hong Kong	Lui, KO (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	kathyolui@cuhk.edu.hk	Lui, Kathy O./E-4883-2015; Lui, Kathy/AAC-8303-2020	Lui, Kathy O./0000-0002-1616-3643; Lui, Kathy/0000-0002-1616-3643; Xu, Feng/0000-0002-2517-9831; Wong, Alan S.L./0000-0003-1790-3233	Research Grants Council of Hong Kong [24110515, 14111916, C4024-16W, C4026-17WF]; Health and Medical Research Fund Grants [03140346, 04152566]; Croucher Foundation; Lui Chi Woo Institute of Innovative Medicine; Chinese University of Hong Kong	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Health and Medical Research Fund Grants; Croucher Foundation; Lui Chi Woo Institute of Innovative Medicine; Chinese University of Hong Kong(Chinese University of Hong Kong)	The authors thank Prof. Joseph Wu (Stanford University, Stanford, CA, USA) for the kind gift of firefly luciferase-expressing hESC line, and Prof. Xiaoqiang Yao (Chinese University of Hong Kong) for the kind gift of mouse H5V EC line. The authors also thank Dr. Ting-hsuan Chen (City University of Hong Kong, Hong Kong, China) for helping with the in vivo BLI experiments, Xisheng Li and Yanli Zhou (both from the Chinese University of Hong Kong) for technical help. The authors thank Prof. Herman Waldmann (University of Oxford, Oxford, United Kingdom) and all members of the K.O.L. Laboratory for insightful discussions throughout the study. This work was supported by the Research Grants Council of Hong Kong (Grants 24110515, 14111916, C4024-16W, and C4026-17WF); Health and Medical Research Fund Grants 03140346 and 04152566; the Croucher Foundation (Innovation Award and Startup Award); Lui Chi Woo Institute of Innovative Medicine Seed Fund, Direct Grant, Faculty Innovation Award; and Postgraduate Studentships from the Chinese University of Hong Kong. The authors declare no conflicts of interest.	Abe M, 2002, J IMMUNOL, V168, P621, DOI 10.4049/jimmunol.168.2.621; Agulnick AD, 2015, STEM CELL TRANSL MED, V4, P1214, DOI 10.5966/sctm.2015-0079; Amash A, 2016, J IMMUNOL, V196, P3331, DOI 10.4049/jimmunol.1502198; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; He HZ, 2002, TRANSPLANTATION, V73, P853, DOI 10.1097/00007890-200203270-00005; Huber BC, 2013, STEM CELLS, V31, P2354, DOI 10.1002/stem.1501; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Kwong LS, 2014, IMMUNOLOGY, V143, P61, DOI 10.1111/imm.12290; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Lee TKW, 2014, HEPATOLOGY, V60, P179, DOI 10.1002/hep.27070; Legrand N, 2011, P NATL ACAD SCI USA, V108, P13224, DOI 10.1073/pnas.1101398108; Liu R, 2017, ONCOTARGET, V8, P39021, DOI 10.18632/oncotarget.16547; Lui K. O., 2008, STEMBOOK; Lui KO, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6629; Lui KO, 2013, CELL RES, V23, P1172, DOI 10.1038/cr.2013.112; Lui KO, 2010, STEM CELLS, V28, P1905, DOI 10.1002/stem.506; Lui KO, 2009, CURR STEM CELL RES T, V4, P70, DOI 10.2174/157488809787169093; Menasche P, 2015, EUR HEART J, V36, P2011, DOI 10.1093/eurheartj/ehv189; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Patsch C, 2015, NAT CELL BIOL, V17, P994, DOI 10.1038/ncb3205; Pearl JI, 2011, CELL STEM CELL, V8, P309, DOI 10.1016/j.stem.2011.01.012; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Schafer N, 2008, TRANSPL INT, V21, P778, DOI 10.1111/j.1432-2277.2008.00676.x; Schmidt A, 2007, J LEUKOCYTE BIOL, V81, P186, DOI 10.1189/jlb.0606377; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Steinert G, 2014, CANCER RES, V74, P1694, DOI 10.1158/0008-5472.CAN-13-1885; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Szot GL, 2015, CELL STEM CELL, V16, P148, DOI 10.1016/j.stem.2014.12.001; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; van den Bosch TPP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00346; Weiskopf K, 2016, J CLIN INVEST, V126, P2610, DOI 10.1172/JCI81603; Wu C, 2016, AM J TRANSPLANT, V16, P2563, DOI 10.1111/ajt.13808; Zhang HM, 2015, P NATL ACAD SCI USA, V112, pE6215, DOI 10.1073/pnas.1520032112	35	15	15	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					484	493		10.1096/fj.201800449R	http://dx.doi.org/10.1096/fj.201800449R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30004796				2022-12-26	WOS:000457401500038
J	Chen, WH; Cai, MY; Zhang, JX; Wang, FW; Tang, LQ; Liao, YJ; Jin, XH; Wang, CY; Guo, L; Jiang, YG; Ren, CP; Mai, HQ; Zeng, MS; Kung, HF; Qian, CN; Xie, D				Chen, Wen-Hui; Cai, Mu-Yan; Zhang, Jia-Xing; Wang, Feng-Wei; Tang, Lin-Quan; Liao, Yi-Ji; Jin, Xiao-Han; Wang, Chen-Yuan; Guo, Ling; Jiang, Yi-Guo; Ren, Cai-Ping; Mai, Hai-Qiang; Zeng, Mu-Sheng; Kung, Hsiang-Fu; Qian, Chao-Nan; Xie, Dan			FMNL1 mediates nasopharyngeal carcinoma cell aggressiveness by epigenetically upregulating MTA1	ONCOGENE			English	Article							LEUKOCYTE FORMIN; CANCER; METASTASIS; REORGANIZATION; CYTOSKELETON; INVADOPODIA; EXPRESSION; MICRORNAS; MECHANISM; CORTACTIN	It has been suggested that formin-like protein 1 (FMNL1) plays an important role in the pathogenic process of several hematopoietic malignancies. In this study, we performed a series of in vivo and in vitro assays to elucidate the biological functions of FMNL1 and underlying mechanisms in human nasopharyngeal carcinoma (NPC) pathogenesis. Herein, we report that high expression of FMNL1 in NPC is positively associated with an aggressive disease and/or poor patient survival. Ectopic overexpression of FMNL1 in NPC cells substantially promoted cell invadopodia formation, epithelial-mesenchymal transition (EMT) and invasiveness, whereas depletion of FMNL1 potently suppressed NPC cells invadopodia formation, EMT, and invasive/metastatic capacities. We further show that FMNL1 could enhance NPC cell aggressiveness by increasing a key downstream target, the metastasis-associated protein 1 (MTA1) gene. Importantly, ectopic overexpression of FMNL1 in NPC cells markedly improved the binding of HDAC1 with Profilin2 in the cytoplasm and suppressed the enrichment of HDAC1 on the promoter of MTA1 and thereby, leading to an increased MTA1 transcription and expression. Furthermore, in addition to the amplification of FMNL1 gene, decreased level of miR-16 in NPCs is another critical mechanism to upregulate FMNL1 expression. These results, collectively, provide first-line of evidences that high expression of FMNL1, resulted from decreased miR-16 and/or MTA1 amplification, has a potent oncogenic role to drive the development and aggressive process of NPC by upregulating MTA1, and FMNL1 might be employed as a new prognostic biomarker and therapeutic target for human NPC.	[Chen, Wen-Hui; Cai, Mu-Yan; Zhang, Jia-Xing; Wang, Feng-Wei; Tang, Lin-Quan; Liao, Yi-Ji; Jin, Xiao-Han; Wang, Chen-Yuan; Guo, Ling; Mai, Hai-Qiang; Zeng, Mu-Sheng; Kung, Hsiang-Fu; Qian, Chao-Nan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Chen, Wen-Hui; Cai, Mu-Yan; Zhang, Jia-Xing; Wang, Feng-Wei; Tang, Lin-Quan; Liao, Yi-Ji; Jin, Xiao-Han; Wang, Chen-Yuan; Guo, Ling; Mai, Hai-Qiang; Zeng, Mu-Sheng; Kung, Hsiang-Fu; Qian, Chao-Nan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Chen, Wen-Hui] Jinan Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Cai, Mu-Yan; Xie, Dan] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, Jia-Xing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Oncol, Guangzhou, Guangdong, Peoples R China; [Tang, Lin-Quan; Guo, Ling; Mai, Hai-Qiang; Qian, Chao-Nan] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Canc, Guangzhou, Guangdong, Peoples R China; [Jiang, Yi-Guo] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Ren, Cai-Ping] Cent South Univ, Sch Basic Med Sci, Collaborat Innovat Ctr Canc Med, Canc Res Inst, Changsha, Hunan, Peoples R China; [Ren, Cai-Ping] Cent South Univ, Sch Basic Med Sci, Chinese Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Kung, Hsiang-Fu] Chinese Univ Hong Kong, State Key Lab Oncol South China, Hong Kong, Hong Kong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Jinan University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Central South University; Central South University; Chinese University of Hong Kong; State Key Lab Oncology South China	Xie, D (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.; Xie, D (corresponding author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Xie, D (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China.	xiedan@sysucc.org.cn	LIAO, YIJI/Z-4902-2019	LIAO, YIJI/0000-0002-0849-4573; zeng, musheng/0000-0003-3509-5591; Jiang, Yiguo/0000-0002-9499-2594	National Key R&D Program of China [2017YFC1309001]; Nature Science Foundation of China [81572359, 81572848, 81702681, 81730072]; Open Project of State Key Laboratory of Respiratory Disease of China [SKLRD2016OP004]	National Key R&D Program of China; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project of State Key Laboratory of Respiratory Disease of China	This work was supported by grants from the National Key R&D Program of China (No. 2017YFC1309001), the Nature Science Foundation of China (No. 81572359, 81572848, 81702681, and 81730072) and Open Project of State Key Laboratory of Respiratory Disease of China (No. SKLRD2016OP004).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bowden ET, 2006, EXP CELL RES, V312, P1240, DOI 10.1016/j.yexcr.2005.12.012; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; FANDI A, 1994, SEMIN ONCOL, V21, P382; Favaro P, 2013, J LEUKOCYTE BIOL, V94, P503, DOI 10.1189/jlb.0113057; Favaro PMB, 2006, LEUKEMIA RES, V30, P735, DOI 10.1016/j.leukres.2005.10.003; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Gardberg M, 2014, J HISTOCHEM CYTOCHEM, V62, P460, DOI 10.1369/0022155414532293; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; He SH, 2013, J CELL PHYSIOL, V228, P1525, DOI 10.1002/jcp.24311; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kuhn Sonja, 2014, Small GTPases, V5, pe29513, DOI 10.4161/sgtp.29513; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Li JS, 2013, CHIN J CANCER, V32, P3, DOI 10.5732/cjc.011.10381; Liu LL, 2014, HEPATOLOGY, V59, P531, DOI 10.1002/hep.26677; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Luger K, 1998, CURR OPIN GENET DEV, V8, P140, DOI 10.1016/S0959-437X(98)80134-2; Marzook H, 2014, CANCER METAST REV, V33, P953, DOI 10.1007/s10555-014-9521-5; Mersich AT, 2010, CYTOSKELETON, V67, P573, DOI 10.1002/cm.20468; Pakala SB, 2011, ONCOGENE, V30, P2230, DOI 10.1038/onc.2010.608; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Schuster IG, 2007, BLOOD, V110, P2931, DOI 10.1182/blood-2006-11-058750; Song QC, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-54; Song QC, 2013, INT J BIOCHEM CELL B, V45, P1439, DOI 10.1016/j.biocel.2013.04.017; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; Tang YN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9230; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Wei William I, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P99, DOI 10.1097/MOO.0b013e3280148a06; West AC, 2014, J CLIN INVEST, V124, P30, DOI 10.1172/JCI69738; Winter M, 2013, EMBO J, V32, P3176, DOI 10.1038/emboj.2013.243; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Young KG, 2010, BBA-MOL CELL RES, V1803, P183, DOI 10.1016/j.bbamcr.2008.09.017; Zhang LF, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0018-6; Zheng F, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004873; Zheng F, 2012, GUT, V61, P278, DOI 10.1136/gut.2011.239145; Zhu W, 2012, GUT, V61, P562, DOI 10.1136/gutjnl-2011-300207	43	17	17	2	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 29	2018	37	48					6243	6258		10.1038/s41388-018-0351-8	http://dx.doi.org/10.1038/s41388-018-0351-8			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HC2HE	30013189				2022-12-26	WOS:000451622100004
J	Park, JW; Chae, YC; Kim, JY; Oh, H; Seo, SB				Park, Jin Woo; Chae, Yun-Cheol; Kim, Ji-Young; Oh, Hyein; Seo, Sang-Beom			Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis	ONCOGENE			English	Article							HISTONE METHYLTRANSFERASE; LYSINE METHYLATION; INHIBITION; PROTEIN	The histone methyltransferase multiple myeloma SET domain protein (MMSET/WHSC1) is highly expressed in diverse tumor types, and its expression appears to be involved in cell proliferation. In this study, we report that MMSET interacts with and methylates Aurora kinase A (AURKA). We show that MMSET-mediated methylation of AURKA induces interaction with p53 as well as enhanced kinase activity of AURKA, which results in the proteasomal degradation of p53. MMSET-mediated p53 degradation increases cell proliferation and results in oncogenic activity. Furthermore, knockdown of MMSET potently inhibits tumorigenic cells and renders them sensitive to growth inhibition by the therapeutic drug, alisertib (AURKA inhibitor). Taken together, our results suggest that MMSET is a regulator of p53 stability via methylation of AURKA in proliferating cells and might be a potential therapeutic target in solid tumors.	[Park, Jin Woo; Chae, Yun-Cheol; Kim, Ji-Young; Oh, Hyein; Seo, Sang-Beom] Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul 06974, South Korea	Chung Ang University	Seo, SB (corresponding author), Chung Ang Univ, Dept Life Sci, Coll Nat Sci, Seoul 06974, South Korea.	sangbs@cau.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1A4A1008035, NRF-2017R1A2B4004407]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning NRF-2016R1A4A1008035 and NRF-2017R1A2B4004407)	Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; De Luca M, 2006, CELL CYCLE, V5, P296; Ertych N, 2014, NAT CELL BIOL, V16, P779, DOI 10.1038/ncb2994; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Hudlebusch HR, 2011, CLIN CANCER RES, V17, P2919, DOI 10.1158/1078-0432.CCR-10-1302; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kurash JK, 2008, MOL CELL, V29, P392, DOI 10.1016/j.molcel.2007.12.025; Laurent B, 2015, MOL CELL, V57, P957, DOI 10.1016/j.molcel.2015.01.010; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lee YF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106661; Li N, 2017, J CLIN INVEST, V127, P1284, DOI 10.1172/JCI91144; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Marxer M, 2014, ONCOGENE, V33, P3550, DOI 10.1038/onc.2013.325; Maxwell CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001199; Moll UM, 2003, MOL CANCER RES, V1, P1001; Morishita M, 2014, BMC STRUCT BIOL, V14, DOI 10.1186/s12900-014-0025-x; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Park JW, 2015, SCI REP-UK, V5, DOI 10.1038/srep12485; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Sammons MA, 2015, GENOME RES, V25, P179, DOI 10.1101/gr.181883.114; Shen C, 2015, MOL CELL, V60, P847, DOI 10.1016/j.molcel.2015.10.033; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55	30	20	22	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 29	2018	37	48					6212	6224		10.1038/s41388-018-0393-y	http://dx.doi.org/10.1038/s41388-018-0393-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HC2HE	30013191				2022-12-26	WOS:000451622100002
J	Lam, KH; Xue, CL; Sun, KL; Zhang, HW; Lam, WWL; Zhu, ZY; Ng, JTY; Sause, WE; Lertsethtakarn, P; Lau, KF; Ottemann, KM; Au, SWN				Lam, Kwok Ho; Xue, Chaolun; Sun, Kailei; Zhang, Huawei; Lam, Wendy Wai Ling; Zhu, Zeyu; Ng, Juliana Tsz Yan; Sause, William E.; Lertsethtakarn, Paphavee; Lau, Kwok Fai; Ottemann, Karen M.; Au, Shannon Wing Ngor			Three SpoA-domain proteins interact in the creation of the flagellar type III secretion system in Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular motor; protein structure; protein-protein interaction; protein assembly; protein export; bacterial motility; flagellar motor switch complex; SpoA domain; type III secretion system; virulence factor; flagellum; Fli protein; Helicobacter pylori; SpoA domain; FliY	C-RING; CRYSTAL-STRUCTURE; TORQUE RING; ROTOR; COMPLEX; MOTOR; FLIY; CHEMOTAXIS; ORGANIZATION; MECHANISM	Bacterial flagella are rotary nanomachines that contribute to bacterial fitness in many settings, including host colonization. The flagellar motor relies on the multiprotein flagellar motor-switch complex to govern flagellum formation and rotational direction. Different bacteria exhibit great diversity in their flagellar motors. One such variation is exemplified by the motor-switch apparatus of the gastric pathogen Helicobacter pylori, which carries an extra switch protein, FliY, along with the more typical FliG, FliM, and FliN proteins. All switch proteins are needed for normal flagellation and motility in H. pylori, but the molecular mechanism of their assembly is unknown. To fill this gap, we examined the interactions among these proteins. We found that the C-terminal SpoA domain of FliY (FliY(C)) is critical to flagellation and forms heterodimeric complexes with the FliN and FliM SpoA domains, which are -sheet domains of type III secretion system proteins. Surprisingly, unlike in other flagellar switch systems, neither FliY nor FliN self-associated. The crystal structure of the FliY(C)-FliN(C) complex revealed a saddle-shaped structure homologous to the FliN-FliN dimer of Thermotoga maritima, consistent with a FliY-FliN heterodimer forming the functional unit. Analysis of the FliY(C)-FliN(C) interface indicated that oppositely charged residues specific to each protein drive heterodimer formation. Moreover, both FliY(C)-FliM(C) and FliY(C)-FliN(C) associated with the flagellar regulatory protein FliH, explaining their important roles in flagellation. We conclude that H. pylori uses a FliY-FliN heterodimer instead of a homodimer and creates a switch complex with SpoA domains derived from three distinct proteins.	[Lam, Kwok Ho; Xue, Chaolun; Sun, Kailei; Zhang, Huawei; Lam, Wendy Wai Ling; Zhu, Zeyu; Ng, Juliana Tsz Yan; Lau, Kwok Fai; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Fac Sci, Shatin, Hong Kong, Peoples R China; [Xue, Chaolun; Zhang, Huawei; Lam, Wendy Wai Ling; Au, Shannon Wing Ngor] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China; [Sause, William E.; Lertsethtakarn, Paphavee; Ottemann, Karen M.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Lam, Kwok Ho] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Lertsethtakarn, Paphavee] Armed Forces Res Inst Med Sci, Dept Enter Dis, Bangkok 10400, Thailand	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; University of California System; University of California Santa Cruz; University of California System; University of California Irvine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Au, SWN (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Ctr Prot Sci & Crystallog, Fac Sci, Shatin, Hong Kong, Peoples R China.; Au, SWN (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen 518057, Peoples R China.	shannon-au@cuhk.edu.hk	zhang, huawei/S-6761-2019	zhang, huawei/0000-0002-5625-5809; LAM, KWOK HO/0000-0002-7173-6600; Lau, Kwok-Fai/0000-0002-0193-1152	National Natural Science Foundation of China [31370713]; Hong Kong Research Grants Council [N_CUHK454/13]; University Grants Committee One-Off Special Equipment Grant [SEG CUHK08]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050000] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grants Council(Hong Kong Research Grants Council); University Grants Committee One-Off Special Equipment Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Natural Science Foundation of China Grant 31370713, Hong Kong Research Grants Council Grant N_CUHK454/13, and University Grants Committee One-Off Special Equipment Grant SEG CUHK08. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beeby M, 2016, P NATL ACAD SCI USA, V113, pE1917, DOI 10.1073/pnas.1518952113; BERG HC, 1979, NATURE, V278, P349, DOI 10.1038/278349a0; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P2715, DOI 10.1111/j.1365-2958.1992.tb01448.x; Boneca IG, 2008, APPL ENVIRON MICROB, V74, P2095, DOI 10.1128/AEM.01348-07; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Bzymek KP, 2012, BIOCHEMISTRY-US, V51, P1669, DOI 10.1021/bi201792p; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; Donahue JP, 2000, MOL MICROBIOL, V37, P1066, DOI 10.1046/j.1365-2958.2000.02036.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; Hauser R, 2014, MOL CELL PROTEOMICS, V13, P1318, DOI 10.1074/mcp.O113.033571; Josenhans C, 2014, MOL MICROBIOL, V91, P6, DOI 10.1111/mmi.12427; Kholod N, 2001, BIOTECHNIQUES, V31, P322, DOI 10.2144/01312st03; Kojima S, 2004, BIOCHEMISTRY-US, V43, P26, DOI 10.1021/bi035405l; Lam KH, 2013, MOL MICROBIOL, V88, P798, DOI 10.1111/mmi.12222; Lam KH, 2012, STRUCTURE, V20, P315, DOI 10.1016/j.str.2011.11.020; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Lertsethtakarn P, 2011, ANNU REV MICROBIOL, V65, P389, DOI 10.1146/annurev-micro-090110-102908; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Lowenthal AC, 2009, J BACTERIOL, V191, P7147, DOI 10.1128/JB.00749-09; Lowenthal AC, 2009, MICROBIOL-SGM, V155, P1181, DOI 10.1099/mic.0.021857-0; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDowell MA, 2016, MOL MICROBIOL, V99, P749, DOI 10.1111/mmi.13267; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; Minamino T, 2015, TRENDS MICROBIOL, V23, P267, DOI 10.1016/j.tim.2014.12.011; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Minamino T, 2009, MOL MICROBIOL, V74, P1471, DOI 10.1111/j.1365-2958.2009.06946.x; Minamino T, 2008, CURR OPIN STRUC BIOL, V18, P693, DOI 10.1016/j.sbi.2008.09.006; Notti RQ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8125; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Parrish JR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r130; Paul K, 2006, J BACTERIOL, V188, P2502, DOI 10.1128/JB.188.7.2502-2511.2006; Paul K, 2011, EMBO J, V30, P2962, DOI 10.1038/emboj.2011.188; Pittman MS, 2001, MICROBIOL-SGM, V147, P2493, DOI 10.1099/00221287-147-9-2493; Qin Z, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00695-16; Raddi G, 2012, J BACTERIOL, V194, P1299, DOI 10.1128/JB.06474-11; Sarkar MK, 2010, P NATL ACAD SCI USA, V107, P9370, DOI 10.1073/pnas.1000935107; Senesi S, 2002, MICROBIOL-SGM, V148, P1785, DOI 10.1099/00221287-148-6-1785; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Sircar R, 2013, J BIOL CHEM, V288, P13493, DOI 10.1074/jbc.M112.445171; Stock D, 2012, CURR OPIN BIOTECH, V23, P545, DOI 10.1016/j.copbio.2012.01.008; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Thomas DR, 1999, P NATL ACAD SCI USA, V96, P10134, DOI 10.1073/pnas.96.18.10134; Vartanian AS, 2012, J BIOL CHEM, V287, P35779, DOI 10.1074/jbc.C112.378380; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452	55	6	7	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13961	13973		10.1074/jbc.RA118.002263	http://dx.doi.org/10.1074/jbc.RA118.002263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29991595	Green Published, hybrid			2022-12-26	WOS:000444070700021
J	Ramirez-Carrillo, E; Lopez-Corona, O; Toledo-Roy, JC; Lovett, JC; de Leon-Gonzalez, F; Osorio-Olvera, L; Equihua, J; Robredo, E; Frank, A; Dirzo, R; Perez-Cirera, V				Ramirez-Carrillo, Elvia; Lopez-Corona, Oliver; Toledo-Roy, Juan C.; Lovett, Jon C.; de Leon-Gonzalez, Fernando; Osorio-Olvera, Luis; Equihua, Julian; Robredo, Everardo; Frank, Alejandro; Dirzo, Rodolfo; Perez-Cirera, Vanessa			Assessing sustainability in North America's ecosystems using criticality and information theory	PLOS ONE			English	Article							PERMUTATION ENTROPY; TIME-SERIES; SCALING LAWS; SELF-ORGANIZATION; FRESH-WATER; COMPLEXITY; ORIGIN; SOIL; INVARIANCE; DYNAMICS	Sustainability is a key concept in economic and policy debates. Nevertheless, it is usually treated only in a qualitative way and has eluded quantitative analysis. Here, we propose a sustainability index based on the premise that sustainable systems do not lose or gain Fisher Information over time. We test this approach using time series data from the Ameri-Flux network that measures ecosystem respiration, water and energy fluxes in order to elucidate two key sustainability features: ecosystem health and stability. A novel definition of ecosystem health is developed based on the concept of criticality, which implies that if a system's fluctuations are scale invariant then the system is in a balance between robustness and adaptability. We define ecosystem stability by taking an information theory approach that measures its entropy and Fisher information. Analysis of the Ameriflux consortium big data set of ecosystem respiration time series is contrasted with land condition data. In general we find a good agreement between the sustainability index and land condition data. However, we acknowledge that the results are a preliminary test of the approach and further verification will require a multi-signal analysis. For example, high values of the sustainability index for some croplands are counter-intuitive and we interpret these results as ecosystems maintained in artificial health due to continuous human-induced inflows of matter and energy in the form of soil nutrients and control of competition, pests and disease.	[Ramirez-Carrillo, Elvia] Univ Autonoma Metropolitana Xochimilco, Ciencias Agr, Mexico City, DF, Mexico; [Lopez-Corona, Oliver] Comis Nacl Conocimiento & Uso Biodiversidad CONAB, Catedra CONACyT, Mexico City, DF, Mexico; [Lopez-Corona, Oliver] Inst Ecol AC Mexico INECOL, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Lopez-Corona, Oliver; Toledo-Roy, Juan C.; Frank, Alejandro] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad C3, Mexico City, DF, Mexico; [Toledo-Roy, Juan C.; Frank, Alejandro] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico; [Lovett, Jon C.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Lovett, Jon C.] Royal Bot Gardens, Richmond TW9 3AB, Surrey, England; [de Leon-Gonzalez, Fernando] Univ Autonoma Metropolitana Xochimilco, Dept Prod Agr & Anim, Mexico City, DF, Mexico; [Osorio-Olvera, Luis] Univ Nacl Autonoma Mexico, Faultad Ciencias, Posgrad Ciencias Biol, Mexico City, DF, Mexico; [Equihua, Julian; Robredo, Everardo] Comis Nacl Conocimiento & Uso Biodiversidad, Mexico City, DF, Mexico; [Frank, Alejandro] Colegio Nacl, Mexico City, DF, Mexico; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Perez-Cirera, Vanessa] Univ Iberoamer, Inst Invest Desarrollo Con Equidad EQUIDE, Mexico City, DF, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Leeds; Royal Botanic Gardens, Kew; Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico; Stanford University; Universidad Iberoamericana Ciudad de Mexico	Lopez-Corona, O (corresponding author), Comis Nacl Conocimiento & Uso Biodiversidad CONAB, Catedra CONACyT, Mexico City, DF, Mexico.; Lopez-Corona, O (corresponding author), Inst Ecol AC Mexico INECOL, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico.; Lopez-Corona, O (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad C3, Mexico City, DF, Mexico.	lopezoliverx@otrasenda.org	Nucleares, Instituto/AAK-6270-2020; Toledo-Roy, Juan Claudio/N-6666-2019; Toledo-Roy, Juan/G-6071-2019; PAN, ZEQIANG/X-6341-2018; Osorio-Olvera, Luis/AAF-5536-2020	Toledo-Roy, Juan Claudio/0000-0002-0267-3378; Toledo-Roy, Juan/0000-0002-0267-3378; Osorio-Olvera, Luis/0000-0003-0701-5398; Lopez Corona, Oliver/0000-0002-2926-7791	Catedras CONACyT fellowship program [30]; Sistema Nacional de Investigadores [62929]; CONACyT [245648]; PAPIIT [IN116018]	Catedras CONACyT fellowship program; Sistema Nacional de Investigadores; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This study was supported by Catedras CONACyT fellowship program (project number 30) and Sistema Nacional de Investigadores (62929). LOO acknowledges partial support from CONACyT 245648 scholarship and PAPIIT IN116018 for partial support in postgraduate studies.	[Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Anteneodo C, 2009, CHAOS, V19, DOI 10.1063/1.3211189; Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Bandt C, 2005, ECOL MODEL, V182, P229, DOI 10.1016/j.ecolmodel.2004.04.003; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Benford F, 1938, P AM PHILOS SOC, V78, P551, DOI DOI 10.2307/984802; Bertini L, 2015, REV MOD PHYS, V87, P593, DOI 10.1103/RevModPhys.87.593; Boulding K. E., 1996, ENV QUALITY GROWING, P3; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burger JR, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001345; Cabezas H, 2000, CHEM ENG-NEW YORK, V107, P107; Cabezas H, 2002, FLUID PHASE EQUILIBR, V194, P3, DOI 10.1016/S0378-3812(01)00677-X; Chandra N, 2013, J AM COLL CARDIOL, V61, P1027, DOI 10.1016/j.jacc.2012.08.1032; Chesworth W, 2008, ENCY SOIL SCI; Cocchi L, 2017, PROG NEUROBIOL, V158, P132, DOI 10.1016/j.pneurobio.2017.07.002; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Costanza Robert, 1992, P239; Di Battista T, 2016, ECOL INDIC, V60, P237, DOI 10.1016/j.ecolind.2015.05.056; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; Fernandez N, 2017, ECOL COMPLEX, V31, P1, DOI 10.1016/j.ecocom.2017.02.002; Fernandez N, 2014, EMERGENCE COMPLEX CO, V9, P19, DOI 10.1007/978-3-642-53734-9_2; Fossion R, 2010, AIP CONF PROC, V1323, P74, DOI 10.1063/1.3537868; Frank B, 2006, MED BIOL ENG COMPUT, V44, P179, DOI 10.1007/s11517-005-0015-z; Frieden B. R., 2007, EXPLORATORY DATA ANA; FRIEDEN BR, 1995, PHYS REV E, V52, P2274, DOI 10.1103/PhysRevE.52.2274; Gershenson C, 2012, COMPLEXITY, V18, P29, DOI 10.1002/cplx.21424; Gisiger T, 2001, BIOL REV, V76, P161, DOI 10.1017/S1464793101005607; Gleick PH, 2010, P NATL ACAD SCI USA, V107, P11155, DOI 10.1073/pnas.1004812107; GOLDBERGER AL, 1992, IEEE ENG MED BIOL, V11, P47, DOI 10.1109/51.139036; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Hak JC, 2017, ECOL INDIC, V82, P206, DOI 10.1016/j.ecolind.2017.06.049; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; James A, 2008, TERRESTRIAL INFLUENC, P46; Janzen HH, 2015, EUR J SOIL SCI, V66, P19, DOI 10.1111/ejss.12194; Jordan D, 2008, ANESTHESIOLOGY, V109, P1014, DOI 10.1097/ALN.0b013e31818d6c55; Keeler BL, 2012, P NATL ACAD SCI USA, V109, P18619, DOI 10.1073/pnas.1215991109; Keller K., 2007, CHAOS COMPLEXITY LET, V2, P247; Keller K, 2007, STOCH DYNAM, V7, P247, DOI 10.1142/S0219493707002025; Kiyono K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.058101; Kleinen T, 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Koorehdavoudi H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27602; Kowalski AM, 2007, PHYSICA D, V233, P21, DOI 10.1016/j.physd.2007.06.015; Kowalski AM, 2011, ENTROPY-SWITZ, V13, P1055, DOI 10.3390/e13061055; Landa E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016224; Rivera AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148378; Li XL, 2008, ANESTHESIOLOGY, V109, P448, DOI 10.1097/ALN.0b013e318182a91b; Mageau M.T., 1995, ECOSYST HEALTH, V1, P201; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mandelbrot B. B., 2001, GAUSSIAN SELF AFFINI; Marsili M, 1998, PHYS REV LETT, V80, P2741, DOI 10.1103/PhysRevLett.80.2741; Mayer A. L., 2007, EXPLORATORY DATA ANA, DOI [10.1007/978-1-84628-777-0_7, DOI 10.1007/978-1-84628-777-0{_}]; Michaelian K, 2005, J THEOR BIOL, V237, P323, DOI 10.1016/j.jtbi.2005.04.019; Michaelian K, 2000, TOPICS CONT PHYS, P195; Mora T, 2011, J STAT PHYS, V144, P268, DOI 10.1007/s10955-011-0229-4; Morales IO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130751; Nel WP, 2010, APPL ENERG, V87, P168, DOI 10.1016/j.apenergy.2009.06.003; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Brien A, 2016, ECOL INDIC, V69, P722, DOI 10.1016/j.ecolind.2016.05.004; Olofsen E, 2008, BRIT J ANAESTH, V101, P810, DOI 10.1093/bja/aen290; Parlitz U, 2012, COMPUT BIOL MED, V42, P319, DOI 10.1016/j.compbiomed.2011.03.017; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pezzey J., 1992, SUSTAINABLE DEV CONC, DOI 10.1596/0-8213-2278-8; Pietronero L, 2001, PHYSICA A, V293, P297, DOI 10.1016/S0378-4371(00)00633-6; Pont D, 2006, J APPL ECOL, V43, P70, DOI 10.1111/j.1365-2664.2005.01126.x; Proekt A, 2012, P NATL ACAD SCI USA, V109, P10564, DOI 10.1073/pnas.1206894109; Prokopenko M, 2009, COMPLEXITY, V15, P11, DOI 10.1002/cplx.20249; Rapport DJ, 1998, TRENDS ECOL EVOL, V13, P397, DOI 10.1016/S0169-5347(98)01449-9; RAPPORT DJ, 1989, PERSPECT BIOL MED, V33, P120; Roli A, 2018, J SYST SCI COMPLEX, V31, P647, DOI 10.1007/s11424-017-6117-5; Saco PM, 2010, PHYSICA A, V389, P5022, DOI 10.1016/j.physa.2010.07.006; SCHAEFFER DJ, 1988, ENVIRON MANAGE, V12, P445, DOI 10.1007/BF01873258; Silva A, 2011, ANESTHESIOLOGY, V115, P303, DOI 10.1097/ALN.0b013e318222ac02; Simkin MV, 2011, REINVENTING WILLIS; Sinn M, 2011, COMPUT STAT DATA AN, V55, P1781, DOI 10.1016/j.csda.2010.11.009; Sippel S., 2016, STATCOMP STAT COMPLE; Sole R. V., 1995, Complexity, V1, P13; Soriano MC, 2011, OPT LETT, V36, P2212, DOI 10.1364/OL.36.002212; Sornette D, 2006, CRITICAL PHENOMENA N; Standing C., 2008, J SYST INF TECHNOL, V10, P186, DOI 10.1108/13287260810916907; STARIK M, 1995, ACAD MANAGE REV, V20, P908, DOI 10.2307/258960; Targulian VO, 2004, REV MEX CIENC GEOL, V21, P1; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Thompson RM, 2012, TRENDS ECOL EVOL, V27, P689, DOI 10.1016/j.tree.2012.08.005; Tiana-Alsina J, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013819; Ulanowicz RE, 2009, ECOL COMPLEX, V6, P27, DOI 10.1016/j.ecocom.2008.10.005; Van Kampen NG, 1965, FLUCTUATIONS NONLINE; West BJ, 2011, COMPLEX WEBS ANTICIP; West BJ, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00001; West G., 2017, SCALE UNIVERSAL LAWS; West GB, 1999, PHYSICA A, V263, P104, DOI 10.1016/S0378-4371(98)00639-6; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; Wu JG, 2012, LASER PHYS, V22, P1476, DOI 10.1134/S1054660X12100246; Xu Z., 2015, UNCERTAIN MULTIATTRI, DOI [10.1007/978-3-662-45640-8, DOI 10.1007/978-3-662-45640-8]; Yaalon D. H., 1983, Pedogenesis and Soil Taxonomy. 1. Concepts and interactions, P233; Zunino L, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.046210; Zunino L, 2012, PHYSICA A, V391, P4342, DOI 10.1016/j.physa.2012.04.009; Zunino L, 2010, PHYSICA A, V389, P1891, DOI 10.1016/j.physa.2010.01.007; Zunino L, 2009, PHYSICA A, V388, P2854, DOI 10.1016/j.physa.2009.03.042	100	7	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200382	10.1371/journal.pone.0200382	http://dx.doi.org/10.1371/journal.pone.0200382			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011317	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800018
J	Rollen, K; Granzin, J; Batra-Safferling, R; Stadler, AM				Rollen, Katrin; Granzin, Joachim; Batra-Safferling, Renu; Stadler, Andreas Maximilian			Small-angle X-ray scattering study of the kinetics of light-dark transition in a LOV protein	PLOS ONE			English	Article							BLUE-LIGHT; PHOTORECEPTOR PHOTOTROPIN; SIGNAL-TRANSDUCTION; CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; NMR-SPECTROSCOPY; STRUCTURAL BASIS; AUREOCHROME-LOV; BINDING DOMAINS; DIMERIZATION	Light, oxygen, voltage (LOV) photoreceptors consist of conserved photo-responsive domains in bacteria, archaea, plants and fungi, and detect blue-light via a flavin cofactor. We investigated the blue-light induced conformational transition of the dimeric photoreceptor PpSB1-LOV-R661 from Pseudomonas putida in solution by using small-angle X-ray scattering (SAXS). SAXS experiments of the fully populated light- and dark-states under steady-state conditions revealed significant structural differences between the two states that are in agreement with the known structures determined by crystallography. We followed the transition from the light- to the dark-state by using SAXS measurements in real-time. A two-state model based on the light- and dark-state conformations could describe the measured timecourse SAXS data with a relaxation time tau(REC) of similar to 34 to 35 min being larger than the recovery time found with UV/vis spectroscopy. Unlike the flavin chromophore-based UV/vis method that is sensitive to the local chromophore environment in flavoproteins, SAXS-based assay depends on protein conformational changes and provides with an alternative to measure the recovery kinetics.	[Rollen, Katrin; Granzin, Joachim; Batra-Safferling, Renu] Forschungszentrum Julich, ICS Struct Biochem 6, Inst Complex Syst, Julich, Germany; [Stadler, Andreas Maximilian] Forschungszentrum Julich, JCNS, Julich, Germany; [Stadler, Andreas Maximilian] Forschungszentrum Julich, ICS, Julich, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Batra-Safferling, R (corresponding author), Forschungszentrum Julich, ICS Struct Biochem 6, Inst Complex Syst, Julich, Germany.; Stadler, AM (corresponding author), Forschungszentrum Julich, JCNS, Julich, Germany.; Stadler, AM (corresponding author), Forschungszentrum Julich, ICS, Julich, Germany.	r.batra-safferling@fz-juelich.de; a.stadler@fz-juelich.de	Stadler, Andreas/B-2735-2009; Granzin, Joachim/G-8937-2013; Batra-Safferling, Renu/G-2918-2013	Stadler, Andreas/0000-0003-2272-5232; Granzin, Joachim/0000-0001-6604-950X; Batra-Safferling, Renu/0000-0002-8597-4335	Federal Ministry of Education and Research [FKZ 031A167B]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (Project OptoSys, FKZ 031A167B).	Berntsson O, 2017, STRUCTURE, V25, P933, DOI 10.1016/j.str.2017.04.006; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Circolone F, 2012, J MOL BIOL, V417, P362, DOI 10.1016/j.jmb.2012.01.056; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Demarsy E, 2009, CURR OPIN PLANT BIOL, V12, P69, DOI 10.1016/j.pbi.2008.09.002; Diensthuber RP, 2013, STRUCTURE, V21, P1127, DOI 10.1016/j.str.2013.04.024; Endres S, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0365-0; Engelhard C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01497-7; Glantz ST, 2016, P NATL ACAD SCI USA, V113, pE1442, DOI 10.1073/pnas.1509428113; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Halavaty AS, 2013, ACTA CRYSTALLOGR F, V69, P1316, DOI 10.1107/S1744309113029199; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; Herman E, 2015, BIOCHEMISTRY-US, V54, P1484, DOI 10.1021/bi501509z; Herman E, 2013, BIOCHEMISTRY-US, V52, P3094, DOI 10.1021/bi400197u; Herrou J, 2011, NAT REV MICROBIOL, V9, P713, DOI 10.1038/nrmicro2622; Inoue R, 2010, BIOPHYS J, V99, P2309, DOI 10.1016/j.bpj.2010.08.017; Jentzsch K, 2009, BIOCHEMISTRY-US, V48, P10321, DOI 10.1021/bi901115z; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Kennis JTM, 2003, BIOCHEMISTRY-US, V42, P3385, DOI 10.1021/bi034022k; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Lamb JS, 2008, J AM CHEM SOC, V130, P12226, DOI 10.1021/ja804236f; Lamb JS, 2009, J MOL BIOL, V393, P909, DOI 10.1016/j.jmb.2009.08.045; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Neiss C, 2003, PHOTOCHEM PHOTOBIOL, V77, P101, DOI 10.1562/0031-8655(2003)077<0101:AIQCIO>2.0.CO;2; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rani R, 2013, BIOCHEMISTRY-US, V52, P4460, DOI 10.1021/bi400311r; Rollen K, 2016, J MOL BIOL, V428, P3721, DOI 10.1016/j.jmb.2016.05.027; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Stadler AM, 2016, BIOPHYS J, V110, P1064, DOI 10.1016/j.bpj.2016.01.021; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Wriggers W, 2012, ACTA CRYSTALLOGR D, V68, P344, DOI 10.1107/S0907444911049791; Yee EF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10079; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	43	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200746	10.1371/journal.pone.0200746	http://dx.doi.org/10.1371/journal.pone.0200746			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011332	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800048
J	Faruqui, SHA; Alaeddini, A; Jaramillo, CA; Potter, JS; Pugh, MJ				Faruqui, Syed Hasib Akhter; Alaeddini, Adel; Jaramillo, Carlos A.; Potter, Jennifer S.; Pugh, Mary Jo			Mining patterns of comorbidity evolution in patients with multiple chronic conditions using unsupervised multi-level temporal Bayesian network	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; VETERANS; PAIN; AFGHANISTAN; DISTURBANCE; PREVALENCE; COHORT; IRAQ	Over the past few decades, the rise of multiple chronic conditions has become a major concern for clinicians. However, it is still not known precisely how multiple chronic conditions emerge among patients. We propose an unsupervised multi-level temporal Bayesian network to provide a compact representation of the relationship among emergence of multiple chronic conditions and patient level risk factors over time. To improve the efficiency of the learning process, we use an extension of maximum weight spanning tree algorithm and greedy search algorithm to study the structure of the proposed network in three stages, starting with learning the inter-relationship of comorbidities within each year, followed by learning the intra-relationship of comorbidity emergence between consecutive years, and finally learning the hierarchical relationship of comorbidities and patient level risk factors. We also use a longest path algorithm to identify the most likely sequence of comorbidities emerging from and/or leading to specific chronic conditions. Using a de-identified dataset of more than 250,000 patients receiving care from the U.S. Department of Veterans Affairs for a period of five years, we compare the performance of the proposed unsupervised Bayesian network in comparison with those of Bayesian networks developed based on supervised and semi-supervised learning approaches, as well as multivariate probit regression, multinomial logistic regression, and latent regression Markov mixture clustering focusing on traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), depression (Depr), substance abuse (SuAb), and back pain (BaPa). Our findings show that the unsupervised approach has noticeably accurate predictive performance that is comparable to the best performing semi-supervised and the second-best performing supervised approaches. These findings also revealed that the unsupervised approach has improved performance over multivariate probit regression, multinomial logistic regression, and latent regression Markov mixture clustering.	[Faruqui, Syed Hasib Akhter; Alaeddini, Adel] Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA; [Jaramillo, Carlos A.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Potter, Jennifer S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Pugh, Mary Jo] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA	University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs	Alaeddini, A (corresponding author), Univ Texas San Antonio, Dept Mech Engn, San Antonio, TX 78249 USA.	adel.alaeddini@utsa.edu	Potter, Jennifer Sharpe/C-6720-2008; Pugh, Mary Jo/K-5336-2019; faruqui, Syed hasib akhter/HCI-3961-2022	Potter, Jennifer Sharpe/0000-0002-7250-4422; Pugh, Mary Jo/0000-0003-4196-7763; Faruqui, Syed Hasib Akhter/0000-0002-5073-8690	National Institutes of Health (NIH/NIGMA) [1SC2GM118266-01]; VA Health Services Research and Development Service [I01 HX000329-05]; VA Clinical Services Research and Development Service [I01 CX001246]; National Institutes of Health (NIH/NIDA) [5UG1DA020024-13]	National Institutes of Health (NIH/NIGMA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Health Services Research and Development Service(US Department of Veterans Affairs); VA Clinical Services Research and Development Service; National Institutes of Health (NIH/NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This work was supported by National Institutes of Health (NIH/NIGMA), Grant number: 1SC2GM118266-01, Grant Title: A Novel Probabilistic Methodology for Prediction of Emerging Diseases in Patients with Multiple Chronic Conditions, PI: Alaeddini; VA Health Services Research and Development Service, Grant Number: I01 HX000329-05, Grant Title: Identifying and Validating Complex Comorbidity Clusters in OEF-OIF Veterans, PI: Pugh; VA Clinical Services Research and Development Service, Grant Number: I01 CX001246, Grant Title: Chronic Effects of Neurotrauma Epidemiology Study, Investigator: Pugh; and National Institutes of Health (NIH/NIDA), Grant Number: 5UG1DA020024-13, Grant Title: Clinical trials network Texas node, Investigator: Potter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RS, 2016, J HEAD TRAUMA REHAB, V31, P13, DOI 10.1097/HTR.0000000000000082; Alaeddini A, 2017, METHOD INFORM MED, V56, P391, DOI 10.3414/ME16-01-0135; [Anonymous], 1995, TUTORIAL LEARNING BA; Bach FR, 2002, ADV NEUR IN, V14, P569; Cai ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120805; Cappellari L, 2003, STATA J, V3, P278, DOI 10.1177/1536867X0300300305; CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; COOPER GF, 1986, COMPUT METH PROG BIO, V22, P223, DOI 10.1016/0169-2607(86)90024-6; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Darwiche A, 2009, MODELING AND REASONING WITH BAYESIAN NETWORKS, P1, DOI 10.1017/CBO9780511811357; Finley EP, 2015, AM J PUBLIC HEALTH, V105, P380, DOI 10.2105/AJPH.2014.301957; Forsberg JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019956; Kwak C, 2002, NURS RES, V51, P406, DOI 10.1097/00006199-200211000-00009; Lappenschaar M, 2013, J CLIN EPIDEMIOL, V66, P1405, DOI 10.1016/j.jclinepi.2013.06.018; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Liao WH, 2009, PATTERN RECOGN, V42, P3046, DOI 10.1016/j.patcog.2009.04.006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Murphy K., 2001, BAYES NET TOOLBOX MA; Pearl J, 2014, PROBABILISTIC REASON; Pepe M. S., 2003, STAT EVALUATION MED; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJ, 2017, ARCH PHYS MED REHABI; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Stojadinovic A, 2013, ANN SURG ONCOL, V20, P161, DOI 10.1245/s10434-012-2555-4; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Zador Z, OPER NEUROSURG, DOI [10.1093/ONS/OPX163/4056268, DOI 10.1093/ONS/OPX163/4056268]; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762; Zhou Y, 2016, DECIS SUPPORT SYST, V87, P69, DOI 10.1016/j.dss.2016.05.001	34	10	10	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199768	10.1371/journal.pone.0199768	http://dx.doi.org/10.1371/journal.pone.0199768			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001371	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400017
J	Janulaitiene, M; Gegzna, V; Baranauskiene, L; Bulavaite, A; Simanavicius, M; Pleckaityte, M				Janulaitiene, Migle; Gegzna, Vilmantas; Baranauskiene, Lina; Bulavaite, Aiste; Simanavicius, Martynas; Pleckaityte, Milda			Phenotypic characterization of Gardnerella vaginalis subgroups suggests differences in their virulence potential	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; BIOFILM FORMATION; CYTOLYTIC ACTIVITY; VAGINOLYSIN; QUANTIFICATION; DEGRADATION; ALGORITHMS; SIALIDASES; DIVERSITY; MODELS	The well-known genotypic and phenotypic diversity of G. vaginalis resulted in its classification into at least four subgroups (clades) with diverse genomic properties. To evaluate the virulence potential of G. vaginalis subgroups, we analyzed the virulence-related phenotypic characteristics of 14 isolates of Glade 1, 12 isolates of Glade 2, 8 isolates of Glade 4 assessing their in vitro ability to grow as a biofilm, produce the toxin vaginolysin, and express sialidase activity. Significant differences in VLY production were found (p = 0.023), but further analysis of Glade pairs did not confirm this finding. The amount of biofim did not differ significantly among the clades. Analysis of sialidase activity indicated statistically significant differences among the clades (p < 0.001). Production of active recombinant G. vaginalis sialidase demonstrated the link between the sld gene and enzymatic activity, which may be differentially regulated at the transcriptional level. Statistical classification analysis (random forests algorithm) showed that G. vaginalis clades could be best defined by the profiles of two phenotypic characteristics: sialidase activity and vaginolysin production. The results of principal component analysis and hierarchical clustering suggested that all isolates can be subgrouped into three clusters, the structures of which are determined based on phenotypic characteristics of the isolates. Clade 4 was the most homogenous group, as all isolates were found in the same cluster, which is characterized by low production of all studied virulence factors. Clade 2 isolates were mainly distributed between two clusters, whereas Glade 1 isolates were found in all three clusters that were characterized by a distinct profile of phenotypic characteristics. Our findings suggest that G. vaginalis subgroups with different virulence potential might play distinct roles in vaginal microbiota.	[Janulaitiene, Migle; Baranauskiene, Lina; Bulavaite, Aiste; Simanavicius, Martynas; Pleckaityte, Milda] Vilnius Univ, Inst Biotechnol, Vilnius, Lithuania; [Janulaitiene, Migle] Natl Publ Hlth Surveillance Lab, Vilnius, Lithuania; [Gegzna, Vilmantas] Vilnius Univ, Inst Photon & Nanotechnol, Vilnius, Lithuania; [Gegzna, Vilmantas] Vilnius Univ, Inst Biosci, Vilnius, Lithuania	Vilnius University; Vilnius University; Vilnius University	Pleckaityte, M (corresponding author), Vilnius Univ, Inst Biotechnol, Vilnius, Lithuania.	milda.pleckaityte@bti.vu.lt	Simanavicius, Martynas/U-3337-2019; Gegzna, Vilmantas/L-3062-2019; Baranauskiene, Lina/P-5088-2016	Simanavicius, Martynas/0000-0003-2996-229X; Baranauskiene, Lina/0000-0002-9924-9177; Bulavaite, Aiste/0000-0002-4219-3985; Pleckaityte, Milda/0000-0002-3291-9033; Gegzna, Vilmantas/0000-0002-9500-5167	Research Council of Lithuania [S-MIP-17-49]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This work was supported by a research grant number S-MIP-17-49 from the Research Council of Lithuania (http://lmt.lt/en/). MP received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Balashov SV, 2014, J MED MICROBIOL, V63, P162, DOI 10.1099/jmm.0.066407-0; BRISELDEN AM, 1992, J CLIN MICROBIOL, V30, P663, DOI 10.1128/JCM.30.3.663-666.1992; BROWN MB, 1974, J AM STAT ASSOC, V69, P364, DOI 10.2307/2285659; Castro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11640; Cauci S, 1998, AM J OBSTET GYNECOL, V178, P511, DOI 10.1016/S0002-9378(98)70430-2; Conover W. J., 1979, MULTIPLE COMP PROCED; DiCiccio TJ, 1996, STAT SCI, V11, P189; Field A., 2012, DISCOVERING STAT USI; FRIGGE M, 1989, AM STAT, V43, P50, DOI 10.2307/2685173; Games P. A., 1976, J EDUCATIONAL STATIS, V1, P113, DOI [10.3102/10769986001002113, DOI 10.2307/1164979]; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Gilbert NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059539; Gramma J, 2007, COMPUT STAT DATA AN, V52, P725, DOI 10.1016/j.csda.2006.09.035; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hilbert DW, 2017, EUR J CLIN MICROBIOL, V36, P1269, DOI 10.1007/s10096-017-2933-8; Ingianni A, 1997, FEMS IMMUNOL MED MIC, V18, P61, DOI 10.1111/j.1574-695X.1997.tb01028.x; Janulaitiene M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2501-y; Jayaprakash TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043009; Kiyohara M, 2011, GLYCOBIOLOGY, V21, P437, DOI 10.1093/glycob/cwq175; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Lewis WG, 2012, J BIOL CHEM, V287, P2079, DOI 10.1074/jbc.M111.278135; Lopes dos Santos Santiago G, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.061; Machado D, 2015, J MICROBIOL METH, V118, P143, DOI 10.1016/j.mimet.2015.09.007; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Moncla BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127091; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; PIOT P, 1984, J CLIN MICROBIOL, V20, P677, DOI 10.1128/JCM.20.4.677-679.1984; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Pomeranskii AA, 1998, J EXP THEOR PHYS+, V86, P839, DOI 10.1134/1.558554; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Schellenberg JJ, 2017, RES MICROBIOL, V168, P837, DOI 10.1016/j.resmic.2017.02.011; Schellenberg JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146510; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2014, HISTOL HISTOPATHOL, V29, P567, DOI 10.14670/HH-29.10.567; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Tankovic J, 2017, ANAEROBE, V47, P132, DOI 10.1016/j.anaerobe.2017.05.010; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Zilnyte M, 2015, TOXINS, V7, P110, DOI 10.3390/toxins7010110; Zozaya-Hinchliffe M, 2010, J CLIN MICROBIOL, V48, P1812, DOI 10.1128/JCM.00851-09; Zvirbliene A, 2010, TOXICON, V56, P19, DOI 10.1016/j.toxicon.2010.03.007	48	34	34	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200625	10.1371/journal.pone.0200625	http://dx.doi.org/10.1371/journal.pone.0200625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001418	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400089
J	Draghi, WO; Degrossi, J; Bialer, M; Brelles-Marino, G; Abdian, P; Soler-Bistue, A; Wall, L; Zorreguieta, A				Omar Draghi, Walter; Degrossi, Jose; Bialer, Magali; Brelles-Marino, Graciela; Abdian, Patricia; Soler-Bistue, Alfonso; Wall, Luis; Zorreguieta, Angeles			Biodiversity of cultivable Burkholderia species in Argentinean soils under no-till agricultural practices	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; CULTURABLE PSEUDOMONADS; LAND MANAGEMENT; CROP PRODUCTION; DIVERSITY; BIOGEOGRAPHY; SENSITIVITY; INDICATORS; SELECTION; FEATURES	No-tillage crop production has revolutionized the agriculture worldwide. In our country more than 30 Mha are currently cultivated under no-till schemes, stressing the importance of this management system for crop production. It is widely recognized that soil microbiota is altered under different soil managements. In this regard the structure of Burkholderia populations is affected by soils management practices such as tillage, fertilization, or crop rotation. The stability of these structures, however, has not been evaluated under sustainable schemes where the impact of land practices could be less deleterious to physicochemical soils characteristics. In order to assess the structure of Burkholderia spp. populations in no-till schemes, culturable Burkholderia spp. strains were quantified and their biodiversity evaluated. Results showed that Burkholderia spp. biodiversity, but not their abundance, clearly displayed a dependence on agricultural managements. We also showed that biodiversity was mainly influenced by two soil factors: Total Organic Carbon and Total Nitrogen. Results showed that no-till schemes are not per se sufficient to maintain a richer Burkholderia spp. soil microbiota, and additional traits should be considered when sustainability of productive soils is a goal to fulfil productive agricultural schemes.	[Omar Draghi, Walter; Bialer, Magali; Abdian, Patricia; Soler-Bistue, Alfonso; Zorreguieta, Angeles] Fdn Inst Leloir, IIBBA CONICET, Buenos Aires, DF, Argentina; [Omar Draghi, Walter] Univ Nacl La Plata, CONICET, CCT La Plata, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina; [Degrossi, Jose] Univ Buenos Aires, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Brelles-Marino, Graciela] Univ Nacl La Plata, Fac Ciencias Exactas, Ctr Res & Dev Ind Fermentat, CINDEFI,CCT PLATA,CONICET, La Plata, Buenos Aires, Argentina; [Wall, Luis] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Draghi, WO; Zorreguieta, A (corresponding author), Fdn Inst Leloir, IIBBA CONICET, Buenos Aires, DF, Argentina.; Draghi, WO (corresponding author), Univ Nacl La Plata, CONICET, CCT La Plata, Inst Biotecnol & Biol Mol, La Plata, Buenos Aires, Argentina.	wdraghi@biol.unlp.edu.ar; azorreguieta@leloir.org.ar	Abdian, Patricia/AAW-2420-2020; Draghi, Walter/HGA-4141-2022; Soler-Bistué, Alfonso/AAV-3123-2021	Abdian, Patricia/0000-0002-8366-8115; Draghi, Walter/0000-0002-6317-2761; Soler-Bistué, Alfonso/0000-0002-3917-0002	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PAE 36976-PID 52, PICT 2010/2691]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	Funded by Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (grants PAE 36976-PID 52 to LW and AZ and PICT 2010/2691 to WOD).; This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (grants PAE 36976-PID 52 and PICT 2010/2691). We thank Prof. Dr. Claudio Valverde, from the Universidad Nacional de Quilmes, Argentina, for critically reading the manuscript and his asserted suggestions. We also thank Prof. Dr. Peter Vandamme, from the Ghent University, Belgium, for provide some of the strain sequences for the MLST analysis.	Agaras B, 2012, APPL SOIL ECOL, V61, P305, DOI 10.1016/j.apsoil.2011.11.016; ANDREWS JH, 1986, ADV MICROB ECOL, V9, P99; Balandreau J., 2007, BURHOLDERIA MOL MICR, P129; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; BURBAGE DA, 1982, PHYTOPATHOLOGY, V72, P706; Agaras BC, 2014, PLANT SOIL, V382, P117, DOI 10.1007/s11104-014-2095-8; Ceja-Navarro JA, 2010, APPL ENVIRON MICROB, V76, P3685, DOI 10.1128/AEM.02726-09; Ciccillo F, 2002, ENVIRON MICROBIOL, V4, P238, DOI 10.1046/j.1462-2920.2002.00291.x; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Collavino MM, 2014, ENVIRON MICROBIOL, V16, P3211, DOI 10.1111/1462-2920.12423; Colwell RK, 2013, USERS GUIDE APPL; Compant S, 2008, FEMS MICROBIOL REV, V32, P607, DOI 10.1111/j.1574-6976.2008.00113.x; Cycon M, 2009, ECOTOXICOLOGY, V18, P632, DOI 10.1007/s10646-009-0321-6; de Lajudie Philippe M, 2017, Int J Syst Evol Microbiol, V67, P2485, DOI 10.1099/ijsem.0.002144; de los Santos-Villalobos S, 2012, WORLD J MICROB BIOT, V28, P2615, DOI 10.1007/s11274-012-1071-9; Delgado-Baquerizo M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10541; Depoorter E, 2016, APPL MICROBIOL BIOT, V100, P5215, DOI 10.1007/s00253-016-7520-x; Di Rienzo JA, 2011, INFOSTAT, DOI [10.1128/JCM.00770-09, DOI 10.1128/JCM.00770-09]; Dobritsa AP, 2016, INT J SYST EVOL MICR, V66, P2836, DOI 10.1099/ijsem.0.001065; Duval ME, 2016, SOIL TILL RES, V159, P9, DOI 10.1016/j.still.2016.01.004; Duval ME, 2013, SOIL TILL RES, V131, P11, DOI 10.1016/j.still.2013.03.001; Eberl L, 2016, F1000RES, V5; Estrada-de los Santos P, 2016, ANN MICROBIOL, V66, P1303, DOI 10.1007/s13213-015-1183-1; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Figuerola E.L., 2015, ENVIRON MICROBIOL, V17, P678, DOI [10.1111/1462-2920.12497, DOI 10.1111/1462-2920.12497]; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Guo LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33155; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEILMANN B, 1995, BIOL FERT SOILS, V19, P186, DOI 10.1007/BF00336157; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Krause S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00251; Legendre P., 2012, NUMERICAL ECOLOGY; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Menard A, 2007, ENVIRON MICROBIOL, V9, P1176, DOI 10.1111/j.1462-2920.2007.01240.x; Montecchia MS, 2011, APPL SOIL ECOL, V47, P176, DOI 10.1016/j.apsoil.2010.12.008; Nardali ET, 2009, NO FARMING EFFECTS S; Omay AB, 1997, SOIL SCI SOC AM J, V61, P1672, DOI 10.2136/sssaj1997.03615995006100060019x; Pallud C, 2001, J MICROBIOL METH, V47, P25, DOI 10.1016/S0167-7012(01)00287-1; Payne GW, 2005, APPL ENVIRON MICROB, V71, P3917, DOI 10.1128/AEM.71.7.3917-3927.2005; Peeters C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00877; Rascovan N, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-21; Salles JF, 2006, MICROB ECOL, V52, P267, DOI 10.1007/s00248-006-9048-6; Salles JF, 2006, SOIL BIOL BIOCHEM, V38, P661, DOI 10.1016/j.soilbio.2005.06.018; Salles JF, 2004, APPL ENVIRON MICROB, V70, P4012, DOI 10.1128/AEM.70.7.4012-4020.2004; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Sawana A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00429; Schmidt S, 2009, ENVIRON MICROBIOL, V11, P1422, DOI 10.1111/j.1462-2920.2009.01870.x; Schonfeld J, 2003, FEMS MICROBIOL ECOL, V43, P63, DOI 10.1111/j.1574-6941.2003.tb01046.x; Singh R, 2013, METALL MATER TRANS B, P1; Spilker T, 2009, J CLIN MICROBIOL, V47, P2607, DOI 10.1128/JCM.00770-09; Stopnisek N, 2014, ENVIRON MICROBIOL, V16, P1503, DOI 10.1111/1462-2920.12211; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tardy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130672; Thompson CE, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-65; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Triplett GB, 2008, AGRON J, V100, pS153, DOI 10.2134/agronj2007.0005c; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Vial, 2007, J MICROBIOL BIOTECHN, V17, P1407; Wall LG, 2011, HDB MOL MICROBIAL EC, P299, DOI [10.1002/9781118010518.ch34, DOI 10.1002/9781118010518.CH34]; Wu T, 2008, MICROB ECOL, V55, P293, DOI 10.1007/s00248-007-9276-4	64	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200651	10.1371/journal.pone.0200651	http://dx.doi.org/10.1371/journal.pone.0200651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001428	Green Submitted, gold, Green Published			2022-12-26	WOS:000438457400091
J	Rafaeli-Yehudai, T; Imterat, M; Douvdevani, A; Tirosh, D; Benshalom-Tirosh, N; Mastrolia, SA; Beer-Weisel, R; Klaitman, V; Riff, R; Greenbaum, S; Alioshin, A; Hanegbi, GR; Loverro, G; Catalano, MR; Erez, O				Rafaeli-Yehudai, Tal; Imterat, Majdi; Douvdevani, Amos; Tirosh, Dan; Benshalom-Tirosh, Neta; Mastrolia, Salvatore Andrea; Beer-Weisel, Ruthy; Klaitman, Vered; Riff, Reut; Greenbaum, Shirley; Alioshin, Alex; Hanegbi, Gal Rodaysky; Loverro, Giuseppe; Catalano, Mariana Rita; Erez, Offer			Maternal total cell-free DNA in preeclampsia and fetal growth restriction: Evidence of differences in maternal response to abnormal implantation	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; ANTI-ANGIOGENIC FACTORS; SIMPLE FLUORESCENT TEST; FREE NUCLEIC-ACIDS; FREE PLASMA DNA; NORMAL-PREGNANCY; DEOXYRIBONUCLEIC-ACID; INFLAMMATORY RESPONSE; DEVELOP PREECLAMPSIA; ONSET PREECLAMPSIA	Objectives Preeclampsia and fetal growth restriction are obstetrical syndromes associated with abnormal placental implantation and changes in the activation status of maternal leukocytes. This study is aimed to determine by a simple, rapid fluorescent assay the changes in maternal serum total cell-free DNA (t-cfDNA) concentrations in women with preeclampsia and those with fetal growth restriction (FGR). Study design A cross-sectional study was conducted measuring maternal serum t-cfDNA concentrations. Women were classified into the following groups: 1) patients with preeclampsia (n = 21); 2) FGR-estimated fetal weight below the 10th percentile (n = 28); and 3) normal pregnancy (n = 39). Serum samples were directly assayed for t-cfDNA using a rapid fluorescent SYBR Gold assay. Elevated maternal serum t-cfDNA concentrations were defined as a cutoff>850ng/ml. Nonparametric statistics were used for analysis. Results Women with preeclampsia had a higher median maternal serum concentration (802 ng/ml, 400-2272 ng/ml) than women with a normal pregnancy (499 ng/ml, 0-1892 ng/ml, p = 0.004) and those with FGR (484 ng/ml, 72-2187 ng/ml, p = 0.012). Moreover, even patients with FGR <5 th percentile and abnormal Doppler had a lower median maternal serum t-cfDNA than those with preeclampsia (median 487 ng/ml, 144-1971 ng/ml, p = 0.022). The median concentration of t-cfDNA did not differ between women with a normal pregnancy and those with FGR (p = 0.54), as well as those with fetuses <5th percentile and abnormal Doppler (p = 0.7). Women with preeclampsia had a higher proportion of elevated t-cfDNA than those with a normal pregnancy (p = 0.015) and patients with FGR (p = 0.025). Conclusions Preeclampsia is associated with higher maternal serum t-cfDNA concentration than normal pregnancy or FGR. This observation may reflect an increased systemic activation of the maternal inflammation, rather than placental; this assumption is supported by the fact that we did not observe a significant change in the maternal serum t-cfDNA in patients with placental-mediated FGR.	[Rafaeli-Yehudai, Tal; Imterat, Majdi; Tirosh, Dan; Benshalom-Tirosh, Neta; Beer-Weisel, Ruthy; Klaitman, Vered; Greenbaum, Shirley; Alioshin, Alex; Hanegbi, Gal Rodaysky] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sch Med, Dept Obstet & Gynecol, Beer Sheva, Israel; [Douvdevani, Amos; Riff, Reut] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sch Med, Dept Clin Biochem & Pharmacol, Beer Sheva, Israel; [Mastrolia, Salvatore Andrea; Loverro, Giuseppe; Catalano, Mariana Rita] Univ Bari Aldo Moro, Azienda Osped Univ Policlin Bari, Sch Med, Dept Obstet & Gynecol, Bari, Italy; [Mastrolia, Salvatore Andrea] Univ Milano Bicocca, San Gerardo Hosp, Sch Med, Fdn MBBM,Dept Maternal Fetal Med, Monza, Italy; [Erez, Offer] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sch Med, Matern Dept D,Obstet Day Care Unit, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Universita degli Studi di Bari Aldo Moro; San Gerardo Hospital; University of Milano-Bicocca; Ben Gurion University; Soroka Medical Center	Erez, O (corresponding author), Ben Gurion Univ Negev, Soroka Univ Med Ctr, Sch Med, Matern Dept D,Obstet Day Care Unit, Beer Sheva, Israel.	erezof@bgu.ac.il	Imterat, Majdi/M-7711-2019; Benshalom-Tirosh, Neta/AAE-9455-2021; Tirosh, Dan/Q-4677-2016; Douvdevani, Amos/E-3803-2010	Imterat, Majdi/0000-0001-7174-8591; Benshalom-Tirosh, Neta/0000-0003-1627-0200; Tirosh, Dan/0000-0002-7570-2272; Douvdevani, Amos/0000-0002-0197-6481				Agassi R, 2015, AM J CLIN PATHOL, V143, P18, DOI 10.1309/AJCPI5YHG0OGFAHM; Ahmed A, 2000, BEST PRACT RES CL OB, V14, P981, DOI 10.1053/beog.2000.0139; Al Nakib M, 2009, FETAL DIAGN THER, V26, P24, DOI 10.1159/000236355; Alberry M, 2007, PRENATAL DIAG, V27, P415, DOI 10.1002/pd.1700; Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Ashoor G, 2013, ULTRASOUND OBST GYN, V41, P26, DOI 10.1002/uog.12331; Atamaniuk J, 2011, EUR J CLIN INVEST, V41, P579, DOI 10.1111/j.1365-2362.2010.02435.x; Avriel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100514; Baltajian K, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.168; Bauer M, 2006, PRENATAL DIAG, V26, P831, DOI 10.1002/pd.1513; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1661, DOI 10.1001/jama.2017.3439; Bischoff FZ, 2005, HUM REPROD UPDATE, V11, P59, DOI 10.1093/humupd/dmh053; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bujold E, 2005, J MATERN-FETAL NEO M, V18, P9, DOI 10.1080/14767050500202493; Chowdhury CS, 2016, FETAL DIAGN THER, V40, P263, DOI 10.1159/000444853; Crowley A, 2007, PRENATAL DIAG, V27, P174, DOI 10.1002/pd.1645; Czeiger D, 2011, AM J CLIN PATHOL, V135, P264, DOI 10.1309/AJCP4RK2IHVKTTZV; Dugoff L, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.009; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Egbor M, 2006, PLACENTA, V27, P727, DOI 10.1016/j.placenta.2005.06.002; El Tarhouny SA, 2010, NUCLEOS NUCLEOT NUCL, V29, P228, DOI 10.1080/15257771003708298; Erez O, 2008, J MATERN-FETAL NEO M, V21, P279, DOI 10.1080/14767050802034545; Farina A, 2004, PRENATAL DIAG, V24, P83, DOI 10.1002/pd.788; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Fisher Susan J, 2004, Reprod Biol Endocrinol, V2, P53, DOI 10.1186/1477-7827-2-53; Gervasi MT, 2001, AM J OBSTET GYNECOL, V185, P1124, DOI 10.1067/mob.2001.117681; Goldshtein H, 2009, ANN CLIN BIOCHEM, V46, P488, DOI 10.1258/acb.2009.009002; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Gotsch F, 2008, J MATERN-FETAL NEO M, V21, P389, DOI 10.1080/14767050802046069; Granger JP, 2002, MICROCIRCULATION, V9, P147, DOI 10.1038/sj.mn.7800137; Gupta A, 2006, ANN NY ACAD SCI, V1075, P118, DOI 10.1196/annals.1368.015; Hahn S, 2011, PLACENTA, V32, pS17, DOI 10.1016/j.placenta.2010.06.018; Hahn S, 2014, J REPROD IMMUNOL, V104, P26, DOI 10.1016/j.jri.2014.03.007; Huppertz B, 2004, J SOC GYNECOL INVEST, V11, P353, DOI 10.1016/j.jsgi.2004.06.002; Ishihara N, 2002, AM J OBSTET GYNECOL, V186, P158, DOI 10.1067/mob.2002.119176; Kamat AA, 2010, CANCER-AM CANCER SOC, V116, P1918, DOI 10.1002/cncr.24997; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Korzeniewski SJ, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.015; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lazar L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-120; Leung TN, 2001, CLIN CHEM, V47, P137; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, AM J OBSTET GYNECOL, V190, P707, DOI 10.1016/j.ajog.2003.12.019; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1999, CLIN CHEM, V45, P184; Lyall F, 2001, AM J PATHOL, V159, P1827, DOI 10.1016/S0002-9440(10)63029-5; Nardozza LMM, 2017, ARCH GYNECOL OBSTET, V295, P1061, DOI 10.1007/s00404-017-4341-9; Malamitsi-Puchner A, 2005, J SOC GYNECOL INVEST, V12, P195, DOI 10.1016/j.jsgi.2005.01.006; Myatt L, 2002, ENDOCRINE, V19, P103, DOI 10.1385/ENDO:19:1:103; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; Netz U, 2017, SURGERY, V162, P1063, DOI 10.1016/j.surg.2017.06.015; Ogge G, 2010, J MATERN-FETAL NEO M, V23, P476, DOI 10.3109/14767050903216033; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Romero R., 1996, PRENAT NEONAT MED, V1, P8; Sacks GP, 1998, AM J OBSTET GYNECOL, V179, P80, DOI 10.1016/S0002-9378(98)70254-6; Saukkonen K, 2008, CLIN CHEM, V54, P1000, DOI 10.1373/clinchem.2007.101030; Schwarzenbach H, 2008, ANN NY ACAD SCI, V1137, P190, DOI 10.1196/annals.1448.025; Sekizawa A, 2003, HUM GENET, V113, P307, DOI 10.1007/s00439-003-0987-4; Sekizawa A, 2003, AM J OBSTET GYNECOL, V188, P480, DOI 10.1067/mob.2003.27; Shimony Avi, 2010, Acute Card Care, V12, P109, DOI 10.3109/17482941.2010.513732; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sifakis S, 2015, MOL MED REP, V11, P2367, DOI 10.3892/mmr.2014.3118; Smid M, 2006, PRENATAL DIAG, V26, P785, DOI 10.1002/pd.1504; Stein W, 2013, EUR J OBSTET GYN R B, V166, P10, DOI 10.1016/j.ejogrb.2012.09.006; Stepan H, 2007, J CLIN ENDOCR METAB, V92, P2831, DOI 10.1210/jc.2006-2774; Taglauer ES, 2014, PLACENTA, V35, pS64, DOI 10.1016/j.placenta.2013.11.014; Thurik FF, 2016, PRENATAL DIAG, V36, P1104, DOI 10.1002/pd.4940; Tovbin D, 2012, NEPHROL DIAL TRANSPL, V27, P3929, DOI 10.1093/ndt/gfs255; von Dadelszen P, 1999, AM J OBSTET GYNECOL, V181, P408, DOI 10.1016/S0002-9378(99)70570-3; Wathen KA, 2006, J CLIN ENDOCR METAB, V91, P180, DOI 10.1210/jc.2005-1076; Zancan M, 2009, INT J BIOL MARKER, V24, P147, DOI 10.1177/172460080902400304; Zeybek YG, 2013, J OBSTET GYNAECOL RE, V39, P632, DOI 10.1111/j.1447-0756.2012.02011.x; Zhang RF, 2010, LUNG CANCER, V69, P225, DOI 10.1016/j.lungcan.2009.11.009; Zhong XY, 2007, CLIN CHEM, V53, P1609, DOI 10.1373/clinchem.2006.084509; Zhong XY, 2002, HYPERTENS PREGNANCY, V21, P77, DOI 10.1081/PRG-120002911; Zhong XY, 2001, AM J OBSTET GYNECOL, V184, P414, DOI 10.1067/mob.2001.109594	79	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200360	10.1371/journal.pone.0200360	http://dx.doi.org/10.1371/journal.pone.0200360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001403	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400049
J	Schaefer, B; Viveiros, A; Al-Zoairy, R; Blach, S; Brandon, S; Razavi, H; Dorn, L; Finkenstedt, A; Effenberger, M; Graziadei, I; Sarcletti, M; Tilg, H; Zoller, H				Schaefer, Benedikt; Viveiros, Andre; Al-Zoairy, Ramona; Blach, Sarah; Brandon, Samantha; Razavi, Homie; Dorn, Livia; Finkenstedt, Armin; Effenberger, Maria; Graziadei, Ivo; Sarcletti, Mario; Tilg, Herbert; Zoller, Heinz			Disease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030	PLOS ONE			English	Article							VIRUS HCV INFECTION; INJECT DRUGS; COLONOSCOPY; PEOPLE; COHORT	Background In 2016, the World Health Organization (WHO) and 69th World Health Assembly approved the first global health sector strategy (GHSS) on viral hepatitis with the goal to eliminate hepatitis C virus (HCV) infections worldwide. The aim is a 90% reduction of new infections and 65% reduction of HCV-related deaths by 2030. Aim This study reports on the epidemiology of HCV infections in the Austrian state of Tyrol (total population 750,000) and uses a predictive model to identify how the WHO strategy for elimination of HCV can be achieved. Methods We developed a regional disease burden model based on observed local diagnosis data from 2001 to 2016. Scenarios were developed to evaluate the impact of diagnosis and treatment on HCV-related outcomes (viremic prevalence, decompensated cirrhosis, hepatocellular carcinoma, and liver-related deaths) from 2015 through 2030. Results In the last 15 years, 1,721 patients living in Tyrol have been diagnosed with chronic HCV infection. When ageing, mortality and treatment were factored in, there were an estimated 2,043 viremic HCV infections in 2016, of which 1,136 cases had been diagnosed. A baseline model predicts a decrease of 588 HCV cases from 2015 to 2030, which would not translate into the significant reduction of infections needed to achieve WHO global health recommendations. A total of 1,843 infected individuals need to be identified and treated to achieve the WHO goals by 2030 (1,254 averted cases as compared to baseline model). Implementation of this strategy would avoid 523 new HCV infections and decreases HCV-related mortality by 73%. Conclusion HCV elimination and >65% reduction of associated mortality are possible for Tyrol, but requires a significant increase in new diagnoses and treatment rate. The model presented in this study could serve as an example for other regions to reliably predict regional disease burden and estimate how WHO goals can be met in the future.	[Schaefer, Benedikt; Viveiros, Andre; Al-Zoairy, Ramona; Finkenstedt, Armin; Effenberger, Maria; Tilg, Herbert; Zoller, Heinz] Med Univ Innsbruck, Dept Med Gastroenterol Hepatol & Endocrinol 1, Innsbruck, Austria; [Blach, Sarah; Brandon, Samantha; Razavi, Homie] CDA, Lafayette, CO USA; [Dorn, Livia] Sozialmed Zentrum Ost Donauspital, Dept Med 2, Vienna, Austria; [Graziadei, Ivo] Landeskrankenhaus Hall, Dept Med, Hall In Tirol, Austria; [Sarcletti, Mario] Med Univ Innsbruck, Dept Dermatol & Venereol, Austrian HIV Cohort Study, Innsbruck, Austria	Medical University of Innsbruck; Donauspital; Medical University of Innsbruck	Zoller, H (corresponding author), Med Univ Innsbruck, Dept Med Gastroenterol Hepatol & Endocrinol 1, Innsbruck, Austria.	heinz.zoller@i-med.ac.at	Zoller, Heinz/AAD-7225-2019; Schaefer, Benedikt/V-6096-2019; Blach, Sarah/J-5833-2019	Blach, Sarah/0000-0002-9252-7576; Razavi, Homie/0000-0002-2658-6930	Gilead Sciences; Verein zur Foerderung der Wissenschaft in Gastroenterologie Hepatologie; Abbvie; Gilead; MSD; Roche	Gilead Sciences(Gilead Sciences); Verein zur Foerderung der Wissenschaft in Gastroenterologie Hepatologie; Abbvie(AbbVie); Gilead(Gilead Sciences); MSD; Roche(Roche Holding)	This study was supported by Gilead Sciences with an unrestricted grant. BS received a grant from the Verein zur Foerderung der Wissenschaft in Gastroenterologie & Hepatologie and speaker fees from Abbvie. HZ received grants and speaker fees from Abbvie, Gilead, MSD and Roche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLD- IDSA, 2017, REC TEST MAN TREAT H; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bourgeois S, 2016, ACTA GASTRO-ENT BELG, V79, P222; Desenclos J-C, 2003, Euro Surveill, V8, P99; Dobler R, 2017, DEMOGRAPHISCHE DATEN; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; Gane E, 2015, J VIRAL HEPATITIS, V22, P46, DOI 10.1111/jvh.12352; Grebely J, 2017, NAT REV GASTRO HEPAT, V14, P641, DOI 10.1038/nrgastro.2017.106; Helsper CW, 2017, INT J DRUG POLICY, V47, P117, DOI 10.1016/j.drugpo.2017.07.022; Hope VD, 2014, EPIDEMIOL INFECT, V142, P270, DOI 10.1017/S0950268813000940; Maieron A, 2010, EUROSURVEILLANCE, V15, P17; Mandorfer M, 2016, HEPATOL INT, V10, P424, DOI 10.1007/s12072-015-9691-4; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Razavi H, 2017, LANCET GASTROENTEROL, V2, P325, DOI 10.1016/S2468-1253(17)30045-6; Scott N, 2017, INT J DRUG POLICY, V47, P107, DOI 10.1016/j.drugpo.2017.07.006; Sears DM, 2013, AM J GASTROENTEROL, V108, P981, DOI 10.1038/ajg.2013.50; Services USDoHH, 2015, KNOW MOR HEP ATL; Soipe AI, 2016, EPIDEMIOL INFECT, V144, P3376, DOI 10.1017/S0950268816001722; Statistik Austria, 2016, BEV TIR; Strauss R, 2003, Euro Surveill, V8, P113; Torres DM, 2013, AM J GASTROENTEROL, V108, P990, DOI 10.1038/ajg.2013.54; World Health Organization, 2016, GLOB HLTH SECT STRAT	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200750	10.1371/journal.pone.0200750	http://dx.doi.org/10.1371/journal.pone.0200750			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001427	gold, Green Submitted, Green Published			2022-12-26	WOS:000438457400096
J	Sorensen, AIV; Rosendal, T; Widgren, S; Halasa, T				Sorensen, Anna Irene Vedel; Rosendal, Thomas; Widgren, Stefan; Halasa, Tariq			Mechanistic modelling of interventions against spread of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) within a Danish farrow-to-finish pig herd	PLOS ONE			English	Article							COLONIZATION; TRANSMISSION; PIGLETS	Knowledge on successful interventions against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) within pig herds is sparse. In situations like this, a mechanistic simulation model can be a valuable tool for assessing the effect of potential intervention strategies, and prioritising which should be tested in the field. We have simulated on-farm interventions in a farrow-to-finish pig herd, with a previously published LA-MRSA spread model, within four different areas: 1) Reduced antimicrobial consumption, 2) Reduced number of pigs within each section, 3) Reduced mixing of pigs, and 4) Improved internal biosecurity. To model a decrease in the selective pressure, the transmission rates were reduced after LA-MRSA had become fully established within a herd, which resulted in a marked decrease in the prevalence within all stable units. However, LA-MRSA rarely disappeared completely from the herd; this was only observed in scenarios where the transmission rates were reduced to <= 30% of the original level. While changes in antimicrobial consumption patterns might be a very important step towards reducing the spread of LAMRSA, the simulation results indicate that it may need to be paired with other preventive or intervention measures. Reducing the number of pigs within each section, reducing mixing of pigs, or improving internal biosecurity after LA-MRSA had become established within the herd only resulted in marginal changes in the median prevalence within the herd. However, these factors might be important in relation to being able to achieve or maintain a low level of antimicrobial consumption, and thus still indirectly influence the LA-MRSA prevalence within the herd. The results of a sensitivity analysis indicated the assumptions regarding the existence of pigs persistently shedding MRSA have a noticeable influence on the model results. The assumptions regarding transmission from sow to offspring at the day of birth also had a considerable influence on the MRSA prevalence within the farrowing unit but did not cause any marked changes in the simulated effect of interventions. Effects might differ between different farm types contaminated in different levels and this simulation study high-lights a strong need for more knowledge from on-farm trials.	[Sorensen, Anna Irene Vedel; Halasa, Tariq] Tech Univ Denmark, Natl Vet Inst, Div Diagnost & Sci Advice, Lyngby, Denmark; [Rosendal, Thomas; Widgren, Stefan] Natl Vet Inst, Dept Dis Control & Epidemiol, Uppsala, Sweden	Technical University of Denmark; National Veterinary Institute SVA	Sorensen, AIV (corresponding author), Tech Univ Denmark, Natl Vet Inst, Div Diagnost & Sci Advice, Lyngby, Denmark.	anvso@vet.dtu.dk		Sorensen, Anna Irene Vedel/0000-0002-3877-4592; Halasa, Tariq/0000-0003-1112-0254; Widgren, Stefan/0000-0001-5745-2284	Danish Ministry of Environment and Food through The Danish Agrifish Agency [33010-NIFA-14-612]	Danish Ministry of Environment and Food through The Danish Agrifish Agency	This study was supported by a grant from the Danish Ministry of Environment and Food through The Danish Agrifish Agency (J. no. 33010-NIFA-14-612), http://en.mfvm.dk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt K, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-69; Angen O, 2017, APPL ENVIRON MICROB, V83, P1; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bos MEH, 2016, J EXPO SCI ENV EPID, V26, P263, DOI 10.1038/jes.2014.85; Broens EM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-58; Burns A, 2014, VET MICROBIOL, V174, P504, DOI 10.1016/j.vetmic.2014.10.009; Cleveland-Nielsen A, 2002, PREV VET MED, V55, P121, DOI 10.1016/S0167-5877(02)00089-2; Collineau L, 2017, PREV VET MED, V144, P167, DOI 10.1016/j.prevetmed.2017.05.023; Crombe F, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00057; Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8; Danish Veterinary and Food Administration, 2017, RES SCREEN HUSD MRSA, P1; Dorado-Garcia A, 2015, EMERG INFECT DIS, V21, P950, DOI 10.3201/eid2106.140706; Espinosa-Gongora C., 2013, EFFECT DISINFECTANT; Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019; Fromm S, 2014, PREV VET MED, V117, P180, DOI 10.1016/j.prevetmed.2014.08.014; Grontvedt CA, 2016, CLIN INFECT DIS, V63, P1431, DOI 10.1093/cid/ciw552; Guardabassi L, 2013, J GLOB ANTIMICROB RE, V1, P55, DOI 10.1016/j.jgar.2013.03.011; Lurette A, 2008, ANIMAL, V2, P105, DOI 10.1017/S1751731107000997; Nicholson TL, 2013, ISOLATES SWINE ORIGI, DOI [10.1371/journal.pone.0073376, DOI 10.1371/JOURNAL.PONE.0073376]; Olsen JV, 2017, BILAGSRAPPORT ERHVER; R Core Team, R LANG ENV STAT COMP; Schmithausen RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138173; Schulz J, 2013, BERL MUNCH TIERARZTL, V126, P143, DOI 10.2376/0005-9366-126-143; Sorensen AIV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188429; The Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP), 2017, DANM 2016 US ANT AG; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; Verhegghe M, 2013, J SWINE HEALTH PROD, V21, P313; Verhegghe M, 2013, VET MICROBIOL, V162, P679, DOI 10.1016/j.vetmic.2012.09.014; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Weese JS, 2011, ZOONOSES PUBLIC HLTH, V58, P238, DOI 10.1111/j.1863-2378.2010.01340.x	31	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200563	10.1371/journal.pone.0200563	http://dx.doi.org/10.1371/journal.pone.0200563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001405	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400079
J	Hwang, J; Jang, M; Kim, N; Choi, S; Oh, YM; Seo, JB				Hwang, Jeongeun; Jang, Miso; Kim, Namkug; Choi, Seunghyun; Oh, Yeon-Mok; Seo, Joon Beom			Positive association between moderate altitude and chronic lower respiratory disease mortality in United States counties	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; GENE-EXPRESSION; PULMONARY-EDEMA; GLOBAL BURDEN; LUNG-DISEASE; RISK-FACTORS; HYPOXIA; PREVALENCE; TUBERCULOSIS; CITIES	For patients with chronic lower respiratory disease, hypobaric hypoxia at a high altitude is considered a risk factor for mortality. However, the effects of residing at moderately high altitudes remain unclear. We investigated the association between moderate altitude and chronic lower respiratory disease mortality. In particular, we examined the lower 48 United States counties for age-adjusted chronic lower respiratory disease mortality rates, altitude, and socioeconomic factors, including tobacco use, per capita income, population density, sex ratio, unemployment, poverty, and education between 1979 and 1998. The socioeconomic factors were incorporated into the correlation analysis as potential covariates. Considerable positive (R = 0.235; P <0.001) and partial (R = 0.260; P <0.001) correlations were observed between altitude and chronic lower respiratory disease mortality rate. In the subgroup with high COPD prevalence subgroup, even stronger positive (R = 0.346; P <0.001) and partial (R = 0.423, P < 0.001) correlations were observed. Multivariate regression analysis of all available socioeconomic factors revealed that additional knowledge on altitude improved the adjusted R-2 values from 0.128 to 0.186 for all counties and from 0.301 to 0.421 for counties with high COPD prevalence. We concluded that in the lower 48 United States counties, even a moderate altitude may pose considerable risks in patients with chronic lower respiratory disease.	[Hwang, Jeongeun] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Jang, Miso] Natl Canc Ctr, Dept Family Med, Goyang, South Korea; [Jang, Miso] Natl Canc Ctr, Ctr Canc Prevent & Detect, Goyang, South Korea; [Kim, Namkug; Seo, Joon Beom] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Namkug; Seo, Joon Beom] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Namkug; Choi, Seunghyun; Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Kim, N (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea.; Kim, N (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea.; Kim, N (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Convergence Med, Seoul, South Korea.	namkugkim@gmail.com	Seo, Joon Beom/AAQ-5445-2021; Kim, Namkug/E-3843-2012; Hwang, Jeongeun/F-7550-2012	Seo, Joon Beom/0000-0003-0271-7884; Kim, Namkug/0000-0002-3438-2217; JANG, MISO/0000-0003-4409-411X; Hwang, Jeongeun/0000-0002-5821-5405	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [20100023051, NRF-2016R1D1A1A02937317]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (http://www.nrf.re. kr/nrf_eng_cms/), which is funded by the Ministry of Education, Science and Technology (No. 20100023051 to NK, and NRF-2016R1D1A1A02937317 to JH). The sponsors had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bishop GA, 2001, ENVIRON SCI TECHNOL, V35, P1574, DOI 10.1021/es001533a; Burney P, 2014, THORAX, V69, DOI 10.1136/thoraxjnl-2014-205474; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Clerici C, 2000, J APPL PHYSIOL, V88, P1890, DOI 10.1152/jappl.2000.88.5.1890; Cogo A, 1997, RESPIRATION, V64, P444; Ezzati M, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.112938; Firth PG, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2654; Gabry AL, 2003, CHEST, V124, P1620, DOI 10.1016/S0012-3692(16)48716-7; GONG H, 1984, AM REV RESPIR DIS, V130, P980; Grissom CK, 2018, HIGH ALT MED BIOL, V19, P109, DOI 10.1089/ham.2016.0142; Hadley Wickham R.F., 2017, DPLYR GRAMMAR DATA M; Hurtado A, 2012, NEPHROL DIAL TRANSPL, V27, piv11, DOI 10.1093/ndt/gfs427; Kaminsky DA, 1996, CHEST, V110, P939, DOI 10.1378/chest.110.4.939; KARAKURUM M, 1994, J CLIN INVEST, V93, P1564, DOI 10.1172/JCI117135; Kim N, 2011, AM J PSYCHIAT, V168, P49, DOI 10.1176/appi.ajp.2010.10020289; Kim S, 2015, COMMUN STAT APPL MET, V22, P665, DOI 10.5351/CSAM.2015.22.6.665; Kubo K, 1996, THORAX, V51, P739, DOI 10.1136/thx.51.7.739; Lewis DR, 2009, INT J TUBERC LUNG D, V13, P1008; Luks AM, 2007, EUR RESPIR J, V29, P770, DOI 10.1183/09031936.00052606; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Menezes Ana Maria Baptista, 2005, Cad. Saúde Pública, V21, P1565, DOI 10.1590/S0102-311X2005000500030; MORTIMER EA, 1977, NEW ENGL J MED, V296, P581, DOI 10.1056/NEJM197703172961101; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nespoulet H, 2012, EUR RESPIR J, V40, P673, DOI 10.1183/09031936.00073111; Perez-Padilla R, 2004, INT J TUBERC LUNG D, V8, P1315; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Richard A., 2017, MAPS DRAW GEOGRAPHIC; Rosenberg SR, 2015, SEMIN RESP CRIT CARE, V36, P457, DOI 10.1055/s-0035-1555607; Saito M, 2006, AM J TROP MED HYG, V75, P49, DOI 10.4269/ajtmh.2006.75.49; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schoene RB, 1999, ADV EXP MED BIOL, V474, P47; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; TUDER RM, 1995, J CLIN INVEST, V95, P1798, DOI 10.1172/JCI117858; Virues-Ortega J, 2009, J AM GERIATR SOC, V57, P1955, DOI 10.1111/j.1532-5415.2009.02468.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkelmayer WC, 2009, JAMA-J AM MED ASSOC, V301, P508, DOI 10.1001/jama.2009.84; World Health Organization, 2017, FACT SHEET TOP 10 CA; World Health Organization, 2017, CHRONIC RESP DIS; Youk AO, 2012, HIGH ALT MED BIOL, V13, P98, DOI 10.1089/ham.2011.1051; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, P4873; Zhang XY, 2014, AM J EPIDEMIOL, V179, P1025, DOI 10.1093/aje/kwu018	43	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200557	10.1371/journal.pone.0200557	http://dx.doi.org/10.1371/journal.pone.0200557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995931	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800083
J	Mukherjee, PK; Chandra, J; Retuerto, M; Tatsuoka, C; Ghannoum, MA; McComsey, GA				Mukherjee, Pranab K.; Chandra, Jyotsna; Retuerto, Mauricio; Tatsuoka, Curtis; Ghannoum, Mahmoud A.; McComsey, Grace A.			Dysbiosis in the oral bacterial and fungal microbiome of HIV-infected subjects is associated with clinical and immunologic variables of HIV infection	PLOS ONE			English	Article							PLAQUE MICROBIOTA; SUBGINGIVAL; DIVERSITY; SEARCH	Background The effect of smoking on microbial dysbiosis and the potential consequence of such shift on markers of HIV disease is unknown. Here we assessed the relationship of microbial dysbiosis with smoking and markers of HIV disease. Methods Oral wash was collected from: (1) HIV-infected smokers (HIV-SM, n = 48), (2) HIV-infected non-smokers (HIV-NS, n = 24), or (3) HIV-uninfected smokers (UI-SM, n = 24). Microbial DNA was extracted and their bacterial and fungal microbiota (bacteriome and mycobiome, respectively) were characterized using Ion-Torrent sequencing platform. Sequencing data were compared using clustering, diversity, abundance and inter-kingdom correlations analyses. Results Bacteriome was more widely dispersed than mycobiome, there was no noticeable difference in clustering between groups. Richness of oral bacteriome in HIV-SM was significantly lower than that of UI-SM (P <= .03). Diversity of HIV-NS was significantly lower than that of HIV-SM or UI-SM at phylum level (P <= .02). Abundance of Phylum Firmicutes was significantly decreased in HIV-NS compared to HIV-SM and UI-SM (P= .007 and .027, respectively), while abundance of Proteobacteria was significantly increased in HIV-NS compared to HIV-SM and UI-SM (P= .0005 and .011, respectively). Fungal phyla did not differ significantly between the three cohorts. Cumulative smoking was positively correlated with Facklamia but negatively with Enhydrobacter, and current alcohol use was negatively correlated with Geniculata. Bacteria Facklamia exhibited weakly positive correlation with longer PI duration r = 0.094, P= 0.012), and a negative correlation with nadir CD4 count (r = -0.345; P= 0.004), while Granulicatella was negatively correlated with nadir CD4 count (r = -0.329; P= 0.007). Fungus Stemphylium correlated negatively with nadir CD4 (r = -0.323; P= 0.008). Conclusions Dysbiosis of the oral microbiota is associated with clinical and immunologic variables in HIV-infected patients.	[Mukherjee, Pranab K.; Chandra, Jyotsna; Retuerto, Mauricio; Ghannoum, Mahmoud A.] Case Western Reserve Univ, Dept Dermatol, Ctr Med Mycol, Cleveland, OH 44106 USA; [Tatsuoka, Curtis] Case Western Reserve Univ, Dept Neurol & Populat & Quantitat Hlth Sci, Cleveland, OH 44106 USA; [McComsey, Grace A.] Univ Hosp Cleveland, Med Ctr, Infect Dis, Cleveland, OH 44106 USA; [McComsey, Grace A.] Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University	Mukherjee, PK (corresponding author), Case Western Reserve Univ, Dept Dermatol, Ctr Med Mycol, Cleveland, OH 44106 USA.; McComsey, GA (corresponding author), Univ Hosp Cleveland, Med Ctr, Infect Dis, Cleveland, OH 44106 USA.; McComsey, GA (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	pranab.mukherjee@case.edu; grace.mccomsey@case.edu		Mukherjee, Pranab/0000-0003-0244-6068	National Institutes of Health [R56HL126526, R01DE024228, U01 AI105937-01]; Center for AIDS Research (CFAR) [P30 AI036219]; Steris Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL126526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, U01AI105937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE024228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research (CFAR); Steris Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We gratefully acknowledge funding support from the National Institutes of Health grant R56HL126526 (to GM), R01DE024228 (to MAG and PKM), U01 AI105937-01, the Center for AIDS Research (CFAR, P30 AI036219), and Steris Foundation grant (to PKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2007, J CLIN PERIODONTOL, V34, P189, DOI 10.1111/j.1600-051X.2006.01034.x; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beck JM, 2015, AM J RESP CRIT CARE, V192, P1335, DOI 10.1164/rccm.201501-0128OC; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandra J, 2016, METHODS MOL BIOL, V1356, P107, DOI 10.1007/978-1-4939-3052-4_9; Delima SL, 2010, J CLIN MICROBIOL, V48, P2344, DOI 10.1128/JCM.01821-09; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fullmer SC, 2009, J DENT RES, V88, P524, DOI 10.1177/0022034509338676; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kumar PS, 2011, INFECT IMMUN, V79, P4730, DOI 10.1128/IAI.05371-11; Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ordovas JM, 2006, CURR OPIN LIPIDOL, V17, P157, DOI 10.1097/01.mol.0000217897.75068.ba; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Shchipkova AY, 2010, J DENT RES, V89, P1247, DOI 10.1177/0022034510377203; Zeigler CC, 2012, OBESITY, V20, P157, DOI 10.1038/oby.2011.305	24	28	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200285	10.1371/journal.pone.0200285	http://dx.doi.org/10.1371/journal.pone.0200285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995962	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800050
J	Withrow, JM; Tarpy, DR				Withrow, James M.; Tarpy, David R.			Cryptic "royal" subfamilies in honey bee (Apis mellifera) colonies	PLOS ONE			English	Article							PATERNITY FREQUENCY; QUEEN; CONFLICT; INSECT; L.; HYMENOPTERA; DIVERSITY; EVOLUTION	During emergency queen rearing, worker honey bees (Apis mellifera) select several otherwise worker-destined larvae to instead rear as candidates to replace their dead or failing queen. This choice is crucial as the queen is the sole reproductive in the colony and her quality is essential to its success. Because honey bee queens mate with and store sperm from multiple drones, emergency queen selection presents workers with an opportunity to increase fitness by selecting full- (0.75 relatedness), rather than half- (0.25 relatedness), sisters as new queen candidates. Through patriline analysis of colonies along with large numbers of emergency queens reared by each we affirm the purported "royal" patriline theory that, instead of competing nepotistically, workers exhibit bias towards selecting individuals from particular "royal" subfamilies during emergency queen rearing events, Further, we show that these "royal" patrilines are cryptic in honey bee colonies; occurring in such low frequency in the overall colony population that they are frequently undetected in traditional tests of queen mating number and colony composition. The identification of these cryptic "royal" subfamilies reveals that honey bee queens, already considered "hyperpolyandrous," are mating with even more males than has been previously recognized. These results alter our understanding of reproductive behavior in honey bees, raising questions about the evolutionary implications of this phenomenon.	[Withrow, James M.; Tarpy, David R.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Withrow, James M.; Tarpy, David R.] North Carolina State Univ, Interdept Program Biol, Raleigh, NC 27695 USA; [Withrow, James M.; Tarpy, David R.] North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Withrow, JM (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Withrow, JM (corresponding author), North Carolina State Univ, Interdept Program Biol, Raleigh, NC 27695 USA.; Withrow, JM (corresponding author), North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA.	jmwithro@ncsu.edu		Tarpy, David/0000-0001-8601-6094	National Honey Board; North Carolina Department of Agriculture and Consumer Services; United States Department of Agriculture Animal and Plant Health Inspection Service [14-8130-0360-CA]; United States Department of Agriculture Agricultural Research Service	National Honey Board; North Carolina Department of Agriculture and Consumer Services; United States Department of Agriculture Animal and Plant Health Inspection Service(United States Department of Agriculture (USDA)); United States Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	National Honey Board, https://www.honey.com/, DRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. North Carolina Department of Agriculture and Consumer Services, http://www.ncagr.gov/, DRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. United States Department of Agriculture Animal and Plant Health Inspection Service, (14-8130-0360-CA), https://www.aphis.usda.gov/aphis/home/, DRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. United States Department of Agriculture Agricultural Research Service, https://www.ars.usda.gov/, DRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beekman M, 2008, ANNU REV ENTOMOL, V53, P19, DOI 10.1146/annurev.ento.53.103106.093515; Bourke AFG, 1999, BEHAV ECOL SOCIOBIOL, V46, P287, DOI 10.1007/s002650050622; BREED MD, 1984, ANN ENTOMOL SOC AM, V77, P737, DOI 10.1093/aesa/77.6.737; BREED MD, 1994, BEHAV PROCESS, V33, P25, DOI 10.1016/0376-6357(94)90058-2; Brodschneider Robert, 2012, Insects, V3, P857, DOI 10.3390/insects3030857; BROUWERS EVM, 1987, J APICULT RES, V26, P11, DOI 10.1080/00218839.1987.11100729; BUTLER C. G., 1957, INSECTES SOCIAUX, V4, P211, DOI 10.1007/BF02222154; Chaline N, 2003, INSECT SOC, V50, P234, DOI 10.1007/s00040-003-0664-6; CORNUET JM, 1980, APIDOLOGIE, V11, P87, DOI 10.1051/apido:19800110; Delaney DA, 2011, APIDOLOGIE, V42, P1, DOI 10.1051/apido/2010027; Delaplane KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142985; Dobata S, 2009, P ROY SOC B-BIOL SCI, V276, P567, DOI 10.1098/rspb.2008.1215; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Goudie F, 2014, APIDOLOGIE, V45, P306, DOI 10.1007/s13592-013-0261-2; Haberl M, 1999, INSECT SOC, V46, P137, DOI 10.1007/s000400050124; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hepburn H.R., 1998, HONEYBEES AFRICA; Hughes WOH, 2008, P NATL ACAD SCI USA, V105, P5150, DOI 10.1073/pnas.0710262105; Keeling CI, 2003, P NATL ACAD SCI USA, V100, P4486, DOI 10.1073/pnas.0836984100; Koyama S, 2007, APPL ENTOMOL ZOOL, V42, P541, DOI 10.1303/aez.2007.541; Kraus FB, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P413, DOI 10.1007/978-3-642-02624-9_14; Lattorff HMG, 2016, BEHAV ECOL SOCIOBIOL, V70, P1411, DOI 10.1007/s00265-016-2151-x; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Martin CG, 2004, BEHAV ECOL SOCIOBIOL, V56, P42, DOI 10.1007/s00265-004-0755-z; Mattila HR, 2012, CURR BIOL, V22, P2027, DOI 10.1016/j.cub.2012.08.021; Mattila HR, 2011, BEHAV ECOL SOCIOBIOL, V65, P799, DOI 10.1007/s00265-010-1083-0; Mattila HR, 2010, BEHAV ECOL SOCIOBIOL, V64, P875, DOI 10.1007/s00265-010-0904-5; Moritz RFA, 2005, NATURWISSENSCHAFTEN, V92, P488, DOI 10.1007/s00114-005-0025-6; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; Onions GW, 1912, AGR J UN S AFR, V1, P720; Osborne KE, 1999, ANIM BEHAV, V58, P267, DOI 10.1006/anbe.1999.1139; Palmer K, 2001, INSECT SOC, V48, P327, DOI 10.1007/PL00001785; Poitout S.H, 1994, CHEMOECOLOGY, V5, P6, DOI [10.1007/BF01259967, DOI 10.1007/BF01259967]; Rangel J, 2009, P ROY SOC B-BIOL SCI, V276, P3895, DOI 10.1098/rspb.2009.1072; Reeve H, LEVELS SELECTION EVO; Reeve H. K., 1993, QUEEN NUMBER SOCIALI, V45, P85; Sagili RR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25976-7; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; Smith ML, 2016, INSECT SOC, V63, P553, DOI 10.1007/s00040-016-0499-6; Tarpy DR, 2016, INSECT SOC, V63, P169, DOI 10.1007/s00040-015-0452-0; Tarpy DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118734; Tarpy DR, 2002, ANN ENTOMOL SOC AM, V95, P513, DOI 10.1603/0013-8746(2002)095[0513:SEEPAE]2.0.CO;2; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; Tarpy DR, 2004, BEHAV ECOL SOCIOBIOL, V55, P513, DOI 10.1007/s00265-003-0738-5; Tarpy DR, 2000, AM NAT, V155, P820, DOI 10.1086/303358; Tilley CA, 1997, ANIM BEHAV, V54, P1483, DOI 10.1006/anbe.1997.0546; TRIVERS RL, 1976, SCIENCE, V191, P249, DOI 10.1126/science.1108197; VERMA S, 1983, APIDOLOGIE, V14, P41, DOI 10.1051/apido:19830104; Visscher PK, 1998, APIDOLOGIE, V29, P23, DOI 10.1051/apido:19980102; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Wheeler William Morton, 1911, Journal of Morphology Philadelphia, V22, DOI 10.1002/jmor.1050220206; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson E.O., 1975, P1; Winston M., 1987, The biology of the honey bee.; WINSTON ML, 1979, INSECT SOC, V26, P373, DOI 10.1007/BF02223556	57	22	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199124	10.1371/journal.pone.0199124	http://dx.doi.org/10.1371/journal.pone.0199124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995879	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800018
J	Kim, YH; Kim, J; Kang, MG; Lee, DH; Chin, HS; Jang, TY; Kim, NR				Kim, Young Hyo; Kim, Joseph; Kang, Min Gu; Lee, Dae Hyung; Chin, Hee Seung; Jang, Tae Young; Kim, Na Rae			Optic nerve changes in chronic sinusitis patients: Correlation with disease severity and relevant sinus location	PLOS ONE			English	Article							FIBER LAYER LOSS; COHERENCE TOMOGRAPHY; RISK-FACTORS; ANATOMY; THICKNESS; NEURITIS	Purpose This study was to evaluate whether optic nerve damage occurs in eyes with adjacent chronic sinusitis. Methods Data were collected from eighty-eight eyes of 46 chronic sinusitis patients and 93 eyes of 57 normal controls. Visual sensitivity using standard automated perimetry (SAP) and inner retinal thickness using optical coherence tomography (OCT) were measured. The Lund-Mackay system was used to quantify radiographic findings on the ostiomeatal unit CT scan with a numerical score representing the severity of sinusitis. Results There was a significant positive correlation between the pattern standard deviation (dB) and Lund-Mackay score (P = 0.031). Nasal retinal nerve fiber layer (RNFL) thickness, average, minimum, superotemporal, superior, superonasal, and inferonasal ganglion cell-inner plexiform layer (GCIPL) thickness were negatively correlated significantly with Lund-Mackay score (all, P < 0.05). Eyes with grade 2 opacification of the posterior ethmoid sinus showed a significantly lower mean deviation (dB) and higher pattern standard deviation (dB) than those with clear respective sinuses (P = 0.007 and <0.001, respectively). Eyes with grades 1,2 and 3 opacification of the sphenoid sinus had a significantly less average RNFL thickness (P = 0.004, <0.001, and <0.001, respectively) and a significantly less average GCIPL thickness (P = 0.004, 0.003, and 0.003, respectively) than those with a clear sphenoid sinus. Conclusions Structural and functional optic nerve changes were correlated with the severity of chronic sinusitis. Inflammation of the posterior ethmoid and sphenoid sinuses was associated with optic nerve changes to a greater extent than that of the other paranasal sinuses.	[Kim, Young Hyo; Jang, Tae Young] Inha Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Incheon, South Korea; [Kim, Joseph; Kang, Min Gu; Chin, Hee Seung; Kim, Na Rae] Inha Univ, Sch Med, Dept Ophthalmol, Incheon, South Korea; [Kim, Joseph; Kang, Min Gu; Chin, Hee Seung; Kim, Na Rae] Inha Univ, Sch Med, Inha Vis Sci Lab, Incheon, South Korea; [Lee, Dae Hyung] Inha Univ Hosp, Clin Trial Ctr, Incheon, South Korea	Inha University; Inha University; Inha University; Inha University; Inha University Hospital	Kim, NR (corresponding author), Inha Univ, Sch Med, Dept Ophthalmol, Incheon, South Korea.; Kim, NR (corresponding author), Inha Univ, Sch Med, Inha Vis Sci Lab, Incheon, South Korea.	nrkim@inha.ac.kr		Kim, Na Rae/0000-0003-4224-5447	INHA University Research Grant	INHA University Research Grant	This work was supported by the INHA University Research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the INHA UNIVERSITY Research Grant.	AHN J, 2008, SURVEY; AVIV RI, 2004, CLIN RADIOL, V5, P17; BANSBERG SF, 1987, OTOLARYNG HEAD NECK, V96, P331, DOI 10.1177/019459988709600405; BECKER M, 2009, EUROPEAN JOURNAL OF, V9, P29; Casselman J, 2008, NEUROIMAG CLIN N AM, V18, P197, DOI 10.1016/j.nic.2008.02.002; COSTELLO F, 1977, MULTIPLE SCLEROSIS; DeLano MC, 1996, AM J NEURORADIOL, V17, P669; DELNOCE C, 1940, PUBMED; FOKKENS WJ, 1998, RHINOLOGY; FUJII K, 1979, J NEUROSURG, V50, P31, DOI 10.3171/jns.1979.50.1.0031; GARG A, 1947, PUBMED, V4, P350; HEO D, 2017, PLOS ONE, V12, P3; Herrmann BW, 2006, J EMERG MED, V135, P328, DOI 10.1016/j.otohns.2005.04.009; Hoover GE, 1997, J ALLERGY CLIN IMMUN, V100, P185, DOI 10.1016/S0091-6749(97)70223-9; JAMA O, 1960, JAMA OTOLARYNGOLOGY; JAMA O, JAMA OTOLARYNGOLOGY; JAMA O, 1979, JAMA OTOLARYNGOL, V50, P1; JAMA O, 2015, JAMA OTOLARYNGOL, V3142, P7377; KANG SH, 1937, INVEST OPHTHALMOL VI; KUPERSMITH MJ, 1948, SOCIETY; LE CP, 2014, THE JOURNAL OF THE L, V166, P70; RENN WH, 1975, J NEUROSURG, V43, P288, DOI 10.3171/jns.1975.43.3.0288; ROSEN P, ELSEVIER, P6; Rosen P, 2005, OTOLARYNGOLOGY D HEA; SAIDHA S, 1977, MULTIPLE SCLEROSIS; SYC SB, 1964, PUBMED; Taflan T, 2013, OCUL IMMUNOL INFLAMM, V21, P247, DOI 10.3109/09273948.2013.766215; Tsujio Gen, 2016, Gan To Kagaku Ryoho, V43, P2246	28	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199875	10.1371/journal.pone.0199875	http://dx.doi.org/10.1371/journal.pone.0199875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990384	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300018
J	Wang, YN; Zeng, ZL; Lu, JH; Wang, Y; Liu, ZX; He, MM; Zhao, Q; Wang, ZX; Li, T; Lu, YX; Wu, QN; Yu, K; Wang, F; Pu, HY; Li, B; Jia, WH; Shi, M; Xie, D; Kang, TB; Huang, P; Ju, HQ; Xu, RH				Wang, Ying-nan; Zeng, Zhao-lei; Lu, Jiahuan; Wang, Yun; Liu, Ze-xian; He, Ming-ming; Zhao, Qi; Wang, Zi-xian; Li, Ting; Lu, Yun-xin; Wu, Qi-nian; Yu, Kai; Wang, Feng; Pu, Heng-Ying; Li, Bo; Jia, Wei-hua; Shi, Ming; Xie, Dan; Kang, Tie-bang; Huang, Peng; Ju, Huai-qiang; Xu, Rui-hua			CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis	ONCOGENE			English	Article							BETA-OXIDATION; LEUKEMIA-CELLS; SURVIVAL; METABOLISM; ETOMOXIR; ENERGY; AXIS; BIOCHEMISTRY; ANTIOXIDANT; HOMEOSTASIS	Anoikis is a critical obstacle to cancer metastasis. Colorectal cancer (CRC) exhibits a high rate of metastasis, leading to death, and the mechanisms involved in anoikis resistance are still unclear. We identified that the fatty acid oxidation (FAO) pathway was activated in detached CRC cells. Multiple genes in the FAO pathway, specifically the rate-limiting enzyme CPT1A, were upregulated in CRC cells grown in suspension. Reactive oxygen species elimination mediated by CPT1A in CRC cells was vital to anoikis resistance. In vivo experiments showed that CPT1A-suppressed CRC cells colonized the lung at a much lower rate than normal CRC cells, suggesting that CPT1A-mediated FAO activation increased metastatic capacity. In clinical tissue specimens from CRC patients, elevated expression of CPT1A was observed in metastatic sites compared with primary sites. Our results demonstrate that CPT1A-mediated FAO activation induces CRC cells to resist anoikis, suggesting that CPT1A is an attractive target for treating metastatic CRC.	[Wang, Ying-nan; Zeng, Zhao-lei; Lu, Jiahuan; Wang, Yun; Liu, Ze-xian; He, Ming-ming; Zhao, Qi; Wang, Zi-xian; Li, Ting; Lu, Yun-xin; Wu, Qi-nian; Yu, Kai; Wang, Feng; Pu, Heng-Ying; Jia, Wei-hua; Shi, Ming; Xie, Dan; Kang, Tie-bang; Ju, Huai-qiang; Xu, Rui-hua] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Li, Bo] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem & Mol Biol, Guangzhou 510080, Guangdong, Peoples R China; [Huang, Peng] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center	Ju, HQ; Xu, RH (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	juhq@sysucc.org.cn; xurh@sysucc.org.cn	Xu, Rui-Hua/AAW-4766-2021; Liu, Zexian/D-1153-2011; Zhao, Qi/X-7899-2019; xu, rui/GRX-5734-2022	Xu, Rui-Hua/0000-0001-9771-8534; Liu, Zexian/0000-0001-9698-0610; Zhao, Qi/0000-0002-8683-6145; Ju, Huai-Qiang/0000-0003-1713-5465; Yu, Kai/0000-0003-3343-2902	National Natural Science Foundation of China [81602137, 81572392]; Natural Science Foundation of Guangdong Province [2017A030313485, 2014A030312015]; Science and Technology Program of Guangdong [2015B020232008]; Science and Technology Program of Guangzhou [15570006, 201508020250, 201604020003]; Pearl River S&T Nova Program of Guangzhou [201806010002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Program of Guangdong; Science and Technology Program of Guangzhou; Pearl River S&T Nova Program of Guangzhou	This research was supported by the National Natural Science Foundation of China (81602137, 81572392); Natural Science Foundation of Guangdong Province (2017A030313485, 2014A030312015); Science and Technology Program of Guangdong (2015B020232008), Science and Technology Program of Guangzhou (15570006, 201508020250, 201604020003) and by grants from Pearl River S&T Nova Program of Guangzhou (201806010002).	Aslan B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8351; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Cabrero A, 2003, J LIPID RES, V44, P388, DOI 10.1194/jlr.M200294-JLR200; Casals N, 2016, PROG LIPID RES, V61, P134, DOI 10.1016/j.plipres.2015.11.004; Chang YS, 2000, P NATL ACAD SCI USA, V97, P14608, DOI 10.1073/pnas.97.26.14608; Conti R, 2011, DIABETES, V60, P644, DOI 10.2337/db10-0346; Cook AD, 2005, ANN SURG ONCOL, V12, P637, DOI 10.1245/ASO.2005.06.012; Cully M, 2017, NAT REV DRUG DISCOV, V16, P15, DOI 10.1038/nrd.2016.274; D'Amato NC, 2015, CANCER RES, V75, P4651, DOI 10.1158/0008-5472.CAN-15-2011; Dey S, 2015, J CLIN INVEST, V125, P2592, DOI 10.1172/JCI78031; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Harjes U, 2016, CRIT REV ONCOL HEMAT, V97, P15, DOI 10.1016/j.critrevonc.2015.10.011; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; Hinderling VB, 2002, AM J CLIN NUTR, V76, P141, DOI 10.1093/ajcn/76.1.141; Holubarsch CJF, 2007, CLIN SCI, V113, P205, DOI 10.1042/CS20060307; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Huang A, 2016, CANCER LETT, V377, P149, DOI 10.1016/j.canlet.2016.04.040; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Ju HQ, 2017, ONCOGENE, V36, P6282, DOI 10.1038/onc.2017.227; Ju HQ, 2016, THERANOSTICS, V6, P1160, DOI 10.7150/thno.14848; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Noguchi T, 2016, ONCOLOGY-BASEL, V90, P221, DOI 10.1159/000444493; Okugawa Y, 2017, GUT, V66, P107, DOI 10.1136/gutjnl-2015-309359; Pacilli A, 2013, JNCI-J NATL CANCER I, V105, P489, DOI 10.1093/jnci/djt030; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pascual G, 2017, NATURE, V541, P41, DOI 10.1038/nature20791; Paumen MB, 1997, BIOCHEM BIOPH RES CO, V231, P523, DOI 10.1006/bbrc.1997.6089; Pollack LA, 2006, CANCER CAUSE CONTROL, V17, P449, DOI 10.1007/s10552-005-0505-1; Qu Q, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.132; Ricciardi MR, 2015, BLOOD, V126, P1925, DOI 10.1182/blood-2014-12-617498; Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645; Rufer AC, 2009, CELL MOL LIFE SCI, V66, P2489, DOI 10.1007/s00018-009-0035-1; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Schackmann RCJ, 2011, J CLIN INVEST, V121, P3176, DOI 10.1172/JCI41695; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schlaepfer IR, 2014, MOL CANCER THER, V13, P2361, DOI 10.1158/1535-7163.MCT-14-0183; Setoyama D, 2013, GENES CELLS, V18, P1107, DOI 10.1111/gtc.12098; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Streuli CH, 1999, J MAMMARY GLAND BIOL, V4, P183, DOI 10.1023/A:1018729308878; Strilic B, 2017, CANCER CELL, V32, P282, DOI 10.1016/j.ccell.2017.07.001; Taylor MA, 2013, J CLIN INVEST, V123, P150, DOI 10.1172/JCI64946; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yawata A, 1998, ONCOGENE, V16, P2681, DOI 10.1038/sj.onc.1201792; Zammit VA, 2008, IUBMB LIFE, V60, P347, DOI 10.1002/iub.78; Zhu L, 2017, J NUCL MED, V58, P533, DOI 10.2967/jnumed.116.182345; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	58	117	119	0	38	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6025	6040		10.1038/s41388-018-0384-z	http://dx.doi.org/10.1038/s41388-018-0384-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29995871				2022-12-26	WOS:000450175900002
J	Chen, KQ; Singh, VK; Tang, P; Bao, ZY; He, TZ; Xiang, Y; Gong, WH; Yoshimura, T; Le, YY; Tessarollo, L; Chen, X; Wang, JM				Chen, Keqiang; Singh, Vijay K.; Tang, Peng; Bao, Zhiyao; He, Tianzhen; Xiang, Yi; Gong, Wanghua; Yoshimura, Teizo; Le, Yingying; Tessarollo, Lino; Chen, Xin; Wang, Ji Ming			Deficiency in Fpr2 results in reduced numbers of Lin(-)cKit(+)Sca1(+) myeloid progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mouse; bone marrow; myeloid cell; proliferation; cytokine; c-KIT; Fpr2; Lin(-)c-Kit(+)Sca1(+)cells; SCF	HEMATOPOIETIC STEM-CELLS; C-KIT LIGAND; ESCHERICHIA-COLI BACTEREMIA; FORMYL-PEPTIDE RECEPTORS; BONE-MARROW; FORMYLPEPTIDE RECEPTOR; PERIPHERAL-BLOOD; DENDRITIC CELLS; LIPOXIN A(4); SELF-RENEWAL	The Lin(-)c-Kit(+) Sca-1(+) cell population in the bone marrow (BM) serves as the direct precursor for differentiation of myeloid cells. In this study, we report that deficiency in Fpr2, a G protein-coupled chemoattractant receptor in mice, is associated with reduced BM nucleated cells, including CD31(+)Ly6C(+) (granulocytes and monocytes), CD31(-)/Ly6C(int) (granuloid cells), and CD31(-)/Ly6C(high) (predominantly monocytes) cells. In particular, the number of Lin(-)c-Kit(+)Sca-1(+) (LKS) cells was reduced in Fpr2(-/-) mouse BM. This was supported by observations of the reduced incorporation of intraperitoneally injected bromodeoxyuridine by cells in the c-Kit(+) population from Fpr2(-/-) mouse BM. Purified c-Kit(+) cells from Fpr2(-/-) mice showed reduced expansion when cultured in vitro with stem cell factor (SCF). SCF/c-Kit-mediated phosphorylation of P38, STAT1, Akt (Thr-308), and Akt (Ser-473) was also significantly reduced in c-Kit(+) cells from Fpr2(-/-) mice. Furthermore, Fpr2 agonists enhanced SCF-induced proliferation of c-Kit(+) cells. Colony-forming unit assays revealed that CFU-granulocyte-macrophage formation of BM cells from Fpr2(-/-) mice was significantly reduced. After heat-inactivated bacterial stimulation in the airway, the expansion of c-kit(+) Sca-1(+) cells in BM and recruitment of Ly6G(+) cells to the lungs and CD11b(+)Ly6C(+)TNF(+) cells to the spleen of Fpr2(-/-) mice was significantly reduced. These results demonstrate an important role for Fpr2 in the development of myeloid lineage precursors in mouse BM.	[Chen, Keqiang; Tang, Peng; Bao, Zhiyao; Gong, Wanghua; Wang, Ji Ming] NCI, Canc & Inflammat Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Tessarollo, Lino] NCI, Mouse Canc Genet Program, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Singh, Vijay K.; Yoshimura, Teizo] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Armed Forces Radiobiol Res Inst, Dept Pharmacol & Mol Therapeut, Bethesda, MD 20814 USA; [Tang, Peng] Third Mil Med Univ, Southwest Hosp, Dept Breast Surg, Chongqing 400038, Peoples R China; [Bao, Zhiyao; Xiang, Yi] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pulm & Crit Care Med, Shanghai 200025, Peoples R China; [He, Tianzhen; Chen, Xin] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau 999078, Peoples R China; [Gong, Wanghua] Leidos Biomed Res Inc, Basic Res Program, Frederick, MD 21702 USA; [Yoshimura, Teizo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pathol & Expt Med, Okayama 7008558, Japan; [Le, Yingying] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Army Medical University; Shanghai Jiao Tong University; University of Macau; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Okayama University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, JM (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, Bldg 560,Rm 31-76, Frederick, MD 21702 USA.	wangji@mail.nih.gov	Singh, Vijay/GWZ-8972-2022; Le, Yingying/L-9785-2017; Chen, Xin n/a/I-6601-2015	Singh, Vijay/0000-0002-6631-3849; Le, Yingying/0000-0002-7990-3899; Chen, Xin n/a/0000-0002-2628-4027	NCI, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NCI, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZICBC011265] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded in part by federal funds from the NCI, National Institutes of Health, under Contract HHSN261200800001E and supported in part by the Intramural Research Program of the NCI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; AVRAHAM H, 1992, BLOOD, V79, P365; Barthlen W, 1999, SURGERY, V126, P41, DOI 10.1067/msy.1999.99060; Broudy VC, 1997, BLOOD, V90, P1345, DOI 10.1182/blood.V90.4.1345.1345_1345_1364; BROXMEYER HE, 1991, CANCER CELL-MON REV, V3, P480; BROXMEYER HE, 1995, EXP HEMATOL, V23, P1121; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Chen KQ, 2014, J BIOL CHEM, V289, P17553, DOI 10.1074/jbc.M113.535674; Chen KQ, 2013, J BIOL CHEM, V288, P16262, DOI 10.1074/jbc.M113.450635; Chen KQ, 2010, J IMMUNOL, V184, P3331, DOI 10.4049/jimmunol.0903022; Chiang N, 2000, J EXP MED, V191, P1197, DOI 10.1084/jem.191.7.1197; Devosse T, 2009, J IMMUNOL, V182, P4974, DOI 10.4049/jimmunol.0803128; Duarte RF, 2000, BLOOD, V96, P3422; Fehniger TA, 1997, BLOOD, V90, P3647, DOI 10.1182/blood.V90.9.3647; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gehling UM, 1997, EXP HEMATOL, V25, P1125; Grafte-Faure S, 2000, CYTOKINE, V12, P1, DOI 10.1006/cyto.1999.0520; HARTMANN DW, 1981, J CELL PHYSIOL, V109, P17, DOI 10.1002/jcp.1041090103; HENDRIE PC, 1991, EXP HEMATOL, V19, P1031; HOFFMAN R, 1993, STEM CELLS, V11, P76; HORIE M, 1995, EXP HEMATOL, V23, P168; Hu JY, 2001, J LEUKOCYTE BIOL, V70, P155; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Iribarren P, 2005, IMMUNOL RES, V31, P165, DOI 10.1385/IR:31:3:165; Jung SK, 2014, J BIOL CHEM, V289, P35839, DOI 10.1074/jbc.M114.585513; KELLER JR, 1995, BLOOD, V86, P1757, DOI 10.1182/blood.V86.5.1757.bloodjournal8651757; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kular J, 2015, J BIOL CHEM, V290, P1729, DOI 10.1074/jbc.M114.567966; Le YY, 2002, TRENDS IMMUNOL, V23, P541, DOI 10.1016/S1471-4906(02)02316-5; Levy BD, 2002, NAT MED, V8, P1018, DOI 10.1038/nm748; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Liu MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090613; Liu MY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00786; Liu XW, 2012, NAT IMMUNOL, V13, P457, DOI 10.1038/ni.2258; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; MCNIECE IK, 1991, EXP HEMATOL, V19, P226; Migeotte I, 2005, J EXP MED, V201, P83, DOI 10.1084/jem.20041277; MORSTYN G, 1994, ONCOLOGY, V51, P205, DOI 10.1159/000227335; OKADA S, 1991, BLOOD, V78, P1706; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Santangelo S, 2001, ANN SURG, V233, P97, DOI 10.1097/00000658-200101000-00015; Sharma S, 2006, STEM CELLS DEV, V15, P755, DOI 10.1089/scd.2006.15.755; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sui XW, 1998, BLOOD, V92, P1142, DOI 10.1182/blood.V92.4.1142.416k42_1142_1149; Swamydas M., 2015, CURR PROTOC IMMUNOL, V110, P3, DOI DOI 10.1002/0471142735.im0320s110; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Ueda Y, 2005, J EXP MED, V201, P1771, DOI 10.1084/jem.20041419; Uittenbogaart CH, 1996, IMMUNOL LETT, V52, P45, DOI 10.1016/0165-2478(96)02580-1; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; Wang J, 2007, CLIN HEMORHEOL MICRO, V37, P291; Xiang Y, 2016, AM J CANCER RES, V6, P2599; Yang D, 2000, J IMMUNOL, V165, P2694, DOI 10.4049/jimmunol.165.5.2694; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Young SM, 2006, CELL SIGNAL, V18, P608, DOI 10.1016/j.cellsig.2005.06.005; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027; Zhang P, 2009, J IMMUNOL, V182, P1568, DOI 10.4049/jimmunol.182.3.1568	58	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13452	13463		10.1074/jbc.RA118.002683	http://dx.doi.org/10.1074/jbc.RA118.002683			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30018139	Green Published, hybrid			2022-12-26	WOS:000443375500009
J	Tieu, HV; Laeyendecker, O; Nandi, V; Rose, R; Fernandez, R; Lynch, B; Hoover, DR; Frye, V; Koblin, BA				Hong-Van Tieu; Laeyendecker, Oliver; Nandi, Vijay; Rose, Rebecca; Fernandez, Reinaldo; Lynch, Briana; Hoover, Donald R.; Frye, Victoria; Koblin, Beryl A.			Prevalence and mapping of hepatitis C infections among men who have sex with men in New York City	PLOS ONE			English	Article							HIV-POSITIVE MEN; RECENT HCV INFECTION; G ANTIBODY AVIDITY; VIRUS-INFECTION; PEGYLATED INTERFERON; PROSPECTIVE COHORT; COST-EFFECTIVENESS; NATURAL-HISTORY; HOMOSEXUAL-MEN; UNITED-STATES	Emerging sexually transmitted hepatitis C virus (HCV) epidemics among men who have sex with men (MSM) have been reported worldwide, with higher HCV infection rates among those who are HIV-infected. This study aims to determine prevalence of recent and chronic HCV infections among community-recruited MSM in New York City (NYC), map HCV infections by home, social, and sexual neighborhoods, and identify clusters of genetically linked HCV variants using phylogenetic analysis. The NYC M2M study recruited MSM via modified time-space, venue-based sampling and internet/mobile app-based recruitment during 2010-13. Participants completed a Google Earth map on neighborhoods of where they lived, socialized, and had sex in the last 3 months, an ACASI questionnaire, and a sexual network inventory about their sex partners. The men received HIV testing and provided serum samples. Testing on stored serum samples included HCV antibody and RNA viral load, HCV antibody avidity assay (avidity index <30% with positive viral load is considered recently infected), and HCV RNA extraction and amplification to generate a 432 base-pair region of Core/E1 for sequencing and phylogenetic analysis. Historic local controls were included in the phylogenetic analysis. Of 1,028 MSM, 79.7% were HIV-negative and 20.3% HIV-positive. Twenty nine MSM (2.8%) were HCV antibody-positive. MSM who were HCV antibody-positive reported a median of 2 male sex partners in last 3 months, with 6.9% aged 18-24, 17.2% 25-29, 13.8% 30-39, and 62.1% 40 and over. 8.1% of HIV-positive MSM were HCV antibody-positive vs. 1.5% of HIV-negative men (p<0.0001). Of 29 HCV-antibody positive MSM, 12 (41%) were HCV RNA-positive (11 subtype la and 1 subtype 1b). Two of 12 HCV RNA-positive participants had low antibody avidity values, suggesting recent HCV infection. HCV antibody seropositivity was significantly associated with older age >40 years, adjusted odds ratio (aOR) 3.56 (95% CI 1.57, 8.08), HIV-positive serostatus, aOR 3.18 (95% CI 1.40, 7.22), any sexually transmitted infection (STI) in the last 3 months, aOR 2.81 (95% CI 1.11, 7.13), and injection drug use (IDU) ever, aOR 4.34 (95% CI 1.69, 11.17). Mapping of HCV infections differed slightly by home, social, and sexual neighborhoods. Based on phylogenetic analysis from 12 HCV RNA-positive samples, no evidence of a clustered HCV epidemic was found. Overall HCV seroprevalence was 2.8% among community-recruited MSM in NYC, with higher prevalence among HIV-positive MSM compared to HIV-negative MSM. Only two participants were found to have recent HCV infection, with no evidence of a clustered HCV epidemic based on phylogenetic analysis. Our results support testing of HCV infection among HIV-negative MSM if they report having a recent STI and IDU in the past rather than universal HCV testing in all HIV-negative MSM.	[Hong-Van Tieu; Koblin, Beryl A.] New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA; [Hong-Van Tieu] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10027 USA; [Laeyendecker, Oliver; Lynch, Briana] NIAID, Baltimore, MD USA; [Laeyendecker, Oliver; Fernandez, Reinaldo] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Nandi, Vijay] New York Blood Ctr, Lab Data Analyt, New York, NY 10021 USA; [Rose, Rebecca] BioInfoExperts LLC, Thibodaux, LA USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Frye, Victoria] CUNY, Sch Med, New York, NY 10031 USA	New York Blood Center; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; New York Blood Center; Rutgers State University New Brunswick; City University of New York (CUNY) System	Tieu, HV (corresponding author), New York Blood Ctr, Lab Infect Dis Prevent, New York, NY 10021 USA.; Tieu, HV (corresponding author), Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10027 USA.	htieu@nybc.org		Laeyendecker, Oliver/0000-0002-6429-4760	Merck Investigator Studies Program (MISP); National Institutes of Health [K01 DA031035, R01 HD059729]; Division of Intramural Research at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; BioInfoExperts, LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069470, ZIAAI000361] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	Merck Investigator Studies Program (MISP); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; BioInfoExperts, LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was funded by the Merck Investigator Studies Program (MISP) to HVT, http://engagezone.msd.com/misp.php. HVT was supported by the National Institutes of Health K01 DA031035. The NYC M2M study was funded by the National Institutes of Health R01 HD059729 (PI: Koblin). OL was funded by the Division of Intramural Research at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BioInfoExperts, LLC provided support in the form of salary for R.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aghemo A, 2013, HEPATOLOGY, V58, P428, DOI 10.1002/hep.26371; Alary M, 2005, AM J PUBLIC HEALTH, V95, P502, DOI 10.2105/AJPH.2003.020388; [Anonymous], 2014, AD POOIIH IAA GUID P; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, p1; Araujo AC, 2012, ANTIVIR THER, V17, P1459, DOI 10.3851/IMP2464; Bradshaw D, 2013, CURR OPIN INFECT DIS, V26, P66, DOI 10.1097/QCO.0b013e32835c2120; Cerda M, 2017, SOC PSYCH PSYCH EPID, V52, P749, DOI 10.1007/s00127-017-1379-8; Coll M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022591; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; den Hollander G, 2005, AIDS, V19, P639, DOI 10.1097/01.aids.0000163947.24059.68; Dominguez S, 2006, AIDS, V20, P1157, DOI 10.1097/01.aids.0000226956.02719.fd; Drobnik A PJ, 2013, INF DIS SOC AM ANN M; Fierer DS, 2014, CLIN INFECT DIS, V58, P873, DOI 10.1093/cid/cit799; Flamm SL, 2003, JAMA-J AM MED ASSOC, V289, P2413, DOI 10.1001/jama.289.18.2413; Force. USPST, 2014, AHRQ PUBLICATION; Fox J, 2008, AIDS, V22, P666, DOI 10.1097/QAD.0b013e3282f5f4cf; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Frye V, 2017, AIDS BEHAV, V21, P870, DOI 10.1007/s10461-016-1596-2; Garg S, 2013, CLIN INFECT DIS, V56, P1480, DOI 10.1093/cid/cit054; Gaudy-Graffin C, 2010, J CLIN MICROBIOL, V48, P3281, DOI 10.1128/JCM.00303-10; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Hagan LM, 2013, J VIRAL HEPATITIS, V20, P847, DOI 10.1111/jvh.12111; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Jaeckel E, 2001, NEW ENGL J MED, V345, P1452, DOI 10.1056/NEJMoa011232; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Kamili S, 2012, CLIN INFECT DIS, V55, pS43, DOI 10.1093/cid/cis368; Kanno A, 2002, J MED VIROL, V68, P229, DOI 10.1002/jmv.10186; Kim JH, 2008, WORLD J GASTROENTERO, V14, P6689, DOI 10.3748/wjg.14.6689; Klimashevskaya S, 2007, J CLIN MICROBIOL, V45, P3400, DOI 10.1128/JCM.01012-07; Koblin BA, 2017, J URBAN HEALTH, V94, P364, DOI 10.1007/s11524-016-0074-5; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lambers FAE, 2011, AIDS, V25, pF21, DOI 10.1097/QAD.0b013e32834bac44; Larsen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029322; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; McEwan P, 2013, HEPATOLOGY, V58, P54, DOI 10.1002/hep.26304; MELBYE M, 1990, BRIT MED J, V301, P210, DOI 10.1136/bmj.301.6745.210; Muir AJ, 2014, AM J GASTROENTEROL, V109, P628, DOI 10.1038/ajg.2014.66; Nishijima T, 2014, JAIDS-J ACQ IMM DEF, V65, P213, DOI 10.1097/QAI.0000000000000044; Patel EU, 2016, J INFECT DIS, V214, P344, DOI 10.1093/infdis/jiw005; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Price H, 2013, HIV MED, V14, P578, DOI 10.1111/hiv.12050; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Raymond HF, 2012, SEX TRANSM DIS, V39, P985, DOI 10.1097/OLQ.0b013e3182716e59; Raymond HF, 2011, SEX TRANSM DIS, V38, P219, DOI 10.1097/OLQ.0b013e3181f68ed4; Richardson D, 2008, J INFECT DIS, V197, P1213, DOI 10.1086/533454; Sagnelli E, 2012, ANTIVIR THER, V17, P1453, DOI 10.3851/IMP2471; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Schmidt AJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-3; Seaberg EC, 2014, J VIRAL HEPATITIS, V21, P696, DOI 10.1111/jvh.12198; Shepherd SJ, 2018, J MED VIROL, V90, P120, DOI 10.1002/jmv.24919; Shepherd SJ, 2013, J CLIN VIROL, V57, P29, DOI 10.1016/j.jcv.2013.01.002; Taylor LE, 2011, CLIN INFECT DIS, V52, P812, DOI 10.1093/cid/ciq201; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Tieu HV, 2016, AIDS PATIENT CARE ST, V30, P39, DOI 10.1089/apc.2015.0237; Turner JM, 2006, SEX TRANSM INFECT, V82, P298, DOI 10.1136/sti.2005.018366; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2011, SEX TRANSM DIS, V38, P102, DOI 10.1097/OLQ.0b013e3181ec9de5; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van Santen DK, 2017, J HEPATOL, V67, P255, DOI 10.1016/j.jhep.2017.03.038; Vanhommerig JW, 2014, JAIDS-J ACQ IMM DEF, V66, pE111, DOI 10.1097/QAI.0000000000000208; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Witt MD, 2013, CLIN INFECT DIS, V57, P77, DOI 10.1093/cid/cit197; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566	70	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200269	10.1371/journal.pone.0200269	http://dx.doi.org/10.1371/journal.pone.0200269			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020960	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400043
J	Wang, QJ; Guo, Y; Zhang, J; Shi, LJ; Ning, HY; Zhang, XL; Lu, YY				Wang, Qingjun; Guo, Yong; Zhang, Jing; Shi, Lijing; Ning, Haoyong; Zhang, Xiliang; Lu, Yuanyuan			Utility of high b-value (2000 sec/mm(2)) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules	PLOS ONE			English	Article							DIFFUSION-COEFFICIENT VALUES; PROSTATE-CANCER; TUMORS; HEAD	Purpose The aim of the study was to evaluate the role of high b-value (2000 sec/mm(2)) diffusion-weighted imaging (DWI) by using Readout Segmentation of Long Variable Echo-trains (RESOLVE) in differentiating papillary thyroid carcinomas (PTCs) and papillary thyroid microcarcinomas (PTMCs) from benign thyroid nodules. Materials and methods Consecutive patients with thyroid nodules scheduled for surgery underwent high b-value DWI with 3 b-values: 0, 800 and 2000 sec/mm(2). Signal intensity ratios (SIRs) of thyroid nodules to adjacent normal thyroid tissue on DWI were measured as: SIRb0, SIRb800 and SIRb2000. Apparent diffusion coefficient (ADC) values based on the 3 different b-values were acquired as: ADC(b0-800), ADC(b0)(-2000), and ADC(b0-800-2000). The 6 diagnostic indicators were evaluated by receiver operating characteristic (ROC) and diagnostic ability was compared between high b-value DWI and Ultrasound (US). Results A total of 52 PTCs including 33 PTMCs (38 patients, 8 men and 30 women, aged 45.68 +/- 11.93 years) and 62 benign thyroid nodules (46 patients, 7 men and 39 women, aged 48.73 +/- 11.98 years) were enrolled into the final statistical analysis. ADC(b0-)(800-)(2000) had the highest diagnostic ability in differentiating PTCs from benign thyroid nodules with area under curve (AUC) of 0.944, sensitivity of 96.15% and specificity of 85.48%, and PTMCs from benign thyroid nodules with AUC of 0.940, sensitivity of 93.94% and specificity of 85.48%. On the strength of lower false-positive rates than US (14.52% vs. 32.26% for PTCs and 14.52% vs. 32.26% for PTMCs), ADC(b0-800-2000) had significantly better diagnostic ability in PTCs (P= 0.002) and PTMCs (P= 0.005). Conclusion High b-value (2000 sec/mm(2)) DWI can contribute to differentiating PTCs and PTMCs from benign thyroid nodules and can be potentially used as an active surveillance imaging method for PTMCs.	[Wang, Qingjun; Guo, Yong; Zhang, Jing; Shi, Lijing] Chinese Navy Gen Hosp PLA, Dept Radiol, Beijing, Peoples R China; [Ning, Haoyong] Chinese Navy Gen Hosp PLA, Dept Pathol, Beijing, Peoples R China; [Zhang, Xiliang] Chinese Navy Gen Hosp PLA, Dept Gen Surg, Beijing, Peoples R China; [Lu, Yuanyuan] Chinese Navy Gen Hosp PLA, Dept Ultrasound, Beijing, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital; Sixth Medical Center of Chinese PLA General Hospital	Guo, Y (corresponding author), Chinese Navy Gen Hosp PLA, Dept Radiol, Beijing, Peoples R China.	guoyonghu27@163.com		Guo, Yong/0000-0002-1945-0197				Agarwal HK, 2017, J MAGN RESON IMAGING, V45, P125, DOI 10.1002/jmri.25353; Brown AM, 2016, MAGN RESON MED, V75, P1708, DOI 10.1002/mrm.25743; Chen HY, 2016, EXP THER MED, V11, P1555, DOI 10.3892/etm.2016.3094; Chen LH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008413; Dighe M, 2013, EUR J RADIOL, V82, pE274, DOI 10.1016/j.ejrad.2013.01.009; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hwang I, 2013, AM J NEURORADIOL, V34, P2343, DOI 10.3174/ajnr.A3603; Koyasu S, 2014, EUR RADIOL, V24, P3088, DOI 10.1007/s00330-014-3369-5; Kwak HY, 2015, INT J CLIN ONCOL, V20, P463, DOI 10.1007/s10147-014-0754-7; Kwak JT, 2015, MED PHYS, V42, P2368, DOI 10.1118/1.4918318; Mutlu H, 2012, CLIN IMAG, V36, P1, DOI 10.1016/j.clinimag.2011.04.001; Nikiforov YE, 2016, JAMA ONCOL, V2, P1023, DOI 10.1001/jamaoncol.2016.0386; Pusztaszeri MP, 2013, ENDOCR PATHOL, V24, P246, DOI 10.1007/s12022-013-9242-2; Razek AAKA, 2008, AM J NEURORADIOL, V29, P563, DOI 10.3174/ajnr.A0849; Rosenkrantz AB, 2016, ACAD RADIOL, V23, P704, DOI 10.1016/j.acra.2016.02.003; Schob S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040821; Schob S, 2016, TRANSL ONCOL, V9, P403, DOI 10.1016/j.tranon.2016.09.001; SOBIN LH, 1990, HISTOPATHOLOGY, V16, P513; Sui Y, 2015, RADIOLOGY, V277, P489, DOI 10.1148/radiol.2015142156; Vermoolen MA, 2012, INSIGHTS IMAGING, V3, P395, DOI 10.1007/s13244-012-0175-y; Wang Xiaoqing, 2015, Zhonghua Zhong Liu Za Zhi, V37, P138; Wetter A, 2015, ACTA RADIOL, V56, P1009, DOI 10.1177/0284185114547900	22	12	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200270	10.1371/journal.pone.0200270	http://dx.doi.org/10.1371/journal.pone.0200270			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020961	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400044
J	da Costa, END; de Souza, MFL; Marrocos, PCL; Lobao, D; da Silva, DML				Dantas da Costa, Eline Nayara; Landim de Souza, Marcelo Friederichs; Lima Marrocos, Paulo Cesar; Lobao, Dan; Lopes da Silva, Daniela Mariano			Soil organic matter and CO2 fluxes in small tropical watersheds under forest and cacao agroforestry	PLOS ONE			English	Article							CARBON-DIOXIDE; TEMPERATURE-DEPENDENCE; LEAF-LITTER; CLIMATE-CHANGE; NITROUS-OXIDE; ELEVATED CO2; ATMOSPHERE EXCHANGE; MICROBIAL BIOMASS; RESPIRATION; DECOMPOSITION	Annual estimates of CO2 and dissolved carbon concentrations in the soil profile provide valuable insight into the dynamics of organic matter in soil and the effect of changes to vegetation cover. The aim of this study was to observe the spatial influence of litter decomposition in the first few centimeters of the soil for CO2 fluxes and to describe the processing of soil organic matter throughout the soil profile by comparing three small tropical watersheds. Data were collected biweekly for six months, from December 2015 to May 2016. CO2 was measured using an infrared gas analyzer in fixed chambers and the dissolved carbon of soil solution was analyzed in a TOC analyzer. No differences were found in the total soil CO2 fluxes (control flux treatments) between the three study areas. In both cacao agroforestry systems (managed and unmanaged), total CO2 fluxes were influenced by the decomposition of litter. CO2 emissions in the soil profile of the cacao agroforestry systems were highly variable, compared to the preserved forest, and highly dependent on the soil characteristics attributed to the type of vegetation cover. Although a definite pattern between the temperature and soil moisture was not identified, these parameters showed a strong relationship in controlling the release of CO2 between treatments. The organic and inorganic dissolved carbon patterns in the soil solution of the three areas revealed different responses of soil organic matter processing related to soil characteristics and vegetation. The results confirm the hypothesis that the top of soils (total CO2 fluxes) of both cacao agroforestry systems (managed and unmanaged) emits fluxes of CO2, which do not differ statistically from the preserved forest. However, depending on the soil characteristics, the cacao agroforestry system can result in an accumulation of CO2 and dissolved inorganic carbon in the soil profile that is prone to being transported by hydrological routes to groundwater and stream water.	[Dantas da Costa, Eline Nayara; Lopes da Silva, Daniela Mariano] Univ Estadual Santa Cruz, Dept Biol Sci, Ilheus, BA, Brazil; [Landim de Souza, Marcelo Friederichs] Univ Estadual Santa Cruz, Dept Exact & Technol Sci, Ilheus, BA, Brazil; [Lima Marrocos, Paulo Cesar; Lobao, Dan] Comissao Execut Plano Lavoura Cacaueira, Cocoa Res Ctr, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz	da Costa, END (corresponding author), Univ Estadual Santa Cruz, Dept Biol Sci, Ilheus, BA, Brazil.	elinendc@gmail.com	Souza, Marcelo F.L./H-8743-2013; Silva, D.M.L./S-1678-2019; da Silva, Daniela Mariano Lopes/G-3563-2012	Silva, D.M.L./0000-0002-9741-6170; Dantas da Costa, Eline Nayara/0000-0003-3018-6566	Fundacao de Amparo a Pesquisa do Estado da Bahia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PPP0040/2011]; Universidade Estadual de Santa Cruz [PROPP 0220.1100.899]	Fundacao de Amparo a Pesquisa do Estado da Bahia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universidade Estadual de Santa Cruz	This work was supported by the Fundacao de Amparo a Pesquisa do Estado da Bahia (URL: www.fapesb.ba.gov.br/); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Grant/Award Number: PPP0040/2011 (URL: www.cnpq.br/); Universidade Estadual de Santa Cruz, Grant/Award Number: PROPP 0220.1100.899 (URL: www.uesc.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MAG., 2003, FITOPATOL BRAS, V28, P148, DOI [10.1590/S0100-41582003000200005, DOI 10.1590/S0100-41582003000200005]; Aleixo S, 2017, AGROFOREST SYST, V91, P423, DOI 10.1007/s10457-016-9939-6; Alexander M., 1977, Introduction to soil microbiology.; AMUNDSON RG, 1990, J GEOCHEM EXPLOR, V38, P13, DOI 10.1016/0375-6742(90)90091-N; Arevalo-Gardini E, 2017, SCI TOTAL ENVIRON, V605, P792, DOI 10.1016/j.scitotenv.2017.06.122; ARGOLO LMH, 2009, THESIS; Asmar SR, 1977, GEOGRAFIA MICROORREG; Barreto PAB, 2011, AGROFOREST SYST, V81, P213, DOI 10.1007/s10457-010-9300-4; Beaubien SE, 2008, INT J GREENH GAS CON, V2, P373, DOI 10.1016/j.ijggc.2008.03.005; Briedis C, 2012, PESQUI AGROPECU BRAS, V47, P1007, DOI 10.1590/S0100-204X2012000700018; BROOK GA, 1984, EARTH SURF PROC LAND, V9, P85, DOI 10.1002/esp.3290090110; Buysse P, 2013, BIOGEOCHEMISTRY, V112, P441, DOI 10.1007/s10533-012-9739-7; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Chen BY, 2010, SOIL BIOL BIOCHEM, V42, P1735, DOI 10.1016/j.soilbio.2010.06.010; Ciais P, 2014, BIOGEOSCIENCES, V11, P3547, DOI 10.5194/bg-11-3547-2014; Costa END., 2017, AGROFOREST SYST, V2, P425, DOI [DOI 10.1007/S10457-017-077-6, 10.1007/s10457-017-077-6]; Costa Falberni de Souza, 2004, Cienc. Rural, V34, P587, DOI 10.1590/S0103-84782004000200041; da Costa END, 2017, ECOL EVOL, V7, P228, DOI 10.1002/ece3.2543; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; DAVIDSON EA, 1995, TELLUS B, V47, P550, DOI 10.1034/j.1600-0889.47.issue5.3.x; Deng Y, 2012, APPL ENVIRON MICROB, V78, P2991, DOI 10.1128/AEM.06924-11; do Carmo JB, 2012, AGR ECOSYST ENVIRON, V148, P37, DOI 10.1016/j.agee.2011.11.010; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Formanek P, 2014, SCI WORLD J, DOI 10.1155/2014/730149; Friend AD, 2014, P NATL ACAD SCI USA, V111, P3280, DOI 10.1073/pnas.1222477110; G?es GS., 2004, REV CIENC AGRAR, V42, P221; Galford GL, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0171; Gama-Rodrigues EF, 2010, ENVIRON MANAGE, V45, P274, DOI 10.1007/s00267-009-9420-7; Gritsch C, 2015, BIOGEOSCIENCES, V12, P5981, DOI 10.5194/bg-12-5981-2015; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Inglett KS, 2012, BIOGEOCHEMISTRY, V108, P77, DOI 10.1007/s10533-011-9573-3; Jardim J. G, 2003, CORREDOR BIODIVERSID, P1; Kassem II, 2008, J INTEGR PLANT BIOL, V50, P1406, DOI 10.1111/j.1744-7909.2008.00752.x; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; KELLER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P399, DOI 10.1029/94GB01660; KELLER M, 1986, J GEOPHYS RES-ATMOS, V91, P1791, DOI 10.1029/JD091iD11p11791; Kirby KR, 2007, FOREST ECOL MANAG, V246, P208, DOI 10.1016/j.foreco.2007.03.072; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Landau EC, 2003, CORREDOR BIODIVERSID; Lipson DA, 2005, APPL ENVIRON MICROB, V71, P8573, DOI 10.1128/AEM.71.12.8573-8580.2005; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; LOBAO DE, 2004, SISTEMA AGROSSIVICUL, V1, P63; Martini AMZ, 2007, BIODIVERS CONSERV, V16, P3111, DOI 10.1007/s10531-007-9166-6; Martins Paulo Fernando da Silva, 2012, Rev. Ceres, V59, P723; MATSON PA, 1990, BIOSCIENCE, V40, P667, DOI 10.2307/1311434; Mbow C, 2014, CURR OPIN ENV SUST, V6, P8, DOI 10.1016/j.cosust.2013.09.002; MCDOWELL WH, 1988, ECOL MONOGR, V58, P177, DOI 10.2307/2937024; Moreau AMSD, 2006, REV BRAS CIENC SOLO, V30, P1007, DOI 10.1590/S0100-06832006000600010; Muller MW, 2007, CIENCIA TECNOLOGIA M, P246; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nair PKR, 2009, J PLANT NUTR SOIL SC, V172, P10, DOI 10.1002/jpln.200800030; Osterreicher-Cunha P, 2015, INT J GREENH GAS CON, V32, P135, DOI 10.1016/j.ijggc.2014.11.009; Oliveira AT, 2000, BIOTROPICA, V32, P793, DOI 10.1646/0006-3606(2000)032[0793:POFDAA]2.0.CO;2; Pierce S, 2009, PLANT SOIL, V325, P197, DOI 10.1007/s11104-009-9969-1; Pulleman M, 1999, SOIL BIOL BIOCHEM, V31, P275, DOI 10.1016/S0038-0717(98)00116-3; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rajkumar M, 2013, ENVIRON INT, V53, P74, DOI 10.1016/j.envint.2012.12.009; Reth S, 2005, PLANT SOIL, V268, P21, DOI 10.1007/s11104-005-0175-5; Rier ST, 2005, CAN J FISH AQUAT SCI, V62, P185, DOI 10.1139/F04-148; Rier ST, 2002, J N AM BENTHOL SOC, V21, P16, DOI 10.2307/1468296; Rita JCO, 2011, ENVIRON MANAGE, V48, P134, DOI 10.1007/s00267-011-9642-3; Sa DF, 1982, REV THEOBROMA, V12, P169; Salimon CI, 2004, GLOBAL CHANGE BIOL, V10, P833, DOI 10.1111/j.1529-8817.2003.00776.x; Sambuichi RHR, 2012, BIODIVERS CONSERV, V21, P1055, DOI 10.1007/s10531-012-0240-3; Santos ERM, 2016, METODOS TECNICAS PES, P121; Savage K, 2014, BIOGEOSCIENCES, V11, P2709, DOI 10.5194/bg-11-2709-2014; Schimel D, 2015, P NATL ACAD SCI USA, V112, P436, DOI 10.1073/pnas.1407302112; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Schroth G, 2011, BIODIVERS CONSERV, V20, P1635, DOI 10.1007/s10531-011-0052-x; Schroth G, 2015, MITIG ADAPT STRAT GL, V20, P1175, DOI 10.1007/s11027-013-9530-7; Shinjo H, 2006, SOIL SCI PLANT NUTR, V52, P233, DOI 10.1111/j.1747-0765.2006.00023.x; Smith KA, 2003, EUR J SOIL SCI, V54, P779, DOI 10.1046/j.1351-0754.2003.0567.x; Smith P, 2007, CLIMATE CHANGE 2007, P497; Somarriba E, 2013, AGR ECOSYST ENVIRON, V173, P46, DOI 10.1016/j.agee.2013.04.013; Neto ES, 2011, BIOGEOSCIENCES, V8, P733, DOI 10.5194/bg-8-733-2011; Thomazini A., 2015, Geoderma Regional, V5, P15, DOI 10.1016/j.geodrs.2015.02.003; Tuchman NC, 2003, HYDROBIOLOGIA, V495, P203, DOI 10.1023/A:1025493018012; Tuchman NC, 2002, GLOBAL CHANGE BIOL, V8, P163, DOI 10.1046/j.1365-2486.2002.00460.x; VANGESTEL M, 1991, SOIL BIOL BIOCHEM, V23, P313, DOI 10.1016/0038-0717(91)90185-M; Villanueva-Lopez G, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0358-x; Willey JM, 2008, PRESCOTT HARLEY KLEI; Wu J, 2005, SOIL BIOL BIOCHEM, V37, P507, DOI 10.1016/j.soilbio.2004.07.043; Zaia FC, 2012, AGROFOREST SYST, V86, P197, DOI 10.1007/s10457-012-9550-4	90	5	6	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200550	10.1371/journal.pone.0200550	http://dx.doi.org/10.1371/journal.pone.0200550			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011307	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800027
J	Auger, JP; Dolbec, D; Roy, D; Segura, M; Gottschalk, M				Auger, Jean-Philippe; Dolbec, Dominic; Roy, David; Segura, Mariela; Gottschalk, Marcelo			Role of the Streptococcus suis serotype 2 capsular polysaccharide in the interactions with dendritic cells is strain-dependent but remains critical for virulence	PLOS ONE			English	Article							SUIS SEROTYPE-2; ZOONOTIC AGENT; PHAGOCYTOSIS; INFECTION; PATHOGEN; CYTOKINE; SUILYSIN; SWINE; MODEL	Streptococcus suis serotype 2 is an important porcine bacterial pathogen and zoonotic agent responsible for sudden death, septic shock, and meningitis. However, serotype 2 strains are heterogeneous, composed of a multitude of sequence types (STs) whose distribution greatly varies worldwide. Of the virulence factors presently described for S. suis, the capsular polysaccharide (CPS) is a critical factor implicated in a multitude of functions, including in impairment of phagocytosis and innate immune cell activation by masking underlying bacterial components. However, these roles have been described using Eurasian ST1 and ST7 strains, which greatly differ from North American ST25 strains. Consequently, the capacity of the CPS to mask surface antigens and putative virulence factors in non-Eurasian strains remains unknown. Herein, the role of the S. suis serotype 2 CPS of a prototype intermediate virulent North American ST25 strain, in comparison with that of a virulent European ST1 strain, with regards to interactions with dendritic cells, as well as virulence during the systemic phase of infection, was evaluated. Results demonstrated that the CPS remains critical for virulence and development of clinical disease regardless of strain background, due to its requirement for survival in blood. However, its role in the interactions with dendritic cells is strain-dependent. Consequently, certain key characteristics associated with the CPS are not necessarily applicable to all S. suis serotype 2 strains. This indicates that though certain factors may be important for S. suis serotype 2 virulence, strain background could be as determining, reiterating the need in using strains from varying backgrounds in order to better characterize the S. suis pathogenesis.	[Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, Res Grp Infect Dis Prod Anim GREMIP, St Hyacinthe, PQ, Canada; Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, Swine & Poultry Infect Dis Res Ctr CRIPA, St Hyacinthe, PQ, Canada	Universite de Montreal; Universite de Montreal	Gottschalk, M (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, Res Grp Infect Dis Prod Anim GREMIP, St Hyacinthe, PQ, Canada.	marcelo.gottschalk@umontreal.ca	Segura, Mariela/AAG-5708-2020		Natural Sciences and Engineering Research Council of Canada [154280]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) - Grant #154280 to MG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auger J-P, 2017, FRONT IMMUNOL, P8; Auger JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181920; Auger JP, 2016, EMERG INFECT DIS, V22, P1793, DOI 10.3201/eid2210.151640; Auger JP, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030048; Auray G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156019; Benga L, 2008, VET MICROBIOL, V132, P211, DOI 10.1016/j.vetmic.2008.05.005; Berthelot-Herault F, 2005, CAN J VET RES, V69, P236; Berthelot-Herault F, 2001, CAN J VET RES, V65, P196; Bonifait L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-42; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; CHARLAND N, 1995, J CLIN MICROBIOL, V33, P2220, DOI 10.1128/JCM.33.8.2220-2221.1995; Chen C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000315; Dale DC, 2008, BLOOD, V112, P935, DOI 10.1182/blood-2007-12-077917; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2008, INFECT IMMUN, V76, P3901, DOI 10.1128/IAI.00350-08; Dominguez-Punaro MD, 2010, INFECT IMMUN, V78, P5074, DOI 10.1128/IAI.00698-10; Feng YJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00710; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; GOTTSCHALK M, 1992, VET MICROBIOL, V30, P59, DOI 10.1016/0378-1135(92)90094-A; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Houde M, 2012, INFECT IMMUN, V80, P506, DOI 10.1128/IAI.05734-11; JACQUES M, 1990, J BACTERIOL, V172, P2833, DOI 10.1128/jb.172.6.2833-2838.1990; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Lachance C, 2013, INFECT IMMUN, V81, P1928, DOI 10.1128/IAI.01317-12; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; Lecours MP, 2012, MICROBES INFECT, V14, P941, DOI 10.1016/j.micinf.2012.03.008; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Okura M, 2013, APPL ENV MICROBIOL; Roy D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04403-3; Roy D, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5030047; Roy D, 2015, CAN J VET RES, V79, P141; Roy D, 2014, MICROB PATHOGENESIS, V67-68, P31, DOI 10.1016/j.micpath.2014.02.002; Segura M, 1999, INFECT IMMUN, V67, P4646, DOI 10.1128/IAI.67.9.4646-4654.1999; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Segura MA, 1998, FEMS IMMUNOL MED MIC, V21, P189, DOI 10.1111/j.1574-695X.1998.tb01165.x; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Segura M, 2016, FEBS LETT, V590, P3772, DOI 10.1002/1873-3468.12364; Slater JD, 2003, VET MICROBIOL, V93, P197, DOI 10.1016/S0378-1135(03)00030-0; Smith HE, 1999, INFECT IMMUN, V67, P1750; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Vadeboncoeur N, 2003, FEMS IMMUNOL MED MIC, V35, P49, DOI 10.1016/S0928-8244(02)00440-6; Van Calsteren MR, 2013, BIOCHEM CELL BIOL, V91, P49, DOI 10.1139/bcb-2012-0036; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; Van Calsteren MR, 2016, J BIOL CHEM; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Ye CY, 2008, EMERG INFECT DIS, V14, P787, DOI 10.3201/eid1405.070437; Zhang YY, 2016, MICROBIOL RES, V185, P45, DOI 10.1016/j.micres.2016.02.002	55	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200453	10.1371/journal.pone.0200453	http://dx.doi.org/10.1371/journal.pone.0200453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001363	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400058
J	Langen, B; Rudqvist, N; Spetz, J; Helou, K; Forssell-Aronsson, E				Langen, Britta; Rudqvist, Nils; Spetz, Johan; Helou, Khalil; Forssell-Aronsson, Eva			Deconvolution of expression microarray data reveals I-131-induced responses otherwise undetected in thyroid tissue	PLOS ONE			English	Article							GENE-EXPRESSION; FREE AT-211; TRANSCRIPTIONAL RESPONSES; MOUSE-TISSUES; KIDNEY TISSUE; DOSE-RATE; C-CELLS; MICE; RADIATION; I-131	High-throughput gene expression analysis is increasingly used in radiation research for discovery of damage-related or absorbed dose-dependent biomarkers. In tissue samples, cell type-specific responses can be masked in expression data due to mixed cell populations which can preclude biomarker discovery. In this study, we deconvolved microarray data from thyroid tissue in order to assess possible bias from mixed cell type data. Transcript expression data [GSE66303] from mouse thyroid that received 5.9 Gy from I-131 over 24 h (or 0 Gy from mock treatment) were deconvolved by cell frequency of follicular cells and C-cells using csSAM and R and processed with Nexus Expression. Literature-based signature genes were used to assess the relative impact from ionizing radiation (IR) or thyroid hormones (TH). Regulation of cellular functions was inferred by enriched biological processes according to Gene Ontology terms. We found that deconvolution increased the detection rate of significantly regulated transcripts including the biomarker candidate family of kallikrein transcripts. Detection of IR-associated and TH-responding signature genes was also increased in deconvolved data, while the dominating trend of TH-responding genes was reproduced. Importantly, responses in biological processes for DNA integrity, gene expression integrity, and cellular stress were not detected in convoluted data-which was in disagreement with expected dose-response relationships-but upon deconvolution in follicular cells and C-cells. In conclusion, previously reported trends of I-131-induced transcriptional responses in thyroid were reproduced with deconvolved data and usually with a higher detection rate. Deconvolution also resolved an issue with detecting damage and stress responses in enriched data, and may reduce false negatives in other contexts as well. These findings indicate that deconvolution can optimize microarray data analysis of heterogeneous sample material for biomarker screening or other clinical applications.	[Langen, Britta; Rudqvist, Nils; Spetz, Johan; Forssell-Aronsson, Eva] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Canc C, Gothenburg, Sweden; [Langen, Britta] Chalmers Univ Technol, Dept Appl Phys, Gothenburg, Sweden; [Helou, Khalil] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Oncol,Inst Clin Sci,Sahlgrenska Canc Ctr, Gothenburg, Sweden; [Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Chalmers University of Technology; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital	Langen, B (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Dept Radiat Phys,Inst Clin Sci,Sahlgrenska Canc C, Gothenburg, Sweden.; Langen, B (corresponding author), Chalmers Univ Technol, Dept Appl Phys, Gothenburg, Sweden.	britta.langen@gu.se	Spetz, Johan/P-1662-2017	Spetz, Johan/0000-0002-5216-9786; Forssell-Aronsson, Eva/0000-0002-7558-4368	Swedish Research Council [21073]; Swedish Cancer Society [3427]; BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Adlerbertska Research Fund; Wilhelm and Martina Lundgren science trust fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); BioCARE - a National Strategic Research Program at the University of Gothenburg; Swedish Radiation Safety Authority; King Gustav V Jubilee Clinic Cancer Research Foundation; Sahlgrenska University Hospital Research Funds; Assar Gabrielsson Cancer Research Foundation; Adlerbertska Research Fund; Wilhelm and Martina Lundgren science trust fund	The presented research was kindly supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, the Adlerbertska Research Fund, and the Wilhelm and Martina Lundgren science trust fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The presented research was kindly supported by grants from the Swedish Research Council (grant no. 21073), the Swedish Cancer Society (grant no. 3427), BioCARE - a National Strategic Research Program at the University of Gothenburg, the Swedish Radiation Safety Authority, the King Gustav V Jubilee Clinic Cancer Research Foundation, the Sahlgrenska University Hospital Research Funds, the Assar Gabrielsson Cancer Research Foundation, the Adlerbertska Research Fund, and the Wilhelm and Martina Lundgren science trust fund.	Albi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048518; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BROWN I, 1986, APPL RADIAT ISOTOPES, V37, P789, DOI 10.1016/0883-2889(86)90273-X; Capurro A, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00441; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Cote GJ, 2015, RECENT RESULTS CANC, V204, P1, DOI 10.1007/978-3-319-22542-5_1; Feinstein RE, 1996, J HISTOCHEM CYTOCHEM, V44, P997, DOI 10.1177/44.9.8773565; HAMILTON JG, 1954, P SOC EXP BIOL MED, V86, P366; HAMILTON JG, 1954, J CLIN ENDOCR METAB, V14, P1161, DOI 10.1210/jcem-14-10-1161; Josefsson A., 2014, THESIS, P29; Josefsson A, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0023-9; Langen B, 2017, J NUCL MED, V58, P346, DOI 10.2967/jnumed.116.176958; Langen B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30738; Langen B, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0150-y; Langen B, 2015, EJNMMI RES, V5, P1, DOI 10.1186/s13550-014-0078-7; Langen B, 2013, J NUCL MED, V54, P990, DOI 10.2967/jnumed.112.114462; Lindencrona U, 2001, NUCL MED BIOL, V28, P41, DOI 10.1016/S0969-8051(00)00179-7; Lundh C, 2006, CANCER BIOTHER RADIO, V21, P591, DOI 10.1089/cbr.2006.21.591; Lundh C, 2009, J NUCL MED, V50, P1161, DOI 10.2967/jnumed.108.061150; MARTINLACAVE I, 1992, CELL TISSUE RES, V270, P73, DOI 10.1007/BF00381881; Rudqvist N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171797; Rudqvist N, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0137-8; Rudqvist N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131686; Rudqvist N, 2015, NUCL MED BIOL, V42, P263, DOI 10.1016/j.nucmedbio.2014.11.006; Rudqvist N, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-32; Schuler E, 2014, NUCL MED BIOL, V41, P825, DOI 10.1016/j.nucmedbio.2014.07.010; Schuler E, 2014, NUCL MED BIOL, V41, P238, DOI 10.1016/j.nucmedbio.2013.12.001; Schuler E, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-29; SHAH KH, 1983, SURGERY, V94, P989; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Snyder AR, 2004, CANCER METAST REV, V23, P259, DOI 10.1023/B:CANC.0000031765.17886.fa; Spetz J, 2013, CANCER BIOTHER RADIO, V28, P657, DOI 10.1089/cbr.2013.1483; THURSTON V, 1982, ACTA ENDOCRINOL-COP, V99, P72, DOI 10.1530/acta.0.0990072; Zhong Y, 2012, NAT METHODS, V9, P8, DOI 10.1038/nmeth.1830	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0197911	10.1371/journal.pone.0197911	http://dx.doi.org/10.1371/journal.pone.0197911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001320	gold, Green Published			2022-12-26	WOS:000438457400003
J	Ozaki, Y; Tanaka, A; Nishiguchi, T; Komukai, K; Taruya, A; Satogami, K; Kashiwagi, M; Kuroi, A; Matsuo, Y; Ino, Y; Kitabata, H; Kubo, T; Hozumi, T; Akasaka, T				Ozaki, Yuichi; Tanaka, Atsushi; Nishiguchi, Tsuyoshi; Komukai, Kenichi; Taruya, Akira; Satogami, Keisuke; Kashiwagi, Manabu; Kuroi, Akio; Matsuo, Yoshiki; Ino, Yasushi; Kitabata, Hironori; Kubo, Takashi; Hozumi, Takeshi; Akasaka, Takashi			High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; FIBROUS CAP THICKNESS; ATHEROSCLEROTIC PLAQUE; STATIN THERAPY; HEART-DISEASE; EVENTS; ATORVASTATIN; PREVENTION; AVERAGE	Objective The current guideline recommends lowering low-density lipoprotein cholesterol (LDL-C) for the primary management of dyslipidemia in patients at high-risk of cardiovascular events. Patients who have achieved LDL-C levels below the recommended targets may still experience cardiovascular events, suggesting additional therapeutic targets beyond LDL-C. The aim of this study was to investigate whether high-density lipoprotein cholesterol (HDL-C) levels had an impact on plaque stabilization in patients with acute coronary syndrome (ACS). Methods This study consisted of 90 ACS patients with untreated dyslipidemia. In optical coherence tomography (OCT) analysis, a plaque with fibrous cap thickness <= 160 mu m was defined as a high-risk plaque. We registered one high-risk plaque per one patient by baseline OCT imaging, and then administrated high-intensity statin. Based on the follow-up OCT results, patients whose registered plaque was no longer high-risk plaque were classified into a responder group and the remains into a non-responder group. Results No differences were observed in the baseline LDL-C and HDL-C levels between the two groups. Reduction of LDL-C levels (delta LDL-C: -53 +/- 21 mg/dL vs. -42 +/- 29 mg/dL, p = 0.036) and increase of HDL-C levels (delta HDL-C: 2.5 +/- 5.9 mg/dL vs. -0.3 +/- 6.7 mg/dL, p= 0.039) were greater in the responder group. On multivariate logistic regression analysis, delta LDL-C levels (OR: 0.956, 95% CI: 0.921-0.993; p = 0.020) and delta HDL-C levels (OR: 1.143; 95% CI: 1.005-1.300, p = 0.041) were independent contributors for plaque stabilization. Conclusions Increase of HDL-C levels is associated with plaque stabilization in patients with ACS. HDL-C could be a therapeutic target for residual risk management.	[Ozaki, Yuichi; Tanaka, Atsushi; Nishiguchi, Tsuyoshi; Komukai, Kenichi; Taruya, Akira; Satogami, Keisuke; Kashiwagi, Manabu; Kuroi, Akio; Matsuo, Yoshiki; Ino, Yasushi; Kitabata, Hironori; Kubo, Takashi; Hozumi, Takeshi; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan; [Komukai, Kenichi] Hidaka Gen Hosp, Dept Cardiovasc Med, Gobo, Japan	Wakayama Medical University	Tanaka, A (corresponding author), Wakayama Med Univ, Dept Cardiovasc Med, Wakayama, Japan.	a-tanaka@wakayama.med.ac.jp	Taruya, Akira/AAT-9538-2021	Ozaki, Yuichi/0000-0002-5273-8133	 [16K19420]		This work was supported in part by Grant-in-Aid for Young Scientists (B), Japan (No. 16K19420). There was no additional external funding received for this study.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Genest J, 1999, J INVEST MED, V47, P31; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Jang IK, 2005, CIRCULATION, V111, P1551, DOI 10.1161/01.CIR.0000159354.43778.69; Jang IK, 2002, J AM COLL CARDIOL, V39, P604, DOI 10.1016/S0735-1097(01)01799-5; Kato K, 2012, CIRC-CARDIOVASC IMAG, V5, P433, DOI 10.1161/CIRCIMAGING.112.973701; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Komukai K, 2014, J AM COLL CARDIOL, V64, P2207, DOI 10.1016/j.jacc.2014.08.045; Nissen SE, 2006, JAMA-J AM MED ASSOC, V295, P1556, DOI 10.1001/jama.295.13.jpc60002; Nissen SE, 2004, JAMA-J AM MED ASSOC, V291, P1071, DOI 10.1001/jama.291.9.1071; Noguchi T, 2015, J AM COLL CARDIOL, V66, P245, DOI 10.1016/j.jacc.2015.05.056; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Ozaki Y, 2013, CIRC J, V77, P2982, DOI 10.1253/circj.CJ-13-0512; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Stein O, 1999, ATHEROSCLEROSIS, V144, P285, DOI 10.1016/S0021-9150(99)00065-9; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Tanaka A, 2008, CIRCULATION, V118, P2368, DOI 10.1161/CIRCULATIONAHA.108.782540; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; von Eckardstein A, 2000, CURR OPIN LIPIDOL, V11, P627, DOI 10.1097/00041433-200012000-00010	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200383	10.1371/journal.pone.0200383	http://dx.doi.org/10.1371/journal.pone.0200383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995934	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800060
J	Zhao, GH; Walsh, K; Long, J; Gui, WH; Denisova, K				Zhao, Guihu; Walsh, Kirwan; Long, Jun; Gui, Weihua; Denisova, Kristina			Reduced structural complexity of the right cerebellar cortex in male children with autism spectrum disorder	PLOS ONE			English	Article							CONSENSUS PAPER; HUMAN BRAIN; INTERNAL-MODELS; PATTERNS; MRI; MUTATIONS; PERCEPTION; LANGUAGE; NETWORKS; DEFICITS	The cerebellum contains 80% of all neurons in the human brain and contributes prominently to implicit learning and predictive processing across motor, sensory, and cognitive domains. As morphological features of the cerebellum in atypically developing individuals remain unexplored in-vivo, this is the first study to use high-resolution 3D fractal analysis to estimate fractal dimension (FD), a measure of structural complexity of an object, of the left and right cerebellar cortex (automatically segmented from Magnetic Resonance Images using Free-Surfer), in male children with Autism Spectrum Disorders (ASD) (N = 20; mean age: 8.8 years old, range: 7.13-10.27) and sex, age, verbal-IQ, and cerebellar volume-matched typically developing (TD) boys (N = 18; mean age: 8.9 years old, range: 6.47-10.52). We focus on an age range within the 'middle and late childhood' period of brain development, between 6 and 12 years. A Mann-Whitney U test revealed a significant reduction in the FD of the right cerebellar cortex in ASD relative to TD boys (P = 0.0063, Bonferroni-corrected), indicating flatter and less regular surface protrusions in ASD relative to TD males. Consistent with the prediction that the cerebellum participates in implicit learning, those ASD boys with a higher (vs. lower) PIQ>VIQ difference showed higher, more normative complexity values, closer to TD children, providing new insight on our understanding of the neurological basis of differences in verbal and performance cognitive abilities that often characterize individuals with ASD.	[Zhao, Guihu; Long, Jun; Gui, Weihua] Cent South Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China; [Zhao, Guihu; Walsh, Kirwan; Denisova, Kristina] Columbia Univ, Dept Psychiat, Coll Physicians & Surg, New York, NY 10027 USA; [Denisova, Kristina] Columbia Univ, Sackler Inst Psychobiol, Coll Physicians & Surg, New York, NY 10027 USA; [Denisova, Kristina] New York State Psychiat Inst & Hosp, Div Dev Neurosci, New York, NY 10032 USA; [Zhao, Guihu] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Dis, Changsha, Hunan, Peoples R China	Central South University; Columbia University; Columbia University; New York State Psychiatry Institute; Central South University	Long, J (corresponding author), Cent South Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.; Denisova, K (corresponding author), Columbia Univ, Dept Psychiat, Coll Physicians & Surg, New York, NY 10027 USA.; Denisova, K (corresponding author), Columbia Univ, Sackler Inst Psychobiol, Coll Physicians & Surg, New York, NY 10027 USA.; Denisova, K (corresponding author), New York State Psychiat Inst & Hosp, Div Dev Neurosci, New York, NY 10032 USA.	jlong@csu.edu.cn; Kristina.denisova@nyspi.columbia.edu			China Scholarship Council [201306370100]; National Natural Science Foundation of China [61272150, 61472450]; Sackler Award in Developmental Psychobiology; Preprocessed Connectomes Project (PCP); Preprocessed Connectomes Project	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sackler Award in Developmental Psychobiology; Preprocessed Connectomes Project (PCP); Preprocessed Connectomes Project	The China Scholarship Council (grant 201306370100) to GHZ, the National Natural Science Foundation of China (grants 61272150 and 61472450) to JL, and the Sackler Award in Developmental Psychobiology to KD. Funding acknowledgments for ABIDE investigators are available at: http://fcon_1000.projects.nitrc.org/indi/abide/abide_l.html. Credits for the Preprocessed Connectomes Project that provided pre-processed structural data used in the current work are available at: http://preprocessedconnectomes-project.org/abide/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the children and their families for their participation and the ABIDE investigators for contributing data. Funding acknowledgments for ABIDE investigators are available at: http://fcon_1000.projects.nitrc.org/indi/abide/abide_I.html. Credits for the Preprocessed Connectomes Project (PCP) that provided pre-processed structural data used in the current work are available at: http://preprocessed-connectomes-project.org/abide/. We thank Anna Silberman for critical reading of the manuscript and helpful comments. Kristina Denisova is the senior author on this work.	Abell F, 1999, NEUROREPORT, V10, P1647, DOI 10.1097/00001756-199906030-00005; Ackermann H, 2007, CEREBELLUM, V6, P202, DOI 10.1080/14734220701266742; Akshoomoff N, 2004, J AM ACAD CHILD PSY, V43, P349, DOI 10.1097/00004583-200403000-00018; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Baillieux H, 2010, CORTEX, V46, P869, DOI 10.1016/j.cortex.2009.09.002; Barnsley M, 1993, FRACTALS EVERYWHERE; BAUMAN M, 1985, NEUROLOGY, V35, P866, DOI 10.1212/WNL.35.6.866; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Baumann O, 2015, CEREBELLUM, V14, P197, DOI 10.1007/s12311-014-0627-7; Becker EBE, 2013, INT REV NEUROBIOL, V113, P1, DOI 10.1016/B978-0-12-418700-9.00001-0; Bishop DVM, 2013, SCIENCE, V340, DOI 10.1126/science.1230531; Bogovic JA, 2013, NEUROIMAGE, V64, P616, DOI 10.1016/j.neuroimage.2012.08.075; BOWER JM, 1990, J COMP NEUROL, V302, P768, DOI 10.1002/cne.903020409; Bower JM, 1997, INT REV NEUROBIOL, V41, P489, DOI 10.1016/S0074-7742(08)60367-0; Buja A, 2018, P NATL ACAD SCI USA, V115, pE1859, DOI 10.1073/pnas.1715427115; Cerminara NL, 2009, J PHYSIOL-LONDON, V587, P429, DOI 10.1113/jphysiol.2008.163337; Cohen J.E., 1988, STAT POWER ANAL BEHA; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Craddock C., 2013, FRONT NEUROINFORM, DOI DOI 10.3389/CONF.FNINF.2013.09.00041; Cullen KE, 2011, EXP BRAIN RES, V210, P377, DOI 10.1007/s00221-011-2555-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dawson M, 2007, PSYCHOL SCI, V18, P657, DOI 10.1111/j.1467-9280.2007.01954.x; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Denisova K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09028-0; Denisova K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.596; Dinstein I, 2012, NEURON, V75, P981, DOI 10.1016/j.neuron.2012.07.026; DMello AM, 2015, NEUROIMAGE-CLIN, V7, P631, DOI 10.1016/j.nicl.2015.02.007; Falconer K., 2014, FRACTAL GEOMETRY MAT; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Feder J, 1988, FRACTALS; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Foroutan-pour K, 1999, APPL MATH COMPUT, V105, P195, DOI 10.1016/S0096-3003(98)10096-6; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Goni J, 2013, NEUROIMAGE, V83, P646, DOI 10.1016/j.neuroimage.2013.06.072; GRASSBERGER P, 1983, PHYS LETT A, V97, P227, DOI 10.1016/0375-9601(83)90753-3; Haar S, 2016, CEREB CORTEX, V26, P1440, DOI 10.1093/cercor/bhu242; Habas PA, 2012, CEREB CORTEX, V22, P13, DOI 10.1093/cercor/bhr053; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Henry B., 2001, NONLINEAR BIOMEDICAL, V2, P1; Hentschel H, 1983, INFINITE NUMBER GEN; Hentschke H, 2011, EUR J NEUROSCI, V34, P1887, DOI 10.1111/j.1460-9568.2011.07902.x; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Hokkanen LSK, 2006, EUR J NEUROL, V13, P161, DOI 10.1111/j.1468-1331.2006.01157.x; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Jeong JW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00110; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Krishnan S, 2016, TRENDS COGN SCI, V20, P701, DOI 10.1016/j.tics.2016.06.012; Lawson RP, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00302; Leggio MG, 2008, BRAIN, V131, P1332, DOI 10.1093/brain/awn040; Limperopoulos C, 2007, PEDIATRICS, V120, P584, DOI 10.1542/peds.2007-1041; Limperopoulos C, 2014, CEREB CORTEX, V24, P728, DOI 10.1093/cercor/bhs354; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Marien P, 2014, CEREBELLUM, V13, P386, DOI 10.1007/s12311-013-0540-5; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Nader AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144645; O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599; Paulin MG, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S06; Paulin MG, 2011, 2011 7 INT C NAT COM; Peitgen H-O., 2004, CHAOS FRACTALS NEW F, DOI 10.1007/b97624; Ramnani N, 2006, NAT REV NEUROSCI, V7, P511, DOI 10.1038/nrn1953; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; RITVO ER, 1986, AM J PSYCHIAT, V143, P862; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Roth MJ, 2013, CURR BIOL, V23, P930, DOI 10.1016/j.cub.2013.04.027; Runyi A., 1970, FDN PROBABILITY; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Tesche CD, 1997, BRAIN RES, V744, P23, DOI 10.1016/S0006-8993(96)01027-X; THEILER J, 1990, J OPT SOC AM A, V7, P1055, DOI 10.1364/JOSAA.7.001055; Volpe JJ, 2009, J CHILD NEUROL, V24, P1085, DOI 10.1177/0883073809338067; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wang SSH, 2014, NEURON, V83, P518, DOI 10.1016/j.neuron.2014.07.016; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Whitney ER, 2009, J NEUROSCI RES, V87, P2245, DOI 10.1002/jnr.22056; Wiener M, 2014, NEUROIMAGE, V89, P10, DOI 10.1016/j.neuroimage.2013.11.019; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; Zhang LD, 2006, J NEUROSCI METH, V150, P242, DOI 10.1016/j.jneumeth.2005.06.021; Zhao GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155415	92	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0196964	10.1371/journal.pone.0196964	http://dx.doi.org/10.1371/journal.pone.0196964			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM7QQ	29995885	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800004
J	Toscano, M; Booth, F; Richards, G; Brown, S; Karcher, D; Tarlton, J				Toscano, Michael; Booth, Francesca; Richards, Gemma; Brown, Steven; Karcher, Darrin; Tarlton, John			Modeling collisions in laying hens as a tool to identify causative factors for keel bone fractures and means to reduce their occurrence and severity	PLOS ONE			English	Article							FOOT PAD DISORDERS; STRENGTH; OSTEOPOROSIS; PREVALENCE; DAMAGE; CAGE	Keel fractures represent a major productivity and welfare issue for the laying hen industry with greater than 50% of birds in recent surveys across various commercial operations and nations exhibiting some form of damage by end of lay. While the causes are likely multifactorial and influenced by age, diet, genetic line, and other factors, high energy collisions with house furnishings and conspecifics in the barn are believed to be a major contribution to the frequency and severity of factures. The current study applies a previously described ex vivo impact testing protocol to quantify susceptibility to keel bone damage across an extensive range of collision energies and ages. We also link fracture susceptibility with bone and physiological measures likely to influence skeletal resilience. Further, we applied the impact testing protocol to evaluate the benefit of an omega-3 enriched diet to improve bone health and reduce fracture susceptibility. Our results indicated that fracture susceptibility increased rapidly from 23 weeks of age, peaking at 49.5 weeks of age and thereafter decreasing. Fracture susceptibility also varied with multiple natural characteristics of bone, including mineral density, though the nature of that relationship was dependent on whether an old fracture was present. Severity of the experimental fracture demonstrated considerable variation with collision energy and biomechanical properties. An omega-3 enhanced diet provided a protective effect against fractures, though only in terms of collision energies that were relatively low. In conclusion, the impact testing protocol provided a unique means to assess fracture susceptibility and quantify the role of likely influencing bird-level biological factors, both those that vary naturally as well as when altered through specific interventions.	[Toscano, Michael] Univ Bern, VPH Inst, Div Anim Welf, Ctr Proper Housing Poultry & Rabbits ZTHZ, Zollikofen, Switzerland; [Booth, Francesca; Richards, Gemma; Brown, Steven; Tarlton, John] Univ Bristol, Sch Vet Sci, Lower Langford, North Somerset, England; [Karcher, Darrin] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	University of Bern; University of Bristol; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Toscano, M (corresponding author), Univ Bern, VPH Inst, Div Anim Welf, Ctr Proper Housing Poultry & Rabbits ZTHZ, Zollikofen, Switzerland.	Michael.toscano@vetsuisse.unibe.ch		Tarlton, John/0000-0002-4886-6634; Karcher, Darrin M/0000-0001-8863-8559	Biological and Biotechnology Sciences Research Councils [BB/K001906/1]; Alltech Nutrition [14-E-9821]; Noble Foods; Alltech Nutrition; BBSRC [BB/K001906/1, BB/N00860X/1, BB/K021303/1] Funding Source: UKRI	Biological and Biotechnology Sciences Research Councils; Alltech Nutrition; Noble Foods; Alltech Nutrition; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Our work was supported by the Biological and Biotechnology Sciences Research Councils (JT/MT: BB/K001906/1; https://www.bbsrc.ac.uk/), Alltech Nutrition (MT:14-E-9821; https://www.alltech.com/), and in-kind contribution from Noble Foods (all hens for the Impact Modelling Experiment). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to recognize the assistance and financial contribution of our industrial partners- Noble Foods and Alltech Nutrition-towards the project. We also thank the animal care staff of the Aviforum for maintaining our study animals and Edi Burkhard and Markus Schwab for their assistance throughout the impact testing procedure. Markus Schwab was also essential in study planning. An additional author, Lindsay J. Wilkins sadly passed away in 2016 and thus was unable to be involved in the editing of the paper. Nonetheless, as his work was essential experimental planning and data collection, we believe his contribution should be acknowledged.	Ammann P, 2003, OSTEOPOROSIS INT, V14, pS13, DOI 10.1007/s00198-002-1345-4; Bishop SC, 2000, BRIT POULTRY SCI, V41, P33, DOI 10.1080/00071660086376; Candelotto L, 2017, POULTRY SCI, V96, P3539, DOI [10.3382/ps/pex189, DOI 10.3382/PS/PEX189]; Casey-Trott T, 2015, POULTRY SCI, V94, P2339, DOI 10.3382/ps/pev223; Casey-Trott TM, 2017, POULTRY SCI, V96, P2518, DOI 10.3382/ps/pex060; Casey-Trott TM, 2017, POULTRY SCI, V96, P2509, DOI 10.3382/ps/pex059; Currey JD, 2001, CALCIFIED TISSUE INT, V68, P205, DOI 10.1007/s002230020040; FAWC, 2013, OP LETT GREAT BRIT G; FAWC, 2010, OP OST BON FRACT LAY; Fleming RH, 2006, BRIT POULTRY SCI, V47, P742, DOI 10.1080/00071660601077949; Harlander-Matauschek A, 2015, WORLD POULTRY SCI J, V71, P461, DOI 10.1017/S0043933915002135; Heerkens J, 2013, 9 EUR POULTR C UPPS, P127; Heerkens JLT, 2016, POULTRY SCI, V95, P2479, DOI 10.3382/ps/pew157; Heerkens JLT, 2016, POULTRY SCI, V95, P482, DOI 10.3382/ps/pev339; Kappeli S, 2011, BRIT POULTRY SCI, V52, P531, DOI 10.1080/00071668.2011.615059; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; MELVIN JW, 1993, J BIOMECH ENG-T ASME, V115, P549, DOI 10.1115/1.2895538; Petrik MT, 2015, POULTRY SCI, V94, P579, DOI 10.3382/ps/pev039; Rasbash J, 2009, USERS GUIDE MLWIN V2, V2, P10; Rath NC, 2000, POULTRY SCI, V79, P1024, DOI 10.1093/ps/79.7.1024; Regmi P., 2013, P 2013 ANN M POULTR, V92, P83; Silver N., 2012, SIGNAL NOISE ART SCI; Stratmann A, 2016, POULTRY SCI, V95, P975, DOI 10.3382/ps/pew026; Stratmann A, 2015, APPL ANIM BEHAV SCI, V165, P112, DOI 10.1016/j.applanim.2015.01.012; Stratmann A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122568; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Toscano MJ, 2015, POULTRY SCI, V94, P823, DOI 10.3382/ps/pev048; Toscano MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066215; Vanden Berge JC, 1975, SISSON GROSSMANS ANA, V2, P1802; Whitehead CC, 2000, POULTRY SCI, V79, P1033, DOI 10.1093/ps/79.7.1033; Whitehead CC, 2004, POULTRY SCI, V83, P193, DOI 10.1093/ps/83.2.193; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; 2015, EUR FOOD SAF AUTH J, V13, DOI DOI 10.2903/J.EFSA.2015.4191	33	14	14	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200025	10.1371/journal.pone.0200025	http://dx.doi.org/10.1371/journal.pone.0200025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990363	gold, Green Published, Green Submitted			2022-12-26	WOS:000438170300025
J	Hurley, PD; Oliver, S; Mehta, A				Hurley, Peter Donald; Oliver, Seb; Mehta, Anil			Creating longitudinal datasets and cleaning existing data identifiers in a cystic fibrosis registry using a novel Bayesian probabilistic approach from astronomy	PLOS ONE			English	Article							RECORD LINKAGE; CROSS-IDENTIFICATION; POPULATION-SIZE; EUROPE	Patient registry data are commonly collected as annual snapshots that need to be amalgamated to understand the longitudinal progress of each patient. However, patient identifiers can either change or may not be available for legal reasons when longitudinal data are collated from patients living in different countries. Here, we apply astronomical statistical matching techniques to link individual patient records that can be used where identifiers are absent or to validate uncertain identifiers. We adopt a Bayesian model framework used for probabilistically linking records in astronomy. We adapt this and validate it across blinded, annually collected data. This is a high-quality (Danish) sub-set of data held in the European Cystic Fibrosis Society Patient Registry (ECFSPR). Our initial experiments achieved a precision of 0.990 at a recall value of 0.987. However, detailed investigation of the discrepancies uncovered typing errors in 27 of the identifiers in the original Danish sub-set. After fixing these errors to create a new gold standard our algorithm correctly linked individual records across years achieving a precision of 0.997 at a recall value of 0.987 without recourse to identifiers. Our Bayesian framework provides the probability of whether a pair of records belong to the same patient. Unlike other record linkage approaches, our algorithm can also use physical models, such as body mass index curves, as prior information for record linkage. We have shown our framework can create longitudinal samples where none existed and validate pre-existing patient identifiers. We have demonstrated that in this specific case this automated approach is better than the existing identifiers.	[Hurley, Peter Donald; Oliver, Seb] Univ Sussex, Dept Phys & Astron, Brighton, E Sussex, England; [Mehta, Anil] Univ Dundee, Div Med Sci, Dundee, Scotland	University of Sussex; University of Dundee	Hurley, PD (corresponding author), Univ Sussex, Dept Phys & Astron, Brighton, E Sussex, England.	p.d.hurley@sussex.ac.uk		Hurley, Peter/0000-0001-8393-8544	Higher Education Innovation Funding; Science and Technology Facilities Council [ST/L000652/1]	Higher Education Innovation Funding; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	PDH was funded by the Higher Education Innovation Funding (http://www.hefce.ac.uk/ke/heif/). SO acknowledges support from the Science and Technology Facilities Council (grant number ST/L000652/1).	Anthony S, 2014, DEMENT GERIATR COGN, V38, P271, DOI 10.1159/000360281; BELIN TR, 1995, J AM STAT ASSOC, V90, P694; Boelle PY, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-64; Budavari T, 2008, ASTROPHYS J, V679, P301, DOI 10.1086/587156; Budavari T, 2015, ANNU REV STAT APPL, V2, P113, DOI 10.1146/annurev-statistics-010814-020231; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Durham Elizabeth, 2010, AMIA Annu Symp Proc, V2010, P182; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Heinis S, 2009, ASTROPHYS J, V698, P1838, DOI 10.1088/0004-637X/698/2/1838; Kho AN, 2015, J AM MED INFORM ASSN; Larsen MD, 2001, J AM STAT ASSOC, V96, P32, DOI 10.1198/016214501750332956; Liseo B, 2011, J OFF STAT, V27, P491; McCracken HJ, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219507; Mehta A, 2010, EARLY HUM DEV, V86, P723, DOI 10.1016/j.earlhumdev.2010.08.006; Mehta G, 2010, J CYST FIBROS, V9, pS5, DOI 10.1016/j.jcf.2010.08.002; Nguyen-Nielsen Mary, 2013, Clin Epidemiol, V5, P249, DOI 10.2147/CLEP.S45228; Oliver SJ, 2012, MON NOT R ASTRON SOC, V424, P1614, DOI 10.1111/j.1365-2966.2012.20912.x; Peckham D, 2014, J CYST FIBROS, V13, P681, DOI 10.1016/j.jcf.2014.03.002; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Richmond RC, 2014, EARLY HUM DEV, V90, P769, DOI 10.1016/j.earlhumdev.2014.08.023; Roseboom IG, 2009, MON NOT R ASTRON SOC, V400, P1062, DOI 10.1111/j.1365-2966.2009.15522.x; Rowan-Robinson M, 2013, MON NOT R ASTRON SOC, V428, P1958, DOI 10.1093/mnras/sts163; Sadinle M, 2014, ANN APPL STAT, V8, P2404, DOI 10.1214/14-AOAS779; Sanders DB, 2007, ASTROPHYS J SUPPL S, V172, P86, DOI 10.1086/517885; Steorts RC, 2014, ARXIV E PRINTS; Tancredi A, 2011, ANN APPL STAT, V5, P1553, DOI 10.1214/10-AOAS447; Taruscio D, 2013, PUBLIC HEALTH GENOM, V16, P288, DOI 10.1159/000355934; Viviani L, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-81; Wainwright CE, 2015, NEW ENGL J MED, V373, P220, DOI 10.1056/NEJMoa1409547; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992	31	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0199815	10.1371/journal.pone.0199815	http://dx.doi.org/10.1371/journal.pone.0199815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985939	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000438035500012
J	Scharmga, A; Peters, M; van den Bergh, JP; Geusens, P; Loeffen, D; van Rietbergen, B; Schoonbrood, T; Vosse, D; Weijers, R; van Tubergen, A				Scharmga, Andrea; Peters, Michiel; van den Bergh, Joop P.; Geusens, Piet; Loeffen, Daan; van Rietbergen, Bert; Schoonbrood, Thea; Vosse, Debby; Weijers, Rene; van Tubergen, Astrid			Development of a scoring method to visually score cortical interruptions on high-resolution peripheral quantitative computed tomography in rheumatoid arthritis and healthy controls	PLOS ONE			English	Article							BONE EROSION; JOINTS	Objectives To develop a scoring method to visually score cortical interruptions in finger joints on High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT), determine its intra-and inter-reader reliability and test its feasibility. Methods The scoring method was developed by integrating results from in-depth discussions with experts, consensus meetings, multiple reading experiments and the literature. Cortical interruptions were scored by two independent readers in an imaging dataset with finger joints from patients with rheumatoid arthritis (RA) and healthy controls and assessed for adjacent trabecular distortion. Reliability for the total number of cortical interruptions per joint and per quadrant was calculated using intraclass correlation coefficient (ICC). Feasibility was tested by recording the time to analyze one joint. Results In 98 joints we identified 252 cortical interruptions, 17% had trabecular distortion. Mean diameter of the interruptions was significantly larger in patients with RA compared with healthy controls (0.88 vs 0.47 mm, p = 0.03). Intra-reader reliability was ICC 0.88 (95% CI 0.83;0.92) per joint and ICC 0.69 (95% CI 0.65;0.73) per quadrant. Inter-reader reliability was ICC 0.48 (95% CI 0.20;0.67) per joint and ICC 0.56 (95% CI 0.49;0.62) per quadrant. The time to score one joint was mean 9.2 (SD 4.9) min. Conclusions This scoring method allows detection of small cortical interruptions on HR-pQCT imaging of finger joints, which is promising for use in clinical studies.	[Scharmga, Andrea; Peters, Michiel; van den Bergh, Joop P.; Geusens, Piet; Schoonbrood, Thea; Vosse, Debby; van Tubergen, Astrid] Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands; [Scharmga, Andrea; Peters, Michiel; van den Bergh, Joop P.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Scharmga, Andrea; Peters, Michiel; Geusens, Piet; van Tubergen, Astrid] Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands; [van den Bergh, Joop P.] Viecuri Med Ctr, Dept Internal Med, Venlo, Netherlands; [van den Bergh, Joop P.; Geusens, Piet] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [Loeffen, Daan; Weijers, Rene] Maastricht Univ, Dept Radiol, Med Ctr, Maastricht, Netherlands; [van Rietbergen, Bert] Eindhoven Univ Technol, Dept Med Engn, Eindhoven, Netherlands; [van Rietbergen, Bert] Maastricht Univ, Dept Orthopaed Surg, Med Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; VieCuri Medical Center; Hasselt University; Maastricht University; Eindhoven University of Technology; Maastricht University	Scharmga, A (corresponding author), Maastricht Univ, Dept Rheumatol, Med Ctr, Maastricht, Netherlands.; Scharmga, A (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands.; Scharmga, A (corresponding author), Maastricht Univ, CAPHRI Care & Publ Hlth Res Inst, Maastricht, Netherlands.	a.scharmga@maastrichtuniversity.nl	van Tubergen, Astrid/AAY-7065-2020	van Tubergen, Astrid/0000-0001-8477-0683; van den Bergh, Joop/0000-0003-3984-2232; Scharmga, Andrea/0000-0001-8940-8827	Weijerhorst foundation (JvdB); Pfizer [WS2056904];  [NL42300.068.12 / METC 12-2-037]	Weijerhorst foundation (JvdB); Pfizer(Pfizer); 	This work was supported by: the Weijerhorst foundation (JvdB) http://www.deweijerhorst.nl/weijerhorst/home. Funding that was used to purchase the HR-pQCT scanner and pay half of the PhD student salaries of MP and AS. It was also supported by Pfizer (PG), grant number: WS2056904, http://www.pfizer.nl/. This funding was used to perform the study (NL42300.068.12 / METC 12-2-037) of HR-pQCT imaging in patients with RA compared to conventional imaging techniques.	Barnabe C, 2016, J RHEUMATOL, V43, P1935, DOI 10.3899/jrheum.160648; Barnabe C, 2012, J RHEUMATOL, V39, P1494, DOI 10.3899/jrheum.120218; Binks DA, 2015, ANN RHEUM DIS, V74, P196, DOI 10.1136/annrheumdis-2013-203972; Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1671, DOI 10.1136/ard.2009.114512; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McGonagle D, 2009, ARTHRITIS RHEUM-US, V60, P1042, DOI 10.1002/art.24417; Peters M., 2016, ARTHRITIS RHEUMA S10, V68; Pialat JB, 2012, BONE, V50, P111, DOI 10.1016/j.bone.2011.10.003; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Scharmga A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1148-y; Scharmga A, 2016, ARTHRITIS RHEUMA S10, V68; Scharmga A, 2016, J RHEUMATOL, V43, P1914, DOI 10.3899/jrheum.160646; Schett G, 2005, ARTHRITIS RHEUM-US, V52, P3192, DOI 10.1002/art.21343; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Sharp JT, 2004, J RHEUMATOL, V31, P1062; Srikhum W, 2013, J RHEUMATOL, V40, P408, DOI 10.3899/jrheum.120780; Stach CM, 2010, ARTHRITIS RHEUM-US, V62, P330, DOI 10.1002/art.27252; van der Heijde D, 2000, J RHEUMATOL, V27, P261; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419	20	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200331	10.1371/journal.pone.0200331	http://dx.doi.org/10.1371/journal.pone.0200331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985943	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500035
J	Vollherbst, DF; Gockner, T; Do, T; Holzer, K; Mogler, C; Flechsig, P; Harms, A; Schlett, CL; Pereira, PL; Richter, GM; Kauczor, HU; Sommer, CM				Vollherbst, Dominik F.; Gockner, Theresa; Do, Thuy; Holzer, Kerstin; Mogler, Carolin; Flechsig, Paul; Harms, Alexander; Schlett, Christopher L.; Pereira, Philippe L.; Richter, Goetz M.; Kauczor, Hans U.; Sommer, Christof M.			Computed tomography and histopathological findings after embolization with inherently radiopaque 40 mu m-microspheres, standard 40 mu m-microspheres and iodized oil in a porcine liver model	PLOS ONE			English	Article							DRUG-ELUTING BEADS; DIFFERENT MINIPIG MODELS; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER EMBOLOTHERAPY; MICROPARTICLE EMBOLIZATION; MULTIMODAL VISIBILITY; PARTICLE EMBOLIZATION; ARTERIAL DISTRIBUTION; POLYZENE-F	Purpose The present study compared standard computed tomography (CT) and histopathological findings after endovascular embolization using a prototype of inherently radiopaque 40 mu m-microspheres with both standard 40 mu m-microspheres and iodized oil in a porcine liver model. Materials and methods Twelve pigs were divided into six study groups, of two pigs each. Four pigs were embolized with iodized oil alone and four with radiopaque microspheres; two animals in each group were sacrificed at 2 hours and two at 7 days. Two pigs were embolized with radiopaque microspheres and heparin and sacrificed at 7 days. Two pigs were embolized with standard microspheres and sacrificed at 2 hours. CT was performed before and after segmental embolization and before sacrifice at 7 days. The distribution of embolic agent, inflammatory response and tissue necrosis were assessed histopathologically. Results Radiopaque microspheres and iodized oil were visible on standard CT 2 hours and 7 days after embolization, showing qualitatively comparable arterial and parenchymal enhancement. Quantitatively, the enhancement was more intense for iodized oil. Standard microspheres, delivered without contrast, were not visible by imaging. Radiopaque and standard microspheres similarly occluded subsegmental and interlobular arteries and, to a lesser extent, sinusoids. Iodized oil resulted in the deepest penetration into sinusoids. Necrosis was always observed after embolization with microspheres, but never after embolization with iodized oil. The inflammatory response was mild to moderate for microspheres and moderate to severe for iodized oil. Conclusion Radiopaque 40 mu m-microspheres are visible on standard CT with qualitatively similar but quantitatively less intense enhancement compared to iodized oil, and with a tendency towards less of an inflammatory reaction than iodized oil. These microspheres also result in tissue necrosis, which was not observed after embolization with iodized oil. Both radiopaque and standard 40 mu m-microspheres are found within subsegmental and interlobar arteries, as well as in hepatic sinusoids.	[Vollherbst, Dominik F.] Univ Hosp Heidelberg, Dept Neuroradiol, Heidelberg, Germany; [Vollherbst, Dominik F.; Gockner, Theresa; Do, Thuy; Flechsig, Paul; Schlett, Christopher L.; Kauczor, Hans U.; Sommer, Christof M.] Univ Hosp Heidelberg, Clin Diagnost & Intervent Radiol, Heidelberg, Germany; [Gockner, Theresa] Univ Hosp Mainz, Clin Diagnost & Intervent Radiol, Mainz, Germany; [Holzer, Kerstin; Harms, Alexander] Univ Hosp Heidelberg, Dept Gen Pathol, Heidelberg, Germany; [Mogler, Carolin] Tech Univ Munich, Inst Pathol, Munich, Germany; [Flechsig, Paul] Univ Hosp Heidelberg, Dept Nucl Med, Heidelberg, Germany; [Pereira, Philippe L.] SLK Klin Heilbronn GmbH, Clin Radiol Minimally Invas Therapies & Nucl Med, Heilbronn, Germany; [Richter, Goetz M.; Sommer, Christof M.] Klinikum Stuttgart, Clin Diagnost & Intervent Radiol, Stuttgart, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University Hospital Mainz; Ruprecht Karls University Heidelberg; Technical University of Munich; Ruprecht Karls University Heidelberg; SLK-Kliniken Heilbronn GmbH; Klinikum Stuttgart	Sommer, CM (corresponding author), Univ Hosp Heidelberg, Clin Diagnost & Intervent Radiol, Heidelberg, Germany.; Sommer, CM (corresponding author), Klinikum Stuttgart, Clin Diagnost & Intervent Radiol, Stuttgart, Germany.	christof.sommer@med.uni-heidelberg.de	Kauczor, HU/AAX-6033-2021; Kauczor, Hans-Ulrich/AAU-5955-2021; Pereira, Philippe/AGA-3925-2022	Schlett, Christopher/0000-0002-1576-1481; Vollherbst, Dominik/0000-0002-8992-4757	Terumo; Angiodynamics/Microsulis; Bayer Global; Bayer Germany; Biocompatibles; BTG; Bracco; CeloNova BioSciences/Boston Scientific; Cook Medical; Covidien/Medtronic; GSK; Novartis; Pharmacept GmbH; Siemens Medical Solutions; SIRTEX; Terumo/Microventure; BSD; Astra Zeneca	Terumo; Angiodynamics/Microsulis; Bayer Global; Bayer Germany(Bayer AG); Biocompatibles; BTG; Bracco; CeloNova BioSciences/Boston Scientific; Cook Medical; Covidien/Medtronic; GSK(GlaxoSmithKline); Novartis(Novartis); Pharmacept GmbH; Siemens Medical Solutions(Siemens AG); SIRTEX; Terumo/Microventure; BSD; Astra Zeneca(AstraZeneca)	data analysis, decision to publish or preparation of the manuscript. No author is employed at these companies. No financial support was provided. No support in the form of salaries for authors was provided. PL Pereira reports consultancy, honoraries, grants and advisory boards for Terumo, Angiodynamics/Microsulis, Bayer Global and Bayer Germany, Biocompatibles and BTG, Bracco, CeloNova BioSciences/Boston Scientific, Cook Medical, Covidien/Medtronic, GSK, Novartis, Pharmacept GmbH, Siemens Medical Solutions, SIRTEX, Terumo/Microventure and BSD. HU Kauczor reports grants, personal fees and nonfinancial support from Siemens, personal fees from Boehringer Ingelheim, personal fees and nonfinancial support from Bayer, personal fees from GSK, personal fees from Novartis, personal fees from Astra Zeneca, personal fees from Philips, personal fees from Bracco. These potential conflicts of interests did not have any influence on study design, data collection, data analysis, decision to publish or preparation of the manuscript. The above-mentioned technical support and the above-mentioned personal affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials. All remaining authors have declared that no competing personal interest exists.This study was technically supported by CeloNova BioSciences, San Antonio, USA/ Boston Scientific, Malborough, USA in terms of provision of the embolic agents. This support had no influence on study design, data collection, data analysis, decision to publish or preparation of the manuscript. The above-mentioned technical support and the above-mentioned personal affiliations do not alter our adherence to PLOS ONE policies on sharing data and materials. All remaining authors have declared that no competing personal interest exists.	Aliberti C, 2017, FUTURE ONCOL, V13, P2243, DOI 10.2217/fon-2017-0364; Bonomo G, 2010, CARDIOVASC INTER RAD, V33, P552, DOI 10.1007/s00270-009-9752-y; Boulin M, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2016.67.2915; Brown KT, 2016, J CLIN ONCOL, V34, P2046, DOI 10.1200/JCO.2015.64.0821; Brown KT, 2004, J VASC INTERV RADIOL, V15, P197, DOI 10.1097/01.RVI.0000109400.52762.1F; de Baere T, 2016, CARDIOVASC INTER RAD, V39, P334, DOI 10.1007/s00270-015-1208-y; Dreher MR, 2012, J VASC INTERV RADIOL, V23, P257, DOI 10.1016/j.jvir.2011.10.019; Duran R, 2016, THERANOSTICS, V6, P28, DOI 10.7150/thno.13137; Gnutzmann DM, 2015, J VASC INTERV RADIOL, V26, P746, DOI 10.1016/j.jvir.2014.12.016; Gockner TL, 2015, CARDIOVASC INTER RAD, V38, P442, DOI 10.1007/s00270-014-0964-4; Golowa YS, 2012, J VASC INTERV RADIOL, V23, P1031, DOI 10.1016/j.jvir.2012.04.020; Imai N, 2014, WORLD J HEPATOL, V6, P844, DOI 10.4254/wjh.v6.i12.844; IWAI K, 1984, CANCER RES, V44, P2115; Lanza E, 2017, LIVER CANCER, V6, P27, DOI 10.1159/000449347; Levy EB, 2016, CARDIOVASC INTER RAD, V39, P1177, DOI 10.1007/s00270-016-1364-8; Loffroy R, 2013, RADIOLOGY, V266, P636, DOI 10.1148/radiol.12112316; Massmann A, 2015, LANGENBECK ARCH SURG, V400, P641, DOI 10.1007/s00423-015-1308-9; Negussie AH, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5530-3; Oh JS, 2013, J VASC INTERV RADIOL, V24, P483, DOI 10.1016/j.jvir.2013.01.001; Osuga K, 2012, INT J CLIN ONCOL, V17, P306, DOI 10.1007/s10147-012-0445-1; Rammohan A, 2012, WORLD J RADIOL, V4, P405, DOI 10.4329/wjr.v4.i9.405; Sergio A, 2008, AM J GASTROENTEROL, V103, P914, DOI 10.1111/j.1572-0241.2007.01712.x; Sharma KV, 2016, BIOMATERIALS, V103, P293, DOI 10.1016/j.biomaterials.2016.06.064; Sharma KV, 2010, J VASC INTERV RADIOL, V21, P865, DOI 10.1016/j.jvir.2010.02.031; Sommer CM, 2017, EUR J RADIOL, V86, P143, DOI 10.1016/j.ejrad.2016.10.024; Sommer CM, 2012, EUR J RADIOL, V81, P1165, DOI 10.1016/j.ejrad.2011.03.022; Sommer CM, 2013, INVEST RADIOL, V48, P213, DOI 10.1097/RLI.0b013e31827f6598; Stampfl S, 2007, CARDIOVASC INTER RAD, V30, P462, DOI 10.1007/s00270-005-0350-3; Stampfl S, 2007, CARDIOVASC INTER RAD, V30, P257, DOI 10.1007/s00270-005-0309-4; Stampfl S, 2008, CARDIOVASC INTER RAD, V31, P799, DOI 10.1007/s00270-007-9268-2; Stampfl S, 2009, J VASC INTERV RADIOL, V20, P1597, DOI 10.1016/j.jvir.2009.08.018; Stampfl U, 2012, J VASC INTERV RADIOL, V23, P1225, DOI 10.1016/j.jvir.2012.06.008; Tacher V, 2016, RADIOLOGY, V279, P741, DOI 10.1148/radiol.2015141624; Takayasu K, 2000, AM J ROENTGENOL, V175, P699, DOI 10.2214/ajr.175.3.1750699; Verret V, 2011, J VASC INTERV RADIOL, V22, P220, DOI 10.1016/j.jvir.2010.10.021; Wang XD, 2013, CARDIOVASC INTER RAD, V36, P1030, DOI 10.1007/s00270-012-0506-x; Wang YXJ, 2015, CHINESE J CANCER RES, V27, P96, DOI 10.3978/j.issn.1000-9604.2015.03.03	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0198911	10.1371/journal.pone.0198911	http://dx.doi.org/10.1371/journal.pone.0198911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985928	Green Published, gold, Green Submitted			2022-12-26	WOS:000438035500008
J	Bellini, L; De Benedictis, GM				Bellini, Luca; De Benedictis, Giulia Maria			Neuromuscular blockade of atracurium in permissive hypercapnic versus normocapnic swine undergoing laparoscopy	PLOS ONE			English	Article							CARBON-DIOXIDE PNEUMOPERITONEUM; ISOFLURANE ANESTHESIA; MUSCLE-RELAXANTS; BLOCKING-AGENT; PIGS; SURGERY; PHARMACOLOGY; VENTILATION	Neuromuscular blocking agents (NMBAs) are commonly used in experimental laparoscopy in swine undergoing carbon dioxide pneumoperitoneum. Hypercapnia may be present and may prolong NMBAs' pharmacologic activity. The aim of this study is to evaluate the effect of permissive hypercapnia on the neuromuscular blockade of atracurium in swine. Six Large White swine weighing 30.5 +/- 1.6 kg were sedated with intramuscular ketamine and medeto-midine, after which anaesthesia was induced with propofol and maintained with sevoflurane. Atracurium 0.4 mg/kg was administered intravenously and the neuromuscular block monitored by acceleromyography during normocapnic and hypercapnic conditions (PaCO2 range 35-45 mmHg and 60-70 mmHg, respectively). Onset time and time to reach a train of four ratio (TOFR) of 0.7 and 0.9 were recorded. Cardiorespiratory parameters, electrolytes and acid-base status were measured under both conditions. Onset time was similar between the two conditions. Time to reach a TOFR of 0.7 and 0.9 (duration of the neuromuscular block) was longer in hypercapnic compared to normocapnic animals being 1325 +/- 300 vs 855 +/- 111 (p = 0.002) and 1823 +/- 434 vs 1218 +/- 210 seconds (p = 0.005), respectively. Three hypercapnic swine had a TOF count of 2 and 1 instead of a count of 4 with fade. Permissive hypercapnia was associated with a decrease in pH from 7.444 +/- 0.039 to 7.257 +/- 0.025 (p < 0.001). No differences were observed for heart rate, end-tidal concentration of sevoflurane, body temperature and arterial haemoglobin saturation. Nonetheless, hypercapnic swine had a statistically significant increase in mean arterial pressure (p = 0.020) and plasma potassium concentration (p = 0.003). The values of PaCO2 achieved during hypercapnia were well tolerated in swine undergoing CO2 pneumoperitoneum for laparoscopy. Permissive hypercapnia increased the duration of the atracurium effect and caused an increase in the intensity of the neuromuscular block in few swine.	[Bellini, Luca; De Benedictis, Giulia Maria] Univ Padua, Dept Anim Med Prod & Hlth, Legnaro, Italy	University of Padua	Bellini, L (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth, Legnaro, Italy.	luca.bellini@unipd.it	Bellini, Luca/P-6957-2018; De Benedictis, Giulia Maria/ABH-1546-2020	Bellini, Luca/0000-0002-7145-6115; De Benedictis, Giulia Maria/0000-0002-8422-6829				Bashirov E, 2007, SURG ENDOSC, V21, P1820, DOI 10.1007/s00464-007-9295-8; Bevan DR, 1997, J CLIN ANESTH, V9, pS36, DOI 10.1016/S0952-8180(97)00120-7; Boccara G, 2003, BRIT J ANAESTH, V90, P343, DOI 10.1093/bja/aeg080; Gyermek L, 1999, ACTA ANAESTH SCAND, V43, P651, DOI 10.1034/j.1399-6576.1999.430610.x; HUGHES R, 1981, BRIT J ANAESTH, V53, P31, DOI 10.1093/bja/53.1.31; Husby P, 1998, LAB ANIM, V32, P316, DOI 10.1258/002367798780559257; Ismaiel NM, 2011, MINERVA ANESTESIOL, V77, P723; Kastrup MR, 2005, VET ANAESTH ANALG, V32, P222, DOI 10.1111/j.1467-2995.2005.00240.x; Komori M, 2007, CRIT CARE MED, V35, P2171, DOI 10.1097/01.ccm.0000281445.77223.31; Kopman AF, 2015, ANESTH ANALG, V120, P51, DOI 10.1213/ANE.0000000000000471; Lindberg F, 2003, SURG ENDOSC, V17, P480, DOI 10.1007/s00464-002-9044-y; Madsen MV, 2014, J CLIN MONIT COMPUT, V28, P351, DOI 10.1007/s10877-013-9539-1; ONO K, 1990, ANESTHESIOLOGY, V73, P710, DOI 10.1097/00000542-199010000-00017; PEARSON MRB, 1994, BRIT J ANAESTH, V72, P602, DOI 10.1093/bja/72.5.602; Pinard AM, 2003, CAN J ANAESTH, V50, P172, DOI 10.1007/BF03017852; PITTET JF, 1990, ANESTHESIOLOGY, V72, P145, DOI 10.1097/00000542-199001000-00024; SHORTEN GD, 1993, RES VET SCI, V55, P392, DOI 10.1016/0034-5288(93)90116-W; Strang CM, 2011, ACTA ANAESTH SCAND, V55, P887, DOI 10.1111/j.1399-6576.2011.02464.x; Valenza F, 2010, BEST PRACT RES-CLIN, V24, P227, DOI 10.1016/j.bpa.2010.02.002; WAUD BE, 1980, BRIT J ANAESTH, V52, P863, DOI 10.1093/bja/52.9.863; WEISKOPF RB, 1990, ANESTH ANALG, V71, P144	21	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200439	10.1371/journal.pone.0200439	http://dx.doi.org/10.1371/journal.pone.0200439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979782	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500111
J	Han, L; Wang, XX; Han, RH; Xu, M; Zhao, Y; Gao, QQ; Shen, HX; Zhang, HD				Han, Lei; Wang, Xiuxia; Han, Ruhui; Xu, Ming; Zhao, Yuan; Gao, Qianqian; Shen, Huanxi; Zhang, Hengdong			Association between blood lead level and blood pressure: An occupational population-based study in Jiangsu province, China	PLOS ONE			English	Article							OXIDATIVE STRESS; ESSENTIAL-HYPERTENSION; ARTERIAL-HYPERTENSION; US ADULTS; EXPOSURE; DISEASE; HEALTH	Studies about the association between lead exposure and the elevation of blood pressure and risk of hypertension are varied, while available data on blood lead levels (BLL) in workers with lead-exposure are scarce. This research aimed to evaluate associations between BLL and blood pressure in an occupational population-based study in Jiangsu province, China. We enrolled 21,688 workers in this study. Information on socioeconomic and occupational background was obtained with face-to-face interviews. BLL, systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured, and hypertension status was confirmed. We found that workers in mini-factories had the highest average BLL (20.3 mu g/dL; 95% CI, 19.0 +/- 21.6 mu g/dL) for overall participants. The employees in private factories had higher BLL (9.6 mu g/dL; 95% CI, 9.5 +/- 9.8 mu g/dL). However, BLL was much lower (4.0 mu g/dL; 95% CI, 3.7 +/- 4.2 mu g/dL) in state-owned factories. Participants working in the electrical machinery and equipment manufacturing industry had higher BLL (9.1 mu g/dL; 95% CI, 9.0 +/- 9.3 mu g/dL). Compared to those workers with <= 4.6 mu g/dL BLL, workers with > 17.5 mu g/dL BLL presented 1.34 mmHg and 0.70 mmHg average difference in SBP and DBP, respectively. The adjusted OR for hypertension was 1.11 (95% CI, 1.08 +/- 1.15) compared to the workers with > 17.5 mu g/dL BLL and to those with <= 4.6 mu g/dL BLL. In summary, we found that BLL was positively associated with SBP and DBP and with the morbidity of hypertension in occupational populations with a high concentration of lead exposure. It is important to formulate new standards of blood lead levels to screen for elevated lead exposure. In addition, a series of new systems of risk assessment should be established to further reduce and prevent lead exposure.	[Han, Lei; Xu, Ming; Zhao, Yuan; Gao, Qianqian; Zhang, Hengdong] Inst Occupat Dis Prevent, Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Wang, Xiuxia] Soochow Univ, Affiliated Guangji Hosp, Suzhou, Peoples R China; [Han, Ruhui] Soochow Univ, Dept Infect Management, Affiliated Hosp 1, Suzhou, Peoples R China; [Shen, Huanxi] Kunshan Municipal Ctr Dis Prevent & Control, Kunshan, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Soochow University - China; Soochow University - China	Zhang, HD (corresponding author), Inst Occupat Dis Prevent, Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.; Shen, HX (corresponding author), Kunshan Municipal Ctr Dis Prevent & Control, Kunshan, Peoples R China.	shenhuanxi@163.com; hd-zhang@263.net			National Natural Science Foundation of China [81470089]; National Natural Science Foundation for Young Scientists of China [81502796, 82703201]; Jiangsu Provincial Youth Medical Talent program [QNRC2016536, QNRC2016528]; Jiangsu Province's Outstanding Medical Academic Leader program [CXTDA2017029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Young Scientists of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Youth Medical Talent program; Jiangsu Province's Outstanding Medical Academic Leader program	This work was supported by National Natural Science Foundation of China 81470089 to HZ, National Natural Science Foundation for Young Scientists of China 81502796 to LH, National Natural Science Foundation for Young Scientists of China 82703201 to MX, Jiangsu Provincial Youth Medical Talent program QNRC2016536 to LH, Jiangsu Provincial Youth Medical Talent program QNRC2016528 to hs, Jiangsu Province's Outstanding Medical Academic Leader program CXTDA2017029 to MX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (No. 81470089), the National Natural Science Foundation for Young Scientists of China (No. 81502796 and 82703201), the Jiangsu Provincial Youth Medical Talent program (QNRC2016536, QNRC2016528) and Jiangsu Province's Outstanding Medical Academic Leader program (CXTDA2017029).	Lopes ACBA, 2016, REV ENVIRON CONTAM T, V236, P193, DOI 10.1007/978-3-319-20013-2_3; Barbosa F, 2005, ENVIRON HEALTH PERSP, V113, P1669, DOI 10.1289/ehp.7917; Bushnik T, 2014, HEALTH REP, V25, P12; Carretero OA, 2000, CIRCULATION, V101, P329, DOI 10.1161/01.CIR.101.3.329; Chen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37809; Commission CsNHaFP, 2002, DIAGN CRIT OCC CHRON; Council On Environmental H, 2016, PEDIATRICS, P138; Den Hond E, 2002, J HUM HYPERTENS, V16, P563, DOI 10.1038/sj.jhh.1001452; Dongre NN, 2013, INDIAN J CLIN BIOCHE, V28, P65, DOI 10.1007/s12291-012-0241-8; Faramawi MF, 2015, INT ARCH OCC ENV HEA, V88, P381, DOI 10.1007/s00420-014-0970-5; Gambelunghe A, 2016, ENVIRON RES, V149, P157, DOI 10.1016/j.envres.2016.05.015; Hara A, 2015, HYPERTENSION, V65, P62, DOI 10.1161/HYPERTENSIONAHA.114.04023; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Hypertension RCoCGfPaTo, 2010, ZHONGHUA XIN XUE GUA, V2011, P579; Jomova K, 2011, TOXICOLOGY, V283, P65, DOI 10.1016/j.tox.2011.03.001; Kaewboonchoo O, 2007, IND HEALTH, V45, P590, DOI 10.2486/indhealth.45.590; Kondrashov Vladislav, 2005, Int J Environ Res Public Health, V2, P164, DOI 10.3390/ijerph2005010164; Krzyzanowski M, 2008, J TOXICOL ENV HEAL A, V71, P47, DOI 10.1080/15287390701557834; Mamtani R, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/319136; Martin D, 2006, AM J EPIDEMIOL, V163, P467, DOI 10.1093/aje/kwj060; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Nawrot TS, 2002, J HUM HYPERTENS, V16, P123, DOI 10.1038/sj.jhh.1001300; (NTP) UNTP, 2012, NTP MONOGR, Vxiii, pxv; Poreba R, 2011, ENVIRON TOXICOL PHAR, V31, P267, DOI 10.1016/j.etap.2010.12.002; Poreba R, 2010, TOXICOL APPL PHARM, V249, P41, DOI 10.1016/j.taap.2010.08.012; Poreba R, 2011, TOXICOL APPL PHARM, V254, P342, DOI 10.1016/j.taap.2011.05.009; Pourmand A, 2012, DARU, V20, DOI 10.1186/2008-2231-20-70; Prokopowicz A, 2017, OCCUP ENVIRON MED, V74, P366, DOI 10.1136/oemed-2016-103996; Ramesh GT, 2001, TOXICOL LETT, V123, P195, DOI 10.1016/S0378-4274(01)00395-2; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Shen XF, 2016, NEUROTOXICOLOGY, V57, P145, DOI 10.1016/j.neuro.2016.09.013; Singh M, 2016, CLIN EXP HYPERTENS, V38, P268, DOI 10.3109/10641963.2015.1116543; WHO, WHO LEAD POIS PREV W; Wijesekara GUS, 2015, CEYLON MED J, V60, P52, DOI 10.4038/cmj.v60i2.7090; Zawadzki Marcin, 2006, Medycyna Pracy, V57, P543	36	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200289	10.1371/journal.pone.0200289	http://dx.doi.org/10.1371/journal.pone.0200289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979755	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500092
J	Schopfer, LM; Lockridge, O				Schopfer, Lawrence M.; Lockridge, Oksana			Chlorpyrifos oxon promotes tubulin aggregation via isopeptide cross-linking between diethoxyphospho-Lys and Glu or Asp: Implications for neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tubulin; neurotoxin; protein misfolding; mass spectrometry (MS); Western blot; crosslink; isopeptide; neurotoxicity; organophosphate; protein aggregation	CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; PHOSPHOROFLUORIDATE (DFP)-TREATED HEN; ORGANOPHOSPHORUS NERVE AGENTS; LOW-LEVEL EXPOSURE; MASS-SPECTROMETRY; MICROTUBULE STRUCTURES; BINDING; BRAIN; PHOSPHORYLATION; PESTICIDE	Exposure to organophosphorus toxicants (OP) can have chronic adverse effects that are not explained by inhibition of acetylcholinesterase, the cause of acute OP toxicity. We therefore hypothesized that OP-induced chronic illness is initiated by the formation of organophosphorus adducts on lysine residues in proteins, followed by protein cross-linking and aggregation. Here, Western blots revealed that exposure to the OP chlorpyrifos oxon converted porcine tubulin from its original 55-kDa mass to high-molecular-weight aggregates. Liquid chromatography-tandem MS analysis of trypsin-digested samples identified several diethoxyphospho-lysine residues in the OP-treated tubulin. Using a search approach based on the Batch Tag program, we identified cross-linked peptides and found that these chemically activated lysines reacted with acidic amino acid residues creating -glutamyl-E-lysine or aspartyl-E-lysine isopeptide bonds between - and -tubulin. Of note, these cross-linked tubulin molecules accounted for the high-molecular-weight aggregates. To the best of our knowledge, this is the first report indicating that chlorpyrifos oxon-exposed tubulin protein forms intermolecular cross-links with other tubulin molecules, resulting in high-molecular-weight protein aggregates. It is tempting to speculate that chronic illness from OP exposure may be explained by a mechanism that starts with OP adduct formation on protein lysines followed by protein cross-linking. We further speculate that OP-modified or cross-linked tubulin can impair axonal transport, reduce neuron connections, and result in neurotoxicity.	[Schopfer, Lawrence M.; Lockridge, Oksana] Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Schopfer, LM; Lockridge, O (corresponding author), Univ Nebraska Med Ctr, Eppley Inst, Omaha, NE 68198 USA.	lmschopf@unmc.edu; olockrid@unmc.edu		Lockridge, Oksana/0000-0002-8345-3640	Fred and Pamela Buffett Cancer Center Support Grant from the National Institutes of Health, NCI [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER	Fred and Pamela Buffett Cancer Center Support Grant from the National Institutes of Health, NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Fred and Pamela Buffett Cancer Center Support Grant P30CA036727 from the National Institutes of Health, NCI. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALLISON RD, 1981, J BIOL CHEM, V256, P2988; Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; Brady ST, 2017, NEUROBIOL DIS, V105, P273, DOI 10.1016/j.nbd.2017.04.010; Brown MA, 1998, J APPL TOXICOL, V18, P393, DOI 10.1002/(SICI)1099-1263(199811/12)18:6<393::AID-JAT528>3.0.CO;2-0; Bui-Nguyen TM, 2014, J PROTEOME RES, V13, P3583, DOI 10.1021/pr5000076; Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259; CHAIKEN IM, 1969, J BIOL CHEM, V244, P4247; Chalkley RJ, 2005, MOL CELL PROTEOMICS, V4, P1189, DOI 10.1074/mcp.D500001-MCP200; Chen SG, 2013, J PHARMACOL EXP THER, V344, P531, DOI 10.1124/jpet.112.201368; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Choudhary S, 2001, BRAIN RES, V897, P60, DOI 10.1016/S0006-8993(00)03222-4; Crow BS, 2014, ANAL CHEM, V86, P10397, DOI 10.1021/ac502886c; Eyer F, 2009, BIOCHEM PHARMACOL, V78, P531, DOI 10.1016/j.bcp.2009.05.004; Gearhart DA, 2007, TOXICOL APPL PHARM, V218, P20, DOI 10.1016/j.taap.2006.10.008; Grigoryan H, 2008, CHEM-BIOL INTERACT, V175, P180, DOI 10.1016/j.cbi.2008.04.013; Grigoryan H, 2009, ANAL BIOCHEM, V394, P92, DOI 10.1016/j.ab.2009.07.008; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Gupta RP, 1999, ARCH BIOCHEM BIOPHYS, V365, P268, DOI 10.1006/abbi.1999.1165; GUPTA RP, 1995, NEUROCHEM RES, V20, P1095, DOI 10.1007/BF00995565; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hayden KM, 2010, NEUROLOGY, V74, P1524, DOI 10.1212/WNL.0b013e3181dd4423; Hernandez CM, 2015, NEUROTOXICOLOGY, V47, P17, DOI 10.1016/j.neuro.2015.01.002; Jiang W, 2010, TOXICOL SCI, V115, P183, DOI 10.1093/toxsci/kfq032; John H, 2018, FORENSIC TOXICOL, V36, P61, DOI 10.1007/s11419-017-0376-7; John H, 2010, ANAL BIOANAL CHEM, V398, P2677, DOI 10.1007/s00216-010-4076-y; Kamel F, 2007, AM J EPIDEMIOL, V165, P364, DOI 10.1093/aje/kwk024; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2011, TRENDS BIOCHEM SCI, V36, P227, DOI 10.1016/j.tibs.2010.09.007; Li B, 2007, ANAL BIOCHEM, V361, P263, DOI 10.1016/j.ab.2006.11.018; Liu M, 2013, ANAL CHEM, V85, P5900, DOI 10.1021/ac400666p; Lockridge O, 2010, CHEM-BIOL INTERACT, V187, P344, DOI 10.1016/j.cbi.2010.03.002; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lotti Marcello, 2005, Toxicol Rev, V24, P37, DOI 10.2165/00139709-200524010-00003; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Meyer A, 2003, ENVIRON HEALTH PERSP, V111, P1871, DOI 10.1289/ehp.6468; MURACHI T, 1965, BIOCHEMISTRY-US, V4, P2815, DOI 10.1021/bi00888a036; MURACHI T, 1970, J BIOCHEM-TOKYO, V68, P239, DOI 10.1093/oxfordjournals.jbchem.a129351; Nemes Z, 2005, ANAL BIOCHEM, V342, P1, DOI 10.1016/j.ab.2004.10.015; Nemes Z, 2004, FASEB J, V18, P1135, DOI 10.1096/fj.04-1493fje; Noort D, 2009, ARCH TOXICOL, V83, P1031, DOI 10.1007/s00204-009-0456-5; Onder S, 2018, CHEM RES TOXICOL, V31, P520, DOI 10.1021/acs.chemrestox.8b00083; Onder S, 2017, CHEM RES TOXICOL, V30, P2218, DOI 10.1021/acs.chemrestox.7b00288; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Rauh VA, 2015, NEUROTOXICOLOGY, V51, P80, DOI 10.1016/j.neuro.2015.09.004; Rauh VA, 2012, P NATL ACAD SCI USA, V109, P7871, DOI 10.1073/pnas.1203396109; Recktenwald CV, 2016, J BIOL CHEM, V291, P13580, DOI 10.1074/jbc.M116.726406; Richardson RJ, 2013, CHEM-BIOL INTERACT, V203, P238, DOI 10.1016/j.cbi.2012.10.024; Ross SM, 2013, CRIT REV TOXICOL, V43, P21, DOI 10.3109/10408444.2012.738645; Sanger F., 1963, P CHEM SOC, V5, P76; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Schmidt C, 2014, ANAL BIOANAL CHEM, V406, P5171, DOI 10.1007/s00216-014-7706-y; Schuh RA, 2002, TOXICOL APPL PHARM, V182, P176, DOI 10.1006/taap.2002.9445; Speed HE, 2012, TOXICOL SCI, V125, P196, DOI 10.1093/toxsci/kfr253; TARCSA E, 1990, ANAL BIOCHEM, V186, P135, DOI 10.1016/0003-2697(90)90586-X; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Williams NH, 2007, ARCH TOXICOL, V81, P627, DOI 10.1007/s00204-007-0191-8; Zamponi E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188340	59	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13566	13577		10.1074/jbc.RA118.004172	http://dx.doi.org/10.1074/jbc.RA118.004172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30006344	Green Published, hybrid			2022-12-26	WOS:000443375500017
J	Gao, YG; Zhang, LJ; Zhao, SC; Yan, YX				Gao, Yonggang; Zhang, LiJuan; Zhao, ShengChao; Yan, Yuanxin			Comparative analysis of the male inflorescence transcriptome profiles of an ms22 mutant of maize	PLOS ONE			English	Article							CYTOPLASMIC MALE-STERILITY; RNA-SEQ; POLLEN GERMINATION; BRASSICA-NAPUS; GENE; ARABIDOPSIS; EXPRESSION; CALCIUM; ANTHERS; POLYGALACTURONASE	In modern agricultural production, maize is the most successful crop utilizing heterosis. 712C-ms22 is an important male sterile material in maize. In this study, we performed transcriptome sequencing analysis of the V10 stage of male inflorescence. Through this analysis, 27.63 million raw reads were obtained, and trimming of the raw data revealed 26.63 million clean reads, with an average match rate of 94.64%. Using Tophat software, we matched these clean reads to the maize reference genome. The abundance of 39,622 genes was measured, and 35,399 genes remained after filtering out the non-expressed genes across all the samples. These genes were classified into 19 categories by clusters of orthologous groups of protein annotation. Transcriptome sequencing analysis of the male sterile and fertile 712C-ms22 maize revealed some key DEGs that may be related to metabolic pathways. qRT-PCR analysis validated the gene expression patterns identified by RNA-seq. This analysis revealed some of the essential genes responsible for pollen development and for pollen tube elongation. Our findings provide useful markers of male sterility and new insights into the global mechanisms mediating male sterility in maize.	[Gao, Yonggang; Zhang, LiJuan; Zhao, ShengChao; Yan, Yuanxin] Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Gao, YG; Yan, YX (corresponding author), Nanjing Agr Univ, Nanjing, Jiangsu, Peoples R China.	gyg912@163.com; YUANXin.YAN@njau.edu.cn			National Natural Science Foundation of China [31571580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31571580).	ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Brady SM, 2009, PLANT CELL, V21, P1034, DOI 10.1105/tpc.109.066050; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; Chen CB, 2002, DEVELOPMENT, V129, P2401; Chen XY, 2009, PLANT PHYSIOL, V150, P105, DOI 10.1104/pp.108.133918; Chen ZJ, 2013, NAT REV GENET, V14, P471, DOI 10.1038/nrg3503; Daher FB, 2011, PLANT CELL PHYSIOL, V52, P1177, DOI 10.1093/pcp/pcr068; Dong XY, 2005, PLANT J, V42, P315, DOI 10.1111/j.1365-313X.2005.02379.x; Enns LC, 2005, PLANT MOL BIOL, V58, P333, DOI 10.1007/s11103-005-4526-7; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gomes S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11976; Gong FP, 2014, OMICS, V18, P714, DOI 10.1089/omi.2014.0125; Gorguet B, 2009, THEOR APPL GENET, V118, P1199, DOI 10.1007/s00122-009-0974-9; Grotewold E, 1998, PLANT CELL, V10, P721, DOI 10.1105/tpc.10.5.721; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Jan A, 2013, PLANT PHYSIOL, V161, P1202, DOI 10.1104/pp.112.205385; Jiang JJ, 2014, PLANT SCI, V229, P66, DOI 10.1016/j.plantsci.2014.08.008; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kobayashi A, 1998, PLANT J, V13, P571, DOI 10.1046/j.1365-313X.1998.00043.x; Li X, 2016, PLANT MOL BIOL REP, V34, P15, DOI 10.1007/s11105-015-0901-y; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065209; Maciver SK, 2002, GENOME BIOL, V3; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Messerli MA, 2000, DEV BIOL, V222, P84, DOI 10.1006/dbio.2000.9709; Min Haowei, 2016, FRONT PLANT SCI, V1080, P1; Miura K, 2011, PLANT PHYSIOL, V155, P1000, DOI 10.1104/pp.110.165191; Mohammad Mehdi, 2009, Journal of Phytology, V1, P448; Muraya MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132120; Nan GL, 2017, DEVELOPMENT, V144, P163, DOI 10.1242/dev.140673; Ranum P, 2014, ANN NY ACAD SCI, V1312, P105, DOI 10.1111/nyas.12396; Rhee SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2186-9; Sander L, 2001, PLANT MOL BIOL, V46, P469, DOI 10.1023/A:1010619002833; Schnable PS, 2013, ANNU REV PLANT BIOL, V64, P71, DOI 10.1146/annurev-arplant-042110-103827; Scott C, 2015, PLANT GENOME, V9, P679; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Sheoran IS, 2010, BOTANY, V88, P217, DOI 10.1139/B09-085; Skibbe DS, 2005, MAYDICA, V50, P367; Steinhorst L, 2013, BBA-MOL CELL RES, V1833, P1573, DOI 10.1016/j.bbamcr.2012.10.009; Suzuki H, 2013, PLANT CELL REP, V32, P1531, DOI 10.1007/s00299-013-1465-7; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Timofejeva L, 2013, G3-GENES GENOM GENET, V3, P231, DOI 10.1534/g3.112.004465; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Varnier AL, 2005, J STRUCT BIOL, V152, P118, DOI 10.1016/j.jsb.2005.07.011; VEDEL F, 1994, PLANT PHYSIOL BIOCH, V32, P601; Wang CS, 2013, INT REV CEL MOL BIO, V301, P37, DOI 10.1016/B978-0-12-407704-1.00002-6; Wang DX, 2010, PLANT J, V63, P939, DOI 10.1111/j.1365-313X.2010.04294.x; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wei MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-97; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; Wu JY, 2011, PLANT PHYSIOL, V155, P963, DOI 10.1104/pp.110.161927; Xie Chao-Tian, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P17; Xu CG, 2013, PROTOPLASMA, V250, P415, DOI 10.1007/s00709-012-0386-6; Yan XH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-26; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758; ZHOU H, 2014, NAT COMMUN, V5; Zhou LM, 2015, PLANT PHYSIOL, V167, P1351, DOI 10.1104/pp.114.256065	64	2	2	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0199437	10.1371/journal.pone.0199437	http://dx.doi.org/10.1371/journal.pone.0199437			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005064	Green Published, gold, Green Submitted			2022-12-26	WOS:000438744200003
J	Dankert, JT; Wiesehofer, M; Czyrnik, ED; Singer, BB; von Ostau, N; Wennemuth, G				Dankert, Jaroslaw Thomas; Wiesehoefer, Marc; Czyrnik, Elena Dilara; Singer, Bernhard B.; von Ostau, Nicola; Wennemuth, Gunther			The deregulation of miR-17/CCND1 axis during neuroendocrine transdifferentiation of LNCaP prostate cancer cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; DOWN-REGULATION; TARGET; PROLIFERATION; EXPRESSION; MICRORNA; PROMOTES; GROWTH; DIFFERENTIATION; MIR-17-5P	Prostate carcinoma contain foci of neuroendocrine transdifferentiation, resulting in an increase of androgen-independent neuroendocrine-like (NE) tumor cells, whose number significantly correlates with tumor aggressiveness and thus lower survival rate. Neuroendocrine transdifferentiation of prostate cancer cells and a potential role of miRNAs within this process are poorly understood. MicroRNAs are small non-coding RNAs which post-transcriptionally regulate gene expression. The aim of this project was to identify new genes and miRNAs involved in neuroendocrine transdifferentiation. LNCaP prostate cancer cells were differentiated to NE-like cancer cells and microarray analyses were performed. Microarray results have been validated for the eight most deregulated mRNAs and microRNAs via qRT-PCR and analyzed with different algorithms to predict new targets for deregulated microRNAs. The induced CyclinD1 gene could be validated as new target gene for the repressed miR-17 family containing miR-17, miR-20a, miR-20b, miR-106a and miR-106b via reporter gene assays and Western Blot. Functional analysis of miR-17 family shows a high influence on cell proliferation, colony forming ability and apoptosis in LNCaP cells. Our data demonstrate wide changes in mRNA and microRNA expression during neuroendocrine transdifferentiation of LNCaP cells and confirm new mRNA-miRNA interactions with potential roles in NE-transdifferentiation of prostate carcinoma.	[Dankert, Jaroslaw Thomas; Wiesehoefer, Marc; Czyrnik, Elena Dilara; Singer, Bernhard B.; von Ostau, Nicola; Wennemuth, Gunther] Duisburg Essen Univ, Univ Hosp, Inst Anat, Essen, Germany	University of Duisburg Essen	Dankert, JT (corresponding author), Duisburg Essen Univ, Univ Hosp, Inst Anat, Essen, Germany.	jaroslaw.dankert@uk-essen.de	Dankert, Jaroslaw Thomas/A-2400-2017; Dankert, Jaroslaw Thomas/GWV-8070-2022; Singer, Bernhard B./AAP-9999-2020	Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Dankert, Jaroslaw Thomas/0000-0002-5950-0742; Czyrnik, Elena/0000-0001-5383-6619; Wennemuth, Gunther/0000-0003-3313-2475; Wiesehofer, Marc/0000-0001-7105-8179	Open Access Publication Fund of the University of Duisburg-Essen	Open Access Publication Fund of the University of Duisburg-Essen	The authors acknowledge support by the Open Access Publication Fund of the University of Duisburg-Essen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OPEN J UROL, DOI DOI 10.4236/OJU.2012.223032; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Berruti A, 2005, ENDOCR-RELAT CANCER, V12, P109, DOI 10.1677/erc.1.00876; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Cai N, 2018, EUR REV MED PHARMACO, V22, P1899, DOI 10.26355/eurrev_201804_14712; Cerasuolo M, 2015, CANCER RES, V75, P2975, DOI 10.1158/0008-5472.CAN-14-3830; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Czapiewski P, 2016, POL J PATHOL, V67, P228, DOI [10.5114/PJP.2016.63774, 10.5114/pjp.2016.63774]; Dai H, 2018, CANCER BIOTHER RADIO, V33, P103, DOI 10.1089/cbr.2017.2386; Das SG, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0699-z; Deeble PD, 2001, MOL CELL BIOL, V21, P8471, DOI 10.1128/MCB.21.24.8471-8482.2001; Ding M, 2015, ONCOTARGET, V6, P7686, DOI 10.18632/oncotarget.3480; Eder IE, 2003, MOL CARCINOGEN, V37, P181, DOI 10.1002/mc.10136; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fukami K, 2015, BIOCHEM PHARMACOL, V97, P300, DOI 10.1016/j.bcp.2015.08.005; Gong AY, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-492; Guo JQ, 2016, BIOCHEM BIOPH RES CO, V478, P804, DOI 10.1016/j.bbrc.2016.08.029; Hart M, 2014, MOL CANCER RES, V12, P250, DOI 10.1158/1541-7786.MCR-13-0230; Hart M, 2013, FEBS J, V280, P2105, DOI 10.1111/febs.12236; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hsieh TC, 1997, INT J ONCOL, V10, P1109; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsegge Ina, 2009, BMC Proc, V3 Suppl 4, pS10, DOI 10.1186/1753-6561-3-S4-S10; Imig J, 2011, NUCLEIC ACIDS RES, V39, P1880, DOI 10.1093/nar/gkq1043; KRIJNEN JLM, 1993, HISTOCHEMISTRY, V100, P393, DOI 10.1007/BF00268938; Limbert C, 2010, STEM CELLS DEV, V19, P679, DOI 10.1089/scd.2009.0241; Lin BY, 1999, CANCER RES, V59, P4180; Ma AH, 2006, CANCER RES, V66, P8439, DOI 10.1158/0008-5472.CAN-06-1636; Martin-Orozco RM, 2007, NEOPLASIA, V9, P614, DOI 10.1593/neo.07337; Maugeri-Sacca M, 2012, CANCER J, V18, P253, DOI 10.1097/PPO.0b013e318258b5b6; Murata T, 2010, PROSTATE CANCER P D, V13, P356, DOI 10.1038/pcan.2010.32; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ottman R, 2016, ONCOTARGET, V7, P73739, DOI 10.18632/oncotarget.12061; Pashaei E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179543; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Schiewer MJ, 2009, ONCOGENE, V28, P1016, DOI 10.1038/onc.2008.446; Shen R, 1997, Urol Oncol, V3, P67, DOI 10.1016/S1078-1439(97)00039-2; Sun GW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190515; Sun XK, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-208; Szczyrba J, 2013, INT J CANCER, V132, P775, DOI 10.1002/ijc.27731; Szczyrba J, 2011, MOL CANCER RES, V9, P791, DOI 10.1158/1541-7786.MCR-10-0573; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tang YL, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0047-5; Terry S, 2013, NEOPLASIA, V15, P761, DOI 10.1593/neo.122070; Torres S, 2017, J PATHOL, V242, P39, DOI 10.1002/path.4874; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uchida K, 2006, PROSTATE, V66, P536, DOI 10.1002/pros.20369; Vashchenko N, 2005, EUR UROL, V47, P147, DOI 10.1016/j.eururo.2004.09.007; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wach S, 2012, INT J CANCER, V130, P611, DOI 10.1002/ijc.26064; Waltering KK, 2011, PROSTATE, V71, P604, DOI 10.1002/pros.21276; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8; Zhang W, 2016, INT J ONCOL, V48, P1877, DOI 10.3892/ijo.2016.3437; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8	58	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200472	10.1371/journal.pone.0200472	http://dx.doi.org/10.1371/journal.pone.0200472			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001402	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400064
J	Raba, DN; Chambre, DR; Copolovici, DM; Moldovan, C; Copolovici, LO				Raba, Diana Nicoleta; Chambre, Dorina Rodica; Copolovici, Dana-Maria; Moldovan, Camelia; Copolovici, Lucian Octav			The influence of high-temperature heating on composition and thermo-oxidative stability of the oil extracted from Arabica coffee beans	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; GREEN COFFEE; LIPID FRACTION; ROASTED COFFEE; VEGETABLE-OILS; THERMAL-DECOMPOSITION; COSMETIC FORMULATIONS; ANTIOXIDANT ACTIVITY; OXIDATIVE STABILITY; SUNFLOWER OIL	The aim of the present study was to establish the influence of high-temperature heating on the composition and thermal behavior of coffee oils obtained from Arabica green and roasted coffee beans, respectively. Morphological studies performed using scanning electron microscopy revealed the oil bodies uniformly distributed within the cells in both types of coffee beans analyzed. The obtained oils have a fatty acid composition rich in linoleic acid, palmitic acid, oleic acid, stearic acid, arachidic acid and linolenic acid. The total content of saturated fatty acids of investigated oils was 49.38 and 46.55%, the others being unsaturated fatty acids. The thermal behavior and thermo-oxidative stability of coffee oils extracted from green coffee beans and roasted coffee beans, the coffee oil high-temperature heated up to 200 degrees C, were investigated using simultaneous thermal analysis TG/DTG/DTA, in an oxidizing atmosphere. The data obtained for the analyzed samples depend mainly on the nature and compositions of fatty acids, and to a lesser extent on the roasting process of the coffee beans and the high-temperature heating process of the extracted oil. The chromatographic and TG/DTG/DTA data suggest that Arabica coffee oil has great potential for use in technological processes which require high-temperature heating (e.g. food industry or pastries).	[Raba, Diana Nicoleta] Banats Univ Agr Sci & Vet Med King Michael I Roma, Dept Food Technol, Timisoara, Romania; [Chambre, Dorina Rodica; Copolovici, Dana-Maria; Copolovici, Lucian Octav] Aurel Vlaicu Univ Arad, Dept Tech & Nat Sci, Arad, Romania; [Chambre, Dorina Rodica; Copolovici, Dana-Maria; Copolovici, Lucian Octav] Aurel Vlaicu Univ Arad, Inst Res Dev Innovat Tech & Nat Sci, Arad, Romania; [Moldovan, Camelia] Banats Univ Agr Sci & Vet Med King Michael I Roma, Dept Food Control, Timisoara, Romania	Banat University of Agricultural Sciences & Veterinary Medicine; Aurel Vlaicu University of Arad; Aurel Vlaicu University of Arad; Banat University of Agricultural Sciences & Veterinary Medicine	Chambre, DR; Copolovici, DM (corresponding author), Aurel Vlaicu Univ Arad, Dept Tech & Nat Sci, Arad, Romania.; Chambre, DR; Copolovici, DM (corresponding author), Aurel Vlaicu Univ Arad, Inst Res Dev Innovat Tech & Nat Sci, Arad, Romania.	dorina.chambre@uav.ro; dana.copolovici@uav.ro	Moldovan, Camelia/ADV-8991-2022; Copolovici, Dana Maria/C-5207-2012; Copolovici, Lucian/B-6552-2011	Moldovan, Camelia/0000-0003-0051-8582; Copolovici, Dana Maria/0000-0002-1491-0473; Copolovici, Lucian/0000-0002-4454-200X	European Commission; Romanian Government [POSCCE 621/2014]	European Commission(European CommissionEuropean Commission Joint Research Centre); Romanian Government(Romanian Government)	This work was supported by The European Commission and The Romanian Government (project POSCCE 621/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlKanhal MA, 1997, INT J FOOD SCI NUTR, V48, P135, DOI 10.3109/09637489709006973; Alvarez AMR, 2000, GRASAS ACEITES, V51, P74; Alves MR, 2003, J AM OIL CHEM SOC, V80, P511, DOI 10.1007/s11746-003-0730-0; Amarowicz R, 2009, EUR J LIPID SCI TECH, V111, P109, DOI 10.1002/ejlt.200900011; Anese M, 2000, ITAL J FOOD SCI, V12, P457; Arora S, 2010, J THERM ANAL CALORIM, V102, P375, DOI 10.1007/s10973-009-0460-2; Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526; Budryn G, 2013, J FOOD PROCESS PRES, V37, P835, DOI 10.1111/j.1745-4549.2012.00710.x; Budryn G, 2013, EUR FOOD RES TECHNOL, V236, P969, DOI 10.1007/s00217-013-1956-3; Budryn G, 2012, EUR J LIPID SCI TECH, V114, P1052, DOI 10.1002/ejlt.201100324; Budryn G, 2011, GRASAS ACEITES, V62, P155, DOI 10.3989/gya.067210; Calligaris S, 2009, EUR J LIPID SCI TECH, V111, P1270, DOI 10.1002/ejlt.200900042; Campos-Vega R, 2015, TRENDS FOOD SCI TECH, V45, P24, DOI 10.1016/j.tifs.2015.04.012; Carvalho AGS, 2014, FOOD RES INT, V61, P236, DOI 10.1016/j.foodres.2013.08.012; Copolovici D, 2017, REV CHIM-BUCHAREST, V68, P507; Couto RM, 2009, J SUPERCRIT FLUID, V51, P159, DOI 10.1016/j.supflu.2009.09.009; de Souza AG, 2004, BRAZ J CHEM ENG, V21, P265, DOI 10.1590/S0104-66322004000200017; Dennis EA, 2009, EAT BEHAV, V10, P237, DOI 10.1016/j.eatbeh.2009.07.006; Dong WJ, 2015, MOLECULES, V20, P16687, DOI 10.3390/molecules200916687; Dweck J, 2004, J THERM ANAL CALORIM, V75, P385, DOI 10.1023/B:JTAN.0000027124.96546.0f; Ferrari M, 2010, COLLOID SURFACE A, V365, P79, DOI 10.1016/j.colsurfa.2010.02.002; Garcia CC, 2007, J THERM ANAL CALORIM, V87, P645, DOI 10.1007/s10973-006-7769-x; Gennaro L, 1998, J AGR FOOD CHEM, V46, P4465, DOI 10.1021/jf980562q; Getachew AT, 2016, LWT-FOOD SCI TECHNOL, V70, P126, DOI 10.1016/j.lwt.2016.02.025; Hurtado-Benavides A, 2016, J SUPERCRIT FLUID, V113, P44, DOI 10.1016/j.supflu.2016.03.008; Kim JH, 2016, ANTIOXIDANTS-BASEL, V5, DOI 10.3390/antiox5030021; Kim MK, 2014, J I BREWING, V120, P537, DOI 10.1002/jib.180; Kobelnilk M, 2014, J THERM ANAL CALORIM, V115, P2045, DOI 10.1007/s10973-013-3150-z; Lercker G, 1996, IND ALIMENT-ITALY, V35, P1186; Wagemaker TAL, 2011, IND CROP PROD, V33, P469, DOI 10.1016/j.indcrop.2010.10.026; Marto J, 2016, J PHOTOCH PHOTOBIO B, V162, P56, DOI 10.1016/j.jphotobiol.2016.06.026; Marto J, 2016, DRUG DELIV, V23, P1594, DOI 10.3109/10717544.2015.1128496; Moustafa H, 2017, ACS SUSTAIN CHEM ENG, V5, P1906, DOI 10.1021/acssuschemeng.6b02633; Naidu MM, 2008, FOOD CHEM, V107, P377, DOI 10.1016/j.foodchem.2007.08.056; Phimsen S, 2016, ENERG CONVERS MANAGE, V126, P1028, DOI 10.1016/j.enconman.2016.08.085; Raba DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138080; Santos JCO, 2004, J THERM ANAL CALORIM, V75, P419, DOI 10.1023/B:JTAN.0000027128.62480.db; Santos JCO, 2002, J FOOD SCI, V67, P1393, DOI 10.1111/j.1365-2621.2002.tb10296.x; Santos JCO, 2007, J FOOD TECHNOL, V5, P79; Speer Karl, 2006, Braz. J. Plant Physiol., V18, P201, DOI 10.1590/S1677-04202006000100014; Sulieman AERM, 2006, J FOOD LIPIDS, V13, P259, DOI 10.1111/j.1745-4522.2006.00050.x; Tsukui A, 2014, FOOD CHEM, V164, P266, DOI 10.1016/j.foodchem.2014.05.039; Vecchio S, 2008, J THERM ANAL CALORIM, V91, P51, DOI 10.1007/s10973-007-8373-4; Vila MA, 2005, J AM OIL CHEM SOC, V82, P639, DOI 10.1007/s11746-005-1122-1; Wagemaker TAL, 2015, INT J COSMETIC SCI, V37, P506, DOI 10.1111/ics.12225; Wagemaker TAL, 2016, DRUG DEV IND PHARM, V42, P1695, DOI 10.3109/03639045.2016.1165692; Wagemaker TAL, 2015, IND CROP PROD, V63, P34, DOI 10.1016/j.indcrop.2014.09.045; Wagemaker TAL, 2013, TOXICOL LETT, V221, pS231, DOI 10.1016/j.toxlet.2013.05.561; Zhang ZS, 2013, ASIAN J CHEM, V25, P10082, DOI 10.14233/ajchem.2013.15159; Zyzelewicz D, 2014, FOOD RES INT, V63, P328, DOI 10.1016/j.foodres.2014.04.053	52	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200314	10.1371/journal.pone.0200314	http://dx.doi.org/10.1371/journal.pone.0200314			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995918	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800052
J	Kodan, LR; Verschueren, KJC; Kanhai, HHH; van Roosmalen, JJM; Bloemenkamp, WM; Rijken, MJ				Kodan, Lachmi R.; Verschueren, Kim J. C.; Kanhai, Humphrey H. H.; van Roosmalen, Jos J. M.; Bloemenkamp, W. M.; Rijken, Marcus J.			The golden hour of sepsis: An in-depth analysis of sepsis-related maternal mortality in middle-income country Suriname	PLOS ONE			English	Article							FAILURE ASSESSMENT SCORE; CLASSIFICATION; DETERMINANT; GUIDELINES; DEATH	Background Sepsis was the main cause of maternal mortality in Suriname, a middle-income country. Objective of this study was to perform a qualitative analysis of the clinical and management aspects of sepsis-related maternal deaths with a focus on the 'golden hour' principle of antibiotic therapy. Methods A nationwide reproductive age mortality survey was performed from 2010 to 2014 to identify and audit all maternal deaths in Suriname. All sepsis-related deaths were reviewed by a local expert committee to assess socio-demographic characteristics, clinical aspects and substandard care. Results Of all 65 maternal deaths in Suriname 29 (45%) were sepsis-related. These women were mostly of low socio-economic class (n = 23, 82%), of Maroon ethnicity (n = 14, 48%) and most deaths occurred postpartum (n = 21, 72%). Underlying causes were pneumonia (n = 14, 48%), wound infections (n = 3, 10%) and endometritis (n = 3, 10%). Bacterial growth was detected in 10 (50%) of the 20 available blood cultures. None of the women with sepsis as underlying cause of death received antibiotic treatment within the first hour, although most women fulfilled the diagnostic criteria of sepsis upon admission. In 27 (93%) of the 29 women from which sufficient information was available, substandard care factors were identified: delay in monitoring in 16 (59%) women, in diagnosis in 17 (63%) and in treatment in 21 (78%). Conclusion In Suriname, a middle-income country, maternal mortality could be reduced by improving early recognition and timely diagnosis of sepsis, vital signs monitoring and immediate antibiotic infusion (within the golden hour).	[Kodan, Lachmi R.] Acad Hosp Paramaribo AZP, Dept Obstet & Gynaecol, Paramaribo, Suriname; [Kodan, Lachmi R.; Verschueren, Kim J. C.; Bloemenkamp, W. M.; Rijken, Marcus J.] Univ Med Ctr Utrecht, Birth Ctr, Div Women & Baby, Dept Obstet, Utrecht, Netherlands; [Kodan, Lachmi R.; Rijken, Marcus J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands; [Kanhai, Humphrey H. H.; van Roosmalen, Jos J. M.] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands; [Kanhai, Humphrey H. H.] Anton de Kom Univ, Paramaribo, Suriname; [van Roosmalen, Jos J. M.] Vrije Univ Amsterdam, Athena Inst, Amsterdam, Netherlands	Anton de Kom Universiteit van Suriname; Academisch Ziekenhuis Paramaribo; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Anton de Kom Universiteit van Suriname; Vrije Universiteit Amsterdam	Kodan, LR (corresponding author), Acad Hosp Paramaribo AZP, Dept Obstet & Gynaecol, Paramaribo, Suriname.; Kodan, LR (corresponding author), Univ Med Ctr Utrecht, Birth Ctr, Div Women & Baby, Dept Obstet, Utrecht, Netherlands.; Kodan, LR (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.	lachmikodan@yahoo.com	Verschueren, Kim/AAW-6227-2020	Verschueren, Kim/0000-0003-1170-6132; Rijken, Marcus/0000-0003-0914-5508; kodan, lachmi/0000-0003-2129-9796				Acosta CD, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012323; Acosta CD, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001672; Albright CM, 2016, J PERINAT NEONAT NUR, V30, P95, DOI 10.1097/JPN.0000000000000159; Aly HAA, 2015, WHO TECH REP SER, V994, P1; Bamfo JEAK, 2013, BEST PRACT RES CL OB, V27, P583, DOI 10.1016/j.bpobgyn.2013.04.003; Bonet M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0321-6; De Brouwere V, 2014, INT J GYNECOL OBSTET, V127, pS21, DOI 10.1016/j.ijgo.2014.07.006; Donnelly JP, 2017, LANCET INFECT DIS, V17, P661, DOI 10.1016/S1473-3099(17)30117-2; Kemp B., 2016, OBSTET GYNAECOLOGY R, V26, P26, DOI [10.1016/j.ogrm.2015.11.003, DOI 10.1016/J.OGRM.2015.11.003]; Kenzaka T, 2012, INTERNAL MED, V51, P871, DOI 10.2169/internalmedicine.51.6951; Kodan LR, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1466-6; Kramer HMC, 2009, ACTA OBSTET GYN SCAN, V88, P647, DOI 10.1080/00016340902926734; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Morgan J, 2013, OBSTET GYN CLIN N AM, V40, P69, DOI 10.1016/j.ogc.2012.11.007; Mungra A, 1999, BRIT J OBSTET GYNAEC, V106, P55, DOI 10.1111/j.1471-0528.1999.tb08085.x; Nair M, 2015, PROGR SEVERE SEPSIS, P1506, DOI [10.1111/1471-0528.13551, DOI 10.1111/1471-0528.13551]; Pan American Health Organization (PAHO) W, 2012, COUNTR COOP STRAT SU; Paternina-Caicedo A, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.09.103; Pfitscher LC, 2016, TROP MED INT HEALTH, V21, P183, DOI 10.1111/tmi.12633; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; van den Akker T, 2017, LANCET GLOB HEALTH, V5, pE1181, DOI 10.1016/S2214-109X(17)30426-6; van den Akker T, 2017, LANCET, V390, P922, DOI 10.1016/S0140-6736(17)31633-1; van Dillen J, 2010, CURR OPIN INFECT DIS, V23, P249, DOI 10.1097/QCO.0b013e328339257c; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vosylius S, 2004, CROAT MED J, V45, P715; WHO, 2011, WORLD REPORT ON DISABILITY, P1; WHO UNICEF UNFPA The World Bank and the United Nations Population Division. World Health Organization, 2014, TRENDS MAT MORT 1990; World Health Organization, 2004, NUMB REV MAT DEATHS, V67, P27; World Health Organization, 2012, WHO APPL ICD 10 DEAT	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200281	10.1371/journal.pone.0200281	http://dx.doi.org/10.1371/journal.pone.0200281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990331	gold, Green Published			2022-12-26	WOS:000438170300037
J	Ooki, A; Dinalankara, W; Marchionni, L; Tsay, JCJ; Goparaju, C; Maleki, Z; Rom, WN; Pass, HI; Hoque, MO				Ooki, Akira; Dinalankara, Wikum; Marchionni, Luigi; Tsay, Jun-Chieh J.; Goparaju, Chandra; Maleki, Zahra; Rom, William N.; Pass, Harvey, I; Hoque, Mohammad O.			Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma	ONCOGENE			English	Article							SELF-RENEWAL; SERUM DNA; SOX2; GENE; DIFFERENTIATION; METHYLATION; EXPRESSION; PATHWAYS; HEDGEHOG; INITIATION	It remains unclear whether PAX6 acts as a crucial transcription factor for lung cancer stem cell (CSC) traits. We demonstrate that PAX6 acts as an oncogene responsible for induction of cancer stemness properties in lung adenocarcinoma (LUAD). Mechanistically, PAX6 promotes GLI transcription, resulting in SOX2 upregulation directly by the binding of GLI to the proximal promoter region of the SOX2 gene. The overexpressed SOX2 enhances the expression of key pluripotent factors (OCT4 and NANOG) and suppresses differentiation lineage factors (HOPX and NKX2-1), driving cancer cells toward a stem-like state. In contrast, in the differentiated non-CSCs, PAX6 is transcriptionally silenced by its promoter methylation. In human lung cancer tissues, the positive linear correlations of PAX6 expression with GLI and SOX2 expression and its negative correlations with HOPX and NKX2-1 expression were observed. Therapeutically, the blockade of the PAX6-GLISOX2 signaling axis elicits a long-lasting therapeutic efficacy by limiting CSC expansion following chemotherapy. Furthermore, a methylation panel including the PAX6 gene yielded a sensitivity of 79.1% and specificity of 83.3% for cancer detection using serum DNA from stage IA LUAD. Our findings provide a rationale for targeting the PAX6-GLI-SOX2 signaling axis with chemotherapy as an effective therapeutic strategy and support the clinical utility of PAX6 gene promoter methylation as a biomarker for early lung cancer detection.	[Ooki, Akira; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21231 USA; [Dinalankara, Wikum; Marchionni, Luigi; Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA; [Tsay, Jun-Chieh J.; Rom, William N.] NYU, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, New York, NY 10016 USA; [Goparaju, Chandra; Pass, Harvey, I] New York Univ Med, Langone Med Ctr, Dept Cardiothorac Surg, Div Thorac Surg, New York, NY 10016 USA; [Maleki, Zahra] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Hoque, Mohammad O.] Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; New York University; New York University; NYU Langone Medical Center; Johns Hopkins University; Johns Hopkins University	Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21231 USA.; Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21231 USA.; Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA.	mhoque1@jhmi.edu	Marchionni, Luigi/S-6774-2017	Marchionni, Luigi/0000-0002-7336-8071; Ooki, Akira/0000-0001-7618-5775; Tsay, Jun-Chieh/0000-0002-2282-2510; Rom, William/0000-0002-8793-7028; Pass, Harvey/0000-0003-3222-3471	Flight Attendant Medical Research Institute Clinical Innovative Award [103015]; NCI [R01CA206027]; SPORE in Cervical Cancer [P50 CA098252]; NATIONAL CANCER INSTITUTE [R01CA206027, P50CA098252] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute Clinical Innovative Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SPORE in Cervical Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Flight Attendant Medical Research Institute Clinical Innovative Award 103015 (M.O. Hoque), NCI R01CA206027 (M.O. Hoque), the Career Development award from SPORE in Cervical Cancer Grants P50 CA098252 (MOH).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Asami M, 2011, DEVELOPMENT, V138, P5067, DOI 10.1242/dev.074591; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436; Belinsky SA, 2004, NAT REV CANCER, V4, P707, DOI 10.1038/nrc1432; Blanchon T, 2007, LUNG CANCER, V58, P50, DOI 10.1016/j.lungcan.2007.05.009; Bora-Singhal N, 2015, NEOPLASIA, V17, P538, DOI 10.1016/j.neo.2015.07.001; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Coutinho P, 2011, GENOME RES, V21, P1349, DOI 10.1101/gr.124115.111; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Greenberg AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039403; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Hu B, 2016, CELL DIFFER INVASIVE, V167, pe18; Infante P, 2015, TRENDS PHARMACOL SCI, V36, P547, DOI 10.1016/j.tips.2015.05.006; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Kamachi Y, 2001, GENE DEV, V15, P1272, DOI 10.1101/gad.887101; Lang D, 2008, MOL CARCINOGEN, V47, P148, DOI 10.1002/mc.20375; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Leon G, 2016, PHARMACOL THERAPEUT, V158, P71, DOI 10.1016/j.pharmthera.2015.12.001; Liu YP, 2013, CANCER RES, V73, P406, DOI 10.1158/0008-5472.CAN-12-1733; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Mascarenhas JB, 2009, J BIOL CHEM, V284, P27524, DOI 10.1074/jbc.M109.047209; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Nam HS, 2014, TUBERC RESPIR DIS, V76, P211, DOI 10.4046/trd.2014.76.5.211; Ooki A, 2010, ONCOGENE, V29, P3263, DOI 10.1038/onc.2010.76; Ooki A, 2018, CANCER RES, V78, P168, DOI 10.1158/0008-5472.CAN-17-0836; Ooki A, 2017, CLIN CANCER RES, V23, P7141, DOI 10.1158/1078-0432.CCR-17-1222; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Po A, 2017, ONCOGENE, V36, P4641, DOI 10.1038/onc.2017.91; Rauch TA, 2012, TUMOR BIOL, V33, P287, DOI 10.1007/s13277-011-0282-2; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Shiraishi M, 2002, ONCOGENE, V21, P3804, DOI 10.1038/sj.onc.1205454; Shyr CR, 2010, PROSTATE, V70, P190, DOI 10.1002/pros.21052; Stolzenburg S, 2012, NUCLEIC ACIDS RES, V40, P6725, DOI 10.1093/nar/gks360; Takebe N, 2015, NAT REV CLIN ONCOL, V12, P445, DOI 10.1038/nrclinonc.2015.61; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Watanabe H, 2013, CANCER CELL, V23, P707, DOI 10.1016/j.ccr.2013.05.013; Yamaoka T, 2000, DIABETOLOGIA, V43, P332, DOI 10.1007/s001250050051; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Zhao XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085738	47	26	26	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5967	5981		10.1038/s41388-018-0373-2	http://dx.doi.org/10.1038/s41388-018-0373-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29980786	Green Accepted			2022-12-26	WOS:000449562500005
J	Santos, MF; Rappa, G; Karbanova, J; Kurth, T; Corbeil, D; Lorico, A				Santos, Mark F.; Rappa, Germana; Karbanova, Jana; Kurth, Thomas; Corbeil, Denis; Lorico, Aurelio			VAMP-associated protein-A and oxysterol-binding protein-related protein 3 promote the entry of late endosomes into the nucleoplasmic reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear envelope; endosome; nuclear transport; cancer biology; exosome (vesicle); extracellular vesicles; nucleus; late endosome; ORP3; oxysterol-binding related protein; VAP-A; VOR complex; endocytosis; vesicle-associated membrane protein	MEMBRANE CONTACT SITES; EXTRACELLULAR VESICLES; ENDOPLASMIC-RETICULUM; MEDIATED TRANSFER; PLASMA-MEMBRANE; ER; VAP; CELLS; ORP1L; TETHER	The endocytic pathway plays an instrumental role in recycling internalized molecules back to the plasma membrane or in directing them to lysosomes for degradation. We recently reported a new role of endosomes-the delivery of components from extracellular vesicles (EVs) to the nucleoplasm of recipient cells. Using indirect immunofluorescence, FRET, immunoisolation techniques, and RNAi, we report here a tripartite protein complex (referred to as the VOR complex) that is essential for the nuclear transfer of EV-derived components by orchestrating the specific localization of late endosomes into nucleoplasmic reticulum. We found that the VOR complex contains the endoplasmic reticulum-localized vesicle-associated membrane protein (VAMP)-associated protein A (VAP-A), the cytoplasmic oxysterol-binding protein-related protein 3 (ORP3), and late endosome-associated small GTPase Rab7. The silencing of VAP-A or ORP3 abrogated the association of Rab7-positive late endosomes with nuclear envelope invaginations and, hence, the transport of endocytosed EV-derived components to the nucleoplasm of recipient cells. We conclude that the VOR complex can be targeted to inhibit EV-mediated intercellular communication, which can have therapeutic potential for managing cancer in which the release of EVs is dysregulated.	[Santos, Mark F.; Rappa, Germana; Corbeil, Denis; Lorico, Aurelio] Roseman Univ, Coll Med, Roseman Canc Ctr, 10530 Discovery Dr, Las Vegas, NV 89135 USA; [Santos, Mark F.; Rappa, Germana; Corbeil, Denis; Lorico, Aurelio] Roseman Univ, Coll Med, Dept Pathol, 10530 Discovery Dr, Las Vegas, NV 89135 USA; [Karbanova, Jana; Kurth, Thomas; Corbeil, Denis] Tech Univ Dresden, Biotechnol Ctr, Tatzberg 47-49, D-01307 Dresden, Germany; [Kurth, Thomas; Corbeil, Denis] Tech Univ Dresden, Ctr Mol & Cellular Bioengn, DFG Ctr Regenerat Therapies, Tatzberg 47-49, D-01307 Dresden, Germany; [Lorico, Aurelio] Mediterranean Inst Oncol Fdn, Via Penninazzo 11, I-95029 Viagrande, Italy	Technische Universitat Dresden; German Research Foundation (DFG); Technische Universitat Dresden	Lorico, A (corresponding author), Roseman Univ, Coll Med, Roseman Canc Ctr, 10530 Discovery Dr, Las Vegas, NV 89135 USA.; Lorico, A (corresponding author), Roseman Univ, Coll Med, Dept Pathol, 10530 Discovery Dr, Las Vegas, NV 89135 USA.; Corbeil, D (corresponding author), Tech Univ Dresden, Biotechnol Ctr BIOTEC, Tissue Engn Lab, Tatzberg 47-49, D-01307 Dresden, Germany.	denis.corbeil@tu-dresden.de; alorico@roseman.edu	Corbeil, Denis/AFL-1008-2022; Lorico, Aurelio/AAG-8095-2021; Corbeil, Denis/A-6519-2010	Lorico, Aurelio/0000-0003-0644-7375; Kurth, Thomas/0000-0001-5624-1717; Karbanova, Jana/0000-0001-7687-0983	European Regional Development Fund	European Regional Development Fund(European Commission)	We thank Fabio Anzanello for skilled technical assistance; Kyle Choi and Matthew Stein for assistance with CLSM; Susanne Kretschmar from the Electron Microscopy/Histology (EMH) Facility at the BIOTEC (Dresden, Germany) for support with immunogold EM; Oystein Fodstad for FEMX-I cells; Eivind Hovig for sharing unpublished data; and Yuri Lazebnik for critical review of the manuscript. The European Regional Development Fund supports the EMH Facility.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Audas TE, 2012, MOL CELL, V45, P147, DOI 10.1016/j.molcel.2011.12.012; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Desrochers LM, 2016, DEV CELL, V37, P301, DOI 10.1016/j.devcel.2016.04.019; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Dovrat S, 2014, MOL ONCOL, V8, P894, DOI 10.1016/j.molonc.2014.03.011; Drozdz MM, 2017, NUCLEUS-PHILA, V8, P34, DOI 10.1080/19491034.2016.1252893; Eisenberg-Bord M, 2016, DEV CELL, V39, P395, DOI 10.1016/j.devcel.2016.10.022; Fais S, 2016, ACS NANO, V10, P3886, DOI 10.1021/acsnano.5b08015; Fischer AH, 2003, AM J PATHOL, V163, P1091, DOI 10.1016/S0002-9440(10)63468-2; FODSTAD O, 1988, CANCER RES, V48, P4382; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Ivanusic D, 2014, BIOTECHNIQUES, V57, P188, DOI 10.2144/000114215; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jorgens DM, 2017, J CELL SCI, V130, P177, DOI 10.1242/jcs.190967; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lehto M, 2005, EXP CELL RES, V310, P445, DOI 10.1016/j.yexcr.2005.08.003; Lehto M, 2008, J CELL SCI, V121, P695, DOI 10.1242/jcs.016964; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Lux K, 2005, J VIROL, V79, P11776, DOI 10.1128/JVI.79.18.11776-11787.2005; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nunukova A, 2015, INT J MOL MED, V36, P65, DOI 10.3892/ijmm.2015.2210; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Raiborg C, 2015, EMBO J, V34, P1848, DOI 10.15252/embj.201591481; Raiborg C, 2015, NATURE, V520, P234, DOI 10.1038/nature14359; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rappa G, 2017, ONCOTARGET, V8, P14443, DOI 10.18632/oncotarget.14804; Rappa G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-62; Rappa G, 2008, STEM CELLS, V26, P3008, DOI 10.1634/stemcells.2008-0601; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Saita S, 2009, J BIOL CHEM, V284, P13766, DOI 10.1074/jbc.M807938200; Sarko DK, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00082; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Soung YH, 2017, CANCERS, V9, DOI 10.3390/cancers9010008; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Kant R, 2013, J LIPID RES, V54, P2153, DOI 10.1194/jlr.M037325; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653; Weber-Boyvat M, 2015, EXP CELL RES, V331, P278, DOI 10.1016/j.yexcr.2014.10.019; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019599	55	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13834	13848		10.1074/jbc.RA118.003725	http://dx.doi.org/10.1074/jbc.RA118.003725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30018135	hybrid, Green Published			2022-12-26	WOS:000444070700009
J	Fajardo, M; Andrade, D; Bonicelli, J; Bon, M; Gomez, G; Riascos, JM; Pacheco, AS				Fajardo, Maritza; Andrade, Diego; Bonicelli, Jessica; Bon, Melanie; Gomez, Gonzalo; Riascos, Jose M.; Pacheco, Aldo S.			Macrobenthic communities in a shallow normoxia to hypoxia gradient in the Humboldt upwelling ecosystem	PLOS ONE			English	Article							OXYGEN MINIMUM ZONE; CONTINENTAL-SHELF; MACROFAUNAL COMMUNITY; ANAEROBIC METABOLISM; ORGANIC-MATTER; MEJILLONES BAY; PUNTA COLOSO; CHILE; ASSEMBLAGES; ANTOFAGASTA	Hypoxia is one of the most important stressors affecting the health conditions of coastal eco-systems. In highly productive ecosystems such as the Humboldt Current ecosystem, the oxygen minimum zone is an important abiotic factor modulating the structure of benthic communities over the continental shelf. Herein, we study soft-bottom macrobenthic communities along a depth gradient-at 10, 20, 30 and 50 m-for two years to understand how hypoxia affects the structure of shallow communities at two sites in Mejillones Bay (23 degrees S) in northern Chile. We test the hypothesis that, during months with shallow hypoxic zones, community structure will be much more dissimilar, thereby depicting a clear structural gradient with depth and correlated abiotic variables (e.g. organic matter, temperature and salinity). Likewise, during conditions of deeper hypoxic zones, communities will be similar among habitats as they could develop structure via succession in conditions with less stress. Throughout the sampling period (October 2015 to October 2017), the water column was hypoxic (from 2 to 0.5ml/l O-2) most of the time, reaching shallow depths of 20 to 10 m. Only one episode of oxygenation was detected in June 2016, where normoxia (> 2ml/l O-2) reached down to 50 m. The structure of the communities depicted a clear pattern of increasing dissimilarity from shallow normoxic and deep hypoxic habitat. This pattern was persistent throughout time despite the occurrence of an oxygenation episode. Contrasting species abundance and biomass distribution explained the gradient in structure, arguably reflecting variable levels of hypoxia adaptation, i.e. few polychaetes such as Magelona physilia and Paraprionospio pinnata were only located in low oxygen habitats. The multivariable dispersion of community composition as a proxy of beta diversity decreased significantly with depth, suggesting loss of community structure and variability when transitioning from normoxic to hypoxic conditions. Our results show the presence of semi-permanent shallow hypoxia at Mejillones Bay, constraining diverse and more variable communities at a very shallow depth (10-20 m). These results must be considered in the context of the current decline of dissolved oxygen in most oceans and coastal regions and their impact on seabed biota.	[Fajardo, Maritza; Gomez, Gonzalo] Univ Antofagasta, Ecol Sistemas Acuat, Antofagasta, Chile; [Andrade, Diego] Univ Antofagasta, CENSOR Lab, Antofagasta, Chile; [Bonicelli, Jessica] Pontificia Univ Catolica Chile, Estn Costera Invest Marinas, Santiago, Chile; [Bonicelli, Jessica] Inst Fomento Pesquero, Dept Oceanog & Medio Ambiente, Valparaiso, Chile; [Bon, Melanie] Univ Antofagasta, Programa Doctorado Ciencias Aplicadas Menc Sistem, Antofagasta, Chile; [Riascos, Jose M.] Univ Valle, Estuaries & Mangroves Res Grp, Cali, Colombia; [Pacheco, Aldo S.] Univ Antofagasta, Inst Ciencias Nat Alexander von Humboldt, CENSOR Lab, Antofagasta, Chile	Universidad de Antofagasta; Universidad de Antofagasta; Pontificia Universidad Catolica de Chile; Instituto de Fomento Pesquero (Valparaiso); Universidad de Antofagasta; Universidad del Valle; Universidad de Antofagasta	Pacheco, AS (corresponding author), Univ Antofagasta, Inst Ciencias Nat Alexander von Humboldt, CENSOR Lab, Antofagasta, Chile.	babuchapv@yahoo.com	Pacheco, Aldo S/L-9939-2017; Riascos, José M./J-5816-2013	Pacheco, Aldo S/0000-0002-2767-6436; Riascos, Jose/0000-0001-8631-8877; Bon, Melanie/0000-0002-0558-4821	Fondo Nacional de Desarrollo Cientifico Tecnologico (Chile) [1150042]	Fondo Nacional de Desarrollo Cientifico Tecnologico (Chile)	This study was funded by the Fondo Nacional de Desarrollo Cientifico Tecnologico (Chile) grant number 1150042 to ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057918; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arntz W. E., 2006, ADV GEOSCI, V6, P243, DOI DOI 10.5194/ADGE0-6-243-2006; ARNTZ WE, 1991, GEOL SOC SPEC PUBL, P131, DOI 10.1144/GSL.SP.1991.058.01.10; Breitburg D, 2018, SCIENCE, V359, P46, DOI 10.1126/science.aam7240; Camus Patricio A., 2008, International Journal of Environment and Health, V2, P5, DOI 10.1504/IJENVH.2008.018668; Carrasco FD, 1997, B MAR SCI, V60, P443; Carrasco FD, 2006, SCI MAR, V70, P169, DOI 10.3989/scimar.2006.70s3169; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Chu JWF, 2015, GLOBAL CHANGE BIOL, V21, P2989, DOI 10.1111/gcb.12898; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Gallardo MD, 2017, CONT SHELF RES, V141, P26, DOI 10.1016/j.csr.2017.04.011; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Diaz RJ, 2009, MAR POLLUT BULL, V58, P1767, DOI 10.1016/j.marpolbul.2009.09.030; Fleddum A, 2011, MAR POLLUT BULL, V63, P221, DOI 10.1016/j.marpolbul.2011.03.019; Froehlich HE, 2015, MAR ECOL PROG SER, V520, P67, DOI 10.3354/meps11105; Gammal J, 2017, ESTUAR COAST, V40, P457, DOI 10.1007/s12237-016-0152-7; Gonzalez RR, 2000, ESTUAR COAST SHELF S, V51, P507, DOI 10.1006/ecss.2000.0693; Gray JS, 2002, MAR ECOL PROG SER, V238, P249, DOI 10.3354/meps238249; Guinez M, 2010, LAT AM J AQUAT RES, V38, P242, DOI 10.3856/vol38-issue2-fulltext-9; Gutierrez D, 2000, MAR ECOL PROG SER, V202, P81, DOI 10.3354/meps202081; Gutierrez D, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046324; Gutierrez D, 2008, PROG OCEANOGR, V79, P177, DOI 10.1016/j.pocean.2008.10.025; Hernandez-Miranda E, 2012, MAR ENVIRON RES, V79, P16, DOI 10.1016/j.marenvres.2012.04.004; IFOP, MON COND BIOOC ENTR; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Laudien J, 2007, HELGOLAND MAR RES, V61, P103, DOI 10.1007/s10152-007-0057-8; Levin LA, 2003, OCEANOGR MAR BIOL, V41, P1; Levin LA, 2000, DEEP-SEA RES PT II, V47, P189, DOI 10.1016/S0967-0645(99)00103-4; Marin VH, 2001, CONT SHELF RES, V21, P1317, DOI 10.1016/S0278-4343(01)00022-X; Pacheco AS, 2012, OIKOS, V121, P2097, DOI 10.1111/j.1600-0706.2012.20257.x; Pacheco AS, 2011, HELGOLAND MAR RES, V65, P413, DOI 10.1007/s10152-010-0238-8; Palma M, 2005, J MAR BIOL ASSOC UK, V85, P233, DOI 10.1017/S0025315405011112h; Quiroga E, 2005, ESTUAR COAST SHELF S, V62, P217, DOI 10.1016/j.ecss.2004.08.020; Quiroga E, 2007, J MAR BIOL ASSOC UK, V87, P459, DOI 10.1017/S0025315407048710; Rakocinski CF, 2016, MAR POLLUT BULL, V105, P299, DOI 10.1016/j.marpolbul.2016.02.006; ROSENBERG R, 1983, J MAR RES, V41, P263, DOI 10.1357/002224083788520153; Schmidtko S, 2017, NATURE, V542, P335, DOI 10.1038/nature21399; Schneider W, 2017, PROG OCEANOGR, V151, P38, DOI 10.1016/j.pocean.2016.11.004; Sellanes J, 2007, CONT SHELF RES, V27, P1002, DOI 10.1016/j.csr.2007.01.001; Soto E, 2016, MAR BIODIVERS, DOI [10.1007/s12526-016-0479-0J, DOI 10.1007/S12526-016-0479-0J]; Stramma L, 2010, DEEP-SEA RES PT I, V57, P587, DOI 10.1016/j.dsr.2010.01.005; Tarazona J, 1996, MAR ECOL-P S Z N I, V17, P425, DOI 10.1111/j.1439-0485.1996.tb00519.x; Tweedley JR, 2016, MAR FRESHWATER RES, V67, P327, DOI 10.1071/MF14216; Underwood A. J., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P3, DOI 10.1023/A:1009983229076; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Veas R, 2012, MAR ENVIRON RES, V78, P1, DOI 10.1016/j.marenvres.2012.02.008; Yannicelli B, 2013, MAR BIOL, V160, P961, DOI 10.1007/s00227-012-2147-7	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200349	10.1371/journal.pone.0200349	http://dx.doi.org/10.1371/journal.pone.0200349			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016340	gold, Green Published, Green Submitted			2022-12-26	WOS:000438866600022
J	Shaka, MF; Wondimagegne, YA				Shaka, Mohammed Feyisso; Wondimagegne, Yohannes Addisu			Anemia, a moderate public health concern among adolescents in South Ethiopia	PLOS ONE			English	Article							IRON-DEFICIENCY; RISK-FACTORS; PREVALENCE	Background Adolescence is characterized by rapid growth and development and iron requirements increase during this time. Adolescents with poor diet in early childhood and/or females with an early onset of menarche may be at greater risk for developing anemia due to the rapid depletion of iron stores in their bodies. Objective The objective of this study was to assess the prevalence and severity of anemia among school adolescents in Wonago district, Gedeo Zone, South Ethiopia. Methods A school based cross-sectional study was conducted among 443 randomly selected school adolescents across 15 schools (2 secondary schools and 13 primary schools) in the district. Hemoglobin concentration from a capillary blood sample was determined by portable hemoglobin meter (HemoCue). Descriptive statistics were computed for prevalence of anemia, anthropometric measurements, socio-economic and socio-demographic variables. A hierarchical multivariable logistic regression analysis was done to identify determinants of anemia among adolescents. Results The prevalence of anemia among adolescents in the study area was 22%. Anemia was higher among those in early adolescence period (10-13 years) (AOR: 4.75, CI: 1.69-13.35) compared to late adolescence (17-19 years) and among those with height for age z-score less than -2 (AOR: 6.23, CI: 1.98-19.62). Similarly, anemia was higher among those in households with a family size greater than five members (AOR: 9.82, CI: 2.42-39.88), adolescents from rural areas (AOR: 4.37, CI: 1.54-12.46) and families who purchase food needed for daily consumption (AOR: 3.25, CI: 1.42-7.45). On the other hand, adolescents from middle wealth quintiles (AOR: 0.26 (CI: 0.07-0.98)) and female adolescents (AOR: 0.34 (CI: 0.15-0.79) were less likely to be anemic in this study. Conclusions The prevalence of anemia in this population is of moderate public health concern, adolescents of both sexes are among groups at risk for the development of anemia. The need for further assessment of the etiology of anemia should be considered to design pragmatic intervention programs.	[Shaka, Mohammed Feyisso; Wondimagegne, Yohannes Addisu] Dilla Univ, Coll Hlth Sci & Med, Dept Publ Hlth, Dilla, Ethiopia	Dilla University	Shaka, MF (corresponding author), Dilla Univ, Coll Hlth Sci & Med, Dept Publ Hlth, Dilla, Ethiopia.	mfeyisso@yahoo.com	, Mohammed/GWZ-2414-2022	Shaka, Mohammed/0000-0001-9352-058X	Dilla University [HMed/PH/2015/2]; Dilla University College of Health Sciences and Medicine	Dilla University; Dilla University College of Health Sciences and Medicine	The over all cost of the study was covered by Dilla University under the project code of HMed/PH/2015/2.; We would like to extend our heartfelt gratitude and appreciation to Dilla University College of Health Sciences and Medicine for coverage of financial support and Gedeo Zone and Wonago district Education office and Health Office for their cooperation in providing necessary information. Our deep appreciation also goes to the parents of the study participants and the participants themselves for their willingness and cooperation to participate in the study.	Abebe Y, 2007, J FOOD COMPOS ANAL, V20, P161, DOI 10.1016/j.jfca.2006.09.003; Adhikari R., 1994, STUDY FACTORS INFLUE; Al-Buhairan AM, 2001, ANN SAUDI MED, V21, P100, DOI 10.5144/0256-4947.2001.100; Al-sharbatti SS, 2002, ANEMIA ADOLESCENTS, P189; [Anonymous], 2011, INT J BIOL MED RES; [Anonymous], 2014, WIKIPEDIA FREE E; Anuradha G., 2013, GUIDELINES CONTROL I; Assefa Selomon, 2014, BMC Hematol, V14, P3, DOI 10.1186/2052-1839-14-3; Atlabachew M, 2008, J FOOD COMPOS ANAL, V21, P545, DOI 10.1016/j.jfca.2008.05.001; Balci YI, 2012, IRAN J PEDIATR, V22, P77; Barugahara E. I., 2013, African Journal of Food, Agriculture, Nutrition and Development, V13, P7679; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Beard JL, 2000, J NUTR, V130, p440S, DOI 10.1093/jn/130.2.440S; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; da Silva LSM, 2001, REV SAUDE PUBL, V35, P66, DOI 10.1590/S0034-89102001000100010; Degefa S, 2016, SOCIO ECOLOGICAL PRO, P28; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Desalegn A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114059; Deshpande N. S., 2013, International Journal of Medicine and Public Health, V3, P235; Dheeraj Gupta, 2013, National Journal of Community Medicine, V4, P20; DiMeglio G, 2000, Pediatr Rev, V21, P32; Ethiopia Central Statistical Agency, 2011, ETH DEM HLTH SURV 20; Fauci AS, 2012, HARRISONS PRINCIPLES; Gupta DP, 2013, NATL J COMMUNITY MED, V4, P20; Gutema Bekele, 2014, BMC Hematol, V14, P13, DOI 10.1186/2052-1839-14-13; Hyder SMZ, 2007, J NUTR, V137, P2147; Kaur IP, 2011, J EXERCISE SCI PHYSI, V7, P11; Lal S., 2007, TXB COMMUNITY MED PR; Lee JO, 2014, J KOREAN MED SCI, V29, P224, DOI 10.3346/jkms.2014.29.2.224; Leenstra T, 2004, PREVALENCE SEVERITY, P681; Lopez MAA, 2004, INT J FOOD SCI NUTR, V55, P597, DOI 10.1080/09637480500085820; Maakaron JE, 2016, ANEMIA PRACTICE ESSE; Mesfin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123615; Mikki N., 2011, Eastern Mediterranean Health Journal, V17, P208; Mulugeta A, 2009, NUTR STATUS ADOLESCE; National Nutrition Monitoring Bureau, 2006, 24 NNMB NIN; Nurfeta A, 2008, TROP ANIM HEALTH PRO, V40, P299, DOI 10.1007/s11250-007-9095-0; Osazuwa F, 2010, N AM J MED SCI, V2, P532, DOI 10.4297/najms.2010.2532; Pee S., EUR J COMMUNITY MED; RAO K V, 1987, Indian Journal of Nutrition and Dietetics, V24, P272; Sinha A. K., 2012, International Journal of Pharmaceutical and Biological Archives, V3, P1077; Tatala S R, 2008, Tanzan J Health Res, V10, P189; Tesfaye M, 2015, ADOLESC HEALTH MED T, V6, P189, DOI 10.2147/AHMT.S94865; USAID; CORE Group; MCHIP; FHI360; FANTA III; SPRING, 2013, CONC FRAM AN MULT AN; WHO, 2011, WHO TECH REP SER, V959, P1; WHO/ UNFPA/ UNICEF, 1989, REPR HLTH AD STRAT A; WHO UNICEF UNU, 2001, WHONHD013; World Health Organization, 2006, AD NUTR REV SIT SEL; World Health Organization, 1986, YOUNG PEOPL HLTH CHA	49	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7								10.1371/journal.pone.0191467	http://dx.doi.org/10.1371/journal.pone.0191467			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016373	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600001
J	Harding, G; Dalziel, J; Vass, P				Harding, Gareth; Dalziel, John; Vass, Peter			Bioaccumulation of methylmercury within the marine food web of the outer Bay of Fundy, Gulf of Maine	PLOS ONE			English	Article							MERCURY METHYLATION; TROPHIC POSITION; SCOTIAN SHELF; FRESH-WATER; FEEDING-BEHAVIOR; HARBOR PORPOISES; STABLE-ISOTOPES; CLUPEA-HARENGUS; SURFACE WATERS; NORTH-ATLANTIC	Mercury and methylmercury were measured in seawater and biota collected from the outer Bay of Fundy to better document mercury bioaccumulation in a temperate marine food web. The size of an organism, together with delta C-13 and delta N-15 isotopes, were measured to interpret mercury levels in biota ranging in size from microplankton (25 mu m) to swordfish, dolphins and whales. Levels of mercury in seawater were no different with depth and not elevated relative to upstream sources. The delta C-13 values of primary producers were found to be inadequate to specify the original energy source of various faunas, however, there was no reason to separate the food web into benthic, demersal and pelagic food chains because phytoplankton has been documented to almost exclusively fuel the ecosystem. The apparent abrupt increase in mercury content from "seawater" to phytoplankton, on a wet weight basis, can be explained from an environmental volume basis by the exponential increase in surface area of smaller particles included in "seawater" determinations. This physical sorption process may be important up to the macroplankton size category dominated by copepods according to the calculated biomagnification factors (BMF). The rapid increase in methylmercury concentration, relative to the total mercury, between the predominantly phytoplankton (<125 mu m) and the zooplankton categories is likely augmented by gut microbe methylation. Further up the food chain, trophic transfer of methylmercury dominates resulting in biomagnification factors greater than 10 in swordfish, Atlantic bluefin tuna, harbour porpoise, Atlantic white-sided dolphin and common thresher shark. The biomagnification power of the northern Gulf of Maine ecosystem is remarkably similar to that measured in tropical, subtropical, other temperate and arctic oceanic ecozones.	[Harding, Gareth; Vass, Peter] Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada; [Dalziel, John] Environm Canada, Dartmouth, NS, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Environment & Climate Change Canada	Harding, G (corresponding author), Bedford Inst Oceanog, Dept Fisheries & Oceans, Dartmouth, NS, Canada.	gareth.harding@dfo-mpo.gc.ca			Fisheries and Oceans Canada internal research funds: Environmental Sciences Strategic Research Fund (ESSRF) [2236]; Environmental Sciences Strategic Research Fund (ESSRF) [2236]	Fisheries and Oceans Canada internal research funds: Environmental Sciences Strategic Research Fund (ESSRF); Environmental Sciences Strategic Research Fund (ESSRF)	This work received support from Fisheries and Oceans Canada internal research funds: Environmental Sciences Strategic Research Fund (ESSRF #2236) between 2001 and 2004.; We thank our manager, Paul Keizer, for supporting the first field season in 2000. Phil Yeats magnanimously encouraged John Dalziel from his chemical group to join forces with ecologists to study mercury dynamics in the environment and advocated for us in Ottawa. Our program was supported by the Environmental Sciences Strategic Research Fund (ESSRF #2236) between 2001 and 2004. Special thanks go to the late Captain Joe Bray, Tim Hubbard and Joe Randall of the CCGV Navicula for three years of successful oceanographic sampling. Scott Wilson, Troy Quinlan, Mark Showell, Peter Hurley and Julie Porter collected fish during government surveys. Fishermen from the Digby Neck area supplied local fish. Ingram Gidney, retired Arctic FRB skipper, coordinated these efforts, collecting fish from the wharves of Digby Neck either by hand line or courtesy of the skippers of returning longliners or trawlers. Harold Ballantyne collected selected tuna tissues for us from Ballantynes Cove, NS. Subba Rao Durvasula identified the dominant phytoplankton species. A host of people shared their knowledge and time providing fish identification, biology and aging: Diane Beanlands, Cynthia Bourbonnais- Boyce, Steve Campana, Erin Carruthers, the late Bob Crawford, Tania Davignan-Burton, Shelly Denny, Isabelle Forest, Peter Hurley, Bette Hatt, Tara Jewett, Warren Joyce, Tim Lambert, the late Jeff McRuer, Yves Richard, Jim Simon and Scott Wilson. Dave Robichaud, DFO St. Andrews, supplied lobsters from the outer Bay of Fundy. Dale Roddick, Mark Lundy and Shelly Armsworthy supplied scallops and information on their biology and aging. Jim McKinnon, DFO Meteghan, notified us of any whale standings along the Gulf of Maine Nova Scotian coast. Laurie Murison and Heather Koopman, of the Grand Manan Whale & Seabird Research Station were very supportive, supplying porpoise and fin whale tissues. Andrea Bogomolni and Michael Moore, of the Cape Cod Stranding Network, Inc., supplied humpback, minke, porpoise and dolphin tissues from their tissue bank from strandings between 2000 and 2004. Andrea showed remarkable cheery perseverance in the yearlong effort to get these tissue samples past Canadian customs. Cam Lirette and Javi Guijarro-Sabaniel prepared the figures. Many thanks go to Ellen Kenchington and Elsie Sunderland for discussions and encouragement. We thank our colleagues Barry Hargrave, Komiko Azetsu-Scott and John Smith for internal reviews and three helpful anonymous reviewers.	AMAP, 2011, ARCT POLL 2011; Ariya PA, 2004, TELLUS B, V56, P397, DOI 10.1111/j.1600-0889.2004.00118.x; Atwell L, 1998, CAN J FISH AQUAT SCI, V55, P1114, DOI 10.1139/cjfas-55-5-1114; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baeyens W, 2003, ARCH ENVIRON CON TOX, V45, P498, DOI 10.1007/s00244-003-2136-4; Balcom PH, 2008, MAR CHEM, V109, P1, DOI 10.1016/j.marchem.2007.09.005; BANSE K, 1982, LIMNOL OCEANOGR, V27, P1059, DOI 10.4319/lo.1982.27.6.1059; Bargagli R, 1998, MAR ECOL PROG SER, V169, P65, DOI 10.3354/meps169065; BEYER F, 1992, SARSIA, V77, P189, DOI 10.1080/00364827.1992.10413504; Bisi TL, 2012, ECOL INDIC, V18, P291, DOI 10.1016/j.ecolind.2011.11.015; BLOOM NS, 1983, MAR CHEM, V14, P49, DOI 10.1016/0304-4203(83)90069-5; Bootsma HA, 1996, ECOLOGY, V77, P1286, DOI 10.2307/2265598; Borga K, 2012, INTEGR ENVIRON ASSES, V8, P64, DOI 10.1002/ieam.244; Bowles KC, 2001, CAN J FISH AQUAT SCI, V58, P888, DOI 10.1139/cjfas-58-5-888; Bowman KL, 2015, DEEP-SEA RES PT II, V116, P251, DOI 10.1016/j.dsr2.2014.07.004; BRODIE PF, 1975, ECOLOGY, V56, P152, DOI 10.2307/1935307; Campbell LM, 2005, SCI TOTAL ENVIRON, V351, P247, DOI 10.1016/j.scitotenv.2005.02.043; CARTER J A, 1985, Canadian Technical Report of Fisheries and Aquatic Sciences, P27; CHECKLEY DM, 1982, MAR ECOL PROG SER, V9, P245, DOI 10.3354/meps009245; Chetelat J, 2017, ENV CLIMATE CHANGE C, P323, DOI [10.1021/es403103t, DOI 10.1021/ES403103T]; COCOROS G, 1973, J FISH BIOL, V5, P641, DOI 10.1111/j.1095-8649.1973.tb04500.x; CONOVER RJ, 1974, J EXP MAR BIOL ECOL, V16, P131, DOI 10.1016/0022-0981(74)90016-1; COSSA D, 1988, ESTUAR COAST SHELF S, V26, P227, DOI 10.1016/0272-7714(88)90052-2; Crotty FV, 2013, SOIL BIOL BIOCHEM, V65, P75, DOI 10.1016/j.soilbio.2013.04.020; Dalziel J, 2010, BOFEP TECHNICAL REPO, P21; DALZIEL JA, 1992, MAR CHEM, V37, P171, DOI 10.1016/0304-4203(92)90076-M; Darbyson E, 2003, J FISH BIOL, V63, P1235, DOI 10.1046/j.1095-8649.2003.00247.x; DAVIES AG, 1974, J MAR BIOL ASSOC UK, V54, P157, DOI 10.1017/S002531540002213X; DAVIS CS, 1984, MAR BIOL, V82, P41, DOI 10.1007/BF00392762; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; DUCKLOW HW, 1986, SCIENCE, V232, P865, DOI 10.1126/science.232.4752.865; Fenchel T, 2008, J EXP MAR BIOL ECOL, V366, P99, DOI 10.1016/j.jembe.2008.07.013; FISHER NS, 1984, MAR ECOL PROG SER, V18, P201, DOI 10.3354/meps018201; FISHER NS, 1991, MAR ECOL PROG SER, V71, P37, DOI 10.3354/meps071037; FISHER NS, 1985, MAR BIOL, V87, P137, DOI 10.1007/BF00539421; Fitzgerald WF, 1998, ENVIRON SCI TECHNOL, V32, P1, DOI 10.1021/es970284w; Foster KL, 2012, ENVIRON SCI TECHNOL, V46, P12952, DOI 10.1021/es303434p; Fowler SW, 1976, ACTIVITIES INT LAB M, P20; Gilmour CC, 2013, ENVIRON SCI TECHNOL, V47, P11810, DOI 10.1021/es403075t; Grandjean P, 2010, ENVIRON HEALTH PERSP, V118, P1137, DOI 10.1289/ehp.0901757; Green RE, 2003, LIMNOL OCEANOGR, V48, P2377, DOI 10.4319/lo.2003.48.6.2377; HAINES EB, 1976, LIMNOL OCEANOGR, V21, P880, DOI 10.4319/lo.1976.21.6.0880; Hammerschmidt CR, 2006, ARCH ENVIRON CON TOX, V51, P416, DOI 10.1007/s00244-005-0265-7; Hammerschmidt CR, 2013, ENVIRON SCI TECHNOL, V47, P3671, DOI 10.1021/es3048619; Han SH, 2005, ENVIRON SCI TECHNOL, V39, P6607, DOI 10.1021/es048667z; Harding G, 2013, TOXIC CHEM CONTAMINA; Harding GC, 1997, MAR CHEM, V56, P145; HARDING GC, 1987, MAR ECOL PROG SER, V41, P29, DOI 10.3354/meps041029; HARDING GCH, 1979, J FISH RES BOARD CAN, V36, P247, DOI 10.1139/f79-040; HARRIS RP, 1982, J MAR BIOL ASSOC UK, V62, P71, DOI 10.1017/S0025315400020117; HAUG A, 1974, ENVIRON POLLUT, V7, P179, DOI 10.1016/0013-9327(74)90065-2; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Heimburger LE, 2010, GEOCHIM COSMOCHIM AC, V74, P5549, DOI 10.1016/j.gca.2010.06.036; Hirose K, 2006, ANAL SCI, V22, P1055, DOI 10.2116/analsci.22.1055; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hook SE, 2001, MAR BIOL, V138, P1131, DOI 10.1007/s002270000533; HORVAT M, 1993, ANAL CHIM ACTA, V282, P153, DOI 10.1016/0003-2670(93)80364-Q; ICCAT, 1990, FIELD MAN STAT SAMPL; Irmer U, 1985, VOM WASSER, V65, P37; Jarman WM, 1996, ENVIRON SCI TECHNOL, V30, P654, DOI 10.1021/es950392n; Jones S, 2010, PROCEEDINGS OF THE 17TH INTERNATIONAL CONGRESS ON SOUND AND VIBRATION; Kainz M, 2005, ENVIRON SCI TECHNOL, V39, P1666, DOI 10.1021/es049119o; Kehrig HA, 2009, ESTUAR COAST SHELF S, V85, P36, DOI 10.1016/j.ecss.2009.05.027; Kehrig HA, 2010, MAR POLLUT BULL, V60, P2350, DOI 10.1016/j.marpolbul.2010.08.010; Kerr SR, 2001, BIOMASS SPECTRUM PRE, P110; Kidd KA, 2003, J GREAT LAKES RES, V29, P258, DOI 10.1016/S0380-1330(03)70553-X; Kim E, 2012, ENVIRON TOXICOL CHEM, V31, P1254, DOI 10.1002/etc.1809; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kirk JL, 2008, ENVIRON SCI TECHNOL, V42, P8367, DOI 10.1021/es801635m; Kirk JL, 2012, ENVIRON RES, V119, P64, DOI 10.1016/j.envres.2012.08.012; KLEIN DH, 1970, ENVIRON SCI TECHNOL, V4, P765; Kotnik J, 2007, MAR CHEM, V107, P13, DOI 10.1016/j.marchem.2007.02.012; LANDRY MR, 1975, LIMNOL OCEANOGR, V20, P854, DOI 10.4319/lo.1975.20.5.0854; Lavoie RA, 2013, ENVIRON SCI TECHNOL, V47, P13385, DOI 10.1021/es403103t; Lavoie RA, 2010, SCI TOTAL ENVIRON, V408, P5529, DOI 10.1016/j.scitotenv.2010.07.053; Lee CS, 2016, LIMNOL OCEANOGR, V61, P1626, DOI 10.1002/lno.10318; Leermakers M, 2001, MAR CHEM, V75, P229, DOI 10.1016/S0304-4203(01)00039-1; Li WKW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020981; LIANG L, 1994, TALANTA, V41, P371, DOI 10.1016/0039-9140(94)80141-X; Lillick LC, 1940, PHYTOPLANKTON PLANKT; Limper U, 2008, J APPL ENTOMOL, V132, P168, DOI 10.1111/j.1439-0418.2007.01236.x; Lindstrom U, 2002, ICES J MAR SCI, V59, P58, DOI 10.1006/jmsc.2001.1135; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; Loseto LL, 2008, J MARINE SYST, V74, P1012, DOI 10.1016/j.jmarsys.2007.10.004; LUCOTTE M, 1995, WATER AIR SOIL POLL, V80, P467, DOI 10.1007/BF01189696; Luengen AC, 2012, ENVIRON TOXICOL CHEM, V31, P1712, DOI 10.1002/etc.1885; Mahon R, 1998, CAN J FISH AQUAT SCI, V55, P1704, DOI 10.1139/cjfas-55-7-1704; Malcolm EG, 2010, MAR CHEM, V122, P11, DOI 10.1016/j.marchem.2010.08.004; Mariottini GL, 2003, RIV BIOL-BIOL FORUM, V96, P55; MASON RP, 1995, WATER AIR SOIL POLL, V80, P915, DOI 10.1007/BF01189744; Mason RP, 1998, MAR CHEM, V61, P37, DOI 10.1016/S0304-4203(98)00006-1; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; MASON RP, 1993, DEEP-SEA RES PT I, V40, P1897, DOI 10.1016/0967-0637(93)90037-4; MCCAVE IN, 1984, DEEP-SEA RES, V31, P329, DOI 10.1016/0198-0149(84)90088-8; MCLAREN IA, 1978, J FISH RES BOARD CAN, V35, P1330, DOI 10.1139/f78-208; MCLAREN IA, 1989, CAN J FISH AQUAT SCI, V46, P560, DOI 10.1139/f89-074; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Miller EK, 2005, ECOTOXICOLOGY, V14, P53, DOI 10.1007/s10646-004-6259-9; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Mitchell E., 1974, P123; Monperrus M, 2007, MAR CHEM, V107, P49, DOI 10.1016/j.marchem.2007.01.018; Nagata T, 1997, ADV MICROB ECOL, V15, P81; Nfon E, 2009, SCI TOTAL ENVIRON, V407, P6267, DOI 10.1016/j.scitotenv.2009.08.032; NOAA, 2012, NMFSNE221 NOAA, Vi-v; Overholtz W.J, 2006, J NW ATL FISH SCI, V36, P55; Overholtz WJ, 2000, ICES J MAR SCI, V57, P1147, DOI 10.1006/jmsc.2000.0802; OVERHOLTZ WJ, 1979, FISH B-NOAA, V77, P285; Peters HP, 1983, CAMBRIDGE STUDIES EC; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Petrie B, 2000, CAN J FISH AQUAT SCI, V57, P2536, DOI 10.1139/cjfas-57-12-2536; Pickhardt PC, 2007, ENVIRON SCI TECHNOL, V41, P125, DOI 10.1021/es060966w; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; POULET SA, 1973, LIMNOL OCEANOGR, V18, P564, DOI 10.4319/lo.1973.18.4.0564; Power M, 2002, J APPL ECOL, V39, P819, DOI 10.1046/j.1365-2664.2002.00758.x; Preston A., 1972, Symposia Zool Soc Lond, VNo. 29, P271; Prouse NJ, 1984, UPDATE MARINE ENV CO, P65; Pucko M, ENV SCI TECHNOLOGY, V48, P7280; RAY GL, 1976, J ENVIRON QUAL, V5, P193, DOI 10.2134/jeq1976.00472425000500020017x; Read AJ, 2003, CONSERV ECOL, V7; Read AJ, 1997, CAN J ZOOL, V75, P122, DOI 10.1139/z97-016; RECCHIA CA, 1989, CAN J ZOOL, V67, P2140, DOI 10.1139/z89-304; Rieder SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061215; Ritterhoff J, 1997, SCI TOTAL ENVIRON, V199, P255, DOI 10.1016/S0048-9697(97)05457-0; RUDD JWM, 1980, APPL ENVIRON MICROB, V40, P777, DOI 10.1128/AEM.40.4.777-782.1980; Runge JA, 2011, ANAL HERRING DIET CO; Schaefer JK, 2014, ENVIRON SCI TECHNOL, V48, P3007, DOI 10.1021/es405215v; Schmidt K, 2010, ADV MAR BIOL, V57, P127, DOI 10.1016/S0065-2881(10)57005-6; Schuster PF, 2002, ENVIRON SCI TECHNOL, V36, P2303, DOI 10.1021/es0157503; Schwartz Jack P., 1996, P285; Sergeant D. E., 1977, Report int. Whal. Commn, V27, P460; SHELDON RW, 1972, LIMNOL OCEANOGR, V17, P327, DOI 10.4319/lo.1972.17.3.0327; Sherman K, 1996, NE SHELF ECOSYSTEM A, Vxxv; Sprules WG, 2016, CAN J FISH AQUAT SCI, V73, P477, DOI 10.1139/cjfas-2015-0115; St Louis VL, 2007, ENVIRON SCI TECHNOL, V41, P6433, DOI 10.1021/es070692s; Struck BD, 1997, SCI TOTAL ENVIRON, V207, P29, DOI 10.1016/S0048-9697(97)00246-5; Sunderland EM, 2008, ENVIRON POLLUT, V156, P526, DOI 10.1016/j.envpol.2008.01.021; Townsend DW, 2005, GLOBAL COASTAL OCEAN, P119; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Turner JT, 2004, ZOOL STUD, V43, P255; U.S. EPA, 2001, EPA821R01020 OFF WAT; US EPA, 1999, EPA821R99005 OFF WAT; *US EPA, 2001, EPA821R01024; WELLS ML, 1994, LIMNOL OCEANOGR, V39, P286, DOI 10.4319/lo.1994.39.2.0286; Wells ML, 2002, BIOGEOCHEMISTRY MARI, P367, DOI DOI 10.1016/B978-012323841-2/50009-9; WILLIAMS PM, 1973, J FISH RES BOARD CAN, V30, P293, DOI 10.1139/f73-051; Wozniak SB, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005554; Zanden M. Jake Vander, 1999, Ecology (Washington D C), V80, P1395, DOI 10.1890/0012-9658(1999)080[1395:PCCANA]2.0.CO;2; ZITKO V, 1971, J FISH RES BOARD CAN, V28, P1285, DOI 10.1139/f71-195	150	43	44	11	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0197220	10.1371/journal.pone.0197220	http://dx.doi.org/10.1371/journal.pone.0197220			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011281	gold, Green Submitted, Green Published			2022-12-26	WOS:000438829800001
J	Augustus, GJ; Roe, DJ; Jacobs, ET; Lance, P; Ellis, NA				Augustus, Gaius Julian; Roe, Denise J.; Jacobs, Elizabeth T.; Lance, Peter; Ellis, Nathan A.			Is increased colorectal screening effective in preventing distant disease?	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; CANCER STATISTICS; MORTALITY; HYPERMETHYLATION; COLONOSCOPY; ADULTS	Background Screening in the average risk population for colorectal cancer (CRC) is expected to reduce the incidence of distant (i.e., metastatic) CRCs at least as much as less advanced CRCs. Indeed, since 2000, during which time colonoscopy became widely used as a screening tool, the overall incidence of CRC has been reduced by 29%. Objective The purpose of the current study was to determine whether the reduction of incidence rates is the same for all stages of disease. Methods We evaluated incidence data from the Surveillance, Epidemiology, and End Results (SEER) program from 2000-2014 for Localized, Regional, and Distant disease. Joinpoint models were compared to assess parallelism of trends. Data were stratified by race, age, tumor location, and sex to determine whether these subgroupings could explain overall trends. Results Inconsistent with the expectations of a successful screening program, the reduction in incidence rates of distant CRCs from 2000-2014 has been slower than the reductions in incidence rates of both regional and localized CRCs. This trend is evident even when the data are stratified by age at diagnosis, sex, race, or tumor location. Conclusions The slower decrease in the incidence rate of distant disease is not consistent with a screening effect, that is, CRC screening may not be effective in preventing many distant CRCs. As a consequence, distant CRCs represent an increasing fraction of all CRCs, accounting for 21% of all CRCs in 2014. The analysis indicates that inadequate screening does not explain the slower decrease in incidence of distant CRCs. Consequently, we suggest that a subtype of CRC exists that advances rapidly, evading detection because screening intervals are too 161 long to prevent it. Microsatellite unstable tumors represent a known subtype that advances more rapidly, and we suggest that another rapidly advancing subtype very likely exists that is microsatellite stable.	[Augustus, Gaius Julian] Canc Biol Grad Interdisciplinary Program, Tucson, AZ USA; [Augustus, Gaius Julian; Roe, Denise J.; Jacobs, Elizabeth T.; Lance, Peter; Ellis, Nathan A.] Univ Arizona, Canc Ctr, Tucson, AZ 85721 USA	University of Arizona	Ellis, NA (corresponding author), Univ Arizona, Canc Ctr, Tucson, AZ 85721 USA.	naellis@email.arizona.edu		Augustus, Gaius/0000-0001-9439-0836	National Cancer Institute [U01 CA153060, P30 CA023074]; Cancer Biology Training Grant [T32 CA009213]; NATIONAL CANCER INSTITUTE [U01CA153060, T32CA009213, P30CA023074] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Biology Training Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (U01 CA153060 and P30 CA023074, NAE). GJA was supported by the Cancer Biology Training Grant T32 CA009213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699; Augustus GJ, 2018, AM J PATHOL, V188, P291, DOI 10.1016/j.ajpath.2017.07.023; Austin H, 2014, CANCER CAUSE CONTROL, V25, P191, DOI 10.1007/s10552-013-0321-y; Bond CE, 2016, ONCOTARGET, V7, P70589, DOI 10.18632/oncotarget.12130; Brenner H, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2467; Centers for Disease Control and Prevention (CDC), 1996, MMWR-MORBID MORTAL W, V45, P57; Chao A, 2000, CANCER EPIDEM BIOMAR, V9, P539; Colditz GA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003218; Coughlin SS, 2016, J RACIAL ETHN HEALTH, V3, P555, DOI 10.1007/s40615-015-0174-z; Croswell JM, 2010, SEMIN ONCOL, V37, P202, DOI 10.1053/j.seminoncol.2010.05.006; Cunningham JM, 1998, CANCER RES, V58, P3455; Edelstein DL, 2011, CLIN GASTROENTEROL H, V9, P340, DOI 10.1016/j.cgh.2010.10.033; Emmons KM, 2017, NEW ENGL J MED, V376, P986, DOI 10.1056/NEJMsb1609101; Friis R, 2014, EPIDEMIOLOGY PUBLIC; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jerant AF, 2008, ARCH INTERN MED, V168, P1317, DOI 10.1001/archinte.168.12.1317; Joseph D. A., 2008, Morbidity and Mortality Weekly Report, V57, P253; Kaminski MF, 2017, GASTROENTEROLOGY, V153, P98, DOI 10.1053/j.gastro.2017.04.006; Kane MF, 1997, CANCER RES, V57, P808; Leslie A, 2002, BRIT J SURG, V89, P845, DOI 10.1046/j.1365-2168.2002.02120.x; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Robertson DJ, 2014, GUT, V63, P949, DOI 10.1136/gutjnl-2012-303796; Sanduleanu S, 2012, NAT REV GASTRO HEPAT, V9, P550, DOI 10.1038/nrgastro.2012.136; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Siegel RL, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw322; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song MY, 2016, JAMA ONCOL, V2, P1154, DOI 10.1001/jamaoncol.2016.0843; Syngal S, 2015, AM J GASTROENTEROL, V110, P223, DOI 10.1038/ajg.2014.435; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; United States Cancer Statistics Working Group, 2017, US CANC STAT 1999 20; US Preventive Services Task Force, 2016, AGENCY HEALTHCARE RE, V315, P2564, DOI [10.1001/jama.2016.5989, DOI 10.1001/JAMA.2016.5989]; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Welch HG, 2016, NEW ENGL J MED, V374, P1605, DOI 10.1056/NEJMp1600448	36	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200462	10.1371/journal.pone.0200462	http://dx.doi.org/10.1371/journal.pone.0200462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001362	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400060
J	Uhrig, M; Simons, D; Schlemmer, HP				Uhrig, Monika; Simons, David; Schlemmer, Heinz-Peter			Incidental pulmonary emboli in stage IV melanoma patients: Prevalence in CT staging examinations and improved detection with vessel reconstructions based on dual energy CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CANCER-PATIENTS; IMAGE QUALITY; ANGIOGRAPHY; THROMBOSIS; MDCT; EXPERIENCE; DIAGNOSIS; HISTORY; LUNG	Objectives Malignancy is the strongest predictor for venous thromboembolism. Dual energy CT (DECT) can support assessment of pulmonary emboli (PE) by providing vessel reconstructions (DECT-VR) and highlighting thrombi. Purpose was to determine prevalence and risk factors of PE in staging examinations of stage IV-melanoma patients and to evaluate the potential of DECT-VR to improve PE diagnosis. Material and methods This retrospective study was approved by IRB. Contrast-enhanced, conventional grey scale CT (cCT) and DECT-VR of 200 stage IV-melanoma patients were reviewed by three radiologists in consensus. Overall prevalence was determined. One-sided Wilcoxon-test was performed to compare the number of detected emboli between cCT and cCT with supplementary DECT-VR. Frequencies of risk factors were compared with chi(2) test. Results On cCT, 9 PE were detected (6 patients, correlating to 3% of the study population with 0.05 emboli per patient). With the supplementary DECT-VR, number of diagnosed emboli increased from 9 to 17 (p < 0.05) (in total 9 patients, correlating to 0.09 emboli per patient). Emboli on DECT-VR were mainly subsegmentally (7 of 8). There was no significant difference in the frequency of risk factors. Conclusions The prevalence of pulmonary emboli in our cohort of 200 stage IV melanoma patients was 5%. DECT-VR improved significantly diagnosis of PE, especially when located subsegmentally.	[Uhrig, Monika; Simons, David; Schlemmer, Heinz-Peter] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Uhrig, M (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.	m.uhrig@dkfz.de		Uhrig, Monika/0000-0002-4609-8184				Apfaltrer P, 2014, EUR J RADIOL, V83, P322, DOI 10.1016/j.ejrad.2013.11.005; Bongers MN, 2016, INVEST RADIOL, V51, P647, DOI 10.1097/RLI.0000000000000293; Bongers MN, 2017, INVEST RADIOL, V52, P240, DOI 10.1097/RLI.0000000000000333; den Exter PL, 2013, BLOOD, V122, P1144, DOI 10.1182/blood-2013-04-497545; Dentali F, 2010, THROMB RES, V125, P518, DOI 10.1016/j.thromres.2010.03.016; Eyer BA, 2005, AM J ROENTGENOL, V184, P623, DOI 10.2214/ajr.184.2.01840623; Gladish GW, 2006, RADIOLOGY, V240, P246, DOI 10.1148/radiol.2401051129; Goodman LR, 2005, RADIOLOGY, V234, P654, DOI 10.1148/radiol.2343041326; Grant KL, 2014, INVEST RADIOL, V49, P586, DOI 10.1097/RLI.0000000000000060; Graser A, 2008, INVEST RADIOL, V43, P112, DOI 10.1097/RLI.0b013e318157a144; Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Khorana AA, 2007, J THROMB HAEMOST, V5, P632, DOI 10.1111/j.1538-7836.2007.02374.x; Krissak R, 2010, INVEST RADIOL, V45, P341, DOI 10.1097/RLI.0b013e3181dfda37; Laack TA, 2004, EMERG MED CLIN N AM, V22, P961, DOI 10.1016/j.emc.2004.05.011; Langenberger H, 2009, EUR J RADIOL, V70, P579, DOI 10.1016/j.ejrad.2008.01.058; Liebman HA, 2016, THROMB RES, V140, pS18, DOI 10.1016/S0049-3848(16)30093-7; Lu GM, 2012, AM J ROENTGENOL, V199, pS40, DOI 10.2214/AJR.12.9112; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Pena E, 2012, J THROMB HAEMOST, V10, P496, DOI 10.1111/j.1538-7836.2011.04612.x; Schoepf UJ, 2002, RADIOLOGY, V222, P483, DOI 10.1148/radiol.2222001802; Storto ML, 2005, AM J ROENTGENOL, V184, P264, DOI 10.2214/ajr.184.1.01840264; Tang CX, 2013, EUR J RADIOL, V82, P2270, DOI 10.1016/j.ejrad.2013.06.021; Tapson VF, 2008, NEW ENGL J MED, V358, P1037, DOI 10.1056/NEJMra072753; Uhrig M, 2017, EUR J RADIOL, V90, P27, DOI 10.1016/j.ejrad.2017.02.024; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744; Wittram C, 2004, RADIOGRAPHICS, V24, P1219, DOI 10.1148/rg.245045008; Zhang LJ, 2012, ACAD RADIOL, V19, P341, DOI 10.1016/j.acra.2011.11.002; Zhang LJ, 2009, EUR RADIOL, V19, P2844, DOI 10.1007/s00330-009-1518-z	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199458	10.1371/journal.pone.0199458	http://dx.doi.org/10.1371/journal.pone.0199458			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001367	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400009
J	Dei Zotti, F; Lobysheva, II; Balligand, JL				Dei Zotti, Flavia; Lobysheva, Irina I.; Balligand, Jean-Luc			Nitrosyl-hemoglobin formation in rodent and human venous erythrocytes reflects NO formation from the vasculature in vivo	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ELECTRON-PARAMAGNETIC-RESONANCE; RED-BLOOD-CELLS; OXIDATIVE STRESS; S-NITROSOHEMOGLOBIN; OXYGEN-BINDING; MECHANISMS; ANEMIA; MICE; BIOAVAILABILITY	Reduced bioavailability of nitric oxide (NO) is a major feature of endothelial dysfunction characteristic of cardiovascular and metabolic diseases but the short half-life of NO precludes its easy quantification in circulating blood for early diagnosis. In erythrocytes, NO can react with hemoglobin to form an iron-nitrosyl complex (5-coordinate-alpha-HbNO) directly quantifiable by Electron Paramagnetic Resonance spectroscopy (EPR) in mouse, rat and human venous blood ex vivo. However, the sources of the nitrosylating species in vivo and optimal conditions of HbNO preservation for diagnostic use in human erythrocytes are unknown. Using EPR spectroscopy, we found that HbNO stability was significantly higher under hypoxia (equivalent to venous pO(2) ; 12.0 +/- 0.2% degradation of HbNO at 30 minutes) than at room air (47.7 +/- 0.2% degradation) in intact erythrocytes; at 20 degrees C (15.2 +/- 0.3% degradation after 30 min versus 29.6 +/- 0.1% at 37 degrees C) and under acidic pH (31.7 +/- 0.8% versus 62.2 +/- 0.4% degradation after 30 min at physiological pH) at 50% of haematocrit. We next examined the relative contribution of NO synthase (NOS) from the vasculature or in erythrocytes themselves as a source of nitrosylating NO. We detected a NOS activity (and eNOS expression) in human red blood cells (RBC), and in RBCs from eNOS((+/+)) (but not eNOS((-/-))) mice, as measured by HbNO formation and nitrite/nitrate accumulation. NO formation was increased after inhibition of arginase but abrogated upon NOS inhibition in human RBC and in RBCs from eNOS((+/+)) (but not eNOS(()(-/)(-))) mice. However, the HbNO signal from freshly drawn venous RBCs was minimally sensitive to the inhibitors ex vivo, while it was enhanced upon caveolin-1 deletion in vivo, suggesting a minor contribution of erythrocyte NOS to HbNO complex formation compared with vascular endothelial NOS or other paracrine NO sources. We conclude that HbNO formation in rodent and human venous erythrocytes is mainly influenced by vascular NO sources despite the erythrocyte NOS activity, so that its measurement by EPR could serve as a surrogate for NO-dependent endothelial function.	[Lobysheva, Irina I.; Balligand, Jean-Luc] Clin Univ St Luc, Pole Pharmacol & Therapeut FATH, IREC, Brussels, Belgium; Catholic Univ Louvain, Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain	Lobysheva, II; Balligand, JL (corresponding author), Clin Univ St Luc, Pole Pharmacol & Therapeut FATH, IREC, Brussels, Belgium.	irina.lobysheva@uclouvain.be; jl.balligand@uclouvain.be	Stefanadis, Christodoulos/ABH-2232-2020; Balligand, Jean-Luc J/D-7543-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; BALLIGAND, Jean-Luc/0000-0002-0522-4156	Fonds National de la Recherche Scientifique (FNRS) [PDR T.0144.13]; Fonds Special de Recherche, European Union [UE LSHM-CT-05-018833]; federation Wallonie-Bruxelles [ARC11-16/035]; Region Wallonne [NOHEMIE: 1217802, NORPE:1217907]; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture, Flavia Dei Zotti	Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Fonds Special de Recherche, European Union; federation Wallonie-Bruxelles; Region Wallonne; Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture, Flavia Dei Zotti(Fonds de la Recherche Scientifique - FNRS)	This work was funded by Fonds National de la Recherche Scientifique (FNRS; PDR T.0144.13) JLB, Fonds Special de Recherche, European Union (UE LSHM-CT-05-018833) JLB, the federation Wallonie-Bruxelles (Action de Recherche ConcerteAe ARC11-16/035), JLB, Region Wallonne (NOHEMIE: 1217802; NORPE:1217907) JLB, and Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture, Flavia Dei Zotti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angermeier E, 2016, HAEMATOLOGICA, V101, pE48, DOI 10.3324/haematol.2015.137026; Azizi F, 2005, FREE RADICAL BIO MED, V39, P145, DOI 10.1016/j.freeradbiomed.2005.03.001; Barodka V, 2014, TRANSFUSION, V54, P434, DOI 10.1111/trf.12291; Belanger AM, 2015, TRANSFUSION, V55, P2464, DOI 10.1111/trf.13134; Benz PM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0145-y; Cortese-Krott MM, 2018, REDOX BIOL, V14, P328, DOI 10.1016/j.redox.2017.08.020; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Daiber A, 2015, ANTIOXID REDOX SIGN, V23, P899, DOI 10.1089/ars.2015.6376; Desjardins F, 2008, CARDIOVASC RES, V79, P527, DOI 10.1093/cvr/cvn080; Diederich L, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00332; Fago A, 2013, BBA-PROTEINS PROTEOM, V1834, P1894, DOI 10.1016/j.bbapap.2013.04.017; Foller M, 2008, P NATL ACAD SCI USA, V105, P6771, DOI 10.1073/pnas.0708940105; Gambaryan S, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0139-9; Gambaryan S, 2015, AMINO ACIDS, V47, P1779, DOI 10.1007/s00726-015-1986-1; Ghimire K, 2017, AM J PHYSIOL-CELL PH, V312, pC254, DOI 10.1152/ajpcell.00315.2016; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; Helms C, 2013, FREE RADICAL BIO MED, V61, P464, DOI 10.1016/j.freeradbiomed.2013.04.028; Henry Y. A., 1997, NITRIC OXIDE RES CHE; Hogg N, 2010, FREE RADICAL BIO MED, V49, P122, DOI 10.1016/j.freeradbiomed.2010.03.009; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Jiang JJ, 2007, FREE RADICAL BIO MED, V43, P1208, DOI 10.1016/j.freeradbiomed.2007.06.024; Kim-Shapiro DB, 2015, NITRIC OXIDE-BIOL CH, V44, P1, DOI 10.1016/j.niox.2014.10.003; Kirima K, 2003, AM J PHYSIOL-HEART C, V285, pH589, DOI 10.1152/ajpheart.01010.2002; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kleschyov AL, 2007, J CHROMATOGR B, V851, P12, DOI 10.1016/j.jchromb.2006.10.006; Kosaka H, 1999, BBA-BIOENERGETICS, V1411, P370, DOI 10.1016/S0005-2728(99)00026-2; Kuhn V, 2017, ANTIOXID REDOX SIGN, V26, P718, DOI 10.1089/ars.2016.6954; Li HT, 2006, J BIOL CHEM, V281, P12546, DOI 10.1074/jbc.M511803200; Lobysheva II, 2017, CLIN APPL EPR SPECTR; Lobysheva I, 2011, ARTERIOSCL THROM VAS, V31, P2098, DOI 10.1161/ATVBAHA.111.230623; Lobysheva II, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076457; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Mateo AO, 2000, PHARMACOL RES, V42, P421, DOI 10.1006/phrs.2000.0701; Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1; Oliver SR, 2012, AM J PHYSIOL-REG I, V302, pR845, DOI 10.1152/ajpregu.00595.2011; Piknova B, 2005, J BIOL CHEM, V280, P40583, DOI 10.1074/jbc.M506292200; Siervo M, 2011, FREE RADICAL BIO MED, V51, P795, DOI 10.1016/j.freeradbiomed.2011.05.032; Singel DJ, 2005, ANNU REV PHYSIOL, V67, P99, DOI 10.1146/annurev.physiol.67.060603.090918; SKIBBA JL, 1991, INT J HYPERTHER, V7, P749, DOI 10.3109/02656739109056444; Stefanovic M, 2013, BIOCHEM J, V449, P143, DOI 10.1042/BJ20120869; Steven S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102176; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Tsikas D, 2015, NITRIC OXIDE-BIOL CH, V45, P1, DOI 10.1016/j.niox.2015.01.001; Vaughn MW, 2000, J BIOL CHEM, V275, P2342, DOI 10.1074/jbc.275.4.2342; Wood KC, 2013, ARTERIOSCL THROM VAS, V33, P1861, DOI 10.1161/ATVBAHA.112.301068; Yang JN, 2013, P NATL ACAD SCI USA, V110, P15049, DOI 10.1073/pnas.1307058110; Yonetani T, 1998, J BIOL CHEM, V273, P20323, DOI 10.1074/jbc.273.32.20323	49	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200352	10.1371/journal.pone.0200352	http://dx.doi.org/10.1371/journal.pone.0200352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995915	Green Submitted, gold, Green Published			2022-12-26	WOS:000438388800056
J	Potter, G; Swart, CW; van Wyk, PWJ; Duvenhage, MM; Coetsee, E; Swart, HC; Budge, SM; Speers, RA				Potter, Greg; Swart, Chantel W.; van Wyk, Pieter W. J.; Duvenhage, Mart-Mari; Coetsee, Elizabeth; Swart, Hendrik C.; Budge, Suzanne M.; Speers, R. Alex			Compositional, ultrastructural and nanotechnological characterization of the SMA strain of Saccharomyces pastorianus: Towards a more complete fermentation yeast cell analysis	PLOS ONE			English	Article							3-OH OXYLIPINS; TOF-SIMS; FLOCCULATION; CEREVISIAE; GAS; ANTIFUNGAL; DYNAMICS; IMPACT; ASSAY	Nano scanning Auger microscopy (NanoSAM) and time-of-flight secondary ion mass spectrometry (TOF-SIMS) have been used in materials science research for some time, but NanoSAM, in particular, has only recently been applied to biological specimens. Here, the first concurrent utilization of NanoSAM, TOF-SIMS and microscopic techniques for the examination of a standard beverage fermentation strain of Saccharomyces pastorianus uncovered the presence of intracellular networks of CO2 in fermenting cells. Respiring cells produced few bubbles and instead had large internal vacuolar structures. Transmission electron microscopy analysis also showed osmiophilic layers at the cell exterior of fermenting cells that became more prevalent with fermentation duration, while osmiophilic layers were largely absent in respiring cells. TOF-SIMS analysis showed a compositional difference at the exterior and interior of SMA cells and between fermenting and respiring cells. Fermenting cells also appeared to have different 3-OH oxylipin profiles compared to respiring cells based upon examination with immunofluorescence microscopy. The results of this work and further study using these materials science techniques will substantially enhance our understanding of the chemical, ultrastructural and metabolic changes that occur in fermentation yeasts.	[Potter, Greg; Speers, R. Alex] Dalhousie Univ, Canadian Inst Fermentat Technol, Dept Proc Engn & Appl Sci, Halifax, NS, Canada; [Swart, Chantel W.; van Wyk, Pieter W. J.] Univ Free State, Fac Nat & Agr Sci, Ctr Microscopy, Bloemfontein, South Africa; [Duvenhage, Mart-Mari; Coetsee, Elizabeth; Swart, Hendrik C.] Univ Free Sate, Dept Phys, Bloemfontein, South Africa; [Budge, Suzanne M.] Dalhousie Univ, Dept Proc Engn & Appl Sci, Halifax, NS, Canada	Dalhousie University; University of the Free State; Dalhousie University	Potter, G (corresponding author), Dalhousie Univ, Canadian Inst Fermentat Technol, Dept Proc Engn & Appl Sci, Halifax, NS, Canada.	gpotter@dal.ca	Swart, Hendrik C/G-2696-2012	Swart, Hendrik C/0000-0001-5233-0130; Budge, Suzanne/0000-0003-4984-7344; Coetsee, Elizabeth/0000-0002-9214-4647	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Fund (NRF) [88415]; University of the Free State; National Science and Engineering Research Council (NSERC) of Canada	South African Research Chairs Initiative of the Department of Science and Technology (DST); National Research Fund (NRF); University of the Free State; National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the support of the South African Research Chairs Initiative of the Department of Science and Technology (DST) and the National Research Fund (NRF) (Grant 88415 to HCS) and the financial support of the University of the Free State. This work was also funded by the National Science and Engineering Research Council (NSERC) of Canada. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	ASBC, 2013, YEAST 14 MIN FERM AS; Barker MG, 1996, J AM SOC BREW CHEM, V54, P121; Belazi D, 2009, HISTOCHEM CELL BIOL, V132, P105, DOI 10.1007/s00418-009-0587-z; BEXELL U., 2003, THESIS; Briggs D. E., 2004, BREWING SCI PRACTICE; Carlquist M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-94; Cersoy S, 2012, J MASS SPECTROM, V47, P338, DOI 10.1002/jms.2979; Choi JY, 2016, MOL MICROBIOL, V99, P999, DOI 10.1111/mmi.13280; DENGIS PB, 1995, APPL ENVIRON MICROB, V61, P718, DOI 10.1128/AEM.61.2.718-728.1995; Evans Analytical Group, 2018, SEC ION MASS SPECT S; Evans Analytical Group, 2018, SIMS TUTORIAL THEORY; Evans Analytical Group A, 2018, AUG EL SPECTR AES AU; Heins AL, 2012, NEW BIOTECHNOL, V29, pS199, DOI 10.1016/j.nbt.2012.08.561; HERSHEY AD, 1952, J GEN PHYSIOL, V36, P39, DOI 10.1085/jgp.36.1.39; ISENSCHMID A, 1995, J BIOTECHNOL, V39, P229, DOI 10.1016/0168-1656(95)00018-L; Kock JLF, 2011, EXPERT OPIN DRUG DIS, V6, P671, DOI 10.1517/17460441.2011.575358; Kock JLF, 2000, ANTON LEEUW INT J G, V77, P401, DOI 10.1023/A:1002735216303; Kock JLF, 1998, FEBS LETT, V427, P345, DOI 10.1016/S0014-5793(98)00406-2; Kock JLF, 2007, FEMS YEAST RES, V7, P1207, DOI 10.1111/j.1567-1364.2007.00273.x; Kock L, 2013, J I BREWING, V119, P201, DOI 10.1002/jib.102; Lake JC, 2008, J AM SOC BREW CHEM, V66, P94, DOI 10.1094/ASBCJ-2008-0213-01; Leefmann T, 2013, ORG GEOCHEM, V57, P23, DOI 10.1016/j.orggeochem.2013.01.005; Leeuw NJ, 2010, CAN J MICROBIOL, V56, P883, DOI [10.1139/W10-074, 10.1139/w10-074]; MacIntosh AJ, 2014, J AM SOC BREW CHEM, V72, P66, DOI 10.1094/ASBCJ-2014-0204-01; Macintosh AJ, 2012, J AM SOC BREW CHEM, V70, P205, DOI 10.1094/ASBCJ-2012-0724-01; Murase A, 2004, R D REV TOYOTA CRDL, V39, P15; Napoli C, 2013, J AM COLL CARDIOL, V62, P89, DOI 10.1016/j.jacc.2013.03.070; Potter G, 2015, J I BREWING, V121, P31, DOI 10.1002/jib.186; Powell CD, 2003, FEMS YEAST RES, V3, P149, DOI 10.1016/S1567-1356(03)00002-3; Powell CD, 2000, MICROBIOL-SGM, V146, P1023, DOI 10.1099/00221287-146-5-1023; Speers RA, 2006, J I BREWING, V112, P246, DOI 10.1002/j.2050-0416.2006.tb00720.x; SPEERS RA, 1993, J I BREWING, V99, P159, DOI 10.1002/j.2050-0416.1993.tb01159.x; Strauss CJ, 2005, J I BREWING, V111, P304, DOI 10.1002/j.2050-0416.2005.tb00688.x; Swart CW, 2013, J I BREWING, V119, P15, DOI 10.1002/jib.60; Swart CW, 2014, ADV EXP MED BIOL, V807, P1, DOI 10.1007/978-81-322-1777-0_1; Swart CW, 2012, FEMS YEAST RES, V12, P867, DOI 10.1111/j.1567-1364.12004.x; Swart CW, 2010, SCI RES ESSAYS, V5, P3411; Vidgren V, 2011, J I BREWING, V117, P475, DOI 10.1002/j.2050-0416.2011.tb00495.x; Xu YX, 2010, BIORESOURCE TECHNOL, V101, P3311, DOI 10.1016/j.biortech.2010.01.006; Yamada H, 2006, CONDENSED MATTER NUCLEAR SCIENCE, P455, DOI 10.1142/9789812701510_0038; Yetik-Anacak G, 2015, BRIT J PHARMACOL, V172, P1434, DOI 10.1111/bph.12700	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200552	10.1371/journal.pone.0200552	http://dx.doi.org/10.1371/journal.pone.0200552			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995965	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800082
J	Thiele, J; Schirmel, J; Buchholz, S				Thiele, Jan; Schirmel, Jens; Buchholz, Sascha			Effectiveness of corridors varies among phytosociological plant groups and dispersal syndromes	PLOS ONE			English	Article							AGRICULTURAL LANDSCAPES; SPECIES DIVERSITY; CIRCUIT-THEORY; GENE FLOW; CONNECTIVITY; BIODIVERSITY; CONSERVATION; INTENSIFICATION; BARRIERS	In agricultural landscapes, semi-natural habitats are scarce and remaining habitat patches are largely isolated. However, linear landscape elements might facilitate dispersal of plant species through the agricultural landscape matrix. We investigated the following research questions: 1. are open linear landscape elements (LLE) effective corridors for dispersal of vascular plant species? 2. Which plant species, with respect to phytosociological group and dispersal-distance class, do use LLE as corridors? 3. To which extent is floristic similarity of communities influenced by dispersal through corridors? Field work was carried out in agricultural landscapes of Northwest Germany. We sampled 50 vegetation releves on open linear landscape elements i.e. field margins (incl. road verges) and ditches, in eight 1-km(2) study areas. Then, we calculated Jaccard similarities of all plot pairs within study areas using either all species or only species of certain phytosociological groups or dispersal-distance classes. We assessed the isolation of the plots from each other using both Euclidean distance and resistance distance along LLE. Resistance distance reflected the degree of connectivity of the LLE network between the plots. A stronger effect on Jaccard similarity of resistance distance compared to Euclidean distance would indicate corridor dispersal of plants through LLE. Relationships between Jaccard similarity and the two isolation measures were analysed with Generalised Linear Mixed Models. Resistance distance of LLE had a stronger negative effect on Jaccard similarity than Euclidean distance in field margins, but not in ditches. This was found for species of 'meadows and pastures' and short to medium dispersal distance. In plot pairs that were highly connected by LLE, the models suggested that roughly 20% of all species occurred in both plots due to dispersal through LLE. Other species groups did not respond more strongly to resistance distance than to Euclidean distance. We conclude that linear landscape elements in agricultural landscapes are effective corridors for dispersal of plant species that are confined to semi-natural habitats, such as traditional grasslands, and lack mechanisms of long-distance dispersal.	[Thiele, Jan] Univ Munster, Inst Landscape Ecol, Munster, Germany; [Thiele, Jan] Thunen Inst Biodivers, Braunschweig, Germany; [Schirmel, Jens] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany; [Buchholz, Sascha] Tech Univ Berlin, Dept Ecol, Berlin, Germany; [Buchholz, Sascha] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany	University of Munster; Johann Heinrich von Thunen Institute; University of Koblenz & Landau; Technical University of Berlin	Thiele, J (corresponding author), Univ Munster, Inst Landscape Ecol, Munster, Germany.; Thiele, J (corresponding author), Thunen Inst Biodivers, Braunschweig, Germany.	jan.thiele@thuenen.de	Schirmel, Jens/I-3467-2012	Thiele, Jan/0000-0002-5649-6397; Schirmel, Jens/0000-0003-0330-3376				Aavik T, 2014, HEREDITY, V112, P471, DOI 10.1038/hdy.2013.120; Aavik T, 2010, AGR ECOSYST ENVIRON, V135, P178, DOI 10.1016/j.agee.2009.09.005; Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Agresti A, 2002, CATEGORICAL DATA ANA; Auffret AG, 2017, J ECOL, DOI [10.1111/1365-274512742, DOI 10.1111/1365-274512742]; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benedetti Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183691; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE, V3, DOI 10.1007/978-3-7091-8110-2; Caplat P, 2016, FRONT ECOL ENVIRON, V14, P262, DOI 10.1002/fee.1280; Christmas MJ, 2016, CONSERV GENET, V17, P305, DOI 10.1007/s10592-015-0782-5; Ayram CAC, 2016, PROG PHYS GEOG, V40, P7, DOI 10.1177/0309133315598713; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Ellenberg H., 1992, SCRIPTA GEOBOT, V18, P1; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Favre-Bac L, 2016, HEREDITY, V116, P200, DOI 10.1038/hdy.2015.90; Favre-Bac L, 2014, ACTA OECOL, V61, P57, DOI 10.1016/j.actao.2014.10.006; Flohre A, 2011, ECOL APPL, V21, P1772, DOI 10.1890/10-0645.1; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Guiller C, 2016, LANDSCAPE ECOL, V31, P1747, DOI 10.1007/s10980-016-0359-9; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Heneberg P, 2017, BIODIVERS CONSERV, V26, P843, DOI 10.1007/s10531-016-1275-7; Hodgson J.-G., 1995, ELECT COMP PLANT ECO; Hopwood JL, 2008, BIOL CONSERV, V141, P2632, DOI 10.1016/j.biocon.2008.07.026; Koen EL, 2010, PLOS ONE, P5, DOI [10.1371/journalpone0011785, DOI 10.1371/JOURNALPONE0011785]; Lechner AM, 2017, LANDSCAPE ECOL, V32, P99, DOI 10.1007/s10980-016-0431-5; McGuire JL, 2016, P NATL ACAD SCI USA, V113, P7195, DOI 10.1073/pnas.1602817113; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Moron D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101297; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; QGIS Development Team, 2009, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; Schaffers AP, 2012, J INSECT CONSERV, V16, P511, DOI 10.1007/s10841-011-9437-0; Selwood KE, 2015, BIOL REV, V90, P837, DOI 10.1111/brv.12136; Smart SM, 2006, J APPL ECOL, V43, P1128, DOI 10.1111/j.1365-2664.2006.01231.x; Smart SM, 2002, AGR ECOSYST ENVIRON, V91, P73, DOI 10.1016/S0167-8809(01)00259-6; Spooner PG, 2015, NAT CONSERV-BULGARIA, P129, DOI 10.3897/natureconservation.11.4434; Stoate C, 2001, J ENVIRON MANAGE, V63, P337, DOI 10.1006/jema.2001.0473; Suarez-Esteban A, 2016, LANDSCAPE ECOL, V31, P721, DOI 10.1007/s10980-015-0329-7; Suarez-Esteban A, 2013, J APPL ECOL, V50, P767, DOI 10.1111/1365-2664.12080; Thiele J, 2018, J PLANT ECOL, V11, P385, DOI 10.1093/jpe/rtx004; Thiele J, 2018, LANDSCAPE ECOL, V33, P173, DOI 10.1007/s10980-017-0606-8; van Dijk WFA, 2014, BIOL CONSERV, V171, P91, DOI 10.1016/j.biocon.2014.01.006	48	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199980	10.1371/journal.pone.0199980	http://dx.doi.org/10.1371/journal.pone.0199980			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995916	Green Published, gold			2022-12-26	WOS:000438388800038
J	Dillard, JP; Yang, C; Li, RB				Dillard, James Price; Yang, Chun; Li, Ruobing			Self-regulation of emotional responses to Zika: Spiral of fear	PLOS ONE			English	Article							FIT INDEXES; TIME; DETERMINANTS; STRATEGIES; PHYSIOLOGY; ANXIETY; MODEL	Fear of infectious disease can create a variety of problems not the least of which is fear itself. An important question is how individuals attempt to manage their fear. The appearance of Zika in the U.S. presented an opportunity to examine this issue in a consequential natural context. Beginning nine days after the W.H.O. declared Zika a world health crisis, two-waves of survey data were collected from women ages 18-35 who were living in the Southern U.S. (N=561). Most respondents (71%) used one or more emotion regulation strategies and a plurality (41%) utilized multiple strategies. Fear of Zika showed no demonstrable effect on avoidance, reappraisal, or contesting and none of these three strategies were effective at down-regulating fear. Fear and suppression, however, showed a self-reinforcing cycle in which fear increased use of suppression and suppression increased intensity of the fear response. Although the observed associations were small, even modest effects can be consequential when cumulated over time or across large numbers of individuals.	[Dillard, James Price] Penn State Univ, Dept Commun Arts & Sci, University Pk, PA 16802 USA; [Yang, Chun; Li, Ruobing] Louisiana State Univ, Manship Sch Mass Commun, Baton Rouge, LA 70803 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Louisiana State University System; Louisiana State University	Dillard, JP (corresponding author), Penn State Univ, Dept Commun Arts & Sci, University Pk, PA 16802 USA.	jpd16@psu.edu		Dillard, James/0000-0001-8109-1562	Communication Arts & Sciences Faculty grant at Penn State University	Communication Arts & Sciences Faculty grant at Penn State University	This research was supported by a Communication Arts & Sciences Faculty grant at Penn State University. JPD received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett R, 2008, J INFECT DIS, V197, pS34, DOI 10.1086/524986; Brans K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092410; Brans K, 2013, EMOTION, V13, P926, DOI 10.1037/a0032400; Campbell A, 2016, PERS INDIV DIFFER, V97, P210, DOI 10.1016/j.paid.2016.03.049; Carmines E.G., 1981, SOCIAL MEASUREMENT, DOI DOI 10.1207/S15327965PLI0404_1; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dillard JP, 2015, NAT COMM ASS LAS VEG; Ekman P, 1989, HDB SOCIAL PSYCHOPHY, P143; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fransen ML, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01201; Frijda N.H., 1986, EMOTIONS STUDIES EMO, DOI DOI 10.1093/0199253048.001.0001; GOLLOB HF, 1987, CHILD DEV, V58, P80, DOI 10.2307/1130293; Golman R, 2017, J ECON LIT, V55, P96, DOI 10.1257/jel.20151245; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gross JJ., 2013, HDB EMOTION REGULATI; Heiy JE, 2014, EMOTION, V14, P878, DOI 10.1037/a0037231; Hovland C.I., 1953, COMMUN PERSUATION; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Jacks JZ, 2003, BASIC APPL SOC PSYCH, V25, P145, DOI 10.1207/S15324834BASP2502_5; Knobloch-Westerwick S, 2009, COMMUN RES, V36, P426, DOI 10.1177/0093650209333030; Lang PJ, 2016, PSYCHOPHYSIOLOGY, V53, P336, DOI 10.1111/psyp.12462; Lederman SA, 2004, ENVIRON HEALTH PERSP, V112, P1772, DOI 10.1289/ehp.7348; Lempel H, 2009, EC COST HLTH CARE WO, DOI [10.1371/currents.RRN1051, DOI 10.1371/CURRENTS.RRN1051]; Little T. D., 2013, LONGITUDINAL STRUCTU; MCCRAE RR, 1984, J PERS SOC PSYCHOL, V46, P919, DOI 10.1037/0022-3514.46.4.919; McNeil Jr Donald G., 2016, NY TIMES; McQueen A, 2013, HEALTH PSYCHOL, V32, P190, DOI 10.1037/a0027311; Oatley K, 2014, TRENDS COGN SCI, V18, P134, DOI 10.1016/j.tics.2013.12.004; Perez-Edgar Koraly E, 2014, Curr Behav Neurosci Rep, V1, P182; Romero S., 2016, NY TIMES; Segerstrom SC, 1998, J BEHAV MED, V21, P433, DOI 10.1023/A:1018732309353; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Shultz JM, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0741-y; Silver RC, 2013, PSYCHOL SCI, V24, P1623, DOI 10.1177/0956797612460406; Smits L, 2006, J PSYCHOSOM RES, V61, P715, DOI 10.1016/j.jpsychores.2006.04.020; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Tamir M, 2016, PERS SOC PSYCHOL REV, V20, P199, DOI 10.1177/1088868315586325; Tavernise S, 2016, NY TIMES; TOMARKEN AJ, 1995, J ABNORM PSYCHOL, V104, P312, DOI 10.1037/0021-843X.104.2.312; Tooby John, 2008, HDB EMOTIONS, V3, P114, DOI DOI 10.2307/2076468; Van't Riet J, 2013, HEALTH PSYCHOL REV, V7, pS104, DOI 10.1080/17437199.2011.606782; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; WEGNER DM, 1994, PSYCHOL REV, V101, P34, DOI 10.1037/0033-295X.101.1.34; Yamanis T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005077; Yang C, 2018, RISK ANAL, V38, P2535, DOI 10.1111/risa.12973	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199828	10.1371/journal.pone.0199828	http://dx.doi.org/10.1371/journal.pone.0199828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM5IS	29990349	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300017
J	Perdijk, O; van Neerven, RJJ; van den Brink, E; Savelkoul, HFJ; Brugman, S				Perdijk, Olaf; van Neerven, R. J. Joost; van den Brink, Erik; Savelkoul, Huub F. J.; Brugman, Sylvia			The oligosaccharides 6 '-sialyllactose, 2 '-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; CYTOKINE PRODUCTION; MONOCYTES; RECEPTOR; VITAMIN-D-3; EXPRESSION; INFLAMMATION; MACROPHAGES; ACTIVATION; INDUCTION	Breast milk plays an important role in immune development in early life and protects against diseases later in life. A wide range of the beneficial effects of breast milk are attributed to human milk oligosaccharides (HMOs) as well as components such as vitamin D3 (VitD3) or TGF beta. One mechanism by which HMOs might contribute to immune homeostasis and protection against disease is the induction of a local tolerogenic milieu. In this study we investigated the effect of the HMOs 6'-sialyllactose (6'SL) and 2'-fucosyllactose (2'FL) as well as prebiotic galactooligosaccharides (GOS) on DC differentiation and maturation. Isolated CD14+ monocytes were cultured for six days in the presence of GM-CSF and IL-4 with or without 6'SL, 2'FL, GOS, VitD3 or TGF beta. Additionally, immature VitD3DC, TGF beta DC and moDC were used as different DC types to investigate the effect of 6'SL, 2'FL and GOS on DC maturation. Surface marker expression and cytokine production was measured by flow cytometry and cytometric bead array, respectively. Unlike TGF beta and vitD3, the oligosaccharides 6'SL, 2'FL and GOS did not influence DC differentiation. Next, we studied the effect of 6'SL, 2'FL and GOS on maturation of moDC, VitD3DC and TGF beta DC that showed different profiles of HMO-binding receptors. 6'SL, 2'FL and GOS did not modulate LPS-induced maturation, even though their putative receptors were present on the different DCs types. Thus, whereas VitD3 and TGF beta halt DC differentiation, which results in phenotypically distinct tolerogenic DCs, 6'SL, 2'FL and GOS do not alter DC differentiation or maturation of in vitro differentiated DC types.	[Perdijk, Olaf; van Neerven, R. J. Joost; van den Brink, Erik; Savelkoul, Huub F. J.; Brugman, Sylvia] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [van Neerven, R. J. Joost] FrieslandCampina, Amersfoort, Netherlands	Wageningen University & Research	Brugman, S (corresponding author), Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands.	sylvia.brugman@wur.nl	Savelkoul, Huub FJ/F-6026-2012; van Neerven, Joost/GWZ-3214-2022	Brugman, Sylvia/0000-0001-9955-0552; Perdijk, Olaf/0000-0002-1843-8858; van Neerven, R.J.Joost/0000-0002-3991-5297	Netherlands Organisation of Scientific Research (NWO) [13017]; Friesland Campina	Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Friesland Campina	This work was supported by the Netherlands Organisation of Scientific Research (NWO) as part of the technology foundation STW (project number 13017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Friesland Campina provided support in the form of salary for author RJJvN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslanoglu S, 2007, J NUTR, V137, P2420, DOI 10.1093/jn/137.11.2420; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bartz H, 2006, BLOOD, V108, P4102, DOI 10.1182/blood-2006-03-008946; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bode L, 2009, NUTR REV, V67, pS183, DOI 10.1111/j.1753-4887.2009.00239.x; Brugman S, 2015, ARCH IMMUNOL THER EX, V63, P251, DOI 10.1007/s00005-015-0329-y; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; Castillo-Courtade L, 2015, ALLERGY, V70, P1091, DOI 10.1111/all.12650; Cernadas M, 2009, CLIN EXP IMMUNOL, V155, P523, DOI 10.1111/j.1365-2249.2008.03853.x; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; den Hartog G, 2013, INT ARCH ALLERGY IMM, V162, P225, DOI 10.1159/000353243; Eiwegger T, 2004, PEDIATR RES, V56, P536, DOI 10.1203/01.PDR.0000139411.35619.B4; Eiwegger T, 2010, PEDIAT ALLERG IMM-UK, V21, P1179, DOI 10.1111/j.1399-3038.2010.01062.x; Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010; Geissmann F, 1998, J EXP MED, V187, P961, DOI 10.1084/jem.187.6.961; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; He YY, 2016, ADV NUTR, V7, P102, DOI 10.3945/an.115.010090; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Kurakevich E, 2013, P NATL ACAD SCI USA, V110, P17444, DOI 10.1073/pnas.1306322110; Lehmann S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132304; LIU FT, 1995, AM J PATHOL, V147, P1016; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Lyakh LA, 2005, J IMMUNOL, V174, P2061, DOI 10.4049/jimmunol.174.4.2061; Martin-Sosa S, 2003, J DAIRY SCI, V86, P52, DOI 10.3168/jds.S0022-0302(03)73583-8; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148; Nikolic T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00113; Noll AJ, 2016, BIOCHEM J, V473, P1343, DOI 10.1042/BCJ20160046; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Perdijk O, 2018, GLYCOBIOLOGY, V28, P126, DOI 10.1093/glycob/cwx106; Piemonti L, 2000, J IMMUNOL, V164, P4443, DOI 10.4049/jimmunol.164.9.4443; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Ruhaak LR, 2014, ANAL BIOANAL CHEM, V406, P5775, DOI 10.1007/s00216-014-8025-z; Teodorowicz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173778; Unger WWJ, 2009, EUR J IMMUNOL, V39, P3147, DOI 10.1002/eji.200839103; Verhasselt V, 2010, MUCOSAL IMMUNOL, V3, P326, DOI 10.1038/mi.2010.25; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Xiao L, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]	43	10	10	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200356	10.1371/journal.pone.0200356	http://dx.doi.org/10.1371/journal.pone.0200356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990329	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300039
J	Oosterom, N; Griffioen, PH; den Hoed, MAH; Pieters, R; de Jonge, R; Tissing, WJE; van den Heuvel-Eibrink, MM; Heil, SG				Oosterom, Natanja; Griffioen, Pieter H.; den Hoed, Marissa A. H.; Pieters, Rob; de Jonge, Robert; Tissing, Wim J. E.; van den Heuvel-Eibrink, Marry M.; Heil, Sandra G.			Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia	PLOS ONE			English	Article							DNA METHYLATION; S-ADENOSYLHOMOCYSTEINE; ONCOLOGY GROUP; HYPOMETHYLATION; ADENOSYLMETHIONINE; METHIONINE; EXPRESSION; ARTHRITIS; TOXICITY; SURVIVAL	Background Children with acute lymphoblastic leukemia (ALL) often suffer from toxicity of chemotherapeutic drugs such as Methotrexate (MTX). Previously, we reported that 20% of patients receiving high-dose MTX developed oral mucositis. MTX inhibits folate metabolism, which is essential for DNA methylation. We hypothesize that MTX inhibits DNA methylation, which results into adverse effects. We studied DNA methylation markers during high-dose methotrexate treatment in pediatric acute lymphoblastic leukemia (ALL) in relation to developing oral mucositis. Materials & methods S-Adenosyl-Methionine (SAM) and S-Adenosyl-Homocysteine (SAH) levels and LINE1 DNA methylation were measured prospectively before and after high-dose methotrexate (HD-MTX 4 x 5g/m2) therapy in 82 children with ALL. Methotrexate-induced oral mucositis was registered prospectively. Oral mucositis (grade >= 3 National Cancer Institute Criteria) was used as clinical endpoint. Results SAM levels decreased significantly during methotrexate therapy (-16.1 nmol/L (-144.0 - +46.0), p<0.001), while SAH levels and the SAM:SAH ratio did not change significantly. LINE1 DNA methylation (+1.4% (-1.1 -+6.5), p<0.001) increased during therapy. SAM and SAH levels were not correlated to LINE1 DNA methylation status. No association was found between DNA methylation markers and developing oral mucositis. Conclusions This was the first study that assessed DNA methylation in relation to MTX-induced oral mucositis in children with ALL. Although global methylation markers did change during methotrexate therapy, methylation status was not associated with developing oral mucositis.	[Oosterom, Natanja; den Hoed, Marissa A. H.; Pieters, Rob; van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Oosterom, Natanja; Griffioen, Pieter H.; Heil, Sandra G.] Erasmus MC Univ, Dept Clin Chem, Med Ctr, Rotterdam, Netherlands; [den Hoed, Marissa A. H.; van den Heuvel-Eibrink, Marry M.] Erasmus MC Univ, Dept Pediat Oncol Hematol, Med Ctr, Sophias Childrens Hosp, Rotterdam, Netherlands; [de Jonge, Robert] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [de Jonge, Robert] Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Oosterom, N (corresponding author), Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands.; Oosterom, N; Heil, SG (corresponding author), Erasmus MC Univ, Dept Clin Chem, Med Ctr, Rotterdam, Netherlands.	n.oosterom@prinsesmaximacentrum.nl; s.heil@erasmusmc.nl	Heil, Sandra/AAM-8104-2020		Stichting Kinderen Kankervrij, Amstelveen, The Netherlands [197]	Stichting Kinderen Kankervrij, Amstelveen, The Netherlands	This project was supported by Stichting Kinderen Kankervrij, Amstelveen, The Netherlands, grant number 197. This grant was received by SGH and MMvdHE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROXSON EH, 1989, CANCER RES, V49, P5879; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; Chen HD, 2016, CIRC RES, V118, P786, DOI 10.1161/CIRCRESAHA.115.305298; Day K, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r102; de Andres MC, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0748-5; De Bustos C, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-7; den Hoed MAH, 2015, PHARMACOGENOMICS J, V15, P248, DOI 10.1038/tpj.2014.63; Dexheimer GM, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/5472893; Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134; Flanagan JM, 2013, ANN ONCOL, V24, P2813, DOI 10.1093/annonc/mdt370; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; Hogarth LA, 2008, BIOCHEM PHARMACOL, V76, P1024, DOI 10.1016/j.bcp.2008.07.026; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Ingrosso D, 2003, LANCET, V361, P1693, DOI 10.1016/S0140-6736(03)13372-7; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kamps WA, 2010, LEUKEMIA, V24, P309, DOI 10.1038/leu.2009.258; Kim YI, 1996, J LAB CLIN MED, V128, P165, DOI 10.1016/S0022-2143(96)90008-6; Li Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173472; Lisanti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079044; NESHER G, 1991, ANN RHEUM DIS, V50, P637, DOI 10.1136/ard.50.9.637; Pieters R, 2016, J CLIN ONCOL, V34, P2591, DOI 10.1200/JCO.2015.64.6364; Pui CH, 2012, BLOOD, V120, P1165, DOI 10.1182/blood-2012-05-378943; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; van Ede AE, 1998, SEMIN ARTHRITIS RHEU, V27, P277, DOI 10.1016/S0049-0172(98)80049-8; Viuff ACF, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0262-x; Wang L, 2010, AM J CLIN NUTR, V91, P1359, DOI 10.3945/ajcn.2009.28858; Wang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121869; Wang YC, 2012, MOL MED, V18, P423, DOI 10.2119/molmed.2011.00048; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0199574	10.1371/journal.pone.0199574	http://dx.doi.org/10.1371/journal.pone.0199574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985926	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500011
J	Jaschinski, W				Jaschinski, Wolfgang			Individual objective versus subjective fixation disparity as a function of forced vergence	PLOS ONE			English	Article							RETINAL CORRESPONDENCE; BORDER ENHANCEMENT; BINOCULAR CAPTURE; VIEWING DISTANCE; MISALIGNMENT; VISION; EYE; SENSITIVITY; MOVEMENTS; POSITION	Inaccuracy in the vergence eye position ("fixation disparity") can occur despite a fusion stimulus. When measured with eye trackers, this inaccuracy is referred to as "objective fixation disparity". It is a matter of debate whether objective fixation disparity can be estimated with a technically simple psycho-physical procedure, i.e. the perceived offset of aligned dichoptic nonius targets, referred to as "subjective fixation disparity". To investigate the relation between these two measures, simultaneous tests were made in far vision when placing prisms in front of the eyes (for a few seconds) in order to induce forced vergence, i.e. to vary the absolute disparity (from 1 deg divergent to 3.4 deg convergent). Frequent repeated measurements in 12 observers allowed for individual analyses. Generally, fixation disparity values and the effects of prisms were much smaller in the subjective than in the objective measures. Some observers differed systematically in the characteristics of the two types of prism-induced curves. Individual regressions showed that the subjective vs. objective slope was 8% on the average (with largest individual values of 18%). This suggests that sensory fusion shifts the visual direction of the (peripheral) binocular targets by the full amount of objective fixation disparity (since single vision was achieved); however, for the (central) monocular nonius lines this shift was more or less incomplete so that the dichoptic nonius targets indicated an individual percentage of objective fixation disparity. The subjective-to-objective ratio seems to be an individual characteristic of fixation disparity in terms of the amount and in terms of the effect of prism-induced forced vergence. Therefore, on the group level the subjective measures do not allow for a precise prediction of the objective measures.	[Jaschinski, Wolfgang] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Jaschinski, W (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	Jaschinski@ifado.de		Jaschinski, Wolfgang/0000-0002-2986-0341	Leibniz Association, Germany	Leibniz Association, Germany	The publication of this article was supported by the Open Access Fund of the Leibniz Association, Germany.	Alhassan M, 2013, MKH HAASE CHARTS BIN; Brautaset RL, 2006, MED SCI MONITOR, V12, pMT1; CARTER D B, 1958, Am J Optom Arch Am Acad Optom, V35, P590; Erkelens CJ, 1997, VISION RES, V37, P1735, DOI 10.1016/S0042-6989(96)00323-9; Evans B. J. W., 2002, PICKWELLS BINOCULAR; Fogt N, 1998, VISION RES, V38, P411, DOI 10.1016/S0042-6989(97)00142-9; Fogt N, 1998, VISION RES, V38, P2711, DOI 10.1016/S0042-6989(97)00448-3; Haase H- J, 1962, J AM OPTOM ASSOC, V34, P115; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Harris JM, 2009, VISION RES, V49, P2666, DOI 10.1016/j.visres.2009.06.021; HEBBARD FW, 1962, J OPT SOC AM, V52, P706, DOI 10.1364/JOSA.52.000706; Heinrich SP, 2005, VISION RES, V45, P1321, DOI 10.1016/j.visres.2004.09.045; Howard I., 2012, PERCEIVING IN DEPTH; Howard IP, 2012, PERCEIVING DEPTH STE; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 1999, VISION RES, V39, P669, DOI 10.1016/S0042-6989(98)00163-1; Jaschinski W, 1997, OPHTHAL PHYSL OPT, V17, P324, DOI 10.1111/j.1475-1313.1997.tb00064.x; Jaschinski W, 2001, OPHTHAL PHYSL OPT, V21, P368, DOI 10.1046/j.1475-1313.2001.00600.x; Jaschinski W, 2008, VISION RES, V48, P253, DOI 10.1016/j.visres.2007.11.004; Jaschinski W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170190; Jaschinski W, 2016, J EYE MOVEMENT RES, V9, DOI 10.16910/jemr.9.4.2; Jaschinski W, 2010, OPHTHAL PHYSL OPT, V30, P379, DOI 10.1111/j.1475-1313.2010.00753.x; JENKINS TCA, 1989, OPHTHAL PHYSL OPT, V9, P121, DOI 10.1111/j.1475-1313.1989.tb00830.x; KERTESZ AE, 1988, VISION RES, V28, P313, DOI 10.1016/0042-6989(88)90159-9; KERTESZ AE, 1987, AM J OPTOM PHYS OPT, V64, P734; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; London Richard, 2006, Optometry, V77, P590, DOI 10.1016/j.optm.2006.09.006; Methling D, 1996, OPHTHAL PHYSL OPT, V16, P211, DOI 10.1016/0275-5408(95)00045-3; Ogle KN, 1967, OCULOMOTOR IMBALANCE; Ono H., 1991, VISION VISUAL DYSFUN, P1; Patel SS, 2001, NEURAL COMPUT, V13, P1495, DOI 10.1162/089976601750264983; Raghunandan A, 2014, VISION RES, V102, P11, DOI 10.1016/j.visres.2014.06.007; Raghunandan A, 2011, VISION RES, V51, P2369, DOI 10.1016/j.visres.2011.09.011; REMOLE A, 1985, AM J OPTOM PHYS OPT, V62, P25; REMOLE A, 1983, AM J OPTOM PHYS OPT, V60, P567; REMOLE A, 1986, AM J OPTOM PHYS OPT, V63, P631; REMOLE A, 1984, AM J OPTOM PHYS OPT, V61, P118; ROBERTSON K, 1986, Investigative Ophthalmology and Visual Science, V27, P79; Scheiman M, 2008, CLIN MANAGEMENT BINO; Schmid LJ, 2018, DTSCH OPTIKERZEITUNG, V72, P198; Schmid LJ, 2018, DTSCH OPTIKERZEITUNG, V72, P192; SCHOR C, 1980, AM J OPTOM PHYS OPT, V57, P618; Schor CM, 1991, VISION VISUAL DISFUN, V9, P179; Schroth V., 2012, BINOCULAR CORRECTION; Schroth V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138871; SCHUMER RA, 1984, VISION RES, V24, P533, DOI 10.1016/0042-6989(84)90107-X; Sheedy JE, 1983, VERGENCE EYE MOVEMEN, P517; Shimono K, 2007, VISION RES, V47, P1027, DOI 10.1016/j.visres.2007.01.012; Shimono K, 1998, VISION RES, V38, P591, DOI 10.1016/S0042-6989(97)00168-5; SIMONSZ HJ, 1991, DOC OPHTHALMOL, V78, P141, DOI 10.1007/BF00165674; Svede A, 2015, PERCEPTION, V44, P1110, DOI 10.1177/0301006615596886; Svede A, 2011, INVEST OPHTH VIS SCI, V52, P4356, DOI 10.1167/iovs.10-6499; Team R. D. C., 2008, R LANG ENV STAT COMP; Tsirlin I, 2011, VISION RES, V51, P1699, DOI 10.1016/j.visres.2011.05.012; Tsirlin I, 2010, J VISION, V10, DOI 10.1167/10.6.11; WICK B, 1991, OPTOMETRY VISION SCI, V68, P146, DOI 10.1097/00006324-199102000-00011; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	57	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199958	10.1371/journal.pone.0199958	http://dx.doi.org/10.1371/journal.pone.0199958			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29980146	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500044
J	Tan, JB; MacRae, TH				Tan, Jiabo; MacRae, Thomas H.			Stress tolerance in diapausing embryos of Artemia franciscana is dependent on heat shock factor 1 (Hsf1)	PLOS ONE			English	Article							MOSQUITO CULEX-PIPIENS; APIS-CERANA-CERANA; ENCYSTED EMBRYOS; PROTEIN GENES; BRINE SHRIMP; INSECT DIAPAUSE; LEA PROTEINS; TRANSCRIPTIONAL REGULATION; DROSOPHILA-MELANOGASTER; OVERWINTERING DIAPAUSE	Embryos of the crustacean, Artemia franciscana, may undergo oviparous development, forming encysted embryos (cysts) that are released from females and enter diapause, a state of suppressed metabolism and greatly enhanced stress tolerance. Diapause-destined embryos of A. franciscana synthesize three small heat shock proteins (sHsps), p26, ArHsp21 and ArHsp22, as well as artemin, a ferritin homologue, all lacking in embryos that develop directly into nauplii. Of these diapause-specific molecular chaperones, p26 and artemin are important contributors to the extraordinary stress tolerance of A. franciscana cysts, but how their synthesis is regulated is unknown. To address this issue, a cDNA for heat shock factor 1 (Hsf1), shown to encode a protein similar to Hsf1 from other organisms, was cloned from A. franciscana. Hsf1 was knocked down by RNA interference (RNAi) in nauplii and cysts of A. franciscana. Nauplii lacking Hsf1 died prematurely upon release from females, showing that this transcription factor is essential to the survival of nauplii. Diapause cysts with diminished amounts of Hsf1 were significantly less stress tolerant than cysts containing normal levels of Hsf1. Moreover, cysts deficient in Hsf1 possessed reduced amounts of p26, ArHsp21, ArHsp22 and artemin, revealing dependence on Hsf1 for expression of their genes and maximum stress tolerance. The results demonstrate an important role for Hsf1, likely in concert with other transcription factors, in the survival and growth of A. franciscana and in the developmentally regulated synthesis of proteins responsible for the stress tolerance of diapausing A. franciscana cysts.	[Tan, Jiabo; MacRae, Thomas H.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	MacRae, TH (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	tmacrae@dal.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-04882]; Chinese Scholarship Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chinese Scholarship Council(China Scholarship Council)	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN-2016-04882 to THM, and Chinese Scholarship Council to JT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Aruda AM, 2011, J INSECT PHYSIOL, V57, P665, DOI 10.1016/j.jinsphys.2011.03.007; Bao B, 2011, INSECT BIOCHEM MOLEC, V41, P670, DOI 10.1016/j.ibmb.2011.04.009; Baumgartner MF, 2017, ANNU REV MAR SCI, V9, P387, DOI 10.1146/annurev-marine-010816-060505; Brunquell J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2837-5; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Clark MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029365; Clegg JS, 2011, J INSECT PHYSIOL, V57, P660, DOI 10.1016/j.jinsphys.2010.11.023; CLEGG JS, 1967, COMP BIOCHEM PHYSIOL, V20, P801, DOI 10.1016/0010-406X(67)90054-0; CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; CLEGG JS, 1962, BIOL BULL, V123, P295, DOI 10.2307/1539275; Clegg JS, 2000, CELL TISSUE RES, V301, P433, DOI 10.1007/s004410000249; Concha C, 2012, INSECT MOL BIOL, V21, P169, DOI 10.1111/j.1365-2583.2011.01123.x; Dai L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020187; de Thonel A, 2012, INT J BIOCHEM CELL B, V44, P1593, DOI 10.1016/j.biocel.2012.06.012; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Donovan MR, 2016, J BIOL CHEM, V291, P19042, DOI 10.1074/jbc.M116.723049; Fan LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060386; Fujimoto M, 2010, FEBS J, V277, P4112, DOI 10.1111/j.1742-4658.2010.07827.x; Gomez-Pastor R, 2018, NAT REV MOL CELL BIO, V19, P4, DOI 10.1038/nrm.2017.73; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hand SC, 2016, AM J PHYSIOL-REG I, V310, pR1193, DOI 10.1152/ajpregu.00250.2015; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hu Y, 2011, CELL STRESS CHAPERON, V16, P133, DOI 10.1007/s12192-010-0225-7; Jackson SA, 1996, DEV GROWTH DIFFER, V38, P153; Jaeger AM, 2016, NAT STRUCT MOL BIOL, V23, P147, DOI 10.1038/nsmb.3150; Janis B, 2018, J BIOMOL STRUCT DYN, V36, P3291, DOI 10.1080/07391102.2017.1387177; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; King AM, 2014, J EXP BIOL, V217, P1719, DOI 10.1242/jeb.100081; King AM, 2013, FEBS J, V280, P4761, DOI 10.1111/febs.12442; King AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043723; King V, 1999, DEV BIOL, V207, P107, DOI 10.1006/dbio.1998.9147; Kostal V, 2017, P NATL ACAD SCI USA, V114, P8532, DOI 10.1073/pnas.1707281114; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Li J, 2016, GENE DEV, V30, P2062, DOI 10.1101/gad.283317.116; Liang P, 1999, DEV BIOL, V207, P445, DOI 10.1006/dbio.1998.9138; Liu ZH, 2014, GENE, V545, P205, DOI 10.1016/j.gene.2014.05.034; Liu ZH, 2012, CELL STRESS CHAPERON, V17, P539, DOI 10.1007/s12192-012-0330-x; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Lu ZC, 2014, NEOTROP ENTOMOL, V43, P362, DOI 10.1007/s13744-014-0216-y; Ma WM, 2013, BIOCHEM J, V449, P285, DOI 10.1042/BJ20121259; MacRae TH, 2003, SEMIN CELL DEV BIOL, V14, P251, DOI 10.1016/j.semcdb.2003.09.019; MacRae TH, 2016, CELL STRESS CHAPERON, V21, P9, DOI 10.1007/s12192-015-0635-7; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Mahat DB, 2016, MOL CELL, V62, P63, DOI 10.1016/j.molcel.2016.02.025; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meuti ME, 2015, J EXP BIOL, V218, P412, DOI 10.1242/jeb.113233; Miozzo F, 2015, J MOL BIOL, V427, P3793, DOI 10.1016/j.jmb.2015.10.007; Moore DS, 2016, BBA-BIOMEMBRANES, V1858, P104, DOI 10.1016/j.bbamem.2015.10.019; Morrow G, 2006, CELL STRESS CHAPERON, V11, P51, DOI 10.1379/CSC-166.1; Morrow G, 2004, J BIOL CHEM, V279, P43382, DOI 10.1074/jbc.C400357200; Morrow G, 2016, MECH AGEING DEV, V155, P36, DOI 10.1016/j.mad.2016.02.011; Morrow G, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2015.00103, 10.3389/fpsyg.2015.01652]; Neudegger T, 2016, NAT STRUCT MOL BIOL, V23, P140, DOI 10.1038/nsmb.3149; Popovic ZD, 2015, COMP BIOCHEM PHYS B, V186, P1, DOI 10.1016/j.cbpb.2015.04.004; Qi XY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2309-3; Qiu ZJ, 2008, FEBS J, V275, P3556, DOI 10.1111/j.1742-4658.2008.06501.x; Qiu ZJ, 2006, GENOMICS, V88, P230, DOI 10.1016/j.ygeno.2006.02.008; Qu ZJ, 2008, BIOCHEM J, V411, P605, DOI 10.1042/BJ20071472; Robbins HM, 2010, J EXP BIOL, V213, P1464, DOI 10.1242/jeb.041772; Saravanakumar R, 2008, BIOLOGIA, V63, P737, DOI 10.2478/s11756-008-0124-x; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Sim C, 2015, P NATL ACAD SCI USA, V112, P3811, DOI 10.1073/pnas.1502751112; Sim C, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00189; Sim C, 2013, INSECT MOL BIOL, V22, P1, DOI 10.1111/j.1365-2583.2012.01166.x; Sim C, 2011, J INSECT PHYSIOL, V57, P628, DOI 10.1016/j.jinsphys.2011.01.012; Solis EJ, 2016, MOL CELL, V63, P60, DOI 10.1016/j.molcel.2016.05.014; Tian SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010669; Tower J, 2011, EXP GERONTOL, V46, P355, DOI 10.1016/j.exger.2010.09.002; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Tu XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11402; Warner AH, 2010, J BIOCHEM, V148, P581, DOI 10.1093/jb/mvq091; Xiang H, 1995, BIOCHEM CELL BIOL, V73, P673, DOI 10.1139/o95-075; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Zhao Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032129; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]	79	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200153	10.1371/journal.pone.0200153	http://dx.doi.org/10.1371/journal.pone.0200153			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979776	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500068
J	Kokoszka, ME; Kall, SL; Khosla, S; McGinnis, JE; Lavie, A; Kay, BK				Kokoszka, Malgorzata E.; Kall, Stefanie L.; Khosla, Sehar; McGinnis, Jennifer E.; Lavie, Arnon; Kay, Brian K.			Identification of two distinct peptide-binding pockets in the SH3 domain of human mixed-lineage kinase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phage display; protein-protein interaction; Src homology 3 domain (SH3 domain); ligand-binding protein; affinity selection; alanine scanning; combinatorial peptides; n-Src insert; mixed-lineage protein kinase; MLK3 SH3 domain-interacting peptide	HEPATITIS-C VIRUS; PHAGE-DISPLAY; PROTEIN INTERACTIONS; ACTIVATION LOOP; NS5A PROTEIN; SRC; RECOGNITION; PROLINE; LIGANDS; MOTIF	Mixed-lineage kinase 3 (MLK3; also known as MAP3K11) is a Ser/Thr protein kinase widely expressed in normal and cancerous tissues, including brain, lung, liver, heart, and skeletal muscle tissues. Its Src homology 3 (SH3) domain has been implicated in MLK3 autoinhibition and interactions with other proteins, including those from viruses. The MLK3 SH3 domain contains a six-amino-acid insert corresponding to the n-Src insert, suggesting that MLK3 may bind additional peptides. Here, affinity selection of a phage-displayed combinatorial peptide library for MLK3's SH3 domain yielded a 13-mer peptide, designated MLK3 SH3-interacting peptide (MIP). Unlike most SH3 domain peptide ligands, MIP contained a single proline. The 1.2- crystal structure of the MIP-bound SH3 domain revealed that the peptide adopts a -hairpin shape, and comparison with a 1.5- apo SH3 domain structure disclosed that the n-Src loop in SH3 undergoes an MIP-induced conformational change. A 1.5- structure of the MLK3 SH3 domain bound to a canonical proline-rich peptide from hepatitis C virus nonstructural 5A (NS5A) protein revealed that it and MIP bind the SH3 domain at two distinct sites, but biophysical analyses suggested that the two peptides compete with each other for SH3 binding. Moreover, SH3 domains of MLK1 and MLK4, but not MLK2, also bound MIP, suggesting that the MLK1-4 family may be differentially regulated through their SH3 domains. In summary, we have identified two distinct peptide-binding sites in the SH3 domain of MLK3, providing critical insights into mechanisms of ligand binding by the MLK family of kinases.	[Kokoszka, Malgorzata E.; Khosla, Sehar; McGinnis, Jennifer E.; Kay, Brian K.] Univ Illinois, Dept Biol Sci, 900 S Ashland Ave, Chicago, IL 60607 USA; [Kall, Stefanie L.; Lavie, Arnon] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kay, BK (corresponding author), Univ Illinois, Dept Biol Sci, 900 S Ashland Ave, Chicago, IL 60607 USA.	bkay@uic.edu		Lavie, Arnon/0000-0001-5591-8722	Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; National Institutes of Health [R01EB013685]; National Institutes of Health from NIDCR Grant [DE018381]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at the Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIDCR Grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust (to B. K. K.), National Institutes of Health Grant R01EB013685 (to A. L.), and National Institutes of Health T32 training support from NIDCR Grant DE018381 (to S. L. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amako Y, 2013, J BIOL CHEM, V288, P24753, DOI 10.1074/jbc.M113.491985; Azuaga A. I., 2015, SH DOMAINS STRUCTURE, P35; Bacarizo J, 2015, J STRUCT BIOL, V189, P67, DOI 10.1016/j.jsb.2014.11.004; Biesova Z, 1997, ONCOGENE, V14, P233, DOI 10.1038/sj.onc.1200822; Carducci M, 2012, BIOTECHNOL ADV, V30, P4, DOI 10.1016/j.biotechadv.2011.06.012; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Douangamath A, 2002, MOL CELL, V10, P1007, DOI 10.1016/S1097-2765(02)00749-9; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; GALLO KA, 1994, J BIOL CHEM, V269, P15092; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Hennigan RF, 2013, ONCOGENE, V32, P1135, DOI 10.1038/onc.2012.135; Houimel M, 2009, J LEUKOCYTE BIOL, V85, P728, DOI 10.1189/jlb.0608380; Huang RH, 2012, METHODS, V58, P10, DOI 10.1016/j.ymeth.2012.08.008; ING YL, 1994, ONCOGENE, V9, P1745; Ivarsson Y, 2014, P NATL ACAD SCI USA, V111, P2542, DOI 10.1073/pnas.1312296111; Jadwin JA, 2012, FEBS LETT, V586, P2586, DOI 10.1016/j.febslet.2012.04.019; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kami K, 2002, EMBO J, V21, P4268, DOI 10.1093/emboj/cdf428; Kaneko T, 2011, TRENDS BIOCHEM SCI, V36, P183, DOI 10.1016/j.tibs.2010.12.001; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Kay BK, 2000, FEBS LETT, V480, P55, DOI 10.1016/S0014-5793(00)01778-6; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; Kokoszka M. E., 2015, PHAGE DISPLAY BIOTEC, P229; Kokoszka ME, 2015, METHODS MOL BIOL, V1248, P173, DOI 10.1007/978-1-4939-2020-4_12; KUNKEL TA, 1991, METHOD ENZYMOL, V204, P125; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leung IWL, 2001, J BIOL CHEM, V276, P1961, DOI 10.1074/jbc.M004092200; Liu Q, 2003, MOL CELL, V11, P471, DOI 10.1016/S1097-2765(03)00046-7; Macdonald A, 2004, J GEN VIROL, V85, P721, DOI 10.1099/vir.0.19691-0; Matoskova B, 1996, ONCOGENE, V12, P2679; Matoskova B, 1996, ONCOGENE, V12, P2563; Mayer BJ, 2015, NAT REV MOL CELL BIO, V16, P691, DOI 10.1038/nrm4068; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Morfini GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065235; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida M, 2001, EMBO J, V20, P2995, DOI 10.1093/emboj/20.12.2995; Oligino L, 1997, J BIOL CHEM, V272, P29046, DOI 10.1074/jbc.272.46.29046; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; RAULF F, 1989, J NEUROSCI RES, V24, P81, DOI 10.1002/jnr.490240112; Rouka E, 2015, J BIOL CHEM, V290, P25275, DOI 10.1074/jbc.M115.637207; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Scholle MD, 2005, COMB CHEM HIGH T SCR, V8, P545, DOI 10.2174/1386207054867337; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SPARKS AB, 1994, J BIOL CHEM, V269, P23853; Sparks AB, 1996, P NATL ACAD SCI USA, V93, P1540, DOI 10.1073/pnas.93.4.1540; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Vacratsis PO, 2000, J BIOL CHEM, V275, P27893; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VIGUERA AR, 1994, BIOCHEMISTRY-US, V33, P10925, DOI 10.1021/bi00202a011; Zhan Y, 2011, ONCOGENE, V30, P781, DOI 10.1038/onc.2010.453; Zhang H, 2001, J BIOL CHEM, V276, P45598, DOI 10.1074/jbc.M107176200; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	63	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13553	13565		10.1074/jbc.RA117.000262	http://dx.doi.org/10.1074/jbc.RA117.000262			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29980598	hybrid, Green Published			2022-12-26	WOS:000443375500016
J	Datta, V; Siddharthan, R; Krishna, S				Datta, Vishaka; Siddharthan, Rahul; Krishna, Sandeep			Detection of cooperatively bound transcription factor pairs using ChIP-seq peak intensities and expectation maximization	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; FACTOR-BINDING; IN-VIVO; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; EVOLUTION; MODELS; GENOME; SITES; SPECIFICITY	Transcription factors (TFs) often work cooperatively, where the binding of one TF to DNA enhances the binding affinity of a second TF to a nearby location. Such cooperative binding is important for activating gene expression from promoters and enhancers in both prokaryotic and eukaryotic cells. Existing methods to detect cooperative binding of a TF pair rely on analyzing the sequence that is bound. We propose a method that uses, instead, only ChlP-seq peak intensities and an expectation maximization (CPI-EM) algorithm. We validate our method using ChlP-seq data from cells where one of a pair of TFs under consideration has been genetically knocked out. Our algorithm relies on our observation that cooperative TFTF binding is correlated with weak binding of one of the TFs, which we demonstrate in a variety of cell types, including E. coli, S. cerevisiae and M. musculus cells. We show that this method performs significantly better than a predictor based only on the ChlP-seq peak distance of the TFs under consideration. This suggests that peak intensities contain information that can help detect the cooperative binding of a TF pair. CPI-EM also outperforms an existing sequence-based algorithm in detecting cooperative binding. The CPI-EM algorithm is available at https://github.com/vishakad/cpi-em.	[Datta, Vishaka; Krishna, Sandeep] Natl Ctr Biol Sci, TIFR, Simons Ctr Study Living Machines, Bengaluru 560065, India; [Siddharthan, Rahul] Inst Math Sci HBNI, Madras 600113, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Homi Bhabha National Institute; Institute of Mathematical Sciences (IMSc) India	Datta, V (corresponding author), Natl Ctr Biol Sci, TIFR, Simons Ctr Study Living Machines, Bengaluru 560065, India.	vishakad@ncbs.res.in		krishna, sandeep/0000-0002-0581-173X; Datta, Vishaka/0000-0002-5582-3130	Simons Foundation; PRISM 12th plan project at Institute of Mathematical Sciences	Simons Foundation; PRISM 12th plan project at Institute of Mathematical Sciences	This work was supported by the Simons Foundation (to S.K. and V.D.) and PRISM 12th plan project at Institute of Mathematical Sciences (to R.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Chen K, 2010, GENOME BIOL EVOL, V2, P697, DOI 10.1093/gbe/evq054; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; Das D, 2004, P NATL ACAD SCI USA, V101, P16234, DOI 10.1073/pnas.0407365101; Girgis HZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-25; Gordan R, 2009, GENOME RES, V19, P2090, DOI 10.1101/gr.094144.109; Guertin MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002610; GuhaThakurta D, 2001, BIOINFORMATICS, V17, P608, DOI 10.1093/bioinformatics/17.7.608; Gutierrez PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044812; Hardison R, 1998, J EXP BIOL, V201, P1099; He QY, 2015, NAT BIOTECHNOL, V33, P395, DOI 10.1038/nbt.3121; He X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008155; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jiang P, 2014, NUCLEIC ACIDS RES, V42, P2833, DOI 10.1093/nar/gkt1302; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Kaplan T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001290; Kazemian M, 2013, NUCLEIC ACIDS RES, V41, P8237, DOI 10.1093/nar/gkt598; Kim S, 2013, SCIENCE, V339, P816, DOI 10.1126/science.1229223; Kinney JB, 2007, P NATL ACAD SCI USA, V104, P501, DOI 10.1073/pnas.0609908104; Kinney JB, 2014, P NATL ACAD SCI USA, V111, P3354, DOI 10.1073/pnas.1309933111; Kivioja T, 2012, NAT METHODS, V9, P72, DOI [10.1038/nmeth.1778, 10.1038/NMETH.1778]; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Morgunova E, 2017, CURR OPIN STRUC BIOL, V47, P1, DOI 10.1016/j.sbi.2017.03.006; Nandi S, 2013, NUCLEIC ACIDS RES, V41, P8822, DOI 10.1093/nar/gkt578; Narasimhan K, 2015, NUCLEIC ACIDS RES, V43, P1513, DOI 10.1093/nar/gku1390; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Reiter F, 2017, CURR OPIN GENET DEV, V43, P73, DOI 10.1016/j.gde.2016.12.007; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Spivak AT, 2016, G3-GENES GENOM GENET, V6, P653, DOI 10.1534/g3.115.024331; Spivak AT, 2012, NUCLEIC ACIDS RES, V40, pD162, DOI 10.1093/nar/gkr1180; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tugrul M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005639; Villar D, 2014, NAT REV GENET, V15, P221, DOI 10.1038/nrg3481; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Whitington T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr341	49	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0199771	10.1371/journal.pone.0199771	http://dx.doi.org/10.1371/journal.pone.0199771			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016330	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600012
J	Wang, JX; Lin, J; Wang, H; Li, XG; Yang, QS; Li, H; Chang, YH				Wang, Jinxing; Lin, Jing; Wang, Hong; Li, Xiaogang; Yang, Qingsong; Li, Hui; Chang, Youhong			Identification and characterization of circRNAs in Pyrus betulifolia Bunge under drought stress	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; CIRCULAR RNAS; EFFICIENT; ABUNDANT; REVEALS; PATHWAY; ROLES; KEGG	Circular RNAs (circRNAs) play important roles in miRNA function and transcriptional control. However, little is known regarding circRNAs in the pear. In this study, we identified circRNAs using deep sequencing and analyzed their expression under drought stress. We identified 899 circRNAs in total, among which 33 (23 upregulated, 10 downregulated) were shown to be dehydration-responsive. We performed GO and KEGG enrichment analysis to predict the functions of differentially expressed circRNAs. 309 circRNAs were predicted to act as sponges for 180 miRNAs. A circRNA-miRNA co-expression network was constructed based on correlation analysis between the differentially expressed circRNAs and their miRNA binding sites. Our study will provide a rich genetic resource for the discovery of genes related to drought stress, and can readily be applied to other fruit trees.	[Wang, Jinxing; Lin, Jing; Wang, Hong; Li, Xiaogang; Yang, Qingsong; Li, Hui; Chang, Youhong] Jiangsu Acad Agr Sci, Jiangsu Key Lab Hort Crop Genet Improvement, Inst Pomol, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Lin, J (corresponding author), Jiangsu Acad Agr Sci, Jiangsu Key Lab Hort Crop Genet Improvement, Inst Pomol, Nanjing, Jiangsu, Peoples R China.	lj84390224@126.com			National Natural Sciences Foundation of China [31540052]; Jiangsu Agricultural Science and Technology Independent Innovation Fund of China [CX(15)1023]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Agricultural Science and Technology Independent Innovation Fund of China	This work was supported by the National Natural Sciences Foundation of China (Grant No. 31540052), and the Jiangsu Agricultural Science and Technology Independent Innovation Fund of China [CX(15)1023].	ARNBERG AC, 1980, CELL, V19, P313, DOI 10.1016/0092-8674(80)90505-X; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Chen G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01678; Chen LL, 2010, CURR OPIN CELL BIOL, V22, P357, DOI 10.1016/j.ceb.2010.03.003; COCQUERELLE C, 1993, FASEB J, V7, P155, DOI 10.1096/fasebj.7.1.7678559; Danan M, 2012, NUCLEIC ACIDS RES, V40, P3131, DOI 10.1093/nar/gkr1009; Fischer JW, 2017, CRIT REV BIOCHEM MOL, V52, P1; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Gruner H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38907; Han YN, 2017, ONCOTARGET, V8, P64551, DOI 10.18632/oncotarget.18350; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hu RY, 2015, INT J MOL SCI, V16, P15194, DOI 10.3390/ijms160715194; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Jin X, 2016, ONCOTARGET, V7, P66455, DOI 10.18632/oncotarget.12186; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Livak KJ., 2001, METHODS, V25, P402; Lu TT, 2015, RNA, V21, P2076, DOI 10.1261/rna.052282.115; Lu XK, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3681-y; Lu XK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156723; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Petkovic S, 2015, NUCLEIC ACIDS RES, V43, P2454, DOI 10.1093/nar/gkv045; Rybak-Wolf A, 2015, MOL CELL, V58, P870, DOI 10.1016/j.molcel.2015.03.027; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Starke S, 2015, CELL REP, V10, P103, DOI 10.1016/j.celrep.2014.12.002; Tang S, 2015, PLANT MOL BIOL REP, V33, P424, DOI 10.1007/s11105-014-0759-4; Vicens Q, 2014, CELL, V159, P13, DOI 10.1016/j.cell.2014.09.005; Wang JX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193076; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Wang X, 2016, NEW PHYTOL, V209, P1442, DOI 10.1111/nph.13718; Wang Y, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00597; Wang YX, 2017, PHYSIOL PLANTARUM, V161, P311, DOI 10.1111/ppl.12600; Wu HJ, 2012, NUCLEIC ACIDS RES, V40, pW22, DOI 10.1093/nar/gks554; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xia SY, 2017, BRIEF BIOINFORM, V18, P984, DOI 10.1093/bib/bbw081; Xu YY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1887-4; Xu YY, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1784-0; Ye CY, 2015, NEW PHYTOL, V208, P88, DOI 10.1111/nph.13585; Zhang XO, 2014, CELL, V159, P134, DOI 10.1016/j.cell.2014.09.001; Zhao W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05922-9; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224; Zong Y, 2014, TREE GENET GENOMES, V10, P739, DOI 10.1007/s11295-014-0718-0; Zuo JH, 2016, BIOCHEM BIOPH RES CO, V479, P132, DOI 10.1016/j.bbrc.2016.07.032	45	17	20	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200692	10.1371/journal.pone.0200692	http://dx.doi.org/10.1371/journal.pone.0200692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016342	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600035
J	Cressman, ENK; Guo, CX; Karbasian, N				Cressman, Erik N. K.; Guo, Chunxiao; Karbasian, Niloofar			Image-guided chemistry altering biology: An in vivo study of thermoembolization	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; ADVANCED HEPATOCELLULAR-CARCINOMA; THERMOCHEMICAL ABLATION; RADIOFREQUENCY ABLATION; MICROWAVE ABLATION; THERAPY; SORAFENIB; EMBOLIZATION; HYPERTHERMIA; CANCER	Rationale Advances in image-guided drug delivery for liver cancer have shown a significant survival benefit. However, incomplete treatment is common and residual disease is often found in explanted liver specimens. In addition, the need to treat a malignancy from multiple mechanisms at the same time for optimal outcomes is becoming more widely appreciated. To address this, we hypothesized that an exothermic chemical reaction could be performed in situ. Such a strategy could in principle combine several angles of attack, including ischemia, hyperthermia, acidic protein denaturation, and metabolic modulation of the local environment. Methods The University of Texas MD Anderson Cancer Center Institutional Animal Care and Use Committee approved this study. Outbred swine (25-35 kg, 5 control and 5 experimental) were treated under general anesthesia. Embolization was performed with coaxial microcatheter technique in a segmental hepatic arterial branch using either ethiodized oil as control or with thermoembolic solutionBlood samples were obtained before, immediately after, and the day following the procedure just before CT scans and euthanasia. Livers were explanted and samples were obtained for histologic analysis. Results All animals survived the procedure and laboratory values of the control and experimental groups remained within normal limits. The control group had a diffuse or cloudy pattern of attenuation on follow-up CT scan the day after, consistent with gradual antegrade sinusoidal transit of the embolic material. The experimental group had clearly defined vascular casts with some degree of peripheral involvement. At histology, the control group samples had the appearance of normal liver, whereas the experimental group had coagulative necrosis in small pale, punctate areas extending several hundred microns away from the treated vessels and a brisk inflammatory response just outside the margins. Conclusion In situ chemistry via thermoembolization shows early promise as a fundamentally new tactic for image-guided therapy of solid tumors.	[Cressman, Erik N. K.; Guo, Chunxiao; Karbasian, Niloofar] Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Cressman, ENK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Intervent Radiol, Houston, TX 77030 USA.	ecressman@mdanderson.org		Cressman, Erik/0000-0002-8671-9862	Institutional Research Grant from the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA201127] Funding Source: NIH RePORTER	Institutional Research Grant from the University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by an Institutional Research Grant from the University of Texas MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyrou C, 2017, J BUON, V22, P6; BODDIE AW, 1985, INVEST RADIOL, V20, P159, DOI 10.1097/00004424-198503000-00012; Bouattour M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1675-8; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Cao W, 2010, EUR J RADIOL, V73, P412, DOI 10.1016/j.ejrad.2008.11.001; Chen XZ, 2015, FREE RADICAL BIO MED, V79, P253, DOI 10.1016/j.freeradbiomed.2014.08.027; Cressman ENK, 2009, IEEE ENG MED BIO, P4291, DOI 10.1109/IEMBS.2009.5333503; Cressman ENK, 2013, INT J HYPERTHER, V29, P71, DOI 10.3109/02656736.2012.756124; Cressman ENK, 2012, INT J HYPERTHER, V28, P113, DOI 10.3109/02656736.2011.644621; Cressman ENK, 2012, INT J HYPERTHER, V28, P105, DOI 10.3109/02656736.2011.644620; Cressman ENK, 2010, INT J HYPERTHER, V26, P327, DOI 10.3109/02656731003614516; Deng ZS, 2013, J HEALTHC ENG, V4, P409, DOI 10.1260/2040-2295.4.3.409; DEVORE JA, 1969, J PHYS CHEM-US, V73, P2644, DOI 10.1021/j100842a031; DOYON D, 1981, B CANCER, V68, P295; Georgiades CS, 2006, J VASC INTERV RADIOL, V17, P1619, DOI 10.1097/01.RVI.0000236608.91960.34; Guo Z. X., 2015, J ELECT ENG, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0138619; HARADA M, 1995, ACAD RADIOL, V2, P475, DOI 10.1016/S1076-6332(05)80403-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keating GM, 2017, TARGET ONCOL, V12, P243, DOI 10.1007/s11523-017-0484-7; Lee HJ, 2017, J VASC INTERV RADIOL, V28, P1240, DOI 10.1016/j.jvir.2017.05.015; Liu Y, 2013, CLIN RADIOL, V68, P21, DOI 10.1016/j.crad.2012.05.007; Lu LC, 2017, ANTICANCER RES, V37, P2593, DOI 10.21873/anticanres.11604; Margini C, 2016, LIVER INT, V36, P317, DOI 10.1111/liv.13031; Marin HL, 2009, J GASTROINTEST LIVER, V18, P169; Massarweh NN, 2017, CANCER CONTROL, V24, DOI 10.1177/1073274817729245; Meloni MF, 2017, INT J HYPERTHER, V33, P15, DOI 10.1080/02656736.2016.1209694; Mitchell J, 2016, ONCOLOGY-BASEL, V91, P90, DOI 10.1159/000446074; Molvar C, 2015, RADIOL CLIN N AM, V53, P973, DOI 10.1016/j.rcl.2015.05.011; Moroz P, 2002, PHYS MED BIOL, V47, P1591, DOI 10.1088/0031-9155/47/9/312; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Rao W, 2008, MINIM INVASIV THER, V17, P43, DOI 10.1080/13645700701803826; Rao W, 2009, MINIM INVASIV THER, V18, P30, DOI 10.1080/13645700802384023; Rhim H, 2008, J GASTROEN HEPATOL, V23, P1492, DOI 10.1111/j.1440-1746.2008.05550.x; Richani M, 2016, ANN HEPATOL, V15, P82, DOI 10.5604/16652681.1184233; Rimassa L, 2009, EXPERT REV ANTICANC, V9, P739, DOI [10.1586/era.09.41, 10.1586/ERA.09.41]; Ryan TP, 2017, INT J HYPERTHER, V33, P3, DOI 10.1080/02656736.2016.1214884; Salamon S, 2017, NUTR CANCER, V69, P177, DOI 10.1080/01635581.2017.1263751; Seki T, 2000, CANCER, V89, P1245, DOI 10.1002/1097-0142(20000915)89:6<1245::AID-CNCR8>3.0.CO;2-F; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Wallace MC, 2017, DIGEST DIS SCI, V62, P2182, DOI 10.1007/s10620-017-4622-y; Yopp AC, 2015, DIGEST DIS, V33, P642, DOI 10.1159/000438473	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200471	10.1371/journal.pone.0200471	http://dx.doi.org/10.1371/journal.pone.0200471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011300	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800020
J	Resurreccion, DM; Motrico, E; Rubio-Valera, M; Mora-Pardo, JA; Moreno-Peral, P				Resurreccion, Davinia Maria; Motrico, Emma; Rubio-Valera, Maria; Antonio Mora-Pardo, Jose; Moreno-Peral, Patricia			Reasons for dropout from cardiac rehabilitation programs in women: A qualitative study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; AMERICAN-ASSOCIATION; SCIENTIFIC STATEMENT; CLINICAL CARDIOLOGY; PHYSICAL-ACTIVITY; HEART-DISEASE; PARTICIPATION; PREVENTION; METABOLISM; NUTRITION	Background Empirical evidence has shown that cardiac rehabilitation programs are effective in reducing morbidity and mortality, improving quality of life in patients with cardiovascular disease. Despite the benefits, women have a high cardiac rehabilitation dropout rate. Our aim was to explore women's perceptions about the reasons they faced for dropout from these programs. Methods Semi-structured interviews were conducted with women (n = 10) after dropping out from three different cardiac rehabilitation centers in Spain. In addition, a focus group and a semistructured interview with cardiovascular professionals were conducted. From a grounded theory perspective, thematic analysis was used to derive themes from interview transcripts. Results The women were between 41 and 70 years. We identified five general themes that illustrated reasons for cardiac rehabilitation dropout: intrapersonal reasons (self-reported health, self-reported mental health, health beliefs); interpersonal reasons (family caregiver role, work conflicts); logistical reasons (transport, distance); cardiac rehabilitation program characteristics (perception of the objective of cardiac rehabilitation, exercise component, inconvenient timing, cardiac rehabilitation equipment); and health system reasons (financial assistance for transport, long waiting list). The cardiovascular professionals found barriers to cardiac rehabilitation completion similar to those found by the women. Conclusions In order to prevent cardiac rehabilitation dropout in women, modular and flexible programs are needed. In addition, the inclusion of primary care centers or community resources could improve cardiac rehabilitation completion in women. Psychological assessment and counseling during cardiac rehabilitation should be included as an essential part of the programs and recommended for those women with depressive symptoms. Finally, improved financial assistance for transport from the health system is essential.	[Resurreccion, Davinia Maria; Motrico, Emma] Univ Loyola Andalucia, Dept Psychol, Seville, Spain; [Motrico, Emma; Moreno-Peral, Patricia] Primary Care Prevent & Hlth Promot Res Network Re, Malaga, Spain; [Rubio-Valera, Maria] Inst Recerca St Joan de Deu, Res & Dev Unit, Barcelona, Spain; [Rubio-Valera, Maria] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Barcelona, Spain; [Antonio Mora-Pardo, Jose] Hosp Nuestra Senora de Valme, Seville, Spain; [Moreno-Peral, Patricia] Inst Invest Biomed Malaga IBIMA, Malaga, Spain	Universidad Loyola Andalucia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Malaga	Motrico, E (corresponding author), Univ Loyola Andalucia, Dept Psychol, Seville, Spain.; Motrico, E (corresponding author), Primary Care Prevent & Hlth Promot Res Network Re, Malaga, Spain.	emotrico@uloyola.es	Resurreccion, Davinia Maria/J-5537-2016; PRISMA, Grupo/AAI-6753-2021; MOTRICO, EMMA/D-2016-2019; Moreno-Peral, Patricia/I-3594-2012; Rubio-Valera, Maria/H-4840-2012	Resurreccion, Davinia Maria/0000-0002-0046-8020; MOTRICO, EMMA/0000-0002-0720-567X; Moreno-Peral, Patricia/0000-0003-4130-9090; Rubio-Valera, Maria/0000-0003-2856-1697				Ades PA, 2017, MAYO CLIN PROC, V92, P234, DOI 10.1016/j.mayocp.2016.10.014; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Arena R, 2012, CIRCULATION, V125, P1321, DOI 10.1161/CIR.0b013e318246b1e5; Balady GJ, 2007, CIRCULATION, V115, P2675, DOI 10.1161/CIRCULATIONAHA.106.180945; Chamosa S, 2015, J CARDIOPULM REHABIL, V35, P255, DOI 10.1097/HCR.0000000000000126; Chauhan U, 2010, EUR J CARDIOVASC NUR, V9, P68, DOI 10.1016/j.ejcnurse.2009.10.003; Clark AM, 2013, CLIN REHABIL, V27, P948, DOI 10.1177/0269215513481046; Garcia P, 2014, ENFERMERIA CARDIOLOG, VXXI, P76; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; McCarthy MM, 2011, J CARDIOVASC NURS, V26, pE1, DOI 10.1097/JCN.0b013e3181f877e9; McSweeney J C, 2001, Rehabil Nurs, V26, P132; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Raeisi-Giglou P, 2018, J WOMENS HEALTH, V27, P128, DOI 10.1089/jwh.2016.6316; Resurreccion DM, 2017, J WOMENS HEALTH, V26, P849, DOI 10.1089/jwh.2016.6249; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Ruano-Ravina A, 2016, INT J CARDIOL, V223, P436, DOI 10.1016/j.ijcard.2016.08.120; Sherwood SA, 2011, INT J THER REHABIL, V18, P266, DOI 10.12968/ijtr.2011.18.5.266; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Suaya JA, 2007, CIRCULATION, V116, P1653, DOI 10.1161/CIRCULATIONAHA.107.701466; Supervia M, 2017, MAYO CLIN PROC, V92, P565, DOI 10.1016/j.mayocp.2017.01.002; Taylor RS, 2015, HEART, V101, P1256, DOI 10.1136/heartjnl-2015-307778; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turk-Adawi KI, 2015, HEART LUNG CIRC, V24, P510, DOI 10.1016/j.hlc.2014.11.013	26	18	20	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200636	10.1371/journal.pone.0200636	http://dx.doi.org/10.1371/journal.pone.0200636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2LQ	30011341	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800037
J	Zacarias, MF; Collado, MC; Gomez-Gallego, C; Flinck, H; Aittoniemi, J; Isolauri, E; Salminen, S				Zacarias, Maria Florencia; Carmen Collado, Maria; Gomez-Gallego, Carlos; Flinck, Heini; Aittoniemi, Janne; Isolauri, Erika; Salminen, Seppo			Pregestational overweight and obesity are associated with differences in gut microbiota composition and systemic inflammation in the third trimester	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MATERNAL OBESITY; BIRTH-WEIGHT; PREGNANCY; RISK; CHILDHOOD	The obesity epidemic is a global challenge, and the velocity of propagation is high in the population at reproductive age. Overweight and obesity during pregnancy have been associated with high birth weight and an increased risk of childhood obesity, reinforcing the risk of other non-communicable diseases. Obesity involves chronic low-grade systemic inflammation. New biomarkers for early detection of obesity risk are urgently required. The aim of this study was to identify the connection between pregestational BMI (pre-BMI) status and inflammatory biomarkers during the third trimester of pregnancy and their association with intestinal microbiota composition. Fifty-four pregnant women were classified according to pre-pregnancy BMI as normoweight, overweight, or obese. Weight gain, inflammatory biomarkers (hs_CRP, haptoglobin, and suPAR), and microbiota composition were assessed during the third trimester. A significant lower weight gain for obese mothers and a positive correlation between pre-BMI and inflammatory biomarkers were detected (Spearman's correlation). Haptoglobin levels were significantly higher in overweight and obese mothers. Higher Firmicutes levels and a higher ratio Firmicutes/Bacteroidetes were observed in the overweight and obese subjects. High hs_CRP and haptoglobin levels were also correlated with decreased microbiota diversity (Shannon index), whereas haptoglobin and hs_CRP values were correlated with several microbiota components, such as Ruminococcus gnavus and Faecalibacterium, and with specific phyla in the normoweight and overweight mothers; no significant associations with microbiota were found for suPAR. In conclusion, haptoglobin and hs_CRP reflected pregestational BMI status and related microbiota components, but haptoglobin was a better biomarker for microbiota associated with overweight. suPAR was associated with low grade inflammation dependent on pre-pregnancy BMI, but it was not related to deviated microbiota profiles.	[Zacarias, Maria Florencia; Carmen Collado, Maria; Gomez-Gallego, Carlos; Salminen, Seppo] Univ Turku, Fac Med, Funct Foods Forum, Turku, Finland; [Carmen Collado, Maria] Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Dept Biotechnol, Valencia, Spain; [Flinck, Heini; Aittoniemi, Janne] Fimlab Labs, Dept Clin Microbiol, Tampere, Finland; [Isolauri, Erika] Turku Univ Hosp, Dept Pediat & Adolescent Med, Turku, Finland; [Isolauri, Erika] Univ Turku, Fac Med, Dept Clin Sci, Turku, Finland	University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Turku; University of Turku	Zacarias, MF (corresponding author), Univ Turku, Fac Med, Funct Foods Forum, Turku, Finland.	maria.zacarias@utu.fi	Gómez-Gallego, Carlos/ABH-9091-2020; COLLADO, MARIA CARMEN/H-4924-2012; Zacarias, Maria Florencia/S-1823-2017; Gómez-Gallego, Carlos/GGG-6822-2022; Gomez-Gallego, Carlos/M-2523-2014	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Zacarias, Maria Florencia/0000-0001-5196-2996; Gómez-Gallego, Carlos/0000-0003-0219-1827; Gomez-Gallego, Carlos/0000-0003-0219-1827	TEKES (Finland) [3825/31/2015]	TEKES (Finland)(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was funded by TEKES (Grant No 3825/31/2015, Finland). TEKES is not a commercial source but a government funding agency and this funding does not alter our adherence to PLOS ONE policies. As for the authors (Flinck, H and Aittoniemi, J) employed by the company Fimlab Laboratories Ltd, the firm is the laboratory service of the Tampere University Hospital and only provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andoh A, 2016, J CLIN BIOCHEM NUTR, V59, P65, DOI 10.3164/jcbn.15-152; [Anonymous], 2012, SDF, V91, P1226, DOI 10.1111/j.1600-0412.2012.01504.x; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Belo L, 2005, EUR J OBSTET GYN R B, V123, P46, DOI 10.1016/j.ejogrb.2005.02.022; BERVOETS L, 2010, GUT PATHOG, DOI DOI 10.HTTPS://D0I.0RG/10.1186/1757-4749-5-10; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Broskey NT, 2017, OBESITY, V25, P1569, DOI 10.1002/oby.21878; CAN U, 2015, IJMR, DOI DOI 10.4103/IJMR.IJMR_; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen JS, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/170987; Chiellini C, 2004, J CLIN ENDOCR METAB, V89, P2678, DOI 10.1210/jc.2003-031965; Christian LM, 2014, CYTOKINE, V70, P134, DOI 10.1016/j.cyto.2014.06.018; Collado MC, 2008, AM J CLIN NUTR, V88, P894, DOI 10.1093/ajcn/88.4.894; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; EARLY P, 2014, ACTA OBSTET GYNECOL; EARLY P, 2008, ACTA OBSTET GYNECOL; EARLY P, 2007, ACTA OBSTET GYNECOL; EARLY P, 2011, ACTA OBSTET GYNECOL; EARLY P, 2012, ACTA OBSTET GYNECOL, V104, P8174; EARLY P, 2007, ACTA OBSTET GYNECOL, V2, P52; EARLY P, 1922, ACTA OBSTET GYNECOL; EARLY P, 2012, ACTA OBSTET GYNECOL, V1504, P4918; EARLY P, ACTA OBSTET GYNECOL, P6; EARLY P, 2014, ACTA OBSTET GYNECOL, V6, P18; EARLY P, 1950, ACTA OBSTET GYNECOL; EARLY P, 2012, ACTA OBSTET GYNECOL, V91, P10; EARLY P, 2004, ACTA OBSTET GYNECOL, V1808, P1354; Ebrahimi M, 2016, J CLIN LAB ANAL, V30, P672, DOI 10.1002/jcla.21920; ELALAMEEY IR, GROWTH; Fain JN, 2010, ACTA OBSTET GYNECOL, DOI 10.1155/2010/; Fain JN, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/513948; FERNA A, 2017, NUTRIENTS, V9, P551; Friis CM, 2013, OBESITY, V21, pE124, DOI 10.1002/oby.20120; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Garcia-Mantrana I, 2016, MOL NUTR FOOD RES, V60, P1865, DOI 10.1002/mnfr.201501018; Gomez-Arango LF, 2016, DIABETES, V65, P2214, DOI 10.2337/db16-0278; Gomez-Gallego C, 2016, SEMIN FETAL NEONAT M, V21, P400, DOI 10.1016/j.siny.2016.05.003; Gram M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138111; Haedersdal S, 2013, INFLAMMATION, V36, P907, DOI 10.1007/s10753-013-9619-x; HAUPT TH, 2010, BMI, V4137, P91, DOI DOI 10.4137/BMI; Heraclides A, 2013, DIABETOLOGIA, V56, P1542, DOI 10.1007/s00125-013-2914-0; HU HJ, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0134333; Kasai C, 2015, ACTA OBSTET GYNECOL, V15, P100; Kolialexi A, 2017, EXPERT REV PROTEOMIC, V14, P269, DOI 10.1080/14789450.2017.1291345; KONG LC, 1934, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0109434; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Laitinen K, 2009, BRIT J NUTR, V101, P1679, DOI 10.1017/S0007114508111461; Lin XXB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083644; Lippert K, 2017, BENEF MICROBES, V8, P545, DOI 10.3920/BM2016.0184; Maffei M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-87; MART O, 2013, ISME J, V7, P269; Matos A, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/361727; Meehan CJ, 2014, GENOME BIOL EVOL, V6, P703, DOI 10.1093/gbe/evu050; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; Nylund L, 2010, J MICROBIOL METH, V83, P231, DOI 10.1016/j.mimet.2010.09.003; Org E, 2017, ACTA OBSTET GYNECOL, V18, P70; Org E, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1194-2; PENDELOSKI K, 2017, AM J REPROD IMMUNOL, V77, P5; PINHEIRO V, 2015, NUTR HOSP, V31, P5, DOI DOI 10.3305/NH.2015.31.5.8525; Presley LL, 2012, INFLAMM BOWEL DIS, V18, P409, DOI 10.1002/ibd.21793; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Ridker PM, 2007, J AM COLL CARDIOL, V49, P2129, DOI 10.1016/j.jacc.2007.02.052; RODR OA, 2015, MICROB ECOL HEALTH D, V26, P26050; RODR OA, 2010, SCI REP, V1038, P45559, DOI DOI 10.1038/SREP45559; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shin D, 2017, NUTRIENTS, V9, DOI 10.3390/nu9040351; Singh S, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0836-9; Stewart FM, 2007, J CLIN ENDOCR METAB, V92, P969, DOI 10.1210/jc.2006-2083; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466; Weissgerber TL, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.009; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhou B, 2014, CANCER CAUSE CONTROL, V25, P1397, DOI 10.1007/s10552-014-0445-8	77	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200305	10.1371/journal.pone.0200305	http://dx.doi.org/10.1371/journal.pone.0200305			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005082	Green Submitted, Green Published, gold			2022-12-26	WOS:000438744200014
J	Boughton, OR; Ma, SC; Zhao, S; Arnold, M; Lewis, A; Hansen, U; Cobb, JP; Giuliani, F; Abel, RL				Boughton, Oliver R.; Ma, Shaocheng; Zhao, Sarah; Arnold, Matthew; Lewis, Angus; Hansen, Ulrich; Cobb, Justin P.; Giuliani, Finn; Abel, Richard L.			Measuring bone stiffness using spherical indentation	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; CORTICAL BONE; ELASTIC-MODULUS; TRABECULAR BONE; YOUNGS MODULUS; FEMORAL-NECK; PRESS-FIT; TISSUE; POROSITY; ERRORS	Objectives Bone material properties are a major determinant of bone health in older age, both in terms of fracture risk and implant fixation, in orthopaedics and dentistry. Bone is an anisotropic and hierarchical material so its measured material properties depend upon the scale of metric used. The scale used should reflect the clinical problem, whether it is fracture risk, a whole bone problem, or implant stability, at the millimetre-scale. Indentation, an engineering technique involving pressing a hard-tipped material into another material with a known force, may be able to assess bone stiffness at the millimetre-scale (the apparent elastic modulus). We aimed to investigate whether spherical-tip indentation could reliably measure the apparent elastic modulus of human cortical bone. Materials and methods Cortical bone samples were retrieved from the femoral necks of nineteen patients undergoing total hip replacement surgery (10 females, 9 males, mean age: 69 years). The samples underwent indentation using a 1.5 mm diameter, ruby, spherical indenter tip, with sixty indentations per patient sample, across six locations on the bone surfaces, with ten repeated indentations at each of the six locations. The samples then underwent mechanical compression testing. The repeatability of indentation measurements of elastic modulus was assessed using the co-efficient of repeatability and the correlation between the bone elastic modulus measured by indentation and compression testing was analysed by least-squares regression. Results In total, 1140 indentations in total were performed. Indentation was found to be repeatable for indentations performed at the same locations on the bone samples with a mean co-efficient of repeatability of 0.4 GigaPascals (GPa), confidence interval (C.I): 0.33-0.42 GPa. There was variation in the indentation modulus results between different locations on the bone samples (mean co-efficient of repeatability: 3.1 GPa, C.I: 2.2-3.90 GPa). No clear correlation was observed between indentation and compression values of bone elastic modulus (r= 0.33, p = 0.17). The mean apparent elastic modulus obtained by spherical indentation was 9.9 GPa, the standard deviation for each indent cycle was 0.11 GPa, and the standard deviation between locations on the same sample was 1.01 GPa. The mean compression apparent elastic modulus was 4.42 GPa, standard deviation 1.02 GPa. Discussion Spherical-tip indentation was found to be a repeatable test for measuring the elastic modulus of human cortical bone, demonstrated by a low co-efficient of repeatability in this study. It could not, however, reliably predict cortical bone elastic modulus determined by platens compression testing in this study. This may be due to indentation only probing mechanical properties at the micro-scale while platens compression testing assesses millimetre length-scale properties. Improvements to the testing technique, including the use of a larger diameter spherical indenter tip, may improve the measurement of bone stiffness at the millimetre scale and should be investigated further.	[Boughton, Oliver R.; Ma, Shaocheng; Zhao, Sarah; Arnold, Matthew; Cobb, Justin P.; Abel, Richard L.] Imperial Coll London, Charing Cross Hosp, MSk Lab, London, England; [Boughton, Oliver R.; Ma, Shaocheng; Hansen, Ulrich] Imperial Coll London, Dept Mech Engn, Biomech Grp, South Kensington Campus, London, England; [Lewis, Angus] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Orthopaed Surg Dept, London, England; [Giuliani, Finn] Imperial Coll London, Ctr Adv Struct Ceram, Dept Mech Engn & Mat, South Kensington Campus, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London	Boughton, OR (corresponding author), Imperial Coll London, Charing Cross Hosp, MSk Lab, London, England.; Boughton, OR (corresponding author), Imperial Coll London, Dept Mech Engn, Biomech Grp, South Kensington Campus, London, England.	o.boughton@imperial.ac.uk	cobb, justin/AAS-9814-2020; Boughton, Oliver R./AAM-8012-2020	cobb, justin/0000-0002-6095-8822; Boughton, Oliver R./0000-0003-0098-1438; Ma, Shaocheng/0000-0003-1221-4826; Zhao, Sarah/0000-0001-5196-1563	United Kingdom National Institute for Health Research (NIHR) [RDB0479560]; Michael Uren Foundation [WSSU_NCN011]; Royal College of Surgeons of England; Dunhill Medical Trust [WSSU_P63898]; NIHR Imperial College Biomedical Research Centre Institute for Translational Medicine and Therapeutics grant; Michael Uren Foundation; Dunhill Medical Trust	United Kingdom National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Michael Uren Foundation; Royal College of Surgeons of England; Dunhill Medical Trust(Dunhill Medical Trust); NIHR Imperial College Biomedical Research Centre Institute for Translational Medicine and Therapeutics grant; Michael Uren Foundation; Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported by funding from the United Kingdom National Institute for Health Research (NIHR) [RDB0479560, https://imperialbrc.nihr.ac.uk]; the Michael Uren Foundation [WSSU_NCN011, https://www.imperial.ac.uk/white-city-campus/research/michael-uren-hub]; the Royal College of Surgeons of England and Dunhill Medical Trust [WSSU_P63898, https://www.rcseng.ac.uk/standards-and-research/research/fellowships-awards-grants/fellowships/5-year-joint-rcs-dunhill-medical-trust]. The UK NIHR funding was from an NIHR Imperial College Biomedical Research Centre Institute for Translational Medicine and Therapeutics grant to JPC, UH, RA and OB. The Michael Uren Foundation provides general laboratory funding to the MSk Lab, Imperial College (JPC, RA, OB). The Royal College of Surgeons of England and Dunhill Medical Trust awarded Clinical Research Fellowship funding to OB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdel MP, 2016, BONE JOINT J, V98B, P461, DOI [10.1302/0301-620X.98B4.37201, 10.1302/0301-620X.98B4]; Arnold M, 2017, BONE JOINT RES, V6, P542, DOI 10.1302/2046-3758.69.BJR-2016-0317.R2; Ascenzi MG, 2011, J BIOMECH, V44, P211, DOI 10.1016/j.jbiomech.2010.10.022; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; Bernard S, 2013, J MECH BEHAV BIOMED, V18, P12, DOI 10.1016/j.jmbbm.2012.09.017; Bland JM, 1996, BRIT MED J, V313, P41, DOI 10.1136/bmj.313.7048.41; Bousson V, 2004, J BONE MINER RES, V19, P794, DOI 10.1359/JBMR.040124; Bridges D, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693085; CURREY JD, 1988, J BIOMECH, V21, P131, DOI 10.1016/0021-9290(88)90006-1; CURTIS MJ, 1992, J BONE JOINT SURG BR, V74, P372, DOI 10.1302/0301-620X.74B3.1587880; Dall'Ara E, 2015, J BIOMECH, V48, P4073, DOI 10.1016/j.jbiomech.2015.10.001; Donnelly E, 2011, CLIN ORTHOP RELAT R, V469, P2128, DOI 10.1007/s11999-010-1702-0; Gao JZ, 2015, EXP GERONTOL, V62, P63, DOI 10.1016/j.exger.2015.01.002; Granke M, 2015, ACTA BIOMATER, V12, P207, DOI 10.1016/j.actbio.2014.10.011; Granke M, 2014, J MECH BEHAV BIOMED, V37, P174, DOI 10.1016/j.jmbbm.2014.05.016; Granke M, 2011, BONE, V49, P1020, DOI 10.1016/j.bone.2011.08.002; Grimal Q, 2014, ULTRASOUND MED BIOL, V40, P1015, DOI 10.1016/j.ultrasmedbio.2013.11.010; Hansen U, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838032; Helgason B, 2008, CLIN BIOMECH, V23, P135, DOI 10.1016/j.clinbiomech.2007.08.024; Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X; Hengsberger S, 2003, J BIOMECH, V36, P1503, DOI 10.1016/S0021-9290(03)00131-3; Hoffler CE, 2000, BONE, V26, P603, DOI 10.1016/S8756-3282(00)00268-4; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; HUISKES R, 1992, CLIN ORTHOP RELAT R, P124; Katsamenis OL, 2013, J MECH BEHAV BIOMED, V17, P152, DOI 10.1016/j.jmbbm.2012.08.016; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; Kerrigan JR, 2014, J MECH BEHAV BIOMED, V33, P99, DOI 10.1016/j.jmbbm.2013.04.027; Langlois J, 2016, BONE JOINT J, V98B, P166, DOI 10.1302/0301-620X.98B2.34728; LINDE F, 1992, J BIOMECH, V25, P359, DOI 10.1016/0021-9290(92)90255-Y; LINDE F, 1993, J BIOMECH, V26, P1249, DOI 10.1016/0021-9290(93)90072-M; Linss V, 2005, SURF COAT TECH, V195, P287, DOI 10.1016/j.surfcoat.2004.06.010; LOTZ JC, 1991, J BIOMECH, V24, P317, DOI 10.1016/0021-9290(91)90350-V; Ma SC, 2016, CLIN REV BONE MINER, V14, P150, DOI 10.1007/s12018-016-9223-3; Macdonald W, 1999, J ARTHROPLASTY, V14, P730, DOI 10.1016/S0883-5403(99)90229-2; Macdonald W, 1999, P I MECH ENG H, V213, P33, DOI 10.1243/0954411991534780; MARTIN RB, 1991, J BIOMECH, V24, P79, DOI 10.1016/0021-9290(91)90379-2; Miles A. W., 2012, SURG OXFORD, V30, P86; Mirzaali MJ, 2016, BONE, V93, P196, DOI 10.1016/j.bone.2015.11.018; Murry RP, 1984, T ORTHOP RES SOC, V9, P197; Novitskaya E, 2011, THEOR APPL MECH, V38, P209, DOI 10.2298/TAM1103209N; Nyman JS, 2016, CURR OSTEOPOROS REP, V14, P138, DOI 10.1007/s11914-016-0314-3; Ohman C, 2007, J BIOMECH, V40, P2426, DOI 10.1016/j.jbiomech.2006.11.020; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Oyen ML, 2006, PHILOS MAG, V86, P5625, DOI 10.1080/14786430600740666; Oyen ML, 2007, ACTA MATER, V55, P3633, DOI 10.1016/j.actamat.2006.12.031; Oyen ML, 2012, J MATER RES, V27, P245, DOI 10.1557/jmr.2011.322; Oyen ML, 2005, J MATER RES, V20, P2094, DOI 10.1557/JMR.2005.0259; Randall C, 2013, J MED DEVICES, V7, DOI 10.1115/1.4024829; Reed K L, 2001, Iowa Orthop J, V21, P53; Reznikov N, 2014, ACTA BIOMATER, V10, P3815, DOI 10.1016/j.actbio.2014.05.024; Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3; Rodriguez-Florez N, 2013, J MECH BEHAV BIOMED, V18, P90, DOI 10.1016/j.jmbbm.2012.11.005; Sabet FA, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0055; Shirazi HA, 2017, COMPUT METHOD BIOMEC, V20, P750, DOI 10.1080/10255842.2017.1299142; Smit TH, 2002, J BIOMECH, V35, P829, DOI 10.1016/S0021-9290(02)00021-0; Sumner DR, 2015, J BIOMECH, V48, P797, DOI 10.1016/j.jbiomech.2014.12.021; Sumner DR, 1998, J BIOMECH, V31, P909, DOI 10.1016/S0021-9290(98)00096-7; Thurner PJ, 2009, WIRES NANOMED NANOBI, V1, P624, DOI 10.1002/wnan.56; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; Winter W, 2014, BIOMED ENG-BIOMED TE, V59, P413, DOI 10.1515/bmt-2014-0039; Wolfram U, 2016, BONEKEY REP, V5, DOI 10.1038/bonekey.2016.60; Zebaze R, 2015, J BONE MINER RES, V30, P24, DOI 10.1002/jbmr.2419; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0; Zysset PK, 2009, OSTEOPOROSIS INT, V20, P1049, DOI 10.1007/s00198-009-0854-9	65	18	18	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200475	10.1371/journal.pone.0200475	http://dx.doi.org/10.1371/journal.pone.0200475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001364	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400066
J	Duan, LC; Ye, LH; Zhuang, L; Zou, XL; Liu, S; Zhang, Y; Zhang, LJ; Jin, CG; Huang, YC				Duan, Lincan; Ye, Lianhua; Zhuang, Li; Zou, Xiaolan; Liu, Shan; Zhang, Yong; Zhang, Lijuan; Jin, Congguo; Huang, Yunchao			VEGFC/NEGFR3 axis mediates TGF beta 1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer cells	PLOS ONE			English	Article							GROWTH-FACTOR-C; VEGF-C; POOR-PROGNOSIS; STEM-CELLS; METASTASIS; EXPRESSION; LYMPHANGIOGENESIS; ROLES	In the tumor progression, transforming growth factor beta 1 (TGF beta 1) plays a critical role in tumorigenesis as well as metastasis. It is known that high plasma level of TGF beta 1 in patients with advanced non-small cell lung cancer (NSCLC) is correlated with poor prognostics. In addition, the generation of cancer stem-like cells is associated with metastasis, drug resistance, and tumor recurrence, which also lead to poor outcomes in NSCLC patients. However, it remains unclear how TGF beta 1 promotes NSCLC cells to acquire stem-like properties and accelerate tumor metastasis. In our study, we found that short term TGF beta 1 treatment resulted in a significant epithelial-mesenchymal transition (EMT) morphological change in TGF beta 1-sensitive NSCLC cells but not in insensitive cells. Western blotting confirmed increased Vimentin and reduced E-Cadherin protein expression after TGF beta 1 treatment in A549, NCI-H1993, and NCI-H358 cells. TGF beta 1 incubation dramatically decreased in vitro cell proliferation and increased cell invasion in TGF beta 1-sensitive NSCLC cells but not in NCI-H1975, NCI-H1650, and HCC827 cells. Moreover, TGF beta 1 was able to enhance the mRNA expression of Oct4, Nanog and Sox2 and drastically increased anchorage-independent colony formation in TGF beta 1-sensitive NSCLC cells, suggesting the acquisition of cancer stemlike properties. Interestingly, we found that vascular endothelial growth factor receptor 3 (VEGFR3) mRNA expression was significantly elevated in TGF beta 1-sensitive NSCLC cells compared to insensitive cells. And TGF beta 1 was capable of inducing VEGF-C gene expression. Pharmacological blocking TGF beta type I receptor kinase (ALK5) significantly inhibited TGF beta 1 -induced VEGF-C expression. Silencing of ALK5 by siRNA also dramatically reduced TGF beta 1 -induced VEGF-C expression in TGF beta 1-sensitive NSCLC cells. Therefore, TGF beta 1 contributes for NSCLC metastasis through promoting EMT, generation of high invasive cancer cells with stem-like properties, and increasing VEGF-C expression. Blocking TGF beta 1pathway is a potential therapeutic target in human non-small cell lung cancer.	[Duan, Lincan; Ye, Lianhua; Zou, Xiaolan; Zhang, Yong; Huang, Yunchao] Kunming Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Kunming, Yunnan, Peoples R China; [Zhuang, Li] Kunming Med Univ, Affiliated Hosp 3, Dept Palliat Med, Kunming, Yunnan, Peoples R China; [Liu, Shan] Kunming Med Univ, Affiliated Hosp 3, Canc Ctr Integrat Med, Kunming, Yunnan, Peoples R China; [Zhang, Lijuan] Kunming Med Univ, Affiliated Hosp 3, Dept Pathol, Kunming, Yunnan, Peoples R China; [Jin, Congguo] Kunming Med Univ, Affiliated Hosp 3, Canc Inst, Kunming, Yunnan, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University	Huang, YC (corresponding author), Kunming Med Univ, Affiliated Hosp 3, Dept Thorac Surg, Kunming, Yunnan, Peoples R China.	daliduanlincan@163.com		can, duan/0000-0001-8262-7824	Yunnan Province Specialized Training Grant for High-Level Healthcare Professionals [D-201614]; Yunnan Province Applied Basic Research foundation [2014FB196]	Yunnan Province Specialized Training Grant for High-Level Healthcare Professionals; Yunnan Province Applied Basic Research foundation	This study was supported by Yunnan Province Specialized Training Grant for High-Level Healthcare Professionals (D-201614) and Yunnan Province Applied Basic Research foundation (2014FB196) to Lincan Duan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SC, 2011, ANN ACAD MED SINGAP, V40, P319; Chen W, 2015, CA CANC J CLIN; Costanza B, 2017, J CLIN MED, V6, DOI 10.3390/jcm6010007; Da CL, 2016, ONCOL REP, V35, P2767, DOI 10.3892/or.2016.4661; Demirkan B, 2013, J CLIN MED, V2, P264, DOI 10.3390/jcm2040264; Duan Lincan, 2008, Zhongguo Fei Ai Za Zhi, V11, P802, DOI 10.3779/j.issn.1009-3419.2008.06.08; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Huang SF, 2016, FOOD CHEM TOXICOL, V94, P1, DOI 10.1016/j.fct.2016.05.009; Khromova N, 2012, ONCOGENE, V31, P1389, DOI 10.1038/onc.2011.330; Li D, 2013, CANC LETT; Li S, 2015, CANCER LETT, V357, P438, DOI 10.1016/j.canlet.2014.12.013; Liu D, 2014, CANCER RES, V74, P5597, DOI 10.1158/0008-5472.CAN-13-3598; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Luo M, 2015, CURR PHARM DESIGN, V21, P1301, DOI 10.2174/1381612821666141211120604; Morfoisse F, 2015, MOL CELL ONCOL, V2, DOI 10.1080/23723556.2015.1024821; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nakajima T, 2012, J THORAC ONCOL, V7, P1661, DOI 10.1097/JTO.0b013e318265b4df; Pirozzi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021548; Regan E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150963; Secker GA, 2015, DEV DYNAM, V244, P323, DOI 10.1002/dvdy.24227; Shibata MA, 2013, ANTICANCER RES, V33, P4237; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sleeman J, 2009, SEMIN CANCER BIOL, V19, P285, DOI 10.1016/j.semcancer.2009.05.005; Stacker Steven A., 2008, Lymphatic Research and Biology, V6, P165, DOI 10.1089/lrb.2008.1015; Takahashi S, 2011, BIOL PHARM BULL, V34, P1785, DOI 10.1248/bpb.34.1785; Wang X, 2014, THORAC CANCER, V5, P383, DOI 10.1111/1759-7714.12104; Wu YC, 2016, ONCOGENE, V35, P2123, DOI 10.1038/onc.2015.274; Yao JB, 2013, TUMOR BIOL, V34, P1493, DOI 10.1007/s13277-013-0674-6; Yoshimatsu Y, 2016, ADV DRUG DELIVER REV, V99, P161, DOI 10.1016/j.addr.2016.01.020	30	16	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200452	10.1371/journal.pone.0200452	http://dx.doi.org/10.1371/journal.pone.0200452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995950	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800069
J	Rehfeld, K; Luders, A; Hokelmann, A; Lessmann, V; Kaufmann, J; Brigadski, T; Muller, P; Muller, NG				Rehfeld, Kathrin; Lueders, Angie; Hokelmann, Anita; Lessmann, Volkmar; Kaufmann, Joern; Brigadski, Tanja; Mueller, Patrick; Mueller, Notger G.			Dance training is superior to repetitive physical exercise in inducing brain plasticity in the elderly	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; AEROBIC EXERCISE; WORKING-MEMORY; BDNF SECRETION; NEUROGENESIS; CORTEX; HIPPOCAMPUS; MOVEMENT; INSIGHTS; ANIMALS	Animal research indicates that a combination of physical activity and sensory enrichment has the largest and the only sustaining effect on adult neuroplasticity. Dancing has been suggested as a human homologue to this combined intervention as it poses demands on both physical and cognitive functions. For the present exploratory study, we designed an especially challenging dance program in which our elderly participants constantly had to learn novel and increasingly difficult choreographies. This six-month-long program was compared to conventional fitness training matched for intensity. An extensive pre/post-assessment was performed on the 38 participants (63-80 y), covering general cognition, attention, memory, postural and cardio-respiratory performance, neurotrophic factors and-most crucially-structural MRI using an exploratory analysis. For analysis of MRI data, a new method of voxel-based morphometry (VBM) designed specifically for pairwise longitudinal group comparisons was employed. Both interventions increased physical fitness to the same extent. Pronounced differences were seen in the effects on brain volumes: Dancing compared to conventional fitness activity led to larger volume increases in more brain areas, including the cingulate cortex, insula, corpus callosum and sensorimotor cortex. Only dancing was associated with an increase in plasma BDNF levels. Regarding cognition, both groups improved in attention and spatial memory, but no significant group differences emerged. The latter finding may indicate that cognitive benefits may develop later and after structural brain changes have taken place. The present results recommend our challenging dance program as an effective measure to counteract detrimental effects of aging on the brain.	[Rehfeld, Kathrin; Lueders, Angie; Mueller, Patrick; Mueller, Notger G.] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Saxony Anhalt, Germany; [Rehfeld, Kathrin; Hokelmann, Anita] Otto von Guericke Univ, Inst Sport Sci, Magdeburg, Saxony Anhalt, Germany; [Lessmann, Volkmar; Brigadski, Tanja] Inst Physiol, Magdeburg, Saxony Anhalt, Germany; [Lessmann, Volkmar; Brigadski, Tanja; Mueller, Notger G.] CBBS, Magdeburg, Saxony Anhalt, Germany; [Kaufmann, Joern; Mueller, Notger G.] Univ Clin Neurol, Magdeburg, Saxony Anhalt, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University	Rehfeld, K (corresponding author), German Ctr Neurodegenerat Dis DZNE, Magdeburg, Saxony Anhalt, Germany.; Rehfeld, K (corresponding author), Otto von Guericke Univ, Inst Sport Sci, Magdeburg, Saxony Anhalt, Germany.	kathrin.rehfeld@ovgu.de	Leßmann, Volkmar/E-8125-2013; Brigadski, Tanja/O-8677-2016	Leßmann, Volkmar/0000-0002-6863-323X; Mueller, Notger/0000-0002-5483-6423; Rehfeld, Kathrin/0000-0001-9775-763X				Aschenbrenner S, 2000, MANUAL ZUM RWT REGEN; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Ball T, 1999, NEUROIMAGE, V10, P682, DOI 10.1006/nimg.1999.0507; Beck AT, 2006, BECK DEPRESSIONS INV; Berchtold Nicole C., 2009, P1, DOI 10.1007/978-1-59745-422-3_1; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Brehm W, 2006, GESUND DURCH GESUNDH, P16; Brigadski T, 2014, E NEUROFORUM, V20, P1, DOI DOI 10.1007/S13295-014-0053-9; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Buckner RL, 2004, NEURON, V44, P195, DOI 10.1016/j.neuron.2004.09.006; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Colucci-D'Amato L, 2008, BIOESSAYS, V30, P135, DOI 10.1002/bies.20703; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Edelmann E, 2014, NEUROPHARMACOLOGY, V76, P610, DOI 10.1016/j.neuropharm.2013.05.043; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Floel A, 2010, NEUROIMAGE, V49, P2756, DOI 10.1016/j.neuroimage.2009.10.043; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Harting C., 2000, WECHSLER GEDACHTNIS; HAUG H, 1991, NEUROBIOL AGING, V12, P336, DOI 10.1016/0197-4580(91)90013-A; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Helmstaedter C, 2001, VERBALER LERN MERKFA, V1; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Hufner K, 2011, HIPPOCAMPUS, V21, P855, DOI 10.1002/hipo.20801; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Kattenstroth JC, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00005; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; KLEIN R, 1994, FASEB J, V8, P738, DOI 10.1096/fasebj.8.10.8050673; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kukolja J, 2011, NEUROLOGISCHE DIFFER, P41; Leff AP, 2009, BRAIN, V132, P3401, DOI 10.1093/brain/awp273; Lessmann V, 2009, NEUROSCI RES, V65, P11, DOI 10.1016/j.neures.2009.06.004; Maass A, 2015, MOL PSYCHIATR, V20, P585, DOI 10.1038/mp.2014.114; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; McCarthy G, 1996, CEREB CORTEX, V6, P600, DOI 10.1093/cercor/6.4.600; Melzer TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143923; Meyers J. E., 1995, REY COMPLEX FIGURE T; O'Sullivan M, 2001, NEUROLOGY, V57, P632, DOI 10.1212/WNL.57.4.632; OSWALD WD, 1978, ZAHLEN VERBINDUNGS T; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Petzold A, 2015, NEUROBIOL LEARN MEM, V120, P52, DOI 10.1016/j.nlm.2015.02.009; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rasmussen P, 2009, EXP PHYSIOL, V94, P1062, DOI 10.1113/expphysiol.2009.048512; Rehfeld K, 2014, Z NEUROPSYCHOL, V25, P99, DOI 10.1024/1016-264X/a000124; Resnick SM, 2003, J NEUROSCI, V23, P3295; Schega L, 2016, J SCI MED SPORT, DOI [10.1016/j.nlm.2015.02.009, DOI 10.1016/J.NLM.2015.02.009]; Seifert T, 2010, AM J PHYSIOL-REG I, V298, pR372, DOI 10.1152/ajpregu.00525.2009; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Soros P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-48; Stemper T, 2003, LEHRBUCH LIZENZIERTE; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Terry RD, 2001, NEUROBIOL AGING, V22, P347, DOI 10.1016/S0197-4580(00)00250-5; Thach WT, 1998, NEUROBIOL LEARN MEM, V70, P177, DOI 10.1006/nlme.1998.3846; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vega SR, 2006, BRAIN RES, V1121, P59, DOI 10.1016/j.brainres.2006.08.105; Wagner AP, 2000, EXP GERONTOL, V35, P1211, DOI 10.1016/S0531-5565(00)00154-6; Willems RM, 2009, NEUROIMAGE, V47, P1992, DOI 10.1016/j.neuroimage.2009.05.066; Zimmermann P., 2002, TESTBATTERIE AUFMERK; Zoladz JA, 2008, J PHYSIOL PHARMACOL, V59, P119	69	90	94	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0196636	10.1371/journal.pone.0196636	http://dx.doi.org/10.1371/journal.pone.0196636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM7QQ	29995884	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800003
J	Salloum, N; Hussein, HM; Jammaz, R; Jiche, S; Uthman, IW; Abdelnoor, AM; Rahal, EA				Salloum, Noor; Hussein, Hadi M.; Jammaz, Rana; Jiche, Sara; Uthman, Imad W.; Abdelnoor, Alexander M.; Rahal, Elias A.			Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ROR-GAMMA-T; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; DISEASE-ACTIVITY; DENDRITIC CELLS; HELPER-CELLS; DIFFERENTIATION; IL-17; MALIGNANCIES	Infection with the Epstein-Barr virus (EBV) has been associated with several autoimmune diseases including rheumatoid arthritis (RA). We have previously reported that DNA from this virus enhances production of the pro-autoimmune interleukin 17A (IL-17A) in mice. In this study we assessed the effect of EBV DNA on regulatory T cell programming and examined whether it mediated its effects via Toll-like receptor 9 (TLR9) in mice; moreover, we evaluated whether EBV DNA in humans had similar effects to those seen in mice. For this purpose, we assessed the linearity of the correlation between EBV DNA and IL-17A levels in RA subjects and matched controls. A modulatory effect for the viral DNA was observed for regulatory T cell markers with an inhibitory effect observed for CTLA4 expression in the EBV DNA-treated mice. To examine whether TLR9 mediated the detection of EBV DNA and enhancement of IL-17A production, mouse peripheral blood mononuclear cells were treated with the DNA in the presence or absence of the TLR9 inhibitor ODN 2088. Subsequently, IL-17A production from these cells was assessed. Treatment with the TLR9 inhibitor resulted in a significant decrease in IL-17A production indicating that TLR9 is involved in this pathway. In human subjects, examining the linearity of the correlation between EBV DNA and IL-17A levels in RA subjects showed a propensity for linearity that was not observed in controls. Our data thus indicates that EBV DNA itself acts as a modulator of the Th17 compartment as well as that of regulatory T cell mechanisms. The involvement of TLR9 in the EBV DNA-triggered induction of IL-17A suggests therapeutic targeting of this endosomal receptor in EBV positive subjects with an autoimmune flare-up or possibly for prophylactic purposes.	[Salloum, Noor; Hussein, Hadi M.; Jammaz, Rana; Jiche, Sara; Abdelnoor, Alexander M.; Rahal, Elias A.] Amer Univ Beirut, Dept Expt Pathol Immunol & Microbiol, Beirut, Lebanon; [Uthman, Imad W.] Amer Univ Beirut, Dept Internal Med, Med Ctr, Beirut, Lebanon	American University of Beirut; American University of Beirut	Rahal, EA (corresponding author), Amer Univ Beirut, Dept Expt Pathol Immunol & Microbiol, Beirut, Lebanon.	er00@au.edu.lb		Rahal, Elias/0000-0002-1096-7042	Lebanese National Council for Scientific Research (CNRS-L)	Lebanese National Council for Scientific Research (CNRS-L)	This study was supported by a grant from the Lebanese National Council for Scientific Research (CNRS-L). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Al-Saadany HM, 2016, EGYPT RHEUMATOL, V38, P1, DOI 10.1016/j.ejr.2015.01.001; Andersson Jan, 2000, Herpes, V7, P76; Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Blaschke S, 2000, J RHEUMATOL, V27, P866; Borza CM, 2002, NAT MED, V8, P594, DOI 10.1038/nm0602-594; Castro G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181868; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Crome SQ, 2010, CLIN EXP IMMUNOL, V159, P109, DOI 10.1111/j.1365-2249.2009.04037.x; Demachi-Okamura A, 2006, EUR J IMMUNOL, V36, P593, DOI 10.1002/eji.200535485; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Erre GL, 2015, VIRAL IMMUNOL, V28, P385, DOI 10.1089/vim.2015.0035; Fiola S, 2010, J IMMUNOL, V185, P3620, DOI 10.4049/jimmunol.0903736; Goetz B, 2016, ONCOTARGET, V7, P51107, DOI 10.18632/oncotarget.9812; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu JL, 2000, CRIT REV ONCOL HEMAT, V34, P27, DOI 10.1016/S1040-8428(00)00046-9; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kakalacheva K, 2011, BBA-MOL BASIS DIS, V1812, P132, DOI 10.1016/j.bbadis.2010.06.012; Kalla M, 2010, P NATL ACAD SCI USA, V107, P850, DOI 10.1073/pnas.0911948107; Kleer CG, 2002, MODERN PATHOL, V15, P759, DOI 10.1038/modpathol.3880602; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Q, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00171; Lundberg P, 2003, J VIROL, V77, P11158, DOI 10.1128/JVI.77.20.11158-11169.2003; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Merza DMTRR, 2015, EUROPEAN SCI J, V11, P358; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Pawar RD, 2007, J AM SOC NEPHROL, V18, P1721, DOI 10.1681/ASN.2006101162; Pindado J, 2007, J IMMUNOL, V179, P4821, DOI 10.4049/jimmunol.179.7.4821; Rahal EA, 2015, VIRAL IMMUNOL, V28, P297, DOI 10.1089/vim.2014.0129; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Takeda T, 2000, ARTHRITIS RHEUM, V43, P1218, DOI 10.1002/1529-0131(200006)43:6<1218::AID-ANR4>3.0.CO;2-2; Wagner H, 1999, ADV IMMUNOL, V73, P329, DOI 10.1016/S0065-2776(08)60790-7; Walker LSK, 2013, J AUTOIMMUN, V45, P49, DOI 10.1016/j.jaut.2013.06.006; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Wu YW, 2015, ACTA PHARMACOL SIN, V36, P1395, DOI 10.1038/aps.2015.91; Yadav P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014488; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116; Zelante T, 2015, CELL REP, V12, P1789, DOI 10.1016/j.celrep.2015.08.030; Zizzo G, 2011, CLIN IMMUNOL, V138, P107, DOI 10.1016/j.clim.2010.10.002	48	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200546	10.1371/journal.pone.0200546	http://dx.doi.org/10.1371/journal.pone.0200546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995930	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800081
J	Pascoalino, JAL; Thompson, JA; Wright, G; Franco, FA; Scheeren, PL; Pauletti, V; Moraes, MF; White, PJ				Lopes Pascoalino, Joao Augusto; Thompson, Jacqueline A.; Wright, Gladys; Franco, Francisco Assis; Scheeren, Pedro Luiz; Pauletti, Volnei; Moraes, Milton Ferreira; White, Philip John			Grain zinc concentrations differ among Brazilian wheat genotypes and respond to zinc and nitrogen supply	PLOS ONE			English	Article							BIOFORTIFICATION; CALCIUM; CROPS; AVAILABILITY; ACCUMULATION; PHOSPHORUS; DEFICIENCY; NUTRITION; IRON	The combined application of nitrogen (N) and zinc (Zn) fertilizers is a promising agronomic strategy for the biofortification of wheat grain with Zn for human nutrition. A glasshouse experiment was carried out to assess the effects of supplying N on the uptake, translocation and accumulation of Zn in tissues of two wheat genotypes (Quartzo and BRS Parrudo) with contrasting potential for grain Zn biofortification. Winter wheat genotypes were grown to maturity in 5 cm diameter, 100 cm length tubes filled with a mixture of sand, grit and gravel (40:40:20 v/v/v) over a layer of 0.1 m(3) of gravel, and supplied a full nutrient solution with low Zn (0.15 mu M) or high Zn (2.25 mu M) and low N (0.4 mM) or high N (4.0 mM) concentrations. High N supply increased biomass production, Zn concentration and Zn content of straw and grain in both Quartzo and BRS Parrudo. Grain Zn content more than doubled when the supplies of Zn and N were both increased from low to high in both genotypes. Quartzo had a greater grain yield than BRS Parrudo. BRS Parrudo had greater grain Zn concentration and Zn content than Quartzo. A greater N supply promoted better uptake, translocation to the shoot and accumulation of Zn within the grain. Quartzo and BRS Parrudo differed in their partitioning of biomass and Zn between tissues. It might be possible to combine the greater grain yield of Quartzo with the greater grain Zn accumulation of BRS Parrudo to deliver a greatly improved genotype for human food security.	[Lopes Pascoalino, Joao Augusto; Pauletti, Volnei; Moraes, Milton Ferreira] Univ Fed Parana, Dept Soil Sci, Curitiba, Parana, Brazil; [Thompson, Jacqueline A.; Wright, Gladys; White, Philip John] James Hutton Inst, Dept Ecol Sci, Dundee, Scotland; [Franco, Francisco Assis] Cent Cooperat Agr Res, Cascavel, Parana, Brazil; [Scheeren, Pedro Luiz] Brazilian Agr Res Co, Nacl Ctr Wheat Res, Passo Fundo, RS, Brazil; [Moraes, Milton Ferreira] Univ Fed Mato Grosso, Dept Trop Agr, Barra Do Garcas, Mato Grosso, Brazil	Universidade Federal do Parana; James Hutton Institute; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso do Sul	Pascoalino, JAL (corresponding author), Univ Fed Parana, Dept Soil Sci, Curitiba, Parana, Brazil.	joaumpascoalino@hotmail.com	White, Philip John/C-5860-2008	White, Philip John/0000-0003-0827-288X; Pauletti, Volnei/0000-0002-9231-7851	Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government; National Council for Scientific and Technological Development (CNPq) of Brazil	Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government; National Council for Scientific and Technological Development (CNPq) of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was supported by the Rural and Environment Science and Analytical Services Division (RESAS) of the Scottish Government and by a Fellowship from The National Council for Scientific and Technological Development (CNPq) of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barunawati N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00320; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Bouis HE, 2010, CROP SCI, V50, pS20, DOI 10.2135/cropsci2009.09.0531; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Cakmak I, 2018, EUR J SOIL SCI, V69, P172, DOI 10.1111/ejss.12437; Cakmak I., 1999, Mineral nutrition of crops: fundamental mechanisms and implications., P141; Cakmak I, 2008, PLANT SOIL, V302, P1, DOI 10.1007/s11104-007-9466-3; Cakmak I, 2017, PLANT SOIL, V411, P1, DOI 10.1007/s11104-016-3166-9; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; Erdal I, 2002, J PLANT NUTR, V25, P113, DOI 10.1081/PLN-100108784; Erenoglu EB, 2011, NEW PHYTOL, V189, P438, DOI 10.1111/j.1469-8137.2010.03488.x; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; FAO, 2015, STATE FOOD INWORLD; Garvin DF, 2006, J SCI FOOD AGR, V86, P2213, DOI 10.1002/jsfa.2601; Gibson RS, 2008, BRIT J NUTR, V99, pS14, DOI 10.1017/S0007114508006818; Guo JX, 2016, J AGR SCI-CAMBRIDGE, V154, P584, DOI 10.1017/S0021859615000441; Gupta N, 2016, REV ENVIRON SCI BIO, V15, P89, DOI 10.1007/s11157-016-9390-1; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; International Zinc Consultative Group, 2004, FOOD NUTR BULL, V25, pS99, DOI DOI 10.1177/15648265040251S205; Krebs NF, 2014, PAEDIATR INT CHILD H, V34, P279, DOI 10.1179/2046905514Y.0000000151; Kumssa DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep10974; Kutman UB, 2010, CEREAL CHEM, V87, P1, DOI 10.1094/CCHEM-87-1-0001; Kutman UB, 2012, PLANT SOIL, V361, P177, DOI 10.1007/s11104-012-1300-x; Kutman UB, 2011, PLANT SOIL, V342, P149, DOI 10.1007/s11104-010-0679-5; Newell-McGloughlin M, 2008, PLANT PHYSIOL, V147, P939, DOI 10.1104/pp.108.121947; Pedas P, 2009, PLANT PHYSIOL BIOCH, V47, P377, DOI 10.1016/j.plaphy.2009.01.006; Pedraza DF, 2017, REV BRAS SAUDE MATER, V17, P233, DOI DOI 10.1590/1806-93042017000200002; Pfeiffer Wolfgang H., 2007, P61, DOI 10.1002/9780470376447.ch3; Poursarebani N, 2014, PLANT J, V79, P334, DOI 10.1111/tpj.12550; Terrin G, 2015, NUTRIENTS, V7, P10427, DOI 10.3390/nu7125542; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Waters BM, 2011, PLANT SCI, V180, P562, DOI 10.1016/j.plantsci.2010.12.003; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; White PJ, 2009, HORTSCIENCE, V44, P6, DOI 10.21273/HORTSCI.44.1.6; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; White PJ, 2016, ELS, DOI [10.1002/9780470015902.A0023743, DOI 10.1002/9780470015902.A0023743]; Xue YF, 2016, CEREAL CHEM, V93, P543, DOI 10.1094/CCHEM-12-15-0243-R; Xue YF, 2012, PLANT SOIL, V361, P153, DOI 10.1007/s11104-012-1510-2; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zhang YQ, 2012, FIELD CROP RES, V125, P1, DOI 10.1016/j.fcr.2011.08.003; Zou CQ, 2012, PLANT SOIL, V361, P119, DOI 10.1007/s11104-012-1369-2	44	7	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199464	10.1371/journal.pone.0199464	http://dx.doi.org/10.1371/journal.pone.0199464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990332	Green Submitted, gold, Green Published			2022-12-26	WOS:000438170300011
J	Pang, YT; Li, LX				Pang, Yutao; Li, Lingxu			Seismic collapse assessment of bridge piers constructed with steel fibers reinforced concrete	PLOS ONE			English	Article							SHEAR-STRENGTH; BEHAVIOR; STRAIN; BEAMS; PERFORMANCE; COMPRESSION	Steel fiber is one of the most widely used reinforcements to improve the performance of concrete members. However, few studies have been proposed to study the seismic performance of bridge piers constructed with steel fiber reinforced concrete. This paper presents the collapse vulnerability assessment of typical single bridge piers constructed with steel fibers. Fiber element models of RC bridge piers with and without steel fibers are firstly built by selecting suitable cyclic constitutive laws of steel fiber reinforced concrete, and then calibrated using the experimental results. The seismic capacity and inelastic demand of RC piers with steel fibers are quantified using both nonlinear static pushover analyses and nonlinear incremental dynamic analyses (IDA). In order to conduct the IDA, a suite of 20 earthquake ground motions are selected and scaled to different levels of peak ground acceleration (PGA). Collapse fragility curves are then generated using the maximum drift ratio of piers as the engineering demand parameter (EDP). In order to investigate the impact of various parameters on the collapse fragility curves, six parameters are considered in the parametric study: peak compressive strength of concrete, yield strength of steel, longitudinal reinforcement ratio, axial load ratio, transverse hoops ratio and steel fiber content. It was observed that the concrete strength, longitudinal reinforcement ratio and steel fiber content could significantly affect the collapse fragility curve of the bridge piers with steel fibers.	[Pang, Yutao; Li, Lingxu] China Univ Geosci, Fac Engn, Wuhan, Hubei, Peoples R China	China University of Geosciences	Pang, YT (corresponding author), China Univ Geosci, Fac Engn, Wuhan, Hubei, Peoples R China.	pangyutaoyy@163.com	Pang, Yutao/ABA-9428-2021		Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) [G1323521673]; China Postdoctoral Science Foundation [2016M592407]; Natural Science Foundation of China [51708527]	Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan)(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) under Grant No. G1323521673, China Postdoctoral Science Foundation under Grant No. 2016M592407 and the Natural Science Foundation of China under Grant No. 51708527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the Fundamental Research Funds for the Central Universities, China University of Geosciences (Wuhan) under Grant No. G1323521673, China Postdoctoral Science Foundation under Grant No. 2016M592407 and the Natural Science Foundation of China under Grant No. 51708527.	Altun F, 2007, CONSTR BUILD MATER, V21, P654, DOI 10.1016/j.conbuildmat.2005.12.006; Baker JW, 2015, EARTHQ SPECTRA, V31, P579, DOI 10.1193/021113EQS025M; Banthia N, 2007, CEMENT CONCRETE RES, V37, P1366, DOI 10.1016/j.cemconres.2007.05.005; Bencardino F, 2008, J MATER CIVIL ENG, V20, P255, DOI 10.1061/(ASCE)0899-1561(2008)20:3(255); Berry MP, 2007, PEER REPORT 200707 P; Buyle-Bodin F, 2002, MATER STRUCT, V35, P402; Dancygier AN, 2011, ADV STRUCT ENG, V14, P745, DOI 10.1260/1369-4332.14.5.745; De Risi R, 2017, ENG STRUCT, V145, P348, DOI 10.1016/j.engstruct.2017.04.053; Filiatrault A, 1995, ACI STRUCT J, V92, P564; Gribniak V, 2012, ENG STRUCT, V42, P387, DOI 10.1016/j.engstruct.2012.04.032; Harajli MH, 2007, J MATER CIVIL ENG, V19, P864, DOI 10.1061/(ASCE)0899-1561(2007)19:10(864); Kotsovos G, 2007, MATER STRUCT, V40, P175, DOI 10.1617/s11527-006-9129-5; Lee HH, 2007, ENG STRUCT, V29, P1253, DOI 10.1016/j.engstruct.2006.08.016; Luco N, 1998, P 6 US NAT C EARTHQ; Nataraja MC, 1999, CEMENT CONCRETE COMP, V21, P383, DOI 10.1016/S0958-9465(99)00021-9; Ozcan DM, 2009, CONSTR BUILD MATER, V23, P1064, DOI 10.1016/j.conbuildmat.2008.05.010; Parghi A, 2016, COMPOS STRUCT, V160, P901; Paulay T., 1992, SEISMIC DESIGN REINF, V768; Robins P, 2001, CEMENT CONCRETE RES, V31, P719, DOI 10.1016/S0008-8846(01)00465-3; Scott, 2008, OPEN SYSTEM EARTHQUA; Shafei B, 2011, ENG STRUCT, V33, P1107, DOI 10.1016/j.engstruct.2010.12.028; TANG JR, 1992, J STRUCT ENG-ASCE, V118, P341; Vamvatsikos D, 2002, EARTHQUAKE ENG STRUC, V31, P491, DOI 10.1002/eqe.141; Wang WW, 2013, ADV STRUCT ENG, V16, P1113, DOI 10.1260/1369-4332.16.6.1113; Yoo DY, 2015, CEMENT CONCRETE COMP, V64, P84, DOI 10.1016/j.cemconcomp.2015.10.001; Zhang YY, 2013, ENG STRUCT, V48, P255, DOI 10.1016/j.engstruct.2012.09.040; Zhang YY, 2016, ADV STRUCT ENG, V19, P837, DOI 10.1177/1369433216630440	27	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200072	10.1371/journal.pone.0200072	http://dx.doi.org/10.1371/journal.pone.0200072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990364	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300028
J	Bohme, F; Bischoff, G; Zebitz, CPW; Rosenkranz, P; Wallner, K				Boehme, Franziska; Bischoff, Gabriela; Zebitz, Claus P. W.; Rosenkranz, Peter; Wallner, Klaus			Pesticide residue survey of pollen loads collected by honeybees (Apis mellifera) in daily intervals at three agricultural sites in South Germany	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; HYMENOPTERA APIDAE; PYRETHROID INSECTICIDE; CONTAMINATED POLLEN; CHRONIC EXPOSURE; COATED SEEDS; BEE; TOXICITY; FIELD; SYNERGISM	In agricultural landscapes honeybees and other pollinators are exposed to pesticides, often surveyed by residue analysis of bee bread. However, bee bread is a mixture of pollen pellets of different plants collected over a longer time period. Therefore, pesticide content in the hive varies with plant species and time of pollen collection. Hence, the analysis of bee bread is an approximate approach to gain information on detailed pesticide exposure during the agronomic active season. As high-resolution data is missing, we carried out a pesticide residue survey over five years (2012-2016) of daily collected pollen pellets at three agricultural distinct sites in southern Germany. 281 single day pollen samples were selected and subjected to a multi-pesticide residue analysis. Pesticide contaminations of pollen differed between the sites. Intensive pesticide exposure can be seen by high pesticide concentrations as well as a high amount of different pesticides detected. During the five years of observation 73 different pesticides were found, of which 84% are characterized as non-harmful to honeybees. To estimate pesticide risks for honeybees, the pollen hazard quotient (PHQ) was calculated. Even though pesticides were detected in sublethal concentrations, we found substances not supposed to be exposed to honey bees, indicating the necessity for further improvement of seed treatments and increasing awareness of flowering shrubs, field margins and pesticide drift. Additionally, an in-depth analysis of nine pollen samples, divided into sub-fractions dominated by single plant species, revealed even higher concentrations in single crops for some pesticides. We give precise residue data of 1,657 single pesticide detections, which should be used for realistic laboratory and field tests.	[Boehme, Franziska; Rosenkranz, Peter; Wallner, Klaus] Univ Hohenheim, Apicultural State Inst, Stuttgart, Germany; [Bischoff, Gabriela] Julius Kuhn Inst, Inst Bee Protect, Berlin, Germany; [Zebitz, Claus P. W.] Univ Hohenheim, Inst Phytomed, Appl Entomol, Stuttgart, Germany	University Hohenheim; Julius Kuhn-Institut; University Hohenheim	Bohme, F (corresponding author), Univ Hohenheim, Apicultural State Inst, Stuttgart, Germany.	franziska.boehme@uni-hohenheim.de	Zebitz, Claus/ABW-3991-2022		organization "Gesellschaft der Freunde der Landesanstalt fur Bienenkunde an der Universitat Hohenheim e.V."	organization "Gesellschaft der Freunde der Landesanstalt fur Bienenkunde an der Universitat Hohenheim e.V."	The project was partially funded by the organization "Gesellschaft der Freunde der Landesanstalt fur Bienenkunde an der Universitat Hohenheim e.V." and the general budget of the Apicultural State Institute, Stuttgart, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktar M.S., 2009, INTERDISCIPLINARY TO, V2, P1; Alkassab AT, 2017, J PLANT DIS PROTECT, V124, P1, DOI 10.1007/s41348-016-0041-0; Anastassiades M, 2003, J AOAC INT, V86, P412; Andrione M, 2016, SCI REP-UK, V6, DOI 10.1038/srep38110; [Anonymous], 2017, PPDB PEST PROP DATAB; Aupinel P, 2007, PEST MANAG SCI, V63, P1090, DOI 10.1002/ps.1446; Bartomeus I, 2014, PEERJ, V2, DOI 10.7717/peerj.328; Bohme F, 2018, APIDOLOGIE, V49, P112, DOI 10.1007/s13592-017-0533-3; Bohme F, 2017, APIDOLOGIE, V48, P353, DOI 10.1007/s13592-016-0479-x; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Botias C, 2016, SCI TOTAL ENVIRON, V566, P269, DOI 10.1016/j.scitotenv.2016.05.065; Botias C, 2015, ENVIRON SCI TECHNOL, V49, P12731, DOI 10.1021/acs.est.5b03459; Brandt A, 2016, J INSECT PHYSIOL, V86, P40, DOI 10.1016/j.jinsphys.2016.01.001; Chaimanee V, 2016, J INSECT PHYSIOL, V89, P1, DOI 10.1016/j.jinsphys.2016.03.004; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; COLIN ME, 1992, PESTIC SCI, V36, P115, DOI 10.1002/ps.2780360206; Cooper J, 2007, CROP PROT, V26, P1337, DOI 10.1016/j.cropro.2007.03.022; Czoppelt C., 1991, Apidologie, V22, P457; Dahlgren L, 2012, J ECON ENTOMOL, V105, P1895, DOI 10.1603/EC12175; Dai PL, 2010, ENVIRON TOXICOL CHEM, V29, P644, DOI 10.1002/etc.67; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2013, NATURE, V497, P188, DOI 10.1038/497188a; DERUIJTER A, 1987, APIDOLOGIE, V18, P356; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; European Commission, 2017, EU PEST DAT; Federal Office of Consumer Protection and Food Safety, 2017, ONL DAT BAS PLANT PR; Federal Office of Consumer Protection and Food Safety, 2017, AUTH PROC PLANT PROT; Forfert N, 2017, J APICULT RES, V56, P467, DOI 10.1080/00218839.2017.1332542; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Geoghegan T., 2013, PREDICTING HONEYBEE, P174; Ghosh S, 2017, J ASIA-PAC ENTOMOL, V20, P245, DOI 10.1016/j.aspen.2017.01.009; Gill RJ, 2014, FUNCT ECOL, V28, P1459, DOI 10.1111/1365-2435.12292; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Godfray HCJ, 2014, J AGR SCI-CAMBRIDGE, V152, pS2, DOI 10.1017/S0021859613000774; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Orantes-Bermejo FJ, 2010, J APICULT RES, V49, P243, DOI 10.3896/IBRA.1.49.3.03; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Koch H, 1997, APIDOLOGIE, V28, P439, DOI 10.1051/apido:19970610; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Lautenbach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035954; McArt SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46554; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; NPIC. Nacional Pesticide Information Center, 2017, PIC TECHN FACT SHEET; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; PILLING ED, 1995, PESTIC BIOCHEM PHYS, V51, P1, DOI 10.1006/pest.1995.1001; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Pistorius J., 2010, JULIUS KUHN ARCH, V423, P118; Porrini C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155411; Reetz JE, 2011, APIDOLOGIE, V42, P596, DOI 10.1007/s13592-011-0049-1; Rolke D, 2016, ECOTOXICOLOGY, V25, P1691, DOI 10.1007/s10646-016-1723-x; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Roschanski N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100956; Rosenkranz P, 2014, DTSCH BIENENMONITORI; Rundlof M, 2015, NATURE, V521, P77, DOI 10.1038/nature14420; Samson-Robert O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108443; Sanchez-Bayo F, 2016, ENVIRON INT, V89-90, P7, DOI 10.1016/j.envint.2016.01.009; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Schaafsma A, 2016, ENVIRON TOXICOL CHEM, V35, P295, DOI 10.1002/etc.3231; Schnier Heinz Friedrich, 2003, Bulletin of Insectology, V56, P73; Skerl MIS, 2009, B ENVIRON CONTAM TOX, V83, P374, DOI 10.1007/s00128-009-9762-0; Smagghe G, 2013, PEST MANAG SCI, V69, P787, DOI 10.1002/ps.3504; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; Straub L, 2015, CURR OPIN INSECT SCI, V12, P109, DOI 10.1016/j.cois.2015.10.010; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tasei JN, 2001, APIDOLOGIE, V32, P527, DOI 10.1051/apido:2001102; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Tosi S, 2018, SCI TOTAL ENVIRON, V615, P208, DOI 10.1016/j.scitotenv.2017.09.226; Tosi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01361-8; Traynor KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33207; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Urlacher E, 2016, J CHEM ECOL, V42, P127, DOI 10.1007/s10886-016-0672-4; US EPA, 2017, US ENV PROT AG EC DA; US EPA, 2005, NEW PEST FACT SHEET; Williamson SM, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00013; Wu JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016521; Wu MC, 2017, INSECT BIOCHEM MOLEC, V88, P12, DOI 10.1016/j.ibmb.2017.06.016; Wu-Smart J, 2016, SCI REP-UK, V6, DOI 10.1038/srep32108; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	86	54	56	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199995	10.1371/journal.pone.0199995	http://dx.doi.org/10.1371/journal.pone.0199995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979756	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500049
J	Esparza, TJ; Gangolli, M; Cairns, NJ; Brody, DL				Esparza, Thomas J.; Gangolli, Mihika; Cairns, Nigel J.; Brody, David L.			Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls	PLOS ONE			English	Article							SYNAPSE LOSS; IMPAIRMENT; OLIGOMERS; BRAIN	An unanswered question regarding Alzheimer disease dementia (ADD) is whether amyloid-beta (A beta) plaques sequester toxic soluble A beta species early during pathological progression. We previously reported that the concentration of soluble A beta aggregates from patients with mild dementia was higher than soluble A beta aggregates from patients with modest A beta plaque burden but no dementia. The ratio of soluble A beta aggregate concentration to A beta plaque area fully distinguished these groups of patients. We hypothesized that initially plaques may serve as a reservoir or sink for toxic soluble A beta aggregates, sequestering them from other targets in the extracellular space and thereby preventing their toxicity. To initially test a generalized version of this hypothesis, we have performed binding assessments using biotinylated synthetic A beta(1-42) peptide. A beta(1-42)-biotin peptide was incubated on unfixed frozen sections from non-demented high plaque pathology controls and patients with ADD. The bound peptide was measured using ELISA and confocal microscopy. We observed no quantitative difference in A beta binding between the groups using either method. Further testing of the buffering hypothesis using various forms of synthetic and human derived soluble A beta aggregates will be required to definitively address the role of plaque buffering as it relates to ADD.	[Esparza, Thomas J.; Cairns, Nigel J.; Brody, David L.] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Gangolli, Mihika; Brody, David L.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Cairns, Nigel J.] Washington Univ, Knight Alzheimer Dis Res Ctr, St Louis, MO USA; [Cairns, Nigel J.; Brody, David L.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Esparza, TJ (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63130 USA.	esparzat@neuro.wustl.edu	Cairns, Nigel/AAB-9713-2020	Cairns, Nigel/0000-0001-9858-3344; Esparza, Thomas/0000-0002-8588-9595	BrightFocus Foundation [A2014270S]; National Institutes of Health [R01 NS065069]; NATIONAL INSTITUTE ON AGING [P01AG003991, P01AG026276, P50AG005681] Funding Source: NIH RePORTER	BrightFocus Foundation(BrightFocus Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the BrightFocus Foundation A2014270S (DLB) and the National Institutes of Health R01 NS065069 (DLB). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody DL, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0293-3; Buckles VD, 2003, NEUROLOGY, V61, P1662, DOI 10.1212/01.WNL.0000098933.34804.FC; Day GS, 2017, ALZ DIS ASSOC DIS, V31, P87, DOI 10.1097/WAD.0000000000000196; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Esparza TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38187; Esparza TJ, 2013, ANN NEUROL, V73, P104, DOI 10.1002/ana.23748; Guo JP, 2010, J ALZHEIMERS DIS, V19, P1359, DOI 10.3233/JAD-2010-1331; Gureviciene I, 2017, J ALZHEIMERS DIS, V55, P147, DOI 10.3233/JAD-160453; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Koffie RM, 2012, BRAIN, V135, P2155, DOI 10.1093/brain/aws127; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Mawuenyega KG, 2013, ANAL BIOCHEM, V440, P56, DOI 10.1016/j.ab.2013.04.031; Noguchi A, 2009, J BIOL CHEM, V284, P32895, DOI 10.1074/jbc.M109.000208; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tseng BP, 1999, BIOCHEMISTRY-US, V38, P10424, DOI 10.1021/bi990718v; Wildburger NC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10422-x	20	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200251	10.1371/journal.pone.0200251	http://dx.doi.org/10.1371/journal.pone.0200251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979775	Green Submitted, gold, Green Published			2022-12-26	WOS:000437809500084
J	Hu, WH; Wang, HY; Kong, XP; Xiong, QP; Poon, KKM; Xu, L; Duan, R; Chan, GKL; Dong, TTX; Tsim, KWK				Hu, Wei-Hui; Wang, Huai-You; Kong, Xiang-Peng; Xiong, Qing-Ping; Poon, Karman Ka-Man; Xu, Li; Duan, Ran; Chan, Gallant Kar-Lun; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung			Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling	FASEB JOURNAL			English	Article						herbal medicine; vasculogenesis; VEGFR2	ENDOTHELIAL-CELL SURVIVAL; POLYGONUM-CUSPIDATUM; TUMOR ANGIOGENESIS; METASTASIS; EXPRESSION; BEVACIZUMAB; SUNITINIB; DISCOVERY; STRESS; HEALTH	Polydatin, also called piceid, is a stilbenoid glucoside of a resveratrol derivative. It derives mainly from the root and rhizome of Polygonum cuspidatum Sieb. et Zucc. Although the role of P. cuspidatum root in angiogenesis has been reported, the active chemical or chemicals responsible for such function is not known. Here, polydatin was proposed to bind VEGF, which therefore altered the functions of VEGF in angiogenesis. Several lines of evidence supported the pharmaceutical effects of polydatin in VEGF-induced angiogenesis. In human umbilical vein endothelial cells, polydatin inhibited VEGF-stimulated cell proliferation, cell migration, and tube formation. Moreover, polydatin showed suppressive effects on the subintestinal vessel formation in zebrafish embryos. In signaling cascades, polydatin application attenuated VEGF-induced phosphorylations of VEGF receptor 2 and JNK. Moreover, the VEGF-induced phosphorylations of Akt, eNOS, and Erk were significantly decreased in the presence of polydatin. In parallel, the formation of reactive oxygen species, triggered by VEGF, was markedly decreased under polydatin application. Thus, our results supported the angiogenic roles of polydatin, as well as its signaling mechanism in blocking VEGF-mediated responses. The current study provides support for the possible development of polydatin as a potential therapeutic agent for treatment and prevention of angiogenesis-related diseases.Hu, W.-H., Wang, H.-Y., Kong, X.-P., Xiong, Q.-P., Poon, K. K.-M., Xu, L., Duan, R., Chan, G. K.-L., Dong, T. T.-X., Tsim, K. W.-K. Polydatin suppresses VEGF-induced angiogenesis through binding with VEGF and inhibiting its receptor signaling.	[Hu, Wei-Hui; Wang, Huai-You; Kong, Xiang-Peng; Xu, Li; Duan, Ran; Chan, Gallant Kar-Lun; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung] HKUST, Shenzhen Res Inst, Shenzhen Key Lab Edible & Med Bioresources, Shenzhen, Peoples R China; [Hu, Wei-Hui; Xiong, Qing-Ping; Poon, Karman Ka-Man; Xu, Li; Duan, Ran; Chan, Gallant Kar-Lun; Dong, Tina Ting-Xia; Tsim, Karl Wah-Keung] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Div Life Sci, Ctr Chinese Med, Hong Kong, Peoples R China; [Xiong, Qing-Ping] Huaiyin Inst Technol, Jiangsu Key Lab Reg Resource Exploitat & Med Res, Lianyungang, Jiangsu, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Huaiyin Institute of Technology	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Ctr Chinese Med, Clear Water Bay Rd, Hong Kong, Peoples R China.	botsim@ust.hk		Wang, Huai-You/0000-0003-1407-9912	Hong Kong Research Grants Council Theme-Based Research Scheme [T13-607/12R]; Innovation Technology Fund [UIM/288, UIM/302, UIT/137, ITS/022/16FP]; Shenzhen Science and Technology Committee Research Grants [CKFW2,016,082,916,015,476, JCYJ20,170,413,173,747,440, ZDSYS201,707,281,432,317, JCYJ20,160,229,205,726,699, JCYJ20,160,229,205,812,004, JCYJ20,160,229,210,027,564, 20,170,326];  [TUYF15SC01]	Hong Kong Research Grants Council Theme-Based Research Scheme(Hong Kong Research Grants Council); Innovation Technology Fund; Shenzhen Science and Technology Committee Research Grants; 	The authors thank Z. Wen and S. Zhao (Hong Kong University of Science and Technology) for their assistance in the zebrafish assay. This study was supported by Hong Kong Research Grants Council Theme-Based Research Scheme (T13-607/12R), Innovation Technology Fund (UIM/288, UIM/302, UIT/137, ITS/022/16FP), TUYF15SC01, Shenzhen Science and Technology Committee Research Grants (CKFW2,016,082,916,015,476, JCYJ20,170,413,173,747,440, ZDSYS201,707,281,432,317, JCYJ20,160,229,205,726,699, JCYJ20,160,229,205,812,004, JCYJ20,160,229,210,027,564 and 20,170,326). The authors declare no conflicts of interest.	Ashton AW, 1999, J BIOL CHEM, V274, P35562, DOI 10.1074/jbc.274.50.35562; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chan GKL, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/1502457; Chen LY, 2013, FOOD CHEM TOXICOL, V52, P28, DOI 10.1016/j.fct.2012.10.037; Cheng YF, 2006, BRAIN RES, V1110, P193, DOI 10.1016/j.brainres.2006.06.065; Cho H, 2013, BRIT J OPHTHALMOL, V97, P1032, DOI 10.1136/bjophthalmol-2013-303344; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Ferrara N, 1996, EUR J CANCER, V32A, P2413, DOI 10.1016/S0959-8049(96)00387-5; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Gao JAP, 2010, FITOTERAPIA, V81, P953, DOI 10.1016/j.fitote.2010.06.023; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Goodman VL, 2007, CLIN CANCER RES, V13, P1367, DOI 10.1158/1078-0432.CCR-06-2328; Gotink KJ, 2011, CLIN CANCER RES, V17, P7337, DOI 10.1158/1078-0432.CCR-11-1667; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Han JH, 2012, IMMUNOPHARM IMMUNOT, V34, P191, DOI 10.3109/08923973.2011.590499; He YD, 2012, BRIT J DERMATOL, V167, P941, DOI 10.1111/j.1365-2133.2012.10951.x; Hu WH, 2018, PHYTOMEDICINE, V42, P135, DOI 10.1016/j.phymed.2018.03.029; Huang M, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0665-9; Huang ZS, 1999, WORLD J GASTROENTERO, V5, P41; Jordan KC, 2008, NUTR RES, V28, P13, DOI 10.1016/j.nutres.2007.11.005; Kang-Decker N, 2007, J CELL SCI, V120, P492, DOI 10.1242/jcs.03361; Liu HH, 2011, J CELL BIOCHEM, V112, P3695, DOI 10.1002/jcb.23303; Lou JS, 2017, ONCOTARGET, V8, P93131, DOI 10.18632/oncotarget.21862; MACCHIARINI P, 1992, LANCET, V340, P145, DOI 10.1016/0140-6736(92)93217-B; Maragoudakis ME, 2000, GEN PHARMACOL-VASC S, V35, P225, DOI 10.1016/S0306-3623(01)00111-2; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Pandir D, 2014, CYTOTECHNOLOGY, V66, P677, DOI 10.1007/s10616-013-9621-z; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Shan B, 2008, FOOD CHEM, V109, P530, DOI 10.1016/j.foodchem.2007.12.064; Stewart MW, 2014, EXPERT REV CLIN PHAR, V7, P167, DOI 10.1586/17512433.2014.884458; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; WEIDNER N, 1993, AM J PATHOL, V143, P401; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Xing WW, 2009, BIOMED PHARMACOTHER, V63, P457, DOI 10.1016/j.biopha.2008.06.035; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	43	22	24	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					532	544		10.1096/fj.201800750R	http://dx.doi.org/10.1096/fj.201800750R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29989844				2022-12-26	WOS:000457401500042
J	Lenting, K; Khurshed, M; Peeters, TH; van den Heuvel, CNAM; van Lith, SAM; de Bitter, T; Hendriks, W; Span, PN; Molenaar, RJ; Botman, D; Verrijp, K; Heerschap, A; ter Laan, M; Kusters, B; van Ewijk, A; Huynen, MA; van Noorden, CJF; Leenders, WPJ				Lenting, Krissie; Khurshed, Mohammed; Peeters, Tom H.; van den Heuvel, Corina N. A. M.; van Lith, Sanne A. M.; de Bitter, Tessa; Hendriks, Wiljan; Span, Paul N.; Molenaar, Remco J.; Botman, Dennis; Verrijp, Kiek; Heerschap, Arend; ter Laan, Mark; Kusters, Benno; van Ewijk, Anne; Huynen, Martijn A.; van Noorden, Cornelis J. F.; Leenders, William P. J.			Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress	FASEB JOURNAL			English	Article						metabolism; anaplerosis; glycolysis; neurotransmitters; diffuse infiltration	T-2 RELAXATION; ONCOMETABOLITE 2-HYDROXYGLUTARATE; EXPRESSION ANALYSIS; MOUSE-BRAIN; RAT-BRAIN; IDH1; MUTATION; GROWTH; CELLS; INHIBITOR	Diffuse gliomas often carry point mutations in isocitrate dehydrogenase (IDH1(mut)), resulting in metabolic stress. Although IDHmut gliomas are difficult to culture in vitro, they thrive in the brain via diffuse infiltration, suggesting brain-specific tumor-stroma interactions that can compensate for IDH-1 deficits. To elucidate the metabolic adjustments in clinical IDHmut gliomas that contribute to their malignancy, we applied a recently developed method of targeted quantitative RNA next-generation sequencing to 66 clinical gliomas and relevant orthotopic glioma xenografts, with and without the endogenous IDH-1(R132H) mutation. Datasets were analyzed in R using Manhattan plots to calculate distance between expression profiles, Ward's method to perform unsupervised agglomerative clustering, and the Mann Whitney U test and Fisher's exact tests for supervised group analyses. The significance of transcriptome data was investigated by protein analysis, in situ enzymatic activity mapping, and in vivo magnetic resonance spectroscopy of orthotopic IDH1(mut)- and IDHwt-glioma xenografts. Gene set enrichment analyses of clinical IDH1(mut) gliomas strongly suggest a role for catabolism of lactate and the neurotransmitter glutamate, whereas, in IDHwt gliomas, processing of glucose and glutamine are the predominant metabolic pathways. Further evidence of the differential metabolic activity in these cancers comes from in situ enzymatic mapping studies and preclinical in vivo magnetic resonance spectroscopy imaging. Our data support an evolutionary model in which IDHmut glioma cells exist in symbiosis with supportive neuronal cells and astrocytes as suppliers of glutamate and lactate, possibly explaining the diffuse nature of these cancers. The dependency on glutamate and lactate opens the way for novel approaches in the treatment of IDHmut gliomas.Lenting, K., Khurshed, M., Peeters, T. H., van den Heuvel, C. N. A. M., van Lith, S. A. M., de Bitter, T., Hendriks, W., Span, P. N., Molenaar, R. J., Botman, D., Verrijp, K., Heerschap, A., ter Laan, M., Kusters, B., van Ewijk, A., Huynen, M. A., van Noorden, C. J. F., Leenders, W. P. J. Isocitrate dehydrogenase 1-mutated human gliomas depend on lactate and glutamate to alleviate metabolic stress.	[Lenting, Krissie; van den Heuvel, Corina N. A. M.; van Ewijk, Anne; Leenders, William P. J.] Radboud Inst Mol Life Sci, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Hendriks, Wiljan] Radboud Inst Mol Life Sci, Dept Cell Biol, Nijmegen, Netherlands; [Huynen, Martijn A.; van Noorden, Cornelis J. F.] Radboud Inst Mol Life Sci, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Lenting, Krissie; van den Heuvel, Corina N. A. M.; van Lith, Sanne A. M.; de Bitter, Tessa; Verrijp, Kiek; Kusters, Benno; Leenders, William P. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, Nijmegen, Netherlands; [Peeters, Tom H.; Heerschap, Arend] Radboud Univ Nijmegen, Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Radiotherapy & Oncoimmunol Lab, Dept Radiat Oncol, Nijmegen, Netherlands; [ter Laan, Mark] Radboud Univ Nijmegen, Med Ctr, Dept Neurosurg, Nijmegen, Netherlands; [Khurshed, Mohammed; Molenaar, Remco J.; Botman, Dennis; van Noorden, Cornelis J. F.] Acad Med Ctr, Canc Ctr Amsterdam, Dept Med Biol, Amsterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Leenders, WPJ (corresponding author), Radboud Inst Mol Life Sci, Dept Biochem, POB 9101, NL-6500 HB Nijmegen, Netherlands.	william.leenders@radboudumc.nl	Huynen, Martijn A/A-1530-2014; Lenting, Krissie/M-9665-2015; Leenders, William/O-2541-2019; Laan, Mark ter/L-4466-2015; Peeters, Tom/Q-4922-2019; van Lith, Sanne AM/D-9732-2016; verrijp, kiek/F-4783-2018; Span, Paul/G-4710-2012; Hendriks, Wiljan J.A.J./A-5214-2013	Huynen, Martijn A/0000-0001-6189-5491; Lenting, Krissie/0000-0002-7166-2621; Leenders, William/0000-0003-0066-220X; Laan, Mark ter/0000-0002-9213-430X; Peeters, Tom/0000-0001-6244-6938; Span, Paul/0000-0002-1930-6638; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; van Lith, Sanne/0000-0001-8584-2546	Dutch Cancer Society [UvA 2014-6839]; Stichting StopHersentumoren; Eurostars; Academic Medical Center (AMC) Ph.D. scholarship; Europees Fonds voor Regionale Ontwikkeling/GO (European Fund for Regional Development (EFRO/GO) Project Ultrasense NMR	Dutch Cancer Society(KWF Kankerbestrijding); Stichting StopHersentumoren; Eurostars; Academic Medical Center (AMC) Ph.D. scholarship; Europees Fonds voor Regionale Ontwikkeling/GO (European Fund for Regional Development (EFRO/GO) Project Ultrasense NMR	The authors thank Dr. Alex Hoischen for helpful discussions and Carlijn van de Water (both from Radboud University Medical Center) for help with the smMIP design. This work was supported by Dutch Cancer Society Grant UvA 2014-6839 (to K.L. and M.K.), Stichting StopHersentumoren (to C.N.A.M.V.D.H.), and Eurostars (to C.N.A.M.V.D.H. and W.P.J.L.); an Academic Medical Center (AMC) Ph.D. scholarship (to R.J.M.) and Europees Fonds voor Regionale Ontwikkeling/GO (European Fund for Regional Development (EFRO/GO) Project Ultrasense NMR (to T.H.P.). The authors declare no conflicts of interest.	Baldock AL, 2014, NEURO-ONCOLOGY, V16, P779, DOI 10.1093/neuonc/nou027; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bleeker FE, 2010, ACTA NEUROPATHOL, V119, P487, DOI 10.1007/s00401-010-0645-6; Botman D, 2014, J HISTOCHEM CYTOCHEM, V62, P802, DOI 10.1369/0022155414549071; Botman D, 2014, J HISTOCHEM CYTOCHEM, V62, P813, DOI 10.1369/0022155414551177; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Caretti V, 2011, BRAIN PATHOL, V21, P441, DOI 10.1111/j.1750-3639.2010.00468.x; Chen RH, 2014, P NATL ACAD SCI USA, V111, P14217, DOI 10.1073/pnas.1409653111; Chieco P, 2013, PROG HISTOCHEM CYTO, V47, P211, DOI 10.1016/j.proghi.2012.09.001; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Claes A, 2008, BRAIN PATHOL, V18, P423, DOI 10.1111/j.1750-3639.2008.00141.x; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Cuyas E, 2015, ONCOTARGET, V6, P12279, DOI 10.18632/oncotarget.3733; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; de Bitter T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11035-0; de Graaf RA, 2006, MAGN RESON MED, V56, P386, DOI 10.1002/mrm.20946; de Groot JF, 2005, CANCER RES, V65, P1934, DOI 10.1158/0008-5472.CAN-04-3626; Eijkelenboom A, 2016, J MOL DIAGN, V18, P851, DOI 10.1016/j.jmoldx.2016.06.010; Esmaeili M, 2014, CANCER RES, V74, P4898, DOI 10.1158/0008-5472.CAN-14-0008; Fack F, 2017, EMBO MOL MED, V9, P1681, DOI 10.15252/emmm.201707729; Fan J, 2013, J BIOL CHEM, V288, P31363, DOI 10.1074/jbc.M113.502740; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Flaherty A. L., 2014, J CLIN ONCOL S, V32, P213; Guilfoyle DN, 2003, MAGNET RESON MED, V49, P576, DOI 10.1002/mrm.10371; Hamans B, 2013, NEURO-ONCOLOGY, V15, P1615, DOI 10.1093/neuonc/not129; Jalbert LE, 2017, SCI REP-UK, V7, DOI 10.1038/srep44792; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Khurshed M, 2017, ONCOTARGET, V8, P49165, DOI 10.18632/oncotarget.17106; Lenting K, 2017, ACTA NEUROPATHOL, V133, P263, DOI 10.1007/s00401-017-1671-4; Lerchundi R, 2015, P NATL ACAD SCI USA, V112, P11090, DOI 10.1073/pnas.1508259112; Li SC, 2013, NEURO-ONCOLOGY, V15, P57, DOI 10.1093/neuonc/nos261; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Malzkorn B, 2011, BRAIN PATHOL, V21, P619, DOI 10.1111/j.1750-3639.2011.00536.x; Massucci FA, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-103; Mazor T, 2017, P NATL ACAD SCI USA, V114, P10743, DOI 10.1073/pnas.1708914114; Min JL, 2007, EUR J HUM GENET, V15, P791, DOI 10.1038/sj.ejhg.5201829; Molenaar RJ, 2018, ONCOGENE, V37, P1949, DOI 10.1038/s41388-017-0077-z; Molenaar RJ, 2015, CANCER RES, V75, P4790, DOI 10.1158/0008-5472.CAN-14-3603; Molenaar RJ, 2014, BBA-REV CANCER, V1846, P326, DOI 10.1016/j.bbcan.2014.05.004; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Navis AC, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-18; Navis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058262; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Philips T, 2017, J CLIN INVEST, V127, P3277, DOI 10.1172/JCI90610; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rossetto M, 2011, REV NEUROL-FRANCE, V167, P699, DOI 10.1016/j.neurol.2011.08.002; Schwarcz A, 2001, MAGN RESON MED, V46, P1246, DOI 10.1002/mrm.1324; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shi JL, 2015, TUMOR BIOL, V36, P655, DOI 10.1007/s13277-014-2644-z; Sottoriva A, 2013, P NATL ACAD SCI USA, V110, P4009, DOI 10.1073/pnas.1219747110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tonjes M, 2013, NAT MED, V19, P901, DOI 10.1038/nm.3217; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; van Lith SAM, 2014, BBA-REV CANCER, V1846, P66, DOI 10.1016/j.bbcan.2014.04.004; Xin L, 2008, NMR BIOMED, V21, P396, DOI 10.1002/nbm.1205; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	62	24	24	1	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					557	571		10.1096/fj.201800907RR	http://dx.doi.org/10.1096/fj.201800907RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30001166				2022-12-26	WOS:000457401500044
J	Kaverina, NV; Kadagidze, ZG; Borovjagin, AV; Karseladze, AI; Kim, CK; Lesniak, MS; Miska, J; Zhang, P; Baryshnikova, MA; Xiao, T; Ornelles, D; Cobbs, C; Khramtsov, A; Ulasov, IV				Kaverina, Natalya, V; Kadagidze, Zaira G.; Borovjagin, Anton, V; Karseladze, Apollon, I; Kim, Chung Kwon; Lesniak, Maciej S.; Miska, Jason; Zhang, Peng; Baryshnikova, Maria A.; Xiao, Ting; Ornelles, David; Cobbs, Charles; Khramtsov, Andrey; Ulasov, Ilya, V			Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX	ONCOGENE			English	Article							NORMAL HUMAN FIBROBLASTS; MALIGNANT GLIOMA; BECLIN 1; SECRETORY PHENOTYPE; PROTEIN EXPRESSION; HUMAN GLIOBLASTOMA; APOPTOSIS; SENESCENCE; DEATH; P53	Autophagy is an evolutionarily conserved process regulating cellular homeostasis via digestion of dysfunctional proteins and whole cellular organelles by mechanisms, involving their enclosure into double-membrane vacuoles that are subsequently fused to lysosomes. Glioma stem cells utilize autophagy as a main mechanism of cell survival and stress response. Most recently, we and others demonstrated induction of autophagy in gliomas in response to treatment with chemical drugs, such as temozolomide (TMZ) or oncolytic adenoviruses (Ads). As autophagy has been implicated in the mechanism of Ad-mediated cell killing, autophagy deficiency in some glioma tumors could be the reason for their resistance to oncolysis. Despite the observed connection, the exact relationship between autophagy-activating cell signaling and adenoviral infection remains unclear. Here, we report that inhibition of autophagy in target glioma cells induces their resistance to killing by oncolytic agent CRAd-S-5/3. Furthermore, we found that downregulation of autophagy inducer Beclin-1 inhibits replication-competent Ad-induced oncolysis of human glioma by suppressing cell proliferation and inducing premature senescence. To overcome the autophagy-deficient state of such glioma cells and restore their susceptibility to oncolytic Ad-infection, we propose treating glioma tumors with an anticancer drug tamoxifen (TAM) as a means to induce apoptosis in Ad-targeted cancer cells via upregulation of BAX/PUMA genes. In agreement with the above hypothesis, our data suggest that TAM improves susceptibility of Beclin-1-deficient glioma cells to CRAd-S-5/3 oncolysis by means of activating autophagy and pro-apoptotic signaling pathways in the target cancer cells.	[Kaverina, Natalya, V; Kadagidze, Zaira G.; Karseladze, Apollon, I] RAMN, NN Blokhin Natl Med Res Ctr Oncol, Kashirskoe Shosse 23, Moscow 115478, Russia; [Kaverina, Natalya, V; Baryshnikova, Maria A.] RAMN, Inst Expt Diagnost & Biotherapy, NN Blokhin Natl Med Res Ctr Oncol, Kashirskoe Shosse 23, Moscow 115478, Russia; [Borovjagin, Anton, V] Univ Alabama Birmingham, Inst Oral Hlth Res, Birmingham Sch Dent, Birmingham, AL 35205 USA; [Kim, Chung Kwon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst Suwon, Suwon 440746, South Korea; [Lesniak, Maciej S.; Miska, Jason; Zhang, Peng; Xiao, Ting; Ulasov, Ilya, V] Northwestern Univ, Northwestern Brain Tumor Inst, Chicago, IL 60611 USA; [Ornelles, David] Wake Forest Sch Med, Dept Microbiol & Immunol, Salem, NC 27101 USA; [Cobbs, Charles] Swedish Neurosci Inst, Seattle, WA 98104 USA; [Khramtsov, Andrey] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pathol & Lab Med, Chicago, IL 60611 USA; [Ulasov, Ilya, V] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow 119991, Russia	University of Alabama System; University of Alabama Birmingham; Sungkyunkwan University (SKKU); Northwestern University; Swedish Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Sechenov First Moscow State Medical University	Ulasov, IV (corresponding author), Northwestern Univ, Northwestern Brain Tumor Inst, Chicago, IL 60611 USA.; Ulasov, IV (corresponding author), Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow 119991, Russia.	ulasov75@yahoo.com	Ulasov, Ilya/A-2352-2014; Khramtsov, Andrey I/H-8701-2018	Ulasov, Ilya/0000-0002-0818-0363; Khramtsov, Andrey I/0000-0001-6301-4619	Russian Fund of Fundamental Research (Russia) [11 411.0008700. 13.082, 13 411. 1008799.13.120]	Russian Fund of Fundamental Research (Russia)	This research was supported by Russian Fund of Fundamental Research (number 11 411.0008700. 13.082 and number 13 411. 1008799.13.120 Russia, MAB) and private donors. We are grateful to Dr. Cobbs for providing patient-derived tumor cells and to Dr. Cobbs's laboratory personnel for their support and technical assistance with experiments.	Abbadie C, 2017, CELL MOL LIFE SCI, V74, P4471, DOI 10.1007/s00018-017-2587-9; Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Chen QM, 2000, BIOCHEM J, V347, P543, DOI 10.1042/0264-6021:3470543; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Criollo A, 2009, CELL CYCLE, V8, P2319, DOI 10.4161/cc.8.15.9153; Culmsee C, 2003, J NEUROSCI, V23, P8586; Fernandez-Cuesta L, 2011, INT J CANCER, V128, P1813, DOI 10.1002/ijc.25512; Fimia GM, 2011, AUTOPHAGY, V7, P115, DOI 10.4161/auto.7.1.14071; Gao W, 2011, CELL DEATH DIFFER, V18, P1598, DOI 10.1038/cdd.2011.33; Giatromanolaki A, 2014, CANCER BIOL THER, V15, P1468, DOI 10.4161/15384047.2014.955719; GRAHAM FL, 1987, J GEN VIROL, V68, P937, DOI 10.1099/0022-1317-68-3-937; Hothi P, 2012, ONCOTARGET, V3, P1124; Huang X, 2010, J CLIN NEUROSCI, V17, P1515, DOI 10.1016/j.jocn.2010.03.051; Ito H, 2005, INT J ONCOL, V26, P1401; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Jiang H, 2009, CURR GENE THER, V9, P422, DOI 10.2174/156652309789753356; Joshi A, 2016, CELL DEATH DIFFER, V23, P216, DOI 10.1038/cdd.2015.88; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023367; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kumar M, 2014, AM J RESP CELL MOL, V51, P323, DOI 10.1165/rcmb.2013-0382PS; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Lefranc F, 2009, ADV TECH STAND NEURO, V34, P3, DOI 10.1007/978-3-211-78741-0_1; Lefranc Florence, 2006, Neurosurg Focus, V20, pE7, DOI 10.3171/foc.2006.20.4.4; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059750; Maciel-Baron LA, 2016, AGE, V38, DOI 10.1007/s11357-016-9886-1; Mirochnik Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031052; Pei L, 2014, J NEUROSCI, V34, P6546, DOI 10.1523/JNEUROSCI.5119-13.2014; Pirtoli L, 2009, AUTOPHAGY, V5, P930, DOI 10.4161/auto.5.7.9227; Piya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029467; Ro SH, 2013, AUTOPHAGY, V9, P2103, DOI 10.4161/auto.26563; Salminen A, 2013, AGEING RES REV, V12, P520, DOI 10.1016/j.arr.2012.11.004; Sasaki T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004409; Schilbach K, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1014760; Shukla S, 2014, J BIOL CHEM, V289, P22306, DOI 10.1074/jbc.M114.567032; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Tepper CG, 2000, EXP CELL RES, V260, P9, DOI 10.1006/excr.2000.4990; Thomas MA, 2009, J VIROL, V83, P2406, DOI 10.1128/JVI.01972-08; Tripathi R, 2014, J CELL MOL MED, V18, P2275, DOI 10.1111/jcmm.12386; Tyler MA, 2009, AUTOPHAGY, V5, P856, DOI 10.4161/auto.8792; Ulasov IV, 2009, BRIT J CANCER, V100, P1154, DOI 10.1038/sj.bjc.6604969; Ulasov IV, 2015, ONCOTARGET, V6, P3977, DOI 10.18632/oncotarget.2897; Vater CA, 1996, ONCOGENE, V13, P739; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; Yee KS, 2009, CELL DEATH DIFFER, V16, P1135, DOI 10.1038/cdd.2009.28; Zhang M, 2016, EUR REV MED PHARMACO, V20, P3152	49	13	14	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6069	6082		10.1038/s41388-018-0395-9	http://dx.doi.org/10.1038/s41388-018-0395-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29991800				2022-12-26	WOS:000450175900005
J	Kriegel, AJ; Terhune, SS; Greene, AS; Noon, KR; Pereckas, MS; Liang, MY				Kriegel, Alison J.; Terhune, Scott S.; Greene, Andrew S.; Noon, Kathleen R.; Pereckas, Michael S.; Liang, Mingyu			Isomer-specific effect of microRNA miR-29b on nuclear morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microRNA (miRNA); microRNA mechanism; proteomics; mitosis; nuclear organization; ADP; ATP translocase 2; nuclei; ribonucleoprotein	PROTEIN COMPLEX; MESSENGER-RNAS; CELLS; TRANSLATION; FIBROSIS; LEUKEMIA; REVEALS; MIR-382	Targeting mRNAs via seed region pairing is the canonical mechanism by which microRNAs (miRNAs) regulate cellular functions and disease processes. Emerging evidence suggests miRNAs might also act through other mechanisms. miRNA isomers that contain identical seed region sequences, such as miR-29a and miR-29b, provide naturally occurring, informative models for identifying those miRNA effects that are independent of seed region pairing. miR-29a and miR-29b are both expressed in HeLa cells, and miR-29b has been reported to localize to the nucleus in early mitosis because of unique nucleotide sequences on its 3 end. Here, we sought to better understand the mechanism of miR-29b nuclear localization and its function in cell division. We hypothesized that its nuclear localization may be facilitated by protein-miRNA interactions unique to miR-29b. Specific blockade of miR-29b resulted in striking nuclear irregularities not observed following miR-29a blockade. We also observed that miR-29b, but not miR-29a, is enriched in the nucleus and perinuclear clusters during mitosis. Targeted proteomic analysis of affinity-purified samples identified several proteins interacting with synthetic oligonucleotides mimicking miR-29b, but these proteins did not interact with miR-29a. One of these proteins, ADP/ATP translocase 2 (ANT2), known to be involved in mitotic spindle formation, colocalized with miR-29b in perinuclear clusters independently of Argonaute 2. Of note, ANT2 knockdown resulted in nuclear irregularities similar to those observed following miR-29b blockade and prevented nuclear uptake of endogenous miR-29b. Our findings reveal that miR-29 regulates nuclear morphology during mitosis and that this critical function is unique to the miR-29b isoform.	[Kriegel, Alison J.; Greene, Andrew S.; Liang, Mingyu] Med Coll Wisconsin, Dept Physiol, Ctr Syst Mol Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Terhune, Scott S.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Terhune, Scott S.; Greene, Andrew S.; Noon, Kathleen R.; Pereckas, Michael S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Kriegel, AJ; Liang, MY (corresponding author), Med Coll Wisconsin, Dept Physiol, Ctr Syst Mol Med, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	akriegel@mcw.edu; mliang@mcw.edu	Liang, Mingyu/A-2331-2008; Greene, Andrew S/B-9696-2015	Greene, Andrew/0000-0002-3191-2112	National Institutes of Health [HL111580, HL082798, HL121233, HL125409, HL128332]; Biotechnology and Bioengineering Center at Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121233, R01HL128332, R01HL125409, P01HL082798, R21HL111580] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Bioengineering Center at Medical College of Wisconsin; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL111580 (to M. L. and A. J. K.); HL082798, HL121233, and HL125409 (to M. L.); and HL128332 (to A. J. K.) and by a grant from the Biotechnology and Bioengineering Center at Medical College of Wisconsin (to M. L. and A. J. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fukuda R, 2005, P NATL ACAD SCI USA, V102, P15213, DOI 10.1073/pnas.0507184102; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Guo YE, 2014, RNA, V20, P985, DOI 10.1261/rna.045054.114; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hinchcliffe EH, 2014, INT REV CEL MOL BIO, V313, P179, DOI 10.1016/B978-0-12-800177-6.00006-2; Huang J, 1996, CANCER LETT, V106, P29, DOI 10.1016/0304-3835(96)04293-0; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P259, DOI 10.1152/physiolgenomics.00173.2011; Kriegel AJ, 2010, NUCLEIC ACIDS RES, V38, P8338, DOI 10.1093/nar/gkq718; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Liu Y, 2010, HYPERTENSION, V55, P974, DOI 10.1161/HYPERTENSIONAHA.109.144428; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007; PEARSON EC, 1986, J CLIN PATHOL, V39, P99, DOI 10.1136/jcp.39.1.99; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Weber A, 2010, CELL ONCOL, V32, P121, DOI 10.3233/CLO-2009-0509	27	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14080	14088		10.1074/jbc.RA117.001705	http://dx.doi.org/10.1074/jbc.RA117.001705			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006350	Green Published, hybrid			2022-12-26	WOS:000444070700029
J	Elnatan, D; Agard, DA				Elnatan, Daniel; Agard, David A.			Calcium binding to a remote site can replace magnesium as cofactor for mitochondrial Hsp90 (TRAP1) ATPase activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; heat shock protein 90 (Hsp90); mitochondria; calcium-binding protein; ATPase; ATP hydrolysis; magnesium cofactor; TNF receptor-associated protein 1	PERMEABILITY TRANSITION PORE; MOLECULAR CHAPERONE HSP90; IN-VIVO; CYCLE; HYDROLYSIS; PHOSPHORYLATION; RESPIRATION	The Hsp90 molecular chaperones are ATP-dependent enzymes that maintain protein homeostasis and regulate many essential cellular processes. Higher eukaryotes have organelle-specific Hsp90 paralogs that are adapted to each subcellular environment. The mitochondrial Hsp90, TNF receptor-associated protein 1 (TRAP1), supports the folding and activity of electron transport components and is increasingly appreciated as a critical player in mitochondrial signaling. Calcium plays a well-known and important regulatory role in mitochondria where it can accumulate to much higher concentrations than in the cytoplasm. Surprisingly, we found here that calcium can replace magnesium, the essential enzymatic cofactor, to support TRAP1 ATPase activity. Anomalous X-ray diffraction experiments revealed a calcium-binding site within the TRAP1 nucleotide-binding pocket located near the ATP -phosphate and completely distinct from the magnesium-binding site adjacent to the - and -phosphates. In the presence of magnesium, ATP hydrolysis by TRAP1, as with other Hsp90s, was noncooperative, whereas calcium binding resulted in cooperative hydrolysis by the two protomers within the Hsp90 dimer. The structural data suggested a mechanism for this cooperative behavior. Because of the cooperativity, at high ATP concentrations, ATPase activity was higher with calcium, whereas the converse was observed at low ATP concentrations. Integrating these observations, we propose a model in which the divalent cation choice can control switching between noncooperative and cooperative TRAP1 ATPase mechanisms in response to varying ATP concentrations. This switching may facilitate coordination between cellular energetics, mitochondrial signaling, and protein homeostasis via alterations in the TRAP1 ATP-driven cycle and its consequent effects on different mitochondrial clients.	[Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Agard, DA (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu		Elnatan, Daniel/0000-0002-8359-0522	National Institutes of Health Protein Structure Initiative-Biology Grant [U01 GM098254]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM098254, T32GM007810] Funding Source: NIH RePORTER	National Institutes of Health Protein Structure Initiative-Biology Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Protein Structure Initiative-Biology Grant U01 GM098254 and the Howard Hughes Medical Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Butler EK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002488; Chae YC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3139; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Costa AC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.205; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Elnatan D, 2017, ELIFE, V6, DOI 10.7554/eLife.25235; Frey S, 2007, J BIOL CHEM, V282, P35612, DOI 10.1074/jbc.M704647200; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Hearnshaw SJ, 2015, ACTA CRYSTALLOGR D, V71, P996, DOI 10.1107/S1399004715002916; Hirshberg M, 1998, BIOCHEMISTRY-US, V37, P10381, DOI 10.1021/bi980428z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lavery LA, 2014, MOL CELL, V53, P330, DOI 10.1016/j.molcel.2013.12.023; Leskovar A, 2008, J BIOL CHEM, V283, P11677, DOI 10.1074/jbc.M709516200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Partridge JR, 2014, ELIFE, V3, DOI 10.7554/eLife.03487; Rasola A, 2014, TRENDS CELL BIOL, V24, P455, DOI 10.1016/j.tcb.2014.03.005; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Soroka J, 2012, MOL CELL, V45, P517, DOI 10.1016/j.molcel.2011.12.031; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Sung N, 2016, P NATL ACAD SCI USA, V113, P2952, DOI 10.1073/pnas.1516167113; Thorn A, 2011, J APPL CRYSTALLOGR, V44, P1285, DOI [10.1107/S00218898110417681285, 10.1107/S0021889811041768]; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolf SG, 2017, ELIFE, V6, DOI 10.7554/eLife.29929; Xiang F, 2010, FEBS J, V277, P1929, DOI 10.1111/j.1742-4658.2010.07615.x; Yoshida S, 2013, P NATL ACAD SCI USA, V110, pE1604, DOI 10.1073/pnas.1220659110; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	33	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13717	13724		10.1074/jbc.RA118.003562	http://dx.doi.org/10.1074/jbc.RA118.003562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991590	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000443375500030
J	Lin, J; Gu, W; Song, MF; Hou, YY				Lin Jing; Gu Wei; Song Mengfan; Hou Yanyan			Effect of site of placentation on pregnancy outcomes in patients with placenta previa	PLOS ONE			English	Article							CESAREAN-SECTION; MASSIVE HEMORRHAGE; ACCRETA	Introduction We aimed to evaluate the site of placentation on the pregnancy outcomes of patients with placenta previa. Methods This retrospective study included 678 cases of placenta previa. Basic information and pregnancy outcome data were collected. Differences between the different placenta previa positions and pregnancy outcomes were compared using the chi-square and independent t tests. Logistic and multiple regression analyses were used to calculate the odds ratios (ORs) to determine the risk factors for PAS disorders and postpartum hemorrhage and evaluate the effect of placental attachment site on pregnancy outcomes. Results There was no significant difference between the PAS disorders rate and the incidence of complete placenta previa depending on the type of piacentation; however, placental attachment site influenced the pregnancy outcome. Placental attachment to the anterior wall was associated with shorter gestational age, low birth weight, lower Apgar score, higher prenatal bleeding rate, increased postpartum hemorrhage, longer duration of hospitalization, and higher blood transfusion and hysterectomy rates compared to cases with lateral/posterior wall placenta. Placental attachment at the incision site of a previous cesarean section significantly increased the incidence of complete placenta previa and PAS disorders compared with placental attachment at a site without incision, but did not significantly influence pregnancy outcomes. Placental attachment to the anterior wall was an independent risk factor for postpartum hemorrhage in patients with placenta previa. Placental attachment to a previous incision site was an independent risk factor for PAS disorders. Conclusion The site of placental attachment in patients with placenta previa has an important influence on the pregnancy outcome. When the placenta is located on the anterior wall, clinicians should pay attention to the adverse pregnancy outcomes and the possibility of massive postpartum hemorrhage. In cases of placental attachment to the uterine incision site, physicians should be highly vigilant regarding the occurrence of PAS disorders.	[Lin Jing; Gu Wei; Song Mengfan; Hou Yanyan] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Dept Gynecol & Obstet, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Gu, W (corresponding author), Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Dept Gynecol & Obstet, Sch Med, Shanghai, Peoples R China.	krisgu2017@yahoo.com			Project of Science and Technology Commission of Shanghai Municipality of China [15411964200]	Project of Science and Technology Commission of Shanghai Municipality of China	This study was funded by the Project of Science and Technology Commission of Shanghai Municipality of China (grant number 15411964200) to GW. The URL is http://www.stcsm.gov.cn/.	Allen L, 2018, INT J GYNECOL OBSTET, V140, P281, DOI 10.1002/ijgo.12409; Ayaz Aqueela, 2012, Kurume Med J, V59, P1, DOI 10.2739/kurumemedj.59.1; Baba Y, 2014, J OBSTET GYNAECOL RE, V40, P1243, DOI 10.1111/jog.12340; Baumfeld Y, 2017, TAIWAN J OBSTET GYNE, V56, P331, DOI [10.1016/j.tjog.2017.04.012, 10.1016/j.tjog.2017.05.012]; CHATTOPADHYAY SK, 1993, EUR J OBSTET GYN R B, V52, P151, DOI 10.1016/0028-2243(93)90064-J; Committee on Obstetric Practice, 2012, Obstet Gynecol, V120, P207, DOI 10.1097/AOG.0b013e318262e340; Eshkoli T, 2013, AM J OBSTET GYNECOL, V208, P1; Fukushima K, 2012, J OBSTET GYNAECOL RE, V38, P192, DOI 10.1111/j.1447-0756.2011.01669.x; Garmi G, 2011, OBSTET GYNECOL, V117, P55, DOI 10.1097/AOG.0b013e31820094f3; Getahun D, 2006, OBSTET GYNECOL, V107, P771, DOI 10.1097/01.AOG.0000206182.63788.80; Hasegawa J, 2009, ULTRASOUND OBST GYN, V34, P80, DOI 10.1002/uog.6426; Jauniaux E, 2012, PLACENTA, V33, P244, DOI 10.1016/j.placenta.2011.11.010; Kollmann M, 2013, J MATERNAL FETAL MED, V29, P1395; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Liu J, 2014, CHINA MODERN MED; LUKE RK, 1966, AM J OBSTET GYNECOL, V95, P660, DOI 10.1016/S0002-9378(16)34741-X; Main EK, 2015, ANESTH ANALG, V121, P142, DOI 10.1097/AOG.0000000000000869; Matsubara S, 2013, ACTA OBSTET GYN SCAN, V92, P372, DOI 10.1111/aogs.12074; Naji O, 2013, HUM REPROD, V28, P1489, DOI 10.1093/humrep/det110; RCOG, 2011, PLAC PRAEV PLAC ACCR; Richa A, 2012, J OBSTET GYN INDIA, V62, P57, DOI 10.1007/s13224-012-0149-5; Roberge S, 2012, AM J PERINAT, V29, P465, DOI 10.1055/s-0032-1304829; Royal College of Obstetricians and Gynaecologists, 2011, ANT HAEM GREEN TOP G; Sholapurkar SL, 2013, J OBSTET GYNAECOL, V33, P806, DOI 10.3109/01443615.2013.823388; Suknikhom Wineeya, 2011, Journal of the Medical Association of Thailand, V94, P272; Tseng Jenn-Jhy, 2006, Taiwan J Obstet Gynecol, V45, P100; Weiner E, 2016, J PERINATOLOGY OFFIC, V36; Yeniel AO, 2012, ARCH GYNECOL OBSTET, V286, P295, DOI 10.1007/s00404-012-2296-4; Yu L, 2016, Zhonghua Fu Chan Ke Za Zhi, V51, P169, DOI 10.3760/cma.j.issn.0529-567X.2016.03.002	29	16	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200252	10.1371/journal.pone.0200252	http://dx.doi.org/10.1371/journal.pone.0200252			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016336	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600018
J	Chhabra, V; Anand, AS; Baidya, AK; Malik, SM; Kohli, E; Reddy, MPK				Chhabra, Varun; Anand, Avnika Singh; Baidya, Amit Kumar; Malik, Shajer Manzoor; Kohli, Ekta; Reddy, Maramreddy Prasanna Kumar			Hypobaric hypoxia induced renal damage is mediated by altering redox pathway	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; DISEASE; BIOMARKERS; PROTEOMICS; ACTIN	Systemic hypobaric hypoxia is reported to cause renal damage; nevertheless the exact pathophysiological mechanisms are not completely understood. Therefore, the present study aims to explore renal pathophysiology by using proteomics approach under hypobaric hypoxia. Six to eight week old male Sprague Dawley rats were exposed to hypobaric hypoxia equivalent to altitude of 7628 metres (pO(2)-282mmhg) at 28 degrees C and 55% humidity in decompression chamber for different time intervals; 1, 3, and7 days. Various physiological, proteomic and bioinformatic studies were carried out to examine the effect of chronic hypobaric hypoxia on kidney. Our data demonstrated mild to moderate degenerative tubular changes, altered renal function, injury biomarkers and systolic blood pressure with increase in duration of hypobaric hypoxia exposure. Renal proteomic analysis showed 38 differential expressed spots, out of which 25 spots were down regulated and 13 were up regulated in 7 dayhypobarichypoxic exposure group of rats as compared to normoxia control. Identified proteins were involved in specific molecular changes pertinent to endogenous redox pathways, cellular integrity and energy metabolism. The study provides an empirical evidence of renal homeostasis under hypobaric hypoxia by investigating both physiological and proteomics changes. The identification of explicit key proteins provides a valuable clue about redox signalling mediated renal damage under hypobaric hypoxia.	[Chhabra, Varun; Baidya, Amit Kumar; Malik, Shajer Manzoor; Reddy, Maramreddy Prasanna Kumar] Minist Def, Cardioresp Div, DIPAS, DRDO, Delhi, India; [Anand, Avnika Singh; Kohli, Ekta] Minist Def, DRDO, DIPAS, Neurobiol Div, Delhi, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Reddy, MPK (corresponding author), Minist Def, Cardioresp Div, DIPAS, DRDO, Delhi, India.	drprasannakreddym@gmail.com		Reddy, Maramreddy Prasanna Kumar/0000-0002-9780-742X	Defence Research Development Organisation (DRDO) [DIP-256/DIPAS]; Ministry of Defence, Government of India	Defence Research Development Organisation (DRDO)(Defence Research & Development Organisation (DRDO)); Ministry of Defence, Government of India	Financial support from the study is provided by Project DIP-256/DIPAS,Defence Research Development Organisation (DRDO); Ministry of Defence, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2009, CYTOM PART A, V75A, P816, DOI 10.1002/cyto.a.20779; Chawla S RB, 2014, PLOS ONE, V9, P9; Debevec T, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00084; Ferdinal Frans, 2010, Acta Med Indones, V42, P135; Fic E, 2010, ELECTROPHORESIS, V31, P3573, DOI 10.1002/elps.201000197; Fu QW, 2016, CLIN MED RES, V14, P15, DOI 10.3121/cmr.2015.1282; Gilbert-Kawai E, 2016, EXTREME PHYSIOL MED, V5, DOI 10.1186/s13728-016-0051-3; Goldfarb-Rumyantzev AS, 2014, NEPHROL DIAL TRANSPL, V29, P497, DOI 10.1093/ndt/gft051; Gowda S, 2010, N AM J MED SCI, V2, P170; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Haditsch B, 2015, PLOS ONE, V10, p1 ; Haller H, 1996, KIDNEY INT, V50, P473, DOI 10.1038/ki.1996.338; Hansell P, 2013, CLIN EXP PHARMACOL P, V40, P123, DOI 10.1111/1440-1681.12034; Hurtado A, 2012, NEPHROL DIAL TRANSPL, V27, piv11, DOI 10.1093/ndt/gfs427; Arestegui AH, 2011, J AM SOC NEPHROL, V22, P1963, DOI 10.1681/ASN.2010121316; Hurtado-Arestegui A, 2018, J NEPHROL, V31, P263, DOI 10.1007/s40620-017-0456-0; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Jain K, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/742059; Janech MG, 2007, AM J PHYSIOL-RENAL, V292, pF501, DOI 10.1152/ajprenal.00298.2006; Jeffrey C., 2011, BIOMARKERS ACUTE KID, V2011; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P3056, DOI 10.1093/ndt/gfs291; Kraut JA, 2010, NAT REV NEPHROL, V6, P274, DOI 10.1038/nrneph.2010.33; Kumar H, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/584758; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li EF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152273; Li XC, 2012, J AGR FOOD CHEM, V60, P6418, DOI 10.1021/jf204970r; Liu M, 2014, EUR REV MED PHARMACO, V18, P2918; Lopes JA, 2013, CLIN KIDNEY J, V6, P8, DOI 10.1093/ckj/sfs160; Luks AM, 2008, J AM SOC NEPHROL, V19, P2262, DOI 10.1681/ASN.2007111199; Malek M, 2015, J RENAL INJ PREV, V4, P20, DOI 10.12861/jrip.2015.06; Mazzali M, 2003, KIDNEY INT, V63, P2088, DOI 10.1046/j.1523-1755.2003.00011.x; Medic B, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/854070; Moore E, 2010, MINERVA ANESTESIOL, V76, P425; Palm F, 2011, CLIN EXP PHARMACOL P, V38, P424, DOI 10.1111/j.1440-1681.2011.05532.x; Peng ZY, 2016, J TRANSL INTERN MED, V4, P95, DOI 10.1515/jtim-2016-0035; Rabb H, 1997, KIDNEY INT, V51, P1463, DOI 10.1038/ki.1997.200; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Savransky V, 2006, KIDNEY INT, V69, P233, DOI 10.1038/sj.ki.5000038; Sean M., 2008, CRIT CARE MED, V36; Shah NM, 2015, OPEN ACCESS J SPORTS, V6, P319, DOI 10.2147/OAJSM.S89856; Shelden EA, 2002, J AM SOC NEPHROL, V13, P2667, DOI 10.1097/01.ASN.0000033353.21502.31; SKSaIA Tasanarong A., 2014, BMC COMPLEMENTARY AL, V14; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Son D, 2008, AM J PHYSIOL-RENAL, V294, pF62, DOI 10.1152/ajprenal.00113.2007; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Terada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080850; Vaziri ND, 1996, KIDNEY INT, V49, P1457, DOI 10.1038/ki.1996.205; Vogler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069128; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yanez AJ, 2005, J CELL PHYSIOL, V202, P743, DOI 10.1002/jcp.20183; Yang CW, 2003, FASEB J, V17, P1754, DOI 10.1096/fj.02-1191fje; Ye SH, 2006, HYPERTENSION, V48, P309, DOI 10.1161/01.HYP.0000231307.69761.2e; Zhou Y, 2008, TOXICOL SCI, V101, P159, DOI 10.1093/toxsci/kfm260	54	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0195701	10.1371/journal.pone.0195701	http://dx.doi.org/10.1371/journal.pone.0195701			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005088	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200001
J	Powell, JE; Eiri, D; Moran, NA; Rangel, J				Powell, J. Elijah; Eiri, Daren; Moran, Nancy A.; Rangel, Juliana			Modulation of the honey bee queen microbiota: Effects of early social contact	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; APIS-MELLIFERA L; GUT MICROBIOTA; BUMBLE BEES; COMMUNITIES; PHEROMONE; SEQUENCES; IMMUNITY; DISEASE; PROPHYLAXIS	As the sole reproductive female in a honey bee (Apis mellifera) colony, the queen's health is critical to colony productivity and longevity. Beekeeping operations typically rely on the commercial mass production of queens for colony multiplication, which involves manipulating and isolating the queens by confining them in cages during early development. Using common queen-rearing techniques, this study shows that segregating newly eclosed queens from their worker attendants for 72 hours using queen protector cages has a significant impact on the total amount of gut bacteria carried by those queens compared to queens that have unrestricted access to attendants upon eclosion. Isolated virgin queens sampled immediately after isolation at 4 days post eclosure had significantly more bacteria and a less consistent microbiota composition than their non-isolated peers. Furthermore, this effect lasted into the mating life of queens, since mated queens that had been isolated after emergence and then sampled at 14 days post eclosure also had significantly more microbiota compared to non-isolated mated queens of the same age. The causes and potential impacts of this alteration are not clear and deserve further investigation. This study also verifies earlier findings that honey bee queens lack the core microbiome found within honey bee workers.	[Powell, J. Elijah; Eiri, Daren; Moran, Nancy A.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Rangel, Juliana] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Moran, NA (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	nancy.moran@austin.utexas.edu		Eiri, Daren/0000-0003-4301-8772; Powell, Jenkyn/0000-0002-2758-6174	USDA-NIFA award [2015-67013-23170]; Texas A&M University's Hatch Project [TEX09557]; National Science Foundation Dimensions of Biodiversity award [1415604]; National Institutes of Health [1R01GM108477-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108477] Funding Source: NIH RePORTER	USDA-NIFA award; Texas A&M University's Hatch Project; National Science Foundation Dimensions of Biodiversity award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding to Juliana Rangel by a USDA-NIFA award (2015-67013-23170) (https://portal.nifa.usda.gov/lmd4/recent_awards) and Texas A&M University's Hatch Project (TEX09557) (https://agrilifeas.tamu.edu/fiscal/project-records/), a National Science Foundation Dimensions of Biodiversity award (1415604) (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1415604) to Nancy A. Moran, and by the National Institutes of Health award (1R01GM108477-01) (http://grantome.com/grant/NIH/R01-GM108477-01) to Nancy A. Moran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kim Hammond for insights regarding apicultural practices and help with figures. This work was supported in part by funding to Juliana Rangel by a USDA-NIFA award (2015-67013-23170) and Texas A&M University's Hatch Project (TEX09557), and to Nancy Moran by a National Science Foundation Dimensions of Biodiversity award (1415604) a National Institutes of Health award (1R01GM108477-01).	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Butler C. G., 1963, Journal of Apicultural Research London, V2, P14; Cai L, 2013, PLOS ONE, V8, P1; Camazine S, 1998, AM BEE J, V138, P677; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cariveau DP, 2014, ISME J, V8, P2369, DOI 10.1038/ismej.2014.68; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; Claesson MJ, 2008, INT J SYST EVOL MICR, V58, P2945, DOI 10.1099/ijs.0.65848-0; Contreras-Garduno J, 2016, ECOL ENTOMOL, V41, P351, DOI 10.1111/een.12300; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eloe-fadrosh EA, 2016, NAT MICROBIOL, V1, P1; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Hamilton C, 2011, BIOL LETTERS, V7, P89, DOI 10.1098/rsbl.2010.0466; Hermesh T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037334; Hoover SER, 2003, NATURWISSENSCHAFTEN, V90, P477, DOI 10.1007/s00114-003-0462-z; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kapheim KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123911; Karst SM, 2018, NAT BIOTECHNOL, V36, P190, DOI 10.1038/nbt.4045; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kocher SD, 2011, J CHEM ECOL, V37, P1263, DOI 10.1007/s10886-011-0036-z; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kulhanek K, 2017, J APICULT RES, V56, P328, DOI 10.1080/00218839.2017.1344496; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Laidlaw HH., 1997, QUEEN REARING BEE BR; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; LOSKOTOVA J, 1980, APIDOLOGIE, V11, P153, DOI 10.1051/apido:19800205; Maori E, 2018, BIORXIV, DOI [10.110/299800, DOI 10.110/299800]; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Melathopoulos AP, 1996, CAN ENTOMOL, V128, P263, DOI 10.4039/Ent128263-2; Nino EL, 2012, J INSECT PHYSIOL, V58, P1082, DOI 10.1016/j.jinsphys.2012.04.015; PANKIW T, 1995, INSECT SOC, V42, P371, DOI 10.1007/BF01242165; PETTIS JS, 1995, INSECT SOC, V42, P113, DOI 10.1007/BF01242447; Pettis JS, 1997, INSECT SOC, V44, P311, DOI 10.1007/s000400050053; Powell JE, 2014, APPL ENVIRON MICROB, V80, P7378, DOI 10.1128/AEM.01861-14; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2021, R LANGUAGE ENV STAT; Rangel J, 2013, INSECT SOC, V60, P65, DOI 10.1007/s00040-012-0267-1; Rangel J, 2012, INSECT SOC, V59, P453, DOI 10.1007/s00040-012-0239-5; Rangel J., 2016, J ENV ANAL TOXICOL, V6, DOI [10.4172/2161-0525.1000377, DOI 10.4172/2161-0525.1000377]; Rangel J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156027; Raymann K, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001861; Richard FJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000980; Seitz N, 2016, J APICULT RES, V54, P292, DOI 10.1080/00218839.2016.1153294; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; St John J, SEQPREP; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tarpy DR, 2015, APPL ENVIRON MICROB, V81, P3182, DOI 10.1128/AEM.00307-15; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Ugelvig LV, 2007, CURR BIOL, V17, P1967, DOI 10.1016/j.cub.2007.10.029; vanEngelsdorp D, 2013, PREV VET MED, V108, P225, DOI 10.1016/j.prevetmed.2012.08.004; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winston M., 1987, The biology of the honey bee.; Zheng H, 2017, P NATL ACAD SCI USA, V114, P4775, DOI 10.1073/pnas.1701819114	66	23	24	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200527	10.1371/journal.pone.0200527	http://dx.doi.org/10.1371/journal.pone.0200527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001407	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400071
J	Shehabeldin, R; Lutz, D; Karsak, M; Frotscher, M; Krieglstein, K; Sharaf, A				Shehabeldin, Reham; Lutz, David; Karsak, Meliha; Frotscher, Michael; Krieglstein, Kerstin; Sharaf, Ahmed			Reelin controls the positioning of brainstem serotonergic raphe neurons	PLOS ONE			English	Article							TOPOGRAPHIC ORGANIZATION; CORTICAL DEVELOPMENT; COFILIN PHOSPHORYLATION; DOPAMINERGIC-NEURONS; PREFRONTAL CORTEX; CEREBRAL-CORTEX; RAT CEREBELLUM; DENTATE GYRUS; KNOCKOUT MICE; ADULT-RAT	Serotonin (5-HT) acts as both a morphogenetic factor during early embryonic development and a neuromodulator of circuit plasticity in the mature brain. Dysregulation of serotonin signaling during critical periods is involved in developmental neurological disorders, such as schizophrenia and autism. In this study we focused on the consequences of defect reelin signaling for the development of the brainstem serotonergic raphe system. We observed that reelin signaling components are expressed by serotonergic neurons during the critical period of their lateral migration. Further, we found that reelin signaling is important for the normal migration of rostral, but not caudal hindbrain raphe nuclei and that reelin deficiency results in the malformation of the paramedian raphe nucleus and the lateral wings of the dorsal raphe nuclei. Additionally, we showed that serotonergic neurons projections to laminated brain structures were severely altered. With this study, we propose that the perturbation of canonical reelin signaling interferes with the orientation of tangentially, but not radially, migrating brainstem 5-HT neurons. Our results open the window for further studies on the interaction of reelin and serotonin and the pathogenesis of neurodevelopmental disorders.	[Shehabeldin, Reham; Krieglstein, Kerstin; Sharaf, Ahmed] Albert Ludwigs Univ, Inst Anat & Cell Biol, Dept Mol Embryol, Freiburg, Germany; [Lutz, David; Frotscher, Michael; Sharaf, Ahmed] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol Hamburg ZMNH, Inst Struct Neurobiol, Hamburg, Germany; [Karsak, Meliha; Sharaf, Ahmed] Univ Med Ctr Hamburg Eppendorf UKE, ZMNH, Res Grp Neuronal & Cellular Signal Transduct, Hamburg, Germany; [Sharaf, Ahmed] Zagazig Univ, Fac Vet Med, Dept Histol & Cytol, Zagazig, Egypt	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Egyptian Knowledge Bank (EKB); Zagazig University	Sharaf, A (corresponding author), Albert Ludwigs Univ, Inst Anat & Cell Biol, Dept Mol Embryol, Freiburg, Germany.; Sharaf, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol Hamburg ZMNH, Inst Struct Neurobiol, Hamburg, Germany.; Sharaf, A (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, ZMNH, Res Grp Neuronal & Cellular Signal Transduct, Hamburg, Germany.; Sharaf, A (corresponding author), Zagazig Univ, Fac Vet Med, Dept Histol & Cytol, Zagazig, Egypt.	ahmed.sharaf@zmnh.uni-hamburg.de	Lutz, David/AAX-1607-2021	Lutz, David/0000-0001-9171-4081; Karsak, Meliha/0000-0001-6612-6317; Sharaf, Ahmed/0000-0002-2691-4834	Deutsche Forschungsgemeinschaft [Kr1477/10-3]; DFG [FOR 2419 (FR620/14-1), FR 620/12-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (Kr1477/10-3) to K.K. and the DFG FOR 2419 (FR620/14-1); DFG (FR 620/12-2) to M.F.; We thank Gabriele Rune for giving us the chance to use the Keyence microscope and Max Anstotz for providing us with CXCR4-eGFP mouse line. Deutsche Forschungsgemeinschaft (Kr1477/10-3) and the DFG FOR 2419 (FR620/14-1; DFG (FR 620/12-2 to M.F.). M.F. is Hertie Research Professor for Neuroscience.	Alenina N, 2015, BEHAV BRAIN RES, V277, P49, DOI 10.1016/j.bbr.2014.07.038; Alonso A, 2013, BRAIN STRUCT FUNCT, V218, P1229, DOI 10.1007/s00429-012-0456-8; Anstotz M, 2014, BRAIN STRUCT FUNCT, V219, P2119, DOI 10.1007/s00429-013-0627-2; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; BEASZARATE C, 1984, J NEUROSCI RES, V12, P129, DOI 10.1002/jnr.490120112; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BISHOP GA, 1985, BRAIN RES, V331, P195, DOI 10.1016/0006-8993(85)91545-8; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Brezun JM, 1999, NEUROSCIENCE, V89, P999, DOI 10.1016/S0306-4522(98)00693-9; Brodski C, 2003, J NEUROSCI, V23, P4199; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Caruncho HJ, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00048; Castagna C, 2014, ANN ANAT, V196, P224, DOI 10.1016/j.aanat.2013.11.004; Chai XJ, 2009, J NEUROSCI, V29, P288, DOI 10.1523/JNEUROSCI.2934-08.2009; Chubakov A R, 1993, Neurosci Behav Physiol, V23, P271, DOI 10.1007/BF01182928; Chugani DC, 2002, MOL PSYCHIATR, V7, pS16, DOI 10.1038/sj.mp.4001167; COFFIELD JA, 1992, J COMP NEUROL, V321, P488, DOI 10.1002/cne.903210314; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DATICHE F, 1995, BRAIN RES, V671, P27, DOI 10.1016/0006-8993(94)01293-Q; Dean B, 2003, PSYCHIAT RES, V119, P25, DOI 10.1016/S0165-1781(03)00108-2; Deller T, 1999, EXP NEUROL, V156, P254, DOI 10.1006/exnr.1999.7021; Deneris ES, 2012, NAT NEUROSCI, V15, P519, DOI 10.1038/nn.3039; Eastwood SL, 2003, MOL PSYCHIATR, V8, P821, DOI 10.1038/sj.mp.4001371; Faber KM, 1999, DEV BRAIN RES, V114, P245, DOI 10.1016/S0165-3806(99)00036-X; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; Fatemi SH, 2003, J DEV PHYS DISABIL, V15, P1, DOI 10.1023/A:1021457519382; Fatemi SH, 2002, CELL MOL NEUROBIOL, V22, P171, DOI 10.1023/A:1019861721160; Fernandez SP, 2012, NEUROPHARMACOLOGY, V62, P144, DOI 10.1016/j.neuropharm.2011.08.049; Forster E, 2006, EUR J NEUROSCI, V23, P901, DOI 10.1111/j.1460-9568.2006.04612.x; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gilerovich E G, 2005, Neurosci Behav Physiol, V35, P887, DOI 10.1007/s11055-005-0140-z; GOFFINET AM, 1984, Z MIKROSK ANAT FORSC, V98, P909; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Hynes M, 1999, CURR OPIN NEUROBIOL, V9, P26, DOI 10.1016/S0959-4388(99)80004-X; Ilijic E, 2005, NEUROSCIENCE, V136, P633, DOI 10.1016/j.neuroscience.2005.01.030; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Janusonis S, 2004, J NEUROSCI, V24, P1652, DOI 10.1523/JNEUROSCI.4651-03.2004; Janusonis S, 1999, J COMP NEUROL, V413, P342, DOI 10.1002/(SICI)1096-9861(19991018)413:2<342::AID-CNE12>3.0.CO;2-#; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Kang WY, 2010, ANAT CELL BIOL, V43, P241, DOI 10.5115/acb.2010.43.3.241; KAWANO H, 1995, DEV BRAIN RES, V86, P101, DOI 10.1016/0165-3806(95)00018-9; KAZAKOV VN, 1993, NEUROSCIENCE, V56, P157, DOI 10.1016/0306-4522(93)90570-6; Kirifides ML, 2001, J COMP NEUROL, V435, P325, DOI 10.1002/cne.1033; KOH T, 1991, BRAIN RES BULL, V27, P675, DOI 10.1016/0361-9230(91)90044-K; KOHLER C, 1982, NEUROSCIENCE, V7, P951, DOI 10.1016/0306-4522(82)90054-9; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Kruger MT, 2010, EUR J NEUROSCI, V32, P1611, DOI 10.1111/j.1460-9568.2010.07433.x; Lau T, 2012, MEMBR TRANSP SIGNAL, V1, P259, DOI DOI 10.1002/wmts.10; Lauder J M, 1981, Adv Exp Med Biol, V133, P477; LAUDER JM, 1990, ANN NY ACAD SCI, V600, P297, DOI 10.1111/j.1749-6632.1990.tb16891.x; Leger L, 2001, J COMP NEUROL, V433, P157; LEVITT P, 1978, ANAT EMBRYOL, V154, P241, DOI 10.1007/BF00345655; LIDOV HGW, 1982, BRAIN RES BULL, V8, P389, DOI 10.1016/0361-9230(82)90077-6; Magdaleno S, 2002, NEURON, V33, P573, DOI 10.1016/S0896-6273(02)00582-2; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mazer C, 1997, BRAIN RES, V760, P68, DOI 10.1016/S0006-8993(97)00297-7; Miyata T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-23; Mosienko V, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0003-6; Mosienko V, 2015, BEHAV BRAIN RES, V277, P78, DOI 10.1016/j.bbr.2014.06.005; Nishikawa S, 2003, J COMP NEUROL, V461, P166, DOI 10.1002/cne.10610; OHEARN E, 1984, BRAIN RES BULL, V13, P709, DOI 10.1016/0361-9230(84)90232-6; OKADO N, 1993, J NEUROBIOL, V24, P687, DOI 10.1002/neu.480240512; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Peyron C, 1998, NEUROSCIENCE, V82, P443; PORRINO LJ, 1982, J COMP NEUROL, V205, P63, DOI 10.1002/cne.902050107; Qui SF, 2006, NEUROBIOL LEARN MEM, V85, P228, DOI 10.1016/j.nlm.2005.11.001; Rossel M, 2005, DEVELOPMENT, V132, P1175, DOI 10.1242/dev.01683; Sharaf A, 2013, PLOS ONE, V16, P8; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; TAKEUCHI Y, 1982, CELL TISSUE RES, V226, P1; Telese F, 2015, NEURON, V86, P696, DOI 10.1016/j.neuron.2015.03.033; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; VILLAR MJ, 1987, NEUROSCIENCE, V22, P681, DOI 10.1016/0306-4522(87)90364-2; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Vitalis T, 2007, EUR J NEUROSCI, V26, P331, DOI 10.1111/j.1460-9568.2007.05661.x; WALLACE JA, 1983, BRAIN RES BULL, V10, P459, DOI 10.1016/0361-9230(83)90144-2; Ware ML, 1997, NEURON, V19, P239, DOI 10.1016/S0896-6273(00)80936-8; WATERHOUSE BD, 1986, J COMP NEUROL, V249, P460, DOI 10.1002/cne.902490403; WATERHOUSE BD, 1993, J COMP NEUROL, V336, P345, DOI 10.1002/cne.903360304; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Whitaker-Azmitia PM, 2001, BRAIN RES BULL, V56, P479, DOI 10.1016/S0361-9230(01)00615-3; Yan W, 1997, DEV BRAIN RES, V98, P177, DOI 10.1016/S0165-3806(96)00176-9; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yip JW, 2000, P NATL ACAD SCI USA, V97, P8612, DOI 10.1073/pnas.150040497; Zhao S, 2007, DEV NEUROSCI-BASEL, V29, P84, DOI 10.1159/000096213	86	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200268	10.1371/journal.pone.0200268	http://dx.doi.org/10.1371/journal.pone.0200268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001399	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400041
J	Ellis-Smith, C; Higginson, IJ; Daveson, BA; Henson, LA; Evans, CJ				Ellis-Smith, Clare; Higginson, Irene J.; Daveson, Barbara A.; Henson, Lesley A.; Evans, Catherine J.		BuildCARE	How can a measure improve assessment and management of symptoms and concerns for people with dementia in care homes? A mixed-methods feasibility and process evaluation of IPOS-Dem	PLOS ONE			English	Article							QUALITY-OF-LIFE; MINIMUM DATA SET; PALLIATIVE CARE; PAIN ASSESSMENT; OUTCOME MEASURE; NURSING-HOMES; OLDER-PEOPLE; END; PREVALENCE; COMMUNICATION	Background Assessment of people with dementia is challenging; with undetected and under treated symptoms and concerns resulting in avoidable distress, and few evidence-based interventions to support this. We aimed to understand the mechanisms of action of a measure to support comprehensive assessment of people with dementia in care homes; and its acceptability, feasibility, and implementation requirements. Methods A qualitative study with an embedded quantitative component in three residential care homes, underpinned by an initial theoretical model of mechanisms of action. The measure, the Integrated Palliative care Outcome Scale for Dementia (IPOS-Dem), was introduced into the care of residents with dementia for 12 weeks. Qualitative data comprised focus groups and semi-structured interviews with family, care home staff, general practitioners and district nurses; and non-participant observations. Quantitative data comprised IPOS-Dem data. Directed content analysis for qualitative data, and descriptive statistics were used for quantitative data. Findings Key mechanisms of action were: improved observation and awareness of residents, collaborative assessment, comprehensive 'picture of the person', systematic record keeping, improved review and monitoring, care planning and changes to care provision, and facilitated multi-agency communication. Potential benefit included improved symptom management, improved comprehensive care, and increased family empowerment and engagement. IPOS-Dem was found to be acceptable and feasible. It was perceived as quick and easy to use, with proportion of overall missing data decreasing from 2.1% to 1.1% from baseline to final time points. 'Trust' in the measure was important; and leadership essential to ensure integration into care processes. Conclusions In a population with complex care needs, with challenges to assessment and barriers to multi-agency working, a measure introduced into routine care is feasible and acceptable, and supports assessment and management of symptoms and concerns. A refined theoretical model demonstrating the likely mechanisms of action was developed. Further evaluation is required to test its effectiveness.	[Ellis-Smith, Clare; Higginson, Irene J.; Daveson, Barbara A.; Henson, Lesley A.; Evans, Catherine J.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Higginson, Irene J.] Kings Coll Hosp NHS Fdn Trust, London, England; [Evans, Catherine J.] Sussex Community NHS Fdn Trust, Brighton, E Sussex, England	University of London; King's College London; King's College Hospital NHS Foundation Trust	Ellis-Smith, C (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England.	alexandra.c.ellis-smith@kcl.ac.uk	Daveson, Barbara/AAO-5876-2021; Evans, Catherine J/AAS-4121-2020; Higginson, Irene Julie/C-7309-2012	Daveson, Barbara/0000-0001-8039-8749; Evans, Catherine J/0000-0003-0034-7402; Henson, Lesley/0000-0003-4799-7365; Ellis-Smith, Clare/0000-0003-3453-3203; Higginson, Irene Julie/0000-0002-3687-1313	Cicely Saunders International; Atlantic Philanthropies; Health Education England (HEE)/National Institute for Health Research (NIHR); NIHR Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; South London and Maudsley NHS Foundation Trust Older Adults Service User and Carer Advisory Group (SUCAG); Cicely Saunders International (CSI)	Cicely Saunders International; Atlantic Philanthropies; Health Education England (HEE)/National Institute for Health Research (NIHR); NIHR Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust; South London and Maudsley NHS Foundation Trust Older Adults Service User and Carer Advisory Group (SUCAG); Cicely Saunders International (CSI)	This study was mainly funded by Cicely Saunders International (https://cicelysaundersinternational.org/) and The Atlantic Philanthropies (http://www.atlanticphilanthropies.org/). C.J.E. is funded by Health Education England (HEE)/National Institute for Health Research (NIHR) Senior Clinical Lectureship; I.J.H. is an NIHR Senior Investigator Emeritus. I.J.H. is supported by the NIHR Collaboration for Leadership in Applied Health Research and Care South London at King's College Hospital NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.; The authors would like to thank all residents, family and staff for participation in the study; and all staff at the participating centres for support in recruiting and conducting the study. The authors thank South London and Maudsley NHS Foundation Trust Older Adults Service User and Carer Advisory Group (SUCAG), Gill Peters as an expert through experience, and Caty Pannell, research nurse for their contribution and study support. BuildCARE is supported by Cicely Saunders International (CSI) and The Atlantic Philanthropies, led by King's College London, Cicely Saunders Institute, Department of Palliative Care, Policy & Rehabilitation, UK. CI: Higginson. Grant leads: Higginson, McCrone, Normand, Lawlor, Meier, Morrison. Project Co-ordinator/ PI: Daveson. Study arm PIs: Pantilat, Selman, Normand, Ryan, McQuillan, Morrison, Daveson. We thank all collaborators & advisors including service-users. BuildCARE members: Emma Bennett, Francesca Cooper, Barbara A Daveson, Susanne de Wolf-Linder, Mendwas Dzingina, Clare Ellis-Smith, Catherine J Evans, Lesley Henson, Irene J Higginson, Bridget Johnston, Paramjote Kaler, Pauline Kane, Lara Klass, Peter Lawlor, Paul McCrone, Regina McQuillan, Diane Meier, Susan Molony, Sean Morrison, Fliss E Murtagh, Charles Normand, Caty Pannell, Steve Pantilat, Karen Ryan, Lucy Selman, Melinda Smith, Katy Tobin, Gao Wei.	[Anonymous], 2005, MENT CAP ACT; [Anonymous], 1995, NEW APPROACHES EVALU; Antunes B, 2013, PALLIAT MED; Bebbington A, 2001, CARE HOMES OLDER PEO, V2; Bloor M, 2001, FOCUS GROUPS SOCIAL, DOI DOI 10.4135/9781849209175; Care Quality Commission, 2016, CAR QUAL COMM CAR HO; Cicely Saunders Institute, 2012, PALLIATIVE CARE OUTC; Cohen-Mansfield J, 1996, Int Psychogeriatr, V8, P233, DOI 10.1017/S104161029600261X; Collins ES, 2015, J PAIN SYMPTOM MANAG; Corp IBM, IBM SPSS STAT WIND V; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Creswell W. C., 2011, DESIGNING CONDUCTING; Davies SL, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-320; De Silva MJ, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-267; Detmar SB, 2002, JAMA-J AM MED ASSOC, V288, P3027, DOI 10.1001/jama.288.23.3027; Dunckley M, 2005, INT J PALLIAT NURS, V11, P218, DOI 10.12968/ijpn.2005.11.5.218; Ellis-Smith C, 2016, 14 WORLD C EUR ASS P; Ellis-Smith C, 2017, PALLIATIVE MED, V31, P651, DOI 10.1177/0269216316675096; Ellis-Smith C, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0582-x; Etkind SN, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0860-2; Etkind SN, 2015, J PAIN SYMPTOM MANAG, V49, P611, DOI 10.1016/j.jpainsymman.2014.07.010; Fuchs-Lacelle S, 2008, CLIN J PAIN, V24, P697, DOI 10.1097/AJP.0b013e318172625a; Gage H, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-71; Goodman C., 2013, STUDY DEV INTEGRATED; Goodman C, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1493-4; Goodman C, 2015, J AM MED DIR ASSOC, V16, P427, DOI 10.1016/j.jamda.2015.01.072; Goodman C, 2011, AGING MENT HEALTH, V15, P475, DOI 10.1080/13607863.2010.543659; Goodman C, 2010, INT J GERIATR PSYCH, V25, P329, DOI 10.1002/gps.2343; Greenhalgh J, 2005, SOC SCI MED, V60, P833, DOI 10.1016/j.socscimed.2004.06.022; Gysels M, 2013, PALLIATIVE MED, V27, P908, DOI 10.1177/0269216313488018; Hall S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007132.pub2; Harding R, 2011, J PAIN SYMPTOM MANAG, V42, P493, DOI 10.1016/j.jpainsymman.2011.06.008; Harwood RH, 2004, B WORLD HEALTH ORGAN, V82, P251; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Hearn J, 1999, QUAL HEALTH CARE, V8, P219, DOI 10.1136/qshc.8.4.219; Hennings J, 2019, DEMENTIA-LONDON, V18, P303, DOI 10.1177/1471301216671418; Higginson IJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-111; Hockley J, 2010, PALLIATIVE MED, V24, P828, DOI 10.1177/0269216310373162; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; International QSR, 2014, QSR INT NVIV 10 WIND; Kerr C, 2010, EXPERT REV PHARM OUT, V10, P269, DOI 10.1586/ERP.10.30; Kinley J, 2014, PALLIATIVE MED, V28, P1099, DOI 10.1177/0269216314539785; Krumm N, 2014, INT J PALLIAT NURS, V20, P187, DOI 10.12968/ijpn.2014.20.4.187; Kupeli N, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0103-x; Lee M, 2009, J AM MED DIR ASSOC, V10, P466, DOI 10.1016/j.jamda.2009.03.014; Lichtner V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-138; Lund S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116629; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Mahoney RI, 1965, MD STATE MED J, P56; Manthorpe J, 2010, INT J OLDER PEOPLE N, V5, P235, DOI 10.1111/j.1748-3743.2010.00231.x; Mason P., 2007, EVALUATION, V13, P151, DOI DOI 10.1177/1356389007075221; Mathillas J, 2011, AGE AGEING, V40, P243, DOI 10.1093/ageing/afq173; Medical Research Council, 2017, FRAM DEV EV RCTS COM; Miles M.B., 2014, QUALITATIVE DATA ANA, V3rd ed.; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; Morgan DL, 1998, PLANNING FOCUS GROUP, V2; Moyle Wendy, 2002, Aust J Adv Nurs, V19, P25; Murphy E, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011513.pub2; National Institute for Health and Clinical Excellence, 2017, MULT CLIN ASS MAN; National Institute for Health and Clinical Excellence/ Social Care Institute for Excellence, 2012, DEM SUPP PEOPL DEM T; Nicklasson M, 2013, SUPPORT CARE CANCER, V21, P87, DOI 10.1007/s00520-012-1496-6; Preston NJ, 2013, PALLIAT MED; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Saliba D, 2012, J AM MED DIR ASSOC, V13, P602, DOI 10.1016/j.jamda.2012.06.002; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Schildmann EK, 2016, PALLIATIVE MED, V30, P599, DOI 10.1177/0269216315608348; Slade M, 2002, PSYCHOL MED, V32, P1339, DOI 10.1017/S0033291701004974; Steel K, 2003, Am J Hosp Palliat Care, V20, P211, DOI 10.1177/104990910302000311; Velikova G, 2004, J CLIN ONCOL, V22, P714, DOI 10.1200/JCO.2004.06.078	71	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200240	10.1371/journal.pone.0200240	http://dx.doi.org/10.1371/journal.pone.0200240			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM7QQ	29995932	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800047
J	Liu, WH; Lin, ZC; Liu, YY; Lin, YL; Xu, XH; Lai, ZX				Liu, Weihua; Lin, Zhengchun; Liu, Yanying; Lin, Yuling; Xu, XuHan; Lai, Zhongxiong			Genome-wide identification and characterization of the CKII gene family in the cultivated banana cultivar (Musa spp. cv Tianbaojiao) and the wild banana (Musa itinerans)	PLOS ONE			English	Article							PROTEIN-KINASE CK2; SUBCELLULAR-LOCALIZATION; ALPHA-SUBUNITS; SALICYLIC-ACID; PLANT-GROWTH; ARABIDOPSIS; CLONING; MAIZE; DOMESTICATION; DUPLICATION	Plant casein kinase II (CKII) plays an essential role in regulating plant growth and development, and responses to biotic and abiotic stresses. Here, we report the identification and characterization of the CKII family genes in Musa spp. cv. 'Tianbaojiao' (AAA group) and the wild banana (Musa itinerans). The 13 cDNA sequences of the CKII family members were identified both in 'Tianbaojiao' and wild banana, respectively. The differences between CKII alpha and CKII beta members are corroborated through the subcellular localizations, phosphorylation sites and gene structures. The cloning of CKII beta-like-2g-DNA sequences in wild banana and 'Tianbaojiao' and the analysis of gene structures showed MiCKII beta-like-2b and MaCKII beta-like-2 are likely alternatively spliced transcripts, which were derived from the alternative splicing events that involved exon deletion. The qPCR validation showed differential expression CKII family members in response to cold stress and also in all tested tissues (leaf, pseudostem and root) of wild banana. In particular, the normal transcript MiCKII beta-like-2a was highly expressed in response to cold stress in wild banana; oppositely, the alternatively spliced transcript MiCKII beta-like-2b was quite lowly expressed. The complex origin and long-term evolution of Musa lineage might explain the alternative splicing events of CKII beta-like-2.	[Liu, Weihua; Lin, Zhengchun; Liu, Yanying; Lin, Yuling; Xu, XuHan; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China	Fujian Agriculture & Forestry University	Lai, ZX (corresponding author), Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China.	laizx01@163.com			earmarked Fund for China Agriculture Research System [CARS-31-15]; Science and Technology Major Science and Technology Project in Fujian Province of China [2015NZ20002-1]	earmarked Fund for China Agriculture Research System; Science and Technology Major Science and Technology Project in Fujian Province of China	This work was supported by the earmarked Fund for China Agriculture Research System (CARS-31-15) and the Science and Technology Major Science and Technology Project in Fujian Province of China (2015NZ20002-1) (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the earmarked Fund for China Agriculture Research System (CARS-31-15) and the Science and Technology Major Science and Technology Project in Fujian Province of China (2015NZ20002-1).	[Anonymous], 2008, THESIS; Armengot L, 2014, PLANT J, V78, P411, DOI 10.1111/tpj.12481; Azhar M, 2008, CYTOGENET GENOME RES, V121, P59, DOI 10.1159/000124383; Brozynska M, 2016, PLANT BIOTECHNOL J, V14, P1070, DOI 10.1111/pbi.12454; Capovilla G, 2015, CURR OPIN PLANT BIOL, V27, P97, DOI 10.1016/j.pbi.2015.06.016; Chamala S, 2014, INT PLANT ANIMAL GEN; Chang CY, 2014, PLANT PHYSIOL, V165, P826, DOI 10.1104/pp.113.230540; Chen F., 2016, THESIS; Chen HB, 2011, SPECIAL FRUIT CULTIV, P73; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; Dennis MD, 2009, J BIOL CHEM, V284, P20602, DOI 10.1074/jbc.M109.006692; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1129, P139, DOI 10.1016/0167-4781(91)90230-J; Espunya MC, 1999, PLANT J, V19, P655, DOI 10.1046/j.1365-313x.1999.00563.x; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Feng X., 2016, THERMAL RUNAWAY INIT; Feng X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2046-7; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hidalgo P, 2001, PLANT PHYSIOL, V125, P396, DOI 10.1104/pp.125.1.396; Hughes TE, 2014, GENOME RES, V24, P1348, DOI 10.1101/gr.172684.114; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Kang HG, 2005, PLANT MOL BIOL, V57, P541, DOI 10.1007/s11103-005-0409-1; Kato K, 2002, THEOR APPL GENET, V104, P1071, DOI 10.1007/s00122-001-0805-0; Lai ZX, 2007, SUBTROPICAL AGR RES, V1, p1 ; Lai ZX, 2007, SUBTROP AGR RES, V3, P1; Lee Y, 1999, PLANT PHYSIOL, V119, P989, DOI 10.1104/pp.119.3.989; Lescot M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-58; Lescot T., 2011, FRUITROP, V189, P58; Lin YL, 2013, MOL BREEDING, V32, P595, DOI 10.1007/s11032-013-9892-2; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Liu HY, 2017, PHYSIOL MOL BIOL PLA, V23, P629, DOI 10.1007/s12298-017-0455-6; Liu W., 2013, THESIS; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mulekar JJ, 2014, J EXP BOT, V65, P2883, DOI 10.1093/jxb/ert401; Mulekar JJ, 2012, PLANT J, V69, P343, DOI 10.1111/j.1365-313X.2011.04794.x; Niefind K, 2001, EMBO J, V20, P5320, DOI 10.1093/emboj/20.19.5320; Ogrzewalla K, 2002, EUR J BIOCHEM, V269, P3329, DOI 10.1046/j.1432-1033.2002.03017_269_13.x; Ortiz R, 2014, BIOTECHNOL ADV, V32, P158, DOI 10.1016/j.biotechadv.2013.09.010; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Portoles S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001201; Qi Q., 2017, THESIS; REED JC, 1994, J BIOL CHEM, V269, P18192; RICHARDSON N., 2010, THESIS; Riera M, 2004, P NATL ACAD SCI USA, V101, P9879, DOI 10.1073/pnas.0306154101; Riera M, 2001, MOL CELL BIOCHEM, V227, P119, DOI 10.1023/A:1013141713277; Riera M., 2013, PROTEIN KINASE CK2, P267, DOI [10.1002/9781118482490.ch9, DOI 10.1002/9781118482490.CH9]; Rodriguez F, 2005, P NATL ACAD SCI USA, V102, P4718, DOI 10.1073/pnas.0501074102; Salinas P, 2006, PLANT CELL PHYSIOL, V47, P1295, DOI 10.1093/pcp/pcj100; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Sugano S, 1999, P NATL ACAD SCI USA, V96, P12362, DOI 10.1073/pnas.96.22.12362; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Vilela B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00966; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Zhang PG, 2010, MOL BIOL EVOL, V27, P1686, DOI 10.1093/molbev/msq054	61	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200149	10.1371/journal.pone.0200149	http://dx.doi.org/10.1371/journal.pone.0200149			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995937	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800043
J	Mark, MD; Donner, M; Eickelbeck, D; Stepien, J; Nowrousian, M; Kuck, U; Paris, F; Hellinger, J; Herlitze, S				Mark, Melanie D.; Donner, Marcel; Eickelbeck, Dennis; Stepien, Jennifer; Nowrousian, Minou; Kueck, Ulrich; Paris, Frank; Hellinger, Jens; Herlitze, Stefan			Visual tuning in the flashlight fish Anomalops katoptron to detect blue, bioluminescent light	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; DEEP-SEA; COLOR-VISION; VERTEBRATE PHOTORECEPTORS; ADAPTIVE EVOLUTION; MOLECULAR-BASIS; RNA-SEQ; PIGMENTS; PHOTOTRANSDUCTION; INHIBITION	Bioluminescence is a fascinating phenomenon and can be found in many different organisms including fish. It has been suggested that bioluminescence is used for example for defense, prey attraction, and for intraspecific communication to attract for example sexual partners. The flashlight fish, Anomalops katoptron (A. katoptron), is a nocturnal fish that produces bioluminescence and lives in shallow waters, which makes it ideal for laboratory studies. In order to understand A. katoptron's ability to detect bioluminescent light (480 to 490 nm) at night, we characterized the visual system adaptation of A. katoptron using phylogenetic, electrophysiological and behavioral studies. We found that the retinae of A. katoptron contain rods and sparse cones. A. katoptron retinae express two main visual pigments, rhodopsin (RH1), and to a lesser extent, rhodopsin-like opsin (RH2). Interestingly, recombinant RH1 and RH2 are maximally sensitive to a wavelength of approximately 490 nm light (A(max)), which correspond to the spectral peak of in vivo electroretinogram (ERG) measurements. In addition, behavioral assays revealed that A. katoptron is attracted by low intensity blue but not red light. Collectively, our results suggest that the A. katoptron visual system is optimized to detect blue light in the frequency range of its own bioluminescence and residual starlight.	[Mark, Melanie D.; Donner, Marcel; Eickelbeck, Dennis; Stepien, Jennifer; Hellinger, Jens; Herlitze, Stefan] Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, Bochum, Germany; [Nowrousian, Minou; Kueck, Ulrich] Ruhr Univ Bochum, Dept Gen & Mol Bot, Bochum, Germany; [Paris, Frank] Ruhr Univ Bochum, Dept Anim Physiol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Mark, MD (corresponding author), Ruhr Univ Bochum, Dept Gen Zool & Neurobiol, Bochum, Germany.	melanie.mark@rub.de	Mark, Melanie/ABF-9102-2020	Mark, Melanie/0000-0002-2788-6003; Nowrousian, Minou/0000-0003-0075-6695; Eickelbeck, Dennis/0000-0002-8494-6543; Kuck, Ulrich/0000-0002-2998-8230	Hans-BoEckler Foundation; German Science Foundation (DFG) [5806/1-2, 5806/2-1]; Ruhr University of Bochum, Germany; Deutsche Forschungsgemeinschaft (DFG) [He2471/18-1, SPP1926]	Hans-BoEckler Foundation; German Science Foundation (DFG)(German Research Foundation (DFG)); Ruhr University of Bochum, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	MD was supported by Hans-BoEckler Foundation. MN and MDM (5806/1-2 and 5806/2-1) were funded by the German Science Foundation (DFG). This work was supported by funds from the Ruhr University of Bochum, Germany and by Deutsche Forschungsgemeinschaft (DFG) grants He2471/18-1 Priority Program (SPP1926).; We thank Dr. Andy Tinker UCL London, UK who kindly provided HEK cells stably expressing GIRK1 and GIRK2 subunits. MD was supported by Hans-Bockler Foundation. MN and MDM (5806/1-2 and 5806/2-1) were funded by the German Science Foundation (DFG). This work was supported by funds from the Ruhr University of Bochum, Germany and by Deutsche Forschungsgemeinschaft (DFG) grants He2471/18-1 Priority Program (SPP1926).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Blum V, 1988, COLOUR ATLAS HISTOLO; BOWLBY MR, 1991, MAR BIOL, V108, P247, DOI 10.1007/BF01344339; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; de Busserolles F, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0070; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Gonzalez JA, 2000, SCI MAR, V64, P107, DOI 10.3989/scimar.2000.64n1107; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Han J, 2006, NEURON, V51, P575, DOI 10.1016/j.neuron.2006.07.012; HANEDA Y, 1971, SCIENCE, V173, P143, DOI 10.1126/science.173.3992.143; Harvey EN, 1921, SCIENCE, V53, P314, DOI 10.1126/science.53.1370.314; HAYGOOD MG, 1993, NATURE, V363, P154, DOI 10.1038/363154a0; Helfman GS, 2009, ATLANTIC, DOI [10.1007/978-1-4615-2664-3_1, DOI 10.1007/978-1-4615-2664-3_1]; Hellinger J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170489; Herlitze S, 2007, CURR OPIN NEUROBIOL, V17, P87, DOI 10.1016/j.conb.2006.12.002; Lamb TD, 2013, PROG RETIN EYE RES, V36, P52, DOI 10.1016/j.preteyeres.2013.06.001; LEISMAN G, 1980, SCIENCE, V208, P1271, DOI 10.1126/science.208.4449.1271; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Maeda T, 2003, PROG RETIN EYE RES, V22, P417, DOI 10.1016/S1350-9462(03)00017-X; Marshall J, 2015, CURR OPIN NEUROBIOL, V34, P86, DOI 10.1016/j.conb.2015.02.002; Masseck OA, 2014, NEURON, V81, P1263, DOI 10.1016/j.neuron.2014.01.041; MCCOSKER JE, 1977, SCI AM, V236, P106, DOI 10.1038/scientificamerican0377-106; MCCOSKER JE, 1987, JPN J ICHTHYOL, V34, P157, DOI 10.1007/BF02912410; MORIN JG, 1975, SCIENCE, V190, P74, DOI 10.1126/science.190.4209.74; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUNZ FW, 1973, VISION RES, V13, P1829, DOI 10.1016/0042-6989(73)90060-6; Myrberg Arthur A. Jr, 2002, P123, DOI 10.1016/B978-012615185-5/50009-8; Oh E, 2010, J BIOL CHEM, V285, P30825, DOI 10.1074/jbc.M110.147298; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pointer MA, 2007, J EXP BIOL, V210, P2829, DOI 10.1242/jeb.006064; Spoida K, 2014, P NATL ACAD SCI USA, V111, P6479, DOI 10.1073/pnas.1321576111; Steche O, 1909, ZWEI OBERFLACHENFISC; Stecher H, 2000, METHOD ENZYMOL, V316, P330; Takahashi Y, 2003, BIOCHEMISTRY-US, V42, P6025, DOI 10.1021/bi020629+; Trezise AEO, 2005, CURR BIOL, V15, pR794, DOI 10.1016/j.cub.2005.09.025; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; WATSON M, 1978, PROC R SOC SER B-BIO, V202, P339, DOI 10.1098/rspb.1978.0071; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197; YANAGIDA T, 1986, JPN J OPHTHALMOL, V30, P298; Yokoyama S, 1999, P NATL ACAD SCI USA, V96, P6279, DOI 10.1073/pnas.96.11.6279; Yokoyama S, 2000, GENE, V261, P35, DOI 10.1016/S0378-1119(00)00474-1; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Yokoyama S, 2008, GENETICS, V179, P2037, DOI 10.1534/genetics.108.090449	48	6	8	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0198765	10.1371/journal.pone.0198765	http://dx.doi.org/10.1371/journal.pone.0198765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995896	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800013
J	Stewart, DC; Berrie, D; Lie, J; Liu, XY; Rickerson, C; Mkoji, D; Iqbal, A; Tan, SD; Doty, AL; Glover, SC; Simmons, CS				Stewart, Daniel C.; Berrie, Dalton; Lie, Jian; Liu, Xinyue; Rickerson, Cooper; Mkoji, David; Iqbal, Atif; Tan, Sanda; Doty, Andria L.; Glover, Sarah C.; Simmons, Chelsey S.			Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease	PLOS ONE			English	Article							COLON-CANCER CELLS; MATRIX STIFFNESS; MECHANICAL-PROPERTIES; MESENCHYMAL TRANSITION; SUBSTRATE STIFFNESS; ULCERATIVE-COLITIS; CROHNS-DISEASE; LIVER FIBROSIS; MOUSE MODELS; METALLOPROTEINASES	Inflammatory bowel disease (IBD) continues to increase in prevalence in industrialized countries. Major complications of IBD include formation of fibrotic strictures, fistulas, reduced absorptive function, cancer risk, and the need for surgery. In other chronic gastrointestinal disease models, stiffness has been shown to precede fibrosis; therefore, stiffness may be a reasonable indicator of progression toward stricture formation in IBD patients. Herein, we seek to quantify tissue stiffness and characterize fibrosis in patients with IBD and to compare mechanical properties of unaffected human tissue to common animal species used for IBD studies. Inflamed and unaffected tissue from IBD patients and unaffected tissue from mice, pigs, and cows were indented using a custom device to determine the effective stiffness. Histology was performed on matched tissues, and total RNA was isolated from IBD tissue samples and used for gene expression analysis of pro-fibrotic genes. We observed an increase in the effective stiffness (steady-state modulus, SSM) (p < 0.0001) and increased expression of the collagen type I gene (COL1A1 , p = 0.01) in inflamed tissue compared to unaffected areas in our IBD patient cohort. We also found that increased staining of collagen fibers in submucosa positively correlated with SSM (p = 0.093). We determined that unaffected animal bowel stiffness is significantly greater than similar human tissues, suggesting additional limitations on animal models for translational investigations regarding stiffness-related hypotheses. Taken together, our data support development of tools for evaluation of bowel stiffness in IBD patients for prognostic applications that may enable more accurate prediction of those who will develop fibrosis and more precise prescription of aggressive therapies.	[Stewart, Daniel C.; Berrie, Dalton; Rickerson, Cooper; Simmons, Chelsey S.] Univ Florida, Herbert Wertheim Coll Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Berrie, Dalton; Lie, Jian; Doty, Andria L.; Glover, Sarah C.] Univ Florida, Coll Med, Div Gastroenterol Hepatol & Nutr, Gainesville, FL USA; [Liu, Xinyue] Univ Florida, Coll Med, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA; [Mkoji, David; Simmons, Chelsey S.] Univ Florida, Herbert Wertheim Coll Engn, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA; [Iqbal, Atif; Tan, Sanda] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA; [Simmons, Chelsey S.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32611 USA; [Berrie, Dalton] Axogen Inc, Alachua, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Simmons, CS (corresponding author), Univ Florida, Herbert Wertheim Coll Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.; Simmons, CS (corresponding author), Univ Florida, Herbert Wertheim Coll Engn, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA.; Simmons, CS (corresponding author), Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32611 USA.	css@ufl.edu	Simmons, Chelsey/AAG-8859-2020	Simmons, Chelsey/0000-0001-6973-9813; Tan, Sanda/0000-0002-3462-4503; Glover, Sarah/0000-0002-9899-0473	University of Florida (UF) Department of Medicine [000127914]; UF Graduate Student Fellowship; UF University Scholars Awards; NATIONAL CANCER INSTITUTE [R01CA113975] Funding Source: NIH RePORTER	University of Florida (UF) Department of Medicine; UF Graduate Student Fellowship; UF University Scholars Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Gatorade Trust through funds distributed by the University of Florida (UF) Department of Medicine, Award No. 000127914 (to SCG); a UF Graduate Student Fellowship to DB; and UF University Scholars Awards to CR and DM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2009, GASTROENTEROL HEPATO, V5, P705; Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Ali MY, 2014, CELL MOL BIOENG, V7, P532, DOI 10.1007/s12195-014-0345-8; Armitage OE, 2017, ACTA BIOMATER, V56, P36, DOI 10.1016/j.actbio.2016.12.036; Baker AM, 2013, ONCOGENE, V32, P1863, DOI 10.1038/onc.2012.202; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; Bush BG, 2015, SOFT MATTER, V11, P7191, DOI 10.1039/c5sm01210d; Carniel EL, 2014, EXP PHYSIOL, V99, P759, DOI 10.1113/expphysiol.2013.076091; Christensen MB, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0922-x; Darling EM, 2007, BIOPHYS J, V92, P1784, DOI 10.1529/biophysj.106.083097; Das T, 2015, NAT CELL BIOL, V17, P276, DOI 10.1038/ncb3115; Davis WC, 2017, EXPERT REV GASTROENT, V11, P393, DOI 10.1080/17474124.2017.1300529; de Bruyn JR, 2015, J CROHNS COLITIS, V9, P966, DOI 10.1093/ecco-jcc/jjv133; DEDOMBAL FT, 1966, BMJ-BRIT MED J, V1, P1442, DOI 10.1136/bmj.1.5501.1442; Degos F, 2010, J HEPATOL, V53, P1013, DOI 10.1016/j.jhep.2010.05.035; Di Paola M, 2009, INT J SOLIDS STRUCT, V46, P3124, DOI 10.1016/j.ijsolstr.2009.03.024; DiMarco RL, 2017, BIOMATERIALS, V129, P152, DOI 10.1016/j.biomaterials.2017.03.023; EDWARDS FC, 1964, GUT, V5, P1, DOI DOI 10.1136/GUT.5.1.1]; Eisenberg JL, 2011, RES REP BIOL, V2, P1, DOI 10.2147/RRB.S13178; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Gadaleta RM, 2011, EXPLORATION INFLAMMA, P13; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; GUMASTE V, 1992, GUT, V33, P938, DOI 10.1136/gut.33.7.938; Haage A, 2014, FASEB J, V28, P3589, DOI 10.1096/fj.13-245613; Hoeg H. D., 2000, Proceedings 2000 ICRA. Millennium Conference. IEEE International Conference on Robotics and Automation. Symposia Proceedings (Cat. No.00CH37065), P1599, DOI 10.1109/ROBOT.2000.844825; Huber A, 2015, EUR J RADIOL OPEN, V2, P90, DOI 10.1016/j.ejro.2015.05.002; Huynh J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002761; Johnson K. L., 1985, CONTACT MECH, DOI 10.1201/b17110-2; Johnson LA, 2013, INFLAMM BOWEL DIS, V19, P891, DOI 10.1097/MIB.0b013e3182813297; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Krndija D, 2010, ONCOGENE, V29, P2724, DOI 10.1038/onc.2010.25; Kyriacou SK, 2002, BIOMECH MODEL MECHAN, V1, P151, DOI 10.1007/s10237-002-0013-0; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Levental I, 2007, SOFT MATTER; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Matsuzaki S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44616; Meliga SC, 2017, ACTA BIOMATER, V48, P341, DOI 10.1016/j.actbio.2016.10.021; Mizoguchi A, 2016, J PATHOL, V238, P205, DOI 10.1002/path.4640; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; National Academy of Engineering, 2017, FRONT ENG, DOI [10.17226/23659, DOI 10.17226/23659]; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Palchesko RN, 2015, SCI REP-UK, V5, DOI 10.1038/srep07955; Pellino Gianluca, 2016, World J Gastrointest Pathophysiol, V7, P266, DOI 10.4291/wjgp.v7.i3.266; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Podra P, 1997, WEAR, V207, P79, DOI 10.1016/S0043-1648(96)07468-6; Qiao Y, 2005, J MATER SCI-MATER M, V16, P183, DOI 10.1007/s10856-005-5988-5; Rieder F, 2007, GUT, V56, P130, DOI 10.1136/gut.2006.090456; Rieder F, 2013, GUT, V62, P1072, DOI 10.1136/gutjnl-2012-304353; Rieder F, 2009, NAT REV GASTRO HEPAT, V6, P228, DOI 10.1038/nrgastro.2009.31; Salari-Sharif P, 2010, CURR PHARM DESIGN, V16, P3661, DOI 10.2174/138161210794079209; Sengupta N, 2007, PHYSIOLOGY, V22, P401, DOI 10.1152/physiol.00027.2007; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Smith LR, 2014, AM J PHYSIOL-CELL PH, V306, pC889, DOI 10.1152/ajpcell.00383.2013; Speca S, 2016, INFLAMM BOWEL DIS, V22, P279, DOI 10.1097/MIB.0000000000000618; Stewart DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177561; Stewart DC, 2016, ACTA BIOMATER, V45, P296, DOI 10.1016/j.actbio.2016.08.045; Stidham RW, 2011, GASTROENTEROLOGY, V141, P819, DOI 10.1053/j.gastro.2011.07.027; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tang X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-131; Vedula SRK, 2014, NAT MATER, V13, P87, DOI [10.1038/NMAT3814, 10.1038/nmat3814]; Vidi P-A, 2012, 3 DIMENSIONAL CULTUR, P193; Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Wells RG, 2013, BBA-MOL BASIS DIS, V1832, P884, DOI 10.1016/j.bbadis.2013.02.007; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamagata M, 2011, DIGESTION, V84, P12, DOI 10.1159/000320773; Zhang C, 2012, TRIBOL LETT, V47, P295, DOI 10.1007/s11249-012-9980-1; Ziegler A, 2016, CELL MOL GASTROENTER, V2, P716, DOI 10.1016/j.jcmgh.2016.09.003	71	34	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200377	10.1371/journal.pone.0200377	http://dx.doi.org/10.1371/journal.pone.0200377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995938	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800059
J	Yoo, S; Park, J; Cho, SY; Cho, MC; Jeong, H; Son, H				Yoo, Sangjun; Park, Juhyun; Cho, Sung Yong; Cho, Min Chul; Jeong, Hyeon; Son, Hwancheol			Usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia in view of global polyuria	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; MEN; NOCTURIA; RELIABILITY; VARIABLES; ADULTS	Purpose We aimed to determine the usefulness of the frequency-volume chart over the International Prostate Symptom Score in patients with benign prostatic hyperplasia. Furthermore, we investigated the clinical characteristics suggesting that patients could benefit from frequency-volume chart assessment in addition to International Prostate Symptom Score assessment. Methods A total of 193 patients with benign prostatic hyperplasia were analyzed. The relationship between the information obtained from the frequency-volume chart and the International Prostate Symptom Score was assessed. Because the urine output per kilogram per hour was not associated with any question in the International Prostate Symptom Score questionnaire, patients were divided into 2 groups according to the presence of global polyuria, defined as urine output >40 mL.kg(-1).h(-1). Multivariable analysis was performed to determine the predictors of global polyuria, and the results were externally validated using 397 patients with benign prostatic hyperplasia. Results Although the other information obtained from the frequency-volume chart correlated with the International Prostate Symptom Score, the urine output was not associated with the International Prostate Symptom Score. Based on these results, patients were dichotomized into the global polyuria group (n = 19, 9.8%) and the non-global polyuria group. Although the patient characteristics did not differ between the 2 groups, the number of voids was higher in patients with global polyuria. Multivariable analysis showed that diabetes mellitus (odds ratio: 3.497, p = 0.039) and increased number of voids (odds ratio: 1.320, p < 0.001) were significant predictors of global polyuria. On external validation, the area under curve for the model was 0.723. Conclusions Global polyuria cannot be suspected using the International Prostate Symptom Score, although it worsens the lower urinary tract symptoms of patients with benign prostatic hyperplasia. Assessment with the frequency-volume chart needs to be considered in diabetic patients with increased number of voids.	[Yoo, Sangjun; Park, Juhyun; Cho, Sung Yong; Cho, Min Chul; Jeong, Hyeon; Son, Hwancheol] Seoul Natl Univ, Dept Urol, Boramae Med Ctr, Seoul, South Korea; [Jeong, Hyeon; Son, Hwancheol] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Urol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Son, H (corresponding author), Seoul Natl Univ, Dept Urol, Boramae Med Ctr, Seoul, South Korea.; Son, H (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Urol, Coll Med, Seoul, South Korea.	volley@snu.ac.kr	CHO, MIN CHUL/R-7835-2019					Abrams P, 2013, J UROLOGY, V189, pS93, DOI 10.1016/j.juro.2012.11.021; BOSCH JLHR, 1995, BRIT J UROL, V75, P622, DOI 10.1111/j.1464-410X.1995.tb07421.x; Bryan NP, 2004, EUR UROL, V46, P636, DOI 10.1016/j.eururo.2004.07.023; D'Silva KA, 2014, JAMA-J AM MED ASSOC, V312, P535, DOI 10.1001/jama.2014.5555; Dani H, 2016, NAT REV UROL, V13, P573, DOI 10.1038/nrurol.2016.134; Fathollahi Ali, 2015, Curr Urol, V8, P119, DOI 10.1159/000365702; Gisolf KWH, 2000, EUR UROL, V38, P45, DOI 10.1159/000020251; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Homma Y, 2006, UROLOGY, V68, P318, DOI 10.1016/j.urology.2006.02.042; Jimenez-Cidre MA, 2015, NEUROUROL URODYNAM, V34, P128, DOI 10.1002/nau.22530; Johnson TV, 2007, J UROLOGY, V178, P623, DOI 10.1016/j.juro.2007.03.118; Ku JH, 2004, UROLOGY, V64, P966, DOI 10.1016/j.urology.2004.06.027; Mariappan P, 2007, BJU INT, V100, P332, DOI 10.1111/j.1464-410X.2007.06979.x; Soda T, 2010, J UROLOGY, V184, P1000, DOI 10.1016/j.juro.2010.05.038; Speakman M, 2015, BJU INT, V115, P508, DOI 10.1111/bju.12745; Stav K, 2009, J UROLOGY, V181, P2176, DOI 10.1016/j.juro.2009.01.042; Tam CA, 2017, UROLOGY, V105, P141, DOI 10.1016/j.urology.2017.03.040; van der Walt CLE, 2011, UROLOGY, V78, P17, DOI 10.1016/j.urology.2011.01.065; van Haarst EP, 2004, BJU INT, V93, P1257, DOI 10.1111/j.1464-4096.2004.04821.x; van Haarst EP, 2012, J UROLOGY, V188, P211, DOI 10.1016/j.juro.2012.03.010; Xiao N, 2013, J UROLOGY, V189, P1130, DOI 10.1016/j.juro.2012.08.222; Yap TL, 2007, BJU INT, V99, P9, DOI 10.1111/j.1464-410X.2006.06499.x; Yap TL, 2007, EUR UROL, V52, P811, DOI 10.1016/j.eururo.2007.01.013; Yap TL, 2009, BJU INT, V104, P1104, DOI 10.1111/j.1464-410X.2009.08497.x; Yokoyama O, 2013, INT J UROL, V20, P193, DOI 10.1111/j.1442-2042.2012.03130.x	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0197818	10.1371/journal.pone.0197818	http://dx.doi.org/10.1371/journal.pone.0197818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995878	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800005
J	Singh, V; Haque, S; Khare, S; Tiwari, AK; Katiyar, D; Banerjee, B; Kumari, K; Tripathi, CKM				Singh, Vineeta; Haque, Shafiul; Khare, Shruti; Tiwari, Anil Kumar; Katiyar, Diksha; Banerjee, Bikram; Kumari, Krishna; Tripathi, C. K. M.			Isolation and purification of antibacterial compound from Streptomyces levis collected from soil sample of north India	PLOS ONE			English	Article							OPTIMIZATION; ANTIBIOTICS; METABOLITES; CHROMONES	During the screening programme for microbial cultures producing antimicrobial agents, an active microbial strain of Streptomyces was isolated from the agricultural soil of Narnaul, Haryana India. Physiological, biochemical characteristics and 16S ribosomal RNA sequence homology studies revealed that it was similar to Streptomyces levis (sequence similarity 100%). The microbial strain was submitted to Genomebio Technologies Pvt. Ltd., Pune, Maharashtra, India under Accession No. EU124569. The isolated strain was found to produce extracellular active compound showing strong antimicrobial activity against Klebsiella pneumoniae MTCC 109, Pseudomonas aeruginosa MTCC 741 and Staphylococcus aureus MTCC 96. The antibacterial compound was successfully isolated and purified. Structure elucidation of antibacterial metabolite with EI-MS/HRMS showed molecular ion peak at m/z 686 [M+H](+). Whereas, elemental analysis of the said compound showed C = 61.31, H = 8.61, N = 2.04 and O = 28.02, and indicated a molecular formula of C35H59NO12. The presence of 'chromone' nucleus in the compound's chemical structure was confirmed by using (HNMR)-H-1 studies. The present study reports the purification of potential antibacterial compound from Streptomyces levis isolated from the unexplored soil of north India and warrants for further characterization of this potential compound for optimum utilization for antimicrobial purposes.	[Singh, Vineeta; Khare, Shruti; Banerjee, Bikram] Cent Drug Res Inst, CSIR, Microbiol Div, Lucknow, Uttar Pradesh, India; [Singh, Vineeta] Inst Engn & Technol, Dept Biotechnol, Lucknow, Uttar Pradesh, India; [Haque, Shafiul] Jazan Univ, Coll Nursing & Allied Hlth Sci, Res & Sci Studies Unit, Jazan, Saudi Arabia; [Tiwari, Anil Kumar] Lucknow Univ, Dept Chem, Lucknow, Uttar Pradesh, India; [Katiyar, Diksha] Banaras Hindu Univ, MMV, Dept Chem, Varanasi, Uttar Pradesh, India; [Kumari, Krishna; Tripathi, C. K. M.] Shri Ramswaroop Mem Univ, Dept Biotechnol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Institute of Engineering & Technology Lucknow; College Nursing & Allied Health Science Saudi Arabia; Jazan University; Lucknow University; Banaras Hindu University (BHU); Shri Ramswaroop Memorial University	Singh, V (corresponding author), Cent Drug Res Inst, CSIR, Microbiol Div, Lucknow, Uttar Pradesh, India.; Singh, V (corresponding author), Inst Engn & Technol, Dept Biotechnol, Lucknow, Uttar Pradesh, India.	vscdri@gmail.com	Singh, Vineeta/AAG-4731-2021; HAQUE, SHAFIUL/AAN-2946-2020	Singh, Vineeta/0000-0001-6787-8203; HAQUE, SHAFIUL/0000-0002-2989-121X; Katiyar, Diksha/0000-0003-4237-5516	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, New Delhi [SR/FT/LS-190/2009]	Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	The author (Dr. Vineeta Singh) sincerely acknowledges the Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, New Delhi for the financial support provided in the form of Young Scientist Fellowship under Fast Track Scheme (NO. SR/FT/LS-190/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BODEY GP, 1983, REV INFECT DIS, V5, P279; Cao LH, 2003, J CHIN CHEM SOC-TAIP, V50, P903, DOI 10.1002/jccs.200300127; Procopio RED, 2012, BRAZ J INFECT DIS, V16, P466, DOI 10.1016/j.bjid.2012.08.014; El Nekidy WS, 2017, IDCases, V9, P53, DOI 10.1016/j.idcr.2017.06.005; El-Sayed M. H., 2014, The Journal of American Science, V10, P169; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gogoi N. K., 2005, Indian Journal of Microbiology, V45, P231; GRIFFITHS PJ, 1972, SPECTROCHIM ACTA A-M, VA 28, P707, DOI 10.1016/0584-8539(72)80039-4; Harvey I, 2001, SYST APPL MICROBIOL, V24, P277, DOI 10.1078/0723-2020-00034; Holt J., 1994, BERGEYS MANUAL DETER; Huang ZH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-87; National Committee for Clinical Laboratory Standards, M7A5 NCCLS; Sharma M., 2014, INT J CURR MICROBIOL, V3, P801, DOI DOI 10.20546/IJCMAS.2017.602.089; Shazia Khaliq, 2013, African Journal of Microbiology Research, V7, P1874; Singh N, 2012, MED CHEM RES, V21, P3140, DOI 10.1007/s00044-011-9845-4; Singh V, 2008, MED CHEM RES, V17, P94, DOI 10.1007/s00044-007-9040-9; Singh V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01921; Taechowisan T., 2013, Journal of Applied Pharmaceutical Science, V3, P104; Tripathi CKM, 2004, MED CHEM RES, V13, P790, DOI 10.1007/s00044-004-0118-3; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345	21	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200500	10.1371/journal.pone.0200500	http://dx.doi.org/10.1371/journal.pone.0200500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990382	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300058
J	Lopez-Angulo, J; Pescador, DS; Sanchez, AM; Mihoc, MAK; Cavieres, LA; Escudero, A				Lopez-Angulo, Jesus; Pescador, David S.; Sanchez, Ana M.; Mihoc, Maritza A. K.; Cavieres, Lohengrin A.; Escudero, Adrian			Determinants of high mountain plant diversity in the Chilean Andes: From regional to local spatial scales	PLOS ONE			English	Article							SPECIES-RICHNESS; VASCULAR PLANTS; LATITUDINAL GRADIENTS; POSITIVE INTERACTIONS; BETA DIVERSITY; SOIL FERTILITY; HUMAN IMPACT; ECOSYSTEM; PATTERNS; HETEROGENEITY	Mountains are considered excellent natural laboratories for studying the determinants of plant diversity at contrasting spatial scales. To gain insights into how plant diversity is structured at different spatial scales, we surveyed high mountain plant communities in the Chilean Andes where man-driven perturbations are rare. This was done along elevational gradients located at different latitudes taking into account factors that act at fine scales, including abiotic (potential solar radiation and soil quality) and biotic (species interactions) factors, and considering multiple spatial scales. Species richness, inverse of Simpson's concentration (Dequiv), beta-diversity and plant cover were estimated using the percentage of cover per species recorded in 34 sites in the different regions with contrasted climates. Overall, plant species richness, Dequiv and plant cover were lower in sites located at higher latitudes. We found a unimodal relationship between species richness and elevation and this pattern was constant independently of the regional climatic conditions. Soil quality decreased the beta-diversity among the plots in each massif and increased the richness, the Dequiv and cover. Segregated patterns of species co-occurrence were related to increases in richness, Dequiv and plant cover at finer scales. Our results showed that elevation patterns of alpine plant diversity remained constant along the regions although the mechanisms underlying these diversity patterns may differ among climatic regions. They also suggested that the patterns of plant diversity in alpine ecosystems respond to a series of factors (abiotic and biotic) that act jointly at different spatial scale determining the assemblages of local communities, but their importance can only be assessed using a multi-scale spatial approach.	[Lopez-Angulo, Jesus; Pescador, David S.; Sanchez, Ana M.; Escudero, Adrian] Univ Rey Juan Carlos, Dept Biol Geol Fis & Quim Inorgan, Madrid, Spain; [Mihoc, Maritza A. K.; Cavieres, Lohengrin A.] Univ Concepcion, Dept Bot, Concepcion, Chile; [Cavieres, Lohengrin A.] Inst Ecol & Biodiversidad, Santiago, Chile	Universidad Rey Juan Carlos; Universidad de Concepcion	Lopez-Angulo, J (corresponding author), Univ Rey Juan Carlos, Dept Biol Geol Fis & Quim Inorgan, Madrid, Spain.	jesus.lopez.angulo@urjc.es	López-Angulo, Jesús/R-9019-2019; Pescador, David Sánchez/F-2672-2015; Escudero, Adrian/H-5046-2015	López-Angulo, Jesús/0000-0003-3539-2545; Pescador, David Sánchez/0000-0003-0395-9543; Escudero, Adrian/0000-0002-1427-5465; Sanchez, Ana M./0000-0002-6220-3001	Spanish Ministry of Economy and Competitiveness under the ROOTS project [CGL2015-66809-P]; pre-doctoral research grant [BES-2013-062921]; visiting researcher grant [EEBB-I-15-09290]; Comunidad de Madrid under the REMEDINAL 3 project [S2013/MAE-2719]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [1171005]; Consejo Nacional de Innovacion, Ciencia y Tecnologia [PFB 023]	Spanish Ministry of Economy and Competitiveness under the ROOTS project; pre-doctoral research grant; visiting researcher grant; Comunidad de Madrid under the REMEDINAL 3 project(Comunidad de Madrid); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Consejo Nacional de Innovacion, Ciencia y Tecnologia	This study was supported by the Spanish Ministry of Economy and Competitiveness under the ROOTS project (CGL2015-66809-P), a pre-doctoral research grant (BES-2013-062921) and a visiting researcher grant (EEBB-I-15-09290), the Comunidad de Madrid under the REMEDINAL 3 project (S2013/MAE-2719), the Fondo Nacional de Desarrollo Cientifico y Tecnologico (1171005) and the Consejo Nacional de Innovacion, Ciencia y Tecnologia (PFB 023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J. M., 1993, DOI 10.1097/00010694-199404000-00012; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; [Anonymous], 2021, LANG ENV STAT COMP; Arroyo MTK, 2003, PLANT ECOL, V169, P121, DOI 10.1023/A:1026281405115; Badano EI, 2006, J BIOGEOGR, V33, P304, DOI 10.1111/j.1365-2699.2005.01384.x; BILLINGS WD, 1973, BIOSCIENCE, V23, P697, DOI 10.2307/1296827; Brooker RW, 2009, AM NAT, V174, P919, DOI 10.1086/648058; Bruun HH, 2006, J VEG SCI, V17, P37, DOI 10.1111/j.1654-1103.2006.tb02421.x; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres L, 2002, J VEG SCI, V13, P547, DOI 10.1111/j.1654-1103.2002.tb02081.x; Cavieres LA, 2006, NEW PHYTOL, V169, P59, DOI 10.1111/j.1469-8137.2005.01573.x; Cavieres LA, 2000, REV CHIL HIST NAT, V73, P331; Cavieres LA, 2007, ARCT ANTARCT ALP RES, V39, P229, DOI 10.1657/1523-0430(2007)39[229:MMOCPA]2.0.CO;2; Cavieres LA, 2016, FUNCT ECOL, V30, P52, DOI 10.1111/1365-2435.12545; Cavieres LA, 2014, ECOL LETT, V17, P193, DOI 10.1111/ele.12217; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Chatterjee S., 2001, REGRESSION ANAL EXAM; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Delgado-Baquerizo M, 2013, NATURE, V502, P672, DOI 10.1038/nature12670; Dorji T, 2014, ARCT ANTARCT ALP RES, V46, P308, DOI 10.1657/1938-4246-46.2.308; EHLERINGER JR, 1975, ECOLOGY, V56, P370, DOI 10.2307/1934967; Eilts JA, 2011, AM NAT, V177, P574, DOI 10.1086/659633; EIVAZI F, 1988, SOIL BIOL BIOCHEM, V20, P601, DOI 10.1016/0038-0717(88)90141-1; Escudero A, 2004, ARCT ANTARCT ALP RES, V36, P518, DOI 10.1657/1523-0430(2004)036[0518:PDAIOF]2.0.CO;2; Gandullo J, 1974, I NAC INVESTIG AGRAR, V1, P95; Gimenez-Benavides L, 2007, NEW PHYTOL, V173, P367, DOI 10.1111/j.1469-8137.2006.01932.x; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Graae BJ, 2018, PERSPECT PLANT ECOL, V30, P41, DOI 10.1016/j.ppees.2017.09.008; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grytnes JA, 2003, ECOGRAPHY, V26, P291, DOI 10.1034/j.1600-0587.2003.03358.x; Grytnes JA, 2006, ACTA OECOL, V29, P241, DOI 10.1016/j.actao.2005.10.007; Harmon LJ, 2015, AM NAT, V185, P584, DOI 10.1086/680859; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huber UM, 2003, HOLOCENE, V13, P567, DOI 10.1191/0959683603hl647rp; Jax K., 2010, ECOSYSTEM FUNCTIONIN; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kikvidze Z, 2005, ECOLOGY, V86, P1395, DOI 10.1890/04-1926; Kikvidze Z, 2015, ECOLOGY, V96, P2064, DOI 10.1890/14-2443.1; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; KUDO G, 1992, VEGETATIO, V98, P165, DOI 10.1007/BF00045554; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lopez-Angulo J, 2018, J VEG SCI, V29, P245, DOI 10.1111/jvs.12607; Luzuriaga AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041270; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; Mendez E, 2014, B SOC ARGENT BOT, V49, P257; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Mihoc MAK, 2016, PLANT SOIL, V408, P31, DOI 10.1007/s11104-016-2908-z; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Moser D, 2005, J BIOGEOGR, V32, P1117, DOI 10.1111/j.1365-2699.2005.01265.x; Munkemuller T, 2014, GLOBAL ECOL BIOGEOGR, V23, P620, DOI 10.1111/geb.12137; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olofsson J, 2008, OECOLOGIA, V156, P825, DOI 10.1007/s00442-008-1038-6; Pescador DS, 2014, NEW PHYTOL, V204, P140, DOI 10.1111/nph.12899; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Reverter BR, 2010, BIOGEOSCIENCES, V7, P2601, DOI 10.5194/bg-7-2601-2010; Reynolds HL, 2009, APPL VEG SCI, V12, P33, DOI 10.1111/j.1654-109X.2009.01020.x; Ricklefs RE, 2008, AM NAT, V172, P741, DOI 10.1086/593002; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rother DC, 2016, OIKOS, V125, P336, DOI 10.1111/oik.02629; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Santibanez F, 1990, ATLAS AGROCLIMATICO; Sarricolea P, 2017, J MAPS, V13, P66, DOI 10.1080/17445647.2016.1259592; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; Schworer C, 2015, J ECOL, V103, P281, DOI 10.1111/1365-2745.12354; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; TABATABAI M. A., 1969, Soil Biology and Biochemistry, V1, P301, DOI 10.1016/0038-0717(69)90012-1; Vazquez JA, 1998, J ECOL, V86, P999, DOI 10.1046/j.1365-2745.1998.00325.x; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	84	13	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200216	10.1371/journal.pone.0200216	http://dx.doi.org/10.1371/journal.pone.0200216			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979767	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500079
J	Romero-Gonzalez, B; Caparros-Gonzalez, RA; Gonzalez-Perez, R; Delgado-Puertas, P; Peralta-Ramirez, MI				Romero-Gonzalez, Borja; Caparros-Gonzalez, Rafael A.; Gonzalez-Perez, Raquel; Delgado-Puertas, Pilar; Isabel Peralta-Ramirez, Maria			Newborn infants' hair cortisol levels reflect chronic maternal stress during pregnancy	PLOS ONE			English	Article							PRENATAL STRESS; SALIVARY CORTISOL; PERCEIVED STRESS; SPANISH VERSION; DISEASE RISK; DISTRESS; OUTCOMES; WOMEN; DETERMINANTS; MECHANISMS	Cortisol obtained from hair samples represents a retrospective biomarker of chronic stress experienced by the subject in previous months. Although hair cortisol levels have been used to study the relationship between maternal and neonatal stress levels in primates, this has not yet been performed in humans using a longitudinal design and focusing specifically on this association. Therefore, the objective of this study was to determine whether a relationship existed between maternal psychological stress and hair cortisol levels during pregnancy and postpartum, and neonatal hair cortisol levels. The sample consisted of 80 pregnant women and their 80 newborn infants. We conducted a longitudinal assessment of hair cortisol levels, psychological stress, anxiety, and depression in the three trimesters of pregnancy and postpartum. After childbirth, neonatal hair cortisol levels were also measured. We found that maternal hair cortisol levels in the first trimester negatively predicted neonatal hair cortisol levels. Perceived stress in the third trimester of pregnancy also predicted lower neonatal cortisol, whereas pregnancy-specific stress in the same trimester had a positive relation with neonatal cortisol. Cortisol is essential for embryonic and fetal development; consequently, if fetal synthesis of cortisol is affected by high maternal cortisol levels, such development could be impaired.	[Romero-Gonzalez, Borja; Caparros-Gonzalez, Rafael A.; Delgado-Puertas, Pilar; Isabel Peralta-Ramirez, Maria] Univ Granada, Fac Psychol, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Romero-Gonzalez, Borja; Isabel Peralta-Ramirez, Maria] Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Caparros-Gonzalez, Rafael A.] Hosp Poniente, Dept Gynecol & Obstet, El Ejido, Spain; [Gonzalez-Perez, Raquel] Univ Granada, Dept Pharmacol, CIBERehd, Sch Pharm,Inst Invest Biosanitaria Ibs, Granada, Spain	University of Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Peralta-Ramirez, MI (corresponding author), Univ Granada, Fac Psychol, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.; Peralta-Ramirez, MI (corresponding author), Univ Granada, Dept Personal Assessment & Psychol Treatment, Granada, Spain.	mperalta@ugr.es	Romero-Gonzalez, Borja/ABF-5918-2020; Romero-Gonzalez, Borja/X-7551-2018; Peralta, Maria Isabel MI/I-3920-2015; Caparros-Gonzalez, Rafael A./P-1519-2015	Romero-Gonzalez, Borja/0000-0002-6350-1836; Romero-Gonzalez, Borja/0000-0002-6350-1836; Peralta, Maria Isabel MI/0000-0001-8201-8906; Caparros-Gonzalez, Rafael A./0000-0002-0565-1123	Spanish Ministry of Science and Innovation [PSI2015-63494-P]; funds/European Regional Development Fund (ERDF); Spanish Ministry of Economy, Industry and Competitiveness, FPI Program [BES-2016-077619]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); funds/European Regional Development Fund (ERDF); Spanish Ministry of Economy, Industry and Competitiveness, FPI Program	This work was supported by the I+D Project "PSI2015-63494-P" of the Spanish Ministry of Science and Innovation (url: http:// www.idi.mineco.gob.es/portal/site/MICINN/ menuitem 00d7c011ca2a3753222b7d100143 2ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD); co-supported by funds/European Regional Development Fund (ERDF)-a way to build Europe (MIPR). Besides, Mr. Borja Romero-Gonzalez has been awarded with an individual research grant (Spanish Ministry of Economy, Industry and Competitiveness, FPI Program, reference number BES-2016-077619) (url: http://www.idi.mineco.gob.es/portal/site/ MICININ/menuitem.00d17c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aet110V gnVCM1000001034e20aRCRD). The funders' role was providing funding for data collection and analysis, and preparation of the manuscript.	Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; Andalusian Ministry of Health, 2010, PREGN HLTH DOC; Bastani Farideh, 2005, J Midwifery Womens Health, V50, pe36, DOI 10.1016/j.jmwh.2004.11.008; Beijers R, 2014, EUR CHILD ADOLES PSY, V23, P943, DOI 10.1007/s00787-014-0566-3; Bernhard W, 2016, ANN ANAT, V208, P146, DOI 10.1016/j.aanat.2016.08.003; Busada JT, 2017, CURR TOP DEV BIOL, V125, P147, DOI 10.1016/bs.ctdb.2016.12.004; Caparros-Caparros B, 2007, INT J CLIN HLTH PSYC, V7, P781; Caparros-Gonzalez RA, 2015, J REPROD INFANT PSYC, V33, pE36; Caparros-Gonzalez RA, 2018, ADV NEONAT CARE, V18, P58, DOI 10.1097/ANC.0000000000000448; Caparros-Gonzalez RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182817; Cardwell MS, 2013, OBSTET GYNECOL SURV, V68, P119, DOI 10.1097/OGX.0b013e31827f2481; Chen Z, 2013, J CHROMATOGR B, V929, P187, DOI 10.1016/j.jchromb.2013.04.026; Chung HR., 2014, KOREAN J PEDIAT, V57, P431, DOI [10.3345/kjp.2014.57.10.431, DOI 10.3345/KJP.2014.57.10.431]; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; Davis EP, 2011, J CHILD PSYCHOL PSYC, V52, P119, DOI 10.1111/j.1469-7610.2010.02314.x; Derogatis LR, 1975, SYMPTOM CHECKLIST 90; Dettmer AM, 2017, AM J PRIMATOL, V79, DOI 10.1002/ajp.22489; Dettmer AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131692; Entringer S, 2015, PSYCHONEUROENDOCRINO, V62, P366, DOI 10.1016/j.psyneuen.2015.08.019; Evans LM, 2008, ARCH WOMEN MENT HLTH, V11, P239, DOI 10.1007/s00737-008-0019-4; Field A., 2013, DISCOVERING STAT USI; Flom M, 2017, DEV PSYCHOBIOL, V59, P26, DOI 10.1002/dev.21449; Glover V, 2009, PSYCHONEUROENDOCRINO, V34, P430, DOI 10.1016/j.psyneuen.2008.10.005; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Grass J, 2015, PSYCHONEUROENDOCRINO, V53, P108, DOI 10.1016/j.psyneuen.2014.12.023; Gray NA, 2018, PSYCHONEUROENDOCRINO, V87, P204, DOI 10.1016/j.psyneuen.2017.10.022; Hoffman MC, 2017, DEV PSYCHOBIOL, V59, P123, DOI 10.1002/dev.21433; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Kapoor A, 2016, PSYCHONEUROENDOCRINO, V66, P111, DOI 10.1016/j.psyneuen.2016.01.010; Karlen J, 2015, PEDIATRICS, V135, pE1450, DOI 10.1542/peds.2014-2561; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; Laurent HK, 2017, DEV PSYCHOL, V53, P417, DOI 10.1037/dev0000258; Liu CH, 2017, DEV PSYCHOBIOL, V59, P916, DOI 10.1002/dev.21557; Lobel M., 2016, ENCY MENTAL HLTH, V3, P318, DOI [DOI 10.1016/B978-0-12-397045-9.00164-6, 10.1016/B978-0-12-397045-9.00164-6]; Massey AJ, 2016, PSYCHONEUROENDOCRINO, V74, P397, DOI 10.1016/j.psyneuen.2016.08.027; Merlot E, 2008, BRAIN BEHAV IMMUN, V22, P42, DOI 10.1016/j.bbi.2007.05.007; Meyer J, 2014, JOVE-J VIS EXP, DOI 10.3791/50882; Mustonen P, 2018, PSYCHONEUROENDOCRINO, V92, P21, DOI 10.1016/j.psyneuen.2018.03.019; Perez-Ramirez F, 2017, J REPROD INFANT PSYC, V35, P159, DOI 10.1080/02646838.2016.1246709; Rakers F, 2020, NEUROSCI BIOBEHAV R, V117, P185, DOI 10.1016/j.neubiorev.2017.02.019; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Roberts D, 2017, COCHRANE DB SYST REV, P1, DOI [10.1002/14651858, DOI 10.1002/14651858.CD004454]; Ruiz RJ, 2005, ADV NURS SCI, V28, P345, DOI 10.1097/00012272-200510000-00006; Russell E, 2015, THER DRUG MONIT, V37, P71, DOI 10.1097/FTD.0000000000000148; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Stalder T, 2017, PSYCHONEUROENDOCRINO, V77, P261, DOI 10.1016/j.psyneuen.2016.12.017; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Steudte S, 2011, PSYCHONEUROENDOCRINO, V36, P1193, DOI 10.1016/j.psyneuen.2011.02.012; Su Q, 2015, PEDIATR NEONATOL, V56, P376, DOI 10.1016/j.pedneo.2015.02.002; Talavera MM, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-1119; Van den Bergh BRH, 2017, NEUROSCI BIOBEHAV R, DOI [10.1016/j.neubiorev.2017.07.003, DOI 10.1016/J.NEUBIOREV.2017.07.003]; Voegtline KM, 2013, ARCH WOMEN MENT HLTH, V16, P101, DOI 10.1007/s00737-012-0321-z; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Witalison EE, 2015, CURR DRUG TARGETS, V16, P700, DOI 10.2174/1389450116666150202160954; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575	56	46	46	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200279	10.1371/journal.pone.0200279	http://dx.doi.org/10.1371/journal.pone.0200279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979751	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500089
J	Dhanasekaran, K; Bose, A; Rao, VJ; Boopathi, R; Shankar, SR; Rao, VK; Swaminathan, A; Vasudevan, M; Taneja, R; Kundu, TK				Dhanasekaran, Karthigeyan; Bose, Arnab; Rao, Vinay J.; Boopathi, Ramachandran; Shankar, Shilpa Rani; Rao, Vinay Kumar; Swaminathan, Amrutha; Vasudevan, Madavan; Taneja, Reshma; Kundu, Tapas K.			Unraveling the role of aurora A beyond centrosomes and spindle assembly: implications in muscle differentiation	FASEB JOURNAL			English	Article						E2F4; subcellular localization; gene network	KINASE-ACTIVITY; A KINASE; E2F4; EXPRESSION; MYOD; TRANSCRIPTION; ACTIVATION; GROWTH	Aurora kinases are critical mitotic serine/threonine kinases and are often implicated in tumorigenesis. Recent studies of the interphase functions for aurora kinase (Aurk)A have considerably expanded our understanding of its role beyond mitosis. To identify the unknown targets of AurkA, we used peptide array-based screening and found E2F4 to be a novel substrate. Phosphorylation of E2F4 by AurkA at Ser75 regulates its DNA binding and subcellular localization. Because E2F4 plays an important role in skeletal muscle differentiation, we attempted to gain insight into E2F4 phosphorylation in this context. We observed that a block in E2F4 phosphorylation retained it better within the nucleus and inhibited muscle differentiation. RNA sequencing analysis revealed a perturbation of the gene network involved in the process of muscle differentiation and mitochondrial biogenesis. Collectively, our findings establish a novel role of AurkA in the process of skeletal muscle differentiation.Dhanasekaran, K., Bose, A., Rao, V. J., Boopathi, R., Shankar, S. R., Rao, V. K., Swaminathan, A., Vasudevan, M., Taneja, R., Kundu, T. K. Unravelling the role of aurora A beyond centrosomes and spindle assembly: implications in muscle differentiation.	[Dhanasekaran, Karthigeyan; Bose, Arnab; Rao, Vinay J.; Boopathi, Ramachandran; Swaminathan, Amrutha; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Jakkur PO, Bangalore 560064, Karnataka, India; [Shankar, Shilpa Rani; Rao, Vinay Kumar; Taneja, Reshma] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol Cellular Differentiat & Apoptosis, Singapore, Singapore; [Vasudevan, Madavan] Bionivid Technol Private Ltd, Bangalore, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); National University of Singapore	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Transcript & Dis Lab, Jakkur PO, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Dhanasekaran, Karthigeyan/AAO-6380-2021; Swaminathan, Amrutha/F-8409-2016; Taneja, Reshma/F-9658-2014	Swaminathan, Amrutha/0000-0002-0177-3756; Taneja, Reshma/0000-0002-2151-2094; Kundu, Tapas/0000-0001-7790-214X; Reshma, Taneja/0000-0001-6214-6177; Rao, Vinay/0000-0002-2188-7670	Government of India's Council of Scientific and Industrial Research (CSIR); Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR); Sir J.C. Bose National Fellowship, Department of Science and Technology, Government of India; Department of Biotechnology, Government of India, through Chromatin and Disease: Program Support [BT/01/CEIB/10/111/01]	Government of India's Council of Scientific and Industrial Research (CSIR); Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR)(Department of Science & Technology (India)); Sir J.C. Bose National Fellowship, Department of Science and Technology, Government of India; Department of Biotechnology, Government of India, through Chromatin and Disease: Program Support	The authors thank Suma Bangalore Srinivas, Jawaharial Nehru Centre for Advanced Scientific Research for confocal imaging. K.D., A.B., and A.S. were supported by grants from Government of India's Council of Scientific and Industrial Research (CSIR). T.K.K. acknowledges Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) for partial financial support. T.K.K. is a recipient of Sir J.C. Bose National Fellowship, Department of Science and Technology, Government of India. This work was supported by grants from the Department of Biotechnology, Government of India, through Chromatin and Disease: Program Support (Grant BT/01/CEIB/10/111/01 dated 30.09.2011). The authors declare no conflicts of interest.	Amabile G, 2009, CELL DEATH DIFFER, V16, P321, DOI 10.1038/cdd.2008.156; Andres V, 1996, J CELL BIOL, V132, P657, DOI 10.1083/jcb.132.4.657; Ayoob JC, 2000, CELL MOTIL CYTOSKEL, V45, P67, DOI 10.1002/(SICI)1097-0169(200001)45:1<67::AID-CM7>3.3.CO;2-K; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; CORBEIL HB, 1995, ONCOGENE, V11, P909; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Ferri P, 2009, J CELL BIOCHEM, V108, P1302, DOI 10.1002/jcb.22360; Fry CJ, 1997, MOL CELL BIOL, V17, P1966, DOI 10.1128/MCB.17.4.1966; Good LF, 1996, J CELL PHYSIOL, V168, P580, DOI 10.1002/(SICI)1097-4652(199609)168:3<580::AID-JCP10>3.0.CO;2-3; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Karthigeyan D, 2011, MED RES REV, V31, P757, DOI 10.1002/med.20203; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koch A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001588; Lee BK, 2011, NUCLEIC ACIDS RES, V39, P3558, DOI 10.1093/nar/gkq1313; Li FQ, 2000, MOL CELL BIOL, V20, P5129, DOI 10.1128/MCB.20.14.5129-5139.2000; Lindeman GJ, 1997, P NATL ACAD SCI USA, V94, P5095, DOI 10.1073/pnas.94.10.5095; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Litovchick L, 2011, GENE DEV, V25, P801, DOI 10.1101/gad.2034211; Lu LY, 2008, J BIOL CHEM, V283, P31785, DOI 10.1074/jbc.M805880200; Puri PL, 1998, CANCER RES, V58, P1325; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Ramachandran B, 2008, J BIOL CHEM, V283, P11935, DOI 10.1074/jbc.M707389200; Sardon T, 2010, EMBO REP, V11, P977, DOI 10.1038/embor.2010.171; Takitoh T, 2012, J NEUROSCI, V32, P11050, DOI 10.1523/JNEUROSCI.5664-11.2012; Tomita M, 2010, CANCER SCI, V101, P1204, DOI 10.1111/j.1349-7006.2010.01499.x; Torchia EC, 2013, J INVEST DERMATOL, V133, P78, DOI 10.1038/jid.2012.249; Troiani S, 2005, J PROTEOME RES, V4, P1296, DOI 10.1021/pr050018e; Turnacioglu KK, 1997, CELL STRUCT FUNCT, V22, P73, DOI 10.1247/csf.22.73; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; Wang DW, 2012, CELL MOL LIFE SCI, V69, P1855, DOI 10.1007/s00018-011-0901-5; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yan M, 2016, MED RES REV, V36, P1036, DOI 10.1002/med.21399	32	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					219	230		10.1096/fj.201800997	http://dx.doi.org/10.1096/fj.201800997			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29995440				2022-12-26	WOS:000457401500018
J	Macdonald-Obermann, JL; Pike, LJ				Macdonald-Obermann, Jennifer L.; Pike, Linda J.			Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epidermal growth factor (EGF); epidermal growth factor receptor (EGFR); tyrosine-protein kinase (tyrosine kinase); growth factor; inhibitor; erlotinib; lapatinib; Ligand binding	C-TERMINAL TAIL; LUNG-CANCER; NEGATIVE COOPERATIVITY; AUTOPHOSPHORYLATION SITES; EXTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; CARCINOMA-CELLS; PHORBOL ESTERS; ACTIVATION; DIMERIZATION	The epidermal growth factor (EGF) receptor is a classical receptor tyrosine kinase with an extracellular ligand-binding domain and an intracellular kinase domain. Mutations in the EGF receptor have been shown to drive uncontrolled cell growth and are associated with a number of different tumors. Two different types of ATP-competitive EGF receptor tyrosine kinase inhibitors have been identified that bind to either the active (type I) or inactive (type II) conformation of the kinase domain. Despite the fact that both types of inhibitors block tyrosine kinase activity, they exhibit differential efficacies in different tumor types. Here, we show that in addition to inhibiting kinase activity, these inhibitors allosterically modulate ligand binding. Our data suggest that the conformations of the EGF receptor extracellular domain and intracellular kinase domain are coupled and that these conformations exist in equilibrium. Allosteric regulators, such as the small-molecule tyrosine kinase inhibitors, as well as mutations in the EGF receptor itself, shift the conformational equilibrium among the active and inactive species, leading to changes in EGF receptor-binding affinity. Our studies also reveal unexpected positive cooperativity between EGF receptor subunits in dimers formed in the presence of type II inhibitors. These findings indicate that there is strong functional coupling between the intracellular and extracellular domains of this receptor. Such coupling may impact the therapeutic synergy between small-molecule tyrosine kinase inhibitors and monoclonal antibodies in vivo.	[Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			NIGMS NIH HHS [R01 GM108785] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108785] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adak S, 2011, J BIOL CHEM, V286, P45146, DOI 10.1074/jbc.M111.274175; Adak S, 2011, J BIOL CHEM, V286, P1545, DOI 10.1074/jbc.M110.182899; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Bessman NJ, 2014, CELL REP, V9, P1306, DOI 10.1016/j.celrep.2014.10.010; Bose R, 2009, EXP CELL RES, V315, P649, DOI 10.1016/j.yexcr.2008.07.031; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; COKER KJ, 1994, P NATL ACAD SCI USA, V91, P6967, DOI 10.1073/pnas.91.15.6967; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gill K, 2017, J BIOL CHEM, V292, P20744, DOI 10.1074/jbc.M117.802553; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; KING AC, 1982, J BIOL CHEM, V257, P3053; Kovacs E, 2015, MOL CELL BIOL, V35, P3083, DOI 10.1128/MCB.00248-15; Kozer N, 2014, BIOCHEMISTRY-US, V53, P2594, DOI 10.1021/bi500182x; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lichtner RB, 2001, CANCER RES, V61, P5790; Lu CF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.414391; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; MARGOLIS BL, 1989, J BIOL CHEM, V264, P10667; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Needham SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13307; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Schlessinger J, 2003, SCI STKE, P12; Schmitz KR, 2013, STRUCTURE, V21, P1214, DOI 10.1016/j.str.2013.05.008; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Valley CC, 2015, MOL BIOL CELL, V26, P4087, DOI 10.1091/mbc.E15-05-0269; Vivanco I, 2012, CANCER DISCOV, V2, P458, DOI 10.1158/2159-8290.CD-11-0284; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	59	10	11	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13401	13414		10.1074/jbc.RA118.004139	http://dx.doi.org/10.1074/jbc.RA118.004139			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29997256	Green Published, hybrid			2022-12-26	WOS:000443375500005
J	Molodtsov, V; Murakami, KS				Molodtsov, Vadim; Murakami, Katsuhiko S.			Minimalism and functionality: Structural lessons from the heterodimeric N4 bacteriophage RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						RNA polymerase; DNA transcription; X-ray crystallography; viral transcription; RNA synthesis; N4 phage; transcription complex; X-ray structure; transcription	TRANSCRIPTION INITIATION; CRYSTAL-STRUCTURE; MITOCHONDRIAL; DNA; ELONGATION; TRANSITION; DOMAIN	Genomes of phages, mitochondria, and chloroplasts are transcribed by a diverse group of transcriptional machineries with structurally related single-subunit RNA polymerases (RNAPs). Our understanding of transcription mechanisms of these enzymes is predominantly based on biochemical and structural studies of three most-studied members, transcription factor-independent phage T7 RNAP, transcription factor-dependent phage N4 virion-encapsidated RNAP, and transcription factor-dependent mitochondrial RNAPs (mtRNAP). Although these RNAPs employ completely different mechanisms for promoter recognition and transcription termination, these enzymes are relatively large and formed by single polypeptides. Historically being a model enzyme for studying the mechanisms of transcription by T7-like RNAPs, however, T7 RNAP represents only a small group of RNAPs in this family. The vast majority of T7-like RNAPs are transcription factor-dependent, and several of them are heterodimeric enzymes. Here, we report X-ray crystal structures of transcription complexes of the smallest and heterodimeric form of T7-like RNAP, bacteriophage N4 RNAPII, providing insights into the structural organization of a minimum RNAP in this family. We analyze structural and functional aspects of heterodimeric architecture of N4 RNAPII concerning the mechanisms of transcription initiation and transition to processive RNA elongation. Interestingly, N4 RNAPII maintains the same conformation in promoter-bound and elongation transcription complexes, revealing a novel transcription mechanism for single-subunit RNAPs. This work establishes a structural basis for studying mechanistic aspects of transcription by factor-dependent minimum RNAP.	[Molodtsov, Vadim; Murakami, Katsuhiko S.] Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Molodtsov, V; Murakami, KS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Ctr RNA Mol Biol, University Pk, PA 16802 USA.	vum5@psu.edu; kum14@psu.edu		Murakami, Katsuhiko/0000-0003-2244-0501; Molodtsov, Vadim/0000-0003-3002-4794	National Institutes of Health [GM087350]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM087350 (to K. S. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAVAYA K, 1989, J BIOL CHEM, V264, P12695; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Basu RS, 2014, J BIOL CHEM, V289, P24549, DOI 10.1074/jbc.M114.584037; Basu RS, 2013, J BIOL CHEM, V288, P3305, DOI 10.1074/jbc.M112.387712; Carter RH, 2003, GENE DEV, V17, P2334, DOI 10.1101/gad.1121403; Cermakian N, 1996, NUCLEIC ACIDS RES, V24, P648, DOI 10.1093/nar/24.4.648; CHAMBERL.M, 1970, NATURE, V228, P227, DOI 10.1038/228227a0; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 2000, CURR OPIN STRUC BIOL, V10, P117, DOI 10.1016/S0959-440X(99)00058-5; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Hillen HS, 2017, CELL, V171, P1072, DOI 10.1016/j.cell.2017.10.036; Hillen HS, 2017, CELL, V171, P1082, DOI 10.1016/j.cell.2017.09.035; Jeruzalmi D, 1998, EMBO J, V17, P4101, DOI 10.1093/emboj/17.14.4101; Kazmierczak KM, 2002, EMBO J, V21, P5815, DOI 10.1093/emboj/cdf584; Lenneman BR, 2015, BIOMOLECULES, V5, P647, DOI 10.3390/biom5020647; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; ROTHMANDENES LB, 1974, VIROLOGY, V60, P65, DOI 10.1016/0042-6822(74)90366-3; Schwinghammer K, 2013, NAT STRUCT MOL BIOL, V20, P1298, DOI 10.1038/nsmb.2683; Segall-Shapiro TH, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145299; Shis DL, 2013, P NATL ACAD SCI USA, V110, P5028, DOI 10.1073/pnas.1220157110; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; VANDERLAAN K, 1977, VIROLOGY, V76, P596, DOI 10.1016/0042-6822(77)90241-0; Willis SH, 2002, J BACTERIOL, V184, P4952, DOI 10.1128/JB.184.18.4952-4961.2002; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	33	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13616	13625		10.1074/jbc.RA118.003447	http://dx.doi.org/10.1074/jbc.RA118.003447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991593	Green Published, hybrid			2022-12-26	WOS:000443375500021
J	Johnstone, AD; Hallett, RM; de Leon, A; Carturan, B; Gibon, J; Barker, PA				Johnstone, Aaron D.; Hallett, Robin M.; de Leon, Andres; Carturan, Bruno; Gibon, Julien; Barker, Philip A.			A novel method for quantifying axon degeneration	PLOS ONE			English	Article							INTRACELLULAR CALCIUM; SENSORY NEURONS; MECHANISMS; APOPTOSIS	Axons normally degenerate during development of the mammalian nervous system, but dysregulation of the same genetically-encoded destructive cellular machinery can destroy crucial structures during adult neurodegenerative diseases. Nerve growth factor (NGF) withdrawal from dorsal root ganglia (DRG) axons is a well-established in vitro experimental model for biochemical and cell biological studies of developmental degeneration. Definitive methods for measuring axon degeneration have been lacking and here we report a novel method of axon degeneration quantification from bulk cultures of DRG that enables objective and automated measurement of axonal density over the entire field of radial axon outgrowth from the ganglion. As proof of principal, this new method, written as an R script called Axoquant 2.0, was used to examine the role of extracellular Ca2+ in the execution of cytoskeletal disassembly during degeneration of NGF-deprived DRG axons. This method can be easily applied to examine degenerative or neuroprotective effects of gene manipulations and pharmacological interventions.	[Johnstone, Aaron D.; de Leon, Andres] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Johnstone, Aaron D.; de Leon, Andres; Carturan, Bruno; Gibon, Julien; Barker, Philip A.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Hallett, Robin M.] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada	McGill University; University of British Columbia; University of British Columbia Okanagan; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Barker, PA (corresponding author), Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada.	philip.barker@ubc.ca		Gibon, Julien/0000-0001-7216-5806; Barker, Philip/0000-0001-7873-8476; Carturan, Bruno/0000-0001-6811-1063	Canadian Institute of Health Research [MOP137057]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by the Canadian Institute of Health Research to P.A.B grant number MOP137057. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DECKWERTH TL, 1993, ANN NY ACAD SCI, V679, P121, DOI 10.1111/j.1749-6632.1993.tb18293.x; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; EICHLER ME, 1992, J NEUROCHEM, V58, P263, DOI 10.1111/j.1471-4159.1992.tb09305.x; Eichler ME, 1994, J NEUROCHEM; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Kandan NM, 2013, EXP NEUROL, V246, P44, DOI 10.1016/j.expneurol.2012.06.003; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384; LEVIMONTALCINI R, 1953, J EXP ZOOL, V123, P233, DOI 10.1002/jez.1401230203; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pchitskaya E, 2018, CELL CALCIUM, V70, P87, DOI 10.1016/j.ceca.2017.06.008; Prudent J, 2015, MOL CELL, V59, P941, DOI 10.1016/j.molcel.2015.08.001; Sanabria-Castro A, 2017, ANN NEUROSCI, V24, P46, DOI 10.1159/000464422; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schampel A, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6040043; Schuldiner O, 2014, CELL MOL LIFE SCI; SHOLL DA, 1953, J ANAT, V87, P387; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Surmeier DJ, 2017, EXP NEUROL, V298, P202, DOI 10.1016/j.expneurol.2017.08.001; Tong JX, 1996, EXP NEUROL, V138, P45, DOI 10.1006/exnr.1996.0045; Unsain N, 2014, JOVE-J VIS EXP, DOI 10.3791/51795; Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Vogelbaum MA, 1998, J NEUROSCI, V18, P8928; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034	26	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199570	10.1371/journal.pone.0199570	http://dx.doi.org/10.1371/journal.pone.0199570			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020957	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400020
J	Kim, Y; Kumar, S				Kim, Yonggyun; Kumar, Sunil			Persistent expression of Cotesia plutellae bracovirus genes in parasitized host, Plutella xylostella	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DIAMONDBACK MOTH; TRANSIENT EXPRESSION; HEMOCYTE POPULATION; CDNA CLONING; PURIFICATION; SILKWORM; SUPPRESS; IMMUNITY; REVEALS	Cotesia plutellae (= vestalis) bracovirus (CpBV) is symbiotic to an endoparasitoid wasp, C. plutellae, and plays crucial roles in parasitism against the diamondback moth, Plutella xylostella. CpBV virion genome consists of 35 circular DNAs encoding 157 putative open reading frames (ORFs). This study re-annotated 157 ORFs with update genome database and analyzed their gene expressions at early and late parasitic stages. Re-annotation has established 15 different viral gene families, to which 83 ORFs are assigned with remaining 74 hypothetical genes. Among 157 ORFs, 147 genes were expressed at early or late parasitic stages, among which 141 genes were expressed in both parasitic stages, indicating persistent nature of gene expression. Relative frequencies of different viral circles present in the ovarian lumen did not explain the expression variation of the viral ORFs. Furthermore, expression level of each viral gene was varied during parasitism along with host development. Highly up-regulated CpBV genes at early parasitic stage included BEN (BANP, E5R and NAC(1)), ELP (EP1-like protein), IkB (inhibitor kB), P494 (protein 494 kDa) family genes, while those at late stage were mostly hypothetical genes. Along with the viral gene expression, 362 host genes exhibited more than two fold changes in expression levels at early parasitic stage compared to nonparasitized host. At late stage, more number (1,858) of host genes was regulated. These results suggest that persistent expression of most CpBV genes may be necessary to regulate host physiological processes during C. plutellae parasitism.	[Kim, Yonggyun; Kumar, Sunil] Andong Natl Univ, Dept Plant Med, Andong, South Korea	Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr		Kim, Yonggyun/0000-0002-6840-2167	National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2017R1A2133009815]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2017R1A2133009815) (YK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MR, 2015, COMP BIOCHEM PHYS A, V179, P44, DOI 10.1016/j.cbpa.2014.09.004; Ali MR, 2012, J INVERTEBR PATHOL, V110, P389, DOI 10.1016/j.jip.2012.05.003; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Bae S, 2009, J INVERTEBR PATHOL, V102, P79, DOI 10.1016/j.jip.2009.06.007; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beliveau C, 2015, J VIROL, V89, P8909, DOI 10.1128/JVI.01001-15; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0047; Bezier A, 2009, J INVERTEBR PATHOL, V101, P194, DOI 10.1016/j.jip.2009.04.006; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Chevignon G, 2015, INSECT BIOCHEM MOLEC, V62, P86, DOI 10.1016/j.ibmb.2014.12.008; Chevignon G, 2014, J VIROL, V88, P8795, DOI 10.1128/JVI.00209-14; Falabella P, 2006, ARCH INSECT BIOCHEM, V61, P157, DOI 10.1002/arch.20120; FLEMING JAGW, 1991, P NATL ACAD SCI USA, V88, P9770, DOI 10.1073/pnas.88.21.9770; Hepat R, 2013, J VIROL, V87, P11223, DOI 10.1128/JVI.01759-13; Herniou EA, 2013, ANNU REV ENTOMOL, V48, P211; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; Ibrahim AMA, 2008, NATURWISSENSCHAFTEN, V95, P25, DOI 10.1007/s00114-007-0290-7; Ibrahim AMA, 2007, DEV COMP IMMUNOL, V31, P978, DOI 10.1016/j.dci.2006.11.005; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Kim E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161661; Kim Yonggyun, 2007, Journal of Asia-Pacific Entomology, V10, P181, DOI 10.1016/S1226-8615(08)60351-9; Kim Y, 2016, INSECT SCI, V23, P235, DOI 10.1111/1744-7917.12237; Kumar S, 2014, COMP BIOCHEM PHYS A, V177, P27, DOI 10.1016/j.cbpa.2014.07.017; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakato H, 1997, INSECT BIOCHEM MOLEC, V27, P701, DOI 10.1016/S0965-1748(97)00048-9; NAKATO H, 1994, BBA-GENE STRUCT EXPR, V1218, P64, DOI 10.1016/0167-4781(94)90101-5; Park SS, 1997, INSECT BIOCHEM MOLEC, V27, P711, DOI 10.1016/S0965-1748(97)00049-0; Pruijssers AJ, 2007, J VIROL, V81, P1209, DOI 10.1128/JVI.02189-06; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Webb B.A., 2000, VIRUS TAXONOMY, P253; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; Whitfield James B., 2000, P97	38	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200663	10.1371/journal.pone.0200663	http://dx.doi.org/10.1371/journal.pone.0200663			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011308	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800040
J	Tian, ZH; Weng, JT; Shih, LJ; Siao, AC; Chan, TY; Tsuei, YW; Kuo, YC; Wang, TS; Kao, YH				Tian, Zi-Han; Weng, Jueng-Tsueng; Shih, Li-Jane; Siao, An-Ci; Chan, Tsai-Yun; Tsuei, Yi-Wei; Kuo, Yow-Chii; Wang, Tsu-Shing; Kao, Yung-Hsi			Arecoline inhibits the growth of 3T3-L1 preadipocytes via AMP-activated protein kinase and reactive oxygen species pathways	PLOS ONE			English	Article							TEA (-)-EPIGALLOCATECHIN GALLATE; CELL-CYCLE ARREST; 67-KDA LAMININ RECEPTOR; BETEL-NUT; ARECA NUT; BODY-WEIGHT; IGF-I; ADIPOCYTES; APOPTOSIS; CONSUMPTION	The present study was designed to investigate the pathways involved in the effect of betel nut arecoline on cell viability in 3T3-L1 preadipocytes. Arecoline, but not arecaidine or guvacine, inhibited preadipocyte viability in a concentration- and time-dependent manner. Arecoline arrested preadipocyte growth in the G2/M phase of the cell cycle; decreased the total levels of cyclin-dependent kinase 1 (CDK1), p21, and p27 proteins; increased p53 and cyclin B1 protein levels; and had no effect on CDK2 protein levels. These results suggested that arecoline selectively affected a particular CDK subfamily. Arecoline inhibited AMP-activated protein kinase (AMPK) activity; conversely, the AMPK activator, AICAR, blocked the arecoline-induced inhibition of cell viability. Pre-treatment with the antioxidant, N-acetylcysteine, prevented the actions of arecoline on cell viability, G2/M growth arrest, reactive oxygen species (ROS) production, and the levels of CDK1, p21, p27, p53, cyclin B1, and phospho-AMPK proteins. These AMPK- and ROS-dependent effects of arecoline on preadipocyte growth may be related to the mechanism underlying the modulatory effect of arecoline on body weight.	[Tian, Zi-Han; Weng, Jueng-Tsueng; Siao, An-Ci; Chan, Tsai-Yun; Kao, Yung-Hsi] Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan; [Weng, Jueng-Tsueng] Chung Shan Hosp, Taipei, Taiwan; [Shih, Li-Jane] Taoyuan Armed Forces Gen Hosp, Med Lab, Taoyuan, Taiwan; [Shih, Li-Jane] Natl Def Med Ctr, Taipei, Taiwan; [Tsuei, Yi-Wei] Taoyuan Armed Forces Gen Hosp, Dept Emergency, Taoyuan, Taiwan; [Kuo, Yow-Chii] Taiwan Landseed Hosp, Dept Gastroenterol, Taoyuan, Taiwan; [Wang, Tsu-Shing] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan	National Central University; National Defense Medical Center; Chung Shan Medical University	Kao, YH (corresponding author), Natl Cent Univ, Dept Life Sci, Taoyuan, Taiwan.; Tsuei, YW (corresponding author), Taoyuan Armed Forces Gen Hosp, Dept Emergency, Taoyuan, Taiwan.	er03@aftygh.gov.tw; ykao@cc.ncu.edu.tw			Ministry of Science and Technology, Taiwan [MOST105-2311-B-008-003, MOST -106-2320-B-008-006, MOST-106-2320-B-008-008-MY3]; Landseed General Hospital, Taiwan; Taoyuan Armed Forces General Hospital [AFTYGH-105-09, AFTYGH-10611, AFTYGH-10716]; Landseed General Hospital	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Landseed General Hospital, Taiwan; Taoyuan Armed Forces General Hospital; Landseed General Hospital	This work was supported by the Ministry of Science and Technology, Taiwan [MOST105-2311-B-008-003, MOST -106-2320-B-008-006, and MOST-106-2320-B-008-008-MY3 to Y.-H.K]; the Landseed General Hospital, Taiwan [Y.-H.K]; and the Taoyuan Armed Forces General Hospital [AFTYGH-105-09 to Y.-H.K; and AFTYGH-10611 and AFTYGH-10716 to Y.-W.T]. Landseed General Hospital provided support in the form of salaries for author YCK. The funding bodies had no role in study design; data collection, analysis, and interpretation; and manuscript writing and submission. The specific roles of these authors are articulated in the 'author contributions' section.	Becker WM, 2003, THE WORLD OF THE CEL; BOUCHER BJ, 1994, DIABETOLOGIA, V37, P49; Boucher BJ, 2002, ADDICT BIOL, V7, P103, DOI 10.1080/13556210120091464; Chang MC, 2001, CARCINOGENESIS, V22, P1527, DOI 10.1093/carcin/22.9.1527; Chang WC, 2006, INT J OBESITY, V30, P359, DOI 10.1038/sj.ijo.0803053; Chen YH, 2006, ENDOCRINOLOGY, V147, P4496, DOI 10.1210/en.2005-1655; Chiang CP, 2004, ORAL ONCOL, V40, P720, DOI 10.1016/j.oraloncology.2003.12.015; Chou WW, 2008, TOXICOLOGY, V243, P1, DOI 10.1016/j.tox.2007.09.003; Dasgupta B, 2016, TRENDS PHARMACOL SCI, V37, P192, DOI 10.1016/j.tips.2015.11.007; Giri S, 2006, CHEM RES TOXICOL, V19, P818, DOI 10.1021/tx0600402; Hsieh TJ, 2011, CELL BIOL TOXICOL, V27, P397, DOI 10.1007/s10565-011-9195-5; Hsu HF, 2010, TOXICOL APPL PHARM, V245, P370, DOI 10.1016/j.taap.2010.04.008; HUANG JL, 1989, J CHROMATOGR, V475, P447, DOI 10.1016/S0021-9673(01)89702-8; Huang LW, 2012, TOXICOL APPL PHARM, V258, P199, DOI 10.1016/j.taap.2011.11.001; Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004; Jeng JH, 2001, ORAL ONCOL, V37, P477, DOI 10.1016/S1368-8375(01)00003-3; Kao YH, 2006, MOL NUTR FOOD RES, V50, P188, DOI 10.1002/mnfr.200500109; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Ku HC, 2014, GEN COMP ENDOCR, V199, P46, DOI 10.1016/j.ygcen.2014.01.008; Ku HC, 2012, MOL NUTR FOOD RES, V56, P580, DOI 10.1002/mnfr.201100438; Ku HC, 2009, AM J PHYSIOL-CELL PH, V297, pC121, DOI 10.1152/ajpcell.00272.2008; Kuo FC, 2005, J PERINAT MED, V33, P399, DOI 10.1515/JPM.2005.072; Lee PH, 2006, TOXICOLOGY, V220, P81, DOI 10.1016/j.tox.2005.07.026; Lin WY, 2009, OBESITY, V17, P1247, DOI 10.1038/oby.2009.38; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Mannan N, 2000, BRIT J NUTR, V83, P267, DOI 10.1017/S0007114500000349; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Peng WH, 2016, CHEM SENSES, V41, P25, DOI 10.1093/chemse/bjv059; Prabhakar PK, 2011, THER ADV ENDOCRINOL, V2, P103, DOI 10.1177/2042018811411356; Thangjam GS, 2009, J PERIODONTAL RES, V44, P673, DOI 10.1111/j.1600-0765.2008.01176.x; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang CT, 2009, MOL NUTR FOOD RES, V53, P349, DOI 10.1002/mnfr.200800013; WENKE G, 1984, IARC SCI PUBL, P859; Wu BT, 2005, J AGR FOOD CHEM, V53, P5695, DOI 10.1021/jf050045p; Yen AMF, 2006, AM J CLIN NUTR, V83, P1153, DOI 10.1093/ajcn/83.5.1153; Yen CY, 2011, ORAL ONCOL, V47, P345, DOI 10.1016/j.oraloncology.2011.02.014	37	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200508	10.1371/journal.pone.0200508	http://dx.doi.org/10.1371/journal.pone.0200508			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011295	gold, Green Published, Green Submitted			2022-12-26	WOS:000438829800021
J	Xaydalasouk, K; Strobel, M; Buisson, Y; Black, AP; Muller, CP				Xaydalasouk, Kinnaly; Strobel, Michel; Buisson, Yves; Black, Antony P.; Muller, Claude P.			Seroprevalence and risk factors of hepatitis B and C virus infections in female workers of Lao garment factories	PLOS ONE			English	Article							BLOOD-DONORS; EPIDEMIOLOGY; PREVALENCE	The prevalence of hepatitis B and C virus infections may be higher in vulnerable populations or in individuals likely to be exposed through risk behaviors such as female garment factory workers in Lao People's Democratic Republic. A cross-sectional study was performed on 400 female garment workers in Vientiane Capital. Women were tested for hepatitis B virus surface antigen and antibodies against hepatitis B core, surface antigen and hepatitis C virus using commercial Enzyme-linked immuno-absorbent assays. Participants completed a standardized questionnaire about potential risk factors for both infections. Sixteen women (4 +/- 1.9%) were HBsAg carriers, 187 (47%) had anti-HBc, 116 (29%) anti-HBs and 7 (1.8 +/- 1.3%) anti-HCV antibodies. Three factors were significantly associated with the presence of anti-HBc (indicating previous exposure to HBV): (i) residence in dormitories, (ii) more than one sexual partner, (iii) history of abortion. Despite a high risk of exposure, the prevalence of anti HBV and anti HCV infection markers in this sample of female workers was not higher than in the Lao general population. Our data suggest that exposure to HBV happens later during life and was significantly associated with sexual risk behavior. Thus, this study highlights the vulnerability of these women who were mostly young, uneducated, unvaccinated, of rural origin and were not aware of the risk of infections. An occupational health program targeting the female factory workers should be implemented in Lao PDR.	[Xaydalasouk, Kinnaly; Strobel, Michel; Buisson, Yves] Inst Francophonie Med Trop, Viangchan, Laos; [Xaydalasouk, Kinnaly; Black, Antony P.; Muller, Claude P.] Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos; [Muller, Claude P.] Luxembourg Inst Hlth, Dept Infect & Immun, Esch Sur Alzette, Luxembourg	Luxembourg Institute of Health	Black, AP (corresponding author), Inst Pasteur Laos, Lao Lux Lab, Viangchan, Laos.	a.black@pasteur.la			Luxembourg Ministry of Cooperation	Luxembourg Ministry of Cooperation	This work was funded by Luxembourg Ministry of Cooperation.	Ali SA, 2009, INT J INFECT DIS, V13, P9, DOI 10.1016/j.ijid.2008.06.019; [Anonymous], 2014, GLOB AIDS RESP PROGR; Black AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123647; Black AP, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-457; Burrows D, 2005, ASSESSMENT INFECTING; Busca A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-22; Ijaz R, 2013, BIOMEDICA, V29, P42; Jutavijittum P, 2014, VOX SANG, V106, P31, DOI 10.1111/vox.12073; Jutavijittum Prapan, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P674; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee MH, 2014, WORLD J GASTROENTERO, V20, P9270, DOI 10.3748/wjg.v20.i28.9270; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Manivone V, 2005, THESIS; Mast EE, 1999, VACCINE, V17, P1730, DOI 10.1016/S0264-410X(98)00415-0; Sene-Asa O., 2007, THESIS, P1; Xaydalasouk K, 2016, Bull Soc Pathol Exot, V109, P13, DOI 10.1007/s13149-016-0474-5; Xeuatvongsa A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088829; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhong BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157530	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199919	10.1371/journal.pone.0199919	http://dx.doi.org/10.1371/journal.pone.0199919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011282	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800006
J	Zhou, NA; Fagnant-Sperati, CS; Shirai, JH; Sharif, S; Zaidi, SZ; Rehman, L; Hussain, J; Agha, R; Shaukat, S; Alam, M; Khurshid, A; Mujtaba, G; Salman, M; Safdar, RM; Mahamud, A; Ahmed, J; Khan, S; Kossik, AL; Beck, NK; Matrajt, G; Asghar, H; Bandyopadhyay, AS; Boyle, DS; Meschke, JS				Zhou, Nicolette Angela; Fagnant-Sperati, Christine Susan; Shirai, Jeffry Hiroshi; Sharif, Salmaan; Zaidi, Sohail Zahoor; Rehman, Lubna; Hussain, Jaffer; Agha, Rahim; Shaukat, Shahzad; Alam, Masroor; Khurshid, Adnan; Mujtaba, Ghulam; Salman, Muhammed; Safdar, Rana Muhammed; Mahamud, Abdirahman; Ahmed, Jamal; Khan, Sadaf; Kossik, Alexandra Lynn; Beck, Nicola Koren; Matrajt, Graciela; Asghar, Humayun; Bandyopadhyay, Ananda Sankar; Boyle, David Scott; Meschke, John Scott			Evaluation of the bag-mediated filtration system as a novel tool for poliovirus environmental surveillance: Results from a comparative field study in Pakistan	PLOS ONE			English	Article							WILD; CIRCULATION	Poliovirus (PV) environmental surveillance (ES) plays an important role in the global eradication program and is crucial for monitoring silent PV circulation especially as clinical cases decrease. This study compared ES results using the novel bag-mediated filtration system (BMFS) with the current two-phase separation method. From February to November 2016, BMFS and two-phase samples were collected concurrently from twelve sites in Pakistan (n = 117). Detection was higher in BMFS than two-phase samples for each Sabin-like (SL) PV serotype (p<0.001) and wild PV type 1 (WPV1) (p = 0.065). Seventeen sampling events were positive for WPV1, with eight discordant in favor of BMFS and two in favor of two-phase. A vaccine-derived PV type 2 was detected in one BMFS sample but not the matched two-phase. After the removal of SL PV type 2 (SL2) from the oral polio vaccine in April 2016, BMFS samples detected SL2 more frequently than two-phase (p = 0.016), with the last detection by either method occurring June 12, 2016. More frequent PV detection in BMFS compared to two-phase samples is likely due to the greater effective volume assayed (1620 mL vs. 150 mL). This study demonstrated that the BMFS achieves enhanced ES for all PV serotypes in an endemic country.	[Zhou, Nicolette Angela; Fagnant-Sperati, Christine Susan; Shirai, Jeffry Hiroshi; Kossik, Alexandra Lynn; Beck, Nicola Koren; Matrajt, Graciela; Meschke, John Scott] Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Sharif, Salmaan; Zaidi, Sohail Zahoor; Rehman, Lubna; Hussain, Jaffer; Shaukat, Shahzad; Alam, Masroor; Khurshid, Adnan; Mujtaba, Ghulam; Salman, Muhammed; Safdar, Rana Muhammed] Natl Inst Hlth, Islamabad, Pakistan; [Agha, Rahim; Mahamud, Abdirahman; Ahmed, Jamal; Asghar, Humayun] WHO, Islamabad, Pakistan; [Agha, Rahim; Safdar, Rana Muhammed; Mahamud, Abdirahman; Ahmed, Jamal] Natl Emergency Operat Ctr, Islamabad, Pakistan; [Khan, Sadaf; Boyle, David Scott] PATH, Seattle, WA USA; [Bandyopadhyay, Ananda Sankar] Bill & Melinda Gates Fdn, Seattle, WA USA	University of Washington; University of Washington Seattle; World Health Organization; Bill & Melinda Gates Foundation	Meschke, JS (corresponding author), Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA.	jmeschke@u.washington.edu	Matrajt, Graciela/A-4812-2017; Shaukat, Shahzad/HHZ-1088-2022	Bandyopadhyay, Ananda/0000-0002-8395-2001; ASGHAR, HUMAYUN/0000-0001-9670-7681	Paul G. Allen Foundation [NPT.1938-603689]; Bill & Melinda Gates Foundation [OPP1044825]; UW NIEHS [NIEHS T32ES015459]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES015459] Funding Source: NIH RePORTER	Paul G. Allen Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); UW NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Paul G. Allen Foundation (Grant Number NPT.1938-603689; http://www.pgaphilanthropies.org/) and the Bill & Melinda Gates Foundation (Grant Number OPP1044825 to DSB; https://www.gatesfoundation.org/). ASB is an employee of the study funder, and was involved in study design, data interpretation, and writing of the report. The funder had no role in data collection. NAZ was further supported in part by the UW NIEHS sponsored Biostatistics, Epidemiologic and Bioinformatic Training in Environmental Health (BEBTEH) Training Grant, Grant #: NIEHS T32ES015459. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2016, CLIN INFECT DIS, V62, P190, DOI 10.1093/cid/civ831; Alam MM, 2014, J INFECT DIS, V210, pS324, DOI 10.1093/infdis/jiu160; Anis E, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.38.20586; [Anonymous], 2013, POL ER ENDG STRAT PL; Asghar H, 2014, J INFECT DIS, V210, pS294, DOI 10.1093/infdis/jiu384; Bandyopadhyay AS, 2015, FUTURE MICROBIOL, V10, P791, DOI [10.2217/FMB.15.19, 10.2217/fmb.15.19]; Biologicals DoVa, 2003, GUID ENV SURV POL CI; Cowger TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180608; Fagerland MW, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-91; Fagnant CS, 2018, FOOD ENVIRON VIROL, V10, P72, DOI 10.1007/s12560-017-9311-7; Fagnant CS, 2017, FOOD ENVIRON VIROL, V9, P383, DOI 10.1007/s12560-017-9306-4; Fagnant CS, 2014, J WATER HEALTH, V12, P747, DOI 10.2166/wh.2014.032; GPEI, 2005, REP CLASS VACC DER P; Hovi T, 2012, EPIDEMIOL INFECT, V140, P1, DOI 10.1017/S095026881000316X; Laassri M, 2005, J INFECT DIS, V192, P2092, DOI 10.1086/498172; Lopalco PL, 2017, EPIDEMIOL INFECT, V145, P413, DOI [10.1017/S0950268816002569, 10.1017/s0950268816002569]; Maes EF, 2017, MMWR-MORBID MORTAL W, V66, P359, DOI 10.15585/mmwr.mm6613a3; Manor Y, 2007, APPL ENVIRON MICROB, V73, P5954, DOI 10.1128/AEM.02537-06; Manor Y, 2014, EUROSURVEILLANCE, V19, P31, DOI 10.2807/1560-7917.ES2014.19.7.20710; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Novel-t, CAT ENV SIT SUPP POL; Organization W.H., 2015, GUID ENV SURV DET PO; Shaukat S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107697; Tangermann R, 2016, WHO WKLY EPIDEMOLOGI, V47; WHO, 2016, GPEI ANN REP 2015; WHO, 2016, SEM STAT REP JAN JUN; World Health Organization (WHO), 2018, GLOB WILD POL 2013 2	27	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200551	10.1371/journal.pone.0200551	http://dx.doi.org/10.1371/journal.pone.0200551			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011304	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800028
J	Al-Darraji, A; Haydar, D; Chelvarajan, L; Tripathi, H; Levitan, B; Gao, E; Venditto, VJ; Gensel, JC; Feola, DJ; Abdel-Latif, A				Al-Darraji, Ahmed; Haydar, Dalia; Chelvarajan, Lakshman; Tripathi, Himi; Levitan, Bryana; Gao, Erhe; Venditto, Vincent J.; Gensel, John C.; Feola, David J.; Abdel-Latif, Ahmed			Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; POSTMYOCARDIAL INFARCTION; NEUTROPHILS; INJURY; RESOLUTION; MONOCYTES; RECOVERY; REPAIR; MICE; ERYTHROMYCIN	Introduction Acute myocardial infarction (MI) is a primary cause of worldwide morbidity and mortality. Macrophages are fundamental components of post-MI inflammation. Pro-inflammatory macrophages can lead to adverse cardiac remodeling and heart failure while anti-inflammatory/reparative macrophages enhance tissue healing. Shifting the balance between proinflammatory and reparative macrophages post-MI is a novel therapeutic strategy. Azithromycin (AZM), a commonly used macrolide antibiotic, polarizes macrophages towards the anti-inflammatory phenotype, as shown in animal and human studies. We hypothesized that AZM modulates post-MI inflammation and improves cardiac recovery. Methods and results Male WT mice (C57BU6, 6-8 weeks old) were treated with either oral AZM (160 mg/kg/day) or vehicle (control) starting 3 days prior to MI and continued to day 7 post-MI. We observed a significant reduction in mortality with AZM therapy. AZM-treated mice showed a significant decrease in pro-inflammatory (CD45(+)/Ly6G(-)/F4-80(+)/CD86(+)) and increase in anti-inflammatory (CD45(+)/Ly6G(-)/F4-80(+)/CD206(+)) macrophages, decreasing the pro-inflammatory/antiinflammatory macrophage ratio in the heart and peripheral blood as assessed by flow cytometry and immunohistochemistry. Macrophage changes were associated with a significant decline in pro- and increase in anti-inflammatory cytokines. Mechanistic studies confirmed the ability of AZM to shift macrophage response towards an anti-inflammatory state under hypoxia/reperfusion stress. Additionally, AZM treatment was associated with a distinct decrease in neutrophil count due to apoptosis, a known signal for shifting macrophages towards the anti-inflammatory phenotype. Finally, AZM treatment improved cardiac recovery, scar size, and angiogenesis. Conclusion Azithromycin plays a cardioprotective role in the early phase post-MI through attenuating inflammation and enhancing cardiac recovery. Post-MI treatment and human translational studies are warranted to examine the therapeutic applications of AZM.	[Al-Darraji, Ahmed; Chelvarajan, Lakshman; Tripathi, Himi; Levitan, Bryana; Abdel-Latif, Ahmed] Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA; [Al-Darraji, Ahmed; Chelvarajan, Lakshman; Tripathi, Himi; Levitan, Bryana; Abdel-Latif, Ahmed] Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40506 USA; [Haydar, Dalia; Venditto, Vincent J.; Feola, David J.] Univ Kentucky, Coll Pharm, Lexington, KY USA; [Gao, Erhe] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19122 USA; [Gensel, John C.] Univ Kentucky, Coll Med, Dept Physiol, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Abdel-Latif, Ahmed] Lexington VA Med Ctr, Lexington, KY 40511 USA	University of Kentucky; University of Kentucky; University of Kentucky; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Abdel-Latif, A (corresponding author), Univ Kentucky, Gill Heart Inst, Lexington, KY 40506 USA.; Abdel-Latif, A (corresponding author), Univ Kentucky, Div Cardiovasc Med, Lexington, KY 40506 USA.; Abdel-Latif, A (corresponding author), Lexington VA Med Ctr, Lexington, KY 40511 USA.	abdel-latif@uky.edu	Haydar, Dalia/O-8198-2019; Abdel-Latif, Ahmed/V-8097-2019; Haydar, Dalia/Y-6839-2019	Haydar, Dalia/0000-0002-7959-2699; Abdel-Latif, Ahmed/0000-0002-8178-7102; , John/0000-0001-8980-108X	National Heart, Lung, and Blood Institute [P20 GM103527, P30 CA177558]; NIH [R01 HL124266]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121266, R01HL138488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Abdel-Latif is supported by the National Heart, Lung, and Blood Institute (P20 GM103527) and the NIH Grant R01 HL124266. This work is supported by National Heart, Lung, and Blood Institute, P30 CA177558. The flow cytometry core facility is supported by the grant P30 CA177558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amantea D, 2016, EXP NEUROL, V275, P116, DOI 10.1016/j.expneurol.2015.10.012; AOSHIBA K, 1995, ANTIMICROB AGENTS CH, V39, P872, DOI 10.1128/AAC.39.4.872; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Ben-Mordechai T, 2015, J CARDIOVASC PHARM T, V20, P36, DOI 10.1177/1074248414534916; BULKLEY BH, 1974, AM J MED, V56, P244, DOI 10.1016/0002-9343(74)90603-2; Carbone F, 2013, THROMB HAEMOSTASIS, V110, P501, DOI 10.1160/TH13-03-0211; Chia S, 2009, AM J CARDIOL, V103, P333, DOI 10.1016/j.amjcard.2008.09.085; Cory TJ, 2014, J CYST FIBROS, V13, P164, DOI 10.1016/j.jcf.2013.08.007; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Dutta P, 2015, ARTERIOSCL THROM VAS, V35, P1066, DOI 10.1161/ATVBAHA.114.304652; Epelman S, 2015, NAT REV IMMUNOL, V15, P117, DOI 10.1038/nri3800; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Garlichs CD, 2004, J LEUKOCYTE BIOL, V75, P828, DOI 10.1189/jlb.0703358; Gensel JC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40144; Gensel JC, 2015, BRAIN RES, V1619, P1, DOI 10.1016/j.brainres.2014.12.045; Gibbs DF, 1999, AM J RESP CELL MOL, V20, P1145, DOI 10.1165/ajrcmb.20.6.3482; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Harel-Adar T, 2011, P NATL ACAD SCI USA, V108, P1827, DOI 10.1073/pnas.1015623108; Heidt T, 2014, CIRC RES, V115, P284, DOI 10.1161/CIRCRESAHA.115.303567; Heo SC, 2017, STEM CELLS, V35, P654, DOI 10.1002/stem.2535; Hodge S, 2006, EUR RESPIR J, V28, P486, DOI 10.1183/09031936.06.00001506; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Inamura K, 2000, RHINOLOGY, V38, P124; Kain V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10441-8; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Klyachkin YM, 2015, STEM CELL TRANSL MED, V4, P1333, DOI 10.5966/sctm.2014-0273; Koch CC, 2000, J ANTIMICROB CHEMOTH, V46, P19, DOI 10.1093/jac/46.1.19; Lambert JM, 2008, INT J CARDIOL, V130, P147, DOI 10.1016/j.ijcard.2008.04.059; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Murphy BS, 2008, J ANTIMICROB CHEMOTH, V61, P554, DOI 10.1093/jac/dkn007; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2016, CIRC RES, V119, P414, DOI 10.1161/CIRCRESAHA.116.309194; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Porrello ER, 2013, P NATL ACAD SCI USA, V110, P187, DOI 10.1073/pnas.1208863110; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Protti A, 2016, J MOL CELL CARDIOL, V90, P120, DOI 10.1016/j.yjmcc.2015.12.007; Qin CX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16317-1; Ramirez TA, 2014, J MOL CELL CARDIOL, V72, P326, DOI 10.1016/j.yjmcc.2014.04.007; Rapp RP, 1998, ANN PHARMACOTHER, V32, P785, DOI 10.1345/aph.17299; Ribeiro CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005806; Saini Harjot K, 2005, Exp Clin Cardiol, V10, P213; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Seropian IM, 2014, J AM COLL CARDIOL, V63, P1593, DOI 10.1016/j.jacc.2014.01.014; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; SUNDERKOTTER C, 1991, PHARMACOL THERAPEUT, V51, P195, DOI 10.1016/0163-7258(91)90077-Y; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; van der Laan AM, 2012, HEART, V98, P1384, DOI 10.1136/heartjnl-2012-301623; Varano GP, 2017, MOL VIS, V23; Zhang B, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0440-3	58	29	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200474	10.1371/journal.pone.0200474	http://dx.doi.org/10.1371/journal.pone.0200474			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001416	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400065
J	Ganor-Stern, D				Ganor-Stern, Dana			Approximation processes in arithmetic in old adulthood	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; COMPUTATIONAL ESTIMATION; WORKING-MEMORY; STRATEGY SELECTION; INHIBITION; CHOICE; YOUNG; TASK	Young and old adults estimated the results of multidigit multiplication problems relative to a reference number. Old adults were slower but slightly more accurate than young adults. They were less affected by the distance between the reference number and the exact answer than the young adults. The same strategies reported by past research-the approximated calculation strategy and the sense of magnitude strategy-were found here. The old adults showed a stronger preference toward the approximated calculation strategy than the young ones, and this probably led to the reduced effect of distance. These patterns are interpreted as reflecting two factors. The first is the extensive experience of the old adults with mental calculation, and the second is the decline in processing speed and in working memory resources with adulthood. The former is responsible for the more frequent use of the approximated calculation strategy and for the higher accuracy of the old adults, while the latter is responsible for their slower responses.	[Ganor-Stern, Dana] Achva Acad Coll, Psychol Dept, Achva, Israel		Ganor-Stern, D (corresponding author), Achva Acad Coll, Psychol Dept, Achva, Israel.	danaganor@gmail.com			Israel Science Foundation [906/12]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation (grant No. 906/12 to Professor Dana Ganor-Stern). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borella E, 2008, ACTA PSYCHOL, V128, P33, DOI 10.1016/j.actpsy.2007.09.008; DeStefano D, 2004, EUR J COGN PSYCHOL, V16, P353, DOI 10.1080/09541440244000328; Duverne S, 2005, CAN J EXP PSYCHOL, V59, P262, DOI 10.1037/h0087479; Duverne S, 2004, J GERONTOL B-PSYCHOL, V59, pP135, DOI 10.1093/geronb/59.3.P135; El Yagoubi R, 2005, J COGNITIVE NEUROSCI, V17, P37, DOI 10.1162/0898929052880084; El Yagoubi R, 2003, NEUROPSYCHOLOGIA, V41, P855, DOI 10.1016/S0028-3932(02)00180-X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ganor-Stern D, 2017, J LEARN DISABIL-US, V50, P23, DOI 10.1177/0022219415587785; Ganor-Stern D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155515; Ganor-Stern D, 2016, PSYCHOL RES-PSYCH FO, V80, P434, DOI 10.1007/s00426-015-0720-7; Ganor-Stern D, 2015, ACTA PSYCHOL, V154, P1, DOI 10.1016/j.actpsy.2014.10.010; GEARY DC, 1991, PSYCHOL AGING, V6, P474, DOI 10.1037/0882-7974.6.3.474; GEARY DC, 1993, PSYCHOL AGING, V8, P242, DOI 10.1037/0882-7974.8.2.242; Hodzik S, 2011, ACTA PSYCHOL, V137, P335, DOI 10.1016/j.actpsy.2011.04.002; LEFEVRE JA, 1993, COGNITION INSTRUCT, V11, P95, DOI 10.1207/s1532690xci1102_1; Lemaire P, 2004, PSYCHOL AGING, V19, P467, DOI 10.1037/0882-7974.19.3.467; Lemaire P, 2002, J EXP CHILD PSYCHOL, V82, P281, DOI 10.1016/S0022-0965(02)00107-8; Lemaire P, 2000, CAN J EXP PSYCHOL, V54, P141, DOI 10.1037/h0087336; Lemaire P, 2008, AM J PSYCHOL, V121, P1, DOI 10.2307/20445440; Lemaire P, 2014, DEV PSYCHOL, V50, P460, DOI 10.1037/a0033527; Lemaire P, 2010, CURR DIR PSYCHOL SCI, V19, P363, DOI 10.1177/0963721410390354; Lemaire P, 2010, MEM COGNITION, V38, P322, DOI 10.3758/MC.38.3.322; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Park D.C., 2000, COGNITIVE AGING PRIM, V1st; Salthouse T.A., 2011, HDB AGING COGNITION; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Tamnes CK, 2013, J COGNITIVE NEUROSCI, V25, P1611, DOI 10.1162/jocn_a_00434; Touron DR, 2009, PSYCHOL AGING, V24, P574, DOI 10.1037/a0015966	29	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200136	10.1371/journal.pone.0200136	http://dx.doi.org/10.1371/journal.pone.0200136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001333	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400024
J	Kato, D; Kurebayashi, Y; Takahashi, T; Otsubo, T; Otake, H; Yamazaki, M; Tamoto, C; Minami, A; Ikeda, K; Suzuki, T				Kato, Daisuke; Kurebayashi, Yuuki; Takahashi, Tadanobu; Otsubo, Tadamune; Otake, Hitomi; Yamazaki, Mika; Tamoto, Chihiro; Minami, Akira; Ikeda, Kiyoshi; Suzuki, Takashi			An easy, rapid, and sensitive method for detection of drug-resistant influenza virus by using a sialidase fluorescent imaging probe, BTP3-Neu5Ac	PLOS ONE			English	Article							A VIRUS; NEURAMINIDASE INHIBITORS; STREPTOCOCCUS-PNEUMONIAE; OSELTAMIVIR; EMERGENCE; EPIDEMIOLOGY; ZANAMIVIR; CHILDREN; JAPAN; ASSAY	Immunochromatographic kits and RT-PCR are widely used as diagnostic tools for influenza detection in clinical and hygiene fields. Immunochromatographic kits are useful for differential typing of influenza A and influenza B but cannot show if the detected virus strains have acquired drug resistance against neuraminidase inhibitors that target sialidase activity of viral neuraminidase. Although RT-PCR enables determination of drug-resistant mutants, its efficacy is limited to viruses carrying a known substitution in their neuraminidase genome sequence. In the present study, an easy, rapid and sensitive method for detection of drug-resistant influenza viruses regardless of major antigenic changes or genomic mutations was developed. By using the method in combination with virus-concentrated membranes in centrifugal filter units and a sialidase imaging probe, 2-(benzothiazol-2-yl)-4-bromophenyl-Nacetylneuraminic acid (BTP3-Neu5Ac), sialidase activity of influenza neuraminidase was visualized on membranes by the green fluorescence of produced hydrophobic BTP3 under UV irradiation with a handheld UV flashlight. Fluorescence images in the presence or absence of neuraminidase inhibitors clearly discriminated drug-resistant influenza viruses from drug-sensitive ones. The assay can be done within 15 min. The detection sensitivity was shown to be equal to or higher than the sensitivities of commercial immunochromatographic kits. The assay will be a powerful tool for screening and monitoring of emerging drug-resistant influenza viruses and would help clinicians decide effective antiviral treatment strategies when such mutants have become prevalent.	[Kato, Daisuke; Kurebayashi, Yuuki; Takahashi, Tadanobu; Otake, Hitomi; Yamazaki, Mika; Tamoto, Chihiro; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Kure, Hiroshima, Japan	University of Shizuoka	Suzuki, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka, Shizuoka, Japan.	suzukit@u-shizuoka-ken.ac.jp		Kurebayashi, Yuuki/0000-0002-7523-6160; Otsubo, Tadamune/0000-0003-1949-9780	Fujinokuni Regional and University Consortium; Takahashi Industrial and Economic Research Foundation; Japan Foundation for Applied Enzymology; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; University of Shizuoka; JSPS KAKENHI [JP18K14905, JP16K15151, JP15H05644]; TERUMO FOUNDATION for LIFE SCIENCES and ARTS; Kanamori Foundation; Lotte Research Promotion Grant; Hitachi Global Foundation; Fujikura Foundation; Mishima Kaiun Memorial Foundation; Research Foundation for Opto-Science and Technology; Futaba Electronics Memorial Foundation; Amano Institute of Technology; Noguchi Institute; Kieikai Research Foundation; Suzuken Memorial Foundation; Sugiyama-houkoukai, Yakurikigakukenkyukai; Kao Research Council for the Study of Healthcare Science; Yakult Honsha; Sugiyama-houkoukai; Yakurikigakukenkyukai; Shizuoka Jidai Scholarship	Fujinokuni Regional and University Consortium; Takahashi Industrial and Economic Research Foundation; Japan Foundation for Applied Enzymology; Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; University of Shizuoka; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); TERUMO FOUNDATION for LIFE SCIENCES and ARTS; Kanamori Foundation; Lotte Research Promotion Grant; Hitachi Global Foundation; Fujikura Foundation; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Research Foundation for Opto-Science and Technology; Futaba Electronics Memorial Foundation; Amano Institute of Technology; Noguchi Institute; Kieikai Research Foundation(Kieikai Research Foundation); Suzuken Memorial Foundation; Sugiyama-houkoukai, Yakurikigakukenkyukai; Kao Research Council for the Study of Healthcare Science; Yakult Honsha; Sugiyama-houkoukai; Yakurikigakukenkyukai; Shizuoka Jidai Scholarship	Grants to Y. K. from Fujinokuni Regional and University Consortium, Shizuoka Jidai Scholarship, Takahashi Industrial and Economic Research Foundation, Japan Foundation for Applied Enzymology, Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, University of Shizuoka and JSPS KAKENHI Grant Number Young Scientists JP18K14905 and by grants to T. T. from TERUMO FOUNDATION for LIFE SCIENCES and ARTS, Kanamori Foundation, Lotte Research Promotion Grant, the Kurata Grant awarded by the Hitachi Global Foundation, The Fujikura Foundation, Mishima Kaiun Memorial Foundation, Research Foundation for Opto-Science and Technology, the Futaba Electronics Memorial Foundation, Amano Institute of Technology, The Noguchi Institute, Kieikai Research Foundation, Suzuken Memorial Foundation, Sugiyama-houkoukai, Yakurikigakukenkyukai, Kao Research Council for the Study of Healthcare Science, University of Shizuoka and JSPS KAKENHI Grant Numbers Challenging Exploratory Research JP16K15151 and Young Scientists (A) JP15H05644 and by grants to T. S. from University of Shizuoka and Yakult Honsha. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2003, LUMINESCENCE, V18, P131, DOI 10.1002/bio.714; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; BURMEISTER WP, 1994, J GEN VIROL, V75, P381, DOI 10.1099/0022-1317-75-2-381; CABEZAS JA, 1989, GLYCOCONJUGATE J, V6, P219, DOI 10.1007/BF01050650; Correia V, 2015, J MED VIROL, V87, P45, DOI 10.1002/jmv.23986; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; DIMMOCK NJ, 1971, J GEN VIROL, V13, P481, DOI 10.1099/0022-1317-13-3-481; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Eshaghi A, 2011, EMERG INFECT DIS, V17, P1472, DOI 10.3201/eid1708.102004; Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002; Gerdil C, 2003, VACCINE, V21, P1776, DOI 10.1016/S0264-410X(03)00071-9; Gubareva LV, 2001, ANTIMICROB AGENTS CH, V45, P3403, DOI 10.1128/AAC.45.12.3403-3408.2001; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Gut H, 2011, J MOL BIOL, V409, P496, DOI 10.1016/j.jmb.2011.04.016; Harrison MS, 2010, INT J BIOCHEM CELL B, V42, P1416, DOI 10.1016/j.biocel.2010.04.005; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Hu Jen-Jan, 2004, Journal of Microbiology Immunology and Infection, V37, P95; Hussain M, 2017, INFECT DRUG RESIST, V10, P121, DOI 10.2147/IDR.S105473; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; Klein EY, 2016, INFLUENZA OTHER RESP, V10, P394, DOI 10.1111/irv.12398; Kurebayashi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156400; Kurebayashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04877; Matsuzaki Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-53; McKimm-Breschkin JL, 2013, INFLUENZA OTHER RESP, V7, P25, DOI 10.1111/irv.12047; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; Murtaugh W, 2013, PUBLIC HEALTH REP, V128, P75, DOI 10.1177/00333549131280S212; National Institute of Infectious Diseases, 2017, INFECT AGENTS SURVEI, V38, P209; Nguyen HT, 2010, CLIN INFECT DIS, V51, P983, DOI 10.1086/656439; Parker D, 2009, INFECT IMMUN, V77, P3722, DOI 10.1128/IAI.00228-09; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Saito M, 2002, HISTOCHEM CELL BIOL, V117, P453, DOI 10.1007/s00418-002-0399-x; Sakai-Tagawa Y, 2014, MICROBIOL IMMUNOL, V58, P600, DOI 10.1111/1348-0421.12185; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Smith A, 2013, J MED MICROBIOL, V62, P1735, DOI 10.1099/jmm.0.063479-0; Sugaya N, 2012, ANTIMICROB AGENTS CH, V56, P369, DOI 10.1128/AAC.00132-11; Sunagawa S, 2013, INFLUENZA OTHER RESP, V7, P1, DOI 10.1111/j.1750-2659.2012.00351.x; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Suzuki T, 1996, BIOCHEM J, V318, P389, DOI 10.1042/bj3180389; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144038; Takahashi T, 2015, BIOL PHARM BULL, V38, P1214, DOI 10.1248/bpb.b15-00298; Takahashi T, 2014, J VIROL METHODS, V209, P136, DOI 10.1016/j.jviromet.2014.09.010; Takahashi T, 2013, GLYCOCONJUGATE J, V30, P709, DOI 10.1007/s10719-013-9477-7; Takano M, 2014, VIROLOGY, V464, P206, DOI 10.1016/j.virol.2014.04.005; Takashita E, 2014, EUROSURVEILLANCE, V19, P4, DOI 10.2807/1560-7917.ES2014.19.1.20666; Tamura D, 2015, J INFECT DIS, V212, P1209, DOI 10.1093/infdis/jiv245; Thompson CI, 2015, EURO SURVEILL, V20; Togashi T, 2004, VIRUS RES, V103, P75, DOI 10.1016/j.virusres.2004.02.016; Uyeki TM, 2008, RESPIROLOGY, V13, pS2, DOI 10.1111/j.1440-1843.2008.01246.x; van der Vries E, 2010, NEW ENGL J MED, V363, P1381, DOI 10.1056/NEJMc1003749; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Watanabe T, 2014, TRENDS MICROBIOL, V22, P623, DOI 10.1016/j.tim.2014.08.008; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003	57	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200761	10.1371/journal.pone.0200761	http://dx.doi.org/10.1371/journal.pone.0200761			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001430	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400097
J	Berg, CJ; King, HP; Delenstarr, G; Kumar, R; Rubio, F; Glaze, T				Berg, Carl J.; King, H. Peter; Delenstarr, Glenda; Kumar, Ritikaa; Rubio, Fernando; Glaze, Tom			Glyphosate residue concentrations in honey attributed through geospatial analysis to proximity of large-scale agriculture and transfer off-site by bees	PLOS ONE			English	Article							RANGE	Honey taken directly from 59 bee hives on the Hawaiian island of Kaua'i was analyzed for glyphosate residue using ELISA techniques. Glyphosate residue was detected (> LOQ) in 27% of honey samples, at concentrations up to 342 ppb, with a mean = 118 ppb, S.E.M. 24 ppb. Of 15 honey samples store-purchased on Kaua'i, glyphosate was detected in 33%, with a mean concentration of 41 ppb, S.E.M. 14. Glyphosate residue was not detected in two samples from the island of Molokai but was in one of four samples from the island of Hawaii. Presence and concentration of glyphosate residues were geospatially mapped with respect to Hawaiian land divisions. Mapping showed higher occurrence of glyphosate that was over LOQ (48%) and concentrations of glyphosate (mean = 125 ppb, S.E.M. 25 ppb; N = 15) in honey from the western, predominantly agricultural, half of Kaua'i versus the eastern half (4%, mean = 15 ppb; N = 1). Geographic Information System analysis of land use percentage was performed within a circular zone of 1 Km radius around each hive. Various land use types within each circular zone were transcribed into polygons and percent land use calculated. Only agriculture land use showed a strong positive correlation with glyphosate concentration. High glyphosate concentrations were also detected when extensive golf courses and/or highways were nearby. This suggests herbicide migration from the site of use into other areas by bees. Best management practices in use for curtailing pesticide migration are not effective and must be carefully re-assessed.	[Berg, Carl J.] Surfrider Fdn, Kauai Chapter, Lihue, HI 96766 USA; [King, H. Peter] DataWise Consulting, Kapaa, HI USA; [Delenstarr, Glenda] Delenstarr Consulting LLC, Koloa, HI USA; [Kumar, Ritikaa] Southern Oregon Univ, Ashland, OR USA; [Rubio, Fernando; Glaze, Tom] Abraxis Inc, Warminster, PA USA		Berg, CJ (corresponding author), Surfrider Fdn, Kauai Chapter, Lihue, HI 96766 USA.	cberg@pixi.com		Delenstarr, Glenda/0000-0003-4023-9115; Berg, Carl/0000-0002-0508-6283; Kumar, Ritikaa/0000-0003-1596-7540	Surfrider Foundation, Kauai Chapter; Abraxis Inc.	Surfrider Foundation, Kauai Chapter; Abraxis Inc.	This study was funded in part by the Surfrider Foundation, Kauai Chapter, who provided funding for equipment and supplies for the collection, processing and analysis of honey samples. This study was also funded in part by Abraxis Inc. who donated supplies and staff time for the analysis of 23 store-bought honey samples and provided funding in the form of salaries for authors FR and TG. The specific roles of these authors are articulated in the 'Author Contributions' section. Abraxis Inc. did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abraxis Inc, 2014, GLYPH HON CORN SYR S; Abraxis Inc, GLYPH ELISA MICR; [Anonymous], ARCGIS 10 5; Barganska Z, 2016, CRIT REV ENV SCI TEC, V46, P235, DOI 10.1080/10643389.2015.1078220; Barganska Z, 2010, CRIT REV ANAL CHEM, V40, P159, DOI 10.1080/10408347.2010.490484; Battaglin WA, 2014, J AM WATER RESOUR AS, V50, P275, DOI 10.1111/jawr.12159; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; California Environmental Protection Agency, 2017, OFF ENV HLTH HAZ ASS; Canadian Food Inspection Agency, 2017, SAF SCI GLYPH TEST 2; Couvillon MJ, 2014, CURR BIOL, V24, P1212, DOI 10.1016/j.cub.2014.03.072; Damalas CA, 2011, INT J ENV RES PUB HE, V8, P1402, DOI 10.3390/ijerph8051402; Donkersley P, 2018, ECOL EVOL, V8, P4743, DOI 10.1002/ece3.3999; Eckert JE, 1933, J AGRIC RES, V47, P0257; Field D.W., 1995, 123 NOAA NMFS; Ford B, 2017, CELL CHEM BIOL, V24, P133, DOI 10.1016/j.chembiol.2016.12.013; Hartel S, 2014, CURR BIOL, V24, pR524, DOI 10.1016/j.cub.2014.04.052; Joint Fact Finding Study Group, 2016, CROPS PEST KAUAI PES; JUVIK SP, 1998, ATLAS HAWAII; Kruger M, 2014, J ENV ANAL TOXICOL, V4, P1, DOI [10.4172/2161-0525.1000210, DOI 10.4172/2161-0525.1000210]; Mensah P.K., 2015, TOXICITY HAZARD AGRO, DOI [10.5772/60767, DOI 10.5772/60767]; Mesnage R, 2017, SCI REP-UK, V7, DOI 10.1038/srep39328; Mills PJ, 2017, JAMA-J AM MED ASSOC, V318, P1610, DOI 10.1001/jama.2017.11726; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Rubio F., 2014, J ENV ANAL TOXICOLOG, V5, DOI [10.4172/2161-0525.1000249, DOI 10.4172/2161-0525.1000249]; Traynor J., 2002, FAR DO BEES FLY ONE; Wilson J., 2016, HAWAIIAN LAND DIVISI; World Health Organization. International Agency for Research on Cancer, 2017, IARC MONOGRAPHS EVAL	27	35	36	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0198876	10.1371/journal.pone.0198876	http://dx.doi.org/10.1371/journal.pone.0198876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995880	Green Submitted, gold, Green Published			2022-12-26	WOS:000438388800014
J	Vardaro, JAC; Epps, CW; Frable, BW; Ray, C				Vardaro, Jessica A. Castillo; Epps, Clinton W.; Frable, Benjamin W.; Ray, Chris			Identification of a contact zone and hybridization for two subspecies of the American pika (Ochotona princeps) within a single protected area	PLOS ONE			English	Article							WESTERN GREAT-BASIN; HYBRID ZONES; POPULATION-STRUCTURE; CLIMATE-CHANGE; BIGHORN SHEEP; GENE FLOW; R-PACKAGE; LAGOMORPHA; EVOLUTIONARY; DISPERSAL	Genetic variation is the basis upon which natural selection acts to yield evolutionary change. In a rapidly changing environment, increasing genetic variation should increase evolutionary potential, particularly for small, isolated populations. However, the introduction of new alleles, either through natural or human-mediated processes, may have unpredictable consequences such as outbreeding depression. In this study, we identified a contact zone and limited gene flow between historically separated genetic lineages of American pikas (Ochotona princeps), representing the northern and southern Rocky Mountain subspecies, within Rocky Mountain National Park. The limited spatial extent of gene flow observed may be the result of geographic barriers to dispersal, selection against hybrid individuals, or both. Our fine-scale population genetic analysis suggests gene flow is limited but not completely obstructed by extreme topography such as glacial valleys, as well as streams including the Colorado River. The discovery of two subspecies within this single protected area has implications for monitoring and management, particularly in the light of recent analyses suggesting that the pikas in this park are vulnerable to fragmentation and local extinction under future projected climates. Future research should focus on the fitness consequences of introgression among distinct genetic lineages in this location and elsewhere, as well as within the context of genetic rescue as a conservation and management strategy for a climate sensitive species.	[Vardaro, Jessica A. Castillo; Epps, Clinton W.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Frable, Benjamin W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Ray, Chris] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	Oregon State University; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Colorado System; University of Colorado Boulder	Vardaro, JAC (corresponding author), Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA.	Castillo.Jessica.A@gmail.com	Epps, Clinton/AAX-3971-2021; Ray, Chris/AAI-1002-2019	Epps, Clinton/0000-0001-6577-1840; Ray, Chris/0000-0002-7963-9637; Castillo Vardaro, Jessica/0000-0001-9580-6987; Frable, Benjamin/0000-0003-4525-0671	National Parks Service Climate Change Response Program [163377]; National Science Foundation; Henry Mastin Graduate Student Fund	National Parks Service Climate Change Response Program; National Science Foundation(National Science Foundation (NSF)); Henry Mastin Graduate Student Fund	This project was funded by the National Parks Service (https://www.NPS.gov) Climate Change Response Program (PMIS #163377), awarded to CWE and CR. Additional support was provided by the National Science Foundation Graduate Research Fellowship Program (to JACV). Publication of this paper was supported, in part, by the Henry Mastin Graduate Student Fund, awarded to CWE. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; Allendorf FW, 2004, CONSERV BIOL, V18, P1203, DOI 10.1111/j.1523-1739.2004.00305.x; ANDERSON E, 1953, BIOL REV, V28, P280, DOI 10.1111/j.1469-185X.1953.tb01379.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Beever EA, 2003, J MAMMAL, V84, P37, DOI 10.1644/1545-1542(2003)084<0037:POAEAI>2.0.CO;2; Beever EA, 2013, ECOLOGY, V94, P1563, DOI 10.1890/12-2174.1; Bell G, 2009, ECOL LETT, V12, P942, DOI 10.1111/j.1461-0248.2009.01350.x; Beschta RL, 2016, BIOL CONSERV, V198, P93, DOI 10.1016/j.biocon.2016.03.031; Biebach I, 2016, REINTRODUCTION OF FISH AND WILDLIFE POPULATIONS, P149; Calkins MT, 2012, ECOGRAPHY, V35, P780, DOI 10.1111/j.1600-0587.2011.07227.x; Castillo JA, 2015, POPULATION GENETICS; Castillo JA, 2016, ECOL APPL, V26, P1660, DOI 10.1890/15-1452.1; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; Collins GH, 2012, J FISH WILDL MANAG, V3, P311, DOI 10.3996/042012-JFWM-032; Conservation Biology Institute, 2012, US POT NAT VEG OR KU; den Hartog PM, 2007, BEHAV ECOL, V18, P608, DOI 10.1093/beheco/arm018; Derryberry EP, 2014, MOL ECOL RESOUR, V14, P652, DOI 10.1111/1755-0998.12209; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ellstrand NC, 2010, BIOSCIENCE, V60, P384, DOI 10.1525/bio.2010.60.5.8; Erb LP, 2011, ECOLOGY, V92, P1730, DOI 10.1890/11-0175.1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fisher RA, 1930, GENETICAL THEORY NAT; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Galbreath KE, 2010, J BIOGEOGR, V37, P344, DOI 10.1111/j.1365-2699.2009.02201.x; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; GERHARDT HC, 1982, AM ZOOL, V22, P581; Gompert Z, 2017, ANNU REV ECOL EVOL S, V48, P207, DOI 10.1146/annurev-ecolsys-110316-022652; Hafner DJ, 2010, J MAMMAL, V91, P401, DOI 10.1644/09-MAMM-A-277.1; HAFNER DJ, 1993, QUATERNARY RES, V39, P373, DOI 10.1006/qres.1993.1044; HAFNER DJ, 1995, J MAMMAL, V76, P302, DOI 10.2307/1382343; Haig Susan M., 2006, P150; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; HEWITT GM, 1975, HEREDITY, V35, P375, DOI 10.1038/hdy.1975.108; Hierfstat Goudet J., 2005, MOL ECOL NOTES, V5, P184, DOI [10.1111/j.1471-8286.2004.00828.x, DOI 10.1111/J.1471-8286.2004.00828.X]; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; HOLMES WG, 1991, ANIM BEHAV, V42, P111, DOI 10.1016/S0003-3472(05)80611-6; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; IVINS BL, 1983, BEHAV ECOL SOCIOBIOL, V13, P277, DOI 10.1007/BF00299675; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janes JK, 2017, MOL ECOL, V26, P3594, DOI 10.1111/mec.14187; Jeffress MR, 2017, WEST N AM NATURALIST, V77, P252, DOI 10.3398/064.077.0213; Jeffress MR, 2013, ECOL APPL, V23, P864, DOI 10.1890/12-0979.1; Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuchler A. W., 1964, AM GEOPHYSICAL SOC S, P36; Landguth EL, 2010, MOL ECOL, V19, P4179, DOI 10.1111/j.1365-294X.2010.04808.x; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Malaney JL, 2015, DIVERS DISTRIB, V21, P1063, DOI 10.1111/ddi.12329; Mathewson PD, 2017, GLOBAL CHANGE BIOL, V23, P1048, DOI 10.1111/gcb.13454; Merila E J, 2014, EVOLUTIONARY APPL, V7, P1, DOI [10.1111/eva.12137, DOI 10.1111/EVA.12137]; Millar CI, 2014, ECOL APPL, V24, P1748, DOI 10.1890/13-0520.1; Millar CI, 2013, WEST N AM NATURALIST, V73, P457, DOI 10.3398/064.073.0412; Millar CI, 2010, ARCT ANTARCT ALP RES, V42, P76, DOI 10.1657/1938-4246-42.1.76; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nichols LB, 2010, WEST N AM NATURALIST, V70, P500; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peacock MM, 1997, BEHAV ECOL, V8, P340, DOI 10.1093/beheco/8.3.340; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2013, TREEANNOTATOR V1 7 0; REMINGTON C L, 1968, Evolutionary Biology (New York), P321; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Schwalm D, 2016, GLOBAL CHANGE BIOL, V22, P1572, DOI 10.1111/gcb.13189; Singer FJ, 2000, RESTOR ECOL, V8, P6, DOI 10.1046/j.1526-100x.2000.80061.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; SMITH A T, 1990, Mammalian Species, P1, DOI 10.2307/3504319; SMITH AT, 1983, BEHAV ECOL SOCIOBIOL, V13, P37, DOI 10.1007/BF00295074; SMITH AT, 1974, ECOLOGY, V55, P1368, DOI 10.2307/1935464; SOMERS P, 1973, ANIM BEHAV, V21, P124, DOI 10.1016/S0003-3472(73)80050-8; Spear SF, 2008, MOL ECOL, V17, P4642, DOI 10.1111/j.1365-294X.2008.03952.x; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stewart JAE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181834; Stewart JAE, 2015, J BIOGEOGR, V42, P880, DOI 10.1111/jbi.12466; Stowell SML, 2017, BIODIVERS CONSERV, V26, P1753, DOI 10.1007/s10531-017-1330-z; Swenson NG, 2005, AM NAT, V166, P581, DOI 10.1086/491688; Team RC, 2015, R LANG ENV STAT COMP; THAELER CS, 1974, SYST ZOOL, V23, P343, DOI 10.2307/2412541; USFWS, 2010, 12 MONTH FIND PET LI, P6437; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; vonHoldt BM, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12371; Wang IJ, 2011, MOL ECOL, V20, P2480, DOI 10.1111/j.1365-294X.2011.05123.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wiedmann BP, 2014, J WILDLIFE MANAGE, V78, P394, DOI 10.1002/jwmg.669; Wilkening Jennifer L., 2015, Biodiversity (Ottawa), V16, P224, DOI 10.1080/14888386.2015.1112304; Winter DJ, 2012, MOL ECOL RESOUR, V12, P1158, DOI 10.1111/j.1755-0998.2012.03174.x; Wringe BF, 2017, MOL ECOL RESOUR, V17, P91, DOI 10.1111/1755-0998.12597; Zgurski JM, 2012, ANIM BEHAV, V83, P1075, DOI 10.1016/j.anbehav.2012.01.038	99	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199032	10.1371/journal.pone.0199032	http://dx.doi.org/10.1371/journal.pone.0199032			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995897	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800015
J	Zhang, Y; Chen, FS; Wu, XQ; Luang, FG; Zhang, LP; Fang, XM; Wan, SZ; Hu, XF; Ye, JR				Zhang, Yang; Chen, Fu-Sheng; Wu, Xiao-Qin; Luang, Feng-Gang; Zhang, Lin-Ping; Fang, Xiang-Min; Wan, Song-Ze; Hu, Xiao-Fei; Ye, Jian-Ren			Isolation and characterization of two phosphate-solubilizing fungi from rhizosphere soil of moso bamboo and their functional capacities when exposed to different phosphorus sources and pH environments	PLOS ONE			English	Article							ORGANIC-ACID PRODUCTION; NITROGEN; TOLERANT; FORESTS	Phosphate-solubilizing fungi (PSF) generally enhance available phosphorus (P) released from soil, which contributes to plants' P requirement, especially in P-limiting regions. In this study, two PSF, TalA-JX04 and AspN-JX16, were isolated from the rhizosphere soil of moso bamboo (Phyllostachys edulis) widely distributed in P-deficient areas in China and identified as Talaromyces aurantiacus and Aspergillus neoniger, respectively. The two PSF were cultured in potato dextrose liquid medium with six types of initial pH values ranging from 6.5 to 1.5 to assess acid resistance. Both PSF were incubated in Pikovskaya's liquid media with different pH values containing five recalcitrant P sources, including Ca-3(PO4)(2), FePO4, CaHPO4, AIPO(4), and C6H6Ca6O24P6, to estimate their P-solubilizing capacity. No significant differences were found in the biomass of both fungi grown in media with different initial pH, indicating that these fungi could grow well under acid stress. The P-solubilizing capacity of TalA-JX04 was highest in medium containing CaHPO4, followed by Ca-3(PO4)(2), FePO4, C6H6Ca6O24P6, and AIPO(4) in six types of initial pH treatments, while the recalcitrant P-solubilizing capacity of AspN-JX16 varied with initial pH. Meanwhile, the P-solubilizing capacity of AspN-JX16 was much higher than TalA-JX04. The pH of fermentation broth was negatively correlated with P-solubilizing capacity (p<0.01), suggesting that the fungi promote the dissolution of P sources by secreting organic acids. Our results showed that TalA-JX04 and AspN-JX16 could survive in acidic environments and both fungi had a considerable ability to release soluble P by decomposing recalcitrant P-bearing compounds. The two fungi had potential for application as environment-friendly biofertilizers in subtropical bamboo ecosystem.	[Zhang, Yang; Wu, Xiao-Qin; Ye, Jian-Ren] Nanjing Forestry Univ, Coll Forest, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China; [Zhang, Yang; Chen, Fu-Sheng; Luang, Feng-Gang; Zhang, Lin-Ping; Fang, Xiang-Min; Wan, Song-Ze] Jiangxi Agr Univ, Coll Forestry, Collaborat Innovat Ctr Jiangxi Typ Trees Cultivat, Nanchang, Jiangxi, Peoples R China; [Hu, Xiao-Fei] Nanchang Univ, Management Sch, Nanchang, Jiangxi, Peoples R China	Nanjing Forestry University; Jiangxi Agricultural University; Nanchang University	Wu, XQ (corresponding author), Nanjing Forestry Univ, Coll Forest, Coinnovat Ctr Sustainable Forestry Southern China, Nanjing, Jiangsu, Peoples R China.	xqwu@njfu.edu.cn	ye, jian/GQH-3702-2022	Wu, Xiao-Qin/0000-0003-0309-1676	National Key Research and Development Program of China [2017YFD0600104]; Jiangxi Provincial Department of Science and Technology [20153BCB22008, 20165BCB19006]; National Natural Science Foundation of China [31660190]; Science and Technology Project of Jiangxi Provincial Education Department [GJJ150412]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China; Jiangxi Provincial Department of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Jiangxi Provincial Education Department; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by grants from the National Key Research and Development Program of China (2017YFD0600104), Jiangxi Provincial Department of Science and Technology (20153BCB22008 & 20165BCB19006), the National Natural Science Foundation of China (31660190), Science and Technology Project of Jiangxi Provincial Education Department (GJJ150412), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo E, 2014, APPL SOIL ECOL, V80, P26, DOI 10.1016/j.apsoil.2014.03.011; Allen S. E., 1974, Chemical analysis of ecological materials.; Barroso CB, 2005, APPL SOIL ECOL, V29, P73, DOI 10.1016/j.apsoil.2004.09.005; Barroso CB, 2006, BRAZ J MICROBIOL, V37, P434, DOI 10.1590/S1517-83822006000400006; Bouwman AF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40366; Chang EH, 2016, APPL SOIL ECOL, V98, P213, DOI 10.1016/j.apsoil.2015.10.018; CHANG S. C., 1957, SOIL SCI, V84, P133, DOI 10.1097/00010694-195708000-00005; CUNNINGHAM JE, 1992, APPL ENVIRON MICROB, V58, P1451, DOI 10.1128/AEM.58.5.1451-1458.1992; Ghosh P, 2015, CHEMOSPHERE, V134, P1, DOI 10.1016/j.chemosphere.2015.03.048; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Guan FY, 2017, CATENA, V150, P161, DOI 10.1016/j.catena.2016.11.017; Guo XM, 2013, BALANCED FERTILIZATI, p27 ; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; [韩烁 HAN Shuo], 2010, [河北农业大学学报, Journal of Agricultural University of Hebei], V33, P26; He ZL, 2004, RED SOILS OF CHINA: THEIR NATURE, MANAGEMENT AND UTILIZATION, P29; Heppell J, 2016, PLANT SOIL, V401, P135, DOI 10.1007/s11104-015-2543-0; Hogarth NJ, 2013, INT FOREST REV, V15, P71, DOI 10.1505/146554813805927237; Kant S., 2000, Forest Policy and Economics, V1, P283, DOI 10.1016/S1389-9341(00)00021-6; KUCEY RMN, 1983, CAN J SOIL SCI, V63, P671, DOI 10.4141/cjss83-068; Li XL, 2015, APPL BIOCHEM BIOTECH, V175, P2755, DOI 10.1007/s12010-014-1465-2; Li Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep25313; Scervino JM, 2013, BIOL FERT SOILS, V49, P779, DOI 10.1007/s00374-013-0811-9; Mendes GD, 2014, APPL ENVIRON MICROB, V80, P3081, DOI 10.1128/AEM.00241-14; Mendes GD, 2014, ANN MICROBIOL, V64, P239, DOI 10.1007/s13213-013-0656-3; Nagaraju A, 2012, AUSTRALAS PLANT PATH, V41, P609, DOI 10.1007/s13313-012-0165-z; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Pitt JI., 2000, INTEGRATION MODERN T, P225; Pitt JI, 1979, GENUS PENICILLIUM IT, P632; Rajput MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138235; Sahoo HR, 2014, PHOSPHATE SOLUBILIZI, P87, DOI [10.1007/978-3-319-08216-5_4, DOI 10.1007/978-3-319-08216-5_4]; Sharma SB, 2013, SPRINGERPLUS, V2, DOI [10.1186/2193-1801-2-587, 10.1186/2193-1801-2-41]; Son HJ, 2006, BIORESOURCE TECHNOL, V97, P204, DOI 10.1016/j.biortech.2005.02.021; Song QN, 2016, PLANT SOIL, V404, P113, DOI 10.1007/s11104-016-2835-z; Song XZ, 2011, ENVIRON REV, V19, P418, DOI [10.1139/a11-015, 10.1139/A11-015]; SPSS Inc, 2007, SPSS WIND 16 0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang XL, 2016, FORESTS, V7, DOI 10.3390/f7110267; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang L, 2012, MYCOTAXON, V120, P373, DOI 10.5248/120.373; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xu QF, 2015, BIOL INVASIONS, V17, P433, DOI 10.1007/s10530-014-0741-y; Zeng WS, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0047-2; Zhang MF, 2004, PROG COLL POL SCI S, V126, P35, DOI 10.1007/b94007	44	37	48	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199625	10.1371/journal.pone.0199625	http://dx.doi.org/10.1371/journal.pone.0199625			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995910	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800027
J	Xu, B; Wang, XQ; Wu, CL; Zhu, LH; Chen, O; Wang, XF				Xu, Bing; Wang, Xueqiang; Wu, Chengliang; Zhu, Lihe; Chen, Ou; Wang, Xiaofeng			Flavonoid compound icariin enhances BMP-2 induced differentiation and signalling by targeting to connective tissue growth factor (CTGF) in SAMP6 osteoblasts	PLOS ONE			English	Article							ACCELERATED MOUSE SAM; BONE-FORMATION; MURINE MODEL; SENILE OSTEOPOROSIS; LONG BONES; IN-VITRO; SENESCENCE; MARROW; PROLIFERATION; MICE	Background Icariin, a major active flavonoid glucoside, is widely used for the treatment of bone injury and rebuilding in the clinic because of its roles in suppressing osteoblastogenesis and promoting osteogenesis. The senescence-accelerated mouse SAMP6 was accepted as a useful murine model to reveal the mechanism of senile osteoporosis and the therapeutic mechanism of drug activity. However, little is known about the characteristics of SAMP6 osteoblasts and the associated regulatory roles of icariin. Methods We isolated and cultured osteoblasts from SAMP6 or SAMR1 mice and compared their proliferation, migration, and differentiation by performing the CCK-8 assay, cell counting assay, EdU staining, cell cycle analysis, ALP staining and activity measurement, Alizarin red staining, and RT-qPCR analysis to measure the levels of osteoblast markers, including RUNX2, Colla1 and Oc. To assess the effects of icariin on BMP-2-induced osteoblast differentiation, after BMP-2 treatment, osteoblast markers were analyzed by RT-qPCR and semi-quantitative Western blotting. The effects of icariin on connective tissue growth factor (CTGF) were measured by RT-qPCR. shRNA targeting CTGF-mRNA was employed to knockdown its expression level in osteoblasts. Results The SAMP6 osteoblasts presented decreased the development and differentiation activity compared with SAMR1 osteoblasts, indicating that they are the potential mechanisms under-lying age-associated disease. Moreover, SAMP6 osteoblasts presented upregulated CTGF compared with SAMR1 osteoblasts. lcariin enhanced BMP-2-induced osteoblast differentiation by downregulating CTGF-expression, which tightly regulates osteoblast differentiation. Conclusion These results suggest that decreased osteoblast development and function potentially contributes to age-associated disease. Icariin exerts enhancing effects on BMP-2-mediated osteoblast development via downregulating CTGF.	[Xu, Bing; Zhu, Lihe; Chen, Ou; Wang, Xiaofeng] Zhejiang Chinese Med Univ, Wenzhou Affilated Hosp, Integrated Tradit Chinese & Western Med Hosp, Hangzhou, Zhejiang, Peoples R China; [Wang, Xueqiang] Shanghai Univ Sport, Dept Sport Rehabil, Shanghai, Peoples R China; [Wu, Chengliang] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Shanghai University of Sport; Zhejiang Chinese Medical University	Wang, XF (corresponding author), Zhejiang Chinese Med Univ, Wenzhou Affilated Hosp, Integrated Tradit Chinese & Western Med Hosp, Hangzhou, Zhejiang, Peoples R China.	wzwxfs@139.com	Wang, Xueqiang/GPW-9671-2022	Wang, Xue-Qiang/0000-0001-5577-5231	Zhejiang Provincial Science foundation [LY16H270015]	Zhejiang Provincial Science foundation	The funder is: Zhejiang Provincial Science foundation (LY16H270015). The website is followed: http://www.zjnsf.gov.cn/. The role of sponsor is design, supervise and manusript writting.	Chen H, 2004, HISTOL HISTOPATHOL, V19, P677, DOI 10.14670/HH-19.677; Chen KM, 2007, PHARMAZIE, V62, P388, DOI 10.1691/ph.2007.5.6682; Ciovacco WA, 2009, BONE, V44, P80, DOI 10.1016/j.bone.2008.08.117; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eleniste PP, 2016, J CELL BIOCHEM, V117, P1396, DOI 10.1002/jcb.25430; Farokhi M, 2016, J CONTROL RELEASE, V225, P152, DOI 10.1016/j.jconrel.2016.01.033; Griffin WST, 1998, NEUROBIOL AGING, V19, P401, DOI 10.1016/S0197-4580(98)00074-8; Higuchi K, 1997, EXP GERONTOL, V32, P129, DOI 10.1016/S0531-5565(96)00060-5; Hsieh CP, 2010, CONNECT TISSUE RES, V51, P497, DOI 10.3109/03008201003746679; Hsieh TP, 2011, PHYTOMEDICINE, V18, P176, DOI 10.1016/j.phymed.2010.04.003; Hsieh TP, 2010, PHYTOMEDICINE, V17, P414, DOI 10.1016/j.phymed.2009.08.007; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kasai S, 2004, J BONE MINER METAB, V22, P207, DOI 10.1007/s00774-003-0471-1; Kawaki H, 2008, BIOCHEM BIOPH RES CO, V366, P450, DOI 10.1016/j.bbrc.2007.11.155; Lambi AG, 2012, DEV DYNAM, V241, P1944, DOI 10.1002/dvdy.23888; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; MATSUSHITA M, 1986, AM J PATHOL, V125, P276; Ming LG, 2013, J CELL PHYSIOL, V228, P513, DOI 10.1002/jcp.24158; Mok SK, 2010, BRIT J PHARMACOL, V159, P939, DOI 10.1111/j.1476-5381.2009.00593.x; Mundy C, 2014, J CELL PHYSIOL, V229, P672, DOI 10.1002/jcp.24491; Nian H, 2009, PHYTOMEDICINE, V16, P320, DOI 10.1016/j.phymed.2008.12.006; O'Sullivan RP, 2012, EXP HEMATOL, V40, P499, DOI 10.1016/j.exphem.2012.01.019; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Silva MJ, 2006, J BONE MINER RES, V21, P78, DOI 10.1359/JBMR.050909; Silva MJ, 2005, J BONE MINER RES, V20, P419, DOI 10.1359/JBMR.041128; Silva MJ, 2002, J BONE MINER RES, V17, P1597, DOI 10.1359/jbmr.2002.17.9.1597; Smerdel-Ramoya' A, 2008, ENDOCRINOLOGY, V149, P4374, DOI 10.1210/en.2008-0254; Song LG, 2013, EUR J PHARMACOL, V714, P15, DOI 10.1016/j.ejphar.2013.05.039; SUDA T, 1994, INT CONGR SER, V1062, P47; TAKAHASHI K, 1994, BONE MINER, V24, P245, DOI 10.1016/S0169-6009(08)80141-9; Takeda T, 1997, EXP GERONTOL, V32, P117, DOI 10.1016/S0531-5565(96)00068-X; Takeda T, 1997, EXP GERONTOL, V32, P105, DOI 10.1016/S0531-5565(96)00036-8; Tirino V, 2011, STEM CELL REV REP, V7, P608, DOI 10.1007/s12015-011-9235-9; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; Xi G, 2014, J BONE MINER RES, V29, P2427, DOI 10.1002/jbmr.2282; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yang D, 2013, J BIOL CHEM, V288, P33530, DOI 10.1074/jbc.M113.497040; Zhai YK, 2014, BONE, V66, P189, DOI 10.1016/j.bone.2014.06.016; Zhang F, 2015, SCI REP-UK, V5, DOI 10.1038/srep13418; Zhang Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00784	42	5	5	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200367	10.1371/journal.pone.0200367	http://dx.doi.org/10.1371/journal.pone.0200367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990327	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300042
J	Shi, WH; Tian, J; Xu, H; Zhou, Q; Qin, M				Shi, Weihua; Tian, Jing; Xu, He; Zhou, Qiong; Qin, Man			Distinctions and associations between the microbiota of saliva and supragingival plaque of permanent and deciduous teeth	PLOS ONE			English	Article							BACTERIAL DIVERSITY; ORAL MICROFLORA; CARIES; DIAGNOSIS; ARGININE; CHILDREN; NETWORK	Background Using salivary microbiota as an accurate proxy for monitoring supragingival microbiota remains controversial because their relationship remains unclear. The eruption of permanent teeth and the exfoliation of primary teeth in mixed dentition greatly alter microbial habitats, which may cause compositional shifts of oral microbiota from childhood to adults. Objective This study's purpose was to assess whether saliva represents a suitable sample for monitoring supragingival microbiota in healthy people, and to explore how the replacement process of deciduous teeth with permanent teeth in mixed dentition influences microbiota within the oral cavity. Design Samples of saliva and of supragingival plaque from permanent and deciduous teeth were collected separately from 20 healthy children with mixed dentition. To characterize their microbial communities, we used the V3-V4 hypervariable region of the bacterial 16S rRNA gene sequence. Results Saliva harbored a less even and less diverse community than did the plaque. Discriminating genera, namely Rothia and Streptococcus, contributed to the saliva and plaque differentiation. About half of predicted KEGG pathways varied between the plaque and saliva communities. Oral bacteria showed significantly associations between their supragingival and salivary states. We identified 20 supragingival plaque-related genera in saliva, such as Corynebacterium, Capnocytophaga, Fusobacterium, and Neisseria. Additionally, the relative abundance of Actinobacteria peaked in the permanent teeth plaque but subsided in deciduous teeth plaque and saliva. The exfoliation of deciduous teeth and eruption of permanent teeth might be related to the reported fluctuation in the relative abundance of Actinobacteria from primary dentition to permanent dentition within the oral cavity. The variation between PT and DT was due mainly to permanent teeth being enriched in Actinomyces and deciduous teeth in Treponema. Conclusion These results suggested that the supragingival plaque-related bacteria could be suitable candidates when sampling saliva for monitoring supragingival microbiota. The replacement process of deciduous teeth with permanent teeth in mixed dentition might be related to the reported age-maturation of phylum Actinobacteria in the oral cavity.	[Shi, Weihua; Tian, Jing; Xu, He; Zhou, Qiong; Qin, Man] Peking Univ Sch & Hosp Stomatol, Dept Pediat Dent, Beijing, Peoples R China		Qin, M (corresponding author), Peking Univ Sch & Hosp Stomatol, Dept Pediat Dent, Beijing, Peoples R China.	qin-man@foxmail.com	Tian, Jing/CAH-2061-2022; qin, man/AAD-3710-2020	Shi, Weihua/0000-0003-3251-8624	Bureau of Health Care for Senior Officials of National Health and Family Planning Commission of the People's Republic of China [220935]; National Natural Science Foundation of China [81641034]	Bureau of Health Care for Senior Officials of National Health and Family Planning Commission of the People's Republic of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Bureau of Health Care for Senior Officials of National Health and Family Planning Commission of the People's Republic of China under Grant 220935; National Natural Science Foundation of China under Grant 81641034.	Belstrom D, 2017, J ORAL MICROBIOL, V9, DOI 10.1080/20002297.2016.1270614; Bos R, 1996, EUR J ORAL SCI, V104, P372, DOI 10.1111/j.1600-0722.1996.tb00094.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fabian TK, 2008, CURR GENOMICS, V9, P11, DOI 10.2174/138920208783884900; Feres M, 2016, PERIODONTOL 2000, V72, P30, DOI 10.1111/prd.12136; Gomez A, 2017, MICROB ECOL, V73, P492, DOI 10.1007/s00248-016-0854-1; Gura T, 2008, NAT MED, V14, P706, DOI 10.1038/nm0708-706; GUSBERTI FA, 1990, J CLIN PERIODONTOL, V17, P685, DOI 10.1111/j.1600-051X.1990.tb01054.x; Hemadi AS, 2017, INT J ORAL SCI, V9, DOI 10.1038/ijos.2017.35; Hojo K, 2009, J DENT RES, V88, P982, DOI 10.1177/0022034509346811; Keijser BJF, 2008, J DENT RES, V87, P1016, DOI 10.1177/154405910808701104; KENNEY EB, 1969, J PERIODONTOL, V40, P630, DOI 10.1902/jop.1969.40.11.630; Koopman JE, 2015, MICROB ECOL, V69, P422, DOI 10.1007/s00248-014-0535-x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Larmas M, 1992, Int Dent J, V42, P199; Liu YL, 2012, INT J ORAL SCI, V4, P135, DOI 10.1038/ijos.2012.54; Luo AH, 2012, ORAL DIS, V18, P595, DOI 10.1111/j.1601-0825.2012.01915.x; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MARQUIS RE, 1995, J IND MICROBIOL, V15, P198, DOI 10.1007/BF01569826; Mashima I, 2015, J BACTERIOL, V197, P13; Nascimento MM, 2009, ORAL MICROBIOL IMMUN, V24, P89, DOI 10.1111/j.1399-302X.2008.00477.x; Palmer RJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00407-17; Proctor DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02900-1; Rath H, 2017, FEMS MICROBIOL ECOL, V93, DOI 10.1093/femsec/fix010; Ren W, 2017, J MICROBIOL, V55, P531, DOI 10.1007/s12275-017-6474-8; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi WH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146938; Simon-Soro A, 2013, J DENT RES, V92, P616, DOI 10.1177/0022034513488119; van Houte J, 1993, Adv Dent Res, V7, P87; Washio J, 2016, BIOMED RES-TOKYO, V37, P251, DOI 10.2220/biomedres.37.251; Xiao CC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01145; Xu X, 2015, ENVIRON MICROBIOL, V17, P699, DOI 10.1111/1462-2920.12502; Yang F, 2012, ISME J, V6, P1, DOI 10.1038/ismej.2011.71; Zaura E, 2017, ISME J, V11, P1218, DOI 10.1038/ismej.2016.199; Zhang CZ, 2016, INT J ORAL SCI, V8, P133, DOI 10.1038/ijos.2016.38; ZHANG X, 2015, J BIOSCIENCES MED, V3, P23, DOI DOI 10.4236/JBM.2015.36004; Zheng H, 2015, SCI REP-UK, V5, DOI 10.1038/srep10948	41	21	22	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200337	10.1371/journal.pone.0200337	http://dx.doi.org/10.1371/journal.pone.0200337			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979786	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500099
J	Ceccato, S; Kettner, SE; Kudielka, BM; Schwieren, C; Voss, A				Ceccato, Smarandita; Kettner, Sara E.; Kudielka, Brigitte M.; Schwieren, Christiane; Voss, Andreas			Social preferences under chronic stress	PLOS ONE			English	Article							CARDIOVASCULAR REACTIVITY; GENDER-DIFFERENCES; SALIVARY CORTISOL; ORAL-CONTRACEPTIVES; PROSOCIAL BEHAVIOR; DECISION-MAKING; RISK-TAKING; LIFE STRESS; RESPONSES; SUPPORT	Even though chronic stress is a pervasive problem in contemporary societies and is known to potentially precede both adverse psychological as well as physiological conditions, its effects on decision making have not been systematically investigated. In this paper, we focus on the relation between self-reported chronic stress and self-reported as well as behaviorally shown social preferences. We measured chronic stress with the Trier Inventory for Chronic Stress. To determine social preferences, participants played a double anonymous dictator game. In order to control for the robustness of social preferences we employed a 2x2x2x2 design where we manipulated four variables: the frame (Give to Recipient vs. Take from Recipient), the decision maker's gender (Female vs. Male), the recipient's gender (Female vs. Male), and the nature of the reward (Real vs. Hypothetical). Results show that perceived chronic stress is not significantly related to social preferences in monetarily rewarded dictator decisions for either gender. However, women's displayed preferences for hypothetical rewards are negatively correlated to chronic stress levels. This indicates that higher chronic stress in women is associated with lower hypothetical transfers but not with altered actual behavior as compared to non-stressed women. For men, we do not observe such effects. Our findings suggest that, while chronic stress leaves social preferences unaffected in an incentive compatible task, it might foster what could be interpreted as a decrease in self-image promotion in women. Thus, we conclude that in a thoroughly controlled behavioral task differences in reported chronic stress do not entail differences in social preferences, but relate to variation in hypothetical decisions for women.	[Ceccato, Smarandita; Kettner, Sara E.; Schwieren, Christiane] Heidelberg Univ, Alfred Weber Inst Econ, Heidelberg, Germany; [Kettner, Sara E.] ConPolicy Inst Consumer Policy, Berlin, Germany; [Kudielka, Brigitte M.] Univ Regensburg, Dept Med Psychol Psychol Diagnost & Res Methodol, Regensburg, Germany; [Voss, Andreas] Univ Regensburg, Inst Psychol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Regensburg; Ruprecht Karls University Heidelberg; University of Regensburg	Schwieren, C (corresponding author), Heidelberg Univ, Alfred Weber Inst Econ, Heidelberg, Germany.	christiane.schwieren@awi.uni-heidelberg.de	Voss, Andreas/F-5087-2011	Voss, Andreas/0000-0002-4499-3660; Kudielka, Brigitte M/0000-0002-8349-926X	German Research Foundation [SCH 1537/1-1]	German Research Foundation(German Research Foundation (DFG))	This research was supported by a grant of the German Research Foundation (SCH 1537/1-1) awarded to the third and fourth authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant of the German Research Foundation (SCH 1537/1-1) awarded to the third and fourth authors.	American Psychological Association, 2013, STRESS AM 2013 IMP S; Branas-Garza P., 2016, GENDER DIFFERENCES A; Brown KM, 2000, J ECON BEHAV ORGAN, V43, P127, DOI 10.1016/S0167-2681(00)00113-X; Buchanan TW, 2014, FRONTIERS BEHAV NEUR; CACIOPPO JT, 1994, PSYCHOPHYSIOLOGY, V31, P113, DOI 10.1111/j.1469-8986.1994.tb01032.x; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Camerer CF, 1999, J RISK UNCERTAINTY, V19, P7, DOI 10.1023/A:1007850605129; Camerer Colin F, 2011, ADV BEHAV EC; Carlsson F, 2001, J ENVIRON ECON MANAG, V41, P179, DOI 10.1006/jeem.2000.1138; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Ceccato S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02036; Christenfeld N, 1997, PSYCHOSOM MED, V59, P388, DOI 10.1097/00006842-199707000-00009; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Ditzen B, 2007, PSYCHONEUROENDOCRINO, V32, P565, DOI 10.1016/j.psyneuen.2007.03.011; Dixon MR, 2013, J APPL BEHAV ANAL, V46, P512, DOI 10.1002/jaba.42; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Fries E, 2009, INT J PSYCHOPHYSIOL, V72, P67, DOI 10.1016/j.ijpsycho.2008.03.014; GERIN W, 1992, PSYCHOSOM MED, V54, P324, DOI 10.1097/00006842-199205000-00008; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Gospic K, 2014, SOC COGN AFFECT NEUR, V9, P1325, DOI 10.1093/scan/nst118; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Heinrichs M, 2003, BIOL PSYCHIAT, V54, P1389, DOI 10.1016/S0006-3223(03)00465-7; Herrmann-Lingen C., 2011, HOSP ANXIETY DEPRESS; Hjortskov N, 2004, STRESS HEALTH, V20, P91, DOI 10.1002/smi.1000; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Innocenti A, 2008, GENDER EFFECT LAB EX; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kandasamy N, 2014, P NATL ACAD SCI USA, V111, P3608, DOI 10.1073/pnas.1317908111; Kang MJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00104; Kang MJ, 2011, J NEUROSCI, V31, P461, DOI 10.1523/JNEUROSCI.1583-10.2011; Kettner SE, 2016, J ECON PSYCHOL, V53, P118, DOI 10.1016/j.joep.2016.01.003; Kettner SE, 2014, DISCUSSION PAPER SER, P557; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; KIRSCHBAUM C, 1995, PSYCHOSOM MED, V57, P468, DOI 10.1097/00006842-199509000-00009; Koch AK, 2008, SOUTH ECON J, V75, P223, DOI 10.2307/20112036; KOLB B, 2001, INTRO BRAIN BEHAV; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kudielka BM, 2010, STRESS, V13, P1, DOI 10.3109/10253890902874913; Leder J, 2015, J ECON PSYCHOL, V49, P133, DOI 10.1016/j.joep.2015.05.006; LEPORE SJ, 1993, PSYCHOSOM MED, V55, P518, DOI 10.1097/00006842-199311000-00007; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; Lighthall NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006002; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Mather M, 2012, CURR DIR PSYCHOL SCI, V21, P36, DOI 10.1177/0963721411429452; Mather M, 2009, PSYCHOL SCI, V20, P174, DOI 10.1111/j.1467-9280.2009.02275.x; Matud MP, 2004, PERS INDIV DIFFER, V37, P1401, DOI 10.1016/j.paid.2004.01.010; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MEULENBERG PMM, 1987, CLIN CHIM ACTA, V165, P379, DOI 10.1016/0009-8981(87)90183-5; Morgenstern R, 2014, THEOR DECIS, V77, P557, DOI 10.1007/s11238-013-9408-x; PETROWSKI K, 2012, BMC MED RES METHODOL, V12; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; Preston SD, 2007, BEHAV NEUROSCI, V121, P257, DOI 10.1037/0735-7044.121.2.257; Rand DG, 2016, J EXP PSYCHOL GEN, V145, P389, DOI 10.1037/xge0000154; Schlotz W, 2008, PSYCHOSOM MED, V70, P787, DOI 10.1097/PSY.0b013e3181810658; Schulz P, 1999, DIAGNOSTICA, V45, P8, DOI 10.1026//0012-1924.45.1.8; Schulz P., 2004, TICS TRIERER INVENTA; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Sutter M, 2009, EXP ECON, V12, P318, DOI 10.1007/s10683-009-9217-9; Taylor MP, 2013, J RISK UNCERTAINTY, V46, P299, DOI 10.1007/s11166-013-9166-8; Taylor SE, 2000, PSYCHOL REV, V107, P411, DOI 10.1037/0033-295X.107.3.411; Taylor SE, 2006, CURR DIR PSYCHOL SCI, V15, P273, DOI 10.1111/j.1467-8721.2006.00451.x; Uchino BN, 1997, J BEHAV MED, V20, P15, DOI 10.1023/A:1025583012283; Vinkers CH, 2013, PSYCHONEUROENDOCRINO, V38, P1467, DOI 10.1016/j.psyneuen.2012.12.012; von Dawans B, 2012, PSYCHOL SCI, V23, P651, DOI 10.1177/0956797611431576; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004	75	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199528	10.1371/journal.pone.0199528	http://dx.doi.org/10.1371/journal.pone.0199528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020926	Green Submitted, gold, Green Published			2022-12-26	WOS:000439022400015
J	Gudina, EK; Tesfaye, M; Wieser, A; Pfister, HW; Klein, M				Gudina, Esayas Kebede; Tesfaye, Markos; Wieser, Andreas; Pfister, Hans-Walter; Klein, Matthias			Outcome of patients with acute bacterial meningitis in a teaching hospital in Ethiopia: A prospective study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; MENINGOCOCCAL MENINGITIS; TUBERCULOUS MENINGITIS; ADDIS-ABABA; ADULTS; DEXAMETHASONE; EPIDEMIOLOGY; ADOLESCENTS; MANAGEMENT; PREDICTORS	Background The mortality and neurologic sequelae associated with acute bacterial meningitis (ABM) remain high despite advances in medical care. The main aim of this study was to evaluate short-term outcome in patients treated as bacterial meningitis at a teaching hospital in Ethiopia to identify factors that could be focused on to improve outcome in this setting. Methods A hospital based longitudinal study was conducted at Jimma University Hospital in southwest Ethiopia from March 1, 2013 to December 31, 2015. Participants of this study were patients of age 18 years and older who were treated as confirmed or possible cases of ABM. Patients were followed throughout their hospital stay for change in their clinical course and predefined end points. A multivariable analysis was done to identify factors associated with unfavorable outcomes. Result 90 patients admitted with diagnosis of acute bacterial meningitis were included in the study; cerebrospinal fluid was analysed for 85 (94.4%) of them. Causative bacteria were isolated in 26 (28.9%) patients only; most of these isolates (84.6%) were either Streptococcus pneumoniae or Neisseria meningitidis. Patients managed as cases of ABM at the hospital suffered from a high rate of unfavorable outcome (36.7%) and an overall mortality rate of 22.2%. Impaired level of consciousness (AOR = 0.766, 95% CI = 0.589-0.995), dexamethasone therapy (AOR = 4.676, 95% CI = 1.12-19.50) and fever persisting after two days of admission (AOR = 24.226, 95% CI = 5.24-111.96) were found to be independently associated with unfavorable outcome. Conclusion Outcome in patients treated for ABM at the hospital was found to be poor. Impaired mentation, treatment with adjunctive dexamethasone and persistent fever were found to be associated with poor outcome. Thus, development of clinical guidelines for treatment of ABM that suit the local context is essential to improve patient management and outcome.	[Gudina, Esayas Kebede] Jimma Univ, Dept Internal Med, Jimma, Ethiopia; [Gudina, Esayas Kebede; Tesfaye, Markos] Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany; [Tesfaye, Markos] St Pauls Hosp, Millennium Med Coll, Dept Psychiat, Addis Ababa, Ethiopia; [Wieser, Andreas] Ludwig Maximilians Univ Munchen, Max von Pettenkofer Inst, Dept Bacteriol, Munich, Germany; [Wieser, Andreas] Univ Munich, Ludwig Maximilians Univ, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Wieser, Andreas] Partner Site Munich, German Ctr Infect Res DZIF, Munich, Germany; [Pfister, Hans-Walter; Klein, Matthias] Ludwig Maximilians Univ Munchen, Klinikum Grosshadern, Dept Neurol, Munich, Germany	Jimma University; University of Munich; University of Munich; University of Munich; German Center for Infection Research; University of Munich	Gudina, EK (corresponding author), Jimma Univ, Dept Internal Med, Jimma, Ethiopia.; Gudina, EK (corresponding author), Ludwig Maximilians Univ Munchen, Ctr Int Hlth, Munich, Germany.	esayas.kebede@ju.edu.et	Tesfaye, Markos/H-9297-2019; Klein, Matthias/F-4118-2017; Gudina, Esayas Kebede/U-9370-2019; Gudina, Esayas Kebede/AAX-2374-2020	Klein, Matthias/0000-0001-9064-6865; Gudina, Esayas Kebede/0000-0002-6264-9695; Gudina, Esayas Kebede/0000-0002-6264-9695; Tesfaye, Markos/0000-0002-3351-701X	Else Kroner-Fresenius-Stiftung, Bad Homburg, Germany;  [2013_HA77]	Else Kroner-Fresenius-Stiftung, Bad Homburg, Germany; 	This research was funded by Else Kroner-Fresenius-Stiftung, Bad Homburg, Germany (https://www.ekfs.de/). MK received the grant (grant number - 2013_HA77). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkali NH, 2013, ANN AFR MED, V12, P1, DOI 10.4103/1596-3519.108242; Assiri AM, 2009, MAYO CLIN PROC, V84, P403, DOI [10.1016/S0025-6196(11)60558-2, 10.4065/84.5.403]; Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024; Bijlsma MW, 2016, LANCET INFECT DIS, V16, P339, DOI 10.1016/S1473-3099(15)00430-2; Borchorst S, 2012, ACTA ANAESTH SCAND, V56, P1210, DOI 10.1111/j.1399-6576.2012.02698.x; Brouwer MC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004405.pub4; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Buchholz G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1498-8; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Desmond NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068163; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; Dzupova O, 2009, SCAND J INFECT DIS, V41, P348, DOI 10.1080/00365540902849391; Ethiopian Health and Nutrition Research Institute, 2013, NAT GUID MEN MEN SUR; FEKADE D, 1992, ETHIOPIAN MED J, V30, P135; [FMHACA Ethiopia FMaHAaCAo], 2014, STAND TREAT GUID GEN; Ghana National Drug Policy (GNDP), 2010, MEN STAND TREATM GUI, P356; Gituro C, 2017, PAN AFRICAN MED J S1, V28; Glimaker M, 2015, CLIN INFECT DIS, V60, P1162, DOI 10.1093/cid/civ011; Global_ Health_ Observatory_(GHO) data, 2015, EP MEN MEN WHO; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gudina EK, 2016, CHALLENGES BACTERIAL; Hailu M, 2001, ETHIOPIAN MED J, V39, P29; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; JENNETT B, 1975, LANCET, V1, P480; Karstaedt AS, 1998, QJM-INT J MED, V91, P743, DOI 10.1093/qjmed/91.11.743; Klein M, 2009, EXPERT OPIN PHARMACO, V10, P2609, DOI 10.1517/14656560903277210; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Mengistu G, 2003, ETHIOPIAN MED J, V41, P319; Mihret W, 2016, EMERG INFECT DIS, V22, P75, DOI 10.3201/eid2201.150432; Mihret Wude, 2014, Ethiop Med J, VSuppl 1, P43; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; Mulu A, 2005, NW ETHIOPIA ETHIOPJH, V19, P160; Rajasingham R, 2015, AM J TROP MED HYG, V92, P274, DOI 10.4269/ajtmh.14-0452; Sanya E, 2006, INTERNET J INFECT DI, V6; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Sheu JJ, 2009, AM J MED SCI, V338, P134, DOI 10.1097/MAJ.0b013e3181a590f1; Short William R., 2001, Curr Infect Dis Rep, V3, P360, DOI 10.1007/s11908-001-0076-6; Thinyane KH, 2015, J TROP MED-US, V2015, DOI 10.1155/2015/423161; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2004, LANCET INFECT DIS, V4, P139, DOI 10.1016/S1473-3099(04)00937-5; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Veltman Jennifer A, 2014, J Int AIDS Soc, V17, P19184, DOI 10.7448/IAS.17.1.19184; Wall EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069783; WHO, 2014, MEN OUTBR RESP SUBS; WHO, 2001, WKLY EPIDEMIOL REC, V76, P282; WHO, 1998, CONTR EP MEN DIS	51	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200067	10.1371/journal.pone.0200067	http://dx.doi.org/10.1371/journal.pone.0200067			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020952	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400039
J	Milioni, F; Leite, JVD; Beneke, R; de Poli, RAB; Papoti, M; Zagatto, AM				Milioni, Fabio; de Mello Leite, Jorge Vieira; Beneke, Ralph; Bonetti de Poli, Rodrigo Araujo; Papoti, Marcelo; Zagatto, Alessandro Moura			Table tennis playing styles require specific energy systems demands	PLOS ONE			English	Article							PHYSIOLOGICAL-RESPONSES; EXERCISE; ENERGETICS; PLAYERS; MATCH; MAOD	The aim of the present study was to investigate the differences in energy system contributions and temporal variables between offensive and all-round playing styles. Fifteen male table tennis players (Offensive players: N = 7; All-round players: N = 8) participated in the study. Matches were monitored by a portable gas analyzer and the blood lactate responses was also measured. The contributions of the oxidative (W-OXID), phosphagen (W-PCr), and glycolytic (W-[La]) energy systems were assumed as the oxygen consumption measured during the matches above of baseline value, the fast component of excess post-exercise oxygen consumption (EPOCFAST) measured after the matches, and the net of blood lactate concentration (Delta[La]), respectively. Energy systems contributions were not significantly different between the offensive and all-round playing styles (W-OXID : 96.1 +/- 2.0 and 97.0 +/- 0.6%, P = 0.86; W-PCr : 2.7 +/- 1.7 and 2.0 +/- 0.6%, P = 0.13; W-[La] : 1.2 +/- 0.5 and 1.0 +/- 0.7%, P = 0.95; respectively), however, magnitude-based analysis of W-PCr presented Likely higher-contribution for offensive compared to all-round players. Regarding temporal variables, only rate of shots presented higher values for offensive when compared to all-round players (P= 0.03), while the magnitude-based analysis presented Very likely lower, Likely lower and Likely higher-outcomes of rate of shots, W-PCr and maximal oxygen consumption, respectively, for all-round players. Strong negative correlation was verified for offensive players between number of shots and W-PCr (r = -0.86, P= 0.01), while all-round players showed strong correlations between rally duration, W-OXID (r = 0.76, P= 0.03) and maximal oxygen consumption (r = 0.81, P= 0.03). Therefore, despite no differences in energy system contributions for offensive and all-round players, different playing styles seems to requires specific energy systems demands.	[Milioni, Fabio; Bonetti de Poli, Rodrigo Araujo; Zagatto, Alessandro Moura] Sao Paulo State Univ UNESP, Sch Sci, Dept Phys Educ, Postgrad Program Movement Sci,Lab Physiol & Sport, Bauru, SP, Brazil; [de Mello Leite, Jorge Vieira] Fed Univ Mato Grosso UFMS, Postgrad Program Hlth & Dev Midwest Reg, Campo Grande, MG, Brazil; [Beneke, Ralph] Philipps Univ Marburg, Marburg, Germany; [Papoti, Marcelo] Univ Sao Paulo, Sch Phys Educ & Sports Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Mato Grosso do Sul; Philipps University Marburg; Universidade de Sao Paulo	Zagatto, AM (corresponding author), Sao Paulo State Univ UNESP, Sch Sci, Dept Phys Educ, Postgrad Program Movement Sci,Lab Physiol & Sport, Bauru, SP, Brazil.	azagatto@yahoo.com.br	de Poli, Rodrigo A.B./L-2199-2016; Zagatto, Alessandro M/F-9969-2012; Milioni, Fabio/J-3640-2012; Papoti, Marcelo MP/D-1725-2012; Papoti, Marcelo/AAM-6394-2021	de Poli, Rodrigo A.B./0000-0001-9539-5954; Zagatto, Alessandro M/0000-0003-1065-4158; Milioni, Fabio/0000-0002-3339-2106; Papoti, Marcelo MP/0000-0002-3702-7149; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/02683-6, 2016/17836-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2016/02683-6 to FM and 2016/17836-2 to RABP). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Cabello Manrique D, 2003, BRIT J SPORT MED, V37, P62; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd, P567, DOI DOI 10.1234/12345678; Davis P, 2014, INT J SPORT PHYSIOL, V9, P233, DOI 10.1123/IJSPP.2013-0006; Bertuzzi RCD, 2007, EUR J APPL PHYSIOL, V101, P293, DOI 10.1007/s00421-007-0501-0; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Fernandez J, 2006, BRIT J SPORT MED, V40, P387, DOI 10.1136/bjsm.2005.023168; Girard O, 2006, BRIT J SPORT MED, V40, P521, DOI 10.1136/bjsm.2005.023754; Girard O, 2007, J STRENGTH COND RES, V21, P909; Glaister M, 2005, SPORTS MED, V35, P757, DOI 10.2165/00007256-200535090-00003; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Kovacs MS, 2006, BRIT J SPORT MED, V40, P381, DOI 10.1136/bjsm.2005.023309; Lanzoni IM, 2014, EUR J SPORT SCI, V14, P309, DOI 10.1080/17461391.2013.819382; Martin C, 2015, J SPORT MED PHYS FIT, V55, P1517; Mello FD, 2009, EUR J APPL PHYSIOL, V107, P615, DOI 10.1007/s00421-009-1172-9; Milioni F, 2017, INT J SPORTS MED, V38, P226, DOI 10.1055/s-0042-117722; Sperlich B, 2011, INT J SPORT PHYSIOL, V6, P234, DOI 10.1123/ijspp.6.2.234; Zagatto A, 2011, SCAND J MED SCI SPOR, V21, pE222, DOI 10.1111/j.1600-0838.2010.01258.x; Zagatto AM, 2016, INT J SPORTS MED, V37, P700, DOI 10.1055/s-0042-104413; Zagatto AM, 2012, INT J SPORTS MED, V33, P613, DOI 10.1055/s-0032-1304648; Zagatto AM, 2017, J SPORT SCI, V35, P2453, DOI 10.1080/02640414.2016.1273539; Zagatto AM, 2010, J STRENGTH COND RES, V24, P942, DOI 10.1519/JSC.0b013e3181cb7003; Zagatto AM, 2018, J SPORT SCI, V36, P724, DOI 10.1080/02640414.2017.1335957; Zagatto AM, 2016, INT J SPORT PHYSIOL, V11, P1012, DOI 10.1123/ijspp.2015-0746	25	12	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199985	10.1371/journal.pone.0199985	http://dx.doi.org/10.1371/journal.pone.0199985			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020946	gold, Green Submitted, Green Published			2022-12-26	WOS:000439022400035
J	Jajack, A; Brothers, M; Kasting, G; Heikenfeld, J				Jajack, Andrew; Brothers, Michael; Kasting, Gerald; Heikenfeld, Jason			Enhancing glucose flux into sweat by increasing paracellular permeability of the sweat gland	PLOS ONE			English	Article							TIGHT JUNCTION PERMEABILITY; CONTAMINATION; CALCIUM	Non-invasive wearable biosensors provide real-time, continuous, and actionable health information. However, difficulties detecting diluted biomarkers in excreted biofluids limit practical applications. Most biomarkers of interest are transported paracellularly into excreted biofluids from biomarker-rich blood and interstitial fluid during normal modulation of cellular tight junctions. Calcium chelators are reversible tight junction modulators that have been shown to increase absorption across the intestinal epithelium. However, calcium chelators have not yet been shown to improve the extraction of biomarkers. Here we show that for glucose, a paracellularly transported biomarker, the flux into sweat can be increased by >10x using citrate, a calcium chelator, in combination with electroosmosis. Our results demonstrate a method of increasing glucose flux through the sweat gland epithelium, thereby increasing the concentration in sweat. Future work should examine if this method enhances flux for other paracellularly transported biomarkers to make it possible to detect more biomarkers with currently available biosensors.	[Jajack, Andrew] Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA; [Brothers, Michael] UES Inc, Dayton, OH USA; [Brothers, Michael] US Air Force, Res Lab, 711th Human Performance Wing, Wright Patterson AFB, OH 45433 USA; [Kasting, Gerald] Univ Cincinnati, James L Winkle Coll Pharm, Cincinnati, OH USA; [Heikenfeld, Jason] Univ Cincinnati, Dept Elect Engn & Comp Syst, Cincinnati, OH USA; [Heikenfeld, Jason] Eccrine Syst Inc, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; UES, Inc.; United States Department of Defense; United States Air Force; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Jajack, A (corresponding author), Univ Cincinnati, Dept Biomed Engn, Cincinnati, OH 45221 USA.	jajackaj@mail.uc.edu			Air Force Research Labs (USAF) [FA8650-16-C-6760]; Ohio Federal Research Network [PO FY16-049, WSARC-1077-700]	Air Force Research Labs (USAF); Ohio Federal Research Network	Jason Heikenfeld received two grants from the following funding agencies: Air Force Research Labs (USAF contract #FA8650-16-C-6760) and the Ohio Federal Research Network (PO FY16-049; WSARC-1077-700). The funder provided support in the form of salaries for authors JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, we note that one or more of the authors are employed by a commercial company: UES, Inc. and Eccrine Systems, Inc.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Baron S, 1996, MED MICROBIOLOGY, V4th, DOI NBK7617; BHAT M, 1993, PHARMACEUT RES, V10, P991, DOI 10.1023/A:1018906504944; BOYSEN TC, 1984, J APPL PHYSIOL, V56, P1302, DOI 10.1152/jappl.1984.56.5.1302; Cha KH, 2014, ANAL CHEM, V86, P1902, DOI 10.1021/ac4040168; Cork MJ, 2006, J ALLERGY CLIN IMMUN, V118, P3, DOI 10.1016/j.jaci.2006.04.042; Deli MA, 2009, BBA-BIOMEMBRANES, V1788, P892, DOI 10.1016/j.bbamem.2008.09.016; Ely MR, 2011, J APPL PHYSIOL, V110, P1534, DOI 10.1152/japplphysiol.01437.2010; Fiume MM, 2014, INT J TOXICOL, V33, p16S, DOI 10.1177/1091581814526891; Ghartey-Tagoe EB, 2005, J CONTROL RELEASE, V103, P177, DOI 10.1016/j.jconrel.2004.11.021; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; GONZALEZMARISCAL L, 1990, AM J PHYSIOL, V259, pC978, DOI 10.1152/ajpcell.1990.259.6.C978; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Heikenfeld J, 2016, ELECTROANAL, V28, P1242, DOI 10.1002/elan.201600018; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Leboulanger B, 2004, PHYSIOL MEAS, V25, pR35, DOI 10.1088/0967-3334/25/3/R01; Lee H, 2016, NAT NANOTECHNOL, V11, P566, DOI [10.1038/NNANO.2016.38, 10.1038/nnano.2016.38]; Lindmark T, 1998, J PHARMACOL EXP THER, V284, P362; Liu G, 2016, SENSOR ACTUAT B-CHEM, V227, P35, DOI 10.1016/j.snb.2015.12.034; Moyer J, 2012, DIABETES TECHNOL THE, V14, P398, DOI 10.1089/dia.2011.0262; Peng R, 2016, LAB CHIP, V16, P4415, DOI 10.1039/c6lc01013j; Potts RO, 2002, DIABETES-METAB RES, V18, pS49, DOI 10.1002/dmrr.210; Salama NN, 2006, ADV DRUG DELIVER REV, V58, P15, DOI 10.1016/j.addr.2006.01.003; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sheu HM, 1999, BRIT J DERMATOL, V140, P385, DOI 10.1046/j.1365-2133.1999.02697.x; Simmer P, 2018, J DERMATOL SCI, V89, P40, DOI 10.1016/j.jdermsci.2017.10.013; Sonner Z, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4921039; Steed E, 2010, TRENDS CELL BIOL, V20, P142, DOI 10.1016/j.tcb.2009.12.002; Tierney MJ, 2001, BIOSENS BIOELECTRON, V16, P621, DOI 10.1016/S0956-5663(01)00189-0; Tierney MJ, 2000, ELECTROANAL, V12, P666, DOI 10.1002/1521-4109(200005)12:9<666::AID-ELAN666>3.0.CO;2-C; Tomita M, 1996, J PHARM SCI, V85, P608, DOI 10.1021/js9504604; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088	32	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200009	10.1371/journal.pone.0200009	http://dx.doi.org/10.1371/journal.pone.0200009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011292	Green Submitted, gold, Green Published			2022-12-26	WOS:000438829800010
J	Pisamai, S; Roytrakul, S; Phaonakrop, N; Jaresitthikunchai, J; Suriyaphol, G				Pisamai, Sirinun; Roytrakul, Sittiruk; Phaonakrop, Narumon; Jaresitthikunchai, Janthima; Suriyaphol, Gunnaporn			Proteomic analysis of canine oral tumor tissues using MALDI-TOF mass spectrometry and in-gel digestion coupled with mass spectrometry (GeLC MS/MS) approaches	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROSTATE-CANCER CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; BRUSH BIOPSY ANALYSIS; HUMAN BREAST-CANCER; IMMUNOHISTOCHEMICAL EXPRESSION; HEPATOCELLULAR-CARCINOMA; DOGS; ACTIVATION; RESISTANCE	Oral tumors, including highly invasive and metastatic oral melanoma (OM), non-tonsillar oral squamous cell carcinoma (OSCC) and benign tumors (BN), are common neoplasms in dogs. Although these tumors behave differently, limited data of their protein expression profiles have been exhibited, particularly at the proteome level. The present study aimed to i.) characterize peptide-mass fingerprints (PMFs) and identify potential protein candidates of OM, OSCC, BN and normal control subjects, using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and liquid chromatography tandem mass spectrometry (LC-MS/MS), ii.) identify potential protein candidates associated with the diseases, using in-gel digestion coupled with mass spectrometric analysis (GeLC-MS/MS) and iii.) search for relationships between chemotherapy drugs and disease-perturbed proteins. A distinct cluster of each sample group and unique PMFs with identified protein candidates were revealed. The unique peptide fragment at 2,274 Da of sacsin molecular chaperone (SACS) was observed in early-stage OM whereas the fragment at 1,958 Da of sodium voltage-gated channel alpha subunit 10 (SCN10A) was presented in early- and late-stage OM. The peptide mass at 2,316 Da of Notch1 appeared in early-stage OM and benign oral tumors while the peptide mass at 2,505 Da of glutamate ionotropic receptor N-methyl-D-aspartate type subunit 3A (GRIN3A) was identified in all groups. Markedly expressed proteins from GeLC-MS/MS included Jumonji domain containing 1C (JMJD1C) in benign tumors, inversin (INVS) and rho guanine nucleotide exchange factor 28 (ARHGEF28) in OM, BTB domain-containing 16 (BTBD16) in OSCC, and protein tyrosine phosphatase non-receptor type 1 (PTPN1), BRCA2, DNA repair associated (BRCA2), WW domain binding protein 2 (WBP2), purinergic receptor P2Y1 and proteasome activator subunit 4 (PSME4) in all cancerous groups. The network connections between these proteins and chemotherapy drugs, cisplatin and doxorubicin, were also demonstrated. In conclusion, this study unveiled the unique PMFs and novel candidate protein markers of canine oral tumors.	[Pisamai, Sirinun; Suriyaphol, Gunnaporn] Chulalongkorn Univ, Fac Vet Sci, Dept Physiol, Biochem Unit, Bangkok, Thailand; [Pisamai, Sirinun; Suriyaphol, Gunnaporn] Chulalongkorn Univ, Fac Vet Sci, Compan Anim Canc Res Unit, Bangkok, Thailand; [Roytrakul, Sittiruk; Phaonakrop, Narumon; Jaresitthikunchai, Janthima] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Genome Inst, Prote Res Lab, Pathum Thani, Thailand	Chulalongkorn University; Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Suriyaphol, G (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Dept Physiol, Biochem Unit, Bangkok, Thailand.; Suriyaphol, G (corresponding author), Chulalongkorn Univ, Fac Vet Sci, Compan Anim Canc Res Unit, Bangkok, Thailand.	Gunnaporn.V@chula.ac.th	Suriyaphol, Gunnaporn/D-2500-2019	Suriyaphol, Gunnaporn/0000-0002-8961-5970; Roytrakul, Sittiruk/0000-0003-3696-8390	Chase Enterprise (Siam) Co., Ltd. [RES_60_229_31_025]; Faculty of Veterinary Science, Chulalongkorn University [RG 1/2559]; 100th Anniversary Chulalongkorn University for Doctoral Scholarship; 90th Anniversary of Chulalongkorn University Scholarship; Overseas Research Experience Scholarship for Graduate Student	Chase Enterprise (Siam) Co., Ltd.; Faculty of Veterinary Science, Chulalongkorn University(Chulalongkorn University); 100th Anniversary Chulalongkorn University for Doctoral Scholarship; 90th Anniversary of Chulalongkorn University Scholarship; Overseas Research Experience Scholarship for Graduate Student	This work was supported by: Chase Enterprise (Siam) Co., Ltd., grant number RES_60_229_31_025 (http://www.chasesiam.com/th) (GS - funding receiver); Faculty of Veterinary Science, Chulalongkorn University, grant number RG 1/2559 (http://www.vet.chula.ac.th/vet2014/) (GS - funding receiver); The 100th Anniversary Chulalongkorn University for Doctoral Scholarship (http://www.grad.chula.ac.th/th/01_information/c01_scholarship_detail_100ys_eng.php) (SP - funding receiver); The 90th Anniversary of Chulalongkorn University Scholarship (http://www.grad.chula.ac.th/th/01_information/c01_scholarship_detail_90yearfund_eng.php) (SP funding receiver); Overseas Research Experience Scholarship for Graduate Student, (http://www.grad.chula.ac.th/th/01_information/c01_scholarship_detail_OverseasResearch_eng.php) (SP - funding receiver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Asa S, 2017, J COMP PATHOL, V157, P27, DOI 10.1016/j.jcpa.2017.05.001; Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103; Atherton MJ, 2013, VET J, V196, P320, DOI 10.1016/j.tvjl.2012.12.010; Baldwin MA, 2004, MOL CELL PROTEOMICS, V3, P1, DOI 10.1074/mcp.R300012-MCP200; Balluff B, 2011, HISTOCHEM CELL BIOL, V136, P227, DOI 10.1007/s00418-011-0843-x; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Bergman PJ, 2007, CLIN TECH SMALL AN P, V22, P55, DOI 10.1053/j.ctsap.2007.03.004; Brackenbury WJ, 2012, CHANNELS, V6, P352, DOI 10.4161/chan.21910; Brockley LK, 2013, NEW ZEAL VET J, V61, P25, DOI 10.1080/00480169.2012.699433; Bronden LB, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-54; Campos CD, 2008, RES VET SCI, V85, P349, DOI 10.1016/j.rvsc.2007.11.006; Chaicherdsakul T, 2017, J PLANT BIOCHEM BIOT, V26, P235, DOI 10.1007/s13562-016-0386-2; Chaiyarit P, 2015, CLIN ORAL INVEST, V19, P729, DOI 10.1007/s00784-014-1293-3; Chang MC, 2016, ONCOTARGET, V7, P16879, DOI 10.18632/oncotarget.7621; Chen S, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0693-9; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Dank G, 2014, VET COMP ONCOL, V12, P78, DOI 10.1111/j.1476-5829.2012.00338.x; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Diss JKJ, 1998, FEBS LETT, V427, P5, DOI 10.1016/S0014-5793(98)00378-0; Doublier S, 2008, MOL CANCER RES, V6, P1607, DOI 10.1158/1541-7786.MCR-08-0251; Dzieciatkowska M, 2014, METHODS MOL BIOL, V1156, P53, DOI 10.1007/978-1-4939-0685-7_4; Elmslie RE, 2008, J VET INTERN MED, V22, P1373, DOI 10.1111/j.1939-1676.2008.0179.x; Floriano-Sanchez E, 2014, ASIAN PAC J CANCER P, V15, P3805, DOI 10.7314/APJCP.2014.15.8.3805; Fraser SP, 2005, CLIN CANCER RES, V11, P5381, DOI 10.1158/1078-0432.CCR-05-0327; Garcia-Martin E, 2002, CANCER LETT, V180, P41, DOI 10.1016/S0304-3835(02)00015-0; Goriki A, 2018, NAT REV UROL, V15, P345, DOI 10.1038/s41585-018-0005-1; Gostelow R, 2013, J VET INTERN MED, V27, P83, DOI 10.1111/jvim.12009; Greene VR, 2013, J VET INTERN MED, V27, P1278, DOI 10.1111/jvim.12169; Guillemette S, 2015, GENE DEV, V29, P489, DOI 10.1101/gad.256214.114; Gunby RH, 2007, ANTI-CANCER AGENT ME, V7, P594, DOI 10.2174/187152007784111340; HAIT WN, 1986, J CLIN ONCOL, V4, P994, DOI 10.1200/JCO.1986.4.6.994; Hirose Yoichiro, 2002, Journal of Nippon Medical School, V69, P243, DOI 10.1272/jnms.69.243; Hu Shen, 2007, Cancer Genomics & Proteomics, V4, P55; Israel MA, 2015, MOL BASIS CANC, P191; Jagadish N, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0425-9; Kaowinn S, 2017, CELL ONCOL, V40, P549, DOI 10.1007/s13402-017-0343-7; Klopfleisch R, 2010, J PROTEOME RES, V9, P6380, DOI 10.1021/pr100671c; Klose P, 2011, J PROTEOME RES, V10, P4405, DOI 10.1021/pr200112q; Lee BH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176370; Leroy B, 2007, VET COMP ONCOL, V5, P119, DOI 10.1111/j.1476-5829.2006.00121.x; Lim JH, 2014, BMB REP, V47, P405, DOI 10.5483/BMBRep.2014.47.7.075; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Liptak JM., 2013, WITHROW MACEWENS SMA, P455; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maekawa N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157176; Masia-Balague M, 2015, J BIOL CHEM, V290, P15197, DOI 10.1074/jbc.M114.628164; Maurer K, 2013, ORAL ONCOL, V49, P152, DOI 10.1016/j.oraloncology.2012.08.012; Mayayo Saray Lorda, 2011, Vet J, V190, pe26, DOI 10.1016/j.tvjl.2011.02.020; Mccaw DL, 2007, CLIN CANCER RES, V13, P2496, DOI 10.1158/1078-0432.CCR-06-2699; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Mestrinho LA, 2017, VET COMP ONCOL, V15, P18, DOI 10.1111/vco.12134; Mestrinho LA, 2015, VET PATHOL, V52, P614, DOI 10.1177/0300985814547391; Molli PR, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-16; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; Murray KK, 2013, PURE APPL CHEM, V85, P1515, DOI 10.1351/PAC-REC-06-04-06; Nel S, 2015, ARCH ORAL BIOL, V60, P1577, DOI 10.1016/j.archoralbio.2015.08.002; Nemec A, 2012, J COMP PATHOL, V147, P111, DOI 10.1016/j.jcpa.2011.11.198; Nishiya Adriana Tomoko, 2016, Vet Sci, V3, DOI 10.3390/vetsci3010007; Niyompanich S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144128; OGILVIE GK, 1989, J AM VET MED ASSOC, V195, P1580; Parfitt DA, 2009, HUM MOL GENET, V18, P1556, DOI 10.1093/hmg/ddp067; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Pisarnai S, 2017, RES VET SCI, V113, P94, DOI 10.1016/j.rvsc.2017.09.009; Remmerbach TW, 2011, ORAL ONCOL, V47, P278, DOI 10.1016/j.oraloncology.2011.02.005; Rungruengphol C, 2015, MICROB PATHOGENESIS, V86, P18, DOI 10.1016/j.micpath.2015.07.003; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Schlieben P, 2013, J COMP PATHOL, V148, P318, DOI 10.1016/j.jcpa.2012.07.006; Schmidt LJ, 2012, MOL ENDOCRINOL, V26, P716, DOI 10.1210/me.2011-1130; Shao Changli, 2012, Am J Biomed Sci, V4, P85; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Shin SH, 2008, EXP MOL MED, V40, P229, DOI 10.3858/emm.2008.40.2.229; Skarmoutsou E, 2018, INT J MOL MED, V42, P392, DOI 10.3892/ijmm.2018.3618; Smith SH, 2002, VET PATHOL, V39, P651, DOI 10.1354/vp.39-6-651; SODHI A, 1994, INT J IMMUNOPHARMACO, V16, P1003, DOI 10.1016/0192-0561(94)90079-5; Sterenczak KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-694; Szklarczyk D, 2016, NUCLEIC ACIDS RES, V44, pD380, DOI 10.1093/nar/gkv1277; Tanca A, 2012, J PROTEOMICS, V77, P561, DOI 10.1016/j.jprot.2012.09.033; Tao YM, 2013, HEPATOLOGY, V57, P2326, DOI 10.1002/hep.26268; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trafalis DT, 2010, EXPERT OPIN DRUG MET, V6, P307, DOI 10.1517/17425250903540238; van Horck FPG, 2001, J BIOL CHEM, V276, P4948, DOI 10.1074/jbc.M003839200; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Verhaert L., 2010, EUROPEAN J COMPANION, V20, P1; Verstraete FJM, 2005, VET CLIN N AM-SMALL, V35, P1009, DOI 10.1016/j.cvsm.2005.03.005; Wei Q, 2011, BIOCHEM PHARMACOL, V82, P418, DOI 10.1016/j.bcp.2011.05.013; Wen W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0366-5; White N, 2005, CANCER LETT, V224, P81, DOI 10.1016/j.canlet.2004.11.027; Wilson CR, 2008, VET COMP ONCOL, V6, P171, DOI 10.1111/j.1476-5829.2008.00158.x; Wolf SS, 2007, ARCH BIOCHEM BIOPHYS, V460, P56, DOI 10.1016/j.abb.2007.01.017; Yamada N, 2012, VET COMP ONCOL, V10, P303, DOI 10.1111/j.1476-5829.2011.00300.x; Yu HG, 2011, CANCER RES, V71, P360, DOI 10.1158/0008-5472.CAN-10-2894; Yue P, 2012, ONCOGENE, V31, P2309, DOI 10.1038/onc.2011.409; Zamani-Ahmadmahmudi M, 2014, ELECTROPHORESIS, V35, P901, DOI 10.1002/elps.201300461; Zhan H, 2016, TUMOR BIOL, V37, P9691, DOI 10.1007/s13277-016-4843-2; Zhang LH, 2017, CELL CYCLE, V16, P999, DOI 10.1080/15384101.2017.1312237; Zhang SY, 2009, MOL CANCER RES, V7, P570, DOI 10.1158/1541-7786.MCR-08-0248	98	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200619	10.1371/journal.pone.0200619	http://dx.doi.org/10.1371/journal.pone.0200619			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001383	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400088
J	Sarkar, D; Jana, T; Saha, S				Sarkar, Debasree; Jana, Tanmoy; Saha, Sudipto			LMDIPred: A web-server for prediction of linear peptide sequences binding to SH3, WW and PDZ domains	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; MOTIFS; DISCOVERY; CONSENSUS; MECHANISM; PROLINE	Protein-peptide interactions form an important subset of the total protein interaction network in the cell and play key roles in signaling and regulatory networks, and in major biological processes like cellular localization, protein degradation, and immune response. In this work, we have described the LMDIPred web server, an online resource for generalized prediction of linear peptide sequences that may bind to three most prevalent and well-studied peptide recognition modules (PRMs)-SH3, WW and PDZ. We have developed support vector machine (SVM)-based prediction models that achieved maximum Matthews Correlation Coefficient (MCC) of 0.85 with an accuracy of 94.55% for SH3, MCC of 0.90 with an accuracy of 95.82% for WW, and MCC of 0.83 with an accuracy of 92.29% for PDZ binding peptides. LMDIPred output combines predictions from these SVM models with predictions using Position-Specific Scoring Matrices (PSSMs) and string-matching methods using known domain-binding motif instances and regular expressions. All of these methods were evaluated using a five-fold cross-validation technique on both balanced and unbalanced datasets, and also validated on independent datasets. LMDIPred aims to provide a preliminary bioinformatics platform for sequence-based prediction of probable binding sites for SH3, WW or PDZ domains.	[Sarkar, Debasree; Jana, Tanmoy; Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, India	Department of Science & Technology (India); Bose Institute	Saha, S (corresponding author), Bose Inst, Bioinformat Ctr, Kolkata, India.	ssaha4@jcbose.ac.in	Sarkar, Debasree/K-1343-2019; Saha, Sudipto/AAF-1034-2020	Sarkar, Debasree/0000-0002-3228-9131; Jana, Tanmoy/0000-0003-1321-2240; Saha, Sudipto/0000-0001-9433-8894	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India [BT/RLF/Re-entry/11/2011]; University Grants Commission (UGC), Government of India [F.2-8/2002(SA-I)/04/04/2013]	Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grants Commission (UGC), Government of India(University Grants Commission, India)	This work was supported by the Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India (BT/RLF/Re-entry/11/2011 to S.S.); and University Grants Commission (UGC), Government of India (F.2-8/2002(SA-I)/04/04/2013 to D.S.). The authors are grateful to the Centre of Excellence in Bioinformatics, Bose Institute, Kolkata, for providing the infrastructure to carry out this work.	Bae JS, 2017, ONCOTARGET, V8, P16084, DOI 10.18632/oncotarget.14306; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Baudry M, 2016, TRENDS NEUROSCI, V39, P235, DOI 10.1016/j.tins.2016.01.007; Brannetti B, 2003, NUCLEIC ACIDS RES, V31, P3709, DOI 10.1093/nar/gkg592; Cahill MA, 2016, BBA-REV CANCER, V1866, P339, DOI 10.1016/j.bbcan.2016.07.004; Corbi-Verge C, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0131-4; Davey NE, 2007, NUCLEIC ACIDS RES, V35, pW455, DOI 10.1093/nar/gkm400; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Diella F, 2008, FRONT BIOSCI-LANDMRK, V13, P6580, DOI 10.2741/3175; Edwards RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000967; Gouw M, 2018, NUCLEIC ACIDS RES, V46, pD428, DOI 10.1093/nar/gkx1077; Guo X, 2017, J CELL PHYSIOL, V232, P1931, DOI 10.1002/jcp.25512; Harris BZ, 2001, J CELL SCI, V114, P3219; Joachims T, 1998, 475 SFB U ET DORT; Kundu K, 2014, BIOINFORMATICS, V30, P2668, DOI 10.1093/bioinformatics/btu350; Kundu K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S5; Kundu K, 2013, BIOINFORMATICS, V29, P335, DOI 10.1093/bioinformatics/btt220; Kundu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062732; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Maroni P, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010075; Mi T, 2012, NUCLEIC ACIDS RES, V40, pD252, DOI 10.1093/nar/gkr1189; Nakariyakul S, 2014, BBA-PROTEINS PROTEOM, V1844, P165, DOI 10.1016/j.bbapap.2013.04.008; Neduva V, 2006, NUCLEIC ACIDS RES, V34, pW350, DOI 10.1093/nar/gkl159; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sarkar D, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav014; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tonikian R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000218; Uyar B, 2014, MOL BIOSYST, V10, P2626, DOI 10.1039/c4mb00290c; Vaquero J, 2017, ONCOGENE, V36, P3067, DOI 10.1038/onc.2016.462; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891	33	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200430	10.1371/journal.pone.0200430	http://dx.doi.org/10.1371/journal.pone.0200430			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001346	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400053
J	Mills, EC; Poulsen, JR; Fay, JM; Morkel, P; Clark, CJ; Meier, A; Beirne, C; White, LJT				Mills, Emily C.; Poulsen, John R.; Fay, J. Michael; Morkel, Peter; Clark, Connie J.; Meier, Amelia; Beirne, Christopher; White, Lee J. T.			Forest elephant movement and habitat use in a tropical forest-grassland mosaic in Gabon	PLOS ONE			English	Article							LOXODONTA-AFRICANA; GPS TELEMETRY; LOPE-RESERVE; PATTERNS; SELECTION; CONSERVATION; CORRIDORS	Poaching of forest elephants (Loxodonta cyclotis) for ivory has decimated their populations in Central Africa. Studying elephant movement can provide insight into habitat and resource use to reveal where, when, and why they move and guide conservation efforts. We fitted 17 forest elephants with global positioning system (GPS) collars in 2015 and 2016 in the tropical forest-grassland mosaic of the Wonga Wongue Presidential Reserve (WW), Gabon. Using the location data, we quantified movement distances, home ranges, and habitat use to examine the environmental drivers of elephant movements and predict where elephants occur spatially and temporally. Forest elephants, on average, traveled 2,840 km annually and had home ranges of 713 km(2), with males covering significantly larger home ranges than females. Forest elephants demonstrated both daily and seasonal movement patterns. Daily, they moved between forest and grassland at dawn and dusk. Seasonally, they spent proportionally more time in grassland than forest during the short-wet season when grasses recruit. Forest elephants also traveled faster during the short-wet season when fruit availability was greatest, likely reflecting long, direct movements to preferred fruiting tree species. Forest elephants tended to select areas with high tree and shrub density that afford cover and browse. When villages occurred in their home ranges elephants spent a disproportionate amount of time near them, particularly in the dry season, probably for access to agricultural crops and preferred habitat. Given the importance of the grassland habitat for elephants, maintenance of the forest-grassland matrix is a conservation priority in WW. Law enforcement, outreach, and education should focus on areas of potential human-elephant conflict near villages along the borders of the reserve. GPS-tracking should be extended into multi-use areas in the peripheries of protected areas to evaluate the effects of human disturbance on elephant movements and to maintain connectivity among elephant populations in Gabon.	[Mills, Emily C.; Poulsen, John R.; Clark, Connie J.; Meier, Amelia; Beirne, Christopher] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Fay, J. Michael; White, Lee J. T.] Agence Natl Pares Nationaux, Batterie 4, Libreville, Gabon; [White, Lee J. T.] Inst Rech Ecol Tropicale, Libreville, Gabon; [White, Lee J. T.] Univ Stirling, African Forest Ecol Grp, Sch Nat Sci, Stirling, Scotland	Duke University; University of Stirling	Poulsen, JR (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	john.poulsen@duke.edu	Poulsen, John/O-5332-2019; Beirne, Christopher/S-9430-2019	Poulsen, John/0000-0002-1532-9808; Mills, Emily/0000-0003-0588-1452				[Anonymous], 2011, ARCMAP 10 4 1 ESRI A; [Anonymous], 2009, SCI REV IDENTIFICATI; Baig MHA, 2014, REMOTE SENS LETT, V5, P423, DOI 10.1080/2150704X.2014.915434; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blake S, 2001, AFR J ECOL, V39, P178, DOI 10.1046/j.1365-2028.2001.00296.x; Blake S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003546; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Chamaille-Jammes S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059164; Chester C., 2006, CONSERVATION BORDERS, P134; Cook RM, 2015, KOEDOE, V57, DOI 10.4102/koedoe.v57i1.1298; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Dyer SJ, 2001, J WILDLIFE MANAGE, V65, P531, DOI 10.2307/3803106; ENVI, 2015, 5 3 HARR GEOSP; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; IUCN African and Asian Specialist Groups, 2013, IUCN AFR AS SPEC GRO; Kolowski JM, 2010, AFR J ECOL, V48, P1134, DOI 10.1111/j.1365-2028.2009.01204.x; Landsat 8 (L8), 2016, DAT US HDB VERS 2 0; Leimgruber P, 2001, BIOL CONSERV, V102, P205, DOI 10.1016/S0006-3207(01)00041-6; Loarie SR, 2009, BIOL CONSERV, V142, P3086, DOI 10.1016/j.biocon.2009.08.008; Maisels F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059469; Morgan BJ, 2007, AFR J ECOL, V45, P664, DOI 10.1111/j.1365-2028.2007.00763.x; Ngene SM, 2010, AFR J ECOL, V48, P386, DOI 10.1111/j.1365-2028.2009.01125.x; Poulsen JR, 2011, ECOL APPL, V21, P1819, DOI 10.1890/10-1083.1; Poulsen JR, 2017, CURR BIOL, V27, pR134, DOI 10.1016/j.cub.2017.01.023; R Core Team, 2021, R LANGUAGE ENV STAT; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Roever CL, 2013, BIOL CONSERV, V157, P128, DOI 10.1016/j.biocon.2012.06.025; Roever CL, 2012, ECOGRAPHY, V35, P972, DOI 10.1111/j.1600-0587.2012.07359.x; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schuttler SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088074; Terborgh J, 2016, ECOGRAPHY, V39, P180, DOI 10.1111/ecog.01641; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Turkalo AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085154; Wall J, 2014, ECOL APPL, V24, P593, DOI 10.1890/13-1971.1; Wall J, 2013, BIOL CONSERV, V157, P60, DOI 10.1016/j.biocon.2012.07.019; WHITE LJT, 1994, J TROP ECOL, V10, P289, DOI 10.1017/S0266467400007975; WHITE LJT, 1994, J TROP ECOL, V10, P121, DOI 10.1017/S0266467400007768; Wrege PH, 2012, AFR J ECOL, V50, P176, DOI 10.1111/j.1365-2028.2011.01310.x; Yackulic CB, 2011, J ANIM ECOL, V80, P1088, DOI 10.1111/j.1365-2656.2011.01851.x; Yackulic CB, 2011, ECOL APPL, V21, P1296, DOI 10.1890/09-1099.1	48	27	27	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199387	10.1371/journal.pone.0199387	http://dx.doi.org/10.1371/journal.pone.0199387			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995886	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800022
J	Achakzai, HK; Barozai, MYK; Din, M; Baloch, IA; Achakzai, AKK				Achakzai, Habibullah Khan; Barozai, Muhammad Younas Khan; Din, Muhammad; Baloch, Iftekhar Ahmed; Achakzai, Abdul Kabir Khan			Identification and annotation of newly conserved microRNAs and their targets in wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CYTOCHROME-C; STRESS TOLERANCE; DROUGHT STRESS; ARABIDOPSIS; GENES; PLANTS; OVEREXPRESSION; BIOGENESIS; DIVERGENCE; METABOLISM	MicroRNAs (miRNAs) are small, non-coding and regulatory RNAs produce by cell endogenously. They are 18-26 nucleotides in length and play important roles at the posttranscriptional stage of gene regulation. Evolutionarily, miRNAs are conserved and their conservation plays an important role in the prediction of new miRNAs in different plants. Wheat (Triticum aestivum L.) is an important diet and consumed as second major crop in the world. This significant cereal crop was focused here through comparative genomics-based approach to identify new conserved miRNAs and their targeted genes. This resulted into a total of 212 new conserved precursor miRNAs (pre-miRNAs) belonging to 185 miRNA families. These newly profiled wheat's miRNAs are also annotated for stem-loop secondary structures, length distribution, organ of expression, sense/antisense orientation and characterization from their expressed sequence tags (ESTs). Moreover, fifteen miRNAs along with housekeeping gene were randomly selected and subjected to RT-PCR expressional validation. A total of 32927 targets are also predicted and annotated for these newly profiled wheat miRNAs. These targets are found to involve in 50 gene ontology (GO) enrichment terms and significant processes. Some of the significant targets are RNA-dependent DNA replication (GO:0006278), RNA binding (GO:0003723), nucleic acid binding (GO:0003676), DNA-directed RNA polymerase activity (GO:0003899), magnesium ion transmembrane transporter activity (GO:0015095), antiporter activity (GO:0015297), solute:hydrogen antiporter activity (GO:0015299), protein kinase activity (GO:0004672), ATP binding (GO:0005524), regulation of Rab GTPase activity (GO:0032313) Rab GTPase activator activity (GO:0005097), regulation of signal transduction (GO:0009966) and phosphoprotein phosphatase inhibitor activity (GO:0004864). These findings will be helpful to manage this economically important grain plant for desirable traits through miRNAs regulation.	[Achakzai, Habibullah Khan; Barozai, Muhammad Younas Khan; Din, Muhammad; Baloch, Iftekhar Ahmed; Achakzai, Abdul Kabir Khan] Univ Balochistan, Dept Bot, Quetta, Balochistan, Pakistan	University of Balochistan	Barozai, MYK (corresponding author), Univ Balochistan, Dept Bot, Quetta, Balochistan, Pakistan.	barozaikhan@gmail.com	Din, Muhammad/AAS-7591-2021	Din, Muhammad/0000-0003-0032-5422				Agarwal P, 2018, CELL STRESS CHAPERON, V23, P253, DOI 10.1007/s12192-017-0838-1; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; [Anonymous], 2016, WOOD FOOD SIT FAO CE; Baloch IA, 2018, TURK J BOT, V42, P382, DOI 10.3906/bot-1712-37; Baloch IA, 2015, PAK J BOT, V47, P1281; Barozai M. Y. K., 2018, Agri Gene, V8, P1, DOI 10.1016/j.aggene.2018.02.001; Barozai MYK, 2008, PLANT PHYSIOL BIOCH, V46, P739, DOI 10.1016/j.plaphy.2008.05.009; Barozai MYK, 2018, PAK J BOT, V50, P817; Barozai MYK, 2017, INT BHURBAN C APPL S, P192, DOI 10.1109/IBCAST.2017.7868055; Barozai MYK, 2012, MOL BIOL REP, V39, P2523, DOI 10.1007/s11033-011-1004-y; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bibi F, 2017, TURK J AGRIC FOR, V41, P191, DOI 10.3906/tar-1612-121; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Chen Z. C., 2017, SEMINARS CELL DEV BI; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; Dahan J, 2014, PLANT PHYSIOL, V166, P1788, DOI 10.1104/pp.114.248526; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Din M, 2016, GENE REP, V5, P62, DOI 10.1016/j.genrep.2016.08.010; Din M, 2014, GENE, V535, P198, DOI 10.1016/j.gene.2013.11.034; Eren H, 2015, ANN APPL BIOL, V167, P208, DOI 10.1111/aab.12219; Garcia L, 2016, PLANT CELL ENVIRON, V39, P628, DOI 10.1111/pce.12647; Gasparis S, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2530-6; Ghani A, 2018, PAK J BOT, V50, P1085; Ghorbel M, 2017, PLANT SCI, V257, P37, DOI 10.1016/j.plantsci.2017.01.006; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gul Z, 2017, AIMS GENET, V4, P138, DOI 10.3934/genet.2017.2.138; Guo L, 2013, J EXP BOT, V64, P1755, DOI 10.1093/jxb/ert040; Guo WL, 2016, CROP J, V4, P83, DOI 10.1016/j.cj.2015.11.003; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037146; Ma YC, 2017, PLANT BIOTECHNOL J, V15, P162, DOI 10.1111/pbi.12599; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Qiu ZB, 2016, PLANT PHYSIOL BIOCH, V101, P60, DOI 10.1016/j.plaphy.2016.01.020; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Shah Jahan, 2017, Pure and Applied Biology, V6, P1044; Shah S. Q., 2016, Pure and Applied Biology, V5, P476; Singh M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177632; Stone SL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00135; Tang RJ, 2017, CURR OPIN PLANT BIOL, V39, P97, DOI 10.1016/j.pbi.2017.06.009; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Wahid HA, 2016, ADVAN LIFE SCI, V4, P20; Wang JJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181963; Watson L., 1992, The grass genera of the world.; Wei QH, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01374; Welchen E, 2012, BBA-BIOENERGETICS, V1817, P990, DOI 10.1016/j.bbabio.2012.04.008; Xie FL, 2010, PLANTA, V232, P417, DOI 10.1007/s00425-010-1182-1; Zhang BH, 2008, PLANTA, V229, P161, DOI 10.1007/s00425-008-0818-x; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200033	10.1371/journal.pone.0200033	http://dx.doi.org/10.1371/journal.pone.0200033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990369	gold, Green Submitted, Green Published			2022-12-26	WOS:000438170300027
J	Ngoma, TN; Chimimba, UK; Mwangwela, AM; Thakwalakwa, C; Maleta, KM; Manary, MJ; Trehan, I				Ngoma, Theresa N.; Chimimba, Ulemu K.; Mwangwela, Agnes M.; Thakwalakwa, Chrissie; Maleta, Kenneth M.; Manary, Mark J.; Trehan, Indi			Effect of cowpea flour processing on the chemical properties and acceptability of a novel cowpea blended maize porridge	PLOS ONE			English	Article							NUTRITIONAL COMPOSITION; MALAWIAN CHILDREN	Childhood growth stunting is a pervasive problem in Malawi and is in large part due to low quality complementary foods and chronic gut inflammation. Introducing legumes such as cowpea (Vigna unguiculata) into the complementary diet has the potential to improve childhood growth by improving diet quality through improvements in macro- and micronutrients and also by reducing gut inflammation. However, cowpea is relatively underutilized in complementary feeding in Malawi due to its strong taste, long processing time, and high energy requirements for processing. Effective utilization of cowpea in complementary feeding requires processing which may affect chemical composition as well as sensory quality. The present study evaluated the effect of processing on the retention of zinc, crude fibre, and flavonoid in roasted, boiled, and dehulled cowpea flours, and assessed the acceptability of maize porridge (70%) enriched with one of the three cowpea flours (30%). Roasting, dehulling, and boiling did not have any effect on zinc content. Crude fibre content increased after processing by all methods. Processing had no effect on measurable flavonoids. Roasted, boiled, and dehulled cowpea blended maize porridges were acceptable to children with mean quantities of leftover food of less than 3g from the given 100g. Caregivers also rated the blended flours to be highly acceptable to them as well, with maize porridge blended with dehulled cowpea flour the most acceptable to both children and caregivers. These results demonstrate that cowpea flour, processed by any of these three different methods, could serve as a useful addition to maize porridge for complementary feeding of children in sub-Saharan Africa.	[Ngoma, Theresa N.; Chimimba, Ulemu K.; Mwangwela, Agnes M.] Lilongwe Univ Agr & Nat Resources, Dept Food Sci & Technol, Lilongwe, Malawi; [Thakwalakwa, Chrissie; Maleta, Kenneth M.; Manary, Mark J.] Univ Malawi, Coll Med, Sch Publ Hlth & Family Med, Blantyre, Malawi; [Manary, Mark J.; Trehan, Indi] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Trehan, Indi] Univ Malawi, Coll Med, Dept Paediat & Child Hlth, Blantyre, Malawi; [Trehan, Indi] Lao Friends Hosp Children, Luang Prabang, Laos	Lilongwe University of Agriculture & Natural Resources; University of Malawi; Washington University (WUSTL); University of Malawi	Trehan, I (corresponding author), Washington Univ, Dept Pediat, St Louis, MO 63130 USA.; Trehan, I (corresponding author), Univ Malawi, Coll Med, Dept Paediat & Child Hlth, Blantyre, Malawi.; Trehan, I (corresponding author), Lao Friends Hosp Children, Luang Prabang, Laos.	indi@alum.berkeley.edu	Mwangwela, Agnes/V-9633-2019; Maleta, Ken M/J-2821-2016; Trehan, Indi/K-7912-2013	Maleta, Ken M/0000-0002-2536-3938; Trehan, Indi/0000-0002-3364-6858; Manary, Mark/0000-0003-2733-9568; Nakoma Ngoma, Theresa/0000-0001-9427-1167	Feed the Future Innovation Lab for Collaborative Research on Grain Legumes [S03.1]; Children's Discovery Institute of Washington University and St. Louis Children's Hospital [MD-FR-2014-427]	Feed the Future Innovation Lab for Collaborative Research on Grain Legumes(United States Agency for International Development (USAID)); Children's Discovery Institute of Washington University and St. Louis Children's Hospital	This research was funded by the Feed the Future Innovation Lab for Collaborative Research on Grain Legumes as Project S03.1 (http://legumelab.msu.edu/) (MJM) and the Children's Discovery Institute of Washington University and St. Louis Children's Hospital as Grant MD-FR-2014-427 (http://childrensdiscovery.org/) (IT). The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuba Fidelis I., 2006, Environmentalist, V26, P295, DOI 10.1007/s10669-006-0158-y; Adams MW, 1984, COWPEA PRODUCTION CO; Association of Official Analytical Chemists, 2005, OFF METH AN ASS AN C, V18th; Asumugha VU, 2002, P 26 ANN C NIG I FOO; AYATSE JO, 1983, FOOD CHEM, V12, P135, DOI 10.1016/0308-8146(83)90024-9; Borresen EC, 2017, CURR DEV NUTR, V1, DOI 10.3945/cdn.117.001610; Bressan IR, 1985, COWPEA RES PRODUCTIO; Copur OU, 2014, FOOD ENG SER, P9, DOI 10.1007/978-1-4939-1378-7_2; Esmaillzadeh A, 2012, J NUTR, V142, P334, DOI 10.3945/jn.111.146167; Faber M, 2008, NUTR CONTENT CONSUME; Fashakin J. B., 1988, NIGERIA TROPICAL SCI, V28, P191; Galpin L, 2005, AM J CLIN NUTR, V82, P1040, DOI 10.1093/ajcn/82.5.1040; Haskey N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030259; Hefnawy T.H., 2011, ANN AGRIC SCI, V56, P57, DOI [DOI 10.1016/j.aoas.2011.07.001, 10.1016/j.aoas.2011.07.001]; Heong ChewShio, 2011, American Journal of Food Technology, V6, P581, DOI 10.3923/ajft.2011.581.593; Magulu K., 2015, African Journal of Agricultural Research, V10, P2480; Malawi Ministry of Agriculture and Food Security, 2012, GUID AGR PROD MAL; MIRECKI RM, 1984, PLANT PHYSIOL, V74, P475, DOI 10.1104/pp.74.3.475; Muhimbula H. S., 2011, African Journal of Food Science, V5, P26; National Statistical Office (NSO) [Malawi] and ICF, 2017, MALAWI DEMOGRAPHIC H; NIELSEN SS, 1993, CROP SCI, V33, P469, DOI 10.2135/cropsci1993.0011183X003300030010x; Odedeji J. O., 2011, Pakistan Journal of Nutrition, V10, P899; Ojwang L., 2012, ANTIINFLAMMATORY PRO; Olapade A.A., 2012, AFRICAN J FOOD SCI T, V3, P102; Osuji CM, 2012, NIGERIAN FOOD J, V30, P33, DOI [10.1016/S0189-7241(15)30032-1, DOI 10.1016/S0189-7241(15)30032-1, 10.1016/s0189-7241(15)30015-1, DOI 10.1016/S0189-7241(15)30015-1]; Owino V, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0641; Pereira EJ, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.20694; PLATT B. S., 1962, Special Report Series. Medical Research Council; Rachie K. O., 1985, COWPEA RES PRODUCTIO; Rangel A, 2003, J AGR FOOD CHEM, V51, P5792, DOI 10.1021/jf0340052; Ryan E, 2018, BURL DODDS AGR SCI, V35, P371, DOI 10.19103/AS.2017.0023.17; Salem A. A., 2014, The Journal of American Science, V10, P276; Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P507, DOI 10.1016/j.tifs.2003.07.002; Trehan I, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1027-0; Trehan I, 2009, AM J GASTROENTEROL, V104, P2326, DOI 10.1038/ajg.2009.270; Carvalho AFU, 2012, J FOOD COMPOS ANAL, V26, P81, DOI 10.1016/j.jfca.2012.01.005; Watanabe K, 2016, EBIOMEDICINE, V10, P25, DOI 10.1016/j.ebiom.2016.07.030; Zambrano-Moreno EL, 2015, FOOD SCI TECH-BRAZIL, V35, P414, DOI 10.1590/1678-457X.6656; Zhang Z, 2011, EUR J CLIN NUTR, V65, P415, DOI 10.1038/ejcn.2010.273	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200418	10.1371/journal.pone.0200418	http://dx.doi.org/10.1371/journal.pone.0200418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990380	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300048
J	Ramirez, VT; van Oeffelen, WEPA; Torres-Fuentes, C; Chruscicka, B; Druelle, C; Golubeva, AV; van de Wouw, M; Dinan, TG; Cryan, JF; Schellekens, H				Ramirez, Valerie T.; van Oeffelen, Wesley E. P. A.; Torres-Fuentes, Cristina; Chruscicka, Barbara; Druelle, Clementine; Golubeva, Anna V.; van de Wouw, Marcel; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet			Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists	FASEB JOURNAL			English	Article						GHSR-1a; GPCR; probe of dependence	HORMONE SECRETAGOGUE RECEPTOR; HIGH CONSTITUTIVE ACTIVITY; CANCER-ANOREXIA-CACHEXIA; G-PROTEIN; GHS-R; ALLOSTERIC MODULATION; CELL-PROLIFERATION; IN-VITRO; LIGANDS; ANAMORELIN	The ghrelin receptor [growth hormone secretagogue receptor (GHSR)-1a] represents a promising pharmacologic target for the treatment of metabolic disorders, including obesity and cachexia, via central appetite modulation. The GHSR-1a has a complex pharmacology, highlighted by G-protein-dependent and -independent downstream signaling pathways and high basal constitutive activity. The functional selectivity and signaling bias of many GHSR-1a-specific ligands has not been fully characterized. In this study, we investigated the pharmacologic properties of ghrelin, MK-0677, L692,585, and [d-Lys3]-growth hormone-releasing peptide-6 (Dlys), JMV2959, and [d-Arg(1),d-Phe(5),d-Trp(7, 9),Leu(11)]-substance P (SP-analog). We investigated their effect on basal GHSR-1a constitutive signaling, ligand-directed downstream GHSR-1a signaling, functional selectivity, and signaling bias. Dlys behaved as a partial antagonist with a strong bias toward GHSR-1a--arrestin signaling, whereas JMV2959 acted as a full unbiased GHSR-1a antagonist. Moreover, the SP-analog behaved as an inverse agonist increasing G-protein-dependent signaling, but only at high concentrations, whereas, at low concentrations, the SP-analog attenuated -arrestin-dependent signaling. Considering the limited success in the clinical development of GHSR-1a-targeted drugs so far, these findings provide a novel insight into the pharmacologic characteristics of GHSR-1a ligands and their signaling bias, which has important implications in the design of novel, more selective GHSR-1a ligands with predictable functional outcome and selectivity for preclinical and clinical drug development.Ramirez, V. T., van Oeffelen, W. E. P. A., Torres-Fuentes, C., Chrucicka, B., Druelle, C., Golubeva, A. V., van de Wouw, M., Dinan, T. G., Cryan, J. F., Schellekens, H. Differential functional selectivity and downstream signaling bias of ghrelin receptor antagonists and inverse agonists.	[Ramirez, Valerie T.; Torres-Fuentes, Cristina; Chruscicka, Barbara; Druelle, Clementine; Golubeva, Anna V.; van de Wouw, Marcel; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Alimentary Pharmabiot Ctr APC Microbiome Ireland, Cork, Ireland; [van Oeffelen, Wesley E. P. A.; van de Wouw, Marcel; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Dinan, Timothy G.] Univ Coll Cork, Dept Psychiat, Cork, Ireland; [Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Food Hlth Ireland, Cork, Ireland	University College Cork; University College Cork; University College Cork; Teagasc; University College Cork	Schellekens, H (corresponding author), Food Hlth Ireland, APC Microbiome Ireland, Dept Anat & Neurosci, Western Rd.,Western Gateway Bldg, Cork T12 XF62, Ireland.; Schellekens, H (corresponding author), Univ Coll Cork, Cork T12 XF62, Ireland.	h.schellekens@ucc.ie	Torres-Fuentes, Cristina/J-5551-2019; Dinan, Timothy/ABA-8284-2020; Cryan, John F./A-6950-2013; Chruścicka-Smaga, Barbara/AAQ-1633-2020	Torres-Fuentes, Cristina/0000-0002-2917-6910; Cryan, John F./0000-0001-5887-2723; Schellekens, Harriet/0000-0002-6065-3797; van de Wouw, Marcel/0000-0002-2607-314X	Science Foundation Ireland Research Centre [SFI/12/RC/2273]; Enterprise Ireland [TC2013-0001]; Irish Health Research Board [HRA_POR/2011/23, HRA_POR/2012/32]	Science Foundation Ireland Research Centre(Science Foundation Ireland); Enterprise Ireland; Irish Health Research Board	The authors thank Naomi Hoevenaars for assistance with the internalization assay and Felipe G. Serrano (Illustrative Science, Santiago, Chile) for graphics work. The study was funded by Science Foundation Ireland Research Centre Grant SFI/12/RC/2273 to the Alimentary Pharmabiotic Centre (APC) Microbiome Ireland (to H.S., J.F.C., and T.G.D.); by Enterprise Ireland Grant TC2013-0001 (to H.S. and J.F.C.); and the Irish Health Research Board, Health Research Awards HRA_POR/2011/23 and HRA_POR/2012/32 (to W.E.P.A.V.O.). The authors declare no conflicts of interest.	Abegg K, 2017, DIABETES OBES METAB, V19, P1740, DOI 10.1111/dom.13020; Al Massadi O, 2017, TRENDS NEUROSCI, V40, P167, DOI 10.1016/j.tins.2016.12.003; Allas S, 2013, ENDOCR DEV, V25, P157, DOI 10.1159/000346065; Bartuzi D, 2019, J BIOMOL STRUCT DYN, V37, P36, DOI 10.1080/07391102.2017.1417914; Bayliss JA, 2016, J NEUROSCI, V36, P3049, DOI 10.1523/JNEUROSCI.4373-15.2016; Beck B, 2004, LIFE SCI, V76, P473, DOI 10.1016/j.lfs.2004.09.001; Bennett KA, 2009, MOL PHARMACOL, V76, P802, DOI 10.1124/mol.109.056101; Berrout L, 2018, BRAIN RES, V1678, P20, DOI 10.1016/j.brainres.2017.09.028; Bologna Z, 2017, BIOMOL THER, V25, P12, DOI 10.4062/biomolther.2016.165; Bouzo-Lorenzo M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22495; Camina JP, 2006, J NEUROENDOCRINOL, V18, P65, DOI 10.1111/j.1365-2826.2005.01379.x; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Carreira MC, 2006, J ENDOCRINOL, V191, P147, DOI 10.1677/joe.1.06714; Cavalier M, 2015, EUR J NEUROSCI, V42, P2568, DOI 10.1111/ejn.13013; Chebani Y, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aae0374; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Cong WN, 2010, CNS NEUROL DISORD-DR, V9, P557, DOI 10.2174/187152710793361513; Currow D, 2017, ANN ONCOL, V28, P1949, DOI 10.1093/annonc/mdx192; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Delporte C, 2012, J OBES, V2012, DOI 10.1155/2012/535624; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Fernandez G, 2018, ENDOCRINOLOGY, V159, P1021, DOI 10.1210/en.2017-03101; Garcia JM, 2015, LANCET ONCOL, V16, P108, DOI 10.1016/S1470-2045(14)71154-4; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gomez JL, 2014, ALCOHOL CLIN EXP RES, V38, P2436, DOI 10.1111/acer.12499; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Holst B, 2004, J BIOL CHEM, V279, P53806, DOI 10.1074/jbc.M407676200; Holst B, 2005, MOL ENDOCRINOL, V19, P2400, DOI 10.1210/me.2005-0059; Holst B, 2004, TRENDS PHARMACOL SCI, V25, P113, DOI 10.1016/j.tips.2004.01.010; Holst B, 2007, J BIOL CHEM, V282, P15799, DOI 10.1074/jbc.M609796200; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Howick K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020273; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Leach K, 2017, PHARMACOL RES, V116, P105, DOI 10.1016/j.phrs.2016.12.006; Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044; Lien GS, 2016, EUR J PHARMACOL, V776, P124, DOI 10.1016/j.ejphar.2016.02.044; Liu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27499; Liu G, 2007, J PHARMACOL EXP THER, V322, P1036, DOI 10.1124/jpet.107.123141; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Mary S, 2012, P NATL ACAD SCI USA, V109, P8304, DOI 10.1073/pnas.1119881109; Mason BL, 2014, ANNU REV PHYSIOL, V76, P519, DOI 10.1146/annurev-physiol-021113-170310; Mear Y, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00087; Mosa R, 2018, AM J PHYSIOL-REG I, V314, pR71, DOI 10.1152/ajpregu.00157.2017; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; Moulin A, 2007, CHEMMEDCHEM, V2, P1242, DOI 10.1002/cmdc.200700015; Moulin A, 2013, AMINO ACIDS, V44, P301, DOI 10.1007/s00726-012-1355-2; Mousseaux D, 2006, BRIT J PHARMACOL, V148, P350, DOI 10.1038/sj.bjp.0706727; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Osterstock G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009159; Pantel J, 2006, J CLIN INVEST, V116, P760, DOI 10.1172/JCI25303; Pastor-Cavada E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36456; Petersen PS, 2009, ENDOCRINOLOGY, V150, P4920, DOI 10.1210/en.2008-1638; Pietra C, 2014, J CACHEXIA SARCOPENI, V5, P329, DOI 10.1007/s13539-014-0159-5; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Rossi F, 2009, ATHEROSCLEROSIS, V203, P97, DOI 10.1016/j.atherosclerosis.2008.06.015; Sanger GJ, 2014, NEUROGASTROENT MOTIL, V26, P149, DOI 10.1111/nmo.12300; Santos-Zas I, 2013, INT J BIOCHEM CELL B, V45, P1281, DOI 10.1016/j.biocel.2013.03.014; Schellekens H, 2015, ACS CHEM NEUROSCI, V6, P1186, DOI 10.1021/cn500318q; Schellekens H, 2013, J PHARM PHARMACOL, V65, P528, DOI 10.1111/jphp.12010; Schellekens H, 2013, VITAM HORM, V91, P285, DOI 10.1016/B978-0-12-407766-9.00013-4; Schellekens H, 2013, J BIOL CHEM, V288, P181, DOI 10.1074/jbc.M112.382473; Schellekens H, 2010, NEUROPHARMACOLOGY, V58, P2, DOI 10.1016/j.neuropharm.2009.06.024; Sivertsen B, 2013, BRIT J PHARMACOL, V170, P1349, DOI 10.1111/bph.12361; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Stallaert W, 2011, EXPERT OPIN DRUG DIS, V6, P811, DOI 10.1517/17460441.2011.586691; Torres-Fuentes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103118; Toth K, 2018, SYNAPSE, V72, DOI 10.1002/syn.22012; Traebert M, 2002, J NEUROENDOCRINOL, V14, P580, DOI 10.1046/j.1365-2826.2002.00810.x; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ueno S, 2012, P NATL ACAD SCI USA, V109, P11121, DOI 10.1073/pnas.1203561109; Vodnik M, 2016, HORM METAB RES, V48, P1, DOI 10.1055/s-0035-1564149; Zhang HJ, 2015, EXPERT OPIN PHARMACO, V16, P1245, DOI 10.1517/14656566.2015.1041500	78	16	16	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					518	531		10.1096/fj.201800655R	http://dx.doi.org/10.1096/fj.201800655R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020830				2022-12-26	WOS:000457401500041
J	Li, TF; Deng, Y; Shi, Y; Tian, RJ; Chen, YL; Zou, L; Kazi, JU; Ronnstrand, L; Feng, B; Chan, SO; Chan, WY; Sun, JM; Zhao, H				Li, Tianfeng; Deng, Yi; Shi, Yu; Tian, Ruijun; Chen, Yonglong; Zou, Lin; Kazi, Julhash U.; Ronnstrand, Lars; Feng, Bo; Chan, Sun On; Chan, Wai Yee; Sun, Jianmin; Zhao, Hui			Bruton's tyrosine kinase potentiates ALK signaling and serves as a potential therapeutic target of neuroblastoma	ONCOGENE			English	Article							POSITIVE NSCLC; CELL LYMPHOMA; IBRUTINIB; BTK; INHIBITOR; ACTIVATION; RESISTANCE; IDENTIFICATION; CRIZOTINIB; MUTATIONS	Aberrant activation of anaplastic lymphoma kinase (ALK) can cause sporadic and familial neuroblastoma. Using a proteomics approach, we identified Bruton's tyrosine kinase (BTK) as a novel ALK interaction partner, and the physical interaction was confirmed by co-immunoprecipitation. BTK is expressed in neuroblastoma cell lines and tumor tissues. Its high expression correlates with poor relapse-free survival probability of neuroblastoma patients. Mechanistically, we demonstrated that BTK potentiates ALK-mediated signaling in neuroblastoma, and increases ALK stability by reducing ALK ubiquitination. Both ALKWT and ALKF1174L can induce BTK phosphorylation and higher capacity of ALKF1174L is observed. Furthermore, the BTK inhibitor ibrutinib can effectively inhibit the growth of neuroblastoma xenograft in nude mice, and the combination of ibrutinib and the ALK inhibitor crizotinib further enhances the inhibition. Our study provides strong rationale for clinical trial of ALK-positive neuroblastoma using ibrutinib or the combination of ibrutinib and ALK inhibitors.	[Li, Tianfeng; Feng, Bo; Chan, Sun On; Chan, Wai Yee; Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, Minist Educ,Fac Med, Hong Kong, Hong Kong, Peoples R China; [Sun, Jianmin] Ningxia Med Univ, Dept Pathogen Biol & Immunol, Sch Basic Med Sci, 1160 Shengli St, Yinchuan 750004, Peoples R China; [Deng, Yi; Chen, Yonglong] Southern Univ Sci & Technol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Dept Biol, Shenzhen 51805, Guangdong, Peoples R China; [Deng, Yi; Chen, Yonglong] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen 51805, Guangdong, Peoples R China; [Shi, Yu] Chongqing Med Univ, Key Lab Child Dev & Disorders, Chongqing Key Lab Translat Med Res Cognit Dev & L, Dept Clin Lab,Minist Educ,Childrens Hosp,Chongqin, Chongqing 400014, Peoples R China; [Tian, Ruijun] South Univ Sci & Technol China, Dept Chem, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Guangdong, Peoples R China; [Tian, Ruijun] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Guangdong, Peoples R China; [Zou, Lin] Chongqing Med Univ, Chongqing Int Sci & Technol Cooperat Ctr Child De, Key Lab Pediat Chongqing, Ctr Clin Mol Med,Childrens Hosp,Minist Educ,Key L, Chongqing 400014, Peoples R China; [Kazi, Julhash U.; Ronnstrand, Lars; Sun, Jianmin] Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden; [Chan, Wai Yee; Zhao, Hui] Chinese Univ Hong Kong, Kunming Inst Zool, Chinese Acad Sci, Joint Lab Bioresources & Mol Res Common Dis, Hong Kong, Hong Kong, Peoples R China; [Ronnstrand, Lars] Lund Univ, Dept Lab Med, Lund Stem Cell Ctr, Lund, Sweden; [Ronnstrand, Lars] Skane Univ Hosp, Div Oncol, Lund, Sweden	Chinese University of Hong Kong; Ningxia Medical University; Southern University of Science & Technology; Southern University of Science & Technology; Chongqing Medical University; Southern University of Science & Technology; Southern University of Science & Technology; Chongqing Medical University; Lund University; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese University of Hong Kong; Lund University; Lund University; Skane University Hospital	Zhao, H (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Key Lab Regenerat Med, Minist Educ,Fac Med, Hong Kong, Hong Kong, Peoples R China.; Sun, JM (corresponding author), Ningxia Med Univ, Dept Pathogen Biol & Immunol, Sch Basic Med Sci, 1160 Shengli St, Yinchuan 750004, Peoples R China.; Sun, JM (corresponding author), Lund Univ, Div Translat Canc Res, Dept Lab Med, Lund, Sweden.; Zhao, H (corresponding author), Chinese Univ Hong Kong, Kunming Inst Zool, Chinese Acad Sci, Joint Lab Bioresources & Mol Res Common Dis, Hong Kong, Hong Kong, Peoples R China.	jianmin.sun@nxmu.edu.cn; zhaohui@cuhk.edu.hk	Zhao, Hui/B-8429-2016; Tian, Ruijun/J-3019-2014; Kazi, Julhash U./D-9190-2011; Feng, Bo/D-7831-2014; Chan, Wai Yee/R-7442-2018; Chan, Sun-On/R-6547-2018	Zhao, Hui/0000-0001-8160-6415; Kazi, Julhash U./0000-0002-0719-5336; Feng, Bo/0000-0002-4018-3257; Chan, Wai Yee/0000-0002-9714-0936; Chan, Sun-On/0000-0002-3221-3786; Sun, Jianmin/0000-0003-2327-4285; Tian, Ruijun/0000-0001-9521-5124; Deng, Yi/0000-0003-1378-015X; Ronnstrand, Lars/0000-0003-1275-5809	Research Grants Council of Hong Kong [CUHK24100414, CUHK14167017]; Guangdong Natural Science of Foundation [2017A030313209]; Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research [2017B030301018]; Shenzhen Key Laboratory of Cell Microenvironment [ZDSYS20140509142721429]; West China Top Class Discipline Project in Basic Medical Sciences of Ningxia Medical University [NXYLXK2017B07]; CUHK; National Natural Science Foundation of China [31471367, 31671519, 81660473]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Guangdong Natural Science of Foundation; Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research; Shenzhen Key Laboratory of Cell Microenvironment; West China Top Class Discipline Project in Basic Medical Sciences of Ningxia Medical University; CUHK(Chinese University of Hong Kong); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr. Marc Vigny for kindly providing the ALK<SUP>WT</SUP> and ALK<SUP>F1174L</SUP> constructs. This work is supported by the Research Grants Council of Hong Kong (CUHK24100414, CUHK14167017) to HZ, the grants from Guangdong Natural Science of Foundation (2017A030313209) and Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research (2017B030301018) and Shenzhen Key Laboratory of Cell Microenvironment (ZDSYS20140509142721429) to YD, the National Natural Science Foundation of China (81660473) and West China Top Class Discipline Project (NXYLXK2017B07) in Basic Medical Sciences of Ningxia Medical University to JS, One-off Funding for KIZ-CUHK Joint Lab/Research Collaboration from CUHK to WYC, the National Natural Science Foundation of China (31471367, 31671519) to YC, and TL is supported by the Graduate Studentships from CUHK. We thank colleagues in our laboratories for the helpful discussion.	Asati V, 2016, EUR J MED CHEM, V109, P314, DOI 10.1016/j.ejmech.2016.01.012; Braun F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125552; Buggy JJ, 2012, INT REV IMMUNOL, V31, P119, DOI 10.3109/08830185.2012.664797; Chakraborty R, 2015, EXPERT REV HEMATOL, V8, P569, DOI 10.1586/17474086.2015.1061427; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; de Claro RA, 2015, CLIN CANCER RES, V21, P3586, DOI 10.1158/1078-0432.CCR-14-2225; Ding N, 2015, ONCOTARGET, V6, P15122, DOI 10.18632/oncotarget.3824; Geoerger B, 2015, J CLIN ONCOL, V33; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Grassilli E, 2016, ONCOGENE, V35, P4368, DOI 10.1038/onc.2015.504; Guo W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.343; Herman SEM, 2014, BLOOD, V123, P3286, DOI 10.1182/blood-2014-02-548610; Holla VR, 2017, CSH MOL CASE STUD, V3, DOI 10.1101/mcs.a001115; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Isozaki H, 2016, CANCER RES, V76, P1506, DOI 10.1158/0008-5472.CAN-15-1010; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Khozin S, 2015, CLIN CANCER RES, V21, P2436, DOI 10.1158/1078-0432.CCR-14-3157; Kodityal S, 2016, LUNG CANCER, V92, P19, DOI 10.1016/j.lungcan.2015.11.023; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Larkins E, 2016, CLIN CANCER RES, V22, P5171, DOI 10.1158/1078-0432.CCR-16-1293; Li Y, 2016, ONCOGENE, V35, P6223, DOI 10.1038/onc.2016.155; Louis CU, 2015, ANNU REV MED, V66, P49, DOI 10.1146/annurev-med-011514-023121; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Metro G, 2017, LUNG CANCER, V106, P58, DOI 10.1016/j.lungcan.2017.02.003; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Roskoski R, 2016, PHARMACOL RES, V113, P395, DOI 10.1016/j.phrs.2016.09.011; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Smith CIE, 2017, ONCOGENE, V36, P2045, DOI 10.1038/onc.2016.343; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Souttou B, 2001, J BIOL CHEM, V276, P9526, DOI 10.1074/jbc.M007333200; Sun J, 2014, ONCOGENE, V33, P5360, DOI 10.1038/onc.2013.479; Tabbo F, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00041; Tan SL, 2013, PHARMACOL THERAPEUT, V138, P294, DOI 10.1016/j.pharmthera.2013.02.001; Tucker DL, 2016, FUTURE ONCOL, V12, P477, DOI 10.2217/fon.15.342; Vela CM, 2016, AM J HEALTH-SYST PH, V73, P367, DOI 10.2146/ajhp140760; Wang CD, 2015, J BIOL CHEM, V290, P21925, DOI 10.1074/jbc.M115.644864; Wang HQ, 2017, ELIFE, V6, DOI 10.7554/eLife.17137; Yau NKM, 2015, CURR CANCER DRUG TAR, V15, P327	43	14	14	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 22	2018	37	47					6180	6194		10.1038/s41388-018-0397-7	http://dx.doi.org/10.1038/s41388-018-0397-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HB2PG	30013190				2022-12-26	WOS:000450883000006
J	Yang, Y; Wu, XQ; Li, WX; Huang, HM; Li, HD; Pan, XY; Li, XF; Huang, C; Meng, XM; Zhang, L; Lv, XW; Wang, H; Li, J				Yang, Yang; Wu, Xiao-qin; Li, Wan-xia; Huang, Hui-min; Li, Hai-di; Pan, Xue-yin; Li, Xiao-feng; Huang, Cheng; Meng, Xiao-ming; Zhang, Lei; Lv, Xiong-wen; Wang, Hua; Li, Jun			PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis	ONCOGENE			English	Article							CHRONIC MULTIFOCAL OSTEOMYELITIS; CHRONIC ACTIVE HEPATITIS; AUTOINFLAMMATORY DISEASE; AUTOIMMUNE HEPATITIS; IN-VIVO; HEPATOCELLULAR-CARCINOMA; PSTPIP2-DEFICIENT MICE; CORTICOSTEROID-THERAPY; LIVER FIBROSIS; ACTIVATION	Macrophages play a crucial role in the progression of hepatic fibrosis (HF). In macrophages, epigenetic mechanisms are increasingly being recognized as crucial controllers of their phenotype. However, the functions of macrophage DNA methylation in experimental models of hepatic fibrosis have not been fully addressed. Here, we analyzed isolated hepatic macrophages DNA methylation from CCL4-induced (4 weeks) mice using reduced representation bisulfite sequencing (RRBS). We identified and validated the methylation status of 26 gene promoter regions associated with CpG islands. We further investigated the function of PSTPIP2 in HF by hepatic-adeno-associated virus (AAV9)-PSTPIP2 overexpression. The molecular mechanisms underlying PSTPIPS2-regulated HF were further explored in mice and RAW264.7 cell line. RRBS results show hypermethylation of PSTPIP2 (chr18: 77,843,840-77,843,968) in the 5'-UTR region. PSTPIP2 expression was significantly decreased in isolated hepatic macrophages from CCL4-induced mice. PSTPIP2 hypermethylation is mediated by the methyltransferases DNMT3a and DNMT3b in LPS-induced RAW264.7 cell line. Further investigation indicated that specific overexpression of PSTPIP2 in C57BL/6 mice reduced the inflammatory response and ameliorated liver fibrosis. These data indicated that hypermethylation of PSTPIP2 caused a mixed induction of hepatic classical macrophage (M1) and alternative macrophage (M2) biomarkers in CCL4-induced HF mice. Furthermore, overexpression of PSTPIP2 inhibited the expression of M1 markers by suppressing STAT1 activity, and enhanced the expression of M2 markers by promoting STAT6 activity. In contrast, knockdown of PSTPIP2 promoted M1 polarization and suppressed M2 polarization in vitro. Adding PSTPIP2 expression alleviates liver fibrosis and hepatic inflammation in mice by regulating macrophage polarization.	[Yang, Yang; Wu, Xiao-qin; Li, Wan-xia; Huang, Hui-min; Li, Hai-di; Pan, Xue-yin; Li, Xiao-feng; Huang, Cheng; Meng, Xiao-ming; Zhang, Lei; Lv, Xiong-wen; Wang, Hua; Li, Jun] Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei 230032, Anhui, Peoples R China; [Yang, Yang; Wu, Xiao-qin; Li, Wan-xia; Huang, Hui-min; Li, Hai-di; Pan, Xue-yin; Li, Xiao-feng; Huang, Cheng; Meng, Xiao-ming; Zhang, Lei; Lv, Xiong-wen; Wang, Hua; Li, Jun] Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Minist Educ, Hefei 230032, Anhui, Peoples R China; [Yang, Yang; Wu, Xiao-qin; Li, Wan-xia; Huang, Hui-min; Li, Hai-di; Pan, Xue-yin; Li, Xiao-feng; Huang, Cheng; Meng, Xiao-ming; Zhang, Lei; Lv, Xiong-wen; Wang, Hua; Li, Jun] Anhui Med Univ, Inst Liver Dis, Hefei 230032, Anhui, Peoples R China; [Yang, Yang; Wu, Xiao-qin; Li, Wan-xia; Huang, Hui-min; Li, Hai-di; Pan, Xue-yin; Li, Xiao-feng; Huang, Cheng; Meng, Xiao-ming; Zhang, Lei; Lv, Xiong-wen; Wang, Hua; Li, Jun] Anhui Med Univ, Anhui Inst Innovat Drugs, Hefei 230032, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Anhui Key Lab Bioact Nat Prod, Hefei 230032, Anhui, Peoples R China.; Li, J (corresponding author), Anhui Med Univ, Key Lab Antiinflammatory & Immune Med, Minist Educ, Hefei 230032, Anhui, Peoples R China.; Li, J (corresponding author), Anhui Med Univ, Inst Liver Dis, Hefei 230032, Anhui, Peoples R China.; Li, J (corresponding author), Anhui Med Univ, Anhui Inst Innovat Drugs, Hefei 230032, Anhui, Peoples R China.	lj@ahmu.edu.cn	li, xiaofeng/GXF-9442-2022; Yang, Yang/AAB-5926-2021; li, xiao/GSN-6181-2022; lv, xiongwen/ABE-6452-2021	lv, xiongwen/0000-0003-2354-0168; Yang, Yang/0000-0002-0942-1800; Meng, Xiao-ming/0000-0002-1166-561X	National Natural Science Foundation of China [81770609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81770609).	Amabile G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8091; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Brombacher Frank, 2009, V531, P225, DOI 10.1007/978-1-59745-396-7_15; BYRD L, 1991, GENOMICS, V11, P794, DOI 10.1016/0888-7543(91)90002-V; Calvisi DF, 2011, J HEPATOL, V54, P311, DOI 10.1016/j.jhep.2010.06.036; Cassel SL, 2014, P NATL ACAD SCI USA, V111, P1072, DOI 10.1073/pnas.1318685111; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Czaja AJ, 2004, HEPATOLOGY, V39, P1631, DOI 10.1002/hep.20235; Czaja AJ, 2004, J HEPATOL, V40, P646, DOI 10.1016/j.jhep.2004.01.009; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dill MT, 2014, J CLIN INVEST, V124, P1568, DOI 10.1172/JCI70408; Drobek A, 2015, J IMMUNOL, V195, P3416, DOI 10.4049/jimmunol.1401494; Ferguson PJ, 2006, BONE, V38, P41, DOI 10.1016/j.bone.2005.07.009; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Ghiassi-Nejad Zahra, 2008, Expert Rev Gastroenterol Hepatol, V2, P803, DOI 10.1586/17474124.2.6.803; Grosse J, 2006, BLOOD, V107, P3350, DOI 10.1182/blood-2005-09-3556; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liao HJ, 2015, RHEUMATOLOGY, V54, P1317, DOI 10.1093/rheumatology/keu481; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; McCarty DM, 2003, GENE THER, V10, P2112, DOI 10.1038/sj.gt.3302134; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mouzaki M, 2015, CURR DRUG TARGETS, V16, P1324, DOI 10.2174/1389450116666150416120351; Nakai H, 1999, J VIROL, V73, P5438, DOI 10.1128/JVI.73.7.5438-5447.1999; Nakai H, 2005, J VIROL, V79, P214, DOI 10.1128/JVI.79.1.214-224.2005; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Ohta M, 2009, GASTROENTEROLOGY, V136, P206, DOI 10.1053/j.gastro.2008.09.063; Ramachandran P, 2012, J HEPATOL, V56, P1417, DOI 10.1016/j.jhep.2011.10.026; Roberts SK, 1996, GASTROENTEROLOGY, V110, P848, DOI 10.1053/gast.1996.v110.pm8608895; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Tao H, 2011, TOXICOLOGY, V290, P327, DOI 10.1016/j.tox.2011.10.011; Vento-Tormo R, 2016, J ALLERGY CLIN IMMUN, P202; Villalta SA, 2011, HUM MOL GENET, V20, P790, DOI 10.1093/hmg/ddq523; WANG KK, 1988, HEPATOLOGY, V8, P1679, DOI 10.1002/hep.1840080635; Wang Z, 2003, GENE THER, V10, P2105, DOI 10.1038/sj.gt.3302133; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yang JJ, 2013, CELL SIGNAL, V25, P1202, DOI 10.1016/j.cellsig.2013.01.005; Yoo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062152	54	34	36	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 22	2018	37	47					6119	6135		10.1038/s41388-018-0383-0	http://dx.doi.org/10.1038/s41388-018-0383-0			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HB2PG	29993036				2022-12-26	WOS:000450883000002
J	White, A; Koelper, A; Russell, A; Larsen, EM; Kim, C; Lavis, LD; Hoops, GC; Johnson, RJ				White, Alex; Koelper, Andrew; Russell, Arielle; Larsen, Erik M.; Kim, Charles; Lavis, Luke D.; Hoops, Geoffrey C.; Johnson, R. Jeremy			Fluorogenic structure activity library pinpoints molecular variations in substrate specificity of structurally homologous esterases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrolase; substrate specificity; fluorescence; chemical biology; carboxylesterase; chemical probes; fluorogenic substrates; structure-activity relationship; serine hydrolase	ALPHA/BETA-HYDROLASE FOLD; SENSITIVE LIPASE FAMILY; MYCOBACTERIUM-TUBERCULOSIS; SERINE HYDROLASES; PROFICIENT ENZYME; TRANSITION-STATE; IDENTIFICATION; SELECTIVITY; INHIBITORS; FINGERPRINTS	Cellular esterases catalyze many essential biological functions by performing hydrolysis reactions on diverse substrates. The promiscuity of esterases complicates assignment of their substrate preferences and biological functions. To identify universal factors controlling esterase substrate recognition, we designed a 32-member structure-activity relationship (SAR) library of fluorogenic ester substrates and used this library to systematically interrogate esterase preference for chain length, branching patterns, and polarity to differentiate common classes of esterase substrates. Two structurally homologous bacterial esterases were screened against this library, refining their previously broad overlapping substrate specificity. Vibrio cholerae esterase ybfF displayed a preference for -position thioethers and ethers, whereas Rv0045c from Mycobacterium tuberculosis displayed a preference for branched substrates with and without thioethers. We determined that this substrate differentiation was partially controlled by individual substrate selectivity residues Tyr-119 in ybfF and His-187 in Rv0045c; reciprocal substitution of these residues shifted each esterase's substrate preference. This work demonstrates that the selectivity of esterases is tuned based on transition state stabilization, identifies thioethers as an underutilized functional group for esterase substrates, and provides a rapid method for differentiating structural isozymes. This SAR library could have multifaceted future applications, including in vivo imaging, biocatalyst screening, molecular fingerprinting, and inhibitor design.	[White, Alex; Koelper, Andrew; Russell, Arielle; Larsen, Erik M.; Hoops, Geoffrey C.; Johnson, R. Jeremy] Butler Univ, Dept Chem & Biochem, 4600 Sunset Ave, Indianapolis, IN 46208 USA; [Kim, Charles; Lavis, Luke D.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA	Butler University; Howard Hughes Medical Institute	Johnson, RJ (corresponding author), Butler Univ, Dept Chem & Biochem, 4600 Sunset Ave, Indianapolis, IN 46208 USA.	rjjohns1@butler.edu		Hoops, Geoffrey/0000-0001-9860-1709	National Institutes of Health [1 R15 GM110641-01A1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM110641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Institutes of Health Grant 1 R15 GM110641-01A1.; Supported by the Howard Hughes Medical Institute.	Bachovchin DA, 2012, NAT REV DRUG DISCOV, V11, P52, DOI 10.1038/nrd3620; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bassett B, 2018, ACS INFECT DIS, V4, P904, DOI 10.1021/acsinfecdis.7b00263; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Breen ME, 2014, ANGEW CHEM INT EDIT, V53, P7010, DOI 10.1002/anie.201311096; Busto E, 2010, CHEM SOC REV, V39, P4504, DOI 10.1039/c003811c; Cai R, 2016, FOOD ANAL METHOD, V9, P1128, DOI 10.1007/s12161-015-0290-8; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Ceccarelli EA, 2008, TRENDS BIOTECHNOL, V26, P117, DOI 10.1016/j.tibtech.2007.11.008; Chapelat J, 2012, EUR J MED CHEM, V57, P1, DOI 10.1016/j.ejmech.2012.08.038; de Freitas RF, 2017, MEDCHEMCOMM, V8, P1970, DOI 10.1039/c7md00381a; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Devamani T, 2016, J AM CHEM SOC, V138, P1046, DOI 10.1021/jacs.5b12209; Dube S, 2017, CHEMBIOCHEM, V18, P1807, DOI 10.1002/cbic.201700278; Eisenthal R, 2007, TRENDS BIOTECHNOL, V25, P247, DOI 10.1016/j.tibtech.2007.03.010; Ellis EE, 2013, CHEMBIOCHEM, V14, P1134, DOI 10.1002/cbic.201300085; Farberg Alexander M, 2016, Biochem Biophys Rep, V7, P415, DOI 10.1016/j.bbrep.2016.07.006; Filippova EV, 2013, J BIOL CHEM, V288, P10522, DOI 10.1074/jbc.M112.446625; Fox RJ, 2009, TRENDS BIOTECHNOL, V27, P137, DOI 10.1016/j.tibtech.2008.12.001; Grognux J, 2004, CHEMBIOCHEM, V5, P826, DOI 10.1002/cbic.200300779; Guo JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013143; Hedge MK, 2012, BBA-PROTEINS PROTEOM, V1824, P1024, DOI 10.1016/j.bbapap.2012.05.009; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Johnson RJ, 2015, J CHEM EDUC, V92, P385, DOI 10.1021/ed500452f; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Kim S, 2015, CHEM-EUR J, V21, P9645, DOI 10.1002/chem.201501127; Kirby AJ, 2009, FROM ENZYME MODELS TO MODEL ENZYMES, P29; Kolbe K, 2018, ACS INFECT DIS, V4, P458, DOI 10.1021/acsinfecdis.7b00242; Komatsu T, 2013, J AM CHEM SOC, V135, P6002, DOI 10.1021/ja401792d; Komatsu T, 2015, ANAL SCI, V31, P257, DOI 10.2116/analsci.31.257; Kourist R, 2010, CHEMBIOCHEM, V11, P1635, DOI 10.1002/cbic.201000213; Kowalski JR, 2016, CBE-LIFE SCI EDUC, V15, DOI 10.1187/cbe.16-02-0089; Kozakov D, 2015, P NATL ACAD SCI USA, V112, pE2585, DOI 10.1073/pnas.1501567112; Larsen EM, 2017, BIOORG MED CHEM LETT, V27, P4544, DOI 10.1016/j.bmcl.2017.08.057; Lavis LD, 2006, ACS CHEM BIOL, V1, P252, DOI 10.1021/cb600132m; Lavis LD, 2014, ACS CHEM BIOL, V9, P855, DOI 10.1021/cb500078u; Lavis LD, 2011, CHEM SCI, V2, P521, DOI 10.1039/c0sc00466a; Lenfant N, 2013, CHEM-BIOL INTERACT, V203, P266, DOI 10.1016/j.cbi.2012.09.003; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Leroy E, 2003, BIOORG MED CHEM LETT, V13, P2105, DOI 10.1016/S0960-894X(03)00377-9; Lewis AK, 2016, NAT CHEM BIOL, V12, P860, DOI [10.1038/NCHEMBIO.2159, 10.1038/nchembio.2159]; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Long JZ, 2011, CHEM REV, V111, P6022, DOI 10.1021/cr200075y; Lukowski JK, 2014, BIOCHEMISTRY-US, V53, P7386, DOI 10.1021/bi501108u; Macarron R, 2011, MOL BIOTECHNOL, V47, P270, DOI 10.1007/s12033-010-9335-9; Maillard N, 2011, ANAL CHEM, V83, P1437, DOI 10.1021/ac102994n; MALINBERDEL J, 1980, CYTOMETRY, V1, P222, DOI 10.1002/cyto.990010308; Martinez-Martinez M, 2018, ACS CHEM BIOL, V13, P225, DOI 10.1021/acschembio.7b00996; McKary MG, 2016, BIOCHEMISTRY-US, V55, P7099, DOI 10.1021/acs.biochem.6b01057; Miller BG, 2000, P NATL ACAD SCI USA, V97, P2011, DOI 10.1073/pnas.030409797; Olguin LF, 2008, J AM CHEM SOC, V130, P16547, DOI 10.1021/ja8047943; Oosterhoff D, 2005, GENE THER, V12, P1011, DOI 10.1038/sj.gt.3302492; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Patterson AW, 2007, NAT PROTOC, V2, P424, DOI 10.1038/nprot.2007.28; Qian L, 2011, J MOL CATAL B-ENZYM, V73, P22, DOI 10.1016/j.molcatb.2011.07.010; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Rauwerdink A, 2015, ACS CATAL, V5, P6153, DOI 10.1021/acscatal.5b01539; Reymond JL, 2009, CHEM COMMUN, P34, DOI 10.1039/b813732c; Romano D, 2015, BIOTECHNOL ADV, V33, P547, DOI 10.1016/j.biotechadv.2015.01.006; Rosenau F, 2010, FEMS MICROBIOL LETT, V309, P25, DOI 10.1111/j.1574-6968.2010.02017.x; Segal E, 2015, CHEM BIOL, V22, P148, DOI 10.1016/j.chembiol.2014.11.008; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Soellner MB, 2007, J AM CHEM SOC, V129, P9613, DOI 10.1021/ja0727520; Sousa SF, 2015, ACS CATAL, V5, P5877, DOI 10.1021/acscatal.5b00923; Tallman KR, 2016, ACS INFECT DIS, V2, P48, DOI 10.1021/acsinfecdis.6b00135; Tian L, 2012, P NATL ACAD SCI USA, V109, P4756, DOI 10.1073/pnas.1111943109; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Varadi L, 2017, CHEM SOC REV, V46, P4818, DOI 10.1039/c6cs00693k; WOLFENDEN R, 1972, ACCOUNTS CHEM RES, V5, P10, DOI 10.1021/ar50049a002; Wolfenden R, 2006, CHEM REV, V106, P3379, DOI 10.1021/cr050311y; Wolfenden R, 2011, ANNU REV BIOCHEM, V80, P645, DOI 10.1146/annurev-biochem-060409-093051; Wood WJL, 2005, J AM CHEM SOC, V127, P15521, DOI 10.1021/ja0547230; Yang YZ, 2006, HELV CHIM ACTA, V89, P404, DOI 10.1002/hlca.200690041; Zadlo-Dobrowolska A, 2016, ORG BIOMOL CHEM, V14, P9146, DOI 10.1039/c6ob01488g; Zheng XD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020506	77	6	6	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13851	13862		10.1074/jbc.RA118.003972	http://dx.doi.org/10.1074/jbc.RA118.003972			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006352	Green Published, hybrid			2022-12-26	WOS:000444070700012
J	Goto, S; Yoshioka, T; Ohta, S; Kita, M; Hamada, H; Shimizu, T				Goto, Shingo; Yoshioka, Terutaka; Ohta, Satoshi; Kita, Masayuki; Hamada, Hiroko; Shimizu, Tokurou			QTL mapping of male sterility and transmission pattern in progeny of Satsuma mandarin	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ABORTED ANTHERS; CYBRID PLANTS; CITRUS; INHERITANCE; SEEDLINGS; MARKERS; MAPS	Seedlessness is one of the important traits in citrus breeding. Male sterility derived from Satsuma mandarin (Citrus unshiu) has been used in Japanese citrus breeding programs to obtain seedless cultivars. The efficiency of seedless cultivar breeding would be improved by developing a selection marker linked to seedlessness. In this study, we performed QTL mapping in 'Okitsu No. 46' x 'Okitsu No. 56' (O46-O56) crosses for the number of pollen grains per anther (NPG) and apparent pollen fertility (APF), two traits used as an index of male sterility, and detected a candidate QTL for NPG (MS-P1) on linkage group 8 with a significant LOD score (7.31) and 47% of variance explained. The QTL for APF (MS-F1) was detected on linkage group 6 with a significant LOD score (5.71) and 63.6% of variance explained. The role of both MS-P1 in reducing NPG and MS-F1 in decreasing APF were confirmed with the 'Okitsu No.46' x 'Kara' (O46-K) cross. Pedigree analysis inferred that both MS-P1 and MS-F1 in 'Okitsu No. 46' were derived from kunenbo (Citrus nobilis) through hassaku (C. hassaku) and 'Sweet Spring'. Cytoplasm analysis revealed that both male-sterile 'Sweet Spring' and 'Okitsu No. 46' have cytoplasm derived from Kishu (C. kinokuni hort. ex Tanaka), but the cytoplasm of male-sterile kunenbo and hassaku were derived from other varieties rather than Kishu. These results suggest that MS-P1 and MS-F1 primarily reduce the NPG and decrease APF, but their expression requires a cytoplasm derived from Kishu. These findings will improve our understanding of the molecular mechanism of male sterility in citrus and help to develop a DNA marker for seedless breeding in citrus.	[Goto, Shingo; Yoshioka, Terutaka; Ohta, Satoshi; Kita, Masayuki; Hamada, Hiroko; Shimizu, Tokurou] NARO, Div Citrus Res, Inst Fruit Tree & Tea Sci, Shizuoka, Japan; [Kita, Masayuki] NARO, Div Hillside Hort Res, Western Reg Agr Res Ctr, Kagawa, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Shimizu, T (corresponding author), NARO, Div Citrus Res, Inst Fruit Tree & Tea Sci, Shizuoka, Japan.	tshimizu@affrc.go.jp	Goto, Shingo/AAU-4777-2021	Goto, Shingo/0000-0002-2298-7016	National Agriculture and Food Research Organization	National Agriculture and Food Research Organization	This work was supported by the basic research fund of National Agriculture and Food Research Organization for TS and SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai XD, 2007, PLANT CELL TISS ORG, V90, P275, DOI 10.1007/s11240-007-9266-8; Chen CX, 2008, TREE GENET GENOMES, V4, P1, DOI 10.1007/s11295-007-0083-3; Chen CX, 2006, THEOR APPL GENET, V112, P1248, DOI 10.1007/s00122-006-0226-1; Dewi PS, 2015, ACTA HORTIC, V1065, P475; Dewi PS, 2013, J JPN SOC HORTIC SCI, V82, P203, DOI 10.2503/jjshs1.82.203; 채치원, 2011, [Journal of Life Science, 생명과학회지], V21, P1659; Fang YN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2882-0; Fujii H, 2016, BREEDING SCI, V66, P683, DOI 10.1270/jsbbs.16060; Goldenberg L, 2018, J SCI FOOD AGR, V98, P18, DOI 10.1002/jsfa.8495; Goto S, 2016, ACTA HORTIC, V1135, P103, DOI 10.17660/ActaHortic.2016.1135.12; Goto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162408; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Guo WW, 2013, SCI HORTIC-AMSTERDAM, V163, P20, DOI 10.1016/j.scienta.2013.07.018; Guo WW, 2004, PLANT CELL REP, V22, P752, DOI 10.1007/s00299-003-0747-x; Haldane JBS, 1919, J GENET, V8, P299; Hasegawa Y, 2013, J JPN SOC FOOD SCI, V60, P609; Imai A, 2017, HORTICULT J, V86, P200, DOI [10.2503/hortj.OKD-013, 10.2503/hortj.okd-013]; IWAMASA M., 1966, Bulletin of the Horticultural Research Station, P1; Nakano M, J JAPAN SOC HORT SCI; Nakano M, 2000, P INT SOC CITR 9 C, P179; Nishiura M., 1983, B FRUIT TREE RES S B, V10, P11; Ollitrault F, 2010, AM J BOT, V97, pE124, DOI 10.3732/ajb.1000280; Omura M, 2016, BREEDING SCI, V66, P3, DOI 10.1270/jsbbs.66.3; Roose ML, 2007, CITRUS GENETICS, BREEDING AND BIOTECHNOLOGY, P275, DOI 10.1079/9780851990194.0275; Ru S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0834-5; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shimizu T, 2016, ACTA HORTIC, V1135, P23, DOI 10.17660/ActaHortic.2016.1135.4; Shimizu T, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00180; Shimizu T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166969; Shimizu Tokurou, 2011, BMC Res Notes, V4, P161, DOI 10.1186/1756-0500-4-161; Van Ooijen J., 2006, SOFTWARE CALCULATION; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xiao SX, 2014, PLANT CELL TISS ORG, V116, P81, DOI 10.1007/s11240-013-0384-1; Yamamoto M, 1997, SCI HORTIC-AMSTERDAM, V70, P9, DOI 10.1016/S0304-4238(97)00017-4; YAMAMOTO M, 1992, J JPN SOC HORTIC SCI, V60, P791, DOI 10.2503/jjshs.60.791; Zheng BB, 2014, J PROTEOME RES, V13, P2998, DOI 10.1021/pr500126g; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	38	13	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200844	10.1371/journal.pone.0200844	http://dx.doi.org/10.1371/journal.pone.0200844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016346	gold, Green Submitted, Green Published			2022-12-26	WOS:000438866600047
J	Gil, H; Fernandez-Garcia, A; Mosquera, MM; Hubschen, JM; Castellanos, AM; de Ory, F; Masa-Calles, J; Echevarria, JE				Gil, Horacio; Fernandez-Garcia, Aurora; Mar Mosquera, Maria; Huebschen, Judith M.; Castellanos, Ana M.; de Ory, Fernando; Masa-Calles, Josefa; Echevarria, Juan E.			Measles virus genotype D4 strains with non-standard length M-F non-coding region circulated during the major outbreaks of 2011-2012 in Spain	PLOS ONE			English	Article							GENOME REGION; WILD-TYPE; REPLICATION; GENE	In recent decades, vaccination has substantially reduced the number of measles cases to levels close to the elimination stage. However, major measles outbreaks occurred in Europe during 2010-2012, after the introduction of the D4-Enfield lineage. We have performed a molecular characterization of 75 measles virus genotype D4 strains from patients infected in Spain between 2004 and 2012 by sequencing the N-450 region and the M-F non-coding region (M-F NCR) in order to identify genetic features of these viruses. The analysis of the N-450 region confirmed that all samples obtained since 2008 belonged to variants or sets of identical sequences of the D4-Enfield lineage, including a new one named MVs/Madrid. ESP/46.10/. Analysis of the M-F NCR showed insertions and deletions associated with previously described, uncommon non-standard genome length measles viruses. This genetic feature was identified in the D4-Enfield lineage viruses, but not in the other D4 viruses that were circulating in Spain before 2008, suggesting that these non-standard length M-F NCR sequences are characteristic of the D4-Enfield lineage. The results of the phylogenetic analysis of Spanish M-F NCRs suggest higher resolution in discriminating strains than did the N-450 analysis. In addition, the results of the analysis of the M-F NCR on the MVs/Madrid. ESP/46.10/ sub-lineage seem to support the potential utility of this region as a tool for epidemiological surveillance complementary to the N-450 region, as previously suggested. Further investigation on this question, as well as the surveillance of new potentially emerging strains with non-standard length M-F NCR are strongly recommended as part of future strategies for measles elimination.	[Gil, Horacio; Fernandez-Garcia, Aurora; Mar Mosquera, Maria; Castellanos, Ana M.; de Ory, Fernando; Echevarria, Juan E.] Inst Salud Carlos III, Ctr Nacl Microbiol, Natl Reference Lab Measles & Rubella, Madrid, Spain; [Gil, Horacio] European Ctr Dis Prevent & Control ECDC, European Program Publ Hlth Microbiol Training EUP, Solna, Sweden; [Fernandez-Garcia, Aurora; Mar Mosquera, Maria; Castellanos, Ana M.; de Ory, Fernando; Masa-Calles, Josefa; Echevarria, Juan E.] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Huebschen, Judith M.] Luxembourg Inst Hlth, Dept Infect & Immun, WHO European Reg Reference Lab Measles & Rubella, Esch Sur Alzette, Luxembourg; [Masa-Calles, Josefa] Inst Salud Carlos III, Ctr Nacl Epidemiol, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); European Centre for Disease Prevention & Control; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Luxembourg Institute of Health; Instituto de Salud Carlos III; Centro Nacional de Epidemiologia (CNE)	Fernandez-Garcia, A (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Natl Reference Lab Measles & Rubella, Madrid, Spain.; Fernandez-Garcia, A (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	aurorafg@externos.isciii.es	Hübschen, Judith/AAF-5113-2020; Hübschen, Judith/ABA-7931-2021; Echevarria, Juan E./F-7913-2016	Hübschen, Judith/0000-0002-5001-2128; Echevarria, Juan E./0000-0001-7522-850X; MASA-CALLES, JOSEFA/0000-0002-2725-417X; Gil, Horacio/0000-0002-7114-6686	Fondo de Investigacion Sanitaria [FIS PI12/02006]; CIBER de Epidemiologia y Salud Publica [ESPG13]; CIBER de Epidemiologia y Salud Publica (CIBERESP), ISCIII; Instituto de Salud Carlos III [FIS PI12/02006, PI15CIII/00023]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); CIBER de Epidemiologia y Salud Publica; CIBER de Epidemiologia y Salud Publica (CIBERESP), ISCIII; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Fondo de Investigacion Sanitaria (FIS PI12/02006) y el Instituto de Salud Carlos III (PI15CIII/00023). AFG was funded by CIBER de Epidemiologia y Salud Publica (ESPG13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Androulla Efstratiou from Public Health England for reviewing this manuscript, and the Genomic Unit of CNM-ISCIII, for technical assistance with sequencing. This work was supported by the Fondo de Investigacion Sanitaria y el Instituto de Salud Carlos III (FIS PI12/02006 and PI15CIII/00023). Aurora Fernandez-Garcia was funded by CIBER de Epidemiologia y Salud Publica (CIBERESP), ISCIII.	Bankamp B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095470; Centro Nacional de Epidemiologia, PLAN NAC EL SAR RUB; Hall T.A, BIOEDIT USER FRIENDL, P19; Harvala H, 2016, J INFECT DIS, V213, P592, DOI 10.1093/infdis/jiv434; Heider A, 1997, ARCH VIROL, V142, P2521, DOI 10.1007/s007050050259; Ivancic-Jelecki J, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0587-2; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liermann H, 1998, VIRUS GENES, V17, P259, DOI 10.1023/A:1008069805011; Mankertz A, 2011, EMERG INFECT DIS, V17, P1396, DOI 10.3201/eid1708.101994; Mosquera MM, 2005, J MED VIROL, V75, P137, DOI 10.1002/jmv.20248; Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081; Rima BK, 2009, CURR TOP MICROBIOL, V329, P77; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Santibanez S, 2015, VIRUS GENES, V50, P2, DOI 10.1007/s11262-015-1173-1; Takeda M, 2005, J VIROL, V79, P14346, DOI 10.1128/JVI.79.22.14346-14354.2005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WONG TC, 1987, VIROLOGY, V157, P497, DOI 10.1016/0042-6822(87)90292-3; World Health Organization, 2015, WKLY EPIDEMIOL REC, V90, P373	19	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199975	10.1371/journal.pone.0199975	http://dx.doi.org/10.1371/journal.pone.0199975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011283	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800008
J	Santos, J; Herrmann, B; Stepputtis, D; Gunther, C; Limmer, B; Mieske, B; Schultz, S; Neudecker, T; Temming, A; Hufnagl, M; Bethke, E; Kraus, G				Santos, Juan; Herrmann, Bent; Stepputtis, Daniel; Gunther, Claudia; Limmer, Bente; Mieske, Bernd; Schultz, Sebastian; Neudecker, Thomas; Temming, Axel; Hufnagl, Marc; Bethke, Eckhard; Kraus, Gerd			Predictive framework for codend size selection of brown shrimp (Crangon crangon) in the North Sea beam-trawl fishery	PLOS ONE			English	Article							SQUARE-MESH CODENDS; CATCH SIZE; DISCARDS; DIAMOND; MODEL	The brown shrimp (Crangon crangon) fishery is of great socio-economic importance to coastal communities on the North Sea. The fishery is exploited by beam trawlers often using codends with very small mesh sizes, leading to concerns about catch rates of undersized shrimp. However, little information is available on codend size selection, making it difficult to provide scientifically based advice on alternative codend designs. Therefore, this study establishes a predictive framework for codend size selection of brown shrimp, based on a large selectivity dataset from 33 different codend designs tested during four experimental fishing cruises, during which more than 350,000 brown shrimp were length measured. Predictions by the framework confirm concerns about the exploitation pattern in the fishery, because the retention probability of undersized shrimp reaches 95% with the currently applied designs. The framework predictions allow the exploration of obtainable exploitation patterns depending on codend design. For example, increasing codend mesh size to 25-29 mm would reduce the retention rate of undersized shrimp to a maximum of 50%, depending on codend mesh type.	[Santos, Juan; Stepputtis, Daniel; Limmer, Bente; Mieske, Bernd] Thunen Inst Balt Sea Fisheries, Rostock, Germany; [Herrmann, Bent] SINTEF Fisheries & Aquaculture, Fishing Gear Technol, Hirtshals, Denmark; [Herrmann, Bent] Univ Tromso, Norwegian Coll Fishery & Aquat Sci, Tromso, Norway; [Gunther, Claudia; Temming, Axel; Hufnagl, Marc] Univ Hamburg, Inst Hydrobiol & Fisheries Sci, Hamburg, Germany; [Schultz, Sebastian; Neudecker, Thomas; Bethke, Eckhard; Kraus, Gerd] Thunen Inst Sea Fisheries, Hamburg, Germany	Johann Heinrich von Thunen Institute; SINTEF; UiT The Arctic University of Tromso; University of Hamburg; Johann Heinrich von Thunen Institute	Santos, J (corresponding author), Thunen Inst Balt Sea Fisheries, Rostock, Germany.	juan.santos@thuenen.de		Stepputtis, Daniel/0000-0003-4824-1631; Herrmann, Bent/0000-0003-1325-6198; Santos Blanco, Juan Jose/0000-0003-4277-7734	European Fisheries Fund (EFF); German states of Schleswig-Holstein	European Fisheries Fund (EFF); German states of Schleswig-Holstein	This study was conducted as part of the project CRANNET "Optimierte Net-Steerte fOr eine okologisch and okonomisch nachhaltige Garnelenfischerei in der Nordsee." The study was co-funded by the European Fisheries Fund (EFF, https://ec.europa.euifisheries/cfpieff en) and the German states of Schleswig-Holstein (https://www. bundeslaenderdeutschland.de/schleswig-hoistein/)	[Anonymous], 2015, 2015SSGEPD07 ICES CM; [Anonymous], 2016, 2016SSGEPD07 ICES CM; Aviat D, 2011, N SEA BROWN SHRIMP F; Broadhurst MK, 2004, FISH RES, V67, P183, DOI 10.1016/j.fishres.2003.09.043; Campos A, 2002, FISH RES, V58, P281, DOI 10.1016/S0165-7836(01)00396-4; Catchpole TL, 2008, ICES J MAR SCI, V65, P267, DOI 10.1093/icesjms/fsn016; Deval MC, 2016, J APPL ICHTHYOL, V32, P1041, DOI 10.1111/jai.13128; Fonteyne R., 1996, ICES COOPER RES REP, V215, P38; Fonteyne R, 2007, FISH RES, V85, P279, DOI 10.1016/j.fishres.2007.02.012; FRYER RJ, 1991, ICES J MAR SCI, V48, P281, DOI 10.1093/icesjms/48.3.281; Herrmann B, 2013, FISH RES, V145, P22, DOI 10.1016/j.fishres.2013.03.002; Hufnagl M, 2011, MAR ECOL PROG SER, V435, P155, DOI 10.3354/meps09224; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; ICES, 2011, P ICES REYKJ IC 4 6; Madsen N, 2007, REV FISH BIOL FISHER, V17, P517, DOI 10.1007/s11160-007-9053-y; MILLAR RB, 1992, FISH RES, V13, P205, DOI 10.1016/0165-7836(92)90077-7; Neudecker T, 2010, J APPL ICHTHYOL, V26, P67, DOI 10.1111/j.1439-0426.2010.01447.x; O'Neill FG, 2005, FISH RES, V72, P163, DOI 10.1016/j.fishres.2004.11.005; O'Neill FG, 2003, FISH RES, V60, P107, DOI 10.1016/S0165-7836(02)00056-5; ONeill FG, 1996, FISH RES, V28, P291, DOI 10.1016/0165-7836(96)00501-2; Polet H, 2000, FISH RES, V48, P167, DOI 10.1016/S0165-7836(00)00125-9; Revill A, 2004, FISH RES, V66, P171, DOI 10.1016/S0165-7836(03)00198-X; Revill AS, 2004, FISH RES, V68, P113, DOI 10.1016/j.fishres.2004.02.001; THORSTEINSSON G, 1992, FISH RES, V13, P255, DOI 10.1016/0165-7836(92)90080-D; Tulp I, 2016, ICES J MAR SCI, V73, P2539, DOI 10.1093/icesjms/fsw141; Ulleweit J, 2010, J APPL ICHTHYOL, V26, P54, DOI 10.1111/j.1439-0426.2010.01449.x; Wienbeck H, 2011, FISH RES, V109, P80, DOI 10.1016/j.fishres.2011.01.019	27	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200464	10.1371/journal.pone.0200464	http://dx.doi.org/10.1371/journal.pone.0200464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011305	Green Accepted, Green Published, gold			2022-12-26	WOS:000438829800019
J	Yao, Y; Ma, Y; Chen, XL; Bade, R; Lv, CL; Zhu, RX				Yao, Yuan; Ma, Yong; Chen, Xiuli; Bade, Rengui; Lv, Cuilan; Zhu, Runxiu			Absence of RstA results in delayed initiation of DNA replication in Escherichia coli	PLOS ONE			English	Article							PROTEIN; MUTANTS; ORIGIN; HU	RstB/RstA is an uncharacterized Escherichia co/itwo-component system, the regulatory effects of which on the E. coli cell cycle remain unclear. We found that the doubling time and average number of replication origins per cell in an Delta rstB mutant were the same as the wild-type, and the average number of replication origins in an Delta rstA mutant was 18.2% lower than in wild-type cells. The doubling times were 34 min, 35 min, and 40 min for the wild-type, Delta rstB, and Delta rstA strains, respectively. Ectopic expression of RstA from plasmid pACYCrstA partly reversed the Delta rstA mutant phenotypes. The amount of initiator protein DnaA per cell was reduced by 40% in the Delta rstA mutant compared with the wild-type, but the concentration of DnaA did not change as the total amount of cellular protein was also reduced in these cells. Deletion or overproduction of RstA does not change the temperature sensitivity of dnaA46, dnaB252 and dnaC2. The expression of hupA was decreased by 0.53-fold in Delta rstA. RstA interacted with Topoisomerase I weakly in vivo and increased its activity of relaxing the negative supercoiled plasmid. Our data suggest that deletion of RstA leads to delayed initiation of DNA replication, and RstA may affect initiation of replication by controlling expression of dnaA or hupA. Furthermore, the delayed initiation may by caused by the decreased activity of topoisomerase I in RstA mutant.	[Yao, Yuan; Lv, Cuilan; Zhu, Runxiu] Inner Mongolia Peoples Hosp, Dept Neurol, Hohhot, Inner Mongolia, Peoples R China; [Yao, Yuan; Ma, Yong] Inner Mongolia Univ, Sch Life Sci, Hohhot, Inner Mongolia, Peoples R China; [Ma, Yong] Baotou Teachers Coll, Dept Biol Sci & Technol, Baotou, Inner Mongolia, Peoples R China; [Bade, Rengui] Baotou Med Coll, Key Lab Hypox Translat Med, Baotou, Innner Mongolia, Peoples R China	Inner Mongolia University; Baotou Teachers College; Baotou Medical College	Zhu, RX (corresponding author), Inner Mongolia Peoples Hosp, Dept Neurol, Hohhot, Inner Mongolia, Peoples R China.	zhjyq129@163.com		/0000-0003-2555-1610	Natural Science Foundations of Inner Mongolia [2014MS0803, 2017MS08156, 2017BS0315]; Natural Science Foundation of Inner Mongolia People's Hospital [2016105]; China Postdoctoral Science Foundation [21400-5175502]; Program for Young Talents of University of Inner Mongolia Autonomous Region Training Program of Baotou Teachers College; China Postdoctoral Science Foundation	Natural Science Foundations of Inner Mongolia; Natural Science Foundation of Inner Mongolia People's Hospital; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for Young Talents of University of Inner Mongolia Autonomous Region Training Program of Baotou Teachers College; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work was supported by grants from the Natural Science Foundations of Inner Mongolia (Grant Nos. 2014MS0803, 2017MS08156 to Runxiu Zhu, Grant No. 2017BS0315 to Yuan Yao), the Natural Science Foundation of Inner Mongolia People's Hospital (Grant No. 2016105 to Yuan Yao), the China Postdoctoral Science Foundation (Grant no. 21400-5175502 to Yuan Yao) and Program for Young Talents of University of Inner Mongolia Autonomous Region Training Program of Baotou Teachers College (to Ma Yong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are deeply grateful to Dr. Tamsin Sheen for their critical readings and polishing. The work was supported by grants from the Natural Science Foundations of Inner Mongolia (Grant No. 2017BS0315 to Yuan Yao; Grant Nos. 2014MS0803, 2017MS08156 to Runxiu Zhu), the Natural Science Foundation of Inner Mongolia People's Hospital (Grant No. 2016105 to Yuan Yao), the China Postdoctoral Science Foundation (to Yuan Yao) and Program for Young Talents of University of Inner Mongolia Autonomous Region Training Program of Baotou Teachers College (to Ma Yong).	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BONNEFOY E, 1992, EMBO J, V11, P4489, DOI 10.1002/j.1460-2075.1992.tb05550.x; BOYE E, 1991, RES MICROBIOL, V142, P131, DOI 10.1016/0923-2508(91)90020-B; BRONDSTED L, 1994, J BACTERIOL, V176, P5423; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chodavarapu S, 2008, MOL MICROBIOL, V67, P1331, DOI 10.1111/j.1365-2958.2008.06127.x; Drolet M, 2003, FRONT BIOSCI, V8, pD210, DOI 10.2741/970; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; HWANG DS, 1992, J BIOL CHEM, V267, P23083; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; Mihaela S, 2008, MICROB CELL FACT, V7, P1; Miller JH., 1972, EXPT MOL GENETICS; Miller RV, 1992, GENE TRANSFERS ENV, P51; Morigen, 2003, MOL MICROBIOL, V50, P349, DOI 10.1046/j.1365-2958.2003.03695.x; Morigen, 2005, J BACTERIOL, V187, P3913, DOI 10.1128/JB.187.12.3913-3920.2005; Morigen, 2001, BBA-GENE STRUCT EXPR, V1521, P73; Nitiss J. L., 2012, CURR PROTOC PHARM; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Ryan VT, 2002, MOL MICROBIOL, V46, P113, DOI 10.1046/j.1365-2958.2002.03129.x; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; Yao Y, 2015, GENET MOL RES, V14, P16888, DOI 10.4238/2015.December.14.16; Yao Y, 2016, GENES, V8, P1; Zhang EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103440	29	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200688	10.1371/journal.pone.0200688	http://dx.doi.org/10.1371/journal.pone.0200688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011323	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800042
J	Hammond, BR; Renzi-Hammond, L				Hammond, Billy R., Jr.; Renzi-Hammond, Lisa			Individual variation in the transmission of UVB radiation in the young adult eye	PLOS ONE			English	Article							PIGMENT OPTICAL-DENSITY; SEXUAL DICHROMATISM; MACULAR PIGMENT; ULTRAVIOLET-RADIATION; OBJECTIVE ASSESSMENT; APHAKIC OBSERVERS; NEAR-ULTRAVIOLET; OCULAR MEDIA; HUMAN VISION; SENSITIVITY	Objectives Data obtained mostly from animal models and ex vivo samples show that a small portion of ultraviolet light (UV, 300-400 nm) penetrates the cornea and crystalline lens and impinges on the human retina. UV transmission to the retina appears to be unique to the young and some older pseudophakes. In this study, we determine the variation in UV transmission in a relatively homogenous sample of young adults. Methods 42 subjects were tested (M= 19 +/- 1.3 years). Absolute thresholds to UV radiation were collected (lambda max = 315 nm, 305-325). Macular pigment optical density (MPOD, measured using heterochromatic flicker photometry) and iris color (using a standardized color scale) were also assessed as potential covariates. Results All of the subjects could detect UV radiation at 315 nm but individual variation was large (over a factor of 30). Higher MPOD and darker iridies were not related to UV sensitivity in this young sample. Males, however, were more sensitive to UV than the females (p<0.05). Conclusions The large individual differences in UV reaching the retina of younger individuals suggests equally significant vulnerability to the actinic effects of this highly energetic light.	[Hammond, Billy R., Jr.] Univ Georgia, Brain & Behav Sci, Athens, GA 30602 USA; [Renzi-Hammond, Lisa] Univ Georgia, Inst Gerontol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Hammond, BR (corresponding author), Univ Georgia, Brain & Behav Sci, Athens, GA 30602 USA.	bhammond@uga.edu		Hammond, Billy/0000-0002-5762-0206; Renzi-Hammond, Lisa/0000-0003-4334-8202				Barker F. M., 1991, DIRECT SPECTRAL TRAN; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Brainard GC, 1999, CLIN NEUROPHYSIOL, V110, P379, DOI 10.1016/S1388-2457(98)00022-4; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Delori F, 2009, FUNDUS AUTOFLUORESCE, P27; Douglas R. H., 2014, P ROYAL SOC B, V281B, P2013; Eaton MD, 2005, P NATL ACAD SCI USA, V102, P10942, DOI 10.1073/pnas.0501891102; Fletcher L. M., 2016, THESIS; Gaillard ER, 2011, PHOTOCHEM PHOTOBIOL, V87, P18, DOI 10.1111/j.1751-1097.2010.00837.x; Goldstein EB, 2016, SENSATION PERCEPTION; Goodeve CF, 1934, NATURE, V134, P416, DOI 10.1038/134416b0; GRISWOLD MS, 1992, VISION RES, V32, P1739, DOI 10.1016/0042-6989(92)90166-G; Hammond BR, 1996, VISION RES, V36, P2001, DOI 10.1016/0042-6989(95)00290-1; Hastad O., 2014, PEERJ, V2, P1; Hastad O, 2014, PEERJ, V2, DOI 10.7717/peerj.621; JACOBS GH, 1992, AM ZOOL, V32, P544; KRINSKY NI, 1990, J NUTR, V120, P1654, DOI 10.1093/jn/120.12.1654; Mackey DA, 2011, CLIN EXP OPHTHALMOL, V39, P462, DOI 10.1111/j.1442-9071.2010.02487.x; Mahler BA, 2002, CONDOR, V104, P248, DOI 10.1650/0010-5422(2002)104[0248:OAOSPD]2.0.CO;2; Mainster MA, 2010, AM J OPHTHALMOL, V149, P543, DOI 10.1016/j.ajo.2009.11.028; Maul JT, 2017, J EUR ACAD DERMATOL, V31, P1208, DOI 10.1111/jdv.13994; Mennill DJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P350, DOI 10.1007/s00265-003-0581-8; Pitts D. G., 1993, ENV VISION INTERACTI; Saidman J, 1933, CR HEBD ACAD SCI, V196, P1537; Schwartz S.H., 2018, VISUAL PERCEPTION CL; Seddon N, 2010, AUK, V127, P283, DOI 10.1525/auk.2009.09070; STARK WS, 1987, CURR EYE RES, V6, P631, DOI 10.3109/02713688709025224; Stringham JM, 2008, EXP EYE RES, V87, P445, DOI 10.1016/j.exer.2008.08.005; Tan KEWP, 1971, VISION ULTRAVIOLET; WERNER JS, 1982, J OPT SOC AM, V72, P247, DOI 10.1364/JOSA.72.000247; WERNER JS, 1989, OPHTHALMOLOGY, V96, P1552; Williams KM, 2017, JAMA OPHTHALMOL, V135, P47, DOI 10.1001/jamaophthalmol.2016.4752; WOLF E, 1949, Trans Am Acad Ophthalmol Otolaryngol, V53, P400; Wolfe J.M., 2018, SENSATION PERCEPTION; Wooten BR, 1999, INVEST OPHTH VIS SCI, V40, P2481; Yones SS, 2007, ARCH DERMATOL, V143, P578, DOI 10.1001/archderm.143.5.578; Zuclich JA, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1990163	37	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199940	10.1371/journal.pone.0199940	http://dx.doi.org/10.1371/journal.pone.0199940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001366	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400020
J	Dedova, T; Grunow, D; Kappert, K; Flach, D; Tauber, R; Blanchard, V				Dedova, Tereza; Grunow, Detlef; Kappert, Kai; Flach, Dagmar; Tauber, Rudolf; Blanchard, Veronique			The effect of blood sampling and preanalytical processing on human N-glycome	PLOS ONE			English	Article							SIALIC-ACID ESTERIFICATION; MALDI-TOF-MS; MASS-SPECTROMETRY; OVARIAN-CANCER; RHEUMATOID-ARTHRITIS; COLORECTAL-CANCER; HUMAN-SERUM; L-SELECTIN; GLYCOSYLATION; BIOMARKER	Glycome modulations have been described in the onset and progression of many diseases. Thus, many studies have proposed glycans from blood glycoproteins as disease markers. Astonishingly, little effort has been given unraveling preanalytical conditions potentially influencing glycan analysis prior to blood biomarker studies. In this work, we evaluate for the first time the effect of hemolysis, storage and blood collection, but also influence of various times and temperatures between individual processing steps on the total N-glycome and on a glycan-biomarker score. Venous blood was collected from 10 healthy donors in 11 blood collection tubes with different additives, processed variously to obtain 16 preanalytical variables and N-glycans released from serum or plasma were analyzed by MALDI-TOF-MS and capillary electrophoresis coupled with fluorescence detection (CE-LIF) for the first time. Long time storage of deep frozen samples at -20 degrees C or -80 degrees C exerted only a minor influence on the glycome as demonstrated by CE-LIF. The N-glycome was very stable evidenced by MALDI-TOF when stored at 4 degrees C for at least 48 hours and blood collected in tubes devoid of additives. The glycome was stable upon storage after centrifugation and aliquoting, which is an important information considering future diagnostic applications. Hemolysis, however, negatively correlated with an established glycan score for ovarian cancer, when evaluated by MALDI-TOF-MS measurement by affecting relative intensities of certain glycans, which could lead to false negative / positive results in glycan biomarker studies.	[Dedova, Tereza; Grunow, Detlef; Kappert, Kai; Tauber, Rudolf; Blanchard, Veronique] Charite Univ Med Berlin, Inst Lab Med, Clin Chem & Pathobiochem, Berlin, Germany; [Dedova, Tereza] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Kappert, Kai] Charite Univ Med Berlin, Ctr Cardiovasc Res, German Ctr Cardiovasc Res, Berlin, Germany; [Flach, Dagmar] Sarstedt AG&Co, Numbrecht, North Rhine Wes, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research	Blanchard, V (corresponding author), Charite Univ Med Berlin, Inst Lab Med, Clin Chem & Pathobiochem, Berlin, Germany.	veronique.blanchard@charite.de		Blanchard, Veronique/0000-0002-5980-6450	Sarstedt; Sonnenfeld foundation	Sarstedt; Sonnenfeld foundation	This project was supported by Sarstedt (D.G.) and by the Sonnenfeld foundation (T.D.). Dr. Flach (affiliation Sarstedt) was involved in the study design. Sarstedt provided blood collection tubes for this study. The funders had no role in data collection and analysis, decision to publish.	Abd Hamid UM, 2008, GLYCOBIOLOGY, V18, P1105, DOI 10.1093/glycob/cwn095; Adamczyk B, 2013, J PROTEOME RES, V12, P444, DOI 10.1021/pr300813h; ALHADEFF JA, 1978, CLIN CHIM ACTA, V82, P133, DOI 10.1016/0009-8981(78)90036-0; Anugraham M, 2014, MOL CELL PROTEOMICS, V13, P2213, DOI 10.1074/mcp.M113.037085; Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Berger-Achituv S, 2010, PEDIATRICS, V126, pE179, DOI 10.1542/peds.2009-2920; Biskup K, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/238197; Biskup K, 2013, J PROTEOME RES, V12, P4056, DOI 10.1021/pr400405x; Bladergroen MR, 2015, J PROTEOME RES, V14, P4080, DOI 10.1021/acs.jproteome.5b00538; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Evans JD., 1996, STRAIGHTFORWARD STAT; Frisch E, 2011, ELECTROPHORESIS, V32, P3510, DOI 10.1002/elps.201100250; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Hamouda H, 2014, J PROTEOME RES, V13, P6144, DOI 10.1021/pr5003005; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Hess C, 2013, J CLIN INVEST, V123, P3788, DOI 10.1172/JCI65938; Huffman JE, 2014, MOL CELL PROTEOMICS, V13, P1598, DOI 10.1074/mcp.M113.037465; Huffman JE, 2011, HUM MOL GENET, V20, P5000, DOI 10.1093/hmg/ddr414; Kara H, 2014, PAK J MED SCI, V30, P50, DOI 10.12669/pjms.301.4228; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Klein A, 2008, ADV CLIN CHEM, V46, P51, DOI 10.1016/S0065-2423(08)00402-2; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Kyselova Z, 2008, CLIN CHEM, V54, P1166, DOI 10.1373/clinchem.2007.087148; Leichtle AB, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13801; Lista S, 2013, PROG NEUROBIOL, V101, P18, DOI 10.1016/j.pneurobio.2012.06.006; Liu XE, 2007, HEPATOLOGY, V46, P1426, DOI 10.1002/hep.21855; Lusch A, 2013, MOL PHARMACEUT, V10, P2616, DOI 10.1021/mp400043r; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; Mechref Y, 2012, ELECTROPHORESIS, V33, P1755, DOI 10.1002/elps.201100715; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; Rudan I, 2009, CROAT MED J, V50, P4, DOI 10.3325/cmj.2009.50.4; Saldova R, 2012, J PROTEOME RES, V11, P1821, DOI 10.1021/pr2010605; SCHAUER R, 1976, H-S Z PHYSIOL CHEM, V357, P559, DOI 10.1515/bchm2.1976.357.1.559; Schwedler C, 2014, ANAL BIOANAL CHEM, V406, P7185, DOI 10.1007/s00216-014-8168-y; Sodi R, 2004, ANN CLIN BIOCHEM, V41, P237, DOI 10.1258/000456304323019631; Sogawa K, 2013, PROTEOM CLIN APPL, V7, P424, DOI 10.1002/prca.201200094; Streck A., GITHUB D XSTRECK1 HP; Trbojevic-Akmacic I, 2016, EXPERT REV PROTEOMIC, V13, P523, DOI 10.1080/14789450.2016.1174584; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Ventham NT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123028; Vuckovic F, 2016, CLIN CANCER RES, V22, P3078, DOI 10.1158/1078-0432.CCR-15-1867; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; Wedepohl S, 2010, J PROTEOME RES, V9, P3403, DOI 10.1021/pr100170c; Wollowitz A, 2013, ACAD EMERG MED, V20, P1151, DOI 10.1111/acem.12245; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719	47	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200507	10.1371/journal.pone.0200507	http://dx.doi.org/10.1371/journal.pone.0200507			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995966	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800076
J	Irhimeh, MR; Hamed, M; Barthelmes, D; Gladbach, Y; Helms, V; Shen, WY; Gillies, MC				Irhimeh, Mohammad R.; Hamed, Mohamed; Barthelmes, Daniel; Gladbach, Yvonne; Helms, Volkhard; Shen, Weiyong; Gillies, Mark C.			Identification of novel diabetes impaired miRNA-transcription factor co-regulatory networks in bone marrow-derived Lin(-)/VEGF-R2(+) endothelial progenitor cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; EXPRESSION; MICRORNA; GENE; DIFFERENTIATION; BIOINFORMATICS; PROLIFERATION; MOBILIZATION; APOPTOSIS; BIOLOGY	Endothelial progenitor cells (EPCs) are a group of rare cells that play an important role in the repair of injured vascular endothelial cells and assist in reperfusion of ischemic tissue. Decreased production and/or loss of function of EPCs are associated with diabetic vasculopathy. The molecular mechanisms by which diabetes impairs EPCs remain unclear. We conducted microarray experiments followed by integrative regulatory analysis on cells isolated from Akita diabetic mice (18-weeks after onset of diabetes) and age-matched non-diabetic controls. Two types of cells were isolated from mice bone marrow; Lin(+) cells and Lin(-)/VEGF-R2(+) EPCs. RNA was hybridized to mouse WG-6 V2 beadchips followed by comprehensive gene network analysis and computational validation of the obtained results. In total, 80 genes were exclusively DE between non-diabetic Lin(-)/VEGF-R2(+) EPCs and diabetic Lin(-)/VEGF-R2(+) EPCs, of which the 3 genes Clcnka, Pik3c2a, and Ptf1a are known to be associated with diabetic complications. Further analysis led to the establishment of a TF-miRNA mediated regulatory network specific to diabetic LinIVEGF-R2+ EPCs and to identify 11 central-hub TFs (Tbp, Ahr, Trp53, Gata1, Foxo1, Foxo4, Yy1, Max, Pparg, Myc, Cebpa), and 2 miRNAs (mir-139-5p, mir-709) that might act as putative genomic drivers of diabetic pathogenesis in Lin(-)/VEGF-R2(+) EPCs. Moreover, we identified multiple TF-miRNA co-regulatory network motifs for which we validated their contribution to diabetic Lin(-)/VEGF-R2(+) EPCs in terms of statistical significance and relevance to biological evidence. Our findings suggest that diabetic Lin(-)/VEGF-R2(+) EPCs have specifically altered signature genes and miRNAs that render their capacity to proliferate and differentiate.	[Irhimeh, Mohammad R.] Fiona Stanley Fremantle Hosp Grp, Royal Perth Hosp, Med Unit, Cell & Tissue Therapies WA, Perth, WA, Australia; [Irhimeh, Mohammad R.; Barthelmes, Daniel; Shen, Weiyong; Gillies, Mark C.] Univ Sydney, Save Sight Inst, Sydney Hosp & Sydney Eye Hosp, Cent Clin Sch, Sydney, NSW, Australia; [Hamed, Mohamed; Gladbach, Yvonne] Rostock Univ, Med Ctr, Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Hamed, Mohamed; Helms, Volkhard] Saarland Univ, Ctr Bioinformat, Saarbrucken, Germany	Royal Perth Hospital; University of Sydney; University of Rostock; Saarland University	Irhimeh, MR (corresponding author), Fiona Stanley Fremantle Hosp Grp, Royal Perth Hosp, Med Unit, Cell & Tissue Therapies WA, Perth, WA, Australia.; Irhimeh, MR (corresponding author), Univ Sydney, Save Sight Inst, Sydney Hosp & Sydney Eye Hosp, Cent Clin Sch, Sydney, NSW, Australia.	mohammad.irhimeh@health.wa.gov.au		Helms, Volkhard/0000-0002-2180-9154; Gladbach, PhD, Yvonne Saara/0000-0002-7633-4782	NHMRC [632839]; University of Sydney; Swiss National Foundation (SNF/SSMBS); Walter and Gertrud Siegenthaler Foundation (Zurich, Switzerland); DAAD [DFG-SFB-1027]; graduate school of computer science, Saarbrucken, Germany	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Swiss National Foundation (SNF/SSMBS)(Swiss National Science Foundation (SNSF)); Walter and Gertrud Siegenthaler Foundation (Zurich, Switzerland); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); graduate school of computer science, Saarbrucken, Germany	This study was supported by NHMRC, grant ID 632839 and a University of Sydney Bridging Support Grant. DB is supported by the Swiss National Foundation (SNF/SSMBS) and the Walter and Gertrud Siegenthaler Foundation (Zurich, Switzerland). MH was supported by DAAD, DFG-SFB-1027, and by the graduate school of computer science, Saarbrucken, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2000, CELL GROWTH DIFFER, V11, P137; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Altomonte J, 2003, AM J PHYSIOL-ENDOC M, V285, pE718, DOI 10.1152/ajpendo.00156.2003; Awad O, 2005, STEM CELLS, V23, P575, DOI 10.1634/stemcells.2004-0185; Barthelmes D, 2013, BLOOD CELL MOL DIS, V51, P163, DOI 10.1016/j.bcmd.2013.05.002; Barthelmes D, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-42; Barthelmes D, 2013, ANN HEMATOL, V92, P1461, DOI 10.1007/s00277-013-1815-0; Betts DH, 2008, MOL HUM REPROD, V14, P445, DOI 10.1093/molehr/gan035; Bretones G, 2015, BBA-GENE REGUL MECH, V1849, P506, DOI 10.1016/j.bbagrm.2014.03.013; Brunner S, 2009, INVEST OPHTH VIS SCI, V50, P392, DOI 10.1167/iovs.08-1748; Bult C, 2007, J BIOMOLECULAR TECHN, V18, P2; Cappola TP, 2011, P NATL ACAD SCI USA, V108, P2456, DOI 10.1073/pnas.1017494108; Chavali V, 2014, CELL BIOCHEM BIOPHYS, V68, P25, DOI 10.1007/s12013-013-9679-4; Chu G, 2001, SIGNIFICANCE ANAL MI; Cines DB, 1998, BLOOD, V91, P3527; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; De Falco E, 2009, J CELL MOL MED, V13, P3405, DOI 10.1111/j.1582-4934.2009.00655.x; Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V; Deriy LV, 2009, CELL METAB, V10, P316, DOI 10.1016/j.cmet.2009.08.012; Di Stefano V, 2009, CARDIOVASC RES, V82, P421, DOI 10.1093/cvr/cvp082; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Ferraro F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002191; Fujiwara TM, 2005, J AM SOC NEPHROL, V16, P2836, DOI 10.1681/ASN.2005040371; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Granjon A, 2009, DIABETES, V58, P2555, DOI 10.2337/db09-0165; Greene SB, 2010, RNA BIOL, V7, P300, DOI 10.4161/rna.7.3.11837; Hahne F, 2008, USE R, P1, DOI 10.1007/978-0-387-77240-0_1; Hamed M, 2015, NUCLEIC ACIDS RES; Hamed M, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S5-S2; Hamed M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050285; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Kaur S, 2009, BASIC RES CARDIOL, V104, P739, DOI 10.1007/s00395-009-0039-x; Kim KA, 2012, ARCH PHARM RES, V35, P223, DOI 10.1007/s12272-012-0203-y; Kloting N, 2004, MOL GENET METAB, V82, P255, DOI 10.1016/j.ymgme.2004.04.007; Laybutt DR, 2002, DIABETES, V51, P1793, DOI 10.2337/diabetes.51.6.1793; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Liu ZP, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav095; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Lu M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-419; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Nair GG, 2014, STEM CELLS, V32, P1195, DOI 10.1002/stem.1616; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Shan ZX, 2010, FEBS LETT, V584, P3592, DOI 10.1016/j.febslet.2010.07.027; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Swafford ADE, 2011, DIABETES, V60, P1041, DOI 10.2337/db10-0446; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tang Y, 2015, FEBS J, V282, P3758, DOI 10.1111/febs.13372; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tombak A, 2015, INDIAN J HEMATOL BLO, V31, P416, DOI 10.1007/s12288-014-0492-z; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Urbich C, 2002, FASEB J, V16, P706, DOI 10.1096/fj.01-0637fje; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wang ZX, 2014, INVEST OPHTH VIS SCI, V55, P3820, DOI 10.1167/iovs.13-13396; Yoon S, 2014, MOL CELLS, V37, P314, DOI 10.14348/molcells.2014.2360; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yun HJ, 2003, J KOREAN MED SCI, V18, P679, DOI 10.3346/jkms.2003.18.5.679	65	7	7	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200194	10.1371/journal.pone.0200194	http://dx.doi.org/10.1371/journal.pone.0200194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995913	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000438388800046
J	Mukhtar, F; Boffetta, P; Dabo, B; Park, JY; Tran, CTD; Tran, TV; Tran, HT; Whitney, M; Risch, HA; Le, LC; Zheng, W; Shu, XO; Luu, HN				Mukhtar, Fahad; Boffetta, Paolo; Dabo, Bashir; Park, Jong Y.; Tran, Chi T. D.; Tran, Thuan, V; Huong Thi-Thanh Tran; Whitney, Madison; Risch, Harvey A.; Le, Linh C.; Zheng, Wei; Shu, Xiao-Ou; Luu, Hung N.			Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; CANCER CLINICAL-TRIALS; LIKELIHOOD RATIO TESTS; UNITED-STATES; FOLLICULAR LYMPHOMA; SOCIOECONOMIC-STATUS; RACIAL DISPARITIES; ELDERLY-PATIENTS; DECISION-MAKING	Objective To evaluate improvement in survival of lymphoma patients from 1990 to 2014, stratified by age, sex and race using Surveillance Epidemiology and End-Result Survey Program (SEER) data. Study design and setting We identified 113,788 incident lymphoma cases from nine SEER cancer registries were followed up for cause-specific mortality from lymphoma. Cox proportional hazard regression was used to estimate hazard ratios (HRs) and their respective 95% confidence interval (Cis) for various time periods within groups stratified by race, age and sex. Results Five-year survival for Hodgkin's lymphoma (HL) was 89% for patients 20-49 years of age. For this age group, compared to 1990-1994, survival significantly improved in 2000-2004 (HR = 0.65; 95% CI: 0.54-0.78), 2005-2009 (HR = 0.46, 95% CI: 0.38-0.57) and 2010-2014 (HR = 0.29, 95% CI: 0.20-0.41). Hodgkin's lymphoma patients aged 75-85 years had 5-year survival of 37% and in these patients, compared to 1990-1994, survival only improved from 2005 onward (HR = 0.67, 95% CI: 0.50-0.90). In patients with non-Hodgkin's Lymphoma (NHL), all age groups showed survival improvements between 1990-1994 period and 2010-2014 period. Improvements in HL and NHL survival were seen for all race categories and both genders. Conclusion Survival among US lymphoma patients has improved substantially between 1990-1994 period and 2010-2014 period, though disease-specific mortality was still higher in older age groups.	[Mukhtar, Fahad; Dabo, Bashir; Whitney, Madison] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Boffetta, Paolo] Mt Sinai Sch Med, Icahn Sch Med, Tisch Canc Inst, New York, NY USA; [Park, Jong Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Tran, Chi T. D.] Vinmec Healthcare Syst, Vietnam Colorectal Canc & Res Program, Hanoi, Vietnam; [Tran, Thuan, V; Huong Thi-Thanh Tran] Vietnam Natl Canc Hosp, Hanoi, Vietnam; [Tran, Thuan, V; Huong Thi-Thanh Tran] Vietnam Natl Inst Canc Control, Hanoi, Vietnam; [Risch, Harvey A.] Yale Univ, Dept Chron Dis Epidemiol, Yale Sch Publ Hlth, New Haven, CT USA; [Le, Linh C.] Vinmec Healthcare Syst, Vinmec Univ Hlth Sci Project, Hanoi, Vietnam; [Zheng, Wei; Shu, Xiao-Ou; Luu, Hung N.] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Luu, Hung N.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Luu, Hung N.] Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA	State University System of Florida; University of South Florida; Icahn School of Medicine at Mount Sinai; H Lee Moffitt Cancer Center & Research Institute; Yale University; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Luu, HN (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Div Epidemiol,Dept Med,Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA.; Luu, HN (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA.; Luu, HN (corresponding author), Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.	luuh@upmc.edu	mukhtar, fahad/AAG-9981-2020; Le, Linh C/G-5957-2012; Boffetta, Paolo/AAI-7767-2021	mukhtar, fahad/0000-0002-5372-1739; Boffetta, Paolo/0000-0002-3811-2791; Le, Linh/0000-0003-2978-936X	US National Institutes of Health/National Cancer Institute [P20 CA210300-01]; University of Pittsburgh Medical Center-UMPC; NATIONAL CANCER INSTITUTE [P20CA210300] Funding Source: NIH RePORTER	US National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Pittsburgh Medical Center-UMPC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the US National Institutes of Health/National Cancer Institute (P20 CA210300-01 to Xiao-Ou Shu and Thuan V. Tran) and Start-up Fund from the University of Pittsburgh Medical Center-UMPC (to Hung N. Luu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balducci L, 2001, CRIT REV ONCOL HEMAT, V37, P137, DOI 10.1016/S1040-8428(00)00109-8; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Caillet P, 2011, J CLIN ONCOL, V29, P3636, DOI 10.1200/JCO.2010.31.0664; Castel AD, 2015, AIDS CARE, V27, P860, DOI 10.1080/09540121.2015.1011074; Chao C, 2015, J ADOLESC YOUNG ADUL, V4, P76, DOI 10.1089/jayao.2014.0037; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Evens AM, 2012, ANN ONCOL, V23, P2128, DOI 10.1093/annonc/mdr578; Foster JA, 2010, ONCOLOGIST, V15, P584, DOI 10.1634/theoncologist.2009-0198; Glick J, 1995, P ANN M AM SOC CLIN; Grillo-Lopez A. J., 2000, Current Pharmaceutical Biotechnology, V1, P1, DOI 10.2174/1389201003379059; Gross GR, 2008, CANCER-AM CANCER SOC, V112, P900, DOI 10.1002/cncr.23228; Han XS, 2008, CANCER CAUSE CONTROL, V19, P841, DOI 10.1007/s10552-008-9147-4; Hasselblom S, 2007, LEUKEMIA LYMPHOMA, V48, P736, DOI 10.1080/10428190601187703; Kaplan LD, 2012, BEST PRACT RES CL HA, V25, P101, DOI 10.1016/j.beha.2012.01.001; Keegan THM, 2009, J CLIN ONCOL, V27, P3044, DOI 10.1200/JCO.2008.18.8052; Kent EE, 2015, CANCER CAUSE CONTROL, V26, P1153, DOI 10.1007/s10552-015-0609-1; KENT JT, 1982, BIOMETRIKA, V69, P19, DOI 10.2307/2335849; Lee L, 2011, J CLIN ONCOL, V29, P106, DOI 10.1200/JCO.2010.31.3049; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Miller TP, 1998, NEW ENGL J MED, V339, P21, DOI 10.1056/NEJM199807023390104; Mukhtar F, 2017, INT J CANCER, V140, P1494, DOI 10.1002/ijc.30576; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Nabhan C, 2014, AM J HEMATOL, V89, P633, DOI 10.1002/ajh.23708; Najari BB, 2013, J UROLOGY, V189, P1470, DOI 10.1016/j.juro.2012.11.153; *NAT CANC I, 2018, OV SEER PROGR; Owusu C, 2008, J CLIN ONCOL, V26, P549, DOI 10.1200/JCO.2006.10.1022; Riihijarvi S, 2011, EUR J HAEMATOL, V86, P124, DOI 10.1111/j.1600-0609.2010.01541.x; Shavers VL, 2002, JNCI-J NATL CANCER I, V94, P334; Shayne M, 2007, CANCER, V110, P1611, DOI 10.1002/cncr.22939; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Smith GL, 2014, J CLIN ONCOL, V32, P2669, DOI 10.1200/JCO.2014.55.1168; Suneja G, 2014, J CLIN ONCOL, V32, P2344, DOI 10.1200/JCO.2013.54.8644; Swenson WT, 2005, J CLIN ONCOL, V23, P5019, DOI 10.1200/JCO.2005.04.503; 't Mannetje A, 2016, ENVIRON HEALTH PERSP, V124, P396, DOI 10.1289/ehp.1409294; Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175; Tao L, 2014, BLOOD, V123, P3553, DOI 10.1182/blood-2013-07-517110; VOSE JM, 1988, J CLIN ONCOL, V6, P1838, DOI 10.1200/JCO.1988.6.12.1838; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wei W, 2017, HEMATOLOGY, V22, P320, DOI 10.1080/10245332.2016.1264163; Zeng CJ, 2015, JAMA ONCOL, V1, P88, DOI 10.1001/jamaoncol.2014.161	40	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199745	10.1371/journal.pone.0199745	http://dx.doi.org/10.1371/journal.pone.0199745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995909	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800035
J	Georgescu, E; Oancea, A; Georgescu, F; Nicolescu, A; Oprita, EI; Vladulescu, L; Vladulescu, MC; Oancea, F; Shova, S; Deleanu, C				Georgescu, Emilian; Oancea, Anca; Georgescu, Florentina; Nicolescu, Alina; Oprita, Elena Iulia; Vladulescu, Lucian; Vladulescu, Marius-Constantin; Oancea, Florin; Shova, Sergiu; Deleanu, Calin			Schiff bases containing a furoxan moiety as potential nitric oxide donors in plant tissues	PLOS ONE			English	Article							UNSYMMETRICALLY SUBSTITUTED FUROXANS; DISEASE RESISTANCE; N-OXIDES; FLUORESCENT INDICATORS; UNEXPECTED FORMATION; ONE-POT; DERIVATIVES; SIGNAL; ASCORBATE; SPECTRA	Stable Schiff bases containing a furoxan moiety are synthesized as single regioisomers by the reaction of 3-methyl-2-oxy-furazan-4-carbaldehydewith various amino compounds at room temperature. The structures of synthesized compounds were fully characterized by multinuclear NMR spectroscopy and X-ray crystallography. The effect of synthesized Schiff bases containing a furoxan moiety on biological generation of reactive oxygen species and nitric oxide in plant tissues was investigated for the first time by fluorescence microscopy and the released NO identified as nitrite with Griess reagent. There is a good correlation between the biological generation of NO determined by fluorescence microscopy and with Griess reagent. Some of the synthesized compounds exhibited both nitric oxide and reactive oxygen species generation abilities and represent potential NO donors in plant tissues.	[Georgescu, Emilian] Res Ctr Oltchim, Ramnicuvalcea, Romania; [Oancea, Anca; Oprita, Elena Iulia] Natl Inst Res & Dev Biol Sci, Bucharest, Romania; [Georgescu, Florentina; Vladulescu, Lucian; Vladulescu, Marius-Constantin] Teso Spec SRL, Res Dept, Fundulea, Calarasi, Romania; [Nicolescu, Alina; Shova, Sergiu; Deleanu, Calin] Romanian Acad, PetruPoni Inst Macromol Chem, Iasi, Romania; [Nicolescu, Alina; Deleanu, Calin] Romanian Acad, CD Nenitescu Ctr Organ Chem, Bucharest, Romania; [Oancea, Florin] Natl Res & Dev Inst Chem & Petrochem ICECHIM, Bucharest, Romania; [Shova, Sergiu] Acad Sci, Inst Chem, Kishinev, Moldova	Oltchim; National Research Institute for Biological Sciences; Romanian Academy of Sciences; Romanian Academy of Sciences; National Institute Research & Development in Chemistry & Petrochemistry; Academy of Sciences of Moldova	Deleanu, C (corresponding author), Romanian Acad, PetruPoni Inst Macromol Chem, Iasi, Romania.; Deleanu, C (corresponding author), Romanian Acad, CD Nenitescu Ctr Organ Chem, Bucharest, Romania.	calin.deleanu@yahoo.com	Shova, Sergiu/AAS-6207-2021; Deleanu, Calin/G-7446-2011; Georgescu, Emilian/A-9844-2012; Oprita, Elena Iulia/F-7830-2011; Nicolescu, Alina/M-8562-2017; Oancea, Florin/F-4187-2011	Deleanu, Calin/0000-0001-8206-5227; Georgescu, Emilian/0000-0002-1544-5323; Nicolescu, Alina/0000-0001-7022-8893; Oancea, Florin/0000-0002-7723-1814	Romanian Ministry of National Education - National Authority for Scientific Research UEFISCDI [PN-II-PT-PCCA-2013-4-0267 - SAFE-SEL, PN-IIIP1-1.2-PCCDI-2017-0569 - PROSPER]; European Social Fund for Regional Development, Competitiveness Operational Programme Axis 1, Project InoMatPol [P_36_570, 142/10.10.2016, MySMIS: 107464]	Romanian Ministry of National Education - National Authority for Scientific Research UEFISCDI; European Social Fund for Regional Development, Competitiveness Operational Programme Axis 1, Project InoMatPol	This work was funded by the Romanian Ministry of National Education - National Authority for Scientific Research UEFISCDI, www.uefiscdi.ro Award Numbers PN-II-PT-PCCA-2013-4-0267 - SAFE-SEL [AO] and PN-IIIP1-1.2-PCCDI-2017-0569 - PROSPER [FO]. The funder provided support in the form of salaries and research materials [FO AO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; Access to research infrastructure developed in the "PetruPoni" Institute of Macromolecular Chemistry through the European Social Fund for Regional Development, Competitiveness Operational Programme Axis 1, Project InoMatPol (ID P_36_570, Contract 142/10.10.2016, cod MySMIS: 107464) is gratefully acknowledged.	Amir M., 2015, INT RES J PHARM, V6, P585, DOI [10.7897/2230-8407.069115, DOI 10.7897/2230-8407.069115]; Anand P., 2012, INT J DRUG DES DISCO, V3, P851; ANET FAL, 1976, ORG MAGN RESONANCE, V8, P158, DOI 10.1002/mrc.1270080312; [Anonymous], CRYSALIS RED; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Bryan NS, 2007, FREE RADICAL BIO MED, V43, P645, DOI 10.1016/j.freeradbiomed.2007.04.026; Cena C, 2006, ARKIVOC, P301, DOI 10.3998/ark.5550190.0007.722; Civelli M, 1996, BRIT J PHARMACOL, V118, P923, DOI 10.1111/j.1476-5381.1996.tb15487.x; Curini M, 2000, TETRAHEDRON LETT, V41, P8817, DOI 10.1016/S0040-4039(00)01422-2; da Silva CM, 2011, J ADV RES, V2, P1, DOI 10.1016/j.jare.2010.05.004; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Durner J, 1999, CURR OPIN PLANT BIOL, V2, P369, DOI 10.1016/S1369-5266(99)00007-2; FERIOLI R, 1995, BRIT J PHARMACOL, V114, P816, DOI 10.1111/j.1476-5381.1995.tb13277.x; Foresi N, 2016, BIO-PROTOCOL, V6, P1; FRUTTERO R, 1989, J HETEROCYCLIC CHEM, V26, P1345, DOI 10.1002/jhet.5570260523; Gasco A., 1981, ADV HETEROCYCLIC CHE, V29, P251; GASCO AM, 1991, LIEBIGS ANN CHEM, P1211; Georgescu E, 2016, TETRAHEDRON, V72, P2507, DOI 10.1016/j.tet.2016.03.086; Georgescu E, 2015, SYNTHESIS-STUTTGART, V47, P1643, DOI 10.1055/s-0034-1380185; Georgescu E, 2014, BEILSTEIN J ORG CHEM, V10, P2377, DOI 10.3762/bjoc.10.248; Georgescu E, 2012, ACS COMB SCI, V14, P101, DOI 10.1021/co2002125; GHIGO D, 1992, BIOCHEM PHARMACOL, V43, P1281, DOI 10.1016/0006-2952(92)90504-C; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Jesmin M., 2010, THAI J PHARM SCI, V34, P20; Kalaivani S, 2012, INT J APPL BIOL PHAR, V3, P219; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; KLAMANN D, 1965, CHEM BER-RECL, V98, P1831, DOI 10.1002/cber.19650980623; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kolbert Zsuzsanna, 2012, Acta Biologica Szegediensis, V56, P37; Kumar KS, 2010, EUR J MED CHEM, V45, P5474, DOI 10.1016/j.ejmech.2010.07.058; Kumar S, 2009, J SCI IND RES INDIA, V68, P181; Kuzniak E, 2001, PLANT SCI, V160, P723, DOI 10.1016/S0168-9452(00)00457-X; Martelli A, 2006, CURR MED CHEM, V13, P609, DOI 10.2174/092986706776055634; Matsubara R, 2013, SYNTHESIS-STUTTGART, V45, P1524, DOI 10.1055/s-0033-1338436; Mur LAJ, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/pls052; Napoli C, 2003, ANNU REV PHARMACOL, V43, P97, DOI 10.1146/annurev.pharmtox.43.100901.140226; Nicolescu A, 2013, TETRAHEDRON LETT, V54, P1486, DOI 10.1016/j.tetlet.2013.01.036; Oancea A, 2017, BEILSTEIN J ORG CHEM, V13, P659, DOI 10.3762/bjoc.13.65; Oancea F, 2017, MOLECULES, V22, DOI 10.3390/molecules22060961; Pandeya S. N., 1999, Indian Journal of Pharmaceutical Sciences, V61, P358; Paraschivescu CC, 2013, J ORG CHEM, V78, P2670, DOI 10.1021/jo400023z; Patel RN, 2012, HETEROCYCL LETT, V2, P99; Perchepied L, 2010, MOL PLANT MICROBE IN, V23, P846, DOI 10.1094/MPMI-23-7-0846; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Popa MM, 2015, BEILSTEIN J ORG CHEM, V11, P1079, DOI 10.3762/bjoc.11.121; Potmischil F, 2009, MAGN RESON CHEM, V47, P1031, DOI 10.1002/mrc.2507; Potmischil F, 2008, MAGN RESON CHEM, V46, P1141, DOI 10.1002/mrc.2335; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Srivastava N, 2009, PLANTA, V229, P757, DOI 10.1007/s00425-008-0855-5; Sunil D, 2013, ARAB J CHEM, V6, P25, DOI 10.1016/j.arabjc.2010.12.016; WEIGEL D, 2002, ARABIDOPSIS LAB MANU, P143; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; WILEY RH, 1960, J ORG CHEM, V25, P546, DOI 10.1021/jo01074a014; Wilson ID, 2008, PLANT CELL ENVIRON, V31, P622, DOI 10.1111/j.1365-3040.2007.01761.x	59	3	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0198121	10.1371/journal.pone.0198121	http://dx.doi.org/10.1371/journal.pone.0198121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990316	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300002
J	Makareeva, E; Sun, GL; Mirigian, LS; Mertz, EL; Vera, JC; Espinoza, NA; Yang, K; Chen, D; Klein, TE; Byers, PH; Leikin, S				Makareeva, Elena; Sun, Guoli; Mirigian, Lynn S.; Mertz, Edward L.; Vera, Juan C.; Espinoza, Nydea A.; Yang, Kathleen; Chen, Diana; Klein, Teri E.; Byers, Peter H.; Leikin, Sergey			Substitutions for arginine at position 780 in triple helical domain of the alpha 1 (I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta	PLOS ONE			English	Article							EHLERS-DANLOS-SYNDROME; MOUSE MODEL; CYSTEINE SUBSTITUTION; COLLAGEN; MUTATIONS; PHENOTYPE; BONE; MATRIX; LETHAL; MICE	OI is a clinically and genetically heterogeneous disorder characterized by bone fragility. More than 90% of patients are heterozygous for mutations in type I collagen genes, COL1 A1 and COL1 A2, and a common mutation is substitution for an obligatory glycine in the triple helical Gly-X-Y repeats. Few non-glycine substitutions in the triple helical domain have been reported; most result in Y-position substitutions of arginine by cysteine. Here, we investigated leucine and cysteine substitutions for one Y-position arginine, p.Arg958 (Arg780 in the triple helical domain) of proal (I) chains that cause mild OI. We compared their effects with two substitutions for glycine located in close proximity. Like substitutions for glycine, those for arginine reduced the denaturation temperature of the whole molecule and caused asymmetric posttranslational overmodification of the chains. Circular dichroism and increased susceptibility to cleavage by MMP1, MMP2 and catalytic domain of MMP1 revealed significant destabilization of the triple helix near the collagenase cleavage site. On a cellular level, we observed slower triple helix folding and intracellular collagen retention, which disturbed the Endoplasmic Reticulum function and affected matrix deposition. Molecular dynamic modeling suggested that Arg780 substitutions disrupt the triple helix structure and folding by eliminating hydrogen bonds of arginine side chains, in addition to preventing HSP47 binding. The pathogenic effects of these non-glycine substitutions in bone are probably caused mostly by procollagen misfolding and its downstream effects.	[Makareeva, Elena; Mirigian, Lynn S.; Mertz, Edward L.; Vera, Juan C.; Espinoza, Nydea A.; Leikin, Sergey] NICHHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; [Sun, Guoli; Yang, Kathleen; Chen, Diana; Byers, Peter H.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Klein, Teri E.] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Byers, Peter H.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; Stanford University; University of Washington; University of Washington Seattle	Leikin, S (corresponding author), NICHHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739; Klein, Teri/0000-0001-5527-6475	NIH [R01AR051582]; Medical Genetics Training Grant at the University of Washington; Department of Pathology, University of Washington; USPHS [AR051582, GM007454]; Intramural Research Program, National Institute of Child Health and Human Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000256, ZIAHD008810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051582] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Genetics Training Grant at the University of Washington; Department of Pathology, University of Washington(University of Washington); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Intramural Research Program, National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH grant R01AR051582 and by funds from the Medical Genetics Training Grant at the University of Washington and from the Department of Pathology, University of Washington (T.E.K.); USPHS grants AR051582 and GM007454 (P.H.B.); and Intramural Research Program, National Institute of Child Health and Human Development, National Institutes of Health (S.L.).	Arita M, 2015, AM J PATHOL, V185, P214, DOI 10.1016/j.ajpath.2014.09.003; Arnold WV, 2013, INT J BIOCHEM CELL B, V45, P1556, DOI 10.1016/j.biocel.2013.05.017; Barat-Houari M, 2016, HUM MUTAT, V37, P7, DOI 10.1002/humu.22915; Bardai G, 2016, OSTEOPOROSIS INT, V27, P3607, DOI 10.1007/s00198-016-3709-1; Barnes AM, 2012, HUM MUTAT, V33, P1589, DOI 10.1002/humu.22139; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; Bi XH, 2017, J BONE MINER RES, V32, P347, DOI 10.1002/jbmr.2997; Bianchi L, 2015, HUM MOL GENET, V24, P6118, DOI 10.1093/hmg/ddv328; Bianchi L, 2012, J PROTEOMICS, V75, P4717, DOI 10.1016/j.jprot.2012.01.038; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Boudko S.P., 2013, CURR GENET MED REP, V1, P239; Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Cabral WA, 2007, HUM MUTAT, V28, P396, DOI 10.1002/humu.20456; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Dalgleish R, 2014, OSTEOGENESIS IMPERFECTA: A TRANSLATIONAL APPROACH TO BRITTLE BONE DISEASE, P103, DOI 10.1016/B978-0-12-397165-4.00010-1; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FIELDS GB, 1991, J THEOR BIOL, V153, P585, DOI 10.1016/S0022-5193(05)80157-2; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Fuccio A, 2011, J MOL DIAGN, V13, P648, DOI 10.1016/j.jmoldx.2011.06.006; Gaines R, 2015, ANN VASC SURG, V29, DOI 10.1016/j.avsg.2014.10.036; Gensure RC, 2005, J CLIN INVEST, V115, P1250, DOI 10.1172/JCI200522760; Grafel I, 2014, NAT MED, V20, P670, DOI 10.1038/nm.3544; Hintze V, 2008, HUM MUTAT, V29, P841, DOI 10.1002/humu.20736; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Lindahl K, 2015, EUR J HUM GENET, V23, P1042, DOI 10.1038/ejhg.2015.81; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Lund AM, 2008, CLIN GENET, V73, P97, DOI 10.1111/j.1399-0004.2007.00926.x; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; Makareeva E, 2008, J BIOL CHEM, V283, P4787, DOI 10.1074/jbc.M705773200; Makareeva E, 2011, TRENDS CELL BIOL, V21, P168, DOI 10.1016/j.tcb.2010.11.007; Malfait F, 2007, HUM MUTAT, V28, P387, DOI 10.1002/humu.20455; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Marini JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.52; Mendoza-Londono R, 2015, AM J HUM GENET, V96, P979, DOI 10.1016/j.ajhg.2015.04.021; Mertz EL, 2016, MATRIX BIOL, V52-54, P29, DOI 10.1016/j.matbio.2016.03.005; Mirigian LS, 2016, J BONE MINER RES, V31, P1608, DOI 10.1002/jbmr.2824; Mirigian LS, 2014, CONNECT TISSUE RES, V55, P403, DOI 10.3109/03008207.2014.959120; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nuytinck L, 2000, AM J HUM GENET, V66, P1398, DOI 10.1086/302859; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollitt R, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9430; Reich A, 2012, BONE, V50, pS166, DOI 10.1016/j.bone.2012.02.520; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro Jr, 2014, OSTEOGENESIS IMPERFECTA: A TRANSLATIONAL APPROACH TO BRITTLE BONE DISEASE, P1; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SPOTILA LD, 1994, J BONE MINER RES, V9, P923; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; VITAGLIANO L, 1993, BIOCHEMISTRY-US, V32, P7354, DOI 10.1021/bi00080a004; Widmer C, 2012, P NATL ACAD SCI USA, V109, P13243, DOI 10.1073/pnas.1208072109	61	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200264	10.1371/journal.pone.0200264	http://dx.doi.org/10.1371/journal.pone.0200264			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990383	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300033
J	Vicente, CSL; Mondal, SI; Akter, A; Ozawa, S; Kikuchi, T; Hasegawa, K				Vicente, Claudia S. L.; Mondal, Shakhinur Islam; Akter, Arzuba; Ozawa, Sota; Kikuchi, Tasei; Hasegawa, Koichi			Genome analysis of new Blattabacterium spp., obligatory endosymbionts of Periplaneta fuliginosa and P. japonica	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; CRYPTOCERCUS-PUNCTULATUS; COCKROACH; EVOLUTION; DIVERSITY; SYMBIONT; SEQUENCE; DATABASE	The successful adaptation of cockroaches is, in part, dependent of the activity of their obligatory endosymbionts, Blattabacterium spp., which are involved in uric acid degradation, nitrogen assimilation and nutrient provisioning. Their strategic localization, within bacteriocytes in the proximities of uric acid storage cells (urocytes), highlights their importance in the recycling of nitrogen from urea and ammonia, end-products not secreted by their host insects. In this study, we present the complete genome sequence of two new Blattabacterium spp. from Periplaneta fuliginosa (BPfu) and P. japonica (BPja), and detailed comparison with other Blattabacterium strains from different cockroach species. The genomes of BPfu and BPja show a high degree of stability as showed with for other Blattabacterium representatives, only presenting a 19-kb fragment inversion between BPja and BPfu. In fact, the phylogenomics showed BPja as an ancestor species of BPfu, BPLAN (P. americana) and BBor (Blatta orientalis), in congruence with their host cockroach phylogeny. Their functional profile is similar and closest to the omnivorous strain BBge (Blattella germanica). Interesting, BPja possesses the complete set of enzymes involved sulfate assimilatory pathway only found in BBge and BMda (Mastotermes darwiniensis). The newly sequenced genomes of BPja and BPfu emphasise the remarkable stability of Blattabacterium genomes supported by their long-term coevolution and obligatory lifestyle in their host insect.	[Vicente, Claudia S. L.] Univ Evora, Nucleo Mitra, Dept Biol, NemaLab,ICAAM, Evora, Portugal; [Vicente, Claudia S. L.; Ozawa, Sota; Hasegawa, Koichi] Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi, Japan; [Mondal, Shakhinur Islam; Akter, Arzuba; Kikuchi, Tasei] Univ Miyazaki, Fac Med, Div Parasitol, Miyazaki, Japan; [Mondal, Shakhinur Islam] Shahjalal Univ Sci & Technol, Genet Engn & Biotechnol Dept, Kumargaon, Sylhet, Bangladesh; [Akter, Arzuba] Shahjalal Univ Sci & Technol, Biochem & Mol Biol Dept, Kumargaon, Sylhet, Bangladesh	University of Evora; Chubu University; University of Miyazaki; Shahjalal University of Science & Technology (SUST); Shahjalal University of Science & Technology (SUST)	Hasegawa, K (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Dept Environm Biol, Kasugai, Aichi, Japan.	koichihasegawa@isc.chubu.ac.jp	Mondal, Shakhinur Islam/AAT-6529-2021; Vicente, Claudia/C-6226-2019; Hasegawa, Koichi/AEW-0200-2022; Vicente, Cláudia SL/X-5058-2019	Vicente, Claudia/0000-0002-3865-5358; Hasegawa, Koichi/0000-0002-9968-8129; Vicente, Cláudia SL/0000-0002-3865-5358	Institute of the Biological Function, Chubu University; JSPS (Japanese Society for the Promotion of Science) KAKENHI [15J09961]	Institute of the Biological Function, Chubu University; JSPS (Japanese Society for the Promotion of Science) KAKENHI	This work was supported by the research fund from Institute of the Biological Function, Chubu University (to KH), and JSPS (Japanese Society for the Promotion of Science) KAKENHI Grant 15J09961 (to SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the research fund from Institute of the Biological Function, Chubu University (to KH), and JSPS (Japanese Society for the Promotion of Science) KAKENHI Grant 15J09961 (to SO).	Appel AG, 2002, ANNU REV ENTOMOL, V47, P33, DOI 10.1146/annurev.ento.47.091201.145106; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; BANDI C, 1995, P ROY SOC B-BIOL SCI, V259, P293, DOI 10.1098/rspb.1995.0043; Bell W. J., 2007, COCKROACHES ECOLOGY; Brooks MA, 1994, BIOL BULL, V109, P22; Caspi R, 2016, NUCLEIC ACIDS RES, V44, pD471, DOI 10.1093/nar/gkv1164; Chaumot A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-199; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Elias-Neto M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160347; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Gonzalez-Domenech C, 2012, BMC MICROBIOL, V12, P55, DOI [10.1186/1471-2180-12-55, DOI 10.1186/1471-2180-12-55]; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; Huang CY, 2012, J BACTERIOL, V194, P4450, DOI 10.1128/JB.00789-12; Husnik F, 2013, CELL, V153, P1567, DOI 10.1016/j.cell.2013.05.040; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Kambhampati S, 2013, GENOMICS, V102, P479, DOI 10.1016/j.ygeno.2013.09.003; Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Lo N, 2003, MOL BIOL EVOL, V20, P907, DOI 10.1093/molbev/msg097; Lopez-Sanchez MJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000721; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; Mullins DE, 2015, ANNU REV ENTOMOL, V60, P473, DOI 10.1146/annurev-ento-011613-162036; Neef A, 2011, GENOME BIOL EVOL, V3, P1437, DOI 10.1093/gbe/evr118; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Patino-Navarrete R, 2013, GENOME BIOL EVOL, V5, P351, DOI 10.1093/gbe/evt011; Ponce-de-Leon M, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-114; Sabree ZL, 2012, APPL ENVIRON MICROB, V78, P204, DOI 10.1128/AEM.06540-11; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sacchi L, 1998, SYMBIOSIS, V25, P251; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Sloan DB, 2013, GENOME BIOL EVOL, V5, P783, DOI 10.1093/gbe/evt044; Tanaka K, 1997, ZOOL SCI, V14, P849, DOI 10.2108/zsj.14.849; Tokuda G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1153; Vicente CSL, 2016, MICROBES ENVIRON, V31, P314, DOI 10.1264/jsme2.ME16088; Wernegreen JJ, 2015, ANN NY ACAD SCI, V1360, P16, DOI 10.1111/nyas.12740; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	43	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200512	10.1371/journal.pone.0200512	http://dx.doi.org/10.1371/journal.pone.0200512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990378	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300059
J	Chauhan, BS; Manalil, S; Florentine, S; Jha, P				Chauhan, Bhagirath Singh; Manalil, Sudheesh; Florentine, Singarayer; Jha, Prashant			Germination ecology of Chloris truncata and its implication for weed management	PLOS ONE			English	Article							SEED-GERMINATION; AUSTRALIA; EMERGENCE; DORMANCY; TILLAGE; BIOLOGY; COTTON; BELT	Chloris truncata is a significant weed in summer crops in the subtropical region of Australia. A study was conducted to evaluate the effect of environmental factors on germination and emergence of two populations of C. truncata. Overall, germination was not affected by the populations. Seeds germinated at a wide range of alternating day/night temperatures, suggesting that seeds can germinate throughout the spring, winter and autumn seasons. Seed germination was stimulated by the presence of light; however, 51 to 71% of these seeds still germinated in the dark. The sodium chloride concentration and osmotic potential required to inhibit germination of 50% of the population were 179 mM and -0.52 MPa, respectively. A high proportion of seeds germinated over a wide pH range (4 to 10). Seeds placed on the soil surface had greatest germination (67%) and a burial depth of 3 cm resulted in complete inhibition of emergence. The sorghum residue amount required to reduce emergence by 50% was 1.8 t ha(-1). The results suggest that, although this weed will be favored in no-till systems, residue retention on the soil surface will help in reducing its infestation. Seed bank buildup can be managed by burying seeds below the depth of emergence.	[Chauhan, Bhagirath Singh; Manalil, Sudheesh] Univ Queensland, QAAFI, Ctr Crop Sci, Gatton, Qld, Australia; [Florentine, Singarayer] Univ Western Australia, Sch Agr & Environm, Inst Agr, Perth, WA, Australia; [Jha, Prashant] Amrita Univ, Coimbatore, Tamil Nadu, India; [Manalil, Sudheesh] Federat Univ Australia, Fac Sci & Technol, Ctr Environm Management, Mt Helen, Vic, Australia; [Manalil, Sudheesh] Montana State Univ, Southern Agr Res Ctr, Huntley, MT USA	University of Queensland; University of Western Australia; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Coimbatore; Federation University Australia; Montana State University System; Montana State University Bozeman	Chauhan, BS (corresponding author), Univ Queensland, QAAFI, Ctr Crop Sci, Gatton, Qld, Australia.	b.chauhan@uq.edu.au	Florentine, Singarayer/Q-7198-2019; Florentine, Singarayer/ABA-7740-2020; Manalil, Sudheesh/GQR-0450-2022; Chauhan, Bhagirath/G-8892-2014	Florentine, Singarayer/0000-0002-5734-3421; Chauhan, Bhagirath/0000-0003-1540-4668	Grains Research and Development Corporation (GRDC) [UA000156]	Grains Research and Development Corporation (GRDC)(Grains R&D Corp)	BSC and SM received funding from the Grains Research and Development Corporation (GRDC) for investing in this research under project UA000156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 1998, SEED SCI RES, V8, P29, DOI 10.1017/S0960258500003883; Baskin CC, 2006, SEED SCI RES, V16, P165, DOI 10.1079/SSR2006247; Borger CPD, 2011, CROP PASTURE SCI, V62, P678, DOI 10.1071/CP11018; Chachalis D, 2000, WEED SCI, V48, P212, DOI 10.1614/0043-1745(2000)048[0212:FACRSG]2.0.CO;2; Chauhan BS, 2006, AUST J EXP AGR, V46, P1557, DOI 10.1071/EA05291; Chauhan BS, 2010, ADV AGRON, V105, P221, DOI 10.1016/S0065-2113(10)05006-6; Chauhan BS, 2009, WEED SCI, V57, P235, DOI 10.1614/WS-08-141.1; Chauhan BS, 2008, WEED SCI, V56, P820, DOI 10.1614/WS-08-070.1; Chauhan BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep26006; DYER WE, 1995, WEED SCI, V43, P498, DOI 10.1017/S0043174500081534; Fernando N, 2016, WEED SCI, V64, P605, DOI 10.1614/WS-D-15-00212.1; Ghorbani R, 1999, WEED SCI, V47, P505, DOI 10.1017/S0043174500092183; Heap I, INT SURVEY HERBICIDE; Llewellyn R.S., 2016, IMPACT WEEDS AUSTR G, P112; Manalil S, 2017, CROP PASTURE SCI, V68, P773, DOI 10.1071/CP17116; McLean A. R., 2012, P 18 AUSTR WEEDS C; Michael PJ, 2010, WEED TECHNOL, V24, P562, DOI 10.1614/WT-D-09-00060.1; MICHEL BE, 1983, PLANT PHYSIOL, V72, P66, DOI 10.1104/pp.72.1.66; Mitchell M., 1994, NATIVE GRASSES IDENT, P41; Ngo TD, 2017, WEED SCI, V65, P395, DOI 10.1017/wsc.2017.5; Osten V., 2006, 15 AUSTR WEEDS C MAN; TEASDALE JR, 1991, WEED SCI, V39, P195, DOI 10.1017/S0043174500071460; Teasdale JR, 1996, J PROD AGRIC, V9, P475, DOI 10.2134/jpa1996.0475; Trewin D., 2002, SALINITY AUSTR FARMS; Werth J, 2013, CROP PASTURE SCI, V64, P791, DOI 10.1071/CP13167; Weston LA, 2013, J CHEM ECOL, V39, P142, DOI 10.1007/s10886-013-0245-8	26	17	17	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0199949	10.1371/journal.pone.0199949	http://dx.doi.org/10.1371/journal.pone.0199949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985944	gold, Green Submitted, Green Published			2022-12-26	WOS:000438035500015
J	Eamudomkarn, C; Sithithaworn, P; Kamamia, C; Yakovleva, A; Sithithaworn, J; Kaewkes, S; Techasen, A; Loilome, W; Yongvanit, P; Wangboon, C; Saichua, P; Itoh, M; Bethony, JM				Eamudomkarn, Chatanun; Sithithaworn, Paiboon; Kamamia, Christine; Yakovleva, Anna; Sithithaworn, Jiraporn; Kaewkes, Sasithorn; Techasen, Anchalee; Loilome, Watcharin; Yongvanit, Puangrat; Wangboon, Chompunoot; Saichua, Prasert; Itoh, Makoto; Bethony, Jeffrey M.			Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; VISCERAL LEISHMANIASIS; CYSTIC ECHINOCOCCOSIS; STERCORALIS INFECTION; MOLECULAR DIAGNOSIS; NORTHEAST THAILAND; AGGLUTINATION-TEST; SAMPLES; SALIVA; COMMUNITY	The diagnosis of strongyloidiasis by coprological methods has a low sensitivity, underestimating the prevalence of Strongyloides stercoralis in endemic areas. Serodiagnostic tests for strongyloidiasis have shown robust diagnostic properties. However, these methods require a blood draw, an invasive and labor-intensive sample collection method, especially in the resource-limited settings where S. stercoralis is endemic. Our study examines a urine-based assay for strongyloidiasis and compares its diagnostic accuracy with coprological and serological methods. Receiver operating characteristic (ROC) curve analyses determined the diagnostic sensitivity (D-Sn) and specificity (D-Sp) of the urine ELISA, as well as estimates its positive predictive value and diagnostic risk. The likelihood ratios of obtaining a positive test result (LR+) or a negative test result (LR-) were calculated for each diagnostic positivity threshold. The urine ELISA assay correlated significantly with the serological ELISA assay for strongyloidiasis, with a D-Sn of 92.7% and a D-Sp of 40.7%, when compared to coprological methods. Moreover, the urine ELISA IgG test had a detection rate of 69%, which far exceeds the coprological method (28%). The likelihood of a positive diagnosis of strongyloidiasis by the urine ELISA IgG test increased significantly with increasing units of IgG detected in urine. The urine ELISA IgG assay for strongyloidiasis assay has a diagnostic accuracy comparable to serological assay, both of which are more sensitive than coprological methods. Since the collection of urine is easy and non-invasive, the urine ELISA IgG assay for strongyloidiasis could be used to screen populations at risk for strongyloidiasis in S. stercoralis endemic areas.	[Eamudomkarn, Chatanun; Sithithaworn, Paiboon; Kaewkes, Sasithorn] Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand; [Eamudomkarn, Chatanun; Sithithaworn, Paiboon; Techasen, Anchalee; Loilome, Watcharin; Yongvanit, Puangrat] Khon Kaen Univ, Cholangiocarcinoma Res Inst CARI, Khon Kaen, Thailand; [Kamamia, Christine; Yakovleva, Anna; Bethony, Jeffrey M.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA; [Sithithaworn, Jiraporn; Techasen, Anchalee] Khon Kaen Univ, Fac Associated Med Sci, Khon Kaen, Thailand; [Sithithaworn, Jiraporn] Mahasarakham Univ, Fac Med, Maha Sarakham, Thailand; [Loilome, Watcharin; Yongvanit, Puangrat] Khon Kaen Univ, Fac Med, Dept Biochem, Khon Kaen, Thailand; [Wangboon, Chompunoot] Khon Kaen Univ, Grad Sch, Biomed Sci Program, Khon Kaen, Thailand; [Saichua, Prasert] Khon Kaen Univ, Fac Med, Trop Med Program, Khon Kaen, Thailand; [Itoh, Makoto] Aichi Med Univ, Sch Med, Dept Infect & Immunol, Nagakute, Aichi, Japan	Khon Kaen University; Khon Kaen University; George Washington University; Khon Kaen University; Mahasarakham University; Khon Kaen University; Khon Kaen University; Khon Kaen University; Aichi Medical University	Sithithaworn, P (corresponding author), Khon Kaen Univ, Fac Med, Dept Parasitol, Khon Kaen, Thailand.; Sithithaworn, P (corresponding author), Khon Kaen Univ, Cholangiocarcinoma Res Inst CARI, Khon Kaen, Thailand.	paibsit@gmail.com	Sithithaworn, Paiboon/E-4378-2019; Loilome, Watcharin/AAW-6203-2021; Eamudomkarn, Chatanun/HGA-5230-2022	Sithithaworn, Paiboon/0000-0002-9480-1778; 	Office of the Higher Education Commission (CHE program); Higher Education Research Promotion and Office of the Higher Education Commission, through health cluster (SHeP-GMS); Faculty of Medicine, Khon Kaen University, Thailand [I 57116]	Office of the Higher Education Commission (CHE program); Higher Education Research Promotion and Office of the Higher Education Commission, through health cluster (SHeP-GMS); Faculty of Medicine, Khon Kaen University, Thailand	This work was supported by the Office of the Higher Education Commission (CHE program) for the Ph.D. program (CE), the Higher Education Research Promotion and Office of the Higher Education Commission, through health cluster (SHeP-GMS) (PS) and Invitation Research fund (I 57116) (CE) from the Faculty of Medicine, Khon Kaen University, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe E, 2002, APMIS, V110, P535, DOI 10.1034/j.1600-0463.2002.11007804.x; Ahmad AF, 2013, PARASITOL RES, V112, P2811, DOI 10.1007/s00436-013-3450-z; Anderson NW, 2014, CLIN VACCINE IMMUNOL, V21, P732, DOI 10.1128/CVI.00041-14; Bisoffi Z, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002640; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chirag S, 2015, J HELMINTHOL, V89, P232, DOI 10.1017/S0022149X13000837; CONNELL JA, 1993, J MED VIROL, V41, P159, DOI 10.1002/jmv.1890410212; DOUCE RW, 1987, INT J PARASITOL, V17, P1343, DOI 10.1016/0020-7519(87)90101-9; Eamudomkarn C, 2015, PARASITOL RES; ELKINS DB, 1990, T ROY SOC TROP MED H, V84, P715, DOI 10.1016/0035-9203(90)90159-C; ELVING LD, 1989, CLIN CHEM, V35, P308; Ghosh P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1667-2; Gotlib J, 2014, AM J HEMATOL, V89, P325, DOI 10.1002/ajh.23664; GRANT GH, 1957, J CLIN PATHOL, V10, P360, DOI 10.1136/jcp.10.4.360; Greaves D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4610; HANSON LA, 1965, J CLIN INVEST, V44, P703, DOI 10.1172/JCI105183; Islam MZ, 2004, AM J TROP MED HYG, V70, P78, DOI 10.4269/ajtmh.2004.70.78; Itoh M, 2001, AM J TROP MED HYG, V65, P362, DOI 10.4269/ajtmh.2001.65.362; Itoh Makoto, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P469; Janwan P, 2011, PARASITOL RES, V109, P1593, DOI 10.1007/s00436-011-2419-z; Jongsuksuntigul P, 2003, ACTA TROP, V88, P229, DOI 10.1016/j.actatropica.2003.01.002; Joshi MS, 2002, CLIN DIAGN LAB IMMUN, V9, P840, DOI 10.1128/CDLI.9.4.840-845.2002; Khieu V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002035; Kimura E, 1999, PARASITOLOGY, V119, P221, DOI 10.1017/S0031182099004631; Klasen IS, 1999, CLIN CHEM, V45, P430; KOGA K, 1991, AM J TROP MED HYG, V45, P518, DOI 10.4269/ajtmh.1991.45.518; Krolewiecki AJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002165; Krolewiecki AJ, 2010, CLIN VACCINE IMMUNOL, V17, P1624, DOI 10.1128/CVI.00259-10; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levenhagen MA, 2014, ACTA TROP, V135, P33, DOI 10.1016/j.actatropica.2014.03.015; Lodh N, 2016, ACTA TROP, V163, P9, DOI 10.1016/j.actatropica.2016.07.014; Luvira V, 2016, AM J TROP MED HYG, V95, P401, DOI 10.4269/ajtmh.16-0068; NEEDHAM CS, 1992, PARASITOLOGY, V105, P273, DOI 10.1017/S0031182000074205; NEVA FA, 1981, J INFECT DIS, V144, P427, DOI 10.1093/infdis/144.5.427; Olsen A, 2009, T ROY SOC TROP MED H, V103, P967, DOI 10.1016/j.trstmh.2009.02.013; Paula FM, 2011, PARASITOLOGY, V138, P1331, DOI 10.1017/S003118201100120X; Requena-Mendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002002; Saichua P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002228; SATO Y, 1990, INT J PARASITOL, V20, P1025, DOI 10.1016/0020-7519(90)90045-O; Sato Yoshiya, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P35, DOI 10.1590/S0036-46651995000100006; Sawangsoda P, 2012, PARASITOL INT, V61, P196, DOI 10.1016/j.parint.2011.06.009; Sayasone S, 2009, T ROY SOC TROP MED H, V103, P247, DOI 10.1016/j.trstmh.2008.10.011; Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288; Siddiqui AA, 2001, CLIN INFECT DIS, V33, P1040, DOI 10.1086/322707; Sithithaworn J, 2005, J CLIN MICROBIOL, V43, P3278, DOI 10.1128/JCM.43.7.3278-3282.2005; Sithithaworn P, 2003, T ROY SOC TROP MED H, V97, P398, DOI 10.1016/S0035-9203(03)90069-1; Steinmann P, 2008, AM J TROP MED HYG, V78, P760, DOI 10.4269/ajtmh.2008.78.760; Sunita T, 2007, ACTA TROP, V101, P187, DOI 10.1016/j.actatropica.2006.07.014; Terada K, 2000, PEDIATR INFECT DIS J, V19, P104, DOI 10.1097/00006454-200002000-00003; Nguyen T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1780-2; van Velthuysen MLF, 2000, CLIN MICROBIOL REV, V13, P55, DOI 10.1128/CMR.13.1.55-66.2000; Vazquez S, 2007, INT J INFECT DIS, V11, P256, DOI 10.1016/j.ijid.2006.05.005; Verweij JJ, 2009, T ROY SOC TROP MED H, V103, P342, DOI 10.1016/j.trstmh.2008.12.001; Wong TYH, 1998, NEPHRON, V79, P333, DOI 10.1159/000045058	54	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0192598	10.1371/journal.pone.0192598	http://dx.doi.org/10.1371/journal.pone.0192598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985913	gold, Green Published, Green Submitted			2022-12-26	WOS:000438035500001
J	Lee, SH; Lee, JY; Hong, TH; Kim, BO; Lee, YJ; Lee, JG				Lee, Seung Hwan; Lee, Jin Young; Hong, Tae Hwa; Kim, Bo Ok; Lee, Yeon Ju; Lee, Jae Gil			Severe persistent hypocholesterolemia after emergency gastrointestinal surgery predicts in-hospital mortality in critically ill patients with diffuse peritonitis	PLOS ONE			English	Article							MULTIPLE-ORGAN FAILURE; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN; CHOLESTEROL; PROGNOSIS; SEPSIS; INJURY; SERUM; PROCALCITONIN; INFECTION	Background Plasma cholesterol acts as a negative acute phase reactant. Total cholesterol decreases after surgery and in various pathological conditions, including trauma, sepsis, burns, and liver dysfunction. This study aimed to determine whether hypocholesterolemia after emergency gastrointestinal (GI) surgery is associated with in-hospital mortality in patients with diffuse peritonitis. Methods The medical records of 926 critically ill patients who had undergone emergency GI surgery for diffuse peritonitis, between January 2007 and December 2015, were retrospectively analyzed. The integrated areas under the curve (iAUCs) were calculated to compare the predictive accuracy of total cholesterol values from postoperative days (PODs) 0, 1, 3, and 7. Cox proportional hazard regression modeling was performed for all possible predictors identified in the univariate and multivariable analyses. Results The total cholesterol level measured on POD 7 had the highest iAUC (0.7292; 95% confidence interval, 0.6696-0.7891) and was significantly better at predicting in-hospital mortality than measurements on other days. The optimal total cholesterol cut-off value for predicting in-hospital mortality was 61 mg/dL and was determined on POD 7. A Cox proportional hazard regression analysis revealed that a POD 7 total cholesterol level <61 mg/dL was an independent predictor of in-hospital mortality after emergency GI surgery (hazard ratio, 3.961; 95% confidence interval, 1.786-8.784). Conclusion Severe persistent hypocholesterolemia (<61 mg/dL) on POD 7 independently predicted in-hospital mortality, after emergency GI surgery, in critically ill patients with diffuse peritonitis.	[Lee, Seung Hwan; Lee, Jae Gil] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Seung Hwan; Lee, Yeon Ju; Lee, Jae Gil] Yonsei Univ Hlth Syst, Severance Hosp, Trauma Training Ctr, Seoul, South Korea; [Lee, Jin Young] Chungbuk Natl Univ Hosp, Dept Trauma Surg, Ctr Trauma, Cheongju, South Korea; [Hong, Tae Hwa] Hallym Univ, Dept Surg, Sacred Heart Hosp, Coll Med, Anyang, South Korea; [Kim, Bo Ok] Yonsei Univ, Dept Res Affairs, Biostat Collaborat Unit, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Chungbuk National University; Chungbuk National University Hospital; Hallym University; Yonsei University; Yonsei University Health System	Lee, JG (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea.; Lee, JG (corresponding author), Yonsei Univ Hlth Syst, Severance Hosp, Trauma Training Ctr, Seoul, South Korea.	jakii@yuhs.ac	Lee, Seung Hwan/AAE-4710-2022; Lee, Jae Gil/O-1464-2017	Lee, Seung Hwan/0000-0001-7325-8262; Lee, Jae Gil/0000-0002-1148-8035				ALVAREZ C, 1986, CLIN CHEM, V32, P142; ARONSEN KF, 1969, ANN SURG, V169, P102, DOI 10.1097/00000658-196901000-00010; Biller K, 2014, SHOCK, V42, P129, DOI 10.1097/SHK.0000000000000187; Bracho-Riquelme RL, 2008, EUR SURG RES, V41, P238, DOI 10.1159/000136480; BUDD D, 1986, CANCER, V58, P1361, DOI 10.1002/1097-0142(19860915)58:6<1361::AID-CNCR2820580630>3.0.CO;2-S; Chiarla C, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.08.006; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; COOMBES EJ, 1980, J TRAUMA, V20, P971, DOI 10.1097/00005373-198011000-00012; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Dunham CM, 2003, CRIT CARE, V7, pR145, DOI 10.1186/cc2382; Evans H L, 2001, Surg Infect (Larchmt), V2, P255, DOI 10.1089/10962960152813296; Fraunberger P, 1999, CLIN CHEM LAB MED, V37, P357, DOI 10.1515/CCLM.1999.059; Giovannini I, 1999, INTENS CARE MED, V25, P748, DOI 10.1007/s001340050940; Giovannini I, 2003, CLIN CHEM, V49, P317, DOI 10.1373/49.2.317; GIOVANNINI I, 1983, JPEN-PARENTER ENTER, V7, P226, DOI 10.1177/0148607183007003226; Giovannini I, 2007, CLIN CHEM LAB MED, V45, P1207, DOI 10.1515/CCLM.2007.247; Gordon BR, 2001, CRIT CARE MED, V29, P1563, DOI 10.1097/00003246-200108000-00011; Guimaraes SM, 2008, CRIT CARE MED, V36, P3165, DOI 10.1097/CCM.0b013e318186ab70; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Horiuchi A, 2007, WORLD J GASTROENTERO, V13, P3228, DOI 10.3748/wjg.v13.i23.3228; Kitchens RL, 2003, J LIPID RES, V44, P2339, DOI 10.1194/jlr.M300228-JLR200; Koperna T, 1996, ARCH SURG-CHICAGO, V131, P180; LINDER MM, 1987, CHIRURG, V58, P84; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; MCLAUCHLAN GJ, 1995, BRIT J SURG, V82, P524, DOI 10.1002/bjs.1800820429; Montravers P, 1996, CLIN INFECT DIS, V23, P486, DOI 10.1093/clinids/23.3.486; Mulari K, 2004, Scand J Surg, V93, P204; Nydam TL, 2011, J TRAUMA, V70, P401, DOI 10.1097/TA.0b013e31820b5c85; Pacelli F, 1996, ARCH SURG-CHICAGO, V131, P641; Palma S, 2007, BRIT J SURG, V94, P369, DOI 10.1002/bjs.5626; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Riche FC, 2000, CRIT CARE MED, V28, P433, DOI 10.1097/00003246-200002000-00024; Sartelli M, 2013, WORLD J EMERG SURG, V8, DOI 10.1186/1749-7922-8-1; Sartelli M, 2010, WORLD J EMERG SURG, V5, DOI 10.1186/1749-7922-5-9; Suarez-de-la-Rica A, 2015, SURG INFECT, V16, P346, DOI 10.1089/sur.2014.178; Sun XL, 1998, J CLIN ANESTH, V10, P302, DOI 10.1016/S0952-8180(98)00032-4; THANNHAUSER S. J., 1926, KLIN WOCHENSCHR, V5, P252, DOI 10.1007/BF01736611; van Leeuwen HJ, 2001, NETH J MED, V59, P102, DOI 10.1016/S0300-2977(01)00144-9; Vyroubal P, 2008, BIOMED PAP, V152, P181, DOI 10.5507/bp.2008.029; Wilson RF, 2003, CRIT CARE, V7, P413, DOI 10.1186/cc2390; Yamano S, 2016, J CRIT CARE, V31, P36, DOI 10.1016/j.jcrc.2015.09.033; [No title captured]	43	10	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200187	10.1371/journal.pone.0200187	http://dx.doi.org/10.1371/journal.pone.0200187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979773	Green Published, gold			2022-12-26	WOS:000437809500074
J	Barnett, JT; Kad, NM				Barnett, Jamie T.; Kad, Neil M.			Understanding the coupling between DNA damage detection and UvrA's ATPase using bulk and single molecule kinetics	FASEB JOURNAL			English	Article						cooperativity; fluorescence imaging; DNA repair; DNA tightropes	ESCHERICHIA-COLI-UVRA; NUCLEOTIDE EXCISION-REPAIR; PROTEIN; BINDING; DOMAINS; DIMERIZATION; COMPLEXES; NUCLEASE; ROLES	Nucleotide excision repair (NER) protects cells against diverse types of DNA damage, principally UV irradiation. In Escherichia coli, damage is recognized by 2 key enzymes: UvrA and UvrB. Despite extensive investigation, the role of UvrA's 2 ATPase domains in NER remains elusive. Combining single-molecule fluorescence microscopy and classic biochemical methods, we have investigated the role of nucleotide binding in UvrA's kinetic cycle. Measurement of UvrA's steady-state ATPase activity shows it is stimulated upon binding DNA (k(cat) 0.71-1.07/s). Despite UvrA's ability to discriminate damage, we find UV-damaged DNA does not alter the steady-state ATPase. To understand how damage affects UvrA, we studied its binding to DNA under various nucleotide conditions at the single molecule level. We have found that both UV damage and nucleotide cofactors affect the attached lifetime of UvrA. In the presence of ATP and UV damage, the lifetime is significantly greater compared with undamaged DNA. To reconcile these observations, we suggest that UvrA uses negative cooperativity between its ATPase sites that is gated by damage recognition. Only in the presence of damage is the second site activated, most likely in a sequential manner.Barnett, J. T., Kad, N. M. Understanding the coupling between DNA damage detection and UvrA's ATPase using bulk and single molecule kinetics.	[Barnett, Jamie T.; Kad, Neil M.] Univ Kent, Sch Biol Sci, Canterbury CT2 7NH, Kent, England	University of Kent	Kad, NM (corresponding author), Univ Kent, Sch Biol Sci, Canterbury CT2 7NH, Kent, England.	n.kad@kent.ac.uk		Kad, Neil/0000-0002-3491-8595; Barnett, Jamie/0000-0003-0731-7249	Biotechnology and Biological Sciences Research Council [BB/P00847X/1, BB/M019144/1, BB/I003460/1, BB/M01603X/1]; Biotechnology and Biological Sciences Research Council [1666540] Funding Source: researchfish; BBSRC [1666540, BB/I003460/1, BB/P00847X/1, BB/M019144/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the Kad group for discussion; Bennett Van Houten (University of Pittsburgh, Pittsburgh, PA, USA), Chris Mulligan, Alex Moores, and Michael Geeves (all of the University of Kent) for reading the manuscript; the National Institute of Genetics, Japan for access to their excellent collection of materials; and Alex Moores for constructing the empty mScarlet vector used in this study. This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/P00847X/1, BB/M019144/1, and BB/I003460/1 (to N.M.K.) and BB/M01603X/1 (to J.T.B.). The authors declare no conflicts of interest.	Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Croteau DL, 2006, J BIOL CHEM, V281, P26370, DOI 10.1074/jbc.M603093200; DellaVecchia MJ, 2004, J BIOL CHEM, V279, P45245, DOI 10.1074/jbc.M408659200; HUSAIN I, 1986, J BIOL CHEM, V261, P4895; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Jaciuk M, 2011, NAT STRUCT MOL BIOL, V18, P191, DOI 10.1038/nsmb.1973; Kad NM, 2008, J BIOL CHEM, V283, P17477, DOI 10.1074/jbc.M800539200; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kraithong T, 2017, DNA REPAIR, V51, P60, DOI 10.1016/j.dnarep.2017.02.003; Lamers MH, 2003, EMBO J, V22, P746, DOI 10.1093/emboj/cdg064; Malta E, 2007, BIOCHEMISTRY-US, V46, P9080, DOI 10.1021/bi7002235; MAZUR SJ, 1991, BIOCHEMISTRY-US, V30, P4432, DOI 10.1021/bi00232a009; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3824, DOI 10.1021/bi00230a004; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3834, DOI 10.1021/bi00230a005; OH EY, 1989, NUCLEIC ACIDS RES, V17, P4145, DOI 10.1093/nar/17.11.4145; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Pakotiprapha D, 2008, MOL CELL, V29, P122, DOI 10.1016/j.molcel.2007.10.026; SANCAR A, 1983, CELL, V33, P249, DOI 10.1016/0092-8674(83)90354-9; SEEBERG E, 1982, P NATL ACAD SCI-BIOL, V79, P988, DOI 10.1073/pnas.79.4.988; Springall L, 2018, NUCLEIC ACIDS RES, V46, P1256, DOI 10.1093/nar/gkx1244; Springall L, 2016, METHODS MOL BIOL, V1431, P141, DOI 10.1007/978-1-4939-3631-1_11; Stracy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12568; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; THIAGALINGAM S, 1991, J BIOL CHEM, V266, P11395; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Van Houten B, 2005, MUTAT RES-FUND MOL M, V577, P92, DOI 10.1016/j.mrfmmm.2005.03.013; Wagner K, 2010, DNA REPAIR, V9, P1176, DOI 10.1016/j.dnarep.2010.08.008; YEUNG AT, 1983, P NATL ACAD SCI-BIOL, V80, P6157, DOI 10.1073/pnas.80.20.6157	30	7	7	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					763	769		10.1096/fj.201800899R	http://dx.doi.org/10.1096/fj.201800899R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020831	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000457401500059
J	Maldifassi, MC; Martin-Sanchez, C; Atienza, G; Cedillo, JL; Arnalich, F; Bordas, A; Zafra, F; Gimenez, C; Extremera, M; Renart, J; Montiel, C				Maldifassi, Maria C.; Martin-Sanchez, Carolina; Atienza, Gema; Cedillo, Jose L.; Arnalich, Francisco; Bordas, Anna; Zafra, Francisco; Gimenez, Cecilio; Extremera, Maria; Renart, Jaime; Montiel, Carmen			Interaction of the 7-nicotinic subunit with its human-specific duplicated dup7 isoform in mammalian cells: Relevance in human inflammatory responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nicotinic acetylcholine receptors (nAChR); inflammation; sepsis; macrophage; protein assembly; -nicotinic subunit; dup7 nicotinic subunit; human sepsis; RAW264; 7 macrophages; GH4C1 cells	NICOTINIC ACETYLCHOLINE-RECEPTOR; ALPHA-7 SUBUNIT; CHRFAM7A GENE; PATHWAY; NERVE; COLOCALIZATION; STIMULATION; EXPRESSION; SCHIZOPHRENIA; REGULATOR	The 7 nicotinic receptor subunit and its partially duplicated human-specific dup7 isoform are coexpressed in neuronal and non-neuronal cells. In these cells, 7 subunits form homopentameric 7 nicotinic acetylcholine receptors (7-nAChRs) implicated in numerous pathologies. In immune cells, 7-nAChRs are essential for vagal control of inflammatory response in sepsis. Recent studies show that the dup7 subunit is a dominant-negative regulator of 7-nAChR activity in Xenopus oocytes. However, its biological significance in mammalian cells, particularly immune cells, remains unexplored, as the duplicated form is indistinguishable from the original subunit in standard tests. Here, using immunocytochemistry, confocal microscopy, coimmunoprecipitation, FRET, flow cytometry, and ELISA, we addressed this challenge in GH4C1 rat pituitary cells and RAW264.7 murine macrophages transfected with epitope- and fluorescent protein-tagged 7 or dup7. We used quantitative RT-PCR of dup7 gene expression levels in peripheral blood mononuclear cells (PBMCs) from patients with sepsis to analyze its relationship with PBMC 7 mRNA levels and with serum concentrations of inflammatory markers. We found that a physical interaction between dup7 and 7 subunits in both cell lines generates heteromeric nAChRs that remain mainly trapped in the endoplasmic reticulum. The dup7 sequestration of 7 subunits reduced membrane expression of functional 7-nAChRs, attenuating their anti-inflammatory capacity in lipopolysaccharide-stimulated macrophages. Moreover, the PBMC's dup7 levels correlated inversely with their 7 levels and directly with the magnitude of the patients' inflammatory state. These results indicate that dup7 probably reduces human vagal anti-inflammatory responses and suggest its involvement in other 7-nAChR-mediated pathophysiological processes.	[Maldifassi, Maria C.; Martin-Sanchez, Carolina; Atienza, Gema; Cedillo, Jose L.; Bordas, Anna; Extremera, Maria; Montiel, Carmen] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Arzobispo Morcillo 4, E-28049 Madrid, Spain; [Renart, Jaime] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28049 Madrid, Spain; [Arnalich, Francisco] Hosp Univ La Paz Madrid, Serv Med Interna, Madrid 28046, Spain; [Zafra, Francisco; Gimenez, Cecilio] Univ Autonoma Madrid, CSIC, Fac Ciencias, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Maldifassi, Maria C.; Martin-Sanchez, Carolina; Atienza, Gema; Cedillo, Jose L.; Arnalich, Francisco; Bordas, Anna; Zafra, Francisco; Gimenez, Cecilio; Extremera, Maria; Renart, Jaime; Montiel, Carmen] Hosp Univ La Paz, Inst Invest Sanitaria, Madrid 28046, Spain	Autonomous University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Hospital Universitario La Paz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Universitario La Paz	Montiel, C (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, Arzobispo Morcillo 4, E-28049 Madrid, Spain.	carmen.montiel@uam.es	Renart, Jaime/B-7661-2009; Arnalich, Francisco/K-7723-2014; Arnalich, Francisco/AAF-5924-2021; Gimenez, Cecilio/K-8027-2014	Renart, Jaime/0000-0001-6620-3706; Arnalich, Francisco/0000-0003-2943-0373; Martin Sanchez, Carolina/0000-0003-4687-5884; Gimenez, Cecilio/0000-0001-6726-8405	Ministry of Economy, Industry and Competitiveness, Government of Spain [SAF2011-23575, SAF2014-56623-R, SAF2017-82689-R]; CONICYT, Ministry of Education, Chile; Ministry of Economy, Industry and Competitiveness; Ministry of Education, Culture and Sports, Government of Spain; Autonomous University of Madrid	Ministry of Economy, Industry and Competitiveness, Government of Spain(Spanish Government); CONICYT, Ministry of Education, Chile; Ministry of Economy, Industry and Competitiveness; Ministry of Education, Culture and Sports, Government of Spain; Autonomous University of Madrid	This work was supported in part by Ministry of Economy, Industry and Competitiveness, Government of Spain Grants SAF2011-23575, SAF2014-56623-R, and SAF2017-82689-R (to C. M. and F. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of Fellowship Beca Chile from CONICYT, Ministry of Education, Chile.; Recipient of Fellowship Beca FPI from Ministry of Economy, Industry and Competitiveness.; Recipient of Fellowship Beca FPU from Ministry of Education, Culture and Sports, Government of Spain.; Recipient of Fellowship Beca FPI from Autonomous University of Madrid.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Arias HR, 2009, INT J BIOCHEM CELL B, V41, P1441, DOI 10.1016/j.biocel.2009.01.013; Baird A, 2016, BBA CLIN, V5, P66, DOI 10.1016/j.bbacli.2015.12.003; Benfante R, 2011, J NEUROIMMUNOL, V230, P74, DOI 10.1016/j.jneuroim.2010.09.008; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bordas A, 2017, ONCOTARGET, V8, P67878, DOI 10.18632/oncotarget.18948; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Casey JP, 2012, HUM GENET, V131, P565, DOI 10.1007/s00439-011-1094-6; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; De Luca V, 2006, ACTA PSYCHIAT SCAND, V114, P211, DOI 10.1111/j.1600-0447.2006.00785.x; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Fasoli F, 2015, CURR TOP BEHAV NEURO, V23, P1, DOI 10.1007/978-3-319-13665-3_1; Freedman R, 2001, AM J MED GENET, V105, P20, DOI 10.1002/1096-8628(20010108)105:1<20::AID-AJMG1047>3.3.CO;2-3; GARCIAGUZMAN M, 1994, BIOCHEMISTRY-US, V33, P15198, DOI 10.1021/bi00254a031; Gault J, 2003, AM J MED GENET B, V123B, P39, DOI 10.1002/ajmg.b.20061; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Kim TH, 2014, J INFECT DIS, V209, P1668, DOI 10.1093/infdis/jit669; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kracun S, 2008, BRIT J PHARMACOL, V153, P1474, DOI 10.1038/sj.bjp.0707676; Li HB, 2005, ONCOGENE, V24, P4206, DOI 10.1038/sj.onc.1208591; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; Maldifassi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108397; Mukherjee J, 2009, J NEUROCHEM, V110, P1885, DOI 10.1111/j.1471-4159.2009.06285.x; Pillai S, 2012, CURR DRUG TARGETS, V13, P671, DOI 10.2174/138945012800398847; Riley B, 2002, GENOMICS, V79, P197, DOI 10.1006/geno.2002.6694; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Schuller HM, 2012, CURR DRUG TARGETS, V13, P680, DOI 10.2174/138945012800398883; Serantes R, 2006, J BIOL CHEM, V281, P14632, DOI 10.1074/jbc.M512489200; Severance EG, 2009, J NEURAL TRANSM, V116, P213, DOI 10.1007/s00702-008-0164-y; Singhal S, 2011, J NANOTECHNOL, V2011, DOI [10.1155/2011/930243, 10.1155/2011/456743]; Solis-Garrido LM, 2004, J BIOL CHEM, V279, P52414, DOI 10.1074/jbc.M408872200; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2014, J BIOL CHEM, V289, P26451, DOI 10.1074/jbc.M114.582858; Yang YH, 2015, CELL PHYSIOL BIOCHEM, V36, P2025, DOI 10.1159/000430170; Zhang C, 2016, ONCOTARGET, V7, P59199, DOI 10.18632/oncotarget.10498	48	18	20	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13874	13888		10.1074/jbc.RA118.003443	http://dx.doi.org/10.1074/jbc.RA118.003443			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006348	Green Published, hybrid			2022-12-26	WOS:000444070700014
J	Kabil, O; Motl, N; Strack, M; Seravalli, J; Metzler-Nolte, N; Banerjee, R				Kabil, Omer; Motl, Nicole; Strack, Martin; Seravalli, Javier; Metzler-Nolte, Nils; Banerjee, Ruma			Mechanism-based inhibition of human persulfide dioxygenase by -glutamyl-homocysteinyl-glycine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen sulfide; iron; dioxygenase; enzyme kinetics; enzyme mechanism; ethylmalonic acid; ethylmalonic encephalopathy; persulfide dioxygenase; sulfide oxidation	HYDROGEN-SULFIDE OXIDATION; ETHYLMALONIC ENCEPHALOPATHY; CYSTEINE DIOXYGENASE; CRYSTAL-STRUCTURE; MUTATIONS; ETHE1; ENZYMES; SULFUR; IDENTIFICATION; THIOSULFATE	Hydrogen sulfide (H2S) is a signaling molecule with many beneficial effects. However, its cellular concentration is strictly regulated to avoid toxicity. Persulfide dioxygenase (PDO or ETHE1) is a mononuclear non-heme iron-containing protein in the sulfide oxidation pathway catalyzing the conversion of GSH persulfide (GSSH) to sulfite and GSH. PDO mutations result in the autosomal-recessive disorder ethylmalonic encephalopathy (EE). Here, we developed -glutamyl-homocysteinyl-glycine (GHcySH), in which the cysteinyl moiety in GSH is substituted with homocysteine, as a mechanism-based PDO inhibitor. Human PDO used GHcySH as an alternative substrate and converted it to GHcy-SO2H, mimicking GS-SO2H, the putative oxygenated intermediate formed with the natural substrate. Because GHcy-SO2H contains a C-S bond rather than an S-S bond in GS-SO2H, it failed to undergo the final hydrolysis step in the catalytic cycle, leading to PDO inhibition. We also characterized the biochemical penalties incurred by the L55P, T136A, C161Y, and R163W mutations reported in EE patients. The variants displayed lower iron content (1.4-11-fold) and lower thermal stability (1.2-1.7-fold) than WT PDO. They also exhibited varying degrees of catalytic impairment; the k(cat)/K-m values for R163W, L55P, and C161Y PDOs were 18-, 42-, and 65-fold lower, respectively, and the T136A variant was most affected, with a 200-fold lower k(cat)/K-m. Like WT enzyme, these variants were inhibited by GHcySH. This study provides the first characterization of an intermediate in the PDO-catalyzed reaction and reports on deficits associated with EE-linked mutations that are distal from the active site.	[Kabil, Omer; Motl, Nicole; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Strack, Martin; Metzler-Nolte, Nils] Ruhr Univ Bochum, Inorgan Chem Bioinorgan Chem, D-44801 Bochum, Germany; [Seravalli, Javier] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA; [Seravalli, Javier] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68588 USA	University of Michigan System; University of Michigan; Ruhr University Bochum; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Metzler-Nolte, Nils/H-7626-2014; Kabil, Omer/AAJ-1435-2020	Metzler-Nolte, Nils/0000-0001-8111-9959; 	National Institutes of Health [GM112455]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant GM112455 (to R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blaesi EJ, 2013, BIOCHEMISTRY-US, V52, P6040, DOI 10.1021/bi400825c; Bostelaar T, 2016, J AM CHEM SOC, V138, P8476, DOI 10.1021/jacs.6b03456; Bruijnincx PCA, 2008, CHEM SOC REV, V37, P2716, DOI 10.1039/b707179p; BURLINA AB, 1991, LANCET, V338, P1522, DOI 10.1016/0140-6736(91)92338-3; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Di Meo I, 2011, ANTIOXID REDOX SIGN, V15, P353, DOI 10.1089/ars.2010.3520; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; GARCIASILVA MT, 1994, J PEDIATR-US, V125, P843, DOI 10.1016/S0022-3476(06)80197-6; Garrett RM, 1998, P NATL ACAD SCI USA, V95, P6394, DOI 10.1073/pnas.95.11.6394; Henriques BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107157; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Kabil O, 2012, J BIOL CHEM, V287, P44561, DOI 10.1074/jbc.M112.407411; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Libiad M, 2015, J BIOL CHEM, V290, P23579, DOI 10.1074/jbc.M115.675694; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Motl N, 2017, J BIOL CHEM, V292, P14026, DOI 10.1074/jbc.M117.790170; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Pettinati I, 2016, TRENDS BIOCHEM SCI, V41, P338, DOI 10.1016/j.tibs.2015.12.007; Pettinati I, 2015, HUM MOL GENET, V24, P2458, DOI 10.1093/hmg/ddv007; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Ruetz M, 2017, J BIOL CHEM, V292, P6512, DOI 10.1074/jbc.M116.770370; Sattler SA, 2015, J BIOL CHEM, V290, P18914, DOI 10.1074/jbc.M115.652537; Tiranti V, 2006, J MED GENET, V43, P340, DOI 10.1136/jmg.2005.036210; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Tiranti V, 2009, NAT MED, V15, P200, DOI 10.1038/nm.1907; Valente L, 2009, BBA-BIOENERGETICS, V1787, P491, DOI 10.1016/j.bbabio.2008.10.001; Vitvitsky V, 2017, J BIOL CHEM, V292, P5584, DOI 10.1074/jbc.M117.774943; Vitvitsky V, 2015, J BIOL CHEM, V290, P8310, DOI 10.1074/jbc.M115.639831; WOOD JL, 1987, METHOD ENZYMOL, V143, P25	30	8	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 10	2018	293	32					12429	12439		10.1074/jbc.RA118.004096	http://dx.doi.org/10.1074/jbc.RA118.004096			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GQ1PU	29980601	Green Published, hybrid			2022-12-26	WOS:000441408500010
J	Kalkowska, DA; Boender, GJ; Smit, LAM; Baliatsas, C; Yzermans, J; Heederik, DJJ; Hagenaars, TJ				Kalkowska, Dominika A.; Boender, Gert Jan; Smit, Lidwien A. M.; Baliatsas, Christos; Yzermans, Joris; Heederik, Dick J. J.; Hagenaars, Thomas J.			Associations between pneumonia and residential distance to livestock farms over a five-year period in a large population-based study	PLOS ONE			English	Article							AIR-POLLUTION	In a recent study of electronic health records (EHR) of general practitioners in a livestockdense area in The Netherlands in 2009, associations were found between residential distance to poultry farms and the occurrence of community-acquired pneumonia (CAP). In addition, in a recent cross-sectional study in 2494 adults in 2014/2015 an association between CAP and proximity to goat farms was observed. Here, we extended the 2009 EHR analyses across a wider period of time (2009-2013), a wider set of health effects, and a wider set of farm types as potential risk sources. A spatial (transmission) kernel model was used to investigate associations between proximity to farms and CAP diagnosis for the period from 2009 to 2013, obtained from EHR of in total 140,059 GP patients. Also, associations between proximity to farms and upper respiratory infections, inflammatory bowel disease, and (as a control disease) lower back pain were analysed. Farm types included as potential risk sources in these analyses were cattle, (dairy) goats, mink, poultry, sheep, and swine. The previously found association between CAP occurrence and proximity to poultry farms was confirmed across the full 5-year study period. In addition, we found an association between increased risk for pneumonia and proximity to (dairy) goat farms, again consistently across all years from 2009 to 2013. No consistent associations were found for any of the other farm types (cattle, mink, sheep and swine), nor for the other health effects considered. On average, the proximity to poultry farms corresponds to approximately 119 extra patients with CAP each year per 100,000 people in the research area, which accounts for approximately 7.2% extra cases. The population attributable risk percentage of CAP cases in the research area attributable to proximity to goat farms is approximately 5.4% over the years 2009-2013. The most probable explanation for the association of CAP with proximity to poultry farms is thought to be that particulate matter and its components are making people more susceptible to respiratory infections. The causes of the association with proximity to goat farms is still unclear. Although the 2007-2010 Q-fever epidemic in the area probably contributed Q-fever related pneumonia cases to the observed additional cases in 2009 and 2010, it cannot explain the association found in lateryears 2011-2013.	[Kalkowska, Dominika A.; Boender, Gert Jan; Hagenaars, Thomas J.] Wageningen Biovet Res, Lelystad, Netherlands; [Smit, Lidwien A. M.; Heederik, Dick J. J.] Univ Utrecht, IRAS, Dept Environm Epidemiol, Utrecht, Netherlands; [Baliatsas, Christos; Yzermans, Joris] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Netherlands Institute for Health Services Research	Hagenaars, TJ (corresponding author), Wageningen Biovet Res, Lelystad, Netherlands.	thomas.hagenaars@wur.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; Heederik, Dick/0000-0002-4550-1437	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands; Lung Foundation Netherlands [3.2.11.022]; Dutch Ministry of Economic Affairs [BO-20-009-030]	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands(Ministry of Economic Affairs, Netherlands); Lung Foundation Netherlands; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	The Livestock Farming and Neighbouring Residents' Health (VGO) study was funded by the Ministry of Health, Welfare and Sports and the Ministry of Economic Affairs of The Netherlands, and supported by a grant from the Lung Foundation Netherlands (Grant number: 3.2.11.022). This research has received additional funding from the Dutch Ministry of Economic Affairs (project code BO-20-009-030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink AJA, 2014, 712 WAG UR LIV RES; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Boers D, 2016, INT ARCH OCC ENV HEA, V89, P521, DOI 10.1007/s00420-015-1092-4; Borlee F, 2017, AM J RESP CRIT CARE, V196, P1152, DOI 10.1164/rccm.201701-0021OC; Cambra-Lopez M, 2010, ENVIRON POLLUT, V158, P1, DOI 10.1016/j.envpol.2009.07.011; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Freidl GS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174796; Hagenaars T, 2017, ANAL GEZONDHEIDSEFFE; Heederik D., 2011, MOGELIJKE EFFECTEN I; Huijskens EGW, 2016, ZOONOSES PUBLIC HLTH, V63, P160, DOI 10.1111/zph.12218; Lamberts H., 1987, ICPC INT CLASSIFICAT; Lee A, 2015, ANN GLOB HEALTH, V81, P368, DOI 10.1016/j.aogh.2015.08.006; Lindstrom T, 2011, P ROY SOC B-BIOL SCI, V278, P1564, DOI 10.1098/rspb.2010.1902; Maassen K, 2016, VEEHOUDERIJ GEZOND H; Poroyko V, 2015, AM J PHYSIOL-LUNG C, V309, pL76, DOI 10.1152/ajplung.00061.2014; Smit LAM, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0027-0; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; van Dijk CE, 2017, ENVIRON POLLUT, V222, P374, DOI 10.1016/j.envpol.2016.12.023; Winkel A, 2016, POULTRY SCI, V95, P2836, DOI 10.3382/ps/pew261; Wolfram Research Inc., 2016, MATH VERS 11 0	21	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200813	10.1371/journal.pone.0200813	http://dx.doi.org/10.1371/journal.pone.0200813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016348	gold, Green Published, Green Submitted			2022-12-26	WOS:000438866600045
J	Sanche, S; Mesplede, T; Sheehan, NL; Li, J; Nekka, F				Sanche, Steven; Mesplede, Thibault; Sheehan, Nancy L.; Li, Jun; Nekka, Fahima			Exploring an alternative explanation for the second phase of viral decay: Infection of short-lived cells in a drug-limited compartment during HAART	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; PERSISTENT HIV-1 REPLICATION; REVERSE-TRANSCRIPTASE; LYMPHATIC TISSUES; BLOOD MONOCYTES; SINGLE-CYCLE; DYNAMICS; PLASMA; RNA	Most HIV-infected patients who initiate combination antiretroviral therapy experience a viral load decline in several phases. These phases are characterized by different rates of viral load decay that decrease when transitioning from one phase to the next. There is no consensus as to the origin of these phases. One hypothesis put forward is that short- and long-lived infected cells are responsible for the first and second phases of decay, respectively. However, significant differences in drug concentrations are observed in monocytes from various tissues, suggesting the first two phases of decay in viral loads could instead be attributed to short-lived cells being differently exposed to drugs. Compared to a well-exposed compartment, new cell infection can be expected in a compartment with limited drug exposure, thus leading to a slower viral load decay with potential virologic failure and drug resistance. In the current study, the latter hypothesis was investigated using a model of viral kinetics. Empirical datasets were involved in model elaboration and parameter estimation. In particular, susceptibility assay data was used for an in vitro to in vivo extrapolation based on the expected drug concentrations inside physiological compartments. Results from numerical experiments of the short-term evolution of viral loads can reproduce the first two phases of viral decay when allowing new short-lived cell infections in an unidentified drug-limited compartment. Model long-term predictions are however less consistent with clinical observations. For the hypothesis to hold, efavirenz, tenofovirand emtricitabine drug exposure in the drug-limited compartment would have to be very low compared to exposure in peripheral blood. This would lead to significant long-term viral growth and the frequent development of resistant strains, a prediction not supported by clinical observations. This suggests that the existence of a drug-limited anatomical compartment is unlikely, by itself, to explain the second phase of viral load decay.	[Sanche, Steven; Sheehan, Nancy L.; Li, Jun; Nekka, Fahima] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Mesplede, Thibault] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, AIDS Ctr, Montreal, PQ, Canada; [Mesplede, Thibault] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Sheehan, Nancy L.] McGill Univ, Chron Viral Illness Serv, Hlth Ctr, Montreal, PQ, Canada; [Li, Jun; Nekka, Fahima] Univ Montreal, Ctr Rech Math, Montreal, PQ, Canada	Universite de Montreal; Lady Davis Institute; McGill University; McGill University; McGill University; Universite de Montreal	Sanche, S (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ, Canada.	steven.sanche@umontreal.ca	Mesplède, Thibault/E-8550-2014	Mesplède, Thibault/0000-0003-0515-9128	Natural Sciences and Engineering Research Council of Canada - Industrial Chair in Pharmacometrics [IRC445178]; Fonds de Recherche du Quebec - Sante [29808]; Fonds de Recherche du Quebec - Nature et technologie [192198]; FRQS Scholarship; NSERC - Industrial Chair in Pharmacometrics-Novartis; Pfizer; Inventiv Health Clinical; FRQNT	Natural Sciences and Engineering Research Council of Canada - Industrial Chair in Pharmacometrics; Fonds de Recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec); Fonds de Recherche du Quebec - Nature et technologie; FRQS Scholarship; NSERC - Industrial Chair in Pharmacometrics-Novartis; Pfizer(Pfizer); Inventiv Health Clinical; FRQNT	This study was supported by the Natural Sciences and Engineering Research Council of Canada - Industrial Chair in Pharmacometrics (IRC445178 to FN), by the Fonds de Recherche du Quebec - Sante (29808 to SS) and by the Fonds de Recherche du Quebec - Nature et technologie (192198 to FN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by the FRQS Scholarship held by SS. Support was also provided by NSERC - Industrial Chair in Pharmacometrics-Novartis, Pfizer and Inventiv Health Clinical as well as FRQNT (FN). The authors acknowledge the help of Nesrine Fazez for her contribution to the figures.	Abram ME, 2014, J VIROL, V88, P7589, DOI 10.1128/JVI.00302-14; Abram ME, 2010, J VIROL, V84, P9864, DOI 10.1128/JVI.00915-10; Acosta EP, 2012, ANTIMICROB AGENTS CH, V56, P5938, DOI 10.1128/AAC.00691-12; Agresti A, 2013, CATEGORICAL DATA ANA; Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Baheti G, 2011, ANTIMICROB AGENTS CH, V55, P5294, DOI 10.1128/AAC.05317-11; Blankson JN, 2002, ANNU REV MED, V53, P557, DOI 10.1146/annurev.med.53.082901.104024; Blum MR, 2007, J CLIN PHARMACOL, V47, P751, DOI 10.1177/0091270007300951; Cardozo EF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006478; Costiniuk CT, 2015, AIDS PATIENT CARE ST, V29, P55, DOI 10.1089/apc.2014.0173; Craig M, 2016, CPT-PHARMACOMET SYST, V5, P158, DOI 10.1002/psp4.12069; De Boer RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000906; ERDI P., 1989, MATH MODELS CHEM REA; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Frenkel LM, 2003, J VIROL, V77, P5721, DOI 10.1128/JVI.77.10.5721-5730.2003; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gilmore JB, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002971; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Hlavacek WS, 2000, P NATL ACAD SCI USA, V97, P10966, DOI 10.1073/pnas.190065897; Hockett RD, 1999, J EXP MED, V189, P1545, DOI 10.1084/jem.189.10.1545; Hu ZX, 2014, J VIROL, V88, P9268, DOI 10.1128/JVI.00695-14; Huang YY, 2016, J ANTIMICROB CHEMOTH, V71, P1954, DOI 10.1093/jac/dkw046; Ioannidis JPA, 2000, AIDS, V14, P1481, DOI 10.1097/00002030-200007280-00003; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Karris MY, 2017, HIV CLIN TRIALS, V18, P67, DOI 10.1080/15284336.2017.1282578; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kupfer B, 2007, J MED VIROL, V79, P1440, DOI 10.1002/jmv.20993; Lewin SR, 1998, AIDS, V12, P719, DOI 10.1097/00002030-199807000-00008; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Maldarelli F, 2015, J VIRUS ERAD, V1, P237; Markowitz M, 2003, J VIROL, V77, P5037, DOI 10.1128/JVI.77.8.5037-5038.2003; McKinstry KK, 2010, IMMUNOL REV, V236, P110, DOI 10.1111/j.1600-065X.2010.00921.x; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rohatgi A., 2012, WEBPLOTDIGITIZER V4; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Sanche S, 2017, CPT-PHARMACOMET SYST, V6, P469, DOI 10.1002/psp4.12200; Sanchez A, 2011, ANTIMICROB AGENTS CH, V55, P5314, DOI 10.1128/AAC.00194-11; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Spivak AM, 2011, AIDS RES HUM RETROV, V27, P759, DOI [10.1089/aid.2010.0199, 10.1089/AID.2010.0199]; SUN Y, 2017, MEDICINE, V96, DOI DOI 10.1097/MD.0000000000007430; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Valade E, 2014, ANTIMICROB AGENTS CH, V58, P2256, DOI 10.1128/AAC.02058-13; Yilmaz A, 2012, J ANTIMICROB CHEMOTH, V67, P299, DOI 10.1093/jac/dkr492; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Zhang LQ, 1999, J VIROL, V73, P855, DOI 10.1128/JVI.73.1.855-860.1999	48	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0198090	10.1371/journal.pone.0198090	http://dx.doi.org/10.1371/journal.pone.0198090			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016329	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600005
J	Stanley, IJ; Kajumbula, H; Bazira, J; Kansiime, C; Rwego, IB; Asiimwe, BB				Stanley, Iramiot Jacob; Kajumbula, Henry; Bazira, Joel; Kansiime, Catherine; Rwego, Innocent B.; Asiimwe, Benon B.			Multidrug resistance among Escherichia coli and Klebsiella pneumoniae carried in the gut of out-patients from pastoralist communities of Kasese district, Uganda	PLOS ONE			English	Article							ENTEROBACTERIACEAE	Background Antimicrobial resistance is a worldwide public health emergency that requires urgent attention. Most of the effort to prevent this coming catastrophe is occurring in high income countries and we do not know the extent of the problem in low and middle-income countries, largely because of low laboratory capacity coupled with lack of effective surveillance systems. We aimed at establishing the magnitude of antimicrobial resistance among Escherichia coli and Klebsiella pneumoniae carried in the gut of out-patients from pastoralist communities of rural Western Uganda. Methods A cross-sectional study was carried out among pastoralists living in and around the Queen Elizabeth Protected Area (QEPA). Stool samples were collected from individuals from pastoralist communities who presented to the health facilities with fever and/or diarrhea without malaria and delivered to the microbiology laboratory of College of Health Sciences-Makerere University for processing, culture and drug susceptibility testing. Results A total of 300 participants fulfilling the inclusion criteria were recruited into the study. Three hundred stool samples were collected, with 209 yielding organisms of interest. Out of 209 stool samples that were positive, 181 (89%) grew E. coli, 23 (11 %) grew K. pneumoniae and five grew Shigella. Generally, high antibiotic resistance patterns were detected among E. coli and K. pneumoniae isolated. High resistance against cotrimoxazole 74%, ampicillin 67%, amoxicillin/clavulanate 37%, and ciprofloxacin 31% was observed among the E. coli. In K. pneumoniae, cotrimoxazole 68% and amoxicillin/clavulanate 46%, were the most resisted antimicrobials. Additionally, 57% and 82% of the E. coli and K. pneumoniae respectively were resistant to at least three classes of the antimicrobials tested. Resistance to carbapenems was not detected among K. pneumoniae and only 0.6% of the E. coli were resistant to carbapenems. Isolates producing ESBLs comprised 12% and 23% of E. coli and K. pneumoniae respectively. Conclusion We demonstrated high antimicrobial resistance, including multidrug resistance, among E. coli and K. pneumoniae isolates from pastoralist out-patients. We recommend a One Health approach to establish the sources and drivers of this problem to inform public health.	[Stanley, Iramiot Jacob; Kajumbula, Henry; Asiimwe, Benon B.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Stanley, Iramiot Jacob] Busitema Univ, Fac Hlth Sci, Dept Microbiol & Immunol, Kampala, Uganda; [Bazira, Joel] Mbarara Univ Sci & Technol, Fac Med, Dept Microbiol, Kampala, Uganda; [Kansiime, Catherine; Rwego, Innocent B.] Makerere Univ, Sch Publ Hlth, OHCEA Network, Kampala, Uganda; [Rwego, Innocent B.] Makerere Univ, Coll Vet Med Anim Resources & Biosecur, Dept Biosecur Ecosyst & Vet Publ Hlth, Kampala, Uganda; [Rwego, Innocent B.] Univ Minnesota, Coll Vet Med, Ecosyst Hlth Div, St Paul, MN 55108 USA	Makerere University; Mbarara University of Science & Technology; Makerere University; Makerere University; University of Minnesota System; University of Minnesota Twin Cities	Stanley, IJ (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.; Stanley, IJ (corresponding author), Busitema Univ, Fac Hlth Sci, Dept Microbiol & Immunol, Kampala, Uganda.	jiramiot@gmail.com	JacobStanley, Iramiot/AAN-4257-2020; Rwego, Innocent Bidason/I-5049-2013	JacobStanley, Iramiot/0000-0002-9239-6641; Kajumbula, Henry/0000-0002-2075-0007; Rwego, Innocent Bidason/0000-0003-1274-7788	International Development Research Centre (IDRC) - Canada; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107743/Z/15/Z]; UK government	International Development Research Centre (IDRC) - Canada(CGIAR); African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	This work was supported by the International Development Research Centre (IDRC) - Canada; grant to One Health Central and Eastern Africa (OHCEA) network and the DELTAS Africa Initiative [grant#107743/Z/15/Z]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107743/Z/15/Z] and the UK government. The views expressed in this manuscript are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Asiimwe BB, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2124-8; Barker AK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4261-4; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Butaye P, 2015, INTRO ANTIMICROBIAL; Carroll KC, 2006, J CLIN MICROBIOL, V44, P3506, DOI 10.1128/JCM.00994-06; Centers for Disease Control and , 2013, ANTIBIOTIC RESISTANC; Chaula T, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/4042686; Critchlow R AJP, 2015, SPATIOTEMPORAL TREND; de Kraker MEA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001104; Disassa Nigatu, 2017, Vet Med Int, V2017, P7581531, DOI 10.1155/2017/7581531; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Kallen AJ, 2010, INFECT CONT HOSP EP, V31, P528, DOI 10.1086/652152; Kateete DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063413; Katongole SP, 2015, OPEN SCI J CLIN MED, V3, P199; Kiiru J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-155; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Moremi N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2082-1; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Mshana SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1527-x; Mshana Stephen E, 2009, BMC Res Notes, V2, P49, DOI 10.1186/1756-0500-2-49; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Mwansa M., 2017, INT J ENV RES PUB HE, V14; Najjuka Christine F, 2016, BMC Res Notes, V9, P235, DOI 10.1186/s13104-016-2049-8; Nelson Edwin, 2014, BMC Res Notes, V7, P279, DOI 10.1186/1756-0500-7-279; Paterson DL, 2007, CLIN INFECT DIS, V45, P1179, DOI 10.1086/522287; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P934, DOI 10.1128/AAC.01247-10; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Ursula Theuretzbacher CA, 2017, LINKING SUSTAINABLE, V9; Woerther PL, 2011, CLIN INFECT DIS, V53, P677, DOI 10.1093/cid/cir522	32	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200093	10.1371/journal.pone.0200093	http://dx.doi.org/10.1371/journal.pone.0200093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016317	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600016
J	Marinova, M; Sasanguie, D; Reynvoet, B				Marinova, Mila; Sasanguie, Delphine; Reynvoet, Bert			Symbolic estrangement or symbolic integration of numerals with quantities: Methodological pitfalls and a possible solution	PLOS ONE			English	Article							HUMAN INTRAPARIETAL CORTEX; SAME-DIFFERENT TASK; NUMBER REPRESENTATIONS; MATHEMATICS ACHIEVEMENT; INDIVIDUAL-DIFFERENCES; NUMERICAL SYMBOLS; TELL US; ASSOCIATION; CAPACITY; BRAIN	Previous studies, which examined whether symbolic and non-symbolic quantity representations are processed by two independent systems or by one common system, reached contradicting findings, possibly due to methodological differences. Indeed, some researchers advocate the two systems approach, based on the presence of notation-specific switch cost in conditions where adults have to compare pairs of symbolic and non-symbolic quantities, in combination with the absence of such a cost in conditions containing quantities of the same notation. However, other researchers used matching instructions, and reported a facilitation in the mixed notation conditions, suggesting that the two systems are automatically integrated. In the current study, we conducted three experiments, in which we examined the existence of two separate quantity systems, but we used various experimental manipulations (e.g., task instructions, presentation order) to unravel the previous inconsistent findings. In Experiment 1, we investigated the role of task instructions by presenting participants with pure and mixed notation trials with both comparison and matching tasks. In Experiment 2, we tested the role of blocked and randomized presentation order for the pure and mixed trials. Our data showed that cost for switching between the symbolic and non-symbolic quantities is present, but is prone to a certain methodological drawback: when the differences between the processing times for two sequentially presented stimuli of different notations are not taken into account, this masks the cost for switching between the two systems. To overcome this problem, in Experiment 3 we used an audio-visual paradigm. Overall, our results provide further evidence for the existence of distinct quantity representations, independently of task instructions or presentation order. Additionally, considering this methodological pitfall we argue that the audio-visual paradigm is better suited when investigating the integration between symbolic and non- symbolic quantities.	[Marinova, Mila; Sasanguie, Delphine; Reynvoet, Bert] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Brain & Cognit, Leuven, Belgium; [Marinova, Mila; Sasanguie, Delphine; Reynvoet, Bert] KU Leuven Kulak, Fac Psychol & Educ Sci, Kortrijk, Belgium	KU Leuven; KU Leuven	Marinova, M (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Brain & Cognit, Leuven, Belgium.; Marinova, M (corresponding author), KU Leuven Kulak, Fac Psychol & Educ Sci, Kortrijk, Belgium.	mila.marinova@kuleuven.be	Marinova, Mila/K-3281-2019	Marinova, Mila/0000-0002-6875-7742; Reynvoet, Bert/0000-0002-4898-2475	Research Fund KU Leuven	Research Fund KU Leuven(KU Leuven)	This research was supported by the Research Fund KU Leuven. Delphine Sasanguie is a postdoctoral research fellow of the Research Fund Flanders (www.fwo.be).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Brysbaert M, 2005, HDB MATH COGNITION, V42, P23; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Bulthe A J, 2015, J COGNITIVE NEUROSCI; Bulthe J, 2014, NEUROIMAGE, V87, P311, DOI 10.1016/j.neuroimage.2013.10.049; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; Cohen DJ, 2009, PSYCHON B REV, V16, P332, DOI 10.3758/PBR.16.2.332; Crollen V, 2011, EXPT PSYCHOL; Defever E, 2012, ACTA PSYCHOL, V140, P35, DOI 10.1016/j.actpsy.2012.02.005; Defever E, 2011, J EXP CHILD PSYCHOL, V109, P174, DOI 10.1016/j.jecp.2011.01.002; Dehaene S, 2001, MIND LANG, V16, P16, DOI 10.1111/1468-0017.00154; Dehaene S., 2007, COGNITION, P52774; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fias W, 2001, PSYCHOL RES-PSYCH FO, V65, P242, DOI 10.1007/s004260100064; Gebuis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037426; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gebuis T, 2011, BEHAV RES METHODS, V43, P981, DOI 10.3758/s13428-011-0097-5; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Kadosh RC, 2008, CORTEX, V44, P470, DOI 10.1016/j.cortex.2007.08.002; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; Krajcsi A, 2016, FRONT PSYCHOL, P7; Leibovich T, 2016, CAN J EXP PSYCHOL, V70, P12, DOI 10.1037/cep0000070; Liu AS, 2015, COGSCI; Los SA, 1996, ACTA PSYCHOL, V94, P145, DOI 10.1016/0001-6918(95)00050-X; Lyons IM, 2015, HUM BRAIN MAPP, V36, P475, DOI 10.1002/hbm.22641; Lyons IM, 2012, J EXP PSYCHOL GEN, V141, P635, DOI 10.1037/a0027248; Lyons IM, 2009, COGNITION, V113, P189, DOI 10.1016/j.cognition.2009.08.003; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Meiran N, 2000, PSYCHOL RES-PSYCH FO, V63, P234, DOI 10.1007/s004269900004; Nieder A, 2016, NAT REV NEUROSCI, V17, P366, DOI 10.1038/nrn.2016.40; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Nunez RE, 2017, TRENDS COGN SCI, V21, P409, DOI 10.1016/j.tics.2017.03.005; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Reynvoet B, 2016, FRONT PSYCHOL, V7; Sasanguie D, 2017, PSYCHOL RES-PSYCH FO, V81, P231, DOI 10.1007/s00426-015-0734-1; Sasanguie D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087739; Sasanguie D, 2014, Q J EXP PSYCHOL, V67, P271, DOI 10.1080/17470218.2013.803581; Sasanguie D, 2013, NEUROPSYCHOLOGIA, V51, P1528, DOI 10.1016/j.neuropsychologia.2013.05.001; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Van Opstal F, 2008, PSYCHON B REV, V15, P419, DOI 10.3758/PBR.15.2.419; van Opstal F, 2011, J COGN PSYCHOL, V23, P112, DOI 10.1080/20445911.2011.466796; Vos H, 2017, J COGN PSYCHOL, P1	45	9	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200808	10.1371/journal.pone.0200808	http://dx.doi.org/10.1371/journal.pone.0200808			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2LQ	30011340	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000438829800050
J	Zhu, Q; Xie, PF; Li, HW; Ma, C; Zhang, WH; Yin, YL; Kong, XF				Zhu, Qian; Xie, Peifeng; Li, Huawei; Ma, Cui; Zhang, Wanghong; Yin, Yulong; Kong, Xiangfeng			Fetal Huanjiang mini-pigs exhibit differences in nutrient composition according to body weight and gestational period	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; WITHIN-LITTER VARIATION; FUNCTIONAL AMINO-ACIDS; GENE-EXPRESSION; BIRTH-WEIGHT; POSTNATAL-GROWTH; SKELETAL-MUSCLE; FATTY-ACIDS; NUTRITION; PREGNANCY	Low birth weight may negatively affect energy storage and nutrient metabolism, and impair fetal growth and development. We analyzed effects of body weight (BW) and gestational period on nutrient composition in fetal Huanjiang mini-pigs. Fetuses with the lowest BW (LBW), middle BW (MBW), and highest BW (HBW) were collected at days 45, 75, and 110 of gestation. Crude protein (CP), crude fat, amino acid (AA), and fatty acid (FA) concentrations were determined. The BW gain, carcass weight, fat percentage, and uterus weight of sows increased as gestation progressed, as did litter weight, average individual fetal weight, fetal body weight, and dry matter (DM). The concentrations of Ala, Arg, crude fat, Gly, Pro, Tyr, C14:0, C16:0, C16:1, C18:1n9c, C18:2n6c, C18:3n3, C18:3n6, C20:0, C20:3n6, saturated FA (SFA), and monounsaturated FA (MUFA) increased significantly as gestation progressed. The percentage of skeleton, and the ratio of the liver, lung, and stomach to BW decreased as gestation progressed. There were also significant reductions in the concentrations of CP, Asp, Glu, His, Ile, Leu, Lys, Phe, Ser, Thr, essential AA (EAA), acidic AA, C17:0, C20:4n6, C22:6n3, unsaturated FA (UFA), polyunsaturated FA (PUFA), n-3PUFA, n-6PUFA as gestation progressed, and reductions in EAA/total AA (TAA), PUFA/SFA, and n-3/n-6 PUFA. The LBW fetuses exhibited the lowest BW and crude fat, C14:0, C16:1, C17:0, C18:2n6c, and MUFA concentrations at days 75 and 110 of gestation. They also exhibited lower Tyr concentration at day 45 of gestation and lower Glu concentration at day 75 of gestation than HBW fetuses. These findings suggest that LBW fetuses exhibit lower amounts of crude fat and several FAs during mid-gestation and late-gestation, which may in turn affect adaptability, growth, and development.	[Zhu, Qian; Xie, Peifeng; Li, Huawei; Ma, Cui; Zhang, Wanghong; Yin, Yulong; Kong, Xiangfeng] Chinese Acad Sci, Inst Subtrop Agr,Key Lab Agroecol Proc Subtrop Re, Hunan Prov Key Lab Anim Nutr Physiol & Metab Proc, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Changsha, Hunan, Peoples R China; [Zhu, Qian; Ma, Cui; Zhang, Wanghong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Kong, Xiangfeng] Chinese Acad Sci, Res Ctr Mini Pig, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Peoples R China	Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Kong, XF (corresponding author), Chinese Acad Sci, Inst Subtrop Agr,Key Lab Agroecol Proc Subtrop Re, Hunan Prov Key Lab Anim Nutr Physiol & Metab Proc, Natl Engn Lab Pollut Control & Waste Utilizat Liv, Changsha, Hunan, Peoples R China.; Kong, XF (corresponding author), Chinese Acad Sci, Res Ctr Mini Pig, Huanjiang Observat & Res Stn Karst Ecosyst, Huanjiang, Peoples R China.	nnkxf@isa.ac.cn			National Natural Science Foundation of China [31572421, 31772613]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The present work was jointly supported by the National Natural Science Foundation of China (no. 31572421 and 31772613).	AOAC, 1996, OFFICIAL METHODS ANA, V16th; Avagliano L, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/972562; Bazer FW, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-23; BAZER FW, 1988, J REPROD FERTIL, V84, P37, DOI 10.1530/jrf.0.0840037; Bidarimath M, 2017, MOL REPROD DEV, V84, P856, DOI 10.1002/mrd.22847; Bloomfield FH, 2002, J PEDIATR GASTR NUTR, V35, P287, DOI 10.1097/00005176-200209000-00010; Brosnan JT, 2001, IUBMB LIFE, V52, P265, DOI 10.1080/152165401317291101; Cetin I, 2005, ACTA PAEDIATR, V94, P7, DOI 10.1080/08035320510043709; Cetina I, 2008, CURR OPIN CLIN NUTR, V11, P297, DOI 10.1097/MCO.0b013e3282f795e6; D'Inca R, 2010, LIVEST SCI, V133, P20, DOI 10.1016/j.livsci.2010.06.015; Douglas SL, 2014, J ANIM SCI, V92, P2280, DOI 10.2527/jas.2013-7388; Hanebutt FL, 2008, CLIN NUTR, V27, P685, DOI 10.1016/j.clnu.2008.05.010; Helland IB, 2006, J MATERN-FETAL NEO M, V19, P397, DOI 10.1080/14767050600738396; Hinkle SN, 2015, EUR J OBSTET GYN R B, V190, P41, DOI 10.1016/j.ejogrb.2015.04.006; Hu CJ, 2017, J ANIM SCI, V95, P5507, DOI 10.2527/jas2017.1703; Jansson T, 1998, PEDIATR RES, V44, P532, DOI 10.1203/00006450-199810000-00011; Ji Y, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0173-5; Kim SW, 2007, ASIAN AUSTRAL J ANIM, V20, P295; Kim SW, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-26; Kong XF, 2009, LIVEST SCI, V123, P261, DOI 10.1016/j.livsci.2008.11.015; Kwon H, 2003, BIOL REPROD, V68, P1813, DOI 10.1095/biolreprod.102.012971; Li FN, 2011, ANIMAL, V5, P1903, DOI 10.1017/S1751731111001194; Li FN, 2015, BRIT J NUTR, V113, P739, DOI 10.1017/S0007114514004346; Lin G, 2014, AMINO ACIDS, V46, P1605, DOI 10.1007/s00726-014-1725-z; Liu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138277; Liu YY, 2015, BRIT J NUTR, V113, P1069, DOI 10.1017/S0007114514004310; McNeil CJ, 2005, REPRODUCTION, V129, P757, DOI 10.1530/rep.1.00451; McPherson RL, 2004, J ANIM SCI, V82, P2534; Metges CC, 2014, J NUTR, V144, P155, DOI 10.3945/jn.113.182691; Milligan BN, 2002, PREV VET MED, V56, P119, DOI 10.1016/S0167-5877(02)00157-5; NOVAKOFSKI J, 1989, J FOOD SCI, V54, P15, DOI 10.1111/j.1365-2621.1989.tb08556.x; Quesnel H, 2014, J ANIM SCI, V92, P1445, DOI 10.2527/jas.2013-6701; Rehfeldt C, 2008, MEAT SCI, V78, P170, DOI 10.1016/j.meatsci.2007.05.029; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rekiel A, 2014, ANN ANIM SCI, V14, P3, DOI 10.2478/aoas-2013-0060; RIGAU AP, 1995, J ANIM SCI, V73, P1372; Robinson DT, 2017, SEMIN FETAL NEONAT M, V22, P8, DOI 10.1016/j.siny.2016.08.009; Sola-Oriol D, 2017, ANIM FEED SCI TECH, V233, P34, DOI 10.1016/j.anifeedsci.2016.07.018; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Suryawan A, 2006, AM J PHYSIOL-ENDOC M, V291, pE849, DOI 10.1152/ajpendo.00069.2006; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wang JJ, 2017, MOL REPROD DEV, V84, P897, DOI 10.1002/mrd.22842; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2014, ANNU REV ANIM BIOSCI, V2, P387, DOI 10.1146/annurev-animal-022513-114113; Wu GY, 2010, ADV NUTR, V1, P31, DOI 10.3945/an.110.1008; Wu GY, 1999, J NUTR, V129, P1031, DOI 10.1093/jn/129.5.1031; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu X, 2012, ANIM REPROD SCI, V132, P187, DOI 10.1016/j.anireprosci.2012.05.002; Yang HS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050921, 10.1371/journal.pone.0029051]; Yang HS, 2012, MOL BIOL REP, V39, P1887, DOI 10.1007/s11033-011-0934-8; Yuan TL, 2015, J ZHEJIANG UNIV-SC B, V16, P417, DOI 10.1631/jzus.B1500010	52	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0199939	10.1371/journal.pone.0199939	http://dx.doi.org/10.1371/journal.pone.0199939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005070	Green Published, gold, Green Submitted			2022-12-26	WOS:000438744200005
J	Baumer, N; Rehkamper, J; Appel, N; Terheyden, L; Hartmann, W; Wardelmann, E; Buchholz, F; Muller-Tidow, C; Berdel, WE; Baumer, S				Baeumer, Nicole; Rehkaemper, Jan; Appel, Neele; Terheyden, Lisa; Hartmann, Wolfgang; Wardelmann, Eva; Buchholz, Frank; Mueller-Tidow, Carsten; Berdel, Wolfgang E.; Baeumer, Sebastian			Downregulation of PIK3CA via antibody-esiRNA-complexes suppresses human xenograft tumor growth	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CHRONIC LYMPHOCYTIC-LEUKEMIA; PROGNOSTIC ROLE; COLON-CANCER; KRAS; CETUXIMAB; THERAPY; RESISTANCE; MUTATION; PATHWAY	Precision cancer therapy requires on the one hand detailed knowledge about a tumor's driver oncogenes and on the other hand an effective targeted therapy that specifically inhibits these oncogenes. While the determination of genomic landscape of a tumor has reached a very precise level, the respective therapy options are scarce. The application of small inhibitory (si) RNAs is a promising field of investigation. Here, we present the effective in vivo-treatment of colorectal cancer (CRC) xenograft tumors with antibody-complexed, endoribonuclease-prepared small inhibitory (esi)RNAs. We chose heterogeneous endoribonuclease-prepared siRNA pools (esiRNAs) against the frequently mutated genes PIK3CA and KRAS and coupled them to the anti-EGFR antibody cetuximab, which was internalized specifically into the tumor cells. esiRNA pools have been shown to exhibit superior specificity in target gene knockdown compared to classic siRNAs. We identified a significant decrease in tumor growth upon this treatment due to decreased tumor cell proliferation. The ex vivo-analysis of the xenograft CRC tumors revealed the expected downregulation of the intended direct targets PIK3CA and KRAS on protein level. Moreover, known downstream targets for EGFR signaling such as p-ERK, p-AKT, and c-MYC were decreased as well. We therefore propose the use of antibody-esiRNA complexes as a novel experimental treatment option against key components of the EGFR signaling cascade.	[Baeumer, Nicole; Appel, Neele; Terheyden, Lisa; Mueller-Tidow, Carsten; Berdel, Wolfgang E.; Baeumer, Sebastian] Univ Munster, Dept Med A, Hematol Oncol, Munster, Germany; [Rehkaemper, Jan; Hartmann, Wolfgang; Wardelmann, Eva] Univ Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ KrebsCtr UCC, Med Fac, Med Syst Biol, Dresden, Germany; [Buchholz, Frank] German Canc Res Ctr, Heidelberg, Germany; [Buchholz, Frank] German Canc Consortium DKTK Partner Site, Dresden, Germany; [Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Buchholz, Frank] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Natl Ctr Tumor Dis NCT, Dresden, Germany; [Mueller-Tidow, Carsten] Heidelberg Univ, Dept Med 5, Heidelberg, Germany	University of Munster; University of Munster; Technische Universitat Dresden; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg	Baumer, S (corresponding author), Univ Munster, Dept Med A, Hematol Oncol, Munster, Germany.	baumers@uni-muenster.de	Müller-Tidow, Carsten/O-7207-2018; Buchholz, Frank/B-4700-2017; Baeumer, Sebastian/GYU-0544-2022; Hartmann, Wolfgang/G-1893-2017	Müller-Tidow, Carsten/0000-0002-7166-5232; Buchholz, Frank/0000-0002-4577-3344; Hartmann, Wolfgang/0000-0002-7609-5021; Baumer, Nicole/0000-0002-7530-467X	Wilhelm Sander-Stiftung [2014.054.1, 2009.041.2, 2017.071.1]; Deutsche Forschungsgemeinschaft-DFG [EXC 1003]; Deutsche Krebshilfe [70112282]; innovative medical research (IMF) University of Muenster [111418, 111501]; Innovative Medical Research (IMF) University of Muenster-Sebastian Baumer Innovative Medical Research (IMF) of the University of Muenster [121314, 211502]	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft-DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); innovative medical research (IMF) University of Muenster; Innovative Medical Research (IMF) University of Muenster-Sebastian Baumer Innovative Medical Research (IMF) of the University of Muenster	This study was funded by Wilhelm Sander-Stiftung-2009.041.2-Carsten MuEller-Tidow, Sebastian Baumer; Wilhelm Sander-Stiftung-2014.054.1-Wolfgang E. Berdel, Sebastian Baumer; Deutsche Forschungsgemeinschaft-DFG EXC 1003-Wolfgang E. Berdel; Deutsche Krebshilfe 70112282-Nicole BaEumer, Sebastian BaEumer; innovative medical research (IMF) University of Muenster-111418-Sebastian Baumer; Innovative Medical Research (IMF) University of Muenster-211502-Sebastian Baumer Innovative Medical Research (IMF) of the University of Muenster-121314-Nicole BaEumer; Innovative Medical Research (IMF) of the University of Muenster-111501- Nicole BaEumer, Sebastian BaEumer; Wilhelm Sander-Stiftung-2017.071.1-Wolfgang E. Berdel, Sebastian BaEumer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, Cancer Discov, V7, pOF2, DOI 10.1158/2159-8290.CD-NB2017-147; Baumer N, 2016, NAT PROTOC, V11, P22, DOI 10.1038/nprot.2015.137; Baumer S, 2015, CLIN CANCER RES, V21, P1383, DOI 10.1158/1078-0432.CCR-13-2017; Balmer N, 2017, MOL PHARMACEUT, V14, P1339, DOI 10.1021/acs.molpharmaceut.6b01039; Brown JR, 2014, BLOOD, V123, P3390, DOI 10.1182/blood-2013-11-535047; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dey N, 2015, AM J CANCER RES, V5, P1; Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Flecknell P, 2002, ALTEX-ALTERN TIEREXP, V19, P73; Furman RR, 2014, NEW ENGL J MED, V370, P997, DOI 10.1056/NEJMoa1315226; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Huang M, 2014, TRENDS PHARMACOL SCI, V35, P41, DOI 10.1016/j.tips.2013.11.004; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Kim RD, 2018, BRIT J CANCER, V118, P462, DOI 10.1038/bjc.2017.428; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Koren S, 2015, NATURE, V525, P114, DOI 10.1038/nature14669; Lazo JS, 2016, ANNU REV PHARMACOL, V56, P23, DOI 10.1146/annurev-pharmtox-010715-103440; Liao XY, 2012, CLIN CANCER RES, V18, P2257, DOI 10.1158/1078-0432.CCR-11-2410; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Massacesi C, 2016, ONCOTARGETS THER, V9, P203, DOI 10.2147/OTT.S89967; Mei ZB, 2016, ANN ONCOL, V27, P1836, DOI 10.1093/annonc/mdw264; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Meyer DS, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.38; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Petrocca F, 2011, J CLIN ONCOL, V29, P747, DOI 10.1200/JCO.2009.27.6287; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Shigeta K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066302; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Surendranath Vineeth, 2013, Methods Mol Biol, V942, P193, DOI 10.1007/978-1-62703-119-6_11; Temraz S, 2015, INT J MOL SCI, V16, P22976, DOI 10.3390/ijms160922976; Therkildsen C, 2014, ACTA ONCOL, V53, P852, DOI 10.3109/0284186X.2014.895036; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Tsai WB, 2012, CANCER RES, V72, P2622, DOI 10.1158/0008-5472.CAN-11-3605; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang X, 2015, ACTA PHARMACOL SIN, V36, P1170, DOI 10.1038/aps.2015.71; Wang XY, 2011, CANCER RES, V71, P925, DOI 10.1158/0008-5472.CAN-10-1032; Wild R, 2006, MOL CANCER THER, V5, P104, DOI 10.1158/1535-7163.MCT-05-0259; Wu P, 2015, TRENDS PHARMACOL SCI, V36, P422, DOI 10.1016/j.tips.2015.04.005; Wu SY, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008362; Yap TA, 2015, CURR OPIN PHARMACOL, V23, P98, DOI 10.1016/j.coph.2015.05.016; Yuan TL, 2014, CANCER DISCOV, V4, P1182, DOI 10.1158/2159-8290.CD-13-0900; Yueh AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148730; Zhang J. Y., 2015, J MODERN POWER SYSTE, V3, P1	56	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200163	10.1371/journal.pone.0200163	http://dx.doi.org/10.1371/journal.pone.0200163			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001368	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400031
J	Bhatt, SP; Guleria, R; Vikram, NK; Nandhan, SV; Singh, Y; Gupta, AK				Bhatt, Surya Prakash; Guleria, Randeep; Vikram, Naval K.; Nandhan, S., V; Singh, Yogendra; Gupta, A. K.			Association of inflammatory genes in obstructive sleep apnea and non alcoholic fatty liver disease in Asian Indians residing in north India	PLOS ONE			English	Article							INSULIN-RESISTANCE SYNDROME; C-REACTIVE PROTEIN; METABOLIC SYNDROME; INTERMITTENT HYPOXIA; OBESITY; LEPTIN; INTERLEUKIN-6; ACTIVATION; RECEPTOR; POLYMORPHISM	Background Previous studies have indicated that variants of the high sensitive C-reactive protein (CRP), Interleukin (IL)-6 and leptin receptor (LEPR) genes are associated with the presence of obstructive sleep apnea (OSA) but not in non-alcoholic fatty liver disease (NAFLD) in Asian Indians. The study was conducted to investigate the association of CRP rs1130864 (1444c/T), IL-6 rs1800795 (-174G/c) and LEPR rs1137101 (Q223R) genes with OSA and NAFLD in Asian Indians residing in North India. Methods 240 overweight/obese subjects [body mass index (BMI>23kg/m(2))], 124 with OSA and with NAFLD (group 1), 47 with OSA without NAFLD (group 2), 44 without OSA and with NAFLD (group 3) and 25 without OSA and without NAFLD (group 4) were recruited in this study. The severity of NAFLD was based on abdomen liver ultrasound and of OSA on overnight polysomnography. Clinical details, anthropometry profile, body composition, biochemical parameters and inflammatory markers were measured. Polymerase chain reaction and restriction fragment length polymorphism of CRP, IL-6 and LEPR gene was performed. The associations of these polymorphisms with clinical, anthropometric and biochemical profiles were investigated. The genotypes were confirmed by DNA sequencing analysis. Results The C, T and R alleles of IL-6, CRP and LEPR genes was more frequent in OSA and NAFLD subjects and significantly correlated with higher protein levels. The prevalence of variant genotypes c/T of CRP, G/c of IL-6 and Q/R of LEPR genes was significantly higher in OSA subjects as compared to non OSA subjects. Further, c/c genotype of IL-6 (G/c), T/T of CRP (c/T) and RR genotype of LEPR (Q/R) was associated with significantly higher BMI, fat mass (kg), % body fat, waist circumference, serum triglycerides, total cholesterol, alkaline phosphate, aspartate transaminase and fasting insulin levels in OSA and NAFLD subjects. Using a multivariate analysis, the combined effect of three polymorphisms of CRP, IL6 and LEPR gene variants on OSA and NAFLD risk was evaluated. Odds ratio for OSA and NAFLD with the combination of the three gene polymorphisms increased to 2.84 (95% CI: 1.08-6.54; p = 0.04) even when adjusted for sex, age and BMI. Conclusion Polymorphisms of pro-inflammatory cytokine genes were associated with increased risk of OSA and NAFLD in Asian Indians.	[Bhatt, Surya Prakash; Guleria, Randeep; Singh, Yogendra] All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India; [Vikram, Naval K.] All India Inst Med Sci, Dept Med, New Delhi, India; [Nandhan, S., V] All India Inst Med Sci, Dept Neurobiochem, New Delhi, India; [Gupta, A. K.] All India Inst Med Sci, Dept Radiol, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Guleria, R (corresponding author), All India Inst Med Sci, Dept Pulm Med & Sleep Disorders, New Delhi, India.	randeep@hotmail.com	Bhatt, Surya Prakash/X-5941-2018; Bhatt, Surya/K-5263-2019	Bhatt, Surya Prakash/0000-0001-9489-9747; Bhatt, Surya/0000-0001-9489-9747	Ministry of Science and Technology, Department of Science and Technology, Government of India [SR/SO/HS-0146/2010]	Ministry of Science and Technology, Department of Science and Technology, Government of India(Department of Science & Technology (India))	This study was fully supported by a grant from the Ministry of Science and Technology, Department of Science and Technology (Ref: SR/SO/HS-0146/2010)., Government of India. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2017, J PHARM BIOALLIED SC, V9, pS26, DOI 10.4103/jpbs.JPBS_155_17; BaHammam AS, 2014, SLEEP BREATH, V18, P767, DOI 10.1007/s11325-014-0939-3; Bajaj S, 2009, INDIAN J MED RES, V129, P285; Bhatt SP, 2013, ATHEROSCLEROSIS, V230, P157, DOI 10.1016/j.atherosclerosis.2013.07.006; Bhushan B, 2009, NUTR METAB CARDIOVAS, V19, P184, DOI 10.1016/j.numecd.2008.06.008; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Boston BA, 2004, J PEDIATR ENDOCR MET, V17, P1289; Dudeja V, 2001, BRIT J NUTR, V86, P105, DOI 10.1079/BJN2001382; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Gami AS, 2003, ENDOCRIN METAB CLIN, V32, P869, DOI 10.1016/S0889-8529(03)00069-0; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gotoda T, 1997, HUM MOL GENET, V6, P869, DOI 10.1093/hmg/6.6.869; Haddy N, 2003, ATHEROSCLEROSIS, V170, P277, DOI 10.1016/S0021-9150(03)00287-9; Hanaoka M, 2008, CHEST, V133, P79, DOI 10.1378/chest.07-1633; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Jun JC, 2011, SLEEP, V34, P1207, DOI 10.5665/SLEEP.1240; Kaditis AG, 2014, SLEEP MED, V15, P228, DOI 10.1016/j.sleep.2013.08.795; Karaduman M, 2006, CLIN EXP IMMUNOL, V143, P452, DOI 10.1111/j.1365-2249.2006.03025.x; Lambert M, 2004, INT J OBESITY, V28, P833, DOI 10.1038/sj.ijo.0802694; Larkin EK, 2010, AM J RESP CRIT CARE, V182, P947, DOI 10.1164/rccm.201002-0192OC; Li J, 2006, AM J PHYSIOL-GASTR L, V291, pG1031, DOI 10.1152/ajpgi.00483.2005; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martinez-Calleja A, 2012, EXP DIABETES RES, DOI 10.1155/2012/982683; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Minoguchi K, 2006, EUR RESPIR J, V28, P378, DOI 10.1183/09031936.06.00084905; Misra A, 2002, CURR SCI INDIA, V83, P1483; Misra A, 2009, J Assoc Physicians India, V57, P163; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Murugesan Devi, 2010, Indian J Hum Genet, V16, P72, DOI 10.4103/0971-6866.69350; Musso G, 2012, SEMIN LIVER DIS, V32, P49, DOI 10.1055/s-0032-1306426; Popko K, 2007, J PHYSIOL PHARMACOL, V58, P551; Prabhakar NR, 2010, RESP PHYSIOL NEUROBI, V174, P156, DOI 10.1016/j.resp.2010.08.021; Rajendran K, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-13; Raji A, 2001, J CLIN ENDOCR METAB, V86, P5366, DOI 10.1210/jc.86.11.5366; Ryan S, 2005, CIRCULATION, V112, P2660, DOI 10.1161/CIRCULATIONAHA.105.556746; Santos-Alvarez J, 1999, CELL IMMUNOL, V194, P6, DOI 10.1006/cimm.1999.1490; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; TAM K-M, 1986, Taiwan yixuehui zazhi, V85, P45; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Tumu VR, 2013, J ASSIST REPROD GEN, V30, P1541, DOI 10.1007/s10815-013-0111-1; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3	42	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199599	10.1371/journal.pone.0199599	http://dx.doi.org/10.1371/journal.pone.0199599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001365	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400014
J	Gu, L; Bok, D; Yu, F; Caprioli, J; Piri, N				Gu, Lei; Bok, Dean; Yu, Fei; Caprioli, Joseph; Piri, Natik			Downregulation of splicing regulator RBFOX1 compromises visual depth perception	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPTIC-NERVE TRANSECTION; MOUSE RETINA; EXPERIMENTAL GLAUCOMA; PIGMENT EPITHELIUM; AMACRINE CELLS; GENE; EXPRESSION; PROTEIN; MORPHOLOGY	Rbfox1 is a splicing regulator that has been associated with various neurological conditions such as autism spectrum disorder, mental retardation, epilepsy, attention-deficit/hyperactivity disorder and schizophrenia. We show that in adult rodent retinas, Rbfox1 is expressed in all types of retinal ganglion cells (RGCs) and in certain subsets of amacrine cells (ACs), within the inner nuclear (INL) and ganglion cell (GCL) layers. In the INL, all Rbfox1-positive cells were colocalized with GABAergic ACs, however not all GABAergic ACs were immunostained for Rbfox1. In the GCL, a vast majority of GABAergic dACs were Rbfox1 -immunopositive. Furthermore, all cholinergic starburst ACs (SACs) in the INL (type a) and in the GCL (type b) were Rbfox1 positive. The expression of Rbfox1 in the retina significantly overlapped with expression of Rbfox2, another member of Rbfox family of proteins. Rbfox2, in addition to RGCs and ACs, was also expressed in horizontal cells. In developing retinas at E12 and E15, Rbfox1 is localized to the cytoplasm of differentiating RGCs and ACs. Between PO and P5, Rbfox1 subcellular localization switched from cytoplasmic to predominantly nuclear. Downregulation of Rbfox1 in adult Rbfox1(loxP/loxP) mice had no detectable effect on retinal gross morphology. However, the visual cliff test revealed marked abnormalities of depth perception of these animals. RNA sequencing of retinal transcriptomes of control and Rbfox1 knockout animals identified a number of Rbfox1 -regulated genes that are involved in establishing neuronal circuits and synaptic transmission, including Vamp1, Vamp2, Snap25, Trak2, and Slc1A7, suggesting the role of Rbfox1 in facilitating synaptic communications between ACs and RGCs.	[Gu, Lei; Bok, Dean; Yu, Fei; Caprioli, Joseph; Piri, Natik] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Piri, N (corresponding author), Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA.	piri@jsei.ucla.edu	Gu, Lei/GWQ-6785-2022	Piri, Natik/0000-0002-0134-1996	NIH/NEI [EY018644]; NINDS (National Institute of Neurological Disorders and Stroke) Informatics Center for Neurogenetics and Neurogenomics [P30 NS062691]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS (National Institute of Neurological Disorders and Stroke) Informatics Center for Neurogenetics and Neurogenomics; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by NIH/NEI EY018644 (NP), NINDS (National Institute of Neurological Disorders and Stroke) Informatics Center for Neurogenetics and Neurogenomics (P30 NS062691; GC) and Research to Prevent Blindness (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; Baden T, 2016, NATURE, V529, P345, DOI 10.1038/nature16468; Bailey MJ, 2004, INVEST OPHTH VIS SCI, V45, P769, DOI 10.1167/iovs.03-1125; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Brake Rachael L, 2004, Genet Mol Res, V3, P456; Cheng CL, 2003, METHOD MOL BIOL, V935, P185; Cupertino RB, 2016, J NEURAL TRANSM, V123, P867, DOI 10.1007/s00702-016-1514-9; DACEY DM, 1992, P NATL ACAD SCI USA, V89, P9666, DOI 10.1073/pnas.89.20.9666; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; DACEY DM, 1993, J NEUROSCI, V13, P5334, DOI 10.1523/JNEUROSCI.13-12-05334.1993; Diaz NM, 2017, MOL NEUROBIOL; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FOX MW, 1965, ANIM BEHAV, V13, P232, DOI 10.1016/0003-3472(65)90040-0; Gehman LT, 2011, NAT GENET, V43, P706, DOI 10.1038/ng.841; HAMANO K, 1990, J COMP NEUROL, V302, P417, DOI 10.1002/cne.903020217; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073323; Lee JA, 2016, NEURON, V89, P113, DOI 10.1016/j.neuron.2015.11.025; Lee JA, 2009, GENE DEV, V23, P2284, DOI 10.1101/gad.1837009; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Mazziotti R, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15488; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Morgan J. L., 2007, WEBVISION; Munemasa Y, 2009, GENE THER, V16, P17, DOI 10.1038/gt.2008.126; Munemasa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034810; Piri N, 2006, MOL VIS, V12, P1660; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RODIECK RW, 1993, J COMP NEUROL, V338, P289, DOI 10.1002/cne.903380211; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sherry DM, 2003, MOL VIS, V9, P673; Xu HP, 2016, J NEUROSCI, V36, P3871, DOI 10.1523/JNEUROSCI.3549-15.2016; Yamada ES, 2001, VISION RES, V41, P119, DOI 10.1016/S0042-6989(00)00244-3	44	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200417	10.1371/journal.pone.0200417	http://dx.doi.org/10.1371/journal.pone.0200417			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001398	gold, Green Published			2022-12-26	WOS:000438457400052
J	Teagle, H; Moore, PJ; Jenkins, H; Smale, DA				Teagle, Harry; Moore, Pippa J.; Jenkins, Helen; Smale, Dan A.			Spatial variability in the diversity and structure of faunal assemblages associated with kelp holdfasts (Laminaria hyperborea) in the northeast Atlantic	PLOS ONE			English	Article							WAVE EXPOSURE; INVERTEBRATE COMMUNITIES; MACROCYSTIS-PYRIFERA; MACROFAUNAL COMMUNITY; LATITUDINAL GRADIENT; SECONDARY PRODUCTION; SPECIES RICHNESS; REEF TOPOGRAPHY; MOBILE EPIFAUNA; SEA-URCHINS	Kelp species are ecologically-important habitat-formers in coastal marine ecosystems, where they alter environmental conditions and promote local biodiversity by providing complex biogenic habitat for an array of associated organisms. While it is widely accepted that kelps harbour significant biodiversity, our current understanding of spatiotemporal variability in kelp-associated assemblages and the key environmental drivers of variability patterns remains limited. Here we examined the influence of ocean temperature and wave exposure on the structure of faunal assemblages associated with the holdfasts of Laminaria hyperborea, the dominant habitat-forming kelp in the northeast Atlantic. We sampled holdfasts from 12 kelp-dominated open-coast sites nested within four regions across the UK, spanning similar to 9 degrees in latitude and similar to 2.7 degrees C in mean sea surface temperature. Overall, holdfast assemblages were highly diverse, with 261 taxa representing 11 phyla recorded across the study. We examined patterns of spatial variability for sessile and mobile taxa separately, and documented high variability between regions, between sites within regions, and between replicate holdfasts for both assemblage types. Mobile assemblage structure was more strongly linked to temperature variability than sessile assemblage structure, which was principally structured by site-level variability in factors such as wave exposure. Patterns in the structure of both biogenic habitat and associated assemblages did not vary predictably along a latitudinal gradient in temperature, indicating that other processes acting across multiple spatial and temporal scales are important drivers of assemblage structure. Overall, kelp holdfasts in the UK supported high levels of diversity, that were similar to other kelp-dominated systems globally and comparable to those recorded for other vegetated marine habitats (i.e. seagrass beds), which are perhaps more widely recognised for their high biodiversity value.	[Teagle, Harry; Jenkins, Helen; Smale, Dan A.] Marine Biol Assoc UK, The Lab, Citadel Hill, Plymouth, Devon, England; [Teagle, Harry] Univ Southampton, Natl Oceanog Ctr Southampton, Ocean & Earth Sci, Southampton, Hants, England; [Moore, Pippa J.] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Moore, Pippa J.] Edith Cowan Univ, Sch Nat Sci, Ctr Marine Ecosyst Res, Joondalup, WA, Australia; [Jenkins, Helen] Nat Hist Museum, Dept Life Sci, London, England	Marine Biological Association United Kingdom; NERC National Oceanography Centre; University of Southampton; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Edith Cowan University; Natural History Museum London	Smale, DA (corresponding author), Marine Biol Assoc UK, The Lab, Citadel Hill, Plymouth, Devon, England.	dansma@MBA.ac.uk	Moore, Pippa/HCH-3738-2022; Moore, Pippa/H-8079-2013; Smale, Daniel/Y-2909-2019	Moore, Pippa/0000-0002-9889-2216; Smale, Daniel/0000-0003-4157-541X	National Environmental Research Council (NERC) Doctoral Training Partnership SPITFIRE [NE/L002531/1]; Independent Research Fellowship - Natural Environment Research Council of the UK [NE/K008439/1]; Marie Curie Career Integration Grant [PCIG10-GA-2011-303685]; NERC National Facility for Scientific Diving [NFSD/14/01]; NERC [dml011000, NE/K008439/1] Funding Source: UKRI	National Environmental Research Council (NERC) Doctoral Training Partnership SPITFIRE; Independent Research Fellowship - Natural Environment Research Council of the UK; Marie Curie Career Integration Grant; NERC National Facility for Scientific Diving; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	H.T. is funded through the National Environmental Research Council (NERC) Doctoral Training Partnership SPITFIRE (NE/L002531/1), administered through Southampton University. D. A.S. was supported by an Independent Research Fellowship awarded by the Natural Environment Research Council of the UK (NE/K008439/1), PM was supported through a Marie Curie Career Integration Grant (PCIG10-GA-2011-303685). Some of the fieldwork was supported by the NERC National Facility for Scientific Diving (NFSD/14/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; H.T. is funded through the National Environmental Research Council (NERC) Doctoral Training Partnership SPITFIRE (NE/L002531/1), administered through Southampton University. D.A.S. was supported by an Independent Research Fellowship awarded by the Natural Environment Research Council of the UK (NE/K008439/1), PM was supported through a Marie Curie Career Integration Grant (PCIG10-GA-2011-303685). Some of the fieldwork was supported by the NERC National Facility for Scientific Diving (NFSD/14/01). We thank Keith Hiscock (Fig 1B and 1E) and Alix Harvey (1d) for contributing images for Fig 1.	Anderson MJ, 2005, J EXP MAR BIOL ECOL, V320, P35, DOI 10.1016/j.jembe.2004.12.023; Anderson MJ, 2008, PERMANOVA PRIMER E G; [Anonymous], 2013, NAT CLIM CHANGE, DOI [10.1038/nclimate1627, DOI 10.1038/NCLIMATE1627]; Azzarello JJ, 2014, MAR BIOL RES, V10, P682, DOI 10.1080/17451000.2013.841945; Ballantine W. J., 1961, FIELD STUDIES, V1, P1; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Bekkby T, 2014, MAR ECOL PROG SER, V506, P61, DOI 10.3354/meps10778; Bekkby T, 2009, ICES J MAR SCI, V66, P2106, DOI 10.1093/icesjms/fsp195; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Blight AJ, 2008, J MAR BIOL ASSOC UK, V88, P469, DOI 10.1017/S0025315408000994; BOLOGNA PAX, 1993, MAR ECOL PROG SER, V100, P127, DOI 10.3354/meps100127; BOROWSKY B, 1983, MAR BIOL, V77, P257, DOI 10.1007/BF00395814; BRATTSTR.H, 1968, SARSIA, P9; Brodie J, 2014, ECOL EVOL, V4, P2787, DOI 10.1002/ece3.1105; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Burrows MT, 2008, MAR ECOL PROG SER, V353, P1, DOI 10.3354/meps07284; Burrows MT, 2012, MAR ECOL PROG SER, V445, P193, DOI 10.3354/meps09422; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cancino J, 1980, P INT S 10 SWED, P241; Christie H, 1998, HYDROBIOLOGIA, V375-76, P49, DOI 10.1023/A:1017021325189; Christie H, 2003, J MAR BIOL ASSOC UK, V83, P687, DOI 10.1017/S0025315403007653h; Christie H, 2009, MAR ECOL PROG SER, V396, P221, DOI 10.3354/meps08351; Clarke KR, 2015, PRIMER V7 USER MANUA; Coleman MA, 2007, MAR FRESHWATER RES, V58, P589, DOI 10.1071/MF06216; Como S, 2008, MAR BIOL, V153, P1087, DOI 10.1007/s00227-007-0881-z; Dick JTA, 1998, ANIM BEHAV, V56, P663, DOI 10.1006/anbe.1998.0797; EDGAR GJ, 1992, J EXP MAR BIOL ECOL, V160, P13, DOI 10.1016/0022-0981(92)90107-L; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V144, P205, DOI 10.1016/0022-0981(90)90029-C; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P215, DOI 10.1016/0022-0981(90)90186-G; Evans SN, 2010, MAR FRESHWATER RES, V61, P1327, DOI 10.1071/MF10007; FENWICK GD, 1976, J EXP MAR BIOL ECOL, V25, P1, DOI 10.1016/0022-0981(76)90072-1; Figurski JD, 2011, LIMNOL OCEANOGR-METH, V9, P204, DOI 10.4319/lom.2011.9.204; FINCHAM A A, 1974, New Zealand Journal of Marine and Freshwater Research, V8, P505; Foster S, 2014, J EXP MAR BIOL ECOL, V453, P43, DOI 10.1016/j.jembe.2013.12.015; Fraschetti S, 2005, MAR ECOL PROG SER, V296, P13, DOI 10.3354/meps296013; Goldson AJ, 2001, MAR BIOL, V138, P1037, DOI 10.1007/s002270000511; Goodsell PJ, 2008, MAR BIOL, V154, P117, DOI 10.1007/s00227-008-0906-2; Goodsell PJ, 2002, MAR ECOL PROG SER, V239, P37, DOI 10.3354/meps239037; GP J., 2004, AUSTRAL ECOLOGY, V29, P350, DOI [10.1111/j.1442-9993.2004.01372.x, DOI 10.1111/J.1442-9993.2004.01372.X]; HAGEN NT, 1983, SARSIA, V68, P177, DOI 10.1080/00364827.1983.10420570; HARROLD C, 1985, ECOLOGY, V66, P1160, DOI 10.2307/1939168; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; Joint I, 2017, FEMS MICROBIOLOGY EC, V93, P1; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; JONES DJ, 1972, HELGOLAND WISS MEER, V23, P248, DOI 10.1007/BF01609692; JONES DJ, 1973, MAR BIOL, V20, P351, DOI 10.1007/BF00354277; Jorgensen NM, 2003, HYDROBIOLOGIA, V503, P69, DOI 10.1023/B:HYDR.0000008491.89382.e5; JUPP BP, 1974, J EXP MAR BIOL ECOL, V15, P185, DOI 10.1016/0022-0981(74)90044-6; Jurgens LJ, 2018, ECOL LETT, V21, P190, DOI 10.1111/ele.12881; KAIN JM, 1963, J MAR BIOL ASSOC UK, V43, P129, DOI 10.1017/S0025315400005312; Knights AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035096; Krumhansl KA, 2012, MAR ECOL PROG SER, V467, P281, DOI 10.3354/meps09940; Ling SD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0269; LOYA Y, 1976, B MAR SCI, V26, P450; MANN KH, 1972, MAR BIOL, V14, P199; Marzinelli EM, 2012, BIOFOULING, V28, P339, DOI 10.1080/08927014.2012.674518; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mieszkowska N, 2006, HYDROBIOLOGIA, V555, P241, DOI 10.1007/s10750-005-1120-6; Molloy FJ, 1996, BOT MAR, V39, P525, DOI 10.1515/botm.1996.39.1-6.525; MOORE P G, 1972, Journal of Experimental Marine Biology and Ecology, V10, P59, DOI 10.1016/0022-0981(72)90093-7; MOORE P G, 1973, Journal of Experimental Marine Biology and Ecology, V13, P127, DOI 10.1016/0022-0981(73)90074-9; Moore P.G., 1972, J EXPT MARINE BIOL E, V13, P97; MOORE PG, 1978, J EXP MAR BIOL ECOL, V32, P53, DOI 10.1016/0022-0981(78)90099-0; MOORE PG, 1981, J EXP MAR BIOL ECOL, V49, P1, DOI 10.1016/0022-0981(81)90145-3; Moy FE, 2012, MAR BIOL RES, V8, P309, DOI 10.1080/17451000.2011.637561; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Norderhaug KM, 2014, MAR ECOL PROG SER, V502, P295, DOI 10.3354/meps10754; Norderhaug KM, 2007, J SEA RES, V58, P120, DOI 10.1016/j.seares.2007.03.001; Norderhaug KM, 2011, ESTUAR COAST SHELF S, V95, P135, DOI 10.1016/j.ecss.2011.08.028; Norderhaug KM, 2012, J SEA RES, V69, P36, DOI 10.1016/j.seares.2012.01.004; OJEDA FP, 1984, MAR ECOL PROG SER, V16, P65, DOI 10.3354/meps016065; OSMAN RW, 1977, ECOL MONOGR, V47, P37, DOI 10.2307/1942223; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Raffo MP, 2009, J MAR BIOL ASSOC UK, V89, P1571, DOI 10.1017/S002531540900071X; Pedersen MF, 2012, MAR ECOL PROG SER, V451, P45, DOI 10.3354/meps09594; Pessarrodona A, 2018, GLOBAL CHANGE BIOL, V24, P4386, DOI 10.1111/gcb.14303; Philippart CJM, 2011, J EXP MAR BIOL ECOL, V400, P52, DOI 10.1016/j.jembe.2011.02.023; Reed DC, 2008, ECOLOGY, V89, P2493, DOI 10.1890/07-1106.1; Richmond M.D., 1991, Biofouling, V3, P151; Schaal G, 2012, MAR ECOL-EVOL PERSP, V33, P370, DOI 10.1111/j.1439-0485.2011.00487.x; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; SCHULTZE K, 1990, HELGOLANDER MEERESUN, V44, P39, DOI 10.1007/BF02365430; SHEPPARD CRC, 1980, MAR ENVIRON RES, V4, P25, DOI 10.1016/0141-1136(80)90057-4; SJOTUN K, 1995, MAR ECOL PROG SER, V126, P213, DOI 10.3354/meps126213; Smale DA, 2017, J EXP MAR BIOL ECOL, V486, P255, DOI 10.1016/j.jembe.2016.10.023; Smale DA, 2016, MAR ECOL PROG SER, V542, P79, DOI 10.3354/meps11544; Smale DA, 2013, ECOL EVOL, V3, P4016, DOI 10.1002/ece3.774; Smale DA, 2010, J EXP MAR BIOL ECOL, V384, P76, DOI 10.1016/j.jembe.2009.11.013; Smith SDA, 1998, MAR BIOL, V131, P567, DOI 10.1007/s002270050349; Smith SDA, 1996, MAR POLLUT BULL, V33, P309, DOI 10.1016/S0025-326X(96)00124-5; Smith SDA, 1996, AUST J ECOL, V21, P81, DOI 10.1111/j.1442-9993.1996.tb00587.x; Smith SDA, 1996, AUST J ECOL, V21, P144, DOI 10.1111/j.1442-9993.1996.tb00595.x; SMITH SDA, 1992, MAR POLLUT BULL, V24, P46, DOI 10.1016/0025-326X(92)90316-X; Smith Stephen D. A., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P259, DOI 10.1023/A:1009993611262; Smyth TJ, 2010, J PLANKTON RES, V32, P585, DOI 10.1093/plankt/fbp128; Steneck RS, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P315; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Teagle H, 2018, DIVERS DISTRIB, V24, P1367, DOI 10.1111/ddi.12775; Teagle H, 2017, J EXP MAR BIOL ECOL, V492, P81, DOI 10.1016/j.jembe.2017.01.017; TEGNER MJ, 1995, J EXP MAR BIOL ECOL, V191, P83, DOI 10.1016/0022-0981(95)00053-T; Tittley I, 1985, T BOT SOC EDINBURGH, V44; Toohey BD, 2008, EUR J PHYCOL, V43, P133, DOI 10.1080/09670260701770554; Toohey BD, 2007, OIKOS, V116, P1618, DOI 10.1111/j.2007.0030-1299.15689.x; Tuya F, 2012, MAR ECOL PROG SER, V466, P9, DOI 10.3354/meps09941; Tuya F, 2011, HYDROBIOLOGIA, V658, P373, DOI 10.1007/s10750-010-0527-x; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Unsworth RKF, 2014, COASTAL CONSERVATION; VASQUEZ JA, 1990, HYDROBIOLOGIA, V204, P41, DOI 10.1007/BF00040213; Voerman SE, 2013, MAR ENVIRON RES, V90, P119, DOI 10.1016/j.marenvres.2013.06.006; Walls AM, 2016, AQUACULT ENV INTERAC, V8, P157, DOI 10.3354/aei00170; WATANABE JM, 1984, ECOLOGY, V65, P920, DOI 10.2307/1938065; Wernberg T, 2005, AQUAT BOT, V83, P61, DOI 10.1016/j.aquabot.2005.05.007; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P264, DOI 10.1016/j.jembe.2011.02.017; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Yesson C, 2015, J MAR BIOL ASSOC UK, V95, P669, DOI 10.1017/S0025315414001453	117	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200411	10.1371/journal.pone.0200411	http://dx.doi.org/10.1371/journal.pone.0200411			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001372	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000438457400051
J	Kim, YR; Lee, B; Byun, MR; Lee, JK; Choi, JW				Kim, Yi Rang; Lee, Bada; Byun, Mi Ran; Lee, Jong Kil; Choi, Jin Woo			Evaluation of pemetrexed and etoposide as therapeutic regimens for human papillomavirus-positive oral and oropharyngeal cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK CANCERS; PLUS GEMCITABINE; METASTATIC HEAD; CLINICAL-TRIAL; MESSENGER-RNA; PHASE-II; RECURRENT; CISPLATIN; CETUXIMAB	Although human papillomavirus (HPV) positive oral and oropharyngeal cancers have distinct epidemiologic and molecular characteristics compared to HPV-negative cancers, all patients with oral and oropharyngeal cancers received same standard regimen regardless of HPV status. For these reasons, specific regimens for patients with HPV-positive oral and oropharyngeal cancer are needed. Differentially expressed genes (DEG) between HPV-positive and HPV-negative oropharyngeal cancers were re-analyzed and categorized from public database. Then, druggable targets to HPV-positive oral and oropharyngeal cancer were identified and were validated with E6/E7, which is oncogene of HPV, transfected oral and oropharyngeal cancer cell lines and HPV infected cell lines. In DEG analysis, HPV-positive oral and oropharyngeal cancer showed distinct disease entity from HPV-negative cancers. Unlike HPV-negative oral and oropharyngeal cancer, thymidylate synthase (TS) and topoisomerase II (Topo II) were overexpressed in HPV-positive cancers. Transfection of Lenti-virus containing E6/E7 to HPV-negative oral and oropharyngeal cancer cells induced upregulation of TS and Topo II in those cells. Although cisplatin, which is standard regimen in head and neck cancers, showed more effectiveness in HPV-negative cells, 5-FU and pemetrexed, which are TS inhibitors, or etoposide, which is Topo II inhibitors, worked more effectively in HPV-positive cells. In addition, cisplatin/etoposide and cisplatin/pemetrexed combination regimens showed synergic effects in HPV-positive cells. Pemetrexed or etoposide alone, or in combination with other chemotherapeutic agents such as cisplatin, can be used as novel substitutes in a regimen of concurrent chemoradiotherapy or a palliative regimen for HPV-positive oral and oropharyngeal cancer patients. However, a well-designed clinical trial is needed.	[Kim, Yi Rang] Yuseong Sun Hosp, Dept Hematooncol, Daejeon, South Korea; [Lee, Bada; Byun, Mi Ran; Lee, Jong Kil; Choi, Jin Woo] Kyung Hee Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea; [Lee, Bada; Byun, Mi Ran; Choi, Jin Woo] Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University; Kyung Hee University	Choi, JW (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Pharmacol, Seoul, South Korea.; Choi, JW (corresponding author), Kyung Hee Univ, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	jinwoo.ch@khu.ac.kr	Lee, Jong Kil/AAK-8231-2020	Choi, Jin Woo/0000-0003-1177-598X	National Research Foundation of Korea [2014R1A1A1002431, NRF-2014R1A1A1002431, NRF-2016R1D1A1B03930490]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grants from National Research Foundation of Korea (2014R1A1A1002431, NRF-2014R1A1A1002431, and NRF-2016R1D1A1B03930490). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelstein D, 2017, J NATL COMPR CANC NE, V15, P761, DOI 10.6004/jnccn.2017.0101; Argiris A, 2011, J CLIN ONCOL, V29, P1140, DOI 10.1200/JCO.2010.33.3591; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Broglie MA, 2017, IMPACT HUMAN PAPILLO; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293; Chu E, 2003, CANCER CHEMOTH PHARM, V52, pS80, DOI 10.1007/s00280-003-0625-9; Dayyani F, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-15; DECKER J, 1982, NEW ENGL J MED, V306, P1151, DOI 10.1056/NEJM198205133061905; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fury MG, 2011, CANCER-AM CANCER SOC, V117, P795, DOI 10.1002/cncr.25464; Gedlicka C, 2006, CANCER INVEST, V24, P252, DOI 10.1080/07357900600633734; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gondivkar SM, 2012, ORAL ONCOL, V48, P195, DOI 10.1016/j.oraloncology.2011.10.007; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Ijuin T, 2007, ACTA OTO-LARYNGOL, V127, P305, DOI 10.1080/00016480600801381; KISH J, 1982, CANCER TREAT REP, V66, P471; Malhotra B, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00362; Martinez I, 2007, EUR J CANCER, V43, P415, DOI 10.1016/j.ejca.2006.09.001; Marur S, 2017, J CLIN ONCOL, V35, P490, DOI 10.1200/JCO.2016.68.3300; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mork J, 2001, NEW ENGL J MED, V344, P1125, DOI 10.1056/NEJM200104123441503; Ndiaye C, 2014, LANCET ONCOL, V15, P1319, DOI 10.1016/S1470-2045(14)70471-1; O'Sullivan B, 2016, LANCET ONCOL, V17, P440, DOI 10.1016/S1470-2045(15)00560-4; Osoba D, 1992, SEMINARS ONCOLOGY; Pivot X, 2001, BRIT J CANCER, V85, P649, DOI 10.1054/bjoc.2001.2010; Pytynia KB, 2014, ORAL ONCOL, V50, P380, DOI 10.1016/j.oraloncology.2013.12.019; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Seiwert TY, 2016, LANCET ONCOL, V17, P956, DOI 10.1016/S1470-2045(16)30066-3; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sturgis EM, 2011, J NATL COMPR CANC NE, V9, P665, DOI 10.6004/jnccn.2011.0055; Tao YG, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-40; Urba S, 2012, CANCER-AM CANCER SOC, V118, P4694, DOI 10.1002/cncr.27449; Vermorken JB, 2013, EUR J CANCER, V49, P2877, DOI 10.1016/j.ejca.2013.05.002; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wiest T, 2002, ONCOGENE, V21, P1510, DOI 10.1038/sj.onc.1205214; Wyss A, 2013, AM J EPIDEMIOL, V178, P679, DOI 10.1093/aje/kwt029	39	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200509	10.1371/journal.pone.0200509	http://dx.doi.org/10.1371/journal.pone.0200509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995943	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800077
J	Yamanaga, S; Rosario, A; Fernandez, D; Kobayashi, T; Tavakol, M; Stock, PG; Kang, SM				Yamanaga, Shigeyoshi; Rosario, Angel; Fernandez, Danny; Kobayashi, Takaaki; Tavakol, Mehdi; Stock, Peter G.; Kang, Sang-Mo			Inferior long-term graft survival after end-to-side reconstruction for two renal arteries in living donor renal transplantation	PLOS ONE			English	Article							LAPAROSCOPIC PROCUREMENT; MULTIPLE ARTERIES; OUTCOMES; SINGLE; NEPHRECTOMY; KIDNEYS; ALLOGRAFTS	Living donor kidneys with two arteries can be revascularized using various techniques depending on anatomy. We hypothesized that the revascularization technique could impact long-term outcomes. We retrospectively analyzed 1714 living donor renal transplants at our institution between 1999 and 2015. Three hundred and eleven kidneys had dual arteries, and these were categorized into 5 groups; end-to-side (n = 18), inferior epigastric artery (n = 21), direct anastomosis (n = 65), side-to-side (n = 126) and ligated (n = 81). We then compared the outcomes with that of a control group (single artery, n = 1403) using Kaplan-Meier and Cox regression analyses. Cox regression was adjusted by age, sex and race/ethnicity of donor and recipient, side of kidney, transplant period and recipient surgeon. Compared to the control group, the end-to-side group had increased all-cause graft loss (10 years: 77.2% vs 24.5%, adjusted hazard ratio [aHR] 3.02, 95% confidence interval [CI] 1.30 +/- 7.03, p = 0.010) and death-censored graft loss (10 years: 82.0% vs 55.9%, aHR 4.17, 95% CI 1.63 +/- 10.68, p = 0.003), whereas the other groups did not. Our study shows that 10-year overall survival and death-censored graft survival were significantly worse for end-to-side arterial reconstruction than for other techniques. Alternative techniques to the end-to-side method should be used for accessory arteries that require revascularization.	[Yamanaga, Shigeyoshi; Rosario, Angel; Fernandez, Danny; Tavakol, Mehdi; Stock, Peter G.; Kang, Sang-Mo] Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA; [Yamanaga, Shigeyoshi] Japanese Red Cross Kumamoto Hosp, Dept Surg, Kumamoto, Japan; [Yamanaga, Shigeyoshi; Kobayashi, Takaaki] Aichi Med Univ, Dept Renal Transplant Surg, Sch Med, Nagakute, Aichi, Japan	University of California System; University of California San Francisco; Aichi Medical University	Kang, SM (corresponding author), Univ Calif San Francisco, Dept Surg, Div Transplant Surg, San Francisco, CA 94143 USA.	Sang-Mo.Kang@ucsf.edu	Yamanaga, Shigeyoshi/AAQ-4641-2020	Yamanaga, Shigeyoshi/0000-0002-4372-0011; Kobayashi, Takaaki/0000-0001-8335-0361				Ahearn AJ, 2011, ARCH SURG-CHICAGO, V146, P859, DOI 10.1001/archsurg.2011.156; Ali-El-Dein B, 2003, J UROLOGY, V169, P2013, DOI 10.1097/01.ju.0000067637.83503.3e; Antonopoulos IM, 2014, UROLOGY, V84, P955, DOI 10.1016/j.urology.2014.06.022; Aydin Cagatay, 2004, BMC Surg, V4, P4, DOI 10.1186/1471-2482-4-4; BENEDETTI E, 1995, ANN SURG, V221, P406, DOI 10.1097/00000658-199504000-00012; Carter JT, 2005, AM J TRANSPLANT, V5, P1312, DOI 10.1111/j.1600-6143.2005.00859.x; Chedid MF, 2013, J AM COLL SURGEONS, V217, P144, DOI 10.1016/j.jamcollsurg.2013.04.010; Cho HJ, 2012, TRANSPL P, V44, P2913, DOI 10.1016/j.transproceed.2012.04.038; Cooper M, 2013, CLIN TRANSPLANT, V27, P261, DOI 10.1111/ctr.12062; Hiramitsu T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005188; Hiramitsu T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001811; Hsu THS, 2003, UROLOGY, V61, P323, DOI 10.1016/S0090-4295(02)02124-6; Hurst FP, 2009, AM J NEPHROL, V30, P459, DOI 10.1159/000242431; Hwang JK, 2010, TRANSPL P, V42, P4053, DOI 10.1016/j.transproceed.2010.09.075; Iwami D, 2012, TRANSPLANTATION, V93, P1013, DOI 10.1097/TP.0b013e31824cd615; Kok NFM, 2008, TRANSPLANTATION, V85, P1760, DOI 10.1097/TP.0b013e318172802d; Makiyama K, 2003, TRANSPLANTATION, V75, P828, DOI 10.1097/01.TP.0000054461.57565.18; McLoughlin LC, 2014, TRANSPL INT, V27, P458, DOI 10.1111/tri.12281; Paragi PR, 2011, WORLD J SURG, V35, P2159, DOI 10.1007/s00268-011-1168-6; Paramesh A, 2009, TRANSPLANTATION, V88, P1203, DOI 10.1097/TP.0b013e3181ba343a; Posselt AM, 2004, TRANSPLANTATION, V78, P1665, DOI 10.1097/01.TP.0000144320.33956.42; Tyson MD, 2011, UROLOGY, V77, P1116, DOI 10.1016/j.urology.2010.07.503; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zorgdrager M, 2016, ANN TRANSPL, V21, DOI 10.12659/AOT.898748	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199629	10.1371/journal.pone.0199629	http://dx.doi.org/10.1371/journal.pone.0199629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995911	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800028
J	Koitsalu, M; Eklund, M; Adolfsson, J; Sprangers, MAG; Gronberg, H; Brandberg, Y				Koitsalu, Marie; Eklund, Martin; Adolfsson, Jan; Sprangers, Mirjam A. G.; Gronberg, Henrik; Brandberg, Yvonne			Predictors of participation in risk-based prostate cancer screening	PLOS ONE			English	Article							QUALITY-OF-LIFE; DECISION-MAKING; MENS KNOWLEDGE; HEALTH; POPULATION; ATTITUDES; IMPACT; TRIAL; PERCEPTION; ONCOLOGY	Background Implementation of risk-based prostate cancer screening has been proposed as a means to reduce the harms of PSA screening. Little is known, however, about the factors influencing men's decision to attend a prostate cancer screening based on a risk assessment. Method We sent postal invitations with a login to a survey to 10.000 men, three months before invitation to a risk-based prostate cancer screening. Prostate cancer specific worry, prostate cancer-related knowledge, health behaviour, and health related quality of life were used as predictors of subsequent participation. Participation to risk-based prostate cancer screening was defined as providing a blood sample for the STHLM3 trial, a study evaluating a risk-based model that predicts the risk for aggressive prostate cancer. Results With a response rate of 20%, 1.347 men (70%) participated in ensuing risk-based prostate cancer screening three months later whereas 568 men (30%) declined participation in the STHLM3-study. These decliners reported less worry and feeling less vulnerable to prostate cancer and responded "Do not know" more often than participants when asked questions about prostate cancer knowledge. Participants reported greater benefits of prostate testing (p = 0.0005), less barriers to prostate testing (p<0.0001), and higher intention to attend prostate cancer testing (p<0.0001) than decliners. Finally, participants reported better overall health than decliners (p<0.0001). Conclusion Prostate cancer worry, PC knowledge, health behaviour and quality of life were identified as predictors of participation in risk-based prostate cancer screening. Targeting these predictors may improve the participation rates. These results can inform policymaking for future population-based prostate cancer screening programs that should address potential worry in men and lack of knowledge about prostate cancer.	[Koitsalu, Marie; Brandberg, Yvonne] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Eklund, Martin; Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Adolfsson, Jan] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Sprangers, Mirjam A. G.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, Amsterdam, Netherlands	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Amsterdam; Academic Medical Center Amsterdam	Koitsalu, M (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	marie.koitsalu@ki.se; Yvonne.Brandberg@ki.se		Koitsalu, Marie/0000-0002-8589-9187; Adolfsson, Jan/0000-0003-2992-1869	Cancer Risk Prediction Center (CRisP), a Linneus Centre - Swedish Research Council (Vetenskapsradet) [70867901]; Swedish Cancer Society (Cancerfonden)	Cancer Risk Prediction Center (CRisP), a Linneus Centre - Swedish Research Council (Vetenskapsradet); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society)	This work was supported by the Cancer Risk Prediction Center (CRisP), a Linneus Centre (Contract ID 70867901) financed by the Swedish Research Council (Vetenskapsradet); and by the Swedish Cancer Society (Cancerfonden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Avery KNL, 2008, EUR UROL, V53, P1186, DOI 10.1016/j.eururo.2007.07.040; Avery KNL, 2012, EUR UROL, V62, P649, DOI 10.1016/j.eururo.2011.12.059; Avery KNL, 2008, BJU INT, V102, P1629, DOI 10.1111/j.1464-410X.2008.07879.x; Basch E, 2012, J CLIN ONCOL, V30, P3020, DOI 10.1200/JCO.2012.43.3441; Essink-Bot ML, 1998, J NATL CANCER I, V90, P925, DOI 10.1093/jnci/90.12.925; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gronberg H, 2015, LANCET ONCOL; Katz DA, 2007, UROLOGY, V69, P215, DOI 10.1016/j.urology.2006.09.059; Koitsalu M, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-017-0467-5; Koitsalu M, 2016, ACTA ONCOL, V55, P45, DOI 10.3109/0284186X.2015.1043024; Malmi H, 2010, BJU INT, V106, P472, DOI 10.1111/j.1464-410X.2010.09165.x; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; Mercer SL, 1997, CAN J PUBLIC HEALTH, V88, P327, DOI 10.1007/BF03403900; Michelson H, 2000, ACTA ONCOL, V39, P477; Mottet N, 2017, EUR UROL, V71, P618, DOI 10.1016/j.eururo.2016.08.003; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nijs HGT, 2000, J PUBLIC HEALTH MED, V22, P312, DOI 10.1093/pubmed/22.3.312; O'Dell KJ, 1999, J FAM PRACTICE, V48, P682; Socialstyrelsen [The Swedish Board of Health and Welfare], 2018, SCREEN PROST REK BED; Steginga SK, 2001, J CANCER EDUC, V16, P42; Taylor KL, 2002, CANCER, V95, P1037, DOI 10.1002/cncr.10781; van Andel G, 2008, EUR J CANCER, V44, P2418, DOI 10.1016/j.ejca.2008.07.030; Watson E, 2006, PATIENT EDUC COUNS, V63, P367, DOI 10.1016/j.pec.2006.05.005; Watson M, 1999, BRIT J CANCER, V79, P868, DOI 10.1038/sj.bjc.6690139; Weinrich S P, 1998, Oncol Nurs Forum, V25, P527; Zhu XY, 2012, EUR UROL, V61, P652, DOI 10.1016/j.eururo.2011.11.029	29	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200409	10.1371/journal.pone.0200409	http://dx.doi.org/10.1371/journal.pone.0200409			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM5IS	29990335	gold, Green Published			2022-12-26	WOS:000438170300046
J	Liu, P; Li, C; Zheng, N; Yuan, XY; Zhou, YT; Chun, P; Chi, Y; Gilmore, C; Yu, SB; Sui, HJ				Liu, Pei; Li, Chan; Zheng, Nan; Yuan, Xiaoying; Zhou, Yutong; Chun, Pu; Chi, Yanyan; Gilmore, Campbell; Yu, Shengbo; Sui, Hongjin			The myodural bridges' existence in the sperm whale	PLOS ONE			English	Article							POSTERIOR MINOR MUSCLE; SPINAL DURA-MATER; CONNECTIVE-TISSUE; CEREBROSPINAL-FLUID; LIGAMENTUM NUCHAE; ANATOMIC RELATION; INTERSPACE; HEADACHE	Recent studies have identified that the myodural bridge (MDB) is located between the suboccipital muscles and cervical dura mater in the posterior atlanto-occipital interspace within humans. The myodural bridge has been considered to have a significant role in physiological functions. However, there is little information about the myodural bridge in marine mammals; we conducted this study to investigate and examine the morphology of the myodural bridge in a sperm whale. We also aim to discuss the physiological functions of the myodural bridge. In this study, a 15.1-meter long sperm whale carcass was examined. Multiple methods were conducted to examine the bridges of the sperm whale which included dissection, P45 plastination and histological analysis. This study confirmed the existence of the myodural bridge in the sperm whale and shows there are two types of the bridge in the sperm whale: one type was the occipital-dural bridge (ODB), the other type was the MDB. A large venous plexus was found within the epidural space and this venous plexus is thought to contain a great amount of blood when in deep water and thus the movements of suboccipital muscles could be a unique power source that drives cerebrospinal fluid circulation.	[Liu, Pei; Zhou, Yutong] Dalian Med Univ, Affiliated Hosp 1, Dalian, Peoples R China; [Li, Chan; Zheng, Nan; Yuan, Xiaoying; Chun, Pu; Chi, Yanyan; Gilmore, Campbell; Yu, Shengbo; Sui, Hongjin] Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China; [Sui, Hongjin] Dalian Hoffen Preservat Inst, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University	Yu, SB; Sui, HJ (corresponding author), Dalian Med Univ, Coll Basic Med, Dept Anat, Dalian, Peoples R China.; Sui, HJ (corresponding author), Dalian Hoffen Preservat Inst, Dalian, Peoples R China.	suihj@hotmail.com; yushengbo86@dmu.edu.cn		Liu, Pei/0000-0002-1761-8339	Natural Science Foundation of China [NSFC31600972, NSFC31571234]; Liaoning Province Natural Science funds [2014023017]; Liaoning Province Department of Education funds [L2016012, L2015156]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Province Natural Science funds; Liaoning Province Department of Education funds	This research was supported by the Natural Science Foundation of China (NSFC31600972 to NZ, NSFC31571234 to HS); Liaoning Province Natural Science funds (2014023017); and Liaoning Province Department of Education funds (L2016012 to NZ, L2015156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alboni P, 2011, J CARDIOVASC MED, V12, P422, DOI 10.2459/JCM.0b013e328344bcdc; Alix ME, 1999, J MANIP PHYSIOL THER, V22, P534, DOI 10.1016/S0161-4754(99)70006-0; Bilston Lynne E., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P235; Bogduk N, 2001, Curr Pain Headache Rep, V5, P382, DOI 10.1007/s11916-001-0029-7; Dean NA, 2002, CLIN ANAT, V15, P182, DOI 10.1002/ca.10001; Fernandez-De-Las-Penas C, 2008, AM J PHYS MED REHAB, V87, P197, DOI 10.1097/PHM.0b013e3181619766; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Hack GD, 2004, HEADACHE, V44, P84, DOI 10.1111/j.1526-4610.2004.04015.x; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; James PSBR, 1981, INDIAN J FISHERIES; Johnson GM, 2000, SPINE, V25, P5, DOI 10.1097/00007632-200001010-00003; KAHN JL, 1992, ACTA ANAT, V144, P65; Kulkarni V, 2001, NEUROL INDIA, V49, P355; Liu P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173630; McPartland JM, 1997, J MANIP PHYSIOL THER, V20, P24; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; NITZ WR, 1992, RADIOLOGY, V183, P395, DOI 10.1148/radiology.183.2.1561340; Noren SR, 2012, J EXP BIOL, V215, P2735, DOI 10.1242/jeb.069583; Palomeque-del-Cerro L, 2017, SPINE, V42, P49, DOI 10.1097/BRS.0000000000001655; Pontell ME, 2013, ANN ANAT, V195, P522, DOI 10.1016/j.aanat.2013.04.013; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; RHODE EA, 1986, AM J PHYSIOL, V251, pR174, DOI 10.1152/ajpregu.1986.251.1.R174; Rutten HP, 1997, SPINE, V22, P924, DOI 10.1097/00007632-199704150-00018; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2013, CLIN ANAT, V26, P444, DOI 10.1002/ca.22094; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Shadwick Robert E., 1995, Symposia of the Society for Experimental Biology, V49, P243; Shinomiya K, 1996, SPINE, V21, P2081, DOI 10.1097/00007632-199609150-00005; SNYDER GK, 1983, RESP PHYSIOL, V54, P269, DOI 10.1016/0034-5687(83)90072-5; [隋鸿锦 Sui Hongjin], 2013, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V31, P489; Tagil SM, 2005, CLIN ANAT, V18, P373, DOI 10.1002/ca.20106; Xu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep31787; Yuan XY, 2017, CEPHALALGIA, V37, P1051, DOI 10.1177/0333102416664775; Yuan XY, 2016, ANAT SCI INT, V91, P175, DOI 10.1007/s12565-015-0282-1; Zhang JH, 2016, ANAT REC, V299, P1402, DOI 10.1002/ar.23445; Zheng N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06863-z; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103451; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	38	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200260	10.1371/journal.pone.0200260	http://dx.doi.org/10.1371/journal.pone.0200260			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985953	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500029
J	Oli, N; Vaidya, A; Pahkala, K; Eiben, G; Krettek, A				Oli, Natalia; Vaidya, Abhinav; Pahkala, Katja; Eiben, Gabriele; Krettek, Alexandra			Knowledge, attitude and practice on diet and physical activity among mothers with young children in the Jhaukhel-Duwakot Health Demographic Surveillance Site, Nepal	PLOS ONE			English	Article							NUTRITIONAL KNOWLEDGE; FOOD-CONSUMPTION; EATING BEHAVIOR; HABITS	The prevalence of cardiovascular diseases is increasing in low and middle-income countries; Nepal's population shows a high prevalence of behavioral risk factors. Our cross-sectional study in the Jhaukhel-Duwakot Health Demographic Surveillance Site (JD-HDSS), located near the capital Kathmandu, explored knowledge, attitude, and practice (KAP) of mothers with young children regarding diet and physical activity and mothers' perception of their children's attitude and behavior toward the same issues. The purpose of our study was to assess needs of the mothers concerning cardiovascular health in general and more specifically regarding diet and physical activity, and to establish a baseline for future intervention in the community by comparing two villages of JD-HDSS. In August-November 2014, nine trained enumerators interviewed all mothers of children aged 1-7 years (N = 962). We scored responses on dietary and physical activity KAP, then categorized the scores based on the percentage obtained out of the maximum possible scores into "poor," "fair," and "good." More highly educated mothers scored higher for KAP (all p<0.001); the children's behavior score reflected their mother's education level (p = 0.007). Most respondents were unfamiliar with the concept of healthy and unhealthy food. Overall, 57% of respondents in JD-HDSS had "good" knowledge, 44.6% had "good" attitude, and most (90%) had "poor" practice. We observed no significant differences between the villages regarding mothers' knowledge and attitude or children's behavior. Practice score of mothers in Jhaukhel was higher than those in Duwakot regarding diet and physical activity (p<0.001). Mothers' perceived barriers for improving lifestyle were high cost of healthy food, taste preference of other family members, and lack of knowledge regarding healthy food. Barriers for physical activity were lack of leisure time, absence of parks and playgrounds, busy caring for children and old people, feeling lazy, and embarrassed to be physically active in front of others. Our findings suggest that a health education intervention promoting a healthy lifestyle for mothers and children might improve KAP and also improve cardiovascular health. To address mothers' gap between knowledge and practice, a future intervention should consider perceived barriers.	[Oli, Natalia; Krettek, Alexandra] Univ Gothenburg, Inst Med, Dept Internal Med & Clin Nutr, Sahlgrenska Acad, Gothenburg, Sweden; [Oli, Natalia; Vaidya, Abhinav] Kathmandu Med Coll, Dept Community Med, Kathmandu, Nepal; [Pahkala, Katja] Univ Turku, Paavo Nurmi Ctr, Dept Hlth & Phys Act, Turku, Finland; [Pahkala, Katja] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Eiben, Gabriele] Univ Gothenburg, Dept Publ Hlth & Community Med, Gothenburg, Sweden; [Eiben, Gabriele; Krettek, Alexandra] Univ Skovde, Sch Hlth & Educ, Dept Biomed & Publ Hlth, Skovde, Sweden; [Krettek, Alexandra] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway	University of Gothenburg; University of Turku; University of Turku; University of Gothenburg; University of Skovde; UiT The Arctic University of Tromso	Oli, N (corresponding author), Univ Gothenburg, Inst Med, Dept Internal Med & Clin Nutr, Sahlgrenska Acad, Gothenburg, Sweden.; Oli, N (corresponding author), Kathmandu Med Coll, Dept Community Med, Kathmandu, Nepal.	natalia.oli@gu.se	Pahkala, Katja/GPX-7471-2022; Yitayih, Gebre/AAH-9868-2019; Pahkala, Katja/D-7449-2013	Pahkala, Katja/0000-0001-9338-4397; Oli, Natalia/0000-0002-1176-196X	Wilhelm and Martina Lundgren Foundation [2016-1179]; Swedish Research Council [2016-05682]; Arvid and Karin Lundahl Foundation [2016-12-01]	Wilhelm and Martina Lundgren Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Arvid and Karin Lundahl Foundation	The study was funded by the following grants: Wilhelm and Martina Lundgren Foundation, grant 2016-1179; the Swedish Research Council, grant 2016-05682; Arvid and Karin Lundahl Foundation, grant 2016-12-01.	Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; Al-Shookri Ali, 2011, Oman Med J, V26, P253, DOI 10.5001/omj.2011.61; Aryal K.K., 2014, NON COMMUNICABLE DIS; Aryal Umesh Raj, 2012, BMC Res Notes, V5, P489, DOI 10.1186/1756-0500-5-489; Campbell K, 2002, ASIA PAC J CLIN NUTR, V11, pS553, DOI 10.1046/j.0964-7058.2002.00346.x; CBS, 2014, POPULATION MONOGRAPH; Central Bureau of Statistics (CBS), 2012, NAT POP HIUS CENS 20; Choulagai BP, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.29396; Darnton-Hill I, 2004, PUBLIC HEALTH NUTR, V7, P101, DOI 10.1079/PHN2003584; El-Nmer F, 2014, MENOUFIA MED J, V27, P612, DOI DOI 10.4103/1110-2098.145529; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hart KH, 2003, J HUM NUTR DIET, V16, P89, DOI 10.1046/j.1365-277X.2003.00429.x; Hendrie G, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-4; Hesketh KR, 2014, PEDIATRICS, V133, pE973, DOI 10.1542/peds.2013-3153; Hosseinzadeh K, 2015, BIOTECH HLTH SCI, V2, DOI [10.17795/bhs-25731, DOI 10.17795/BHS-25731]; Keedy NH, 2009, THESIS; Lanfer A, 2011, INT J OBESITY, V35, pS61, DOI 10.1038/ijo.2011.36; Liu WH, 2014, APPETITE, V80, P55, DOI 10.1016/j.appet.2014.04.030; Fernandez-Alvira JM, 2013, PUBLIC HEALTH NUTR, V16, P487, DOI 10.1017/S136898001200290X; Nang EEK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-644; Ng N, 2009, GLOBAL HEALTH ACTION, V2, P44, DOI 10.3402/gha.v2i0.1985; Nutbeam D, 1999, THEORY NUTSHELL GUID; Oikonen M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000244; Oli N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008197; Pearson N, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-34; Perneger TV, 2015, QUAL LIFE RES, V24, P147, DOI 10.1007/s11136-014-0752-2; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ranasinghe CD, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-116; Roberts K, 2011, NATL OBESITY OBSERVA, P1; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Talvia S, 2011, PUBLIC HEALTH NUTR, V14, P2065, DOI 10.1017/S1368980011000905; Tamang Seira, 2000, STUDIES NEPALI HIST, V5, P127; Thompson SC, 2008, PERCEIVED CONTROL; Vaidya A, 2014, J KATH MANDU MED COL, V2, P3, DOI DOI 10.3126/JKMC.V2I1.10512; Vaidya A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-39; Vaidya A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002976; Valente TW, 1998, HUM COMMUN RES, V24, P366, DOI 10.1111/j.1468-2958.1998.tb00421.x; van Ansem WJC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0113-0; Vereecken C, 2010, APPETITE, V54, P44, DOI 10.1016/j.appet.2009.09.005; Warmbrod JR, 2014, J AGR ED, V55, P30, DOI [DOI 10.5032/jae.2014.05030, DOI 10.5032/JAE.2014.05030]; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2014, TOBACCO CONTROL COUN; World Health Organization, 2003, DIET NUTRITION AND T; World Health Organization, 2018, GLOB PHYS ACT QUEST; Wyse R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-938; Yabanci N, 2014, PROCD SOC BEHV, V116, P4477, DOI 10.1016/j.sbspro.2014.01.970	46	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200329	10.1371/journal.pone.0200329	http://dx.doi.org/10.1371/journal.pone.0200329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985946	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500034
J	Yamada, M; Hamaguchi, T				Yamada, Masahito; Hamaguchi, Tsuyoshi			The sulfation code for propagation of neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							AMYLOID ANGIOPATHY	Prion-like propagation of protein aggregates is thought to be an essential feature in many neurodegenerative diseases, but the mechanisms underlying transcellular transfer of protein aggregates remain unclear. Stopschinski et al. now demonstrate that the cellular uptake of tau, A, and -synuclein aggregates mediated by heparan sulfate proteoglycans (HSPGs) varies with distinct glycosaminoglycan chain length and sulfation patterns. The results help us to understand how different protein aggregates propagate, leading to distinct neurodegenerative pathologies.	[Yamada, Masahito; Hamaguchi, Tsuyoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Takara Machi, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University	Yamada, M (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Takara Machi, Kanazawa, Ishikawa 9208640, Japan.	m-yamada@med.kanazawa-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [JP15K15336, JP17H04194, JP17K09752]; Japan Agency for Medical Research and Development (AMED) [JP16dk0207021h0001, JP17dk0207021h0002]; Ministry of Health, Labour and Welfare, Japan [JPH29-nanchito(nan)-ippan-036]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Science (JSPS) under Grants JP15K15336 (to M. Y. and T. H.), JP17H04194 (to M. Y. and T. H.), and JP17K09752 (to T. H. and M. Y.), Grants-in-Aid for Research and Development Grants for Dementia from the Japan Agency for Medical Research and Development (AMED) under Grants JP16dk0207021h0001 and JP17dk0207021h0002 (to M. Y. and T. H.), and Grants-in-Aid for the Research Committee of Prion Disease and Slow Virus Infection from the Ministry of Health, Labour and Welfare, Japan, under Grants JPH29-nanchito(nan)-ippan-036 (to M. Y. and T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Goedert M, 2017, BRAIN, V140, P266, DOI 10.1093/brain/aww230; Hamaguchi T, 2016, ACTA NEUROPATHOL, V132, P313, DOI 10.1007/s00401-016-1588-3; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Ihse E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08720-5; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Walker LC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a024398; Watanabe-Nakayama T, 2016, P NATL ACAD SCI USA, V113, P5835, DOI 10.1073/pnas.1524807113	10	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10841	10842		10.1074/jbc.H118.003970	http://dx.doi.org/10.1074/jbc.H118.003970			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29980653	hybrid, Green Published			2022-12-26	WOS:000437828400037
J	Takahata, Y; Nakamura, E; Hata, K; Wakabayashi, M; Murakami, T; Wakamori, K; Yoshikawa, H; Matsuda, A; Fukui, N; Nishimura, R				Takahata, Yoshifumi; Nakamura, Eriko; Hata, Kenji; Wakabayashi, Makoto; Murakami, Tomohiko; Wakamori, Kanta; Yoshikawa, Hiroshi; Matsuda, Akio; Fukui, Naoshi; Nishimura, Riko			Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5	FASEB JOURNAL			English	Article						osteoarthritis; transcription factor; articular cartilage; aggrecan; aggrecanase	MESSENGER-RNA EXPRESSION; ARTICULAR-CARTILAGE; AGGRECANASE ACTIVITY; IN-VITRO; KAPPA-B; INTERLEUKIN-1; CHONDROCYTES; DEGRADATION; HIF-2-ALPHA; DEFICIENT	Osteoarthritis is a common disease in joint cartilages. Because the molecular pathogenesis of osteoarthritis remains elusive, early diagnostic markers and effective therapeutic agents have not been developed. To understand the molecular mechanisms, we attempted to identify transcription factors involved in the onset of osteoarthritis. Microarray analysis of mouse articular cartilage cells indicated that retinoic acid, a destructive stimulus in articular cartilage, up-regulated expression of sex-determining region Y-box (Sox)4, a SoxC family transcription factor, together with increases in Adamts4 and Adamts5, both of which are aggrecanases of articular cartilages. Overexpression of Sox4 induced a disintegrin-like and metallopeptidase with thrombospondin type 4 and 5 motif (ADAMTS4 and ADAMTS5, respectively) expression in chondrogenic cell lines C3H10T1/2 and SW1353. In addition, luciferase reporter and chromatin immunoprecipitation assays showed that Sox4 up-regulated ADAMTS4 and Adamts5 gene promoter activities by binding to their gene promoters. Another SoxC family member, Sox11, evoked similar effects. To evaluate the roles of Sox4 and Sox11 in articular cartilage destruction, we performed organ culture experiments using mouse femoral head cartilages. Sox4 and Sox11 adenovirus infections caused destruction of articular cartilage associated with increased Adamts5 expression. Finally, SOX4 and SOX11 mRNA expression was increased in cartilage of patients with osteoarthritis compared with nonosteoarthritic subjects. Thus, Sox4, and presumably Sox11, are involved in osteoarthritis onset by up-regulating ADAMTS4 and ADAMTS5.Takahata, Y., Nakamura, E., Hata, K., Wakabayashi, M., Murakami, T., Wakamori, K., Yoshikawa, H., Matsuda, A., Fukui, N., Nishimura, R. Sox4 is involved in osteoarthritic cartilage deterioration through induction of ADAMTS4 and ADAMTS5.	[Takahata, Yoshifumi; Nakamura, Eriko; Hata, Kenji; Murakami, Tomohiko; Wakamori, Kanta; Yoshikawa, Hiroshi; Nishimura, Riko] Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan; [Wakabayashi, Makoto; Matsuda, Akio] Asahi Kasei Pharma Corp, Lab Adv Drug Discovery Pharmaceut, Res Ctr, Izunokuni, Japan; [Fukui, Naoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo, Japan; [Fukui, Naoshi] Natl Hosp Org Sagamihara Hosp, Clin Res Ctr, Sagamihara, Kanagawa, Japan	Osaka University; Asahi Kasei Pharma Corporation; University of Tokyo	Takahata, Y (corresponding author), Osaka Univ, Grad Sch Dent, Dept Mol & Cellular Biochem, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	takahata@dent.osaka-u.ac.jp	Takahata, Yoshifumi/AAZ-6869-2021	Nishimura, Riko/0000-0001-7279-8363	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japan Health Foundation; Suzuken Memorial Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Health Foundation(Japan Health Foundation); Suzuken Memorial Foundation	This study was supported, in part, by the Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (to Y.T. and R.N.), the Japan Health Foundation (to Y.T.), and Suzuken Memorial Foundation (to Y.T.). The authors declare no conflicts of interest.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2014, J CELL BIOL, V207, P657, DOI 10.1083/jcb.201405098; Bijlsma JWJ, 2011, LANCET, V377, P2115, DOI 10.1016/S0140-6736(11)60243-2; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Cai LP, 2001, CYTOKINE, V16, P10, DOI 10.1006/cyto.2001.0939; Chen Y, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.34; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; East CJ, 2007, J BIOL CHEM, V282, P8632, DOI 10.1074/jbc.M605750200; Flannery CR, 1999, BIOCHEM BIOPH RES CO, V260, P318, DOI 10.1006/bbrc.1999.0909; Fujii Y, 2014, PROTEIN EXPRES PURIF, V95, P240, DOI 10.1016/j.pep.2014.01.009; Fukui N, 2008, ARTHRITIS RHEUM-US, V58, P154, DOI 10.1002/art.23175; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Ilic MZ, 2007, J BIOL CHEM, V282, P37420, DOI 10.1074/jbc.M703184200; Jeong JW, 2016, INT J MOL MED, V37, P452, DOI 10.3892/ijmm.2015.2443; Jules J, 2014, METHODS MOL BIOL, V1155, P109, DOI 10.1007/978-1-4939-0669-7_10; Kan A, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-4; Kato K, 2015, J BONE MINER RES, V30, P1560, DOI 10.1002/jbmr.2504; Kobayashi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13336; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Lefebvre V, 2016, CURR OSTEOPOROS REP, V14, P32, DOI 10.1007/s11914-016-0296-1; Li GY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4405; Little CB, 2002, ARTHRITIS RHEUM-US, V46, P124, DOI 10.1002/1529-0131(200201)46:1<124::AID-ART10121>3.0.CO;2-X; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Rogerson FM, 2010, ARTHRITIS RHEUM-US, V62, P3365, DOI 10.1002/art.27661; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Shiraishi A, 2016, BIOCHEM BIOPH RES CO, V469, P62, DOI 10.1016/j.bbrc.2015.11.072; Snelling SJB, 2016, OSTEOARTHR CARTILAGE, V24, P883, DOI 10.1016/j.joca.2015.11.021; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Takahata Y, 2011, J BIOL CHEM, V286, P32906, DOI 10.1074/jbc.M111.253526; Takahata Y, 2009, J CELL PHYSIOL, V218, P268, DOI 10.1002/jcp.21594; Taniguchi Y, 2017, ARTHRITIS RHEUMATOL, V69, P598, DOI 10.1002/art.39976; Thysen S, 2015, DIS MODEL MECH, V8, P17, DOI 10.1242/dmm.016881; Tortorella MD, 2008, CURR PHARM BIOTECHNO, V9, P16, DOI 10.2174/138920108783497622; Tortorella MD, 2002, MATRIX BIOL, V21, P499, DOI 10.1016/S0945-053X(02)00069-0; Tortorella MD, 2001, OSTEOARTHR CARTILAGE, V9, P539, DOI 10.1053/joca.2001.0427; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Wang MN, 2011, ANN NY ACAD SCI, V1240, P61, DOI 10.1111/j.1749-6632.2011.06258.x; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Yatabe T, 2009, ANN RHEUM DIS, V68, P1051, DOI 10.1136/ard.2007.086884; Yoshida M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7653	54	35	37	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					619	630		10.1096/fj.201800259R	http://dx.doi.org/10.1096/fj.201800259R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30016600				2022-12-26	WOS:000457401500048
J	Wangeline, MA; Hampton, RY				Wangeline, Margaret A.; Hampton, Randolph Y.			"Mallostery"-ligand-dependent protein misfolding enables physiological regulation by ERAD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic-reticulum-associated protein degradation; ERAD; ubiquitin; cholesterol regulation; allosteric regulation; protein misfolding; HMG-CoA reductase; HRD pathway; mallostery; chemical chaperones	RETICULUM-ASSOCIATED DEGRADATION; HMG-COA REDUCTASE; ANCHORED UBIQUITIN LIGASE; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; QUALITY-CONTROL; ACCELERATED DEGRADATION; ALLOSTERIC MODULATION; STEROL; DOMAIN; GERANYLGERANYL	HMG-CoA reductase (HMGR) undergoes regulated degradation as part of feedback control of the sterol pathway. In yeast, the stability of the HMGR isozyme Hmg2 is controlled by the 20-carbon isoprenoid geranylgeranyl pyrophosphate (GGPP). Increasing GGPP levels cause more efficient degradation by the HMG-CoA reductase degradation (HRD) pathway, allowing for feedback regulation of HMGR. The HRD pathway is critical for the endoplasmic reticulum (ER)-associated degradation (ERAD) of misfolded ER proteins. Here, we have explored GGPP's role in HRD-dependent Hmg2 degradation. We found that GGPP potently regulates Hmg2 levels in vivo and causes reversible Hmg2 misfolding at nanomolar concentrations in vitro. These GGPP-mediated effects were absent in several stabilized or nonregulated Hmg2 mutants. Consistent with its high potency, GGPP's effects were highly specific such that other structurally related molecules were ineffective in altering Hmg2 structure. For instance, two closely related GGPP analogues, 2F-GGPP and GGSPP, were completely inactive at all concentrations tested. Furthermore, GGSPP antagonized GGPP's effects in vivo and in vitro. Chemical chaperones reversed GGPP's effects on Hmg2 structure and degradation, suggesting that GGPP causes selective Hmg2 misfolding. These results indicate that GGPP functions in a manner similar to an allosteric ligand, causing Hmg2 misfolding through interaction with a reversible, specific binding site. Consistent with this, the Hmg2 protein formed multimers, typical of allosteric proteins. We propose that this "allosteric misfolding," or mallostery, observed here for Hmg2 may be a widely used tactic of biological regulation with potential for development of therapeutic small molecules that induce selective misfolding.	[Wangeline, Margaret A.; Hampton, Randolph Y.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5R37DK051996-18]; National Institutes of Health Cell Molecular Genetics (CMG) Training Grant [5T32GM007240-35]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cell Molecular Genetics (CMG) Training Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant 5R37DK051996-18 (to R. Y. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Cell Molecular Genetics (CMG) Training Grant 5T32GM007240-35.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Ascenzi P, 2005, BIOCHEM MOL BIOL EDU, V33, P169, DOI 10.1002/bmb.2005.494033032470; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bondeson DP, 2017, ANNU REV PHARMACOL, V57, P107, DOI 10.1146/annurev-pharmtox-010715-103507; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Crews CM, 2010, CHEM BIOL, V17, P551, DOI 10.1016/j.chembiol.2010.05.011; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Gao Y, 2012, NAT PROD REP, V29, P1153, DOI 10.1039/c2np20059g; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gu X, 2017, J BIOL CHEM, V292, P12653, DOI 10.1074/jbc.M117.793018; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hwang S, 2016, J BIOL CHEM, V291, P13479, DOI 10.1074/jbc.M116.728469; JIANG Y, 1995, J BIOL CHEM, V270, P21793, DOI 10.1074/jbc.270.37.21793; JIANG Y, 1993, NATURE, V366, P84, DOI 10.1038/366084a0; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Lin FY, 2010, P NATL ACAD SCI USA, V107, P21337, DOI 10.1073/pnas.1010907107; Liu J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004966; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Neal S, 2017, J BIOL CHEM, V292, P3112, DOI 10.1074/jbc.M116.770610; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Nguyen AD, 2009, J BIOL CHEM, V284, P26778, DOI 10.1074/jbc.M109.032342; Nussinov R, 2016, CHEM REV, V116, P6263, DOI 10.1021/acs.chemrev.6b00283; ROITELMAN J, 1984, J BIOL CHEM, V259, P870; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Rosenbaum JC, 2011, NUCLEUS-PHILA, V2, P264, DOI 10.4161/nucl.2.4.16118; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stirtan WG, 1997, BIOCHEMISTRY-US, V36, P4552, DOI 10.1021/bi962579c; Theesfeld CL, 2013, J BIOL CHEM, V288, P8519, DOI 10.1074/jbc.M112.404517; Theesfeld CL, 2011, J BIOL CHEM, V286, P26298, DOI 10.1074/jbc.M111.244798; Vashistha N, 2016, P NATL ACAD SCI USA, V113, P5934, DOI 10.1073/pnas.1603079113; Wangeline MA, 2017, ANNU REV CELL DEV BI, V33, P467, DOI 10.1146/annurev-cellbio-111315-125036; Witter DJ, 1996, BIOCHEMISTRY-US, V35, P10454, DOI 10.1021/bi960500y; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002	57	22	22	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 21	2018	293	38					14937	14950		10.1074/jbc.RA118.001808	http://dx.doi.org/10.1074/jbc.RA118.001808			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GV5PS	30018140	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000446155000029
J	Bharati, BK; Mukherjee, R; Chatterji, D				Bharati, Binod K.; Mukherjee, Raju; Chatterji, Dipankar			Substrate-induced domain movement in a bifunctional protein, DcpA, regulates cyclic di-GMP turnover: Functional implications of a highly conserved motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic di-GMP (c-di-GMP); fluorescence resonance energy transfer (FRET); c-di-GMP turnover; DcpA; diguanylate cyclase; phosphodiesterase; domain movement; Forster's distance; second messenger; bacterial virulence; fluorescence anisotropy	RESONANCE ENERGY-TRANSFER; COLI RNA-POLYMERASE; MYCOBACTERIUM-SMEGMATIS; STREPTOCOCCUS-EQUISIMILIS; BACTERIAL 2ND-MESSENGER; PROXIMITY RELATIONSHIP; SPECTROSCOPIC RULER; RESPONSE REGULATOR; BIOFILM FORMATION; OUTPUT DOMAIN	In eubacteria, cyclic di-GMP (c-di-GMP) signaling is involved in virulence, persistence, motility and generally orchestrates multicellular behavior in bacterial biofilms. Intracellular c-di-GMP levels are maintained by the opposing activities of diguanylate cyclases (DGCs) and cognate phosphodiesterases (PDEs). The c-di-GMP homeostasis in Mycobacterium smegmatis is supported by DcpA, a conserved, bifunctional protein with both DGC and PDE activities. DcpA is a multidomain protein whose GAF-GGDEF-EAL domains are arranged in tandem and are required for these two activities. To gain insight into how interactions among these three domains affect DcpA activity, here we studied its domain dynamics using real-time FRET. We demonstrate that substrate binding in DcpA results in domain movement that prompts a switch from an open to a closed conformation and alters its catalytic activity. We found that a single point mutation in the conserved EAL motif (E384A) results in complete loss of the PDE activity of the EAL domain and in a significant decrease in the DGC activity of the GGDEF domain. Structural analyses revealed multiple hydrophobic and aromatic residues around Cys(579) that are necessary for proper DcpA folding and maintenance of the active conformation. On the basis of these observations and taking into account additional bioinformatics analysis of EAL domain-containing proteins, we identified a critical putatively conserved motif, GCXXXQGF, that plays an important role in c-di-GMP turnover. We conclude that a substrate-induced conformational switch involving movement of a loop containing a conserved motif in the bifunctional diguanylate cyclase-phosphodiesterase DcpA controls c-di-GMP turnover in M. smegmatis.	[Bharati, Binod K.; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Mukherjee, Raju] Indian Inst Sci Educ & Res, Dept Biol, Tirupati 517507, Andhra Prades, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science Education & Research (IISER) - Tirupati	Chatterji, D (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@iisc.ac.in	Bharati, Binod K./W-6044-2019	Bharati, Binod Kumar/0000-0003-1112-8846	Department of Biotechnology, Government of India; Indian Institute of Science; Council of Scientific and Industrial Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Institute of Science; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Biotechnology, Government of India. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Indian Institute of Science research fellowship.; Supported by a Council of Scientific and Industrial Research fellowship.	Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bharati BK, 2013, GENE, V528, P99, DOI 10.1016/j.gene.2013.07.043; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Cantor C.R., 1980, BIOPHYS CHEM; Chen Y, 2012, J BACTERIOL, V194, P5080, DOI 10.1128/JB.01092-12; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chowdhury RP, 2007, BIOPHYS CHEM, V128, P19, DOI 10.1016/j.bpc.2007.02.005; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Feinstein E, 2003, BIOPHYS J, V84, P599, DOI 10.1016/S0006-3495(03)74880-2; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Jain V, 2007, BIOPHYS CHEM, V127, P41, DOI 10.1016/j.bpc.2006.12.003; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; KUMAR KP, 1990, BIOCHEMISTRY-US, V29, P317, DOI 10.1021/bi00454a003; KUMAR KP, 1992, BIOCHEMISTRY-US, V31, P7519, DOI 10.1021/bi00148a012; Lakowicz J R, 1988, Subcell Biochem, V13, P89; Lakowicz J. R., 1983, PRINCIPALS FLUORESCE; Levet-Paulo M, 2011, J BIOL CHEM, V286, P31136, DOI 10.1074/jbc.M111.231340; Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f; Liu N, 2010, MOL BIOSYST, V6, P1557, DOI 10.1039/c002246b; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Mechold U, 1997, J BACTERIOL, V179, P2658, DOI 10.1128/jb.179.8.2658-2667.1997; Mechold U, 2002, J BACTERIOL, V184, P2878, DOI 10.1128/JB.184.11.2878-2888.2002; Nguyen MN, 2011, NUCLEIC ACIDS RES, V39, pW24, DOI 10.1093/nar/gkr393; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nyitrai M, 2000, J BIOL CHEM, V275, P41143, DOI 10.1074/jbc.M004146200; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Perez-Iratxeta C, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-25; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2006, J BACTERIOL, V188, P8327, DOI 10.1128/JB.01079-06; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seshasayee ASN, 2010, NUCLEIC ACIDS RES, V38, P5970, DOI 10.1093/nar/gkq382; Sharma IM, 2014, MICROBIOL-SGM, V160, P2304, DOI 10.1099/mic.0.080200-0; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Syal K, 2015, FEBS J, V282, P3773, DOI 10.1111/febs.13373; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; Wilkins MR, 1999, METH MOL B, V112, P531; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zoraghi R, 2004, MOL PHARMACOL, V65, P267, DOI 10.1124/mol.65.2.267	58	2	2	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14065	14079		10.1074/jbc.RA118.003917	http://dx.doi.org/10.1074/jbc.RA118.003917			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29980599	Green Published, hybrid			2022-12-26	WOS:000444070700028
J	Hannan, S; Smart, TG				Hannan, Saad; Smart, Trevor G.			Cell surface expression of homomeric GABA(A) receptors depends on single residues in subunit transmembrane domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GABA receptor; trafficking; homology modeling; receptor; ion channel; homomers; inhibition; receptor assembly	SUBCELLULAR-LOCALIZATION; INTERSUBUNIT CONTACTS; ALPHA-SUBUNITS; A RECEPTORS; IDENTIFICATION; TRAFFICKING; MODULATION; CHANNELS; PHARMACOLOGY; RECOMBINANT	Cell surface expression of type A GABA receptors (GABA(A)Rs) is a critical determinant of the efficacy of inhibitory neurotransmission. Pentameric GABA(A)Rs are assembled from a large pool of subunits according to precise co-assembly rules that limit the extent of receptor structural diversity. These rules ensure that particular subunits, such as 1 and 3, form functional cell surface ion channels when expressed alone in heterologous systems, whereas other brain-abundant subunits, such as and , are retained within intracellular compartments. Why some of the most abundant GABA(A)R subunits fail to form homomeric ion channels is unknown. Normally, surface expression of and subunits requires co-assembly with subunits via interactions between their N-terminal sequences in the endoplasmic reticulum. Here, using molecular biology, imaging, and electrophysiology with GABA(A)R chimeras, we have identified two critical residues in the transmembrane domains of and subunits, which, when substituted for their 1 counterparts, permit cell surface expression as homomers. Consistent with this, substitution of the 1 transmembrane residues for the subunit equivalents reduced surface expression and altered channel gating, highlighting their importance for GABA(A)R trafficking and signaling. Although not ligand-gated, the formation of and homomeric ion channels at the cell surface was revealed by incorporating a mutation that imparts the functional signature of spontaneous channel activity. Our study identifies two single transmembrane residues that enable homomeric GABA(A)R subunit cell surface trafficking and demonstrates that and subunits can form functional ion channels.	[Hannan, Saad; Smart, Trevor G.] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England	University of London; University College London	Hannan, S; Smart, TG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	s.hannan@ucl.ac.uk; t.smart@ucl.ac.uk	Hannan, Saad/AAX-6478-2020	Hannan, Saad/0000-0003-4594-0808; Smart, Trevor/0000-0002-9089-5375	MRC [MR/K005537/1] Funding Source: UKRI; Medical Research Council [MR/K005537/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Amin J, 1999, MOL PHARMACOL, V55, P411; AMIN J, 1994, RECEPTOR CHANNEL, V2, P227; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Bollan K, 2003, J BIOL CHEM, V278, P4747, DOI 10.1074/jbc.M210229200; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; BORMANN J, 1995, TRENDS NEUROSCI, V18, P515, DOI 10.1016/0166-2236(95)98370-E; Bracamontes JR, 2014, MOL PHARMACOL, V86, P20, DOI 10.1124/mol.114.092791; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1996, P NATL ACAD SCI USA, V93, P9899, DOI 10.1073/pnas.93.18.9899; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Davies PA, 1997, BRIT J PHARMACOL, V120, P899, DOI 10.1038/sj.bjp.0700987; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Hannan S, 2013, METHOD ENZYMOL, V521, P109, DOI 10.1016/B978-0-12-391862-8.00006-5; Hannan S, 2012, P NATL ACAD SCI USA, V109, P12171, DOI 10.1073/pnas.1201660109; Has ATC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28674; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Kang JQ, 2009, TRENDS MOL MED, V15, P430, DOI 10.1016/j.molmed.2009.07.003; Klausberger T, 2000, J BIOL CHEM, V275, P8921, DOI 10.1074/jbc.275.12.8921; Klausberger T, 2001, J BIOL CHEM, V276, P16024, DOI 10.1074/jbc.M009508200; Klausberger T, 2001, J NEUROSCI, V21, P9124, DOI 10.1523/JNEUROSCI.21-23-09124.2001; Krishek BJ, 1998, J PHYSIOL-LONDON, V507, P639, DOI 10.1111/j.1469-7793.1998.639bs.x; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Lummis SCR, 2009, BIOCHEM SOC T, V37, P1343, DOI 10.1042/BST0371343; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramamoorthi K, 2011, TRENDS MOL MED, V17, P452, DOI 10.1016/j.molmed.2011.03.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sarto-Jackson I, 2008, MOL MEMBR BIOL, V25, P302, DOI 10.1080/09687680801914516; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; SHIVERS BD, 1989, NEURON, V3, P327, DOI 10.1016/0896-6273(89)90257-2; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Smart TG, 2015, HDB ION CHANNELS, P345; Smith KS, 2012, NEUROPHARMACOLOGY, V62, P54, DOI 10.1016/j.neuropharm.2011.07.026; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tretter V, 1997, J NEUROSCI, V17, P2728; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	51	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13427	13439		10.1074/jbc.RA118.002792	http://dx.doi.org/10.1074/jbc.RA118.002792			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986886	hybrid, Green Published			2022-12-26	WOS:000443375500007
J	Hutt, DM; Mishra, SK; Roth, DM; Larsen, MB; Angles, F; Frizzell, RA; Balch, WE				Hutt, Darren M.; Mishra, Sanjay Kumar; Roth, Daniela Martino; Larsen, Mads Breum; Angles, Frederic; Frizzell, Raymond A.; Balch, William E.			Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; cystic fibrosis transmembrane conductance regulator (CFTR); autophagy; 70 kilodalton heat shock protein (Hsp70); protein folding; BAG3; BCL2-associated athanogene; cystic fibrosis; maladaptive stress response	TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-QUALITY CONTROL; HEAT-SHOCK PROTEINS; CYSTIC-FIBROSIS; SELECTIVE AUTOPHAGY; MISFOLDED PROTEINS; MOLECULAR CHAPERONES; AGGRESOME FORMATION; UBIQUITIN LIGASE; CO-CHAPERONES	The protein chaperones heat shock protein 70 (Hsp70) and Hsp90 are required for de novo folding of proteins and protect against misfolding-related cellular stresses by directing misfolded or slowly folding proteins to the ubiquitin/proteasome system (UPS) or autophagy/lysosomal degradation pathways. Here, we examined the role of the Bcl2-associated athanogene (BAG) family of Hsp70-specific nucleotide-exchange factors in the biogenesis and functional correction of genetic variants of the cystic fibrosis transmembrane conductance regulator (CFTR) whose mutations cause cystic fibrosis (CF). We show that siRNA-mediated silencing of BAG1 and -3, two BAG members linked to the clearance of misfolded proteins via the UPS and autophagy pathways, respectively, leads to functional correction of F508del-CFTR and other disease-associated CFTR variants. BAG3 silencing was the most effective, leading to improved F508del-CFTR stability, trafficking, and restoration of cell-surface function, both alone and in combination with the FDA-approved CFTR corrector, VX-809. We also found that the BAG3 silencing-mediated correction of F508del-CFTR restores the autophagy pathway, which is defective in F508del-CFTR-expressing cells, likely because of the maladaptive stress response in CF pathophysiology. These results highlight the potential therapeutic benefits of targeting the cellular chaperone system to improve the functional folding of CFTR variants contributing to CF and possibly other protein-misfolding-associated diseases.	[Hutt, Darren M.; Roth, Daniela Martino; Angles, Frederic; Balch, William E.] Scripps Res, Skaggs Inst Chem Biol, Dept Mol Med, La Jolla, CA 92037 USA; [Mishra, Sanjay Kumar; Larsen, Mads Breum; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Mishra, Sanjay Kumar; Larsen, Mads Breum; Frizzell, Raymond A.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15224 USA	Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Balch, WE (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.	webalch@scripps.edu			NHLBI NIH HHS [R01 HL095524] Funding Source: Medline; NIA NIH HHS [P01 AG049665] Funding Source: Medline; NIDDK NIH HHS [R01 DK051870, R01 DK068196] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068196, R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Amaral MD, 2015, J CYST FIBROS, V14, P687, DOI 10.1016/j.jcf.2015.09.006; Amaral MD, 2006, J INHERIT METAB DIS, V29, P477, DOI 10.1007/s10545-006-0251-x; Arakawa A, 2010, STRUCTURE, V18, P309, DOI 10.1016/j.str.2010.01.004; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Bartsch G, 2016, ONCOL REP, V35, P1629, DOI 10.3892/or.2015.4505; Behl C, 2016, TRENDS PHARMACOL SCI, V37, P672, DOI 10.1016/j.tips.2016.04.007; Behl C, 2011, AUTOPHAGY, V7, P795, DOI 10.4161/auto.7.7.15844; Bitzer A, 2016, MOL IMMUNOL, V69, P99, DOI 10.1016/j.molimm.2015.11.004; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Brive L, 2001, BIOCHEM BIOPH RES CO, V289, P1099, DOI 10.1006/bbrc.2001.6087; Brockman SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184793; Bruchmann A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-96; Cao YL, 2017, NEUROBIOL AGING, V60, P104, DOI 10.1016/j.neurobiolaging.2017.08.023; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Coppinger JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037682; Crippa V, 2010, HUM MOL GENET, V19, P3440, DOI 10.1093/hmg/ddq257; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; De Marco M, 2018, SEMIN CELL DEV BIOL, V78, P85, DOI 10.1016/j.semcdb.2017.08.049; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Esposito Speranza, 2016, Mol Cell Pediatr, V3, P13, DOI 10.1186/s40348-016-0040-z; Ferrari E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.476; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Gamerdinger M, 2011, EMBO REP, V12, P149, DOI 10.1038/embor.2010.203; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gentilella A, 2011, J BIOL CHEM, V286, P9205, DOI 10.1074/jbc.M110.175836; Gupta MK, 2016, J CELL BIOCHEM, V117, P1813, DOI 10.1002/jcb.25481; Hantouche C, 2017, J BIOL CHEM, V292, P2287, DOI 10.1074/jbc.M116.752618; Holleran JP, 2012, MOL MED, V18, P685, DOI 10.2119/molmed.2012.00001; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Ji CH, 2017, MOL CELLS, V40, P441, DOI 10.14348/molcells.2017.0115; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kalia SK, 2010, CNS NEUROL DISORD-DR, V9, P741; Kley RA, 2016, CURR OPIN NEUROL, V29, P628, DOI 10.1097/WCO.0000000000000357; Klimek C, 2017, J CELL SCI, V130, P2781, DOI 10.1242/jcs.203679; Knezevic T, 2015, HEART FAIL REV, V20, P423, DOI 10.1007/s10741-015-9487-6; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Larsen MB, 2016, METHODS, V96, P40, DOI 10.1016/j.ymeth.2015.09.006; Lei ZN, 2015, NEUROBIOL AGING, V36, P241, DOI 10.1016/j.neurobiolaging.2014.08.012; Li ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153526; Liang JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006132; Luciani A, 2012, AUTOPHAGY, V8, P1657, DOI 10.4161/auto.21483; Luciani A, 2011, AUTOPHAGY, V7, P104, DOI 10.4161/auto.7.1.13987; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Merabova N, 2015, J CELL PHYSIOL, V230, P831, DOI 10.1002/jcp.24811; Morimoto RI, 2011, COLD SH Q B, V76, P91, DOI 10.1101/sqb.2012.76.010637; O'Donnell BM, 2017, CHANNELS, V11, P499, DOI 10.1080/19336950.2017.1357944; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oliver KE, 2017, CURR OPIN PHARMACOL, V34, P76, DOI 10.1016/j.coph.2017.09.018; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Perkins LA, 2018, MOL PHARMACEUT, V15, P759, DOI 10.1021/acs.molpharmaceut.7b00928; Qin LX, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0020-2; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Romani L, 2017, NAT MED, V23, P590, DOI 10.1038/nm.4305; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Rusmini P, 2016, J MOL NEUROSCI, V58, P348, DOI 10.1007/s12031-015-0675-6; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Sosnay PR, 2014, THORAX, V69, P295, DOI 10.1136/thoraxjnl-2013-204903; Sosnay PR, 2013, NAT GENET, V45, P1160, DOI 10.1038/ng.2745; Sturner E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00177; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Sun X, 2008, J CLIN INVEST, V118, P1578, DOI 10.1172/JCI34599; TAKAYAMA S, 1995, CELL, V80, P279, DOI 10.1016/0092-8674(95)90410-7; Tosco A, 2017, CELL DEATH DIFFER, V24, P1305, DOI 10.1038/cdd.2016.43; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Tschopp J, 1999, CURR BIOL, V9, pR381, DOI 10.1016/S0960-9822(99)80233-4; Turnbull EL, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S11; Veit G, 2016, MOL BIOL CELL, V27, P424, DOI 10.1091/mbc.E14-04-0935; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Vij N, 2017, EXPERT OPIN DRUG DEL, V14, P483, DOI 10.1080/17425247.2016.1223040; Villella VR, 2013, AUTOPHAGY, V9, P1431, DOI 10.4161/auto.25517; Villella VR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00001; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Yue XT, 2015, ELIFE, V4, DOI 10.7554/eLife.08401; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	91	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13682	13695		10.1074/jbc.RA118.002607	http://dx.doi.org/10.1074/jbc.RA118.002607			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986884	Green Published, hybrid			2022-12-26	WOS:000443375500027
J	Tan, VPK; Ngim, CF; Lee, EZ; Ramadas, A; Pong, LY; Ng, JI; Hassan, SS; Ng, XY; Dhanoa, A				Tan, Victoria Phooi Khei; Ngim, Chin Fang; Lee, Erika Ziyan; Ramadas, Amutha; Pong, Lian Yih; Ng, Joo Ing; Hassan, Sharifah Syed; Ng, Xuan Ye; Dhanoa, Amreeta			The association between obesity and dengue virus (DENV) infection in hospitalised patients	PLOS ONE			English	Article							NUTRITIONAL-STATUS; RISK-FACTORS; SEVERITY; CHILDREN; LEPTIN; PATHOGENESIS; INVOLVEMENT	Both obesity and DENV infections are growing public health concerns that have far-ranging socioeconomic effects, especially in developing countries. Despite the increasing prevalence of these conditions, there is a scarcity of data investigating the potential relationships between these two entities. Our study aims to examine the influence of obesity on various clinical and laboratory parameters amongst patients with DENV infections. A total of 335 hospitalized patients aged > 12 years who were DENV non-structural protein 1 (NS1) antigen-positive were enrolled in this study. Clinical and laboratory variables were compared between patients with and without obesity. Multivariate analysis showed that the following admission clinical findings and laboratory results were independently associated with obesity; chills and rigors (AOR:2.653, 95% CI: 1.286-5.474), higher temperature (AOR:1.485, 95% CI: 1.08-02.042), higher systolic BP (AOR:1.057, 95% CI:1.0371.078), raised haematocrit (AOR: 1.953, 95% CI: 1.010-3.778), elevated creatinine (AOR:3.504, 95% CI:1.351-9.008) and elevated ALT (AOR: 4.146, 95% CI:1.878-9.154). Obesity was found to be significantly associated with hospitalization > 3 days (AOR: 1.990, 95% CI: 1.134-3.494) and the presence of increasing haematocrit with decreasing platelets (AOR: 2.134, 95% CI = 1.235-3.688). Serial assessment of laboratory data revealed that peak haematocrit was significantly higher and nadir platelets levels were significantly lower in obese patients. Both peak and admission levels of leukocyte counts, AST, ALT and creatinine were significantly higher in the obese group. Conversely, both admission and nadir albumin levels were lower for the obese group, although only nadir albumin levels achieved statistical significance. These findings support closer clinical monitoring of obese patients who present with DENV infections, as this patient cohort may possess an increased tendency towards developing more severe clinical manifestations of DENV infections as compared to non-obese patients.	[Tan, Victoria Phooi Khei; Lee, Erika Ziyan; Ramadas, Amutha; Pong, Lian Yih; Ng, Joo Ing; Hassan, Sharifah Syed; Ng, Xuan Ye; Dhanoa, Amreeta] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Selangor, Malaysia; [Ngim, Chin Fang] Monash Univ Malaysia, Clin Sch Johor Bahru, Jeffrey Cheah Sch Med & Hlth Sci, Johor Baharu, Johor, Malaysia	Monash University; Monash University Sunway; Monash University; Monash University Sunway	Dhanoa, A (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Selangor, Malaysia.	amreeta.dhanoa@monash.edu	Ramadas, Amutha/G-7532-2014; Dhanoa, Amreeta/J-1227-2019	Ngim, Chin Fang/0000-0002-9417-273X; Dhanoa, Amreeta/0000-0002-4541-4819; Pong, Lian Yih/0000-0002-8789-3520; Ramadas, Amutha/0000-0002-8238-9659				Academy of Medicine Malaysia, 2015, CLIN PRACT GUID MAN; Academy of Medicine of Malaysia, 2004, CLIN PRACT GUID MAN; Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; Anderson GS, 1999, INT J BIOMETEOROL, V43, P99, DOI 10.1007/s004840050123; [Anonymous], 2017, MAL DENG INC RAT CAS; Aris T, 2015, NATL HLTH MORBIDITY, VII; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Choi JW, 2003, ANN CLIN LAB SCI, V33, P257; Dhanoa A, 2017, PLATELETS, V28, P724, DOI 10.1080/09537104.2017.1293802; Dhanoa A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1731-8; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Halstead Scott B., 1997, P23; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Hegde V, 2013, CLIN MICROBIOL INFEC, V19, P314, DOI 10.1111/1469-0691.12157; Hemalatha Rajkumar P.B., 2013, ENDOCRINOL METAB SYN, DOI [10.4172/2161-1017.1000113, DOI 10.4172/2161-1017.1000113]; Iantorno M, 2014, J BIOL REG HOMEOS AG, V28, P169; Jain S, 2011, CLIN INFECT DIS, V53, P422, DOI 10.1093/cid/cir448; Junia J, 2007, PAEDIATR INDONES, V47, P7, DOI 10.14238/pi47.1.2007.7-11; Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378; Krishnamurti C, 2002, AM J TROP MED HYG, V66, P435, DOI 10.4269/ajtmh.2002.66.435; Laharrague P, 2000, INT J OBESITY, V24, P1212, DOI 10.1038/sj.ijo.0801377; Libraty DH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004267; Maron GM, 2010, AM J TROP MED HYG, V82, P324, DOI 10.4269/ajtmh.2010.09-0365; Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440; Trang NTH, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1498-y; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Pichainarong Natchaporn, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P283; Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386; Seneviratne SL, 2006, T ROY SOC TROP MED H, V100, P608, DOI 10.1016/j.trstmh.2005.10.007; Srikiatkhachorn A, 2014, ANTIVIR RES, V109, P160, DOI 10.1016/j.antiviral.2014.07.005; Suwarto S, 2017, J INFECT DIS, V215, P992, DOI 10.1093/infdis/jix041; Tackling obesity in ASEAN D Prevalence impact and guidance on interventions, 2017, PREV IMP GUID INT EC; Teran-Cabanillas E, 2017, INFLAMMATION, V40, P58, DOI 10.1007/s10753-016-0452-x; THISYAKORN U, 1993, CLIN INFECT DIS, V16, P295, DOI 10.1093/clind/16.2.295; Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370; Washington IM, 2012, AM COLL LAB, P57, DOI 10.1016/B978-0-12-380920-9.00003-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; World Health Organization, 2009, DENGUE GUIDELINES DI; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031	40	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200698	10.1371/journal.pone.0200698	http://dx.doi.org/10.1371/journal.pone.0200698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016369	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600036
J	Pyuen, AA; Meuten, T; Rose, BJ; Thamm, DH				Pyuen, Alex A.; Meuten, Travis; Rose, Barbara J.; Thamm, Douglas H.			In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; RECEPTOR TYROSINE KINASES; TUMOR-GROWTH; DOXORUBICIN; PATHWAY; EXPRESSION; DOGS; RAPAMYCIN; MODELS; TARGET	While extremely rare in humans, hemangiosarcoma (HSA) accounts for nearly 2% of canine neoplasia, and is characterized by both aggressive local growth/invasion and a high rate of metastasis. Both canine and human HSA exhibit sustained aberrant PI3K/Akt/mTOR pathway signaling. The purpose of this study was to examine the in vitro effects of a novel dual PI3K/mTOR inhibitor, VDC-597, in three canine HSA cell lines (DEN-, CIN-, and SB-HSA). VDC-597 suppressed activation of both Akt and 4eBP1 in canine HSA cells in a dosedependent fashion, with an IC50 of approximately 0.3 uM, a concentration predicted to be clinically achievable based on preliminary early-phase canine and human studies. VDC-597 dose-dependently reduced proliferation, migration, and vascular endothelial growth factor production in HSA cells, while promoting tumor cell apoptosis. VDC-597 demonstrated additive antiproliferative effects when combined with doxorubicin. These results suggest that inhibitors of the PI3K/mTOR pathway may act against multiple components of the neoplastic process, including proliferation/apoptosis, chemosensitivity, migration, and angiogenesis, and justify the evaluation of PI3K/mTOR inhibitors in canine, and potentially human, HSA.	[Pyuen, Alex A.; Meuten, Travis; Rose, Barbara J.; Thamm, Douglas H.] Colorado State Univ, Coll Vet Med & Biomed Sci, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA; [Pyuen, Alex A.; Thamm, Douglas H.] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Thamm, Douglas H.] Univ Colorado, Comprehens Canc Ctr, Aurora, CO 80045 USA	Colorado State University; Colorado State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Thamm, DH (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Flint Anim Canc Ctr, Ft Collins, CO 80523 USA.; Thamm, DH (corresponding author), Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA.; Thamm, DH (corresponding author), Univ Colorado, Comprehens Canc Ctr, Aurora, CO 80045 USA.	dthamm@colostate.edu	Thamm, Douglas/I-5976-2013; Meuten, Travis/G-5243-2016	Thamm, Douglas/0000-0002-8914-7767; Meuten, Travis/0000-0002-4094-7616	Colorado State University Cancer Supercluster; VetDC, Inc.; NIH [5T32OD012201-05]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD012201] Funding Source: NIH RePORTER	Colorado State University Cancer Supercluster; VetDC, Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Colorado State University Cancer Supercluster and VetDC, Inc., VDC-597 was graciously donated by VetDC. AAP was supported by NIH Grant #5T32OD012201-05. Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by grants from the Colorado State University Cancer Supercluster and VetDC, Inc. VDC-597 was graciously donated by VetDC. AAP was supported by NIH Grant #5T32OD012201-05. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Adachi M, 2016, CAN J VET RES, V80, P209; Akhtar N, 2004, NEOPLASIA, V6, P106, DOI 10.1593/neo.03334; Amo Y, 2001, ARCH DERMATOL RES, V293, P296, DOI 10.1007/s004030100228; Bundscherer A, 2010, ANTICANCER RES, V30, P4017; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chen YT, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-73; Clifford CA, 2000, J VET INTERN MED, V14, P479, DOI 10.1892/0891-6640(2000)014&lt;0479:TOCHAB&gt;2.3.CO;2; Cohen SM, 2009, TOXICOL SCI, V111, P4, DOI 10.1093/toxsci/kfp131; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dervisis NG, 2011, J AM ANIM HOSP ASSOC, V47, P170, DOI 10.5326/JAAHA-MS-5525; Dickerson EB, 2005, VET PATHOL, V42, P618, DOI 10.1354/vp.42-5-618; Farhang Ghahremani M, 2014, CELL CYCLE, V13, P1501, DOI 10.4161/cc.28474; Fowles JS, 2017, VET COMP ONCOL, V15, P481, DOI 10.1111/vco.12192; Hamada K, 2005, GENE DEV, V19, P2054, DOI 10.1101/gad.1308805; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; JOHNSON KA, 1989, J VET INTERN MED, V3, P160, DOI 10.1111/j.1939-1676.1989.tb03092.x; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Lamerato-Kozicki AR, 2006, EXP HEMATOL, V34, P870, DOI 10.1016/j.exphem.2006.04.013; Matsumura I, 2008, CANCER SCI, V99, P479, DOI 10.1111/j.1349-7006.2007.00717.x; Murai A, 2012, J COMP PATHOL, V147, P430, DOI 10.1016/j.jcpa.2012.05.002; Murai A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-128; O'Donoghue LE, 2011, J VET DIAGN INVEST, V23, P780, DOI 10.1177/1040638711408064; Ogilvie GK, 1996, J VET INTERN MED, V10, P379, DOI 10.1111/j.1939-1676.1996.tb02085.x; Podar K, 2005, BLOOD, V105, P1383, DOI 10.1182/blood-2004-07-2909; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Smith AN, 2003, VET CLIN N AM-SMALL, V33, P533, DOI 10.1016/S0195-5616(03)00002-0; SORENMO KU, 1993, J VET INTERN MED, V7, P370, DOI 10.1111/j.1939-1676.1993.tb01033.x; Sorenmo KU, 2004, J VET INTERN MED, V18, P209, DOI 10.1892/0891-6640(2004)18&lt;209:EATOAD&gt;2.0.CO;2; SREBERNIK N, 1991, VET REC, V129, P408, DOI 10.1136/vr.129.18.408; Tang L, 2015, ACS NANO, V9, P5072, DOI 10.1021/acsnano.5b00166; Thamm DH, 2006, RES VET SCI, V81, P76, DOI 10.1016/j.rvsc.2005.09.005; Thamm DH., 2012, SMALL ANIMAL CLIN ON, P679; Vail DM, 2000, CANCER INVEST, V18, P781, DOI 10.3109/07357900009012210; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wei BR, 2016, PIGM CELL MELANOMA R, V29, P643, DOI 10.1111/pcmr.12512; Yonemaru K, 2006, VET PATHOL, V43, P971, DOI 10.1354/vp.43-6-971; Young RJ, 2014, EXP MOL PATHOL, V97, P148, DOI 10.1016/j.yexmp.2014.06.010; Zimmer A, 2016, P NATL ACAD SCI USA, V113, P10442, DOI 10.1073/pnas.1606301113	41	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200634	10.1371/journal.pone.0200634	http://dx.doi.org/10.1371/journal.pone.0200634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011343	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800036
J	Paik, SH; Ahn, JS; Min, S; Park, KC; Kim, MH				Paik, Soo-Hyun; Ahn, Joung-Sook; Min, Seongho; Park, Ki-Chang; Kim, Min-Hyuk			Impact of psychotic symptoms on clinical outcomes in delirium	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ALZHEIMER-DISEASE; MOTORIC SUBTYPES; OLDER PERSONS; RATING-SCALE; PREVALENCE; PHENOMENOLOGY; FEATURES; SYSTEM	Delirium is an acute disturbance in attention and awareness in response to one or more physiological stressors that is closely related to poor clinical outcomes. The aim of this study is to investigate whether delirium patients with psychotic symptoms (PS) would have unique clinical characteristics and outcomes. A retrospective chart review was performed on the patients with delirium due to general medical conditions to assess clinical characteristics and outcomes. All patients were assessed by Delirium Rating Scale-revised-98 and classified as having PS when scored two or more on at least one of the psychotic symptom items (perceptual disturbances, delusions, and thought process abnormalities). Of 233 patients with delirium, 116 (49.8%) manifested PS. Patients with PS were younger, more likely to use antipsychotics to manage delirium, and had more hyperactive motor subtype than patients without PS. Logistic regression analysis showed that odds ratio of psychotic symptoms for having in-hospital mortality was 0.27 (95% CI = 0.08-0.94) after controlling age, sex, disease severity, comorbidity, number of medications, etiologies, motor subtypes, delirium severity and use of antipsychotics. The present study demonstrated that PS of delirium was associated with unique clinical characteristics and may affect the clinical course in a psychiatry-referral sample.	[Paik, Soo-Hyun] Bucheon Ki Hosp, Bucheon, South Korea; [Ahn, Joung-Sook; Min, Seongho; Park, Ki-Chang; Kim, Min-Hyuk] Yonsei Univ, Wonju Coll Med, Dept Psychiat, Wonju, South Korea	Yonsei University	Kim, MH (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Psychiat, Wonju, South Korea.	mhkim09@yonsei.ac.kr		Min-Hyuk, Kim/0000-0002-6130-3254				Grover S, 2013, East Asian Arch Psychiatry, V23, P56; Grover S, 2014, PSYCHIAT CLIN NEUROS, V68, P283, DOI 10.1111/pcn.12131; Gupta N, 2008, J PSYCHOSOM RES, V65, P215, DOI 10.1016/j.jpsychores.2008.05.020; Hales RE., 2008, AM PSYCHIAT PUBLISHI, V5th edition; Hall WH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-94; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lee Y, 2011, PSYCHIAT INVEST, V8, P30, DOI 10.4306/pi.2011.8.1.30; LIPOWSKI ZJ, 1989, NEW ENGL J MED, V320, P578; LIPTZIN B, 1992, BRIT J PSYCHIAT, V161, P843, DOI 10.1192/bjp.161.6.843; Marchena-Gomez J, 2009, ANN VASC SURG, V23, P458, DOI 10.1016/j.avsg.2008.10.008; Meagher D, 2012, BRIT J PSYCHIAT, V200, P37, DOI 10.1192/bjp.bp.111.095273; Meagher DJ, 2008, PSYCHOSOMATICS, V49, P300, DOI 10.1176/appi.psy.49.4.300; Meagher DJ, 2007, BRIT J PSYCHIAT, V190, P135, DOI 10.1192/bjp.bp.106.023911; Murray PS, 2014, BIOL PSYCHIAT, V75, P542, DOI 10.1016/j.biopsych.2013.08.020; OH TE, 1993, CRIT CARE MED, V21, P698, DOI 10.1097/00003246-199305000-00013; Peterson JF, 2006, J AM GERIATR SOC, V54, P479, DOI 10.1111/j.1532-5415.2005.00621.x; Ross C A, 1991, Int Psychogeriatr, V3, P135, DOI 10.1017/S1041610291000613; Sampson EL, 2014, BRIT J PSYCHIAT, V205, P189, DOI 10.1192/bjp.bp.113.130948; Santos FS, 2005, DEMENT GERIATR COGN, V20, P231, DOI 10.1159/000087311; Scarmeas N, 2005, ARCH NEUROL-CHICAGO, V62, P1601, DOI 10.1001/archneur.62.10.1601; Stagno Daniele, 2004, Palliat Support Care, V2, P171; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; TRZEPACZ PT, 1995, GEN HOSP PSYCHIAT, V17, P75, DOI 10.1016/0163-8343(94)00095-U; Vilalta-Franch J, 2013, AM J GERIAT PSYCHIAT, V21, P1135, DOI 10.1016/j.jagp.2013.01.051; Webster R, 2000, PSYCHOSOMATICS, V41, P519, DOI 10.1176/appi.psy.41.6.519; Yang FM, 2009, PSYCHOSOMATICS, V50, P248, DOI 10.1176/appi.psy.50.3.248; Zhang ZG, 2013, GEN HOSP PSYCHIAT, V35, P105, DOI 10.1016/j.genhosppsych.2012.11.003	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200538	10.1371/journal.pone.0200538	http://dx.doi.org/10.1371/journal.pone.0200538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN1IZ	30005081	gold, Green Published, Green Submitted			2022-12-26	WOS:000438744200019
J	Peixoto, LD; Teodoro, PE; Silva, LA; Rodrigues, EV; Laviola, BG; Bhering, LL				Peixoto, Leonardo de Azevedo; Teodoro, Paulo Eduardo; Silva, Lidiane Aparecida; Rodrigues, Erina Vitorio; Laviola, Bruno Galveas; Bhering, Leonardo Lopes			Jatropha half-sib family selection with high adaptability and genotypic stability	PLOS ONE			English	Article							PHYSIC NUT; GENETIC-PARAMETERS; CURCAS L; BIOFUEL; TRAITS	Jatropha (Jatropha curcas) has become one of the most important species for producing biofuels. Currently, Genotype x Environment (GxE) interaction is the biggest challenge that breeders should solve to increase the section accuracy in the plant breeding. Therefore, the objectives in this study were to estimate the parameters in the 180 half-sib families in Jatropha evaluated for five production years, to verify the significance of the GxE interaction variance, to evaluate the adaptability and stability for each family based on three prediction methods, to select superior half-sib families based on the adaptability and stability analyses, and to predict the accuracy for the sixth production year. Jatropha half-sib families were classified and selected using the follow adaptability and stability methods: linear regression, bi-segmented linear regression and mixed models concepts called harmonic mean of the relative performance of genetic values (HMRPGV). The prediction accuracy was estimated by the Pearson correlation between the predicted genetic values by adaptability and stability methods and the phenotypic value in the sixth production year. In result, most half-sib families were classified as general adaptability and general stability for the evaluated traits. The selection gain obtained via HMRPGV was higher than other methods. The prediction accuracy for the sixth production year was 0.45. Therefore, HMRPGV is efficient to maximize the genetic gain, and it can be a useful strategy to select genotype with high adaptability and stability in Jatropha breeding as well as other species that should be evaluated for many years to take a suitable selection accuracy.	[Peixoto, Leonardo de Azevedo; Teodoro, Paulo Eduardo; Silva, Lidiane Aparecida; Bhering, Leonardo Lopes] Univ Fed Vicosa, Ave Peter Henry Rolfs S-N,Campus Univ, Vicosa, MG, Brazil; [Rodrigues, Erina Vitorio; Laviola, Bruno Galveas] Embrapa Agroenergia, Parque Estacao Biol PqEB, Brasilia, DF, Brazil	Universidade Federal de Vicosa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Bhering, LL (corresponding author), Univ Fed Vicosa, Ave Peter Henry Rolfs S-N,Campus Univ, Vicosa, MG, Brazil.	leonardo.bhering@ufv.br	TEODORO, PAULO/D-5903-2014; Laviola, Bruno Galvêas/AAK-8551-2020; Bhering, Leonardo/AAK-9548-2020; Laviola, Bruno G/F-5855-2010	TEODORO, PAULO/0000-0002-8236-542X; Laviola, Bruno/0000-0002-6360-1204; Bhering, Leonardo/0000-0002-6072-0996; Rodrigues, Erina/0000-0002-2120-0533	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior); Cnpq (National Counsel of Technological and Scientific Development); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Cnpq (National Counsel of Technological and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Funarbe (Fundacao Arthur Bernardes); Federal University of Vicosa	This study was supported by CAPES (Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior), Cnpq (National Counsel of Technological and Scientific Development), FAPEMIG (Fundacao de Amparo a Pesquisa de Minas Gerais), Funarbe (Fundacao Arthur Bernardes) and Federal University of Vicosa.	Alves AA, 2015, BIOTECHNOL J, V10, P505, DOI 10.1002/biot.201400201; Becker K., 2008, LIPID TECHNOL, V20, P104, DOI [DOI 10.1002/LITE.200800023, 10.1002/lite.200800023]; CRUZ CD, 1989, REV BRAS GENET, V12, P567; Cruz CD, 2012, MODELOS BIOMETRICOS; Cruz CD, 2013, ACTA SCI-AGRON, V35, P271, DOI 10.4025/actasciagron.v35i3.21251; de Barros Rocha MdG, 2006, AVALIAC MEIO EUCALYP; de Farias Neto JT, 2001, REV BRAS FRUTIC, P320; de Resende MDV, 2004, METODOS ESTATISTICOS; Dias LAdS, 2007, CULTIVO MANSO JATROP, V1, P1; Duarte J., 1988, ESTUDO ADAPTABILIDAD; Duarte J. B, 1999, MONOGRAFIAS SERIE RI; Duarte JB, 2001, PESQUI AGROPECU BRAS, V36, P1155, DOI 10.1590/S0100-204X2001000900009; Duraes FOM, 2012, PLANT SCI REV, V2011, P179; EBERHART SA, 1966, CROP SCI, V6, P36, DOI 10.2135/cropsci1966.0011183X000600010011x; Grattapaglia D, 2011, TREE GENET GENOMES, V7, P241, DOI 10.1007/s11295-010-0328-4; Jarquin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-740; Laviola BG, 2011, BIOSCIENCE J, V27; Laviola BG, 2014, PESQUI AGROPECU BRAS, V49, P356, DOI 10.1590/S0100-204X2014000500005; Laviola BG, 2012, CIENC RURAL, V42, P429, DOI 10.1590/S0103-84782012000300008; Laviola BG, 2010, PESQUI AGROPECU BRAS, V45, P1117, DOI 10.1590/S0100-204X2010001000010; Montes JM, 2016, TRENDS PLANT SCI, V21, P1045, DOI 10.1016/j.tplants.2016.08.008; Nithiyanantham S, 2012, J AM OIL CHEM SOC, V89, P961, DOI 10.1007/s11746-012-2012-3; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; Resende M.D.V, 2007, SELEGEN REML BLUP SI; RESENDE M.D.V. de, 2002, GENETICA BIOMETRICA; Resende MDV, 2000, ANALISE ESTATISTICA; Resende MDV., 2002, SOFTWARE SELEGEN REM, V77, P67; Shivani Sharma, 2012, Asian Journal of Research Pharmaceutical Sciences, V2, P107; Spinelli VM, 2015, IND CROP PROD, V69, P355, DOI 10.1016/j.indcrop.2015.02.024; Teodoro PE, 2016, BRAGANTIA, V75, P51, DOI 10.1590/1678-4499.314; Teodoro PE, 2016, GENETICS MOL RES GMR, V15	31	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199880	10.1371/journal.pone.0199880	http://dx.doi.org/10.1371/journal.pone.0199880			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001344	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400019
J	Ali, S; Xu, YY; Jia, QM; Ahmed, I; Ma, XC; Henchiri, M; Ren, XL; Zhang, P; Cai, T; Zhang, JH; Jia, ZK				Ali, Shahzad; Xu, Yueyue; Jia, Qianmin; Ahmed, Irshad; Ma, Xiangcheng; Henchiri, Malak; Ren, Xiaolong; Zhang, Peng; Cai, Tie; Zhang, Jiahua; Jia, Zhikuan			Ridge-furrow mulched with plastic film improves the anti-oxidative defence system and photosynthesis in leaves of winter wheat under deficit irrigation	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ENZYME-ACTIVITY; ACTIVE OXYGEN; ABSCISIC-ACID; DROUGHT; STRESS; TOLERANCE; RESPONSES; MAIZE; YIELD	In semi-arid areas of China, the ridge-furrow mulched with plastic film (RF) cultivation system is a common water-saving agricultural technique where the shortage of water resources has become a serious problem. Therefore, we aimed to explore whether this cultivation is actually an improvement over the traditional flat planting (TF) method while testing two deficit irrigation (150, 75 mm) levels to grow winter wheat. Furthermore, we examined the responses of the anti-oxidative defence system and photosynthetic capacity of winter wheat flag leaves under three simulated rainfall (275, 200 and 125 mm) conditions. The results showed that the RF system with 150 mm deficit irrigation and 200 mm simulated rainfall condition (RF2(150)) treatment raised soil water content (%) at the jointing and flowering stages and achieved higher net photosynthesis rates (Pn) in flag leaves. Furthermore, such improvements were due to the reduction of malondialdehyde (MDA) content and oxidative damage during different growth stages of winter wheat. The RF2(150) treatment significantly increased the activities of superoxide dismutase (SOD); peroxidise (POD), catalase (CAT) and ascorbate peroxidase (APX) and the content of soluble protein (SP) during different growth stages of winter wheat. Furthermore, RF2(150) treatment attained the highest value at the flowering stage, while also exhibiting significant declines in contents of proline, MDA, H2O2 and O-2 in flag leaves. The higher free H2O2 and O-2 scavenging capacity and better anti-oxidative enzyme activities under the RF2(150) treatment were due to the lower level of lipid peroxidation, which effectively protected the photosynthetic machinery. The net photosynthetic rate of flag leaves was positively correlated with SOD, POD, CAT, APX and SP activities, and negatively correlated with proline, MDA, H2O2 and O-2 contents. We concluded that the RF2(150) treatment was the better water-saving management strategy because it significantly delayed flag leaf senescence and caused the increases in SWC, WUE, Pn, antioxidant enzyme activities and grain yield of winter wheat grown in semi-arid regions of China.	[Ali, Shahzad; Xu, Yueyue; Jia, Qianmin; Ahmed, Irshad; Ma, Xiangcheng; Ren, Xiaolong; Zhang, Peng; Cai, Tie; Jia, Zhikuan] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Ali, Shahzad; Henchiri, Malak; Zhang, Jiahua] Qingdao Univ, Sch Comp Sci & Technol, Remote Sensing & Climate Change, Qingdao, Shandong, Peoples R China	Northwest A&F University - China; Qingdao University	Jia, ZK (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Zhang, JH (corresponding author), Qingdao Univ, Sch Comp Sci & Technol, Remote Sensing & Climate Change, Qingdao, Shandong, Peoples R China.	zhangjh_radicas@163.com; zhikuan.jia@hotmail.com		Cai, Tommaso/0000-0002-7234-3526; HENCHIRI, MALAK/0000-0002-0201-0566	China Support Program for Dry-land Farming [2012BAD09B03]; National High-Tech Research and Development Programs of China ("863 Program") [2013AA102902]; Special Fund for Agro-scientific Research in the Public Interest [201303104]; Key basic research project of Shandong natural science foundation of China [ZR2017ZB0422]; "Taishan Scholar" project of Shandong Province; Program of Introducing Talents of Discipline to Universities [B12007]	China Support Program for Dry-land Farming; National High-Tech Research and Development Programs of China ("863 Program")(National High Technology Research and Development Program of China); Special Fund for Agro-scientific Research in the Public Interest; Key basic research project of Shandong natural science foundation of China; "Taishan Scholar" project of Shandong Province; Program of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by China Support Program (2012BAD09B03) for Dry-land Farming in the 12th 5-year plan period, the National High-Tech Research and Development Programs of China ("863 Program") for the 12th 5-Year Plans (2013AA102902), the Special Fund for Agro-scientific Research in the Public Interest under Grant (201303104), and the Key basic research project of Shandong natural science foundation of China (ZR2017ZB0422), and "Taishan Scholar" project of Shandong Province, the Program of Introducing Talents of Discipline to Universities (No.B12007) (ZJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by China Support Program (2012BAD09B03) for Dry-land Farming in the 12th 5-year plan period, the National High-Tech Research and Development Programs of China ("863 Program") for the 12th 5-Year Plans (2013AA102902), the Special Fund for Agro-scientific Research in the Public Interest under Grant (201303104), and the Key basic research project of Shandong natural science foundation of China (ZR2017ZB0422), and "Taishan Scholar" project of Shandong Province. We are also grateful to Wang Junpeng, Nie Junfeng, Yang Baoping and Ding Ruixia for help during experimental period.	Ali S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01408; AMAKO K, 1994, PLANT CELL PHYSIOL, V35, P497; Anjum SA, 2011, J AGRON CROP SCI, V197, P177, DOI 10.1111/j.1439-037X.2010.00459.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Blandino M, 2009, EUR J AGRON, V30, P275, DOI 10.1016/j.eja.2008.12.005; BRENNAN T, 1977, PLANT PHYSIOL, V59, P411, DOI 10.1104/pp.59.3.411; Cui YK, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1944-2; Ding R. X., 2004, TRITICEAE CROPS, V5, P110; ELSTNER EF, 1976, ANAL BIOCHEM, V70, P616, DOI 10.1016/0003-2697(76)90488-7; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fazeli F, 2007, BIOL PLANTARUM, V51, P98, DOI 10.1007/s10535-007-0020-1; Fotelli MN, 2002, PLANT BIOLOGY, V4, P311, DOI 10.1055/s-2002-32334; Guo ZJ, 2014, FIELD CROP RES, V166, P102, DOI 10.1016/j.fcr.2014.06.004; Gupta A. K., 2011, American Journal of Plant Sciences, V2, P70, DOI 10.4236/ajps.2011.21010; Huseynova IM, 2012, BBA-BIOENERGETICS, V1817, P1516, DOI 10.1016/j.bbabio.2012.02.037; Jiang MY, 2002, PLANTA, V215, P1022, DOI 10.1007/s00425-002-0829-y; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kaur K, 2013, PLANT GROWTH REGUL, V70, P49, DOI 10.1007/s10725-012-9777-0; Li H.S., 2000, PRINCIPLES TECHNIQUE, P119; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lum MS, 2014, J ANIM PLANT SCI, V24, P1487; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; QUARTACCI MF, 1995, PLANT PHYSIOL, V108, P191, DOI 10.1104/pp.108.1.191; READ SM, 1981, ANAL BIOCHEM, V116, P53, DOI 10.1016/0003-2697(81)90321-3; Reddy A. R., 2004, J PLANT PHYSL, V11; Ren XL, 2008, AGR WATER MANAGE, V95, P1293, DOI 10.1016/j.agwat.2008.05.007; Sairam RK, 1998, BIOL PLANTARUM, V41, P387, DOI 10.1023/A:1001898310321; Sairam RK, 1997, J AGRON CROP SCI, V178, P171, DOI 10.1111/j.1439-037X.1997.tb00486.x; Sairam RK, 2001, J AGRON CROP SCI, V186, P63, DOI 10.1046/j.1439-037x.2001.00461.x; Sawhney V, 2002, FIELD CROP RES, V77, P1, DOI 10.1016/S0378-4290(01)00192-7; Shi JC, 2014, AGR WATER MANAGE, V146, P163, DOI 10.1016/j.agwat.2014.08.006; Tan W, 2008, PHOTOSYNTHETICA, V46, P21, DOI 10.1007/s11099-008-0005-0; Thompson TL, 2009, AGR SCI CHINA, V8, P850, DOI 10.1016/S1671-2927(08)60287-4; Tian Y, 2003, FIELD CROP RES, V84, P385, DOI 10.1016/S0378-4290(03)00118-7; Villagra PE, 2006, J ARID ENVIRON, V64, P390, DOI 10.1016/j.jaridenv.2005.06.008; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang Q, 2008, WATER RESOUR MANAG, V22, P1431, DOI 10.1007/s11269-007-9235-3; Wang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165733; Wang YJ, 2009, AGR WATER MANAGE, V96, P374, DOI 10.1016/j.agwat.2008.09.012; Wu FZ, 2008, PHOTOSYNTHETICA, V46, P40, DOI 10.1007/s11099-008-0008-x; Yu ZhenWen, 1995, Acta Agronomica Sinica, V21, P503; Zhang XZ, 1992, CROP PHYSL RES METHO, P131	44	10	11	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e020027	10.1371/journal.pone.0200277	http://dx.doi.org/10.1371/journal.pone.0200277			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995903	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800049
J	Hupman, K; Stockin, KA; Pollock, K; Pawley, MDM; Dwyer, SL; Lea, C; Tezanos-Pinto, G				Hupman, Krista; Stockin, Karen A.; Pollock, Kenneth; Pawley, Matthew D. M.; Dwyer, Sarah L.; Lea, Catherine; Tezanos-Pinto, Gabriela			Challenges of implementing Mark-recapture studies on poorly marked gregarious delphinids	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PACIFIC HUMPBACK DOLPHINS; BEAKED COMMON DOLPHINS; TURSIOPS-TRUNCATUS; CAPTURE-RECAPTURE; SITE FIDELITY; HAURAKI GULF; PHOTOGRAPHIC IDENTIFICATION; HABITAT PREFERENCES; SEASONAL ABUNDANCE	Population parameters of poorly marked gregarious species are difficult to estimate. This is the case for common dolphins (Delphinus sp.), a genus known for its lack of distinctive marks resulting in a low mark ratio. Furthermore, the widespread nature of common dolphins results in low recaptures. We developed reliable photo-identification protocols to ensure accurate identification of individuals in the Hauraki Gulf, New Zealand. These protocols combined the use of nicks and notches and pigmentation patterns for identification and included the development of a distinctiveness threshold. The data were further stratified by the level of distinctiveness of each individual (as distinctive or highly-distinctive). Photo-identification surveys were conducted from January 2010 to December 2013. Mark-recapture techniques were implemented through a POPAN super-population approach to estimate seasonal apparent survival, capture probability and abundance of dolphins. A total of 2,083 unique adult common dolphins were identified, 51.3% were classified as D1 (highly distinctive; n = 1,069) and 48.7% as D2 (distinctive; n = 1,014). Of all individuals identified, 34.3% (n = 704) were re-sighted over subsequent years. The proportion of marked dolphins (when compared to unmarked dolphins) was 26.3% for D1 and 46.4% for D1 & D2, respectively. Apparent survival was estimated at 0.767 (CI = 0.694-0.827) for D1 animals, and 0.796 (CI = 0.729-0.850) for D1 & D2 combined. For D1 only, seasonal abundance varied from 732 (CI = 460-1,177) in autumn 2010 to 5,304 (CI = 4,745-5,930) in spring 2013. While the inclusion of D2 individuals may offer a more precise estimate of total abundance, the inability to determine additional sources of bias (for example, arising from under or overestimated mark ratios) meant that estimates for D1 individuals were deemed the least biased for this population. The photo-identification protocol, stratification of the data and steps taken to eliminate potential model violations provided a useful and novel approach to estimate population parameters for common dolphins. These approaches could be implemented for other large gregarious populations (>= 500 individuals) of animals with poor natural markings.	[Hupman, Krista; Stockin, Karen A.; Pawley, Matthew D. M.; Dwyer, Sarah L.; Lea, Catherine; Tezanos-Pinto, Gabriela] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Hupman, Krista] Massey Univ, Inst Nat & Math Sci, Coastal Marine Res Grp, Auckland, New Zealand; [Pollock, Kenneth] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC USA	National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Massey University; University of North Carolina; North Carolina State University	Hupman, K (corresponding author), Natl Inst Water & Atmospher Res, Wellington, New Zealand.; Hupman, K (corresponding author), Massey Univ, Inst Nat & Math Sci, Coastal Marine Res Grp, Auckland, New Zealand.	krista.hupman@niwa.co.nz	Stockin, Karen A/B-4452-2010	Stockin, Karen/0000-0002-2981-3983; Dwyer, Sarah/0000-0002-9244-8114	Massey University; Freemasons Society; New Zealand Federation for Graduate Women; Department of Conservation Auckland Conservancy	Massey University; Freemasons Society; New Zealand Federation for Graduate Women; Department of Conservation Auckland Conservancy	Dolphin Explorer for access to their vessel and their ongoing support and assistance and various funding sources including Massey University, the Freemasons Society, the New Zealand Federation for Graduate Women and the Department of Conservation Auckland Conservancy for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 2011, P 25 ANN M EUR CET S; Alves F, 2014, MAR MAMMAL SCI, V31, P1; Amstrup S, 2005, HANDBOOK OF CAPTURE-RECAPTURE ANALYSIS, P1; Andrews KR, 2010, MOL ECOL, V19, P1755, DOI 10.1111/j.1365-294X.2010.04592.x; [Anonymous], 2002, MODEL SELECTION MULT; Baird RA, 2001, 40JGNF000262 SW FISH, P1; Baird RW, 2009, MAR MAMMAL SCI, V25, P251, DOI 10.1111/j.1748-7692.2008.00257.x; Balmer B. C., 2008, Journal of Cetacean Research and Management, V10, P157; Balmer BC, 2014, MAR MAMMAL SCI, V30, P656, DOI 10.1111/mms.12072; Bamford CCG, 2016, J MAR BIOL ASSOC UK, V96, P999, DOI 10.1017/S0025315415001150; Barco SG, 1999, MAR MAMMAL SCI, V15, P394, DOI 10.1111/j.1748-7692.1999.tb00809.x; Bearzi G, 2005, AQUAT CONSERV, V15, P243, DOI 10.1002/aqc.667; Bearzi G, 2004, P 15 ANN M EUR CET S; Bearzi Giovanni, 2008, Endangered Species Research, V5, P1, DOI 10.3354/esr00103; Bearzi G, 2008, AQUAT CONSERV, V18, P130, DOI 10.1002/aqc.843; Bearzi G, 2011, MAR MAMMAL SCI, V27, pE165, DOI 10.1111/j.1748-7692.2010.00448.x; Beasley I, 2013, MAR MAMMAL SCI, V29, pE226, DOI 10.1111/j.1748-7692.2012.00614.x; Beausoleil NJ, METHODS MARKING NZ W; Behrens S., 2009, THESIS, P1; Bejder L, 2001, NEW ZEAL J MAR FRESH, V35, P277, DOI 10.1080/00288330.2001.9516998; Berrow S, 2012, AQUAT MAMM, V38, P136, DOI 10.1578/AM.38.2.2012.136; Brager S, 1998, NEW ZEAL J MAR FRESH, V32, P105, DOI 10.1080/00288330.1998.9516809; Brown A.J., 2014, ARXIV 1401 7434V1401; Burnham K.P., 1987, American Fisheries Society Monograph, P1; Burnham KP, MARKED INDIVIDUALS S; Cagnazzi DD, 2009, MAR MAMMAL SCI, V27, P255; Canadas A., 2008, Endangered Species Research, V4, P309, DOI 10.3354/esr00073; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Chilvers BL, 2003, MAR MAMMAL SCI, V19, P85, DOI 10.1111/j.1748-7692.2003.tb01094.x; Choquet R, 2005, U CARE 2 02 UTILITIE, P1; Constantine R., 2002, THESIS, P1; Constantine R., 1997, WATER-SUI, V56, P1; Cooch E, 2014, PROGRAM MARK GENTLE, P1; Currey RJC, 2008, NEW ZEAL J MAR FRESH, V42, P439, DOI 10.1080/00288330809509972; Davidson EH, 2014, WHALE DOLPHIN TRAC B, V65b, P1; de Boer Marijke N., 2013, Open Journal of Marine Science, V3, P66; de Boer MN, 2010, MAR ECOL PROG SER, V408, P265, DOI 10.3354/meps08598; Dwyer SL, 2016, NEW ZEAL J MAR FRESH, V50, P457, DOI 10.1080/00288330.2016.1160942; Dwyer SL, 2014, ENDANGER SPECIES RES, V25, P97, DOI 10.3354/esr00613; Estman-Lind J, 2004, DELPHINID ABUNDANCE, P1; Eyre Elizabeth J., 2012, Journal of Cetacean Research and Management, V12, P277; Ferreira T., 2012, IMAGEJ USER GUIDE IJ; Filby N., 2006, THESIS, P1; FORNEY KA, 1995, FISH B-NOAA, V93, P15; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Friday N, 1997, SC49O19 INT WHAL COM, P1; Friday NA, 2008, MAR MAMMAL SCI, V24, P253, DOI 10.1111/j.1748-7692.2008.00187.x; Fury CA, 2008, MAR FRESHWATER RES, V59, P1015, DOI 10.1071/MF08109; Geelhoed SCV, 2015, SC66ASH11REV3 INT WH, p1 ; Gerrodette Tim, 2008, NOAA Technical Memorandum NMFS-SWFSC, V422, P1; Gimenez J, 2012, P 26 ANN M EUR CET S; Gimenez J, 2009, P 23 ANN M EUR CET S; Gnone G, 2011, AQUAT CONSERV, V21, P372, DOI 10.1002/aqc.1191; Gormley A., 2002, THESIS, P1; Gormley AM, 2005, MAR MAMMAL SCI, V21, P204, DOI 10.1111/j.1748-7692.2005.tb01224.x; Green EL, 2003, THESIS, P1; Halliday KR, 2013, THESIS, P1; Hammond P.S., 1990, Reports of the International Whaling Commission Special Issue, P1; Hammond PS, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P705; Hupman K, 2015, NEW ZEAL J MAR FRESH, V49, P132, DOI 10.1080/00288330.2014.980278; Hupman K., 2016, THESIS, P1; Ingram SN, 2007, J MAR BIOL ASSOC UK, V87, P149, DOI 10.1017/S0025315407054884; Isojunno S, 2012, MAR ECOL PROG SER, V448, P155, DOI 10.3354/meps09415; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Karczmarski L, 1999, MAR MAMMAL SCI, V15, P1115, DOI 10.1111/j.1748-7692.1999.tb00880.x; Kiszka J, 2007, ICES J MAR SCI, V64, P1033, DOI 10.1093/icesjms/fsm067; Kreb D., 2004, Journal of Cetacean Research and Management, V6, P269; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lukoschek V, 2008, WILDLIFE RES, V35, P593, DOI 10.1071/WR07021; Luksenburg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088988; Mackay K, 2012, NIWA CHART MISCELLAN, V91; Macleod CD, 2009, J MAR BIOL ASSOC UK, V89, P1059, DOI 10.1017/S0025315408002828; Markowitz TM, 2004, THESIS, P1; Martinho F, 2015, MAR BIOL RES, V11, P144, DOI 10.1080/17451000.2014.894244; Martz E, 2010, TRAUMA REHABILITATION AFTER WAR AND CONFLICT: COMMUNITY AND INDIVIDUAL PERSPECTIVES, P1, DOI 10.1007/978-1-4419-5722-1_1; Mason S, 2009, P 18 BIENN C SOC MAR; Merriman Monika G., 2009, Aquatic Mammals, V35, P511, DOI 10.1578/AM.35.4.2009.511; Moeller L. M., 2002, Australian Mammalogy, V24, P11; Mussi B, 2002, P 16 ANN M EUR CET S; Neumann DR, 2002, NEW ZEAL J MAR FRESH, V36, P593, DOI 10.1080/00288330.2002.9517115; Neumann DR, 2001, THESIS, P1; Nicholson K, 2012, MAR FRESHWATER RES, V63, P1059, DOI 10.1071/MF12210; Norris KS, 1994, HAWAIIAN SPINNER DOL, P1; Oremus M, 2007, MAR ECOL PROG SER, V336, P275, DOI 10.3354/meps336275; Palacios Daniel M., 2012, Journal of Cetacean Research and Management, V12, P45; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Pulcini M, 2014, J MAR BIOL ASSOC UK, V94, P1175, DOI 10.1017/S0025315413000842; Pusineri C, 2014, ENDANGER SPECIES RES, V23, P23, DOI 10.3354/esr00555; Ramp C, 2006, MAR ECOL PROG SER, V319, P287, DOI 10.3354/meps319287; Ryan GE, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00171.1; Schaub M, 2014, METHODS ECOL EVOL, V5, P1316, DOI 10.1111/2041-210X.12134; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Scott M.D., 1990, P489; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; SLOOTEN E, 1992, MAR MAMMAL SCI, V8, P327, DOI 10.1111/j.1748-7692.1992.tb00049.x; Smit HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068610; Sprinthall RC, 2012, BASIC STAT ANAL, P1; Stevick PT, 2001, CAN J FISH AQUAT SCI, V58, P1861, DOI 10.1139/cjfas-58-9-1861; Stockin K.A., 2009, J CETACEAN RES MANAG, VSC/61/SM20, P1; Stockin KA, 2008, MAR ECOL PROG SER, V355, P287, DOI 10.3354/meps07386; Stockin KA, 2009, MAR MAMMAL SCI, V25, P283, DOI 10.1111/j.1748-7692.2008.00262.x; Stockin Karen A., 2008, Aquatic Mammals, V34, P200, DOI 10.1578/AM.34.2.2008.200; Sutaria D, 2011, MAR MAMMAL SCI, V27, pE338, DOI 10.1111/j.1748-7692.2011.00471.x; Tavares M, 2010, MAMMAL REV, V40, P40, DOI 10.1111/j.1365-2907.2009.00154.x; Tezanos-Pinto G, 2013, MAR MAMMAL SCI, V29, pE390, DOI 10.1111/mms.12008; Turek JL, 2011, THESIS, P1; Tyne JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086132; Urian K, 2015, MAR MAMMAL SCI, V31, P298, DOI 10.1111/mms.12141; Urian KW, 1999, WORKSH CAT CONTR NAT, P298; Wang JY, 2012, B MAR SCI, V88, P885, DOI 10.5343/bms.2010.1097; Webster I, 2015, AFR J MAR SCI, V37, P115, DOI 10.2989/1814232X.2015.1017004; Webster T, 2006, REPORT IDENTIFIABLE, P1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H, 2000, CETACEAN SOCIETIES, P219; WILLIAMS BK, 2002, ANAL MANAGEMENT WILD; WILLIAMS JA, 1993, CAN J ZOOL, V71, P2080, DOI 10.1139/z93-293; Williams R, 2006, ECOL SOC, V11; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2; Wiseman N, 2011, MARINE MAMMAL SCI, V27, P1; WURSIG B, 1977, SCIENCE, V198, P755, DOI 10.1126/science.198.4318.755; Wursig B., 1990, Reports of the International Whaling Commission Special Issue, P43; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1; Zaeschmar JR, 2014, MAR MAMMAL SCI, V30, P594, DOI 10.1111/mms.12065	126	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0198167	10.1371/journal.pone.0198167	http://dx.doi.org/10.1371/journal.pone.0198167			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995888	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800008
J	Shaw, M; Zhan, HY; Elmi, M; Pawar, V; Essmann, C; Srinivasan, MA				Shaw, Michael; Zhan, Haoyun; Elmi, Muna; Pawar, Vijay; Essmann, Clara; Srinivasan, Mandayam A.			Three-dimensional behavioural phenotyping of freely moving C. elegans using quantitative light field microscopy	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; GENETICS; CUTICLE	Behavioural phenotyping of model organisms is widely used to investigate fundamental aspects of organism biology, from the functioning of the nervous system to the effects of genetic mutations, as well as for screening new drug compounds. However, our capacity to observe and quantify the full range and complexity of behavioural responses is limited by the inability of conventional microscopy techniques to capture volumetric image information at sufficient speed. In this article we describe how combining light field microscopy with computational depth estimation provides a new method for fast, quantitative assessment of 3D posture and movement of the model organism Caenorhabditis elegans (C. elegans). We apply this technique to compare the behaviour of cuticle collagen mutants, finding significant differences in 3D posture and locomotion. We demonstrate the ability of quantitative light field microscopy to provide new fundamental insights into C. elegans locomotion by analysing the 3D postural modes of a freely swimming worm. Finally, we consider relative merits of the method and its broader application for phenotypic imaging of other organisms and for other volumetric bioimaging applications.	[Shaw, Michael; Zhan, Haoyun; Elmi, Muna; Pawar, Vijay; Essmann, Clara; Srinivasan, Mandayam A.] UCL, Dept Comp Sci, London, England; [Shaw, Michael] Natl Phys Lab, Biometrol Grp, Teddington, Middx, England; [Srinivasan, Mandayam A.] MIT, MIT TouchLab, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Srinivasan, Mandayam A.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA	University of London; University College London; National Physical Laboratory - UK; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Shaw, M (corresponding author), UCL, Dept Comp Sci, London, England.; Shaw, M (corresponding author), Natl Phys Lab, Biometrol Grp, Teddington, Middx, England.	mike.shaw@ucl.ac.uk	Shaw, Michael J/J-1064-2014	Shaw, Michael J/0000-0001-6099-3217; Pawar, Vijay/0000-0003-1963-5201	European Research Council (ERC-2009-AdG, MicroNanoTeleHaptics) [247401]; UK's Engineering and Physical Sciences Research Council [EP/K005030/1]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER; EPSRC [EP/K005030/1] Funding Source: UKRI	European Research Council (ERC-2009-AdG, MicroNanoTeleHaptics); UK's Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by an Advanced Grant 247401 to MAS from the European Research Council (ERC-2009-AdG, MicroNanoTeleHaptics), and a Capital grant for Great Technologies grant (EP/K005030/1 to MAS) from the UK's Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by Advanced Grant 247401 from the European Research Council (ERC-2009-AdG, MicroNanoTeleHaptics), and a Capital grant for Great Technologies grant (EP/K005030/1) from the UK's Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Caenorhabditis Genetics Center (CGC), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing dpy mutant C. elegans strains.	Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; BRENNER S, 1974, GENETICS, V77, P71; Broekmans OD, 2016, ELIFE, V5, DOI 10.7554/eLife.17227; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Broxton M, 2013, OPT EXPRESS, V21, P25418, DOI 10.1364/OE.21.025418; Cong L, 2017, ELIFE, V6, DOI 10.7554/eLife.28158; Essmann CL, 2017, NANOMED-NANOTECHNOL, V13, P183, DOI 10.1016/j.nano.2016.09.006; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; Graf R, 2005, ADV BIOCHEM ENG BIOT, V95, P57, DOI 10.1007/b102210; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; JOHNSTONE IL, 1994, BIOESSAYS, V16, P171, DOI 10.1002/bies.950160307; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kwon N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09564; Kwon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057484; Laissue PP, 2017, NAT METHODS, V14, P657, DOI 10.1038/nmeth.4344; Levoy M, 2009, J MICROSC-OXFORD, V235, P144, DOI 10.1111/j.1365-2818.2009.03195.x; Levoy M, 2006, ACM T GRAPHIC, V25, P924, DOI 10.1145/1141911.1141976; Magnes J, 2013, BIOPHYS J, V104, p669A, DOI 10.1016/j.bpj.2012.11.3694; Ng R, 2005, ACM T GRAPHIC, V24, P735, DOI 10.1145/1073204.1073256; O'Reilly LP, 2014, ADV DRUG DELIVER REV, V69, P247, DOI 10.1016/j.addr.2013.12.001; Olsen A., 2017, AGEING LESSONS C ELE; Prevedel R, 2014, NAT METHODS, V11, P727, DOI [10.1038/NMETH.2964, 10.1038/nmeth.2964]; Riddle DL, 1997, C ELEGANS; Sengupta P, 2009, CURR OPIN NEUROBIOL, V19, P637, DOI 10.1016/j.conb.2009.09.009; Shaw M, 2016, BIOMED OPT EXPRESS, V7, P2877, DOI 10.1364/BOE.7.002877; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stiernagle T, 2006, MAINTENANCE C ELEGAN; Sydor AM, 2015, TRENDS CELL BIOL, V25, P730, DOI 10.1016/j.tcb.2015.10.004; Tao MW, 2013, IEEE I CONF COMP VIS, P673, DOI 10.1109/ICCV.2013.89; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Zhang M, 2017, OPT COMMUN, V403, P133, DOI 10.1016/j.optcom.2017.07.026	32	12	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200108	10.1371/journal.pone.0200108	http://dx.doi.org/10.1371/journal.pone.0200108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995960	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800042
J	Zhang, LQ; Wang, JJ; Liang, JQ; Feng, D; Deng, F; Yang, Y; Lu, Y; Hu, Z				Zhang, Liangqing; Wang, Jingjing; Liang, Jiuqing; Feng, Du; Deng, Fan; Yang, Yue; Lu, Yue; Hu, Zhe			Propofol prevents human umbilical vein endothelial cell injury from Ang II-induced apoptosis by activating the ACE2-(1-7)-Mas axis and eNOS phosphorylation	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; CARDIOVASCULAR INJURY; HYPERTENSIVE-RATS; NADPH OXIDASE; UP-REGULATION; EXPRESSION; CARBOXYPEPTIDASE; ANTIOXIDANT	Angiotensin II (AngII), a vasoactive peptide that elevates arterial blood pressure and results in hypertension, has been reported to directly induce vascular endothelial cell apoptosis. Recent work has demonstrated that propofol pre-treatment attenuates angiotensin II-induced apoptosis in human coronary artery endothelial cells. However, the underlying mechanism remains largely unknown. Here, we investigated human umbilical vein endothelial cells (HUVECs) subjected to angiotensin II-induced apoptosis in the presence or absence of propofol treatment and found that angiotensin II-induced apoptosis was attenuated by propofol in a dose-dependent manner. Furthermore, ELISA assays demonstrated that the ratio of angiotensin (1-7) (Ang (1-7)) to Ang II was increased after propofol treatment. We examined the expression of ACE2, Ang (1-7) and Mas and found that the ACE2-Ang (1-7)-Mas axis was up-regulated by propofol, while ACE2 overexpression increased phosphorylated endothelial nitric oxide synthase (phosphorylated eNOS) expression and siACE2 resulted in the repression of endothelial nitric oxide synthase (eNOS) phosphorylation. In conclusion, our study revealed that propofol can inhibit endothelial cell apoptosis induced by Ang II by activating the ACE2-Ang (1-7)-Mas axis and further up-regulating the expression and phosphorylation of eNOS.	[Zhang, Liangqing; Wang, Jingjing; Liang, Jiuqing; Deng, Fan; Yang, Yue; Lu, Yue; Hu, Zhe] Guangdong Med Univ, Dept Anesthesiol, Affiliated Hosp, Zhanjiang, Peoples R China; [Feng, Du] Guangdong Med Univ, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac Cerebral Va, Zhanjiang, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Medical University	Hu, Z (corresponding author), Guangdong Med Univ, Dept Anesthesiol, Affiliated Hosp, Zhanjiang, Peoples R China.	biohuzhe@hotmail.com	WANG, JINGYI/GSJ-1241-2022; liang, jiuqing/E-4140-2015; Deng, Fan/GRJ-9300-2022; wang, jing/GRS-7509-2022; wang, jing/GVT-8700-2022	liang, jiuqing/0000-0002-2267-014X; 	National Natural Science Foundation of China [81270916, 81470405, 81302246, 81401906]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (81270916, 81470405, 81302246, 81401906). All the funding or sources of support were received during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This study was funded by the National Natural Science Foundation of China (81270916, 81470405, 81302246, 81401906). The authors would like to thank the donors and the Department of Respirology (Affiliated Hospital of Guangdong Medical University) for the HUVEC cell lines used in this study.	Al-Maghrebi M, 2009, PHARMACOL RES, V59, P263, DOI 10.1016/j.phrs.2008.12.008; Alvarez E, 2010, J CARDIOVASC PHARM, V55, P203, DOI 10.1097/FJC.0b013e3181ce5f5a; Bader M, 2008, J MOL MED, V86, P615, DOI 10.1007/s00109-008-0336-0; Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Balyasnikova IV, 2005, ANESTH ANALG, V100, P929, DOI 10.1213/01.ANE.0000147707.49192.88; Bodelsson G, 2000, EUR J ANAESTH, V17, P720, DOI 10.1046/j.1365-2346.2000.00749.x; Cao LJ, 2012, PHARMACOLOGY, V90, P342, DOI 10.1159/000338754; Chen JW, 2010, MOL CELL BIOCHEM, V339, P43, DOI 10.1007/s11010-009-0368-y; CHEN ZJ, 2013, J PROBAB STAT, DOI DOI 10.1155/2013/; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Der Sarkissian S, 2006, PROG BIOPHYS MOL BIO, V91, P163, DOI 10.1016/j.pbiomolbio.2005.05.011; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Dworakowski R, 2008, PHARMACOL REP, V60, P21; Ferrario CM, 2010, HYPERTENSION, V55, P445, DOI 10.1161/HYPERTENSIONAHA.109.145839; Griendling KK, 2003, CIRCULATION, V108, P1912, DOI 10.1161/01.CIR.0000093660.86242.BB; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Gulcin I, 2005, CHEM PHARM BULL, V53, P281, DOI 10.1248/cpb.53.281; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Kobayashi K, 2008, ANESTHESIOLOGY, V109, P426, DOI 10.1097/ALN.0b013e318182a903; Le T, 2017, 1 AID BASIC SCI; Li DY, 1999, CARDIOVASC RES, V41, P109, DOI 10.1016/S0008-6363(98)00196-5; Liu XH, 2007, BIOCHEM BIOPH RES CO, V359, P628, DOI 10.1016/j.bbrc.2007.05.129; Luo T, 2005, ANESTH ANALG, V100, P1653, DOI 10.1213/01.ANE.0000150945.95254.D8; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Montezano AC, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0431-2; MURPHY PG, 1992, BRIT J ANAESTH, V68, P613, DOI 10.1093/bja/68.6.613; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Robbins SL, 2010, ROBBINS COTRAN PATHO; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Waghe P, 2015, CHEM-BIOL INTERACT, V237, P104, DOI 10.1016/j.cbi.2015.06.014; Wang BH, 2009, BIOCHEM BIOPH RES CO, V389, P105, DOI 10.1016/j.bbrc.2009.08.097; Wang L, 2010, BRIT J ANAESTH, V104, P606, DOI 10.1093/bja/aeq064; Xia ZY, 2010, J CARDIOVASC PHARM, V55, P358, DOI 10.1097/FJC.0b013e3181d265a3; Xu JJ, 2008, EUR J ANAESTH, V25, P395, DOI 10.1017/S0265021508003542; Yee AH, 2010, NEUROSURG CLIN N AM, V21, P339, DOI 10.1016/j.nec.2009.10.011; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	40	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199373	10.1371/journal.pone.0199373	http://dx.doi.org/10.1371/journal.pone.0199373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995907	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800021
J	Fahlbusch, FB; Heinlein, T; Rauh, M; Dittrich, S; Cesnjevar, R; Moosmann, J; Nadal, J; Schmid, M; Muench, F; Schroth, M; Rascher, W; Topf, HG				Fahlbusch, Fabian B.; Heinlein, Thomas; Rauh, Manfred; Dittrich, Sven; Cesnjevar, Robert; Moosmann, Julia; Nadal, Jennifer; Schmid, Matthias; Muench, Frank; Schroth, Michael; Rascher, Wolfgang; Topf, Hans-Georg			Influence of factor XIII activity on post-operative transfusion in congenital cardiac surgery-A retrospective analysis	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; FRESH-FROZEN PLASMA; OPEN-HEART-SURGERY; PROLONGED MECHANICAL VENTILATION; CATEGORIES REFLECT MORTALITY; CLINICAL-PRACTICE GUIDELINE; BLOOD-CELL TRANSFUSION; LOW-BIRTH-WEIGHT; CARDIOPULMONARY BYPASS; CORONARY SURGERY	Objectives Coagulation factor XIII (FXIII) plays a key role in fibrin clot stabilization-an essential process for wound healing following cardiothoracic surgery. However, FXIII deficiency as a risk for post-operative bleeding in pediatric cardiac surgery involving cardiopulmonary bypass (CPB) for congenital heart disease (CHD) is controversially discussed. Thus, as primary outcome measures, we analyzed the association of pre-operative FXIII activity and postoperative chest tube drainage (CTD) loss with transfusion requirements post-operatively. Secondary outcomes included the influence of cyanosis and sex on transfusion. Methods Our retrospective analysis (2009-2010) encompassed a single center series of 76 cardio-surgical cases with CPB (0-17 years, mean age 5.61 years) that were post-operatively admitted to our pediatric intensive care unit (PICU). The observational period was 48 hours after cardiac surgery. Blood cell counts and coagulation status, including FXIII activity were routinely performed pre- and post-operatively. The administered amount of blood products and volume expanders was recorded electronically, along with the amount of CTD loss. Uni-and multivariate logistic regression analysis was performed to calculate the associations (odds ratios) of variables with post-operative transfusion needs. Results FXIII activities remained stable following CPB surgery. There was no association of pre- and post-operative FXIII activities and transfusion of blood products or volume expanders in the first 48 hours after surgery. Similarly, FXIII showed no association with CTD loss. Cyanosis and female sex were associated with transfusion rates. Conclusions Although essentially involved in wound healing and clotting after surgery, FXIII activity does not serve as a valid predictor of post-operative transfusion need.	[Fahlbusch, Fabian B.; Heinlein, Thomas; Rauh, Manfred; Rascher, Wolfgang; Topf, Hans-Georg] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany; [Dittrich, Sven; Moosmann, Julia] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pediat Cardiol, Erlangen, Germany; [Cesnjevar, Robert; Muench, Frank] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pediat Cardiac Surg, Erlangen, Germany; [Nadal, Jennifer; Schmid, Matthias] Univ Hosp, IMBIE, Bonn, Germany; [Schroth, Michael] Diakonie Neuendettelsau, Cnopfsche Kinderklin, Nurnberg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bonn	Fahlbusch, FB (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, Erlangen, Germany.	Fabian.Fahlbusch@uk-erlangen.de	Cesnjevar, Robert/AAD-6215-2019; Dittrich, Sven/T-2753-2019	Dittrich, Sven/0000-0002-8455-3416; Schmid, Matthias/0000-0002-0788-0317; Cesnjevar, Robert/0000-0002-3575-6647	CSL Behring Foundation for Research and Advancement of Patient Health, Marburg, Germany [34019178]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	CSL Behring Foundation for Research and Advancement of Patient Health, Marburg, Germany; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	This study was supported by a grant (ID 34019178) from CSL Behring Foundation for Research and Advancement of Patient Health, Marburg, Germany (http://www.cslbehring.de/home) to M. Schroth. The funding source was neither involved in the design and execution of this study, nor in data analysis, interpretation or decision to publish the results. There was no additional external funding received for this study.; Data acquisition was performed by Thomas Heinlein in partial fulfillment of the requirements for obtaining the degree "Dr. med." at the Friedrich-Alexander University of Erlangen-Nurnberg, Department of Pediatrics and Adolescent Medicine, Germany. We thank PD Dr. med. J Strobel at the Department of Transfusion Medicine and Haemostaseology, University Hospital Erlangen-Nuremberg, Germany for providing the analysis data of FXIII activity in fresh frozen plasma. Furthermore, the authors thank Prof. Dr. rer. nat. A. Hartner for critically revising the manuscript. We acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-University Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; Appel IM, 2012, J THROMB HAEMOST, V10, P2254, DOI 10.1111/j.1538-7836.2012.04905.x; Azakie A, 2011, INTERACT CARDIOV TH, V12, P409, DOI 10.1510/icvts.2010.253823; Bocsi J, 2002, CRIT CARE, V6, P226, DOI 10.1186/cc1494; Boethig D, 2004, EUR J CARDIO-THORAC, V26, P12, DOI 10.1016/j.ejcts.2004.03.039; Bove T, 2004, ANN THORAC SURG, V78, P181, DOI 10.1016/j.athoracsur.2003.12.066; BRODY JI, 1986, TRANSFUSION, V26, P478, DOI 10.1046/j.1537-2995.1986.26587020130.x; Brown KL, 2003, CRIT CARE MED, V31, P28, DOI 10.1097/00003246-200301000-00004; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Chandler WL, 2001, BLOOD COAGUL FIBRIN, V12, P101, DOI 10.1097/00001721-200103000-00003; Chermesh I, 2014, EUR J PREV CARDIOL, V21, P475, DOI 10.1177/2047487312452969; Corwin HL, 2007, NEW ENGL J MED, V356, P1667, DOI 10.1056/NEJMe078019; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Curzon CL, 2008, J THORAC CARDIOV SUR, V135, P546, DOI 10.1016/j.jtcvs.2007.09.068; Eaton MP, 2011, PEDIATR ANESTH, V21, P31, DOI 10.1111/j.1460-9592.2010.03467.x; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Gertler R, 2013, PEDIATR ANESTH, V23, P1035, DOI 10.1111/pan.12193; Godje O, 2006, THORAC CARDIOV SURG, V54, P26, DOI 10.1055/s-2005-872853; Godje O, 1998, THORAC CARDIOV SURG, V46, P263, DOI 10.1055/s-2007-1010236; Gombotz H, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012210; Haas T, 2012, PEDIATR ANESTH, V22, P641, DOI 10.1111/j.1460-9592.2011.03709.x; Haas T, 2012, TRANSFUS MED HEMOTH, V39, P114, DOI 10.1159/000337245; Ho AMH, 2005, AM J SURG, V190, P479, DOI 10.1016/j.amjsurg.2005.03.034; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lacour-Gayet F, 2004, EUR J CARDIO-THORAC, V25, P911, DOI 10.1016/j.ejcts.2004.03.027; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Larsen SH, 2005, EUR J CARDIO-THORAC, V28, P877, DOI 10.1016/j.ejcts.2005.09.008; Levy JH, 2009, THROMB HAEMOSTASIS, V102, P765, DOI 10.1160/TH08-12-0826; Li J, 2004, ANN THORAC SURG, V78, P1389, DOI 10.1016/j.athoracsur.2004.02.032; Lomivorotov VV, 2013, INTERACT CARDIOV TH, V16, P612, DOI 10.1093/icvts/ivs549; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Mazine A, 2015, ANN THORAC SURG, V100, P671, DOI 10.1016/j.athoracsur.2015.04.033; McCall MM, 2004, ANN THORAC SURG, V77, P983, DOI 10.1016/j.athoracsur.2003.09.030; MCDONAGH J, 1969, J CLIN INVEST, V48, P940, DOI 10.1172/JCI106053; Meier J, 2016, BRIT J ANAESTH, V116, P255, DOI 10.1093/bja/aev456; Miller BE, 1997, ANESTH ANALG, V85, P1196, DOI 10.1097/00000539-199712000-00003; Myburgh JA, 2012, NEW ENGL J MED, V367, P1901, DOI 10.1056/NEJMoa1209759; NAIK SK, 1991, CIRCULATION, V84, P422; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b; Oliver WC, 2003, ANN THORAC SURG, V75, P1506, DOI 10.1016/S0003-4975(02)04991-3; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Othman H, 2014, AM HEART J, V168, P552, DOI 10.1016/j.ahj.2014.07.012; Pagowska-Klimek I, 2011, EUR J CARDIO-THORAC, V40, P179, DOI 10.1016/j.ejcts.2010.11.038; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Phillips DP, 2013, CRIT CARE, V17, DOI 10.1186/cc12708; Polito A, 2011, PEDIATR CRIT CARE ME, V12, pE122, DOI 10.1097/PCC.0b013e3181e912bd; Radman M, 2014, J THORAC CARDIOV SUR, V147, P442, DOI 10.1016/j.jtcvs.2013.03.023; Ried M, 2012, CLIN RES CARDIOL, V101, P437, DOI 10.1007/s00392-011-0410-4; Ruffer A, 2017, ANN THORAC SURG, V103, P178, DOI 10.1016/j.athoracsur.2016.05.088; Schneider SO, 2009, SCAND J IMMUNOL, V70, P101, DOI 10.1111/j.1365-3083.2009.02278.x; Schroeder V, 2013, J THROMB HAEMOST, V11, P234, DOI 10.1111/jth.12074; Schroth M, 2006, PEDIATR CARDIOL, V27, P56, DOI 10.1007/s00246-005-0993-5; SHAINOFF JR, 1994, J THORAC CARDIOV SUR, V108, P437, DOI 10.1016/S0022-5223(94)70253-5; Shi SS, 2008, CHEST, V134, P768, DOI 10.1378/chest.07-2573; Simsic Janet M, 2006, Congenit Heart Dis, V1, P148, DOI 10.1111/j.1747-0803.2006.00026.x; Sparger K, 2015, CLIN PERINATOL, V42, P613, DOI 10.1016/j.clp.2015.04.009; Stehling L, 1998, TRANSFUSION, V38, P392, DOI 10.1046/j.1537-2995.1998.38498257379.x; Stiller B, 2001, INTENS CARE MED, V27, P193, DOI 10.1007/s001340000704; Szekely A, 2006, PEDIATR ANESTH, V16, P1166, DOI 10.1111/j.1460-9592.2006.01957.x; Topf HG, 2011, KLIN PADIATR, V223, P165, DOI 10.1055/s-0031-1275310; Van der Linden P, 2006, CAN J ANAESTH, V53, pS30; Wernovsky G, 2001, CLIN PERINATOL, V28, P249, DOI 10.1016/S0095-5108(05)70078-6; Wilkinson KL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009752.pub2; WMA World Medical Association, 2013, JAMA-J AM MED ASSOC, V227, P925	67	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199240	10.1371/journal.pone.0199240	http://dx.doi.org/10.1371/journal.pone.0199240			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990321	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300008
J	Leitner, G; Zilberman, D; Papirov, E; Shefy, S				Leitner, Gabriel; Zilberman, David; Papirov, Eduard; Shefy, Sela			Assessment of acoustic pulse therapy (APT), a non-antibiotic treatment for dairy cows with clinical and subclinical mastitis	PLOS ONE			English	Article							SHOCK-WAVE THERAPY; ERECTILE DYSFUNCTION; LACTATION; MILK; STRATEGIES	Clinical and subclinical mastitis affects 30% of cows and is regarded as the most significant economic burden on the dairy farm reducing milk yield and quality and increasing culling rate. A proprietary Acoustic Pulse Therapy (APT) device was developed specifically for treating dairy cows. The APT device was designed to produce deep penetrating acoustic pulses that are distributed over a large treated area at a therapeutic level. This paper presents findings from a clinical assessment of this technology for the treatment of dairy cows with subclinical and clinical mastitis. In subclinical mastitis, a group of 116 cows from 3 herds were identified with subclinical intramammary infection and enrolled in the study; 78 cows were assigned to the treatment group and 38 cows to the control group. Significant differences (P<0.001) were found where 70.5% of the cows in the treatment group returned to normal milk production, compared with only 18.4% of the control group. Daily milk yields of the treated cows increased significantly (P<0.05) and the percentage of cows with log somatic cell count under 5.6 cells/mL was significantly higher (P<0.001). Milk of the infected quarters appeared normal with lactose greater than 4.8%, but this difference was not significant. Of the treated cows with identified bacteria, 52.6% of the quarters were cured, while in the control group only 25.0% (P<0.001). Specifically, all cows identified with Escherichia coli in the treatment group were cured, with 66.6% cured with no intervention in the control. Spontaneous cure of glands infected with coagulase negative staphylococci (CNS) and Streptococci was low while treatment successfully increased the cure of CNS from 13.3% to 53.8% and that of Streptococci from 18.2% to 36.4%. Of the 4 cows identified with Staphylococcus aureus, 3 were cured. The clinical mastitis study group included 29 infected cows that were submitted either to a gold standard antibiotic treatment subgroup of 16 cows (n = 16) or to an APT treatment subgroup of 13 cows (n = 13). A cure of 18.7% was shown for the antibiotic treatment, of which logSCC returned to <5.6 cell/mL and 56.2% were culled. A cure of 76.9% was shown for the APT treatment with only one cow culled (7.7%).	[Leitner, Gabriel] Kimron Vet Inst, Natl Mastitis Reference Ctr, Bet Dagan, Israel; [Zilberman, David] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA; [Papirov, Eduard; Shefy, Sela] HI Impacts, Raanana, Israel	Kimron Veterinary Institute; University of California System; University of California Berkeley	Leitner, G (corresponding author), Kimron Vet Inst, Natl Mastitis Reference Ctr, Bet Dagan, Israel.	leitnerg1@gmail.com			Hi-Impacts LTD.; Hi-Impacts LTD	Hi-Impacts LTD.; Hi-Impacts LTD	The study was funded by Hi-Impacts LTD. As employees of Hi-Impacts Papirov and Shefy conducted the treatments of the cows and collected data from the herd computers. They also were involved in writing the technical information of the device that was used for the treatment. The treatment protocol was suggested by Papirov and is based on experience from medical treatments for orthopedic disorders. Hi-Impacts LTD provided support in the form of salaries for authors EP and SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barlow JW, 2009, PREV VET MED, V90, P31, DOI 10.1016/j.prevetmed.2009.03.016; Blum SE, 2014, VET J, V201, P72, DOI 10.1016/j.tvjl.2014.04.008; Contreras GA, 2011, COMP IMMUNOL MICROB, V34, P281, DOI 10.1016/j.cimid.2011.01.004; Crowe O., 2002, Proceedings of the 48th Annual Convention of the American Association of Equine Practitioners, Orlando, Florida, USA, 4-8 December 2002, P322; Gruenwald I, 2013, THER ADV UROL, V5, P95, DOI 10.1177/1756287212470696; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Hillerton JE, 2005, J APPL MICROBIOL, V98, P1250, DOI 10.1111/j.1365-2672.2005.02649.x; Huijps K, 2008, J DAIRY RES, V75, P113, DOI 10.1017/S0022029907002932; Katz G, 2007, J ANIM SCI, V85, P377; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Kisch T, 2016, J SURG RES, V201, P440, DOI 10.1016/j.jss.2015.11.049; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Leitner G, 2006, INT DAIRY J, V16, P648, DOI 10.1016/j.idairyj.2005.10.020; Leitner G, 2014, ISR J VET MED, V69, P141; Leitner G, 2011, INT DAIRY J, V21, P279, DOI 10.1016/j.idairyj.2010.11.013; Losinger WC, 2005, JAVMA-J AM VET MED A, V226, P1652, DOI 10.2460/javma.2005.226.1652; Mariotto S, 2009, CURR MED CHEM, V16, P2366, DOI 10.2174/092986709788682119; McClure S., 2003, EXTRACORPOREAL SHOCK; McDougall S, 2009, VET MICROBIOL, V134, P177, DOI 10.1016/j.vetmic.2008.09.026; Molbak K, 2004, J VET MED B, V51, P364, DOI 10.1111/j.1439-0450.2004.00788.x; Nir O., 2003, ACTA VET SCAND, V44, pS21, DOI [10.1186/1751-0147-44-S1-S21, 10.1186/1751-0147-44-S1-P1, DOI 10.1186/1751-0147-44-S1-P1]; Owens, 2004, MICROBIOLOGICAL PROC, V4th ed.; Pyorala S, 2002, REPROD DOMEST ANIM, V37, P211, DOI 10.1046/j.1439-0531.2002.00378.x; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Rollin E, 2015, PREV VET MED, V122, P257, DOI 10.1016/j.prevetmed.2015.11.006; Slavich M, 2015, AC CARD CAR C VIENN; Souza ANA, 2016, VET COMP ORTHOPAED, V29, P108, DOI 10.3415/VCOT-15-01-0017; Steeneveld W, 2011, J DAIRY SCI, V94, P174, DOI 10.3168/jds.2010-3367; Steeneveld W, 2007, J DAIRY RES, V74, P459, DOI 10.1017/S0022029907002828; van den Borne BHP, 2010, J DAIRY SCI, V93, P218, DOI 10.3168/jds.2009-2567; Vardi Y, 2010, EUR UROL, V58, P243, DOI 10.1016/j.eururo.2010.04.004; Zissler A, 2017, AM J SPORT MED, V45, P676, DOI 10.1177/0363546516668622	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199195	10.1371/journal.pone.0199195	http://dx.doi.org/10.1371/journal.pone.0199195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990317	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300006
J	Luo, LY; Tang, HL; Ling, L; Li, N; Jia, XT; Zhang, ZJ; Wang, XR; Shi, LJ; Yin, J; Qiu, N; Liu, H; Song, Y; Luo, K; Li, HS; He, ZM; Zheng, GP; Xie, XM				Luo, Liyun; Tang, Hailin; Ling, Li; Li, Nan; Jia, Xiaoting; Zhang, Zhijie; Wang, Xiaorong; Shi, Lejuan; Yin, Jiang; Qiu, Ni; Liu, Hao; Song, Ying; Luo, Kai; Li, Hongsheng; He, Zhimin; Zheng, Guopei; Xie, Xiaoming			LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer	ONCOGENE			English	Article							LONG NONCODING RNAS; PROMOTES; METASTASIS; CHEMORESISTANCE; METADHERIN; PROTEIN	Breast cancer is a heterogeneous disease, and triple-negative breast cancer (TNBC) continues to be a serious health problem. The potential involvement of lncRNAs in TNBC progression remains unexplored. Here, we demonstrated that LINC01638 is highly expressed in TNBC tissues and cells. LINC01638 maintains the mesenchymal traits of TNBC cells, including an enriched epithelial-mesenchymal transition (EMT) signature and cancer stem cell-like state. LINC01638 knockdown suppresses tumor proliferation and metastasis both in vitro and in vivo. LINC01638 overexpression predicts a poor outcome of breast cancer patients. Mechanistically, LINC01638 interacts with c-Myc to prevent SPOP-mediated c-Myc ubiquitination and degradation. C-Myc transcriptionally enhances MTDH (metadherin) expression and subsequently activates Twist1 expression to induce EMT. Our findings describe LINC01638-mediated signal transduction and highlight the crucial role of LINC01638 in TNBC progression.	[Luo, Liyun; Ling, Li; Li, Nan; Jia, Xiaoting; Zhang, Zhijie; Wang, Xiaorong; Shi, Lejuan; Yin, Jiang; Qiu, Ni; Liu, Hao; Song, Ying; Luo, Kai; Li, Hongsheng; He, Zhimin; Zheng, Guopei] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Hengzhigang Rd 78, Guangzhou 510095, Guangdong, Peoples R China; [Luo, Liyun; Ling, Li; Li, Nan; Jia, Xiaoting; Zhang, Zhijie; Wang, Xiaorong; Shi, Lejuan; Yin, Jiang; Qiu, Ni; Liu, Hao; Song, Ying; Luo, Kai; Li, Hongsheng; He, Zhimin; Zheng, Guopei] Guangzhou Key Lab Translat Med Malignant Tumor Tr, Hengzhigang Rd 78, Guangzhou 510095, Guangdong, Peoples R China; [Luo, Liyun; Ling, Li; Li, Nan; Jia, Xiaoting; Zhang, Zhijie; Wang, Xiaorong; Shi, Lejuan; Yin, Jiang; Qiu, Ni; Liu, Hao; Song, Ying; Luo, Kai; Li, Hongsheng; He, Zhimin; Zheng, Guopei] Guangzhou Med Univ, Prot Modificat & Degradat Lab, Hengzhigang Rd 78, Guangzhou 510095, Guangdong, Peoples R China; [Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol,Canc Ctr, Dongfeng Rd 651 E, Guangzhou 510060, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Lab Oncology South China; Sun Yat Sen University	Zheng, GP (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, Hengzhigang Rd 78, Guangzhou 510095, Guangdong, Peoples R China.; Zheng, GP (corresponding author), Guangzhou Key Lab Translat Med Malignant Tumor Tr, Hengzhigang Rd 78, Guangzhou 510095, Guangdong, Peoples R China.; Zheng, GP (corresponding author), Guangzhou Med Univ, Prot Modificat & Degradat Lab, Hengzhigang Rd 78, Guangzhou 510095, Guangdong, Peoples R China.; Xie, XM (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Breast Oncol,Canc Ctr, Dongfeng Rd 651 E, Guangzhou 510060, Guangdong, Peoples R China.	zhengguopei@126.com; xiexm@sysucc.org.cn	wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341	National Natural Science Foundation of China [81672616, 81402196, 81772961, 81401989, 81772825]; Guangdong Natural Science Funds for Distinguished Young Scholars [2016A030306003]; Guangdong Natural Science Funds [2017A030313867]; Science and Technology Program of Guangzhou [201710010100]; Guangzhou Municipal University Scientific Research project [1201610027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Funds for Distinguished Young Scholars; Guangdong Natural Science Funds; Science and Technology Program of Guangzhou; Guangzhou Municipal University Scientific Research project	This study was supported by grants from the National Natural Science Foundation of China: No. 81672616 (GZ), No. 81402196 (GZ), No. 81772961 (HT), No. 81401989 (NL) and No. 81772825 (HL); supported by grants from Guangdong Natural Science Funds for Distinguished Young Scholars: No. 2016A030306003 (GZ) and Guangdong Natural Science Funds: No. 2017A030313867 (GZ); supported by grants from Science and Technology Program of Guangzhou: No. 201710010100 (GZ) and Guangzhou Municipal University Scientific Research project: 1201610027 (GZ).	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Booy EP, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0679-7; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Cho MH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8821; Emdad L, 2013, ADV CANCER RES, V120, P75, DOI 10.1016/B978-0-12-401676-7.00003-6; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flynn RA, 2014, CELL STEM CELL, V14, P752, DOI 10.1016/j.stem.2014.05.014; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Geng C, 2017, ONCOGENE, V36, P4767, DOI 10.1038/onc.2017.80; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Jiang ZY, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0853-2; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Lee SG, 2006, P NATL ACAD SCI USA, V103, P17390, DOI 10.1073/pnas.0608386103; Liang YJ, 2015, CANCER RES, V75, P3672, DOI 10.1158/0008-5472.CAN-15-0930; Lin AF, 2016, NAT CELL BIOL, V18, P213, DOI 10.1038/ncb3295; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Ni M, 2013, GENE DEV, V27, P734, DOI 10.1101/gad.209569.112; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podo F, 2010, MOL ONCOL, V4, P209, DOI 10.1016/j.molonc.2010.04.006; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Sarkar D, 2013, ADV CANCER RES, V120, P39, DOI 10.1016/B978-0-12-401676-7.00002-4; Shi J, 2014, CANCER CELL, V25, P210, DOI 10.1016/j.ccr.2014.01.028; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Yin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073268; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zheng GP, 2018, CLIN CANCER RES, V24, P1163, DOI 10.1158/1078-0432.CCR-17-2619	37	77	81	2	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 22	2018	37	47					6166	6179		10.1038/s41388-018-0396-8	http://dx.doi.org/10.1038/s41388-018-0396-8			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HB2PG	30002443				2022-12-26	WOS:000450883000005
J	Zhou, YS; Xu, ZJ; Quan, D; Zhang, F; Zhang, H; Xiao, TQ; Hou, SL; Qiao, H; Harismendy, O; Wang, JYJ; Suo, GL				Zhou, Yuanshuai; Xu, Zhongjuan; Quan, Daniel; Zhang, Fan; Zhang, Hai; Xiao, Tongqian; Hou, Shulan; Qiao, Hong; Harismendy, Olivier; Wang, Jean Y. J.; Suo, Guangli			Nuclear respiratory factor 1 promotes spheroid survival and mesenchymal transition in mammary epithelial cells	ONCOGENE			English	Article							MITOCHONDRIAL CALCIUM UNIPORTER; BREAST-CANCER CELLS; PANCREATIC-CANCER; FACTOR-I; BIOGENESIS; EXPRESSION; TRANSCRIPTION; DETACHMENT; REGULATOR; CCDC90A	Epithelial cells aggregate into spheroids when deprived of matrix, and the proclivity for spheroid formation and survival is a hallmark of normal and tumorigenic mammary stem cells. We show here that Nuclear Respiratory Factor 1 (NRF1) is a spheroid promoter by in silico identification of this transcription factor as highly connected to top shRNA-hits deduced from re-iterative selections for shRNAs enriched in MCF10A spheroids. NRF1-promoted spheroid survival is linked to its stimulation of mitochondrial OXPHOS, cell migration, invasion, and mesenchymal transition. Conversely, NRF1 knockdown in breast cancer MDA-MB-231 cells reduced spheroids, migration, invasion, and mesenchymal marker expression. NRF1 knockdown also reduced tumor burden in mammary fat pads and lungs of orthotopic-or tail vein-transplanted mice. With the Luminal A subtype of breast cancer, higher NRF1 expression is associated with lower survival. These results show that NRF1, an activator of mitochondrial metabolism, supports mammary spheroid survival and tumor development.	[Zhou, Yuanshuai; Xu, Zhongjuan; Zhang, Hai; Xiao, Tongqian; Hou, Shulan; Suo, Guangli] Chinese Acad Sci, CAS Key Lab Nanobio Interface, Suzhou Inst Nanotech & Nanobion, Nanjing 215123, Jiangsu, Peoples R China; [Zhou, Yuanshuai; Xiao, Tongqian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Quan, Daniel; Harismendy, Olivier; Wang, Jean Y. J.] Univ Calif San Diego, Sch Med, Dept Med, Div Hematol Oncol,Moores Canc Ctr, La Jolla, CA 92093 USA; [Zhang, Fan; Qiao, Hong] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	Chinese Academy of Sciences; Suzhou Institute of Nano-Tech & Nano-Bionics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California San Diego; University of Texas System; University of Texas Austin	Suo, GL (corresponding author), Chinese Acad Sci, CAS Key Lab Nanobio Interface, Suzhou Inst Nanotech & Nanobion, Nanjing 215123, Jiangsu, Peoples R China.	glsuo2013@sinano.ac.cn	Harismendy, Olivier/AAM-2072-2021	Harismendy, Olivier/0000-0002-8098-9888; Quan, Daniel/0000-0003-1752-0080; Wang, Jean Yin Jen/0000-0002-8217-0868	pilot project in the San Diego Systems Biology Center [NIH P50GM085764]; National Natural Science Foundation of China [31471307]; Ministry of Science and Technology (MOST) [2014CB965003, 2017YFA0104301]; Hundred Talent Program of Chinese Academy of Sciences; CAS/SAFEA International Innovation Teams program; NIH [R01CA043054]; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764] Funding Source: NIH RePORTER	pilot project in the San Diego Systems Biology Center; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); Hundred Talent Program of Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Innovation Teams program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Dai, Q. Wang, Z. Zhang, and G. Cheng for insightful comments on the study, and X. He for technical assistance. Nano-Bio-Chem Centre in Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO) is acknowledged for professional assistance of cell imaging and FACS assay. This study was initiated as a pilot project in the San Diego Systems Biology Center (NIH P50GM085764) that supported G.S., D.Q., O.H., and J.Y.J.W.; D.Q. was also supported by a grant to J.Y.J.W. (NIH R01CA043054). The study of NFR1 was supported by National Natural Science Foundation of China (Grant No. 31471307), Ministry of Science and Technology (MOST) (Grant No. 2014CB965003, and 2017YFA0104301) to G.S., who is also supported by Hundred Talent Program of Chinese Academy of Sciences. The study was also supported by the CAS/SAFEA International Innovation Teams program.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Au SH, 2016, P NATL ACAD SCI USA, V113, P4947, DOI 10.1073/pnas.1524448113; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Dey D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005329; Dey P, 2017, NATURE, V542, P119, DOI 10.1038/nature21052; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Grassian AR, 2011, J BIOL CHEM, V286, P79, DOI 10.1074/jbc.M110.169821; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Hindupur SK, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0420-z; Ivanova MM, 2011, FASEB J, V25, P1402, DOI 10.1096/fj.10-169029; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Koike-Yusa H, 2014, NAT BIOTECHNOL, V32, P267, DOI 10.1038/nbt.2800; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mason JA, 2017, TRENDS CANCER, V3, P475, DOI 10.1016/j.trecan.2017.04.009; Mattingly KA, 2008, MOL ENDOCRINOL, V22, P609, DOI 10.1210/me.2007-0029; Mattingly KA, 2012, ARCH TOXICOL, V86, P633, DOI 10.1007/s00204-011-0778-y; Ng TL, 2012, CELL DEATH DIFFER, V19, P501, DOI 10.1038/cdd.2011.119; Oliver D, 2017, SCI REP-UK, V7, DOI 10.1038/srep43023; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Paupe V, 2015, CELL METAB, V21, P109, DOI 10.1016/j.cmet.2014.12.004; Qu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131285; Rayavarapu RR, 2015, J BIOL CHEM, V290, P8722, DOI 10.1074/jbc.M114.612754; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, ANN NY ACAD SCI, V1147, P321, DOI 10.1196/annals.1427.006; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Sims D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r104; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Vais H, 2015, CELL METAB, V22, P533, DOI 10.1016/j.cmet.2015.09.015; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Vlahakis A, 2017, J MOL BIOL, V429, P515, DOI 10.1016/j.jmb.2016.11.027; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	37	16	17	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 22	2018	37	47					6152	6165		10.1038/s41388-018-0349-2	http://dx.doi.org/10.1038/s41388-018-0349-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HB2PG	29995872	Green Accepted			2022-12-26	WOS:000450883000004
J	McCormick, CD; Waters, HN; Bezrukov, L; Taginya, R; Parikh, V; Onyekaba, GI; Levine, JA; Demidowich, AP; Yanovski, JA; Blank, PS; Zimmerberg, J				McCormick, Chad D.; Waters, Hang N.; Bezrukov, Ludmila; Taginya, Roxana; Parikh, Viraj; Onyekaba, Ginikanwa I.; Levine, Jordan A.; Demidowich, Andrew P.; Yanovski, Jack A.; Blank, Paul S.; Zimmerberg, Joshua			Subcutaneous adipose tissue imaging of human obesity reveals two types of adipocyte membranes: Insulin-responsive and -nonresponsive	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; adipose tissue metabolism; Akt PKB; biostatistics; cellular regulation; insulin; insulin resistance; metabolic syndrome; obesity; subcutaneous fat	METABOLIC SYNDROME; MODEL SELECTION; RESISTANCE; GLUCOSE; GLUT4; FAT; SENSITIVITY; ACTIVATION; VESICLES; PROTEIN	In adipose tissue, resistance to insulin's ability to increase glucose uptake can be induced by multiple factors, including obesity. Impaired insulin action may take place at different spatial loci at the cellular or subcellular level. To begin to understand the spatial response to insulin in human subcutaneous adipose tissue (hSAT), we developed a quantitative imaging method for activation of a major signaling node in the glucoregulatory insulin signaling pathway. After treatment with insulin or control media, biopsied tissues were immunostained for Akt phosphorylation at Thr-308/9 (pAkt) and then imaged by confocal fluorescence microscopy automated to collect a large grid of high resolution fields. In hSAT from 40 men and women with obesity, substantial heterogeneity of pAkt densities in adipocyte membranes were quantified in each image mosaic using a spatial unit of at least twice the size of the point spread function. Statistical analysis of the distribution of pAkt spatial units was best fit as the weighted sum of two separate distributions, corresponding to either a low or high pAkt density. A high pAkt fraction metric was calculated from the fraction of high pAkt distributed units over the total units. Importantly, upon insulin stimulation, tissues from the same biopsy showed either a minimal or a substantial change in the high pAkt fraction. Further supporting a two-state response to insulin stimulation, subjects with similar insulin sensitivity indices are also segregated into either of two clusters identified by the amount of membrane-localized pAkt.	[McCormick, Chad D.; Waters, Hang N.; Bezrukov, Ludmila; Taginya, Roxana; Blank, Paul S.; Zimmerberg, Joshua] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Integrat Biophys, NIH, Bethesda, MD 20892 USA; [Parikh, Viraj; Onyekaba, Ginikanwa I.; Levine, Jordan A.; Demidowich, Andrew P.; Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, NIH, Bethesda, MD 20892 USA; [Yanovski, Jack A.; Zimmerberg, Joshua] US PHS, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); United States Public Health Service	Zimmerberg, J (corresponding author), 10 Ctr Dr,Bldg 10,Room 10D14, Bethesda, MD 20892 USA.	joshz@helix.nih.gov	Blank, Paul/Q-9673-2019	McCormick, Chad/0000-0003-0070-166X	Division of Intramural Research (DIR) of the NICHD, National Institutes of Health [ZIAHD000641, ZIAHD001415]; NICHD DIR Director's Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641, ZIAHD001415] Funding Source: NIH RePORTER	Division of Intramural Research (DIR) of the NICHD, National Institutes of Health; NICHD DIR Director's Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Division of Intramural Research (DIR) of the NICHD, National Institutes of Health Projects ZIAHD000641 (to J. Y.) and ZIAHD001415 (to J. Z.), with additional support from an NICHD DIR Director's Award. The authors declare that they have no conflicts of interest with the contents of this article. The opinions and assertions expressed herein are those of the authors and are not to be construed as reflecting the views of the USPHS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSON RL, 1995, AM J EPIDEMIOL, V142, P724, DOI 10.1093/aje/142.7.724; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; BASTARD JP, 1994, JPEN-PARENTER ENTER, V18, P466, DOI 10.1177/0148607194018005466; Beg M, 2017, ELIFE, V6, DOI 10.7554/eLife.26896; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Busse BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30284; Cizmeci D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083640; Cook SA, 2010, EUR HEART J, V31, P100, DOI 10.1093/eurheartj/ehp396; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Di Camillo B, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0281-4; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Garg A, 2004, J CLIN ENDOCR METAB, V89, P4206, DOI 10.1210/jc.2004-0631; Gastaldelli A, 2017, DIABETES, V66, P815, DOI 10.2337/db16-1167; Gil A, 2011, INT J PEDIATR OBES, V6, P13, DOI 10.3109/17477166.2011.604326; GLIEMANN J, 1974, J PHYSIOL-LONDON, V236, P499, DOI 10.1113/jphysiol.1974.sp010449; GLIEMANN J, 1972, ISRAEL J MED SCI, V8, P807; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Hales Craig M, 2017, NCHS Data Brief, P1; Humphrey SJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003085; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; KAHN BB, 1986, ANN NY ACAD SCI, V488, P356; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; Koshy Shyny, 2010, J Vis Exp, DOI 10.3791/2429; Lee KY, 2017, DIABETES, V66, P2822, DOI 10.2337/db17-0218; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Lizunov VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119291; Lizunov VA, 2013, DIABETES, V62, P3114, DOI 10.2337/db12-1741; Lizunov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057559; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Magkos F, 2010, OBESITY, V18, P1510, DOI 10.1038/oby.2010.90; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ninfa Alexander J, 2004, Sci STKE, V2004, ppe20, DOI 10.1126/stke.2322004pe20; Norris DM, 2018, METHODS MOL BIOL, V1713, P193, DOI 10.1007/978-1-4939-7507-5_15; Patel P, 2013, J OBES, V2013, DOI 10.1155/2013/489187; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Saltiel AR, 2003, TRAFFIC, V4, P711, DOI 10.1034/j.1600-0854.2003.00119.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sedaghat AR, 2002, AM J PHYSIOL-ENDOC M, V283, pE1084, DOI 10.1152/ajpendo.00571.2001; Shao J, 2000, J ENDOCRINOL, V167, P107, DOI 10.1677/joe.0.1670107; Shigematsu S, 2001, J BIOL CHEM, V276, P15292, DOI 10.1074/jbc.M009684200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Veeriah S, 2014, CANCER RES, V74, P4983, DOI 10.1158/0008-5472.CAN-13-3382; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang QT, 2017, CIRCULATION, V135, P73, DOI 10.1161/CIRCULATIONAHA.116.022281; Xiong WY, 2010, MOL BIOL CELL, V21, P1375, DOI 10.1091/mbc.E09-08-0751; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	54	1	1	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14249	14259		10.1074/jbc.RA118.003751	http://dx.doi.org/10.1074/jbc.RA118.003751			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30006347	hybrid, Green Published			2022-12-26	WOS:000444671500006
J	Soll, JM; Brickner, JR; Mudge, MC; Mosammaparast, N				Soll, Jennifer M.; Brickner, Joshua R.; Mudge, Miranda C.; Mosammaparast, Nima			RNA ligase-like domain in activating signal cointegrator 1 complex subunit 1 (ASCC1) regulates ASCC complex function during alkylation damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA repair; alkB; DNA damage response; cell signaling; DNA demethylation	DNA-DAMAGE; OXIDATIVE DEMETHYLATION; ESCHERICHIA-COLI; REPAIR; PROTEIN; 3,N-4-ETHENOCYTOSINE; GLYCOSYLASE; PREDICTION; CONTAINS; CANCER	Multiple DNA damage response (DDR) pathways have evolved to sense the presence of damage and recruit the proper repair factors. We recently reported a signaling pathway induced upon alkylation damage to recruit the AlkB homolog 3, -ketoglutarate-dependent dioxygenase (ALKBH3)-activating signal cointegrator 1 complex subunit 3 (ASCC3) dealkylase-helicase repair complex. As in other DDR pathways, the recruitment of these repair factors is mediated through a ubiquitin-dependent mechanism. However, the machinery that coordinates the proper assembly of this repair complex and controls its recruitment is still poorly defined. Here, we demonstrate that the ASCC1 accessory subunit is important for the regulation of ASCC complex function. ASCC1 interacts with the ASCC complex through the ASCC3 helicase subunit. We find that ASCC1 is present at nuclear speckle foci prior to damage, but leaves the foci in response to alkylation. Strikingly, ASCC1 loss significantly increases ASCC3 foci formation during alkylation damage, yet most of these foci lack ASCC2. These results suggest that ASCC1 coordinates the proper recruitment of the ASCC complex during alkylation, a function that appears to depend on a putative RNA-binding motif near the ASCC1 C terminus. Consistent with its role in alkylation damage signaling and repair, ASCC1 knockout through a CRISPR/Cas9 approach results in alkylation damage sensitivity in a manner epistatic with ASCC3. Together, our results identify a critical regulator of the ALKBH3-ASCC alkylation damage signaling pathway and suggest a potential role for RNA-interacting domains in the alkylation damage response.	[Soll, Jennifer M.; Brickner, Joshua R.; Mudge, Miranda C.; Mosammaparast, Nima] Washington Univ, Dept Pathol & Immunol, Div Lab & Genom Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Mosammaparast, N (corresponding author), Washington Univ, Dept Pathol & Immunol, Campus Box 8118,4939 Childrens Pl, St Louis, MO 63110 USA.	Nima@wustl.edu			National Institutes of Health [R01 CA193318]; Alvin Siteman Cancer Research Fund; Siteman Investment Program; Children's Discovery Institute of St. Louis Children's Hospital Grant [MC-II-2015-453]; Monsanto Company; Cell and Molecular Biology Training Grant from the National Institutes of Health [5T32GM007067-40]; Shawn Hu and Angela Zeng student scholarship; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA193318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alvin Siteman Cancer Research Fund; Siteman Investment Program; Children's Discovery Institute of St. Louis Children's Hospital Grant; Monsanto Company; Cell and Molecular Biology Training Grant from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shawn Hu and Angela Zeng student scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant R01 CA193318, the Alvin Siteman Cancer Research Fund, the Siteman Investment Program, and the Children's Discovery Institute of St. Louis Children's Hospital Grant MC-II-2015-453 (to N.M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a graduate student fellowship from the Monsanto Company.; Supported by Cell and Molecular Biology Training Grant 5T32GM007067-40 from the National Institutes of Health and the Shawn Hu and Angela Zeng student scholarship.	Brickner JR, 2017, NATURE, V551, P389, DOI 10.1038/nature24484; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Doherty AJ, 2000, NUCLEIC ACIDS RES, V28, P4051, DOI 10.1093/nar/28.21.4051; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; EADIE JS, 1984, NATURE, V308, P201, DOI 10.1038/308201a0; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fu D, 2012, DNA REPAIR, V11, P46, DOI 10.1016/j.dnarep.2011.10.004; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gold MG, 2008, J MOL BIOL, V375, P1329, DOI 10.1016/j.jmb.2007.11.037; Gros L, 2004, J BIOL CHEM, V279, P17723, DOI 10.1074/jbc.M314010200; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konishi N, 2005, CLIN CANCER RES, V11, P5090, DOI 10.1158/1078-0432.CCR-05-0195; KOONIN EV, 1990, FEBS LETT, V268, P231, DOI 10.1016/0014-5793(90)81015-G; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Lingaraju GM, 2011, J BIOL CHEM, V286, P13205, DOI 10.1074/jbc.M110.192435; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; Mosammaparast N, 2013, J CELL BIOL, V203, P457, DOI 10.1083/jcb.201302092; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007; SIOMI H, 1993, NUCLEIC ACIDS RES, V21, P1193, DOI 10.1093/nar/21.5.1193; Soll JM, 2017, TRENDS BIOCHEM SCI, V42, P206, DOI 10.1016/j.tibs.2016.10.001; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tasaki M, 2011, BRIT J CANCER, V104, P700, DOI 10.1038/sj.bjc.6606012; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Xu-Welliver M, 2002, CARCINOGENESIS, V23, P823, DOI 10.1093/carcin/23.5.823; ZAK P, 1994, J BIOL CHEM, V269, P730; Zhao Y, 2015, EMBO J, V34, P1687, DOI 10.15252/embj.201490497	36	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13524	13533		10.1074/jbc.RA117.000114	http://dx.doi.org/10.1074/jbc.RA117.000114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29997253	Green Published, hybrid			2022-12-26	WOS:000443375500014
J	Sun, B; Wei, JH; Zhong, XW; Guo, WT; Yao, JJ; Wang, RW; Vallmitjana, A; Benitez, R; Hove-Madsen, L; Chen, SRW				Sun, Bo; Wei, Jinhong; Zhong, Xiaowei; Guo, Wenting; Yao, Jinjing; Wang, Ruiwu; Vallmitjana, Alexander; Benitez, Raul; Hove-Madsen, Leif; Chen, S. R. Wayne			The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca2+-ATPase, is a major determinant of Ca2+ alternans in intact mouse hearts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ryanodine receptor; sarcoplasmic reticulum (SR); endoplasmic reticulum (ER); calcium; calcium ATPase; calcium imaging; calcium intracellular release; Ca2+alternans; Ca2+release refractoriness; intact heart imaging; phospholamban; ventricular tachyarrhythmia; confocal Ca2+ imaging; intact heart imaging; cardiac dysfunction	POLYMORPHIC VENTRICULAR-TACHYCARDIA; T-WAVE ALTERNANS; INTRACELLULAR CALCIUM; MECHANICAL ALTERNANS; ATRIAL MYOCYTES; RAT-HEART; REPOLARIZATION ALTERNANS; CONTENT FLUCTUATIONS; SUDDEN-DEATH; RELEASE	Sarcoplasmic reticulum (SR) Ca2+ cycling is governed by the cardiac ryanodine receptor (RyR2) and SR Ca2+-ATPase (SERCA2a). Abnormal SR Ca2+ cycling is thought to be the primary cause of Ca2+ alternans that can elicit ventricular arrhythmias and sudden cardiac arrest. Although alterations in either RyR2 or SERCA2a function are expected to affect SR Ca2+ cycling, whether and to what extent altered RyR2 or SERCA2a function affects Ca2+ alternans is unclear. Here, we employed a gain-of-function RyR2 variant (R4496C) and the phospholamban-knockout (PLB-KO) mouse model to assess the effect of genetically enhanced RyR2 or SERCA2a function on Ca2+ alternans. Confocal Ca2+ imaging revealed that RyR2-R4496C shortened SR Ca2+ release refractoriness and markedly suppressed rapid pacing-induced Ca2+ alternans. Interestingly, despite enhancing RyR2 function, intact RyR2-R4496C hearts exhibited no detectable spontaneous SR Ca2+ release events during pacing. Unlike for RyR2, enhancing SERCA2a function by ablating PLB exerted a relatively minor effect on Ca2+ alternans in intact hearts expressing RyR2 WT or a loss-of-function RyR2 variant, E4872Q, that promotes Ca2+ alternans. Furthermore, partial SERCA2a inhibition with 3 m 2,5-di-tert-butylhydroquinone (tBHQ) also had little impact on Ca2+ alternans, whereas strong SERCA2a inhibition with 10 m tBHQ markedly reduced the amplitude of Ca2+ transients and suppressed Ca2+ alternans in intact hearts. Our results demonstrate that enhanced RyR2 function suppresses Ca2+ alternans in the absence of spontaneous Ca2+ release and that RyR2, but not SERCA2a, is a key determinant of Ca2+ alternans in intact working hearts, making RyR2 an important therapeutic target for cardiac alternans.	[Sun, Bo; Wei, Jinhong; Zhong, Xiaowei; Guo, Wenting; Yao, Jinjing; Wang, Ruiwu; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB T2N 4N1, Canada; [Vallmitjana, Alexander; Benitez, Raul] Univ Politecn Cataluna, Dept Automat Control, ES-08034 Barcelona, Spain; [Hove-Madsen, Leif] Hosp Sant Pau, CSIC, Biomed Res Inst Barcelona IIBB, Barcelona 08025, Spain	Libin Cardiovascular Institute Of Alberta; University of Calgary; Universitat Politecnica de Catalunya; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); Hospital of Santa Creu i Sant Pau	Chen, SRW (corresponding author), 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.	swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022; Vallmitjana, Alexander/B-5058-2019; Benítez, Raúl/AGO-5018-2022	Wei, Jinhong/0000-0002-5251-9192; Vallmitjana, Alexander/0000-0002-7149-9385; Benítez, Raúl/0000-0002-8782-9406; Hove-Madsen, Leif/0000-0001-5493-3998	Canadian Institutes of Health Research; Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Canada Foundation for Innovation (CFI); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions; Spanish Ministry of Economy and Competitiveness (MINECO) [DPI2013-44584-R, SAF2014-58286-C2-1R]; Generalitat de Catalunya [SGR2014-1465]; Alberta Innovates-Health Solutions (AIHS) Fellowship Award; Libin Cardiovascular Institute of Alberta; AIHS Studentship Award; Cumming School of Medicine Postdoctoral Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Heart and Stroke Foundation Chair in Cardiovascular Research; Alberta Innovates-Health Solutions; Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Alberta Innovates-Health Solutions (AIHS) Fellowship Award; Libin Cardiovascular Institute of Alberta; AIHS Studentship Award; Cumming School of Medicine Postdoctoral Fellowship Award	This work was supported by research grants from the Canadian Institutes of Health Research; the Heart and Stroke Foundation of Alberta, Northwest Territories, and Nunavut; the Canada Foundation for Innovation (CFI); the Heart and Stroke Foundation Chair in Cardiovascular Research; the Alberta Innovates-Health Solutions (to S. R. W. C.); Spanish Ministry of Economy and Competitiveness (MINECO) Grants DPI2013-44584-R (to R.B.) and SAF2014-58286-C2-1R (to L. H. M.), and Generalitat de Catalunya Grant SGR2014-1465 (to L. H. M. and R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of the Alberta Innovates-Health Solutions (AIHS) Fellowship Award.; Recipient of the Libin Cardiovascular Institute of Alberta and Cumming School of Medicine Postdoctoral Fellowship Award.; Recipient of the AIHS Studentship Award.	Aistrup GL, 2009, CIRC RES, V104, P639, DOI 10.1161/CIRCRESAHA.108.181909; Alvarez-Lacalle E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055042; Armoundas AA, 2002, J AM COLL CARDIOL, V40, P207, DOI 10.1016/S0735-1097(02)01960-5; Bai YL, 2013, CIRC RES, V113, P517, DOI 10.1161/CIRCRESAHA.113.301678; Belevych AE, 2009, CARDIOVASC RES, V84, P387, DOI 10.1093/cvr/cvp246; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chen B, 2012, CIRC-ARRHYTHMIA ELEC, V5, P841, DOI 10.1161/CIRCEP.111.969733; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chudin E, 1999, BIOPHYS J, V77, P2930, DOI 10.1016/S0006-3495(99)77126-2; Cordeiro JM, 2007, AM J PHYSIOL-HEART C, V293, pH3506, DOI 10.1152/ajpheart.00757.2007; Cutler MJ, 2012, CIRCULATION, V126, P2095, DOI 10.1161/CIRCULATIONAHA.111.071480; Cutler MJ, 2009, CIRC-ARRHYTHMIA ELEC, V2, P686, DOI 10.1161/CIRCEP.109.863118; Diaz ME, 2004, CIRC RES, V94, P650, DOI 10.1161/01.RES.0000119923.64774.72; Diaz ME, 2002, CIRC RES, V91, P585, DOI 10.1161/01.RES.0000035527.53514.C2; Edwards JN, 2014, CLIN EXP PHARMACOL P, V41, P524, DOI 10.1111/1440-1681.12231; Eisner DA, 2006, HEART RHYTHM, V3, P743, DOI 10.1016/j.hrthm.2005.12.020; Escobar AL, 2014, CIRC RES, V114, P1369, DOI 10.1161/CIRCRESAHA.114.303823; Faggioni M, 2013, CIRC RES, V112, P689, DOI 10.1161/CIRCRESAHA.111.300076; Fernandez-Velasco M, 2009, CIRC RES, V104, P201, DOI 10.1161/CIRCRESAHA.108.177493; Ferrantini C, 2016, J GEN PHYSIOL, V147, P39, DOI 10.1085/jgp.201511450; Goldhaber JI, 2005, CIRC RES, V96, P459, DOI 10.1161/01.RES.0000156891.66893.83; Huser J, 2000, J PHYSIOL-LONDON, V524, P795, DOI 10.1111/j.1469-7793.2000.00795.x; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Kameyama M, 2003, J ELECTROCARDIOL, V36, P125, DOI 10.1054/jelc.2003.50021; Kanaporis G, 2015, CIRC RES, V116, P846, DOI 10.1161/CIRCRESAHA.116.305404; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; Kapur S, 2010, AM J PHYSIOL-HEART C, V299, pH1843, DOI 10.1152/ajpheart.00623.2010; Kapur S, 2009, AM J PHYSIOL-HEART C, V296, pH1491, DOI 10.1152/ajpheart.00539.2008; KIHARA Y, 1991, AM J PHYSIOL, V261, pH1746, DOI 10.1152/ajpheart.1991.261.6.H1746; Kockskamper J, 2005, J PHYSIOL-LONDON, V564, P697, DOI 10.1113/jphysiol.2004.078782; Kornyeyev D, 2012, J MOL CELL CARDIOL, V52, P21, DOI 10.1016/j.yjmcc.2011.09.020; Laurita KR, 2008, PROG BIOPHYS MOL BIO, V97, P332, DOI 10.1016/j.pbiomolbio.2008.02.014; Laurita KR, 2008, J MOL CELL CARDIOL, V44, P31, DOI 10.1016/j.yjmcc.2007.10.012; Llach A, 2011, J PHYSIOL-LONDON, V589, P3247, DOI 10.1113/jphysiol.2010.197715; Lugo CA, 2014, AM J PHYSIOL-HEART C, V306, pH1540, DOI 10.1152/ajpheart.00515.2013; LUO WS, 1994, CIRC RES, V75, P401, DOI 10.1161/01.RES.75.3.401; Narayan SM, 2006, J AM COLL CARDIOL, V47, P269, DOI 10.1016/j.jacc.2005.08.066; Nassal MMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137359; ORCHARD CH, 1991, CIRC RES, V68, P69, DOI 10.1161/01.RES.68.1.69; Picht E, 2006, CIRC RES, V99, P740, DOI 10.1161/01.RES.0000244002.88813.91; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Qu Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep35625; Qu ZL, 2013, J MOL CELL CARDIOL, V58, P100, DOI 10.1016/j.yjmcc.2012.10.007; Qu ZL, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00154; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; Rovetti R, 2010, CIRC RES, V106, P1582, DOI 10.1161/CIRCRESAHA.109.213975; Sabir IN, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00126; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Stary V, 2016, J APPL PHYSIOL, V120, P865, DOI 10.1152/japplphysiol.00588.2015; Verrier RL, 2013, J ELECTROCARDIOL, V46, P580, DOI 10.1016/j.jelectrocard.2013.07.003; Verrier RL, 2010, J CARDIOVASC PHARM, V55, P544, DOI 10.1097/FJC.0b013e3181d6b781; Wan XP, 2005, J MOL CELL CARDIOL, V39, P419, DOI 10.1016/j.yjmcc.2005.06.004; Wang LG, 2014, CIRC RES, V114, P1410, DOI 10.1161/CIRCRESAHA.114.302505; Wasserstrom JA, 2009, CIRC-HEART FAIL, V2, P223, DOI 10.1161/CIRCHEARTFAILURE.108.811539; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Wilson LD, 2009, HEART RHYTHM, V6, P251, DOI 10.1016/j.hrthm.2008.11.008; Xie LH, 2008, BIOPHYS J, V95, P3100, DOI 10.1529/biophysj.108.130955; Xie LH, 2009, AM J PHYSIOL-HEART C, V297, pH997, DOI 10.1152/ajpheart.00390.2009; Xie WJ, 2013, J MOL CELL CARDIOL, V64, P120, DOI 10.1016/j.yjmcc.2013.09.003; Zhang JQ, 2014, BIOCHEM J, V461, P99, DOI 10.1042/BJ20140126; Zhong XW, 2016, BIOCHEM J, V473, P3951, DOI 10.1042/BCJ20160606; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	63	20	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13650	13661		10.1074/jbc.RA118.003760	http://dx.doi.org/10.1074/jbc.RA118.003760			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986885	Green Published, hybrid			2022-12-26	WOS:000443375500024
J	Augusto, O; Keyes, EE; Madede, T; Abacassamo, F; de la Corte, P; Chilundo, B; Bailey, PE				Augusto, Orvalho; Keyes, Emily E.; Madede, Tavares; Abacassamo, Fatima; de la Corte, Pilar; Chilundo, Baltazar; Bailey, Patricia E.			Progress in Mozambique: Changes in the availability, use, and quality of emergency obstetric and newborn care between 2007 and 2012	PLOS ONE			English	Article							MATERNAL MORBIDITY; PROCESS INDICATORS; NEEDS-ASSESSMENT; UNITED-STATES; SERVICES; PREGNANCY; MORTALITY	Introduction Maternal mortality in Mozambique has not declined significantly in the last 10-15 years, plateauing around 480 maternal deaths per 100,000 live births. Good quality antenatal care and routine and emergency intrapartum care are critical to reducing preventable maternal and newborn deaths. Materials and methods We compare the findings from two national cross-sectional facility-based assessments conducted in 2007 and 2012. Both were designed to measure the availability, use and quality of emergency obstetric and neonatal care. Indicators for monitoring emergency obstetric care were used as were descriptive statistics. Results The availability of facilities providing the full range of obstetric life-saving procedures (signal functions) decreased. However, an expansion in the provision of individual signal functions was highly visible in health centers and health posts, but in hospitals, performance was less satisfactory, with proportionally fewer hospitals providing assisted vaginal delivery, obstetric surgery and blood transfusions. All other key indicators showed signs of improvements: the institutional delivery rate, the cesarean delivery rate, met need for emergency obstetric care (EmOC), institutional stillbirth and early neonatal death rates, and cause-specific case fatality rates (CFRs). CFRs for most major obstetric complications declined between 17% and 69%. The contribution of direct causes to maternal deaths decreased while the proportion of indirect causes doubled during the five-year interval. Conclusions The indicator of EmOC service availability, often used for planning and developing EmONC networks, requires close examination. The standard definition can mask programmatic weaknesses and thus, fails to inform decision makers of what to target. In this case, the decline in the use of assisted vaginal delivery explained much of the difference in this indicator between the two surveys, as did faltering hospital performance. Despite this backsliding, many signs of improvement were also observed in this 5-year period, but indicator levels continue below recommended thresholds. The quality of intrapartum care and the adverse consequences from infectious diseases during pregnancy point to priority areas for programmatic improvement.	[Augusto, Orvalho; Madede, Tavares; Abacassamo, Fatima; Chilundo, Baltazar] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Keyes, Emily E.; Bailey, Patricia E.] FHI 360, Durham, NC USA; [Keyes, Emily E.; Bailey, Patricia E.] Columbia Univ, Averting Maternal Death & Disabil, New York, NY USA; [de la Corte, Pilar] UNFPA, Maputo, Mozambique	Eduardo Mondlane University; FHI 360; Columbia University	Augusto, O (corresponding author), Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique.	orvaquim@gmail.com	Madede, Tavares/GWD-0998-2022; Augusto, Orvalho/J-8767-2019	Augusto, Orvalho/0000-0002-0005-3968	United States Agency for International Development (USAID) [GHA-A-00-08-00003-00]; MEASURE Evaluation Phase IV Project [FHI 360]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); MEASURE Evaluation Phase IV Project	The United States Agency for International Development (USAID) funded the preparation of this publication through a cooperative agreement (GHA-A-00-08-00003-00) with the MEASURE Evaluation Phase IV Project under a contract with FHI 360. The manuscript represents the views of the authors and does not represent the views of USAID or the US Government. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, I NAC EST; Baguiya A, 2016, INT J GYNECOL OBSTET, V135, pS2, DOI 10.1016/j.ijgo.2016.09.004; Bailey P, 2017, BRIT J OBSTET GYNAEC, DOI [10.1111/1471-05-28.14477, DOI 10.1111/1471-05-28.14477]; Bailey PE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1479-1; Bailey PE, 2015, BMC PREGNANCY CHILDB, V15, DOI [10.1186/s12884-015-0725-7, 10.1186/s12884-016-1035-4]; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Bank W, 2015, GROSS NAT INC; Banke-Thomas A, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31880; Bennett TA, 1998, AM J OBSTET GYNECOL, V178, P346, DOI 10.1016/S0002-9378(98)80024-0; Bosomprah S, 2016, INT J GYNECOL OBSTET, V132, P130, DOI 10.1016/j.ijgo.2015.11.004; Campbell OMR, 2016, LANCET, V388, P2193, DOI 10.1016/S0140-6736(16)31528-8; Chavane L, J OBSTET GYNAECOLOGY; DARMSTADT GL, 2009, BMC PREGNANCY CHI S1, V9; Gabrysch S, 2012, TROP MED INT HEALTH, V17, P2, DOI 10.1111/j.1365-3156.2011.02851.x; Holmer H, 2015, BJOG-INT J OBSTET GY, V122, P183, DOI 10.1111/1471-0528.13230; Hussein J, 2001, INT J GYNECOL OBSTET, V75, P63, DOI 10.1016/S0020-7292(01)00474-X; Instituto Nacional de Estat oA stica, 2012, AN EST 2012 MOC; Instituto Nacional de Estat oA stica Ministe A rio da Sau A de ORC Macro/ DHS Program, 2005, ORC MACR DHS PROGR M; Keyes E, 2017, IMPROVEMENTS FACILIT; Kouanda S, 2016, INT J GYNECOL OBSTET, V135, pS11, DOI 10.1016/j.ijgo.2016.08.008; Lauritsen J, 2008, EPIDATA ENTRY VERSI; Lobis S, 2005, INT J GYNECOL OBSTET, V88, P203, DOI 10.1016/j.ijgo.2004.11.025; Long Q, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0686-x; Makanga PT, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-016-0074-4; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; McCord C, 2001, INT J GYNECOL OBSTET, V75, P297, DOI 10.1016/S0020-7292(01)00526-4; McKinnon B, 2014, TROP MED INT HEALTH, V19, P780, DOI 10.1111/tmi.12323; Ministe A rio de Sau A de (MISAU) Instituto Nacional de Estat oA stica (INE) ICF Internacional, ICF INT INQ IND IM M; Ministerio da Saude (MISAU) Instituto Nacional de Estatistica (INE) & ICF International (ICFI), 2011, MOZ DEM HLTH SURV 20; MOXON SG, 2015, BMC PREGNANCY CHI S2, V15; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Nolens B, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1052-3; Ntambue AM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1224-9; Panciera R, 2016, BMC PREGNANCY CHILDB, V16; Paxton A, 2006, INT J GYNECOL OBSTET, V95, P192, DOI 10.1016/j.ijgo.2006.08.009; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; StataCorp LLC, 2015, US GUID; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; World Health Organization (WHO); UNFPA; UNICEF; Columbia University. Mailman School of Public Health, 2009, MON EM OBST CAR HDB	39	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199883	10.1371/journal.pone.0199883	http://dx.doi.org/10.1371/journal.pone.0199883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020958	Green Submitted, gold, Green Published			2022-12-26	WOS:000439022400030
J	Truchado, P; Gil, MI; Suslow, T; Allende, A				Truchado, Pilar; Isabel Gil, Maria; Suslow, Trevor; Allende, Ana			Impact of chlorine dioxide disinfection of irrigation water on the epiphytic bacterial community of baby spinach and underlying soil	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; MICROORGANISMS; PHYLLOSPHERE; RESILIENCE; VEGETABLES; PRODUCERS; RICHNESS; CROPS; DGGE	The contamination of pathogenic bacteria through irrigation water is a recognized risk factor for fresh produce. Irrigation water disinfection is an intervention strategy that could be applied to reduce the probability of microbiological contamination of crops. Disinfection treatments should be applied ensuring minimum effective doses, which are efficient in inhibiting the microbial contamination while avoiding formation and accumulation of chemical residues. Among disinfection technologies available for growers, chlorine dioxide (ClO2) represents, after sodium hypochlorite, an alternative disinfection treatment, which is commercially applied by growers in the USA and Spain. However, in most of the cases, the suitability of this treatment has been tested against pathogenic bacteria and low attention have been given to the impact of chemical residues on the bacterial community of the vegetable tissue. The aim of this study was to (i) to evaluate the continual application of chlorine dioxide (ClO2) as a water disinfection treatment of irrigation water during baby spinach growth in commercial production open fields, and (ii) to determine the subsequent impact of these treatments on the bacterial communities in water, soil, and baby spinach. To gain insight into the changes in the bacterial community elicited by ClO2, samples of treated and untreated irrigation water as well as the irrigated soil and baby spinach were analyzed using Miseq (R) Illumina sequencing platform. Next generation sequencing and multivariate statistical analysis revealed that ClO2 treatment of irrigation water did not affect the diversity of the bacterial community of water, soil and crop, but significant differences were observed in the relative abundance of specific bacterial genera. This demonstrates the different susceptibility of the bacteria genera to the ClO2 treatment. Based on the obtained results it can be concluded that the phyllosphere bacterial community of baby spinach was more influenced by the soil bacteria community rather than that of irrigation water. In the case of baby spinach, the use of low residual ClO2 concentrations (approx. 0.25 mg/L) to treat irrigation water decreased the relative abundance of Pseudomonaceae (2.28-fold) and Enterobacteriaceae (2.5-fold) when comparing treated versus untreated baby spinach. Members of these two bacterial families are responsible for food spoilage and foodborne illnesses. Therefore, a reduction of these bacterial families might be beneficial for the crop and for food safety. In general it can be concluded that the constant application of ClO2 as a disinfection treatment for irrigation water only caused changes in two bacterial families of the baby spinach and soil microbiota, without affecting the major phyla and classes. The significance of these changes in the bacterial community should be further evaluated.	[Truchado, Pilar; Isabel Gil, Maria; Allende, Ana] CSIC, CEBAS, Res Grp Qual Safety & Bioact Plant Foods, Campus Univ Espinardo, Murcia, Spain; [Suslow, Trevor] Univ Calif Davis, Dept Plant Sci, Mann Lab, One Shields Ave, Davis, CA 95616 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Murcia; University of California System; University of California Davis	Allende, A (corresponding author), CSIC, CEBAS, Res Grp Qual Safety & Bioact Plant Foods, Campus Univ Espinardo, Murcia, Spain.	aallende@cebas.csic.es	Gil, Maria Isabel/AAB-1929-2019; ALLENDE, ANA/D-1867-2012; Gil, Maria Isabel/D-2237-2012	Gil, Maria Isabel/0000-0003-4340-7727; ALLENDE, ANA/0000-0002-5622-4332; Gil, Maria Isabel/0000-0003-4340-7727	Center for Produce Safety [2015-374, 2017-01]; MINECO [AGL2013-48529-R, AGL2016-75878-R, IJCI-2014-20932]; FundacioAn SeAneca [19900/GERM/15]; Proyecto Intramural [201670E056]	Center for Produce Safety; MINECO(Spanish Government); FundacioAn SeAneca; Proyecto Intramural	Authors are thankful for the financial support from the Center for Produce Safety Grant Agreement (Projects 2015-374 and 2017-01 to A.A.) and the MINECO (Projects AGL2013-48529-R and AGL2016-75878-R to M.I.G.). P. Truchado is holder of a Juan de la Cierva incorporation contract from the MINECO (IJCI-2014-20932). Support provided by the Fundacion SeAneca (19900/GERM/15) and Proyecto Intramural (201670E056 to M.I.G.) is also appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende A, 2015, INT J ENV RES PUB HE, V12, P7457, DOI 10.3390/ijerph120707457; [Anonymous], 2016, INT J ENV AGR RES; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Becerra-Castro C, 2016, SCI TOTAL ENVIRON, V573, P313, DOI 10.1016/j.scitotenv.2016.08.054; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Burch AY, 2016, APPL ENVIRON MICROB, V82, P5997, DOI 10.1128/AEM.01751-16; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiao TH, 2016, ENVIRON SCI TECHNOL, V48, P4038; Dees MW, 2015, APPL ENVIRON MICROB, V81, P1530, DOI 10.1128/AEM.03470-14; Deng WJ, 2017, INT J FOOD MICROBIOL, V258, P28, DOI 10.1016/j.ijfoodmicro.2017.07.010; Frenk S, 2014, ENVIRON MICROBIOL, V16, P559, DOI 10.1111/1462-2920.12183; Gil MI, 2015, CRIT REV FOOD SCI, V55, P453, DOI 10.1080/10408398.2012.657808; Gomez-Alvarez V, 2016, ENVIRON SCI-WAT RES, V2, P645, DOI [10.1039/c6ew00053c, 10.1039/C6EW00053C]; Gu GY, 2018, FOOD MICROBIOL, V73, P73, DOI 10.1016/j.fm.2018.01.002; Hausdorf L, 2013, FOOD MICROBIOL, V34, P406, DOI 10.1016/j.fm.2012.10.008; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Hunter PJ, 2010, APPL ENVIRON MICROB, V76, P8117, DOI 10.1128/AEM.01321-10; Ibekwe AM, 2004, FEMS MICROBIOL ECOL, V48, P239, DOI 10.1016/j.femsec.2004.01.012; Ishaq SL, 2017, MICROB ECOL, V73, P417, DOI 10.1007/s00248-016-0861-2; Izhaki I, 2013, CURR MICROBIOL, V66, P227, DOI 10.1007/s00284-012-0261-x; Jackson CR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-274; Jensen B, 2013, INT J FOOD MICROBIOL, V160, P313, DOI 10.1016/j.ijfoodmicro.2012.11.005; Keinanen-Toivola MM, 2006, FEMS MICROBIOL LETT, V257, P182, DOI 10.1111/j.1574-6968.2006.00167.x; Kuo-Shan Yao, 2010, Journal of Environmental Engineering and Management, V20, P157; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee DH, 2013, J FOOD PROTECT, V76, P1350, DOI 10.4315/0362-028X.JFP-12-439; Leff JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059310; Lopez-Galvez F, 2018, J SCI FOOD AGR, V98, P2973, DOI 10.1002/jsfa.8794; Lopez-Galvez F, 2017, AGR WATER MANAGE, V192, P98, DOI 10.1016/j.agwat.2017.07.001; Lopez-Velasco G, 2013, FEMS MICROBIOL LETT, V346, P146, DOI 10.1111/1574-6968.12216; Lopez-Velasco G, 2012, INT J FOOD MICROBIOL, V153, P351, DOI 10.1016/j.ijfoodmicro.2011.11.026; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Monaghan JM, 2017, J FOOD PROTECT, V80, P725, DOI 10.4315/0362-028X.JFP-16-237; Mowlick S, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-46; Nocker A, 2009, FEMS MICROBIOL LETT, V291, P137, DOI 10.1111/j.1574-6968.2008.01429.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ottesen AR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-114; Pachepsky Y, 2011, ADV AGRON, V113, P73, DOI 10.1016/B978-0-12-386473-4.00007-5; Pang YC, 2016, APPL MICROBIOL BIOT, V100, P6435, DOI 10.1007/s00253-016-7452-5; Park S, 2013, APPL ENVIRON MICROB, V79, P4347, DOI 10.1128/AEM.00474-13; Qin Y, 2016, SCI REP-UK, V6, DOI [10.1038/srep35602, 10.1038/srep35232]; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Reitz SR, 2015, ASABE IA IRR S EM TE; Saul-Tcherkas V, 2011, MICROB ECOL, V61, P64, DOI 10.1007/s00248-010-9763-x; Scarlett K, 2016, EUR J PLANT PATHOL, V145, P27, DOI 10.1007/s10658-015-0811-8; Schlatter DC, 2015, ECOLOGY, V96, P134, DOI 10.1890/13-1648.1; Sklarz MY, 2013, J ENVIRON QUAL, V42, P1226, DOI 10.2134/jeq2012.0416; Suslow T. V., 2010, STANDARDS IRRIGATION; Taylor RH, 2000, APPL ENVIRON MICROB, V66, P1702, DOI 10.1128/AEM.66.4.1702-1705.2000; Telias A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-81; Tournas VH, 2005, CRIT REV MICROBIOL, V31, P33, DOI 10.1080/10408410590886024; Truchado P, 2016, FOOD CONTROL, V62, P150, DOI 10.1016/j.foodcont.2015.10.014; Vaz-Moreira I, 2013, FEMS MICROBIOL ECOL, V83, P361, DOI 10.1111/1574-6941.12002; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wei F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22611; Wei YM, 2015, ENVIRON SCI POLLUT R, V22, P12605, DOI 10.1007/s11356-015-4534-3; Williams MM, 2004, J APPL MICROBIOL, V96, P954, DOI 10.1111/j.1365-2672.2004.02229.x; Williams TR, 2014, MBIO, V5, DOI 10.1128/mBio.01564-14; Williams TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068642; Zwielehner J, 2008, MOL NUTR FOOD RES, V52, P614, DOI 10.1002/mnfr.200700158	62	21	22	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199291	10.1371/journal.pone.0199291	http://dx.doi.org/10.1371/journal.pone.0199291			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020939	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400010
J	Lopez-Aparicio, S; Grythe, H; Vogt, M; Pierce, M; Vallejo, I				Lopez-Aparicio, Susana; Grythe, Henrik; Vogt, Matthias; Pierce, Matthew; Vallejo, Islen			Webcrawling and machine learning as a new approach for the spatial distribution of atmospheric emissions	PLOS ONE			English	Article							ONLINE CONTENT; INVENTORY; MODEL	In this study we apply two methods for data collection that are relatively new in the field of atmospheric science. The two developed methods are designed to collect essential geolocalized information to be used as input data for a high resolution emission inventory for residential wood combustion (RWC). The first method is a webcrawler that extracts openly online available real estate data in a systematic way, and thereafter structures them for analysis. The webcrawler reads online Norwegian real estate advertisements and it collects the geo-position of the dwellings. Dwellings are classified according to the type (e.g., apartment, detached house) they belong to and the heating systems they are equipped with. The second method is a model trained for image recognition and classification based on machine learning techniques. The images from the real estate advertisements are collected and processed to identify wood burning installations, which are automatically classified according to the three classes used in official statistics, i.e., open fireplaces, stoves produced before 1998 and stoves produced after 1998. The model recognizes and classifies the wood appliances with a precision of 81%, 85% and 91% for open fireplaces, old stoves and new stoves, respectively. Emission factors are heavily dependent on technology and this information is therefore essential for determining accurate emissions. The collected data are compared with existing information from the statistical register at county and national level in Norway. The comparison shows good agreement for the proportion of residential heating systems between the webcrawled data and the official statistics. The high resolution and level of detail of the extracted data show the value of open data to improve emission inventories. With the increased amount and availability of data, the techniques presented here add significant value to emission accuracy and potential applications should also be considered across all emission sectors.	[Lopez-Aparicio, Susana; Grythe, Henrik; Vogt, Matthias; Vallejo, Islen] NILU Norwegian Inst Air Res, Kjeller, Norway; [Pierce, Matthew] Univ Helsinki, Helsinki, Finland	Norwegian Institute for Air Research; University of Helsinki	Lopez-Aparicio, S (corresponding author), NILU Norwegian Inst Air Res, Kjeller, Norway.	sla@nilu.no	Lopez-Aparicio, Susana/C-5772-2013; Grythe, Henrik/O-4933-2019; Grythe, Henrik/Q-4072-2019; Lopez-Aparicio, Susana/O-9952-2019	Lopez-Aparicio, Susana/0000-0003-0426-9667; Grythe, Henrik/0000-0001-5074-4858; Lopez-Aparicio, Susana/0000-0003-0426-9667; Vallejo-Henao, Islen/0000-0003-2934-1792	Research Council of Norway [247884/O70]; NILU (DataML) [117017]	Research Council of Norway(Research Council of Norway); NILU (DataML)	This study was made possible thanks to the financial support of the Research Council of Norway through the financing of the iResponse project (247884/O70) and internal support by NILU (DataML, 117017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was made possible thanks to the financial support of the Research Council of Norway through the financing of the iResponse project (247884/O70) and internal support by NILU (DataML, 117017). We thanks www.finn.no for allowing us to extract open data from their site for research purposes. We would like to thank two anonymous reviewers for comments that significantly helped improve the manuscript and Dr Paul Hamer for proofreading.	Audeh B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169658; Bond TC, 2013, J GEOPHYS RES-ATMOS, V118, P5380, DOI 10.1002/jgrd.50171; Evangeliou N, 2018, ATMOS CHEM PHYS, V18, P963, DOI 10.5194/acp-18-963-2018; Glez-Pena D, 2014, BRIEF BIOINFORM, V15, P788, DOI 10.1093/bib/bbt026; Grythe H, 2018, P 11 INT C AIR QUAL; Helfenstein A, 2017, BIOINFORMATICS, V33, P1205, DOI 10.1093/bioinformatics/btw782; Houyoux MR, 2000, J GEOPHYS RES-ATMOS, V105, P9079, DOI 10.1029/1999JD900975; Kindbom K, 2017, TEMANORD, P570; Kuenen JJP, 2014, ATMOS CHEM PHYS, V14, P10963, DOI 10.5194/acp-14-10963-2014; Li Y, 2016, AIR QUAL ATMOS HLTH, V9, P51, DOI 10.1007/s11869-015-0321-z; Lopez-Aparicio S, 2018, CLAIRCITY PUBL M; Lopez-Aparicio S, 2017, ATMOS ENVIRON, V154, P285, DOI 10.1016/j.atmosenv.2017.02.004; Lopez-Aparicio S, 2017, J ENVIRON MANAGE, V191, P179, DOI 10.1016/j.jenvman.2017.01.018; Maes J, 2009, ATMOS ENVIRON, V43, P1246, DOI 10.1016/j.atmosenv.2008.11.040; Norwegian Environment Agency, 2014, INF INV REP IIR 2014; Pasquale, 2017, TRANSPARENT DATA MIN, DOI 10.1007/978-3-319-54024-5; Plejdrup MS, 2016, ATMOS ENVIRON, V144, P389, DOI 10.1016/j.atmosenv.2016.09.013; Redmon J, DARKNET OPEN SOURCE; Redmon J, 2017, COMPUTER VISION PATT, P6517; Seljeskog M, 2013, PARTICLE EMISSION FA; Sheng JX, 2017, ATMOS ENVIRON, V158, P211, DOI 10.1016/j.atmosenv.2017.02.036; Statistics Norway, EN CONS HOUS; Tarrason L, 2017, 212017 NILU NORW ENV; Terrenoire E, 2015, GEOSCI MODEL DEV, V8, P21, DOI 10.5194/gmd-8-21-2015; Tsikrika T, 2014, P INT WORKSH ENV MUL; Xu SH, 2014, BIOINFORMATICS, V30, P104, DOI 10.1093/bioinformatics/btt571	26	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200650	10.1371/journal.pone.0200650	http://dx.doi.org/10.1371/journal.pone.0200650			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011313	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800039
J	Kothe, TB; Royse, E; Kemp, MW; Usuda, H; Saito, M; Musk, GC; Jobe, AH; Hillman, NH				Kothe, T. Brett; Royse, Emily; Kemp, Matthew W.; Usuda, Haruo; Saito, Masatoshi; Musk, Gabrielle C.; Jobe, Alan H.; Hillman, Noah H.			Epidermal growth factor receptor inhibition with Gefitinib does not alter lung responses to mechanical ventilation in fetal, preterm lambs	PLOS ONE			English	Article							INDUCED PULMONARY-FIBROSIS; EGF RECEPTOR; INDUCED CHORIOAMNIONITIS; SIGNALING PATHWAY; EPITHELIAL-CELLS; SHEEP; INJURY; MATURATION; ENDOTOXIN; LIPOPOLYSACCHARIDE	Background Epidermal growth factor receptor (EGFR) is important for airway branching and lung maturation. Mechanical ventilation of preterm lambs causes increases in EGFR and EGFR ligand mRNA in the lung. Abnormal EGFR signaling may contribute to the development of bronchopulmonary dysplasia. Hypothesis Inhibition of EGFR signaling will decrease airway epithelial cell proliferation and lung inflammation caused by mechanical ventilation in preterm, fetal sheep. Methods Following exposure of the fetal head and chest at 123 +/- 1 day gestational age and with placental circulation intact, fetal lambs (n = 4-6/group) were randomized to either: 1) Gefitinib 15 mg IV and 1 mg intra-tracheal or 2) saline IV and IT. Lambs were further assigned to 15 minutes of either: a) Injurious mechanical ventilation (MV) or b) Continuous positive airway pressure (CPAP) 5 cmH(2)O. After the 15 minute intervention, the animals were returned to the uterus and delivered after i) 6 or ii) 24 hours in utero. Results MV caused lung injury and inflammation, increased lung mRNA for cytokines and EGFR ligands, caused airway epithelial cell proliferation, and decreased airway epithelial phosphorylated ERK1/2. Responses to MV were unchanged by Gefitinib. Gefitinib altered expression of EGFR mRNA in the lung and liver of both CPAP and MV animals. Gefitinib decreased the liver SAA3 mRNA response to MV at 6 hours. There were no differences in markers of lung injury or inflammation between CPAP animals receiving Gefitinib or saline. Conclusion Inhibition of the EGFR pathway did not alter acute lung inflammation or injury from mechanical ventilation in preterm sheep.	[Kothe, T. Brett; Royse, Emily; Hillman, Noah H.] St Louis Univ, Cardinal Glennon Childrens Hosp, Div Neonatol, St Louis, MO 63103 USA; [Kemp, Matthew W.; Usuda, Haruo; Jobe, Alan H.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Saito, Masatoshi] Tohoku Univ Hosp, Ctr Perinatal & Neonatal Med, Sendai, Miyagi, Japan; [Musk, Gabrielle C.] Univ Western Australia, Anim Care Serv, Perth, WA, Australia; [Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH USA	Saint Louis University; University of Western Australia; Tohoku University; University of Western Australia; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hillman, NH (corresponding author), St Louis Univ, Cardinal Glennon Childrens Hosp, Div Neonatol, St Louis, MO 63103 USA.	Noah.Hillman@health.slu.edu		Usuda, Haruo/0000-0002-9334-8086	National Institute of Child Health and Human Development, NICHD [R01-HD072842]; National Heart, Lung, and Blood Institute NHLBI [K08-HL097085]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072842] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL097085] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors have received funding from The National Institute of Child Health and Human Development, NICHD R01-HD072842 (PI: Jobe) and The National Heart, Lung, and Blood Institute NHLBI K08-HL097085 (PI: Hillman) for this study.	Bierman A, 2008, TRANSL RES, V152, P265, DOI 10.1016/j.trsl.2008.10.004; Boucherat O, 2014, DEVELOPMENT, V141, P3197, DOI 10.1242/dev.110254; Brechbuhl HM, 2014, AM J PHYSIOL-LUNG C, V307, pL800, DOI 10.1152/ajplung.00201.2014; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Deptula N, 2016, AM J PHYSIOL-LUNG C, V311, pL412, DOI 10.1152/ajplung.00181.2016; El-Hashim AZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09349-0; Fawke J, 2010, AM J RESP CRIT CARE, V182, P237, DOI 10.1164/rccm.200912-1806OC; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hennessy EM, 2008, ARCH DIS CHILD, V93, P1037, DOI 10.1136/adc.2008.140830; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hillman NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096087; Hillman NH, 2013, AM J PHYSIOL-LUNG C, V305, pL446, DOI 10.1152/ajplung.00162.2013; Hillman NH, 2012, PEDIATR RES, V72, P593, DOI 10.1038/pr.2012.135; Hillman Noah H, 2012, Clin Perinatol, V39, P769, DOI 10.1016/j.clp.2012.09.009; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Hillman NH, 2010, PEDIATR RES, V67, P60, DOI 10.1203/PDR.0b013e3181c1b09e; Horbar JD, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4396; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC; Kramer BW, 2005, AM J RESP CRIT CARE, V171, P73, DOI 10.1164/rccm.200406-745OC; Kramer BW, 2001, AM J RESP CRIT CARE, V164, P982, DOI 10.1164/ajrccm.164.6.2103061; Laughon MM, 2011, AM J RESP CRIT CARE, V183, P1715, DOI 10.1164/rccm.201101-0055OC; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Liu CY, 2013, DNA CELL BIOL, V32, P423, DOI 10.1089/dna.2013.2079; Liu W, 2010, BBA-MOL CELL RES, V1803, P832, DOI 10.1016/j.bbamcr.2010.03.003; MARIASSY AT, 1983, ANAT REC, V205, P263, DOI 10.1002/ar.1092050304; MERCER RR, 1994, AM J RESP CELL MOL, V10, P613, DOI 10.1165/ajrcmb.10.6.8003339; Miettinen PJ, 1997, DEV BIOL, V186, P224, DOI 10.1006/dbio.1997.8593; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nadel JA, 2001, RESP RES, V2, P85, DOI 10.1186/rr43; Nielsen HC, 1997, BIOCHEM MOL MED, V60, P38, DOI 10.1006/bmme.1996.2560; Patel NV, 2000, AM J RESP CELL MOL, V22, P432, DOI 10.1165/ajrcmb.22.4.3854; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; RAABERG L, 1995, PEDIATR RES, V37, P175, DOI 10.1203/00006450-199502000-00009; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; Sanchez-Esteban J, 2004, AM J RESP CELL MOL, V30, P76, DOI 10.1165/rcmb.2003-0121OC; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Shah TA, 2010, PEDIATR RES, V68, P210, DOI 10.1203/00006450-201011001-00409; Shan XO, 2017, ONCOTARGET, V8, P26648, DOI 10.18632/oncotarget.15790; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Siddiqui S, 2013, AM J PHYSIOL-LUNG C, V304, pL853, DOI 10.1152/ajplung.00047.2012; Song LQ, 2016, CELL PHYSIOL BIOCHEM, V38, P194, DOI 10.1159/000438621; STGEORGE JA, 1991, AM J RESP CELL MOL, V4, P95, DOI 10.1165/ajrcmb/4.2.95; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; SUNDELL HW, 1980, AM J PATHOL, V100, P707; Vrijlandt EJLE, 2006, AM J RESP CRIT CARE, V173, P890, DOI 10.1164/rccm.200507-1140OC; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824	50	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200713	10.1371/journal.pone.0200713	http://dx.doi.org/10.1371/journal.pone.0200713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005089	Green Published, gold, Green Submitted			2022-12-26	WOS:000438744200021
J	Stacy, NI; Lynch, JM; Arendt, MD; Avens, L; McNeill, JB; Cray, C; Day, RD; Harms, CA; Lee, AM; Peden-Adams, MM; Thorvalson, K; Segars, A; Norton, TM				Stacy, Nicole I.; Lynch, Jennifer M.; Arendt, Michael D.; Avens, Larisa; McNeill, Joanne Braun; Cray, Carolyn; Day, Rusty D.; Harms, Craig A.; Lee, A. Michelle; Peden-Adams, Margie M.; Thorvalson, Kelly; Segars, Al L.; Norton, Terry M.			Chronic debilitation in stranded loggerhead sea turtles (Caretta caretta) in the southeastern United States: Morphometrics and clinicopathological findings	PLOS ONE			English	Article							PLASMA BIOCHEMISTRY; HEALTH PARAMETERS; NORTH-CAROLINA; BLOOD; IMMUNITY; PROTEIN; ELECTROPHORESIS; PROLIFERATION; CHEMOTHERAPY; HEMATOLOGY	Chronically debilitated loggerhead sea turtles (Caretta caretta) (DT) are characterized by emaciation, lethargy, and heavy barnacle coverage. Although histopathological findings associated with this condition have been reported, only limited data is available on health variables with clinical application. The objectives of this study were to 1) to compare morphometrics, clinicopathological variables, and immune functions of DTs to a group of apparently healthy loggerhead turtles to better understand the pathophysiology of the condition and 2) to assess health parameters in live debilitated turtles as they recovered during rehabilitation in order to identify potential prognostic indicators. We examined and sampled 43 DTs stranded from North Carolina to Florida for 47 health variables using standardized protocols to further characterize the condition. DTs were grouped into categories of severity of the condition, and those that survived were sampled at four time points through rehabilitation. All groups and time points were compared among DTs and to clinically healthy loggerhead turtles. Compared to healthy turtles, DTs had significantly lower body condition index, packed cell volume (PCV), total white blood cell (WBC) count, lymphocytes, glucose (Glc), total protein, all protein fractions as determined by electrophoresis, calcium (Ca), phosphorus (P), Ca:P ratio, potassium (K), lymphocyte proliferation, and greater heterophil toxicity and left-shifting, uric acid (UA), aspartate aminotransferase, creatine kinase, lysozyme, and respiratory burst. From admission to recovery, hematology and plasma chemistry data improved as expected. The most informative prognostic indicators, as determined by correlations with a novel severity indicator (based on survival times), were plastron concavity, P, albumin, total solids, UA, lymphocyte proliferation, WBC, K, Glc, Ca:P, and PCV. The results of this study document the wide range and extent of morphometric and metabolic derangements in chronically debilitated turtles. Monitoring morphometrics and clinicopathological variables of these animals is essential for diagnosis, treatment, and prognosis during rehabilitation.	[Stacy, Nicole I.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA; [Lynch, Jennifer M.; Day, Rusty D.] NIST, Chem Sci Div, Hollings Marine Lab, Charleston, SC USA; [Arendt, Michael D.; Segars, Al L.] South Carolina Dept Nat Resources, Charleston, SC USA; [Avens, Larisa; McNeill, Joanne Braun] NOAA, Natl Marine Fisheries Serv, Beaufort Lab, Beaufort, NC USA; [Cray, Carolyn] Univ Miami, Sch Med, Dept Pathol & Lab Med, Div Comparat Pathol, Miami, FL USA; [Harms, Craig A.] North Carolina State Univ, Ctr Marine Sci & Technol, Morehead City, NC USA; [Lee, A. Michelle; Peden-Adams, Margie M.] Med Univ South Carolina, Charleston, SC 29425 USA; [Thorvalson, Kelly] South Carolina Aquarium, Charleston, SC USA; [Norton, Terry M.] Jekyll Isl Author, Georgia Sea Turtle Ctr, Jekyll Isl, GA USA; [Norton, Terry M.] St Catherines Isl Fdn, Midway, GA USA; [Lynch, Jennifer M.] Hawaii Pacific Univ, NIST, Chem Sci Div, Kaneohe, HI USA; [Lee, A. Michelle] Trident Tech Coll, Charleston, SC USA; [Peden-Adams, Margie M.] Peden Adams & Assoc LLC, Charleston, SC USA	State University System of Florida; University of Florida; National Institute of Standards & Technology (NIST) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami; University of North Carolina; North Carolina State University; Medical University of South Carolina; National Institute of Standards & Technology (NIST) - USA	Stacy, NI (corresponding author), Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32611 USA.	stacyn@ufl.edu		Stacy, Nicole/0000-0003-4258-4414	U.S. National Oceanic and Atmospheric Administration's National Marine Fisheries Service	U.S. National Oceanic and Atmospheric Administration's National Marine Fisheries Service	Funding was provided by the U.S. National Oceanic and Atmospheric Administration's National Marine Fisheries Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almawi WY, 1999, CELL TRANSPLANT, V8, P637, DOI 10.1177/096368979900800610; Anderson ET, 2013, J ZOO WILDLIFE MED, V44, P62, DOI 10.1638/1042-7260-44.1.62; Balfry SK, 2004, COMP BIOCHEM PHYS B, V138, P207, DOI 10.1016/j.cbpc.2003.12.010; Biller-Takahashi JD, 2013, BRAZ J BIOL, V73, P425, DOI 10.1590/S1519-69842013000200026; Bjorndal KA, 2013, MAR BIOL, V160, P2711, DOI 10.1007/s00227-013-2264-y; Bradbury C, 2010, J AM ANIM HOSP ASSOC, V46, P31, DOI 10.5326/0460031; BRAUN DP, 1981, CLIN IMMUNOL IMMUNOP, V20, P193, DOI 10.1016/0090-1229(81)90178-1; Camacho M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132217; Camacho M, 2013, JAVMA-J AM VET MED A, V242, P396, DOI 10.2460/javma.242.3.396; Campbell Terry W., 1996, P248; Casal AB, 2009, VET REC, V164, P663, DOI 10.1136/vr.164.21.663; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Chang L, 1999, EUR J BIOCHEM, V259, P534, DOI 10.1046/j.1432-1327.1999.00076.x; CHEEMA AR, 1971, CANCER, V28, P851, DOI 10.1002/1097-0142(1971)28:4<851::AID-CNCR2820280408>3.0.CO;2-E; Cray C, 1998, J AVIAN MED SURG, V12, P4; Crowder LB, 1995, COPEIA, P773, DOI 10.2307/1447026; Day RD, 2007, ENVIRON HEALTH PERSP, V115, P1421, DOI 10.1289/ehp.9918; Day RD, 2010, J WILDLIFE DIS, V46, P111, DOI 10.7589/0090-3558-46.1.111; Deem SL, 2009, J WILDLIFE DIS, V45, P41, DOI 10.7589/0090-3558-45.1.41; Demas G., 2012, ECOIMMUNOLOGY; Eckersall PD, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P117; Flint M, 2009, J VET DIAGN INVEST, V21, P733, DOI 10.1177/104063870902100601; George Robert H., 1997, P363; GRIEBEL PJ, 1987, CAN J VET RES, V51, P428; Harms C, 2000, P 12 ANN S SEA TURTL, P190; Harvey J.W., 2012, VET HEMATOLOGY DIAGN, P328, DOI 10.1016/C2009-0-39565-3; Helsel D. R., 2005, NONDETECTS DATA ANAL; Heppell SS, 2003, CRC MAR BIOL SER, P275; Hsieh EA, 2005, AM J PHYSIOL-ENDOC M, V288, pE965, DOI 10.1152/ajpendo.00368.2004; Innis CJ, 2009, JAVMA-J AM VET MED A, V235, P426, DOI 10.2460/javma.235.4.426; Ito Y, 1997, FEBS LETT, V415, P285, DOI 10.1016/S0014-5793(97)01140-X; Keller JM, 2006, N P TOX ENV, P199; Keller JM, 2006, ENVIRON HEALTH PERSP, V114, P70, DOI 10.1289/ehp.8143; Keller JM, 2005, VET IMMUNOL IMMUNOP, V103, P269, DOI 10.1016/j.vetimm.2004.09.029; Keller JM, 2004, ENVIRON HEALTH PERSP, V112, P1074, DOI 10.1289/ehp.6923; Macrelli Roberto, 2013, Journal of Herpetological Medicine and Surgery, V23, P20, DOI 10.5818/1529-9651-23.1.20; Manire C, 2017, SEA TURTLE HLTH REHA, P707; McAdam AJ, 2010, ROBBINS COTRANS PATH, P346; Moeller KT, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-23; NATHAN D B, 1977, Poultry Science, V56, P1468, DOI 10.3382/ps.0561468; National Marine Fisheries Services (NMFS) United States Fish and Wildlife Service (USFWS), 2011, FED REGISTER, P58868; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Osborne AC, 2010, JAVMA-J AM VET MED A, V237, P561, DOI 10.2460/javma.237.5.561; OWENS DW, 1980, HERPETOLOGICA, V36, P17; Rousselet E, 2013, J ZOO WILDLIFE MED, V44, P859, DOI 10.1638/2012-0162R1.1; Stacy BA, 2007, INFECT DIS PATHOLOGY, P259; Stacy NI., 2017, SEA TURTLE HLTH REHA, P147; Stamper MA, 2005, J ZOO WILDLIFE MED, V36, P635, DOI 10.1638/04-074.1; Stay NI, 2011, CLIN LAB MED, V31, P87, DOI 10.1016/j.cll.2010.10.006; Stringer Elizabeth M., 2010, Journal of Herpetological Medicine and Surgery, V20, P122, DOI 10.5818/1529-9651-20.4.122; Vera-Jimenez NI, 2013, FISH SHELLFISH IMMUN, V34, P1216, DOI 10.1016/j.fsi.2013.02.004; Weiss D J, 1984, Vet Clin Pathol, V13, P27, DOI 10.1111/j.1939-165X.1984.tb00836.x; Zimmerman LM, 2010, J EXP BIOL, V213, P661, DOI 10.1242/jeb.038315	54	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200355	10.1371/journal.pone.0200355	http://dx.doi.org/10.1371/journal.pone.0200355			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990325	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300038
J	Lee, KY; Graham, L; Spooner, DE; Xenopoulos, MA				Lee, Kern Y.; Graham, Lisa; Spooner, Daniel E.; Xenopoulos, Marguerite A.			Tracing anthropogenic inputs in stream foods webs with stable carbon and nitrogen isotope systematics along an agricultural gradient	PLOS ONE			English	Article							SPATIAL VARIABILITY; LAND-USE; NITRATE; FRACTIONATION; DELTA-N-15; DARTER; LEVEL; BASE; FISH	Stable carbon (C-13) and nitrogen isotopes (N-15) are useful tools in determining the presence of agricultural influences in freshwater ecosystems. Here we examined delta N-15 and delta C-13 signatures in nitrate, fish, and mussel tissues, from rivers in Southern Ontario, Canada, that vary in their catchment proportion of agriculture land use, nutrients and organic matter quality. We found comparatively N-15-enriched delta N-15 values in animal tissues and dissolved nitrates, relative to expected values characterized by natural sources. We also observed a strong, positive correlation between riparian agriculture percentages and delta N-15 values in animal tissues and nitrates, indicating a significant influence of agricultural land use and the probable dominance of organic fertilizer and manure inputs in particular. The use of a N-15-based equation for the estimation of fish trophic position confirmed dietary analyses is showing all fish species to be tertiary consumers, with a relatively consistent N-15-enrichment in animal tissues between trophic levels. This indicates that variability in N-15-trophic fractionation is minor, and that fish and mussel tissue delta N-15 values are largely representative of source nitrogen. However, the trophic fractionation value varied from accepted literature values, suggesting strong influences from either local environmental conditions or dietary variation. The delta C-13 datasets did not correlate with riparian agriculture, and animal delta C-13 signatures in their tissues are consistent with terrestrial C3 vegetation, suggesting the dominance of allochthonous DOC sources. We found that changes in water chemistry and dissolved organic matter quality brought about by agricultural inputs were clearly expressed in the delta N-15 signatures of animal tissues from all trophic levels. As such, this study confirmed the source of anthropogenic nitrogen in the studied watersheds, and demonstrated that this agriculturally-derived nitrogen could be traced with delta N-15 signatures through successive trophic levels in local aquatic food webs. The delta C-13 data was less diagnostic of local agriculture, due to the more complex interplay of carbon cycling and environmental conditions.	[Lee, Kern Y.; Xenopoulos, Marguerite A.] Trent Univ, Dept Biol, Peterborough, ON, Canada; [Graham, Lisa] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada; [Spooner, Daniel E.] US Geol Survey, Leetown Sci Ctr, Wellsboro, PA USA	Trent University; Trent University; United States Department of the Interior; United States Geological Survey	Lee, KY (corresponding author), Trent Univ, Dept Biol, Peterborough, ON, Canada.	kern.y.lee@gmail.com	Lee, Kern Young/AAC-9074-2019		Canada's Natural Sciences and Engineering Research Council (NSERC)	Canada's Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by Canada's Natural Sciences and Engineering Research Council (NSERC). The funding was received by Dr. Marguerite Xenopoulos and Kern Young Lee. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We give thanks to Andrew Scott and Dr. Jean-Francois Koprivnjak for their advice and invaluable assistance with the laboratory analyses. This study was funded by Canada's Natural Sciences and Engineering Research Council (NSERC).	Anderson C, 2005, J FISHERIES AQUATIC, V62, P333; Anderson C, 2006, SCI TOTAL ENVIRON, V367, P968, DOI 10.1016/j.scitotenv.2006.01.029; [Anonymous], CANADIAN MANUSCRIPT; Bucci JP, 2011, J FRESHWATER ECOL, V26, P19, DOI 10.1080/02705060.2011.553817; Bunt CM, 1998, ENVIRON BIOL FISH, V51, P297, DOI 10.1023/A:1007444811400; CABANA G, 1994, NATURE, V372, P255, DOI 10.1038/372255a0; Clark I.D., 2013, ENV ISOTOPES HYDROGE; Davis J, 1986, STAT DATA ANAL GEOLO; Diebel MW, 2009, ECOL APPL, V19, P1127, DOI 10.1890/08-0327.1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Granger J, 2008, LIMNOL OCEANOGR, V53, P2533, DOI 10.4319/lo.2008.53.6.2533; Gustafson L, 2007, OECOLOGIA, V152, P140, DOI 10.1007/s00442-006-0633-7; Harrington RR, 1998, CHEM GEOL, V147, P281, DOI 10.1016/S0009-2541(98)00018-7; HESSLEIN RH, 1991, CAN J FISH AQUAT SCI, V48, P2258, DOI 10.1139/f91-265; Kendall C, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P519; KLING GW, 1992, ECOLOGY, V73, P561, DOI 10.2307/1940762; Kulasekera K., 2011, SO ONTARIO REGION GL; Layman CA, 1999, ECOLOGY, V80, P1395; MARIOTTI A, 1982, PLANT PHYSIOL, V69, P880, DOI 10.1104/pp.69.4.880; Mayer B, 2002, BIOGEOCHEMISTRY, V57, P171, DOI 10.1023/A:1015744002496; McFeeters BJ, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00112.1; McKinney RA, 1999, HYDROBIOLOGIA, V412, P17, DOI 10.1023/A:1003887913402; MEGLEN RR, 1992, MAR CHEM, V39, P217, DOI 10.1016/0304-4203(92)90103-H; Muholland P, 2004, LINX 2 STREAM 15N EX; (OMNR) OMoNR, 2010, WAT RES INF PROJ STR; Pastor A, 2014, ENVIRON SCI TECHNOL, V48, P6612, DOI 10.1021/es405493k; Peipoch M, 2014, AQUAT SCI, V76, P203, DOI 10.1007/s00027-013-0330-7; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; ROSENFELD JS, 1992, J N AM BENTHOL SOC, V11, P1, DOI 10.2307/1467877; Smith VH, 2009, TRENDS ECOL EVOL, V24, P201, DOI 10.1016/j.tree.2008.11.009; Spooner DE, 2013, ECOL LETT, V16, P1115, DOI 10.1111/ele.12146; STRANGE RM, 1991, J FRESHWATER ECOL, V6, P377, DOI 10.1080/02705060.1991.9665317; Vaughn CC, 2008, J N AM BENTHOL SOC, V27, P409, DOI 10.1899/07-058.1; Williams CJ, 2016, GLOBAL CHANGE BIOL, V22, P613, DOI 10.1111/gcb.13094; Williams CJ, 2012, AQUAT SCI, V74, P483, DOI 10.1007/s00027-011-0242-3; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; Zanden M. Jake Vander, 1999, Ecology (Washington D C), V80, P1395, DOI 10.1890/0012-9658(1999)080[1395:PCCANA]2.0.CO;2	38	10	10	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200312	10.1371/journal.pone.0200312	http://dx.doi.org/10.1371/journal.pone.0200312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979760	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500096
J	Segura-Wang, M; Gorzer, I; Jaksch, P; Puchhammer-Stockl, E				Segura-Wang, Maia; Goerzer, Irene; Jaksch, Peter; Puchhammer-Stoeckl, Elisabeth			Temporal dynamics of the lung and plasma viromes in lung transplant recipients	PLOS ONE			English	Article							TORQUE TENO VIRUS; HUMAN MICROBIOME; READ ALIGNMENT; CYTOMEGALOVIRUS; IMMUNOSUPPRESSION; GENOTYPES; LOAD	The human virome plays an important role for the clinical outcome of lung transplant recipients (LTRs). While pathogenic viruses may cause severe infections, non-pathogenic viruses may serve as potential markers for the level of immunosuppression. However, neither the complexity of the virome in different compartments nor the dynamics of the virus populations posttransplantation are yet understood. Therefore, in this study the virome was analyzed by metagenomic sequencing in simultaneously withdrawn bronchoalveolar lavage (BAL) and plasma samples of 15 LTRs. In seven patients, also follow-up samples were investigated for abundance and dynamics of virus populations posttransplantation. Five eukaryotic and two prokaryotic virus families were identified in BAL, and nine eukaryotic and two prokaryotic families in plasma. Anelloviruses were the most abundant in both compartments, followed by Herpes-and Coronaviruses. Virus abundance was significantly higher in LTRs than in healthy controls (Kruskal-Wallis test, p<0.001). Up to 48 different anellovirus strains were identified within a single LTR. Analyses in the follow-up patients revealed for the first time a highly complex and unique dynamics of individual anellovirus strains in the posttransplantation period. The abundance of anelloviruses in plasma was inversely correlated with that of other eukaryotic viruses (Pearson correlation coefficient r = -0.605; p<0.05). A broad spectrum of virus strains co-exists in BAL and plasma of LTRs. Especially for the anelloviruses, a high degree of co-infections and a highly individual and complex dynamics after transplantation was observed. The biological impact of these findings and their relation to clinical variables remain to be elucidated by future analyses.	[Segura-Wang, Maia; Goerzer, Irene; Puchhammer-Stoeckl, Elisabeth] Med Univ Vienna, Ctr Virol, Vienna, Austria; [Jaksch, Peter] Med Univ Vienna, Div Thorac Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Puchhammer-Stockl, E (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.	elisabeth.puchhammer@meduniwien.ac.at		jaksch, peter/0000-0003-4635-3242; Segura-Wang, Maia/0000-0003-2424-618X				Abbas AA, 2016, AM J TRANSPLANT, P1; Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423; Blatter JA, 2018, PEDIATR TRANSPLANT, V22, P1; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Fishman JA, 2013, AM J TRANSPLANT, V13, P1, DOI 10.1111/ajt.12002; Focosi D, 2014, J INFECT DIS, V210, P667, DOI 10.1093/infdis/jiu209; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Gerber GK, 2014, FEBS LETT, V588, P4131, DOI 10.1016/j.febslet.2014.02.037; Gorzer I, 2008, J MED VIROL, V80, P1405, DOI 10.1002/jmv.21225; Gorzer I, 2017, J HEART LUNG TRANSPL, V36, P366, DOI 10.1016/j.healun.2016.10.011; Gorzer I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122975; Gorzer I, 2014, J HEART LUNG TRANSPL, V33, P320, DOI 10.1016/j.healun.2013.12.007; Gorzer I, 2010, J VIROL, V84, P7195, DOI 10.1128/JVI.00475-10; Hirsch HH, 2013, AM J TRANSPLANT, V13, P179, DOI 10.1111/ajt.12110; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Lewandowska DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0317-z; Lewandowska DW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177340; Lewandowska DW, 2015, DIAGN MICR INFEC DIS, V83, P133, DOI 10.1016/j.diagmicrobio.2015.06.017; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Maggi F, 2005, J CLIN MICROBIOL, V43, P4807, DOI 10.1128/JCM.43.9.4807-4810.2005; Maggi F, 2009, CURR TOP MICROBIOL, V331, P65; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Nishizawa Y, 2000, J GASTROEN HEPATOL, V15, P1292, DOI 10.1046/j.1440-1746.2000.02342.x; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pflughoeft KJ, 2012, ANNU REV PATHOL-MECH, V7, P99, DOI 10.1146/annurev-pathol-011811-132421; Pinho-Nascimento CA, 2011, J MED VIROL, V83, P1107, DOI 10.1002/jmv.22024; R Core Team, 2015, R FDN STAT COMP; Razonable RR, 2013, AM J TRANSPLANT, V13, P93, DOI 10.1111/ajt.12103; Snyder LD, 2016, AM J RESP CRIT CARE, V193, P78, DOI 10.1164/rccm.201504-0733OC; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Vu DL, 2011, AM J TRANSPLANT, V11, P1071, DOI 10.1111/j.1600-6143.2011.03490.x; Young JC, 2015, AM J TRANSPLANT, V15, P200, DOI 10.1111/ajt.13031	40	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200428	10.1371/journal.pone.0200428	http://dx.doi.org/10.1371/journal.pone.0200428			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979780	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500109
J	Kuefner, MS; Deng, X; Stephenson, EJ; Pham, K; Park, EA				Kuefner, Michael S.; Deng, Xiong; Stephenson, Erin J.; Pham, Kevin; Park, Edwards A.			Secretory phospholipase A(2) group IIA enhances the metabolic rate and increases glucose utilization in response to thyroid hormone	FASEB JOURNAL			English	Article						PLA2G2A; brown adipose tissue; UCP1	BROWN ADIPOSE-TISSUE; MESSENGER-RNA; UNCOUPLING PROTEIN-2; GENE-TRANSCRIPTION; ENERGY-BALANCE; FAT; EXPRESSION; OBESITY; MECHANISMS; ENZYMES	Secretory phospholipase A(2) group IIA (PLA2G2A) is a phospholipase which has a role in inflammation, atherogenesis, and host defense. Previously, we found that PLA2G2A protects mice on high-fat diets from weight gain and insulin resistance. Here, we examined the regulation of PLA2G2A and the metabolic changes that occur in response to variations in thyroid status. In particular, the impact of PLA2G2A on the brown adipose tissue (BAT) thermogenic gene expression was explored. We induced hypothyroidism in C57BL/6 and PLA2G2A-overexpressing (IIA+) mice over a 10 wk period or treated them with thyroid hormone (T-3) for 5 wk. There were no significant changes in PLA2G2A abundance in response to thyroid status. The energy expenditure of hypothyroid IIA+ mice did not increase; however, the energy expenditure, substrate utilization, insulin sensitivity, and glucose tolerance were all elevated in the IIA+ mice given T-3. Moreover, white adipocytes from IIA+ mice were much more prone to beiging, including increased expression of brown adipose thermogenic markers such as uncoupling protein 1 (UCP1), PR domain containing 16, and early B cell factor 2. Finally, the BAT of IIA+ mice had increased UCP1 and other proteins indicative of mitochondrial uncoupling and nonshivering adaptive thermogenesis. These data reveal a novel role for PLA2G2A on adipose tissue thermogenesis depending on thyroid status.Kuefner, M. S., Deng, X., Stephenson, E. J., Pham, K., Park, E. A. Secretory phospholipase A(2) group IIA enhances the metabolic rate and increases glucose utilization in response to thyroid hormone.	[Kuefner, Michael S.; Deng, Xiong; Pham, Kevin; Park, Edwards A.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Coll Med, Memphis, TN USA; [Stephenson, Erin J.] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Pediat, Memphis, TN USA; [Kuefner, Michael S.; Deng, Xiong; Pham, Kevin; Park, Edwards A.] Dept Vet Affairs Med Ctr, Memphis, TN USA; [Stephenson, Erin J.] LeBonheur Childrens Hosp, Childrens Fdn Res Inst, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Park, EA (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Dept Vet Affairs Med Ctr, 71 S Manassas, Memphis, TN 38163 USA.	epark@uthsc.edu	Stephenson, Erin J/AHD-5759-2022	Stephenson, Erin J/0000-0001-5812-408X	U.S. Veterans Administration [1I01BX002408]; University of Tennessee Health Science Center; LeBonheur Children's Hospital; Children's Foundation Research Institute; LeBonheur Associate Board via Junior Investigator Grant [651602]; Veterans Affairs [I01BX002408] Funding Source: NIH RePORTER	U.S. Veterans Administration(US Department of Veterans Affairs); University of Tennessee Health Science Center; LeBonheur Children's Hospital; Children's Foundation Research Institute; LeBonheur Associate Board via Junior Investigator Grant; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the U.S. Veterans Administration 1I01BX002408 (to E.A.P.). M.S.K. was supported in part by the Frank Dugan Scholarship from the University of Tennessee Health Science Center. E.J.S. receives support from LeBonheur Children's Hospital, the Children's Foundation Research Institute, and the LeBonheur Associate Board via Junior Investigator Grant #651602. The authors declare no conflicts of interest.	AARSMAN AJ, 1989, J BIOL CHEM, V264, P10008; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Brent GA, 2012, WILLIAMS TXB ENDOCRI, P406; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chakraborty D, 2015, INDIAN J NUCL MED, V30, P320, DOI 10.4103/0972-3919.164147; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Coe NR, 1999, J BIOL CHEM, V274, P36300, DOI 10.1074/jbc.274.51.36300; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Harms MJ, 2014, CELL METAB, V19, P593, DOI 10.1016/j.cmet.2014.03.007; Hones S. G., 2014, END SOC 96 ANN M  EX; Hope PJ, 1997, AM J PHYSIOL-REG I, V273, pR161, DOI 10.1152/ajpregu.1997.273.1.R161; HORIGOME K, 1987, J BIOCHEM-TOKYO, V101, P53, DOI 10.1093/oxfordjournals.jbchem.a121907; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kuefner MS, 2017, J LIPID RES, V58, P1822, DOI 10.1194/jlr.M076141; Lahesmaa M, 2014, J CLIN ENDOCR METAB, V99, pE28, DOI 10.1210/jc.2013-2312; Lanni A, 1997, FEBS LETT, V418, P171, DOI 10.1016/S0014-5793(97)01375-6; Lopez M, 2013, TRENDS MOL MED, V19, P418, DOI 10.1016/j.molmed.2013.04.004; Martinez-Sanchez N, 2017, J ENDOCRINOL, V232, P351, DOI 10.1530/JOE-16-0425; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Masuda S, 2005, BBA-MOL CELL BIOL L, V1736, P200, DOI 10.1016/j.bbalip.2005.08.014; McAninch EA, 2014, ANN NY ACAD SCI, V1311, P77, DOI 10.1111/nyas.12374; Menschikowski M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-576; MIZUSHIMA H, 1989, J BIOCHEM-TOKYO, V105, P520, DOI 10.1093/oxfordjournals.jbchem.a122699; Mullur R, 2014, PHYSIOL REV, V94, P355, DOI 10.1152/physrev.00030.2013; Murakami M, 2015, J LIPID RES, V56, P1248, DOI 10.1194/jlr.R058123; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; Oetting A, 2007, BEST PRACT RES CL EN, V21, P193, DOI 10.1016/j.beem.2007.04.004; Okita Y, 2016, INFECT IMMUN, V84, P573, DOI 10.1128/IAI.01000-15; PERONNET F, 1991, CAN J SPORT SCI, V16, P23; PRUZANSKI W, 1988, J RHEUMATOL, V15, P1601; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; REED BC, 1980, P NATL ACAD SCI-BIOL, V77, P285, DOI 10.1073/pnas.77.1.285; SAKATA T, 1989, BIOCHIM BIOPHYS ACTA, V1007, P124, DOI 10.1016/0167-4781(89)90141-3; Sato H, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0012-7; Sato H, 2014, CELL METAB, V20, P119, DOI 10.1016/j.cmet.2014.05.002; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sharma P, 2014, BIOCHEM BIOPH RES CO, V444, P56, DOI 10.1016/j.bbrc.2014.01.003; Sharma P, 2013, J BIOL CHEM, V288, P16321, DOI 10.1074/jbc.M112.445569; Shimizu Y, 2002, J VET MED SCI, V64, P677, DOI 10.1292/jvms.64.677; Shore AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068933; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Stine RR, 2016, MOL METAB, V5, P57, DOI 10.1016/j.molmet.2015.11.001; Suzuki N, 2000, J BIOL CHEM, V275, P5785, DOI 10.1074/jbc.275.8.5785; Thyagarajan B, 2017, HORM MOL BIOL CLIN I, V31, DOI 10.1515/hmbci-2017-0016; Valentin E, 1999, J BIOL CHEM, V274, P31195, DOI 10.1074/jbc.274.44.31195; van der Lans AAJJ, 2013, J CLIN INVEST, V123, P3395, DOI 10.1172/JCI68993; Wang WS, 2016, NAT REV MOL CELL BIO, V17, P691, DOI 10.1038/nrm.2016.96; Warner A, 2012, J MOL ENDOCRINOL, V49, pR29, DOI 10.1530/JME-12-0068; Weiner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38124; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; Zhi H, 2015, OBESITY, V23, P760, DOI 10.1002/oby.21015	65	9	8	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					738	749		10.1096/fj.201800711R	http://dx.doi.org/10.1096/fj.201800711R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020829				2022-12-26	WOS:000457401500057
J	Yosef, G; Arkadash, V; Papo, N				Yosef, Gal; Arkadash, Valeria; Papo, Niv			Targeting the MMP-14/MMP-2/integrin alpha(v)beta(3) axis with multispecific N-TIMP2 based antagonists for cancer therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; BREAST-CARCINOMA CELLS; YEAST SURFACE DISPLAY; FOCAL ADHESION KINASE; TISSUE INHIBITOR; TUMOR ANGIOGENESIS; IN-VITRO; INTEGRIN ALPHA-V-BETA-3; DIRECTED EVOLUTION; ENDOTHELIAL-CELLS	The pathophysiological functions of the signaling molecules matrix metalloproteinase-14 (MMP-14) and integrin alpha(v)beta(3) in various types of cancer are believed to derive from their collaborative activity in promoting invasion, metastasis, and angiogenesis, as shown in vitro and in vivo. The two effectors act in concert in a cell-specific manner through the localization of pro-MMP-2 to the cell surface, where it is processed to intermediate and matured MMP-2. The matured MMP-2 product is localized to the cell surface via its binding to integrin alpha(v)beta(3). The MMP-14/MMP-2/integrin alpha(v)beta(3) axis thus constitutes an attractive putative target for therapeutic interventions, but the development of inhibitors that target this axis remains an unfulfilled task. To address the lack of such multitarget inhibitors, we have established a combinatorial approach that is based on flow cytometry screening of a yeast-displayed N-TIMP2 (N-terminal domain variant of tissue inhibitor of metalloRroteinase-2) mutant library. On the basis of this screening, we generated protein monomers and a heterodimer that contain monovalent and bivalent binding epitopes to MMP-14 and integrin alpha(v)beta(3). Among these proteins, the bi-specific heterodimer, which bound strongly to both MMP-14 and integrin alpha(v)beta(3), exhibited superior ability to inhibit MMP-2 activation and displayed the highest inhibitory activity in cell-based models of a MMP-14-, MMP-2-, and integrin alpha(v)beta(3)-dependent glioblastoma and of endothelial cell invasiveness and endothelial capillary tube formation. These assays enabled us to show the superiority of the combined target effects of the inhibitors and to investigate separately the role each of the three signaling molecules in various malignant processes.	[Papo, Niv] Ben Gurion Univ Negev, Dept Biotechnol Engn, Beer Sheva, Israel; Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Papo, N (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, Beer Sheva, Israel.	papo@bgu.ac.il			European Research Council [336041]; Israel Science Foundation [615/14]	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	This work was supported by European Research Council "Ideas Program" ERC-2013-StG, Contract Grant 336041, and Israel Science Foundation Grant 615/14 (to N.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Lazikani B, 2012, NAT BIOTECHNOL, V30, P679, DOI 10.1038/nbt.2284; ALBELDA SM, 1990, CANCER RES, V50, P6757; Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Anderson GP, 2013, ANAL CHIM ACTA, V786, P132, DOI 10.1016/j.aca.2013.05.010; Arkadash V, 2017, J BIOL CHEM, V292, P3481, DOI 10.1074/jbc.M116.756718; AZZAM HS, 1993, J NATL CANCER I, V85, P1758, DOI 10.1093/jnci/85.21.1758; Babae N, 2014, ONCOTARGET, V5, P6687, DOI 10.18632/oncotarget.2235; Baciu PC, 2003, EXP CELL RES, V291, P167, DOI 10.1016/S0014-4827(03)00387-2; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brooks PC, 1998, CELL, V92, P391, DOI 10.1016/S0092-8674(00)80931-9; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Butler GS, 1998, J BIOL CHEM, V273, P871, DOI 10.1074/jbc.273.2.871; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Deryugina EI, 2004, TRAFFIC, V5, P627, DOI 10.1111/j.1600-0854.2004.00206.x; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Elliot S, 2006, INVEST OPHTH VIS SCI, V47, P1696, DOI 10.1167/iovs.05-1258; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Frankowski H, 2012, METHODS MOL BIOL, V814, P221, DOI 10.1007/978-1-61779-452-0_15; Galvez BG, 2002, J CELL BIOL, V159, P509, DOI 10.1083/jcb.200205026; Genis L, 2006, CANCER METAST REV, V25, P77, DOI 10.1007/s10555-006-7891-z; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Gridelli C, 2016, CLIN LUNG CANCER, V17, P461, DOI 10.1016/j.cllc.2016.04.001; Hernandez-Barrantes S, 2000, J BIOL CHEM, V275, P12080, DOI 10.1074/jbc.275.16.12080; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Hofmann UB, 2000, J PATHOL, V191, P245; Hofmann UB, 2000, INT J CANCER, V87, P12, DOI 10.1002/1097-0215(20000701)87:1<12::AID-IJC3>3.0.CO;2-A; Husain SR, 2001, INT J CANCER, V92, P168, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1182>3.0.CO;2-N; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Itoh Y, 2004, TRENDS BIOCHEM SCI, V29, P285, DOI 10.1016/j.tibs.2004.04.001; Johanns M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04648-y; Kikuchi R, 2000, BRIT J CANCER, V83, P215; Kumar CC, 2001, CANCER RES, V61, P2232; Kummar S, 2010, NAT REV DRUG DISCOV, V9, P843, DOI 10.1038/nrd3216; Lafleur MA, 2001, BIOCHEM J, V357, P107, DOI 10.1042/0264-6021:3570107; Li RH, 2003, PROTEIN ENG, V16, P65, DOI 10.1093/proeng/gzg002; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Lopez-Otin C, 2009, CELL CYCLE, V8, P3657, DOI 10.4161/cc.8.22.9956; Lu KV, 2004, LAB INVEST, V84, P8, DOI 10.1038/labinvest.3700003; May C, 2012, BIOCHEM PHARMACOL, V84, P1105, DOI 10.1016/j.bcp.2012.07.011; McDonagh CF, 2012, MOL CANCER THER, V11, P582, DOI 10.1158/1535-7163.MCT-11-0820; Miles D, 2002, ONCOLOGIST, V7, P13; Mizejewski GJ, 1999, P SOC EXP BIOL MED, V222, P124, DOI 10.1046/j.1525-1373.1999.d01-122.x; Morgunova E, 2002, P NATL ACAD SCI USA, V99, P7414, DOI 10.1073/pnas.102185399; Nakamura H, 1999, CANCER RES, V59, P467; NOMURA H, 1995, CANCER RES, V55, P3263; Nuti E, 2007, CURR PHARM DESIGN, V13, P2087; Ogata H, 2014, ACTA CRYSTALLOGR F, V70, P232, DOI 10.1107/S2053230X13034857; Papo N, 2011, P NATL ACAD SCI USA, V108, P14067, DOI 10.1073/pnas.1016635108; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Sato H, 2010, CANCER SCI, V101, P843, DOI 10.1111/j.1349-7006.2010.01498.x; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sharabi O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093712; Shen QA, 2010, MOL CANCER RES, V8, P939, DOI 10.1158/1541-7786.MCR-09-0523; Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298; Srichai M., 2010, INTEGRIN STRUCTURE F; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Stetler-Stevenson WG, 1999, J CLIN INVEST, V103, P1237, DOI 10.1172/JCI6870; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Tamura M, 1999, CANCER RES, V59, P442; Toth M, 2001, Methods Mol Med, V57, P163, DOI 10.1385/1-59259-136-1:163; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wingfield PT, 1999, J BIOL CHEM, V274, P21362, DOI 10.1074/jbc.274.30.21362; Yap TA, 2013, J CLIN ONCOL, V31, P1592, DOI 10.1200/JCO.2011.37.6418; Zhang WY, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-52	78	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13310	13326		10.1074/jbc.RA118.004406	http://dx.doi.org/10.1074/jbc.RA118.004406			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29986882	hybrid, Green Published			2022-12-26	WOS:000442730200028
J	Hagens, SV; Rendall, AR; Whisson, DA				Hagens, Stiele V.; Rendall, Anthony R.; Whisson, Desley A.			Passive acoustic surveys for predicting species' distributions: Optimising detection probability	PLOS ONE			English	Article							PHASCOLARCTOS-CINEREUS GOLDFUSS; KOALA; POPULATION; ABUNDANCE; CAPTIVITY; BEHAVIOR; BELLOWS	Surveying terrestrial species across diverse habitats is important for predicting species' distributions and implementing conservation actions. For vocalising species, passive acoustic monitoring (PAM) is increasing in popularity; however, survey design rarely considers the factors influencing the timing and occurrence of vocalisations and in turn, how they may influence detectability of the species. Here, we use the koala (Phascolarctos cinereus) as a case study to show how PAM can be used to first examine the factors influencing vocalisations, and then use occupancy modelling to make recommendations on survey design for the species. We used automated recording units to monitor koala vocalisations at ten sites between August 2016 and January 2017. The timing of male koala vocalisations was linked to time of sunset with vocalisations increasing two hours prior to sunset and peaking at four hours after sunset. Vocalisations had a seasonal trend, increasing from the early to middle stage of the breeding season. Koala population density and stage of the breeding season had more influence on detection probability than daily sampling schedule. Where population density was low, and during the early stage of the breeding season, 7 survey nights (recording for 6 hours from 20:00h to 02:00h; i.e. the period of peak bellowing activity) were required to be 95% confident of a site-specific absence. Our study provides an approach for designing effective passive acoustic surveys for terrestrial species.	[Hagens, Stiele V.; Rendall, Anthony R.; Whisson, Desley A.] Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic, Australia	Deakin University	Whisson, DA (corresponding author), Deakin Univ, Ctr Integrat Ecol, Sch Life & Environm Sci, Geelong, Vic, Australia.	dwhisson@deakin.edu.au	Whisson, Desley A/H-9578-2013; Whisson, Desley/V-9422-2019	Whisson, Desley A/0000-0002-4221-0706; Whisson, Desley/0000-0002-4221-0706; Rendall, Anthony/0000-0002-7286-9288				Barker RJ, 2014, J WILDLIFE MANAGE, V78, P701, DOI 10.1002/jwmg.694; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Campos-Cerqueira M, 2016, METHODS ECOL EVOL, V7, P1340, DOI 10.1111/2041-210X.12599; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Charlton BD, 2017, ETHOLOGY, V123, P571, DOI 10.1111/eth.12628; Charlton BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138670; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045420; Darras K, 2016, BIOL CONSERV, V201, P29, DOI 10.1016/j.biocon.2016.06.021; Department of the Environment, 2009, NAT KOAL CONS MAN ST; Digby A, 2013, METHODS ECOL EVOL, V4, P675, DOI 10.1111/2041-210X.12060; Dique DS, 2003, WILDLIFE RES, V30, P127, DOI 10.1071/WR02042; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130657; Ellis W, 2010, J MAMMAL, V91, P177, DOI 10.1644/08-MAMM-A-358R.1; Field SA, 2005, J WILDLIFE MANAGE, V69, P473, DOI 10.2193/0022-541X(2005)069[0473:OAOMEU]2.0.CO;2; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Gil D, 2002, TRENDS ECOL EVOL, V17, P133, DOI 10.1016/S0169-5347(02)02410-2; Gillooly JF, 2010, P ROY SOC B-BIOL SCI, V277, P1325, DOI 10.1098/rspb.2009.2134; Heinicke S, 2015, METHODS ECOL EVOL, V6, P753, DOI 10.1111/2041-210X.12384; Johnston SD, 2000, J REPROD FERTIL, V120, P49, DOI 10.1530/reprod/120.1.49; Kuhl HS, 2013, TRENDS ECOL EVOL, V28, P432, DOI 10.1016/j.tree.2013.02.013; Law B, 2017, ECOL EVOL, V7, P7475, DOI 10.1002/ece3.3300; Lindenmayer DB, 2012, AUSTRAL ECOL, V37, P285, DOI 10.1111/j.1442-9993.2011.02314.x; Llusia D, 2011, BIOACOUSTICS, V20, P277, DOI 10.1080/09524622.2011.9753651; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Marques TA, 2013, BIOL REV, V88, P287, DOI 10.1111/brv.12001; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McLean N, 2006, AUST J ZOOL, V54, P385, DOI 10.1071/ZO06015; Mennill DJ, 2012, METHODS ECOL EVOL, V3, P704, DOI 10.1111/j.2041-210X.2012.00209.x; Mitchell P., 1990, P151; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Phillips Stephen, 2011, Australian Zoologist, V35, P774; R Core Team, 2016, R FDN STAT COMP; Ryan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080366; SMITH M, 1980, AUST WILDLIFE RES, V7, P41; SMITH M, 1980, AUST WILDLIFE RES, V7, P13; Whisson DA, 2010, J MAMMAL, V91, P1160, DOI 10.1644/09-MAMM-A-384.1; Wimmer J, 2013, FUTURE GENER COMP SY, V29, P560, DOI 10.1016/j.future.2012.03.004; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zwart MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102770	42	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199396	10.1371/journal.pone.0199396	http://dx.doi.org/10.1371/journal.pone.0199396			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020938	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400012
J	Ogunniyi, AD; Kopecki, Z; Hickey, EE; Khazandi, M; Peel, E; Belov, K; Boileau, A; Garg, S; Venter, H; Chan, WY; Hill, PB; Page, SW; Cowin, AJ; Trott, DJ				Ogunniyi, Abiodun D.; Kopecki, Zlatko; Hickey, Elizabeth E.; Khazandi, Manouchehr; Peel, Emma; Belov, Katherine; Boileau, Alexandra; Garg, Sanjay; Venter, Henrietta; Chan, Wei Yee; Hill, Peter B.; Page, Stephen W.; Cowin, Allison J.; Trott, Darren J.			Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; STREPTOCOCCUS-PNEUMONIAE; MOUSE MODEL; METHICILLIN-RESISTANT; BIOFILM INFECTION; MICE; COLONIZATION; DAPTOMYCIN; BODY; CARE	There are very few articles in the literature describing continuous models of bacterial infections that mimic disease pathogenesis in humans and animals without using separate cohorts of animals at each stage of disease. In this work, we developed bioluminescent mouse models of partial-thickness scald wound infection and sepsis that mimic disease pathogenesis in humans and animals using a recombinant luciferase-expressing Staphylococcus aureus strain (Xen29). Two days post-scald wound infection, mice were treated twice daily with a 2% topical mupirocin ointment for 7 days. For sepsis experiments, mice were treated intraperitoneally with 6 mg/kg daptomycin 2 h and 6 h post-infection and time to moribund monitored for 72 h. Consistent bacterial burden data were obtained from individual mice by regular photon intensity quantification on a Xenogen IVIS Lumina XRMS Series III biophotonic imaging system, with concomitant significant reduction in photon intensities in drug-treated mice. Post-mortem histopathological examination of wounds and bacterial counts in blood correlated closely with disease severity and total flux obtained from Xen29. The bioluminescent murine models provide a refinement to existing techniques of multiple bacterial enumeration during disease pathogenesis and promote animal usage reduction. The models also provide an efficient and information-rich platform for preclinical efficacy evaluation of new drug classes for treating acute and chronic human and animal bacterial infections.	[Ogunniyi, Abiodun D.; Hickey, Elizabeth E.; Khazandi, Manouchehr; Boileau, Alexandra; Chan, Wei Yee; Hill, Peter B.; Trott, Darren J.] Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Roseworthy, SA, Australia; [Kopecki, Zlatko; Cowin, Allison J.] Univ South Australia, Future Ind Inst, Mawson Lakes, SA, Australia; [Peel, Emma; Belov, Katherine] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Garg, Sanjay; Venter, Henrietta] Univ South Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA, Australia; [Page, Stephen W.] Luoda Pharma, Caringbah, NSW, Australia; [Page, Stephen W.] Neoculi Pty Ltd, Burwood, Vic, Australia	University of Adelaide; University of South Australia; University of Sydney; University of South Australia	Ogunniyi, AD (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Australian Ctr Antimicrobial Resistance Ecol, Roseworthy, SA, Australia.	david.ogunniyi@adelaide.edu.au	Khazandi, Manouchehr/ABC-5930-2020; Kopecki, Zlatko/F-3672-2013; Venter, Rietie/E-4795-2013; Page, Stephen/AAX-2920-2021; Cowin, Allison/AAM-3105-2020; Garg, Sanjay/B-2516-2012; Cowin, Allison/F-4281-2013	Kopecki, Zlatko/0000-0002-8072-4222; Venter, Rietie/0000-0001-5569-7755; Page, Stephen/0000-0001-5312-2149; Cowin, Allison/0000-0003-2885-2080; Garg, Sanjay/0000-0001-7253-2629; Cowin, Allison/0000-0003-2885-2080; Peel, Emma/0000-0002-2335-8983; Hickey, Elizabeth/0000-0002-4862-503X; Chan, Wei Yee/0000-0002-9415-9893; Ogunniyi, Abiodun/0000-0001-9308-5629; Belov, Katherine/0000-0002-9762-5554	Australian Research Council (ARC) [LP130100736]; Luoda Pharma; ARC Linkage grant [LP110200770]; Neoculi Pty Ltd	Australian Research Council (ARC)(Australian Research Council); Luoda Pharma(Dexcel Pharma); ARC Linkage grant(Australian Research Council); Neoculi Pty Ltd	This study was funded by Australian Research Council (ARC; arc.gov.au) Linkage Project LP130100736 to SWP and DJT, with Luoda Pharma as the Partner Organization, and by an ARC Linkage grant (LP110200770) to SWP and DJT, with Neoculi Pty Ltd as the Partner Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Partner Organizations (Luoda Pharma and Neoculi Pty Ltd) provided support in the form of salary for SWP but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of SWP are articulated in the 'author contributions' section.	Adams DH, 2009, BRIT J DERMATOL, V161, P326, DOI 10.1111/j.1365-2133.2009.09296.x; Bjorn C, 2015, INT J ANTIMICROB AG, V45, P519, DOI 10.1016/j.ijantimicag.2014.12.015; Campbell-Valois FX, 2014, FEBS LETT, V588, P2428, DOI 10.1016/j.febslet.2014.05.022; European Centre for Disease Prevention and Control, 2015, ANN REPORT EUROPEAN, DOI [10.2900/23549, DOI 10.2900/23549]; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Fritz SA, 2013, ANTIMICROB AGENTS CH, V57, P559, DOI 10.1128/AAC.01633-12; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; Fritz SA, 2009, J INFECTION, V59, P394, DOI 10.1016/j.jinf.2009.09.001; Groves MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146034; Hart J, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-7; Henken S, 2010, ANTIMICROB AGENTS CH, V54, P707, DOI 10.1128/AAC.00943-09; Kadurugamuwa JL, 2003, ANTIMICROB AGENTS CH, V47, P3130, DOI 10.1128/AAC.47.10.3130-3137.2003; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Knox J, 2015, EPIDEMIOL INFECT, V143, P354, DOI 10.1017/S0950268814000983; Kuklin NA, 2003, ANTIMICROB AGENTS CH, V47, P2740, DOI 10.1128/AAC.47.9.2740-2748.2003; Mortin LI, 2007, ANTIMICROB AGENTS CH, V51, P1787, DOI 10.1128/AAC.00738-06; Muenks CE, 2016, J INFECTION, V72, P698, DOI 10.1016/j.jinf.2016.03.015; Orihuela CJ, 2003, SCAND J INFECT DIS, V35, P647, DOI 10.1080/00365540310015854; Parveen A, 2001, FEMS MICROBIOL LETT, V199, P115, DOI 10.1111/j.1574-6968.2001.tb10660.x; Plaut RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059232; Pletzer D, 2017, MBIO, V8, DOI 10.1128/mBio.00140-17; Simonetti O, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00606-17, 10.1128/aac.00606-17]; Thampi N, 2015, AM J INFECT CONTROL, V43, P739, DOI 10.1016/j.ajic.2015.01.031; Turnidge JD, 2009, MED J AUSTRALIA, V191, P368, DOI 10.5694/j.1326-5377.2009.tb02841.x; World Health Organization, 2014, ANT RES GLOB REP SUR	26	21	21	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200195	10.1371/journal.pone.0200195	http://dx.doi.org/10.1371/journal.pone.0200195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011298	Green Accepted, Green Published, gold			2022-12-26	WOS:000438829800014
J	Haegelen, C; Baumgarten, C; Houvenaghel, JF; Zhao, YL; Peron, J; Drapier, S; Jannin, P; Morandi, X				Haegelen, Claire; Baumgarten, Clement; Houvenaghel, Jean-Francois; Zhao, Yulong; Peron, Julie; Drapier, Sophie; Jannin, Pierre; Morandi, Xavier			Functional atlases for analysis of motor and neuropsychological outcomes after medial globus pallidus and subthalamic stimulation	PLOS ONE			English	Article							DEEP-BRAIN-STIMULATION; ADVANCED PARKINSON-DISEASE; NUCLEUS STIMULATION; VERBAL FLUENCY; DBS; METAANALYSIS; PALLIDOTOMY; CONNECTIVITY; PERFORMANCE; ACTIVATION	Anatomical atlases have been developed to improve the targeting of basal ganglia in deep brain stimulation. However, the sole anatomy cannot predict the functional outcome of this surgery. Deep brain stimulation is often a compromise between several functional outcomes: motor, fluency and neuropsychological outcomes in particular. In this study, we have developed anatomo-clinical atlases for the targeting of subthalamic and medial globus pallidus deep brain stimulation. The activated electrode coordinates of 42 patients implanted in the subthalamic nucleus and 29 patients in the medial globus pallidus were studied. The atlas was built using the representation of the volume of tissue theoretically activated by the stimulation. The UPDRS score was used to represent the motor outcome. The Stroop test was represented as well as semantic and phonemic fluencies. For the subthalamic nucleus, best motor outcomes were obtained when the supero-lateral part of the nucleus was stimulated whereas the semantic fluency was impaired in this same region. For the medial globus pallidus, best outcomes were obtained when the postero ventral part of the nucleus was stimulated whereas the phonemic fluency was impaired in this same region. There was no significant neuropsychological impairment. We have proposed new anatomo-clinical atlases to visualize the motor and neuropsychological consequences at 6 months of subthalamic nucleus and pallidal stimulation in patients with Parkinson's disease.	[Haegelen, Claire; Morandi, Xavier] CHU Pontchaillou, Dept Neurosurg, Rennes, France; [Haegelen, Claire; Baumgarten, Clement; Zhao, Yulong; Jannin, Pierre; Morandi, Xavier] INSERM, LTSI U1099, Fac Med, Rennes, France; [Haegelen, Claire; Baumgarten, Clement; Zhao, Yulong; Jannin, Pierre; Morandi, Xavier] Univ Rennes 1, Rennes, France; [Houvenaghel, Jean-Francois; Drapier, Sophie] CHU Pontchaillou, Dept Neurol, Rennes, France; [Houvenaghel, Jean-Francois; Drapier, Sophie] Univ Rennes 1, Behav & Basal Ganglia Host Team 4712, Rennes, France; [Peron, Julie] Swiss Ctr Affect Sci, Geneva, Switzerland; [Haegelen, Claire; Drapier, Sophie; Morandi, Xavier] CHU Pontchaillou, Rue Henri Le Guilloux, Rennes, France; [Baumgarten, Clement; Houvenaghel, Jean-Francois; Zhao, Yulong; Jannin, Pierre] Fac Med, Rennes, France; [Peron, Julie] Fac Psychol & Educ Sci, Geneva, Switzerland	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes	Haegelen, C (corresponding author), CHU Pontchaillou, Dept Neurosurg, Rennes, France.; Haegelen, C (corresponding author), INSERM, LTSI U1099, Fac Med, Rennes, France.; Haegelen, C (corresponding author), Univ Rennes 1, Rennes, France.; Haegelen, C (corresponding author), CHU Pontchaillou, Rue Henri Le Guilloux, Rennes, France.	claire.haegelen@chu-rennes.fr	Jannin, Pierre/P-9958-2019; Baumgarten, Clément/ABD-4671-2020; Haegelen, Claire CH/J-5332-2016; MORANDI, Xavier/ABC-5851-2020; Jannin, Pierre/F-5538-2010; Peron, Julie Anne/C-5658-2013	Jannin, Pierre/0000-0002-7415-071X; Baumgarten, Clément/0000-0002-7959-7502; MORANDI, Xavier/0000-0002-8031-7221; Jannin, Pierre/0000-0002-7415-071X; Peron, Julie Anne/0000-0002-6579-4011; Houvenaghel, Jean-Francois/0000-0001-5424-2759				Akram H, 2017, NEUROIMAGE, V158, P332, DOI 10.1016/j.neuroimage.2017.07.012; Benabid AL, 2000, ARCH MED RES, V31, P282, DOI 10.1016/S0188-4409(00)00077-1; Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Butson CR, 2011, NEUROIMAGE, V54, P2096, DOI 10.1016/j.neuroimage.2010.10.059; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Combs HL, 2015, NEUROPSYCHOL REV, V25, P439, DOI 10.1007/s11065-015-9302-0; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; D'Albis T, 2015, INT J COMPUT ASS RAD, V10, P117, DOI 10.1007/s11548-014-1007-y; D'Haese PF, 2012, MED IMAGE ANAL, V16, P744, DOI 10.1016/j.media.2010.07.009; Dietz J, 2013, BRAIN STIMUL, V6, P248, DOI 10.1016/j.brs.2012.05.011; Drapier D, 2008, NEUROPSYCHOLOGIA, V46, P2796, DOI 10.1016/j.neuropsychologia.2008.05.006; Dujardin K, 2004, J NEUROL NEUROSUR PS, V75, P202; Fahn S., 1987, RECENT DEV PARKINSON, P153; Follett KA, 2010, NEW ENGL J MED, V362, P2077, DOI 10.1056/NEJMoa0907083; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Greenhouse I, 2011, NEUROPSYCHOLOGIA, V49, P528, DOI 10.1016/j.neuropsychologia.2010.12.030; Guo Ting, 2006, Comput Aided Surg, V11, P231, DOI 10.1080/10929080600997232; Haegelen C, 2013, INT J COMPUT ASS RAD, V8, P99, DOI 10.1007/s11548-012-0675-8; Horn A, 2017, ANN NEUROL, V82, P67, DOI 10.1002/ana.24974; Houvenaghel JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140083; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; LAITINEN LV, 1992, STEREOT FUNCT NEUROS, V58, P14, DOI 10.1159/000098965; LAITINEN LV, 1992, J NEUROSURG, V76, P53, DOI 10.3171/jns.1992.76.1.0053; Lalys F, 2013, J NEUROSCI METH, V212, P297, DOI 10.1016/j.jneumeth.2012.11.002; LANGSTON JW, 1992, MOVEMENT DISORD, V7, P2, DOI 10.1002/mds.870070103; Lombardi WJ, 2000, BRAIN, V123, P746, DOI 10.1093/brain/123.4.746; Mahlknecht P, 2017, MOVEMENT DISORD, V32, P1174, DOI 10.1002/mds.27042; Mangin JF, 2000, IEEE WORKSHOP ON MATHEMATICAL METHODS IN BIOMEDICAL IMAGE ANALYSIS, PROCEEDINGS, P162, DOI 10.1109/MMBIA.2000.852374; Massano Joao, 2012, Front Neurol, V3, P66, DOI 10.3389/fneur.2012.00066; Mattis S, 1988, DEMENTIA RATING SCAL; Mikos A, 2011, NEUROIMAGE, V54, pS238, DOI 10.1016/j.neuroimage.2010.03.068; Nowinski WL, 2007, STEREOT FUNCT NEUROS, V85, P88, DOI 10.1159/000097924; Nowinski WL, 2005, NEUROSURGERY, V57, P319, DOI 10.1227/01.NEU.0000180960.75347.11; Nowinski WL, 2003, NEUROIMAGE, V18, P143, DOI 10.1006/nimg.2002.1299; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Okun MS, 2009, ANN NEUROL, V65, P586, DOI 10.1002/ana.21596; Pallavaram S, 2008, LECT NOTES COMPUT SC, V5241, P670, DOI 10.1007/978-3-540-85988-8_80; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Rouaud T, 2010, MOVEMENT DISORD, V25, P1839, DOI 10.1002/mds.23171; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Talairach J., 1988, COPLANAR STEREOTAXIC; Temel Y, 2006, PARKINSONISM RELAT D, V12, P265, DOI 10.1016/j.parkreldis.2006.01.004; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929; Williams NR, 2014, MOV DISORD CLIN PRAC, V1, P24, DOI 10.1002/mdc3.12004; Witt K, 2008, LANCET NEUROL, V7, P605, DOI 10.1016/S1474-4422(08)70114-5; Yelnik J, 2000, NEUROSCIENCE, V101, P77, DOI 10.1016/S0306-4522(00)00364-X	48	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200262	10.1371/journal.pone.0200262	http://dx.doi.org/10.1371/journal.pone.0200262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005077	Green Published, gold, Green Submitted			2022-12-26	WOS:000438744200009
J	Hitz, M; Schutz, P; Angst, M; Taylor, WR; List, R				Hitz, Marina; Schutz, Pascal; Angst, Michael; Taylor, William R.; List, Renate			Influence of the moving fluoroscope on gait patterns	PLOS ONE			English	Article							TOTAL KNEE ARTHROPLASTY; GROUND REACTION FORCES; IN-VIVO KINEMATICS; LEVEL WALKING; VARIABILITY	Video-fluoroscopic analysis can provide important insights for the evaluation of outcome and functionality after total knee arthroplasty, allowing the in vivo assessment of tibiofemoral kinematics without soft tissue artefacts. To enable measurement of the knee throughout activities of daily living such as gait, robotic systems like the moving fluoroscope have been developed that follow the knee movement and maintain the joint in front of the image intensifier. Since it is unclear whether walking while being accompanied by moving fluoroscope affects normal gait, the objective of this study was to investigate its influence on gait characteristics in healthy subjects. In addition, the impact of the motors' noise was analysed. By means of skin markers analysis (VICON MX system, Oxford Metrics Group, UK) and simultaneous measurement of ground reaction forces (Kistler force plates, Kistler, Switzerland), gait characteristics when walking with and without the moving fluoroscope as well as with and without ear protectors in combination with the moving fluoroscope, were obtained in young (n = 10, 24.5y +/- 3.0y) and elderly (n = 9, 61.6y +/- 5.3y) subjects during level gait and stair descent. Walking with the moving fluoroscope significantly decreased gait velocity in level gait and stair descent over the respective movement without the fluoroscope. Statistical analysis, including gait velocity as a covariate, resulted in no differences on the ground reaction force parameters. However, some kinematic parameters (ankle, knee and hip ranges of motion, minimal knee angle in late stance phase, maximal knee angles in stance and swing phase) seemed to be modified by the presence of the moving fluoroscope, but statistical comparison was limited due to velocity differences between the conditions. Wearing ear protectors to avoid the influence of motor sound during walking with the moving fluoroscope caused no significant difference. Walking with the moving fluoroscope has been shown to decrease gait velocity and small alterations in kinematic parameters were observed. Therefore, gait and movement alterations due to the moving fluoroscope cannot completely be excluded. However, based on the absence of differences in ground reaction force parameters (when adjusted for velocity within ANCOVA), as well as based on the comparable shape of the angular curves to the slow control condition, it can be concluded that changes in gait when walking with the moving fluoroscope are small, especially in comparison to natural slow walking. In order to allow assessment of joint replacement with the moving fluoroscope, including an understanding of the effects of joint pain, clinical analyses can only be compared to gait activities showing similarly reduced velocities. Importantly, the reduced gait speeds observed in similar to those observed after total knee arthroplasty, suggesting that analyses in such subjects are appropriate. However, the moving fluoroscope would likely need to be optimized in order to detect natural gait characteristics at the higher gait velocities of healthy young subjects. The moving fluoroscope can be applied for comparisons between groups measured with the moving fluoroscope, but care should be taken when comparing data to subjects walking at self-selected speed without the moving fluoroscope.	[Hitz, Marina; Schutz, Pascal; Angst, Michael; Taylor, William R.; List, Renate] Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	List, R (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Zurich, Switzerland.	rlist@ethz.ch	List, Renate/D-3884-2011; Taylor, William R./F-8692-2010; Schütz, Pascal/E-4745-2014	List, Renate/0000-0003-3292-1915; Taylor, William R./0000-0003-4060-4098; Schütz, Pascal/0000-0003-1711-7881				Abbasi-Bafghi H, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-66; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; Banks S, 2006, J BIOMECHANICS S1, V39, pS446, DOI [10.1016/S0021-9290(06)84824-4, DOI 10.1016/S0021-9290(06)84824-4]; Banks SA, 2005, KNEE SURG SPORT TR A, V13, P551, DOI 10.1007/s00167-004-0565-x; Banks SA, 1996, IEEE T BIO-MED ENG, V43, P638, DOI 10.1109/10.495283; Chen JL, 2009, ANN NY ACAD SCI, V1169, P15, DOI 10.1111/j.1749-6632.2009.04556.x; de Bruin N, 2015, J MUSIC THER; deQuervain IAK, 1997, J ARTHROPLASTY, V12, P168, DOI 10.1016/S0883-5403(97)90063-2; Foresti M., 2009, VIVO MEASUREMENT TOT; Foresti M, 2008, 8 INT S COMP METH BI; Giakas G, 1997, GAIT POSTURE, V5, P189, DOI 10.1016/S0966-6362(96)01083-1; Guan S, 2017, J ORTHOP RES, V35, P1634, DOI 10.1002/jor.23466; Guan S, 2016, IEEE T MED IMAGING, V35, P326, DOI 10.1109/TMI.2015.2473168; Hoff WA, 1998, CLIN BIOMECH, V13, P455, DOI 10.1016/S0268-0033(98)00009-6; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kaipust JP, 2013, ANN BIOMED ENG, V41, P1595, DOI 10.1007/s10439-012-0654-9; Kramers de Quervain I.A., 2008, SCHWEIZERISCHE Z SPO, V56, P35; Li GA, 2004, J BIOMECH ENG-T ASME, V126, P314, DOI 10.1115/1.1691448; List R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185952; List R, 2013, J STRENGTH COND RES, V27, P1529, DOI 10.1519/JSC.0b013e3182736034; Liu F, 2006, J BIOMECH, V39, pS213, DOI 10.1016/S0021-9290(06)83779-6; Moro-oka T, 2007, KNEE SURG SPORT TR A, V15, P93, DOI 10.1007/s00167-006-0134-6; MURRAY M P, 1984, Journal of Orthopaedic Research, V2, P272, DOI 10.1002/jor.1100020309; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; Perry J., 1992, GAIT ANAL NORMAL PAT; Riener R, 2002, GAIT POSTURE, V15, P32, DOI 10.1016/S0966-6362(01)00162-X; Sejdic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043104; Sharma A, 2008, J BIOMECH, V41, P642, DOI 10.1016/j.jbiomech.2007.09.027; Stacoff A, 2005, GAIT POSTURE, V21, P24, DOI 10.1016/j.gaitpost.2003.11.003; Stagni R, 2005, CLIN BIOMECH; Stussi E, 1980, BIOMED TECH, V25, P222, DOI 10.1515/bmte.1980.25.s1.222; White R, 1999, CLIN BIOMECH, V14, P185, DOI 10.1016/S0268-0033(99)80003-5; WOLTRING HJ, 1994, J BIOMECH, V27, P1399, DOI 10.1016/0021-9290(94)90191-0; Yamokoski JD, 2011, GAIT POSTURE, V34, P508, DOI 10.1016/j.gaitpost.2011.07.002; Zihlmann M, 2006, J BIOMECH, V39, pS128; Zihlmann MS, 2006, GAIT POSTURE, V24, P475, DOI 10.1016/j.gaitpost.2005.12.012	38	10	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200608	10.1371/journal.pone.0200608	http://dx.doi.org/10.1371/journal.pone.0200608			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005086	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200020
J	Gadbail, AR; Chaudhary, M; Sarode, SC; Gondivkar, S; Tekade, SA; Zade, P; Hande, A; Sarode, GS; Patil, S				Gadbail, Amol R.; Chaudhary, Minal; Sarode, Sachin C.; Gondivkar, Shailesh; Tekade, Satyajit A.; Zade, Prajakta; Hande, Alka; Sarode, Gargi S.; Patil, Shankargouda			Ki67, CD105, and alpha-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; MALIGNANT-TRANSFORMATION; STROMAL MYOFIBROBLASTS; DISEASE SEVERITY; ENDOGLIN CD105; FIBROBLASTS; INDUCTION; PHENOTYPE; LESIONS; MARKER	Background The grading of oral epithelial dysplasia is not possible in the atrophic epithelium of oral submucous fibrosis (OSMF). Recently, we found that features such as increased basal cell layer hyperplasia, abnormal superficial mitosis, increased nuclear-cytoplasmic ratio, increased nuclear size, and hyperchromasia represent transformation-relevant dysplastic features in the atrophic epithelium of OSMF. The presence of these features can be considered a high-risk feature for patients. However, these findings have not been tested and authenticated using markers relevant to oral carcinogenesis. Method Paraffin-embedded tissues from 30 normal oral mucosa (NOM) and 50 OSMF were retrieved from 2008 to 2016 and subjected to immunohistochemical expression using Ki67, CD105 and alpha-SMA antibodies. Results Ki67 LI showed significant increases from NOM (12.47 +/- 2.34) to LRED (23.47 +/- 3.75) to HRED (34.31 +/- 7.31) (<0.0001). Similarly, MVD was increased significantly from NOM (3.53 +/- 5.17) to LRED (27.57 +/- 12.25) to HRED (46.18 +/- 12.55) (p<0.0001). The expression of alpha-SMA was significantly increased from LRED (0.21 +/- 0.41) to HRED (1.13 +/- 0.56) (<0.0001). The Ki67 LI and alpha-SMA; MVD and alpha-SMA; and Ki67Ki67 LI and MVD in NOM, LRED and HRED showed a statistically significant positive correlation (P<0.0001). The increase in Ki67 LI was directly proportional to MVD and alpha-SMA expression from NOM to LRED to HRED (P<0.0001). The connective tissue stroma of NOM lacks alpha-SMA expression. Mild myofibroblast expression was noted in 4 cases of LRED (14.28%) and in 18 cases of HRED (81.81%). Moderate expression was noted only in 4 cases of HRED (22.22%). Conclusion Ki67 LI, CD105, and alpha-SMA expression showed significant differences between normal, LRED and HRED. These findings further support that features such as increased basal cell layer hyperplasia, abnormal superficial mitosis, increased nuclear-cytoplasmic ratio, and hyperchromasia could be transformation-relevant dysplastic features.	[Gadbail, Amol R.] Indira Gandhi Govt Med Coll, Dept Dent, Nagpur, Maharashtra, India; [Chaudhary, Minal; Zade, Prajakta; Hande, Alka] Sharad Pawar Dent Coll & Hosp, Datta Meghe Inst Med Sci, Dept Oral & Maxillofacial Pathol & Microbiol, Wardha, Maharashtra, India; [Sarode, Sachin C.; Sarode, Gargi S.] Dr DY Patil Vidyapeeth, Dr DY Patil Dent Coll & Hosp, Dept Oral & Maxillofacial Pathol & Microbiol, Pune, Maharashtra, India; [Gondivkar, Shailesh] Govt Dent Coll & Hosp, Dept Oral Med & Radiol, Nagpur, Maharashtra, India; [Tekade, Satyajit A.] Modern Dent Coll & Res Ctr, Dept Oral & Maxillofacial Pathol & Microbiol, Indore, Madhya Pradesh, India; [Patil, Shankargouda] Jazan Univ, Coll Dent, Dept Maxillofacial Surg & Diagnost Sci, Div Oral Pathol, Jazan, Saudi Arabia	Datta Meghe Institute of Medical Sciences - Deemed to be University; Sharad Pawar Dental College & Hospital (SPDC); Dr DY Patil Vidyapeeth Pune; Dr D Y Patil Dental College & Hospital; Jazan University	Gadbail, AR (corresponding author), Indira Gandhi Govt Med Coll, Dept Dent, Nagpur, Maharashtra, India.	gadbail@yahoo.co.in	Hande, Alka/ABB-7293-2020; Patil, Shankargouda/G-5256-2013; chaudhary, Minal/ABB-6395-2020; hande, alka/O-2216-2019; Sarode, Sachin/I-5048-2014; Gadbail, Amol/I-5387-2013	hande, alka/0000-0002-8576-7897; Sarode, Sachin/0000-0003-1856-0957; Gadbail, Amol/0000-0002-6546-7694; Sarode, Gargi/0000-0003-4628-8866; Gondivkar, Shailesh/0000-0003-0704-7509				Angadi PV, 2011, J ORAL PATHOL MED, V40, P208, DOI 10.1111/j.1600-0714.2010.00995.x; Anura A, 2016, HEAD NECK-J SCI SPEC, V38, P653, DOI 10.1002/hed.23962; Baglole CJ, 2006, IMMUNOL INVEST, V35, P297, DOI 10.1080/08820130600754960; Bazarsad S, 2017, J ORAL PATHOL MED, V46, P431, DOI 10.1111/jop.12483; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Chauhan GR, 2012, INT J BIOL MED RES, V3, P2261; Dallas NA, 2008, CLIN CANCER RES, V14, P1931, DOI 10.1158/1078-0432.CCR-07-4478; Desai RS, 2010, ORAL ONCOL, V46, P553, DOI 10.1016/j.oraloncology.2010.04.004; Ding SG, 2006, HUM PATHOL, V37, P861, DOI 10.1016/j.humpath.2006.02.006; Ekanayaka RP, 2016, OR SURG OR MED OR PA, V122, P192, DOI 10.1016/j.oooo.2015.12.018; Etemad-Moghadam S, 2009, J ORAL PATHOL MED, V38, P639, DOI 10.1111/j.1600-0714.2009.00768.x; Fonsatti E, 2003, ONCOGENE, V22, P6557, DOI 10.1038/sj.onc.1206813; Gupta K, 2015, J CANCER RES THER, V11, P893, DOI 10.4103/0973-1482.147700; Hua M, 2009, P NATL ACAD SCI USA, V106, P3372, DOI 10.1073/pnas.0813306106; Jayaraj G, 2015, INDIAN J CANCER, V52, P87, DOI 10.4103/0019-509X.175580; Kellermann MG, 2008, ORAL ONCOL, V44, P509, DOI 10.1016/j.oraloncology.2007.07.001; LAI DR, 1995, J ORAL PATHOL MED, V24, P402, DOI 10.1111/j.1600-0714.1995.tb01209.x; Lalli A, 2008, J ORAL PATHOL MED, V37, P211, DOI 10.1111/j.1600-0714.2007.00609.x; Philip T, 2014, SRM J RES DENT SCI, V5, P243; PINDBORG JJ, 1984, SCAND J DENT RES, V92, P224; PINDBORG JJ, 1966, ORAL SURG ORAL MED O, V22, P764, DOI 10.1016/0030-4220(66)90367-7; Ranganathan K, 2011, J Oral Maxillofac Pathol, V15, P148, DOI 10.4103/0973-029X.84478; Rao KB, 2014, J CLIN DIAGN RES, V8, pZC14, DOI 10.7860/JCDR/2014/7820.4231; Sabarinath B, 2011, Indian J Dent Res, V22, P116, DOI 10.4103/0970-9290.80009; Sarode SC, 2018, J ORAL PATHOL MED, V47, P410, DOI 10.1111/jop.12699; Sarode SC, 2013, MED HYPOTHESES, V81, P540, DOI 10.1016/j.mehy.2013.07.001; Siar CH, 2009, EUR J MED RES, V14, P315; Tuxhorn JA, 2002, CLIN CANCER RES, V8, P2912; Wang WC, 2011, HUM PATHOL, V42, P1430, DOI 10.1016/j.humpath.2010.12.009; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200171	10.1371/journal.pone.0200171	http://dx.doi.org/10.1371/journal.pone.0200171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001387	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400033
J	Sado, F; Yap, HJ; Ghazilla, RAR; Ahmad, N				Sado, Fatai; Yap, Hwa Jen; Ghazilla, Raja Ariffin Raja; Ahmad, Norhafizan			Exoskeleton robot control for synchronous walking assistance in repetitive manual handling works based on dual unscented Kalman filter	PLOS ONE			English	Article							REHABILITATION; ORTHOSES; NURSES; DESIGN	Prolong walking is a notable risk factor for work-related lower-limb disorders (WRLLD) in industries such as agriculture, construction, service profession, healthcare and retail works. It is one of the common causes of lower limb fatigue or muscular exhaustion leading to poor balance and fall. Exoskeleton technology is seen as a modern strategy to assist worker's in these professions to minimize or eliminate the risk of WRLLDs. Exoskeleton has potentials to benefit workers in prolong walking (amongst others) by augmenting their strength, increasing their endurance, and minimizing high muscular activation, resulting in overall work efficiency and productivity. Controlling exoskeleton to achieve this purpose for able-bodied personnel without impeding their natural movement is, however, challenging. In this study, we propose a control strategy that integrates a Dual Unscented Kalman Filter (DUKF) for trajectory generation/prediction of the spatio-temporal features of human walking (i.e. joint position, and velocity, and acceleration) and an impedance cum supervisory controller to enable the exoskeleton to follow this trajectory to synchronize with the human walking. Experiment is conducted with four subjects carrying a load and walking at their normal speed- a typical scenario in industries. EMG signals taken at two muscles: Right Vastus Intermedius (on the thigh) and Right Gastrocnemius (on the calf) indicated reduction in muscular activation during the experiment. The results also show the ability of the control system to predict spatio-temporal features of the pilots' walking and to enable the exoskeleton to move in concert with the pilot.	[Sado, Fatai; Yap, Hwa Jen; Ghazilla, Raja Ariffin Raja; Ahmad, Norhafizan] Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia	Universiti Malaya	Yap, HJ (corresponding author), Univ Malaya, Fac Engn, Dept Mech Engn, Kuala Lumpur, Malaysia.	hjyap737@um.edu.my	Sado, Fatai/AAB-3114-2020; Sado, Fatai/AGR-6834-2022; YAP, HWA JEN/C-1065-2010; Ghazilla, Raja Ariffin Raja/B-9540-2010; Ghazilla, Raja Ariffin Raja/AFW-5646-2022; Ahmad, Norhafizan/B-9358-2010	Sado, Fatai/0000-0003-1870-9862; Sado, Fatai/0000-0003-1870-9862; YAP, HWA JEN/0000-0001-7637-9297; Ghazilla, Raja Ariffin Raja/0000-0002-6464-1822; Ghazilla, Raja Ariffin Raja/0000-0002-6464-1822; Ahmad, Norhafizan/0000-0003-2725-9795	University of Malaya under RU Operation Grant [RU016-2016]; Ministry of Higher Education, Government of Malaysia [UM.C/625/1/HIR/MOHE/ENG/41]	University of Malaya under RU Operation Grant; Ministry of Higher Education, Government of Malaysia	The authors wish to acknowledge the support by University of Malaya under RU Operation Grant (RU016-2016) and in part by the Ministry of Higher Education, Government of Malaysia under Grant UM.C/625/1/HIR/MOHE/ENG/41. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ollinger G, 2016, AUTON ROBOT, V40, P701, DOI 10.1007/s10514-015-9490-8; Aguirre-Ollinger G, 2013, IEEE INT C INT ROBOT, P1182, DOI 10.1109/IROS.2013.6696500; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; Bouri M, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P1616, DOI 10.1109/ROBIO.2006.340186; Brinker JO, 2015, INT C REHAB ROBOT, P139, DOI 10.1109/ICORR.2015.7281189; Cao H, 2006, LECT NOTES COMPUT SC, V4234, P702; de Looze MP, 2016, ERGONOMICS, V59, P671, DOI 10.1080/00140139.2015.1081988; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Gams A, 2014, IEEE T ROBOT, V30, P816, DOI 10.1109/TRO.2014.2304775; Ghan J, 2006, ADV ROBOTICS, V20, P989, DOI 10.1163/156855306778394012; Gruneberg P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194214; Han YL, 2010, IEEE INT C INT ROBOT, P3398, DOI 10.1109/IROS.2010.5650497; Hayashi T., 2005, 2005 IEEE/RSJ International Conference on Intelligent Robots and Systems, P3063; Haykin S., 2001, REDES NEURAIS PRINC; Health and Safety Executive, 2017, WORK REL MUSC DIS WR; Herr H, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-21; Huang LH, 2005, P ASME DYNAMIC SYS A; Huang R., 2017, INFORM SCI; Huang R, 2016, IEEE INT CONF ROBOT, P257, DOI 10.1109/ICRA.2016.7487142; Ijspeert AJ, 2002, 2002 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS I-IV, PROCEEDINGS, P1398, DOI 10.1109/ROBOT.2002.1014739; Ijspeert AJ, 2013, NEURAL COMPUT, V25, P328, DOI 10.1162/NECO_a_00393; Jezernik S, 2003, NEUROMODULATION, V6, P108, DOI 10.1046/j.1525-1403.2003.03017.x; Kawamoto H, 2003, IEEE SYS MAN CYBERN, P1648; Kazerooni H, 2005, IEEE INT CONF ROBOT, P4353; Kimura H, 2006, ADAPTIVE MOTION OF ANIMALS AND MACHINES, P217, DOI 10.1007/4-431-31381-8_19; Kirkwood Renata Noce, 2007, Acta ortop. bras., V15, P267, DOI 10.1590/S1413-78522007000500007; Lefebvre T, 2004, INT J CONTROL, V77, P639, DOI 10.1080/00207170410001704998; Lenzi T, 2013, IEEE T NEUR SYS REH, V21, P938, DOI 10.1109/TNSRE.2013.2248749; Long Y, 2017, LECT NOTES ELECTR EN, V399, P165, DOI 10.1007/978-981-10-2404-7_14; [龙亿 Long Yi], 2015, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V47, P26; Marchal-Crespo L, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-20; Marder E, 2000, CURR OPIN NEUROBIOL, V10, P691, DOI 10.1016/S0959-4388(00)00157-4; Matsubara T, 2012, IEEE INT C INT ROBOT, P3914, DOI 10.1109/IROS.2012.6385528; Nakagawa Shotaro, 2013, 2013 IEEE International Symposium on Robot and Human Interactive Communication (RO-MAN), P762, DOI 10.1109/ROMAN.2013.6628405; Nelson Alex T, 2000, NONLINEAR ESTIMATION; Okunribido OO, 2009, CONT ERGONOMICS HUMA, P333; Peternel L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148942; Righetti L, 2006, PHYSICA D, V216, P269, DOI 10.1016/j.physd.2006.02.009; Ronsse R, 2012, IEEE INT C INT ROBOT, P3362, DOI 10.1109/IROS.2012.6385702; Ronsse R, 2011, INT C REHAB ROBOT; Ronsse R, 2011, MED BIOL ENG COMPUT, V49, P1173, DOI 10.1007/s11517-011-0816-1; Ronsse R, 2011, IEEE T BIO-MED ENG, V58, P1001, DOI 10.1109/TBME.2010.2089629; Rubinstein Reuven Y., 2016, SIMULATION MONTE CAR, V10; Ryder MC, 2013, REH ROB ICORR 2013 I, P1; Sawicki GS, 2008, J EXP BIOL, V211, P1402, DOI 10.1242/jeb.009241; Schneider E, 2010, OSH FIGURES WORK REL; SELVERSTON AI, 1980, BEHAV BRAIN SCI, V3, P535, DOI 10.1017/S0140525X00006580; Shieh SH, 2016, TAIWAN J OBSTET GYNE, V55, P525, DOI 10.1016/j.tjog.2016.06.013; Stadler KS, 2014, MOBILE SERVICE ROBOTICS, P53; Stolt M, 2016, SCAND J PUBLIC HEALT, V44, P106, DOI 10.1177/1403494815602989; Sutherland D.H., 1994, HUMAN WALKING, P27; Unluhisarcikli O., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4893, DOI 10.1109/IROS.2011.6048649; Vaughan C., 1999, DYNAMICS HUMAN GAIT; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Wan EA, 2000, IEEE 2000 ADAPTIVE SYSTEMS FOR SIGNAL PROCESSING, COMMUNICATIONS, AND CONTROL SYMPOSIUM - PROCEEDINGS, P153, DOI 10.1109/ASSPCC.2000.882463; Winfree K. N., 2011, P IEEE INT C REH ROB, P1, DOI [10.1109/ICORR.2011.5975499, DOI 10.1109/ICORR.2011.5975499]; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu JP, 2016, MECHATRONICS, V33, P13, DOI 10.1016/j.mechatronics.2015.11.010; Yan TF, 2015, ROBOT AUTON SYST, V64, P120, DOI 10.1016/j.robot.2014.09.032; Yang Z, 2017, FORCE CONTROL THEORY, P73	63	12	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200193	10.1371/journal.pone.0200193	http://dx.doi.org/10.1371/journal.pone.0200193			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001415	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400036
J	Tzen, YT; Weinheimer-Haus, EM; Corbiere, TF; Koh, TJ				Tzen, Yi-Ting; Weinheimer-Haus, Eileen M.; Corbiere, Thomas F.; Koh, Timothy J.			Increased skin blood flow during low intensity vibration in human participants: Analysis of control mechanisms using short-time Fourier transform	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; SPINAL-CORD-INJURY; WAVELET ANALYSIS; NITRIC-OXIDE; OSCILLATIONS; ELECTROMYOSTIMULATION; PRESSURE; ISCHEMIA; THERAPY; PEOPLE	Aim Investigate the immediate effect of low intensity vibration on skin blood flow and its underlying control mechanisms in healthy human participants. Materials and methods One-group pre-post design in a university laboratory setting. Nine adults underwent two bouts of 10-minute vibration (30Hz, peak acceleration 0.4g). Outcome measures include skin blood flow, and skin temperature on the right foot. To examine the control mechanisms underlying the vibration-induced blood flow response, SHORT-TIME Fourier analyses were computed to obtain the spectral densities for three frequency bands: metabolic (0.0095-0.02Hz), neurogenic (0.02-0.06Hz), and myogenic (0.06-0.15Hz). Non-parametric Friedman's tests were computed to compare changes of the outcome measures and control mechanisms over the course of vibration. Results Vibration increased skin blood flow during both bouts of vibration, however the effect did not last after vibration was terminated. Myogenic spectral density increased during both bouts of vibration, whereas the metabolic and neurogenic spectral densities increased only during the 2 nd bout of vibration. Interestingly, only the metabolic spectral density remained elevated after vibration ended. Conclusion Low intensity vibration produced acute increases in skin blood flow mediated in part by vascular control mechanisms of myogenic origin. Further investigation is warranted to determine whether low intensity vibration induces similar increases in skin blood flow in populations prone to developing chronic non-healing wounds, such as spinal cord injury and diabetes.	[Tzen, Yi-Ting] Univ Illinois, Dept Phys Therapy, Chicago, IL USA; [Weinheimer-Haus, Eileen M.; Corbiere, Thomas F.; Koh, Timothy J.] Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Koh, TJ (corresponding author), Univ Illinois, Dept Kinesiol & Nutr, Chicago, IL 60607 USA.	tjkoh@uic.edu		Koh, Timothy/0000-0001-6549-7060; Weinheimer-Haus, Eileen/0000-0001-5408-0024	Department of Defense [W81XWH-14-1-0281]	Department of Defense(United States Department of Defense)	This study is funded by the Department of Defense (#W81XWH-14-1-0281) to TJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arashi M, 2010, ADV SKIN WOUND CARE, V23, P321, DOI 10.1097/01.ASW.0000383752.39220.fb; Archer C, 2010, ROOKS TXB DERMATOLOG; Bracic M., 1999, Nonlinear Phenomena in Complex Systems, V2, P68; Bracic M, 1998, B MATH BIOL, V60, P919, DOI 10.1006/bulm.1998.0047; Brienza DM, 2005, ARCH PHYS MED REHAB, V86, P1245, DOI 10.1016/j.apmr.2004.11.038; Camm AJ, 1996, CIRCULATION, V93, P1043; Cankar K, 2016, MICROVASC RES, V108, P34, DOI 10.1016/j.mvr.2016.07.006; Cohen L., 1995, TIME FREQUENCY ANAL, P93; Cracowski JL, 2006, TRENDS PHARMACOL SCI, V27, P503, DOI 10.1016/j.tips.2006.07.008; Ennis WJ, 2016, PLAST RECONSTR SURG, V138, p94S, DOI 10.1097/PRS.0000000000002680; Field A., 2009, DISCOVERING STAT USI, P539, DOI DOI 10.1111/J.1365-2648.2007.04270_1.X; Geyer MJ, 2004, J REHABIL RES DEV, V41, P797, DOI 10.1682/JRRD.2003.10.0159; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Herrero AJ, 2011, SPINAL CORD, V49, P554, DOI 10.1038/sc.2010.151; Ichioka S, 2011, OSTOMY WOUND MANAG, V57, P40; Jan YK, 2013, ARCH PHYS MED REHAB, V94, P1982, DOI 10.1016/j.apmr.2013.03.022; Jan YK, 2013, MICROVASC RES, V89, P40, DOI 10.1016/j.mvr.2013.05.004; Jan YK, 2009, MICROVASC RES, V78, P162, DOI 10.1016/j.mvr.2009.05.004; Jia GH, 2016, DIABETES, V65, P2118, DOI 10.2337/dbi16-0026; Johnson Paula K, 2014, J Diabetes Sci Technol, V8, P889, DOI 10.1177/1932296814536289; KASTRUP J, 1989, INT J MICROCIRC, V8, P205; Kvandal P, 2006, MICROVASC RES, V72, P120, DOI 10.1016/j.mvr.2006.05.006; Li ZY, 2006, ARCH PHYS MED REHAB, V87, P1207, DOI 10.1016/j.apmr.2006.05.025; Lohman EB, 2007, MED SCI MONITOR, V13, pCR71; Lohman EB, 2011, MED SCI MONITOR, V17, pMT72, DOI 10.12659/MSM.881921; Lythgo N, 2009, CLIN PHYSIOL FUNCT I, V29, P53, DOI 10.1111/j.1475-097X.2008.00834.x; Maloney-Hinds C, 2008, MED SCI MONITOR, V14, pCR112; Maloney-Hinds C, 2009, DIABETES TECHNOL THE, V11, P39, DOI 10.1089/dia.2008.0011; McCulloch J, 2010, BIOPHYSICAL TECHNOLO, P450; Menendez H, 2016, SPINAL CORD, V54, P383, DOI 10.1038/sc.2015.181; Menendez H, 2015, EUR J APPL PHYSIOL, V115, P1747, DOI 10.1007/s00421-015-3161-5; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Mustoe TA, 2006, PLAST RECONSTR SURG, V117, p35S, DOI 10.1097/01.prs.0000225431.63010.1b; NEWSON TP, 1987, J BIOMED ENG, V9, P169, DOI 10.1016/0141-5425(87)90030-6; Robbins D, 2014, CLIN PHYSIOL FUNCT I, V34, P364, DOI 10.1111/cpf.12103; Sanudo B, 2013, EUR J APPL PHYSIOL, V113, P2245, DOI 10.1007/s00421-013-2654-3; Stefanovska A, 1999, IEEE T BIO-MED ENG, V46, P1230, DOI 10.1109/10.790500; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tzen YT, 2013, J SPINAL CORD MED, V36, P357, DOI 10.1179/2045772312Y.0000000085; Tzen YT, 2010, J TISSUE VIABILITY, V19, P86, DOI 10.1016/j.jtv.2009.12.003; van der Heijden DJ, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006082; Weinheimer-Haus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091355	42	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200247	10.1371/journal.pone.0200247	http://dx.doi.org/10.1371/journal.pone.0200247			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001409	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400038
J	Boke-Olen, N; Ardo, J; Eklundh, L; Holst, T; Lehsten, V				Boke-Olen, Niklas; Ardo, Jonas; Eklundh, Lars; Holst, Thomas; Lehsten, Veiko			Remotely sensed soil moisture to estimate savannah NDVI	PLOS ONE			English	Article							TIME-SERIES; FOREST COVER; PRODUCTS; MODIS	Satellite derived normalized difference vegetation index (NDVI) is a common data source for monitoring regional and global ecosystem properties. In dry lands it has contributed to estimation of inter-annual and seasonal vegetation dynamics and phenology. However, due to the spectral properties of NDVI it can be affected by clouds which can introduce missing data in the time series. Remotely sensed soil moisture has in contrast to NDVI the benefit of being unaffected by clouds due to the measurements being made in the microwave domain. There is therefore a potential in combining the remotely sensed NDVI with remotely sensed soil moisture to enhance the quality and estimate the missing data. We present a step towards the usage of remotely sensed soil moisture for estimation of savannah NDVI. This was done by evaluating the European Space Agency (ESA) Climate Change Initiative (CCI) soil moisture and three of its individual products with respect to their relative performance. The individual products are from the advance scatterometer (ASCAT), Soil Moisture and Ocean Salinity (SMOS), and the Land Parameter Retrieval Model-Advanced Microwave Scanning Radiometer-Earth Observing System (LPRM-AMSR-E). Each dataset was used to simulate NDVI, which was subsequently compared to remotely sensed NDVI from MODIS. Differences in their ability to estimate NDVI indicated that, on average, CCI soil moisture differs from its individual products by showing a higher average correlation with measured NDVI. Overall NDVI modelled from CCI soil moisture gave an average correlation of 0.81 to remotely sensed NDVI which indicates its potential to be used to estimate seasonal variations in savannah NDVI. Our result shows promise for further development in using CCI soil moisture to estimate NDVI. The modelled NDVI can potentially be used together with other remotely sensed vegetation datasets to enhance the phenological information that can be acquired, thereby, improving the estimates of savannah vegetation phenology.	[Boke-Olen, Niklas; Ardo, Jonas; Eklundh, Lars; Holst, Thomas; Lehsten, Veiko] Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden; [Lehsten, Veiko] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	Lund University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Boke-Olen, N (corresponding author), Lund Univ, Dept Phys Geog & Ecosyst Sci, Lund, Sweden.	Niklas.Boke-Olen@nateko.lu.se	Zou, Pengfei/V-5059-2019; Eklundh, Lars R/G-4253-2010; Boke-Olen, Niklas/AAQ-8047-2020	Eklundh, Lars R/0000-0001-7644-6517; Boke-Olen, Niklas/0000-0003-2441-7153; Ardo, Jonas/0000-0002-9318-0973; Holst, Thomas/0000-0002-3360-9395				Albergel C, 2012, REMOTE SENS ENVIRON, V118, P215, DOI 10.1016/j.rse.2011.11.017; [Anonymous], 2011, COLL; Archibald S, 2007, J VEG SCI, V18, P583, DOI 10.1111/j.1654-1103.2007.tb02572.x; Bartalis Z, 2008, ASCAT SOIL MOISTURE, P15; Boke-Olen N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154615; Brocca L, 2011, REMOTE SENS ENVIRON, V115, P3390, DOI 10.1016/j.rse.2011.08.003; Donohue RJ, 2013, GEOPHYS RES LETT, V40, P3031, DOI 10.1002/grl.50563; Dorigo WA, 2015, REMOTE SENS ENVIRON, V162, P380, DOI 10.1016/j.rse.2014.07.023; Dorigo W, 2016, INT J APPL EARTH OBS, V48, P1, DOI 10.1016/j.jag.2016.02.007; Glarner H., 2011, LENGTH DAY TWILIGHT; Gruhier C, 2010, HYDROL EARTH SYST SC, V14, P141, DOI 10.5194/hess-14-141-2010; Gruhier C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033330; Hansen MC, 2008, REMOTE SENS ENVIRON, V112, P2495, DOI 10.1016/j.rse.2007.11.012; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heumann BW, 2007, REMOTE SENS ENVIRON, V108, P385, DOI 10.1016/j.rse.2006.11.025; Jonsson P, 2004, COMPUT GEOSCI-UK, V30, P833, DOI 10.1016/j.cageo.2004.05.006; Escorihuela MJ, 2016, REMOTE SENS ENVIRON, V180, P99, DOI 10.1016/j.rse.2016.02.046; Kandasamy S, 2013, BIOGEOSCIENCES, V10, P4055, DOI 10.5194/bg-10-4055-2013; Kerr YH, 2010, P IEEE, V98, P666, DOI 10.1109/JPROC.2010.2043032; Leroux DJ, 2013, REMOTE SENS ENVIRON, V133, P240, DOI 10.1016/j.rse.2013.02.017; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; McNally A, 2016, INT J APPL EARTH OBS, V48, P96, DOI 10.1016/j.jag.2016.01.001; Meng JH, 2013, INT J DIGIT EARTH, V6, P203, DOI 10.1080/17538947.2011.623189; Naeimi V, 2009, IEEE T GEOSCI REMOTE, V47, P1999, DOI 10.1109/TGRS.2008.2011617; Njoku EG, 2003, IEEE T GEOSCI REMOTE, V41, P215, DOI 10.1109/TGRS.2002.808243; Owe M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000769; Rebel KT, 2012, HYDROL EARTH SYST SC, V16, P833, DOI 10.5194/hess-16-833-2012; Rodriguez-Iturbe I, 2000, WATER RESOUR RES, V36, P3, DOI 10.1029/1999WR900210; Rudiger C, 2009, J HYDROMETEOROL, V10, P431, DOI 10.1175/2008JHM997.1; Stoms DM, 2000, INT J REMOTE SENS, V21, P401, DOI 10.1080/014311600210920; Trabucco A, 2009, CGIAR CONSORT SPATIA; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Wagner W, 2012, P 22 INT SOC PHOT RE; Wardlow BD, 2007, REMOTE SENS ENVIRON, V108, P290, DOI 10.1016/j.rse.2006.11.021; Weedon GP, 2014, WATER RESOUR RES, V50, P7505, DOI 10.1002/2014WR015638; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Zeng JY, 2015, REMOTE SENS ENVIRON, V163, P91, DOI 10.1016/j.rse.2015.03.008	38	7	7	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200328	10.1371/journal.pone.0200328	http://dx.doi.org/10.1371/journal.pone.0200328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995901	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800054
J	Hermes, R; Hildebrandt, TB; Goritz, F				Hermes, Robert; Hildebrandt, Thomas Bernd; Goeritz, Frank			Cryopreservation in rhinoceros-Setting a new benchmark for sperm cryosurvival	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-COTTONI; OF-THE-ART; ARTIFICIAL-INSEMINATION; STALLION SEMEN; EPIDIDYMAL SPERM; BLACK RHINOCEROS; CRYOPROTECTANTS; EXTENDERS; FROZEN; SPERMATOZOA	At times when rhinoceros are fiercely poached, when some rhinoceros species are closer than ever to extinction, and when the scientific community is in debate over the use of advanced cell technologies as a remaining resort it is time to simplify and improve existing assisted reproduction techniques to enhance breeding and genetic diversity in the living populations under our care. Semen cryopreservation has been performed in all captive rhinoceros species with limited degree of success. Here we tested three freezing extenders, containing different cryoprotectants and various freezing rates for the cryopreservation of rhinoceros sperm from 14 bulls. In experiment I, semen from 9 bulls was used to determine the most suitable diluent, cryoprotectant and freezing rate for the successful cryopreservation of rhinoceros sperm. In experiment II, semen from 5 bulls was used to assess whether the removal of seminal plasma could further improve post thaw sperm quality following cryopreservation with conditions identified in Experiment I. Semen was diluted with Berliner Cryomedia, ButoCrio (R) or INRA Freeze (R), packaged in 0.5 mL straws and frozen 3, 4, and 5 cm over liquid nitrogen (LN) vapour or directly in a dryshipper. It was found that semen extended with ButoCrio (R) (containing glycerol and methylformamide) and frozen 3cm over LN vapour provided the best protection to rhinoceros spermatozoa during cryopreservation. When pooled over treatments, total and progressive post thaw motility was 75.3 +/- 4.2% and 68.5 +/- 5.7%, respectively marking a new benchmark for the cryopreservation of rhinoceros sperm. Post thaw total and progressive motility, viability and acrosome integrity of semen diluted in ButoCrio (R) was significantly higher than semen extended in Berliner Cryomedia or INRA Freeze (R). The removal of seminal plasma did not improve post thaw sperm survival (p > 0.05). In conclusion, the cryosurvival of rhinoceros spermatozoa was significantly improved when using a mixture of glycerol and methylformamide in combination with a fast freezing rate at 3cm. These results describe a new protocol for the improved cryosurvival of rhinoceros spermatozoa and will enable a more successful preservation of genetic diversity between males, especially in donors whose spermatozoa may already be compromised prior to or during collection. The successful reduction of glycerol concentration in favour of methylformamide as a cryoprotectant could be a novel suggestion for the improvement of cryopreservation techniques in other wildlife species.	[Hermes, Robert; Hildebrandt, Thomas Bernd; Goeritz, Frank] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Leibniz Institut fur Zoo und Wildtierforschung	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, Berlin, Germany.	hermes@izw-berlin.de						Alvarenga MA, 2005, ANIM REPROD SCI, V89, P105, DOI 10.1016/j.anireprosci.2005.07.001; BLOTTNER S, 1998, ADV ETHOL S, V33, P9; CHUPIN D., 1995, ANIMAL MUNDIAL REV, V82, P58; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hermes R, 2005, THERIOGENOLOGY, V63, P219, DOI 10.1016/j.theriogenology.2004.04.007; Hermes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057616; Hermes Robert, 2012, P546; Hildebrandt TB, 2000, THERIOGENOLOGY, V53, P73, DOI 10.1016/S0093-691X(99)00241-1; Lagares MA, 2000, ANDROLOGIA, V32, P163, DOI 10.1046/j.1439-0272.2000.00351.x; Lubbe K, 1999, THERIOGENOLOGY, V51, P288, DOI 10.1016/S0093-691X(99)91847-2; Melo CM, 2008, ANIM REPROD SCI, V107, P331, DOI 10.1016/j.anireprosci.2008.05.108; O'Brien JK, 2000, J REPROD FERTIL, V118, P263, DOI 10.1530/reprod/118.2.263; Papa FO, 2008, ANIM REPROD SCI, V107, P293, DOI 10.1016/j.anireprosci.2008.05.003; PLATZ CC, 1979, J AM VET MED ASSOC, V175, P1002; POLGE C, 1952, NATURE, V169, P626, DOI 10.1038/169626b0; Portas T, 2009, THERIOGENOLOGY, V72, P711, DOI 10.1016/j.theriogenology.2009.05.008; Prieto MT, 2014, EUR J WILDLIFE RES, V60, P851, DOI 10.1007/s10344-014-0858-4; Pucci B, 2008, ANIM REPROD SCI, V107, P342, DOI 10.1016/j.anireprosci.2008.05.119; Reid CE, 2009, THERIOGENOLOGY, V71, P275, DOI 10.1016/j.theriogenology.2008.07.009; Rickard J, 2014, REPROD FERT DEVELOP, V28, P516; Rickard JP, 2015, J PROTEOMICS, V126, P303, DOI 10.1016/j.jprot.2015.05.017; Roth T. L., 2006, International Zoo Yearbook, V40, P130, DOI 10.1111/j.1748-1090.2006.00130.x; Roth TL, 2016, ANIM REPROD SCI, V167, P22, DOI 10.1016/j.anireprosci.2016.01.019; Samper JC, 2008, ANIM REPROD SCI, V107, P348, DOI 10.1016/j.anireprosci.2008.05.125; Saragusty Joseph, 2016, Zoo Biology, V34, P280, DOI 10.1002/zoo.21284; Saragusty J, 2009, ANIM REPROD SCI, V115, P255, DOI 10.1016/j.anireprosci.2008.11.010; Singleton WL, 2001, THERIOGENOLOGY, V56, P1305, DOI 10.1016/S0093-691X(01)00631-8; Squires EL, 2004, THERIOGENOLOGY, V62, P1056, DOI 10.1016/j.theriogenology.2003.12.024; Stoops MA, 2010, THERIOGENOLOGY, V73, P1104, DOI 10.1016/j.theriogenology.2010.01.011; Stoops MA, 2016, ANIM REPROD SCI, V172, P60, DOI 10.1016/j.anireprosci.2016.07.003; Terraciano PB, 2008, ANIM REPROD SCI, V107, P350, DOI 10.1016/j.anireprosci.2008.05.127; Thibier M, 2000, LIVESTOCK REPROD SCI, V74, P203; Verberckmoes S, 2004, REPROD DOMEST ANIM, V39, P195, DOI 10.1111/j.1439-0531.2004.00512.x; Vishwanath R, 2003, THERIOGENOLOGY, V59, P571, DOI 10.1016/S0093-691X(02)01241-4	34	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200154	10.1371/journal.pone.0200154	http://dx.doi.org/10.1371/journal.pone.0200154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995941	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800044
J	Langhoff, W; Riggs, A; Hinow, P				Langhoff, William; Riggs, Alexander; Hinow, Peter			Scaling behavior of drug transport and absorption in in silico cerebral capillary networks	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; MICROVASCULAR NETWORKS; FOCUSED ULTRASOUND; OXYGEN-TRANSPORT; MODEL; DELIVERY; LEVODOPA; CORTEX; FLOW	Drug delivery to the brain is challenging due to the presence of the blood-brain barrier. Mathematical modeling and simulation are essential tools for the deeper understanding of transport processes in the blood, across the blood-brain barrier and within the tissue. Here we present a mathematical model for drug delivery through capillary networks with increasingly complex topologies with the goal to understand the scaling behavior of model predictions on a coarse-to-fine sequence of grids. We apply our model to the delivery of L-Dopa, the primary drug used in the therapy of Parkinson's Disease. Our model replicates observed blood flow rates and ratios between plasma and tissue concentrations. We propose an optimal network grain size for the simulation of tissue volumes of 1 cm(3) that allows to make reliable predictions with reasonable computational costs.	[Langhoff, William; Riggs, Alexander; Hinow, Peter] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Hinow, P (corresponding author), Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA.	hinow@uwm.edu		Hinow, Peter/0000-0001-5875-1470	Simons Foundation grant "Collaboration on Mathematical Biology" [278436]; Support for Undergraduate Research Fellows (SURF) program at the University of Wisconsin-Milwaukee	Simons Foundation grant "Collaboration on Mathematical Biology"; Support for Undergraduate Research Fellows (SURF) program at the University of Wisconsin-Milwaukee	PH has been partially supported by the Simons Foundation grant "Collaboration on Mathematical Biology" (Award 278436)(https://www.simonsfoundation.org/). AR received an award from the Support for Undergraduate Research Fellows (SURF) program at the University of Wisconsin-Milwaukee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astradsson A, 2009, NEUROBIOL DIS, V35, P348, DOI 10.1016/j.nbd.2009.05.018; Ball K, 2012, J PHARM SCI-US, V101, P4277, DOI 10.1002/jps.23266; Bickel Ulrich, 2005, NeuroRx, V2, P15, DOI 10.1007/BF03206639; Boas DA, 2008, NEUROIMAGE, V40, P1116, DOI 10.1016/j.neuroimage.2007.12.061; Bollobas B., 1998, GRADUATE TEXTS MATH, V84; Burgess A, 2013, ACS CHEM NEUROSCI, V4, P519, DOI 10.1021/cn300191b; Cascaval RC, 2017, MATH BIOSCI ENG, V14, P607, DOI 10.3934/mbe.2017035; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen H, 2014, J CEREBR BLOOD F MET, V34, P1197, DOI 10.1038/jcbfm.2014.71; Cohnheim J, 1872, UNTERSUCHUNGEN EMBOL; Cumming P, 1998, SYNAPSE, V29, P37, DOI 10.1002/(SICI)1098-2396(199805)29:1<37::AID-SYN4>3.0.CO;2-C; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; Deng CX, 2010, THER DELIV, V1, P819, DOI 10.4155/TDE.10.66; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; El-Bouri WK, 2015, J THEOR BIOL, V380, P40, DOI 10.1016/j.jtbi.2015.05.011; Errico C, 2015, NATURE, V527, P499, DOI 10.1038/nature16066; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Goldman D, 2000, J THEOR BIOL, V206, P181, DOI 10.1006/jtbi.2000.2113; Hinow P, 2016, J LIPOSOME RES, V26, P233, DOI 10.3109/08982104.2015.1102277; Hinow P, 2012, J LIPOSOME RES, V22, P237, DOI 10.3109/08982104.2012.675338; Hirsch S, 2012, J CEREBR BLOOD F MET, V32, P952, DOI 10.1038/jcbfm.2012.39; Jespersen SN, 2012, J CEREBR BLOOD F MET, V32, P264, DOI 10.1038/jcbfm.2011.153; Jones E., 2001, SCIPY OPEN SOURCE SC; Langhoff W., 2017, HEMOBRAIN DRUG DELIV; Lauwers F, 2008, NEUROIMAGE, V39, P936, DOI 10.1016/j.neuroimage.2007.09.024; Linninger AA, 2013, ANN BIOMED ENG, V41, P2264, DOI 10.1007/s10439-013-0828-0; Nord M, 2010, MOVEMENT DISORD, V25, P363, DOI 10.1002/mds.22613; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; PARDRIDGE WM, 1990, J PHARMACOL EXP THER, V253, P884; PARDRIDGE WM, 1975, BIOCHIM BIOPHYS ACTA, V401, P128, DOI 10.1016/0005-2736(75)90347-8; Park CS, 2016, MED ENG PHYS, V38, P41, DOI 10.1016/j.medengphy.2015.09.004; PAWLIK G, 1981, BRAIN RES, V208, P35, DOI 10.1016/0006-8993(81)90619-3; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Ravenstijn PGM, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-4; Reichmann H, 2012, EXPERT REV NEUROTHER, V12, P119, DOI [10.1586/ern.11.203, 10.1586/ERN.11.203]; Reichold J, 2009, J CEREBR BLOOD F MET, V29, P1429, DOI 10.1038/jcbfm.2009.58; Rostrup E, 2000, NEUROIMAGE, V11, P87, DOI 10.1006/nimg.1999.0526; Safaeian N, 2011, J THEOR BIOL, V271, P145, DOI 10.1016/j.jtbi.2010.11.038; Schmid F., 2017, NEUROIMAGE; Schulz M, 2012, CRIT CARE, V16, DOI 10.1186/cc11441; SMITH RV, 1985, J MED CHEM, V28, P613, DOI 10.1021/jm50001a014; Staruch R, 2011, INT J HYPERTHER, V27, P156, DOI 10.3109/02656736.2010.518198; Truskey G., 2009, TRANSPORT PHENOMENA; Tucker IG, 2012, J MICROENCAPSUL, V29, P475, DOI 10.3109/02652048.2012.658445; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; White D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162215; Xiang Y, 2012, J DRUG TARGET, V20, P67, DOI 10.3109/1061186X.2011.595490; Zsigmond P, 2014, NEUROL CLIN NEUROSCI, V2, P149, DOI 10.1111/ncn3.109	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200266	10.1371/journal.pone.0200266	http://dx.doi.org/10.1371/journal.pone.0200266			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990324	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300034
J	Blesinger, H; Kaulfuss, S; Aung, T; Schwoch, S; Prantl, L; Rossler, J; Wilting, J; Becker, J				Blesinger, Hannah; Kaulfuss, Silke; Aung, Thiha; Schwoch, Sonja; Prantl, Lukas; Roessler, Jochen; Wilting, Joerg; Becker, Juergen			PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations	PLOS ONE			English	Article							LYMPHANGIOGENESIS; MICE; TUMORIGENESIS; ANGIOGENESIS; MALIGNANCIES; PROGENITOR; INHIBITOR; ALLELES; ORIGIN; BREAST	Lymphatic malformations (LM) are characterized by the overgrowth of lymphatic vessels during pre- and postnatal development. Macrocystic, microcystic and combined forms of LM are known. The cysts are lined by lymphatic endothelial cells (LECs). Resection and sclerotherapy are the most common treatment methods. Recent studies performed on LM specimens in the United States of America have identified activating mutations in the phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene in LM. However, whole tissue but not isolated cell types were studied. Here, we studied LM tissues resected at the University Hospitals Freiburg and Regensburg, Germany. We isolated LECs and fibroblasts separately, and sequenced the commonly affected exons 8, 10, and 21 of the PIK3CA gene. We confirm typical monoallelic mutations in 4 out of 6 LM-derived LEC lines, and describe two new mutations i.) in exon 10 (c.1636C>A; p.GIn546Lys), and ii.) a 3bp in-frame deletion of GAA (Glu109del). LM-derived fibroblasts did not possess such mutations, showing cell-type specificity of the gene defect. High activity of the PIK3CA- AKT- mTOR pathway was demonstrated by hyperphosphorylation of AKT-Ser473 in all LM-derived LECs (including the ones with newly identified mutations), as compared to normal LECs. Additionally, hyperphosphorylation of ERK was seen in all LM-derived LECs, except for the one with Glu109del. In vitro, the small molecule kinase inhibitors Buparlisib/BKM-120, Wortmannin, and Ly294002, (all inhibitors of PIK3CA), CAL-101 (inhibitor of PIK3CD), MK-2206 (AKT inhibitor), Sorafenib (multiple kinases inhibitor), and rapamycin (mTOR inhibitor) significantly blocked proliferation of LM-derived LECs in a concentration-dependent manner, but also blocked proliferation of normal LECs. However, MK-2206 appeared to be more specific for mutated LECs, except in case of Glu109 deletion. In sum, children that are, or will be, treated with kinase inhibitors must be monitored closely.	[Blesinger, Hannah; Schwoch, Sonja; Wilting, Joerg; Becker, Juergen] Univ Med Sch Gottingen, Inst Anat & Cell Biol, UMG, Gottingen, Germany; [Kaulfuss, Silke] Univ Med Sch Gottingen, Inst Human Genet, UMG, Gottingen, Germany; [Aung, Thiha; Prantl, Lukas] Univ Med Ctr Regensburg, Ctr Plast Hand & Reconstruct Surg, Regensburg, Germany; [Roessler, Jochen] Univ Med Hosp Freiburg, Clin Pediat Hematol & Oncol, Freiburg, Germany; [Roessler, Jochen] Univ Hosp Bern, Clin Pediat, Dept Pediat Hematol & Oncol, Bern, Switzerland	University of Regensburg; University of Freiburg; University of Bern; University Hospital of Bern	Wilting, J (corresponding author), Univ Med Sch Gottingen, Inst Anat & Cell Biol, UMG, Gottingen, Germany.	joerg.wilting@med.uni-goettingen.de	Prantl, Lukas/AAM-1848-2021	Prantl, Lukas/0000-0003-2454-2499; Wilting, Jorg/0000-0001-8337-2296; Kaulfuss, Silke/0000-0003-2577-9711; Rossler, Jochen/0000-0003-4022-4917	Deutsche Gesellschaft fur Lymphologie (DGL)	Deutsche Gesellschaft fur Lymphologie (DGL)	The studies were funded by a grant from the Deutsche Gesellschaft fur Lymphologie (DGL) to JW. The DGL did not have any influence on the performance of the study and the interpretation of the results.; We are grateful to B. Manshausen and Ch. Zelent for their excellent technical assistance. The studies were funded by a grant from the Deutsche Gesellschaft fur Lymphologie (DGL). The DGL did not have any influence on the performance of the study and the interpretation of the results.	Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Alders M, 2013, MOL SYNDROMOL, V4, P107, DOI [10.1159/000342486, 10.1159/000354097]; Arai E, 2006, J CUTAN PATHOL, V33, P492, DOI 10.1111/j.1600-0560.2006.00461.x; Becker J, 2006, CANCER RES, V66, P5314, DOI 10.1158/0008-5472.CAN-05-3049; Boscolo E, 2015, ANGIOGENESIS, V18, P151, DOI 10.1007/s10456-014-9453-2; Braunschweiger A, 2012, LYMPH FORSCH, V16, P6; Buttler K, 2014, CELL MOL LIFE SCI, V71, P1513, DOI 10.1007/s00018-013-1460-8; Castel P, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1164; Castillo SD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9982; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Desmedt C, 2015, J PATHOL, V236, P457, DOI 10.1002/path.4540; FOLKMAN J, 1979, P NATL ACAD SCI USA, V76, P5217, DOI 10.1073/pnas.76.10.5217; Folkman J, 1976, Int Rev Exp Pathol, V16, P207; Glaser K, 2018, LYMPHAT RES BIOL, V16, P43, DOI 10.1089/lrb.2017.0033; Guo GW, 2013, NAT GENET, V45, P1459, DOI 10.1038/ng.2798; Hasselhof V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164964; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kasten P, 2007, DEV DYNAM, V236, P2952, DOI 10.1002/dvdy.21298; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Limaye N, 2015, HEMANGIOMAS VASCULAR, P21; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; Manner J, 2015, HEMANGIOMAS VASCULAR, P3; Martinez-Corral I, 2015, CIRC RES, V116, P1649, DOI 10.1161/CIRCRESAHA.116.306170; Moon A, 2016, PATHOLOGY, V48, P35, DOI 10.1016/j.pathol.2015.11.011; Norgall S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-105; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Osborn AJ, 2015, HUM MOL GENET, V24, P926, DOI 10.1093/hmg/ddu505; Park SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094781; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Wilting J, 2002, FASEB J, V16, P1271, DOI 10.1096/fj.01-1010fje; Wilting J, 2000, DEV DYNAM, V217, P271, DOI 10.1002/(SICI)1097-0177(200003)217:3<271::AID-DVDY5>3.3.CO;2-U; Young AE, 1988, VASCULAR BIRTHMARKS, P24	36	42	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200343	10.1371/journal.pone.0200343	http://dx.doi.org/10.1371/journal.pone.0200343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985963	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500036
J	Tsujimoto, S; Mokuda, S; Matoba, K; Yamada, A; Jouyama, K; Murata, Y; Ozaki, Y; Ito, T; Nomura, S; Okuda, Y				Tsujimoto, Saki; Mokuda, Sho; Matoba, Kenichiro; Yamada, Akihiro; Jouyama, Kazuo; Murata, Yosuke; Ozaki, Yoshio; Ito, Tomoki; Nomura, Shosaku; Okuda, Yasuaki			The prevalence of endoscopic gastric mucosal damage in patients with rheumatoid arthritis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL COMPLICATIONS; CYCLOOXYGENASE-2 INHIBITOR; HELICOBACTER-PYLORI; DUODENAL-ULCERS; PEPTIC-ULCER; PREVENTION; CELECOXIB; MISOPROSTOL; THERAPY	Objectives Rheumatoid arthritis (RA) patients often take non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids as supportive drugs. In this study, we investigated the prevalence of endoscopic gastric damage and their prescribed medications under an actual clinical condition. Methods We collected the data of 1704 RA patients who underwent upper gastrointestinal fiberscopy. Gastric mucosal erosion and ulcer were classified using modified LANZA score. We analyzed these data with a multiple regression analysis. Results The prevalence of endoscopic gastric mucosal damage in these RA patients was 16.7% (285 cases). A multiple regression analysis indicated that prednisolone (PSL), NSAIDs and proton pump inhibitors (PPIs) were independent risk factors associated with the modified LANZA score. PSL and NSAIDs were positively correlated with the score, while the administration of PPIs was inversely correlated with the score. The modified LANZA score in RA patients treated with both PSL and NSAIDs was significantly higher than that in those treated with PSL alone (no NSAIDs use). Conclusions Our findings suggest that PSL and NSAIDs were exacerbating factors for gastric mucosal damage, while PPIs usage was a protective factor. And, the combined usage of corticosteroids and NSAIDs may induce the development of gastric ulcers.	[Tsujimoto, Saki; Mokuda, Sho; Matoba, Kenichiro; Yamada, Akihiro; Jouyama, Kazuo; Murata, Yosuke; Okuda, Yasuaki] Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, Matsuyama, Ehime, Japan; [Tsujimoto, Saki; Ozaki, Yoshio; Ito, Tomoki; Nomura, Shosaku] Kansai Med Univ, Dept Internal Med 1, Hirakata, Osaka, Japan; [Mokuda, Sho] Hiroshima Univ Hosp, Dept Clin Immunol & Rheumatol, Hiroshima, Hiroshima, Japan	Kansai Medical University; Hiroshima University	Mokuda, S (corresponding author), Dohgo Spa Hosp, Ctr Rheumat Dis, Dept Internal Med, Matsuyama, Ehime, Japan.; Mokuda, S (corresponding author), Hiroshima Univ Hosp, Dept Clin Immunol & Rheumatol, Hiroshima, Hiroshima, Japan.	sho-mokuda@hiroshima.ac.jp		Mokuda, Sho/0000-0002-8529-1016				ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bandyopadhyay U, 1999, MOL CELL BIOCHEM, V202, P31, DOI 10.1023/A:1007018212822; Choi IA, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-375; CONN HO, 1994, J INTERN MED, V236, P619, DOI 10.1111/j.1365-2796.1994.tb00855.x; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; Rodriguez LAG, 2007, GASTROENTEROLOGY, V132, P498, DOI 10.1053/j.gastro.2006.12.007; Goldstein JL, 2001, AM J GASTROENTEROL, V96, P1019; GRAHAM DY, 1993, ANN INTERN MED, V119, P257, DOI 10.7326/0003-4819-119-4-199308150-00001; Griffin MR., 1998, AM J MED, V104, p23S; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; Ishikawa N, 2002, RHEUMATOLOGY, V41, P72, DOI 10.1093/rheumatology/41.1.72; Kargman S, 1996, GASTROENTEROLOGY, V111, P445, DOI 10.1053/gast.1996.v111.pm8690211; Laine L, 1996, Gastrointest Endosc Clin N Am, V6, P489; Lanza FL, 1998, AM J GASTROENTEROL, V93, P2037; Matsukawa Y, 2003, RHEUMATOLOGY, V42, P947, DOI 10.1093/rheumatology/keg258; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; PIPER JM, 1991, ANN INTERN MED, V114, P735, DOI 10.7326/0003-4819-114-9-735; Porro GB, 1998, ITAL J GASTROENTEROL, V30, P43; RASKIN JB, 1995, ANN INTERN MED, V123, P344, DOI 10.7326/0003-4819-123-5-199509010-00004; Schett G, 2016, ANN RHEUM DIS, V75, P1428, DOI 10.1136/annrheumdis-2016-209201; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shiokawa Y, 1991, Ryumachi, V31, P96; Smolen JS, 2017, ANN RHEUM DIS, V76, P960, DOI 10.1136/annrheumdis-2016-210715; Taha AS, 1996, NEW ENGL J MED, V334, P1435, DOI 10.1056/NEJM199605303342204; Tsuji S, 2012, MOD RHEUMATOL, V22, P353, DOI 10.1007/s10165-011-0524-6; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407; Yajima H, 2007, J ORTHOP SCI, V12, P341, DOI 10.1007/s00776-007-1139-9; YANAGAWA A, 1992, J RHEUMATOL, V19, P1075; Yanagawa A, 1990, ROY SOC MED INT CONG, V21, P97; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	30	11	13	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200023	10.1371/journal.pone.0200023	http://dx.doi.org/10.1371/journal.pone.0200023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985937	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500019
J	Zhang, YZ; Huang, BQ				Zhang, Yongzhong; Huang, Binquan			Identification of multiple genes encoding SnRK1 subunits in potato tuber	PLOS ONE			English	Article							PROTEIN KINASE1 ACTIVITY; ARABIDOPSIS-THALIANA; SNF1-RELATED KINASE; EXPRESSION; REGULATORS; PATHWAYS; COMPLEX; SUGAR; YEAST	Background Many studies have proven the importance of SnRK1 in the regulation of carbohydrate metabolism and plant development. Compared to Arabidopsis, much less is known about SnRK1 complexes in crop plants, and therefore, more work needs to be done to identify SnRK1 genes and to investigate their function in crop plants. Methods In this study we identified five SnRK1-related genes in potato by analyzing the potato genome through BLAST, which encode one a-subunit isoform (stKIN), two beta-subunit isoforms (stKIN beta 1 and stKIN beta 2) and two.-subunit isoforms (stKIN gamma and stKIN beta gamma). To investigate the functions of SnRK1 in the tuber development of potato, we further made overexpression and RNAi transgenic plants of these five genes. Based on these overexpression transgenic plants, the Fast protein liquid chromatography (FPLC) were employed to purify SnRK1 complexes, which were tracked by western-blot. Results Experiments in vivo and in vitro showed that these five proteins in potato are functional SNF1/AMPK/SnRK1-related proteins. The SnRK1 activity decreased by 60% in the RNAi transgenic lines of stKIN; the starch content increased by 25% in the overexpression transgenic lines of stKIN, compared to that in the wild-type lines, whereas there is no significant difference in SnRK1 activity and starch content in the RNAi transgenic or overexpression lines of stKIN beta 1, stKIN beta 2, stKIN gamma and stKIN beta gamma. In addition, we found that a few different SnRK1 complexes are present in potato by partially purifying SnRK1 complexes from these overexpression transgenic plants. Conclusions Five functional SnRK1-related genes were identified in potato, including three novel genes, which encode one a-subunit isoform (stKIN), two beta-subunit isoforms (stKIN beta 1 and stKIN beta 2) and two.-subunit isoforms (stKIN gamma and stKIN beta gamma). We found that a few SnRK1 related genes are present in potato tuber, which form several different SnRK1 isoenzymes. We found that stKIN is the primary a subunit of SnRK1 in potato tuber and plays important roles in the development of potato tubers.	[Zhang, Yongzhong] Shandong Agr Univ, Coll Agron Sci, Tai An, Shandong, Peoples R China; [Huang, Binquan] Univ Lille, CNRS, UMR, Lille, France	Shandong Agricultural University; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Huang, BQ (corresponding author), Univ Lille, CNRS, UMR, Lille, France.	huangbinquan@126.com			National Natural Science Foundation of China [31601320]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by National Natural Science Foundation of China [Grant No. 31601320 to Y. Z.].	Bledsoe SW, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1018-2; Crozet P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00190; Emanuelle S, 2015, PLANT J, V82, P183, DOI 10.1111/tpj.12813; Gissot L, 2004, PLANT MOL BIOL, V56, P747, DOI 10.1007/s11103-004-5111-1; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Lakatos L, 1999, PLANT J, V17, P569, DOI 10.1046/j.1365-313X.1999.00406.x; Lin CR, 2014, PLANT CELL, V26, P808, DOI 10.1105/tpc.113.121939; Lin Y, 2015, PLANT PHYSIOL, V168, P1807, DOI 10.1104/pp.15.00664; Lopez-Paz C, 2009, FEBS LETT, V583, P1887, DOI 10.1016/j.febslet.2009.05.022; Martinez-Barajas E, 2011, PLANT PHYSIOL, V156, P373, DOI 10.1104/pp.111.174524; McKibbin RS, 2006, PLANT BIOTECHNOL J, V4, P409, DOI 10.1111/j.1467-7652.2006.00190.x; Millam S, 2007, METHOD MOL BIOL, V344, P2; Polge C, 2007, TRENDS PLANT SCI, V12, P20, DOI 10.1016/j.tplants.2006.11.005; Sreenivasulu N, 2006, PLANT J, V47, P310, DOI 10.1111/j.1365-313X.2006.02789.x; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	17	2	2	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200321	10.1371/journal.pone.0200321	http://dx.doi.org/10.1371/journal.pone.0200321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979765	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500097
J	Desbois, M; Crawley, O; Evans, PR; Baker, ST; Masuho, I; Yasuda, R; Grill, B				Desbois, Muriel; Crawley, Oliver; Evans, Paul R.; Baker, Scott T.; Masuho, Ikuo; Yasuda, Ryohei; Grill, Brock			PAM forms an atypical SCF ubiquitin ligase complex that ubiquitinates and degrades NMNAT2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; neuron; axon; proteasome; fluorescence resonance energy transfer (FRET); Caenorhabditis elegans (C; elegans); neurodegeneration; FBXO45; MYCBP2; NMNAT; PAM; RPM-1; PHR protein; ubiquitin ligase; FSN-1; F-box; axon degeneration; ubiquitination	REGULATES AXON TERMINATION; C-ELEGANS RPM-1; WALLERIAN DEGENERATION; NEURONAL DEVELOPMENT; PROTEIN-DEGRADATION; CANCER; SYNAPTOGENESIS; DROSOPHILA; REVEALS; GROWTH	PHR (PAM/Highwire/RPM-1) proteins are conserved RING E3 ubiquitin ligases that function in developmental processes, such as axon termination and synapse formation, as well as axon degeneration. At present, our understanding of how PHR proteins form ubiquitin ligase complexes remains incomplete. Although genetic studies indicate NMNAT2 is an important mediator of PHR protein function in axon degeneration, it remains unknown how PHR proteins inhibit NMNAT2. Here, we decipher the biochemical basis for how the human PHR protein PAM, also called MYCBP2, forms a noncanonical Skp/Cullin/F-box (SCF) complex that contains the F-box protein FBXO45 and SKP1 but lacks CUL1. We show FBXO45 does not simply function in substrate recognition but is important for assembly of the PAM/FBXO45/SKP1 complex. Interestingly, we demonstrate a novel role for SKP1 as an auxiliary component of the target recognition module that enhances binding of FBXO45 to NMNAT2. Finally, we provide biochemical evidence that PAM polyubiquitinates NMNAT2 and regulates NMNAT2 protein stability and degradation by the proteasome.	[Desbois, Muriel; Crawley, Oliver; Baker, Scott T.; Masuho, Ikuo; Grill, Brock] Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA; [Evans, Paul R.; Yasuda, Ryohei] Max Planck Florida Inst Neurosci, Jupiter, FL 33458 USA	Scripps Research Institute; Max Planck Society	Grill, B (corresponding author), Scripps Res Inst, Dept Neurosci, 130 Scripps Way, Jupiter, FL 33458 USA.	bgrill@scripps.edu	Crawley, Oliver/U-2606-2018; Desbois, Muriel/AAD-3598-2022; Crawley, Oliver/AAE-9865-2019	Crawley, Oliver/0000-0002-5054-0051; Desbois, Muriel/0000-0002-8070-2525; Crawley, Oliver/0000-0002-5054-0051; Grill, Brock/0000-0002-0379-3267; Yasuda, Ryohei/0000-0001-6263-9297	National Institutes of Health [R01 NS072129]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant R01 NS072129 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali YO, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002472; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Babetto E, 2013, CELL REP, V3, P1422, DOI 10.1016/j.celrep.2013.04.013; Baker ST, 2017, J BIOL CHEM, V292, P2519, DOI 10.1074/jbc.M116.748004; Baker ST, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004297; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Borgen M, 2017, GENETICS, V205, P1229, DOI 10.1534/genetics.116.197343; Borgen MA, 2017, DEVELOPMENT, V144, P4658, DOI 10.1242/dev.154187; Brace EJ, 2014, J NEUROSCI, V34, P8398, DOI 10.1523/JNEUROSCI.4715-13.2014; Brazill JM, 2017, CURR OPIN GENET DEV, V44, P156, DOI 10.1016/j.gde.2017.03.014; Chang JY, 2017, NEURON, V94, P800, DOI 10.1016/j.neuron.2017.04.041; Chang LF, 2014, CURR OPIN STRUC BIOL, V29, P1, DOI 10.1016/j.sbi.2014.08.003; Chen X, 2014, CELL DEATH DIFFER, V21, P1535, DOI 10.1038/cdd.2014.92; Chung FZ, 2014, J BIOL CHEM, V289, P28448, DOI 10.1074/jbc.M114.561241; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Davis MA, 2013, GENE DEV, V27, P151, DOI 10.1101/gad.207720.112; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; Gao MX, 2008, CELL DEATH DIFFER, V15, P1054, DOI 10.1038/cdd.2008.30; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Goo MS, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00060; Grill B, 2007, NEURON, V55, P587, DOI 10.1016/j.neuron.2007.07.009; Grill B, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0063-0; Hebbar N, 2017, CANCER RES, V77, P4039, DOI 10.1158/0008-5472.CAN-16-1970; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Huntwork-Rodriguez S, 2013, J CELL BIOL, V202, P747, DOI 10.1083/jcb.201303066; Kirkin V, 2011, CURR OPIN GENET DEV, V21, P21, DOI 10.1016/j.gde.2010.10.004; Kitay BM, 2013, HUM MOL GENET, V22, P1601, DOI 10.1093/hmg/ddt009; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Matarin M, 2015, CELL REP, V10, P633, DOI 10.1016/j.celrep.2014.12.041; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Neukomm LJ, 2017, NEURON, V95, P78, DOI 10.1016/j.neuron.2017.06.031; Opperman KJ, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-10; Pao KC, 2018, NATURE, V556, P381, DOI 10.1038/s41586-018-0026-1; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reitsma JM, 2017, CELL, V171, P1326, DOI 10.1016/j.cell.2017.10.016; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruan K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10057; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Salat D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130288; Scaravilli M, 2015, PROSTATE, V75, P798, DOI 10.1002/pros.22961; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Sharma J, 2014, J BIOL CHEM, V289, P34654, DOI 10.1074/jbc.M114.614065; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tricoli JV, 2018, CANCER-AM CANCER SOC, V124, P1070, DOI 10.1002/cncr.31136; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wu CL, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-16; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xiong X, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001440; Xu M, 2015, ONCOTARGET, V6, P979, DOI 10.18632/oncotarget.2825; Yamagishi Y, 2016, CELL REP, V17, P774, DOI 10.1016/j.celrep.2016.09.043; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Yasuda R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005611; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	66	20	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					13897	13909		10.1074/jbc.RA118.002176	http://dx.doi.org/10.1074/jbc.RA118.002176			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	29997255	hybrid, Green Published			2022-12-26	WOS:000444070700016
J	Ruwaimana, M; Satyanarayana, B; Otero, V; Muslim, AM; Syafiq, AM; Ibrahim, S; Raymaekers, D; Koedam, N; Dahdouh-Guebas, F				Ruwaimana, Monika; Satyanarayana, Behara; Otero, Viviana; Muslim, Aidy M.; Syafiq, Muhammad A.; Ibrahim, Sulong; Raymaekers, Dries; Koedam, Nico; Dahdouh-Guebas, Farid			The advantages of using drones over space-borne imagery in the mapping of mangrove forests	PLOS ONE			English	Article							LAND-COVER CLASSIFICATION; MUI CA MAU; HIGH-RESOLUTION; SHORELINE CHANGES; UAV IMAGERY; AREA; METAANALYSIS; ECOSYSTEMS; MANAGEMENT; QUANTITY	Satellite data and aerial photos have proved to be useful in efficient conservation and management of mangrove ecosystems. However, there have been only very few attempts to demonstrate the ability of drone images, and none so far to observe vegetation (specieslevel) mapping. The present study compares the utility of drone images (DJI-Phantom-2 with SJ4000 RGB and IR cameras, spatial resolution: 5cm) and satellite images (Pleiades-1B, spatial resolution: 50cm) for mangrove mapping-specifically in terms of image quality, efficiency and classification accuracy, at the Setiu Wetland in Malaysia. Both object- and pixel-based classification approaches were tested (QGIS v.2.12.3 with Orfeo Toolbox). The object-based classification (using a manual rule-set algorithm) of drone imagery with dominant land-cover features (i.e. water, land, Avicennia alba, Nypa fruticans, Rhizophora apiculata and Casuarina equisetifolia) provided the highest accuracy (overall accuracy (OA): 94.0 +/- 0.5% and specific producer accuracy (SPA): 97.0 +/- 9.3%) as compared to the Pleiades imagery (OA: 72.2 +/- 2.7% and SPA: 51.9 +/- 22.7%). In addition, the pixel-based classification (using a maximum likelihood algorithm) of drone imagery provided better accuracy (OA: 90.0 +/- 1.9% and SPA: 87.2 +/- 5.1%) compared to the Pleiades (OA: 82.8 +/- 3.5% and SPA: 80.4 +/- 14.3%). Nevertheless, the drone provided higher temporal resolution images, even on cloudy days, an exceptional benefit when working in a humid tropical climate. In terms of the user-costs, drone costs are much higher, but this becomes advantageous over satellite data for long-term monitoring of a small area. Due to the large data size of the drone imagery, its processing time was about ten times greater than that of the satellite image, and varied according to the various image processing techniques employed (in pixel-based classification, drone >50 hours, Pleiades <5 hours), constituting the main disadvantage of UAV remote sensing. However, the mangrove mapping based on the drone aerial photos provided unprecedented results for Setiu, and was proven to be a viable alternative to satellite-based monitoring/management of these ecosystems. The improvements of drone technology will help to make drone use even more competitive in the future.	[Ruwaimana, Monika; Satyanarayana, Behara; Otero, Viviana; Dahdouh-Guebas, Farid] ULB, Syst Ecol & Resource Management, Brussels, Belgium; [Ruwaimana, Monika; Koedam, Nico; Dahdouh-Guebas, Farid] VUB, Ecol & Biodivers APNA, Brussels, Belgium; [Ruwaimana, Monika] Univ Atma Jaya Yogyakarta, Dept Biol, Yogyakarta, Indonesia; [Satyanarayana, Behara; Muslim, Aidy M.; Syafiq, Muhammad A.; Ibrahim, Sulong] UMT, Inst Oceanog & Environm, Mangrove Res Unit MARU, Kuala Terengganu, Malaysia; [Raymaekers, Dries] VITO, Mol, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universitas Atma Jaya Yogyakarta; Universiti Malaysia Terengganu; VITO	Ruwaimana, M (corresponding author), ULB, Syst Ecol & Resource Management, Brussels, Belgium.; Ruwaimana, M (corresponding author), VUB, Ecol & Biodivers APNA, Brussels, Belgium.; Ruwaimana, M (corresponding author), Univ Atma Jaya Yogyakarta, Dept Biol, Yogyakarta, Indonesia.	monruw@gmail.com	Muslim, Aidy M/L-8645-2018; Satyanarayana, Behara/F-7694-2013	Muslim, Aidy M/0000-0001-8421-5874; Satyanarayana, Behara/0000-0003-4191-2607; DAHDOUH-GUEBAS, Farid/0000-0002-5906-8996; Ruwaimana, Monika/0000-0003-3891-4177; Otero, Viviana/0000-0002-1055-5697	European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Erasmus Mundus Caterogy A full grant from European Commission for Master Study in Tropical Biodiversity and Ecosystem (https://www.tropimundo.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the European Commission for funding the Erasmus Mundus Masters Course in Tropical Biodiversity and Ecosystem (TROPIMUNDO). The help rendered by the local people especially, Cik Azmi, Yoi and Sidhi Penyu at Setiu Wetland was highly appreciated. We also thank the Photonic Lab at VUB, and finally the authorities providing opensource software such as QGIS, SCP, SAGA, OTB, Geosetter, GPSconverter and Rstudio. The GISstackexchange community and forum was useful in helping to resolve the technical issues encountered during the present study. We also thank Ron Lilley for proofreading this manuscript.	ABC, 2017, BIRDS DRON WEDG TAIL; Amir AA, 2012, FOREST ECOL MANAG, V269, P60, DOI 10.1016/j.foreco.2011.12.040; [Anonymous], 2016, DAT SPECSH SEQ MULT; [Anonymous], 2014, VALUING POTENTIAL EC, V2, P487; [Anonymous], 2006, MARINE COASTAL ECOSY; [Anonymous], 2013, STAR ONLINE; [Anonymous], 2017, DAILYMAIL; Baba S., 2013, ISME MANGROVE ED BOO, V3; Blaschke T, 2010, ISPRS J PHOTOGRAMM, V65, P2, DOI 10.1016/j.isprsjprs.2009.06.004; Brander LM, 2012, ECOSYST SERV, V1, P62, DOI 10.1016/j.ecoser.2012.06.003; Brooker G., 2009, INTRO SENSORS RANGIN; Carleer AP, 2005, PHOTOGRAMM ENG REM S, V71, P1285, DOI 10.14358/PERS.71.11.1285; Chong V. C., 2006, Aquatic Ecosystem Health & Management, V9, P249, DOI 10.1080/14634980600717084; CNES, 2016, ORF TOOLBOX COOKB GU; CNES, 2012, PLEIAD US GUID; Congedo L., 2014, SEMIAUTOMATIC CLASSI, P107; Crutsinger GM, 2016, J UNMANNED VEH SYST, V4, P161, DOI 10.1139/juvs-2016-0008; Dahdouh-Guebas F, 2008, AQUAT BOT, V89, P80, DOI 10.1016/j.aquabot.2008.03.012; Dahdouh-Guebas F, 2006, INT J SUST DEV WORLD, V13, P62, DOI 10.1080/13504500609469662; Dahdouh-Guebas F., 2002, Environment Development and Sustainability, V4, P185, DOI 10.1023/A:1020854413866; Dahdouh-Guebas F., 2004, Systematics and Biodiversity, V2, P113; Dahdouh-Guebas F, 2005, CURR BIOL, V15, P579, DOI 10.1016/j.cub.2005.01.053; Dahdouh-Guebas F, 2000, B MAR SCI, V67, P741; Dahdouh-Guebas F, 2004, MAR ECOL PROG SER, V272, P77, DOI 10.3354/meps272077; Dahdouh-Guebas Farid, 2002, Environment Development and Sustainability, V4, P93, DOI 10.1023/A:1020887204285; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; DJI, 2020, DJI STOR; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Flytrex, 2015, FLYTR COR V2; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Ford M, 2013, REMOTE SENS ENVIRON, V135, P130, DOI 10.1016/j.rse.2013.03.027; Giri C, 2011, GLOBAL ECOL BIOGEOGR, V20, P154, DOI 10.1111/j.1466-8238.2010.00584.x; Green EP, 2000, REMOTE SENSING BOOK; Griffin C, 2013, OCEAN COAST MANAGE, V71, P176, DOI 10.1016/j.ocecoaman.2012.10.017; Hammer O, 2011, PALAEONTOL ELECT, V4; Hansen MC, 2012, REMOTE SENS ENVIRON, V122, P66, DOI 10.1016/j.rse.2011.08.024; ITRES, 2016, CASI 1500H SPEC, P2; Jamilah MS, 2013, CONSERVATION MALAYSI, P1; Jamilah MS, 2013, SETIU WETLANDS STATE; Jenoh EM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154849; Kaneko K., 2014, Journal of Geographic Information System, V6, P733, DOI 10.4236/jgis.2014.66060; Khatami R, 2016, REMOTE SENS ENVIRON, V177, P89, DOI 10.1016/j.rse.2016.02.028; Kohavi R., 1995, IJCAI, V14, P2; Kuenzer C, 2011, REMOTE SENS-BASEL, V3, P878, DOI 10.3390/rs3050878; Leempoel K, 2013, BIOGEOSCIENCES, V10, P5681, DOI 10.5194/bg-10-5681-2013; Lim CK, 2002, CLASSIFICATION DISTR; Lucieer A., 2010, P 15 AUSTR REM SENS, P1; Castillejo-Gonzalez IL, 2009, COMPUT ELECTRON AGR, V68, P207, DOI 10.1016/j.compag.2009.06.004; Maresma A, 2016, REMOTE SENS, V8, P1, DOI DOI 10.3390/RS8120973; Masso i Aleman S, 2010, PLANT ECOL EVOL, V143, P225, DOI 10.5091/plecevo.2010.439; Mather PM, 2004, COMPUTE PROCESSING R; Michel J, 2015, IEEE T GEOSCI REMOTE, V53, P952, DOI 10.1109/TGRS.2014.2330857; Mukherjee N, 2014, ECOL EVOL, V4, P2247, DOI 10.1002/ece3.1085; Mukherjee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086731; Nakisah M. A., 2003, SETIU WETLANDS TRANQ; Neukermans G, 2008, J SPAT SCI, V53, P75, DOI 10.1080/14498596.2008.9635137; Nijland W, 2014, AGR FOREST METEOROL, V184, P98, DOI 10.1016/j.agrformet.2013.09.007; Otero V, 2016, REMOTE SENS, V8, P1; Otero V, 2018, FOREST ECOL MANAG, V411, P35, DOI 10.1016/j.foreco.2017.12.049; Paneque-Galvez J, 2014, FORESTS, V5, P1481, DOI 10.3390/f5061481; Perry TS, 2013, ANIMATION, V27; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Pontius RG, 2014, INT J REMOTE SENS, V35, P7543, DOI 10.1080/2150704X.2014.969814; Pontius RG, 2011, INT J REMOTE SENS, V32, P4407, DOI 10.1080/01431161.2011.552923; QGIS Development Team, 2018, GEOGRAPHIC INFORM SY; Rodriguez W, 2004, NATL MUSEUM NAT HIST; Rstudio Team, 2015, RSTUDIO INT DEV R; Salami E, 2014, REMOTE SENS-BASEL, V6, P11051, DOI 10.3390/rs61111051; Satyanarayana B, 2011, MAR ECOL PROG SER, V443, P51, DOI 10.3354/meps09397; Satyanarayana B, 2011, INT J REMOTE SENS, V32, P1635, DOI 10.1080/01431160903586781; Schmidt F., 2011, GEOSETTER VERSION 3; Schneider A., 2015, GPS VISUALIZER DO IT; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shafri Helmi Zulhaidi Mohd, 2007, Journal of Computer Sciences, V3, P419, DOI 10.3844/jcssp.2007.419.423; Spalding M., 2010, WETLANDS, V31, P1003, DOI 10.1007/s13157-011-0224-1; Strecha C., 2012, ISPRS ANN PHOTOGRAMM, VI, P311, DOI DOI 10.5194/ISPRSANNALS-I-3-311-2012; Sulong I., 2002, Environment Development and Sustainability, V4, P135, DOI 10.1023/A:1020844620215; Tang LN, 2015, J FORESTRY RES, V26, P791, DOI 10.1007/s11676-015-0088-y; Thi VT, 2014, BIOGEOSCIENCES, V11, P3781, DOI 10.5194/bg-11-3781-2014; Thomlinson JR, 1999, REMOTE SENS ENVIRON, V70, P16, DOI 10.1016/S0034-4257(99)00055-3; Tian JY, 2017, INT J APPL EARTH OBS, V61, P22, DOI 10.1016/j.jag.2017.05.002; Tucker CJ, 1980, INT J REMOTE SENS, V1, P241, DOI DOI 10.1080/01431168008948235; Van TT, 2015, ACTA OECOL, V63, P71, DOI 10.1016/j.actao.2014.11.007; Ventura D, 2016, ESTUAR COAST SHELF S, V171, P85, DOI 10.1016/j.ecss.2016.01.030; Wang L, 2004, INT J REMOTE SENS, V25, P5655, DOI 10.1080/014311602331291215; Wang L, 2004, REMOTE SENS ENVIRON, V91, P432, DOI 10.1016/j.rse.2004.04.005; Wu ST, 2014, CAN J REMOTE SENS, V40, P315, DOI 10.1080/07038992.2014.979488; Zainun I., 2007, SOCIOECONOMIC ASPECT; Zhang J, 2016, BIOL CONSERV, V198, P60, DOI 10.1016/j.biocon.2016.03.027; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	91	58	60	11	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200288	10.1371/journal.pone.0200288	http://dx.doi.org/10.1371/journal.pone.0200288			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020959	gold, Green Submitted, Green Published			2022-12-26	WOS:000439022400045
J	Alkaissi, H; Havarinasab, S; Nielsen, JB; Soderkvist, P; Hultman, P				Alkaissi, Hammoudi; Havarinasab, Said; Nielsen, Jesper Bo; Soderkvist, Peter; Hultman, Per			Bank1 and NF-kappaB as key regulators in anti-nucleolar antibody development	PLOS ONE			English	Article							MERCURY-INDUCED AUTOIMMUNITY; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; IMMUNE-COMPLEX DEPOSITS; ANTINUCLEAR ANTIBODIES; B-CELLS; MICE; RECEPTOR; DISEASE; MOUSE	Systemic autoimmune rheumatic disorders (SARD) represent important causes of morbidity and mortality in humans. The mechanisms triggering autoimmune responses are complex and involve a network of genetic factors. Mercury-induced autoimmunity (HgIA) in mice is an established model to study the mechanisms of the development of antinuclear antibodies (ANA), which is a hallmark in the diagnosis of SARD. A.SW mice with HgIA show a significantly higher titer of antinucleolar antibodies (ANoA) than the B10.S mice, although both share the same MHC class II (H-2). We applied a genome-wide association study (GWAS) to their Hg-exposed F2 offspring to investigate the non-MHC genes involved in the development of ANoA. Quantitative trait locus (QTL) analysis showed a peak logarithm of odds ratio (LOD) score of 3.05 on chromosome 3. Microsatellites were used for haplotyping, and fine mapping was conducted with next generation sequencing. The candidate genes Bank1 (B-cell scaffold protein with ankyrin repeats 1) and Nfkbl (nuclear factor kappa B subunit 1) were identified by additional QTL analysis. Expression of the Bank1 and Nfkb1 genes and their downstream target genes involved in the intracellular pathway (Tlr9,II6, Tnf) was investigated in mercury-exposed A.SW and B10.S mice by real-time PCR. Bank1 showed significantly lower gene expression in the A.SW strain after Hg-exposure, whereas the B10.S strain showed no significant difference. Nfkb1, Tlr9, II6 and Tnf had significantly higher gene expression in the A.SW strain after Hg-exposure, while the B10.S strain showed no difference. This study supports the roles of Bank1 (produced mainly in B-cells) and Nfkbl (produced in most immune cells) as key regulators of ANoA development in HgIA.	[Alkaissi, Hammoudi; Havarinasab, Said; Hultman, Per] Linkoping Univ, Dept Clin Pathol & Clin Genet, Mol & Immunol Pathol, Linkoping, Sweden; [Alkaissi, Hammoudi; Havarinasab, Said; Hultman, Per] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Nielsen, Jesper Bo] Univ Southern Denmark, Inst Publ Hlth, Res Unit Gen Practice, Odense C, Denmark; [Soderkvist, Peter] Linkoping Univ, Dept Clin & Expt Med, Cell Biol, Linkoping, Sweden	Linkoping University; Linkoping University; University of Southern Denmark; Linkoping University	Alkaissi, H (corresponding author), Linkoping Univ, Dept Clin Pathol & Clin Genet, Mol & Immunol Pathol, Linkoping, Sweden.; Alkaissi, H (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	hammoudi.alkaissi@liu.se		Alkaissi, Hammoudi/0000-0003-4867-105X	Swedish Research Council Branch of Medicine; County Council of Ostergotland; Linkoping University	Swedish Research Council Branch of Medicine(Swedish Research Council); County Council of Ostergotland; Linkoping University	This work was supported by the Swedish Research Council Branch of Medicine, the County Council of Ostergotland, and funds from Linkoping University. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Alkaissi H, 2016, ENVIRON HEALTH PERSP, V124, P920, DOI 10.1289/ehp.1409284; Angelotti F, 2017, CLIN EXP RHEUMATOL, V35, P368; Ashok Kumar T, 2013, WIDE SPECTRUM, V1, P15, DOI DOI 10.5281/ZENODO.50733; Atkinson TP, 2012, CURR OPIN RHEUMATOL, V24, P515, DOI 10.1097/BOR.0b013e32835680c6; Bao Y, 2014, J AUTOIMMUN, V55, P10, DOI 10.1016/j.jaut.2014.04.001; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Barr TA, 2010, J IMMUNOL, V185, P2783, DOI 10.4049/jimmunol.1001431; Bengtsson AA, 2017, J INTERN MED, V281, P52, DOI 10.1111/joim.12529; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Bridges CC, 2004, J AM SOC NEPHROL, V15, P663, DOI 10.1097/01.ASN.0000113553.62380.F5; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chaturvedi A, 2008, IMMUNITY, V28, P799, DOI 10.1016/j.immuni.2008.03.019; CHURCHILL GA, 1994, GENETICS, V138, P963; Crowe W, 2017, AUTOIMMUN REV, V16, P72, DOI 10.1016/j.autrev.2016.09.020; Dong F, 2001, NUCLEIC ACIDS RES, V29, P3248, DOI 10.1093/nar/29.15.3248; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gutierrez-Arcelus M, 2016, NAT REV GENET, V17, P160, DOI 10.1038/nrg.2015.33; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hanley GA, 1997, CLIN IMMUNOL IMMUNOP, V84, P328, DOI 10.1006/clin.1997.4405; Havarinasab S, 2006, TOXICOL APPL PHARM, V214, P43, DOI 10.1016/j.taap.2005.12.004; Havarinasab S, 2009, CLIN EXP IMMUNOL, V155, P567, DOI 10.1111/j.1365-2249.2008.03831.x; HULTMAN P, 1988, CLIN EXP IMMUNOL, V71, P269; HULTMAN P, 1987, CLIN EXP IMMUNOL, V67, P283; Hultman P, 1996, J AUTOIMMUN, V9, P139, DOI 10.1006/jaut.1996.0017; Hultman P, 2001, J AUTOIMMUN, V17, P27, DOI 10.1006/jaut.2001.0521; Hultman P, 1999, TOXICOL APPL PHARM, V154, P203, DOI 10.1006/taap.1998.8576; Ishihara K, 2002, CYTOKINE GROWTH F R, V13, P357, DOI 10.1016/S1359-6101(02)00027-8; Janeways K M., 2012, JANEWAYS IMMUNOBIOLO, P612; Johansson U, 1998, INT ARCH ALLERGY IMM, V116, P295, DOI 10.1159/000023959; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kochi Y, 2016, INT IMMUNOL, V28, P155, DOI 10.1093/intimm/dxw002; Kono DH, 1998, J IMMUNOL, V161, P234; Kono DH, 2001, J IMMUNOL, V167, P2396, DOI 10.4049/jimmunol.167.4.2396; Kozyrev SV, 2012, GENES IMMUN, V13, P129, DOI 10.1038/gene.2011.62; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lafontaine DLJ, 2000, MOL CELL BIOL, V20, P2650, DOI 10.1128/MCB.20.8.2650-2659.2000; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manichaikul A, 2007, GENETICS, V177, P1963, DOI 10.1534/genetics.107.080093; Matzaraki V, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1207-1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Molnarfi N, 2013, J EXP MED, V210, P2921, DOI 10.1084/jem.20130699; Newton K, 2003, MOL CELL BIOL, V23, P8519, DOI 10.1128/MCB.23.23.8519-8527.2003; Nielsen JB, 2002, ENVIRON HEALTH PERSP, V110, P877, DOI 10.1289/ehp.02110s5877; Nishimoto N, 2000, ANN RHEUM DIS, V59, P21, DOI 10.1136/ard.59.suppl_1.i21; Ohtsuka T, 2010, J DERMATOL, V37, P801, DOI 10.1111/j.1346-8138.2010.00883.x; PIETSCH P, 1989, INT ARCH ALLER A IMM, V90, P47, DOI 10.1159/000234999; Pollard KM, 1997, J IMMUNOL, V158, P3521; Pollard KM, 1997, MET IONS BIOL SYST, V34, P421; ROBINSON CJG, 1984, CLIN EXP IMMUNOL, V58, P300; Rubio-Rivas M, 2017, CLIN RHEUMATOL, V36, P569, DOI 10.1007/s10067-016-3533-1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu YY, 2013, J IMMUNOL, V191, P6110, DOI 10.4049/jimmunol.1301203; Yi AK, 2003, INT IMMUNOL, V15, P577, DOI 10.1093/intimm/dxg058; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83	62	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0199979	10.1371/journal.pone.0199979	http://dx.doi.org/10.1371/journal.pone.0199979			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016332	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600014
J	Doggett, JW; Locher, A				Doggett, Jacob W.; Locher, Alexandra			Assessment of northern bobwhite survival and fitness in the West Gulf Coastal Plain ecoregion	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; NEST-SITE SELECTION; HOME-RANGE; MICROHABITAT SELECTION; POPULATION; HABITAT; REPRODUCTION; OKLAHOMA; SUCCESS; RESTORATION	In the West Gulf Coastal Plains (WGCP) northern bobwhite (Colinus virginianus) are declining faster than range-wide averages and such declines have been linked to the consequences of land management. Management for the endangered red-cockaded woodpecker (Picoides borealis) has benefitted northern bobwhite by restoring mature pine-grassland ecosystems in some areas of the region. However, at Felsenthal National Wildlife Refuge, Crossett, Arkansas, USA, the bobwhite population was not increasing despite the availability of seemingly suitable habitat from management for the endangered species. To understand factors that may be affecting bobwhite survival on Felsenthal National Wildlife Refuge we conducted a telemetry study and assessed summer survival, brood survival, and nest success from 1 April- 11 August in 2013 and 1 April- 15 August in 2014. We also calculated home-range sizes and measured microhabitat characteristics around nests. Summer survival rates were 71% (SE = 0.17) and 47% (SE = 0.14); while nest success was 47% (SE = 0.02) and 100% for 2013 and 2014, respectively. Between years, both 95% and 50% kernel home-ranges were not different (pooled, 63.92 +/- 6.07 ha and 14.94 +/- 1.75 ha); however minimum convex polygon home-range sizes were (113.8 +/- 20.1 ha in 2013; and 393.1 +/- 49.0 ha in 2014, P < 0.001). Only numerical differences in microhabitat vegetation characteristics of nest sites and non- nest sites were observed. We suggest management for red-cockaded woodpeckers supports bobwhite populations but only as a buffer against more severe declines. Since bobwhites are declining range-wide, we believe areas federally managed for red-cockaded woodpeckers will become increasingly more important for sustaining regional bobwhite population levels.	[Doggett, Jacob W.] Montana Fish Wildlife & Pk, Great Falls, MT USA; [Doggett, Jacob W.; Locher, Alexandra] Grand Valley State Univ, Biol Dept, Allendale, MI 49401 USA	Grand Valley State University	Locher, A (corresponding author), Grand Valley State Univ, Biol Dept, Allendale, MI 49401 USA.	lochera@gvsu.edu			US Fish and Wildlife Service; Grand Valley State University; Special Projects Assistantship	US Fish and Wildlife Service(US Fish & Wildlife Service); Grand Valley State University; Special Projects Assistantship	This work was supported by the following: US Fish and Wildlife Service: $27,626. October 1, 2011 - November 1, 2014; Grand Valley State University: $16,000. Special Projects Assistantship to support graduate student.	Amlaner CJ., 1988, INT BIOTELEM S, P263; [Anonymous], 2002, NO BOBWHITE CONSERVA; Bell B, 1985, P ANN C SE ASS FISH, V39, P512; Berkman LK, 2013, CONSERV GENET, V14, P323, DOI 10.1007/s10592-013-0471-1; Bowman JL, 1999, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL CONFERENCE OF THE SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P220; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; BURGER LW, 1995, J WILDLIFE MANAGE, V59, P401, DOI 10.2307/3808954; BURGER LW, 1995, J WILDLIFE MANAGE, V59, P417, DOI 10.2307/3802447; Burke JD, 2008, J WILDLIFE MANAGE, V72, P1361, DOI 10.2193/2007-290; Chamberlain Michael J., 2005, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V59, P10; Collins BM, 2009, WILSON J ORNITHOL, V121, P688, DOI 10.1676/09-040.1; Cox SA, 2005, J WILDLIFE MANAGE, V69, P133, DOI 10.2193/0022-541X(2005)069<0133:RBNBIW>2.0.CO;2; Cox SA, 2004, J WILDLIFE MANAGE, V68, P663, DOI 10.2193/0022-541X(2004)068[0663:SACMON]2.0.CO;2; Cram DS, 2002, J WILDLIFE MANAGE, V66, P1031, DOI 10.2307/3802935; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; De Vos T., 1993, P NATL QUAIL S, P83; DEMASO SJ, 1992, WILDLIFE SOC B, V20, P94; DeMaso SJ, 1997, J WILDLIFE MANAGE, V61, P846, DOI 10.2307/3802193; DEVOS T, 1995, WILDLIFE SOC B, V23, P267; Dimmick RW, 1974, P ANN C SE ASS GAM F, V28, P594; Dumke R.T., 1973, USDA TECHNICAL B, V72; Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x; Engstrom R. T., 2005, PSWGTR191 USDA FOR S; ERRINGTON PL, 1945, ECOL MONOGR, V15, P1, DOI 10.2307/1943293; FIES M L, 1992, Virginia Journal of Science, V43, P143; Fies M. L., 2000, QUAIL 4, V4, P96; Folk TH, 2007, POPUL ECOL, V49, P211, DOI 10.1007/s10144-007-0037-5; Gates R.J., 2012, P 7 NAT QUAIL S TUCS, P184; Gotmark F, 1995, J AVIAN BIOL, V26, P305, DOI 10.2307/3677045; Gottschalk JS, 2011, FED REGISTER, V35, P16047; Guthery F.S., 2000, ON BOBWHITES; Guthery FS, 2004, WILDLIFE SOC B, V32, P194, DOI 10.2193/0091-7648(2004)32[194:RSAWRN]2.0.CO;2; GUTHERY FS, 1988, J WILDLIFE MANAGE, V52, P144, DOI 10.2307/3801075; Guthery FS, 1998, J WILDLIFE MANAGE, V62, P540, DOI 10.2307/3802327; Hernandez F, 2007, J WILDLIFE MANAGE, V71, P895, DOI 10.2193/2006.101; Horne JS, 2009, ANIMAL SPACE USE; Hunter WC, 1994, PROCEEDINGS OF THE FORTY-EIGHTH ANNUAL CONFERENCE - SOUTHEASTERN ASSOCIATION OF FISH AND WILDLIFE AGENCIES, P383; Jackson C, 2015, STRATEGIC QUAIL MANA; Jackson Jerome A., 1994, Birds of North America, V85, P1; Janke AK, 2015, CONDOR, V117, P41, DOI 10.1650/CONDOR-14-115.1; Janke AK, 2013, J WILDLIFE MANAGE, V77, P405, DOI 10.1002/jwmg.461; JOHNSON DH, 1979, AUK, V96, P651; Kabat C., 1963, WISCONSIN CONSERVATI, V30; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keane RE, 2006, 164CD RMRSGTR USDA F; Klimstra WD, 2006, NESTING ECOLOGY BOBW; LEHMANN VW, 1946, J WILDLIFE MANAGE, V10, P111, DOI 10.2307/3796072; Leif A, 1993, P NATL QUAIL S, P126; Liu X., 2002, QUAIL 5, P168; Lohr M, 2011, J WILDLIFE MANAGE, V75, P52, DOI 10.1002/jwmg.25; Lusk JJ, 2006, J WILDLIFE MANAGE, V70, P564, DOI 10.2193/0022-541X(2006)70[564:FINBNS]2.0.CO;2; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; McKenzie DF, 2016, NBCIS BOBWHITE ALMAN; National Bobwhite Technical Committee [NBTC], 2011, NATL BOBWHITE TECHNI; National Climate Data Center, 2014, NCDC REL 2014 GLOB C; Palmer WE, 2011, NATL BOBWHITE CONSER; Parnell IB, 2002, P 5 NAT QUAIL S, P158; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Potter LM, 2011, J WILDLIFE MANAGE, V75, P46, DOI 10.1002/jwmg.18; Puckett K, 1995, P ANN C SE ASS FISH, V49, P507; Rasband WS, 1997, IMAGEJ; Rolland V, 2011, EUR J WILDLIFE RES, V57, P717, DOI 10.1007/s10344-010-0479-5; Roseberry J.L., 1984, POPULATION ECOLOGY B; ROSEBERRY JL, 1987, WILDLIFE SOC B, V15, P449; Sandercock BK, 2008, J WILDLIFE MANAGE, V72, P970, DOI 10.2193/2007-124; Sauer J.R., 2017, N AM BREEDING BIRD S; Schroeder RL, 1985, US FISH WILDL SERV B, V82; Seaman DE, 1996, ECOLOGY, V77, P2075, DOI 10.2307/2265701; Simpson R.C., 1972, P NATIONAL BOBWHITE, V1, P199; Singh A, 2011, EUR J WILDLIFE RES, V57, P15, DOI 10.1007/s10344-010-0393-x; Sisson DC, 2002, QUAIL 4, V5; Staller EL, 2005, J WILDLIFE MANAGE, V69, P124, DOI 10.2193/0022-541X(2005)069&lt;0124:IPANBN&gt;2.0.CO;2; Stoddard JL, 1931, BOBWHITE QUAIL ITS H; Tanner EP, 2012, THESIS; Taylor JS, 1999, J WILDLIFE MANAGE, V63, P675, DOI 10.2307/3802657; Taylor JS, 1999, J WILDLIFE MANAGE, V63, P686, DOI 10.2307/3802658; Terhune TM, 2007, J WILDLIFE MANAGE, V71, P1288, DOI 10.2193/2005-640; Terhune TM, 2010, ECOLOGICAL APPL, P1040; Townsend DE, 2003, AM MIDL NAT, V150, P73, DOI 10.1674/0003-0031(2003)150[0073:FCABAW]2.0.CO;2; Townsend DE, 2001, J RANGE MANAGE, V54, P260, DOI 10.2307/4003244; Twedt DJ, 2007, J WILDLIFE MANAGE, V71, P1808, DOI 10.2193/2006-567; Twedt DJ, 2006, CONSERV BIOL, V20, P100, DOI 10.1111/j.1523-1739.2005.00303.x; United States Fish and Wildlife Service (USFWS), 2010, COMPR CONS PLAN FELS; United States Fish and Wildlife Service (USFWS), 2010, DRAFT COMPR CONS PLA; Urban D, 1972, P 1 NAT BOBWH QUAIL, V1, P194; *USFWS, 1985, RED COCK WOODP REC P; Weil ND, 2012, THESIS; West, 2012, PROCL NAT QUAIL S, V7, P217; WHITE DH, 1990, B ENVIRON CONTAM TOX, V44, P73, DOI 10.1007/BF01702364; White G.C., 1990, ANAL WILDLIFE RADIO; WILEY MJ, 2012, P NATL QUAIL S, V7, P235; Williams CK, 2004, WILDLIFE SOC B, V32, P861, DOI 10.2193/0091-7648(2004)032<0861:TNBDSO>2.0.CO;2; Williams CK, 2003, ECOLOGY, V84, P2654, DOI 10.1890/03-0038; WINKER K, 1995, OECOLOGIA, V101, P211, DOI 10.1007/BF00317286; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yoho NS., 1972, NATL QUAIL S P, V1, P90; [No title captured]	97	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200544	10.1371/journal.pone.0200544	http://dx.doi.org/10.1371/journal.pone.0200544			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016337	Green Published, gold			2022-12-26	WOS:000438866600027
J	Schmahl, MJ; Regan, DP; Rivers, AC; Joesten, WC; Kennedy, MA				Schmahl, Michelle J.; Regan, Daniel P.; Rivers, Adam C.; Joesten, William C.; Kennedy, Michael A.			NMR-based metabolic profiling of urine, serum, fecal, and pancreatic tissue samples from the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; INTRAEPITHELIAL NEOPLASIA; METABOANALYST; METABONOMICS; STATISTICS; PATHWAYS; HMDB; CLASSIFICATION; EXCRETION; HIPPURATE	Pancreatic cancer is the third leading cause of cancer deaths in the United States with more than 53,000 expected to be diagnosed with the disease in 2018. The median survival time after diagnosis is four to six months. The poor survival statistics are due in part to the fact that pancreatic cancer is typically asymptomatic until it reaches advanced stages of the disease. Although surgical resection provides the best chance of survival, pancreatic cancer is rarely detected when surgery is still possible due, in part, to lack of effective biomarkers for early detection. The goal of the research reported here was to determine if it was possible to identify metabolic biomarkers for detection of pre-cancerous pancreatic intraepithelial neoplasia (PanIN) that precede pancreatic adenocarcinoma. The transgenic Ptf1a-Cre; LSL-KrasG12D mouse strain was used as a model of pancreatic cancer progression. Nuclear magnetic resonance (NMR) spectroscopy was employed to compare metabolic profiles of urine, sera, fecal extracts, and pancreatic tissue extracts collected from control and study mice aged 5, 11, and 15 months, including 47 mice with tumors. We were able to identify the following potential biomarkers: decreased 3-indoxylsulfate, benzoate and citrate in urine, decreased glucose, choline, and lactate in blood, and decreased phenylalanine and benzoate and increased acetoin in fecal extracts. Potential biomarkers were validated by p-values, PLS-DA VIP scores, and accuracies based on area under ROC curve analyses. Essentially, all of the metabolic profiling changes could be explained as being associated with the consequences of bicarbonate wasting caused by a complete substitution of the normal pancreatic acinar tissue by tissue entirely composed of PanIN. Given the nature of the mouse model used here, our results indicate that it may be possible to use NMR-based metabolic profiling to identify biomarkers for detection of precancerous PanIN that immediately precede pancreatic cancer.	[Schmahl, Michelle J.; Regan, Daniel P.; Rivers, Adam C.; Joesten, William C.; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA	University System of Ohio; Miami University	Kennedy, MA (corresponding author), Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.	kennedm4@miamioh.edu	Kennedy, Michael/M-2578-2019; Kennedy, Michael/ABE-6002-2021	Kennedy, Michael/0000-0001-6462-665X; Regan, Daniel/0000-0002-6363-0144	NIH/NCI [1R15CA152985]; Miami University Undergraduate Research Award Program; Miami University Undergraduate Summer Scholars Program; Miami University Doctoral Undergraduate Opportunity for Scholarship Program; NATIONAL CANCER INSTITUTE [R15CA152985] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Miami University Undergraduate Research Award Program; Miami University Undergraduate Summer Scholars Program; Miami University Doctoral Undergraduate Opportunity for Scholarship Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work conducted in this study was supported by a grant from the NIH/NCI (1R15CA152985) to MAK. The authors would like to acknowledge support from the Miami University Undergraduate Research Award Program, the Miami University Undergraduate Summer Scholars Program and the Miami University Doctoral Undergraduate Opportunity for Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth SC, 2013, COMPUT STRUCT BIOTEC, V4, DOI 10.5936/csbj.201301003; Bralley AA, 2013, TXB NATURAL MED, P224; Cameron JL, 2015, J AM COLL SURGEONS, V220, P530, DOI 10.1016/j.jamcollsurg.2014.12.031; Chihanga T, 2018, AM J PHYSIOL-RENAL, V314, pF154, DOI 10.1152/ajprenal.00363.2017; Chuvin N, 2017, CELL MOL GASTROENTER, V4, P263, DOI 10.1016/j.jcmgh.2017.05.005; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Eser S, 2011, P NATL ACAD SCI USA, V108, P9945, DOI 10.1073/pnas.1100890108; Fang F, 2007, CANCER SCI, V98, P1678, DOI 10.1111/j.1349-7006.2007.00589.x; Farrell James J., 2005, Cancer Biomarkers, V1, P157; Fesinmeyer MD, 2005, CANCER EPIDEM BIOMAR, V14, P1766, DOI 10.1158/1055-9965.EPI-05-0120; Geng WP, 1999, J PHARMACOL EXP THER, V288, P597; Goodpaster AM, 2011, CHEMOMETR INTELL LAB, V109, P162, DOI 10.1016/j.chemolab.2011.08.009; Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005; Hackert Thilo, 2014, Viszeralmedizin, V30, P190, DOI 10.1159/000363778; Halfdanarson TR, 2008, ENDOCR-RELAT CANCER, V15, P409, DOI 10.1677/ERC-07-0221; Haug U, 2008, EXPERT REV MOL DIAGN, V8, P753, DOI 10.1586/14737159.8.6.753; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hollenbeck Clarie B., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P100; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Hurton S, 2014, PANCREAS, V43, P879, DOI 10.1097/MPA.0000000000000147; Jain D., 2018, CHRONIC PANCREATITIS; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Joesten WC, 2018, METABOLOMICS; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Kanda M, 2012, GASTROENTEROLOGY, V142, P730, DOI 10.1053/j.gastro.2011.12.042; Kobayashi T, 2013, CANCER EPIDEM BIOMAR, V22, P571, DOI 10.1158/1055-9965.EPI-12-1033; Kota Sunil Kumar, 2013, Indian J Endocrinol Metab, V17, P799, DOI 10.4103/2230-8210.117208; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Lord RS, 2008, ALTERN MED REV, V13, P292; Macgregor-Das AM, 2013, J SURG ONCOL, V107, P8, DOI 10.1002/jso.23213; Melamed P, 2014, J PANCREAS, V15, P552, DOI 10.6092/1590-8577/2854; Morrow AL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-13; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Ottenhof NA, 2009, ARCH PATHOL LAB MED, V133, P375, DOI 10.1043/1543-2165-133.3.375; Park H.W., 2012, COLD SPRING HARB PER, V2; Romick-Rosendale LE, 2012, J MOL BIOMARK DIA S3; Romick-Rosendale LE, 2014, METABOLOMICS, V10, P8, DOI 10.1007/s11306-013-0546-5; Romick-Rosendale LE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3530; Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511; RUDMAN D, 1980, NEW ENGL J MED, V303, P657, DOI 10.1056/NEJM198009183031201; SAKHAEE K, 1993, J BONE MINER RES, V8, P789; Shi ZQ, 2014, PLOS ONE, V9; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Thiamin R., 1998, DIET REF INT THIAM R; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Usui Yukio, 2003, Tokai J Exp Clin Med, V28, P65; Veite-Schmahl MJ, 2017, JOVE-J VIS EXP, DOI 10.3791/55647; Veite-Schmahl MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187552; Veite-Schmahl MJ, 2017, BRIT J CANCER, V117, P639, DOI 10.1038/bjc.2017.216; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang AS, 2014, NMR BIOMED, V27, P1361, DOI 10.1002/nbm.3198; Wang B, 2015, METABOLOMICS, V11, P1243, DOI 10.1007/s11306-015-0782-y; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Watanabe M., 2012, J MOL BIOMARK DIAGN, V3, DOI [10.4172/2155-9929.S3-002, DOI 10.4172/2155-9929.S3-002]; Watanabe M, 2012, METABOLOMICS, V8, P854, DOI 10.1007/s11306-011-0380-6; Watanabe M, 2011, INT J PEPT RES THER, V17, P281, DOI 10.1007/s10989-011-9264-x; Weber D, 2015, BLOOD, V126, P1723, DOI 10.1182/blood-2015-04-638858; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Wishart DS, 1997, J BIOMOL NMR, V10, P329, DOI 10.1023/A:1018373822088; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xiao ZJ, 2007, CRIT REV MICROBIOL, V33, P127, DOI 10.1080/10408410701364604; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zuckerman Jack M, 2009, Rev Urol, V11, P134	76	9	9	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200658	10.1371/journal.pone.0200658	http://dx.doi.org/10.1371/journal.pone.0200658			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016349	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600031
J	Cholvin, T; Giorgi, L; Baril, N; Brezun, JM; Poucet, B; Chaillan, FA				Cholvin, Thibault; Giorgi, Lisa; Baril, Nathalie; Brezun, Jean-Michel; Poucet, Bruno; Chaillan, Franck A.			Using MRI to predict the fate of excitotoxic lesions in rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBRAL-ISCHEMIA; T2-WEIGHTED MRI; ISOFLURANE; EVOLUTION; SECTIONS; STROKE; MODEL; AREA	Excitotoxic lesions are frequently used to assess the role of cerebral structures in cognitive processes in rodents. However, the precise site and extent of these lesions remain unknown without histological verifications. Using a 7-Teslas MRI system and a T2-weighted turbo-RARE sequence, MR images were acquired at several time points following NMDA lesions (1h, 6h, 24h, 48h, 1 week and 2 weeks). NMDA infusions into the parenchyma induced a clear and delineable hyperintense signal from 1 h up to 1-week post-surgery. Hyperintensity volumes were compared with NeuN and Cresyl violet histological quantifications of the lesion magnitude. NMDA-induced hypersignal is observed as soon as 1 h post-injection and is a reliable estimate of the presence (or absence) of a lesion. Compared to NeuN, Cresyl violet staining underestimates the extent of the lesion in significant proportions. The MRI hyperintensity generated by NMDA instillation into the parenchyma can be used as a powerful tool to confirm the diffusion of the drug into the cerebral tissue, to ascertain the locus of injection and predict with a high success rate the fate of NMDA lesions as soon as 1 h post-surgery. This approach could be very useful in a large variety of lesion studies in rodents.	[Cholvin, Thibault; Giorgi, Lisa; Poucet, Bruno; Chaillan, Franck A.] Aix Marseille Univ, CNRS, LNC, Marseille, France; [Cholvin, Thibault; Baril, Nathalie; Poucet, Bruno; Chaillan, Franck A.] Aix Marseille Univ, CNRS, Federat 3C, Marseille, France; [Brezun, Jean-Michel] Aix Marseille Univ, Inst Sci Mouvement UMR 7287, Equipe Plasticite Syst Nerveux & Musculaire PSNM, Fac Sci Sport, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Chaillan, FA (corresponding author), Aix Marseille Univ, CNRS, LNC, Marseille, France.; Chaillan, FA (corresponding author), Aix Marseille Univ, CNRS, Federat 3C, Marseille, France.	franck.chaillan@univ-amu.fr	Poucet, Bruno/B-4019-2010	Poucet, Bruno/0000-0003-2704-804X; Cholvin, Thibault/0000-0002-9964-7693; Chaillan, Franck Antoine/0000-0002-5518-9627	Aix Marseille Univ, CNRS, Agence Nationale de la recherche [ANR-14-CE13-0029-02]	Aix Marseille Univ, CNRS, Agence Nationale de la recherche	This work was supported by Aix Marseille Univ, CNRS, Agence Nationale de la recherche (ANR-14-CE13-0029-02 "THALAME") to BP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey P, 2005, J NEUROSCI METH, V145, P233, DOI 10.1016/j.jneumeth.2005.01.006; Basile BM, 2017, FRONT INTEGR NEUROSC, V11, DOI 10.3389/fnint.2017.00012; BENVENISTE H, 1992, STROKE, V23, P746, DOI 10.1161/01.STR.23.5.746; Brace H, 1997, BRAIN RES BULL, V43, P447, DOI 10.1016/S0361-9230(97)00064-6; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; CAMPAGNE MV, 1994, J CEREBR BLOOD F MET, V14, P1011, DOI 10.1038/jcbfm.1994.133; Cholvin T, 2018, J NEUROSCI, V38, P158, DOI 10.1523/JNEUROSCI.2039-17.2017; Cross DJ, 2006, NEUROIMAGE, V32, P1265, DOI 10.1016/j.neuroimage.2006.04.229; Cruz-Orive LM, 1999, J MICROSC-OXFORD, V193, P182, DOI 10.1046/j.1365-2818.1999.00460.x; Dijkhuizen RM, 1996, NMR BIOMED, V9, P84, DOI 10.1002/(SICI)1099-1492(199604)9:2<84::AID-NBM401>3.0.CO;2-B; Fau S, 2013, AM J NEURORADIOL, V34, pE73, DOI 10.3174/ajnr.A3069; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Haseneder R, 2009, EUR J PHARMACOL, V623, P47, DOI 10.1016/j.ejphar.2009.09.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; John J, 1996, BRAIN RES BULL, V40, P273, DOI 10.1016/0361-9230(96)00047-0; KING MD, 1991, MAGNET RESON MED, V20, P158, DOI 10.1002/mrm.1910200117; Kumar VM, 1996, NEUROSCI RES, V24, P207, DOI 10.1016/0168-0102(95)00995-7; Laurent D, 1996, NEUROSCI LETT, V213, P209; Lingamaneni R, 2001, ANESTHESIOLOGY, V95, P1460, DOI 10.1097/00000542-200112000-00027; Malkova L, 2001, HIPPOCAMPUS, V11, P361, DOI 10.1002/hipo.1050.abs; Milidonis X, 2015, STROKE, V46, P843, DOI 10.1161/STROKEAHA.114.007560; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; MOSELEY ME, 1990, MAGN RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; STEWART GR, 1986, BRAIN RES, V369, P377, DOI 10.1016/0006-8993(86)90555-X; Tourdias T, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-143; Turtzo LC, 2013, NMR BIOMED, V26, P468, DOI 10.1002/nbm.2886; VERHEUL HB, 1993, BRAIN RES, V618, P203, DOI 10.1016/0006-8993(93)91267-V	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200659	10.1371/journal.pone.0200659	http://dx.doi.org/10.1371/journal.pone.0200659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001411	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400093
J	Ghanipoor-Samami, M; Javadmanesh, A; Burns, BM; Thomsen, DA; Nattrass, GS; Estrella, CAS; Kind, KL; Hiendleder, S				Ghanipoor-Samami, Mani; Javadmanesh, Ali; Burns, Brian M.; Thomsen, Dana A.; Nattrass, Greg S.; Estrella, Consuelo Amor S.; Kind, Karen L.; Hiendleder, Stefan			Atlas of tissue- and developmental stage specific gene expression for the bovine insulin-like growth factor (IGF) system	PLOS ONE			English	Article							FACTOR BINDING-PROTEINS; FACTOR-I GENE; MESSENGER-RNA VARIANTS; AMNIOTIC-FLUID VOLUME; LEADER-EXON USAGE; RECEPTOR GENE; HORMONE RECEPTOR; NONCODING RNA; OVINE INSULIN; INITIAL-CHARACTERIZATION	The insulin-like growth factor (IGF) axis is fundamental for mammalian growth and development. However, no comprehensive reference data on gene expression across tissues and pre- and postnatal developmental stages are available for any given species. Here we provide systematic promoter- and splice variant specific information on expression of IGF system components in embryonic (Day 48), fetal (Day 153), term (Day 277, placenta) and juvenile (Day 365-396) tissues of domestic cow, a major agricultural species and biomedical model. Analysis of spatiotemporal changes in expression of IGF1, IGF2, IGF1 R, IGF2R, IGFBP1-8 and IR genes, as well as IncRNAs H19 and AIRN, by qPCR, indicated an overall increase in expression from embryo to fetal stage, and decrease in expression from fetal to juvenile stage. The stronger decrease in expression of IncRNAs (average -16-fold) and ligands (average -12.1-fold) compared to receptors (average -5.7-fold) and binding proteins (average -4.3-fold) is consistent with known functions of IGF peptides and supports important roles of IncRNAs in prenatal development. Pronounced overall reduction in postnatal expression of IGF system components in lung (-12.9-fold) and kidney (-13.2-fold) are signatures of major changes in organ function while more similar hepatic expression levels (-2.2-fold) are evidence of the endocrine rather than autocrine/paracrine role of IGFs in postnatal growth regulation. Despite its rapid growth, placenta displayed a more stable expression pattern than other organs during prenatal development. Quantitative analyses of contributions of promoters PO-P4 to global IGF2 transcript in fetal tissues revealed that P4 accounted for the bulk of transcript in all tissues but skeletal muscle. Demonstration of IGF2 expression in fetal muscle and postnatal liver from a promoter orthologous to mouse and human promoter PO provides further evidence for an evolutionary and developmental shift from placenta-specific PO-expression in rodents and suggests that some aspects of bovine IGF expression may be closer to human than mouse.	[Ghanipoor-Samami, Mani; Javadmanesh, Ali; Thomsen, Dana A.; Estrella, Consuelo Amor S.; Hiendleder, Stefan] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Ghanipoor-Samami, Mani; Javadmanesh, Ali; Thomsen, Dana A.; Estrella, Consuelo Amor S.; Kind, Karen L.; Hiendleder, Stefan] Univ Adelaide, Sch Anim & Vet Sci, Davies Res Ctr, JS Davies Epigenet & Genet Grp, Roseworthy Campus, Roseworthy, SA, Australia; [Burns, Brian M.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Anim Sci, Rockhampton, Qld, Australia; [Nattrass, Greg S.] SARDI, Livestock Syst, Roseworthy, SA, Australia; [Javadmanesh, Ali] Ferdowsi Univ Mashhad, Fac Agr, Dept Anim Sci, Mashhad, Iran; [Estrella, Consuelo Amor S.] Univ Philippines, Laguna, Philippines	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Queensland; Ferdowsi University Mashhad; University of the Philippines System; University of the Philippines Los Banos	Hiendleder, S (corresponding author), Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia.; Hiendleder, S (corresponding author), Univ Adelaide, Sch Anim & Vet Sci, Davies Res Ctr, JS Davies Epigenet & Genet Grp, Roseworthy Campus, Roseworthy, SA, Australia.	stefan.hiendleder@adelaide.edu.au	Kind, Karen/AAA-3811-2021; Javadmanesh, Ali/P-6065-2015	Kind, Karen/0000-0002-4674-9207; Javadmanesh, Ali/0000-0001-6016-5905	Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund; Iranian Ministry of Science, Research Technology; Australian Government	Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund(Australian GovernmentDepartment of Agriculture and Water Resources); Iranian Ministry of Science, Research Technology; Australian Government(Australian GovernmentCGIAR)	This work was funded by the JS Davies Bequest with support from the Queensland Government through the Department of Agriculture, Fisheries and Forestry's Reinvestment Fund. AJ and MGS received PhD Scholarships from the Iranian Ministry of Science, Research & Technology and CASE received an Australia Awards Scholarship provided by the Australian Government. SH is a JS Davies Professorial Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Ainscough JFX, 2000, MECH DEVELOP, V91, P365, DOI 10.1016/S0925-4773(99)00289-0; Alfieri CM, 2007, AM J PHYSIOL-CELL PH, V292, pC1887, DOI 10.1152/ajpcell.00506.2006; Allan GJ, 2001, REPRODUCTION, V122, P31, DOI 10.1530/reprod/122.1.31; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amarger V, 2002, MAMM GENOME, V13, P388, DOI 10.1007/s00335-001-3059-x; Anand-Ivell R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019821; BACH LA, 1995, ENDOCRINOLOGY, V136, P5061, DOI 10.1210/en.136.11.5061; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Beall MH, 2007, PLACENTA, V28, P816, DOI 10.1016/j.placenta.2006.11.009; Bebbere D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059564; Belfiore A, 2017, ENDOCR REV, V38, P379, DOI 10.1210/er.2017-00073; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Berkowicz EW, 2012, ANIM GENET, V43, P81, DOI 10.1111/j.1365-2052.2011.02211.x; Bloomfield FH, 2002, PEDIATR RES, V51, P361, DOI 10.1203/00006450-200203000-00016; Borel C, 2008, MAMM GENOME, V19, P503, DOI 10.1007/s00335-008-9137-6; BORNFELDT KE, 1989, J ENDOCRINOL, V122, P651, DOI 10.1677/joe.0.1220651; BOULLE N, 1993, J MOL ENDOCRINOL, V11, P117, DOI 10.1677/jme.0.0110117; Braidotti G, 2004, COLD SPRING HARB SYM, V69, P55, DOI 10.1101/sqb.2004.69.55; BRISMAR K, 1994, J CLIN ENDOCR METAB, V79, P872, DOI 10.1210/jc.79.3.872; BROWN AL, 1986, J BIOL CHEM, V261, P3144; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CARR JM, 1995, J ENDOCRINOL, V145, P545, DOI 10.1677/joe.0.1450545; Chango A, 2015, NUTRIENTS, V7, P2748, DOI 10.3390/nu7042748; Chu CH, 2008, J ENDOCRINOL, V197, P381, DOI 10.1677/JOE-07-0619; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Coulter CL, 1996, PLACENTA, V17, P451, DOI 10.1016/S0143-4004(96)90027-2; Curchoe C, 2005, BIOL REPROD, V73, P1275, DOI 10.1095/biolreprod.105.044727; Damon SE, 1997, EXP CELL RES, V237, P192, DOI 10.1006/excr.1997.3787; DAVIES SM, 1994, CANCER RES, V54, P2560; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DELHANTY PJD, 1993, ENDOCRINOLOGY, V132, P41, DOI 10.1210/en.132.1.41; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; DEPAGTERHOLTHUIZEN P, 1987, FEBS LETT, V214, P259, DOI 10.1016/0014-5793(87)80066-2; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; DICKSON MC, 1991, J MOL ENDOCRINOL, V6, P17, DOI 10.1677/jme.0.0060017; Dindot SV, 2004, MAMM GENOME, V15, P966, DOI 10.1007/s00335-004-2407-z; DONOVAN SM, 1989, ENDOCRINOLOGY, V125, P2621, DOI 10.1210/endo-125-5-2621; EKSTROM TJ, 1995, DEVELOPMENT, V121, P309; El-Shewy HM, 2007, J BIOL CHEM, V282, P26150, DOI 10.1074/jbc.M703276200; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Farmer WT, 2013, ANIM REPROD SCI, V138, P64, DOI 10.1016/j.anireprosci.2013.01.009; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Fowden AL, 2006, HORM RES, V65, P50, DOI 10.1159/000091506; Fowden AL, 2003, PLACENTA, V24, P803, DOI 10.1016/S0143-4004(03)00080-8; Frasca F, 1999, MOL CELL BIOL, V19, P3278, DOI 10.1128/mcb.19.5.3278; Frasca Francesco, 2008, Archives of Physiology and Biochemistry, V114, P23, DOI [10.1080/13813450801969715, 10.1080/13813450801969715 ]; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gabory A, 2010, BIOESSAYS, V32, P473, DOI 10.1002/bies.200900170; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Gerrard DE, 1999, J ANIM SCI, V77, P1431; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GIANNOUKAKIS N, 1993, NAT GENET, V4, P98, DOI 10.1038/ng0593-98; Goodall JJ, 2007, ANIM GENET, V38, P154, DOI 10.1111/j.1365-2052.2007.01576.x; GRAY A, 1987, DNA-J MOLEC CELL BIO, V6, P283, DOI 10.1089/dna.1987.6.283; HALL K, 1991, ACTA ENDOCRINOL-COP, V124, P48; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; Han VKM, 1996, HORM RES, V45, P160, DOI 10.1159/000184780; Haugk KL, 2000, ENDOCRINOLOGY, V141, P100, DOI 10.1210/en.141.1.100; Heude B, 2007, J CLIN ENDOCR METAB, V92, P2734, DOI 10.1210/jc.2006-1948; Hiendleder S, 2006, BIOL REPROD, V75, P17, DOI 10.1095/biolreprod.105.043919; HOLLY JMP, 1989, J ENDOCRINOL, V122, P611, DOI 10.1677/joe.0.1220611; Holt RIG, 2002, TRENDS ENDOCRIN MET, V13, P392, DOI 10.1016/S1043-2760(02)00697-5; HOLTHUIZEN P, 1990, BIOCHIM BIOPHYS ACTA, V1087, P341, DOI 10.1016/0167-4781(90)90010-Y; HOLTHUIZEN PE, 1993, REGUL PEPTIDES, V48, P77, DOI 10.1016/0167-0115(93)90337-8; Huang YZ, 2014, GENE, V534, P356, DOI 10.1016/j.gene.2013.09.111; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Hwa V, 2013, NESTLE NUTR WORKS SE, V71, P43, DOI 10.1159/000342548; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; JANSEN E, 1992, BIOCHEM BIOPH RES CO, V187, P1219, DOI 10.1016/0006-291X(92)90433-L; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Johnson JW, 2004, ORGAN RES METHODS, V7, P283, DOI 10.1177/1094428104266018; Johnson JW, 2000, MULTIVAR BEHAV RES, V35, P1, DOI 10.1207/S15327906MBR3501_1; Jospe N, 1996, CLIN ENDOCRINOL, V45, P229; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; Killian JK, 2001, HUM MOL GENET, V10, P1721, DOI 10.1093/hmg/10.17.1721; Kim HS, 1997, P NATL ACAD SCI USA, V94, P12981, DOI 10.1073/pnas.94.24.12981; KIND KL, 1995, J ENDOCRINOL, V146, P23, DOI 10.1677/joe.0.1460023; Klover P, 2007, ENDOCRINOLOGY, V148, P1489, DOI 10.1210/en.2006-1431; Kostecka Z, 2002, VET MED-CZECH, V47, P75, DOI 10.17221/5807-VETMED; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48; LEE CY, 1993, MOL CELL ENDOCRINOL, V93, P71, DOI 10.1016/0303-7207(93)90141-6; LEE CY, 1991, ENDOCRINOLOGY, V128, P2336, DOI 10.1210/endo-128-5-2336; LEE PDK, 1993, P SOC EXP BIOL MED, V204, P4; Lee RSF, 2002, GENE, V301, P67, DOI 10.1016/S0378-1119(02)01085-5; LEROITH D, 1991, MOL CELL ENDOCRINOL, V77, pC57, DOI 10.1016/0303-7207(91)90054-V; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Leroith Derek, 1992, Biological Signals, V1, P173; LEWITT MS, 1991, ENDOCRINOLOGY, V129, P2254, DOI 10.1210/endo-129-4-2254; Li C, 2008, ANIM BIOTECHNOL, V19, P22, DOI 10.1080/10495390701758563; Li X, 1996, J ENDOCRINOL, V149, P117, DOI 10.1677/joe.0.1490117; Li ZC, 2013, MOL BIOL REP, V40, P3569, DOI 10.1007/s11033-012-2430-1; Lighten AD, 1997, MOL REPROD DEV, V47, P134, DOI 10.1002/(SICI)1098-2795(199706)47:2<134::AID-MRD2>3.0.CO;2-N; LIU F, 1991, J CLIN ENDOCR METAB, V72, P905, DOI 10.1210/jcem-72-4-905; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lonergan P, 2000, MOL REPROD DEV, V57, P146, DOI 10.1002/1098-2795(200010)57:2&lt;146::AID-MRD5&gt;3.0.CO;2-2; Lorenzo-Seva U, 2010, BEHAV RES METHODS, V42, P29, DOI 10.3758/BRM.42.1.29; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Ludwig T, 1996, DEV BIOL, V177, P517, DOI 10.1006/dbio.1996.0182; LUND PK, 1986, J BIOL CHEM, V261, P4539; Lupu F, 2001, DEV BIOL, V229, P141, DOI 10.1006/dbio.2000.9975; LUSTIG O, 1994, MOL REPROD DEV, V38, P239, DOI 10.1002/mrd.1080380302; Ma N, 2014, EVOL DEV, V16, P1, DOI 10.1111/ede.12057; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; McKinnon T, 2001, J CLIN ENDOCR METAB, V86, P3665, DOI 10.1210/jc.86.8.3665; McLaren RJ, 1999, MAMM GENOME, V10, P588, DOI 10.1007/s003359901050; MERIMEE TJ, 1984, J CLIN ENDOCR METAB, V59, P752, DOI 10.1210/jcem-59-4-752; Merkenschlager M, 2013, CELL, V152, P1285, DOI 10.1016/j.cell.2013.02.029; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P2641, DOI 10.1210/en.142.6.2641; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Monk D, 2006, HUM MOL GENET, V15, P1259, DOI 10.1093/hmg/ddl041; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; MOSTHAF L, 1990, EMBO J, V9, P2409, DOI 10.1002/j.1460-2075.1990.tb07416.x; Murali SG, 2012, AM J PHYSIOL-GASTR L, V302, pG794, DOI 10.1152/ajpgi.00372.2011; MURPHY LJ, 1987, ENDOCRINOLOGY, V121, P684, DOI 10.1210/endo-121-2-684; MURPHY LJ, 1990, MOL ENDOCRINOL, V4, P329, DOI 10.1210/mend-4-2-329; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; NISSLEY P, 1993, MOL REPROD DEV, V35, P408, DOI 10.1002/mrd.1080350415; Nordin M, 2014, CELL PROLIFERAT, V47, P189, DOI 10.1111/cpr.12106; O'Dell SD, 1998, INT J BIOCHEM CELL B, V30, P767, DOI 10.1016/S1357-2725(98)00048-X; O'Sullivan DC, 2002, J ANIM SCI, V80, P1074; OHLSEN SM, 1994, DNA CELL BIOL, V13, P377, DOI 10.1089/dna.1994.13.377; Ohlsson C, 2009, ENDOCR REV, V30, P494, DOI 10.1210/er.2009-0010; OHLSSON R, 1994, DEVELOPMENT, V120, P361; Ohtsuki T, 2007, ZOOL SCI, V24, P241, DOI 10.2108/zsj.24.241; Ohtsuki T, 2005, ZOOL SCI, V22, P1011, DOI 10.2108/zsj.22.1011; OMAHONEY JV, 1991, MOL CELL ENDOCRINOL, V78, P87, DOI 10.1016/0303-7207(91)90189-Y; OOI GT, 1990, MOL ENDOCRINOL, V4, P321, DOI 10.1210/mend-4-2-321; Ouni M, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0062-8; Pandini G, 2002, J BIOL CHEM, V277, P39684, DOI 10.1074/jbc.M202766200; PELL JM, 1993, ENDOCRINOLOGY, V132, P1797, DOI 10.1210/en.132.4.1797; Pellegrini M, 1998, DEV DYNAM, V213, P431, DOI 10.1002/(SICI)1097-0177(199812)213:4<431::AID-AJA8>3.0.CO;2-7; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qi YB, 2013, INT J BIOL MACROMOL, V61, P43, DOI 10.1016/j.ijbiomac.2013.06.006; Qiao Y, 2016, BIOCHEM BIOPH RES CO, V477, P541, DOI 10.1016/j.bbrc.2016.06.051; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rosen CJ, 2000, BONE, V27, P521, DOI 10.1016/S8756-3282(00)00354-9; ROTWEIN P, 1987, ENDOCRINOLOGY, V121, P2141, DOI 10.1210/endo-121-6-2141; Santoro F, 2011, SEMIN CELL DEV BIOL, V22, P328, DOI 10.1016/j.semcdb.2011.02.018; SCHOFIELD PN, 1987, DEVELOPMENT, V101, P793; SCHULLER AGP, 1993, ADV EXP MED BIOL, V343, P267; SHEMER J, 1992, ENDOCRINOLOGY, V131, P2793, DOI 10.1210/en.131.6.2793; Shen WH, 2003, AM J PHYSIOL-ENDOC M, V284, pE748, DOI 10.1152/ajpendo.00399.2002; Sherman EL, 2008, J ANIM SCI, V86, P1, DOI 10.2527/jas.2006-799; Shoba L, 1999, MOL CELL ENDOCRINOL, V152, P125, DOI 10.1016/S0303-7207(99)00045-3; Silha JV, 2002, ENDOCRINOLOGY, V143, P3711, DOI 10.1210/en.2002-220116; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; SOARES MB, 1986, J MOL BIOL, V192, P737, DOI 10.1016/0022-2836(86)90025-2; Sullivan TM, 2009, J ANIM SCI, V87, P3304, DOI 10.2527/jas.2008-1753; SUSSENBACH JS, 1992, GROWTH REGULAT, V2, P1; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; TOMODA S, 1985, AM J PHYSIOL, V249, pR133, DOI 10.1152/ajpregu.1985.249.1.R133; Tran VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037923; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANDIJK MA, 1991, MOL CELL ENDOCRINOL, V81, P81, DOI 10.1016/0303-7207(91)90207-9; VANOTTERLO LC, 1977, BRIT J OBSTET GYNAEC, V84, P205; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vickers MH, 2014, NUTRIENTS, V6, P2165, DOI 10.3390/nu6062165; VU TH, 1994, NATURE, V371, P714, DOI 10.1038/371714a0; Vykoukalova Z, 2006, J ANIM BREED GENET, V123, P204, DOI 10.1111/j.1439-0388.2006.00580.x; Wang Y, 2003, DOMEST ANIM ENDOCRIN, V25, P315, DOI 10.1016/j.domaniend.2003.06.001; WANG ZQ, 1994, NATURE, V372, P464, DOI 10.1038/372464a0; WELLER PA, 1993, J MOL ENDOCRINOL, V11, P201, DOI 10.1677/jme.0.0110201; WERNER H, 1989, P NATL ACAD SCI USA, V86, P7451, DOI 10.1073/pnas.86.19.7451; Wood TL, 2000, MOL ENDOCRINOL, V14, P1472, DOI 10.1210/me.14.9.1472; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Xiang RD, 2014, J BONE MINER RES, V29, P2392, DOI 10.1002/jbmr.2263; Xiang RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053402; Xiao SQ, 2009, MOL BIOL REP, V36, P415, DOI 10.1007/s11033-007-9195-y; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yotova IY, 2008, GENOMICS, V92, P464, DOI 10.1016/j.ygeno.2008.08.004; Young L E, 2001, Twin Res, V4, P307, DOI 10.1375/twin.4.5.307; Young LE, 2003, MECH DEVELOP, V120, P1433, DOI 10.1016/j.mod.2003.09.006; Zhang JY, 2011, J ANIM VET ADV, V10, P2459; Zhang SQ, 2004, BIOL REPROD, V71, P1540, DOI 10.1095/biolreprod.104.031807; Zhao Q, 2002, 7 WORLD C GEN APPL L; Zwierzchowski L, 2010, CZECH J ANIM SCI, V55, P227, DOI 10.17221/94/2009-CJAS	186	13	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200466	10.1371/journal.pone.0200466	http://dx.doi.org/10.1371/journal.pone.0200466			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001361	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400062
J	Ivanusic, D; Pietsch, H; Konig, J; Denner, J				Ivanusic, Daniel; Pietsch, Heiko; Koenig, Jasper; Denner, Joachim			Absence of IL-10 production by human PBMCs co-cultivated with human cells expressing or secreting retroviral immunosuppressive domains	PLOS ONE			English	Article							FELINE LEUKEMIA-VIRUS; PROTEIN-KINASE-C; TRANSMEMBRANE ENVELOPE PROTEIN; HUMAN ENDOGENOUS RETROVIRUS; SYNTHETIC PEPTIDE; SEQUENCE IDENTITY; LYMPHOCYTE-PROLIFERATION; 15,000-DALTON PROTEIN; HUMAN MONOCYTES; IMMUNE-SYSTEM	Immunosuppression by retroviruses including the human immunodeficiency virus-1 (HIV-1) is well known, however the mechanisms how retroviruses induce this immunosuppression is not fully investigated. It was shown that non-infectious retroviral particles as well as retroviral or recombinant retroviral transmembrane envelope (TM) proteins demonstrated immunosuppressive properties. The same was shown for peptides corresponding to a highly conserved domain in the TM protein. This domain is called immunosuppressive (ISU) domain and it induces modulation of the cytokine release of peripheral blood mononuclear cells (PBMCs) from healthy donors. In addition, it changes the gene expression of these cells. Common indications for the immunosuppressive activity were tumour growth in vivo and interleukin-10 (IL-10) release from human PBMCs in vitro. Single mutations in the ISU domain abrogated the immunosuppressive activity. In order to develop a new model system for the expression of the ISU domain and presentation to PBMCs which is not prone to possible endotoxin contaminations, two expression systems were developed. In the first system, designated pOUT, retroviral proteins containing the ISU domain were expressed and released into the cell culture medium, and in the second system, tANCHOR, the ISU domain was presented by a tetraspanin-anchored sequence on the cell surface of human cells. Both systems were exploited to express the wild-type (wt) ISU domains of HIV-1, of the porcine endogenous retrovirus (PERV) and of the murine leukaemia virus (MuLV) as well as to express mutants (mut) of these ISU domains. PERV is of special interest in the context of virus safety of xenotransplantation using pig organs. Expression of the TM proteins was demonstrated by confocal laser scanning microscopy, ELISA and Western blot analyses using specific antibodies. However, when cells expressing and releasing the ISU were coincubated with human PBMCs, no increased production of IL-10 was observed when compared with the mutants. Similar results were obtained when the released TM proteins were concentrated by immunoprecipitation and added to PBMCs. We suggest that the absence of IL-10 induction can be explained by a low amount of protein, by the lack of a biologically active conformation or the absence of additional factors.	[Ivanusic, Daniel; Pietsch, Heiko; Koenig, Jasper; Denner, Joachim] Robert Koch Inst, Berlin, Germany	Robert Koch Institute	Denner, J (corresponding author), Robert Koch Inst, Berlin, Germany.	DennerJ@rki.de		Pietsch, Heiko/0000-0002-1661-159X	Friede Springer Stiftung; Friede Springer Foundation, Berlin, Germany	Friede Springer Stiftung; Friede Springer Foundation, Berlin, Germany	This study was supported by the Friede Springer Stiftung (http://www.friedespringerstiftung.de/).; The work was supported by the Friede Springer Foundation, Berlin, Germany.	Avota E, 2010, MED MICROBIOL IMMUN, V199, P227, DOI 10.1007/s00430-010-0152-3; Bar S, 2004, J VIROL, V78, P811, DOI 10.1128/JVI.78.2.811-820.2004; Barcova M, 1999, PFLUG ARCH EUR J PHY, V437, P538, DOI 10.1007/s004240050815; Bhandary YP, 2009, AM J RESP CRIT CARE, V179, P288, DOI 10.1164/rccm.200712-1787OC; Cesta MF, 2010, AM J RESP CELL MOL, V43, P142, DOI 10.1165/rcmb.2009-0113OC; Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; CHEN YH, 1993, IMMUNOL LETT, V37, P41, DOI 10.1016/0165-2478(93)90130-T; CHEN YH, 1993, MOL IMMUNOL, V30, P1583, DOI 10.1016/0161-5890(93)90449-L; CIANCIOLO GJ, 1985, SCIENCE, V230, P453, DOI 10.1126/science.2996136; Darkow R, 1999, BIOMATERIALS, V20, P1277, DOI 10.1016/S0142-9612(99)00022-8; de Vries RD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004482; Denner J, 1998, ANN NY ACAD SCI, V862, P75, DOI 10.1111/j.1749-6632.1998.tb09119.x; Denner J, 1996, J ACQ IMMUN DEF SYND, V12, P442, DOI 10.1097/00042560-199608150-00002; Denner J, 2013, PLOS ONE, V8; Denner J, 2016, EUR J IMMUNOL, V46, P253, DOI 10.1002/eji.201545851; Denner J, 2014, AIDS, V28, P1081, DOI 10.1097/QAD.0000000000000195; Fiebig U, 2017, VIRUSES, V28, P9; Fiebig U, 2006, J VIROL, V80, P5651, DOI 10.1128/JVI.02597-05; Fruci D, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00689; Gokyu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115107; Gomez-Mejiba SE, 2010, J BIOL CHEM, V285, P20062, DOI 10.1074/jbc.M109.086579; GOTTLIEB RA, 1990, J IMMUNOL, V145, P2566; Griffin DE, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100282; HARAGUCHI S, 1995, IMMUNOL TODAY, V16, P595, DOI 10.1016/0167-5699(95)80083-2; HEBEBRAND LC, 1979, CANCER RES, V39, P443; HEBEBRAND LC, 1977, CANCER RES, V37, P4532; Hummel J, 2015, EUR J IMMUNOL, V45, P1748, DOI 10.1002/eji.201445366; Isshiki M, 2006, PLANT CELL, V18, P146, DOI 10.1105/tpc.105.037069; Ivanusic D, 2014, BIOTECHNIQUES, V57, P188, DOI 10.2144/000114215; KADOTA J, 1991, MICROBIOL IMMUNOL, V35, P443, DOI 10.1111/j.1348-0421.1991.tb01575.x; KIZAKI T, 1991, IMMUNOL LETT, V28, P11, DOI 10.1016/0165-2478(91)90121-P; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Koutsonikolis A, 1997, IMMUNOL LETT, V55, P109, DOI 10.1016/S0165-2478(97)02695-3; LAFRADO LJ, 1987, J GEN VIROL, V68, P507, DOI 10.1099/0022-1317-68-2-507; Li LP, 1997, BIOTECHNOL LETT, V19, P135, DOI 10.1023/A:1018304128932; Libbey J.E., 2002, POLYMICROBIAL DIS; Mangeney M, 2001, J GEN VIROL, V82, P2515, DOI 10.1099/0022-1317-82-10-2515; Mangeney M, 2007, P NATL ACAD SCI USA, V104, P20534, DOI 10.1073/pnas.0707873105; Manley JL, 2010, GENE DEV, V24, P1073, DOI 10.1101/gad.1934910; MATHES LE, 1978, NATURE, V274, P687, DOI 10.1038/274687a0; MATHES LE, 1979, CANCER RES, V39, P950; Moller R, 2018, P NATL ACAD SCI USA, V115, P1069, DOI 10.1073/pnas.1719036115; Morozov VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070399; Morozov VA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-67; Moss WJ, 2002, J INFECT DIS, V186, P879, DOI 10.1086/344230; Muhle M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173454; Muhle M, 2016, IMMUNOL RES, V64, P721, DOI 10.1007/s12026-015-8776-4; Nathe KE, 2012, PEDIATR RES, V72, P203, DOI 10.1038/pr.2012.61; OLSEN RG, 1977, CANCER RES, V37, P2082; OOSTENDORP RAJ, 1993, CRIT REV ONCOL HEMAT, V14, P189, DOI 10.1016/1040-8428(93)90009-S; Palesch D, 2018, NATURE, V553, P77, DOI 10.1038/nature25140; Plotzki E, 2016, J IMMUNOL METHODS, V437, P37, DOI 10.1016/j.jim.2016.08.001; Pulendran B, 2001, J IMMUNOL, V167, P5067, DOI 10.4049/jimmunol.167.9.5067; QURESHI NM, 1990, AIDS, V4, P553, DOI 10.1097/00002030-199006000-00009; RE F, 1993, EUR J IMMUNOL, V23, P570, DOI 10.1002/eji.1830230242; RUEGG CL, 1989, J VIROL, V63, P3257, DOI 10.1128/JVI.63.8.3257-3260.1989; RUEGG CL, 1989, J VIROL, V63, P3250, DOI 10.1128/JVI.63.8.3250-3256.1989; RUEGG CL, 1990, J IMMUNOL, V144, P3928; RUEGG CL, 1991, CELL IMMUNOL, V137, P1, DOI 10.1016/0008-8749(91)90051-C; Schlecht-Louf G, 2014, J VIROL, V88, P992, DOI 10.1128/JVI.02234-13; Schlecht-Louf G, 2010, P NATL ACAD SCI USA, V107, P3782, DOI 10.1073/pnas.0913122107; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Soderberg-Naucler C, 2006, CRIT REV IMMUNOL, V26, P231, DOI 10.1615/CritRevImmunol.v26.i3.30; Song H, 2015, SCAND J IMMUNOL, V81, P186, DOI 10.1111/sji.12268; Speth C, 2000, AIDS, V14, P629, DOI 10.1097/00002030-200004140-00001; Stern B., 2007, TRENDS CELL MOL BIOL, V2, P1; Vink C, 2001, J CLIN VIROL, V23, P43, DOI 10.1016/S1386-6532(01)00184-6; WARD BJ, 1991, CLIN IMMUNOL IMMUNOP, V61, P236, DOI 10.1016/S0090-1229(05)80027-3; Yu XL, 2008, J IMMUNOL, V181, P7356, DOI 10.4049/jimmunol.181.10.7356; Zhao Y, 1998, J VIROL, V72, P5392, DOI 10.1128/JVI.72.7.5392-5398.1998	72	0	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200570	10.1371/journal.pone.0200570	http://dx.doi.org/10.1371/journal.pone.0200570			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001404	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400083
J	McDermott, B; O'Halloran, M; Porter, E; Santorelli, A				McDermott, Barry; O'Halloran, Martin; Porter, Emily; Santorelli, Adam			Brain haemorrhage detection using a SVM classifier with electrical impedance tomography measurement frames	PLOS ONE			English	Article							TISSUE; STROKE; CONDUCTIVITY; DIAGNOSIS; EIT	Brain haemorrhages often require urgent treatment with a consequent need for quick and accurate diagnosis. Therefore, in this study, we investigate Support Vector Machine (SVM) classifiers for detecting brain haemorrhages using Electrical Impedance Tomography (EIT) measurement frames. A 2-layer model of the head, along with a series of haemorrhages, is designed as both numerical models and physical phantoms. EIT measurement frames, taken from an electrode array placed on the head surface, are used to train and test linear SVM classifiers. Various scenarios are implemented on both platforms to examine the impact of variables such as noise level, lesion location, lesion size, variation in electrode positioning, and variation in anatomy, on the classifier performance. The classifier performed well in numerical models (sensitivity and specificity of 90%(+)) with signal-to-noise ratios of 60 dB(+), was independent of lesion location, and could detect lesions reliably down to the tested minimum volume of 5 ml. Slight variations in electrode layout did not affect performance. Performance was affected by variations in anatomy however, emphasising the need for large training sets covering different anatomies. The phantom models proved more challenging, with maximal sensitivity and specificity of 75% when used with the linear SVM. Finally, the performance of two more complex classifiers is briefly examined and compared to the linear SVM classifier. These results demonstrate that a radial basis function (RBF) SVM classifier and a neural network classifier can improve detection accuracy. Classifiers applied to EIT measurement frames is a novel approach for lesion detection and may offer an effective diagnostic tool clinically. A challenge is to translate the strong results from numerical models into real world phantoms and ultimately human patients, as well as the selection and development of optimal classifiers for this application.	[McDermott, Barry; O'Halloran, Martin; Porter, Emily; Santorelli, Adam] Natl Univ Ireland Galway, Translat Med Device Lab, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	McDermott, B (corresponding author), Natl Univ Ireland Galway, Translat Med Device Lab, Galway, Ireland.	b.mcdermott3@nuigalway.ie		OHalloran, Martin/0000-0002-1650-2940; Porter, Emily/0000-0002-7787-3139; McDermott, Barry/0000-0002-4593-5331	European Research Council under the European Union's Horizon 2020 Programme/ERC Grant [637780]; Science Foundation Ireland (SFI) grant [15/ERCS/3276]; Hardiman Research Scholarship from NUIG; RESPECT charity; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA Grant [PCOFUND-GA-2013-608728]; Irish Research Council	European Research Council under the European Union's Horizon 2020 Programme/ERC Grant; Science Foundation Ireland (SFI) grant(Science Foundation Ireland); Hardiman Research Scholarship from NUIG; RESPECT charity; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7) under REA Grant; Irish Research Council(Irish Research Council for Science, Engineering and Technology)	This work was supported by European Research Council under the European Union's Horizon 2020 Programme/ERC Grant Agreement BioElecPro n.637780 (https://ec.europa.eu/programmes/horizon2020/en/h2020-section/european-research-council); Science Foundation Ireland (SFI) grant number 15/ERCS/3276 (http://www.sfi.ie/); Hardiman Research Scholarship from NUIG (http://www.nuigalway.ie/hardiman-scholarships/); RESPECT charity (http://www.assistid.eu/fellows/); The People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA Grant Agreement no. PCOFUND-GA-2013-608728 (https://ec.europa.eu/research/fp7/index_en.cfm); and Irish Research Council (http://research.ie/funding/goipd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2006, PHYSIOL MEAS, V27, pS25, DOI 10.1088/0967-3334/27/5/S03; Adler A, 2017, IEEE T BIO-MED ENG, V64, P2494, DOI 10.1109/TBME.2017.2728323; Adler A, 2015, PHYSIOL MEAS, V36, P1067, DOI 10.1088/0967-3334/36/6/1067; [Anonymous], MATLAB 2017A; Autodesk, FUS 360; Avery J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17020280; Birenbaum D, 2011, WEST J EMERG MED, V12, P67; Bonmassar Giorgio, 2010, Int J Bioelectromagn, V12, P32; Brown B. H., 2003, Journal of Medical Engineering & Technology, V27, P97, DOI 10.1080/0309190021000059687; BUSHBY KMD, 1992, ARCH DIS CHILD, V67, P1286, DOI 10.1136/adc.67.10.1286; Conceicao R. C., 2010, Progress In Electromagnetics Research B, V23, P311, DOI 10.2528/PIERB10062407; Cristianini N, 2000, INTRO SUPPORT VECTOR; Dilmen N., NIH 3D PRINT EXCHANG; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Dowrick T, 2015, PHYSIOL MEAS, V36, P1273, DOI 10.1088/0967-3334/36/6/1273; EASYCAP GmBH, EASYCAP EEG REC CAPS; Gabriel C, 2009, PHYS MED BIOL, V54, P4863, DOI 10.1088/0031-9155/54/16/002; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Grewal PK, 2014, IET SCI MEAS TECHNOL, V8, P579, DOI 10.1049/iet-smt.2013.0087; Grozny, THING D HUM HEAD; Grychtol B, 2013, IEEE ENG MED BIO, P6429, DOI 10.1109/EMBC.2013.6611026; Gur D, 2010, SUPPORT VECTOR MACHI, DOI [10.1117/12.844452, DOI 10.1117/12.844452]; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Holder D. S, 2005, ELECT IMPEDANCE TOMO; Hudson DL, 1999, NEURAL NETWORKS ARTI, DOI [10.1109/9780470545355, DOI 10.1109/9780470545355]; Jehl M, 2015, PHYSIOL MEAS, V36, P2423, DOI 10.1088/0967-3334/36/12/2423; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Laufer S, 2009, IEEE T BIO-MED ENG, V56, P525, DOI 10.1109/TBME.2008.2003105; Lee Bruce, 2005, NeuroRx, V2, P372; McDermott B, 2018, P 19 INT C BIOM APPL, DOI [10.5281/zenodo.1210247, DOI 10.5281/ZENODO.1210247]; McDermott B, 2018, P 40 INT C IEEE ENG; McDermott B, 2018, BIOMED PHYS ENG EXPR, V4, DOI 10.1088/2057-1976/aa922d; Miller DJ, 2011, NEUROHOSPITALIST, V1, P138, DOI 10.1177/1941875211408731; NICE (National Institute for Health and Care Excellence), ALT TREAT AC ISCH ST; Persson M, 2014, IEEE T BIO-MED ENG, V61, P2806, DOI 10.1109/TBME.2014.2330554; Samore A, 2017, IEEE T INSTRUM MEAS, V66, P2666, DOI 10.1109/TIM.2017.2711818; Santorelli A, 2014, PROG ELECTROMAGN RES, V144, P45, DOI 10.2528/PIER13110709; Schlebusch T, 2014, PHYSIOL MEAS, V35, P1813, DOI 10.1088/0967-3334/35/9/1813; Schoeberl J., NETGEN; Shini MA, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/9/002; Velayudhan V., MEDSCAPE; Wi H, 2014, IEEE T BIOMED CIRC S, V8, P119, DOI 10.1109/TBCAS.2013.2256785	42	10	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200469	10.1371/journal.pone.0200469	http://dx.doi.org/10.1371/journal.pone.0200469			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001401	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400063
J	Prehn-Kristensen, A; Zimmermann, A; Tittmann, L; Lieb, W; Schreiber, S; Baving, L; Fischer, A				Prehn-Kristensen, Alexander; Zimmermann, Alexandra; Tittmann, Lukas; Lieb, Wolfgang; Schreiber, Stefan; Baving, Lioba; Fischer, Annegret			Reduced microbiome alpha diversity in young patients with ADHD	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GUT-MICROBIOTA; DOPAMINE TRANSPORTER; NEUROPSYCHIATRIC DISORDERS; MOLECULAR-GENETICS; IRON-DEFICIENCY; RATING-SCALE; CHILDREN; BRAIN	ADHD is a psychiatric disorder which is characterized by hyperactivity, impulsivity and attention problems. Due to recent findings of microbial involvement in other psychiatric disorders like autism and depression, a role of the gut microbiota in ADHD pathogenesis is assumed but has not yet been investigated. In this study, the gut microbiota of 14 male ADHD patients (mean age: 11.9 yrs.) and 17 male controls (mean age: 13.1 yrs.) was examined via next generation sequencing of 16S rDNA and analyzed for diversity and biomarkers. We found that the microbial diversity (alpha diversity) was significantly decreased in ADHD patients compared to controls (p(shannon) = 0.036) and that the composition (beta diversity) differed significantly between patients and controls (P-ANOSIM = 0.033, P-ADONIS = 0.006, P-betadisper = 0.002). In detail, the bacterial family Prevotellacae was associated with controls, while patients with ADHD showed elevated levels of Bacteroidaceae, and both Neisseriaceae and Neisseria spec. were found as possible biomarkers for juvenile ADHD. Our results point to a possible link of certain microbiota with ADHD, with Neisseria spec. being a very promising ADHD-associated candidate. This finding provides the basis for a systematic, longitudinal assessment of the role of the gut microbiome in ADHD, yielding promising potential for both prevention and therapeutic intervention.	[Prehn-Kristensen, Alexander; Zimmermann, Alexandra; Baving, Lioba] Univ Hosp Schleswig Holstein, Ctr Integrat Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany; [Zimmermann, Alexandra; Tittmann, Lukas; Schreiber, Stefan; Fischer, Annegret] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Lieb, Wolfgang] Univ Hosp Schleswig Holstein, Inst Epidemiol, Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Clin Internal Med 1, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Prehn-Kristensen, A (corresponding author), Univ Hosp Schleswig Holstein, Ctr Integrat Psychiat, Dept Child & Adolescent Psychiat & Psychotherapy, Kiel, Germany.	a.prehn@zip-kiel.de	Prehn-Kristensen, Alexander/A-3234-2019; Lieb, Wolfgang/AAC-7650-2022; Tittmann, Lukas/A-7295-2017	Prehn-Kristensen, Alexander/0000-0002-3510-9888; Tittmann, Lukas/0000-0002-8731-4592	medical faculty of the University Hospital Schleswig-Holstein	medical faculty of the University Hospital Schleswig-Holstein	This study was funded by an intramural grant of the medical faculty of the University Hospital Schleswig-Holstein.; We thank Michaela Hilgert, Dr. Gunnar Jacobs, Susanne Kell, and Petra Schneckenburger for their technical support and Dr. Manuel Munz for his medical support. This study was funded by an intramural grant of the medical faculty of the University Hospital Schleswig-Holstein.	Achenbach T.M., 1991, MANUAL CHILD BEHAV C, DOI DOI 10.1023/A; Agans R, 2011, FEMS MICROBIOL ECOL, V77, P404, DOI 10.1111/j.1574-6941.2011.01120.x; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bellgrove MA, 2008, ANN NY ACAD SCI, V1129, P200, DOI 10.1196/annals.1417.013; Bener A, 2014, ANN MED HEALTH SCI R, V4, P291, DOI 10.4103/2141-9248.141974; Berg S, 2002, EUR J PEDIATR, V161, P330, DOI 10.1007/s00431-002-0957-1; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Bonvicini C, 2016, MOL PSYCHIATR, V21, P872, DOI 10.1038/mp.2016.74; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brevik EJ, 2016, AM J MED GENET B, V171, P733, DOI 10.1002/ajmg.b.32434; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Capusan AJ, 2016, PSYCHOL MED, V46, P2637, DOI 10.1017/S0033291716001021; Cenit MC, 2017, EUR CHILD ADOLES PSY, V26, P1081, DOI 10.1007/s00787-017-0969-z; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Clark A, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0155-6; Coghill DR, 2014, BIOL PSYCHIAT, V76, P603, DOI 10.1016/j.biopsych.2013.10.005; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Angelis M, 2015, GUT MICROBES, V6, P207, DOI 10.1080/19490976.2015.1035855; De Crescenzo F, 2014, ADHD-ATTEND DEFICIT, V6, P49, DOI 10.1007/s12402-013-0122-x; Delmo C., 2000, KIDDIE SADS PRESENT, V3rd ed.; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Dinan TG, 2015, J PSYCHIATR RES, V63, P1, DOI 10.1016/j.jpsychires.2015.02.021; Dolina S, 2014, MED HYPOTHESES, V82, P111, DOI 10.1016/j.mehy.2013.11.018; Dopfner M, 2008, DIAGNOSTIK SYSTEM PS, V3; Dore J, 2015, CURR OPIN BIOTECH, V32, P195, DOI 10.1016/j.copbio.2015.01.002; Dvorakova M, 2007, NUTR NEUROSCI, V10, P151, DOI 10.1080/09513590701565443; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Esparham A, 2014, CHILDREN-BASEL, V1, P186, DOI 10.3390/children1020186; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Fowler JS, 2001, NUCL MED BIOL, V28, P561, DOI 10.1016/S0969-8051(01)00211-6; Frodl T, 2012, ACTA PSYCHIAT SCAND, V125, P114, DOI 10.1111/j.1600-0447.2011.01786.x; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Haro C, 2016, INTESTINAL MICROBIOT, V11, DOI [10.1371/journal.pone.0154090, DOI 10.1371/JOURNAL.PONE.0154090]; HASE, 2008, HASE HOMBURGER ADHS; Hawi Z, 2015, MOL PSYCHIATR, V20, P289, DOI 10.1038/mp.2014.183; Herpertz-Dahlmann B, 2017, EUR CHILD ADOLES PSY, V26, P1031, DOI 10.1007/s00787-017-0945-7; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kiraly DD, 2016, SCI REP-UK, V6, DOI 10.1038/srep35455; Krishnan C, 2015, BRAIN STIMUL, V8, P76, DOI 10.1016/j.brs.2014.10.012; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Lisko DJ, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5010006; Liu GY, 2015, MICROBIOL-SGM, V161, P1297, DOI 10.1099/mic.0.000086; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Ludolph AG, 2008, NEUROIMAGE, V41, P718, DOI 10.1016/j.neuroimage.2008.02.025; Lukiw WJ, 2016, J SPORT HEALTH SCI, V5, P393, DOI 10.1016/j.jshs.2016.08.008; Ly V, 2017, EUR CHILD ADOLES PSY, V26, P1067, DOI 10.1007/s00787-017-0959-1; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Margari F, 2013, RES DEV DISABIL, V34, P1036, DOI 10.1016/j.ridd.2012.12.001; Middeldorp CM, 2016, J AM ACAD CHILD PSY, V55, P896, DOI 10.1016/j.jaac.2016.05.025; Nakao T, 2011, AM J PSYCHIAT, V168, P1154, DOI 10.1176/appi.ajp.2011.11020281; Niederhofer Helmut, 2006, J Atten Disord, V10, P200, DOI 10.1177/1087054706292109; Oksanen J., 2013, R PACKAGE VERSION 23, V2; Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51; Pelsser LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169277; Peng XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079476; Percinel I, 2016, CHILD PSYCHIAT HUM D, V47, P259, DOI 10.1007/s10578-015-0562-y; Petra AI, 2015, CLIN THER, V37, P984, DOI 10.1016/j.clinthera.2015.04.002; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Putignani L, 2014, PEDIATR RES, V76, P2, DOI 10.1038/pr.2014.49; Rea K, 2016, NEUROBIOL STRESS, V4, P23, DOI 10.1016/j.ynstr.2016.03.001; Retz-Junginger P, 2007, NERVENARZT, V78, P1046, DOI 10.1007/s00115-006-2242-4; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Rieder R, 2017, BRAIN BEHAV IMMUN, V66, P9, DOI 10.1016/j.bbi.2017.01.016; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; Salehi B, 2016, J RES PHARM PRACT, V5, P22, DOI 10.4103/2279-042X.176561; Sampson TR, 2015, CELL HOST MICROBE, V17, P565, DOI 10.1016/j.chom.2015.04.011; Santocchi E, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0887-5; Savignac HM, 2015, BEHAV BRAIN RES, V287, P59, DOI 10.1016/j.bbr.2015.02.044; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sfera A, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00020; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2009, CURR PSYCHIAT REP, V11, P393, DOI 10.1007/s11920-009-0059-0; Sonuga-Barke EJS, 2013, AM J PSYCHIAT, V170, P275, DOI 10.1176/appi.ajp.2012.12070991; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X; Tuohy KM, 2016, J PEDIAT GASTROENTER; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Vastag B, 2001, JAMA-J AM MED ASSOC, V286, P905, DOI 10.1001/jama.286.8.905; Verlaet AAJ, 2017, TRIALS, V18, DOI 10.1186/s13063-017-1879-6; Verlaet AAJ, 2014, EUR CHILD ADOLES PSY, V23, P519, DOI 10.1007/s00787-014-0522-2; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Volpe GE, 2014, J STUD ALCOHOL DRUGS, V75, P347, DOI 10.15288/jsad.2014.75.347; Wallace CJK, 2017, ANN GEN PSYCHIATR, V16, DOI 10.1186/s12991-017-0138-2; WARD MF, 1993, AM J PSYCHIAT, V150, P885; Wu H, 2006, INFECT IMMUN, V74, P4094, DOI 10.1128/IAI.00433-06; Wu J, 2012, MOL NEUROBIOL, V45, P605, DOI 10.1007/s12035-012-8278-5; Yunes RA, 2016, ANAEROBE, V42, P197, DOI 10.1016/j.anaerobe.2016.10.011; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z; Zhu J, 2008, CNS NEUROL DISORD-DR, V7, P393, DOI 10.2174/187152708786927877	103	109	112	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200728	10.1371/journal.pone.0200728	http://dx.doi.org/10.1371/journal.pone.0200728			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001426	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400095
J	Riedemann, T; Straub, T; Sutor, B				Riedemann, Therese; Straub, Tobias; Sutor, Bernd			Two types of somatostatin-expressing GABAergic interneurons in the superficial layers of the mouse cingulate cortex	PLOS ONE			English	Article							SINGLE-CELL TRANSCRIPTOMICS; RAT FRONTAL-CORTEX; ANTERIOR CINGULATE; NEOCORTICAL INTERNEURONS; DISYNAPTIC INHIBITION; MARTINOTTI CELLS; TRANSGENIC MICE; CLASSIFICATION; SUBTYPES; DIVERSITY	Somatostatin-expressing (SOM+), inhibitory interneurons represent a heterogeneous group of cells and given their remarkable diversity, classification of SOM+ interneurons remains a challenging task. Electrophysiological, morphological and neurochemical classes of SOM+ interneurons have been proposed in the past but it remains unclear as to what extent these classes are congruent. We performed whole-cell patch-clamp recordings from 127 GFP-labeled SOM+ interneurons ('GIN') of the superficial cingulate cortex with subsequent biocytin-filling and immunocytochemical labeling. Principal component analysis followed by k-means clustering predicted two putative subtypes of SOM+ interneurons, which we designated as group I and group II GIN. A key finding of our study is the fact that these electrophysiologically and morphologically distinct groups of SOM+ interneurons can be correlated with two neurochemical subtypes of SOM+ interneurons described recently in our laboratory. In particular, all SOM+ interneurons expressing calbindin but no calretinin could be classified as group I GIN, whereas all but one neuropeptide Y- and calretinin-positive interneurons were found in group II.	[Riedemann, Therese; Sutor, Bernd] Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany; [Straub, Tobias] Ludwig Maximilians Univ Munchen, Biomed Ctr, Core Facil Bioinformat, Munich, Germany	University of Munich; University of Munich	Riedemann, T (corresponding author), Ludwig Maximilians Univ Munchen, Biomed Ctr, Physiol Genom, Munich, Germany.	therese.riedemann@med.uni-muenchen.de	Straub, Tobias/B-2023-2009; Riedemann, Therese/GYU-4626-2022	Straub, Tobias/0000-0002-0547-0453; 	Friedrich-Baur-Stiftung [04/13]	Friedrich-Baur-Stiftung	This work was supported by the Friedrich-Baur-Stiftung, grant# 04/13 (http://www.klinikum.uni-muenchen.de/Friedrich-Baur-Institut/de/institut/friedrich_baur_stiftung/) to TR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; BENES FM, 1991, ARCH GEN PSYCHIAT, V48, P996; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Buchanan KA, 2009, J PHYSIOL-LONDON, V587, P5301, DOI 10.1113/jphysiol.2009.182980; Cadwell CR, 2016, NAT BIOTECHNOL, V34, P199, DOI 10.1038/nbt.3445; Cauli B, 1997, J NEUROSCI, V17, P3894; Cauli B, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00052; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; Elgueta C, 2015, J NEUROSCI, V35, P4131, DOI 10.1523/JNEUROSCI.3671-14.2015; Emmenegger V, 2018, CEREB CORTEX, V28, P1439, DOI 10.1093/cercor/bhx352; Gao YJ, 2004, PAIN, V110, P343, DOI 10.1016/j.pain.2004.04.030; Halabisky B, 2006, J NEUROPHYSIOL, V96, P834, DOI 10.1152/jn.01079.2005; Jiang XL, 2015, SCIENCE, V350, DOI 10.1126/science.aac9462; Jones SL, 2017, ELIFE, V6, DOI 10.7554/eLife.30333; Karagiannis A, 2009, J NEUROSCI, V29, P3642, DOI 10.1523/JNEUROSCI.0058-09.2009; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kawaguchi Y, 1996, J NEUROSCI, V16, P2701; Kuo CC, 2005, J NEUROPHYSIOL, V94, P1825, DOI 10.1152/jn.00294.2005; Large AM, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00062; Ma YY, 2006, J NEUROSCI, V26, P5069, DOI 10.1523/JNEUROSCI.0661-06.2006; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MARSHALL PW, 1993, J CARDIOVASC PHARM, V21, P902, DOI 10.1097/00005344-199306000-00008; Marx M, 2012, NAT PROTOC, V7, P394, DOI 10.1038/nprot.2011.449; McGarry LM, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00012; Nassarlt M, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00020; Oborne J, 2004, PRAC ASSESS RES EVAL, V9; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Poulin JF, 2016, NAT NEUROSCI, V19, P1131, DOI 10.1038/nn.4366; Riedemann T, 2016, PFLUG ARCH EUR J PHY, V468, P1725, DOI 10.1007/s00424-016-1868-8; Riedemann T, 2016, J COMP NEUROL, V524, P2281, DOI 10.1002/cne.23948; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Santana R, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00185; Savanthrapadian S, 2014, J NEUROSCI, V34, P8197, DOI 10.1523/JNEUROSCI.5433-13.2014; Scheyltjens I, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8723623; Schreiber S, 2009, J NEUROPHYSIOL, V101, P2239, DOI 10.1152/jn.90711.2008; Seney ML, 2015, NEUROBIOL DIS, V73, P213, DOI 10.1016/j.nbd.2014.10.005; Sheffield MEJ, 2011, NAT NEUROSCI, V14, P200, DOI 10.1038/nn.2728; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sosulina L, 2010, J NEUROPHYSIOL, V104, P617, DOI 10.1152/jn.00207.2010; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tripp A, 2011, NEUROBIOL DIS, V42, P116, DOI 10.1016/j.nbd.2011.01.014; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Wierenga CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015915; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	47	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200567	10.1371/journal.pone.0200567	http://dx.doi.org/10.1371/journal.pone.0200567			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001424	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400081
J	Salovska, B; Janeckova, H; Fabrik, I; Karlikova, R; Cechakova, L; Ondrej, M; Link, M; Friedecky, D; Tichy, A				Salovska, Barbora; Janeckova, Hana; Fabrik, Ivo; Karlikova, Radana; Cechakova, Lucie; Ondrej, Martin; Link, Marek; Friedecky, David; Tichy, Ales			Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; GAMMA-RADIATION; MASS-SPECTROMETRY; OXIDATIVE STRESS; LEUKEMIC-CELLS; TARGETING ATR; HL-60 CELLS; PHOSPHORYLATION; KINASE; MTOR	Current anti-cancer strategy takes advantage of tumour specific abnormalities in DNA damage response to radio- or chemo-therapy. Inhibition of the ATR/Chk1 pathway has been shown to be synthetically lethal in cells with high levels of oncogene-induced replication stress and in p53- or ATM- deficient cells. In the presented study, we aimed to elucidate molecular mechanisms underlying radiosensitization of T-lymphocyte leukemic MOLT-4 cells by VE-821, a higly potent and specific inhibitor of ATR. We combined multiple approaches: cell biology techniques to reveal the inhibitor-induced phenotypes, and quantitative proteomics, phosphoproteomics, and metabolomics to comprehensively describe drug-induced changes in irradiated cells. VE-821 radiosensitized MOLT-4 cells, and furthermore 10 mu M VE-821 significantly affected proliferation of sham-irradiated MOLT-4 cells. We detected 623 differentially regulated phosphorylation sites. We revealed changes not only in DDR-related pathways and kinases, but also in pathways and kinases involved in maintaining cellular metabolism. Notably, we found downregulation of mTOR, the main regulator of cellular metabolism, which was most likely caused by an off-target effect of the inhibitor, and we propose that mTOR inhibition could be one of the factors contributing to the phenotype observed after treating MOLT-4 cells with 10 mu M VE-821. In the metabolomic analysis, 206 intermediary metabolites were detected. The data indicated that VE-821 potentiated metabolic disruption induced by irradiation and affected the response to irradiation-induced oxidative stress. Upon irradiation, recovery of damaged deoxynucleotides might be affected by VE-821, hampering DNA repair by their deficiency. Taken together, this is the first study describing a complex scenario of cellular events that might be ATR-dependent or triggered by ATR inhibition in irradiated MOLT-4 cells. Data are available via ProteomeXchange with identifier PXD008925.	[Salovska, Barbora; Cechakova, Lucie; Ondrej, Martin; Tichy, Ales] Univ Def Brno, Fac Mil Hlth Sci Hradec Kralove, Dept Radiobiol, Hradec Kralove, Czech Republic; [Salovska, Barbora] Czech Acad Sci, Inst Mol Genet, Dept Genome Integr, Prague, Czech Republic; [Janeckova, Hana; Friedecky, David] Palacky Univ Olomouc, Fac Med & Dent, Lab Inherited Metab Disorders, Olomouc, Czech Republic; [Janeckova, Hana; Karlikova, Radana; Friedecky, David] Univ Hosp Olomouc, Dept Clin Biochem, Olomouc, Czech Republic; [Fabrik, Ivo; Link, Marek] Univ Def Brno, Fac Mil Hlth Sci Hradec Kralove, Dept Mol Pathol & Biol, Hradec Kralove, Czech Republic; [Fabrik, Ivo; Tichy, Ales] Univ Hosp, Biomed Res Ctr, Hradec Kralove, Czech Republic; [Karlikova, Radana; Friedecky, David] PalackY Univ Olomouc, Fac Med & Dent, Inst Mol & Translat Med, Olomouc, Czech Republic	University of Defence - Czech Republic; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Palacky University Olomouc; University Hospital Olomouc; University of Defence - Czech Republic; University Hospital Hradec Kralove; Palacky University Olomouc	Tichy, A (corresponding author), Univ Def Brno, Fac Mil Hlth Sci Hradec Kralove, Dept Radiobiol, Hradec Kralove, Czech Republic.; Tichy, A (corresponding author), Univ Hosp, Biomed Res Ctr, Hradec Kralove, Czech Republic.	ales.tichy@unob.cz	Fabrik, Ivo/V-4188-2017; Ondrej, Martin/ABG-5074-2020; FRIEDECKÝ, David/AAR-5649-2021; Tichy, Ales/A-3368-2013	Fabrik, Ivo/0000-0002-3027-1253; Ondrej, Martin/0000-0002-2640-3348; Tichy, Ales/0000-0002-8262-5703; Friedecky, David/0000-0002-3448-9073; Brumarova (Karlikova), Radana/0000-0003-1180-6977; Janeckova, Hana/0000-0002-2581-6116; Salovska, Barbora/0000-0002-7093-4576; Link, Marek/0000-0003-4601-4523	Ministry of Defence, Czech Republic [1011]; Czech Science Foundation [18-12204S]	Ministry of Defence, Czech Republic(Czech Republic Government); Czech Science Foundation(Grant Agency of the Czech Republic)	This work was supported by Ministry of Defence, Czech Republic (project: Long-term organization development plan 1011), by the Czech Science Foundation Grant 18-12204S. The infrastructural part (Institute of Molecular and Translational Medicine) was supported by NPU I (LO1304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Beyaert M, 2016, BIOCHEM PHARMACOL, V100, P40, DOI 10.1016/j.bcp.2015.11.022; Blethrow JD, 2008, P NATL ACAD SCI USA, V105, P1442, DOI 10.1073/pnas.0708966105; Cheema AK, 2014, J PROTEOME RES, V13, P3065, DOI 10.1021/pr500278t; Chen T, 2012, DRUG DISCOV TODAY, V17, P194, DOI 10.1016/j.drudis.2011.12.009; Chi Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r149; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croft David, 2013, Methods Mol Biol, V1021, P273, DOI 10.1007/978-1-62703-450-0_14; Dillon LM, 2014, CURR DRUG TARGETS, V15, P65, DOI 10.2174/1389450114666140106100909; Dokmeci D, 2006, SCAND J LAB ANIM SCI, V33, P75; Fabrik I, 2018, MOL CELL PROTEOMICS, V17, P95, DOI 10.1074/mcp.RA117.000160; Ferrao PT, 2012, ONCOGENE, V31, P1661, DOI 10.1038/onc.2011.358; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fokas E, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.181; Fokas E, 2014, CANCER TREAT REV, V40, P109, DOI 10.1016/j.ctrv.2013.03.002; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gabant G, 2008, J MOL BIOL, V380, P489, DOI 10.1016/j.jmb.2008.04.053; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; GOODWIN PM, 1978, BIOCHIM BIOPHYS ACTA, V543, P576, DOI 10.1016/0304-4165(78)90312-4; Guo X, 2010, J BIOL CHEM, V285, P33348, DOI 10.1074/jbc.M110.149609; Hoglund A, 2011, CLIN CANCER RES, V17, P7067, DOI 10.1158/1078-0432.CCR-11-1198; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlikova R, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0303-5; Khan AR, 2011, INT J RADIAT BIOL, V87, P91, DOI 10.3109/09553002.2010.518211; Klammer M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-351; Kozlov SV, 2011, J BIOL CHEM, V286, P9107, DOI 10.1074/jbc.M110.204065; Kwon YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113573; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lee R, 2009, ANAL CHEM, V81, P7047, DOI 10.1021/ac901174g; Macheret M, 2015, ANNU REV PATHOL-MECH, V10, P425, DOI 10.1146/annurev-pathol-012414-040424; Marekova M, 2003, GEN PHYSIOL BIOPHYS, V22, P191; Mathews CK, 2015, NAT REV CANCER, V15, P528, DOI 10.1038/nrc3981; McNulty DE, 2008, MOL CELL PROTEOMICS, V7, P971, DOI 10.1074/mcp.M700543-MCP200; Mendes RD, 2016, HAEMATOLOGICA, V101, P1010, DOI 10.3324/haematol.2016.146381; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Muthna D, 2012, Mol Biol (Mosk), V46, P122; Najdekr L, 2015, TALANTA, V139, P62, DOI 10.1016/j.talanta.2015.02.041; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ondrej M, 2016, RADIOTHER ONCOL, V119, P265, DOI 10.1016/j.radonc.2016.02.028; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Ong Shao-En, 2006, Curr Protoc Protein Sci, VChapter 14, DOI 10.1002/0471140864.ps1409s46; Paglin S, 2005, CANCER RES, V65, P11061, DOI 10.1158/0008-5472.CAN-05-1083; Park JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100819; Patterson AD, 2008, ANAL CHEM, V80, P665, DOI 10.1021/ac701807v; Peasland A, 2011, BRIT J CANCER, V105, P372, DOI 10.1038/bjc.2011.243; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Rezacova M, 2008, LEUKEMIA RES, V32, P1259, DOI 10.1016/j.leukres.2007.12.014; Rogers LD, 2010, MOL BIOSYST, V6, P822, DOI 10.1039/b915986j; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Salovska B, 2014, INT J MOL SCI, V15, P12007, DOI 10.3390/ijms150712007; Salovska B, 2013, ANAL LETT, V46, P1505, DOI 10.1080/00032719.2013.773437; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Sellick CA, 2011, NAT PROTOC, V6, P1241, DOI 10.1038/nprot.2011.366; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; SHINOHARA K, 1993, RADIAT RES, V135, P197, DOI 10.2307/3578295; Song CX, 2012, MOL CELL PROTEOMICS, V11, P1070, DOI 10.1074/mcp.M111.012625; Staub M., 2007, DEOXYNUCLEOSIDE ANAL, P29, DOI [10.1007/978-1-59745-148-2_2, DOI 10.1007/978-1-59745-148-2_2]; Szkanderova S, 2005, RADIAT RES, V163, P307, DOI 10.1667/RR3309; Szkanderova S, 2003, FOLIA BIOL-PRAGUE, V49, P191; Tichy A, 2009, FOLIA BIOL-PRAGUE, V55, P41; Tichy A, 2008, INT J RADIAT BIOL, V84, P523, DOI 10.1080/09553000802078404; Tichy A, 2007, ACTA BIOCHIM POL, V54, P281; Tichy A, 2014, RADIAT ENVIRON BIOPH, V53, P83, DOI 10.1007/s00411-013-0494-5; Tichy Ales, 2012, Acta Medica (Hradec Kralove), V55, P66; Tichy A, 2011, J APPL BIOMED, V9, P49, DOI 10.2478/v10136-009-0031-7; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Tsuyama N, 2015, J RADIAT RES, V56, P46, DOI 10.1093/jrr/rru078; Vavrova J, 2004, PHYSIOL RES, V53, P335; Vavrova J, 2013, RADIAT ENVIRON BIOPH, V52, P471, DOI 10.1007/s00411-013-0486-5; Vendetti FP, 2015, ONCOTARGET, V6, P44289, DOI 10.18632/oncotarget.6247; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wu J, 2006, CELL MOL LIFE SCI, V63, P2538, DOI 10.1007/s00018-006-6138-z; Yardim-Akaydin S, 2004, FREE RADICAL RES, V38, P623, DOI 10.1080/10715760410001694044; Yeung Yee-Guide, 2010, Curr Protoc Protein Sci, VChapter 16, DOI 10.1002/0471140864.ps1612s59; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Yugi K, 2014, CELL REP, V8, P1171, DOI 10.1016/j.celrep.2014.07.021; Zaskodova D, 2006, ANN NY ACAD SCI, V1091, P385, DOI 10.1196/annals.1378.082; Zhou YY, 2007, BIOINFORMATICS, V23, P2073, DOI 10.1093/bioinformatics/btm292	98	6	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199349	10.1371/journal.pone.0199349	http://dx.doi.org/10.1371/journal.pone.0199349			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001349	Green Submitted, gold, Green Published			2022-12-26	WOS:000438457400007
J	Jinguji, H; Ohtsu, K; Ueda, T; Goka, K				Jinguji, Hiroshi; Ohtsu, Kazuhisa; Ueda, Tetsuyuki; Goka, Koichi			Effects of short-term, sublethal fipronil and its metabolite on dragonfly feeding activity	PLOS ONE			English	Article							SULFONE METABOLITE; SYMPETRUM-FREQUENS; CHLORIDE CHANNELS; CHRONIC TOXICITY; SAKURA RIVER; NEONICOTINOIDS; INSECTICIDES; EXPOSURE; LARVAE; PESTICIDES	Dragonflies, Sympetrum spp., are indispensable to agriculture and are a central element of culture in Japan. However, S. frequens populations in rice paddy fields have declined in recent decades. Dragonfly larvae are predatory aquatic insects that feed on other organisms found in habitats with slow-moving or standing water. The increasing use of fipronil and neonicotinoid insecticides in agriculture is also increasing exposure to Sympetrum spp. in larval stages through paddy soil and water. The role of fipronil insecticides in the decline of dragonflies is of concern, and we here examine the sublethal effects of this insecticide on the feeding behaviors of two Sympetrum spp. Based on the quantity of prey items consumed and the time to capture prey items, feeding inhibition was determined to be a potential mechanism of the decline of Sympetrum spp. following 48-h exposure to fipronil and fipronil sulfone. Prey consumption by S. infuscatum was significantly reduced for fipronil sulfone at all concentrations (0.01-1000 mu g/L). S. frequens exposed to 1, 10, 100 and 1000 mu g/L fipronil sulfone had significantly longer prey capture times. Fipronil sulfone was 2.8, 9.7 and 10.5 times more toxic to S. infuscatum than fipronil in terms of acute toxicity, feeding inhibition and delayed toxicity, respectively. In addition, fipronil sulfone was 6.6, 2.9 and 9.1 times more toxic, respectively, to S. frequens than fipronil. Our findings suggest that sublethal effects on feeding inhibition lead to severe mortality at realistic paddy soil and water concentrations. Our results provide the first demonstration that short-term exposure to fipronil and fipronil sulfone can consequently cause significant harm to dragonfly larvae survival due to feeding inhibition. These findings have implications for current pesticide risk assessment and dragonfly protection.	[Jinguji, Hiroshi] Miyagi Univ, Sch Food Agr & Environm Sci, Sendai, Miyagi, Japan; [Ohtsu, Kazuhisa] Natl Agr & Food Res Org, Chem Subst Effect Assessment Unit, Div Biodivers, Tsukuba, Ibaraki, Japan; [Ueda, Tetsuyuki] Ishikawa Prefectural Coll, Environm Sci, Nonoichi, Ishikawa, Japan; [Goka, Koichi] Natl Inst Environm Sci, Tsukuba, Ibaraki, Japan	Miyagi University; National Agriculture & Food Research Organization - Japan; National Institute for Environmental Studies - Japan	Jinguji, H (corresponding author), Miyagi Univ, Sch Food Agr & Environm Sci, Sendai, Miyagi, Japan.	jinguji@myu.ac.jp		Jinguji, Hiroshi/0000-0003-0888-0965				Aajoud A, 2003, J AGR FOOD CHEM, V51, P1347, DOI 10.1021/jf025843j; Alexander AC, 2008, FRESHWATER BIOL, V53, P171, DOI 10.1111/j.1365-2427.2007.01880.x; Alexander AC, 2007, ENVIRON TOXICOL CHEM, V26, P1726, DOI 10.1897/07-015R.1; Anderson JC, 2015, SCI TOTAL ENVIRON, V505, P409, DOI 10.1016/j.scitotenv.2014.09.090; [Anonymous], 2012, NATURE INSECTS; Azevedo-Pereira HMVS, 2011, ECOTOX ENVIRON SAFE, V74, P1210, DOI 10.1016/j.ecoenv.2011.03.018; Benzidane Y, 2010, PEST MANAG SCI, V66, P1351, DOI 10.1002/ps.2022; Bethany ST, 2012, ENVIRON TOXICOL CHEM, V31, P1; BLOISHEULIN C, 1990, OECOLOGIA, V84, P295, DOI 10.1007/BF00329753; Camp AA, 2016, AQUAT TOXICOL, V178, P49, DOI 10.1016/j.aquatox.2016.07.011; Campero M, 2007, ECOL APPL, V17, P2111, DOI 10.1890/07-0442.1; Carpenter KD, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5215-5; Charreton M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144879; Corbet P. S., 1962, BIOL DRAGONFLIES; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Thuyet DQ, 2013, AGR ECOSYST ENVIRON, V179, P69, DOI 10.1016/j.agee.2013.07.012; Thuyet DQ, 2012, J PESTIC SCI, V37, P20, DOI 10.1584/jpestics.G11-19; Thuyet DQ, 2011, J PESTIC SCI, V36, P9, DOI 10.1584/jpestics.G10-49; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; Fossen M., 2006, ENV FATE LMIDACLOPRI; Gibbons D, 2015, ENVIRON SCI POLLUT R, V22, P103, DOI 10.1007/s11356-014-3180-5; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gonzalez-Pradas E, 1999, PESTIC SCI, V55, P1109, DOI 10.1002/(SICI)1096-9063(199911)55:11&lt;1109::AID-PS64&gt;3.0.CO;2-T; Guez D, 2001, NEUROBIOL LEARN MEM, V76, P183, DOI 10.1006/nlme.2000.3995; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; Hayasaka D., 2013, JPN J PESTIC SCI, V38, P101, DOI [DOI 10.1584/JPESTICS.W13-05, 10.1584/jpestics.W13-05]; Hayasaka D, 2012, ECOTOXICOLOGY, V21, P191, DOI 10.1007/s10646-011-0778-y; Henry M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.2110; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Hladik ML, 2016, ENVIRON CHEM, V13, P12, DOI 10.1071/EN15061; Hook SE, 2018, ECOTOX ENVIRON SAFE, V148, P770, DOI 10.1016/j.ecoenv.2017.11.028; Insecticide Resistance Action Committee, 2017, IRAC MOD ACT CLASS S; Iwafune T, 2011, ENVIRON TOXICOL CHEM, V30, P1834, DOI 10.1002/etc.569; Iwafune T, 2010, J PESTIC SCI, V35, P114, DOI 10.1584/jpestics.G09-49; Janssens L, 2012, AQUAT TOXICOL, V110, P91, DOI 10.1016/j.aquatox.2011.12.019; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Jinguji H, 2009, STADIUM CONSTRUCTION, V51, P38; Jinguji H, 2015, ODONATOLOGICA, V44, P63; Jinguji H, 2013, PADDY WATER ENVIRON, V11, P277, DOI 10.1007/s10333-012-0317-3; Jinguji H, 2010, PADDY WATER ENVIRON, V8, P385, DOI 10.1007/s10333-010-0217-3; Jinguji Hiroshi, 2009, Transactions of the Japanese Society of Irrigation Drainage and Rural Engineering, V77, P35; Karube H., 2012, NATURE INSECTS, V47, P2; Kasai A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23055; Kobashi K, 2017, ECOTOX ENVIRON SAFE, V138, P122, DOI 10.1016/j.ecoenv.2016.12.025; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Mandal SK, 2008, ACTA TROP, V106, P109, DOI 10.1016/j.actatropica.2008.02.002; Maul JD, 2008, ENVIRON TOXICOL CHEM, V27, P2582, DOI 10.1897/08-185.1; MCPEEK MA, 1990, ECOLOGY, V71, P83, DOI 10.2307/1940249; Miles JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174171; Morrissey CA, 2015, ENVIRON INT, V74, P291, DOI 10.1016/j.envint.2014.10.024; Nicodemo D, 2014, ENVIRON TOXICOL CHEM, V33, P2070, DOI 10.1002/etc.2655; Nyman AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062472; OECD, 2004, DAPHN SP AC IMM TEST, P202; Pestana JLT, 2009, AQUAT TOXICOL, V93, P138, DOI 10.1016/j.aquatox.2009.04.008; Phong TK, 2009, WATER AIR SOIL POLL, V202, P3, DOI 10.1007/s11270-008-9953-z; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; R Development Core Team, 2014, R LANG ENV STAT COMP; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; Sanchez-Bayo F, 2006, ENVIRON TOXICOL CHEM, V25, P1677, DOI 10.1897/05-404R.1; Schlenk D, 2001, ARCH ENVIRON CON TOX, V41, P325, DOI 10.1007/s002440010255; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; SEBASTIAN A, 1990, B ENTOMOL RES, V80, P223, DOI 10.1017/S0007485300013468; SEBASTIAN A, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P104; Shaalan EAS, 2009, TROP BIOMED, V26, P223; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Thompson HM, 2007, PEST MANAG SCI, V63, P1058, DOI 10.1002/ps.1458; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tosi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15308-6; Tosi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1711; Tosi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01361-8; Tosi S, 2016, J INSECT PHYSIOL, V93-94, P56, DOI 10.1016/j.jinsphys.2016.08.010; Ueda Tetsuyuki, 2013, Tombo (Tokyo), V55, P1; URABE K, 1986, JPN J APPL ENTOMOL Z, V30, P129, DOI 10.1303/jjaez.30.129; *US EPA, 1996, EPA737F96005; Uuda T., 1998, CONSERVATION WETLAND, P93; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; Wu J, 2015, SCI TOTAL ENVIRON, V518, P139, DOI 10.1016/j.scitotenv.2014.12.103; Zhao XL, 2005, J PHARMACOL EXP THER, V314, P363, DOI 10.1124/jpet.104.077891; Zhao XL, 2004, NEUROTOXICOLOGY, V25, P967, DOI 10.1016/j.neuro.2004.04.004	84	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200299	10.1371/journal.pone.0200299	http://dx.doi.org/10.1371/journal.pone.0200299			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995904	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800051
J	Miotto, BA; Guilloux, AGA; Tozzi, BF; Moreno, LZ; da Hora, AS; Dias, RA; Heinemann, MB; Moreno, AM; de Souza, AF; Lilenbaum, W; Hagiwara, MK				Miotto, Bruno Alonso; Alves Guilloux, Aline Gil; Tozzi, Barbara Furlan; Moreno, Luisa Zanolli; da Hora, Aline Santana; Dias, Ricardo Augusto; Heinemann, Marcos Bryan; Moreno, Andrea Micke; de Souza Filho, Antonio Francisco; Lilenbaum, Walter; Hagiwara, Mitika Kuribayashi			Prospective study of canine leptospirosis in shelter and stray dog populations: Identification of chronic carriers and different Leptospira species infecting dogs	PLOS ONE			English	Article							CHAIN-REACTION ASSAY; TANDEM-REPEAT ANALYSIS; PATHOGENIC LEPTOSPIRA; MOLECULAR CHARACTERIZATION; SAO-PAULO; BRAZIL; SANTAROSAI; ANIMALS; HUMANS; SEJROE	Dogs are highly susceptible to the leptospiral infection, notably stray and sheltered dogs. Unsanitary conditions often observed in dog shelters may predispose the introduction and spread of leptospires among sheltered populations, potentially increasing the chances for the inadvertent adoption of asymptomatically infected animals. The present work describes a longitudinal study using a multidisciplinary approach for the identification of chronically infected dogs and the characterization of potentially pathogenic strains circulating among stray and sheltered dog populations in Sao Paulo, Brazil. A total of 123 dogs from three populations were included. The initial evaluation consisted of blood and urine quantitative PCR testing (qPCR), the detection of specific antibodies by microscopic agglutination test (MAT), physical examination and hematological and serum biochemistry analyses. The qPCR-positive dogs were prospectively examined, and reevaluations also included culture from urine samples. Positive qPCR samples were subjected to 16S rRNA and secYgene phylogenetic analysis. The recovered strains were characterized by Multilocus Sequence Typing, polyclonal serogroup identification and virulence determination. Leptospiruria was detected in all populations studied (13/123), and phylogenetic analysis revealed that 10 dogs had L. interrogans infection. Three dogs (3/13) had L. santarosai infection. The secYphylogenetic analysis revealed that the L. santarosai sequences clustered separately from those obtained from other hosts. Ten leptospiruric dogs were reevaluated, and three dogs presented persistent leptospiruria, allowing culturing from two dogs. The strains were characterized as L. interrogans serogroup Canicola (virulent) and L. santarosai serogroup Sejroe (not virulent). Serum samples were retested by MAT using the DU92 and DU114 strains as antigens, and no increased seroreactivity was detected. Asymptomatic L. santarosai infection was observed in all populations studied, suggesting a possible role of dogs in the chain of transmission of this leptospiral species. The results suggest a genetic distinction between lineages of Brazilian L. santarosai maintained by dogs and other animal hosts. Our findings revealed that dogs could act as maintenance hosts for distinct pathogenic Leptospira, highlighting also that asymptomatically infected dogs can be inadvertently admitted and adopted in dog shelters, potentially increasing the risks of zoonotic transmission.	[Miotto, Bruno Alonso; Tozzi, Barbara Furlan; Hagiwara, Mitika Kuribayashi] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Clin Med, Sao Paulo, SP, Brazil; [Alves Guilloux, Aline Gil; Moreno, Luisa Zanolli; da Hora, Aline Santana; Dias, Ricardo Augusto; Heinemann, Marcos Bryan; Moreno, Andrea Micke; de Souza Filho, Antonio Francisco] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Med Vet Prevent & Saude Anim, Sao Paulo, SP, Brazil; [Lilenbaum, Walter] Univ Fed Fluminense, Dept Microbiol & Parasitol, Niteroi, RJ, Brazil; [Miotto, Bruno Alonso] Univ Sao Paulo, Lab Microbiol & Imunodiag, Dept Clin Med, Fac Med Vet & Zootecnia, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal Fluminense; Universidade de Sao Paulo	Miotto, BA (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Clin Med, Sao Paulo, SP, Brazil.; Miotto, BA (corresponding author), Univ Sao Paulo, Lab Microbiol & Imunodiag, Dept Clin Med, Fac Med Vet & Zootecnia, Sao Paulo, SP, Brazil.	brunomiotto@hotmail.com	de Souza Filho, Antonio Francisco/G-2382-2015; Guilloux, Aline G A/J-6881-2012; Hora, Aline S/B-7974-2014; Heinemann, Marcos Bryan/AAI-9390-2020; Moreno, Andrea M/B-7861-2012; Heinemann, Marcos B/G-2780-2015; Dias, Ricardo A/D-5977-2013; Moreno, Luisa Z/K-5800-2012	de Souza Filho, Antonio Francisco/0000-0003-4728-1228; Guilloux, Aline G A/0000-0002-2760-3720; Hora, Aline S/0000-0003-2999-323X; Heinemann, Marcos Bryan/0000-0001-6444-9788; Moreno, Andrea M/0000-0002-3290-566X; Heinemann, Marcos B/0000-0001-6444-9788; Moreno, Luisa Z/0000-0003-0134-9741; Dias, Ricardo Augusto/0000-0002-8241-7699	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/14681-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2012/13022-0, 164284/2014]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [12/111]; FAPESP [2013/17136-2]; FAPESP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; http://www.fapesp.br/ - Grant Number 2012/14681-7); B.A.M. was recipient of the PhD fellowship from FAPESP and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; http://cnpq.br/) (grant numbers 2012/13022-0 and 164284/2014); A.G.A. G. was recipient of the PhD fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; http://www.capes.gov.br Grant number 12/111); L.Z.M. was recipient of the PhD fellowship from FAPESP (2013/17136-2); A. M.M., M.K.H., M.B.H., R.A.D. and P.E.B. are CNPq research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Andre-Fontaine G, 2006, VET MICROBIOL, V117, P19, DOI 10.1016/j.vetmic.2006.04.005; Awosanya EJ, 2013, NIGERIA PAN AFR MED, V16, P144, DOI DOI 10.11604/PAMJ.2013.16.144.3529; Azocar-Aedo L, 2016, ZOONOSES PUBLIC HLTH, V63, P328, DOI 10.1111/zph.12236; Barr SC, 2005, AM J VET RES, V66, P1780, DOI 10.2460/ajvr.2005.66.1780; Barragan Veronica, 2017, BMC Res Notes, V10, P71, DOI 10.1186/s13104-017-2384-4; Barragan V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004990; Boonsilp S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-338; Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0; Bourhy P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002114; Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007; Cai HY, 2002, J VET DIAGN INVEST, V14, P164, DOI 10.1177/104063870201400214; Chen HY, 2014, RELEVANCE RAINFALL L, V12, DOI [10.5897/AJMR12.1053, DOI 10.5897/AJMR12.1053]; Chou LF, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.78; CLEGG FG, 1975, VET REC, V96, P385, DOI 10.1136/vr.96.17.385; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; Cruz-Romero A., 2013, African Journal of Microbiology Research, V7, P1518; Dreer MKD, 2013, J VENOM ANIM TOXINS, V19, DOI 10.1186/1678-9199-19-23; Delaude A, 2017, PREV VET MED, V141, P48, DOI 10.1016/j.prevetmed.2017.04.008; Desvars A, 2012, AM J TROP MED HYG, V87, P134, DOI 10.4269/ajtmh.2012.12-0102; Dias RA, 2013, PREV VET MED, V110, P263, DOI 10.1016/j.prevetmed.2012.12.002; Dikken H., 1978, METHODS MICROBIOL, P259, DOI DOI 10.1016/S0580-9517(08)70493-8; EVERARD COR, 1979, INT J ZOONOSES, V6, P33; Felzemburgh RDM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002927; Fink JM, 2015, J VET DIAGN INVEST, V27, P159, DOI 10.1177/1040638715571360; Fung HL, 2014, ACTA TROP, V135, P67, DOI 10.1016/j.actatropica.2014.03.010; Gay N, 2014, INT J ENV RES PUB HE, V11, P4316, DOI 10.3390/ijerph110404316; Gould K, 1979, INFECT DIS CURRENT T; Greene CE, 2012, INFECT DIS DOG CAT, P431, DOI DOI 10.1016/J.PREVETMED.2017.04.008; Guernier V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004733; Hamond C, 2015, EPIDEMIOLOGY INFECT, V16, P1; Hamond C, 2015, J MED MICROBIOL, V64, P507, DOI 10.1099/jmm.0.000045; Harkin KR, 2016, JAVMA-J AM VET MED A, V249, P399, DOI 10.2460/javma.249.4.399; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1230, DOI 10.2460/javma.2003.222.1230; Harkin KR, 2003, J AM VET MED ASSOC, V222, P1224, DOI 10.2460/javma.2003.222.1224; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Jittapalapong S, 2009, SE ASIAN J TROP MED, V40, P247; Jorge S, 2015, CURR MICROBIOL, V71, P496, DOI 10.1007/s00284-015-0857-z; Juvet F, 2011, VET REC, V168, DOI 10.1136/vr.d740; Kanthaswamy S, 2012, FORENSIC SCI INT-GEN, V6, pE97, DOI 10.1016/j.fsigen.2011.09.001; Khorami N., 2010, Comparative Clinical Pathology, V19, P271, DOI 10.1007/s00580-009-0856-1; Klaasen HLBM, 2013, VET REC, V172, P181, DOI 10.1136/vr.101100; Kurilung A, 2017, RES VET SCI, V115, P146, DOI 10.1016/j.rvsc.2017.03.017; Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405; Lilenbaum W, 2014, BRAZ J MICROBIOL, V45, P1527, DOI 10.1590/S1517-83822014000400050; Llewellyn JR, 2016, BERL MUNCH TIERARZTL, V129, P251, DOI 10.2376/0005-9366-129-15061; MACKINTOSH CG, 1980, NEW ZEAL VET J, V28, P100, DOI 10.1080/00480169.1980.34709; Martin LER, 2014, J VET INTERN MED, V28, P789, DOI 10.1111/jvim.12337; Martins G, 2012, EPIDEMIOL INFECT, V140, P207, DOI 10.1017/S0950268811000276; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Miller MD, 2011, J VET INTERN MED, V25, P426, DOI 10.1111/j.1939-1676.2011.0704.x; Miotto BA, 2018, BRAZ J MICROBIOL, V49, P584, DOI 10.1016/j.bjm.2017.09.004; Miotto BA, 2016, ACTA TROP, V162, P1, DOI 10.1016/j.actatropica.2016.06.007; Miraglia F, 2012, TROP ANIM HEALTH PRO, V45, P117, DOI 10.1007/s11250-012-0181-6; Mohammed H., 2011, BACTERIOL PARASITOL, V02, P6, DOI [10.4172/2155-9597.1000120, DOI 10.4172/2155-9597.1000120]; Murray CK, 2011, T ROY SOC TROP MED H, V105, P209, DOI 10.1016/j.trstmh.2010.12.004; Naotunna C, 2016, ASIAN PAC J TROP MED, V9, P381, DOI 10.1016/j.apjtm.2016.03.009; Panaphut T, 2003, CLIN INFECT DIS, V36, P1507, DOI 10.1086/375226; Sanchez RGP, 2016, MEM I OSWALDO CRUZ, V111, P737, DOI 10.1590/0074-02760160245; Pinto PS, 2015, ACTA TROP, V149, P163, DOI 10.1016/j.actatropica.2015.05.008; da Cunha CEP, 2016, AM J TROP MED HYG, V94, P519, DOI 10.4269/ajtmh.15-0505; Raptis L, 2006, INT J ANTIMICROB AG, V28, P259, DOI 10.1016/j.ijantimicag.2006.04.011; Rojas P, 2010, EUR J CLIN MICROBIOL, V29, P1305, DOI 10.1007/s10096-010-0991-2; Romero EC, 2009, LETT APPL MICROBIOL, V48, P623, DOI 10.1111/j.1472-765X.2009.02580.x; Romero EC, 2006, MEM I OSWALDO CRUZ, V101, P373, DOI 10.1590/S0074-02762006000400005; Ruhl-Fehlert CI, 2000, EXP TOXICOL PATHOL, V52, P201; Samir A, 2015, REV SOC BRAS MED TRO, V48, P272, DOI 10.1590/0037-8682-0102-2015; SCANZIANI E, 1995, LAB ANIM, V29, P300, DOI 10.1258/002367795781088261; Scanziani E, 2002, J SMALL ANIM PRACT, V43, P154, DOI 10.1111/j.1748-5827.2002.tb00048.x; Schneider MC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004095; Schuller S, 2015, J SMALL ANIM PRACT, V56, P159, DOI 10.1111/jsap.12328; Steneroden KK, 2011, ZOONOSES PUBLIC HLTH, V58, P449, DOI 10.1111/j.1863-2378.2011.01389.x; Suepaul SM, 2015, TROP BIOMED, V32, P1; THIERMANN AB, 1980, AM J VET RES, V41, P1659; Trevejo RT, 1998, J INFECT DIS, V178, P1457, DOI 10.1086/314424; Valverde MDA, 2013, J MED MICROBIOL, V62, P1263, DOI 10.1099/jmm.0.058545-0; Vasconcellos SA, 2001, BRAZ J MICROBIOL, V32, P298; Viegas SARA, 2001, REV BRAS SAUDE PROD, V1; Wang Y, 2015, PLOS NEGLECT TROP D, V9, DOI DOI 10.1371/; Zakeri S, 2010, INFECT GENET EVOL, V10, P273, DOI 10.1016/j.meegid.2010.01.001	80	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200384	10.1371/journal.pone.0200384	http://dx.doi.org/10.1371/journal.pone.0200384			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995963	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800061
J	Mazoni, I; Borro, LC; Jardine, JG; Yano, IH; Salim, JA; Neshich, G				Mazoni, Ivan; Borro, Luiz Cesar; Jardine, Jose Gilberto; Yano, Inacio Henrique; Salim, Jose Augusto; Neshich, Goran			Study of specific nanoenvironments containing alpha-helices in all-alpha and (alpha plus beta) plus (alpha/beta) proteins	PLOS ONE			English	Article							SECONDARY STRUCTURE; STRUCTURE PREDICTION	Protein secondary structure elements (PSSEs) such as alpha-helices, beta-strands, and turns are the primary building blocks of the tertiary protein structure. Our primary interest here is to reveal the characteristics of the nanoenvironment formed by both PSSEs and their surrounding amino acid residues (AARs), which might contribute to the general understanding of how proteins fold. The characteristics of such nanoenvironments must be specific to each secondary structure element, and we have set our goal here to gather the fullest possible description of the alpha-helical nanoenvironment. In general, this postulate (the existence of specific nanoenvironments for specific protein substructures/neighbourhoods/regions with distinct functionality) was already successfully explored and confirmed for some protein regions, such as protein-protein interfaces and enzyme catalytic sites. Consequently, PSSEs were the obvious next choice for additional work for further evidence showing that specific nanoenvironments (having characteristics fully describable by means of structural and physical chemical descriptors) do exist for the corresponding and determined intraprotein regions. The nanoenvironment of alpha-helices (nEo alpha H) is defined as any region of the protein where this secondary structure element type is detected. The nEo alpha H, therefore, includes not only the alpha-helix amino acid residues but also the residues immediately around the alpha-helix. The hypothesis that motivated this work is that it might in fact be possible to detect a postulated "signal" or "signature" that distinguishes the specific location of alpha-helices. This "signal" must be discernible by tracking differences in the values of physical, chemical, physicochemical, structural and geometric descriptors immediately before (or after) the PSSE from those in the region along the alpha-helices. The search for this specific nanoenvironment "signal" was made possible by aligning previously selected alpha-helices of equal length. Afterward, we calculated the average value, standard deviation and mean square error at each aligned residue position for each selected descriptor. We applied Student's t-test, the Kolmogorov-Smirnov test and MANOVA statistical tests to the dataset constructed as described above, and the results confirmed that the hypothesized "signal"/ "signature" is both existing/identifiable and capable of distinguishing the presence of an alpha-helix inside the specific nanoenvironment, contextualized as a specific region within the whole protein. However, such conclusion might rarely be reached if only one descriptor is considered at a time. A more accurate signal with broader coverage is achieved only if one applies multivariate analysis, which means that several descriptors (usually approximately 10 descriptors) should be considered at the same time. To a limited extent (up to a maximum of 15% of cases), such conclusion is also possible with only a single descriptor, and the conclusion is also possible in general for up to 50-80% of cases when no less than 5 nonlinear descriptors are selected and considered. Using all the descriptors considered in this work, provided all assumptions about data characteristics for this analysis are met, multivariate analysis regularly reached a coverage and accuracy above 90%. Understanding how secondary structure elements are formed and maintained within a protein structure could enable a more detailed understanding of how proteins reach their final 3D structure and consequently, their function. Likewise, this knowledge may also improve the tools used to determine how good a structure is by means of comparing the "signal" around a selected PSSE with the one obtained from the best (resolution and quality wise) protein structures available.	[Mazoni, Ivan; Yano, Inacio Henrique; Neshich, Goran] Embrapa Agr Informat, Campinas, SP, Brazil; [Borro, Luiz Cesar] Univ Estadual Campinas, Inst Biol, Campinas, SP, Brazil; [Jardine, Jose Gilberto] Embrapa Terr Management, Campinas, SP, Brazil; [Salim, Jose Augusto] Univ Sao Paulo, Res Ctr Biodivers & Comp, Sao Paulo, SP, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Neshich, G (corresponding author), Embrapa Agr Informat, Campinas, SP, Brazil.	goran.neshich@embrapa.br	Borro, Luiz/N-7616-2018; Salim, José Augusto/AAY-4366-2020; Yano, Inacio H/F-3109-2013	Borro, Luiz/0000-0002-8630-5950; Salim, José Augusto/0000-0002-8675-7068; 	Embrapa	Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	Funded by Embrapa Internal Financing.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Biasini M, 2014, NUCLEIC ACIDS RES; Chakravarti L., 1967, HDB METHODS APPL STA; Christoph W, 2013, BIOINFORMATICS; Crick FHC, 1958, ON PROTEIN SYNTHESIS, P138; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Drozdetskiy A., 2015, NUCLEIC ACIDS RES; EFIMOV AV, 1995, J MOL BIOL, V245, P402, DOI 10.1006/jmbi.1994.0033; Elmar K, 2002, PROTEIN-STRUCT FUNCT, P393; Faraggi E, 2012, J COMPUT CHEM, P259; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Haynes W., 2013, ENCY SYSTEMBIOL, P2023; Heffernan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11476; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; KABSCH W, 1983, FEBS LETT, V155, P179, DOI 10.1016/0014-5793(82)80597-8; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Lee Jooyoung, 2009, P3, DOI 10.1007/978-1-4020-9058-5_1; Li W, 2006, BIOINFORMATICS; Lin KL, 2013, EUR BIOPHYS J BIOPHY, V42, P455, DOI 10.1007/s00249-013-0896-y; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Magnan CN, 2014, BIOINFORMATICS, V30, P2592, DOI 10.1093/bioinformatics/btu352; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Moraes FR, 2014, PLOS ONE, P87; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neshich G, 2005, NUCLEIC ACIDS RES, V33, pD269, DOI 10.1093/nar/gki111; Neshich G, 2003, NUCLEIC ACIDS RES, V31, P3386, DOI 10.1093/nar/gkg578; Neshich G, 2014, USING STRUCTURAL PHY; Neshich G, 2003, STING MILLENNIUM SUI, V3; Oliveira SRM, 2007, GENET MOL RES, V6, P911; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Seeley M, 2013, 13 IEEE INT C BIOINF; SHARMA KK, 1994, IEEE T RELIAB, V43, P630, DOI 10.1109/24.370217; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spencer M, 2015, IEEE ACM T COMPUT BI, V12, P103, DOI 10.1109/TCBB.2014.2343960; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; Wadood A, 2013, OA DRUG DESIGN D APR; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; WILK MB, 1968, BIOMETRIKA, V55, P1; Xu D, 2012, FUNCTION OTEINS STRU, P1715; Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2	49	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200018	10.1371/journal.pone.0200018	http://dx.doi.org/10.1371/journal.pone.0200018			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990352	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300024
J	Liu, WH; Cheng, CZ; Lin, YL; Xu, XH; Lai, ZX				Liu, Weihua; Cheng, Chunzhen; Lin, Yuling; Xu XuHan; Lai, Zhongxiong			Genome-wide identification and characterization of mRNAs and lncRNAs involved in cold stress in the wild banana (Musa itinerans)	PLOS ONE			English	Article							LONG NONCODING RNAS; LOW-TEMPERATURE; TRANSCRIPTION FACTORS; CLIMATIC STRESS; PLANTS; DROUGHT; GENE; BIOSYNTHESIS; EXPRESSION; EVOLUTION	Cold stress seriously affects banana growth, yield and fruit quality. Long noncoding RNAs (lncRNAs) have been demonstrated as key regulators of biotic and abiotic stress in plants, but the identification and prediction of cold responsive mRNAs and lncRNAs in wild banana remains unexplored. In present study, a cold resistant wild banana line from China was used to profile the cold-responsive mRNAs and lncRNAs by RNA-seq under cold stress conditions, i.e. 13 degrees C (critical growth temperature), 4 degrees C (chilling temperature), 0 degrees C (freezing temperature) and normal growing condition, i.e. 28 degrees C (control group). A total of 12,462 lncRNAs were identified in cold-stressed wild banana. In mRNA, much more alternative splicing events occurred in wild banana under the cold stress conditions compared with that in the normal growing condition. The GO analysis of differential expression genes (DEGs) showed the biochemical processes and membrane related genes responded positively to the cold stress. The KEGG pathway enrichment analysis of the DEGs showed that the pathways of photosynthesis, photosynthesis-antenna proteins, circadian rhythm-plant, glutathione metabolism, starch and sucrose metabolism, cutin/suberine/biosynthesis were altered or affected by the cold stress conditions. Our analyses of the generated transcriptome and lncRNAs provide new insights into regulating expression of genes and lncRNAs that respond to cold stress in the wild banana.	[Liu, Weihua; Cheng, Chunzhen; Lin, Yuling; Xu XuHan; Lai, Zhongxiong] Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China; [Xu XuHan] IRIT ARI, Inst Rech Interdisciplinaire Toulouse, Toulouse, France	Fujian Agriculture & Forestry University	Lai, ZX (corresponding author), Fujian Agr & Forestry Univ, Inst Hort Biotechnol, Fuzhou, Fujian, Peoples R China.	laizx01@163.com	Cheng, Chunzhen/HGA-1240-2022	Cheng, Chunzhen/0000-0003-1978-0097	Fund for China Agriculture Research System [CARS-31-15]; National Natural Science Foundation of China [31601713]; Science and Technology Major Science and Technology Project in Fujian Province of China [2015NZ20002-1]; earmarked Fund for China Agriculture Research System [CARS-31-15]	Fund for China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Major Science and Technology Project in Fujian Province of China; earmarked Fund for China Agriculture Research System	The Fund for China Agriculture Research System (CARS-31-15) sponsors for the lncRNA sequencing, the National Natural Science Foundation of China (31601713) sponsors for the mRNA sequencing, the Science and Technology Major Science and Technology Project in Fujian Province of China (2015NZ20002-1) sponsors for the qPCR.; This work was supported by the earmarked Fund for China Agriculture Research System (CARS-31-15), the National Natural Science Foundation of China (31601713) and the Science and Technology Major Science and Technology Project in Fujian Province of China (2015NZ20002-1).	Abeynayake SW, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0643-x; Albertsson PA, 1995, PHOTOSYNTH RES, V46, P141, DOI 10.1007/BF00020424; Appelhagen I, 2011, PLANT J, V67, P406, DOI 10.1111/j.1365-313X.2011.04603.x; Bai B, 2015, INT J MOL SCI, V16, P11398, DOI 10.3390/ijms160511398; BAKER EA, 1974, NEW PHYTOL, V73, P955, DOI 10.1111/j.1469-8137.1974.tb01324.x; Barah P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-722; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Cagirici HB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11170-8; Chen F., 2016, THESIS; Chen HB, 2011, SPECIAL FRUIT CULTIV, P73; Cheng YL, 2003, DEV CELL, V4, P53, DOI 10.1016/S1534-5807(02)00399-4; Cui J, 2017, PLANT J, V89, P577, DOI 10.1111/tpj.13408; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; De Quattro C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11206-z; Feng RJ, 2015, J AM SOC HORTIC SCI, V140, P214, DOI 10.21273/JASHS.140.3.214; Gao J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40852; GARBER MP, 1976, PLANT PHYSIOL, V57, P681, DOI 10.1104/pp.57.5.681; GAUVRIT C, 1991, WEED RES, V31, P135, DOI 10.1111/j.1365-3180.1991.tb01752.x; Schlaen RG, 2015, P NATL ACAD SCI USA, V112, P9382, DOI 10.1073/pnas.1504541112; Hao ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121800; Hasselt PRV, 1974, PHOTOOXIDATIVE DAMAG, V77, P50; HELDT HW, 1971, BIOCHIM BIOPHYS ACTA, V234, P83, DOI 10.1016/0005-2728(71)90133-2; Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023; Hippler M, 2001, PLANT J, V28, P595, DOI 10.1046/j.1365-313X.2001.01175.x; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Joshi RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158784; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim ED, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03878-4; KIMBALL SL, 1973, AM J BOT, V60, P1028, DOI 10.2307/2441517; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; Kwenda S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2967-9; LAETSCH WM, 1968, AM J BOT, V55, P875, DOI 10.2307/2440550; Lai ZX, 2007, SUBTROP AGR RES, V3, P1; Lessard WO, 1992, COMPLETE BOOK BANANA; Leviatan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066511; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li SX, 2017, SCI REP-UK, V7, DOI 10.1038/srep45981; Lightfoot DJ, 2008, MOL GENET GENOMICS, V279, P75, DOI 10.1007/s00438-007-0297-y; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu WH, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1617-z; Mano H, 2007, PLANT PHYSIOL, V143, P1252, DOI 10.1104/pp.106.094425; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; MARTIN B, 1986, PLANT CELL ENVIRON, V9, P323, DOI 10.1111/1365-3040.ep11611711; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Morton J., 1987, FRUITS WARM CLIMATES, P328; Muthusamy M, 2015, PLANT BIOTECHNOL REP, V9, P279, DOI 10.1007/s11816-015-0363-6; Nejat N, 2018, CRIT REV BIOTECHNOL, V38, P93, DOI 10.1080/07388551.2017.1312270; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Poldervaart MT, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072610, 10.1371/journal.pone.0082817]; Qin T, 2017, PLANT PHYSIOL, V175, P1321, DOI 10.1104/pp.17.00574; Quattro CD, 2017, SCI REPORTS, V7, P1, DOI [10.1038/s41598-016-0028-X, DOI 10.1038/s41598-016-0028-X]; Seo PJ, 2013, PLANTA, V237, P1415, DOI 10.1007/s00425-013-1882-4; Shepherd T, 2006, NEW PHYTOL, V171, P469, DOI 10.1111/j.1469-8137.2006.01826.x; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Shumayla, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01019; SHUMWAY LK, 1967, AM J BOT, V54, P773, DOI 10.2307/2440955; Tan HQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151105; TAYLOR AO, 1971, PLANT PHYSIOL, V47, P713, DOI 10.1104/pp.47.5.713; TAYLOR AO, 1971, PLANT PHYSIOL, V47, P719, DOI 10.1104/pp.47.5.719; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; TURNER DW, 1983, AUST J PLANT PHYSIOL, V10, P43, DOI 10.1071/PP9830043; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang CY, 2017, SCI REP-UK, V7, DOI 10.1038/srep43226; Wang JM, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-203, 10.1186/1471-2156-15-33, 10.1186/1471-2164-15-415]; Wang M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1629-7; Wang ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05377-y; WISE RR, 1983, PLANT CELL ENVIRON, V6, P525, DOI 10.1111/j.1365-3040.1983.tb01165.x; Wu JR, 1997, PLANT PHYSIOL, V113, P347, DOI 10.1104/pp.113.2.347; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Yang QS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1551-z; Yang QS, 2012, MOL CELL PROTEOMICS, V11, P1853, DOI 10.1074/mcp.M112.022079; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhang JZ, 2012, S AFR J BOT, V78, P290, DOI 10.1016/j.sajb.2011.08.002; Zhang JZ, 2009, PLANTA, V229, P847, DOI 10.1007/s00425-008-0885-z; Zhang YC, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0512-1; Zhao L, 2013, FUNCT INTEGR GENOMIC, V13, P75, DOI 10.1007/s10142-012-0301-4; Zhu BZ, 2015, J EXP BOT, V66, P4483, DOI 10.1093/jxb/erv203	87	24	29	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200002	10.1371/journal.pone.0200002	http://dx.doi.org/10.1371/journal.pone.0200002			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985922	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500017
J	Dal Molin, A; Minio, A; Griggio, F; Delledonne, M; Infantino, A; Aragona, M				Dal Molin, Alessandra; Minio, Andrea; Griggio, Francesca; Delledonne, Massimo; Infantino, Alessandro; Aragona, Maria			The genome assembly of the fungal pathogen Pyrenochaeta lycopersici from Single-Molecule Real-Time sequencing sheds new light on its biological complexity	PLOS ONE			English	Article							CORKY ROOT-ROT; TRANSPOSABLE ELEMENTS; EUKARYOTIC GENOMES; GENE; TOMATO; AMPLIFICATION; ADAPTATION; EVOLUTION; PLANT; IDENTIFICATION	The first draft genome sequencing of the non-model fungal pathogen Pyrenochaeta lycopersici showed an expansion of gene families associated with heterokaryon incompatibility and lacking of mating-type genes, providing insights into the genetic basis of this "imperfect" fungus which lost the ability to produce the sexual stage. However, due to the Illumina short-read technology, the draft genome was too fragmented to allow a comprehensive characterization of the genome, especially of the repetitive sequence fraction. In this work, the sequencing of another P. lycopersici isolate using long-read Single Molecule Real-Time sequencing technology was performed with the aim of obtaining a gapless genome. Indeed, a gapless genome assembly of 62.7 Mb was obtained, with a fraction of repetitive sequences representing 30% of the total bases. The gene content of the two P. lycopersici isolates was very similar, and the large difference in genome size (about 8 Mb) might be attributable to the high fraction of repetitive sequences detected for the new sequenced isolate. The role of repetitive elements, including transposable elements, in modulating virulence effectors is well established in fungal plant pathogens. Moreover, transposable elements are of fundamental importance in creating and re-modelling genes, especially in imperfect fungi. Their abundance in P. lycopersici, together with the large expansion of heterokaryon incompatibility genes in both sequenced isolates, suggest the presence of possible mechanisms alternative to gene re-assorting mediated by sexual recombination. A quite large fraction (similar to 9%) of repetitive elements in P. lycopersici, has no homology with known classes, strengthening this hypothesis. The availability of a gapless genome of P. lycopersici allowed the in-depth analysis of its genome content, by annotating functional genes and TEs. This goal will be an important resource for shedding light on the evolution of the reproductive and pathogenic behaviour of this soilborne pathogen and the onset of a possible speciation within this species.	[Dal Molin, Alessandra; Minio, Andrea; Griggio, Francesca; Delledonne, Massimo] Univ Verona, Dipartimento Biotecnol, Verona, Italy; [Infantino, Alessandro; Aragona, Maria] Consiglio Ric Agr & Anal Econ Agr, Res Ctr Plant Protect & Certificat, Rome, Italy	University of Verona; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Aragona, M (corresponding author), Consiglio Ric Agr & Anal Econ Agr, Res Ctr Plant Protect & Certificat, Rome, Italy.	maria.aragona@crea.gov.it	Delledonne, Massimo/O-8685-2017; Aragona, Maria/AAB-2189-2020; Infantino, Alessandro/ABD-1366-2020	Aragona, Maria/0000-0002-1320-2141; Dal Molin, Alessandra/0000-0001-6281-9589; Delledonne, Massimo/0000-0002-7100-4581	Italian Ministry of Agriculture, project BIOMED "Tecnologie innovative per la protezione biologica di colture mediterranee da patogeni e parassiti tellurici"	Italian Ministry of Agriculture, project BIOMED "Tecnologie innovative per la protezione biologica di colture mediterranee da patogeni e parassiti tellurici"	This study was partly funded by the Italian Ministry of Agriculture, project BIOMED "Tecnologie innovative per la protezione biologica di colture mediterranee da patogeni e parassiti tellurici". There was no additional external funding received for this study.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amselem J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1347-1; Aragona M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-313; CAMPBELL RN, 1982, PLANT DIS, V66, P657, DOI 10.1094/PD-66-657; Castanera R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006108; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Cho YR, 2013, PLANT J, V75, P498, DOI 10.1111/tpj.12217; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Dhillon B, 2010, GENETICS, V186, P67, DOI 10.1534/genetics.110.117408; Doganlar S, 1998, THEOR APPL GENET, V97, P784, DOI 10.1007/s001220050956; Ekengren SK, 2008, PLANT BIOTECHNOL-NAR, V25, P265, DOI 10.5511/plantbiotechnology.25.265; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Grandaubert J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-891; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hieno A, 2016, ACTA AGR SCAND B-S P, V66, P353, DOI 10.1080/09064710.2015.1120341; Hoede C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091929; Infantino A, 2005, EUR J PLANT PATHOL, V112, P337, DOI 10.1007/s10658-005-6605-7; Infantino A, 2015, PLANT PATHOL, V64, P941, DOI 10.1111/ppa.12326; Infantino A, 2003, MYCOL RES, V107, P707, DOI 10.1017/S0953756203007962; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Laterrot H, 1983, REV HORT, V238, P143; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Pohronezny K.L., 1991, COMPENDIUM TOMATO DI, P12; Pritham EJ, 2009, J HERED, V100, P648, DOI 10.1093/jhered/esp065; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Rybak K, 2017, MOL PLANT PATHOL, V18, P420, DOI 10.1111/mpp.12511; Santana MF., 2015, SCI J GENETICS GEN T, V1, P12, DOI [10.17352/sjggt.000003, DOI 10.17352/SJGGT.000003]; Seidl MF, 2015, MOL PLANT MICROBE IN, V28, P362, DOI 10.1094/MPMI-06-14-0173-R; Seidl MF, 2014, BIOESSAYS, V36, P335, DOI 10.1002/bies.201300155; Spanu PD, 2010, SCIENCE, V330, P1543, DOI 10.1126/science.1194573; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Strom Noah B, 2016, Fungal Biol Biotechnol, V3, P4, DOI 10.1186/s40694-016-0022-x; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tan KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006241; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; TERMOHLEN G. P., 1962, TIJSCHR PLANTEZIEKTEN, V68, P295, DOI 10.1007/BF01980554; Testa AC, 2016, GENOME BIOL EVOL, V8, P2044, DOI 10.1093/gbe/evw121; Valente MT, 2011, CURR GENET, V57, P241, DOI 10.1007/s00294-011-0343-5; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	53	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200217	10.1371/journal.pone.0200217	http://dx.doi.org/10.1371/journal.pone.0200217			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979772	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500080
J	Smith, JT; White, JW; Dungrawala, H; Hua, H; Schneider, BL				Smith, Jessica T.; White, Jill W.; Dungrawala, Huzefa; Hua, Hui; Schneider, Brandt L.			Yeast lifespan variation correlates with cell growth and SIR2 expression	PLOS ONE			English	Article							BILINSKI ET-AL; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; STRESS-RESPONSE; GENETIC-DETERMINANTS; RIBOSOME BIOGENESIS; BUDDING YEAST; CYCLE ARREST; LONGEVITY; SIZE	Isogenic wild type yeast cells raised in controlled environments display a significant range of lifespan variation. Recent microfluidic studies suggest that differential growth or gene expression patterns may explain some of the heterogeneity of aging assays. Herein, we sought to complement this work by similarly examining a large set of replicative lifespan data from traditional plate assays. In so doing, we reproduced the finding that short-lived cells tend to arrest at senescence with a budded morphology. Further, we found that wild type cells born unusually small did not have an extended lifespan. However, large birth size and/or high inter-generational growth rates significantly correlated with a reduced lifespan. Finally, we found that SIR2 expression levels correlated with lifespan and intergenerational growth. SIR2 expression was significantly reduced in large cells and increased in small wild type cells. A moderate increase in SIR2 expression correlated with reduced growth, decreased proliferation and increased lifespan in plate aging assays. We conclude that cellular growth rates and SIR2 expression levels may contribute to lifespan variation in individual cells.	[Smith, Jessica T.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [White, Jill W.] Texas Tech Univ, Ctr Integrat STEM Educ & Res, Lubbock, TX 79409 USA; [Dungrawala, Huzefa] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Hua, Hui; Schneider, Brandt L.] Texas Tech Univ, Hlth Sci Ctr, Dept Med Educ, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Vanderbilt University; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Schneider, BL (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Med Educ, Lubbock, TX 79430 USA.	brandt.schneider@ttuhsc.edu	Dungrawala, Huzefa/AAO-1931-2021; Smith, Jessica Thorsheim/HCI-9791-2022	Dungrawala, Huzefa/0000-0003-1868-7923; Smith, Jessica Thorsheim/0000-0001-7884-923X	Texas Tech University Health Sciences Center	Texas Tech University Health Sciences Center	BLS was financially supported by funding from the Texas Tech University Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk J, 2016, ONCOTARGET, V7, P29958, DOI 10.18632/oncotarget.8673; Sorolla MA, 2011, ARCH BIOCHEM BIOPHYS, V510, P27, DOI 10.1016/j.abb.2011.04.002; Aldea M, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00057; Anzi S, 2018, DEV CELL, V45, P726, DOI 10.1016/j.devcel.2018.05.024; Apelo SIA, 2016, J GERONTOL A-BIOL, V71, P841, DOI 10.1093/gerona/glw090; Bamps S, 2009, MECH AGEING DEV, V130, P762, DOI 10.1016/j.mad.2009.10.001; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Chandler-Brown D, 2017, CURR BIOL, V27, P2774, DOI 10.1016/j.cub.2017.08.015; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Collart MA, 2001, CURRENT PROTOCOLS MO, DOI 10.1002/0471142727.mb1312s23; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Delaney JR, 2013, FEMS YEAST RES, V13, P267, DOI 10.1111/1567-1364.12030; Delaney JR, 2011, CELL CYCLE, V10, P156, DOI 10.4161/cc.10.1.14457; Dungrawala H, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-24; Ferrezuelo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2015; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Ganley ARD, 2012, FEMS YEAST RES, V12, P267, DOI 10.1111/j.1567-1364.2012.00796.x; Gems D, 2008, CELL METAB, V7, P200, DOI 10.1016/j.cmet.2008.01.001; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gladyshev VN, 2016, AGING CELL, V15, P594, DOI 10.1111/acel.12480; Guo ZH, 2011, FEMS YEAST RES, V11, P345, DOI 10.1111/j.1567-1364.2011.00723.x; He C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004860; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Holmes SG, 1997, GENETICS, V145, P605; Huberts DHEW, 2014, P NATL ACAD SCI USA, V111, P11727, DOI 10.1073/pnas.1410024111; Janssens GE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167394; Janssens GE, 2016, MICROB CELL, V3, P263, DOI 10.15698/mic2016.07.510; Jiang JC, 2000, FASEB J, V14, P2135; Jo MC, 2015, P NATL ACAD SCI USA, V112, P9364, DOI 10.1073/pnas.1510328112; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kaeberlein M, 2005, PLOS GENET, V1, P614, DOI 10.1371/journal.pgen.0010069; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, MECH AGEING DEV, V126, P491, DOI 10.1016/j.mad.2004.10.007; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2012, FEMS YEAST RES, V12, P269, DOI 10.1111/j.1567-1364.2012.00798.x; KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Laskar S, 2015, MOL CELL BIOL, V35, P437, DOI 10.1128/MCB.01046-14; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; Li Y, 2017, P NATL ACAD SCI USA, V114, P11253, DOI 10.1073/pnas.1703379114; Liao CY, 2013, EXP GERONTOL, V48, P1025, DOI 10.1016/j.exger.2013.03.010; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; Lippuner AD, 2014, FEMS MICROBIOL REV, V38, P300, DOI 10.1111/1574-6976.12060; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lucanic M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14256; Mason AG, 2017, AGING CELL, V16, P785, DOI 10.1111/acel.12611; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; Mei SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106496; Michel AH, 2005, GENE DEV, V19, P1199, DOI 10.1101/gad.340205; Moretto F, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.60; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; Passarino G, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0066-z; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Rattan SIS, 2008, AGEING RES REV, V7, P63, DOI 10.1016/j.arr.2007.03.002; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Sanchez-Blanco A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002047; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Smith J, 2017, METHODS MOL BIOL, V1524, P215, DOI 10.1007/978-1-4939-6603-5_14; Smith JS, 1998, GENETICS, V149, P1205; Soma S, 2014, MICROB CELL, V1, P256, DOI 10.15698/mic2014.08.160; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; Stumpferl SW, 2012, GENOME RES, V22, P1963, DOI 10.1101/gr.136549.111; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Truong SK, 2013, G3-GENES GENOM GENET, V3, P1525, DOI 10.1534/g3.113.007062; Turner JJ, 2012, CURR BIOL, V22, pR350, DOI 10.1016/j.cub.2012.02.041; Wasko BM, 2014, FEMS YEAST RES, V14, P148, DOI 10.1111/1567-1364.12104; Weindling E, 2015, BIOCHEM BIOPH RES CO, V457, P473, DOI 10.1016/j.bbrc.2015.01.021; Westholm JO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-601; Wierman MB, 2014, FEMS YEAST RES, V14, P73, DOI 10.1111/1567-1364.12115; Yanai H, 2017, AGING CELL, V16, P1267, DOI 10.1111/acel.12659; Yang JY, 2011, CELL CYCLE, V10, P144, DOI 10.4161/cc.10.1.14455; Zadrag R, 2006, ACTA BIOCHIM POL, V53, P747, DOI 10.18388/abp.2006_3302; Zadrag-Tecza R, 2009, BIOGERONTOLOGY, V10, P481, DOI 10.1007/s10522-008-9192-0	83	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200275	10.1371/journal.pone.0200275	http://dx.doi.org/10.1371/journal.pone.0200275			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979754	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500087
J	Zhu, BY; Cao, XY; Zhang, WQ; Pan, GP; Yi, Q; Zhong, WB; Yan, DG				Zhu, Biying; Cao, Xiuye; Zhang, Wenqiang; Pan, Guoping; Yi, Qing; Zhong, Wenbin; Yan, Daoguang			MicroRNA-31-5p enhances the Warburg effect via targeting FIH	FASEB JOURNAL			English	Article						miR-31-5p; HIF; ATP	CANCER; METABOLISM; EXPRESSION; CELLS; CARCINOMA; GLUTAMINE; UNCOVERS; PATHWAYS; HIF-1; NOTCH	The enhanced expression of miR-31 has been observed in many human malignancies including lung cancer, and this microRNA regulates several aspects of oncogenesis. However, the role of miR-31-5p in energy metabolism remains elusive. Here, we confirm that H1299 and A549 cells, 2 lung cancer cell lines, relay on aerobic glycolysis as main source of ATP. Inhibition of miR-31-5p leads to decreased glycolysis and ATP production, while miR-31-5p overexpression increases them. Hypoxia inducible factor 1 (HIF-1) up-regulates the expression of glycolytic enzymes, and the HIF-1 inhibitor (FIH) inhibits HIF-1 activity. Because FIH is a direct target of miR-31-5p, inhibition of miR-31-5p results in enhanced FIH expression and suppression of HIF-1 signaling, while overexpression of miR-31-5p has the opposite effects. Via this mechanism, miR-31-5p up-regulates aerobic glycolytic genes and maintains energy homeostasis. To further validate the mechanism of miR-31-5p in glycolysis regulation, we show that overexpression or knockdown of FIH rescued the effects of miR-31-5p or miR-31-5p inhibitor on HIF activation and its target gene expression, respectively. Finally, by means of an A549 cell xenograft mouse model, we demonstrate that the miR-31-5p promotes cell proliferation via enhancing glycolysis. In summary, this study reveals that miR-31-5p promotes the Warburg effect via direct targeting of FIH.Zhu, B., Cao, X., Zhang, W., Pan, G., Yi, Q., Zhong, W., Yan, D. MicroRNA-31-5p enhances the Warburg effect via targeting FIH.	[Zhu, Biying; Cao, Xiuye; Zhang, Wenqiang; Pan, Guoping; Zhong, Wenbin; Yan, Daoguang] Jinan Univ, Dept Biol, 601 Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China; [Yi, Qing] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA	Jinan University; Cleveland Clinic Foundation	Zhong, WB; Yan, DG (corresponding author), Jinan Univ, Dept Biol, 601 Huangpu Ave, Guangzhou 510632, Guangdong, Peoples R China.	twbzhong@jnu.edu.cn; tydg@jnu.edu.cn		Zhu, Biying/0000-0003-2358-2739	Major Research Program of Guangdong Science and Technology [2017A030308002]; National Natural Science Foundation of China [81770438, 91439122]	Major Research Program of Guangdong Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank V. Ollkonen (Minerva Foundation Institute for Medical Research, Helsinki, Finland) for his critical reading. This work was supported by grants from Major Research Program of Guangdong Science and Technology (Grant 2017A030308002 to D.Y.), and from the National Natural Science Foundation of China (Grants 81770438 and 91439122 to D.Y.). The authors declare no conflicts of interest.	Assaily W, 2006, CANCER CELL, V10, P4, DOI 10.1016/j.ccr.2006.06.014; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Cejudo-Martin P, 2005, DEV CELL, V9, P575, DOI 10.1016/j.devcel.2005.10.001; Chen XS, 2016, ACTA PHARMACOL SIN, V37, P1013, DOI 10.1038/aps.2016.47; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Dong Z, 2014, CANCER LETT, V343, P249, DOI 10.1016/j.canlet.2013.09.034; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Edmonds MD, 2016, J CLIN INVEST, V126, P349, DOI 10.1172/JCI82720; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu CH, 2013, EXP THER MED, V6, P1265, DOI 10.3892/etm.2013.1311; Igarashi H, 2015, ANN SURG ONCOL, V22, P2640, DOI 10.1245/s10434-014-4264-7; Jia D, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7030021; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koumangoye RB, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0284-y; LASZLO J, 1967, BLOOD-J HEMATOL, V30, P151, DOI 10.1182/blood.V30.2.151.151; Lee MR, 2016, STEM CELL REP, V7, P1, DOI 10.1016/j.stemcr.2016.05.012; Lei SL, 2014, ONCOL LETT, V8, P1768, DOI 10.3892/ol.2014.2328; Levy P, 2016, ONCOGENE, V35, P4155, DOI 10.1038/onc.2015.479; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lin SB, 2015, NAT REV CANCER, V15, P321, DOI 10.1038/nrc3932; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Mohamed A, 2014, CLIN LUNG CANCER, V15, P7, DOI 10.1016/j.cllc.2013.09.001; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Su Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.210; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	42	34	34	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					545	556		10.1096/fj.201800803R	http://dx.doi.org/10.1096/fj.201800803R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30004795				2022-12-26	WOS:000457401500043
J	Fu, QH; Zhang, Q; Lou, Y; Yang, JQ; Nie, G; Chen, Q; Chen, YW; Zhang, JY; Wang, JX; Wei, T; Qin, H; Dang, XW; Bai, XL; Liang, TB				Fu, Qihan; Zhang, Qi; Lou, Yu; Yang, Jiaqi; Nie, Gang; Chen, Qi; Chen, Yiwen; Zhang, Jingying; Wang, Jianxin; Wei, Tao; Qin, Hao; Dang, Xiaowei; Bai, Xueli; Liang, Tingbo			Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; COLORECTAL-CANCER; NICHE FORMATION; TGF-BETA; RESECTION; SURVIVAL; GROWTH; PROLIFERATION; DISSEMINATION	Hepatocellular carcinoma (HCC) is a fatal disease and patients with HCC frequently die from metastasis. The mechanisms of HCC metastasis are not completely understood. In the present study, in vitro and in vivo data showed that HCC cells promoted cancer cell proliferation and lung metastases formation in a paracrinal/endocrinal way. We found that HCC-derived exosomes mediated this phenomenon and observed enhanced cell adhesion in the presence of these malignant exosomes. We further identified that reactive oxygen species (ROS) regulated the adhesive molecules. Intriguingly, attached HCC cells released exosomes containing both SMAD Family Member 3 (SMAD3) protein and mRNA, which were delivered to detached HCC cells and facilitated their adhesion. These exosomes induced enhanced SMAD3 signaling in the recipient HCC cells and increased their adhesive ability. In addition, we showed that SMAD3-abundant exosomes existed in the peripheral blood of patients with HCC, and their levels correlated with disease stage and the SMAD3 expression of primary tumors. Our study suggested a possible mechanism by which primary HCC supported metastases formation and revealed the role of SMAD3 in the exosomes-mediated crosstalk between primary and circulating HCC cells.	[Fu, Qihan; Zhang, Qi; Lou, Yu; Yang, Jiaqi; Nie, Gang; Chen, Qi; Chen, Yiwen; Zhang, Jingying; Wang, Jianxin; Wei, Tao; Qin, Hao; Bai, Xueli; Liang, Tingbo] Zhejiang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Fu, Qihan; Zhang, Qi; Lou, Yu; Yang, Jiaqi; Nie, Gang; Chen, Qi; Chen, Yiwen; Zhang, Jingying; Wang, Jianxin; Wei, Tao; Qin, Hao; Bai, Xueli; Liang, Tingbo] Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Zhejiang, Peoples R China; [Fu, Qihan] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China; [Dang, Xiaowei] Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatopancreatobiliary Surg, Zhengzhou, Henan, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou University	Bai, XL; Liang, TB (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Hepatobiliary & Pancreat Surg, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Bai, XL; Liang, TB (corresponding author), Zhejiang Prov Key Lab Pancreat Dis, Hangzhou, Zhejiang, Peoples R China.	liangtingbo@zju.edu.cn; shirleybai@zju.edu.cn			National Program on Key Basic Research Project (973 Program) [2014CB542101]; National Natural Science Foundation of China [81401954, 81472212]; Key Program of Medical Scientific Research Foundation of Zhejiang Province, China [WKJ-ZJ-1410]; Medical Science & Technology Program of Zhejiang Province, China [2015KYA114]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Key Program of Administration of Traditional Chinese Medicine of Zhejiang Province, China [2014ZZ007]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Medical Scientific Research Foundation of Zhejiang Province, China; Medical Science & Technology Program of Zhejiang Province, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents; Key Program of Administration of Traditional Chinese Medicine of Zhejiang Province, China	This work was financially supported by the National Program on Key Basic Research Project (973 Program, No. 2014CB542101), the National Natural Science Foundation of China (No. 81401954, No. 81472212), Key Program of Medical Scientific Research Foundation of Zhejiang Province, China (No. WKJ-ZJ-1410), the Medical Science & Technology Program of Zhejiang Province, China (No. 2015KYA114), the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, and the Key Program of Administration of Traditional Chinese Medicine of Zhejiang Province, China (No. 2014ZZ007).	Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Coulouarn C, 2008, HEPATOLOGY, V47, P2059, DOI 10.1002/hep.22283; Demicheli R, 2008, ANN ONCOL, V19, P1821, DOI 10.1093/annonc/mdn386; Fu QH, 2016, TUMOR BIOL, V37, P7277, DOI 10.1007/s13277-015-4560-2; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; He M, 2015, CARCINOGENESIS, V36, P1008, DOI 10.1093/carcin/bgv081; Hong YP, 2016, INT J ONCOL, V49, P2206, DOI 10.3892/ijo.2016.3747; Jiang F, 2014, REDOX BIOL, V2, P267, DOI 10.1016/j.redox.2014.01.012; Kim SH, 2012, HEPATOB PANCREAT DIS, V11, P51, DOI 10.1016/S1499-3872(11)60125-2; Li JM, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00079, 10.3389/fonc.2012.00029]; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Mao K, 2017, J CLIN ONCOL S15, V35; Musri FY, 2016, J GASTRIC CANCER, V16, P78, DOI 10.5230/jgc.2016.16.2.78; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; OReilly MS, 1996, NAT MED, V2, P689, DOI 10.1038/nm0696-689; Peeters CFJM, 2006, INT J CANCER, V119, P1249, DOI 10.1002/ijc.21928; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Rashid OM, 2013, SURGERY, V153, P771, DOI 10.1016/j.surg.2013.02.002; Ren T, 2017, ONCOGENE, V36, P5897, DOI 10.1038/onc.2017.167; Rocken M, 2010, J CLIN INVEST, V120, P1800, DOI 10.1172/JCI43424; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Singletary SE, 2003, ONCOLOGIST, V8, P241, DOI 10.1634/theoncologist.8-3-241; SLOOTER GD, 1995, BRIT J SURG, V82, P129, DOI 10.1002/bjs.1800820144; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Wen SW, 2016, CANCER RES, V76, P6816, DOI 10.1158/0008-5472.CAN-16-0868; Xu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep16516; Zhang Q, 2013, CARCINOGENESIS, V34, P962, DOI 10.1093/carcin/bgt027; Zhang ZC, 2017, CANCER LETT, V397, P33, DOI 10.1016/j.canlet.2017.03.004	33	87	90	4	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 22	2018	37	47					6105	6118		10.1038/s41388-018-0391-0	http://dx.doi.org/10.1038/s41388-018-0391-0			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HB2PG	29991801	Green Published, hybrid			2022-12-26	WOS:000450883000001
J	Mutvei, AP; Landor, SKJ; Fox, R; Braune, EB; Tsoi, YL; Phoon, YP; Sahlgren, C; Hartman, J; Bergh, J; Jin, SB; Lendahl, U				Mutvei, Anders P.; Landor, Sebastian K-J; Fox, Rhys; Braune, Eike-Benjamin; Tsoi, Yat Long; Phoon, Yee Peng; Sahlgren, Cecilia; Hartman, Johan; Bergh, Jonas; Jin, Shaobo; Lendahl, Urban			Notch signaling promotes a HIF2 alpha-driven hypoxic response in multiple tumor cell types	ONCOGENE			English	Article							INDUCIBLE FACTOR (HIF)-1-ALPHA; HIF2A MUTATIONS; HIF-2-ALPHA; INHIBITION; FACTOR-2; HIF-2; PHEOCHROMOCYTOMAS; DIFFERENTIATION; PARAGANGLIOMA; EXPRESSION	Hyperactivation of Notch signaling and the cellular hypoxic response are frequently observed in cancers, with increasing reports of connections to tumor initiation and progression. The two signaling mechanisms are known to intersect, but while it is well established that hypoxia regulates Notch signaling, less is known about whether Notch can regulate the cellular hypoxic response. We now report that Notch signaling specifically controls expression of HIF2 alpha, a key mediator of the cellular hypoxic response. Transcriptional upregulation of HIF2 alpha by Notch under normoxic conditions leads to elevated HIF2 alpha protein levels in primary breast cancer cells as well as in human breast cancer, medulloblastoma, and renal cell carcinoma cell lines. The elevated level of HIF2 alpha protein was in certain tumor cell types accompanied by downregulation of HIF1 alpha protein levels, indicating that high Notch signaling may drive a HIF1 alpha-to-HIF2 alpha switch. At the transcriptome level, the presence of HIF2 alpha was required for approximately 21% of all Notch-induced genes: among the 1062 genes that were upregulated by Notch in medulloblastoma cells during normoxia, upregulation was abrogated in 227 genes when HIF2 alpha expression was knocked down by HIF2 alpha siRNA. In conclusion, our data show that Notch signaling affects the hypoxic response via regulation of HIF2 alpha, which may be important for future cancer therapies.	[Mutvei, Anders P.; Landor, Sebastian K-J; Fox, Rhys; Braune, Eike-Benjamin; Tsoi, Yat Long; Phoon, Yee Peng; Jin, Shaobo; Lendahl, Urban] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Landor, Sebastian K-J; Sahlgren, Cecilia] Univ Turku, Turku Ctr Biotechnol, Turku 20520, Finland; [Landor, Sebastian K-J; Sahlgren, Cecilia] Abo Akad Univ, Turku 20520, Finland; [Hartman, Johan] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Bergh, Jonas] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Radiumhemmet,Breast Canc,Canc Theme, Stockholm, Sweden; [Bergh, Jonas] Univ Oxford, Dept Publ Hlth, Oxford OX1 2JD, England	Karolinska Institutet; University of Turku; Abo Akademi University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Oxford	Jin, SB; Lendahl, U (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	Shaobo.Jin@ki.se; Urban.Lendahl@ki.se	Braune, Eike-Benjamin/AAI-5820-2020; Hartman, Johan/N-1406-2015	Hartman, Johan/0000-0002-6500-8527; MUTVEI, ANDERS/0000-0002-2498-5225; Fox, Rhys/0000-0002-7433-0331; Bergh, Jonas/0000-0001-5526-1847	Swedish Cancer Society; Swedish Research Council; BRECT Consortium at Karolinska Institutet; ICMC (AstraZeneca); Albin K. Johanssons Foundation; Jane & Aatos Erkko Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); BRECT Consortium at Karolinska Institutet; ICMC (AstraZeneca)(AstraZeneca); Albin K. Johanssons Foundation; Jane & Aatos Erkko Foundation	The financial support from the Swedish Cancer Society, the Swedish Research Council, the BRECT Consortium at Karolinska Institutet, and ICMC (AstraZeneca) (UL) is gratefully acknowledged. SKJL was supported by the Jane & Aatos Erkko and Albin K. Johanssons Foundations. This work is dedicated to the memory of the late friend and colleague Lorenz Poellinger.	Toledo RA, 2017, ENDOCR-RELAT CANCER, V24, pC9, DOI 10.1530/ERC-16-0479; Andersson ER, 2014, NAT REV DRUG DISCOV, V13, P359, DOI 10.1038/nrd4252; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Aster JC, 2017, ANNU REV PATHOL-MECH, V12, P245, DOI 10.1146/annurev-pathol-052016-100127; Ayaz F, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00345; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bertout JA, 2009, CANCER RES, V69, P3213, DOI 10.1158/0008-5472.CAN-08-4223; Braune EB, 2016, STEM CELL REP, V6, P643, DOI 10.1016/j.stemcr.2016.03.004; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Brogi E, 1996, J CLIN INVEST, V97, P469, DOI 10.1172/JCI118437; Burroughs SK, 2013, FUTURE MED CHEM, V5, P553, DOI [10.4155/fmc.13.17, 10.4155/FMC.13.17]; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen WF, 2016, NATURE, V539, P112, DOI 10.1038/nature19796; Cho H, 2016, NATURE, V539, P107, DOI 10.1038/nature19795; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Danza G, 2012, MOL CANCER RES, V10, P230, DOI 10.1158/1541-7786.MCR-11-0296; De Bels D, 2011, NEW ENGL J MED, V365, P1845, DOI 10.1056/NEJMc1110602; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Favier J, 2012, NEW ENGL J MED, V367, P2161, DOI 10.1056/NEJMc1211953; Gao W, 2012, ARTHRITIS RHEUM-US, V64, P2104, DOI 10.1002/art.34397; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Jin S, 2013, ONCOGENE, V32, P4892, DOI 10.1038/onc.2012.517; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Koh MY, 2015, CANCER RES, V75, P316, DOI 10.1158/0008-5472.CAN-13-2190; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Landor SKJ', 2017, EXP CELL RES, V356, P146, DOI 10.1016/j.yexcr.2017.04.030; Lanner F, 2013, STEM CELLS DEV, V22, P1360, DOI 10.1089/scd.2012.0259; Lim KJ, 2015, ONCOTARGET, V6, P1666, DOI 10.18632/oncotarget.2762; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Martini S, 2013, STEM CELLS, V31, P741, DOI 10.1002/stem.1320; Meunier A, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00104; O'Reilly SM, 2006, AM J PHYSIOL-CELL PH, V290, pC592, DOI 10.1152/ajpcell.00278.2005; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Petrella BL, 2005, ONCOGENE, V24, P1043, DOI 10.1038/sj.onc.1208305; Pietras A, 2011, MOL CANCER RES, V9, P626, DOI 10.1158/1541-7786.MCR-10-0508; Pietras A, 2009, P NATL ACAD SCI USA, V106, P16805, DOI 10.1073/pnas.0904606106; Pirot P, 2004, BIOCHEM BIOPH RES CO, V322, P526, DOI 10.1016/j.bbrc.2004.07.157; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Qiang L, 2012, CELL DEATH DIFFER, V19, P284, DOI 10.1038/cdd.2011.95; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Scheuermann TH, 2013, NAT CHEM BIOL, V9, P271, DOI [10.1038/nchembio.1185, 10.1038/NCHEMBIO.1185]; Scheuerrnann TH, 2015, J MED CHEM, V58, P5930, DOI 10.1021/acs.jmedchem.5b00529; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Siebel C, 2017, PHYSIOL REV, V97, P1235, DOI 10.1152/physrev.00005.2017; Toledo RA, 2013, ENDOCR-RELAT CANCER, V20, P349, DOI 10.1530/ERC-13-0101; Uchida T, 2004, J BIOL CHEM, V279, P14871, DOI 10.1074/jbc.M400461200; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Wettersten HI, 2017, NAT REV NEPHROL, V13, P410, DOI 10.1038/nrneph.2017.59; Xing F, 2011, ONCOGENE, V30, P4075, DOI 10.1038/onc.2011.122; Zhao JD, 2015, CANCER TREAT REV, V41, P623, DOI 10.1016/j.ctrv.2015.05.004; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	62	14	15	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6083	6095		10.1038/s41388-018-0400-3	http://dx.doi.org/10.1038/s41388-018-0400-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29993038	Green Published, hybrid			2022-12-26	WOS:000450175900006
J	Guo, X; Zhang, Y; Mayakonda, A; Madan, V; Ding, LW; Lin, LH; Zia, S; Gery, S; Tyner, JW; Zhou, W; Yin, D; Lin, DC; Koeffler, HP				Guo, Xiao; Zhang, Yin; Mayakonda, Anand; Madan, Vikas; Ding, Ling-Wen; Lin, Le-Hang; Zia, Saadiya; Gery, Sigal; Tyner, Jeffrey W.; Zhou, Wu; Yin, Dong; Lin, De-Chen; Koeffler, H. Phillip			ARID1A and CEBP alpha cooperatively inhibit UCA1 transcription in breast cancer	ONCOGENE			English	Article							REMODELING GENE ARID1A; CLEAR-CELL CARCINOMA; NONCODING RNA UCA1; TUMOR-SUPPRESSOR; ARID1A/BAF250A EXPRESSION; BLADDER-CANCER; MUTATIONS; PROLIFERATION; ENDOMETRIOSIS; PROGNOSIS	As one of the primary members of SWI/SNF chromatin remodeling complexes, ARID1A contains frequent loss-of-function mutations in many types of cancers. However, the molecular mechanisms underlying ARID1A deficiency in cancer biology remain to be investigated. Using breast cancer as a model, we report that silencing ARID1A significantly increased cellular proliferation and migration. Mechanistically, primarily functioning as a transcriptional repressor, loss of ARID1A profoundly alters histone modifications and the transcriptome. Notably, ARID1A inhibited the expression of a long noncoding RNA, UCA1, by regulating chromatin access of the transcription factor CEBPa. Restoration experiments showed that UCA1 mediates the functions of ARID1A that induces loss of cellular proliferation and migration. Together, our findings characterize ARID1A as a key tumor-suppressor gene in breast cancer through cooperation with CEBPa, and loss-of-function mutations of ARID1A activates UCA1.	[Guo, Xiao; Zhang, Yin; Lin, Le-Hang; Yin, Dong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Res Ctr Med, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China; [Guo, Xiao; Zia, Saadiya; Gery, Sigal; Lin, De-Chen; Koeffler, H. Phillip] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Mayakonda, Anand; Madan, Vikas; Ding, Ling-Wen; Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Tyner, Jeffrey W.] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA; [Zhou, Wu] Lishui Univ, Coll Med & Hlth, Dept Med, Lishui, Zhejiang, Peoples R China; [Koeffler, H. Phillip] Natl Univ Singapore Hosp, Natl Univ Canc Inst, Singapore, Singapore	Sun Yat Sen University; Cedars Sinai Medical Center; National University of Singapore; Oregon Health & Science University; Lishui University; National University of Singapore	Guo, X (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Res Ctr Med, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China.; Guo, X; Lin, DC (corresponding author), Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA.	guoxiao152@163.com; De-Chen.Lin@cshs.org	Ding, Ling-Wen/H-6916-2019	Ding, Ling-Wen/0000-0003-0022-1551; Madan, Vikas/0000-0001-7876-624X; zhou, wu/0000-0003-3105-8064	National Research Foundation Singapore under its Singapore Translational Research Investigator Award [NMRC/STaR/0021/2014]; NMRC Centre Grant; National Research Foundation Singapore; Singapore Ministry of Education under its Research Centers of Excellence initiatives; RNA Biology Center at the Cancer Science Institute of Singapore; NUS, Singapore Ministry of Education's Tier 3 grants [MOE2014-T3-1-006]; Tower Cancer Research Foundation; National Natural Science Foundation of China (NSFC) [31401594]; Michele and Ted Kaplan Family Fund; Tower Foundation	National Research Foundation Singapore under its Singapore Translational Research Investigator Award(National Research Foundation, Singapore); NMRC Centre Grant(National Medical Research Council, Singapore); National Research Foundation Singapore(National Research Foundation, Singapore); Singapore Ministry of Education under its Research Centers of Excellence initiatives(Ministry of Education, Singapore); RNA Biology Center at the Cancer Science Institute of Singapore; NUS, Singapore Ministry of Education's Tier 3 grants(Ministry of Education, SingaporeNational University of Singapore); Tower Cancer Research Foundation; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Michele and Ted Kaplan Family Fund; Tower Foundation	ARID1A shRNA and ARID1A CRISPR-Cas9 plasmid are gifts from Vikas Madan, Cancer Science Institute of Singapore; pCDH-CMV-UCA1-EF1-copGFP is a gift from Yin-Yuan Mo, University of Mississippi Medical Center. This research was supported by the National Research Foundation Singapore under its Singapore Translational Research Investigator Award (NMRC/STaR/0021/2014) and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), the NMRC Centre Grant awarded to National University Cancer Institute, the National Research Foundation Singapore, and the Singapore Ministry of Education under its Research Centers of Excellence initiatives to H.P.K. This study was additionally funded by the RNA Biology Center at the Cancer Science Institute of Singapore, NUS, as part of funding under the Singapore Ministry of Education's Tier 3 grants (MOE2014-T3-1-006). D.-C.L was supported by Tower Cancer Research Foundation. Part research was supported by National Natural Science Foundation of China (NSFC, 31401594, to X.G.) and the generous support of Michele and Ted Kaplan Family Fund and the Tower Foundation.	Alteri R, 2015, BREAST CANC FACTS FI; Baker K, 2013, IMMUNITY, V39, P1095, DOI 10.1016/j.immuni.2013.11.003; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; Cho H, 2013, HUM PATHOL, V44, P1365, DOI 10.1016/j.humpath.2012.11.007; Cho HD, 2015, J BREAST CANCER, V18, P339, DOI 10.4048/jbc.2015.18.4.339; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Cornen S, 2012, ONCOGENE, V31, P4255, DOI 10.1038/onc.2011.598; Fan Y, 2014, FEBS J, V281, P1750, DOI 10.1111/febs.12737; Guan B, 2012, NEOPLASIA, V14, P986, DOI 10.1593/neo.121218; Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562; Guo X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.349; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Hughes JM, 2015, ONCOTARGET, V6, P18534, DOI 10.18632/oncotarget.4069; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Li XC, 2016, TUMOR BIOL, V37, P7599, DOI 10.1007/s13277-015-4655-9; Lin DC, 2018, GUT, V67, P1769, DOI 10.1136/gutjnl-2017-314607; Mamo A, 2012, ONCOGENE, V31, P2090, DOI 10.1038/onc.2011.386; Mathur R, 2017, NAT GENET, V49, P296, DOI 10.1038/ng.3744; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Priam P, 2017, NAT GENET, V49, P753, DOI 10.1038/ng.3812; Samartzis EP, 2014, ONCOTARGET, V5, P5295, DOI 10.18632/oncotarget.2092; Shen JF, 2015, CANCER DISCOV, V5, P752, DOI 10.1158/2159-8290.CD-14-0849; Sun XX, 2016, CELL STEM CELL, V18, P456, DOI 10.1016/j.stem.2016.03.001; Takao C, 2017, J CANCER, V8, P1, DOI 10.7150/jca.16602; Takeda T, 2016, ONCOL REP, V35, P607, DOI 10.3892/or.2015.4421; Wang HH, 2017, ONCOTARGET, V8, P64638, DOI 10.18632/oncotarget.18344; Wang Z, 2017, TUMOR BIOL, V39, DOI DOI 10.1177/101042831770999028639914; Wang ZQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.143; Wiegand KC, 2011, J PATHOL, V224, P328, DOI 10.1002/path.2911; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xiao WB, 2012, INT J CLIN EXP PATHO, V5, P642; Yuan J, 2017, CANCER RES, V77, P6614, DOI 10.1158/0008-5472.CAN-17-1143; Zhang L, 2016, CANCER CHEMOTH PHARM, V77, P629, DOI 10.1007/s00280-016-2963-4; Zhang XY, 2012, CANCER EPIDEMIOL, V36, P288, DOI 10.1016/j.canep.2011.07.006; Zhao J, 2014, TUMOR BIOL, V35, P4813, DOI 10.1007/s13277-014-1632-7	37	19	20	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5939	5951		10.1038/s41388-018-0371-4	http://dx.doi.org/10.1038/s41388-018-0371-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29980791				2022-12-26	WOS:000449562500003
J	Johnson, CE; Dunlop, EA; Seifan, S; McCann, HD; Hay, T; Parfitt, GJ; Jones, AT; Giles, PJ; Shen, MH; Sampson, JR; Errington, RJ; Davies, DM; Tee, AR				Johnson, Charlotte E.; Dunlop, Elaine A.; Seifan, Sara; McCann, Henry D.; Hay, Trevor; Parfitt, Geraint J.; Jones, Ashley T.; Giles, Peter J.; Shen, Ming H.; Sampson, Julian R.; Errington, Rachel J.; Davies, D. Mark; Tee, Andrew R.			Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir - bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death	ONCOGENE			English	Article							HIV PROTEASE INHIBITOR; RENAL ANGIOMYOLIPOMA; ER STRESS; AUTOPHAGY; MTOR	Cancer cells lose homeostatic flexibility because of mutations and dysregulated signaling pathways involved in maintaining homeostasis. Tuberous Sclerosis Complex 1 (TSC1) and TSC2 play a fundamental role in cell homeostasis, where signal transduction through TSC1/TSC2 is often compromised in cancer, leading to aberrant activation of mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 hyperactivation increases the basal level of endoplasmic reticulum (ER) stress via an accumulation of unfolded protein, due to heightened de novo protein translation and repression of autophagy. We exploit this intrinsic vulnerability of tumor cells lacking TSC2, by treating with nelvinavir to further enhance ER stress while inhibiting the proteasome with bortezomib to prevent effective protein removal. We show that TSC2-deficient cells are highly dependent on the proteosomal degradation pathway for survival. Combined treatment with nelfinavir and bortezomib at clinically relevant drug concentrations show synergy in selectively killing TSC2-deficient cells with limited toxicity in control cells. This drug combination inhibited tumor formation in xenograft mouse models and patient-derived cell models of TSC and caused tumor spheroid death in 3D culture. Importantly, 3D culture assays differentiated between the cytostatic effects of the mTORC1 inhibitor, rapamycin, and the cytotoxic effects of the nelfinavir/bortezomib combination. Through RNA sequencing, we determined that nelfinavir and bortezomib tip the balance of ER protein homeostasis of the already ER-stressed TSC2-deficient cells in favor of cell death. These findings have clinical relevance in stratified medicine to treat tumors that have compromised signaling through TSC and are inflexible in their capacity to restore ER homeostasis.	[Johnson, Charlotte E.; Dunlop, Elaine A.; Seifan, Sara; McCann, Henry D.; Jones, Ashley T.; Giles, Peter J.; Shen, Ming H.; Sampson, Julian R.; Errington, Rachel J.; Davies, D. Mark; Tee, Andrew R.] Cardiff Univ, Div Canc & Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Hay, Trevor; Parfitt, Geraint J.] Cardiff Univ, European Canc Stem Cell Res Inst, Hadyn Ellis Bldg,Maindy Rd, Cardiff CF24 4HQ, S Glam, Wales; [Davies, D. Mark] Singleton Hosp, South West Wales Canc Ctr, Dept Oncol, Swansea SA2 8QA, W Glam, Wales	Cardiff University; Cardiff University; Singleton Hospital	Tee, AR (corresponding author), Cardiff Univ, Div Canc & Genet, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	teea@cardiff.ac.uk	/J-6218-2019; Parfitt, Geraint/J-2778-2018	/0000-0002-9209-7561; Parfitt, Geraint/0000-0002-8704-7906; Davies, Mark/0000-0002-0688-3129	Health and Care Research Wales (Wales Cancer Research Centre); Tuberous Sclerosis Association; Cancer Research Wales; Tuberous Sclerosis Alliance; BBSRC; Hospital Saturday Fund	Health and Care Research Wales (Wales Cancer Research Centre); Tuberous Sclerosis Association; Cancer Research Wales; Tuberous Sclerosis Alliance; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Hospital Saturday Fund	This work was supported by Health and Care Research Wales (the Wales Cancer Research Centre) (to EAD, ART, PJG and TH), the Tuberous Sclerosis Association (to EAD, ART, and MHS), Cancer Research Wales (to CEJ, RJE, and ART), the Tuberous Sclerosis Alliance (to EAD and ART), the Hospital Saturday Fund (to ART) and BBSRC (to RJE). We would like to thank the Wales Gene Park for their contribution to this study.	Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962; Auricchio N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031900; Babcock JT, 2013, J BIOL CHEM, V288, P15687, DOI 10.1074/jbc.M112.431056; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Driessen C, 2016, HAEMATOLOGICA, V101, P346, DOI 10.3324/haematol.2015.135780; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Dunlop EA, 2017, ONCOTARGET, V8, P48711, DOI 10.18632/oncotarget.16232; Dunlop EA, 2011, AUTOPHAGY, V7, P737, DOI 10.4161/auto.7.7.15491; Gandolfi S, 2017, CANCER METAST REV, V36, P561, DOI 10.1007/s10555-017-9707-8; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Johnson CE, 2015, MOL ONCOL, V9, P675, DOI 10.1016/j.molonc.2014.11.005; Kang YJ, 2011, CELL DEATH DIFFER, V18, P133, DOI 10.1038/cdd.2010.82; Kawabata S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.87; Kraus M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.2; Kraus M, 2014, LEUKEMIA RES, V38, P383, DOI 10.1016/j.leukres.2013.12.017; Lam HC, 2017, J PATHOL, V241, P219, DOI 10.1002/path.4827; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Peng ZF, 2014, J UROLOGY, V192, P1424, DOI 10.1016/j.juro.2014.04.096; Shim JS, 2012, JNCI-J NATL CANCER I, V104, P1576, DOI 10.1093/jnci/djs396; Siroky BJ, 2012, AM J PHYSIOL-RENAL, V303, pF831, DOI 10.1152/ajprenal.00441.2011; Stengel S, 2017, BBA-MOL CELL RES, V1864, P2183, DOI 10.1016/j.bbamcr.2017.07.008; Tee AR, 2000, ONCOGENE, V19, P3021, DOI 10.1038/sj.onc.1203622; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang YN, 2014, NATURE, V513, P440, DOI 10.1038/nature13492	27	8	8	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5913	5925		10.1038/s41388-018-0381-2	http://dx.doi.org/10.1038/s41388-018-0381-2			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29980790	Green Accepted, hybrid			2022-12-26	WOS:000449562500001
J	Yang, TT; Ren, C; Qiao, PY; Han, X; Wang, L; Lv, SJ; Sun, YH; Liu, ZJ; Du, Y; Yu, ZH				Yang, Tingting; Ren, Chune; Qiao, Pengyun; Han, Xue; Wang, Li; Lv, Shijun; Sun, Yonghong; Liu, Zhijun; Du, Yu; Yu, Zhenhai			PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer	ONCOGENE			English	Article							GLYCOLYSIS; AUTOPHAGY; INCREASES; KINASES; PKM2; PIM2	Hexokinase-II (HK2) is a key enzyme involved in glycolysis, which is required for breast cancer progression. However, the underlying post-translational mechanisms of HK2 activity are poorly understood. Here, we showed that Proviral Insertion in Murine Lymphomas 2 (PIM2) directly bound to HK2 and phosphorylated HK2 on Thr473. Biochemical analyses demonstrated that phosphorylated HK2 Thr473 promoted its protein stability through the chaperone-mediated autophagy (CMA) pathway, and the levels of PIM2 and pThr473-HK2 proteins were positively correlated with each other in human breast cancer. Furthermore, phosphorylation of HK2 on Thr473 increased HK2 enzyme activity and glycolysis, and enhanced glucose starvation-induced autophagy. As a result, phosphorylated HK2 Thr473 promoted breast cancer cell growth in vitro and in vivo. Interestingly, PIM2 kinase inhibitor SMI-4a could abrogate the effects of phosphorylated HK2 Thr473 on paclitaxel resistance in vitro and in vivo. Taken together, our findings indicated that PIM2 was a novel regulator of HK2, and suggested a new strategy to treat breast cancer.	[Yang, Tingting; Ren, Chune; Qiao, Pengyun; Han, Xue; Wang, Li; Yu, Zhenhai] Weifang Med Univ, Affiliated Hosp, Dept Reprod Med, Weifang, Shandong, Peoples R China; [Lv, Shijun; Sun, Yonghong] Weifang Med Univ, Affiliated Hosp, Dept Pathol, Weifang, Shandong, Peoples R China; [Liu, Zhijun; Du, Yu] Weifang Med Univ, Dept Med Microbiol, Weifang, Shandong, Peoples R China	Weifang Medical University; Weifang Medical University; Weifang Medical University	Yu, ZH (corresponding author), Weifang Med Univ, Affiliated Hosp, Dept Reprod Med, Weifang, Shandong, Peoples R China.	tomsyu@163.com	Liu, Zhijun/AAV-9805-2021		Innovation Fund of National Natural Science Foundation of China [81602440, 81602301, 81471048]; Shandong Province College Science and Technology Plan Project [J16LL08, J17KA254]; Projects of Medical and Health Technology Development Program in Shandong province [2016WS0688, 2017WS398]; National Natural Science Foundation of Shangdong Province [ZR2014HM086]	Innovation Fund of National Natural Science Foundation of China; Shandong Province College Science and Technology Plan Project; Projects of Medical and Health Technology Development Program in Shandong province; National Natural Science Foundation of Shangdong Province	The study was supported by research grants from Innovation Fund of National Natural Science Foundation of China (Grant no. 81602440, 81602301, and 81471048), Shandong Province College Science and Technology Plan Project (Grant no. J16LL08 and J17KA254), Projects of Medical and Health Technology Development Program in Shandong province (Grant no. 2016WS0688 and 2017WS398), National Natural Science Foundation of Shangdong Province (Grant no. ZR2014HM086).	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Deng GP, 2015, J BIOL CHEM, V290, P20211, DOI 10.1074/jbc.M115.638221; Denkert C, 2017, LANCET, V389, P2430, DOI 10.1016/S0140-6736(16)32454-0; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jiang S, 2012, EMBO J, V31, P1985, DOI 10.1038/emboj.2012.45; Lee JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00906-9; Lu J, 2013, BLOOD, V122, P1610, DOI 10.1182/blood-2013-01-481457; McDonald JE, 2017, CLIN CANCER RES, V23, P1981, DOI 10.1158/1078-0432.CCR-16-0235; Narlik-Grassow M, 2014, MED RES REV, V34, P136, DOI 10.1002/med.21284; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Ren CN, 2018, MOL ONCOL, V12, P690, DOI 10.1002/1878-0261.12192; Roberts DJ, 2014, MOL CELL, V53, P521, DOI 10.1016/j.molcel.2013.12.019; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Tan VP, 2015, AUTOPHAGY, V11, P963, DOI 10.1080/15548627.2015.1042195; Uddin N, 2015, CANCER SCI, V106, P718, DOI 10.1111/cas.12668; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Xia HG, 2015, J CELL BIOL, V210, P705, DOI 10.1083/jcb.201503044; Xiong XP, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.103; Yu ZH, 2016, BIOCHEM BIOPH RES CO, V473, P953, DOI 10.1016/j.bbrc.2016.03.160; Yu ZH, 2014, CELL SIGNAL, V26, P1560, DOI 10.1016/j.cellsig.2014.03.016; Yu ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088301; Yu ZH, 2013, J BIOL CHEM, V288, P35406, DOI 10.1074/jbc.M113.508226; Zhang XH, 2015, INT J MED SCI, V12, P487, DOI 10.7150/ijms.10982; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	29	61	63	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5997	6009		10.1038/s41388-018-0386-x	http://dx.doi.org/10.1038/s41388-018-0386-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29985480	hybrid, Green Published			2022-12-26	WOS:000449562500007
J	Matsubara, T; Yasumori, H; Ito, K; Shimoaka, T; Hasegawa, T; Sato, T				Matsubara, Teruhiko; Yasumori, Hanaki; Ito, Koichiro; Shimoaka, Takafumi; Hasegawa, Takeshi; Sato, Toshinori			Amyloid- fibrils assembled on ganglioside-enriched membranes contain both parallel -sheets and turns	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid (A); fibril; ganglioside; Fourier transform IR (FTIR); atomic force microscopy (AFM); Alzheimer's disease; parallel -structure; lipid bilayer; neuronal membrane; neurodegeneration	TRANSFORM INFRARED-SPECTROSCOPY; PROTEIN SECONDARY STRUCTURES; SOLID-STATE NMR; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; BETA-PROTEIN; FTIR SPECTROSCOPY; STRUCTURAL MODEL; PEPTIDE; OLIGOMERS	Some protein and peptide aggregates, such as those of amyloid- protein (A), are neurotoxic and have been implicated in several neurodegenerative diseases. A accumulates at nanoclusters enriched in neuronal lipids called gangliosides in the presynaptic neuronal membrane, and the resulting oligomeric and/or fibrous forms accelerate the development of Alzheimer's disease. Although the presence of A deposits at such nanoclusters is known, the mechanism of their assembly and the relationship between A secondary structure and topography are still unclear. Here, we first confirmed by atomic force microscopy that A(40) fibrils can be obtained by incubating seed-free A(40) monomers with a membrane composed of sphingomyelin, cholesterol, and the ganglioside GM1. Using Fourier transform infrared (FTIR) reflection-absorption spectroscopy, we then found that these lipid-associated fibrils contained parallel -sheets, whereas self-assembled A(40) molecules formed antiparallel -sheets. We also found that the fibrils obtained at GM1-rich nanoclusters were generated from turn A(40). Our findings indicate that A generally self-assembles into antiparallel -structures but can also form protofibrils with parallel -sheets by interacting with ganglioside-bound A. We concluded that by promoting the formation of parallel -sheets, highly ganglioside-enriched nanoclusters help accelerate the elongation of A fibrils. These results advance our understanding of ganglioside-induced A fibril formation in neuronal membranes and may help inform the development of additional therapies for Alzheimer's disease.	[Matsubara, Teruhiko; Yasumori, Hanaki; Ito, Koichiro; Sato, Toshinori] Keio Univ, Dept Biosci & Informat, Kouhoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan; [Shimoaka, Takafumi; Hasegawa, Takeshi] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan	Keio University; Kyoto University	Sato, T (corresponding author), Keio Univ, Dept Biosci & Informat, Kouhoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	sato@bio.keio.ac.jp	; Hasegawa, Takeshi/G-6659-2018	Sato, Toshinori/0000-0002-4429-6101; Hasegawa, Takeshi/0000-0001-5574-9869	Kakenhi from the Japan Society for the Promotion of Science [22300118]; Suzuken Memorial Foundation [11-093]; Keio Gijuku Academic Development Funds; National Center for Geriatrics and Gerontology, Japan [25-19]	Kakenhi from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Suzuken Memorial Foundation; Keio Gijuku Academic Development Funds; National Center for Geriatrics and Gerontology, Japan	This work was supported by Kakenhi Grant 22300118 from the Japan Society for the Promotion of Science (to T. M.), by Grant 11-093 from the Suzuken Memorial Foundation (to T. M.), by the Keio Gijuku Academic Development Funds (to T. M.), and by Research Funding for Longevity Sciences, Grant 25-19, from the National Center for Geriatrics and Gerontology, Japan (to T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; BANDEKAR J, 1992, BIOCHIM BIOPHYS ACTA, V1120, P123, DOI 10.1016/0167-4838(92)90261-B; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Dreissig I, 2009, SPECTROCHIM ACTA A, V71, P2069, DOI 10.1016/j.saa.2008.08.008; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Evangelisti E, 2016, SCI REP-UK, V6, DOI 10.1038/srep32721; Fu Z, 2015, BIOCHEMISTRY-US, V54, P4197, DOI 10.1021/acs.biochem.5b00467; Fukunaga S, 2012, BIOCHEMISTRY-US, V51, P8125, DOI 10.1021/bi300839u; GUN J, 1984, J COLLOID INTERF SCI, V101, P201, DOI 10.1016/0021-9797(84)90020-1; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hoshino T, 2013, J PHYS CHEM B, V117, P8085, DOI 10.1021/jp4029062; Hu ZP, 2015, PHYS CHEM CHEM PHYS, V17, P22711, DOI 10.1039/c5cp02366a; Kakio A, 2001, J BIOL CHEM, V276, P24985, DOI 10.1074/jbc.M100252200; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; LANSBURY PT, 1995, NAT STRUCT BIOL, V2, P990, DOI 10.1038/nsb1195-990; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Matsubara T, 2017, LANGMUIR, V33, P13874, DOI 10.1021/acs.langmuir.7b02091; Matsubara T, 2013, LANGMUIR, V29, P2258, DOI 10.1021/la3038999; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; McLaurin J, 1996, J BIOL CHEM, V271, P26482, DOI 10.1074/jbc.271.43.26482; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Moore DJ, 1997, J PHYS CHEM B, V101, P8933, DOI 10.1021/jp9718109; Oikawa N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121356; Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Qiang W, 2017, NATURE, V541, P217, DOI 10.1038/nature20814; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Shimoaka T, 2013, ANAL BIOANAL CHEM, V405, P9411, DOI 10.1007/s00216-013-7400-5; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Sonnino S, 2006, CHEM REV, V106, P2111, DOI 10.1021/cr0100446; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; SUSI H, 1983, BIOCHEM BIOPH RES CO, V115, P391, DOI 10.1016/0006-291X(83)91016-1; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Utsumi M, 2009, GLYCOCONJUGATE J, V26, P999, DOI 10.1007/s10719-008-9216-7; WISNIEWSKI T, 1991, BIOCHEM BIOPH RES CO, V179, P1247, DOI 10.1016/0006-291X(91)91706-I; Yagi-Utsumi M, 2015, GLYCOCONJUGATE J, V32, P105, DOI 10.1007/s10719-015-9587-5; Yagi-Utsumi M, 2010, FEBS LETT, V584, P831, DOI 10.1016/j.febslet.2010.01.005; Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 2007, BBA-BIOMEMBRANES, V1768, P1943, DOI 10.1016/j.bbamem.2007.01.018; Yanagisawa K, 2015, GLYCOCONJUGATE J, V32, P87, DOI 10.1007/s10719-015-9579-5; Yanagisawa K, 2011, J NEUROCHEM, V116, P806, DOI 10.1111/j.1471-4159.2010.07006.x; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n	55	21	21	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14146	14154		10.1074/jbc.RA118.002787	http://dx.doi.org/10.1074/jbc.RA118.002787			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30018137	hybrid, Green Published			2022-12-26	WOS:000444070700035
J	Sharma, A; Dubey, V; Sharma, R; Devnath, K; Gupta, VK; Akhter, J; Bhando, T; Verma, A; Ambatipudi, K; Sarkar, M; Pathania, R				Sharma, Atin; Dubey, Vineet; Sharma, Rajnikant; Devnath, Kuldip; Gupta, Vivek Kumar; Akhter, Jawed; Bhando, Timsy; Verma, Aparna; Ambatipudi, Kiran; Sarkar, Mihir; Pathania, Ranjana			The unusual glycine-rich C terminus of the Acinetobacter baumannii RNA chaperone Hfq plays an important role in bacterial physiology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virulence factor; gene regulation; biofilm; bacterial adhesion; RNA binding protein; AbsR25; chaperone; Gram negative pathogen; resistance; small RNA; intrinsically disordered protein; pathogen	ESCHERICHIA-COLI HFQ; MULTIDRUG-RESISTANT; VIRULENCE; PROTEINS; DOMAIN; BIOREMEDIATION; INSIGHTS	Acinetobacter baumannii is a Gram-negative nosocomial pathogen that causes soft tissue infections in patients who spend a long time in intensive care units. This recalcitrant bacterium is very well known for developing rapid drug resistance, which is a combined outcome of its natural competence and mobile genetic elements. Successful efforts to treat these infections would be aided by additional information on the physiology of A. baumannii. Toward that end, we recently reported on a small RNA (sRNA), AbsR25, in this bacterium that regulates the genes of several efflux pumps. Because sRNAs often require the RNA chaperone Hfq for assistance in binding to their cognate mRNA targets, we identified and characterized this protein in A. baumannii. The homolog in A. baumannii is a large protein with an extended C terminus unlike Hfqs in other Gram-negative pathogens. The extension has a compositional bias toward glycine and, to a lower extent, phenylalanine and glutamine, suggestive of an intrinsically disordered region. We studied the importance of this glycine-rich tail using truncated versions of Hfq in biophysical assays and complementation of an hfq deletion mutant, finding that the tail was necessary for high-affinity RNA binding. Further tests implicate Hfq in important cellular processes of A. baumannii like metabolism, drug resistance, stress tolerance, and virulence. Our findings underline the importance of the glycine-rich C terminus in RNA binding, ribo-regulation, and auto-regulation of Hfq, demonstrating this hitherto overlooked protein motif to be an indispensable part of the A. baumannii Hfq.	[Sharma, Atin; Dubey, Vineet; Sharma, Rajnikant; Devnath, Kuldip; Gupta, Vivek Kumar; Akhter, Jawed; Bhando, Timsy; Verma, Aparna; Ambatipudi, Kiran; Pathania, Ranjana] Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India; [Sarkar, Mihir] Indian Vet Res Inst, ICAR, Div Physiol & Climatol, Izatnagar 243122, UP, India; [Sharma, Rajnikant] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; University of North Carolina; University of North Carolina Chapel Hill	Pathania, R (corresponding author), Indian Inst Technol Roorkee, Dept Biotechnol, Roorkee 247667, Uttar Pradesh, India.	rpathfbs@iitr.ac.in	Sharma, Atin/HII-8073-2022; Sharma, Rajnikant/AGO-9487-2022; Sharma, Atin/N-5204-2015	Pathania, Ranjana/0000-0002-7965-8176; Sharma, Atin/0000-0002-9422-1853; Devnath, Kuldip/0000-0001-9466-4577	Department of Biotechnology, Government of India [BT/PR11943/MED/29/874/2014]; Ministry of Human Resource Development, Government of India; Department of Biotechnology, Government of India; Indian Council of Medical Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by Department of Biotechnology, Government of India, Grant BT/PR11943/MED/29/874/2014; Ministry of Human Resource Development, Government of India, Ph.D. support fellowships (to A.S., R.S., T.B., and A.V.); a grant from the Department of Biotechnology, Government of India (to V.D.); and a grant from the Indian Council of Medical Research (to J.A.). The authors declare that they have no conflicts of interest with the contents of this article. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abbott A, 2005, NATURE, V436, P758, DOI 10.1038/436758a; Abdel-el-haleem D., 2003, AFR J BIOTECHNOL, V2, P71, DOI 10.5897/AJB2003.000-1014; Amin SV, 2016, RNA BIOL, V13, P331, DOI 10.1080/15476286.2016.1144010; Arluison V, 2004, EUR J BIOCHEM, V271, P1258, DOI 10.1111/j.1432-1033.2004.04026.x; Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bigot S, 2017, VIRULENCE, V8, P653, DOI 10.1080/21505594.2017.1283465; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Chiang MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022248; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Fortas E, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140128; Garcia-Quintanilla M, 2016, ANTIMICROB AGENTS CH, V60, P5076, DOI 10.1128/AAC.00407-16; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Hanson KG, 1997, CURR MICROBIOL, V35, P191, DOI 10.1007/s002849900237; Kawamura-Sato K, 2010, J ANTIMICROB CHEMOTH, V65, P1975, DOI 10.1093/jac/dkq227; Kim JS, 2007, NUCLEIC ACIDS RES, V35, P506, DOI 10.1093/nar/gkl1076; Kuo HY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02068; Lee CR, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00055; Masse E, 2005, J BACTERIOL, V187, P6962, DOI 10.1128/JB.187.20.6962-6971.2005; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Paisio CE, 2016, ENVIRON TECHNOL, V37, P2379, DOI 10.1080/09593330.2016.1150352; Papenfort K, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00091; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Poulikakos P, 2014, EUR J CLIN MICROBIOL, V33, P1675, DOI 10.1007/s10096-014-2124-9; Rogelj B., 2011, RNA BINDING PROTEINS, P1; Sachetto-Martins G, 2000, BBA-GENE STRUCT EXPR, V1492, P1, DOI 10.1016/S0167-4781(00)00064-6; Santiago-Frangos A, 2017, ELIFE, V6, DOI 10.7554/eLife.27049; Schilling D, 2009, J BACTERIOL, V191, P5553, DOI 10.1128/JB.00490-09; Sharma A, 2017, J ANTIMICROB CHEMOTH, V72, P68, DOI 10.1093/jac/dkw382; Sharma R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093833; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sobrero P, 2012, CRIT REV MICROBIOL, V38, P276, DOI 10.3109/1040841X.2012.664540; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Svensson SL, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0028-2015; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Updegrove TB, 2016, CURR OPIN MICROBIOL, V30, P133, DOI 10.1016/j.mib.2016.02.003; Valentine SC, 2008, J CLIN MICROBIOL, V46, P2499, DOI 10.1128/JCM.00367-08; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vincent HA, 2012, J MOL BIOL, V420, P56, DOI 10.1016/j.jmb.2012.03.028; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Zhang AX, 2013, J MOL BIOL, V425, P3678, DOI 10.1016/j.jmb.2013.01.006	44	9	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13377	13388		10.1074/jbc.RA118.002921	http://dx.doi.org/10.1074/jbc.RA118.002921			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30002121	hybrid, Green Published			2022-12-26	WOS:000443375500003
J	Labarge, B; Walter, V; Lengerich, EJ; Crist, H; Karamchandani, D; Williams, N; Goldenberg, D; Bann, DV; Warrick, JI				Labarge, Brandon; Walter, Vonn; Lengerich, Eugene J.; Crist, Henry; Karamchandani, Dipti; Williams, Nicole; Goldenberg, David; Bann, Darrin V.; Warrick, Joshua I.			Evidence of a positive association between malpractice climate and thyroid cancer incidence in the United States	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MEDICAL MALPRACTICE; COLORECTAL-CANCER; DEFENSIVE MEDICINE; BREAST-CANCER; CARCINOMA; DIAGNOSIS; INTEROBSERVER; CALIFORNIA; MORTALITY	The incidence of thyroid cancer has risen dramatically in the past few decades. The cause of this is unclear, but several lines of evidence indicate it is largely due to overdiagnosis, the diagnosis of tumors that would have never manifest clinically if untreated. Practices leading to overdiagnosis may relate to defensive medicine. In this study, we evaluated the association between malpractice climate and incidence of thyroid, breast, prostate, colon, and lung cancer in U.S. states from 1999-2012 using publicly available government data. State-level malpractice risk was quantified as malpractice payout rate, the number of malpractice payouts per 100,000 people per state per year. Associations between state-level cancer incidence, malpractice payout rate, and several cancer risk factors were evaluated. Risk factors included several social determinants of health, including factors predicting healthcare access. States with higher malpractice payout rate had higher thyroid cancer incidence, on both univariate analysis (r = 0.51, P = 0.009, Spearman) and multivariate analysis (P<0.001, multilevel model). In contrast, state-level malpractice payout rate was not associated with incidence of any other cancer type. Malpractice climate may be a social determinant for being diagnosed with thyroid cancer. This may be a product of greater defensive medicine in states with higher malpractice risk, which leads to increased diagnostic testing of patients with thyroid nodules and potential overdiagnosis. Alternatively, malpractice risk may be a proxy for another, unmeasured risk factor.	[Labarge, Brandon] Penn State Univ, Coll Med, Hershey, PA USA; [Walter, Vonn; Lengerich, Eugene J.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Walter, Vonn] Penn State Univ, Coll Med, Dept Biochem, Hershey, PA USA; [Lengerich, Eugene J.; Warrick, Joshua I.] Penn State Canc Inst, Hershey, PA 17033 USA; [Crist, Henry; Karamchandani, Dipti; Williams, Nicole; Warrick, Joshua I.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA; [Goldenberg, David; Bann, Darrin V.] Penn State Univ, Coll Med, Dept Surg, Div Otolaryngol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Warrick, JI (corresponding author), Penn State Canc Inst, Hershey, PA 17033 USA.; Warrick, JI (corresponding author), Penn State Univ, Coll Med, Dept Pathol, Hershey, PA 17033 USA.	jwarrick@pennstatehealth.psu.edu	Walter, Vonn/AAI-3450-2021; Bann, Darrin/ABI-6703-2020	Walter, Vonn/0000-0001-6114-6714; Bann, Darrin/0000-0002-0246-4912				[Anonymous], 2017, R PACKAGE CORRPLOT V; [Anonymous], 2015, UROLOGY PRACTICE, V2, P17; Aschebrook-Kilfoy B, 2014, OCCUP ENVIRON MED, V71, P366, DOI 10.1136/oemed-2013-101929; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1882, DOI 10.1001/jama.2017.4011; Carney PA, 2016, J AM ACAD DERMATOL, V74, P317, DOI 10.1016/j.jaad.2015.09.037; CDC, 2016, BRFSS PREV TRENDS DA; Centers for Disease Control and Prevention, US CANC STAT USCS; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Cheng I, 2009, CANCER CAUSE CONTROL, V20, P1431, DOI 10.1007/s10552-009-9369-0; Cheng JM, 2015, EUR J CANCER PREV, V24, P6, DOI 10.1097/CEJ.0000000000000011; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Dubay L, 1999, J HEALTH ECON, V18, P491, DOI 10.1016/S0167-6296(99)00004-1; Franc B, 2003, HUM PATHOL, V34, P1092, DOI 10.1016/S0046-8177(03)00403-9; Furuya-Kanamori L, 2016, J CLIN ONCOLOGY OFFI; Goldberg JCP, 2010, OXFORD INTRO US LAW, pxv; Goyal N, 2015, LARYNGOSCOPE, V125, pE45, DOI 10.1002/lary.24815; Hall SF, 2014, CANCER MED-US, V3, P154, DOI 10.1002/cam4.184; HAMMOND EC, 1958, JAMA-J AM MED ASSOC, V166, P1294, DOI 10.1001/jama.1958.02990110030007; Heiman H, 2015, HJ KAISER FAMILY FDN; Kojima M, 2017, HUM PATHOL, V66, P230, DOI 10.1016/j.humpath.2017.04.031; Lehrer S, 2016, BREAST J, V22, P564, DOI 10.1111/tbj.12630; Lloyd RV, 2004, AM J SURG PATHOL, V28, P1336, DOI 10.1097/01.pas.0000135519.34847.f6; Lydiatt DD, 2003, HEAD NECK-J SCI SPEC, V25, P429, DOI 10.1002/hed.10254; Moffett P, 2011, WEST J EMERG MED, V12, P109; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529; Park S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5745; Reisch LM, 2015, AM J CLIN PATHOL, V144, P916, DOI 10.1309/AJCP80LYIMOOUJIF; Reitzel LR, 2014, THYROID, V24, P556, DOI 10.1089/thy.2013.0284; Rundle A, 2013, CANCER CAUSE CONTROL, V24, P297, DOI 10.1007/s10552-012-0108-6; Singh H, 2007, J CLIN ONCOL, V25, P5009, DOI 10.1200/JCO.2007.13.2142; Smith TR, 2015, NEUROSURGERY, V76, P105, DOI 10.1227/NEU.0000000000000576; Steinbrecher A, 2012, CANCER EPIDEM BIOMAR, V21, P1814, DOI 10.1158/1055-9965.EPI-12-0659; Team RC, 2014, R LANG ENV STAT COMP; The Surveillance E and End Results Program (SEER), 1992, SURV EP END RES PROG; Tozbikian G, 2017, INT J SURG PATHOL, V25, P100, DOI 10.1177/1066896916662154; Troxel DB, 2006, ARCH PATHOL LAB MED, V130, P617; United States Census Bureau, 2016, HIST INC TABL HOUS T; US Census Bureau, INT EST RES POP SEX; Wallace E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002929; Yost K, 2001, CANCER CAUSE CONTROL, V12, P703, DOI 10.1023/A:1011240019516; Zevallos JP, 2015, CANCER-AM CANCER SOC, V121, P741, DOI 10.1002/cncr.29122	44	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199862	10.1371/journal.pone.0199862	http://dx.doi.org/10.1371/journal.pone.0199862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020955	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400029
J	Loots, AK; Mokgokong, PS; Mitchell, E; Venter, EH; Kotze, A; Dalton, DL				Loots, Angelika K.; Mokgokong, Prudent S.; Mitchell, Emily; Venter, Estelle H.; Kotze, Antoinette; Dalton, Desire Lee			Phylogenetic analysis of canine distemper virus in South African wildlife	PLOS ONE			English	Article							DOMESTIC DOGS; HEMAGGLUTININ GENES; SERENGETI ECOSYSTEM; SLAM CD150; STRAINS; INFECTION; DISEASE; MORBILLIVIRUS; REVEALS; LINEAGE	Canine distemper virus (CDV) causes a severe contagious disease in a broad range of hosts. This is the first study to genetically characterise CDV strains from four different wildlife species in South Africa. The phylogenetic diversity of CDV is examined, using the haemagglutinin gene. The South African wildlife CDV isolates showed a high degree of similarity to CDV in South African domestic dogs. Phylogenetic analyses confirmed the presence of 12 geographical lineages with CDV strains from South African wildlife falling within the Southern African lineage. The study reveals two possible co-circulating sub-genotypes corresponding to the northern and southern regions of South Africa respectively. CDV strains from the non-canid species were distinct, but similar to CDV isolates from domestic dog and wild canids. Residues at amino acid sites of the SLAM binding region support the notion that CDV strains encoding 5191/549H are better adapted to non-canid species than canid species. The amino acids present at site 530 are conserved regardless of host species. Strains from South African wild carnivores showed no difference between host species with all strains presenting 530N. All non-canid strains in this study presented the combination 5191/549H. No evidence of host adaptation or lineage grouping was observed for the Nectin-4 binding region. Further studies should include CDV strains isolated from various hosts from a wider geographical range in South Africa.	[Loots, Angelika K.; Mokgokong, Prudent S.; Mitchell, Emily; Kotze, Antoinette; Dalton, Desire Lee] South African Natl Biodivers Inst, Natl Zool Garden, Pretoria, South Africa; [Loots, Angelika K.; Venter, Estelle H.] Univ Pretoria, Fac Vet Sci, Dept Vet Trop Dis, Onderstepoort, South Africa; [Venter, Estelle H.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Kotze, Antoinette] Univ Free State, Genet Dept, Bloemfontein, Free, South Africa; [Dalton, Desire Lee] Univ Venda, Dept Zool, Thohoyandou, South Africa	South African National Biodiversity Institute; University of Pretoria; James Cook University; University of the Free State; University of Venda	Dalton, DL (corresponding author), South African Natl Biodivers Inst, Natl Zool Garden, Pretoria, South Africa.; Dalton, DL (corresponding author), Univ Venda, Dept Zool, Thohoyandou, South Africa.	d.dalton@sanbi.org.za	; Venter, Estelle/O-6953-2014	Lane, Emily/0000-0003-0379-3790; Dalton, Desire Lee/0000-0001-5975-6425; Venter, Estelle/0000-0001-7351-0827; Loots, Angelika/0000-0002-3982-3309				Alexander KA, 1996, J ZOO WILDLIFE MED, V27, P426; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002; Budaszewski RD, 2014, VIRUS RES, V180, P76, DOI 10.1016/j.virusres.2013.12.024; Calderon MG, 2007, VET MICROBIOL, V125, P341, DOI 10.1016/j.vetmic.2007.05.020; Deem SL, 2000, J ZOO WILDLIFE MED, V31, P441, DOI 10.1638/1042-7260(2000)031[0441:CDITCA]2.0.CO;2; DIALLO A, 1990, VET MICROBIOL, V23, P155, DOI 10.1016/0378-1135(90)90145-L; Espinal MA, 2014, VET MICROBIOL, V172, P168, DOI 10.1016/j.vetmic.2014.05.019; Feng N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27518; Goller KV, 2010, VET MICROBIOL, V146, P245, DOI 10.1016/j.vetmic.2010.05.018; Gordon CH, 2015, EMERG INFECT DIS, V21, P824, DOI 10.3201/eid2105.141920; HAIG D. A., 1956, Onderstepoort Journal of Veterinary Research, V27, P19; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hashimoto M, 2001, ARCH VIROL, V146, P149, DOI 10.1007/s007050170198; Iwatsuki K, 1997, J GEN VIROL, V78, P373, DOI 10.1099/0022-1317-78-2-373; Ke GM, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0491-9; Langedijk JPM, 2011, J VIROL, V85, P11242, DOI 10.1128/JVI.05340-11; Liao P, 2015, INT J CLIN EXP MED, V8, P6607; Loots AK, 2017, J GEN VIROL, V98, P311, DOI 10.1099/jgv.0.000666; Martella V, 2006, VET MICROBIOL, V116, P301, DOI 10.1016/j.vetmic.2006.04.019; Martinez-Gutierrez M, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0702-z; McCarthy AJ, 2007, P ROY SOC B-BIOL SCI, V274, P3165, DOI 10.1098/rspb.2007.0884; Mochizuki M, 1999, J CLIN MICROBIOL, V37, P2936, DOI 10.1128/JCM.37.9.2936-2942.1999; Nikolin VM, 2017, MOL ECOL, V26, P2111, DOI 10.1111/mec.13902; Nikolin VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050955; Nikolin VM, 2012, VET MICROBIOL, V156, P45, DOI 10.1016/j.vetmic.2011.10.009; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Panzera Y, 2015, MOL PHYLOGENET EVOL, V92, P147, DOI 10.1016/j.ympev.2015.06.015; Riley MC, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0445-7; ROCKBORN G, 1959, NATURE, V184, P822, DOI 10.1038/184822a0; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sarute N, 2014, VIRUS GENES, V48, P474, DOI 10.1007/s11262-014-1054-z; Sawatsky B, 2012, J VIROL, V86, P3658, DOI 10.1128/JVI.06414-11; Seki F, 2003, J VIROL, V77, P9943, DOI 10.1128/JVI.77.18.9943-9950.2003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR J, 1994, DEV BIOL STAND, V82, P131; Terio KA, 2013, MBIO, V4, DOI 10.1128/mBio.00702-13; van de Bildt MWG, 2002, EMERG INFECT DIS, V8, P211; Viana M, 2015, P NATL ACAD SCI USA, V112, P1464, DOI 10.1073/pnas.1411623112; von Messling V, 2003, J VIROL, V77, P12579, DOI 10.1128/JVI.77.23.12579-12591.2003; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Woma TY, 2010, VET MICROBIOL, V143, P126, DOI 10.1016/j.vetmic.2009.11.013	42	9	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199993	10.1371/journal.pone.0199993	http://dx.doi.org/10.1371/journal.pone.0199993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020954	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400038
J	McConkey, KR; Nathalang, A; Brockelman, WY; Saralamba, C; Santon, J; Matmoon, U; Somnuk, R; Srinoppawan, K				McConkey, Kim R.; Nathalang, Anuttara; Brockelman, Warren Y.; Saralamba, Chanpen; Santon, Jantima; Matmoon, Umaporn; Somnuk, Rathasart; Srinoppawan, Kanchit			Different megafauna vary in their seed dispersal effectiveness of the megafaunal fruit Platymitra macrocarpa (Annonaceae)	PLOS ONE			English	Article							FOREST; EXTINCTION; ELEPHANTS; FRUGIVORY; ABUNDANCE; BEHAVIOR; SHADOW	The world's largest terrestrial animals (megafauna) can play profound roles in seed dispersal. Yet, the term `megafauna' is often used to encompass a diverse range of body sizes and physiologies of, primarily, herbivorous animals. To determine the extent to which these animals varied in their seed dispersal effectiveness (SDE), we compared the contribution of different megafauna for the large-fruited Platymitra macrocarpa (Annonaceae), in a tropical evergreen forest in Thailand. We quantified 'seed dispersal effectiveness' by measuring the quantity and quality contributions of all consumers of P. macrocarpa fruit. Seed dispersal quantity was the proportion of the crop consumed by each species. Quality was defined as the proportion of seeds handled by each animal taxon that survived to produce a 2-month seedling. Megafauna (elephants, sambar deer, bears) dispersed 78% of seeds that produced seedlings, with 21% dispersed by gibbons (a medium-sized frugivore). The main megafaunal consumers displayed different dispersal strategies. Elephants were the most effective dispersers (37% of seedlings) and they achieved this by being high-quality and low-quantity dispersers. Bears displayed a similar strategy but were especially rare visitors to the trees (24% of the total seedlings produced). Sambar were high-quantity dispersers, but most seeds they handled did not survive and they were responsible for only 17% of seedlings. Gibbons displayed a high SDE relative to their body size, but they probably cannot match the role of elephants despite being more regular consumers of the fruit. The low density and poor regeneration of P. macrocarpa in the study site suggest that current dispersal rates by megafauna are insufficient, possibly reflecting reduced or missing megafauna populations. We show that different megafaunal species disperse seeds in different ways and may make unique contributions to the reproductive success of the plant species.	[McConkey, Kim R.] Natl Inst Adv Studies, Sch Nat Sci & Engn, Indian Inst Sci Campus, Bangalore, Karnataka, India; [McConkey, Kim R.] Univ Nottingham, Sch Geog, Malaysia Campus, Semenyih, Selangor, Malaysia; [Nathalang, Anuttara; Brockelman, Warren Y.; Santon, Jantima; Matmoon, Umaporn; Somnuk, Rathasart] Natl Sci & Technol Dev Agcy, Ecol Lab, BIOTEC, Pathum Thani, Thailand; [Brockelman, Warren Y.] Mahidol Univ Salaya, Inst Mol Biosci, Phutthamonthon, Nakhon Pathom, Thailand; [Saralamba, Chanpen] Mahidol Univ, Conservat Biol Program, Kanchanaburi Campus, Sai Yok, Kanchanaburi, Thailand; [Srinoppawan, Kanchit] Dept Natl Parks Wildlife & Plant Conservat, Bangkok, Thailand	University of Nottingham Malaysia; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University; Mahidol University	McConkey, KR (corresponding author), Natl Inst Adv Studies, Sch Nat Sci & Engn, Indian Inst Sci Campus, Bangalore, Karnataka, India.; McConkey, KR (corresponding author), Univ Nottingham, Sch Geog, Malaysia Campus, Semenyih, Selangor, Malaysia.; Nathalang, A (corresponding author), Natl Sci & Technol Dev Agcy, Ecol Lab, BIOTEC, Pathum Thani, Thailand.	kimmcconkey@gmail.com; anut@biotec.or.th	Nathalang, Anuttara/P-3925-2018; McConkey, Kim/AAP-5609-2021	Nathalang, Anuttara/0000-0003-2780-0289; 	Cluster and Program Management Office, National Science and Technology Development Agency [P-13-00434]; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency [P-16-50439]	Cluster and Program Management Office, National Science and Technology Development Agency; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency	This work was supported by P-13-00434 by The Cluster and Program Management Office, National Science and Technology Development Agency. URL: https://www.nstda.or.th/en/index.php/research/bioresources-and-community. The funding receiver was W. Y. Brockelman. It was also supported by P-16-50439 by National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency. URL: http://www.biotec.or.th/en/index.php. The funding receiver was A. Nathalang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockelman W., 2017, MO SINGTO PLOT FLORA; Brockelman Warren Y., 2011, P195; Brodie JF, 2009, ECOLOGY, V90, P688, DOI 10.1890/08-0111.1; Campos-Arceiz A, 2008, ECOLOGY, V89, P2684, DOI 10.1890/07-1573.1; Campos-Arceiz A, 2011, ACTA OECOL, V37, P542, DOI 10.1016/j.actao.2011.01.014; Corlett RT, 2007, BIOTROPICA, V39, P292, DOI 10.1111/j.1744-7429.2007.00271.x; Corlett RT, 1998, BIOL REV, V73, P413, DOI 10.1017/S0006323198005234; Doughty CE, 2016, ECOGRAPHY, V39, P194, DOI 10.1111/ecog.01587; Estes JA, 2016, ANNU REV ENV RESOUR, V41, P83, DOI 10.1146/annurev-environ-110615-085622; Forget P.M., 2002, SEED DISPERSAL FRUGI, P241; Froyd CA, 2014, ECOL LETT, V17, P144, DOI 10.1111/ele.12203; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Harich FK, 2016, ACTA OECOL, V77, P144, DOI 10.1016/j.actao.2016.10.005; Jadejaroen J, 2003, THESIS; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jenks KE, 2011, TROP CONSERV SCI, V4, P113, DOI 10.1177/194008291100400203; Jose-Dominguez JM, 2015, AM J PRIMATOL, V77, P841, DOI 10.1002/ajp.22409; Kitamura S, 2007, J TROP ECOL, V23, P373, DOI 10.1017/S0266467407004026; Koike S, 2011, OIKOS, V120, P280, DOI 10.1111/j.1600-0706.2010.18626.x; Lynam AJ, 2006, THAILANDS DONG PHAYA; Malhi Y, 2016, P NATL ACAD SCI USA, V113, P838, DOI 10.1073/pnas.1502540113; McClenachan L, 2016, CURR BIOL, V26, P1640, DOI 10.1016/j.cub.2016.05.026; McConkey K, 1999, J TROP ECOL, V15, P237, DOI 10.1017/S0266467499000784; McConkey KR, 2015, ECOLOGY, V96, P2737, DOI [10.1890/14-1931.1, 10.1890/14-1931.1.sm]; McConkey KR, 2014, BIOTROPICA, V46, P647, DOI 10.1111/btp.12156; McConkey KR, 2011, ECOLOGY, V92, P1492, DOI 10.1890/10-1255.1; McConkey KR, 2004, ORYX, V38, P439, DOI 10.1017/S0030605304000821; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Perez HE, 2008, J TROP ECOL, V24, P555, DOI 10.1017/S0266467408005257; Pires MM, 2018, ECOGRAPHY, V41, P153, DOI 10.1111/ecog.03163; Prasad S, 2010, OIKOS, V119, P514, DOI 10.1111/j.1600-0706.2009.17971.x; Rood E, 2010, DIVERS DISTRIB, V16, P975, DOI 10.1111/j.1472-4642.2010.00704.x; Savini T, 2009, BIOTROPICA, V41, P503, DOI 10.1111/j.1744-7429.2009.00507.x; Schupp EW, 2010, NEW PHYTOL, V188, P333, DOI 10.1111/j.1469-8137.2010.03402.x; Sebastian-Gonzalez E., 2017, J ANIM ECOL, V38, P42; Sekar N, 2015, ECOLOGY, V96, P2093, DOI 10.1890/14-1543.1; Sekar N, 2013, J ECOL, V101, P1379, DOI 10.1111/1365-2745.12157; Sridhara Sachin, 2016, Ecological Studies, V225, P121; Suwanvecho U., 2017, BIOTROPICA, DOI 10. 1111/btp. 12525; Tella JL, 2015, FRONT ECOL ENVIRON, V13, P338, DOI 10.1890/1540-9295-13.6.338	40	22	23	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0198960	10.1371/journal.pone.0198960	http://dx.doi.org/10.1371/journal.pone.0198960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020929	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400007
J	Pagliuca, P; Milano, N; Nolfi, S				Pagliuca, Paolo; Milano, Nicola; Nolfi, Stefano			Maximizing adaptive power in neuroevolution	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORKS; EVOLUTION STRATEGIES; BEHAVIOR; ENVIRONMENTS; ALGORITHMS	In this paper we compare systematically the most promising neuroevolutionary methods and two new original methods on the double-pole balancing problem with respect to: the ability to discover solutions that are robust to variations of the environment, the speed with which such solutions are found, and the ability to scale-up to more complex versions of the problem. The results indicate that the two original methods introduced in this paper and the Exponential Natural Evolutionary Strategy method largely outperform the other methods with respect to all considered criteria. The results collected in different experimental conditions also reveal the importance of regulating the selective pressure and the importance of exposing evolving agents to variable environmental conditions. The data collected and the results of the comparisons are used to identify the most effective methods and the most promising research directions.	[Pagliuca, Paolo; Milano, Nicola; Nolfi, Stefano] Natl Res Council CNR, Inst Cognit Sci & Technol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Pagliuca, P (corresponding author), Natl Res Council CNR, Inst Cognit Sci & Technol, Rome, Italy.	paolo.pagliuca@istc.cnr.it		Pagliuca, Paolo/0000-0002-3780-3347; Milano, Nicola/0000-0002-1604-5161				Ackley D., 1991, SFI STUDIES SCI COMP, V10, P487; Belew R. K., 1990, CS90174 U CAL; Bongard J, 2002, IEEE C EVOL COMPUTAT, P1872, DOI 10.1109/CEC.2002.1004528; Bongard J, 2011, P NATL ACAD SCI USA, V108, P1234, DOI 10.1073/pnas.1015390108; DAmbrosio D. B., 2014, GROWING ADAPTIVE MAC, P159; Durr P, 2006, P 9 C PAR PROBL SOLV, V9; Floreano D., 1996, From Animals to Animats 4. Proceedings of the Fourth International Conference on Simulation of Adaptive Behavior, P402; Floreano D, 2001, AUTON ROBOT, V11, P311, DOI 10.1023/A:1012459627968; FLOREANO D, 1997, COM ADAP SY, P378; Floreano D, 2008, EVOL INTELL, V1, P47, DOI 10.1007/s12065-007-0002-4; Gauci J., 2007, P GEN EV COMP C; Goldberg D. E., 1987, GEN ALG THEIR APPL P; Gomez F, 1997, ADAPT BEHAV, V5, P317, DOI 10.1177/105971239700500305; Gomez F, 2008, J MACH LEARN RES, V9, P937; Gruau F., 1996, P 1 ANN C GEN PROGR; Gruau F., 1995, ADAPTIVE BEHAV, V3; Harvey I, 1994, ANIMALS ANIMATS; Harvey I., 2001, LNCS, P94, DOI DOI 10.1007/3-540-45502-7_; Hornby GS, 2002, ARTIF LIFE, V8, P223, DOI 10.1162/106454602320991837; Husbands P, 1994, PERCEPTION ACTION; Igel C, 2003, IEEE C EVOL COMPUTAT, P2588; Jin Y, 2005, IEEE T EVOLUT COMPUT, V9, P303, DOI 10.1109/TEVC.2005.846356; Khan MM, 2013, NEUROCOMPUTING, V121, P274, DOI 10.1016/j.neucom.2013.04.005; Khan MM, 2010, P INT C ART INT ICAI; Lehman J., 2013, SCHOLARPEDIA, V8, P30977, DOI DOI 10.4249/SCHOLARPEDIA.30977; Massera G, 2013, P 12 EUR C ART LIF; Massera G, 2014, ADAPT BEHAV, V22, P255, DOI 10.1177/1059712314536909; Miller JF, 2000, LECT NOTES COMPUT SC, V1802, P121; Moriarty DE, 1997, EVOL COMPUT, V5, P373, DOI 10.1162/evco.1997.5.4.373; NOLFI S, 1994, ADAPT BEHAV, V3, P5, DOI 10.1177/105971239400300102; Nolfi S, 1996, ADAPT BEHAV, V5, P75, DOI 10.1177/105971239600500104; Nolfi S, 1994, PERCEPTION ACTION; Parisi D, 1990, NETWORK-COMP NEURAL, V1, P149, DOI 10.1088/0954-898X/1/2/003; Petrosino G, 2013, ADAPT BEHAV, V21, P356, DOI 10.1177/1059712313487389; Philippides A, 2005, ARTIF LIFE, V11, P139, DOI 10.1162/1064546053279044; Rechenberg I, 1973, EVOLUTIONSTRATEGIE O; Sasaki T, 1997, P 4 EUR C ART LIF; Schwefel H., 1977, NUMERISCHE OPTIMIERU, V26; Sims K., 1994, P ARTIFICIAL LIFE; Stanley KO, 2009, ARTIF LIFE, V15, P185, DOI 10.1162/artl.2009.15.2.15202; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Stanley KO, 2003, P C EV COMP CEC 2003, V4; Stanley KO, 2007, GENETIC PROGRAMMING, V8, p121 ; Sutton S., 1984, THESIS; Tuci E, 2002, ADAPT BEHAV, V10, P201, DOI 10.1177/1059712302010003004; Turner AJ, 2014, EVOL INTELL, V7, P135, DOI 10.1007/s12065-014-0115-5; Whiteson S, 2006, J MACH LEARN RES, V7, P877; WHITLEY D, 1990, PARALLEL COMPUT, V14, P347, DOI 10.1016/0167-8191(90)90086-O; Whitley D, 2001, INFORM SOFTWARE TECH, V43, P817, DOI 10.1016/S0950-5849(01)00188-4; Wieland A., 1991, P INT JOINT C NEUR N, VII, P667; Wierstra D., 2008, P C EV COMP CEC08; Wierstra D, 2014, J MACH LEARN RES, V15, P949; Yamauchi Brian M., 1994, Adaptive Behavior, V2, P219, DOI 10.1177/105971239400200301; Yao X, 1999, P IEEE, V87, P1423, DOI 10.1109/5.784219; Yao X., 1991, INT S AI REAS CREAT	55	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0198788	10.1371/journal.pone.0198788	http://dx.doi.org/10.1371/journal.pone.0198788			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020942	gold, Green Published, Green Submitted			2022-12-26	WOS:000439022400005
J	Donnelly, TT; Al-Thani, ABM; Benjamin, K; Al-Khater, A; Fung, TS; Ahmedna, M; Welch, A				Donnelly, Tam Truong; Al-Thani, Al-Anoud Bint Mohammed; Benjamin, Kathleen; Al-Khater, Al-Hareth; Fung, Tak Shing; Ahmedna, Mohamed; Welch, Ailsa			Arab female and male perceptions of factors facilitating and inhibiting their physical activity: Findings from a qualitative study in the Middle East	PLOS ONE			English	Article							HEALTHY LIFE-STYLE; RISK-FACTORS; WOMEN; QATAR; POPULATION; BARRIERS; ASSOCIATION; PREVALENCE; HABITS; CARE	Objectives Physical inactivity is a leading global risk to health by contributing to obesity and other chronic diseases. Many chronic non-communicable diseases, such as cancer, diabetes, and cardiovascular diseases (CVDs), can be prevented and controlled by modifying lifestyle behaviors such as physical activity [PA]. However, prevalence of insufficient physical activity and obesity is high in the Middle East Region. In Qatar, the incidence rates of CVDs, diabetes, colon, and breast cancer have been rising rapidly. The purpose of this study was to explore facilitators and barriers influencing PA of adult Arab men and women living in Qatar and to understand what they think would be helpful to increase PA. The goal of the research is to identify culturally appropriate and effective interventions that improve the health of Arab population. Design Using the socioecological model as the theoretical framework, we conducted an exploratory qualitative study with 128 Arab adult men and women living in Qatar. We utilized focus group interviews to collect the data and performed thematic analysis to generate themes. Results At the individual level, perceived benefits of PA, presence of diseases, person's will, motivation and goals, and time to exercise influenced the individual's PA. At the sociocultural level, religious teachings of Islam, cultural, attitude, beliefs, and practices, and informal support influenced the participants' PA. At the organizational and political level, physical environment to exercise, accessibility of facilities, organizational support, and health information about PA influenced their PA. Conclusion Arab men and women are aware of the importance and benefits of PA. They have the motivation to be physically active, but in the absence of supportive environment, their knowledge might not translate into action. Creating supportive environments at multiple levels that are conducive to PA is warranted.	[Donnelly, Tam Truong; Fung, Tak Shing] Univ Calgary, Fac Nursing & Med, Calgary, AB, Canada; [Al-Thani, Al-Anoud Bint Mohammed] Publ Hlth Dept, Qatar Minist Publ Hlth, Doha, Qatar; [Benjamin, Kathleen] Univ Calgary Qatar, Doha, Qatar; [Al-Khater, Al-Hareth] Hamad Med Corp, Natl Ctr Canc Care & Res, Doha, Qatar; [Ahmedna, Mohamed] Qatar Univ, Doha, Qatar; [Welch, Ailsa] Univ East Anglia, Norwich, Norfolk, England	University of Calgary; Hamad Medical Corporation; Qatar University; University of East Anglia	Donnelly, TT (corresponding author), Univ Calgary, Fac Nursing & Med, Calgary, AB, Canada.	tdonnell@ucalgary.ca			Qatar National Research Fund under its National Priority Research Program [NPRP 6 - 049 - 3 - 009, NPRP6-049-3-009]	Qatar National Research Fund under its National Priority Research Program(Qatar National Research Fund (QNRF))	This study and publications was made possible by a grant from Qatar National Research Fund under its National Priority Research Program (NPRP 6 - 049 - 3 - 009) for which we are very grateful. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of Qatar National Research Fund.; This study and publications was made possible by a grant from Qatar National Research Fund under its National Priority Research Program (NPRP6-049-3-009) for which we are very grateful. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of Qatar National Research Fund.	Al-Bibi KW, STATE QATAR NATL PHY; Al-Kaabi Juma, 2009, Rev Diabet Stud, V6, P271, DOI 10.1900/RDS.2009.6.271; Al-Nakeeb Y, 2015, INT J ENV RES PUB HE, V12, P4380, DOI 10.3390/ijerph120404380; Al-Saad S, 2009, BAHRAIN MED B, V31; Al-Thani MH, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009514; Ali HI, 2010, HEALTH SOC CARE COMM, V18, P219, DOI 10.1111/j.1365-2524.2009.00896.x; AlQuaiz AM, 2009, ANN SAUDI MED, V29, P30, DOI 10.4103/0256-4947.51818; Amin TT, 2011, J PHYS ACT HEALTH, V8, P775, DOI 10.1123/jpah.8.6.775; [Anonymous], 2009, INP DISCH DIAGN HAM; Bener A, 2010, ASIAN PAC J CANCER P, V11, P963; Bener A, 2008, ASIAN PAC J CANCER P, V9, P19; Bener A, 2009, DIABETES RES CLIN PR, V84, P99, DOI 10.1016/j.diabres.2009.02.003; Benjamin K, 2013, AVICENNA, DOI 10.5339/avi.2013.8; Berger G, 2009, HEALTH PLACE, V15, P117, DOI 10.1016/j.healthplace.2008.03.003; Bullo M, 2011, PREV MED, V53, P155, DOI 10.1016/j.ypmed.2011.06.008; Cesar L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017263; Chanpong GF, 2008, QATAR 2006 WORLD HLT; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Donnelly TT, 2012, HEALTH CARE WOMEN IN, V33, P1114, DOI 10.1080/07399332.2012.712172; Donnelly TT, 2011, AVICENNA; Epp J., 1986, ACHIEVING HLTH ALL F; GANSTER DC, 1983, ACAD MANAGE J, V26, P321, DOI 10.2307/255979; Green L.W., 1991, HLTH PROMOTION PLANN; Green LW, 1996, AM J HEALTH PROMOT, V10, P270, DOI 10.4278/0890-1171-10.4.270; Griffiths A, 2014, EUR J PUBLIC HEALTH, V24, P813, DOI 10.1093/eurpub/ckt199; Hamilton N., 1996, POPULATION HLTH PROM; Jackson EA, 2010, CLIN CARDIOL, V33, P765, DOI 10.1002/clc.20839; Kahan D, 2011, RES Q EXERCISE SPORT, V82, P118, DOI 10.1080/02701367.2011.10599728; Keese F, 2011, J STRENGTH COND RES, V25, P1429, DOI 10.1519/JSC.0b013e3181d6d968; Kreuger R., 2000, FOCUS GROUPS PRACTIC; Lalonde M, 1974, NEW PERSPECTIVE HLTH; Min-Lee I, 2000, LANCET, V380, P219; Mirsafian H, 2014, IRAN STUD-UK, V47, P951, DOI 10.1080/00210862.2013.823790; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Morse J. M., 1994, HDB QUALITATIVE RES, P220, DOI DOI 10.1109/HICSS.2013.531; Nagy S, 2006, URBAN STUD, V43, P119, DOI 10.1080/00420980500409300; Nakamura Y, 2002, WSPAJ, V11, P21, DOI [10.1123/wspaj.11.2.21, DOI 10.1123/WSPAJ.11.2.21]; NAMAT, 2015, QAT ACT SCH PROGR QA; Poland BD, 2000, SETTINGS HLTH PROMOT; Qahoush R, 2010, EUR J CARDIOVASC NUR, V9, P263, DOI 10.1016/j.ejcnurse.2010.03.002; Rimer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub5; Sallis JF, 2008, HLTH BEHAV HLTH ED T, V260, P465; Shuval K, 2008, PREVENTING CHRONIC D, V5, P1; Sorace P, 2012, ACSMS HEALTH FIT J, V16, P13, DOI 10.1249/FIT.0b013e31823d0079; Supreme Council of Health, 2014, QAT HLTH REP 2012; Vollman AR, 2008, CANADIAN COMMUNITY P; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2017, PHYS ACTIVITY; WHO, 2015, GLOB REC PHYS ACT HL; WHO, 1995, US; Wilkinson S, 1998, J Health Psychol, V3, P329, DOI 10.1177/135910539800300304; World Health Organization, 2009, HLTH LIT HLTH BEH; World Health Organization, 2006, WORLD HLTH SURV WHS; World Health Organization, 2008, PREV INS PHYS ACT; World Health Organization, 2010, REG E MED; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization (WHO), 2008, WHO WORKSH PHYS ACT; World Health Organization (WHO), 2010, HLTH WORKPL WHO GLOB	58	19	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199336	10.1371/journal.pone.0199336	http://dx.doi.org/10.1371/journal.pone.0199336			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2LQ	30011280	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000438829800002
J	Meriki, HD; Tufon, KA; Anong, DN; Tony, NJ; Kwenti, TE; Bolimo, AF; Kouanou, YS; Nkuo-Akenji, T				Meriki, Henry Dilonga; Tufon, Kukwah Anthony; Anong, Damian Nota; Tony, Nyeke James; Kwenti, Tebit Emmanuel; Bolimo, Ayah Flora; Kouanou, Youmbi Sylvain; Nkuo-Akenji, Theresa			Vaccine uptake and immune responses to HBV infection amongst vaccinated and non-vaccinated healthcare workers, household and sexual contacts to chronically infected HBV individuals in the South West Region of Cameroon	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; MEDICAL-STUDENTS; VIRAL-HEPATITIS; SURFACE-ANTIGEN; VIRUS INFECTION; NONRESPONDERS; PERSONNEL; ANTIBODY; ADULTS; IMMUNOGENICITY	Background HBV infection affects about 257 million people globally and Sub-Saharan Africa has the highest burden. The disease still constitutes a major public health problem despite the advent of preventive measures like the HBV vaccine. This study was aimed at identifying factors that influence vaccine uptake and the efficacy of administered vaccines among people at high risk of HBV infection. Methods This was a cross-sectional study conducted between January 2016 and December 2017. A pretested semi-structured questionnaire was used to capture information on sociodemographic and vaccination status from healthcare workers, household and sexual contacts to HBV infected people. HBV serological panel as well as quantitative anti-HBs ELISA test was done for all participants. Additional information was obtained from the institutions that administered the vaccines. Results A total of 265 participants with a mean age of 32.1 +/- 8.7 were enrolled. Eighty (30.2%) of them had received at least 1 dose of the HBV vaccine while 185 (69.8%) were unvaccinated. Healthcare workers were the most vaccinated (37%). Ignorance, negligence, fear of injection and the cost of the vaccine all contributed to poor vaccine uptake in the study population. Natural immunity was seen in 9 (3.4%) of the participants. Only 64.9% of the vaccinated participants attained the desirable level of anti-HBs (>= 10mlU/ml) 1-2 months after >= 3 doses of the vaccine. Age, gender, obesity, alcohol and smoking were not significantly associated with poor immune responses. No standardized protocol was followed by the institutions administering the vaccine. Conclusion This study revealed very poor vaccine uptake and poor immune responses to the HBV vaccine in the study population and this should urge the health sector in Cameroon to intensify their sensitization on HBV vaccine, standardize the protocol for storing and administering the vaccine, subsidize the cost of the vaccine especially amongst healthcare workers and encourage anti-HBs post vaccination testing.	[Meriki, Henry Dilonga; Tufon, Kukwah Anthony; Tony, Nyeke James; Kwenti, Tebit Emmanuel] Univ Buea, Dept Microbiol & Parasitol, Buea, South West Regi, Cameroon; [Meriki, Henry Dilonga; Tufon, Kukwah Anthony; Kwenti, Tebit Emmanuel; Bolimo, Ayah Flora; Kouanou, Youmbi Sylvain] Buea Reg Hosp, Buea, Southwest Regio, Cameroon; [Meriki, Henry Dilonga; Kwenti, Tebit Emmanuel] Univ Buea, Fac Hlth Sci, Dept Publ Hlth & Hyg, Buea, Southwest Regio, Cameroon; [Anong, Damian Nota; Nkuo-Akenji, Theresa] Univ Bamenda, Fac Sci, Dept Biol Sci, Bamenda, North West Regi, Cameroon; [Kwenti, Tebit Emmanuel] Univ Buea, Fac Hlth Sci, Dept Med Lab Sci, Buea, Southwest Regio, Cameroon		Tufon, KA (corresponding author), Univ Buea, Dept Microbiol & Parasitol, Buea, South West Regi, Cameroon.; Tufon, KA (corresponding author), Buea Reg Hosp, Buea, Southwest Regio, Cameroon.	drkapt@yahoo.com	Kwenti, Tebit E./P-8688-2018; Meriki, Henry Dilonga/V-4634-2019	Kwenti, Tebit E./0000-0001-5526-9179; Meriki, Henry Dilonga/0000-0002-9148-0171; Tufon, Kukwah/0000-0002-5643-0515; James Tony, Nyeke/0000-0003-1191-3502				Abdela Abdnur, 2016, BMC Res Notes, V9, P410, DOI 10.1186/s13104-016-2216-y; Al-Dabbas M., 2012, Eastern Mediterranean Health Journal, V18, P700; ALPER CA, 1989, NEW ENGL J MED, V321, P708, DOI 10.1056/NEJM198909143211103; ANDRE FE, 1989, AM J MED, V87, pS14, DOI 10.1016/0002-9343(89)90525-1; [Anonymous], 2009, HEPATITIS B VACCINE; Averhoff F, 1998, AM J PREV MED, V15, P1, DOI 10.1016/S0749-3797(98)00003-8; Bigna JJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015298; Cardell K, 2008, J INFECT DIS, V198, P299, DOI 10.1086/589722; CDC, 2017, IMM ACT COAL; CDC, 2016, LOC TRACK AD VACC RE; Crockett M, 2005, J TRAVEL MED, V12, pS41; Danta M, 2014, ALL YOU WANTED KNOW, P31; Elzouki AN, 2014, J INFECT PUBLIC HEAL, V7, P534, DOI 10.1016/j.jiph.2014.07.006; Fritzsche C, 2013, T ROY SOC TROP MED H, V107, P158, DOI 10.1093/trstmh/trs087; Gasim GI, 2015, WORLD J HEPATOL, V7, P270, DOI 10.4254/wjh.v7.i2.270; GUPTA S, 1990, J CLIN GASTROENTEROL, V12, P562, DOI 10.1097/00004836-199010000-00015; HADLER SC, 1989, VACCINE, V7, P106, DOI 10.1016/0264-410X(89)90046-7; Hepatitis B., 2015, EPIDEMIOLOGY PREVENT, V13th, P149; JILG W, 1989, J INFECT DIS, V160, P766, DOI 10.1093/infdis/160.5.766; KESSLER HA, 1985, ANN INTERN MED, V103, P21, DOI 10.7326/0003-4819-103-1-21; Kim MJ, 2003, VACCINE, V21, P1174, DOI 10.1016/S0264-410X(02)00626-6; KING JW, 1990, REV INFECT DIS, V12, P1035; Krajden Mel, 2005, Can J Infect Dis Med Microbiol, V16, P65; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Lavanchy D, 2012, J CLIN VIROL, V55, P296, DOI 10.1016/j.jcv.2012.08.022; Lee DH, 2001, INT J EPIDEMIOL, V30, P766, DOI 10.1093/ije/30.4.766; Lemon SM, 1997, NEW ENGL J MED, V336, P196, DOI 10.1056/NEJM199701163360307; LEVITZ RE, 1995, INFECT CONT HOSP EP, V16, P88; Malewezi B, 2016, J EPIDEMIOL GLOB HEA, V6, P229, DOI 10.1016/j.jegh.2016.04.003; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Merck, 2010, HEP B VACC MERCK; Mueller A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1129-z; Nansseu NJR, 2014, INT J INFECT DIS, V21, P448, DOI 10.1016/j.ijid.2014.03.1345; Nir Y, 2003, AM J TROP MED HYG, V68, P341, DOI 10.4269/ajtmh.2003.68.341; Noubiap Jean Jacques N, 2014, Int Arch Med, V7, P11, DOI 10.1186/1755-7682-7-11; Okeke E N, 2008, Niger J Med, V17, P330; Pang J, 2014, ALL YOU WANTED KNOW, P43; Pasricha N, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-65; ROOME AJ, 1993, JAMA-J AM MED ASSOC, V270, P2931, DOI 10.1001/jama.270.24.2931; Roukens AH, 2011, HUM VACCINES, V7, P654, DOI 10.4161/hv.7.6.14986; Schillie S, 2013, MMWR RECOMM REP, V62, P1; SHAW FE, 1989, VACCINE, V7, P425, DOI 10.1016/0264-410X(89)90157-6; Sofola OO, 2007, J DENT EDUC, V71, P832; STEPHENNE J, 1990, VACCINE, V8, pS69, DOI 10.1016/0264-410X(90)90221-7; Swinscow TD V, 2002, BRIT MED J, DOI [10.1136/bmj.1.6020.12621186/s12889-016-3388-z, DOI 10.1136/BMJ.1.6020.12621186/S12889-016-3388-Z]; Tatsilong HOP, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3388-z; Wang RX, 2004, WORLD J GASTROENTERO, V10, P260; WEBER DJ, 1985, JAMA-J AM MED ASSOC, V254, P3187, DOI 10.1001/jama.254.22.3187; WERNER BG, 1985, ANN INTERN MED, V103, P201, DOI 10.7326/0003-4819-103-2-201; WHO, 2014, IMM STAND; WHO, 2009, VIR HEP, P1; WHO, 2015, WHO GUID PREV CAR TR; Wistrom J, 1999, VACCINE, V17, P2162, DOI 10.1016/S0264-410X(99)00012-2; WOOD RC, 1993, JAMA-J AM MED ASSOC, V270, P2935, DOI 10.1001/jama.270.24.2935; World Health Organization, 2022, HEP B; Yano Y, 2016, J HEPAT, V2, P1; Yao J, 2016, HUM VACC IMMUNOTHER, V12, P1847, DOI 10.1080/21645515.2016.1139256; ZIMMERMAN FH, 1989, B NEW YORK ACAD MED, V65, P741	58	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200157	10.1371/journal.pone.0200157	http://dx.doi.org/10.1371/journal.pone.0200157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011286	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800012
J	Wallace, JG; Potts, RH; Szamosi, JC; Surette, MG; Sloboda, DM				Wallace, Jessica G.; Potts, Ryan H.; Szamosi, Jake C.; Surette, Michael G.; Sloboda, Deborah M.			The murine female intestinal microbiota does not shift throughout the estrous cycle	PLOS ONE			English	Article							GUT MICROBIOTA; METABOLISM; HEALTH; DIET; ESTROGENS; OBESITY; AGE	Pregnancy is accompanied by maternal physiological adaptations including metabolic, endocrine, immune, cardiovascular, skeletomuscular and neurological modifications that facilitate fetal and placental growth and development. Emerging evidence suggests that the maternal intestinal microbiota is modified over the course of healthy pregnancy. We have recently identified a maternal intestinal microbial shift within hours of conception; a shift that continued with advancing gestation. It is possible that maternal gut bacterial profiles might be associated with the known endocrine changes that accompany the female reproductive (estrous) cycle. Methods: To determine whether the estrous cycle influenced the shifts in the maternal intestinal microbiota, time-matched fecal pellets were collected daily for 3 consecutive estrous cycles from individually housed, non-pregnant female C57BL/6J mice (n = 10) fed a control diet. Estrous stage was identified by cell type predominance in vaginal cytological samples. The corresponding fecal pellets for each estrous stage were processed for bacterial 16S rRNA sequencing of the variable 3 (V3) region. Results: Estrous cycle stage accounted for a very small and not statistically significant proportion of the variation in the fecal microbiota according to PERMANOVA testing performed on Bray-Curtis dissimilarity scores. These values displayed no significant clustering of fecal microbial communities by estrous stage. Conclusion: The estrous cycle does not result in any significant shift in the intestinal microbial community in the reproductively mature, regularly cycling female mouse.	[Wallace, Jessica G.; Potts, Ryan H.; Surette, Michael G.; Sloboda, Deborah M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Wallace, Jessica G.; Potts, Ryan H.; Szamosi, Jake C.; Surette, Michael G.; Sloboda, Deborah M.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada; [Surette, Michael G.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Sloboda, Deborah M.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Sloboda, Deborah M.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University	Sloboda, DM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Sloboda, DM (corresponding author), McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON, Canada.; Sloboda, DM (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada.; Sloboda, DM (corresponding author), McMaster Univ, Dept Pediat, Hamilton, ON, Canada.	sloboda@mcmaster.ca	Surette, Michael G/AAE-8825-2020		Canada Research Chair in Perinatal Programming; Canada Research Chair in Interdisciplinary Microbiome Research	Canada Research Chair in Perinatal Programming; Canada Research Chair in Interdisciplinary Microbiome Research	DMS is supported by Canada Research Chair in Perinatal Programming and MGS is supported by Canada Research Chair in Interdisciplinary Microbiome Research.	Alexander AD, 2006, MAMM GENOME, V17, P1093, DOI 10.1007/s00335-006-0063-1; ARIES V, 1969, GUT, V10, P575, DOI 10.1136/gut.10.7.575; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaban B, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-23; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253; Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222; Gohir W, 2015, GUT MICROBES, V6, P310, DOI 10.1080/19490976.2015.1086056; GOLDIN BR, 1982, NEW ENGL J MED, V307, P1542, DOI 10.1056/NEJM198212163072502; Hadley Wickham R.F., 2017, DPLYR GRAMMAR DATA M; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; IBNSALEM J, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; ISOLAURI E, 1993, GASTROENTEROLOGY, V105, P1643, DOI 10.1016/0016-5085(93)91059-Q; Jari Oksanen F.G.B, 2013, VEGAN COMMUNITY ECOL; JARVENPAA P, 1980, J STEROID BIOCHEM, V13, P345, DOI 10.1016/0022-4731(80)90014-X; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; LEVITZ M, 1968, J CLIN ENDOCR METAB, V28, P862, DOI 10.1210/jcem-28-6-862; Lorenzen E, 2015, VET RES, V46, DOI 10.1186/s13567-015-0274-0; MARCONDES F. K., 2002, Braz. J. Biol., V62, P609, DOI 10.1590/S1519-69842002000400008; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McCafferty J, 2013, ISME J, V7, P2116, DOI 10.1038/ismej.2013.106; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Menon R, 2013, APPL ENVIRON MICROB, V79, P5763, DOI 10.1128/AEM.01182-13; Miller EA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0228-z; Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008; RCore Team, 2020, R LANG ENV STAT COMP; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sender R, 2016, REVISED ESTIMATES NU, V14, DOI [10.1371/journal.pbio.1002533, DOI 10.1371/JOURNAL.PBIO.1002533]; Shinoda M, 1980, Jikken Dobutsu, V29, P55; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Syukuda Y, 1978, Jikken Dobutsu, V27, P271; Team R, 2016, RSTUDIO INT DEV R; THOMPSON GR, 1971, GUT, V12, P230, DOI 10.1136/gut.12.3.230; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uchihashi M, 2015, AM J PRIMATOL, V77, P563, DOI 10.1002/ajp.22378; VANELDERE J, 1988, APPL ENVIRON MICROB, V54, P2112, DOI 10.1128/AEM.54.8.2112-2117.1988; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whelan FJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0314-2; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wickham H., 2016, TIDYR EASILY TIDY DA; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WINTER J, 1987, J STEROID BIOCHEM, V27, P1145, DOI 10.1016/0022-4731(87)90201-9; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Ye YZ, 2010, IEEE INT C BIOINFORM, P153, DOI 10.1109/BIBM.2010.5706555	53	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200729	10.1371/journal.pone.0200729	http://dx.doi.org/10.1371/journal.pone.0200729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011327	Green Submitted, gold, Green Published			2022-12-26	WOS:000438829800047
J	Gardiner, SJ; Drennan, PG; Begg, R; Zhang, M; Green, JK; Isenman, HL; Everts, RJ; Chambers, ST; Begg, EJ				Gardiner, Sharon J.; Drennan, Philip G.; Begg, Ronald; Zhang, Mei; Green, Jared K.; Isenman, Heather L.; Everts, Richard J.; Chambers, Stephen T.; Begg, Evan J.			In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances	PLOS ONE			English	Article							STAPHYLOCOCCAL INFECTIONS; ISOXAZOLYL PENICILLIN; PHARMACOKINETICS; DICLOXACILLIN; CLOXACILLIN; PARAMETERS; SKIN	It is usually recommended that flucloxacillin is given on an empty stomach. The aim of this study was to compare total and free flucloxacillin concentrations after oral flucloxacillin, given with and without food, based on contemporary pharmacokinetic and pharmacodynamic targets. Flucloxacillin 1000 mg orally was given to 12 volunteers, after a standardised breakfast and while fasting, on two separate occasions. Flucloxacillin concentrations over 12 hours were measured by liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters, and pharmacodynamic endpoints related to target concentration achievement, were compared in the fed and fasting states. For free flucloxacillin, the fed/fasting area under the concentration-time curve from zero to infinity (AUC(0-infinity)) ratio was 0.80 (p<0.01, 90% CI 0.70-0.92), the peak concentraton (C-max) ratio 0.51 (p<0.001, 0.42-0.62) and the time to peak concentration (T-max) ratio 2.2 (p<0.001, 1.87-2.55). The ratios for total flucloxacillin concentrations were similar. The mean (90% CI) fed/fasting ratios of free concentrations exceeded for 30%, 50% and 70% of the first 6 hours post-dose were 0.74 (0.63-0.87, fed inferior p<0.01), 0.95 (0.81-1.11, bioequivalent) and 1.15 (0.97-1.36, fed non-inferior), respectively. Results for 8 hours post-dose and those predicted for steady state were similar. Comparison of probability of target attainments for fed versus fasting across a range of minimum inhibitory concentrations (MICs) were in line with these results. Overall, this study shows that food reduced the AUC(0-infinity) and C-max, and prolonged the T-max of both free and total flucloxacillin concentrations compared with the fasting state, but achievement of free concentration targets associated with efficacy was in most circumstances equivalent. These results suggest that taking flucloxacillin with food is unlikely to compromise efficacy in most circumstances.	[Gardiner, Sharon J.; Drennan, Philip G.; Green, Jared K.; Isenman, Heather L.; Chambers, Stephen T.] Christchurch Hosp, Dept Infect Dis, Christchurch, New Zealand; [Gardiner, Sharon J.; Drennan, Philip G.] Christchurch Hosp, Dept Clin Pharmacol, Christchurch, New Zealand; [Gardiner, Sharon J.] Christchurch Hosp, Pharm Serv, Christchurch, New Zealand; [Begg, Ronald; Zhang, Mei; Begg, Evan J.] Univ Otago Christchurch, Dept Med, Christchurch, New Zealand; [Zhang, Mei] Canterbury Hlth Labs, Toxicol, Christchurch, New Zealand; [Everts, Richard J.] Nelson Hosp, Dept Med, Nelson, New Zealand; [Chambers, Stephen T.] Univ Otago Christchurch, Dept Pathol, Christchurch, New Zealand	Christchurch Hospital New Zealand; Christchurch Hospital New Zealand; Christchurch Hospital New Zealand; University of Otago; Canterbury Health Laboratories; University of Otago	Gardiner, SJ (corresponding author), Christchurch Hosp, Dept Infect Dis, Christchurch, New Zealand.; Gardiner, SJ (corresponding author), Christchurch Hosp, Dept Clin Pharmacol, Christchurch, New Zealand.; Gardiner, SJ (corresponding author), Christchurch Hosp, Pharm Serv, Christchurch, New Zealand.	sharon.gardiner@cdhb.health.nz		Chambers, Stephen/0000-0002-0698-3285	New Zealand Pharmacy Education and Research Foundation, Wellington, New Zealand [260]; Jim and Mary Carney Charitable Trust	New Zealand Pharmacy Education and Research Foundation, Wellington, New Zealand; Jim and Mary Carney Charitable Trust	This work was supported by: 1) New Zealand Pharmacy Education and Research Foundation, Wellington, New Zealand (www.psnz.org.nz; grant number 260; SG = applicant) (Funding covered costs of consumables, and drug assay, as well as volunteer costs); and 2) Jim and Mary Carney Charitable Trust (www.otago.ac.nz/christchurch/research/carneycentre/) (Funded RB for modelling and data analysis).	Antibiotic Expert Groups, 2014, THER GUID ANT VERS 1; BODEY GP, 1972, CLIN PHARMACOL THER, V13, P512; Center for Drug Evaluation and Research, 2002, GUID IND FOOD FOOD E; Chira S, 2010, EPIDEMIOL INFECT, V138, P313, DOI 10.1017/S0950268809990483; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; GATH J, 1995, J CLIN PHARMACOL, V35, P31, DOI 10.1002/j.1552-4604.1995.tb04742.x; Gunderson CG, 2012, J INFECTION, V64, P148, DOI 10.1016/j.jinf.2011.11.004; HEDSTROM SA, 1980, SCAND J INFECT DIS, V12, P221, DOI 10.3109/inf.1980.12.issue-3.10; Joint Formulary Committee, 2015, BRIT NAT FORM VERS 6; KAMME C, 1974, SCAND J INFECT DIS, V6, P273, DOI 10.3109/inf.1974.6.issue-3.11; Kirkpatrick C, 2001, THE DISPENSING GUIDE; Landersdorfer CB, 2007, ANTIMICROB AGENTS CH, V51, P3290, DOI 10.1128/AAC.01410-06; Levey AS, 2011, ANN INTERN MED, V155, P408, DOI 10.7326/0003-4819-155-6-201109200-00024; Mouton JW, 1997, J ANTIMICROB CHEMOTH, V39, P75, DOI 10.1093/jac/39.suppl_1.75; NAUTA EH, 1975, BRIT J CLIN PHARMACO, V2, P111, DOI 10.1111/j.1365-2125.1975.tb01566.x; Nenoff P, 2004, CHEMOTHERAPY, V50, P196, DOI 10.1159/000081032; Nielsen E, 2013, TARGET ATTAINMENT AN; RODER BL, 1995, INFECTION, V23, P107, DOI 10.1007/BF01833876; Rouse C, 2017, INT J PHARM PRACT, V25, P326, DOI 10.1111/ijpp.12308; SUMMANEN PH, 1995, CLIN INFECT DIS, V20, pS279, DOI 10.1093/clinids/20.Supplement_2.S279; SUTHERLAND R, 1970, BMJ-BRIT MED J, V4, P455, DOI 10.1136/bmj.4.5733.455; THIJSSEN HHW, 1982, EUR J CLIN PHARMACOL, V22, P429, DOI 10.1007/BF00542548; Turnidge JD, 1998, CLIN INFECT DIS, V27, P10, DOI 10.1086/514622; VOGELMAN B, 1988, J INFECT DIS, V158, P831, DOI 10.1093/infdis/158.4.831; Zhang M, 2014, J ANAL BIOANALYTICAL, V5, P182, DOI [10.4172/2155-9872.1000182, DOI 10.4172/2155-9872.1000182]; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007	26	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199370	10.1371/journal.pone.0199370	http://dx.doi.org/10.1371/journal.pone.0199370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001392	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400008
J	Huynh, N; Dubrovsky, G; Rouch, JD; Scott, A; Chiang, E; Nguyen, T; Wu, BM; Shekherdimian, S; Krummel, TM; Dunn, JCY				Nhan Huynh; Dubrovsky, Genia; Rouch, Joshua D.; Scott, Andrew; Chiang, Elvin; Nguyen, Tommy; Wu, Benjamin M.; Shekherdimian, Shant; Krummel, Thomas M.; Dunn, James C. Y.			Three-dimensionally printed surface features to anchor endoluminal spring for distraction enterogenesis	PLOS ONE			English	Article							SHORT-BOWEL SYNDROME; MECHANICALLY LENGTHENED JEJUNUM; SMALL-INTESTINE; GROWTH-FACTOR; DEVICE; MODEL; CONTINUITY; RATS; RESTORATION; MANAGEMENT	Spring-mediated distraction enterogenesis has been studied as a novel treatment for short bowel syndrome (SBS). Previous approaches are limited by multiple surgeries to restore intestinal continuity. Purely endoluminal devices require a period of intestinal attachment for enterogenesis. The purpose of this study is to modify the device to prevent premature spring migration in a porcine model. Two models were created in juvenile mini-Yucatan pigs for the placement of three-dimensionally printed springs. (1) Two Roux-en-y jejunojenostomies with two Roux limbs were made. A spring with bidirectional hooked surface features was placed in one Roux limb and a spring with smooth surface was placed in the other Roux limb. (2) The in-continuity model had both hooked and smooth surface springs placed directly in intestinal continuity. Spring location was evaluated by weekly radiographs, and the intestine was retrieved after 2 to 4 weeks. Springs with smooth surfaces migrated between 1 to 3 weeks after placement in both porcine models. Springs with bidirectional hooked surface features were anchored to the intestine for up to 4 weeks without migration. Histologically, the jejunal architecture showed significantly increased crypt depth and muscularis thickness compared to normal jejunum. Bidirectional features printed on springs prevented the premature migration of endoluminal springs. These novel spring anchors allowed for their endoluminal placement without any sutures. This approach may lead to the endoscopic placement of the device for patients with SBS.	[Nhan Huynh; Dubrovsky, Genia; Rouch, Joshua D.; Scott, Andrew; Chiang, Elvin; Shekherdimian, Shant; Dunn, James C. Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Pediat Surg, Los Angeles, CA 90095 USA; [Nhan Huynh; Krummel, Thomas M.; Dunn, James C. Y.] Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA; [Nguyen, Tommy; Wu, Benjamin M.; Dunn, James C. Y.] Univ Calif Los Angeles, Sch Engn, Dept Bioengn, Los Angeles, CA 90095 USA; [Krummel, Thomas M.; Dunn, James C. Y.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA; [Shekherdimian, Shant] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Dunn, James C. Y.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; University of California System; University of California Los Angeles; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University	Dunn, JCY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Pediat Surg, Los Angeles, CA 90095 USA.; Dunn, JCY (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Pediat Surg, Stanford, CA 94305 USA.; Dunn, JCY (corresponding author), Univ Calif Los Angeles, Sch Engn, Dept Bioengn, Los Angeles, CA 90095 USA.; Dunn, JCY (corresponding author), Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA.; Dunn, JCY (corresponding author), Stanford Univ, Dept Surg, Stanford, CA 94305 USA.	jdunn2@stanford.edu		Wu, Benjamin/0000-0001-5236-8534; Dunn, James/0000-0002-6826-7065	Sun West Company; Coulter Foundation	Sun West Company; Coulter Foundation	This study was funded by Sun West Company and the Coulter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, OBJET CONNEX 3D PRIN; Bianchi A, 1997, J ROY SOC MED, V90, P429, DOI 10.1177/014107689709000804; Chen YJ, 1997, CHINESE MED J-PEKING, V110, P354; Chung H, 2008, MAT SCI ENG A-STRUCT, V487, P251, DOI 10.1016/j.msea.2007.10.082; Demehri FR, 2016, J PEDIATR SURG, V51, P101, DOI 10.1016/j.jpedsurg.2015.10.026; Demehri FR, 2014, PEDIATR SURG INT, V30, P1223, DOI 10.1007/s00383-014-3612-9; Dunn JCY, 2007, J PEDIATR SURG, V42, P2057, DOI 10.1016/j.jpedsurg.2007.08.027; Fisher JG, 2015, J PEDIATR SURG, V50, P938, DOI 10.1016/j.jpedsurg.2015.03.013; Han SH, 2014, CLIN ENDOSC, V47, P415, DOI 10.5946/ce.2014.47.5.415; Hollander J, 2016, J PHARM SCI-US, V105, P2665, DOI 10.1016/j.xphs.2015.12.012; ISRAELSSON LA, 1994, BRIT J SURG, V81, P1606, DOI 10.1002/bjs.1800811114; Kim HB, 2003, J PEDIATR SURG, V38, P425, DOI 10.1053/jpsu.2003.50073; Kurenov SN, 2015, J THORAC CARDIOV SUR, V149, P973, DOI 10.1016/j.jtcvs.2014.12.059; Huynh N, 2016, J PEDIATR SURG, V51, P1983, DOI 10.1016/j.jpedsurg.2016.09.024; Park J, 2004, J PEDIATR SURG, V39, P1823, DOI 10.1016/j.jpedsurg.2004.08.022; Puapong DP, 2006, J PEDIATR SURG, V41, P763, DOI 10.1016/j.jpedsurg.2006.02.017; Reinshagen K, 2009, Minerva Pediatr, V61, P273; Rouch JD, 2016, J PEDIATR SURG, V51, P1988, DOI 10.1016/j.jpedsurg.2016.09.023; Rouch JD, 2016, J PEDIATR SURG, V51, P960, DOI 10.1016/j.jpedsurg.2016.02.065; Safford SD, 2005, GUT, V54, P1085, DOI 10.1136/gut.2004.061481; Scott A, 2016, J PEDIATR SURG, V51, P995, DOI 10.1016/j.jpedsurg.2016.02.074; Scott A, 2015, J PEDIATR SURG, V50, P954, DOI 10.1016/j.jpedsurg.2015.03.020; Shekherdimian S, 2010, J PEDIATR SURG, V45, P1575, DOI 10.1016/j.jpedsurg.2010.03.015; Shekherdimian S, 2009, SURGERY, V146, P291, DOI 10.1016/j.surg.2009.03.034; Sims K, 2016, SURG ENDOSC, V30, pS342; Spencer AU, 2006, SURGERY, V140, P212, DOI 10.1016/j.surg.2006.03.005; Spencer AU, 2008, AM J CLIN NUTR, V88, P1552, DOI 10.3945/ajcn.2008.26007; Squires RH, 2012, J PEDIATR-US, V161, P723, DOI 10.1016/j.jpeds.2012.03.062; Stark R, 2012, J PEDIATR SURG, V47, P136, DOI 10.1016/j.jpedsurg.2011.10.031; Stark R, 2011, J PEDIATR SURG, V46, P2321, DOI 10.1016/j.jpedsurg.2011.09.019; Sueyoshi R, 2014, TISSUE ENG PT A, V20, P830, DOI 10.1089/ten.TEA.2013.0383; Sullins VF, 2014, J PEDIATR SURG, V49, P1791, DOI 10.1016/j.jpedsurg.2014.09.022; Sullins VF, 2014, J PEDIATR SURG, V49, P971, DOI 10.1016/j.jpedsurg.2014.01.033; Sullins VF, 2014, J PEDIATR SURG, V49, P109, DOI 10.1016/j.jpedsurg.2013.09.040; Thompson JS, 2011, SURG CLIN N AM, V91, P493, DOI 10.1016/j.suc.2011.02.006; Verschuur EML, 2006, GASTROINTEST ENDOSC, V63, P134, DOI 10.1016/j.gie.2005.07.051; Wales PW, 2004, J PEDIATR SURG, V39, P690, DOI 10.1016/j.jpedsurg.2004.01.036; Zein NN, 2013, LIVER TRANSPLANT, V19, P1304, DOI 10.1002/lt.23729	38	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200529	10.1371/journal.pone.0200529	http://dx.doi.org/10.1371/journal.pone.0200529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001433	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400072
J	Johnson-Sasso, CP; Tompkins, C; Kao, DP; Walker, LA				Johnson-Sasso, Cecelia P.; Tompkins, Christine; Kao, David P.; Walker, Lori A.			Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction	PLOS ONE			English	Article							NON-TOBACCO CIGARETTES; MORTALITY; SMOKING; RISK; ACTIVATION; SURVIVORS; PROTECTS; PARADOX	Marijuana use is increasing worldwide, and it is ever more likely that patients presenting with acute myocardial infarctions (AMI) will be marijuana users. However, little is known about the impact of marijuana use on short-term outcomes following AMI. Accordingly, we compared in-hospital outcomes of AMI patients with reported marijuana use to those with no reported marijuana use. We hypothesized that marijuana use would be associated with increased risk of adverse outcomes in AMI patients. Hospital records from 8 states between 1994-2013 were screened for patients with a diagnosis of AMI. Clinical profiles and outcomes in patients with reported use of marijuana were compared to patients without reported marijuana use. Short-term outcomes were defined as adverse events that occurred during hospitalization for an admitting diagnosis of AMI. The composite primary outcome included death, intraaortic balloon pump placement, (IABP), mechanical ventilation, cardiac arrest, and shock. In total, 3,854 of 1,273,897 AMI patients reported use of marijuana. The marijuana cohort was younger than (47.2 vs. 57.2, respectively) and had less coronary artery disease than the non-marijuana cohort. In multivariable analysis including age, race and common cardiac risk factors, there was no association between marijuana use and the primary outcome (p = 0.53), but marijuana users were more likely to be placed on mechanical ventilation (OR (odds ratio) 1.19, p = 0.004). Interestingly, marijuana-using patients were significantly less likely to die (OR 0.79, p = 0.016), experience shock (OR 0.74, p = 0.001), or require an IABP (OR 0.80, p = 0.03) post AMI than patients with no reported marijuana use. These results suggest that, contrary to our hypothesis, marijuana use was not associated with increased risk of adverse short-term outcomes following AMI. Furthermore, marijuana use was associated with decreased in-hospital mortality post-AMI.	[Johnson-Sasso, Cecelia P.; Tompkins, Christine; Kao, David P.; Walker, Lori A.] Univ Colorado, Div Cardiol, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Walker, LA (corresponding author), Univ Colorado, Div Cardiol, Dept Med, Anschutz Med Campus, Aurora, CO 80045 USA.	lori.walker@ucdenver.edu	Kao, David P/K-3288-2013; Walker, Lori/J-7098-2013	Kao, David P/0000-0002-2832-9348; Walker, Lori/0000-0003-2556-8076	National Institute of Health [L30 HL110124]; NIH/NCATS Colorado CTSA Grant [UL1 TR001082]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS Colorado CTSA Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this research was provided by the National Institute of Health (L30 HL110124) and NIH/NCATS Colorado CTSA Grant Number UL1 TR001082. The funders had no role in the study design, data collection and analysis, decision to publish or preparations of the manuscript. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	ARONOW WS, 1974, NEW ENGL J MED, V291, P65, DOI 10.1056/NEJM197407112910203; Arora S, 2012, AM J EMERG MED, V30, pe3, DOI DOI 10.1016/j.ajem.2011.12.033; Aune E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-97; Basnet S, 2009, PEDIATR CARDIOL, V30, P543, DOI 10.1007/s00246-009-9384-7; Bastos-Amador P, 2016, REV CLIN ESP, V216, P301, DOI 10.1016/j.rce.2016.03.006; Bell TM, 2015, NICOTINE TOB RES, V17, P1499, DOI 10.1093/ntr/ntv027; BLOOM JW, 1987, BMJ-BRIT MED J, V295, P1516, DOI 10.1136/bmj.295.6612.1516; Casier I, 2014, ACTA CARDIOL, V69, P131, DOI 10.1080/AC.69.2.3017293; CELERMAJER DS, 1991, BRIT HEART J, V65, P332; Defer N, 2009, FASEB J, V23, P2120, DOI 10.1096/fj.09-129478; Desai R, 2017, CUREUS, V9, DOI 10.7759/cureus.1816; Devlin RJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6166; Dhingra R, 2012, MED CLIN N AM, V96, P87, DOI 10.1016/j.mcna.2011.11.003; Frost L, 2013, AM HEART J, V165, P170, DOI 10.1016/j.ahj.2012.11.007; GRINES CL, 1995, CIRCULATION, V91, P298, DOI 10.1161/01.CIR.91.2.298; Gupta T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003370; Ingraham C., 2017, MANY AM REGULARLY US; IVERSEN LL, 1993, NATURE, V365, P12, DOI 10.1038/365012a0; Jouanjus E, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000638; Krylatov AV, 2001, B EXP BIOL MED+, V131, P523, DOI 10.1023/A:1012381914518; Mittleman MA, 2001, CIRCULATION, V103, P2805; Montecucco F, 2009, J MOL CELL CARDIOL, V46, P612, DOI 10.1016/j.yjmcc.2008.12.014; Mukamal KJ, 2008, AM HEART J, V155, P465, DOI 10.1016/j.ahj.2007.10.049; Rezkalla SH, 2003, ANN EMERG MED, V42, P365, DOI 10.1016/S0196-0644(03)00426-8; Rodondi N, 2006, AM J CARDIOL, V98, P478, DOI 10.1016/j.amjcard.2006.03.024; SHERRILL DL, 1991, INT J EPIDEMIOL, V20, P132, DOI 10.1093/ije/20.1.132; Shmist YA, 2006, MOL CELL BIOCHEM, V283, P75, DOI 10.1007/s11010-006-2346-y; Waldman M, 2013, BIOCHEM PHARMACOL, V85, P1626, DOI 10.1016/j.bcp.2013.03.014	28	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199705	10.1371/journal.pone.0199705	http://dx.doi.org/10.1371/journal.pone.0199705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995914	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800033
J	Prakash, J; Sharma, R; Patel, SKS; Kim, IW; Kalia, VC				Prakash, Jyotsana; Sharma, Rakesh; Patel, Sanjay K. S.; Kim, In-Won; Kalia, Vipin Chandra			Bio-hydrogen production by co-digestion of domestic wastewater and biodiesel industry effluent	PLOS ONE			English	Article							BIOHYDROGEN PRODUCTION; METHANE PRODUCTION; CRUDE GLYCEROL; REACTORS; BACILLUS; BIOCONVERSION; PARTICLE; SLUDGE; UASB	The increasing water crisis makes fresh water a valuable resource, which must be used wisely. However, with growing population and inefficient waste treatment systems, the amount of wastewater dispelled in rivers is increasing abominably. Utilizing this freely available waste-water along with biodiesel industry waste- crude glycerol for bio-hydrogen production is being reported here. The bacterial cultures of Bacillus thuringiensis strain EGU45 and Bacillus amyloliquefaciens strain CD16 produced2.4-3.0 L H-2/day/L feed during a 60 days continuous culture system at hydraulic retention time of 2 days. An average H-2 yield of 100-120 UL CG was reported by the two strains. Recycling of the effluent by up to 25% resulted in up to 94% H-2 production compared to control.	[Prakash, Jyotsana; Patel, Sanjay K. S.; Kim, In-Won; Kalia, Vipin Chandra] Konkuk Univ, Dept Chem Engn, Seoul, South Korea; [Prakash, Jyotsana; Sharma, Rakesh; Kalia, Vipin Chandra] CSIR, IGIB, Delhi Univ Campus, Delhi, India; [Prakash, Jyotsana; Kalia, Vipin Chandra] Acad Sci & Innovat Res AcSIR, New Delhi, India	Konkuk University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Kim, IW; Kalia, VC (corresponding author), Konkuk Univ, Dept Chem Engn, Seoul, South Korea.; Kalia, VC (corresponding author), CSIR, IGIB, Delhi Univ Campus, Delhi, India.; Kalia, VC (corresponding author), Acad Sci & Innovat Res AcSIR, New Delhi, India.	inwon@konkuk.ac.kr; vckaliaku@gmail.com	Patel, Sanjay Kumar Singh/ABE-7571-2020; Sharma, Rakesh/F-4859-2012	Sharma, Rakesh/0000-0003-3320-4491; KALIA, Vipin/0000-0001-7892-2601	Konkuk University	Konkuk University	This paper was supported by Konkuk University in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbomi J, 2015, MEMBRANES, V5, P616, DOI 10.3390/membranes5040616; Al-Mailem DM, 2014, APPL BIOCHEM BIOTECH, V174, P1736, DOI 10.1007/s12010-014-1067-z; Andreani CL, 2015, ENG AGR-JABOTICABAL, V35, P578, DOI 10.1590/1809-4430-Eng.Agric.v35n3p578-587/2015; Chookaew T, 2014, INT J HYDROGEN ENERG, V39, P9580, DOI 10.1016/j.ijhydene.2014.04.083; Ercan D, 2015, CRIT REV BIOTECHNOL, V35, P1, DOI 10.3109/07388551.2013.793170; Farghaly A, 2016, ENVIRON SCI POLLUT R, V23, P3834, DOI 10.1007/s11356-015-5652-7; Gokfiliz P, 2017, INT J HYDROGEN ENERG, V42, P2553, DOI 10.1016/j.ijhydene.2016.03.041; Hallenbeck PC, 2012, BIORESOURCE TECHNOL, V110, P1, DOI 10.1016/j.biortech.2012.01.103; Hemalatha M, 2017, BIORESOURCE TECHNOL, V242, P60, DOI 10.1016/j.biortech.2017.03.118; Intanoo P, 2016, INT J HYDROGEN ENERG, V41, P6107, DOI 10.1016/j.ijhydene.2015.10.125; Jaikeaw S., 2017, INT J CHEM MOL ENG, V11, P1; Junior A. D. N. F., 2015, ANAEROBE, V34, P94, DOI DOI 10.1016/J.ANAEROBE.2015.04.008; KALIA VC, 1995, BIORESOURCE TECHNOL, V53, P165, DOI 10.1016/0960-8524(95)00077-R; Kalia VC, 2007, APPL MICROBIOL; Kalia VC, 2016, INDIAN J MICROBIOL, V56, P113, DOI 10.1007/s12088-016-0583-7; Khongkliang P, 2017, INT J HYDROGEN ENERG, V42, P27584, DOI 10.1016/j.ijhydene.2017.06.145; Kiran B., 2017, MICROBIAL APPL, P3, DOI [10.1007/978-3-319-52666-9_1, DOI 10.1007/978-3-319-52666-9_1]; Kirli B, 2016, RENEW ENERG, V87, P697, DOI 10.1016/j.renene.2015.11.003; Kumar P, 2015, INT J BIOL MACROMOL, V78, P9, DOI 10.1016/j.ijbiomac.2015.03.046; Kumar P, 2015, BIORESOURCE TECHNOL, V182, P383, DOI 10.1016/j.biortech.2015.01.138; Li N, 2015, J FUNDAM RENEWABLE E, V5, P181; Patel SKS, 2017, INDIAN J MICROBIOL, V57, P171, DOI 10.1007/s12088-017-0643-7; Patel SKS, 2014, INT J HYDROGEN ENERG, V39, P14663, DOI 10.1016/j.ijhydene.2014.07.084; Porwal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004438; Prakash J, 2018, APPL BIOCHEM BIOTECH, V185, P179, DOI 10.1007/s12010-017-2637-7; Prakash J, 2018, INDIAN J MICROBIOL, V58, P127, DOI 10.1007/s12088-017-0703-z; Sato T, 2013, AGR WATER MANAGE, V130, P1, DOI 10.1016/j.agwat.2013.08.007; Silva S., 2017, WASTE BIOMASS MANAGE, DOI [10.1007/978-3-319-49595-8_15, DOI 10.1007/978-3-319-49595-8_15]; Sonune A, 2004, DESALINATION, V167, P55, DOI 10.1016/j.desal.2004.06.113; Tangkathitipong P, 2017, RENEW ENERG, V113, P1077, DOI 10.1016/j.renene.2017.06.056; Venkata Mohan S., 2017, ENERG ENG, P29, DOI DOI 10.1007/978-981-10-3102-1_4; Wang SJ, 2016, RENEW ENERG, V96, P1135, DOI 10.1016/j.renene.2015.11.072	32	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199059	10.1371/journal.pone.0199059	http://dx.doi.org/10.1371/journal.pone.0199059			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995877	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800016
J	Okrent, RA; Trippe, KM; Manning, VA; Walsh, CM				Okrent, Rachel A.; Trippe, Kristin M.; Manning, Viola A.; Walsh, Callee M.			Detection of 4-formylaminooxyvinylglycine in culture filtrates of Pseudomonas fluorescens WH6 and Pantoea ananatis BRT175 by laser ablation electrospray ionization-mass spectrometry	PLOS ONE			English	Article							GERMINATION-ARREST-FACTOR; FACTOR GAF; ERWINIA-AMYLOVORA; RHIZOSPHERE BACTERIA; ACID; AERUGINOSA	The oxyvinylglycine 4-formylaminooxyvinylglycine (FVG) arrests the germination of weedy grasses and inhibits the growth of the bacterial plant pathogen Erwinia amylovora. Both biological and analytical methods have previously been used to detect the presence of FVG in crude and extracted culture filtrates of several Pseudomonas fluorescens strains. Although a combination of these techniques is adequate to detect FVG, none is amenable to high-throughput analysis. Likewise, filtrates often contain complex metabolite mixtures that prevent the detection of FVG using established chromatographic techniques. Here, we report the development of a new method that directly detects FVG in crude filtrates using laser ablation electrospray ionization-mass spectrometry (LAESI-MS). This approach overcomes limitations with our existing methodology and allows for the rapid analysis of complex crude culture filtrates. To validate the utility of the LAESI-MS method, we examined crude filtrates from Pantoea ananatis BRT175 and found that this strain also produces FVG. These findings are consistent with the antimicrobial activity of P. ananatis BRT175 and indicate that the spectrum of bacteria that produce FVG stretches beyond rhizosphere-associated Pseudomonas fluorescens.	[Okrent, Rachel A.; Trippe, Kristin M.; Manning, Viola A.] USDA ARS, Forage Seed Prod Res Unit, Corvallis, OR 97331 USA; [Trippe, Kristin M.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Walsh, Callee M.] Protea Biosci Inc, Morgantown, WV USA; [Okrent, Rachel A.] Novozymes Inc, Davis, CA USA	United States Department of Agriculture (USDA); Oregon State University; Novozymes	Trippe, KM (corresponding author), USDA ARS, Forage Seed Prod Res Unit, Corvallis, OR 97331 USA.; Trippe, KM (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	Kristin.Trippe@ARS.USDA.GOV		Trippe, Kristin/0000-0003-1518-2727; Walsh, Callee/0000-0002-3368-9209	US Department of Agriculture Agricultural Research Service [2072-21410-004-00D]; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2012-67012-19868]; Protea BioSciences, Inc.	US Department of Agriculture Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Protea BioSciences, Inc.	Research in the laboratory of K.T. is supported by US Department of Agriculture Agricultural Research Service (https://www.ars.usda.gov) Project # 2072-21410-004-00D to KT. This work was also supported by the Agriculture and Food Research Initiative Competitive Grant No. 2012-67012-19868 from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/) to R.O. During data collection, C.W. was employed by Protea BioSciences, Inc. Protea Biosciences, Inc. provided support in the form of salaries for C.W. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Armstrong D, 2009, BIOL CONTROL, V51, P181, DOI 10.1016/j.biocontrol.2009.06.004; Banowetz GM, 2008, BIOL CONTROL, V46, P380, DOI 10.1016/j.biocontrol.2008.04.016; Banowetz GM, 2009, BIOL CONTROL, V50, P103, DOI 10.1016/j.biocontrol.2009.03.011; Beach DG, 2014, TOXICON, V92, P75, DOI 10.1016/j.toxicon.2014.10.009; Berkowitz DB, 2006, TETRAHEDRON-ASYMMETR, V17, P869, DOI 10.1016/j.tetasy.2006.02.026; Dean SN, 2015, BIOFOULING, V31, P151, DOI 10.1080/08927014.2015.1011067; Elliott L. F., 1998, SOIL SCI AGROCHEMI E, V33, P3; Halgren A, 2011, J APPL MICROBIOL, V111, P949, DOI 10.1111/j.1365-2672.2011.05098.x; Halgren A, 2013, MICROBIOL-SGM, V159, P36, DOI 10.1099/mic.0.062166-0; JOHNSON KB, 1993, PHYTOPATHOLOGY, V83, P995, DOI 10.1094/Phyto-83-995; Kimbrel JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-522; Lee X, 2013, ENV MICROBIOL REP, V5, P83, DOI 10.1111/j.1758-2229.2012.00395.x; Li H., 2016, ANGEW CHEM, V128, P15259, DOI DOI 10.1002/ANGE.201607751; McPhail KL, 2010, J NAT PROD, V73, P1853, DOI 10.1021/np1004856; Nemes P, 2007, ANAL CHEM, V79, P8098, DOI 10.1021/ac071181r; Okrent RA, 2017, MICROBIOL-SGM, V163, P207, DOI 10.1099/mic.0.000418; Okrent RA, 2014, MICROBIOL-SGM, V160, P2432, DOI 10.1099/mic.0.080317-0; OWENS LD, 1972, J CHEM SOC CHEM COMM, P714, DOI 10.1039/c39720000714; Parsiegla G, 2012, ANAL CHEM, V84, P34, DOI 10.1021/ac202831w; PRUESS DL, 1974, J ANTIBIOT, V27, P229, DOI 10.7164/antibiotics.27.229; SCANNELL JP, 1975, J ANTIBIOT, V28, P1; Walterson AM, 2015, FEMS MICROBIOL REV, V39, P968, DOI 10.1093/femsre/fuv027; Walterson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096208	23	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200481	10.1371/journal.pone.0200481	http://dx.doi.org/10.1371/journal.pone.0200481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990341	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300054
J	Zanga, D; Sanahuja, G; Eizaguirre, M; Albajes, R; Christou, P; Capell, T; Fraser, P; Gerrisch, C; Lopez, C				Zanga, Daniela; Sanahuja, Georgina; Eizaguirre, Matilde; Albajes, Ramon; Christou, Paul; Capell, Teresa; Fraser, Paul; Gerrisch, Chris; Lopez, Carmen			Carotenoids moderate the effectiveness of a Bt gene against the European corn borer, Ostrinia nubilalis	PLOS ONE			English	Article							SESAMIA-NONAGRIOIDES LEPIDOPTERA; ANTIOXIDANT ENZYMES; SUSCEPTIBILITY; PROTEIN; MAIZE; GLUTATHIONE; EXPRESSION; RESISTANT; PATHWAY; CRY1AB	We assessed the effectiveness of a biofortified maize line (4BtxHC) which accumulates high levels of antioxidant carotenoids that also expressed the insecticidal Cry1 Ac Bacillus thuringiensis (Bt) gene against the European corn borer Ostrinia nubilalis. This line had been previously engineered to accumulate carotenoids specifically in the seed endosperm, whereas the Bt gene was expressed constitutively. The concentrations of Bt toxin (Cry 1Ac) in the leaves of the 4Bt and 4BtxHC lines were not significantly different at 47 +/- 6 pg/g of fresh weight (FW); neither were they in the kernels of both lines (35 +/- 3 mu g/g FW). The kernels and leaves were toxic to the larvae of O. nubilalis. However, the insecticidal activity was substantially lower (ca. 20%) than that of lines that expressed only Bt in spite that the two lines showed a quantity of toxin not significantly different in kernels or in leaves. Although the reduced effectiveness of Cry1Ac in kernels may not be entirely surprising, the observation of the same phenomenon in vegetative tissues was unexpected. When semi-artificial diets containing kernels from 4Bt supplemented with different levels of beta-carotene were used in insect bioassays, the beta-carotene moderated the effectiveness of the Bt similarly to the plant material with carotenoid enrichment. To elucidate the biochemical basis of the reduced effectiveness of Bt toxin in the carotenoid-enriched plants, we measured the activity of three enzymes known to be implicated in the detoxification defence, namely, catalase, superoxide dismutase and glutathione S-transferase. Whereas Cry1Ac expression significantly increased SOD and CAT enzymatic activity in the absence of carotenoids, carotenoids, either in 4BtxHC or in artificial diets enriched with beta-carotene, significantly lowered CAT activity. Carotenoids can therefore moderate the susceptibility of the maize borer O. nubilalis to Cry1Ac, and we hypothesize that their role as antioxidants could explain this phenomenon via their scavenging of reactive oxygen species produced during Cry1Ac detoxification in the larvae. The involvement of this mechanism in the decreased mortality caused by Cry1Ac when carotenoids are present in the diet is discussed.	[Zanga, Daniela; Sanahuja, Georgina; Eizaguirre, Matilde; Albajes, Ramon; Christou, Paul; Capell, Teresa; Lopez, Carmen] Univ Lleida Agrotecnio Ctr, Dept Crop & Forest Sci, Lleida, Spain; [Fraser, Paul; Gerrisch, Chris] Royal Holloway Univ London, Sch Biol Sci, Egham, Surrey, England; [Zanga, Daniela] Generalitat Catalunya, Dept Agr Ramadera & Pesca, Lab Sanitat Vegetal, Lleida, Spain; [Sanahuja, Georgina] Univ Florida, Trop Res & Educ Ctr, Homestead, FL USA	Centre de Recerca en Agrotecnologia (Agrotecnio); University of London; Royal Holloway University London; State University System of Florida; University of Florida	Eizaguirre, M (corresponding author), Univ Lleida Agrotecnio Ctr, Dept Crop & Forest Sci, Lleida, Spain.	eizaguirre@pvcf.udl.cat	Capell, Teresa/AAD-8609-2022; Lopez, Carmen/K-9280-2014; Eizaguirre, Matilde/B-4109-2011; Albajes, Ramon/AAZ-3784-2021; Capell, Teresa/B-2757-2011	Lopez, Carmen/0000-0001-5447-009X; Eizaguirre, Matilde/0000-0001-9371-3314; Albajes, Ramon/0000-0003-3133-7944; Capell, Teresa/0000-0002-6436-4538	RecerCaixa - CaixaBank [PC084082]; Ministerio Economia y Competitividad - Spanish RD Programme [AGL2011-23966, AGL2014-53970, BIO2014-54426-P]	RecerCaixa - CaixaBank; Ministerio Economia y Competitividad - Spanish RD Programme	This work was supported by RecerCaixa PC084082 VitaMaize, funded by CaixaBank, to PC; Ministerio Economia y Competitividad AGL2011-23966, AGL2014-53970, to RA; and BIO2014-54426-P, funded by the Spanish R&D Programme, to PC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broderick NA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-129; Caceres LA, 2016, J CHEM ECOL, V42, P107, DOI 10.1007/s10886-016-0669-z; Chen HX, 2016, ENVIRON SCI POLLUT R, V23, P21511, DOI 10.1007/s11356-016-7340-7; Cruz D, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev018; Deans CA, 2016, CURR OPIN INSECT SCI, V15, P97, DOI 10.1016/j.cois.2016.04.005; Deans CA, 2017, SCI REP, V7, P3970, DOI [10.1038/S41598-017-04015-X, DOI 10.1038/S41598-017-04015-X]; EIZAGUIRRE M, 1992, ENTOMOL GEN, V17, P277; Eizaguirre M, 2006, TRANSGENIC RES, V15, P1, DOI 10.1007/s11248-005-3998-1; Fraser PD, 2000, PLANT J, V24, P551, DOI 10.1111/j.1365-313X.2000.00896.x; Gonzalez-Nunez M, 2000, J ECON ENTOMOL, V93, P459, DOI 10.1603/0022-0493-93.2.459; Gui ZZ, 2009, J ECON ENTOMOL, V102, P1591, DOI 10.1603/029.102.0425; Heath JJ, 2013, ARTHROPOD-PLANT INTE, V7, P1, DOI 10.1007/s11829-012-9239-7; Hellmich Richard L., 2008, V5, P119, DOI 10.1007/978-1-4020-8373-0_5; ICHIKAWA I, 1994, KIDNEY INT, V45, P1, DOI 10.1038/ki.1994.1; Li HR, 2004, BIOCHEM BIOPH RES CO, V323, P52, DOI 10.1016/j.bbrc.2004.08.054; Li Z, 2016, PEST MANAG SCI, V72, P1359, DOI 10.1002/ps.4160; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Perez-Hedo M, 2012, B ENTOMOL RES, V102, P737, DOI 10.1017/S0007485312000351; Sanahuja G., 2013, THESIS; Hernandez-Rodriguez CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068164; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Shu YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41577; Srivastava S, 2011, PLANT GROWTH REGUL, V64, P1, DOI 10.1007/s10725-010-9526-1; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Wang Yue-Qin, 2014, Chinese Journal of Applied Entomology, V51, P636, DOI 10.7679/j.issn.2095-1353.2014.076; Winterhalter P., 2001, CAROTENOID DERIVED A, P1, DOI [10.1021/bk-2002-0802.ch001, DOI 10.1021/BK-2002-0802.CH001]; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yao JX, 2014, TOXINS, V6, P1274, DOI 10.3390/toxins6041274; Zanga D, 2016, SCI REP-UK, V6, DOI 10.1038/srep38288; Zhou Qiong, 2013, Jiangsu Journal of Agricultural Sciences, V29, P502; Zhu CF, 2008, P NATL ACAD SCI USA, V105, P18232, DOI 10.1073/pnas.0809737105	32	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199317	10.1371/journal.pone.0199317	http://dx.doi.org/10.1371/journal.pone.0199317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990319	gold, Green Published			2022-12-26	WOS:000438170300009
J	Alshora, DH; Ibrahim, MA; Elzayat, E; Almeanazel, OT; Alanazi, F				Alshora, Doaa H.; Ibrahim, Mohamed A.; Elzayat, Ehab; Almeanazel, Osaid T.; Alanazi, Fars			Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign	PLOS ONE			English	Article							DISSOLUTION RATE; DRUG-DELIVERY; NANOSUSPENSIONS; STABILITY; NANOCRYSTALS; ENHANCEMENT	Purpose Rosuvastatin calcium (ROSCa) is a poorly soluble drug with bioavailability not exceeding 20%. Decreasing the particle size may enhance its solubility, dissolution rate and bioavailability. Therefore, the aim of the current study is to prepare ROSCa nanoparticles by wet milling technique using planetary ball mill. The codesign between formulation and stabilization of nanoparticles was studied to achieve both high dissolution as well as bioavailability. Methodology ROSCa nanosuspensions was prepared by wet milling technique using planetary ball mill, by applying milling ball size of 0.1 mm at speed of 800 rpm for 3 cycles each cycle composed of 10 minutes. HPMC, PVP k-30, pluronic F-127, Tween 80 and PEG 6000 were used as stabilizers. The nanosuspensions were then freeze-dried, and the dried nanoparticles were evaluated for particle size, zeta potential, in-vitro dissolution test, XRPD and in-vivo study. Results ROSCa nanoparticles stabilized with 10% PVP (P3) had a good stability with smallest particle size, which in turn enhanced the dissolution rate. The particle size of the leading formula was 461.8 +/- 16.68 nm with zeta potential of -31.8 +/- 7.22 mV compared to untreated drug that has a particle size of 618pm. The percent of ROSCa dissolved after 1 hour enhanced significantly which reached 72% and 58.25% for leading nanoparticle formula and untreated ROSCa, respectively (P < 0.05). The in-vivo study of ROSCa from the leading nanoparticle formula showed a significant enhancement in the C max after 2 h (82.35 ng/ml) compared to 9.2 ng/ml for untreated drug. Conclusion Wet milling technique is a successful method to prepare ROSCa nanoparticles. From different stabilizer used, PVP (10%) was able to produce stable nanoparticle with small particle size which significantly enhance the dissolution rate and pharmacokinetics parameters of ROSCa.	[Alshora, Doaa H.; Ibrahim, Mohamed A.; Elzayat, Ehab; Almeanazel, Osaid T.; Alanazi, Fars] King Saud Univ, Coll Pharm, Dept Pharmaceut, Kayyali Chair Pharmaceut Ind, Riyadh, Saudi Arabia; [Ibrahim, Mohamed A.] Al Azhar Univ, Coll Pharm, Dept Pharmaceut, Assiut, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Al Azhar University	Alshora, DH (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Kayyali Chair Pharmaceut Ind, Riyadh, Saudi Arabia.	dalahora@ksu.edu.sa	Ibrahim, Mohamed/AFX-3593-2022; Elzayat, Ehab/GRY-0433-2022; Shorah, Doaa/ACN-2651-2022; Elzayat, Ehab/AAZ-6628-2021	Shorah, Doaa/0000-0002-1276-2665; Elzayat, Ehab/0000-0001-5177-4477; Ibrahim, Mohamed/0000-0001-7535-5453	King Saud University, Vice Deanship of Research Chairs, Kayyali Chair for Pharmaceutical Industry [DO-2017]	King Saud University, Vice Deanship of Research Chairs, Kayyali Chair for Pharmaceutical Industry	The project was funded by King Saud University, Vice Deanship of Research Chairs, Kayyali Chair for Pharmaceutical Industry (grant no. DO-2017).	Aboutaleb A. E., 2016, J APPL PHARM SCI, V6, P133, DOI DOI 10.7324/JAPS.2016.60720; Alshora D. H., 2018, THESIS; Angelescu DG, 2012, COLLOID SURFACE A, V394, P57, DOI 10.1016/j.colsurfa.2011.11.025; Attari Z, 2016, J EXP NANOSCI, V11, P276, DOI 10.1080/17458080.2015.1055841; Badran MM, 2016, J DRUG DELIV SCI TEC, V32, P1, DOI 10.1016/j.jddst.2016.01.004; Balakumar K, 2013, COLLOID SURFACE B, V112, P337, DOI 10.1016/j.colsurfb.2013.08.025; Boldyreva E, 2013, CHEM SOC REV, V42, P7719, DOI 10.1039/c3cs60052a; Esfandi E, 2014, IRAN J PHARM RES, V13, P809; Gabr MM, 2018, EUR J PHARM SCI, V111, P1, DOI 10.1016/j.ejps.2017.09.026; Ibrahim MA, 2014, ACTA POL PHARM, V71, P647; Kakran M, 2012, EUR J PHARM BIOPHARM, V80, P113, DOI 10.1016/j.ejpb.2011.08.006; KHAN KA, 1975, J PHARM PHARMACOL, V27, P48, DOI 10.1111/j.2042-7158.1975.tb09378.x; Knieke C, 2013, CHEM ENG RES DES, V91, P1245, DOI 10.1016/j.cherd.2013.02.008; Liu P., 2013, NANOCRYSTAL FORMULAT, P1; Loh ZH, 2015, ASIAN J PHARM SCI, V10, P255, DOI 10.1016/j.ajps.2014.12.006; Lu GW, 2010, HANDBOOK OF NON-INVASIVE DRUG DELIVERY SYSTEMS: NON-INVASIVE AND MINIMALLY-INVASIVE DRUG DELIVERY SYSTEMS FOR PHARMACEUTICAL AND PERSONAL CARE PRODUCTS, P59, DOI 10.1016/B978-0-8155-2025-2.10003-4; Mokarram AR, 2010, DARU, V18, P185; Palani K, 2015, ASIAN J PHARM CLIN R, V8, P88; Patel DD, 2015, KINETICS MECH CRYSTA, P1; Peltonen L, 2010, J PHARM PHARMACOL, V62, P1569, DOI 10.1111/j.2042-7158.2010.01022.x; Rachmawati H, 2016, SCI PHARM, V84, P685, DOI 10.3390/scipharm84040685; Amado JRR, 2017, SAUDI PHARM J, V25, P1158, DOI 10.1016/j.jsps.2017.07.008; Salah N, 2011, INT J NANOMED, V6, P863, DOI 10.2147/IJN.S18267; Shahbaziniaz M, 2013, IRAN J PHARM RES, V12, P587; Sharma S., 2014, COLLOID INTERFACE SC, P149, DOI [10.1016/B978-0-444-62614-1.00008-9, DOI 10.1016/B978-0-444-62614-1.0000-9]; Shete G., 2014, J EX FOOD CHEM, V5, P184; Tuomela A, 2016, PHARMACEUTICS, V8, DOI 10.3390/pharmaceutics8020016; Van Nijlen T, 2003, INT J PHARMACEUT, V254, P173, DOI 10.1016/S0378-5173(03)00009-7; Wang YC, 2013, J CONTROL RELEASE, V172, P1126, DOI 10.1016/j.jconrel.2013.08.006; Wu LB, 2011, ADV DRUG DELIVER REV, V63, P456, DOI 10.1016/j.addr.2011.02.001	30	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200218	10.1371/journal.pone.0200218	http://dx.doi.org/10.1371/journal.pone.0200218			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985967	Green Submitted, gold, Green Published			2022-12-26	WOS:000438035500026
J	Gantenberg, JR; King, M; Montgomery, MC; Galarraga, O; Prosperi, M; Chant, PA; Marshall, BDL				Gantenberg, Jason R.; King, Maximilian; Montgomery, Madeline C.; Galarraga, Omar; Prosperi, Mattia; Chant, Philip A.; Marshall, Brandon D. L.			Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study	PLOS ONE			English	Article							UNITED-STATES; CAUSAL INFERENCE; RISK; TRANSMISSION; COHORT; EPIDEMIOLOGY; POPULATION; PREVALENCE; PREVENTION; BEHAVIORS	Objectives Identifying prescribing strategies that improve the efficiency of PrEP should increase its impact at the population level. This study identifies PrEP allocation criteria that most effectively reduce 10-year HIV incidence by 25%, in accordance with the US National HIV/AIDS Strategy's goal for the proportionate reduction in new diagnoses. Methods We used a discrete-time stochastic agent-based model to simulate several PrEP engagement strategies. The model represented MSM aged 15-74 in Rhode Island and was calibrated to statewide prevalence from 2009-2014. We simulated HIV transmission in the absence of PrEP and compared the following PrEP engagement scenarios: 1) allocation to the current patient population; 2) random allocation; 3) allocation to MSM with greater than 5 sexual partners in one year; 4) allocation to MSM with greater than 10 sexual partners in one year. For each scenario and coverage level we estimated the number and proportion of infections averted and the person-years on PrEP per averted infection. Results In 2014, HIV prevalence before PrEP implementation was between 4% and 5%. In the No PrEP scenario 826 new infections (95% simulation limits [SL]: 711, 955) occurred over 10 years, with an incidence rate of 3.51 per 1000 person-years (95% SL: 3.00, 4.08). Prevalence rose to 7.4% (95% SL: 6.7, 8.1). None of the PrEP scenarios reduced new HIV infections by 25% while covering less than 15% of the HIV-uninfected population. At 15% coverage, allocating PrEP to the current patient population, MSM with greater than 5 sexual partners in a year, and MSM with greater than 10 partners reduced new infections by at least 25%, requiring 161 (95% SL: 115, 289), 150 (95% SL: 107, 252), and 128 (95% SL: 100, 184) person-years on PrEP per averted infection, respectively. Conclusions Engaging MSM with high numbers of sexual partners would improve the population-level impact and efficiency of PrEP in settings where PrEP coverage remains low. However, the sustained population-level PrEP coverage needed to reduce new infections by 25% is substantially higher than current levels of PrEP uptake.	[Gantenberg, Jason R.; King, Maximilian; Marshall, Brandon D. L.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA; [Montgomery, Madeline C.; Chant, Philip A.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Galarraga, Omar] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Providence, RI USA; [Prosperi, Mattia] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Epidemiol, Gainesville, FL USA; [Prosperi, Mattia] Univ Florida, Coll Med, Gainesville, FL USA	Brown University; Brown University; Brown University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Marshall, BDL (corresponding author), Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI 02912 USA.	brandon_marshall@brown.edu	Gantenberg, Jason/Y-7532-2019; Galarraga, Omar/N-1622-2019	Gantenberg, Jason/0000-0002-8144-4273; Galarraga, Omar/0000-0002-9985-9266; Montgomery, Madeline/0000-0002-4528-1964	National Institute of Mental Health [R21MH109360]; National Institute on Drug Abuse [DP2DA040236]; Providence/Boston Center for AIDS Research - National Institute of Allergy and Infectious Diseases [P30AI042853]; Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH109360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP2DA040236] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Providence/Boston Center for AIDS Research - National Institute of Allergy and Infectious Diseases; Brown University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Mental Health (R21MH109360, co-PIs: Brandon D.L. Marshall, Philip A. Chan). Brandon D. L. Marshall is further supported by the National Institute on Drug Abuse (DP2DA040236). Additional support was provided by the Providence/Boston Center for AIDS Research, funded by the National Institute of Allergy and Infectious Diseases (P30AI042853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Brown University through the use of the facilities of its Center for Computation and Visualization.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Anema A, 2013, CURR HIV-AIDS REP, V10, P398, DOI 10.1007/s11904-013-0187-3; [Anonymous], 2016, 2015 RHOD ISL HIV AI; [Anonymous], 2014, PREEXP PROPH PREV HI, P499; [Anonymous], 2015, NAT HIV AIDS STRAT U; [Anonymous], RHOD ISL INT PREV CA; [Anonymous], 2015, 2014 RHOD ISL HIV AI; Carnegie NB, 2015, JAIDS-J ACQ IMM DEF, V69, P119, DOI 10.1097/QAI.0000000000000555; Centers for Disease Control and Prevention, 2020, HIV SURV REP, V33; Centers for Disease Control and Prevention, 2016, UND CAUS DEATH 1999; Chan PA, 2016, SEX TRANSM DIS, V43, P717, DOI 10.1097/OLQ.0000000000000514; Chan PA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20903; Chan PA, 2015, AIDS PATIENT CARE ST, V29, P597, DOI 10.1089/apc.2015.0113; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; del Pino HE, 2018, AIDS BEHAV, V22, P649, DOI 10.1007/s10461-017-1694-9; Eyawo O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2254-7; Goodreau SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050522; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gorbach PM, 2006, JAIDS-J ACQ IMM DEF, V42, P80, DOI 10.1097/01.qai.0000196665.78497.f1; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hall H Irene, 2017, JMIR Public Health Surveill, V3, pe8, DOI 10.2196/publichealth.7051; Hall HI, 2015, MMWR-MORBID MORTAL W, V64, P657; Hall HI, 2013, JAMA INTERN MED, V173, P1337, DOI 10.1001/jamainternmed.2013.6841; Hernan MA, 2015, AM J EPIDEMIOL, V181, P103, DOI 10.1093/aje/kwu272; Tieu HV, 2013, JAIDS-J ACQ IMM DEF, V64, P121, DOI 10.1097/QAI.0b013e318299cede; Jenness SM, 2016, J INFECT DIS, V214, P1800, DOI 10.1093/infdis/jiw223; Jensen-Fangel S, 2004, AIDS, V18, P89, DOI 10.1097/00002030-200401020-00011; Kasaie P, 2017, JAIDS-J ACQ IMM DEF, V75, P175, DOI 10.1097/QAI.0000000000001354; Keyes KM, 2017, AM J EPIDEMIOL, V186, P146, DOI 10.1093/aje/kwx090; Krivitsky PN, 2011, STAT METHODOL, V8, P319, DOI 10.1016/j.stamet.2011.01.005; Lieb S, 2011, PUBLIC HEALTH REP, V126, P60, DOI 10.1177/003335491112600110; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marshall BDL, 2015, AM J EPIDEMIOL, V181, P92, DOI 10.1093/aje/kwu274; Mayer KH, 2018, JAIDS-J ACQ IMM DEF, V77, P119, DOI 10.1097/QAI.0000000000001579; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Montgomery MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157742; Murray EJ, 2017, AM J EPIDEMIOL, V186, P131, DOI 10.1093/aje/kwx091; Oldenburg CE, 2018, AIDS BEHAV, V22, P1075, DOI 10.1007/s10461-017-1701-1; Oster AM, 2008, TRENDS HIV INFECT DI; Parsons JT, 2017, JAIDS-J ACQ IMM DEF, V74, P285, DOI 10.1097/QAI.0000000000001251; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Rosenberger JG, 2012, J SEX MED, V9, P1037, DOI 10.1111/j.1743-6109.2012.02650.x; Snowden JM, 2017, SEX TRANSM INFECT, V93, P52, DOI 10.1136/sextrans-2015-052382; Touzard Romo Francine, 2014, R I Med J (2013), V98, P26; Twenge JM, 2017, ARCH SEX BEHAV, V46, P2389, DOI 10.1007/s10508-017-0953-1; United States Department of Health and Human Services (US DHHS) Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), BRIDG RAC POP EST US; Volk JE, 2015, CLIN INFECT DIS, V61, P1601, DOI 10.1093/cid/civ778; Wall KM, 2013, J HOMOSEXUAL, V60, P1520, DOI 10.1080/00918369.2013.819256	50	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0199915	10.1371/journal.pone.0199915	http://dx.doi.org/10.1371/journal.pone.0199915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM3UN	29985949	Green Published, gold, Green Submitted			2022-12-26	WOS:000438035500014
J	Choi, BH; Jin, Z; Yi, CO; Oh, J; Jeong, EA; Lee, JY; Park, KA; Kim, KE; Lee, JE; Kim, HJ; Hahm, JR; Roh, GS				Choi, Bong-Hoi; Jin, Zhen; Yi, Chin-ok; Oh, Juhong; Jeong, Eun Ae; Lee, Jong Youl; Park, Kyung-ah; Kim, Kyung Eun; Lee, Jung Eun; Kim, Hyun-Jin; Hahm, Jong Ryeal; Roh, Gu Seob			Effects of lobeglitazone on insulin resistance and hepatic steatosis in high-fat diet-fed mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; TYPE-2 DIABETES-MELLITUS; PPAR-GAMMA; HYPOTHALAMIC INFLAMMATION; GLUCOSE-INTOLERANCE; ENERGY-EXPENDITURE; DOUBLE-BLIND; OBESITY; PIOGLITAZONE; THIAZOLIDINEDIONES	Lobeglitazone (Lobe) is a novel thiazolidinedione antidiabetic drug that reduces insulin resistance by activating peroxisome proliferator-activated receptor-gamma (PPAR.). However, the exact mechanisms of antidiabetic effects of Lobe have not been established in an animal model. The aim of this study was to evaluate the hypoglycemic effects of Lobe and investigate possible factors involved in Lobe-enhanced hepatic steatosis in high-fat diet (HFD)-fed mice. Mice were fed an HFD for 15 weeks. Lobe was administrated orally during the last 9 weeks. Lobe treatment significantly reduced insulin resistance and increased expression of hepatic glucose transporter 4 (GLUT4) and PPARs in HFD-fed mice. However, increased body weight and hepatic steatosis were not reduced by Lobe in these mice. Metabolomics fingerprinting showed that several lipogenesis-related hepatic and serum metabolites in HFD-fed mice had positive or negative correlations with Lobe administration. In particular, increased leptin levels during HFD were further increased by Lobe. HFDinduced signaling transducer and activator of transcription 3 (STAT3) phosphorylation in the hypothalamus was increased by Lobe. In addition, immunohistochemical analysis showed more proopiomelanocortin (POMC)-positive neurons in the hypothalamus of HFD-fed mice (with or without Lobe) compared with normal diet-fed mice. Despite improving leptin signaling in the hypothalamus and enhancing insulin sensitivity in HFD-fed mice, Lobe increased body weight and steatosis. Further research is necessary regarding other factors affecting Lobe-enhanced hepatic steatosis and hyperphagia.	[Choi, Bong-Hoi] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Nucl Med, Coll Med, Jinju, Gyeongnam, South Korea; [Jin, Zhen; Yi, Chin-ok; Jeong, Eun Ae; Lee, Jong Youl; Park, Kyung-ah; Kim, Kyung Eun; Roh, Gu Seob] Gyeongsang Natl Univ, Dept Anat & Convergence Med Sci, Bio Antiaging Med Res Ctr, Inst Hlth Sci,Coll Med, Jinju, Gyeongnam, South Korea; [Oh, Juhong; Kim, Hyun-Jin] EZmass Co Ltd, Jinju, Gyeongnam, South Korea; [Lee, Jung Eun] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Jinju, Gyeongnam, South Korea; [Kim, Hyun-Jin] Gyeongsang Natl Univ, Dept Food Sci & Technol, Div Appl Life Sci Plus Bk21, Inst Agr & Life Sci, Jinju, Gyeongnam, South Korea; [Hahm, Jong Ryeal] Gyeongsang Natl Univ, Div Endocrinol & Metab, Dept Internal Med, Inst Hlth Sci,Coll Med, Jinju, Gyeongnam, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University	Roh, GS (corresponding author), Gyeongsang Natl Univ, Dept Anat & Convergence Med Sci, Bio Antiaging Med Res Ctr, Inst Hlth Sci,Coll Med, Jinju, Gyeongnam, South Korea.; Hahm, JR (corresponding author), Gyeongsang Natl Univ, Div Endocrinol & Metab, Dept Internal Med, Inst Hlth Sci,Coll Med, Jinju, Gyeongnam, South Korea.	jrhahm@gnu.ac.kr; anaroh@gnu.ac.kr	Choi, Bong-Hoi/ABA-3648-2021	PARK, GYEONGAH/0000-0003-4368-8813; jin, zhen/0000-0003-0540-5173	Basic Science Research Program through the National Research Foundation (NRF) of Korea [2015R1A5A2008833]; EZmass Co., Ltd.	Basic Science Research Program through the National Research Foundation (NRF) of Korea; EZmass Co., Ltd.	This study (GSR) was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea (No. 2015R1A5A2008833). Author Hyun-Jin Kim is affiliated to EZmass Co., Ltd., which is a Personal Venture Company of Dr. Hyun-Jin Kim's lab at Gyeongsang National University. EZmass Co., Ltd. provided support in the form of salary for author H-JK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Asimakopoulou A, 2016, HEPATOLOGY, V63, P669, DOI 10.1002/hep.27930; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Basu A, 2006, DIABETES CARE, V29, P510, DOI 10.2337/diacare.29.03.06.dc05-2004; Corzo C, 2013, DIABETES METAB J, V37, P395, DOI 10.4093/dmj.2013.37.6.395; da Silva RP, 2014, BBA-MOL CELL BIOL L, V1841, P1639, DOI 10.1016/j.bbalip.2014.09.001; Davidson MA, 2018, CRIT REV TOXICOL, V48, P52, DOI 10.1080/10408444.2017.1351420; Fonseca V, 2003, AM J MED, V115, P42, DOI 10.1016/j.amjmed.2003.09.005; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Hand CE, 2005, J NAT PROD, V68, P293, DOI 10.1021/np049685x; Hansen MJ, 2005, BRAIN RES, V1039, P137, DOI 10.1016/j.brainres.2005.01.063; Hauner H, 2002, DIABETES-METAB RES, V18, pS10, DOI 10.1002/dmrr.249; Hollenberg NK, 2003, AM J MED, V115, P111, DOI 10.1016/j.amjmed.2003.09.018; Hutley LJ, 2003, EUR J CLIN INVEST, V33, P574, DOI 10.1046/j.1365-2362.2003.01178.x; Jeon BT, 2014, METAB BRAIN DIS, V29, P635, DOI 10.1007/s11011-014-9542-3; Jeon BT, 2012, DIABETES, V61, P1444, DOI 10.2337/db11-1498; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; Jin SM, 2015, DIABETES OBES METAB, V17, P599, DOI 10.1111/dom.12435; Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748; Kim JW, 2011, CLIN THER, V33, P1819, DOI 10.1016/j.clinthera.2011.09.023; Kim KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30111; Kim SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092843; Kim SH, 2015, DIABETES RES CLIN PR, V110, pE27, DOI 10.1016/j.diabres.2015.09.009; Ko KD, 2017, J OBES METAB SYNDR, V26, P102, DOI 10.7570/jomes.2017.26.2.102; Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470; Lee YH, 2017, J KOREAN MED SCI, V32, P60, DOI 10.3346/jkms.2017.32.1.60; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Nafrialdi, 2012, Acta Med Indones, V44, P28; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Quaresma PGF, 2016, INT J OBESITY, V40, P138, DOI 10.1038/ijo.2015.134; Raskin P, 2001, DIABETES CARE, V24, P1226, DOI 10.2337/diacare.24.7.1226; Rodriguez WE, 2006, AM J PHYSIOL-HEART C, V291, pH81, DOI 10.1152/ajpheart.01331.2005; Ryan KK, 2011, NAT MED, V17, P623, DOI 10.1038/nm.2349; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shimizu H, 1998, DIABETES CARE, V21, P1470, DOI 10.2337/diacare.21.9.1470; Soccio RE, 2014, CELL METAB, V20, P573, DOI 10.1016/j.cmet.2014.08.005; Torri C, 2002, PEPTIDES, V23, P1063, DOI 10.1016/S0196-9781(02)00030-X; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Wunderlich Claudia M, 2013, JAKSTAT, V2, pe23878, DOI 10.4161/jkst.23878; Yasuda S, 2009, AM J PHYSIOL-HEART C, V296, pH1558, DOI 10.1152/ajpheart.00712.2008; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	41	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200336	10.1371/journal.pone.0200336	http://dx.doi.org/10.1371/journal.pone.0200336			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979770	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500098
J	Joao, EAC; Ferreira, OD; Gouvea, MI; Teixeira, MDB; Tanuri, A; Higa, LM; Costa, DA; Mohana-Borges, R; Arruda, MB; Matos, HJ; Cruz, ML; Mendes-Silva, W; Read, JS				Joao, Esau A. C.; Ferreira, Orlando da C., Jr.; Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.; Tanuri, Amilcar; Higa, Luiza M.; Costa, Deise A.; Mohana-Borges, Ronaldo; Arruda, Monica B.; Matos, Haroldo J.; Cruz, Maria Leticia; Mendes-Silva, Wallace; Read, Jennifer S.			Pregnant women co-infected with HIV and Zika: Outcomes and birth defects in infants according to maternal symptomatology	PLOS ONE			English	Article							RIO-DE-JANEIRO; VIRUS-INFECTION; BRAZIL	Background Zika virus (ZIKV) was first isolated in Uganda in 1947. In Brazil, the first reported case of ZIKV infection was in May 2015. Additionally, dengue (DENV) is endemic and there has been a recent outbreak of chikungunya (CHIKV). Since the clinical manifestations of different arboviral infections (AI) can be similar, definitive diagnosis requires laboratory testing. Objectives To determine the prevalence of ZIKV, DENV, and CHIKV infections in a Brazilian cohort of HIV-infected pregnant women, to assess clinical/immunological characteristics and pregnancy outcomes of women with evidence of recent AI. Study design Laboratory diagnosis of ZIKV, DENV and CHIKV infections utilized serological assays, RT-PCR and PRNT. The tests were performed at the first visit, 34-36 weeks of gestation and at any time if a woman had symptoms suggestive of AI. Mann-Whitney tests were used for comparison of medians, Chi-square or Fisher's to compare proportions; p<0.05 was considered statistically significant. Poisson regression was used to analyze risk factors for central nervous system (CNS) malformations in the infant according to maternal symptomatology. Results Of 219 HIV-infected pregnant women enrolled, 92% were DENV IgG+; 47(22%) had laboratory evidence of recent AI. Of these, 34 (72%) were ZIKV+, nine (19%) CHIKV+, and two (4%) DENV+. Symptoms consistent with AI were observed in 23 (10%) women, of whom 10 (43%) were ZIKV+, eight (35%) CHIKV+. No CNS abnormalities were observed among infants of DENV+ or CHIKV+ women; four infants with CNS abnormalities were born to ZIKV+ women (three symptomatic). Infants born to ZIKV+ women had a higher risk of CNS malformations if the mother was symptomatic (RR = 7.20), albeit not statistically significant (p = 0.066). Conclusions Among HIV-infected pregnant women with laboratory evidence of a recent AI, 72% were ZIKV-infected. In this cohort, CNS malformations occurred among infants born to both symptomatic and asymptomatic pregnant women with Zika infection.	[Joao, Esau A. C.; Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.; Cruz, Maria Leticia] Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, RJ, Brazil; [Ferreira, Orlando da C., Jr.; Tanuri, Amilcar; Higa, Luiza M.; Arruda, Monica B.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Biol Mol, Rio De Janeiro, RJ, Brazil; [Gouvea, Maria Isabel; Teixeira, Maria de Lourdes B.] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil; [Costa, Deise A.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, Rio De Janeiro, RJ, Brazil; [Matos, Haroldo J.] Inst Evandro Chagas, Dept Epidemiol, Belem, Para, Brazil; [Mendes-Silva, Wallace] Hosp Fed Servidores Estado, Maternal Fetal Unit, Rio De Janeiro, RJ, Brazil; [Read, Jennifer S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Instituto Evandro Chagas; University of California System; University of California San Francisco	Joao, EAC (corresponding author), Hosp Fed Servidores Estado, Dept Infect Dis, Rio De Janeiro, RJ, Brazil.	esaujoao@gmail.com	amsalu, ribka/G-8780-2019; Higa, Luiza/W-2698-2019; Tanuri, Amilcar/AAM-8601-2021; Cruz, Maria Leticia/Y-5632-2019; Borges, Ronaldo S Mohana/C-5575-2013	Joao, Esau/0000-0002-2412-0627; Mendes da Silva, Wallace/0000-0002-5195-4061; /0000-0002-6896-0089				Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012; Adams L, 2017, 2017 ANN M AM SOC TR; Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1; [Anonymous], 2017, ZIK VIR GUID US LAB; Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014; Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6; Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367; Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720; Gabaglia CR, 2017, CURR OPIN PEDIATR, V29, P107, DOI 10.1097/MOP.0000000000000446; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Joao EC, 2012, INT J STD AIDS, V23, P44, DOI 10.1258/ijsa.2011.010545; Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; Menting S, 2011, ADV VIROL, V2011, DOI 10.1155/2011/514681; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Rothan HA, 2018, J AUTOIMMUN, V89, P11, DOI 10.1016/j.jaut.2018.01.002; SELVIN S, 1998, MODERN APPL BIOSTATI; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1	25	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200168	10.1371/journal.pone.0200168	http://dx.doi.org/10.1371/journal.pone.0200168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979796	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500071
J	Lura, MP; Gorlanova, O; Muller, L; Proietti, E; Vienneau, D; Reppucci, D; Pavlovic, R; Dahinden, C; Roosli, M; Latzin, P; Frey, U				Lura, Marco Patrick; Gorlanova, Olga; Mueller, Loretta; Proietti, Elena; Vienneau, Danielle; Reppucci, Diana; Pavlovic, Rodoljub; Dahinden, Clemens; Roosli, Martin; Latzin, Philipp; Frey, Urs			Response of cord blood cells to environmental, hereditary and perinatal factors: A prospective birth cohort study	PLOS ONE			English	Article							AIR-POLLUTION; DENDRITIC CELLS; IMMUNE-SYSTEM; TOBACCO-SMOKE; EXPOSURE; DELIVERY; PREGNANCY; NEWBORNS; MOTHERS; SUBSETS	Background Many studies investigating the impact of individual risk factors on cord blood immune cell counts may be biased given that cord blood composition is influenced by a multitude of factors. The aim of this study was to comprehensively investigate the relative impact of environmental, hereditary and perinatal factors on cord blood cells. Methods In 295 neonates from the prospective Basel-Bern Infant Lung Development Cohort, we performed complete blood counts and fluorescence-activated cell sorting scans of umbilical cord blood. The associations between risk factors and cord blood cells were assessed using multivariable linear regressions. Results The multivariable regression analysis showed that an increase per 10 mu g/m(3) of the average nitrogen dioxide 14 days before birth was associated with a decrease in leukocyte (6.7%, 95% CI:-12.1,-1.0) and monocyte counts (11.6%, 95% CI:-19.6,-2.8). Maternal smoking during pregnancy was associated with significantly lower cord blood cell counts in multiple cell populations. Moreover, we observed sex differences regarding eosinophilic granulocytes and plasmacytoid dendritic cells. Finally, significantly increased numbers of cord blood cells were observed in infants exposed to perinatal stress. Cesarean section seems to play a significant role in Th1/Th2 balance. Conclusions Our results suggest that all three: environmental, hereditary and perinatal factors play a significant role in the composition of cord blood cells at birth, and it is important to adjust for all of these factors in cord blood studies. In particular, perinatal circumstances seem to influence immune balance, which could have far reaching consequences in the development of immune mediated diseases.	[Lura, Marco Patrick; Gorlanova, Olga; Mueller, Loretta; Proietti, Elena; Reppucci, Diana; Latzin, Philipp; Frey, Urs] Univ Basel, Univ Childrens Hosp Basel, Div Pulmonol, Basel, Switzerland; [Vienneau, Danielle; Roosli, Martin] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Pavlovic, Rodoljub; Dahinden, Clemens] Univ Bern, Inst Immunol, Inselspital, Bern, Switzerland; [Latzin, Philipp] Univ Bern, Div Resp Med, Dept Paediat, Inselspital, Bern, Switzerland	University of Basel; University of Basel; Swiss Tropical & Public Health Institute; University of Bern; University of Bern	Gorlanova, O (corresponding author), Univ Basel, Univ Childrens Hosp Basel, Div Pulmonol, Basel, Switzerland.	olga.gorlanova@ukbb.ch	Röösli, Martin/A-2658-2008; Vienneau, Danielle/L-1558-2019	Röösli, Martin/0000-0002-7475-1531; Vienneau, Danielle/0000-0002-6309-6439; Frey, Urs/0000-0003-3773-2822	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung [324730_144280, 320030_163311]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	Funding was provided by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (324730_144280 and 320030_163311) to Dr. Urs Frey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almanzar G, 2015, EARLY HUM DEV, V91, P663, DOI 10.1016/j.earlhumdev.2015.09.010; Baiz N, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-87; BLACHE D, 1992, ATHEROSCLEROSIS, V93, P179, DOI 10.1016/0021-9150(92)90254-E; Castellazzi AM, 1999, J ALLERGY CLIN IMMUN, V103, P172, DOI 10.1016/S0091-6749(99)70542-7; Chang YH, 2011, PEDIATR NEONATOL, V52, P155, DOI 10.1016/j.pedneo.2011.03.007; Chen XQ, 2013, INT J CLIN EXP PATHO, V6, P290; Dietert RR, 2000, ENVIRON HEALTH PERSP, V108, P483, DOI 10.2307/3454540; Ewetz L, 1993, Scand J Work Environ Health, V19 Suppl 2, P21; Frampton MW, 2002, AM J PHYSIOL-LUNG C, V282, pL155, DOI 10.1152/ajplung.2002.282.1.L155; Fuchs O, 2012, INT J EPIDEMIOL, V41, P366, DOI 10.1093/ije/dyq239; Glasser L, 2015, J PERINATOL, V35, P469, DOI 10.1038/jp.2014.241; Herr CEW, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-46; Hertz-Picciotto I, 2005, ENVIRON HEALTH PERSP, V113, P1391, DOI 10.1289/ehp.7610; Hertz-Picciotto I, 2002, EPIDEMIOLOGY, V13, P172, DOI 10.1097/00001648-200203000-00012; Hertz-Picciotto I, 2008, BASIC CLIN PHARMACOL, V102, P146, DOI 10.1111/j.1742-7843.2007.00190.x; Hodgkins SR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-102; Hrdy J, 2012, CLIN EXP IMMUNOL, V170, P10, DOI 10.1111/j.1365-2249.2012.04630.x; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Latzin P, 2009, EUR RESPIR J, V33, P594, DOI 10.1183/09031936.00084008; Latzin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023130; Lim FTH, 2000, AM J OBSTET GYNECOL, V183, P1144, DOI 10.1067/mob.2000.108848; Lommatzsch M, 2010, EUR RESPIR J, V35, P1130, DOI 10.1183/09031936.00090109; MercelinaRoumans PEAM, 1996, J CLIN EPIDEMIOL, V49, P449, DOI 10.1016/0895-4356(95)00542-0; Pennell LM, 2012, J AUTOIMMUN, V38, pJ282, DOI 10.1016/j.jaut.2011.11.013; Porter M, 2007, AM J RESP CELL MOL, V37, P706, DOI 10.1165/rcmb.2007-0199OC; Prescott SL, 1998, J IMMUNOL, V160, P4730; Proietti E, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0145-9; Proietti E, 2013, J AEROSOL MED PULM D, V26, P9, DOI 10.1089/jamp.2011.0932; Protonotariou E, 2010, IN VIVO, V24, P117; SAMELSON R, 1992, AM J REPROD IMMUNOL, V28, P71, DOI 10.1111/j.1600-0897.1992.tb00761.x; Schmid JMP, 2007, PEDIATR RES, V61, P462, DOI 10.1203/pdr.0b013e3180332d02; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Steenhof M, 2014, INHAL TOXICOL, V26, P141, DOI 10.3109/08958378.2013.861884; Vassallo R, 2005, J IMMUNOL, V175, P2684, DOI 10.4049/jimmunol.175.4.2684; Wang L, 2007, J ALLERGY CLIN IMMUN, V120, P445, DOI 10.1016/j.jaci.2007.03.028	35	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200236	10.1371/journal.pone.0200236	http://dx.doi.org/10.1371/journal.pone.0200236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979752	Green Published, gold, Green Accepted			2022-12-26	WOS:000437809500082
J	Peterson, SM; Furuichi, E; Ferris, DP				Peterson, Steven M.; Furuichi, Emily; Ferris, Daniel P.			Effects of virtual reality high heights exposure during beam-walking on physiological stress and cognitive loading	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; ELECTRODERMAL ACTIVITY; SKIN-CONDUCTANCE; POSTURAL CONTROL; BALANCE; GAIT; SYSTEM; FALLS; PREVENTION; EQUILIBRIUM	Virtual reality has been increasingly used in research on balance rehabilitation because it provides robust and novel sensory experiences in controlled environments. We studied 19 healthy young subjects performing a balance beam walking task in two virtual reality conditions and with unaltered view (15 minutes each) to determine if virtual reality high heights exposure induced stress. We recorded number of steps off the beam, heart rate, electrodermal activity, response time to an auditory cue, and high-density electroencephalography (EEG). We hypothesized that virtual high heights exposure would increase measures of physiological stress compared to unaltered viewing at low heights. We found that the virtual high height condition increased heart rate variability and heart rate frequency power relative to virtual low heights. Virtual reality use resulted in increased number of step-offs, heart rate, electrodermal activity, and response time compared to the unaltered viewing at low heights condition. Our results indicated that virtual reality decreased dynamic balance performance and increased physical and cognitive loading compared to unaltered viewing at low heights. In virtual reality, we found significant decreases in source-localized EEG peak amplitude relative to unaltered viewing in the anterior cingulate, which is considered important in sensing loss of balance. Our findings indicate that virtual reality provides realistic experiences that can induce physiological stress in humans during dynamic balance tasks, but virtual reality use impairs physical and cognitive performance during balance.	[Peterson, Steven M.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Furuichi, Emily] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Ferris, Daniel P.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida	Peterson, SM (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	stepeter@umich.edu	Ferris, Daniel P/A-9624-2008; Ferris, Daniel P./N-6436-2019	Ferris, Daniel P/0000-0001-6373-6021; Ferris, Daniel P./0000-0001-6373-6021; Peterson, Steven/0000-0003-0782-5788	National Science Foundation [DGE 1256260]; Army Research Laboratory [W911NF-10-2-0022]	National Science Foundation(National Science Foundation (NSF)); Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL))	This research was sponsored by a Graduate Research Fellowship Program grant from the National Science Foundation (DGE 1256260) to Steven M. Peterson: https://www.nsfgrfp.org/. It was also sponsored by the Army Research Laboratory under Cooperative Agreement Number W911NF-10-2-0022 (Cognition and Neuroergonomics Collaborative Technology Alliance) to Daniel P. Ferris: https://www.arl.army.mil/www/default.cfm?page=393. The views and conclusions contained in this research article are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akizuki H, 2005, NEUROSCI LETT, V379, P23, DOI 10.1016/j.neulet.2004.12.041; AMBLARD B, 1980, PERCEPT MOTOR SKILL, V51, P903, DOI 10.2466/pms.1980.51.3.903; ASSAIANTE C, 1989, J MOTOR BEHAV, V21, P72; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Boesch M, 2014, PSYCHONEUROENDOCRINO, V43, P41, DOI 10.1016/j.psyneuen.2014.02.003; Bogost MD, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00524; Booth V, 2014, CLIN REHABIL, V28, P419, DOI 10.1177/0269215513509389; Brown LA, 2006, GAIT POSTURE, V24, P397, DOI 10.1016/j.gaitpost.2005.04.013; Camm AJ, 1996, EUR HEART J, V17, P354; Carpenter MG, 1999, J VESTIBUL RES-EQUIL, V9, P277; Carter ND, 2001, SPORTS MED, V31, P427, DOI 10.2165/00007256-200131060-00003; Clays E, 2011, INT ARCH OCC ENV HEA, V84, P185, DOI 10.1007/s00420-010-0537-z; Clemson L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4547; Cleworth TW, 2012, GAIT POSTURE, V36, P172, DOI 10.1016/j.gaitpost.2012.02.010; Corbetta D, 2015, J PHYSIOTHER, V61, P117, DOI 10.1016/j.jphys.2015.05.017; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Domingo A, 2010, EXP BRAIN RES, V206, P359, DOI 10.1007/s00221-010-2409-x; Domingo A, 2009, GAIT POSTURE, V30, P464, DOI 10.1016/j.gaitpost.2009.07.114; Duque G, 2013, CLIN INTERV AGING, V8, P257, DOI 10.2147/CIA.S41453; Emmelkamp PMG, 2001, CYBERPSYCHOL BEHAV, V4, P335, DOI 10.1089/109493101300210222; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gentili RJ, 2014, IEEE ENG MED BIO, P5860, DOI 10.1109/EMBC.2014.6944961; Gianaros PJ, 2001, AVIAT SPACE ENVIR MD, V72, P115; Giromini L, 2016, PSYCHIAT RES, V246, P166, DOI 10.1016/j.psychres.2016.09.036; Gonzalez-Franco M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01125; Gonzalez-Franco M, 2014, EXP BRAIN RES, V232, P875, DOI 10.1007/s00221-013-3800-1; Gutekunst M, 2014, ICAT EGVE 2014, P9; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Hjortskov N, 2004, EUR J APPL PHYSIOL, V92, P84, DOI 10.1007/s00421-004-1055-z; Horlings CGC, 2009, NEUROSCI LETT, V451, P227, DOI 10.1016/j.neulet.2008.12.057; Howell DR, 2016, GAIT POSTURE, V49, P176, DOI 10.1016/j.gaitpost.2016.07.008; Hulsdunker T, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00695; Huppert D, 2013, J NEUROL, V260, P597, DOI 10.1007/s00415-012-6685-1; Ibrahim MS, 2016, J PHYS THER SCI, V28, P20, DOI 10.1589/jpts.28.20; Kalron A, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0124-y; Kanekar N, 2014, EXP BRAIN RES, V232, P1127, DOI 10.1007/s00221-014-3822-3; Kannus P, 2005, LANCET, V366, P1885, DOI 10.1016/S0140-6736(05)67604-0; Kelly JW, 2008, PERCEPT PSYCHOPHYS, V70, P158, DOI 10.3758/PP.70.1.158; Kline JE, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046022; Kline JE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00288; Kolasinski EM.., 1995, SIMULATOR SICKNESS V, DOI 10.1121/1.404501; Lach HW, 2005, PUBLIC HEALTH NURS, V22, P45, DOI 10.1111/j.0737-1209.2005.22107.x; Lasikiewicz N, 2013, STRESS, V16, P44, DOI 10.3109/10253890.2012.682109; Lawrence CA, 2010, INT J PSYCHOPHYSIOL, V78, P100, DOI 10.1016/j.ijpsycho.2010.06.027; Lim CL, 1997, INT J PSYCHOPHYSIOL, V25, P97, DOI 10.1016/S0167-8760(96)00713-1; Little CE, 2015, EXP BRAIN RES, V233, P27, DOI 10.1007/s00221-014-4111-x; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 1996, ADV NEUR IN, V8, P145; McCraty Rollin, 2015, Glob Adv Health Med, V4, P46, DOI 10.7453/gahmj.2014.073; Meehan M, 2002, ACM T GRAPHIC, V21, P645, DOI 10.1145/566570.566630; Mellman TA, 2004, BIOL PSYCHIAT, V55, P953, DOI 10.1016/j.biopsych.2003.12.018; Mirelman A, 2011, J GERONTOL A-BIOL, V66, P234, DOI 10.1093/gerona/glq201; Munoz E, 2015, PSYCHOL AGING, V30, P487, DOI 10.1037/pag0000036; Neelon MF, 2006, BRAIN RES, V1118, P94, DOI 10.1016/j.brainres.2006.08.006; Ogaya S, 2011, J STRENGTH COND RES, V25, P2616, DOI 10.1519/JSC.0b013e31820019cf; Oliveira AS, 2017, J NEUROPHYSIOL, V118, P1943, DOI 10.1152/jn.00926.2016; Oostenveld R, 2002, HUM BRAIN MAPP, V17, P179, DOI 10.1002/hbm.10061; Padrao G, 2016, NEUROIMAGE, V124, P147, DOI 10.1016/j.neuroimage.2015.08.022; Palmer JA, 2008, INT CONF ACOUST SPEE, P1805, DOI 10.1109/ICASSP.2008.4517982; Palmer JA, 2006, LECT NOTES COMPUT SC, V3889, P854; Picard RW, 2016, EMOT REV, V8, P62, DOI 10.1177/1754073914565517; Poh MZ, 2010, IEEE T BIO-MED ENG, V57, P1243, DOI 10.1109/TBME.2009.2038487; Regenbogen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052267; Reinhardt T, 2012, PSYCHIAT RES, V198, P106, DOI 10.1016/j.psychres.2011.12.009; Sabri M, 2014, NEUROPSYCHOLOGIA, V61, P269, DOI 10.1016/j.neuropsychologia.2014.06.009; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Schlink BR, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00310; Schmidt S, 2000, J PARAPSYCHOL, V64, P139; Schniepp R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00963; Seinfeld S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01969; Shaw EP, 2018, BIOL PSYCHOL, V134, P39, DOI 10.1016/j.biopsycho.2018.01.009; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Simeonov PI, 2005, HUM FACTORS, V47, P430, DOI 10.1518/0018720054679506; Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012; Slobounov S, 2009, EXP BRAIN RES, V199, P1, DOI 10.1007/s00221-009-1956-5; Steinman SA, 2011, J ANXIETY DISORD, V25, P896, DOI 10.1016/j.janxdis.2011.05.001; Sterling DA, 2001, J TRAUMA, V50, P116, DOI 10.1097/00005373-200101000-00021; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2011, HANDBOOK OF BEHAVIORAL MEDICINE: METHODS AND APPLICATIONS, P723, DOI 10.1007/978-0-387-09488-5_47; Walker HK, 1976, CLIN METHODS HIST PH; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	88	39	39	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200306	10.1371/journal.pone.0200306	http://dx.doi.org/10.1371/journal.pone.0200306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979750	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500094
J	van Wijngaarden, JWDL; Ching, AD; Settle, E; van Griensven, F; Cruz, RC; Newman, PA				van Wijngaarden, Jan W. de Lind; Ching, Andrew D.; Settle, Edmund; van Griensven, Frits; Cruz, Rolando C.; Newman, Peter A.			"I am not promiscuous enough!": Exploring the low uptake of HIV testing by gay men and other men who have sex with men in Metro Manila, Philippines	PLOS ONE			English	Article							CHENNAI; INDIA; PREVENTION; CARE; MSM	The Philippines faces a severe HIV epidemic among gay and other men who have sex with men (MSM). HIV testing uptake remains low. A case series of 12 men from Metro Manila were interviewed to explore barriers to uptake of HIV testing services. Most did not see the need to get tested for HIV despite significant risk, based on the misconception they were feeling well or showed no symptoms. Being of a higher socioeconomic class, feeling morally superior to other gay men, distance of the testing facility, fear of what will happen once infected, fear of HIV- and sexual stigma, fear of side effects of antiretroviral drugs and fear of high health care expenses after testing positive for HIV were key reasons why MSM kept postponing their test. Misconceptions about HIV risk, disease, and treatment and care need to be addressed in order to increase uptake of HIV services in this population.	[van Wijngaarden, Jan W. de Lind] Burapha Univ, Fac Publ Hlth, Bang Saen, Chonburi, Thailand; [Ching, Andrew D.] HASH Community Ctr, Manila, Philippines; [Settle, Edmund] United Nations Dev Programme, Bangkok, Thailand; [van Griensven, Frits] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [van Griensven, Frits] Univ Calif San Francisco, Div Epidemiol & Biostat, San Francisco, CA 94143 USA; [Cruz, Rolando C.] Dept Hlth, Quezon City, Philippines; [Newman, Peter A.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada	Burapha University; Thai Red Cross Society; University of California System; University of California San Francisco; University of Toronto	van Wijngaarden, JWDL (corresponding author), Burapha Univ, Fac Publ Hlth, Bang Saen, Chonburi, Thailand.	jwdlvw@gmail.com	Newman, Peter A/P-7056-2019	Newman, Peter A/0000-0003-0444-5915; de Lind van Wijngaarden, Jan Willem/0000-0003-2611-8739	United Nations Development Programme	United Nations Development Programme	The study was funded by the United Nations Development Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc ME, 2005, INT SOC SCI J, V57, P661, DOI 10.1111/j.1468-2451.2005.583.x; Bureau Epidemiology, 2016, NEWL DIAGN HIV CAS P; Bureau Epidemiology, 2015, INT HIV BEH SER SURV; Casey K, 2014, UNPUB; Chakrapani V, 2008, CULT HEALTH SEX, V10, P313, DOI 10.1080/13691050701816714; De Lind van Wijngaarden JW, 2018, FEMININITY MASCULINI; De Lind van Wijngaarden JW, 2017, EXPLORING BARRIERS H; Duncan D, 2015, J SEX MARITAL THER, V41, P345, DOI 10.1080/0092623X.2014.915902; Francis C, 2015, HIV CASCADE FRAMEWOR; Garcia J. Neil, 2004, INT I ASIAN STUDIES, V35, P13; Guzman R, 2005, JAIDS-J ACQ IMM DEF, V38, P82, DOI 10.1097/00126334-200501010-00015; Italia W., 2014, ASIA PACIFIC J MULTI, V2, P125; Kilmarx PH, 2013, CURR OPIN HIV AIDS, V8, P59, DOI 10.1097/COH.0b013e32835b806e; Marks G, 2010, SEX TRANSM DIS, V37, P325, DOI 10.1097/OLQ.0b013e3181c95dac; Murdoch David M, 2007, AIDS Res Ther, V4, P9, DOI 10.1186/1742-6405-4-9; Population Services International (PSI), 2015, LESS LEARN 2014 2015; Ross AGP, 2015, INT J INFECT DIS, V37, P6, DOI 10.1016/j.ijid.2015.06.001; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tarr CM, 1999, AIDS CARE, V11, P375, DOI 10.1080/09540129947992; Wah-Shan C, 2001, J HOMOSEXUAL, V40, P27, DOI 10.1300/J082v40n03_03; Woodford MR, 2016, GLOB PUBLIC HEALTH, V11, P363, DOI 10.1080/17441692.2015.1057757; Woodford MR, 2012, AIDS BEHAV, V16, P53, DOI 10.1007/s10461-011-9974-2; Yan HJ, 2014, SEX TRANSM INFECT, V90, P388, DOI 10.1136/sextrans-2013-051397	23	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200256	10.1371/journal.pone.0200256	http://dx.doi.org/10.1371/journal.pone.0200256			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979766	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500086
J	Weitzel, T; Jiang, J; Acosta-Jamett, G; Martinez-Valdebenito, C; Lopez, J; Richards, AL; Abarca, K				Weitzel, Thomas; Jiang, Ju; Acosta-Jamett, Gerardo; Martinez-Valdebenito, Constanza; Lopez, Javier; Richards, Allen L.; Abarca, Katia			Canine seroprevalence to Orientia species in southern Chile: A cross-sectional survey on the Chiloe A Island	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; ENDEMIC SCRUB TYPHUS; SEROLOGICAL EVIDENCE; DOGS; TSUTSUGAMUSHI; INFECTION; SENTINEL	Background Scrub typhus is a potentially life-threatening vector- borne infection caused by Orientia species. It occurs mainly in the Asian-Pacific region, where it causes significant morbidity and mortality. Recently, an endemic focus of scrub typhus has been described in South America, on Chiloe A Island in southern Chile. Dogs have been used as sentinel hosts to determine the presence and spatial distribution of various vector-borne infections. Their suitability to gain insight into human exposure to Orientia tsutsugamushi has been suggested in studies from Asia. Methodology In January 2016, we conducted a cross-sectional study, which included the two main cities on Chiloe A Island. Canine blood samples were obtained in households, chosen by double stratified random sampling in urban and by convenience in rural locations. Specimens were tested by ELISA for IgG antibodies against whole-cell antigen preparations from three strains of O. tsutsugamushi. Data were further analyzed for factors associated with seropositivity including spatial clustering. Results Serum samples from 202 dogs (104 urban, 98 rural) were tested for IgG against O. tsutsugamushi, of which 43 (21.3%) were positive. Seroprevalence rates were higher in rural than in urban settings (p<0.01) and in older compared to younger dogs (p<0.01). Spatial analysis by LISA indicated the presence of four localities of highly grouped cases. Conclusions The detected seroprevalence supports the endemicity of scrub typhus in southern Chile and suggests a wide exposure of household dogs to the infected, yet unknown vector(s). The spatial data will be used for future research identifying further human cases as well as the local vector(s)/reservoirs for scrub typhus in southern Chile. The study reinforces that dogs are useful sentinels for Orientia spp. in regions of uncertain endemicity and distribution.	[Weitzel, Thomas] Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Lab Clin, Santiago, Chile; [Jiang, Ju; Richards, Allen L.] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Silver Spring, MD USA; [Acosta-Jamett, Gerardo] Univ Austral Chile, Inst Med Prevent Vet, Fac Ciencias Vet, Valdivia, Chile; [Acosta-Jamett, Gerardo] Univ Austral Chile, Programa Invest Aplicada Fauna Silvestre, Fac Ciencias Vet, Valdivia, Chile; [Martinez-Valdebenito, Constanza; Abarca, Katia] Pontificia Univ Catolica Chile, Escuela Med, Dept Enfermedades Infecciosas & Inmunol Pediat, Santiago, Chile; [Lopez, Javier] Hosp Vet Puente Alto, Santiago, Chile; [Abarca, Katia] Pontificia Univ Catolica Chile, Escuela Med, Millennium Inst Immunol & Immunotherapy, Santiago, Chile	Clinica Alemana; Universidad del Desarrollo; Naval Medical Research Center (NMRC); Universidad Austral de Chile; Universidad Austral de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Weitzel, T (corresponding author), Univ Desarrollo, Fac Med Clin Alemana, Clin Alemana Santiago, Lab Clin, Santiago, Chile.; Abarca, K (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Dept Enfermedades Infecciosas & Inmunol Pediat, Santiago, Chile.; Abarca, K (corresponding author), Pontificia Univ Catolica Chile, Escuela Med, Millennium Inst Immunol & Immunotherapy, Santiago, Chile.	thomas.weitzel@gmail.com; katia@med.puc.cl	ABARCA, KATIA/HDM-9351-2022	Weitzel, Thomas/0000-0002-9804-2123; Acosta, Gerardo/0000-0002-9645-3551	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1130817, 1170810]; Global Emerging Infections Surveillance System, a Division of the Armed Forces Health Surveillance Branch, Defense Health Agency, U.S. Department of Defense [A1402]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Global Emerging Infections Surveillance System, a Division of the Armed Forces Health Surveillance Branch, Defense Health Agency, U.S. Department of Defense(United States Department of Defense)	The work was funded by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT No 1130817 and No 1170810) and by the Global Emerging Infections Surveillance System, a Division of the Armed Forces Health Surveillance Branch, Defense Health Agency, U.S. Department of Defense; work unit #A1402. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Jamett G, 2010, PREV VET MED, V94, P272, DOI 10.1016/j.prevetmed.2010.01.002; ALEXANDER AD, 1972, INFECT IMMUN, V5, P745, DOI 10.1128/IAI.5.5.745-749.1972; Balcells ME, 2011, EMERG INFECT DIS, V17, P1659, DOI 10.3201/eid1709.100960; Batista FG, 2010, REV BRAS PARASITOL V, V19, P205, DOI 10.1590/S1984-29612010000400003; Bennett MD, 2017, AM J TROP MED HYG, V97, P407, DOI 10.4269/ajtmh.16-0998; BLAKE FG, 1945, AM J PUBLIC HEALTH, V35, P1121; Castanera MB, 1998, ANN TROP MED PARASIT, V92, P671, DOI 10.1080/00034983.1998.11813327; Cleaveland S, 2006, NATURE, V440, P605, DOI 10.1038/440605b; Day MJ, 2011, PARASITE VECTOR, V4, DOI [10.1186/1756-3305-4-49, 10.1186/1756-3305-4-48]; Duncan AW, 2005, VECTOR-BORNE ZOONOT, V5, P101, DOI 10.1089/vbz.2005.5.101; Halliday J.E.B., 2010, THESIS DISSERTATION; HARRISON JL, 1951, ANN TROP MED PARASIT, V45, P171, DOI 10.1080/00034983.1951.11685486; HARRISON JL, 1951, ANN TROP MED PARASIT, V45, P186, DOI 10.1080/00034983.1951.11685487; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HUXSOLL D L, 1977, Southeast Asian Journal of Tropical Medicine and Public Health, V8, P232; Izzard L, 2010, J CLIN MICROBIOL, V48, P4404, DOI 10.1128/JCM.01526-10; Jiang J, 2003, AM J TROP MED HYG, V69, P60, DOI 10.4269/ajtmh.2003.69.60; Jiang J, 2015, EMERG INFECT DIS, V21, P1073, DOI 10.3201/eid2106.141487; Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908; Leighton FA, 2001, CAN J PUBLIC HEALTH, V92, P67, DOI 10.1007/BF03404848; Liyanapathirana VC, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-328; Namikawa K, 2014, SE ASIAN J TROP MED, V45, P395; Nanayakkara DM, 2013, VECTOR-BORNE ZOONOT, V13, P545, DOI 10.1089/vbz.2012.1049; Ortuno A, 2009, CLIN MICROBIOL INFEC, V15, P241, DOI 10.1111/j.1469-0691.2008.02158.x; Paris DH, 2013, AM J TROP MED HYG, V89, P301, DOI 10.4269/ajtmh.13-0064; R Development Core Team, R LANG ENV STAT COMP; SHIRAI A, 1979, JPN J MED SCI BIOL, V32, P175, DOI 10.7883/yoken1952.32.175; Stekolnikov AA, 2016, VET PARASITOL, V221, P60, DOI 10.1016/j.vetpar.2016.03.009; Suwanabun N, 1997, AM J TROP MED HYG, V56, P38, DOI 10.4269/ajtmh.1997.56.38; Tay ST, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002341; Wachter M, 2015, VECTOR-BORNE ZOONOT, V15, P191, DOI 10.1089/vbz.2014.1715; Walker DH, 2016, NEW ENGL J MED, V375, P913, DOI 10.1056/NEJMp1608499; Ward MP, 2000, PREV VET MED, V45, P257, DOI 10.1016/S0167-5877(00)00133-1; Weitzel T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1880-9; Weitzel T, 2016, NEW ENGL J MED, V375, P954, DOI 10.1056/NEJMoa1603657; Weller, 2011, TROPICAL INFECT DIS, P334; Xu G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006062; Yancey CB, 2014, VECTOR-BORNE ZOONOT, V14, P724, DOI 10.1089/vbz.2014.1592	38	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200362	10.1371/journal.pone.0200362	http://dx.doi.org/10.1371/journal.pone.0200362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979764	Green Published, gold, Green Submitted			2022-12-26	WOS:000437809500101
J	Zhao, CY; Fu, HT; Sun, SM; Qiao, H; Zhang, WY; Jin, SB; Jiang, SF; Xiong, YW; Gong, YS				Zhao, Caiyuan; Fu, Hongtuo; Sun, Shengming; Qiao, Hui; Zhang, Wenyi; Jin, Shubo; Jiang, Sufei; Xiong, Yiwei; Gong, Yongsheng			A transcriptome study on Macrobrachium nipponense hepatopancreas experimentally challenged with white spot syndrome virus (WSSV)	PLOS ONE			English	Article							SHRIMP LITOPENAEUS-VANNAMEI; IMMUNE-RELATED GENES; HEAT-SHOCK PROTEINS; FENNEROPENAEUS-CHINENSIS; EXPRESSION PROFILES; PENAEUS-MONODON; ANTIOXIDANT ENZYMES; VIBRIO-ANGUILLARUM; PEROXIREDOXIN GENE; MOLECULAR-CLONING	White spot syndrome virus (WSSV) is one of the most devastating pathogens of cultured shrimp, responsible for massive loss of its commercial products worldwide. The oriental river prawn Macrobrachium nipponense is an economically important species that is widely farmed in China and adult prawns can be infected by WSSV. However, the molecular mechanisms of the host pathogen interaction remain unknown. There is an urgent need to learn the host pathogen interaction between M. nipponense and WSSV which will be able to offer a solution in controlling the spread of WSSV. Next Generation Sequencing (NGS) was used in this study to determin the transcriptome differences by the comparison of control and WSSV-challenged moribund samples, control and WSSV-challenged survived samples of hepatopancreas in M. nipponense. A total of 64,049 predicted unigenes were obtained and classified into 63 functional groups. Approximately, 4,311 differential expression genes were identified with 3,308 genes were up-regulated when comparing the survived samples with the control. In the comparison of moribund samples with control, 1,960 differential expression genes were identified with 764 genes were up-regulated. In the contrast of two comparison libraries, 300 mutual DEGs with 95 up-regulated genes and 205 down-regulated genes. All the DEGs were performed GO and KEGG analysis, overall a total of 85 immune-related genes were obtained and these gene were groups into 13 functions and 4 KEGG pathways, such as protease inhibitors, heat shock proteins, oxidative stress, pathogen recognition immune receptors, PI3K/AKT/mTOR pathway, MAPK signaling pathway and Ubiquitin Proteasome Pathway. Ten genes that valuable in immune responses against WSSV were selected from those DEGs to furture discuss the response of host to WSSV. Results from this study contribute to a better understanding of the immune response of M. nipponense to WSSV, provide information for identifying novel genes in the absence of genome of M. nipponense. Furthermore, large number of transcripts obtained from this study could provide a strong basis for future genomic research on M. nipponense.	[Zhao, Caiyuan; Fu, Hongtuo] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China; [Fu, Hongtuo; Sun, Shengming; Qiao, Hui; Zhang, Wenyi; Jin, Shubo; Jiang, Sufei; Xiong, Yiwei; Gong, Yongsheng] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China	Nanjing Agricultural University; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Fu, HT (corresponding author), Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China.; Fu, HT (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China.	fuht@ffrc.cn	Zhao, Caiyuan/AAY-4428-2021	Jin, Shubo/0000-0002-6550-9268; caiyuan, zhao/0000-0002-8110-7509	National Natural Science Foundation of China [31572617]; New Cultivar Breeding Major Project in Jiangsu Province [PZCZ201745]; Science & Technology Supporting Program of Jiangsu Province [BE2016308]; China Agriculture Research System-48 [CARS-48]; Central Public-interest Scientific Institution Basal Research Fund CAFS [2017JBFZ05]; Science and Technology Development Fund of Wuxi [CLE02N1514]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Cultivar Breeding Major Project in Jiangsu Province; Science & Technology Supporting Program of Jiangsu Province; China Agriculture Research System-48; Central Public-interest Scientific Institution Basal Research Fund CAFS; Science and Technology Development Fund of Wuxi	This work was supported by the National Natural Science Foundation of China (Grant No. 31572617), the New Cultivar Breeding Major Project in Jiangsu Province (PZCZ201745), the Science & Technology Supporting Program of Jiangsu Province (BE2016308), the China Agriculture Research System-48(CARS-48), the Central Public-interest Scientific Institution Basal Research Fund CAFS (2017JBFZ05), the Science and Technology Development Fund of Wuxi (CLE02N1514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; APHIS-USDA (Animal and Plant Health Inspection Serv-ice-United States Department of Agriculture), 2005, IMP WORKSH WHIT SPOT; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bank World, 2013, FISH 2030 PROSP FISH; Baruah K, 2014, DEV COMP IMMUNOL, V46, P470, DOI 10.1016/j.dci.2014.06.004; Battistini A, 2009, J INTERF CYTOK RES, V29, P765, DOI 10.1089/jir.2009.0030; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bureau of Fishery Ministry of Agriculture PRC, 2016, FISH EC STAT CHIN FI, P30; Byadgi O, 2016, FISH SHELLFISH IMMUN, V58, P593, DOI 10.1016/j.fsi.2016.10.006; Cao J, 2017, FISH SHELLFISH IMMUN, V67, P27, DOI 10.1016/j.fsi.2017.05.059; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chaurasia MK, 2016, FISH SHELLFISH IMMUN, V54, P353, DOI 10.1016/j.fsi.2016.04.031; Chaurasia MK, 2016, FISH SHELLFISH IMMUN, V48, P228, DOI 10.1016/j.fsi.2015.11.034; Cheesman HK, 2016, G3-GENES GENOM GENET, V6, P541, DOI 10.1534/g3.115.025650; Chen IT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27732; Chen MZ, 2006, VIRAL IMMUNOL, V19, P349, DOI 10.1089/vim.2006.19.349; Chen P, 2011, AQUACULTURE, V322, P10, DOI 10.1016/j.aquaculture.2011.09.009; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; Chen YH, 2016, FISH SHELLFISH IMMUN, V54, P153, DOI 10.1016/j.fsi.2015.10.027; Chou HY, 1995, DIS AQUAT ORGAN, V23, P165, DOI 10.3354/dao023165; Christie AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145964; Colaco CA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/461230; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Medeiros MC, 2014, J APPL ORAL SCI, V22, P185, DOI 10.1590/1678-775720130593; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dieu BTM, 2004, J GEN VIROL, V85, P3607, DOI 10.1099/vir.0.80344-0; Du ZQ, 2010, FISH SHELLFISH IMMUN, V28, P134, DOI 10.1016/j.fsi.2009.10.009; Duan YF, 2013, FISH SHELLFISH IMMUN, V35, P661, DOI 10.1016/j.fsi.2013.05.016; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Feng WR, 2014, GENE, V544, P184, DOI 10.1016/j.gene.2014.04.051; Flegel TW, 2011, MAR BIOTECHNOL, V13, P587, DOI 10.1007/s10126-010-9287-x; Fu HT, 2012, AQUAC RES, V43, P993, DOI 10.1111/j.1365-2109.2011.03085.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; He W, 2015, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2015.01086; He YY, 2018, GENE, V642, P381, DOI 10.1016/j.gene.2017.11.050; Hu KJ, 2007, COMP BIOCHEM PHYS B, V146, P69, DOI 10.1016/j.cbpb.2006.09.010; Huang CH, 2001, VIRUS RES, V76, P115, DOI 10.1016/S0168-1702(01)00247-7; Hughes EM, 2004, COMP BIOCHEM PHYS C, V137, P237, DOI 10.1016/j.cca.2004.01.006; Ikushima H, 2013, COLD SH Q B, V78, P105, DOI 10.1101/sqb.2013.78.020321; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; James R, 2010, FISH SHELLFISH IMMUN, V29, P884, DOI 10.1016/j.fsi.2010.07.029; Ji PF, 2009, FISH SHELLFISH IMMUN, V27, P563, DOI 10.1016/j.fsi.2009.08.001; Jiang H, 2014, MAR BIOTECHNOL, V16, P111, DOI 10.1007/s10126-013-9538-8; Jin SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076840; Joly AL, 2010, J INNATE IMMUN, V2, P238, DOI 10.1159/000296508; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapoor C., 2013, AM J MED DENT SCI, V1, P31; Keezhedath J, 2013, INDIAN J VIROL, V24, P48, DOI 10.1007/s13337-013-0131-6; KIM YS, 2009, FISH SHELLFISH IMMUN, V27, P336, DOI DOI 10.1016/j.fsi.2009.06.006; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar SR, 2008, FISH SHELLFISH IMMUN, V24, P467, DOI 10.1016/j.fsi.2008.01.004; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee XZ, 2016, FISH SHELLFISH IMMUN, V49, P213, DOI 10.1016/j.fsi.2015.12.007; Leng XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep17749; Li CZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15078; Li CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047442; Li JT, 2018, J OCEAN U CHINA, V17, P399, DOI 10.1007/s11802-018-3392-2; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Loureiro J, 2006, ADV IMMUNOL, V92, P225, DOI 10.1016/S0065-2776(06)92006-9; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Marks H, 2005, THESIS; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Mjahed H, 2012, EXP CELL RES, V318, P1946, DOI 10.1016/j.yexcr.2012.05.012; Mohankumar K, 2006, VIRUS RES, V115, P69, DOI 10.1016/j.virusres.2005.07.006; Moody D.E., 2001, J ANIM SCI, V79, pE128, DOI [10.2527/jas2001.79E-SupplE128x, DOI 10.2527/JAS2001.79E-SUPPLE128X]; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V58, P469, DOI 10.1111/j.1865-1682.2011.01231.x; OIE (Office International des Epizooties/World Animal Health Organization), 2011, IMM NOT; Pandey S, 2003, SCI TOTAL ENVIRON, V309, P105, DOI 10.1016/S0048-9697(03)00006-8; Parrilla-Taylor DP, 2013, AQUACULTURE, V380, P41, DOI 10.1016/j.aquaculture.2012.11.031; Pinsino A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14492; Pradeep B, 2008, VIROLOGY, V376, P24, DOI 10.1016/j.virol.2008.02.037; Pradeep B, 2012, INDIAN J VIROL, V23, P161, DOI 10.1007/s13337-012-0079-y; Qiao H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10439-2; Rao R, 2016, J INVERTEBR PATHOL, V136, P10, DOI 10.1016/j.jip.2016.01.002; Ren Q, 2009, COMP BIOCHEM PHYS C, V149, P613, DOI 10.1016/j.cbpc.2009.01.007; Rosenberry B., 2001, SHRIMP NEWS INT, P324; Sablok G, 2012, ARCH VIROL, V157, P2357, DOI 10.1007/s00705-012-1395-7; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Shi H, 2012, FISH SHELLFISH IMMUN, V33, P813, DOI 10.1016/j.fsi.2012.07.008; Shi H, 2012, DEV COMP IMMUNOL, V37, P421, DOI 10.1016/j.dci.2012.03.002; Shi JX, 2016, CELL STRESS CHAPERON, V21, P295, DOI 10.1007/s12192-015-0660-6; Silke J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008730; Sithigorngul W, 2006, DIS AQUAT ORGAN, V72, P101, DOI 10.3354/dao072101; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004196; Subasinghe R.P., 2001, FAO FISHERIES TECHNI; Sun SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1701-3; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang KFJ, 2012, DIS AQUAT ORGAN, V99, P179, DOI 10.3354/dao02470; Tendencia EA, 2011, ISR J AQUACULT-BAMID, V63; Tian JX, 2011, FISH SHELLFISH IMMUN, V30, P234, DOI 10.1016/j.fsi.2010.10.013; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Velma V, 2011, ENVIRON TOXICOL, V26, P649, DOI 10.1002/tox.20602; Vidya R, 2013, INDIAN J VIROL, V24, P82, DOI 10.1007/s13337-012-0113-0; Wang PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072592; Wang S, 2018, DEV COMP IMMUNOL, V78, P61, DOI 10.1016/j.dci.2017.09.015; Wang S, 2016, FISH SHELLFISH IMMUN, V48, P285, DOI 10.1016/j.fsi.2015.12.014; Wang XW, 2013, FISH SHELLFISH IMMUN, V34, P981, DOI 10.1016/j.fsi.2012.08.008; Xu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059703; Xu JH, 2016, FISH SHELLFISH IMMUN, V56, P417, DOI 10.1016/j.fsi.2016.07.032; Ye T, 2015, FISH SHELLFISH IMMUN, V42, P138, DOI 10.1016/j.fsi.2014.10.039; Yin Rong, 2017, Sheng Wu Gong Cheng Xue Bao, V33, P946, DOI 10.13345/j.cjb.170005; Yuan JL, 2015, TOXINS, V7, P4006, DOI 10.3390/toxins7104006; Yuan K, 2017, DEV COMP IMMUNOL, V72, P9, DOI 10.1016/j.dci.2017.02.003; Yun JM, 2014, CRUSTACEANA, V87, P866, DOI 10.1163/15685403-00003327; Zhang HJ, 2018, FISH SHELLFISH IMMUN, V76, P279, DOI 10.1016/j.fsi.2018.02.045; Zhang QL, 2008, FISH SHELLFISH IMMUN, V24, P584, DOI 10.1016/j.fsi.2008.01.008; Zhang QL, 2007, MOL IMMUNOL, V44, P3501, DOI 10.1016/j.molimm.2007.03.014; Zhao CY, 2017, DIS AQUAT ORGAN, V126, P125, DOI 10.3354/dao03165	114	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200222	10.1371/journal.pone.0200222	http://dx.doi.org/10.1371/journal.pone.0200222			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979781	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500081
J	Fortin, GM; Ducrot, C; Giguere, N; Kouwenhoven, WM; Bourque, MJ; Pacelli, C; Varaschin, RK; Brill, M; Singh, S; Wiseman, PW; Trudeau, LE				Fortin, Guillaume M.; Ducrot, Charles; Giguere, Nicolas; Kouwenhoven, Willemieke M.; Bourque, Marie-Josee; Pacelli, Consiglia; Varaschin, Rafael Koerich; Brill, Marion; Singh, Sherdeep; Wiseman, Paul W.; Trudeau, Louis-Eric			Segregation of dopamine and glutamate release sites in dopamine neuron axons: regulation by striatal target cells	FASEB JOURNAL			English	Article						neurobiology; neurotransmitter; plasticity; VGLUT2	TYROSINE-HYDROXYLASE; GABAERGIC PHENOTYPE; NUCLEUS-ACCUMBENS; GRANULE CELLS; MIDBRAIN; RAT; CORELEASE; DORSAL; VGLUT2; EXPRESSION	Dopamine (DA) is a key regulator of circuits controlling movement and motivation. A subset of midbrain DA neurons has been shown to express the vesicular glutamate transporter (VGLUT)2, underlying their capacity for glutamate release. Glutamate release is found mainly by DA neurons of the ventral tegmental area (VTA) and can be detected at terminals contacting ventral, but not dorsal, striatal neurons, suggesting the possibility that target-derived signals regulate the neurotransmitter phenotype of DA neurons. Whether glutamate can be released from the same terminals that release DA or from a special subset of axon terminals is unclear. Here, we provide in vitro and in vivo data supporting the hypothesis that DA and glutamate-releasing terminals in mice are mostly segregated and that striatal neurons regulate the cophenotype of midbrain DA neurons and the segregation of release sites. Our work unveils a fundamental feature of dual neurotransmission and plasticity of the DA system.Fortin, G. M., Ducrot, C., Giguere, N., Kouwenhoven, W. M., Bourque, M.-J., Pacelli, C., Varaschin, R. K., Brill, M., Singh, S., Wiseman, P. W., Trudeau, L.-E. Segregation of dopamine and glutamate release sites in dopamine neuron axons: regulation by striatal target cells.	[Fortin, Guillaume M.; Ducrot, Charles; Giguere, Nicolas; Kouwenhoven, Willemieke M.; Bourque, Marie-Josee; Pacelli, Consiglia; Varaschin, Rafael Koerich; Brill, Marion; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ, Canada; [Ducrot, Charles; Giguere, Nicolas; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Neurosci, Montreal, PQ, Canada; [Trudeau, Louis-Eric] Univ Montreal, Fac Med, Grp Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Singh, Sherdeep; Wiseman, Paul W.] McGill Univ, Dept Chem, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; McGill University	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Downtown Branch, CP 6128,Succursale Ctr Ville Montreal, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020; Core, Vector/CAF-4832-2022	Trudeau, Louis-Eric/0000-0003-4684-1377; Ducrot, Charles/0000-0002-5451-1610	Canadian Institutes of Health Research (CIHR) [MOP-106556]; Brain Canada Foundation (Krembil Foundation); Fonds de la Recherche du Quebec en Sante (FRQS); Parkinson Society of Canada; FRQS; National Council for Scientific and Technological Development (CNPq); National Sciences and Engineering Research Council (NSERC) of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Brain Canada Foundation (Krembil Foundation); Fonds de la Recherche du Quebec en Sante (FRQS); Parkinson Society of Canada; FRQS; National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors thank Dr. Kazuto Kobayashi (Fukushima University, Fukushima, Japan) for providing the TH-GFP mice. This work was funded by grants to L.-E.T. from the Canadian Institutes of Health Research (CIHR; MOP-106556) and the Brain Canada Foundation (Krembil Foundation). L.-E.T. also benefited from an infrastructure grant of the Fonds de la Recherche du Quebec en Sante (FRQS) to the Groupe de Recherche sur le Systeme Nerveux Central. G.M.F., N.G., and C.P. received partial salary support from the Parkinson Society of Canada, and R.K.V. was the recipient of a postdoctoral fellowship from FRQS and National Council for Scientific and Technological Development (CNPq). Research in the P.W.W. laboratory was supported by the National Sciences and Engineering Research Council (NSERC) of Canada. The authors declare no conflicts of interest.	Adrover MF, 2014, J NEUROSCI, V34, P3183, DOI 10.1523/JNEUROSCI.4958-13.2014; Aguilar JI, 2017, NEURON, V95, P1074, DOI 10.1016/j.neuron.2017.07.038; Alsio J, 2011, J NEUROSCI, V31, P12593, DOI 10.1523/JNEUROSCI.2397-11.2011; Avelar AJ, 2013, J NEUROCHEM, V125, P373, DOI 10.1111/jnc.12197; Berube-Carriere N, 2012, EUR J NEUROSCI, V35, P527, DOI 10.1111/j.1460-9568.2012.07992.x; Berube-Carriere N, 2009, J COMP NEUROL, V517, P873, DOI 10.1002/cne.22194; Birgner C, 2010, P NATL ACAD SCI USA, V107, P389, DOI 10.1073/pnas.0910986107; Bolam JP, 2012, MOVEMENT DISORD, V27, P1478, DOI 10.1002/mds.25135; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; Cartier EA, 2010, J BIOL CHEM, V285, P1957, DOI 10.1074/jbc.M109.054510; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Dal Bo G, 2004, J NEUROCHEM, V88, P1398, DOI 10.1046/j.1471-4159.2003.02277.x; Depuy SD, 2013, J NEUROSCI, V33, P1486, DOI 10.1523/JNEUROSCI.4269-12.2013; Descarries L, 2008, BRAIN RES REV, V58, P290, DOI 10.1016/j.brainresrev.2007.10.005; El Mestikawy S, 2011, NAT REV NEUROSCI, V12, P204, DOI 10.1038/nrn2969; FAHN S, 1969, J NEUROCHEM, V16, P1293, DOI 10.1111/j.1471-4159.1969.tb05979.x; Fasano Caroline, 2008, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0321s44; Forlano PM, 2010, J COMP NEUROL, V518, P1330, DOI 10.1002/cne.22279; Fortin GM, 2012, J NEUROSCI, V32, P17477, DOI 10.1523/JNEUROSCI.1939-12.2012; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Godin AG, 2011, P NATL ACAD SCI USA, V108, P7010, DOI 10.1073/pnas.1018658108; Gorelova N, 2012, CEREB CORTEX, V22, P327, DOI 10.1093/cercor/bhr107; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Halskau O, 2009, J BIOL CHEM, V284, P32758, DOI 10.1074/jbc.M109.027706; Hnasko TS, 2012, ANNU REV PHYSIOL, V74, P225, DOI 10.1146/annurev-physiol-020911-153315; Hnasko TS, 2010, NEURON, V65, P643, DOI 10.1016/j.neuron.2010.02.012; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; Kawano M, 2006, J COMP NEUROL, V498, P581, DOI 10.1002/cne.21054; Li XP, 2013, BRAIN STRUCT FUNCT, V218, P1159, DOI 10.1007/s00429-012-0452-z; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Mingote S, 2017, ELIFE, V6, DOI 10.7554/eLife.27566; Moss J, 2011, EUR J NEUROSCI, V33, P1205, DOI 10.1111/j.1460-9568.2011.07594.x; Onoa B, 2010, J NEUROSCI, V30, P7917, DOI 10.1523/JNEUROSCI.5298-09.2010; Prensa L, 2001, J NEUROSCI, V21, P7247, DOI 10.1523/JNEUROSCI.21-18-07247.2001; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Steinkellner T, 2018, J CLIN INVEST, V128, P774, DOI 10.1172/JCI95795; Stuber GD, 2010, J NEUROSCI, V30, P8229, DOI 10.1523/JNEUROSCI.1754-10.2010; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Tritsch NX, 2014, ELIFE, V3, DOI 10.7554/eLife.01936; Tritsch NX, 2012, NATURE, V490, P262, DOI 10.1038/nature11466; Trudeau LE, 2014, PROG BRAIN RES, V211, P141, DOI 10.1016/B978-0-444-63425-2.00006-4; Wang DV, 2017, CELL REP, V18, P2584, DOI 10.1016/j.celrep.2017.02.062; Yamaguchi T, 2011, J NEUROSCI, V31, P8476, DOI 10.1523/JNEUROSCI.1598-11.2011; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004; Yue M, 2015, NEUROBIOL DIS, V78, P172, DOI 10.1016/j.nbd.2015.02.031; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945; Zhang T, 2009, J NEUROSCI, V29, P4035, DOI 10.1523/JNEUROSCI.0261-09.2009; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	53	20	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					400	417		10.1096/fj.201800713RR	http://dx.doi.org/10.1096/fj.201800713RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30011230				2022-12-26	WOS:000457401500032
J	Jaggupilli, A; Singh, N; De Jesus, VC; Gounni, MS; Dhanaraj, P; Chelikani, P				Jaggupilli, Appalaraju; Singh, Nisha; De Jesus, Vivianne Cruz; Gounni, Mohamed Soussi; Dhanaraj, Premnath; Chelikani, Prashen			Chemosensory bitter taste receptors (T2Rs) are activated by multiple antibiotics	FASEB JOURNAL			English	Article						levofloxacin; tobramycin; structure-function; GPCR; cystic fibrosis	PROTEIN-COUPLED RECEPTORS; EXPRESSION; CELLS; LEVOFLOXACIN; INFECTION; FAMILY	Many medications including antibiotics taste bitter. The potency of these antibiotics on the 25 bitter taste receptors (T2Rs) in humans remains poorly understood. Here we characterize by sensory and structure-function analyses how antibiotics frequently used to treat airway infections in cystic fibrosis activate multiple human T2Rs. The potency of the broad-spectrum antibiotics, tobramycin, levofloxacin, and azithromycin on the highly expressed T2Rs in airways, T2R4, T2R14, and T2R20 was pursued. The amino acids and structural features of T2R4, T2R14, and T2R20 important for antibiotic binding were characterized by mutational analysis in heterologous cell-based assays. Strikingly, extracellular loop 2 in T2Rs performs a key function in binding to antibiotics with contribution from residues in transmembrane helices. Our results suggest that different antibiotics activate multiple T2Rs with different potencies. An understanding of the nonantibiotic and physiologic effects mediated through T2Rs on the host cells is much needed.Jaggupilli, A., Singh, N., De Jesus, V. C., Gounni, M. S., Dhanaraj, P., Chelikani, P. Chemosensory bitter taste receptors (T2Rs) are activated by multiple antibiotics.	Univ Manitoba, CHRIM, Manitoba Chemosensory Biol Res Grp, Winnipeg, MB, Canada; Univ Manitoba, CHRIM, Dept Oral Biol, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chelikani, P (corresponding author), Univ Manitoba, Manitoba Chemosensory Biol Res Grp, D319,780 Bannatyne Ave, Winnipeg, MB R3E 0W4, Canada.; Chelikani, P (corresponding author), Univ Manitoba, Dept Oral Biol, D319,780 Bannatyne Ave, Winnipeg, MB R3E 0W4, Canada.	prashen.chelikani@.umanitoba.ca	de Jesus, Vivianne Cruz/AAJ-2645-2021; dhanaraj, premnath/C-2265-2011	Chelikani, Prashen/0000-0003-1129-7957; dhanaraj, premnath/0000-0002-1969-4917; Cruz de Jesus, Vivianne/0000-0002-9755-7037; Singh, Nisha/0000-0003-0330-6411; Jaggupilli, Appalaraju/0000-0002-1718-8551	Cystic Fibrosis Canada Operating Grant [491120]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04099]; University of Manitoba Graduate Fellowship; University of Manitoba Mitacs Accelerate Fellowship	Cystic Fibrosis Canada Operating Grant; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Manitoba Graduate Fellowship; University of Manitoba Mitacs Accelerate Fellowship	The authors thank the following members of the P.K. laboratory at the University of Manitoba: Feroz Ahmed Shaik for providing T2R14 stable cell line, Kun Liu for assisting with flow cytometry method, and Anurag Singh Sikarwar for comments on the manuscript. This work was supported by Cystic Fibrosis Canada Operating Grant 491120, and Discovery Grant RGPIN-2014-04099 from the Natural Sciences and Engineering Research Council of Canada (to P.C.), and University of Manitoba Graduate Fellowship and Mitacs Accelerate Fellowship (to A.J.). The authors declare no conflicts of interest.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Avau B, 2016, ACTA PHYSIOL, V216, P407, DOI 10.1111/apha.12621; Babu KS, 2013, RESP MED, V107, P800, DOI 10.1016/j.rmed.2013.02.009; Badal S, 2015, J BIOL CHEM, V290, P22287, DOI 10.1074/jbc.M115.671222; Chakraborty R, 2015, METHOD ENZYMOL, V556, P267, DOI 10.1016/bs.mie.2014.12.013; Chmiel James F, 2014, Ann Am Thorac Soc, V11, P1298, DOI 10.1513/AnnalsATS.201405-203AS; Clark AA, 2012, FASEB J, V26, P4827, DOI 10.1096/fj.12-215087; Culic O, 2001, EUR J PHARMACOL, V429, P209, DOI 10.1016/S0014-2999(01)01321-8; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Di Pizio A, 2016, METHOD CELL BIOL, V132, P401, DOI 10.1016/bs.mcb.2015.10.005; Dotson CD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003974; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Foster SR, 2014, PHARMACOL THERAPEUT, V142, P41, DOI 10.1016/j.pharmthera.2013.11.004; Foster SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064579; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Gao XG, 2010, PULM PHARMACOL THER, V23, P97, DOI 10.1016/j.pupt.2009.10.010; Geller DE, 2009, RESP CARE, V54, P658, DOI 10.4187/aarc0537; Good JT, 2012, CURR OPIN PULM MED, V18, P76, DOI 10.1097/MCP.0b013e32834daff8; Hobson-Webb LD, 2006, J CHILD NEUROL, V21, P429, DOI 10.1177/08830738060210051201; Huth ME, 2015, J CLIN INVEST, V125, P583, DOI 10.1172/JCI77424; Jaggupilli A, 2018, ACS INFECT DIS, V4, P1146, DOI 10.1021/acsinfecdis.8b00094; Jaggupilli A, 2017, MOL CELL BIOCHEM, V426, P137, DOI 10.1007/s11010-016-2902-z; Jaggupilli A, 2016, INT J BIOCHEM CELL B, V77, P184, DOI 10.1016/j.biocel.2016.03.005; Jiang MY, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00308; Kitazawa T, 2007, LIFE SCI, V80, P1572, DOI 10.1016/j.lfs.2007.01.025; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Liggett Stephen B, 2014, Trans Am Clin Climatol Assoc, V125, P64; Liu K, 2018, BBA-BIOMEMBRANES, V1860, P991, DOI 10.1016/j.bbamem.2018.01.014; Lu P, 2017, J GEN PHYSIOL, V149, P181, DOI 10.1085/jgp.201611637; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Miravitlles M, 2013, AM J RESP CRIT CARE, V188, P1052, DOI 10.1164/rccm.201302-0289PP; Munk C, 2016, BRIT J PHARMACOL, V173, P2195, DOI 10.1111/bph.13509; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Orsmark-Pietrast C, 2013, EUR RESPIR J, V42, P65, DOI 10.1183/09031936.00077712; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Pawlowski AC, 2016, CURR OPIN BIOTECH, V42, P108, DOI 10.1016/j.copbio.2016.04.006; Perry JA, 2014, BIOESSAYS, V36, P1179, DOI 10.1002/bies.201400128; Pydi SP, 2014, J BIOL CHEM, V289, P25054, DOI 10.1074/jbc.M114.576975; Pydi SP, 2016, BBA-BIOMEMBRANES, V1858, P2081, DOI 10.1016/j.bbamem.2016.06.005; Pydi SP, 2012, CURR PROTEIN PEPT SC, V13, P501; Reichling C, 2008, J NEUROCHEM, V106, P1138, DOI 10.1111/j.1471-4159.2008.05453.x; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Rollins DR, 2010, CURR ALLERGY ASTHM R, V10, P67, DOI 10.1007/s11882-009-0086-2; Rozengurt N, 2006, AM J PHYSIOL-GASTR L, V291, pG792, DOI 10.1152/ajpgi.00074.2006; Sadarangani SP, 2015, MAYO CLIN PROC, V90, P109, DOI 10.1016/j.mayocp.2014.09.006; Sengupta S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00047; Shaik FA, 2016, INT J BIOCHEM CELL B, V77, P197, DOI 10.1016/j.biocel.2016.03.011; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Singh N, 2011, J BIOL CHEM, V286, P36032, DOI 10.1074/jbc.M111.246983; Siva R, 2014, INT J CHRONIC OBSTR, V9, P179, DOI 10.2147/COPD.S55419; Stockmann C, 2013, PEDIATR PULM, V48, P211, DOI 10.1002/ppul.22667; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Uchida T, 2003, J PHARM PHARMACOL, V55, P1479, DOI 10.1211/0022357022106; Upadhyaya J, 2015, BBA-BIOMEMBRANES, V1848, P1502, DOI 10.1016/j.bbamem.2015.03.035; Upadhyaya JD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156347; Upadhyaya JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110373; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yan CH, 2017, AM J RHINOL ALLERGY, V31, P85, DOI 10.2500/ajra.2017.31.4424; Zhang CL, 2018, J AGR FOOD CHEM, V66, P4902, DOI 10.1021/acs.jafc.8b00830; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11720-0	62	28	28	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					501	517		10.1096/fj.201800521RR	http://dx.doi.org/10.1096/fj.201800521RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30011231				2022-12-26	WOS:000457401500040
J	Kong, FY; Deng, X; Kong, XY; Du, YQ; Li, L; Zhu, HY; Wang, YX; Xie, DC; Guha, S; Li, ZS; Guan, M; Xie, KP				Kong, Fanyang; Deng, Xuan; Kong, Xiangyu; Du, Yiqi; Li, Lei; Zhu, Huiyun; Wang, Yuxin; Xie, Dacheng; Guha, Shivani; Li, Zhaoshen; Guan, Ming; Xie, Keping			ZFPM2-AS1, a novel IncRNA, attenuates the p53 pathway and promotes gastric carcinogenesis by stabilizing MIF	ONCOGENE			English	Article							MIGRATION-INHIBITORY FACTOR; LONG NONCODING RNAS; MOLECULAR-MECHANISMS; PANCREATIC-CANCER; CELL-PROLIFERATION; ANTISENSE LNCRNA; EXPRESSION; PROGRESSION; GROWTH; ADENOCARCINOMA	Long non-coding RNAs (lncRNAs) are implicated to be involved in the pathogenesis of many cancers. Herein we report on our discovery of a novel lncRNA, ZFPM2 antisense RNA 1 (ZFPM2-AS1), and its critical role in gastric carcinogenesis. ZFPM2-AS1 expression in gastric cancer specimens was analyzed using Gene Expression Omnibus data set and validated in 73 paired gastric tumor and normal adjacent gastric tissue specimens using qRT-PCR. The effect of ZFPM2-AS1 expression on proliferation and apoptosis in gastric cancer cells was assessed by altering its expression in vitro and in vivo. Mechanistic investigation was carried out using cell and molecular biological approaches. ZFPM2-AS1 expression was higher in gastric tumors than in normal gastric tissue. Also, increased ZFPM2-AS1 expression in gastric cancer specimens was associated with tumor size, depth of tumor invasion, differentiation grade, and TNM stage. High ZFPM2-AS1 expression predicted markedly reduced overall and disease-free survival in gastric cancer patients. Functional experiments demonstrated that ZFPM2-AS1 expression promoted proliferation and suppressed apoptosis of gastric cancer cells in vitro and promoted tumor growth in vivo. This effect is associated with attenuated nuclear translocation of p53. Mechanistic experiments demonstrated that tumor-activated ZFPM2-AS1 could bind to and protect the degradation of macrophage migration inhibitory factor (MIF), a potent destabilizer of p53. Knockdown of MIF expression diminished ZFPM2-AS1's impact on p53 expression in gastric cancer cells. Our findings demonstrated that ZFPM2-AS1 regulates gastric cancer progression and revealed a novel ZFPM2-AS1/MIF/p53 signaling axis, shedding light on the molecular mechanisms underlying the tumorigenicity of certain malignant gastric cells.	[Kong, Fanyang; Kong, Xiangyu; Du, Yiqi; Li, Lei; Zhu, Huiyun; Wang, Yuxin; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Kong, Fanyang; Kong, Xiangyu; Xie, Dacheng; Guha, Shivani; Xie, Keping] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Deng, Xuan; Guan, Ming] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Lab Med, Shanghai, Peoples R China	Naval Medical University; University of Texas System; UTMD Anderson Cancer Center; Fudan University	Li, ZS (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai, Peoples R China.; Xie, KP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.; Guan, M (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Lab Med, Shanghai, Peoples R China.	zhaoshenli5610@hotmail.com; guanminghsyy@hotmail.com; kepxie@mdanderson.org	Zhu, Huiyun/S-8032-2019		National Cancer Institute, National Institutes of Health [R01CA172233, R01CA195651, R01CA198090]; National Natural Science Foundation of China [81772640]; NATIONAL CANCER INSTITUTE [R21CA140999, R01CA220236, R01CA172233, R01CA195651, R01CA198090] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA172233, R01CA195651, and R01CA198090 from the National Cancer Institute, National Institutes of Health (to K.X.) and grant 81772640 from the National Natural Science Foundation of China (to X.K.).	Amit-Avraham I, 2015, P NATL ACAD SCI USA, V112, pE982, DOI 10.1073/pnas.1420855112; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Beermann J, 2016, PHYSIOL REV, V96, P1297, DOI 10.1152/physrev.00041.2015; Bellini MF, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/891961; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Fu M, 2016, ONCOL REP, V36, P1207, DOI 10.3892/or.2016.4929; Fukaya R, 2016, CANCER RES, V76, P2813, DOI 10.1158/0008-5472.CAN-15-1011; GABBERT HE, 1995, CANCER, V76, P720, DOI 10.1002/1097-0142(19950901)76:5<720::AID-CNCR2820760503>3.0.CO;2-E; Guo K, 2017, CLIN CANCER RES, V23, P687, DOI 10.1158/1078-0432.CCR-16-1064; He XX, 2006, GUT, V55, P797, DOI 10.1136/gut.2005.078113; Huang B, 2016, ONCOGENE, V35, P4927, DOI 10.1038/onc.2016.25; Huarte M, 2015, NAT MED, V21, P1253, DOI 10.1038/nm.3981; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; IMAZEKI F, 1992, GASTROENTEROLOGY, V103, P892, DOI 10.1016/0016-5085(92)90022-Q; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kong FY, 2017, CANCER RES, V77, P6851, DOI 10.1158/0008-5472.CAN-17-0067; Larsen M, 2008, CANCER LETT, V265, P239, DOI 10.1016/j.canlet.2008.02.012; Li TW, 2016, ONCOTARGET, V7, P8601, DOI 10.18632/oncotarget.6926; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Lopez-Saez JF, 1998, HISTOL HISTOPATHOL, V13, P1197, DOI 10.14670/HH-13.1197; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Oda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002215; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Schulz R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.508; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Shi XF, 2015, TUMOR BIOL, V36, P503, DOI 10.1007/s13277-015-3106-y; Shun CT, 2005, WORLD J GASTROENTERO, V11, P3767, DOI 10.3748/wjg.v11.i24.3767; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sugano K, 2015, BEST PRACT RES CL GA, V29, P895, DOI 10.1016/j.bpg.2015.09.013; Sun BL, 2003, INT J MOL MED, V12, P633; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Villegas VE, 2015, INT J MOL SCI, V16, P3251, DOI 10.3390/ijms16023251; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wei N, 2015, ANIM GENET, V46, P133, DOI 10.1111/age.12275; Werner A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-31; Wight M, 2013, ESSAYS BIOCHEM, V54, P91, DOI [10.1042/BSE0540091, 10.1042/bse0540091]; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Yang SH, 2016, CANCER RES, V76, P3838, DOI 10.1158/0008-5472.CAN-15-2841; Zhang CL, 2017, CANCER LETT, V396, P66, DOI 10.1016/j.canlet.2017.03.018	52	65	68	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5982	5996		10.1038/s41388-018-0387-9	http://dx.doi.org/10.1038/s41388-018-0387-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29985481	Green Accepted			2022-12-26	WOS:000449562500006
J	Sweeny, EA; Singh, AB; Chakravarti, R; Martinez-Guzman, O; Saini, A; Haque, MM; Garee, G; Dans, PD; Hannibal, L; Reddi, AR; Stuehr, DJ				Sweeny, Elizabeth A.; Singh, Anuradha Bharara; Chakravarti, Ritu; Martinez-Guzman, Osiris; Saini, Arushi; Haque, Mohammad Mahfuzul; Garee, Greer; Dans, Pablo D.; Hannibal, Luciana; Reddi, Amit R.; Stuehr, Dennis J.			Glyceraldehyde-3-phosphate dehydrogenase is a chaperone that allocates labile heme in cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heme; hemostasis; kinetics; iron; intracellular trafficking; GAPDH; heme chaperone; heme trafficking; porphyrin; tetrapyrroles; heme toxicity	PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; NITRIC-OXIDE; ERYTHROLEUKEMIA-CELLS; PROTEIN; BINDING; BIOSYNTHESIS; SIMULATIONS; TRANSPORT; DIFFERENTIATION	Cellular heme is thought to be distributed between a pool of sequestered heme that is tightly bound within hemeproteins and a labile heme pool required for signaling and transfer into proteins. A heme chaperone that can hold and allocate labile heme within cells has long been proposed but never been identified. Here, we show that the glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) fulfills this role by acting as an essential repository and allocator of bioavailable heme to downstream protein targets. We identified a conserved histidine in GAPDH that is needed for its robust heme binding both in vitro and in mammalian cells. Substitution of this histidine, and the consequent decreases in GAPDH heme binding, antagonized heme delivery to both cytosolic and nuclear hemeprotein targets, including inducible nitric-oxide synthase (iNOS) in murine macrophages and the nuclear transcription factor Hap1 in yeast, even though this GAPDH variant caused cellular levels of labile heme to rise dramatically. We conclude that by virtue of its heme-binding property, GAPDH binds and chaperones labile heme to create a heme pool that is bioavailable to downstream proteins. Our finding solves a fundamental question in cell biology and provides a new foundation for exploring heme homeostasis in health and disease.	[Sweeny, Elizabeth A.; Singh, Anuradha Bharara; Chakravarti, Ritu; Haque, Mohammad Mahfuzul; Garee, Greer; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA; [Martinez-Guzman, Osiris; Saini, Arushi; Reddi, Amit R.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Martinez-Guzman, Osiris; Saini, Arushi; Reddi, Amit R.] Georgia Inst Technol, Parker Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Dans, Pablo D.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Balidiri Reixac 10-12, Barcelona 08028, Spain; [Hannibal, Luciana] Univ Freiburg, Med Ctr, Ctr Pediat, Lab Clin Biochem & Metab, D-79106 Freiburg, Germany; [Chakravarti, Ritu] Univ Toledo, Dept Physiol & Pharmacol, Toledo, OH 43614 USA	Cleveland Clinic Foundation; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Freiburg; University System of Ohio; University of Toledo	Stuehr, DJ (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Inflammat & Immun, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Chakravarti, Ritu/K-8928-2019; Dans, Pablo D./K-6330-2019; Hannibal, Luciana/AAY-7689-2021	Chakravarti, Ritu/0000-0003-4680-8374; Dans, Pablo D./0000-0002-5927-372X; Hannibal, Luciana/0000-0002-0911-5758; HAQUE, MOHAMMAD/0000-0003-0852-6368; Saini, Arushi/0000-0003-1917-4468; Sweeny, Elizabeth/0000-0001-7818-9112	National Institutes of Health [RO1 GM097041, PO1 HL081064, PO1 HL103453, R21 ES025661]; National Science Foundation Grant [MCB-1552791]; American Heart Association Postdoctoral Fellowship; Blanchard Professorship; Georgia Institute of Technology start-up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, U10HL109250, P01HL103453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Grant(National Science Foundation (NSF)); American Heart Association Postdoctoral Fellowship(American Heart Association); Blanchard Professorship; Georgia Institute of Technology start-up funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants RO1 GM097041 (to D. J. S.), PO1 HL081064 Project 3 and PO1 HL103453 Project 3 (to D. J. S.), and R21 ES025661 (to A. R. R.), National Science Foundation Grant MCB-1552791 (to A. R. R.), an American Heart Association Postdoctoral Fellowship (to E. A. S.), the Blanchard Professorship (to A. R. R.), and Georgia Institute of Technology start-up funds (to A. R. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adachi Y, 2017, ARCH BIOCHEM BIOPHYS, V631, P19, DOI 10.1016/j.abb.2017.08.006; Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Capece L, 2009, PROTEINS, V75, P885, DOI 10.1002/prot.22297; Chakravarti R, 2015, FREE RADICAL BIO MED, V82, P105, DOI 10.1016/j.freeradbiomed.2015.01.030; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Cheatham TE., 2017, AMBER 16; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Dans PD, 2016, NUCLEIC ACIDS RES, V44, P4052, DOI 10.1093/nar/gkw264; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; EBERT PS, 1979, BIOCHEM BIOPH RES CO, V88, P1382, DOI 10.1016/0006-291X(79)91133-1; Ghosh A, 2018, P NATL ACAD SCI USA, V115, pE1117, DOI 10.1073/pnas.1717993115; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; Hanna DA, 2016, P NATL ACAD SCI USA, V113, P7539, DOI 10.1073/pnas.1523802113; Hannibal L, 2014, HANDB PORPHYR SCI, V30, P55; Hannibal L, 2012, BIOCHEMISTRY-US, V51, P8514, DOI 10.1021/bi300863a; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HARVEY JW, 1982, BLOOD, V60, P1227; Huang Y, 2017, ARCH BIOCHEM BIOPHYS, V619, P54, DOI 10.1016/j.abb.2017.03.005; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nadra AD, 2008, PROTEINS, V71, P695, DOI 10.1002/prot.21814; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; Ness F, 1998, J BACTERIOL, V180, P1913, DOI 10.1128/JB.180.7.1913-1919.1998; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Severance S, 2009, CHEM REV, V109, P4596, DOI 10.1021/cr9001116; SHEDLOFSKY SI, 1987, BIOCHEM J, V248, P229, DOI 10.1042/bj2480229; SMITH DE, 1994, J CHEM PHYS, V100, P3757, DOI 10.1063/1.466363; Stover PJ, 1997, J BIOL CHEM, V272, P1842, DOI 10.1074/jbc.272.3.1842; Sun FX, 2015, SCI CHINA LIFE SCI, V58, P757, DOI 10.1007/s11427-015-4885-5; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; VINCENT SH, 1985, J BIOL CHEM, V260, P4521; Waheed SM, 2010, FREE RADICAL BIO MED, V48, P1548, DOI 10.1016/j.freeradbiomed.2010.02.038; Walker RC, 2002, J PHYS CHEM B, V106, P11658, DOI 10.1021/jp0261814; Yuan XJ, 2013, CURR OPIN CHEM BIOL, V17, P204, DOI 10.1016/j.cbpa.2013.01.010; ZHANG J, 1992, P NATL ACAD SCI USA, V89, P9382, DOI 10.1073/pnas.89.20.9382	49	61	61	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 14	2018	293	37					14557	14568		10.1074/jbc.RA118.004169	http://dx.doi.org/10.1074/jbc.RA118.004169			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GT7AG	30012884	Green Published, hybrid			2022-12-26	WOS:000444671500032
J	You, XH; Guo, ZF; Cheng, F; Yi, B; Yang, F; Liu, XZ; Zhu, N; Zhao, XX; Yan, GJ; Ma, XL; Sun, JX				You, Xiaohua; Guo, Zhi-Fu; Cheng, Fang; Yi, Bing; Yang, Fan; Liu, Xinzhu; Zhu, Ni; Zhao, Xianxian; Yan, Guijun; Ma, Xin-Liang; Sun, Jianxin			Transcriptional up-regulation of relaxin-3 by Nur77 attenuates -adrenergic agonist-induced apoptosis in cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transcription factor; nuclear receptor; cardiomyocyte; apoptosis; relaxin; isoprenoid; Nur77; relaxin-3; beta-adrenergic receptor; transcriptional regulator; promoter	NUCLEAR RECEPTOR NUR77; ACUTE HEART-FAILURE; H3 RELAXIN; EXPRESSION; SERELAXIN; ACTIVATION; INJURY; NR4A1; GENE; HYPERTROPHY	The relaxin family peptides have been shown to exert several beneficial effects on the heart, including anti-apoptosis, anti-fibrosis, and anti-hypertrophy activity. Understanding their regulation might provide new opportunities for therapeutic interventions, but the molecular mechanism(s) coordinating relaxin expression in the heart remain largely obscured. Previous work demonstrated a role for the orphan nuclear receptor Nur77 in regulating cardiomyocyte apoptosis. We therefore investigated Nur77 in the hopes of identifying novel relaxin regulators. Quantitative real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) data indicated that ectopic expression of orphan nuclear receptor Nur77 markedly increased the expression of latexin-3 (RLN3), but not relaxin-1 (RLN1), in neonatal rat ventricular cardiomyocytes (NRVMs). Furthermore, we found that the -adrenergic agonist isoproterenol (ISO) markedly stimulated RLN3 expression, and this stimulation was significantly attenuated in Nur77 knockdown cardiomyocytes and Nur77 knockout hearts. We showed that Nur77 significantly increased RLN3 promoter activity via specific binding to the RLN3 promoter, as demonstrated by electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation (ChIP) assays. Furthermore, we found that Nur77 overexpression potently inhibited ISO-induced cardiomyocyte apoptosis, whereas this protective effect was significantly attenuated in RLN3 knockdown cardiomyocytes, suggesting that Nur77-induced RLN3 expression is an important mediator for the suppression of cardiomyocyte apoptosis. These findings show that Nur77 regulates RLN3 expression, therefore suppressing apoptosis in the heart, and suggest that activation of Nur77 may represent a useful therapeutic strategy for inhibition of cardiac fibrosis and heart failure.	[You, Xiaohua; Guo, Zhi-Fu; Zhu, Ni; Zhao, Xianxian; Sun, Jianxin] Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai 200433, Peoples R China; [You, Xiaohua; Guo, Zhi-Fu; Cheng, Fang; Yi, Bing; Yang, Fan; Liu, Xinzhu; Ma, Xin-Liang; Sun, Jianxin] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St, Philadelphia, PA 19107 USA; [Yan, Guijun] Nanjing Univ, Med Sch, Reprod Med Ctr, Affiliated Drum Tower Hosp, Nanjing 211166, Jiangsu, Peoples R China	Naval Medical University; Jefferson University; Nanjing University	Sun, JX (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St, Philadelphia, PA 19107 USA.	jianxin.sun@jefferson.edu	Zhu, Ni/AAU-7427-2021		National Institutes of Health [R01 HL103869, R01GM123047]; American Heart Association Established Investigator Award [16EIA27710023]; Chinese Natural Science Foundation [81370418]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM123047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 HL103869 and R01GM123047, American Heart Association Established Investigator Award 16EIA27710023, and Chinese Natural Science Foundation Grant 81370418 (to J. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bathgate RAD, 2003, TRENDS ENDOCRIN MET, V14, P207, DOI 10.1016/S1043-2760(03)00081-X; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Cheng ZK, 2011, EUR HEART J, V32, P2179, DOI 10.1093/eurheartj/ehq496; De Paoli F, 2015, ATHEROSCLEROSIS, V241, P18, DOI 10.1016/j.atherosclerosis.2015.04.798; Dschietzig T, 2001, FASEB J, V15, P2187, DOI 10.1096/fj.01-0070com; Fang Y, 2013, P NATL ACAD SCI USA, V110, P13416, DOI 10.1073/pnas.1309810110; Felker GM, 2014, J AM COLL CARDIOL, V64, P1591, DOI 10.1016/j.jacc.2014.05.071; Feng XJ, 2015, BRIT J PHARMACOL, V172, P2852, DOI 10.1111/bph.13091; Ghosh RK, 2017, CARDIOVASC THER, V35, P55, DOI 10.1111/1755-5922.12231; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Kamat AA, 2004, ENDOCRINOLOGY, V145, P4712, DOI 10.1210/en.2004-0515; McGowan BM, 2008, AM J PHYSIOL-ENDOC M, V295, pE278, DOI 10.1152/ajpendo.00028.2008; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; McGowan BM, 2014, J ENDOCRINOL, V221, P337, DOI 10.1530/JOE-13-0603; McGowan BMC, 2005, ENDOCRINOLOGY, V146, P3295, DOI 10.1210/en.2004-1532; Medzikovic L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15404; Mullican SE, 2007, NAT MED, V13, P730, DOI 10.1038/nm1579; Myers SA, 2009, MOL CELL ENDOCRINOL, V309, P101, DOI 10.1016/j.mce.2009.05.006; Nistri Silvia, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P101, DOI 10.2174/187152507780363179; Nonhoff J, 2017, CARDIOVASC RES, V113, P598, DOI 10.1093/cvr/cvw245; Patil NA, 2017, BRIT J PHARMACOL, V174, P950, DOI 10.1111/bph.13684; Qin Q, 2014, J MOL CELL CARDIOL, V77, P20, DOI 10.1016/j.yjmcc.2014.09.027; Ranhotra HS, 2015, J RECEPT SIG TRANSD, V35, P184, DOI 10.3109/10799893.2014.948555; Samuel CS, 2006, PHARMACOL THERAPEUT, V112, P529, DOI 10.1016/j.pharmthera.2005.05.012; Samuel CS, 2014, HYPERTENSION, V64, P315, DOI 10.1161/HYPERTENSIONAHA.114.03594; Samuel CS, 2005, ANN NY ACAD SCI, V1041, P173, DOI 10.1196/annals.1282.025; Soloff MS, 2003, GENE, V323, P149, DOI 10.1016/j.gene.2003.09.015; Sudo S, 2003, J BIOL CHEM, V278, P7855, DOI 10.1074/jbc.M212457200; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teichman SL, 2009, HEART FAIL REV, V14, P321, DOI 10.1007/s10741-008-9129-3; van der Westhuizen ET, 2008, DRUG DISCOV TODAY, V13, P640, DOI 10.1016/j.drudis.2008.04.002; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; Wenzl K, 2015, CURR DRUG TARGETS, V16, P38, DOI 10.2174/1389450115666141120112818; Xie J, 2015, INT J CLIN EXP MED, V8, P4420; Yan GJ, 2015, MOL CELL BIOL, V35, P3312, DOI 10.1128/MCB.00229-15; You B, 2009, CIRC RES, V104, P742, DOI 10.1161/CIRCRESAHA.108.192286; Zhang J, 2005, PEPTIDES, V26, P1632, DOI 10.1016/j.peptides.2005.02.008; Zhang XH, 2018, J CELL MOL MED, V22, P1816, DOI 10.1111/jcmm.13464; Zhang XH, 2017, CELL PHYSIOL BIOCHEM, V43, P1311, DOI 10.1159/000481843; Zhang XH, 2015, BIOCHIMIE, V108, P59, DOI 10.1016/j.biochi.2014.11.004; Zhao Yue, 2009, Drug Discov Today Dis Mech, V6, pe43	44	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14001	14011		10.1074/jbc.RA118.003099	http://dx.doi.org/10.1074/jbc.RA118.003099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30006349	hybrid, Green Published			2022-12-26	WOS:000444070700024
J	Chen, J; Wang, YJ				Chen, Jie; Wang, Yu-Jin			New Saussurea (Asteraceae) species from Bogeda Mountain, eastern Tianshan, China, and inference of its evolutionary history and medical usage	PLOS ONE			English	Article							INVOLUCRATA KAR.	In this study, Saussurea bogedaensis Yu-J. Wang & Jie Chen, a new species from Bogeda Mountain in the eastern part of the Tianshan Mountains, is described and discussed based on evidence in terms of both morphological and genetic data. S. bogedaensis is morphologically similar to S. involucrata, which is distributed in the western part of the Tianshan Mountains, and it is well known because of its beauty, rarity, and medicinal value. The new species is also similar to S. orgaadayi, which is distributed in the nearby Altai Mountains. Our genetic data support the close relationships among these three species. According to their allopathic distributions, we suggest that these three species are derived from the same ancestor but that they differentiated after reaching their current range. In addition, we propose that the new species might serve as an alternative to S. involucrata in medicine due to their very high similarity. However, this species appears to be rare because we only found six mature individuals in the field despite extensive investigations.	[Chen, Jie; Wang, Yu-Jin] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China	Lanzhou University	Wang, YJ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China.	wangyujin@lzu.edu.cn			National Natural Science Foundation of China [81274024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81274024).; We are grateful to Jian-Quan Liu, Zhong-Hu Li, Yi-Xuan Kou, Fu-Shen Yang, Sonam Tso and Hiroshi Ikeda for helping with our field investigation. This study was supported by the National Natural Science Foundation of China (81274024).	Chen W. L., 2011, TURCZANINOWIA, V14, p75 ; Chik WI, 2015, J ETHNOPHARMACOL, V172, P44, DOI 10.1016/j.jep.2015.06.033; Doyle J. J., 1987, PHYTOCHEM B, P11; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Fu LK, 1992, CHINA PLANT RED DATA, p234~235; Guo B, 2007, PLANT CELL REP, V26, P261, DOI 10.1007/s00299-006-0230-6; Guo B, 2013, IN VITRO CELL DEV-PL, V49, P320, DOI 10.1007/s11627-013-9497-9; Guo B, 2012, IN VITRO CELL DEV-PL, V48, P609, DOI 10.1007/s11627-012-9468-6; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; [JIA Jingming 贾景明], 2005, [沈阳药科大学学报, Journal of Shenyang Pharmaceutical University], V22, P444; Jia ZX, 2014, RAPID COMMUN MASS SP, V28, P2237, DOI 10.1002/rcm.7014; Kita Y, 2004, TAXON, V53, P679, DOI 10.2307/4135443; [李锦轶 LI Jinyi], 2006, [地质通报, Geological Bulletin of China], V25, P895; LI Y, 1989, PHYTOCHEMISTRY, V28, P3395, DOI 10.1016/0031-9422(89)80398-X; Liu HL, 2015, BIOL PLANTARUM, V59, P316, DOI 10.1007/s10535-015-0487-0; Madhavi M., 2012, INT J LIFE SCI MED R, V2, P24; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Mpala L, 2010, J PHARM NEGAT RESULT, V1, P10; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu HL, 2014, PLANT MOL BIOL, V84, P707, DOI 10.1007/s11103-013-0164-7; Raab-Straube EV, 2017, TAXONOMIC REVISION S; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; SEXTON TB, 1990, CURR GENET, V17, P445, DOI 10.1007/BF00334526; Shen Chuan-bo, 2008, Journal of Mineralogy and Petrology, V28, P63; Shi C., 2011, FLORA CHINA, V20-21, P56; Smirnov S. V., 2004, TURCZANINOWIA, V7, P11; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Yaping, 2012, Sheng Wu Gong Cheng Xue Bao, V28, P705; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Von Raab-Straube E., 2003, WILLDENOWIA, V33, P379, DOI [10.3372/wi.33.33214, DOI 10.3372/WI.33.33214]; von Raab-Straube Eckhard, 2009, Willdenowia, V39, P101, DOI 10.3372/wi.39.39112; Wang XL, 2007, J INTEGR PLANT BIOL, V49, P609, DOI 10.1111/j.1744-7909.2007.00370.x; Wang YJ, 2009, BIOL J LINN SOC, V97, P893, DOI 10.1111/j.1095-8312.2009.01225.x; Way TD, 2010, J AGR FOOD CHEM, V58, P3356, DOI 10.1021/jf903793p; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang L, 2006, J CENTRAL U NATL, V15, P26; Zhou P. W., 2002, CHIN J PHARM SCI, V37, P98	40	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199416	10.1371/journal.pone.0199416	http://dx.doi.org/10.1371/journal.pone.0199416			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020935	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400013
J	Fairee, S; Prom-On, S; Sirinaovakul, B				Fairee, Suthida; Prom-On, Santitham; Sirinaovakul, Booncharoen			Reinforcement learning for solution updating in Artificial Bee Colony	PLOS ONE			English	Article							SOFTWARE TOOL; ALGORITHM; OPTIMIZATION; KEEL	In the Artificial Bee Colony (ABC) algorithm, the employed bee and the onlooker bee phase involve updating the candidate solutions by changing a value in one dimension, dubbed one-dimension update process. For some problems which the number of dimensions is very high, the one-dimension update process can cause the solution quality and convergence speed drop. This paper proposes a new algorithm, using reinforcement learning for solution updating in ABC algorithm, called R-ABC. After updating a solution by an employed bee, the new solution results in positive or negative reinforcement applied to the solution dimensions in the onlooker bee phase. Positive reinforcement is given when the candidate solution from the employed bee phase provides a better fitness value. The more often a dimension provides a better fitness value when changed, the higher the value of update becomes in the onlooker bee phase. Conversely, negative reinforcement is given when the candidate solution does not provide a better fitness value. The performance of the proposed algorithm is assessed on eight basic numerical benchmark functions in four categories with 100,500, 700, and 900 dimensions, seven CEC2005's shifted functions with 100, 500, 700, and 900 dimensions, and six CEC2014's hybrid functions with 100 dimensions. The results show that the proposed algorithm provides solutions which are significantly better than all other algorithms for all tested dimensions on basic benchmark functions. The number of solutions provided by the R-ABC algorithm which are significantly better than those of other algorithms increases when the number of dimensions increases on the CEC2005's shifted functions. The R-ABC algorithm is at least comparable to the state-of-the-art ABC variants on the CEC2014's hybrid functions.	[Fairee, Suthida; Prom-On, Santitham; Sirinaovakul, Booncharoen] King Mongkuts Univ Technol Thonburi, Dept Comp Engn, Bangkok, Thailand	King Mongkuts University of Technology Thonburi	Sirinaovakul, B (corresponding author), King Mongkuts Univ Technol Thonburi, Dept Comp Engn, Bangkok, Thailand.	boon@kmutt.ac.th	Fairee, Suthida/AAU-6444-2020	Fairee, Suthida/0000-0003-2746-0595	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program [PHD/0099/2557]	Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF))	This work is supported by the Thailand Research Fund through the Royal Golden Jubilee Ph.D. Program (http://rgj.trf.or.th) under Grant No. PHD/0099/2557 (BS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akay B, 2012, INFORM SCIENCES, V192, P120, DOI 10.1016/j.ins.2010.07.015; Alcala-Fdez J, 2009, SOFT COMPUT, V13, P307, DOI 10.1007/s00500-008-0323-y; Alcala-Fdez J, 2011, J MULT-VALUED LOG S, V17, P255; Amaratunga D, 2016, J NATL SCI FOUND SRI, V44, P3, DOI 10.4038/jnsfsr.v44i1.7976; Banharnsakun A, 2011, APPL SOFT COMPUT, V11, P2888, DOI 10.1016/j.asoc.2010.11.025; Bush Robert R., 1955, STOCHASTIC MODELS LE; Cui L, 2017, INFORM SCIENCES, V417, P169, DOI 10.1016/j.ins.2017.07.011; Cui LZ, 2017, INFORM SCIENCES, V414, P53, DOI 10.1016/j.ins.2017.05.044; Gao WF, 2015, INFORM SCIENCES, V316, P180, DOI 10.1016/j.ins.2015.04.006; Jamil Momin, 2013, International Journal of Mathematical Modelling and Numerical Optimisation, V4, P150; Karaboga D., 2005, IDEA BASED HONEY BEE, DOI 10.1.1.714.4934; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Karaboga D, 2016, APPL SOFT COMPUT, V49, P423, DOI 10.1016/j.asoc.2016.07.039; Kennedy J, 2003, PROCEEDINGS OF THE 2003 IEEE SWARM INTELLIGENCE SYMPOSIUM (SIS 03), P80, DOI 10.1109/SIS.2003.1202251; Kiran MS, 2015, INFORM SCIENCES, V300, P140, DOI 10.1016/j.ins.2014.12.043; Li GH, 2017, APPL SOFT COMPUT, V52, P146, DOI 10.1016/j.asoc.2016.12.017; Li X, 2013, BENCHMARK FUNCTIONS; Liang J. J., 2013, 201311 ZHENGZH U ZHE; Narendra K.S., 2012, LEARNING AUTOMATA IN; Netjinda N, 2015, APPL SOFT COMPUT, V35, P411, DOI 10.1016/j.asoc.2015.06.052; Suganthan P. N., 2005, 2005005 KANGAL NAN T; Tang J, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P287, DOI 10.1145/2872427.2883041; Tang K., 2009, BENCHMARK FUNCTIONS; Yasukawa K., ANIMAL BEHAV WHY ANI; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Zhu GP, 2010, APPL MATH COMPUT, V217, P3166, DOI 10.1016/j.amc.2010.08.049	26	8	8	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200738	10.1371/journal.pone.0200738	http://dx.doi.org/10.1371/journal.pone.0200738			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016357	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600039
J	Lee, CY; Wu, CF; Chen, CM; Chang, YY				Lee, Chen-Yi; Wu, Chih-Feng; Chen, Chun-Ming; Chang, Yong-Yuan			Qualitative study for betel quid cessation among oral cancer patients	PLOS ONE			English	Article							ARECA NUT; TAIWAN; EPIDEMIOLOGY; DEPENDENCE; HEALTH; USAGE	The psychoactive effects of using areca nut and its potential for dependence have been observed. However, the factors that create barriers to or promote chewing cessation are not well understood. This study aims to explore the behavioral changes of betel quid chewers who have been diagnosed with oral cancer within a transtheoretical model framework. Thirty oral cancer patients with betel quid chewing history were chosen for in-depth interviews. Qualitative content analysis was used to analyze the data and identify themes that described the behavioral changes of betel quid cessation. Our research showed that betel quid chewers with oral cancer typically experience four significant stages of behavior: pre-contemplation, contemplation, action, and maintenance. Each stage change was marked by specific characteristics. At first, chewers showed positive attitudes toward the psychoactive or social effects of betel quid. They then realized the negative effects of betel quid, such as dental or other physical problems. Some also realized that they were addicted to betel quid. When they decided to quit, most chewers reported going "cold turkey." Some chewers successfully quit betel quid and attributed it to willpower. Those quitting because of the loss of oral functions were unable to chew anymore, though some chewers had experienced a relapse. In the maintenance stage, ex-chewers reported overcoming their addiction; however, relapse was possible. In this study, those who quit betel quid because of oral cancer usually quit tobacco and alcohol as well, with a lesser chance of recurrence. As the maintenance of chewing betel quid is multifactorial, this study provides information for betel quid cessation and oral cancer prevention.	[Lee, Chen-Yi] Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, Kaohsiung, Taiwan; [Lee, Chen-Yi] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Wu, Chih-Feng] Kaohsiung Med Univ Hosp, Dept Surg, Div Surg Oncol, Kaohsiung, Taiwan; [Wu, Chih-Feng] Kaohsiung Med Univ, Coll Med, Sch Med, Kaohsiung, Taiwan; [Chen, Chun-Ming] Kaohsiung Med Univ Hosp, Dept Dent, Div Oral & Maxillofacial Surg, Kaohsiung, Taiwan; [Chen, Chun-Ming] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Chang, Yong-Yuan] Kaohsiung Med Univ, Coll Hlth Sci, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lee, CY (corresponding author), Kaohsiung Med Univ, Coll Dent Med, Dept Oral Hyg, Kaohsiung, Taiwan.; Lee, CY (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	cylee@kmu.edu.tw	Lee, Chen-Yi/K-5228-2015	Lee, Chen-Yi/0000-0002-8234-1524	Ministry of Science and Technology, Taiwan [MOST 103-2410-H-037-003]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The study was supported by the Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/)[grant number: MOST 103-2410-H-037-003]. The MOST had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAWTE J, 1985, AUST NZ J PSYCHIAT, V19, P83, DOI 10.3109/00048678509158818; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Cyriac M. B., 2012, International Journal of Research in Ayurveda and Pharmacy (IJRAP), V3, P81; Dahlen G, 2010, ANAEROBE, V16, P331, DOI 10.1016/j.anaerobe.2010.04.003; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Hung YT, 2005, CHINESE DENT J, V24, P101; Kuo S. C., 2006, TAIWAN RADICAL Q SOC, V63, P143; Kuo SC, 2005, TAIWAN J PUBLIC HLTH, V24, P239, DOI DOI 10.6288/TJPH2005-24-03-09; Lee CY, 2012, DRUG ALCOHOL DEPEN, V121, P18, DOI 10.1016/j.drugalcdep.2011.07.027; Lee CY, 2016, NEUROPATHOLOGY DRUG, P827; Li S, 2015, ORAL ONCOL, V51, P1082, DOI 10.1016/j.oraloncology.2015.10.014; Lin CC, 2017, SUBST USE MISUSE, V52, P646, DOI 10.1080/10826084.2016.1246572; Lin F. S., 2014, J CHINESE DIET CULT, V10, P43; Naik S, 2006, ORAL ONCOL, V42, P668, DOI 10.1016/j.oraloncology.2005.10.020; Neelufar Shama S, 2014, INT J PHARM RES, V4, P17; Taiwan Ministry of Health and Welfare, 2015, TAIW HLTH WELF REP; THOMAS SJ, 1992, LANCET, V340, P577, DOI 10.1016/0140-6736(92)92109-S; Trivedy CR, 2002, ADDICT BIOL, V7, P115, DOI 10.1080/13556210120091482; Velasquez MM, 2015, GROUP TREATMENT SUBS; Wang SG, 1999, EVERGREEN BETEL NUTS; Winstock A, 2002, ADDICT BIOL, V7, P133, DOI 10.1080/13556210120091509; Winstock AR, 2000, ADDICT BIOL, V5, P173, DOI 10.1080/13556210050003766; Wu D. M., 1999, CHINESE J PUBLIC HLT, V18, P453; Wu DM, 2007, ADDICT BEHAV, V32, P1302, DOI 10.1016/j.addbeh.2006.09.002; Yang TY, 2017, J CLIN NURS, V26, P1031, DOI 10.1111/jocn.13599	26	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0199503	10.1371/journal.pone.0199503	http://dx.doi.org/10.1371/journal.pone.0199503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2XR	30016322	gold, Green Submitted, Green Published			2022-12-26	WOS:000438866600008
J	Schaake, W; van der Schaaf, A; van Dijk, LV; van den Bergh, ACM; Langendijk, JA				Schaake, Wouter; van der Schaaf, Arjen; van Dijk, Lisanne, V; van den Bergh, Alfons C. M.; Langendijk, Johannes A.			Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients	PLOS ONE			English	Article							DOSE-SURFACE MAPS; QUALITY-OF-LIFE; GENITOURINARY TOXICITY; PUBOPROSTATIC LIGAMENT; RADIATION-THERAPY; GRADING-SYSTEM; 68 GY; RADIOTHERAPY; BRACHYTHERAPY; CONSTRAINTS	Background and purpose Incontinence, hematuria, voiding frequency and pain during voiding are possible side effects of radiotherapy among patients treated for prostate cancer. The objective of this study was to develop multivariable NTCP models for these side effects. Material and methods This prospective cohort study was composed of 243 patients with localized or locally advanced prostate cancer (stage T1-3). Genito-urinary (GU) toxicity was assessed using a standardized follow-up program. The GU toxicity endpoints were scored using the Common Terminology Criteria for Adverse Events version 3.0 (CTCAE 3.0) scoring system. The full bladder and different anatomical subregions within the bladder were delineated. A least absolute shrinkage and selection operator (LASSO) logistic regression analysis was used to analyze dose volume effects on the four individual endpoints. Results In the univariable analysis, urinary incontinence was significantly associated with dose distributions in the trigone (V55-V75, mean). Hematuria was significantly associated with the bladder wall dose (V40-V75, mean), bladder dose (V70-V75), cardiovascular disease and anticoagulants use. Pain during urinating was associated with the dose to the trigone (V50-V75, mean) and with trans transurethral resection of the prostate (TURP). In the final multi-variable model urinary incontinence was associated with the mean dose of the trigone. Hematuria was associated with bladder wall dose (V75) and cardiovascular disease, while pain during urinating was associated with trigone dose (V75) and TURP. No significant associations were found for increase in voiding frequency. Conclusions Radiation-induced urinary side effects are associated with dose distributions to different organs as risk. Given the dose effect relationships found, decreasing the dose to the trigone and bladder wall may reduce the incidence of incontinence, pain during voiding and hematuria, respectively.	[Schaake, Wouter; van der Schaaf, Arjen; van Dijk, Lisanne, V; van den Bergh, Alfons C. M.; Langendijk, Johannes A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [Schaake, Wouter] Hanze Univ Appl Sci, Allied Hlth Care & Nursing, Res Grp Hlth Ageing, Groningen, Netherlands	University of Groningen	Schaake, W (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands.; Schaake, W (corresponding author), Hanze Univ Appl Sci, Allied Hlth Care & Nursing, Res Grp Hlth Ageing, Groningen, Netherlands.	schaakew@umcg.nl	Van+Der+Schaaf, Arjen/AEX-0530-2022; van Dijk, Lisanne/AAA-2199-2021	Van+Der+Schaaf, Arjen/0000-0003-4067-7975; Langendijk, Johannes A./0000-0003-1083-372X				Ahmed AA, 2013, INT J RADIAT ONCOL, V86, P709, DOI 10.1016/j.ijrobp.2013.03.020; De Langhe S, 2014, RADIOTHER ONCOL, V112, P95, DOI 10.1016/j.radonc.2014.04.005; Fiorino C, 2009, RADIOTHER ONCOL, V93, P153, DOI 10.1016/j.radonc.2009.08.004; Foroudi F, 2013, INT J RADIAT ONCOL, V86, P77, DOI 10.1016/j.ijrobp.2012.11.035; Ghadjar P, 2014, INT J RADIAT ONCOL, V88, P339, DOI 10.1016/j.ijrobp.2013.10.042; Gurka MK, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0351-6; Hakenberg OW, 2000, NEUROUROL URODYNAM, V19, P585, DOI 10.1002/1520-6777(2000)19:5<585::AID-NAU5>3.0.CO;2-U; Harsolia A, 2007, INT J RADIAT ONCOL, V69, P1100, DOI 10.1016/j.ijrobp.2007.04.076; Hathout L, 2014, INT J RADIAT ONCOL, V90, P312, DOI 10.1016/j.ijrobp.2014.06.031; Heemsbergen WD, 2010, INT J RADIAT ONCOL, V78, P19, DOI 10.1016/j.ijrobp.2009.07.1680; HOSMER DW, 1989, APPL LOGISTIC REGRES; Leapman MS, 2013, BJU INT, V111, pE319, DOI 10.1111/j.1464-410X.2012.11697.x; Mathieu R, 2014, WORLD J UROL, V32, P743, DOI 10.1007/s00345-013-1146-8; McLaughlin PW, 2005, INT J RADIAT ONCOL, V63, P479, DOI 10.1016/j.ijrobp.2005.02.036; Palorini F, 2016, PHYS MEDICA, V32, P506, DOI 10.1016/j.ejmp.2016.03.006; Palorini F, 2016, RADIOTHER ONCOL, V119, P123, DOI 10.1016/j.radonc.2016.02.025; Palorini F, 2016, RADIOTHER ONCOL, V118, P92, DOI 10.1016/j.radonc.2015.11.036; Peeters STK, 2005, INT J RADIAT ONCOL, V61, P1019, DOI 10.1016/j.ijrobp.2004.07.715; Poore RE, 1998, UROLOGY, V51, P67, DOI 10.1016/S0090-4295(97)00479-2; Schaake W, 2016, RADIOTHER ONCOL, V119, P381, DOI 10.1016/j.radonc.2016.04.005; Schaake W, 2014, RADIOTHER ONCOL, V110, P284, DOI 10.1016/j.radonc.2013.11.011; Schaake W, 2013, RADIOTHER ONCOL, V108, P299, DOI 10.1016/j.radonc.2013.06.039; Steggerda MJ, 2013, RADIOTHER ONCOL, V109, P251, DOI 10.1016/j.radonc.2013.07.019; STEINER MS, 1994, UROLOGY, V44, P530, DOI 10.1016/S0090-4295(94)80052-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; van der Laan HP, 2008, INT J RADIAT ONCOL, V70, P1138, DOI 10.1016/j.ijrobp.2007.07.2363; van der Schaaf A, 2015, INT J RADIAT ONCOL, V93, pS182, DOI 10.1016/j.ijrobp.2015.07.436; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wopken K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094879; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029	32	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0197757	10.1371/journal.pone.0197757	http://dx.doi.org/10.1371/journal.pone.0197757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016325	gold, Green Submitted, Green Published			2022-12-26	WOS:000438866600004
J	Seong, CY; Chai, YJ; Lee, SM; Kim, SJ; Choi, JY; Lee, KE; Hwang, KT; Park, SW; Yi, KH				Seong, Chan Yong; Chai, Young Jun; Lee, Sang Mok; Kim, Su-jin; Choi, June Young; Lee, Kyu Eun; Hwang, Ki-Tae; Park, Sun-Won; Yi, Ka Hee			Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients	PLOS ONE			English	Article							NECK DISSECTION; PROGNOSTIC-FACTORS; RECURRENCE; CANCER; ULTRASOUND	The aim of this study was to evaluate preoperativeiy identifiable clinical and ultrasonographic characteristics associated with central lymph node metastasis (CLNM) in clinically node negative papillary thyroid carcinoma (PTC) patients. Records of the patients who underwent thyroidectomy with prophylactic central lymph node dissection due to clinically node negative PTC (size, 1.0-3.0 cm) were reviewed. Of a total of 174 patients, 71 (40.8%) had CLNMs. CLNM was more associated with capsule invasion than capsule non-invasion on ultrasonography (68.4% vs. 37.4%, p = 0.009). In the 155 patients without capsule invasion, a distance from the capsule < 1.9 mm was associated with CLNM in univariable (p = 0.002) and multivariable analysis (p < 0.001). Any PTC patient with a distance from the capsule >= 1.9 mm did not have CLNM whereas 40.8% (58/142) of PTC patients with a distance from the capsule < 1.9 mm had CLNM. CLNM was not associated with age, gender, or tumor size on ultrasonography. Distance from capsule >= 1.9 mm on preoperative ultrasonography was a significant indicator for not having CLNM in clinically node negative PTC patients. Measuring distance from the capsule on preoperative ultrasonography images could help select patients with PTC who could benefit from prophylactic central lymph node dissection.	[Seong, Chan Yong; Chai, Young Jun; Lee, Sang Mok; Hwang, Ki-Tae] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Surg, Seoul, South Korea; [Kim, Su-jin; Lee, Kyu Eun] Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea; [Kim, Su-jin; Lee, Kyu Eun] Coll Med, Seoul, South Korea; [Choi, June Young] Seoul Natl Univ, Bundang Hosp, Dept Surg, Gyeonggi Do, South Korea; [Park, Sun-Won] Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Coll Med,Dept Radiol, Seoul, South Korea; [Yi, Ka Hee] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Chai, YJ (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Surg, Seoul, South Korea.; Yi, KH (corresponding author), Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea.	kevinjoon@naver.com; imykh@naver.com	Kim, Su-jin/AAR-5059-2020; Chai, Young/AAW-6684-2021	Kim, Su-jin/0000-0001-5511-3596; Chai, Young Jun/0000-0001-8830-3433; Park, Sun-Won/0000-0002-5063-2685	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2016-9]	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center	This work was supported by a clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (03-2016-9, recipient: KHY).	Choi JS, 2011, ANN SURG ONCOL, V18, P3572, DOI 10.1245/s10434-011-1783-3; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Ito Y, 2006, WORLD J SURG, V30, P1821, DOI 10.1007/s00268-006-0211-5; Ito Y, 2013, ENDOCR J, V60, P113; Ito Y, 2010, WORLD J SURG, V34, P2333, DOI 10.1007/s00268-010-0712-0; Jiang LH, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/385787; Kamaya A, 2015, J ULTRAS MED, V34, P2225, DOI 10.7863/ultra.15.02006; Khokhar MT, 2015, THYROID, V25, P1351, DOI 10.1089/thy.2015.0176; Kim E, 2008, THYROID, V18, P411, DOI 10.1089/thy.2007.0269; Kim JW, 2017, ANN SURG ONCOL, V24, P460, DOI 10.1245/s10434-016-5594-4; Lang BHH, 2014, ENDOCR-RELAT CANCER, V21, P285, DOI 10.1530/ERC-13-0291; Leboulleux S, 2005, J CLIN ENDOCR METAB, V90, P5723, DOI 10.1210/jc.2005-0285; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Moreno MA, 2012, THYROID, V22, P347, DOI 10.1089/thy.2011.0121; Na DK, 2015, ULTRASONOGRAPHY, V34, P39, DOI 10.14366/usg.14030; Pelizzo MR, 1997, J EXP CLIN CANC RES, V16, P261; Roh JL, 2007, ANN SURG, V245, P604, DOI 10.1097/01.sla.0000250451.59685.67; Roh JL, 2011, ANN SURG ONCOL, V18, P2245, DOI 10.1245/s10434-011-1600-z; Seo GH, 2016, CLIN ENDOCRINOL, V85, P483, DOI 10.1111/cen.13082; Siddiqui S, 2016, THYROID, V26, P807, DOI 10.1089/thy.2015.0429; Suman P, 2016, SURGERY, V159, P31, DOI 10.1016/j.surg.2015.08.032; Sun W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139021; Viola D, 2015, J CLIN ENDOCR METAB, V100, P1316, DOI 10.1210/jc.2014-3825; Wang TS, 2013, ANN SURG ONCOL, V20, P3477, DOI 10.1245/s10434-013-3125-0; Yang YL, 2014, CLIN ENDOCRINOL, V81, P282, DOI 10.1111/cen.12417	27	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200166	10.1371/journal.pone.0200166	http://dx.doi.org/10.1371/journal.pone.0200166			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016353	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600017
J	Williams, MR				Williams, Matthew R.			A pilot study into reaching performance after severe to moderate stroke using upper arm support	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; UPPER-LIMB; UPPER EXTREMITY; REHABILITATION; INDIVIDUALS; STIMULATION; THERAPY; ORTHOSIS; IMPACT; WRIST	Stroke effects millions of people each year and can have a significant impact on the ability to use the impaired arm and hand. One of the results of stroke is the development of an abnormal shoulder-elbow flexion synergy, where lifting the arm can cause the elbow, wrist, and finger flexors to involuntarily contract, reducing the ability to reach with the arm and hand opening. This study explored the effect of using support at the upper arm to improve hand and arm reaching performance. Nine participants were studied while performing a virtual reaching task under three conditions: while the weight of their impaired arm was supported by a robot arm, while unsupported, and while using their non-impaired arm. Most subjects exhibited faster and more accurate reaching while supported compared to unsupported. For the subjects who could voluntarily open their hand, most were able to more swiftly open their hand when using upper arm support. In many cases, performance with support was not statistically different than the unaffected arm and hand. Muscle activity of the impaired limb with upper arm support showed decreased effort to lift the arm and reduced biceps activity in most subjects, pointing to a reduction in the abnormal flexion synergy while using upper arm support. While arm support can help to reduce the activation of abnormal synergies, weakness resulting from hemiparesis remains an issue impacting performance. Future systems will need to address both of these causes of disability to more fully restore function after stroke.	[Williams, Matthew R.] Louis Stokes Cleveland VA Med Ctr, Cleveland, OH 44106 USA; [Williams, Matthew R.] Cleveland FES Ctr, Cleveland, OH 44106 USA; [Williams, Matthew R.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University	Williams, MR (corresponding author), Louis Stokes Cleveland VA Med Ctr, Cleveland, OH 44106 USA.; Williams, MR (corresponding author), Cleveland FES Ctr, Cleveland, OH 44106 USA.; Williams, MR (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.	mwilliams@fescenter.org			U.S. Department of Veterans Affairs Office of Research and Development, Rehabilitation Research and Development Service as part of the Small Projects in Rehabilitation Research (SPiRE) program;  [1I21RX002196-01]; Veterans Affairs [I21RX002196] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs Office of Research and Development, Rehabilitation Research and Development Service as part of the Small Projects in Rehabilitation Research (SPiRE) program; ; Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the U.S. Department of Veterans Affairs Office of Research and Development, Rehabilitation Research and Development Service as part of the Small Projects in Rehabilitation Research (SPiRE) program. MRW is the recipient of the funding under award number 1I21RX002196-01, "Effect of Upper Arm Support on the Hemiparetic Arm". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, ENABLING ENV MEASURI; Arling G, 2012, CIRC-CARDIOVASC QUAL, V5, P44, DOI 10.1161/CIRCOUTCOMES.111.961474; Balasubramanian S, 2008, 2008 VIRTUAL REHABILITATION, P163, DOI 10.1109/ICVR.2008.4625154; Beer RF, 2007, MUSCLE NERVE, V36, P242, DOI 10.1002/mus.20817; Belmont Philip J, 2010, J Surg Orthop Adv, V19, P2; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Cauraugh J, 2000, STROKE, V31, P1360, DOI 10.1161/01.STR.31.6.1360; Chen J, 2017, IEEE T NEUR SYS REH, V25, P2305, DOI 10.1109/TNSRE.2017.2695379; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Cohen J., 2013, APPL MULTIPLE REGRES; Dewald JPA, 2001, MUSCLE NERVE, V24, P273, DOI 10.1002/1097-4598(200102)24:2<273::AID-MUS130>3.0.CO;2-Z; Ellis MD, 2007, EXP BRAIN RES, V176, P594, DOI 10.1007/s00221-006-0637-x; Ellis MD, 2017, CLIN NEUROPHYSIOL, V128, P1308, DOI 10.1016/j.clinph.2017.04.028; Glenn MB, 2010, J HEAD TRAUMA REHAB, V25, P68, DOI 10.1097/HTR.0b013e3181be1eab; Gresham G, 1997, FUNCTIONAL ASSESSMEN; He JP, 2005, INT C REHAB ROBOT, P95; Iwamuro BT, 2008, ARCH PHYS MED REHAB, V89, P2121, DOI 10.1016/j.apmr.2008.04.022; Jarrasse N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00947; Knutson JS, 2009, NEUROREHAB NEURAL RE, V23, P17, DOI 10.1177/1545968308317577; Krebs Hermano I, 2004, J Neuroeng Rehabil, V1, P5, DOI 10.1186/1743-0003-1-5; Kumar A, 2013, J REHABIL RES DEV, V50, P61, DOI 10.1682/JRRD.2012.03.0047; Kwakkel G, 2003, STROKE, V34, P2181, DOI 10.1161/01.STR.0000087172.16305.CD; Makowski NS, 2015, IEEE T NEUR SYS REH, V23, P221, DOI 10.1109/TNSRE.2014.2364273; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Mihelj M, 2007, IEEE INT CONF ROBOT, P4120, DOI 10.1109/ROBOT.2007.364112; Miller LC, 2012, CLIN NEUROPHYSIOL, V123, P1216, DOI 10.1016/j.clinph.2012.01.009; Moubarak S, 2010, IEEE ENG MED BIO, P4489, DOI 10.1109/IEMBS.2010.5626036; Nef T, 2005, INT C REHAB ROBOT, P57; Nef T, 2006, IEEE INT CONF ROBOT, P3152, DOI 10.1109/ROBOT.2006.1642181; Oguntosin VW, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00352; Peters HT, 2017, ARCH PHYS MED REHAB, V98, P1821, DOI 10.1016/j.apmr.2016.12.016; Polygerinos P, 2015, ROBOT AUTON SYST, V73, P135, DOI 10.1016/j.robot.2014.08.014; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Roh J, 2013, J NEUROPHYSIOL, V109, P768, DOI 10.1152/jn.00670.2012; Sanchez RJ, 2005, INT C REHAB ROBOT, P500; Seo NJ, 2009, J NEUROPHYSIOL, V101, P3108, DOI 10.1152/jn.91108.2008; Thrasher TA, 2008, NEUROREHAB NEURAL RE, V22, P706, DOI 10.1177/1545968308317436; Umemura Atushi, 2009, 2009 IEEE International Conference on Rehabilitation Robotics: Reaching Users & the Community (ICORR), P451, DOI 10.1109/ICORR.2009.5209512; Williams MR, 2008, IEEE T NEUR SYS REH, V16, P485, DOI 10.1109/TNSRE.2008.2006216	39	4	4	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200787	10.1371/journal.pone.0200787	http://dx.doi.org/10.1371/journal.pone.0200787			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016364	gold, Green Submitted, Green Published			2022-12-26	WOS:000438866600043
J	AlRabiah, H; Allwood, JW; Correa, E; Xu, Y; Goodacre, R				AlRabiah, Haitham; Allwood, J. William; Correa, Elon; Xu, Yun; Goodacre, Royston			pH plays a role in the mode of action of trimethoprim on Escherichia coli	PLOS ONE			English	Article							MINIMUM REPORTING STANDARDS; URINARY-TRACT-INFECTIONS; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; HOMEOSTASIS; PATHOGENS; SERUM; BIOSYNTHESIS; SPECTROSCOPY; METABOLOMICS	Metabolomics-based approaches were applied to understand interactions of trimethoprim with Escherichia coli K-12 at sub-minimum inhibitory concentrations (MIC approximate to 0.2, 0.03 and 0.003 mg L-1). Trimethoprim inhibits dihydrofolate reductase and thereby is an indirect inhibitor of nucleic acid synthesis. Due to the basicity of trimethoprim, two pH levels (5 and 7) were selected which mimicked healthy urine pH. This also allowed investigation of the effect on bacterial metabolism when trimethoprim exists in different ionization states. UHPLC-MS was employed to detect trimethoprim molecules inside the bacterial cell and this showed that at pH 7 more of the drug was recovered compared to pH 5; this correlated with classical growth curve measurements. FT-IR spectroscopy was used to establish recovery of reproducible phenotypes under all 8 conditions (3 drug levels and control in 2 pH levels) and GCMS was used to generate global metabolic profiles. In addition to finding direct mode-of-action effects where nucleotides were decreased at pH 7 with increasing trimethoprim levels, off-target pH-related effects were observed for many amino acids. Additionally, stress-related effects were observed where the osmoprotectant trehalose was higher at increased antibiotic levels at pH 7. This correlated with glucose and fructose consumption and increase in pyruvate-related products as well as lactate and alanine. Alanine is a known regulator of sugar metabolism and this increase may be to enhance sugar consumption and thus trehalose production. These results provide a wider view of the action of trimethoprim. Metabolomics indicated alternative metabolism areas to be investigated to further understand the off-target effects of trimethoprim.	[AlRabiah, Haitham; Allwood, J. William; Correa, Elon; Xu, Yun; Goodacre, Royston] Univ Manchester, Sch Chem, Manchester, Lancs, England; [AlRabiah, Haitham; Allwood, J. William; Correa, Elon; Xu, Yun; Goodacre, Royston] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [AlRabiah, Haitham] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Allwood, J. William] James Hutton Inst, Environm & Biochem Sci Grp, Dundee, Scotland	University of Manchester; University of Manchester; King Saud University; James Hutton Institute	Goodacre, R (corresponding author), Univ Manchester, Sch Chem, Manchester, Lancs, England.; Goodacre, R (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	roy.goodacre@manchester.ac.uk	Allwood, James William/AAI-8794-2020; Correa, Elon/T-8686-2019; Goodacre, Roy/AAO-3194-2021; AlRabiah, Haitham/S-6017-2018; Xu, Yun/ABG-2114-2021	Goodacre, Roy/0000-0003-2230-645X; Xu, Yun/0000-0003-3228-5111; Correa, Elon/0000-0002-5122-4384; Allwood, James/0000-0001-6433-2694	Deanship of Scientific Research; Research Center of the College of Pharmacy, KSU; Cancer Research UK; UK MRC [G1001375]; UK BBSRC [BB/M017702/1]; BBSRC [BB/M017702/1] Funding Source: UKRI; MRC [G1001375] Funding Source: UKRI	Deanship of Scientific Research; Research Center of the College of Pharmacy, KSU; Cancer Research UK(Cancer Research UK); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HR thanks the Deanship of Scientific Research and the Research Center of the College of Pharmacy, KSU for funding. EC, JWA and RG are also indebted to the Cancer Research UK for funding. RG is also grateful to the UK MRC (G1001375). RG thanks UK BBSRC (BB/M017702/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD J, 1991, INFECTION, V19, pS167, DOI 10.1007/BF01643691; Allwood JW, 2010, PHYTOCHEM ANALYSIS, V21, P33, DOI 10.1002/pca.1187; AlRabiah H, 2013, ANALYST, V138, P1363, DOI 10.1039/c3an36517d; Anderson R., 2012, ANTIBACTERIAL AGENTS; Baerheim A, 2001, BRIT MED J, V323, P1197, DOI 10.1136/bmj.323.7323.1197; Begley P, 2009, ANAL CHEM, V81, P7038, DOI 10.1021/ac9011599; BioCyc, 2012, CAND PHYT MAL REACT; Breitling R, 2006, TRENDS BIOTECHNOL, V24, P543, DOI 10.1016/j.tibtech.2006.10.006; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; Correa E, 2012, ANAL BIOANAL CHEM, V403, P2591, DOI 10.1007/s00216-012-6068-6; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Dobson PD, 2008, NAT REV DRUG DISCOV, V7, P205, DOI 10.1038/nrd2438; Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; EcoCyc, 2012, ESCH COL K 12 SUBSTR; Fihn SD, 2003, NEW ENGL J MED, V349, P259, DOI 10.1056/NEJMcp030027; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gangjee A, 2007, ANTI-CANCER AGENT ME, V7, P524, DOI 10.2174/187152007781668724; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; GIANNELLA RA, 1972, GUT, V13, P251, DOI 10.1136/gut.13.4.251; Goodacre R, 2007, METABOLOMICS, V3, P231, DOI 10.1007/s11306-007-0081-3; Griebling TL, 2005, J UROLOGY, V173, P1281, DOI 10.1097/01.ju.0000155596.98780.82; HITCHINGS GH, 1989, IN VITRO CELL DEV B, V25, P303; Horlacher R, 1996, J BACTERIOL, V178, P6250, DOI 10.1128/jb.178.21.6250-6257.1996; Jia J, 2009, NAT REV DRUG DISCOV, V8, P111, DOI 10.1038/nrd2683; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Katzung B, 2018, BASIC CLIN PHARMACOL, V14th; KEGG, 2012, TRYPT MET ESCH COL K; KEGG, 2012, NIC NIC MET ESCH COL; Kim DH, 2010, ANAL BIOANAL CHEM, V398, P3051, DOI 10.1007/s00216-010-4283-6; Kwon YK, 2008, NAT CHEM BIOL, V4, P602, DOI 10.1038/nchembio.108; Kwon YK, 2010, ACS CHEM BIOL, V5, P787, DOI 10.1021/cb100096f; Martens H, 2003, ANAL CHEM, V75, P394, DOI 10.1021/ac020194w; Michal G, 1998, BIOCH PATHWAYS ATLAS; Nam SH, 2011, J BACTERIOL, V193, P1014, DOI [10.1128/JB.01394-10, 10.1128/JB.01027-10]; O'Grady F, 1997, ANTIBIOTIC CHEMOTHER; Quinlivan EP, 2000, FASEB J, V14, P2519, DOI 10.1096/fj.99-1037com; Ronald A, 2003, DM-DIS MON, V49, P71, DOI 10.1067/mda.2003.8; SAKAMOTO N, 1975, J BACTERIOL, V124, P775, DOI 10.1128/JB.124.2.775-783.1975; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; Sangurdekar DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-583; Scheltema RA, 2010, PARASITOLOGY, V137, P1291, DOI 10.1017/S0031182009992022; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; STROM AR, 1993, MOL MICROBIOL, V8, P205, DOI 10.1111/j.1365-2958.1993.tb01564.x; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Voet D., 2005, BIOCHEMISTRY-US; Waterman SR, 1998, APPL ENVIRON MICROB, V64, P3882; Watson DG., 1999, PHARM ANAL TXB PHARM; Wedge DC, 2011, ANAL CHEM, V83, P6689, DOI 10.1021/ac2012224; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wilson M, 2004, MICROBIAL INHABITANT; Winder CL, 2006, MICROBIOL-SGM, V152, P2757, DOI 10.1099/mic.0.28986-0; Xu Y, 2012, METABOLOMICS, V8, pS37, DOI 10.1007/s11306-011-0361-9; Yeagle P.L, 2016, MEMBRANE CELLS, Vthird, P452; Zhu H, 2006, J MED MICROBIOL, V55, P1265, DOI 10.1099/jmm.0.46611-0	58	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200272	10.1371/journal.pone.0200272	http://dx.doi.org/10.1371/journal.pone.0200272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005078	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200010
J	Shehata, M; Mahmoud, A; Soliman, A; Khalifa, F; Ghazal, M; Abou El-Ghar, M; El-Melegy, M; Ei-Baz, A				Shehata, Mohamed; Mahmoud, Ali; Soliman, Ahmed; Khalifa, Fahmi; Ghazal, Mohammed; Abou El-Ghar, Mohamed; El-Melegy, Moumen; Ei-Baz, Ayman			3D kidney segmentation from abdominal diffusion MRI using an appearance-guided deformable boundary	PLOS ONE			English	Article							GRAPH CUTS; LEVEL SET; PERFORMANCE; FRAMEWORK; PERFUSION; MODEL	A new technique for more accurate automatic segmentation of the kidney from its surrounding abdominal structures in diffusion-weighted magnetic resonance imaging (DW-MRI) is presented. This approach combines a new 3D probabilistic shape model of the kidney with a first-order appearance model and fourth-order spatial model of the diffusion-weighted signal intensity to guide the evolution of a 3D geometric deformable model. The probabilistic shape model was built from labeled training datasets to produce a spatially variant, independent random field of region labels. A Markov-Gibbs random field spatial model with up to fourth-order interactions was adequate to capture the inhomogeneity of renal tissues in the DW-MRI signal. A new analytical approach estimated the Gibbs potentials directly from the DW-MRI data to be segmented, in order that the segmentation procedure would be fully automatic. Finally, to better distinguish the kidney object from the surrounding tissues, marginal gray level distributions inside and outside of the deformable boundary were modeled with adaptive linear combinations of discrete Gaussians (first-order appearance model). The approach was tested on a cohort of 64 DW-MRI datasets with b-values ranging from 50 to 1000 s/mm(2). The performance of the presented approach was evaluated using leave-one-subject-out cross validation and compared against three other well-known segmentation methods applied to the same DW-MRI data using the following evaluation metrics: 1) the Dice similarity coefficient (DSC); 2) the 95-percentile modified Hausdorff distance (MHD); and 3) the percentage kidney volume difference (PKVD). High performance of the new approach was confirmed by the high DSC (0.95 +/- 0.01), low MHD (3.9 +/- 0.76) mm, and low PKVD (9.5 +/- 2.2)% relative to manual segmentation by an MR expert (a board certified radiologist).	[Shehata, Mohamed; Mahmoud, Ali; Soliman, Ahmed; Ghazal, Mohammed; Ei-Baz, Ayman] Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA; [Khalifa, Fahmi] Mansoura Univ, Dept Elect & Commun Engn, Mansoura, Egypt; [Ghazal, Mohammed] Abu Dhabi Univ, Elect & Comp Engn Dept, Abu Dhabi, U Arab Emirates; [Abou El-Ghar, Mohamed] Univ Mansoura, Radiol Dept, Urol & Nephrol Ctr, Mansoura, Egypt; [El-Melegy, Moumen] Assiut Univ, Dept Elect Engn, Assiut, Egypt	University of Louisville; Egyptian Knowledge Bank (EKB); Mansoura University; Abu Dhabi University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Assiut University	Ei-Baz, A (corresponding author), Univ Louisville, Bioengn Dept, Louisville, KY 40292 USA.	aselba01@louisville.edu	El-Ghar, Mohamed Abou/ABD-2475-2020; El-Baz, Ayman/AAC-6689-2019; Khalifa, Fahmi/I-5663-2018; Soliman, Ahmed/I-1601-2013	El-Ghar, Mohamed Abou/0000-0003-2713-4394; El-Baz, Ayman/0000-0001-7264-1323; Khalifa, Fahmi/0000-0003-3318-2851; , Mohamed/0000-0001-6640-6183; El-Melegy, Moumen/0000-0003-0146-5515; Soliman, Ahmed/0000-0002-1931-3416; Ghazal, Mohammed/0000-0002-9045-6698	U.S.-Egypt Science and Technology Joint Fund [2000007145]	U.S.-Egypt Science and Technology Joint Fund(United States Agency for International Development (USAID)Science and Technology Development Fund (STDF)US-Egypt Science and Technology Joint Fund)	This research is supported by the U.S.-Egypt Science and Technology Joint Fund (2000007145).	Abdelmunim H., 2008, 2008 IEEE Computer Society Conference on Computer Vision and Pattern Recognition Workshops (CVPR Workshops), P1, DOI 10.1109/CVPRW.2008.4563025; Abou-El-Ghar ME, 2012, BRIT J RADIOL, V85, pE206, DOI 10.1259/bjr/53260155; Ali AM, 2007, LECT NOTES COMPUT SC, V4791, P384; Balafar MA, 2010, ARTIF INTELL REV, V33, P261, DOI 10.1007/s10462-010-9155-0; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; Campadelli P, 2010, ARTIF INTELL MED, V50, P3, DOI 10.1016/j.artmed.2010.04.010; Centers for Disease Control and Prevention, 2017, NAT CHRON KIDN DIS F; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Chevaillier B, 2011, NEURAL PROCESS LETT, V34, P71, DOI 10.1007/s11063-011-9184-y; Cuingnet R, 2012, LECT NOTES COMPUT SC, V7512, P66, DOI 10.1007/978-3-642-33454-2_9; de Priester JA, 2001, J MAGN RESON IMAGING, V14, P134, DOI 10.1002/jmri.1163; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; El Munim HEA, 2007, IEEE T PATTERN ANAL, V29, P945, DOI 10.1109/TPAMI.2007.1100; El-Baz A, 2012, IEEE T BIO-MED ENG, V59, P2019, DOI 10.1109/TBME.2012.2196434; Farag AA, 2006, IEEE T IMAGE PROCESS, V15, P952, DOI 10.1109/TIP.2005.863949; Freiman M, 2010, LECT NOTES COMPUT SC, V6363, P73; Gerig G, 2001, LECT NOTES COMPUTER, V2208, P516; Giele E., 2002, THESIS; Giele ELW, 2001, J MAGN RESON IMAGING, V14, P741, DOI 10.1002/jmri.10020; Glocker B., 2010, MED IMAGE ANAL CLIN, P147; Gloger O, 2012, IEEE T MED IMAGING, V31, P312, DOI 10.1109/TMI.2011.2168609; Hollis E, 2017, EGYPT J RADIOL NUC M, V48, P257, DOI 10.1016/j.ejrnm.2016.11.005; Hueper K, 2016, J MAGN RESON IMAGING, V44, P112, DOI 10.1002/jmri.25158; Jensen HG, 2015, LECT NOTES COMPUT SC, V9350, P305, DOI 10.1007/978-3-319-24571-3_37; Khalifa F, 2013, IEEE T MED IMAGING, V32, P1910, DOI 10.1109/TMI.2013.2269139; Kim S, 2005, 2005 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY (ISSPIT), VOLS 1 AND 2, P743; Koh H., 2006, P INT C CONTR AUT RO, P1; LEVENTON ME, 2000, PROC CVPR IEEE, P316, DOI DOI 10.1109/CVPR.2000.855835; Li S, 2012, COMPUT MED IMAG GRAP, V36, P108, DOI 10.1016/j.compmedimag.2011.06.005; Lie J, 2006, IEEE T IMAGE PROCESS, V15, P1171, DOI 10.1109/TIP.2005.863956; Liu GY, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-158; Liu X, 2009, IEEE ENG MED BIO, P3613, DOI 10.1109/IEMBS.2009.5333519; Mackelaite L, 2012, AM J TRANSPLANT, V12, P329; Mavromatis S, 2001, P ANN INT IEEE EMBS, V23, P2673, DOI 10.1109/IEMBS.2001.1017333; Osher S., 2006, LEVEL SET METHODS DY, V153; Park SY, 2014, EUR J RADIOL, V83, P2114, DOI 10.1016/j.ejrad.2014.09.017; Pohle R., 2001, Computer Analysis of Images and Patterns. 9th International Conference, CAIP 2001. Proceedings (Lecture Notes in Computer Science Vol.2124), P238; Rudra AK, 2013, PATTERN RECOGN LETT, V34, P1470, DOI 10.1016/j.patrec.2013.05.013; Rusinek H, 2007, MAGN RESON MED, V57, P1159, DOI 10.1002/mrm.21240; Shehata M, 2015, IEEE IMAGE PROC, P4441, DOI 10.1109/ICIP.2015.7351646; Shehata M, 2015, I S BIOMED IMAGING, P951, DOI 10.1109/ISBI.2015.7164028; Song T, 2006, IEEE INT C ENG MED B, P3067; Spiegel M, 2009, COMPUT MED IMAG GRAP, V33, P29, DOI 10.1016/j.compmedimag.2008.10.002; Steiger P, 2017, EUR RADIOL, V27, P4336, DOI 10.1007/s00330-017-4814-z; Sun Y, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P700; Sun Y, 2004, IEEE IMAGE PROC, P1923; Sun Y, 2004, THESIS; Tsagaan B, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P1059, DOI 10.1109/ICIP.2001.958309; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang X, 2004, INT J COMPUT VISION, V59, P87, DOI 10.1023/B:VISI.0000020672.14006.ad; Wypych-Klunder K, 2014, POL J RADIOL, V79, P94, DOI 10.12659/PJR.890502; Yan PK, 2009, IEEE T INF TECHNOL B, V13, P252, DOI 10.1109/TITB.2008.2010492; Yang XF, 2012, PROC SPIE, V8314, DOI 10.1117/12.912190; Yap PT, 2015, LECT NOTES COMPUT SC, V9351, P132, DOI 10.1007/978-3-319-24574-4_16; Yuksel SE, 2007, J VIB CONTROL, V13, P1505, DOI 10.1177/1077546307077417	55	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200082	10.1371/journal.pone.0200082	http://dx.doi.org/10.1371/journal.pone.0200082			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005069	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200006
J	Fisher, HP; Pascual, MG; Jimenez, SI; Michaelson, DA; Joncas, CT; Quenzer, ED; Christie, AE; Horch, HW				Fisher, Harrison P.; Pascual, Micah G.; Jimenez, Sylvia, I; Michaelson, David A.; Joncas, Colby T.; Quenzer, Eleanor D.; Christie, Andrew E.; Horch, Hadley W.			De novo assembly of a transcriptome for the cricket Gryllus bimaculatus prothoracic ganglion: An invertebrate model for investigating adult central nervous system compensatory plasticity	PLOS ONE			English	Article							MEDIATED AXONAL REPULSION; DROSOPHILA VISUAL-SYSTEM; SPINAL-CORD; CNS MIDLINE; SEMAPHORIN-1A FUNCTIONS; DEVELOPMENTAL GUIDANCE; SECRETED SEMAPHORINS; DENDRITIC GUIDANCE; LATERAL POSITION; APICAL DENDRITES	The auditory system of the cricket, Gryllus bimaculatus, demonstrates an unusual amount of anatomical plasticity in response to injury, even in adults. Unilateral removal of the ear causes deafferented auditory neurons in the prothoracic ganglion to sprout dendrites across the midline, a boundary they typically respect, and become synaptically connected to the auditory afferents of the contralateral ear. The molecular basis of this sprouting and novel synaptogenesis in the adult is not understood. We hypothesize that well-conserved developmental guidance cues may recapitulate their guidance functions in the adult in order to facilitate this compensatory growth. As a first step in testing this hypothesis, we have generated a de novo assembly of a prothoracic ganglion transcriptome derived from control and deafferented adult individuals. We have mined this transcriptome for orthologues of guidance molecules from four well-conserved signaling families: Slit, Netrin, Ephrin, and Semaphorin. Here we report that transcripts encoding putative orthologues of most of the candidate developmental ligands and receptors from these signaling families were present in the assembly, indicating expression in the adult G. bimaculatus prothoracic ganglion.	[Fisher, Harrison P.; Jimenez, Sylvia, I; Michaelson, David A.; Joncas, Colby T.; Quenzer, Eleanor D.; Horch, Hadley W.] Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA; [Pascual, Micah G.; Christie, Andrew E.] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Pacific Biosci Res Ctr, Bekesy Lab Neurobiol, Honolulu, HI USA	Bowdoin College; University of Hawaii System; University of Hawaii Manoa	Horch, HW (corresponding author), Bowdoin Coll, Dept Biol, Brunswick, ME 04011 USA.	hhorch@bowdoin.edu	Fisher, Harrison/AAW-7442-2020; Fisher, Harrison/AAX-8315-2020	Quenzer, Eleanor/0000-0002-4951-5692; Fisher, Harrison/0000-0002-6800-3107	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM0103423]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM0103423.	Akbik FV, 2013, NEURON, V77, P859, DOI 10.1016/j.neuron.2012.12.027; Alavi M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002560; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Awata H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15885; Ayoob JC, 2004, J NEUROSCI, V24, P6639, DOI 10.1523/JNEUROSCI.1104-04.2004; Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; Bando T, 2013, DEVELOPMENT, V140, P959, DOI 10.1242/dev.084590; Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; Bossing T, 2002, DEVELOPMENT, V129, P4205; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; BRODFUEHRER PD, 1988, J NEUROBIOL, V19, P17, DOI 10.1002/neu.480190104; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; Carr L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172736; Christie AE, 2016, GEN COMP ENDOCRINOL; Christie AE, MAR GENOMICS; Christie AE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145964; Davidson NM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0410-6; Dearborn R, 2002, J NEUROSCI, V22, P1338, DOI 10.1523/JNEUROSCI.22-04-01338.2002; Dorsten JN, 2008, INT J DEV NEUROSCI, V26, P753, DOI 10.1016/j.ijdevneu.2008.07.004; Duan YT, 2014, ELIFE, V3, DOI 10.7554/eLife.04390; Duman-Scheel M, 2007, EVOL DEV, V9, P131, DOI 10.1111/j.1525-142X.2007.00144.x; Evans TA, 2010, CURR BIOL; Evans TA, 2016, CURR OPIN INSECT SCI, V18, P11, DOI 10.1016/j.cois.2016.08.007; Evans TA, 2012, DEV BIOL, V363, P266, DOI 10.1016/j.ydbio.2011.12.046; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Francis WR, 2013, COMP NON MODEL ANIMA; Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882; Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamada A, 2009, LOSS FUNCTION ANAL F; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDRICK L, 1992, COLD SPRING HARB SYM, V57, P345, DOI 10.1101/SQB.1992.057.01.039; Holtmaat AJGD, 2003, EXP NEUROL, V182, P142, DOI 10.1016/S0014-4886(03)00035-9; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hong K, 1999, CELL; Horch H. W., 2017, CRICKET MODEL ORGANI, DOI [10.1007/978-4-431-56478-2, DOI 10.1007/978-4-431-56478-2]; Horch HW, 2011, DEV NEUROSCI-BASEL, V33, P21, DOI 10.1159/000322887; HOY RR, 1985, P NATL ACAD SCI USA, V82, P7772, DOI 10.1073/pnas.82.22.7772; Hruska M, 2012, MOL CELL NEUROSCI, V50, P35, DOI 10.1016/j.mcn.2012.03.004; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Jacobi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088449; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; Kennedy TE, 1994, CELL; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim S, 2004, TRENDS NEUROSCI, V27, P194, DOI 10.1016/j.tins.2004.02.011; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung-Hagesteijn C, 1992, CELL; Linne V, 2011, DEV BIOL, V353, P134, DOI 10.1016/j.ydbio.2011.02.006; Ludke J, 2008, ARTHROPOD STRUCT DEV, V37, P210, DOI 10.1016/j.asd.2007.10.001; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maynard KR, 2007, J COMP NEUROL, V503, P169, DOI 10.1002/cne.21392; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; MOORE DR, 1990, J COMP NEUROL, V302, P810, DOI 10.1002/cne.903020412; Morikawa RK, 2011, P NATL ACAD SCI USA, V108, P19389, DOI 10.1073/pnas.1109843108; Morita A, 2006, J NEUROSCI, V26, P2971, DOI 10.1523/JNEUROSCI.5453-05.2006; Nakamura F, 2009, J COMP NEUROL, V516, P360, DOI 10.1002/cne.22125; Nakamura T, 2010, CURR BIOL, V20, P1641, DOI 10.1016/j.cub.2010.07.044; Neuhaus-Follini A, 2015, NEURON, V87, P751, DOI 10.1016/j.neuron.2015.08.006; Ng TFF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066937; NORDEEN KW, 1983, J COMP NEUROL, V214, P144, DOI 10.1002/cne.902140204; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Organisti C, 2015, GENES CELLS, V20, P50, DOI 10.1111/gtc.12202; PALLAS SL, 1986, J COMP NEUROL, V248, P348, DOI 10.1002/cne.902480305; Park JH, 2016, BRAIN RES, V1634, P45, DOI 10.1016/j.brainres.2015.12.056; Pasterkarnp RJ, 2006, PHILOS T R SOC B, V361, P1499, DOI 10.1098/rstb.2006.1892; Pfister A, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00367; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Puettmann-Holgado R, 2006, CELL; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rau F, 2015, J COMP PHYSIOL A, V201, P1075, DOI 10.1007/s00359-015-1036-1; Ricolo D, 2015, MECH DEVELOP, V137, P11, DOI 10.1016/j.mod.2015.04.003; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; SCHILDBERGER K, 1986, J COMP PHYSIOL A, V158, P291, DOI 10.1007/BF00603613; Scully AL, 1999, MOL CELL NEUROSCI, V13, P337, DOI 10.1006/mcne.1999.0752; Shatzmiller RA, 2008, NEUROSCIENCE, V157, P621, DOI 10.1016/j.neuroscience.2008.09.031; Shim SO, 2012, MOL CELL NEUROSCI, V50, P193, DOI 10.1016/j.mcn.2012.04.007; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Song L, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0089-y; Stern M, 2012, J COMP NEUROL, V520, P679, DOI 10.1002/cne.22770; Sweeney LB, 2011, NEURON, V72, P734, DOI 10.1016/j.neuron.2011.09.026; Syed DS, 2016, ELIFE, V5, DOI 10.7554/eLife.11572; Tavosanis G, 2012, DEV NEUROBIOL, V72, P73, DOI 10.1002/dneu.20951; Taylor H, 2017, CURR BIOL, V27, pR90, DOI 10.1016/j.cub.2017.01.003; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Terman JR, 2004, SCIENCE, V303, P1204, DOI 10.1126/science.1092121; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Tsuchiya A, 2007, BRAIN RES, V1159, P1, DOI 10.1016/j.brainres.2006.12.096; Vellichirammal NN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082129; Watanabe T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2020; Wehrle R, 2005, EUR J NEUROSCI, V22, P2134, DOI 10.1111/j.1460-9568.2005.04419.x; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong JTW, 1999, NAT NEUROSCI, V2, P798, DOI 10.1038/12168; Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006; Zinn K, 2007, CELL, V129, P455, DOI 10.1016/j.cell.2007.04.024	124	8	8	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199070	10.1371/journal.pone.0199070	http://dx.doi.org/10.1371/journal.pone.0199070			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995882	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800017
J	Fried, HG; Narayanan, S; Fallen, B				Fried, Harrison Gregory; Narayanan, Sruthi; Fallen, Benjamin			Characterization of a soybean (Glycine max L. Merr.) germplasm collection for root traits	PLOS ONE			English	Article							CICER-ARIETINUM L.; MECHANICAL IMPEDANCE; PHOSPHORUS EFFICIENCY; PENETRATION ABILITY; GENETIC-VARIABILITY; GENOTYPIC VARIATION; DROUGHT TOLERANCE; NUTRIENT-UPTAKE; GROWTH; REGISTRATION	Root systems that improve resource uptake and penetrate compacted soil (hardpan) are important for improving soybean (Glycine max L. Merr.) productivity in optimal and sub-optimal environments. The objectives of this research were to evaluate a soybean germplasm collection of 49 genotypes for root traits, determine whether root traits are related with plant height, shoot dry weight, chlorophyll index, and seed size, and identify genotypes that can penetrate a hardpan. Plants were maintained under optimal growth conditions in a greenhouse. Single plants were grown in mesocosms, constructed of two stacked columns (top and bottom columns had 25 and 46 cm height, respectively, and 15 cm inside diameter) with a 2-cm thick wax layer (synthetic hardpan; penetration resistance, 1.5 MPa at 30 degrees C) in between. Plants were harvested at 42 days after planting. Significant genetic variability was observed for root traits in the soybean germplasm collection, and genotypes that penetrated the synthetic hardpan were identified. Genotypes NTCPR94-5157, NMS4-1-83, and N09-13128 were ranked high and PI 424007 and R01-581F were ranked low for most root traits. Shoot dry weight and chlorophyll index were positively related with total root length, surface area, and volume, and fine root length (Correlation coefficient, r >= 0.60 and P-value < 0.0001 for shoot dry weight and r >= 0.37 and P-value < 0.01 for chlorophyll index]. Plant height was negatively correlated with total root surface area, total root volume, and average root diameter (vertical bar r vertical bar >= 0.29, P-value < 0.05). Seed size was not correlated with any root traits. The genetic variability identified in this research for root traits and penetration are critical for soybean improvement programs in choosing genotypes with improved root characteristics to increase yield in stressful or optimum environments.	[Fried, Harrison Gregory; Narayanan, Sruthi] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA; [Fallen, Benjamin] Clemson Univ, Pee Dee Res & Educ Ctr, Florence, SC 29506 USA	Clemson University; Clemson University	Narayanan, S (corresponding author), Clemson Univ, Dept Plant & Environm Sci, Clemson, SC 29634 USA.	skutty@clemson.edu		Narayanan, Sruthi/0000-0002-8844-7880; Fallen, Ben/0000-0001-7185-5493	Clemson University Research Grant Committee; NIFA/USDA [SC-1700533]	Clemson University Research Grant Committee; NIFA/USDA(United States Department of Agriculture (USDA))	This research was funded by Clemson University Research Grant Committee, Project Initiation Grant and NIFA/USDA, project number SC-1700533 to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna TLB, 2007, PLANT SOIL, V301, P135, DOI 10.1007/s11104-007-9428-9; Acuna TLB, 2005, AUST J AGR RES, V56, P1235, DOI 10.1071/AR05067; Akpertey A., 2015, GENETIC INTROGRESSIO; [Anonymous], 2017, SOYSTATS REF GUID IM; [Anonymous], 1999, P WORLD SOYB RES C C; Ao JH, 2010, FUNCT PLANT BIOL, V37, P304, DOI 10.1071/FP09215; BARRACLOUGH PB, 1988, J AGR SCI, V110, P207, DOI 10.1017/S0021859600081235; Bellaloui N, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00498; Bengough AG, 2011, J EXP BOT, V62, P59, DOI 10.1093/jxb/erq350; BENGOUGH AG, 1990, J SOIL SCI, V41, P341, DOI 10.1111/j.1365-2389.1990.tb00070.x; BOWERS GR, 1990, CROP SCI, V30, P427, DOI 10.2135/cropsci1990.0011183X003000020049x; Bunce J. A., 2016, American Journal of Plant Sciences, V7, P773, DOI 10.4236/ajps.2016.76071; Burton JW, 2006, CROP SCI, V46, P2654; BUSSCHER WJ, 1986, SOIL SCI, V141, P144, DOI 10.1097/00010694-198602000-00007; CAASSEN N, 1976, AGRON J, V68, P961, DOI 10.2134/agronj1976.00021962006800060030x; CARPENTER JA, 1986, CROP SCI, V26, P681, DOI 10.2135/cropsci1986.0011183X002600040008x; Carter T. E., 1989, PROCEEDING WORLD SOY, P1001; Carter TE, 2016, J PLANT REGIST, V10, P238, DOI 10.3198/jpr2015.09.0057crc; Carter TE, 2011, J PLANT REGIST, V5, P309, DOI 10.3198/jpr2010.09.0565crc; Carter TE, 2009, J PLANT REGIST, V3, P22, DOI 10.3198/jpr2008.05.0259crc; Carter TE, 2003, CROP SCI, V43, P1126, DOI 10.2135/cropsci2003.1126; CARTER TE, 2003, CROP SCI, V43, P1128; Chen P, 2007, J PLANT REGIST, V1, P166, DOI 10.3198/jpr2007.01.0046crg; Chimungu JG, 2015, J EXP BOT, V66, P3151, DOI 10.1093/jxb/erv121; Clark LJ, 2008, FUNCT PLANT BIOL, V35, P1163, DOI 10.1071/FP08132; Clark LJ, 2000, PLANT SOIL, V219, P187, DOI 10.1023/A:1004753900945; Clark LJ, 2002, FIELD CROP RES, V76, P189, DOI 10.1016/S0378-4290(02)00039-4; Devi MJ, 2013, CROP SCI, V53, P2072, DOI 10.2135/cropsci2013.02.0095; Djanaguiraman M, 2013, CROP SCI, V53, P1594, DOI 10.2135/cropsci2012.07.0441; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; FITTER AH, 2002, PLANT ROOTS HIDDEN H, P249; Gahoonia TS, 2006, J PLANT NUTR, V29, P643, DOI 10.1080/01904160600564378; Gaur PM, 2008, PLANT PROD SCI, V11, P3, DOI 10.1626/pps.11.3; Gillen A.M., 2012, UNIFORM SOYBEAN TEST; Gillen A.M., 2016, UNIFORM SOYBEAN TEST; Gillen A.M., 2015, UNIFORM SOYBEAN TEST; GRIN, 2013, GERMPL RES INF NETW; Guerrero-Campo J, 2001, ACTA OECOL, V22, P77, DOI 10.1016/S1146-609X(00)01101-2; Hodge A, 1999, PLANT CELL ENVIRON, V22, P811, DOI 10.1046/j.1365-3040.1999.00454.x; HUDAK CM, 1995, CROP SCI, V35, P464, DOI 10.2135/cropsci1995.0011183X003500020031x; Hufstetler EV, 2007, CROP SCI, V47, P25, DOI 10.2135/cropsci2006.04.0243; KIANG YT, 1992, J HERED, V83, P325, DOI 10.1093/oxfordjournals.jhered.a111225; King ZR, 2016, J PLANT REGIST, V10, P189, DOI 10.3198/jpr2015.04.0027crg; Lee GJ, 2002, AGRONOMY ABSTRACTS, P711, DOI [10.1007/BF00303516, DOI 10.1007/BF00303516]; Lee SH, 1996, CROP SCI, V36, P728, DOI 10.2135/cropsci1996.0011183X003600030035x; Liang QA, 2010, ANN BOT-LONDON, V106, P223, DOI 10.1093/aob/mcq097; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Manavalan LP, 2010, PLANT SOIL, V330, P503, DOI 10.1007/s11104-009-0222-8; Manschadi AM, 2008, PLANT SOIL, V303, P115, DOI 10.1007/s11104-007-9492-1; McPhee K, 2005, CROP SCI, V45, P1758, DOI 10.2135/cropsci2004.0544; Narayanan S, 2014, AGRON J, V106, P1593, DOI 10.2134/agronj14.0015; Narayanan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100317; Pierret A, 2005, NEW PHYTOL, V166, P967, DOI 10.1111/j.1469-8137.2005.01389.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Prince SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1334-6; Purcell LC, 2004, AGRON MONOGR ASA, V16, P520; Ross J., 2015, ARKANSAS SOYBEAN RES; Sadok W, 2012, CROP SCI, V52, P1261, DOI 10.2135/cropsci2011.11.0622; Sanguineti MC, 2007, ANN APPL BIOL, V151, P291, DOI 10.1111/j.1744-7348.2007.00198.x; Scofield S, 2016, UNIFORM SOYBEAN TEST; Serraj R, 2004, FIELD CROP RES, V88, P115, DOI 10.1016/j.fcr.2003.12.001; Shipe ER, 2003, CROP SCI, V43, P2305, DOI 10.2135/cropsci2003.2305; SINGH RJ, 1988, THEOR APPL GENET, V76, P705, DOI 10.1007/BF00303516; Smucker AJM, 2004, SPECIAL PUBLICATION, V49, p27 ; SoyBase and the Soybean Breeder's Toolbox, DAT SOYB; Specht JE, 1999, CROP SCI, V39, P1560, DOI 10.2135/cropsci1999.3961560x; SPONCHIADO BN, 1989, EXP AGR, V25, P249, DOI 10.1017/S0014479700016756; Thomas CL, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0902-5; TU JC, 1991, SOIL BIOL BIOCHEM, V23, P233, DOI 10.1016/0038-0717(91)90057-Q; TURMAN PC, 1995, PLANT SOIL, V176, P235, DOI 10.1007/BF00011787; Waisel Y, 2002, KAFKAFI U PLANT ROOT, P1120; Wu ChengJun, 2017, American Journal of Plant Sciences, V8, P53; YU LX, 1995, CROP SCI, V35, P684, DOI 10.2135/cropsci1995.0011183X003500030005x; Zheng HG, 2000, GENOME, V43, P53, DOI 10.1139/gen-43-1-53	74	21	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200463	10.1371/journal.pone.0200463	http://dx.doi.org/10.1371/journal.pone.0200463			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995945	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800070
J	Siqueira, AFP; de Castro, LS; de Assis, PM; Bicudo, LD; Mendes, CM; Nichi, M; Visintin, JA; Assumpcao, MEOD				Perez Siqueira, Adriano Felipe; de Castro, Leticia Signori; de Assis, Patricia Monken; Bicudo, Luana de Cassia; Mendes, Camilla Mota; Nichi, Marcillio; Visintin, Jose Antonio; Ortiz D'Avila Assumpcao, Mayra Elena			Sperm traits on in vitro production (IVP) of bovine embryos: Too much of anything is good for nothing	PLOS ONE			English	Article							FROZEN-THAWED SEMEN; OXIDATIVE STRESS; DNA FRAGMENTATION; BULL SPERMATOZOA; SPERMATOLOGICAL PARAMETERS; MOTILITY CHARACTERISTICS; QUALITY PARAMETERS; PROGNOSTIC VALUE; HOLSTEIN BULLS; FLOW-CYTOMETRY	Sperm samples used on fertilization strongly influence the in vitro production (IVP) rates. However, sperm traits behind this effect are not stated consistently until now. This study aimed to evaluate the isolated and combined effect of some sperm traits (MB: total motility before Percoll (R) gradient, MA: total motility after Percoll (R) gradient, Al: acrosome integrity, MI: membrane integrity, MP: mitochondrial membrane potential, and CR: chromatin resistance) on IVP rates. This is the first study focusing on the isolated effect of distinct traits. For this purpose, the experiment was divided in three steps. In first step, to study behavior of traits sperm samples (n = 63 batches) were analyzed and ranked based on each trait. In second step, samples ranked were selected from target ranks regions and allocated in groups of four to five batches, creating Higher and Lower groups, according to two different approaches. One aimed to form groups that differed to all sperm traits simultaneously (effect of combined traits). The other aimed to form groups that differed only to a single sperm trait while no differences were observed for the remaining traits (effect of each isolated trait). In third step, for each group successfully formed in step 2, sperm samples were individually and prospectively used for IVP. Cleavage, embryo development and blastocyst rates were recorded and compared between Higher and Lower of respective trait groups. Surprisingly, evaluation of isolated effects revealed that lower levels of MB, Al and MP resulted in higher embryo development and blastocyst rates (p<0.05), which was not observed on cleavage rate. We conclude that sperm traits strongly influence embryo development after in vitro fertilization (IVF), affecting the zygote competence to achieve blastocyst stage. Individually, levels of MB, Al or MP could be some of the key traits that may define IVP efficiency on current systems of embryo production.	[Perez Siqueira, Adriano Felipe; de Castro, Leticia Signori; de Assis, Patricia Monken; Bicudo, Luana de Cassia; Mendes, Camilla Mota; Ortiz D'Avila Assumpcao, Mayra Elena] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Spermatozoa Biol, Sao Paulo, Brazil; [Mendes, Camilla Mota; Visintin, Jose Antonio] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Vitro Fertilizat Cloning & Anim Transgenesis, Sao Paulo, Brazil; [Nichi, Marcillio] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Androl, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Assumpcao, MEOD (corresponding author), Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Anim Reprod, Lab Spermatozoa Biol, Sao Paulo, Brazil.	meoaa@usp.br	Nichi, Marcílio/H-8244-2014; Assumpção, Mayra Elena O A/P-8683-2016	Nichi, Marcílio/0000-0003-4262-0825; Assumpção, Mayra Elena O A/0000-0002-5967-9316	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07940-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); MEODAA [2016/15147-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); MEODAA	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Grant number: 2013/07940-9 (AFPS), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); (AFPS), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Grant number: 2016/15147-5 (MEODAA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183; Alomar M, 2008, ANIM REPROD SCI, V107, P48, DOI 10.1016/j.anireprosci.2007.06.009; Alomar M, 2006, REPROD FERT DEVELOP, V18, P395, DOI 10.1071/RD05132; BLOTTNER S, 1990, THERIOGENOLOGY, V34, P619, DOI 10.1016/0093-691X(90)90017-N; Bollwein H, 2008, REPROD DOMEST ANIM, V43, P189, DOI 10.1111/j.1439-0531.2007.00876.x; Burruel V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06598; Carreira JT, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-1; Carvalho JO, 2010, THERIOGENOLOGY, V74, P1521, DOI 10.1016/j.theriogenology.2010.06.030; Castro LS, 2018, THERIOGENOLOGY, V107, P142, DOI 10.1016/j.theriogenology.2017.11.006; de Castro LS, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/8213071; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/revreprod/2.1.48; Escoffier J, 2015, MOL HUM REPROD, V21, P157, DOI 10.1093/molehr/gau098; Espinoza JA, 2009, ANDROLOGIA, V41, P51, DOI 10.1111/j.1439-0272.2008.00878.x; Ferraz MAMM, 2014, THERIOGENOLOGY, V81, P1067, DOI 10.1016/j.theriogenology.2014.01.033; Gallon F, 2006, FERTIL STERIL, V86, P1526, DOI 10.1016/j.fertnstert.2006.03.055; Ikeda H, 2002, THERIOGENOLOGY, V57, P1309, DOI 10.1016/S0093-691X(02)00630-1; Kasai T, 2002, ASIAN J ANDROL, V4, P97; Kato Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129285; KJAESTAD H, 1993, ACTA VET SCAND, V34, P299; Koppers AJ, 2008, J CLIN ENDOCR METAB, V93, P3199, DOI 10.1210/jc.2007-2616; Lane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100832; Lessard C, 2011, THERIOGENOLOGY, V76, P891, DOI 10.1016/j.theriogenology.2011.04.020; Lonergan P, 2016, ANNU REV ANIM BIOSCI, V4, P255, DOI 10.1146/annurev-animal-022114-110822; Ma L, 2013, J BIOL CHEM, V288, P10154, DOI 10.1074/jbc.M112.445866; Machado GM, 2009, THERIOGENOLOGY, V71, P1289, DOI 10.1016/j.theriogenology.2009.01.002; Marchetti C, 2002, HUM REPROD, V17, P1257, DOI 10.1093/humrep/17.5.1257; Marchetti P, 2012, ANDROLOGIA, V44, P136, DOI 10.1111/j.1439-0272.2010.01117.x; Morrell JM, 2017, ANIM REPROD SCI, V185, P42, DOI 10.1016/j.anireprosci.2017.08.001; Muino R, 2008, ANIM REPROD SCI, V109, P27, DOI 10.1016/j.anireprosci.2007.10.007; OTOI T, 1993, THERIOGENOLOGY, V39, P713, DOI 10.1016/0093-691X(93)90256-5; Palma GA, 2004, ANAT HISTOL EMBRYOL, V33, P257, DOI 10.1111/j.1439-0264.2004.00543.x; Palomo MJ, 2016, ZYGOTE, V24, P831, DOI 10.1017/S0967199416000162; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Pena AI, 2012, ANIM REPROD SCI, V133, P214, DOI 10.1016/j.anireprosci.2012.06.016; Perez L, 2015, ANDROLOGIA, V47, P1196, DOI 10.1111/and.12412; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; Samardzija M, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-58; Sapanidou V, 2015, THERIOGENOLOGY, V84, P1273, DOI 10.1016/j.theriogenology.2015.07.005; Selvaraju S, 2009, REPROD DOMEST ANIM, V44, P6, DOI 10.1111/j.1439-0531.2007.00979.x; Silva PFN, 2007, THERIOGENOLOGY, V67, P609, DOI 10.1016/j.theriogenology.2006.09.032; Simoes R, 2013, REPRODUCTION, V146, P433, DOI 10.1530/REP-13-0123; Siqueira AFP, 2016, LASER MED SCI, V31, P1245, DOI 10.1007/s10103-016-1966-z; Suzuki K, 2003, ANIM REPROD SCI, V77, P157, DOI 10.1016/S0378-4320(03)00035-6; Tanghe S, 2002, REPROD DOMEST ANIM, V37, P127, DOI 10.1046/j.1439-0531.2002.00343.x; Tartaglione CM, 2004, THERIOGENOLOGY, V62, P1245, DOI 10.1016/j.theriogenology.2004.01.012; Thundathil J, 2000, THERIOGENOLOGY, V54, P921, DOI 10.1016/S0093-691X(00)00402-7; Thundathil J, 2001, ANIM REPROD SCI, V67, P231, DOI 10.1016/S0378-4320(01)00127-0; Utt MD, 2016, ANIM REPROD SCI, V169, P37, DOI 10.1016/j.anireprosci.2015.12.011; VIANA J.H.M., 2010, ACTA SCI VET, V38, P661; Ward F, 2003, THERIOGENOLOGY, V59, P1575, DOI 10.1016/S0093-691X(02)01202-5; Zambrano F, 2016, THERIOGENOLOGY, V86, P1489, DOI 10.1016/j.theriogenology.2016.05.007; Zhang BR, 1997, THERIOGENOLOGY, V48, P221, DOI 10.1016/S0093-691X(97)84069-1; Zhang BR, 1999, INT J ANDROL, V22, P253, DOI 10.1046/j.1365-2605.1999.00178.x; Zhao XM, 2014, REPROD DOMEST ANIM, V49, P543, DOI 10.1111/rda.12305	54	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200273	10.1371/journal.pone.0200273	http://dx.doi.org/10.1371/journal.pone.0200273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990330	gold, Green Published, Green Submitted			2022-12-26	WOS:000438170300035
J	Albert, C; Luque, GM; Courchamp, F				Albert, Celine; Luque, Gloria M.; Courchamp, Franck			The twenty most charismatic species	PLOS ONE			English	Article							CONSERVATION; FLAGSHIPS; BIODIVERSITY; SURROGATES; UMBRELLAS; PAY	Charisma is a term commonly used in conservation biology to describe species. However, as the term "charismatic species" has never been properly defined, it needs to be better characterized to fully meet its potential in conservation biology. To provide a more complete depiction, we collected information from four different sources to define the species currently considered to be the most charismatic and to understand what they represent to the Western public. First, we asked respondents of two separate surveys to identify the 10 animal species that they considered to be the most charismatic and associate them with one to six traits: Rare, Endangered, Beautiful, Cute, Impressive, and Dangerous. We then identified the wild animals featured on the website homepages of the zoos situated in the world's 100 largest cities as well as on the film posters of all Disney and Pixar films, assuming in both cases that the most charismatic species were generally chosen to attract viewers. By combining the four approaches, we set up a ranked list of the 20 most charismatic animals. The majority are large exotic, terrestrial mammals. These species were deemed charismatic, mainly because they were regarded as beautiful, impressive, or endangered, although no particular trait was discriminated, and species were heterogeneously associated with most of the traits. The main social characteristics of respondents did not have a significant effect on their choices. These results provide a concrete list of the most charismatic species and offer insights into the Western public's perception of charismatic species, both of which could be helpful to target new species for conservation campaigns.	[Albert, Celine; Luque, Gloria M.; Courchamp, Franck] Univ Paris Saclay, Ecol Systemat Evolut, Univ Paris Sud, CNRS,AgroParisTech, Orsay, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Courchamp, F (corresponding author), Univ Paris Saclay, Ecol Systemat Evolut, Univ Paris Sud, CNRS,AgroParisTech, Orsay, France.	franck.courchamp@u-psud.fr	albert, céline/ABB-8769-2021; Courchamp, Franck/ABE-7204-2020	albert, céline/0000-0001-8220-0476; Courchamp, Franck/0000-0001-7605-4548	Biodiversa Eranet (FFII); ANR; BNP-Paribas (Invacost)	Biodiversa Eranet (FFII); ANR(French National Research Agency (ANR)); BNP-Paribas (Invacost)	This work was supported by grants from Biodiversa Eranet (FFII), ANR and BNP-Paribas (Invacost).	Andelman SJ, 2000, P NATL ACAD SCI USA, V97, P5954, DOI 10.1073/pnas.100126797; [Anonymous], 1995, GLOBAL BIODIVERSITY; Ballouard JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023152; Barua M, 2011, BIODIVERS CONSERV, V20, P1427, DOI 10.1007/s10531-011-0035-y; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bowen-Jones E, 2002, ORYX, V36, P189, DOI 10.1017/S0030605302000261; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Caro T, 2004, ANIM CONSERV, V7, P63, DOI 10.1017/S136794300300115X; Caro T. M, 2010, CONSERVATION PROXY I; Chessel D., 2004, R NEWS, V4, P5; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Colleony A, 2017, BIOL CONSERV, V206, P263, DOI 10.1016/j.biocon.2016.11.035; Courchamp F, 2017, SCIENCE NEW YO UNPUB, DOI [10.1186/s12879-017-2768-z, DOI 10.1186/S12879-017-2768-Z]; Cronin DT, 2014, INT J COMP PSYCHOL, V27; Douglas LR, 2014, BIODIVERS CONSERV, V23, P979, DOI 10.1007/s10531-014-0647-0; Entwistle A, 2000, ORYX, V34, P239, DOI 10.1046/j.1365-3008.2000.00140.x; Entwistle A, 2000, PRIORITIES CONSERVAT; Fazey I, 2005, BIOL CONSERV, V124, P63, DOI 10.1016/j.biocon.2005.01.013; Genovart M, 2013, BIOL CONSERV, V159, P484, DOI 10.1016/j.biocon.2012.10.028; Hunter M, 2016, ECOL INDIC, V63, P121, DOI 10.1016/j.ecolind.2015.11.049; Jepson P, 2015, CONSERV SOC, V13, P95, DOI 10.4103/0972-4923.161228; Jepson P, 2011, SCIENCE, V334, P1351, DOI 10.1126/science.1213189; Kontoleon A, 2003, LAND ECON, V79, P483, DOI 10.2307/3147295; Leader-Williams Nigel, 2000, Conservation Biology Series (Cambridge), V3, P53; Lorimer J, 2007, ENVIRON PLANN D, V25, P911, DOI 10.1068/d71j; Macdonald EA, 2015, GLOB ECOL CONSERV, V3, P851, DOI 10.1016/j.gecco.2015.04.006; Metrick A, 1996, LAND ECON, V72, P1, DOI 10.2307/3147153; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Panwar, 1982, AMBIO, V11, P330; R Core Team, 2021, R LANGUAGE ENV STAT; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Seddon PJ, 2008, ORYX, V42, P240, DOI 10.1017/S003060530806119X; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Smith RJ, 2012, CONSERV LETT, V5, P205, DOI 10.1111/j.1755-263X.2012.00229.x; Tisdell C, 2005, ANTHROZOOS, V18, P160, DOI 10.2752/089279305785594216; Trimble MJ, 2010, CONSERV BIOL, V24, P886, DOI 10.1111/j.1523-1739.2010.01453.x; Verissimo D, 2017, BIOL CONSERV, V211, P95, DOI 10.1016/j.biocon.2017.04.018; Verissimo D, 2011, CONSERV LETT, V4, P1, DOI 10.1111/j.1755-263X.2010.00151.x; Ward PI, 1998, CONSERV BIOL, V12, P1408, DOI 10.1046/j.1523-1739.1998.97402.x; White PCL, 1997, BIOL CONSERV, V82, P345, DOI 10.1016/S0006-3207(97)00036-0; Zanin M, 2015, ORYX, V49, P96, DOI 10.1017/S0030605313001609	42	121	125	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0199149	10.1371/journal.pone.0199149	http://dx.doi.org/10.1371/journal.pone.0199149			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM3UN	29985962	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500009
J	Zhang, B; Alruwaili, N; Kandhi, S; Deng, WS; Huang, A; Wolin, MS; Sun, D				Zhang, Bin; Alruwaili, Norah; Kandhi, Sharath; Deng, Wensheng; Huang, An; Wolin, Michael S.; Sun, Dong			Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; PULMONARY-ARTERY RELAXATION; SHOCK-PROTEIN 90; NITRIC-OXIDE; SUPEROXIDE-DISMUTASE; ENDOTHELIAL FUNCTION; THERAPEUTIC TARGET; HEME DEFICIENCY; ACTIVATION; MITOCHONDRIAL	Ferrochelatase (FECH) is an enzyme necessary for heme synthesis, which is essential for maintaining normal functions of endothelial nitric oxide synthase (eNOS) and soluble guanylyl cyclase (sGC). We tested the hypothesis that inhibition of vascular FECH to attenuate heme synthesis downregulates eNOS and sGC expression, resulting in impaired NO/cGMP-dependent relaxation. To this end, isolated bovine coronary arteries (BCAs) were in vitro incubated without (as controls) or with N-methyl protoporphyrin (NMPP; 10(-5) -10(-7) M; a selective FECH antagonist) for 24 and 72 hours respectively. Tissue FECH activity, heme, nitrite/NO and superoxide levels were sequentially measured. Protein expression of FECH, eNOS and sGC was detected by western blot analysis. Vascular responses to various vasoactive agents were evaluated via isometric tension studies. Treatment of BCAs with NMPP initiated a time- and dose-dependent attenuation of FECH activity without changes in its protein expression, followed by significant reduction in the heme level. Moreover, ACh-induced relaxation and ACh-stimulated release of NO were significant reduced, associated with suppression of eNOS protein expression in NMPP-treated groups. Decreased relaxation to NO donor spermine-NONOate reached the statistical significance in BCAs incubated with NMPP for 72 hours, concomitantly with downregulation of sGC beta 1 expression that was independent of heat shock protein 90 (HSP90), nor did it significantly affect BCA relaxation caused by BAY 58-2667 that activates sGC in the heme-deficiency. Neither vascular responses to non-NO/sGC-mediators nor production of superoxide was affected by NMPP-treatment. In conclusion, deletion of vascular heme production via inhibiting FECH elicits downregulation of eNOS and sGC expression, leading to an impaired NO-mediated relaxation in an oxidative stress-independent manner.	[Zhang, Bin; Alruwaili, Norah; Kandhi, Sharath; Deng, Wensheng; Huang, An; Wolin, Michael S.; Sun, Dong] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Zhang, Bin] Renji Hosp, Dept GI Surg, Shanghai, Peoples R China; [Deng, Wensheng] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Sch Med, Dept Gen Surg, Shanghai, Peoples R China	New York Medical College; Shanghai Jiao Tong University	Sun, D (corresponding author), New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA.	dong_sun@nymc.edu			NIH [HL070653, HL129797]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115124, R01HL129797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants NIH HL070653 and HL129797. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Alhawaj R, 2015, AM J PHYSIOL-LUNG C, V308, pL719, DOI 10.1152/ajplung.00155.2014; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Atamna H, 2001, J BIOL CHEM, V276, P48410, DOI 10.1074/jbc.M108362200; Basavarajappa HD, 2017, EMBO MOL MED, V9, P786, DOI 10.15252/emmm.201606561; Bourque SL, 2010, J PHARMACOL EXP THER, V333, P290, DOI 10.1124/jpet.109.162966; Case AJ, 2013, FREE RADICAL BIO MED, V56, P17, DOI 10.1016/j.freeradbiomed.2012.11.018; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; da Guarda CC, 2016, MICROVASC RES, V106, P128, DOI 10.1016/j.mvr.2016.04.002; Ghosh A, 2014, J BIOL CHEM, V289, P15259, DOI 10.1074/jbc.M114.559393; Ghosh A, 2012, P NATL ACAD SCI USA, V109, P12998, DOI 10.1073/pnas.1205854109; Ghosh A, 2011, FASEB J, V25, P2049, DOI 10.1096/fj.10-180554; Gupte SA, 1999, AM J PHYSIOL-HEART C, V276, pH1535, DOI 10.1152/ajpheart.1999.276.5.H1535; Gupte SA, 1999, AM J PHYSIOL-LUNG C, V277, pL1124, DOI 10.1152/ajplung.1999.277.6.L1124; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Huang A, 2000, AM J PHYSIOL-HEART C, V278, pH762, DOI 10.1152/ajpheart.2000.278.3.H762; Huang A, 2012, DIABETES, V61, P3181, DOI 10.2337/db12-0559; Immenschuh S, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00146; Irvine JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044481; Kandhi S, 2017, AM J PHYSIOL-LUNG C, V313, pL350, DOI 10.1152/ajplung.00038.2017; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Mingone CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL337, DOI 10.1152/ajplung.00482.2005; Missirlis F, 2003, J BIOL CHEM, V278, P47365, DOI 10.1074/jbc.M307700200; Nedvetsky PI, 2008, FEBS LETT, V582, P327, DOI 10.1016/j.febslet.2007.12.025; Patel D, 2016, AM J PHYSIOL-HEART C, V310, pH1439, DOI 10.1152/ajpheart.00859.2015; Patel D, 2014, AM J PHYSIOL-REG I, V307, pR426, DOI 10.1152/ajpregu.00257.2013; Priviero FBM, 2010, J CARDIOVASC PHARM, V56, P229, DOI 10.1097/FJC.0b013e3181eb4e75; Qiao AJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000121; Sawicki KT, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001138; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Tawa M, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.261; Wolin MS, 2009, AM J PHYSIOL-HEART C, V296, pH539, DOI 10.1152/ajpheart.01167.2008; Yang YM, 2009, AM J PHYSIOL-HEART C, V297, pH1829, DOI 10.1152/ajpheart.00230.2009; Zhang HL, 2008, BIOINFORMATION, V2, P296, DOI 10.6026/97320630002296	36	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200307	10.1371/journal.pone.0200307	http://dx.doi.org/10.1371/journal.pone.0200307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985945	Green Published, Green Submitted, gold			2022-12-26	WOS:000438035500030
J	Causevic, M; Dominko, K; Malnar, M; Vidatic, L; Cermak, S; Pigoni, M; Kuhn, PH; Colombo, A; Havas, D; Flunkert, S; McDonald, J; Gunnersen, JM; Hutter-Paier, B; Tahirovic, S; Windisch, M; Krainc, D; Lichtenthaler, SF; Hecimovic, S				Causevic, Mirsada; Dominko, Kristina; Malnar, Martina; Vidatic, Lea; Cermak, Stjepko; Pigoni, Martina; Kuhn, Peer-Hendrik; Colombo, Alessio; Havas, Daniel; Flunkert, Stefanie; McDonald, Jessica; Gunnersen, Jenny M.; Hutter-Paier, Birgit; Tahirovic, Sabina; Windisch, Manfred; Krainc, Dimitri; Lichtenthaler, Stefan F.; Hecimovic, Silva			BACE1-cleavage of Sez6 and Sez6L is elevated in Niemann-Pick type C disease mouse brains	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; ALZHEIMERS-DISEASE; CHOLESTEROL HOMEOSTASIS; PYRAMIDAL NEURONS; MEMORY DEFICITS; TRANSGENIC MICE; APP; CELLS; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	It is intriguing that a rare, inherited lysosomal storage disorder Niemann-Pick type C (NPC) shares similarities with Alzheimer's disease (AD). We have previously reported an enhanced processing of beta-amyloid precursor protein (APP) by beta-secretase (BACE1), a key enzyme in the pathogenesis of AD, in NPC1-null cells. In this work, we characterized regional and temporal expression and processing of the recently identified BACE1 substrates seizure protein 6 (Sez6) and seizure 6-like protein (Sez6L), and APP, in NPC1(-/-) NPC1) and NPC1(+/+) (wt) mouse brains. We analysed 4-weeks old brains to detect the earliest changes associated with NPC, and 10-weeks of age to identify changes at terminal disease stage. Sez6 and Sez6L were selected due to their predominant cleavage by BACE1, and their potential role in synaptic function that may contribute to presentation of seizures and/or motor impairments in NPC patients. While an enhanced BACE1-cleavage of all three substrates was detected in NPC1 vs. wt-mouse brains at 4-weeks of age, at 10-weeks increased proteolysis by BACE1 was observed for Sez6L in the cortex, hippocampus and cerebellum of NPC1-mice. Interestingly, both APP and Sez6L were found to be expressed in Purkinje neurons and their immunostaining was lost upon Purkinje cell neurodegeneration in 10-weeks old NPC1 mice. Furthermore, in NPC1-vs. wt-mouse primary cortical neurons, both Sez6 and Sez6L showed increased punctuate staining within the endolysosomal pathway as well as increased Sez6L and BACE1-positive puncta. This indicates that a trafficking defect within the endolysosomal pathway may play a key role in enhanced BACE1-proteolysis in NPC disease. Overall, our findings suggest that enhanced proteolysis by BACE1 could be a part of NPC disease pathogenesis. Understanding the basic biology of BACE1 and the functional impact of cleavage of its substrates is important to better evaluate the therapeutic potential of BACE1 against AD and, possibly, NPC disease.	[Causevic, Mirsada; Dominko, Kristina; Malnar, Martina; Vidatic, Lea; Cermak, Stjepko; Hecimovic, Silva] Rudjer Boskovic Inst, Div Mol Med, Lab Neurodegenerat Dis Res, Zagreb, Croatia; [Pigoni, Martina; Colombo, Alessio; Tahirovic, Sabina; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Kuhn, Peer-Hendrik] Tech Univ Munich, Klinikum Rechts Isar, Inst Allgemeine Pathol & Pathol Anat, Munich, Germany; [Kuhn, Peer-Hendrik] Inst Adv Study, Munich, Germany; [Havas, Daniel; Flunkert, Stefanie; Hutter-Paier, Birgit; Windisch, Manfred] QPS Austria GmbH, Grambach, Austria; [McDonald, Jessica; Krainc, Dimitri] Northwestern Univ, Feinberg Sch Med, Ken & Ruth Davee Dept Neurol & Clin Neurol Sci, Chicago, IL 60611 USA; [Gunnersen, Jenny M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic, Australia; [Gunnersen, Jenny M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Lichtenthaler, Stefan F.] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, Klinikum Rechts Isar, Neuroprote, Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, Inst Adv Study, Munich, Germany; [Havas, Daniel; Windisch, Manfred] NeuroScios GmbH, St Radegund Graz, Austria	Rudjer Boskovic Institute; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Northwestern University; Feinberg School of Medicine; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Munich; Technical University of Munich; Technical University of Munich	Hecimovic, S (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Lab Neurodegenerat Dis Res, Zagreb, Croatia.	silva.hecimovic@irb.hr	Windisch, Manfred/AAG-9663-2021; Causevic, Mirsada/AAM-7423-2020; Hecimovic, Silva/T-8091-2017	Windisch, Manfred/0000-0003-1490-7933; Causevic, Mirsada/0000-0002-6099-6415; Pigoni, Martina/0000-0002-7896-6978; Gunnersen, Jenny/0000-0002-6310-7724; Hecimovic, Silva/0000-0001-6077-433X; Flunkert, Stefanie/0000-0003-3806-3907	Croatian Science Foundation [IP-2016-06-2799]; Deutscher Akademischer Austauschdienst (DAAD); Ministry of Science and Education, Republic of Croatia (MZO); JPND; Breuer Foundation Alzheimer Award; Centers of Excellence in Neurodgeneration (CoEN) initiative; HelmholtzIsrael project	Croatian Science Foundation; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Science and Education, Republic of Croatia (MZO); JPND; Breuer Foundation Alzheimer Award; Centers of Excellence in Neurodgeneration (CoEN) initiative; HelmholtzIsrael project	This work was supported by the Croatian Science Foundation (http://www.hrzz.hr) project IP-2016-06-2799 (to S.H.), the bilateral project between the Deutscher Akademischer Austauschdienst (DAAD; https://www.daad.de/en/) and the Ministry of Science and Education, Republic of Croatia (MZO; https://mzo.hr/) in 2016-2017. (to S.H. and S.T.) and by JPND (http://www.neurodegenerationresearch.eu/) (RiModFTD), the Breuer Foundation Alzheimer Award (https://www.breuerstiftung.de/eng/research-promotion/research-award/), the Centers of Excellence in Neurodgeneration (CoEN) initiative (http://www.coen.org/home.html) and a HelmholtzIsrael project (https://www.dkfz.de/en/helmholtzisrael-kooperation-personalisierte-medizin/index.html) (to S.F.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Cheret C, 2013, EMBO J, V32, P2015, DOI 10.1038/emboj.2013.146; Filser S, 2015, BIOL PSYCHIAT, V77, P729, DOI 10.1016/j.biopsych.2014.10.013; Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018; Guo QX, 2012, J BIOL CHEM, V287, P2437, DOI 10.1074/jbc.M111.315051; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kandalepas PC, 2013, ACTA NEUROPATHOL, V126, P329, DOI 10.1007/s00401-013-1152-3; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Killick R, 2015, BIOL PSYCHIAT, V77, P683, DOI 10.1016/j.biopsych.2015.03.001; Kodam A, 2010, GLIA, V58, P1267, DOI 10.1002/glia.21001; Kosicek M, 2010, BIOCHEM BIOPH RES CO, V393, P404, DOI 10.1016/j.bbrc.2010.02.007; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lahiri DK, 2014, ALZHEIMERS DEMENT, V10, pS411, DOI 10.1016/j.jalz.2013.11.004; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Malnar M, 2014, NEUROBIOL DIS, V72, P37, DOI 10.1016/j.nbd.2014.05.033; Malnar M, 2012, BBA-MOL BASIS DIS, V1822, P1270, DOI 10.1016/j.bbadis.2012.04.002; Malnar M, 2010, BBA-MOL BASIS DIS, V1802, P682, DOI 10.1016/j.bbadis.2010.05.006; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Nixon RA, 2004, AM J PATHOL, V164, P757, DOI 10.1016/S0002-9440(10)63163-X; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Osaki G, 2011, BRAIN RES, V1386, P58, DOI 10.1016/j.brainres.2011.02.025; Peake KB, 2012, J BIOL CHEM, V287, P9290, DOI 10.1074/jbc.M111.326405; PENTCHEV PG, 1980, BIOCHIM BIOPHYS ACTA, V619, P669, DOI 10.1016/0005-2760(80)90116-2; Pigoni M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0134-z; Platt N, 2016, J NEUROCHEM, V136, P74, DOI 10.1111/jnc.13138; Stutzer I, 2013, J BIOL CHEM, V288, P10536, DOI 10.1074/jbc.M112.444703; Thakker DR, 2015, J NEUROSCI, V35, P6931, DOI 10.1523/JNEUROSCI.2262-14.2015; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vanier MT, 1999, NEUROCHEM RES, V24, P481, DOI 10.1023/A:1022575511354; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Virador VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005136; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465; Zhu KC, 2018, BIOL PSYCHIAT, V83, P428, DOI 10.1016/j.biopsych.2016.12.023	44	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200344	10.1371/journal.pone.0200344	http://dx.doi.org/10.1371/journal.pone.0200344			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979789	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500100
J	Earp, M; Tyrer, JP; Winham, SJ; Lin, HY; Chornokur, G; Dennis, J; Aben, KKH; Anton-Culver, H; Antonenkova, N; Bandera, EV; Bean, YT; Beckmann, MW; Bjorge, L; Bogdanova, N; Brinton, LA; Brooks-Wilson, A; Bruinsma, F; Bunker, CH; Butzow, R; Campbell, IG; Carty, K; Chang-Claude, J; Cook, LS; Cramer, DW; Cunningham, JM; Cybulski, C; Dansonka-Mieszkowska, A; Despierre, E; Doherty, JA; Dork, T; du Bois, A; Durst, M; Easton, DF; Eccles, DM; Edwards, RP; Ekici, AB; Fasching, PA; Fridley, BL; Gentry-Maharaj, A; Giles, GG; Glasspool, R; Goodman, MT; Gronwald, J; Harter, P; Hein, A; Heitz, F; Hildebrandt, MAT; Hillemanns, P; Hogdall, CK; Hogdall, E; Hosono, S; Iversen, ES; Jakubowska, A; Jensen, A; Ji, BT; Jung, AY; Karlan, BY; Kellar, M; Kiemeney, LA; Lim, BK; Kjaer, SK; Krakstad, C; Kupryjanczyk, J; Lambrechts, D; Lambrechts, S; Le, ND; Lele, S; Lester, J; Levine, DA; Li, Z; Liang, D; Lissowska, J; Lu, KR; Lubinski, J; Lundvall, L; Massuger, LFAG; Matsuo, K; McGuire, V; McLaughlin, JR; McNeish, I; Menon, U; Milne, RL; Modugno, F; Moysich, KB; Ness, RB; Nevanlinna, H; Odunsi, K; Olson, SH; Orlow, I; Orsulic, S; Paul, J; Pejovic, T; Pelttari, LM; Permuth, JB; Pike, MC; Poole, EM; Rosen, B; Rossing, MA; Rothstein, JH; Runnebaum, IB; Rzepecka, IK; Schernhammer, E; Schwaab, I; Shu, XO; Shvetsov, YB; Siddiqui, N; Sieh, W; Song, HL; Southey, MC; Spiewankiewicz, B; Sucheston-Campbell, L; Tangen, IL; Teo, SH; Terry, KL; Thompson, PJ; Thomsen, L; Tworoger, SS; van Altena, AM; Vergote, I; Thomsen, LCV; Vierkant, RA; Walsh, CS; Wang-Gohrke, S; Wentzensen, N; Whittemore, AS; Wicklund, KG; Wilkens, LR; Woo, YL; Wu, AH; Wu, XF; Xiang, YB; Yang, H; Zheng, W; Ziogas, A; Lee, AW; Pearce, CL; Berchuck, A; Schildkraut, JM; Ramus, SJ; Monteiro, ANA; Narod, SA; Sellers, TA; Gayther, SA; Kelemen, LE; Chenevix-Trench, G; Risch, HA; Pharoah, PDP; Goode, EL; Phelan, CM				Earp, Madalene; Tyrer, Jonathan P.; Winham, Stacey J.; Lin, Hui-Yi; Chornokur, Ganna; Dennis, Joe; Aben, Katja K. H.; Anton-Culver, Hoda; Antonenkova, Natalia; Bandera, Elisa V.; Bean, Yukie T.; Beckmann, Matthias W.; Bjorge, Line; Bogdanova, Natalia; Brinton, Louise A.; Brooks-Wilson, Angela; Bruinsma, Fiona; Bunker, Clareann H.; Butzow, Ralf; Campbell, Ian G.; Carty, Karen; Chang-Claude, Jenny; Cook, Linda S.; Cramer, Daniel W.; Cunningham, Julie M.; Cybulski, Cezary; Dansonka-Mieszkowska, Agnieszka; Despierre, Evelyn; Doherty, Jennifer A.; Doerk, Thilo; du Bois, Andreas; Duerst, Matthias; Easton, Douglas F.; Eccles, Diana M.; Edwards, Robert P.; Ekici, Arif B.; Fasching, Peter A.; Fridley, Brooke L.; Gentry-Maharaj, Aleksandra; Giles, Graham G.; Glasspool, Rosalind; Goodman, Marc T.; Gronwald, Jacek; Harter, Philipp; Hein, Alexander; Heitz, Florian; Hildebrandt, Michelle A. T.; Hillemanns, Peter; Hogdall, Claus K.; Hogdall, Estrid; Hosono, Satoyo; Iversen, Edwin S.; Jakubowska, Anna; Jensen, Allan; Ji, Bu-Tian; Jung, Audrey Y.; Karlan, Beth Y.; Kellar, Melissa; Kiemeney, Lambertus A.; Lim, Boon Kiong; Kjaer, Susanne K.; Krakstad, Camilla; Kupryjanczyk, Jolanta; Lambrechts, Diether; Lambrechts, Sandrina; Le, Nhu D.; Lele, Shashi; Lester, Jenny; Levine, Douglas A.; Li, Zheng; Liang, Dong; Lissowska, Jolanta; Lu, Karen; Lubinski, Jan; Lundvall, Lene; Massuger, Leon F. A. G.; Matsuo, Keitaro; McGuire, Valerie; McLaughlin, John R.; McNeish, Iain; Menon, Usha; Milne, Roger L.; Modugno, Francesmary; Moysich, Kirsten B.; Ness, Roberta B.; Nevanlinna, Heli; Odunsi, Kunle; Olson, Sara H.; Orlow, Irene; Orsulic, Sandra; Paul, James; Pejovic, Tanja; Pelttari, Liisa M.; Permuth, Jenny B.; Pike, Malcolm C.; Poole, Elizabeth M.; Rosen, Barry; Rossing, Mary Anne; Rothstein, Joseph H.; Runnebaum, Ingo B.; Rzepecka, Iwona K.; Schernhammer, Eva; Schwaab, Ira; Shu, Xiao-Ou; Shvetsov, Yurii B.; Siddiqui, Nadeem; Sieh, Weiva; Song, Honglin; Southey, Melissa C.; Spiewankiewicz, Beata; Sucheston-Campbell, Lara; Tangen, Ingvild L.; Teo, Soo-Hwang; Terry, Kathryn L.; Thompson, Pamela J.; Thomsen, Lotte; Tworoger, Shelley S.; van Altena, Anne M.; Vergote, Ignace; Thomsen, Liv Cecilie Vestrheim; Vierkant, Robert A.; Walsh, Christine S.; Wang-Gohrke, Shan; Wentzensen, Nicolas; Whittemore, Alice S.; Wicklund, Kristine G.; Wilkens, Lynne R.; Woo, Yin-Ling; Wu, Anna H.; Wu, Xifeng; Xiang, Yong-Bing; Yang, Hannah; Zheng, Wei; Ziogas, Argyrios; Lee, Alice W.; Pearce, Celeste L.; Berchuck, Andrew; Schildkraut, Joellen M.; Ramus, Susan J.; Monteiro, Alvaro N. A.; Narod, Steven A.; Sellers, Thomas A.; Gayther, Simon A.; Kelemen, Linda E.; Chenevix-Trench, Georgia; Risch, Harvey A.; Pharoah, Paul D. P.; Goode, Ellen L.; Phelan, Catherine M.			Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CARCINOMA	Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality in American women. Normal ovarian physiology is intricately connected to small GTP binding proteins of the Ras superfamily (Ras, Rho, Rab, Arf, and Ran) which govern processes such as signal transduction, cell proliferation, cell motility, and vesicle transport. We hypothesized that common germline variation in genes encoding small GTPases is associated with EOC risk. We investigated 322 variants in 88 small GTPase genes in germline DNA of 18,736 EOC patients and 26,138 controls of European ancestry using a custom genotype array and logistic regression fitting log-additive models. Functional annotation was used to identify bio-features and expression quantitative trait loci that intersect with risk variants. One variant, ARHGEF10L (Rho guanine nucleotide exchange factor 10 like) rs2256787, was associated with increased endometrioid EOC risk (OR = 1.33, p = 4.46 x 10(-6)). Other variants of interest included another in ARHGEF10L, rs10788679, which was associated with invasive serous EOC risk (OR = 1.07, p = 0.00026) and two variants in AKAP6 (A-kinase anchoring protein 6) which were associated with risk of invasive EOC (rs1955513, OR = 0.90, p = 0.00033; rs927062, OR = 0.94, p = 0.00059). Functional annotation revealed that the two ARHGEF10L variants were located in super-enhancer regions and that AKAP6 rs927062 was associated with expression of GTPase gene ARHGAP5 (Rho GTPase activating protein 5). Inherited variants in ARHGEF10L and AKAP6, with potential transcriptional regulatory function and association with EOC risk, warrant investigation in independent EOC study populations.	[Earp, Madalene; Winham, Stacey J.; Li, Zheng; Vierkant, Robert A.; Goode, Ellen L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Tyrer, Jonathan P.; Dennis, Joe; Pharoah, Paul D. P.] Univ Cambridge, Dept Oncol, Strangeways Res Lab, Cambridge, England; [Lin, Hui-Yi] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat & Bioinformat, Tampa, FL USA; [Lin, Hui-Yi; Song, Honglin] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA; [Chornokur, Ganna; Permuth, Jenny B.; Tworoger, Shelley S.; Monteiro, Alvaro N. A.; Sellers, Thomas A.; Phelan, Catherine M.] H Lee Moffitt Canc Ctr & Res Inst, Div Populat Sci, Dept Canc Epidemiol, Tampa, FL USA; [Aben, Katja K. H.] Netherlands Comprehens Canc Org, Utrecht, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands; [Anton-Culver, Hoda; Ziogas, Argyrios] Univ Calif Irvine, Genet Epidemiol Res Inst, Sch Med, UCI Ctr Canc Genet Res & Prevent,Dept Epidemiol, Irvine, CA USA; [Antonenkova, Natalia] Byelorussian Inst Oncol & Med Radiol Aleksandrov, Minsk, BELARUS; [Bandera, Elisa V.] Rutgers Canc Inst New Jersey, Canc Prevent & Control, New Brunswick, NJ USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; [Bean, Yukie T.; Kellar, Melissa; Pejovic, Tanja] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Beckmann, Matthias W.; Fasching, Peter A.; Hein, Alexander] Univ Hosp Erlangen, Univ Breast Ctr Franconia, Dept Gynecol & Obstet, Erlangen, Germany; [Bjorge, Line; Krakstad, Camilla; Tangen, Ingvild L.; Thomsen, Liv Cecilie Vestrheim] Haukeland Hosp, Dept Gynecol & Obstet, Bergen, Norway; [Bjorge, Line] Univ Bergen, Dept Clin Med, Ctr Canc Biomarkers, Bergen, Norway; [Bogdanova, Natalia; Doerk, Thilo; Hillemanns, Peter] Hannover Med Sch, Gynaecol Res Unit, Hannover, Germany; [Brinton, Louise A.; Ji, Bu-Tian; Wentzensen, Nicolas; Yang, Hannah] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Brooks-Wilson, Angela] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC, Canada; [Brooks-Wilson, Angela] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Bruinsma, Fiona; Giles, Graham G.; Milne, Roger L.] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia; [Bunker, Clareann H.; Modugno, Francesmary] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Butzow, Ralf] Univ Helsinki, Dept Pathol, Cent Hosp, Helsinki, Finland; [Butzow, Ralf; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Butzow, Ralf; Nevanlinna, Heli; Pelttari, Liisa M.] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Campbell, Ian G.] Peter MacCallum Canc Ctr, Div Res, Canc Genet Lab, Melbourne, Australia; [Campbell, Ian G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Campbell, Ian G.; Southey, Melissa C.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Carty, Karen; Glasspool, Rosalind; Paul, James] Beatson W Scotland Canc Ctr, CRUK Clin Trials Unit, Glasgow, Lanark, Scotland; [Carty, Karen] Glasgow Royal Infirm, Dept Gynaecol Oncol, Glasgow, Lanark, Scotland; [Chang-Claude, Jenny; Jung, Audrey Y.] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Chang-Claude, Jenny] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hamburg, Germany; [Cook, Linda S.] Univ New Mexico, Div Epidemiol & Biostat, Albuquerque, NM 87131 USA; [Cramer, Daniel W.] Brigham & Womens Hosp, Obstet & Gynecol Ctr, 75 Francis St, Boston, MA 02115 USA; [Cramer, Daniel W.; Poole, Elizabeth M.; Schernhammer, Eva; Tworoger, Shelley S.] Harvard Med Sch, Boston, MA USA; [Cunningham, Julie M.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Cybulski, Cezary; Gronwald, Jacek; Jakubowska, Anna; Lubinski, Jan] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Dansonka-Mieszkowska, Agnieszka; Kupryjanczyk, Jolanta; Rzepecka, Iwona K.] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol, Warsaw, Poland; [Despierre, Evelyn] Univ Hosp Leuven, Div Gynecol Oncol, Dept Obstet & Gynecol, Leuven, Belgium; [Despierre, Evelyn] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium; [Doherty, Jennifer A.; Rossing, Mary Anne; Wicklund, Kristine G.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Program Epidemiol, 1124 Columbia St, Seattle, WA 98104 USA; [Doherty, Jennifer A.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Dr Horst Schmidt Kliniken Wiesbaden, Dept Gynaecol & Gynaecol Oncol, Wiesbaden, Germany; [du Bois, Andreas; Harter, Philipp; Heitz, Florian] Kliniken Essen Mitte Evang Huyssens Stiftung Knap, Dept Gynaecol & Gynaecol Oncol, Essen, Germany; [Duerst, Matthias; Runnebaum, Ingo B.] Friedrich Schiller Univ, Dept Gynecol, Jena, Germany; [Easton, Douglas F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Easton, Douglas F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England; [Eccles, Diana M.] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Edwards, Robert P.; Modugno, Francesmary] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Ekici, Arif B.] Friedrich Alexander Univ Erlangen Nuremberg, Univ Hosp Erlangen, Inst Human Genet, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Fridley, Brooke L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; [Gentry-Maharaj, Aleksandra; Menon, Usha] UCL, Inst Womens Hlth, Dept Womens Canc, Gynaecol Canc Res Ctr, London, England; [Giles, Graham G.; Milne, Roger L.] Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia; [Goodman, Marc T.; Thompson, Pamela J.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Hildebrandt, Michelle A. T.; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Hogdall, Claus K.; Lundvall, Lene] Univ Copenhagen, Rigshosp, Dept Gynaecol, Copenhagen, Denmark; [Hogdall, Estrid; Jensen, Allan; Kjaer, Susanne K.] Danish Canc Soc Res Ctr, Virus Lifestyle & Genes, Copenhagen, Denmark; [Hogdall, Estrid] Univ Copenhagen, Herlev Hosp, Dept Pathol, Mol Unit, Copenhagen, Denmark; [Hosono, Satoyo; Matsuo, Keitaro] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Iversen, Edwin S.] Duke Univ, Dept Stat, Durham, NC USA; [Karlan, Beth Y.; Lester, Jenny; Orsulic, Sandra; Walsh, Christine S.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Womens Canc Program, Los Angeles, CA 90048 USA; [Lim, Boon Kiong; Woo, Yin-Ling] Univ Malaya, Med Ctr, Dept Obstet & Gynaecol, Kuala Lumpur, Malaysia; [Kjaer, Susanne K.] Univ Copenhagen, Dept Gynecol, Rigshosp, Copenhagen, Denmark; [Lambrechts, Diether] Univ Leuven, Dept Oncol, Lab Translat Genet, Leuven, Belgium; [Lambrechts, Diether] Univ Leuven, Vesalius Res Ctr, VIB, Leuven, Belgium; [Lambrechts, Sandrina; Vergote, Ignace] Katholieke Univ Leuven, Univ Hosp Leuven, Div Gynecol Oncol, Leuven Canc Inst, Leuven, Belgium; [Le, Nhu D.] BC Canc Agcy, Canc Control Res, Vancouver, BC, Canada; [Lele, Shashi; Moysich, Kirsten B.; Sucheston-Campbell, Lara] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Levine, Douglas A.] Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; [Li, Zheng] Kunming Med Univ, Dept Gynecol Oncol, Affiliated Hosp 3, Yunnan Tumor Hosp, Kunming, Yunnan, Peoples R China; [Liang, Dong] Texas Southern Univ, Coll Pharm & Hlth Sci, Houston, TX 77004 USA; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Canc Epidemiol & Prevent, Warsaw, Poland; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Massuger, Leon F. A. G.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Nijmegen, Netherlands; [McGuire, Valerie] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [McLaughlin, John R.; McNeish, Iain] Publ Hlth Ontario, Toronto, ON, Canada; [Modugno, Francesmary] Magee Womens Res Inst, Womens Canc Res Program, Pittsburgh, PA USA; [Modugno, Francesmary] Univ Pittsburgh, Canc Inst, Pittsburgh, PA USA; [Ness, Roberta B.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Odunsi, Kunle] Roswell Pk Canc Inst, Dept Gynecol Oncol, Buffalo, NY 14263 USA; [Olson, Sara H.; Orlow, Irene; Pike, Malcolm C.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Poole, Elizabeth M.; Schernhammer, Eva; Tworoger, Shelley S.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Poole, Elizabeth M.; Schernhammer, Eva; Terry, Kathryn L.; Tworoger, Shelley S.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rosen, Barry] Univ Toronto, Princess Margaret Hosp, Dept Gynecol Oncol, Fac Med, Toronto, ON, Canada; [Rosen, Barry] Univ Toronto, Dept Obstet & Gynecol, Fac Med, Toronto, ON, Canada; [Rothstein, Joseph H.; Sieh, Weiva] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Dept Genet & Genom Sci, Mt Sinai, New York, NY 10029 USA; [Schwaab, Ira] Inst Humangenet Wiesbaden, Wiesbaden, Germany; [Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Epidemiol Ctr, Nashville, TN 37212 USA; [Shu, Xiao-Ou] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Shvetsov, Yurii B.; Siddiqui, Nadeem; Wilkens, Lynne R.] Univ Hawaii, Ctr Canc, Canc Epidemiol Program, Honolulu, HI 96822 USA; [Spiewankiewicz, Beata] Inst Oncol, Dept Gynecol Oncol, Warsaw, Poland; [Teo, Soo-Hwang] NCI, Div Canc Etiol & Genet, Bethesda, MD 20892 USA; [Teo, Soo-Hwang] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Terry, Kathryn L.; Pearce, Celeste L.] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Thomsen, Lotte] Univ Copenhagen, Dept Pathol, Rigshosp, Copenhagen, Denmark; [van Altena, Anne M.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, Nijmegen, Netherlands; [Wang-Gohrke, Shan] German Canc Consortium DKTK, Heidelberg, Germany; [Wang-Gohrke, Shan] German Canc Res Ctr, Heidelberg, Germany; [Whittemore, Alice S.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Dept Biomed Data Sci, Stanford, CA USA; [Woo, Yin-Ling] Canc Res Malaysia, Subang Jaya Selangor, Malaysia; [Wu, Anna H.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Xiang, Yong-Bing] Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China; [Zheng, Wei] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37212 USA; [Lee, Alice W.] Calif State Univ Fullerton, Dept Hlth Sci, Fullerton, CA 92634 USA; [Berchuck, Andrew] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Schildkraut, Joellen M.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Ramus, Susan J.] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Ramus, Susan J.] Garvan Inst, Sydney, NSW, Australia; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Gayther, Simon A.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Ctr Canc Prevent & Translat Genom, Los Angeles, CA 90048 USA; [Kelemen, Linda E.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Chenevix-Trench, Georgia] QIMR Berghofer Med Res Inst, Dept Genet, Brisbane, Qld, Australia; [Risch, Harvey A.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Pharoah, Paul D. P.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Worts Causeway, Cambridge, England	Mayo Clinic; University of Cambridge; H Lee Moffitt Cancer Center & Research Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; H Lee Moffitt Cancer Center & Research Institute; Radboud University Nijmegen; University of California System; University of California Irvine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Oregon Health & Science University; Oregon Health & Science University; University of Erlangen Nuremberg; University of Bergen; Haukeland University Hospital; University of Bergen; Hannover Medical School; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); British Columbia Cancer Agency; Simon Fraser University; Cancer Council Victoria; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Beatson Oncology Centre; University of Glasgow; Helmholtz Association; German Cancer Research Center (DKFZ); University of Hamburg; University Medical Center Hamburg-Eppendorf; University of New Mexico; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Mayo Clinic; Pomeranian Medical University; Maria Sklodowska-Curie National Research Institute of Oncology; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Fred Hutchinson Cancer Center; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Kliniken Essen-Mitte; Friedrich Schiller University of Jena; University of Cambridge; University of Cambridge; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; H Lee Moffitt Cancer Center & Research Institute; University of London; University College London; University of Melbourne; Cedars Sinai Medical Center; University of Texas System; UTMD Anderson Cancer Center; Rigshospitalet; University of Copenhagen; Danish Cancer Society; University of Copenhagen; Herlev & Gentofte Hospital; Aichi Cancer Center; Duke University; Cedars Sinai Medical Center; Universiti Malaya; Rigshospitalet; University of Copenhagen; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; University Hospital Leuven; British Columbia Cancer Agency; Roswell Park Cancer Institute; Memorial Sloan Kettering Cancer Center; Kunming Medical University; Texas Southern University; Maria Sklodowska-Curie National Research Institute of Oncology; University of Texas System; UTMD Anderson Cancer Center; Radboud University Nijmegen; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Roswell Park Cancer Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Icahn School of Medicine at Mount Sinai; Vanderbilt University; Vanderbilt University; Cancer Research Center of Hawaii; University of Hawaii System; Maria Sklodowska-Curie National Research Institute of Oncology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universiti Malaya; University of Michigan System; University of Michigan; Rigshospitalet; University of Copenhagen; Radboud University Nijmegen; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Stanford University; University of Southern California; Shanghai Jiao Tong University; Vanderbilt University; California State University System; California State University Fullerton; Duke University; University of Virginia; University of New South Wales Sydney; Garvan Institute of Medical Research; University of Toronto; University Toronto Affiliates; Womens College Hospital; Cedars Sinai Medical Center; Medical University of South Carolina; QIMR Berghofer Medical Research Institute; Yale University; University of Cambridge	Goode, EL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA.	egoode@mayo.edu	Woo, Yin Ling/GPX-0086-2022; Vierkant, Robert/AAP-4927-2020; Woo, Yin Ling/B-5198-2010; Pharoah, Paul/V-6658-2019; Bjorge, Line/AAD-6179-2021; Shvetsov, Yurii/ABA-3196-2020; Rzepecka, Iwona K/AFO-1670-2022; Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; Brooks-Wilson, Angela/E-9399-2012; Monteiro, Alvaro N. A./A-7566-2009; Bogdanova, Natalia V./Y-2205-2019; Hein, Alexander/F-6999-2010; Ekici, Arif B/C-3971-2013; Chenevix-Trench, Georgia/AAV-2014-2020; Lambrechts, Diether/AAJ-3167-2020; Wentzensen, Nicolas/AAG-8522-2019; Jakubowska, Anna/O-8050-2014; Matsuo, Keitaro/H-6758-2019; Menon, Usha/C-4716-2008; Ramus, Susan/AAG-8352-2019; Lissowska, Jolanta/AAH-3252-2020; Modugno, Francesmary/AIB-6722-2022; Fasching, Peter A/ABH-9912-2020; Bjorge, Line/C-1307-2017; Eccles, Diana/K-6327-2019; Li, Zheng/B-3191-2017; Narod, Steven A/AAA-6112-2022; Krakstad, Camilla/AAB-5138-2020; Dörk, Thilo/J-8620-2012; Teo, Soo-hwang/H-2353-2014	Woo, Yin Ling/0000-0003-1742-1066; Vierkant, Robert/0000-0001-6242-5221; Woo, Yin Ling/0000-0003-1742-1066; Pharoah, Paul/0000-0001-8494-732X; Bjorge, Line/0000-0002-0240-2770; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Brooks-Wilson, Angela/0000-0003-1009-6408; Monteiro, Alvaro N. A./0000-0002-8448-4801; Hein, Alexander/0000-0003-2601-3398; Ekici, Arif B/0000-0001-6099-7066; Chenevix-Trench, Georgia/0000-0002-1878-2587; Lambrechts, Diether/0000-0002-3429-302X; Jakubowska, Anna/0000-0002-5650-0501; Matsuo, Keitaro/0000-0003-1761-6314; Menon, Usha/0000-0003-3708-1732; Ramus, Susan/0000-0003-0005-7798; Lissowska, Jolanta/0000-0003-2695-5799; Fasching, Peter A/0000-0003-4885-8471; Bjorge, Line/0000-0002-0240-2770; Eccles, Diana/0000-0002-9935-3169; Li, Zheng/0000-0002-6141-4990; Krakstad, Camilla/0000-0002-0174-8139; Dörk, Thilo/0000-0002-9458-0282; Teo, Soo/0000-0002-0444-590X; Goodman, Marc/0000-0002-4839-3021; McNeish, Iain/0000-0002-9387-7586; Jensen, Allan/0000-0001-8124-4880; Kupryjanczyk, Jolanta/0000-0001-5820-0214; Lubinski, Jan/0000-0003-2931-3003; Hogdall, Estrid/0000-0003-4689-5658; Heitz, Florian/0000-0002-2412-0352; Dansonka-Mieszkowska, Agnieszka/0000-0002-2482-6523; Jung, Audrey/0000-0003-0875-6673; Lee, Alice/0000-0001-8756-7066; Rzepecka, Iwona Krystyna/0000-0001-7305-6687; Hogdall, Claus/0000-0002-5959-8874	NIH [R01 CA-1491429]; US National Cancer Institute [R01-CA076016, K07-CA095666, K07 CM 43047, K22-CA138563, N01-CN55424, N01-PC67001, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P01-CA087969, R01-CA016056, R01-CA017054, R01CA049449, R01-CA050385, R01-CA054419, R01CA058598]; COGS project through a European Commission's Seventh Framework Programme [223175 HEALTH F2 2009-223175]; Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative [U19-CA148112]; Ovarian Cancer Research Fund [PPD/RPCI.07]; National Health and Medical Research Council; American Cancer Society Early Detection Professorship [SIOP-06-258-01-COUN]; National Center for Advancing Translational Sciences (NCATS) [UL1TR000124]; Canadian Institute of Health Research New Investigator Award [MSH-87734]; California Cancer Research Program [00-01389V-20170, N01-CN25403, 2110200]; Canadian Institutes of Health Research [MOP-86727]; Cancer Australia; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; Cancer Institute of New Jersey; Cancer Research UK [C490/A6187, C490/A10119, C490/A10124]; Danish Cancer Society [94-222-52]; ELAN Program of the University of Erlangen-Nuremberg; Eve Appeal; Helsinki University Central Hospital Research Fund; Helse Vest; Norwegian Cancer Society; Norwegian Research Council; Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Ministry of Health Labour and Welfare of Japan; L & S Milken Foundation; Polish Ministry of Science and Higher Education [4 P05C 02814, 2 P05A 068 27]; Roswell Park Cancer Institute Alliance Foundation; US Army Medical Research and Material Command [DAMD17-01-10729, DAMD17-02-1-0666, DAM D17-02-1-0669, W81XWH-07-0449, W81XWH-10-1-02802]; US Public Health Service [PSA-042205]; National Health and Medical Research Council of Australia [199600, 400281]; German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research [01GB 9401]; State of Baden-Wurttemberg through Medical Faculty of the University of Ulm [P.685]; Minnesota Ovarian Cancer Alliance; Mayo Foundation; Fred C. and Katherine B. Andersen Foundation; Lon V. Smith Foundation [LVS-39420]; Oak Foundation; OHSU Foundation; Mermaid I project; Rudolf-Bartling Foundation; UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge; Imperial College London, University College Hospital "Womens Health Theme"; Royal Marsden Hospital; WorkSafeBC; NATIONAL CANCER INSTITUTE [R01CA050385, R01CA126841, R01CA067262, K07CA095666, R01CA054419, R03CA115195, U01CA069417, R01CA049449, K07CA143047, R01CA122443, UM1CA182910, R03CA113148, R01CA083918, R01CA136924, K22CA138563, UM1CA186107, P30CA071789, R01CA149429, R01CA074850, P50CA136393, R01CA114343, R01CA112523, P50CA105009, R01CA058860, U19CA148112, R01CA087538, R01CA058598, R01CA080742] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U01AR067166] Funding Source: NIH RePORTER; MRC [G0501974, G0601891] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); COGS project through a European Commission's Seventh Framework Programme; Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative; Ovarian Cancer Research Fund; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Cancer Society Early Detection Professorship(American Cancer Society); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Canadian Institute of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); California Cancer Research Program; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Australia; Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Queensland(Cancer Council Queensland); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Council Tasmania(Cancer Council Tasmania); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Institute of New Jersey; Cancer Research UK(Cancer Research UK); Danish Cancer Society(Danish Cancer Society); ELAN Program of the University of Erlangen-Nuremberg; Eve Appeal; Helsinki University Central Hospital Research Fund; Helse Vest; Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Ministry of Health Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); L & S Milken Foundation; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Roswell Park Cancer Institute Alliance Foundation; US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research; State of Baden-Wurttemberg through Medical Faculty of the University of Ulm; Minnesota Ovarian Cancer Alliance; Mayo Foundation; Fred C. and Katherine B. Andersen Foundation; Lon V. Smith Foundation; Oak Foundation; OHSU Foundation; Mermaid I project; Rudolf-Bartling Foundation; UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge; Imperial College London, University College Hospital "Womens Health Theme"; Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); WorkSafeBC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The scientific development and funding for this project were funded by the following: NIH R01 CA-1491429 (Phelan PI); the US National Cancer Institute (R01-CA076016); the COGS project is funded through a European Commission's Seventh Framework Programme grant (agreement number 223175 HEALTH F2 2009-223175); the Genetic Associations and Mechanisms in Oncology (GAME-ON): a NCI Cancer Post-GWAS Initiative (U19-CA148112); the Ovarian Cancer Association Consortium is supported by a grant from the Ovarian Cancer Research Fund thanks to donations by the family and friends of Kathryn Sladek Smith (PPD/RPCI.07). Investigator-specific funding: G.C.-T. is supported by the National Health and Medical Research Council; B.K. is funded by the American Cancer Society Early Detection Professorship (SIOP-06-258-01-COUN) and the National Center for Advancing Translational Sciences (NCATS), Grant UL1TR000124; L.E.K. is supported by a Canadian Institute of Health Research New Investigator Award (MSH-87734). Funding of included studies: Funding of the constituent studies was provided by the California Cancer Research Program (00-01389V-20170, N01-CN25403, 2110200); the Canadian Institutes of Health Research (MOP-86727); Cancer Australia; Cancer Council Victoria; Cancer Council Queensland; Cancer Council New South Wales; Cancer Council South Australia; Cancer Council Tasmania; Cancer Foundation of Western Australia; the Cancer Institute of New Jersey; Cancer Research UK (C490/A6187, C490/A10119, C490/A10124); the Danish Cancer Society (94-222-52); the ELAN Program of the University of Erlangen-Nuremberg; the Eve Appeal; the Helsinki University Central Hospital Research Fund; Helse Vest; the Norwegian Cancer Society; the Norwegian Research Council; the Ovarian Cancer Research Fund; Nationaal Kankerplan of Belgium; Grant-in-Aid for the Third Term Comprehensive 10-Year Strategy For Cancer Control from the Ministry of Health Labour and Welfare of Japan; the L & S Milken Foundation; the Polish Ministry of Science and Higher Education (4 P05C 02814, 2 P05A 068 27); the Roswell Park Cancer Institute Alliance Foundation; the US National Cancer Institute (K07-CA095666, K07 CM 43047, K22-CA138563, N01-CN55424, N01-PC67001, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P01-CA087969, CA072720, P50-CA105009, P50-CA136393, P30-R01CA014089, R01-CA016056, R01-CA017054, R01CA049449, R01-CA050385, R01-CA054419, R01CA058598, R01-CA058860, R01-CA061107, R01CA061132, R01-CA067262, R01-CA071766, R01CA074850, R01-CA080742, R01-CA080978, R01CA083918, R01-CA087538, R01-CA092044, 801095023, R01-CM 22443, R01-CA112523, R01CA114343, R01-CA126841, R01-CA136924, R03 CM 13148, R03-CM 15195, U01-CA069417, U01CA071966, UM1-CM 82910, UM 1-CM 86107 and Intramural research funds); the US Army Medical Research and Material Command (DAMD17-01-10729, DAMD17-02-1-0666, DAM D17-02-1-0669, W81XWH-07-0449, W81XWH-10-1-02802); the US Public Health Service (PSA-042205); The National Health and Medical Research Council of Australia (199600 and 400281); the German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research (01GB 9401); the State of Baden-Wurttemberg through Medical Faculty of the University of Ulm (P.685); the Minnesota Ovarian Cancer Alliance; the Mayo Foundation; the Fred C. and Katherine B. Andersen Foundation; the Lon V.; Smith Foundation (LVS-39420); the Oak Foundation; the OHSU Foundation; the Mermaid I project; the Rudolf-Bartling Foundation; the UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge, Imperial College London, University College Hospital "Womens Health Theme" and the Royal Marsden Hospital; WorkSafeBC.	Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Davies G, 2015, MOL PSYCHIATR, V20, P183, DOI 10.1038/mp.2014.188; Fritz G, 2015, BIOMOLECULES, V5, P2417, DOI 10.3390/biom5042417; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hoon JL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020017; Just WW, 2016, BBA-MOL CELL RES, V1863, P1006, DOI 10.1016/j.bbamcr.2016.01.004; Kar SP, 2017, CANCER EPIDEM BIOMAR; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Konecny GE, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju249; Li Guangpu, 2015, Methods Mol Biol, V1298, P1, DOI 10.1007/978-1-4939-2569-8_1; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McConechy MK, 2014, MODERN PATHOL, V27, P128, DOI 10.1038/modpathol.2013.107; Nussinov R, 2016, CANCER RES, V76, P18, DOI 10.1158/0008-5472.CAN-15-1536; Pajic Marina, 2015, Small GTPases, V6, P123, DOI 10.4161/21541248.2014.973749; Pharoah PDP, 2013, NAT GENET, V45, P362, DOI 10.1038/ng.2564; Pharoah PDP, 2002, BEST PRACT RES CL OB, V16, P449, DOI 10.1053/beog.2002.0296; Shirakawa R, 2015, J BIOCHEM, V157, P285, DOI 10.1093/jb/mvv029; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; Stacey SN, 2008, NAT GENET, V40, P1313, DOI 10.1038/ng.234; Wang C, 2016, BRIT J CANCER, V114, P1412, DOI 10.1038/bjc.2016.124; Wang K, 2011, MOL PSYCHIATR, V16, P949, DOI 10.1038/mp.2010.107; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Winkler S, 2005, BIOCHEM BIOPH RES CO, V335, P1280, DOI 10.1016/j.bbrc.2005.08.025	25	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0197561	10.1371/journal.pone.0197561	http://dx.doi.org/10.1371/journal.pone.0197561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979793	Green Accepted, Green Published, gold			2022-12-26	WOS:000437809500005
J	Huynh, NPT; Zhang, B; Guilak, F				Huynh, Nguyen P. T.; Zhang, Bo; Guilak, Farshid			High-depth transcriptomic profiling reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis	FASEB JOURNAL			English	Article						RNA-Seq; chondrocyte; pericyte; lncRNA; miRNA	TISSUE-ENGINEERED CARTILAGE; MICRORNA TARGET PREDICTION; IN-VITRO CULTURE; FUNCTIONAL-CHARACTERIZATION; RNA-SEQ; DIFFERENTIATION; MATRIX; SOX9; OSTEOARTHRITIS; CHONDROCYTES	Mesenchymal stem/stromal cells (MSCs) provide an attractive cell source for cartilage repair and cell therapy; however, the underlying molecular pathways that drive chondrogenesis of these populations of adult stem cells remain poorly understood. We generated a rich data set of high-throughput RNA sequencing of human MSCs throughout chondrogenesis at 6 different time points. Our data consisted of 18 libraries with 3 individual donors as biologic replicates, with each library possessing a sequencing depth of 100 million reads. Computational analyses with differential gene expression, gene ontology, and weighted gene correlation network analysis identified dynamic changes in multiple biologic pathways and, most importantly, a chondrogenic gene subset, whose functional characterization promises to further harness the potential of MSCs for cartilage tissue engineering. Furthermore, we created a graphic user interface encyclopedia built with the goal of producing an open resource of transcriptomic regulation for additional data mining and pathway analysis of the process of MSC chondrogenesis.Huynh, N. P. T., Zhang, B., Guilak, F. High-depth transcriptomic profiling reveals the temporal gene signature of human mesenchymal stem cells during chondrogenesis.	[Huynh, Nguyen P. T.; Guilak, Farshid] Washington Univ, Dept Orthoped Surg, St Louis, MO USA; [Huynh, Nguyen P. T.; Zhang, Bo; Guilak, Farshid] Washington Univ, Ctr Regenerat Med, St Louis, MO USA; [Huynh, Nguyen P. T.; Guilak, Farshid] Shriners Hosp Children, St Louis, MO USA; [Huynh, Nguyen P. T.] Duke Univ, Dept Cell Biol, Durham, NC USA	Washington University (WUSTL); Washington University (WUSTL); Duke University	Guilak, F (corresponding author), Washington Univ, 4515 McKinley Ave, St Louis, MO 63110 USA.	guilak@wustl.edu	Zhang, Bo/A-6874-2011	Zhang, Bo/0000-0003-2962-5314	Duke University Genomics Core Facility; Washington University in St. Louis Pathology Core Labs; Washington University Center of Regenerative Medicine; Arthritis Foundation; U.S. National Institutes of Health (NIH) [AR50245, AR48852, AG15768, AR48182, AR067467]; Nancy Taylor Foundation for Chronic Diseases; Collaborative Research Center of the AO Foundation, Davos, Switzerland; Washington University Musculoskeletal Research Center (NIH) [P30 AR057235]; NIH [DA027995]; Goldman Sachs Philanthropy Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067467, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA027995] Funding Source: NIH RePORTER	Duke University Genomics Core Facility; Washington University in St. Louis Pathology Core Labs; Washington University Center of Regenerative Medicine; Arthritis Foundation; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Taylor Foundation for Chronic Diseases; Collaborative Research Center of the AO Foundation, Davos, Switzerland; Washington University Musculoskeletal Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Goldman Sachs Philanthropy Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Duke University Genomics Core Facility, the Washington University in St. Louis Pathology Core Labs, and the Washington University Center of Regenerative Medicine for their resources and support. The authors also wish to thank S. Oswald (Washington University in St. Louis) for assistance with technical writing. This work was supported by the Arthritis Foundation, U.S. National Institutes of Health (NIH) Grants AR50245, AR48852, AG15768, AR48182, and AR067467, the Nancy Taylor Foundation for Chronic Diseases, the Collaborative Research Center of the AO Foundation, Davos, Switzerland, and the Washington University Musculoskeletal Research Center (NIH P30 AR057235). B.Z. was supported by NIH grant DA027995 and the Goldman Sachs Philanthropy Fund. The authors declare no conflicts of interest.	Abrahamsson CK, 2010, TISSUE ENG PT A, V16, P3709, DOI [10.1089/ten.tea.2010.0190, 10.1089/ten.TEA.2010.0190]; Ahmed TAE, 2014, HISTOL HISTOPATHOL, V29, P669, DOI 10.14670/HH-29.669; ANDERS S, 2010, GENOME BIOL, V11; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B; Backesjo CM, 2009, CELLS TISSUES ORGANS, V189, P93, DOI 10.1159/000151744; Baker BM, 2010, BIOMATERIALS, V31, P6190, DOI 10.1016/j.biomaterials.2010.04.036; Bara JJ, 2014, STEM CELLS, V32, P1713, DOI 10.1002/stem.1649; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Bhaskar B, 2014, CURR STEM CELL RES T, V9, P508, DOI 10.2174/1574888X09666140812112002; Bian L, 2011, TISSUE ENG PT A, V17, P1137, DOI [10.1089/ten.tea.2010.0531, 10.1089/ten.TEA.2010.0531]; Bian LM, 2013, P NATL ACAD SCI USA, V110, P10117, DOI 10.1073/pnas.1214100110; Brunger JM, 2014, P NATL ACAD SCI USA, V111, pE798, DOI 10.1073/pnas.1321744111; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Chang W., 2017, SHINY WEB APPL FRAME; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dudek KA, 2010, J BIOL CHEM, V285, P24381, DOI 10.1074/jbc.M110.111328; Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Glass KA, 2014, BIOMATERIALS, V35, P5921, DOI 10.1016/j.biomaterials.2014.03.073; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hagmann S, 2013, CELL PROLIFERAT, V46, P396, DOI 10.1111/cpr.12046; Hall B.K., 2015, BONES AND CARTILAGE, VSecond; Hicks MR, 2018, NAT CELL BIOL, V20, P46, DOI 10.1038/s41556-017-0010-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh NPT, 2017, CONNECT TISSUE RES, V58, P116, DOI 10.1080/03008207.2016.1194406; Ikeda T, 2004, ARTHRITIS RHEUM-US, V50, P3561, DOI 10.1002/art.20611; Ionescu A, 2012, DEV CELL, V22, P927, DOI 10.1016/j.devcel.2012.03.011; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; King BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157106; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Kwong FNK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2436; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2012, J STAT SOFTW, V46, P1; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee W, 2017, CURR TOP MEMBR, V79, P263, DOI 10.1016/bs.ctm.2016.10.003; Lee W, 2014, P NATL ACAD SCI USA, V111, pE5114, DOI 10.1073/pnas.1414298111; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Mansson R, 2004, J BIOL CHEM, V279, P17905, DOI 10.1074/jbc.M400589200; Mareschi K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/920581; Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021; Moutos FT, 2016, P NATL ACAD SCI USA, V113, pE4513, DOI 10.1073/pnas.1601639113; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Ng JJ, 2017, P NATL ACAD SCI USA, V114, P2556, DOI 10.1073/pnas.1611771114; Nguyen USDT, 2011, ANN INTERN MED, V155, P725, DOI 10.7326/0003-4819-155-11-201112060-00004; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Phan MN, 2009, ARTHRITIS RHEUM-US, V60, P3028, DOI 10.1002/art.24799; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Posel C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050293; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Somoza RA, 2018, TISSUE ENG PT A, V24, P335, DOI [10.1089/ten.tea.2016.0559, 10.1089/ten.TEA.2016.0559]; Steck E, 2012, J MOL MED, V90, P1185, DOI 10.1007/s00109-012-0895-y; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Wagner EF, 2002, ANN RHEUM DIS, V61, P40, DOI 10.1136/ard.61.suppl_2.ii40; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Yang YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5232; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403; Zhao W, 2010, J BIOPHARM STAT, V20, P281, DOI 10.1080/10543400903572753	79	20	20	4	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					358	372		10.1096/fj.201800534R	http://dx.doi.org/10.1096/fj.201800534R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29985644	Green Published			2022-12-26	WOS:000457401500029
J	Shao, LL; Chen, Z; Soutto, M; Zhu, SM; Lu, H; Romero-Gallo, J; Peek, R; Zhang, ST; El-Rifai, W				Shao, Linlin; Chen, Zheng; Soutto, Mohammed; Zhu, Shoumin; Lu, Heng; Romero-Gallo, Judith; Peek, Richard; Zhang, Shutian; El-Rifai, Wael			Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer	FASEB JOURNAL			English	Article						microRNA; tff1 knockout; inflammation; KLF4; H; pylori	NF-KAPPA-B; CELL-PROLIFERATION; DOWN-REGULATION; EXPRESSION; PROTEIN; TUMORIGENESIS; MIRNAS; CHEMORESISTANCE; INFLAMMATION; ACTIVATION	Helicobacter pylori infection is a major risk factor for the development of gastric cancer. Aberrant expression of microRNAs is strongly implicated in gastric tumorigenesis; however, their contribution in response to H. pylori infection has not been fully elucidated. In this study, we evaluated the expression of miR-135b-5p and its role in gastric cancer. We describe the overexpression of miR-135b-5p in human gastric cancer tissue samples compared with normal tissue samples. Furthermore, we found that miR-135b-5p is also up-regulated in gastric tumors from the trefoil factor 1-knockout mouse model. Infection with H. pylori induced the expression of miR-135b-5p in the in vitro and in vivo models. miR-135b-5p induction was mediated by NF-B. Treatment of gastric cancer cells with TNF- induced miR-135b-5p in a NF-B-dependent manner. Mechanistically, we found that miR-135b-5p targets Kruppel-like factor 4 (KLF4) and binds to its 3 UTR, leading to reduced KLF4 expression. Functionally, high levels of miR-135b-5p suppress apoptosis and induce cisplatin resistance. Our results uncovered a mechanistic link between H. pylori infection and miR-135b-5p-KLF4, suggesting that targeting miR-135b-5p could be a potential therapeutic approach to circumvent resistance to cisplatin.Shao, L., Chen, Z., Soutto, M., Zhu, S., Lu, H., Romero-Gallo, J., Peek, R., Zhang, S., El-Rifai, W. Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer.	[Shao, Linlin; Zhang, Shutian] Capital Med Univ, Beijing Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Shao, Linlin; Chen, Zheng; Soutto, Mohammed; El-Rifai, Wael] Miami Healthcare Syst, Dept Vet Affairs, Miami, FL USA; [Chen, Zheng; Zhu, Shoumin; Lu, Heng; El-Rifai, Wael] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Surg, Miami, FL USA; [Romero-Gallo, Judith; Peek, Richard] Vanderbilt Univ, Med Ctr, Div Gastroenterol Hematol & Nutr, Nashville, TN USA	Capital Medical University; University of Miami; Vanderbilt University	Zhang, ST (corresponding author), Capital Med Univ, Beijing Friendship Hosp, 95 Yongan Rd, Beijing 10050, Peoples R China.; El-Rifai, W (corresponding author), Univ Miami, Miller Sch Med, 1600 NW 10th Ave, Miami, FL 33136 USA.	zhangshutian@ccmu.edu.cn; wxe45@miami.edu	Shao, Linlin/AAW-4439-2021		U.S. National Institutes of Health, National Cancer Institute [R01CA93999, R01CA177372]; U.S. Department of Veterans Affairs [1IK6BX003787, I01BX001179]; Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center, University of Miami; NATIONAL CANCER INSTITUTE [P01CA116087, R01CA077955, R01CA093999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; Veterans Affairs [IK6BX003787, I01BX001179] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center, University of Miami; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the U.S. National Institutes of Health, National Cancer Institute (R01CA93999 and R01CA177372), a Research Career Scientist Award (1IK6BX003787), and a merit award (I01BX001179) from the U.S. Department of Veterans Affairs (to W.E.-R.). The results were also supported by the Biostatistics and Bioinformatics Shared Resource at the Sylvester Comprehensive Cancer Center, University of Miami. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the Department of Veterans Affairs, the U.S. National Institutes of Health, or the University of Miami. The authors declare no conflicts of interest.	Bagheri V, 2018, J CELL PHYSIOL, V233, P2791, DOI 10.1002/jcp.25822; BATESON MC, 1994, GUT, V35, P716, DOI 10.1136/gut.35.5.716; Chen GD, 2017, BIOCHEM BIOPH RES CO, V484, P311, DOI 10.1016/j.bbrc.2017.01.110; Chen HF, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/6439864; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Darnet S, 2015, BIOINFORM BIOL INSIG, V9, P1, DOI 10.4137/BBI.S23773; Dou L, 2017, CELL PHYSIOL BIOCHEM, V41, P2419, DOI 10.1159/000475912; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Floris I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140488; Gao SG, 2016, TUMOR BIOL, V37, P9411, DOI 10.1007/s13277-016-4824-5; GATELY DP, 1993, BRIT J CANCER, V67, P1171, DOI 10.1038/bjc.1993.221; Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x; Hamajima Nobuyuki, 2002, Asian Pac J Cancer Prev, V3, P23; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hashimoto I, 2017, ONCOL LETT, V13, P819, DOI 10.3892/ol.2016.5499; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Huan YW, 2015, ONCOL REP, V34, P843, DOI 10.3892/or.2015.4007; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kwon OH, 2014, INT J ONCOL, V44, P583, DOI 10.3892/ijo.2013.2211; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Leng ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056082; Lin CC, 2011, MOL CELL BIOL, V31, P2513, DOI 10.1128/MCB.01189-10; Liu B, 2017, MOL CARCINOGEN, V56, P2669, DOI 10.1002/mc.22710; Liu L, 2017, ONCOGENE, V36, P5874, DOI 10.1038/onc.2017.193; Liu SG, 2016, ONCOL RES, V24, P81, DOI 10.3727/096504016X14597766487717; Lu MD, 2018, INT J ONCOL, V52, P589, DOI 10.3892/ijo.2017.4222; Ma ZH, 2015, INT J CLIN EXP PATHO, V8, P5071; Matsushima K, 2011, INT J CANCER, V128, P361, DOI 10.1002/ijc.25348; Mo DL, 2016, CANCER RES, V76, P3057, DOI 10.1158/0008-5472.CAN-15-2361; Moss SF, 2017, CELL MOL GASTROENTER, V3, P183, DOI 10.1016/j.jcmgh.2016.12.001; Nezu Y, 2016, ONCOGENE, V35, P6177, DOI 10.1038/onc.2016.157; Noto JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00021; O'Brien DP, 2008, J BIOL CHEM, V283, P23922, DOI 10.1074/jbc.M801144200; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Rad R, 2002, J IMMUNOL, V168, P3033, DOI 10.4049/jimmunol.168.6.3033; Rinnerthaler G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020156; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Smale S. T., 2010, COLD SPRING HARB PRO, V5, P5423, DOI DOI 10.1101/PDB.PROT5423; Soutto M, 2015, CANCER-AM CANCER SOC, V121, P4348, DOI 10.1002/cncr.29644; Soutto M, 2011, J CLIN INVEST, V121, P1753, DOI 10.1172/JCI43922; Su WM, 2016, BIOMED PHARMACOTHER, V84, P123, DOI 10.1016/j.biopha.2016.09.027; Tanida S., 2012, INT J SURG ONCOL, V2012, DOI [10.1155/2012/862879, DOI 10.1155/2012/862879]; Rossi AFT, 2016, CELL MICROBIOL, V18, P1444, DOI 10.1111/cmi.12587; Tse MCL, 2017, DIABETES, V66, P1858, DOI 10.2337/db16-0270; Wang Q, 2012, MED ONCOL, V29, P77, DOI 10.1007/s12032-010-9766-y; Wei DY, 2005, CANCER RES, V65, P2746, DOI 10.1158/0008-5472.CAN-04-3619; Wilson TR, 2009, CURR CANCER DRUG TAR, V9, P307, DOI 10.2174/156800909788166547; Xu ZL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12276; Yamashita A, 2007, OBESITY, V15, P2549, DOI 10.1038/oby.2007.305; Yan C, 2015, BIOCHEM BIOPH RES CO, V467, P913, DOI 10.1016/j.bbrc.2015.10.044; Yang LF, 2017, TOXICOLOGY, V389, P74, DOI 10.1016/j.tox.2017.07.010; Yu YH, 2017, BIOCHEM BIOPH RES CO, V491, P478, DOI 10.1016/j.bbrc.2017.07.021; Zhao LM, 2017, FASEB J, V31, P893, DOI 10.1096/fj.201600994R; Zheng J., 2017, INT J MOL SCI, V18, pE910; Zhu SM, 2017, GUT, V66, P802, DOI 10.1136/gutjnl-2016-312141	57	45	48	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					264	274		10.1096/fj.201701456RR	http://dx.doi.org/10.1096/fj.201701456RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29985646	Green Published			2022-12-26	WOS:000457401500022
J	Frick, IM; Shannon, O; Neumann, A; Karlsson, C; Wikstrom, M; Bjorck, L				Frick, Inga-Maria; Shannon, Oonagh; Neumann, Ariane; Karlsson, Christofer; Wikstrom, Mats; Bjorck, Lars			Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						thrombin; plasminogen; innate immunity; Streptococcus pyogenes (S; pyogenes); fibrinolysis; antimicrobial agent; bacterial clearance; group A streptococci; streptococcal inhibitor of complement; virulence	GROUP-A STREPTOCOCCI; INNATE IMMUNITY; PLASMINOGEN ACTIVATION; COAGULATION SYSTEM; BINDING-PROTEIN; ANTIBACTERIAL PEPTIDES; CONTACT SYSTEM; PYOGENES; STREPTOKINASE; VIRULENCE	Some strains of the bacterial pathogen Streptococcus pyogenes secrete protein SIC (streptococcal inhibitor of complement), including strains of the clinically relevant M1 serotype. SIC neutralizes the effect of a number of antimicrobial proteins/peptides and interferes with the function of the host complement system. Previous studies have shown that some S. pyogenes proteins bind and modulate coagulation and fibrinolysis factors, raising the possibility that SIC also may interfere with the activity of these factors. Here we show that SIC interacts with both human thrombin and plasminogen, key components of coagulation and fibrinolysis. We found that during clot formation, SIC binds fibrin through its central region and that SIC inhibits fibrinolysis by interacting with plasminogen. Flow cytometry results indicated that SIC and plasminogen bind simultaneously to S. pyogenes bacteria, and fluorescence microscopy revealed co-localization of the two proteins at the bacterial surface. As a consequence, SIC-expressing bacteria entrapped in clots inhibit fibrinolysis, leading to delayed bacterial escape from the clots as compared with mutant bacteria lacking SIC. Moreover, within the clots SIC-expressing bacteria were protected against killing. In an animal model of subcutaneous infection, SIC-expressing bacteria exhibited a delayed systemic spread. These results demonstrate that the bacterial protein SIC interferes with coagulation and fibrinolysis and thereby enhances bacterial survival, a finding that has significant implications for S. pyogenes virulence.	[Frick, Inga-Maria; Shannon, Oonagh; Neumann, Ariane; Karlsson, Christofer; Bjorck, Lars] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden; [Wikstrom, Mats] Univ Copenhagen, Prot Funct & Interact Grp, Novo Nordisk Fdn, Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Wikstrom, Mats] Amgen Inc, One Amgen Ctr Dr, Thousand Oaks, CA 91320 USA	Lund University; Novo Nordisk Foundation; University of Copenhagen; Amgen	Frick, IM (corresponding author), Lund Univ, Dept Clin Sci, Div Infect Med, SE-22184 Lund, Sweden.	Inga-Maria.Frick@med.lu.se		Shannon, Oonagh/0000-0001-8291-8189; Frick, Inga-Maria/0000-0003-3860-3010	Swedish Research Council [7480]; Knut and Alice Wallenberg Foundation; Torsten Soderberg Foundation; Alfred Osterlund Foundation; O. E. and Edla Johansson Foundation; Hansa Medical AB; Swedish Government Funds for Clinical Research (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Torsten Soderberg Foundation; Alfred Osterlund Foundation; O. E. and Edla Johansson Foundation; Hansa Medical AB; Swedish Government Funds for Clinical Research (ALF)	This work was supported by Project 7480 from the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Torsten Soderberg Foundation, the Alfred Osterlund Foundation, the O. E. and Edla Johansson Foundation, Hansa Medical AB, and Swedish Government Funds for Clinical Research (ALF). The authors declare that they have no conflicts of interest with the contents of this article.	Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Akesson P, 2010, MICROBIOL-SGM, V156, P3660, DOI 10.1099/mic.0.039578-0; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Binks MJ, 2005, J BIOL CHEM, V280, P20120, DOI 10.1074/jbc.M414194200; BROZE GJ, 1995, ANNU REV MED, V46, P103, DOI 10.1146/annurev.med.46.1.103; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Facklam RF, 2002, CLIN INFECT DIS, V34, P28, DOI 10.1086/324621; Fernie-King BA, 2004, IMMUNOLOGY, V111, P444, DOI 10.1111/j.0019-2805.2004.01837.x; Fernie-King BA, 2002, INFECT IMMUN, V70, P4908, DOI 10.1128/IAI.70.9.4908-4916.2002; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Frick IM, 2003, J BIOL CHEM, V278, P16561, DOI 10.1074/jbc.M301995200; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Frick IM, 2011, J BIOL CHEM, V286, P1331, DOI 10.1074/jbc.M110.178350; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Glinton K, 2017, J BIOL CHEM, V292, P6775, DOI 10.1074/jbc.M116.768937; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; HERWALD H, 1995, J BIOL CHEM, V270, P14634; Hoe NP, 2002, P NATL ACAD SCI USA, V99, P7646, DOI 10.1073/pnas.112039899; Iba T, 2014, CRIT CARE, V18, DOI 10.1186/cc13983; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Levi M, 2003, CARDIOVASC RES, V60, P26, DOI 10.1016/S0008-6363(02)00857-X; Li ZQ, 1999, J INFECT DIS, V179, P907, DOI 10.1086/314654; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P863, DOI 10.1111/j.1432-1033.1994.00863.x; Loof TG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00128; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Loof TG, 2011, J INNATE IMMUN, V3, P34, DOI 10.1159/000321641; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Malmstrom E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10261; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Pahlman LI, 2013, THROMB HAEMOSTASIS, V109, P930, DOI 10.1160/TH12-10-0739; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Papareddy P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000857; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Peetermans M, 2016, CRIT REV MICROBIOL, V42, P866, DOI 10.3109/1040841X.2015.1080214; Pence MA, 2010, J INNATE IMMUN, V2, P587, DOI 10.1159/000317672; Potempa J, 2009, J INNATE IMMUN, V1, P70, DOI 10.1159/000181144; Shannon O, 2013, CURR TOP MICROBIOL, V368, P189, DOI 10.1007/82_2012_283; Shannon O, 2010, BLOOD, V116, P2365, DOI 10.1182/blood-2010-02-271858; Shelburne SA, 2005, INFECT IMMUN, V73, P4723, DOI 10.1128/IAI.73.8.4723-4731.2005; Smith SA, 2015, CRIT REV BIOCHEM MOL, V50, P326, DOI 10.3109/10409238.2015.1050550; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2006, PHYSIOLOGY, V21, P281, DOI 10.1152/physiol.00059.2005; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; Tsakiris DA, 1999, THROMB HAEMOSTASIS, V81, P177, DOI 10.1055/s-0037-1614439; Waldetoft KW, 2016, INFECT IMMUN, V84, P2813, DOI 10.1128/IAI.00307-16; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Wattam AR, 2017, NUCLEIC ACIDS RES, V45, pD535, DOI 10.1093/nar/gkw1017; Winram SB, 1996, MICROBIOL-SGM, V142, P2311, DOI 10.1099/13500872-142-8-2311; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	65	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13578	13591		10.1074/jbc.RA118.001988	http://dx.doi.org/10.1074/jbc.RA118.001988			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30002122	Green Published, hybrid			2022-12-26	WOS:000443375500018
J	Hauck, AK; Zhou, T; Hahn, W; Petegrosso, R; Kuang, R; Chen, Y; Bernlohr, DA				Hauck, Amy K.; Zhou, Tong; Hahn, Wendy; Petegrosso, Raphael; Kuang, Rui; Chen, Yue; Bernlohr, David A.			Obesity-induced protein carbonylation in murine adipose tissue regulates the DNA-binding domain of nuclear zinc finger proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; zinc finger; adipose tissue; nuclear receptor; obesity; carbonylation; zinc finger proteins; nucleus; estrogen-related receptor; reactive oxygen species; metabolic syndrome; transcription factor	LARGE GENE LISTS; OXIDATIVE STRESS; ERR-GAMMA; INSULIN-RESISTANCE; PROTEOMIC ANALYSIS; METABOLIC SYNDROME; ACID OXIDATION; ALDEHYDES; PRODUCT; IDENTIFICATION	In obesity-linked insulin resistance, oxidative stress in adipocytes leads to lipid peroxidation and subsequent carbonylation of proteins by diffusible lipid electrophiles. Reduction in oxidative stress attenuates protein carbonylation and insulin resistance, suggesting that lipid modification of proteins may play a role in metabolic disease, but the mechanisms remain incompletely understood. Herein, we show that in vivo, diet-induced obesity in mice surprisingly results in preferential carbonylation of nuclear proteins by 4-hydroxy-trans-2,3-nonenal (4-HNE) or 4-hydroxy-trans-2,3-hexenal (4-HHE). Proteomic and structural analyses revealed that residues in or around the sites of zinc coordination of zinc finger proteins, such as those containing the C2H2 or MATRIN, RING, C3H1, or N4-type DNA-binding domains, are particularly susceptible to carbonylation by lipid aldehydes. These observations strongly suggest that carbonylation functionally disrupts protein secondary structure supported by metal coordination. Analysis of one such target, the nuclear protein estrogen-related receptor (ERR-), showed that ERR- is modified by 4-HHE in the obese state. In vitro carbonylation decreased the DNA-binding capacity of ERR- and correlated with the obesity-linked down-regulation of many key genes promoting mitochondrial bioenergetics. Taken together, these findings reveal a novel mechanistic connection between oxidative stress and metabolic dysfunction arising from carbonylation of nuclear zinc finger proteins, such as the transcriptional regulator ERR-.	[Hauck, Amy K.; Zhou, Tong; Hahn, Wendy; Chen, Yue; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Petegrosso, Raphael; Kuang, Rui] Univ Minnesota Twin Cities, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	bernl001@umn.edu			National Institutes of Health [R01 DK084669, T32 GM008347]; Minnesota Agricultural Experiment Station; CAPES Foundation, Ministry of Education of Brazil [BEX 13250/13-2]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008347] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Agricultural Experiment Station; CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 DK084669 and the Minnesota Agricultural Experiment Station (to D.A.B.), National Institutes of Health Grant T32 GM008347 (to A.K.H.), and the CAPES Foundation, Ministry of Education of Brazil (BEX 13250/13-2) (to R.P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andringa KK, 2014, REDOX BIOL, V2, P1038, DOI 10.1016/j.redox.2014.09.006; Atsriku C, 2005, J AM SOC MASS SPECTR, V16, P2017, DOI 10.1016/j.jasms.2005.08.009; Awada M, 2012, J LIPID RES, V53, P2069, DOI 10.1194/jlr.M026179; Ayyadevara S, 2005, AGING CELL, V4, P257, DOI 10.1111/j.1474-9726.2005.00168.x; Boden G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4765; BRUENNER BA, 1995, CHEM RES TOXICOL, V8, P552, DOI 10.1021/tx00046a009; Chavez JD, 2011, J PROTEOMICS, V74, P2417, DOI 10.1016/j.jprot.2011.03.031; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1316s36, 10.1002/0471250953.bi1315s35]; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curtis JM, 2012, J BIOL CHEM, V287, P32967, DOI 10.1074/jbc.M112.400663; Curtis JM, 2012, TRENDS ENDOCRIN MET, V23, P399, DOI 10.1016/j.tem.2012.05.008; Curtis JM, 2010, DIABETES, V59, P1132, DOI 10.2337/db09-1105; Dixen K, 2013, OBESITY, V21, P516, DOI 10.1002/oby.20067; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Ecco G, 2017, DEVELOPMENT, V144, P2719, DOI 10.1242/dev.132605; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fedotova AA, 2017, ACTA NATURAE, V9, P47, DOI 10.32607/20758251-2017-9-2-47-58; Frohnert BI, 2014, DIABETES, V63, P89, DOI 10.2337/db13-0777; Frohnert BI, 2011, OBESITY, V19, P1735, DOI 10.1038/oby.2011.115; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Galinier A, 2006, J BIOL CHEM, V281, P12682, DOI 10.1074/jbc.M506949200; Garton M, 2015, NUCLEIC ACIDS RES, V43, P9147, DOI 10.1093/nar/gkv919; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Grimsrud PA, 2007, MOL CELL PROTEOMICS, V6, P624, DOI 10.1074/mcp.M600120-MCP200; Gueraud F, 2010, FREE RADICAL RES, V44, P1098, DOI 10.3109/10715762.2010.498477; Hahn WS, 2014, AM J PHYSIOL-ENDOC M, V306, pE1033, DOI 10.1152/ajpendo.00422.2013; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hauck AK, 2016, J LIPID RES, V57, P1976, DOI 10.1194/jlr.R066597; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ilbert M, 2006, ANTIOXID REDOX SIGN, V8, P835, DOI 10.1089/ars.2006.8.835; Iuchi S, 2001, CELL MOL LIFE SCI, V58, P625, DOI 10.1007/PL00000885; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kida YS, 2015, CELL STEM CELL, V16, P547, DOI 10.1016/j.stem.2015.03.001; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kroncke KD, 2009, ANTIOXID REDOX SIGN, V11, P1015, DOI [10.1089/ars.2008.2269, 10.1089/ARS.2008.2269]; Long EK, 2008, J NEUROCHEM, V105, P714, DOI 10.1111/j.1471-4159.2007.05175.x; Long EK, 2013, FREE RADICAL BIO MED, V63, P390, DOI 10.1016/j.freeradbiomed.2013.05.030; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Misra J, 2017, TRENDS ENDOCRIN MET, V28, P261, DOI 10.1016/j.tem.2016.12.005; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; NADKARNI DV, 1995, CHEM RES TOXICOL, V8, P284, DOI 10.1021/tx00044a014; Pace NJ, 2014, BIOMOLECULES, V4, P419, DOI 10.3390/biom4020419; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Shearn CT, 2015, FREE RADICAL BIO MED, V89, P1144, DOI 10.1016/j.freeradbiomed.2015.10.420; Shearn CT, 2016, REDOX BIOL, V7, P68, DOI 10.1016/j.redox.2015.11.013; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang T, 2015, MOL CELL BIOL, V35, P1281, DOI 10.1128/MCB.01156-14; Wong CM, 2008, CIRC RES, V102, P310, DOI 10.1161/CIRCRESAHA.107.159814; Wong HL, 2008, CHEM RES TOXICOL, V21, P796, DOI 10.1021/tx700433m; Xu QH, 2014, METHOD ENZYMOL, V538, P249, DOI 10.1016/B978-0-12-800280-3.00014-1; Yoshihara E, 2016, CELL METAB, V23, P622, DOI 10.1016/j.cmet.2016.03.005	61	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13464	13476		10.1074/jbc.RA118.003469	http://dx.doi.org/10.1074/jbc.RA118.003469			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30012885	hybrid, Green Published			2022-12-26	WOS:000443375500010
J	Mandon, EC; Butova, C; Lachapelle, A; Gilmore, R				Mandon, Elisabet C.; Butova, Cameron; Lachapelle, Amber; Gilmore, Reid			Conserved motifs on the cytoplasmic face of the protein translocation channel are critical for the transition between resting and active conformations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); membrane protein; protein synthesis; protein translocation; ribosome; Sec61; translocation channel	SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; RIBOSOME-BINDING; COTRANSLATIONAL TRANSLOCATION; SEQUENCE RECOGNITION; TARGETING ROUTE; SEC61 COMPLEX; ER MEMBRANE; YEAST	The Sec61 complex is the primary cotranslational protein translocation channel in yeast (Saccharomyces cerevisiae). The structural transition between the closed inactive conformation of the Sec61 complex and its open and active conformation is thought to be promoted by binding of the ribosome nascent-chain complex to the cytoplasmic surface of the Sec61 complex. Here, we have analyzed new yeast Sec61 mutants that selectively interfere with cotranslational translocation across the endoplasmic reticulum. We found that a single substitution at the junction between transmembrane segment TM7 and the L6/7 loop interferes with cotranslational translocation by uncoupling ribosome binding to the L6/7 loop from the separation of the lateral gate transmembrane spans. Substitutions replacing basic residues with acidic residues in the C-terminal tail of Sec61 had an unanticipated impact upon binding of ribosomes to the Sec61 complex. We found that similar charge-reversal mutations in the N-terminal tail and in cytoplasmic loop L2/3 did not alter ribosome binding but interfered with translocation channel gating. These findings indicated that these segments are important for the structural transition between the inactive and active conformations of the Sec61 complex. In summary our results have identified additional cytosolic segments of the Sec61 complex important for promoting the structural transition between the closed and open conformations of the complex. We conclude that positively charged residues in multiple cytosolic segments, as well as bulky hydrophobic residues in the L6/7-TM7 junction, are required for cotranslational translocation or integration of membrane proteins by the Sec61 complex.	[Mandon, Elisabet C.; Butova, Cameron; Lachapelle, Amber; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Butova, Cameron] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Lachapelle, Amber] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Amherst; Framingham Heart Study	Gilmore, R (corresponding author), 364 Plantat St, Worcester, MA 01605 USA.	reid.gilmore@umassmed.edu			NIGMS, National Institutes of Health [RO1 GM35687]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035687] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIGMS, National Institutes of Health Grant RO1 GM35687. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARNOLD CE, 1994, J BIOL CHEM, V269, P30412; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Cheng ZL, 2006, NAT STRUCT MOL BIOL, V13, P930, DOI 10.1038/nsmb1146; Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188; Corsi AK, 1996, J BIOL CHEM, V271, P30299, DOI 10.1074/jbc.271.48.30299; Costa EA, 2018, SCIENCE, V359, P689, DOI 10.1126/science.aar3607; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; DESHAIES RJ, 1991, NATURE, V349, P806, DOI 10.1038/349806a0; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Jiang Y, 2008, J CELL BIOL, V180, P1149, DOI 10.1083/jcb.200707196; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Prinz A, 2000, BIOL CHEM, V381, P1025, DOI 10.1515/BC.2000.126; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Raden D, 2000, J CELL BIOL, V150, P53, DOI 10.1083/jcb.150.1.53; ROTHBLATT J, 1989, METHOD CELL BIOL, V32, P3; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1991, METHOD ENZYMOL, V194, P302; SILBERSTEIN S, 1995, J CELL BIOL, V131, P371, DOI 10.1083/jcb.131.2.371; Song WQ, 2000, CELL, V100, P333, DOI 10.1016/S0092-8674(00)80669-8; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tripathi A, 2017, J BIOL CHEM, V292, P8007, DOI 10.1074/jbc.M116.761122; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Trueman SF, 2011, MOL BIOL CELL, V22, P2983, DOI 10.1091/mbc.E11-01-0070; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	48	5	5	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13662	13672		10.1074/jbc.RA118.004123	http://dx.doi.org/10.1074/jbc.RA118.004123			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986881	Green Published, hybrid			2022-12-26	WOS:000443375500025
J	Tajiri, M; Suzuki, Y; Sugai, T; Tsuneyama, N; Someya, T				Tajiri, Misuzu; Suzuki, Yutaro; Sugai, Takuro; Tsuneyama, Nobuto; Someya, Toshiyuki			Effects of olanzapine on resting heart rate in Japanese patients with schizophrenia	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; AUTONOMIC MODULATION; DISEASE; IMPACT; ANTIPSYCHOTICS; DYSFUNCTION; MORTALITY; OBESITY	It has long been known that antipsychotic drugs (ATP) causes tachycardia, however details such as the differences between ATP are not well known. In recent years, the relationship between the rise in resting heart rate (RHR) and the increased risk of death in the general population has been garnering attention. In this study, we examined the difference in action on RHR between olanzapine (OLZ) and aripiprazole (ARP). The changes in the RHR on switching from OLZ to ARP and on increasing from the starting OLZ dose to the final one were evaluated in 19 outpatients (Study 1) and in 29 outpatients with schizophrenia (Study 2), respectively. To analyze the RHR, electrocardiographic measurements were obtained. At the same day, the Brief Psychiatric Rating Scale (BPRS) was evaluated, and fasting blood samples were drawn after an overnight fast of at least 8 h to examine electrolytes. Both Study 1 and 2 were conducted with the approval of the Gene Ethics Committee of Niigata University Graduate School of Medical and Dental Sciences, and the patients were treated at the outpatient psychiatric clinic at Niigata University Medical and Dental Hospital. All patients had been diagnosed with schizophrenia based on the DSM-IV-TR. In the Study 1, OLZ of 14.6 +/- 9.2mg (mean +/- standard deviation) was switched to ARP of 20.8 +/- 8.1 mg. Significant decreases were observed in the mean RHR after the switch to ARP (73.7 +/- 9.7 vs 65.8 +/- 10.9 beats/min, p = 0.008). In the Study 2, the starting OLZ dose was 7.2 +/- 3.2mg and the increasing OLZ dose was 18.3 +/- 7.4mg. Significant increases were observed in the mean RHR after increasing OLZ (69.7 +/- 14.0 vs 75.6 +/- 14.3 beats/min, p = 0.004). In this study, it was shown that OLZ has a stronger RHR enhancing effect compared to ARP and its effects are dose-dependent. If the increase in RHR increases the mortality rate of patients with schizophrenia, it may be necessary to further investigate the differences between ATP in terms of the effect on RHR of second-generation antipsychotics with a strong anticholinergic action or phenothiazine antipsychotics.	[Tajiri, Misuzu; Suzuki, Yutaro; Sugai, Takuro; Tsuneyama, Nobuto; Someya, Toshiyuki] Niigata Univ, Dept Psychiat, Grad Sch Med & Dent Sci, Niigata, Japan	Niigata University	Suzuki, Y (corresponding author), Niigata Univ, Dept Psychiat, Grad Sch Med & Dent Sci, Niigata, Japan.	yutaro@med.niigata-u.ac.jp	Someya, Toshiyuki/ABD-1878-2021		Japan Society for the Promotion of Research (JSPS) [17591199, 19591344, 20591362]; Health and Labour Sciences Research Grants (Research on Psychiatric and Neurological Diseases and Mental Health) [H17-kokoro-002]; Mitsubishi Pharma Research Foundation	Japan Society for the Promotion of Research (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labour Sciences Research Grants (Research on Psychiatric and Neurological Diseases and Mental Health); Mitsubishi Pharma Research Foundation	The study was funded by a Grants-in-Aid for Scientific Research (Kakenhi) from the Japan Society for the Promotion of Research (JSPS, #17591199 and #19591344), Mitsubishi Pharma Research Foundation and Health and Labour Sciences Research Grants (Research on Psychiatric and Neurological Diseases and Mental Health, H17-kokoro-002) to Toshiyuki Someya, and a Grant-in-Aid for Scientific Research (Kakenhi) from JSPS (#20591362) to Yutaro Suzuki. The funding sources played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. The other authors have no sources of funding.	Agelink MW, 2001, J CLIN PSYCHOPHARM, V21, P8, DOI 10.1097/00004714-200102000-00003; Alvares GA, 2016, J PSYCHIATR NEUROSCI, V41, P89, DOI 10.1503/jpn.140217; BILLMAN GE, 2015, FRONT PHYSIOL, V6; Bymaster FP, 1996, NEUROPSYCHOPHARMACOL, V14, P87, DOI 10.1016/0893-133X(94)00129-N; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; FRANK S, 1986, J AM COLL CARDIOL, V7, P295, DOI 10.1016/S0735-1097(86)80494-6; Hennekens CH, 2005, AM HEART J, V150, P1115, DOI 10.1016/j.ahj.2005.02.007; Huang WL, 2013, J CLIN PSYCHOPHARM, V33, P170, DOI 10.1097/JCP.0b013e3182839052; Iwamoto Y, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-199; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Mason JW, 2007, J ELECTROCARDIOL, V40, P228, DOI 10.1016/j.jelectrocard.2006.09.003; Rossi RC, 2015, AUTON NEUROSCI-BASIC, V193, P138, DOI 10.1016/j.autneu.2015.07.424; Sarlon J, 2016, PHARMACOPSYCHIATRY, V49, P18, DOI 10.1055/s-0035-1565204; SHAPER AG, 1993, BRIT HEART J, V70, P49; Teodorescu C, 2013, HEART RHYTHM, V10, P1153, DOI 10.1016/j.hrthm.2013.05.009	15	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0199922	10.1371/journal.pone.0199922	http://dx.doi.org/10.1371/journal.pone.0199922			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016331	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600013
J	Depardon, E; Kanoun, S; Humbert, O; Bertaut, A; Riedinger, JM; Tal, I; Vrigneaud, JM; Lasserre, M; Toubeau, M; Berriolo-Riedinger, A; Dygai-Cochet, I; Fumoleau, P; Brunotte, F; Cochet, A				Depardon, Edouard; Kanoun, Salim; Humbert, Olivier; Bertaut, Aurelie; Riedinger, Jean-Marc; Tal, Ilan; Vrigneaud, Jean-Marc; Lasserre, Maud; Toubeau, Michel; Berriolo-Riedinger, Alina; Dygai-Cochet, Inna; Fumoleau, Pierre; Brunotte, Francois; Cochet, Alexandre			FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; RESPONSE EVALUATION; F-18 FLUORODEOXYGLUCOSE; TUMOR RESPONSE; SOLID TUMORS; BODY-WEIGHT; RECOMMENDATIONS; CHEMOTHERAPY; RECIST	Aim Evaluate response and predict prognosis of patients with newly diagnosed metastatic breast cancer treated with first line systemic therapy using European Organization for Research and Treatment of Cancer (EORTC) criteria and PET Response Criteria in solid Tumours (PERCIST). Methods From December 2006 to August 2013, 57 women with newly diagnosed metastatic breast cancer were retrospectively evaluated. FDG-PET/CT was performed within one month before treatment and repeated after at least 3 cycles of treatment. Metabolic response evaluation was evaluated by two readers according to both EORTC criteria and PERCIST, classifying the patients into 4 response groups: complete metabolic response (CMR), partial metabolic response (PMR), stable metabolic disease (SMD), and progressive metabolic disease (PMD). Results With EORTC criteria, 22 patients had CMR, 17 PMR, 6 SMD and 12 PMD. With PERCIST, 20 patients had CMR, 15 PMR, 10 SMD and 12 PMD. There was agreement between EORTC and PERCIST in 84% of the patients. By log-rank analysis, metabolic response evaluated with both EORTC criteria and PERCIST was able to predict overall survival (p = 0.028 and 0.002 respectively). CMR patient group had longer median OS than patients in the combined PMR+SMD+PMD group (60 vs 26 months both with EORTC and PERCIST; p = 0.009 and 0.006 respectively). By multivariate analysis, CMR either with EORTC or PERCIST remained an independent predictor of survival. Conclusion Metabolic response evaluation with EORTC criteria and PERCIST gave similar prognostic stratification for metastatic breast cancer treated with a first line of systemic therapy.	[Depardon, Edouard; Kanoun, Salim; Humbert, Olivier; Riedinger, Jean-Marc; Vrigneaud, Jean-Marc; Lasserre, Maud; Toubeau, Michel; Berriolo-Riedinger, Alina; Dygai-Cochet, Inna; Brunotte, Francois; Cochet, Alexandre] Ctr Georges Francois Leclerc, Dept Nucl Med, Dijon, France; [Kanoun, Salim; Humbert, Olivier; Brunotte, Francois; Cochet, Alexandre] Univ Bourgogne Franche Comte, CNRS, Le2i UMR 6306, Arts & Metiers, Dijon, France; [Bertaut, Aurelie] Ctr Georges Francois Leclerc, Dept Biostat & Methodol, Dijon, France; [Tal, Ilan] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Fumoleau, Pierre] Ctr Georges Francois Leclerc, Dept Med Oncol, Dijon, France	UNICANCER; Centre Georges-Francois Leclerc; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; UNICANCER; Centre Georges-Francois Leclerc; Harvard University; Beth Israel Deaconess Medical Center; UNICANCER; Centre Georges-Francois Leclerc	Depardon, E (corresponding author), Ctr Georges Francois Leclerc, Dept Nucl Med, Dijon, France.	edouarddepardon@hotmail.fr	Kanoun, Salim/AAA-9679-2021	bertaut, Aurelie/0000-0002-7934-9509; VRIGNEAUD, Jean-Marc/0000-0002-3441-7520				Benard F, 1999, J NUCL MED, V40, P1257; Benz MR, 2008, J NUCL MED, V49, P1038, DOI 10.2967/jnumed.107.050187; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Buckler AJ, 2011, J NUCL MED, V52, P171, DOI 10.2967/jnumed.110.081224; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cachin F, 2006, J CLIN ONCOL, V24, P3026, DOI 10.1200/JCO.2005.04.6326; Couturier O, 2006, CLIN CANCER RES, V12, P6437, DOI 10.1158/1078-0432.CCR-06-0383; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Humbert O, 2015, ONCOLOGIST, V20, P94, DOI 10.1634/theoncologist.2014-0342; Kaufmann M, 2007, ANN ONCOL, V18, P1927, DOI 10.1093/annonc/mdm201; Ligibel JA, 2002, SEMIN ONCOL, V29, P38, DOI 10.1053/sonc.2002.34054; Lobbezoo DJA, 2015, BRIT J CANCER, V112, P1445, DOI 10.1038/bjc.2015.127; Mortazavi-Jehanno N, 2012, EUR J NUCL MED MOL I, V39, P450, DOI 10.1007/s00259-011-1981-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider-Kolsky ME, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2591; Skougaard K, 2013, J NUCL MED, V54, P1026, DOI 10.2967/jnumed.112.111757; Specht JM, 2007, BREAST CANCER RES TR, V105, P87, DOI 10.1007/s10549-006-9435-1; Sugawara Y, 1999, RADIOLOGY, V213, P521, DOI 10.1148/radiology.213.2.r99nv37521; Tahari AK, 2014, J NUCL MED, V55, P1481, DOI 10.2967/jnumed.113.136986; Tateishi U, 2008, RADIOLOGY, V247, P189, DOI 10.1148/radiol.2471070567; Torrisi R, 2007, BREAST, V16, P73, DOI 10.1016/j.breast.2006.06.005; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Weber WA, 2009, J NUCL MED, V50, p1S, DOI 10.2967/jnumed.108.057174; Young H, 1999, EUR J CANCER, V35, P1773, DOI 10.1016/S0959-8049(99)00229-4; ZASADNY KR, 1993, RADIOLOGY, V189, P847, DOI 10.1148/radiology.189.3.8234714; Ziai D, 2013, CANCER IMAGING, V13, P73, DOI 10.1102/1470-7330.2013.0008	27	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199529	10.1371/journal.pone.0199529	http://dx.doi.org/10.1371/journal.pone.0199529			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011328	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800004
J	Finkelmeier, F; Canli, O; Peiffer, KH; Walter, D; Tal, A; Koch, C; Pession, U; Vermehren, J; Trojan, J; Zeuzem, S; Piiper, A; Greten, FR; Grammatikos, G; Waidmann, O				Finkelmeier, Fabian; Canli, Ozge; Peiffer, Kai-Henrik; Walter, Dirk; Tal, Andrea; Koch, Christine; Pession, Ursula; Vermehren, Johannes; Trojan, Joerg; Zeuzem, Stefan; Piiper, Albrecht; Greten, Florian R.; Grammatikos, Georgios; Waidmann, Oliver			Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis	PLOS ONE			English	Article							SERUM CA9; EXPRESSION; TUMOR; REGENERATION; PROGNOSIS; RELEVANCE; SURVIVAL	Background and aims Expression of carbonic anhydrase IX (CA9), an enzyme expressed in response to hypoxia, acidosis and oncogenic alterations, is reported to be a prognostic factor in HCC patients. Here we evaluated serum CA9 levels in HCC and cirrhosis patients. Methods HCC and cirrhosis patients were prospectively recruited and CA9 levels were determined. CA9 levels were compared to stages of cirrhosis and HCC stages. The association of the CA9 levels and overall survival (OS) was assessed. Furthermore, immunohistochemical CA9 expression in HCC and cirrhosis was evaluated. Results 215 patients with HCC were included. The median serum CA9 concentration in patients with HCC was 370 pg/ml and significantly higher than in a healthy cohort. Patients with advanced cancer stages (BCLC and ALBI score) had hid significant higher levels of CA9 in the serum. HCC patients with high serum CA9 concentrations (>400 pg/ml) had an increased mortality risk (hazard ratio (HR) 1.690, 95% confidence interval (CI) 1.017-2.809, P= 0.043). Serum CA9 concentration in cirrhotic patients did not differ significantly from HCC patients. Higher CA9 levels in cirrhotic patients correlated with portal hypertension and esophageal varices. Patients with ethanol induced cirrhosis had the highest CA9 levels in both cohorts. Levels of CA9 did not correlate with immunohistochemical expression. Conclusions We conclude that a high CA9 level is a possible prognostic indicator for a poor outcome in HCC patients. The high CA9 levels are probably mainly associated with portal hypertension. Ductular reactions might be a possible source of serum CA9.	[Finkelmeier, Fabian; Peiffer, Kai-Henrik; Walter, Dirk; Tal, Andrea; Koch, Christine; Vermehren, Johannes; Trojan, Joerg; Zeuzem, Stefan; Piiper, Albrecht; Grammatikos, Georgios; Waidmann, Oliver] Univ Hosp Frankfurt, Dept Gastroenterol Hepatol & Endocrinol, Frankfurt, Germany; [Finkelmeier, Fabian; Canli, Ozge; Greten, Florian R.] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany; [Pession, Ursula] Univ Hosp Frankfurt, Dept Gen & Visceral Surg, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Finkelmeier, F (corresponding author), Univ Hosp Frankfurt, Dept Gastroenterol Hepatol & Endocrinol, Frankfurt, Germany.; Finkelmeier, F (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany.	fabian.finkelmeier@kgu.de	Greten, Florian R/AAF-5196-2020; Zeuzem, Stefan/AAE-7435-2019; Finkelmeier, Fabian/J-8185-2019; Koch, Christine/J-8698-2019	Greten, Florian R/0000-0002-3928-6080; Finkelmeier, Fabian/0000-0001-8559-9910; 	Else-Kroner-Forschungskolleg; Deutsche Forschungsgemeinschaft [SFB 0815]; Frankfurter ForschungsfoErderung	Else-Kroner-Forschungskolleg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Frankfurter ForschungsfoErderung	Parts of the work were supported by the Frankfurter ForschungsfoErderung, the Else-Kroner-Forschungskolleg and Deutsche Forschungsgemeinschaft SFB 0815. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breton S, 2001, JOP, V2, P159; Ditte P, 2011, CANCER RES, V71, P7558, DOI 10.1158/0008-5472.CAN-11-2520; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Falkowski O, 2003, J HEPATOL, V39, P357, DOI 10.1016/S0168-8278(03)00309-X; Fidan E, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0540-9; Finkelmeier F, 2016, EUR J CANCER, V59, P152, DOI 10.1016/j.ejca.2016.03.002; Finkelmeier F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132119; Gigante M, 2012, ANTICANCER RES, V32, P5447; Gouw ASH, 2011, HEPATOLOGY, V54, P1853, DOI 10.1002/hep.24613; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114910, 10.1371/journal.pone.0131053]; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Ju C, 2016, J MOL MED, V94, P613, DOI 10.1007/s00109-016-1408-1; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Kang HJ, 2015, VIRCHOWS ARCH, V466, P403, DOI 10.1007/s00428-014-1709-0; Kock L, 2011, INT J GYNECOL CANCER, V21, P141, DOI 10.1097/IGC.0b013e318204c34f; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Luong-Player A, 2014, AM J CLIN PATHOL, V141, P219, DOI 10.1309/AJCPVJDS28KNYZLD; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Papworth K, 2010, ANTICANCER RES, V30, P2953; Pastorekova S, 1997, GASTROENTEROLOGY, V112, P398, DOI 10.1053/gast.1997.v112.pm9024293; Potter C, 2004, CELL CYCLE, V3, P164; Richardson MM, 2007, GASTROENTEROLOGY, V133, P80, DOI 10.1053/j.gastro.2007.05.012; Schutze D, 2013, J CANCER RES CLIN, V139, P747, DOI 10.1007/s00432-013-1378-4; Smith AD, 2016, ANTICANCER RES, V36, P4489, DOI 10.21873/anticanres.10994; Takacova M, 2013, ONCOL LETT, V5, P191, DOI 10.3892/ol.2012.1001; Vidlickova I, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2267-4; Waidmann O, 2016, LIVER INT, V36, P1464, DOI 10.1111/liv.13117; Waidmann O, 2013, J HEPATOL, V58, P956, DOI 10.1016/j.jhep.2013.01.005; WOELBER L, 2011, BMC CANCER, V11, DOI DOI 10.11186/1471-2407-11-12; Wykoff CC, 2000, CANCER RES, V60, P7075; Zatovicova M, 2005, BRIT J CANCER, V93, P1267, DOI 10.1038/sj.bjc.6602861; Zavada J, 2003, BRIT J CANCER, V89, P1067, DOI 10.1038/sj.bjc.6601264	37	12	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200855	10.1371/journal.pone.0200855	http://dx.doi.org/10.1371/journal.pone.0200855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011326	gold, Green Published, Green Submitted			2022-12-26	WOS:000438829800053
J	Wang, X; Huang, S; Li, XC; Jiang, DR; Yu, HZ; Wu, Q; Gao, CB; Wu, ZS				Wang, Xian; Huang, Shan; Li, Xiaocan; Jiang, Dongrui; Yu, Hongzhen; Wu, Qiang; Gao, Chaobing; Wu, Zhengsheng			A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma	PLOS ONE			English	Article							BRAF V600E MUTATION; HASHIMOTOS-THYROIDITIS; CANCER; EXPRESSION; DIAGNOSIS; SURVIVAL; GROWTH; GENE; PROLIFERATION; RECURRENCE	Papillary thyroid carcinoma (PTC) is the most common endocrine cancer with a significantly increase of the incidence recently. Several cytokines, such as thyroid peroxidase (TPO), cluster of differentiation 56 (CD56), Galectin-3, mesothelial cell (MC), cytokeratin 19 (CK19) and BRAF (B-raf) were recommended to be tested by immunohistochemistry (IHC) for a definitive diagnosis, but were still limited in clinical use because of their relative lower sensitivity and specificity. MicroRNA (miRNA), as a new molecular biomarkers, however, has not been reported yet so far. To address this, hsa-miR-200a-5p, a miRNA, was selected and detected in PTC patients by in situ hybrization with benign thyroid tumor with papillary hyperplasia as a control, and the differential expression of hsa-miR-200a-5p between fresh PTC tissues and control was detected by qRT-PCR. Expressive levels of cytokines of TPO, CD56, Galectin-3, MC, CK19 and B-raf were also detected by immunohistochemistry. The correlation was analyzed by SPSS software using Spearman methods. As expected, the hsa-miR-200a-5p expressive level was significantly increased in PTC patients, compared to that of control, and was consistent with that of TPO, CD56, Galectin-3, MC, CK19 and B-raf. In addition, expression of hsa-miR-200a-5p showed negative correlation to that of TPO (r(s) = - 0.734; **: P< 0.01) and CD56 (r(s) = - 0.570; **: P< 0.01), but positive correlation to that of Galectin-3 (r(s) = 0.601; **: P< 0.01), MC (r(s) = 0.508; **: P< 0.01), CK19 (r(s) = 0.712; **: P < 0.01) and B-raf (r(s) = 0.378; **: P < 0.01). PTC and papillary benign thyroid papillary hyperplasia are difficult to distinguish in morphology, so requiring immunohistochemistry to further differentiate the diagnosis, however, for the existing clinical common diagnostic marker for immunohistochemistry, the sensitivity and accuracy are low, it is easy to miss diagnosis. Therefore, there is an urgent need for a rapid and sensitive molecular marker. So miR-200a-5p can be used to assist in the diagnosis of PTC at the molecular level, and as a biomarker, can be effectively used to distinguish between PTC and benign thyroid tumor with papillary hyperplasia.	[Wang, Xian; Huang, Shan; Yu, Hongzhen; Wu, Qiang; Wu, Zhengsheng] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Wang, Xian; Huang, Shan; Li, Xiaocan; Jiang, Dongrui; Yu, Hongzhen] Anhui Med Univ, Affiliated Hosp 2, Dept Pathol, Hefei, Anhui, Peoples R China; [Gao, Chaobing] Anhui Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Wu, ZS (corresponding author), Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China.; Gao, CB (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Hefei, Anhui, Peoples R China.	gcbl10011@163.com; woozson@126.com		Wu, Zhengsheng/0000-0002-7571-8215	Natural Science Research Project of Colleges and Universities in Anhui Province [KJ2015A036]; Natural Science Foundation of Anhui Province [1608085MH189]	Natural Science Research Project of Colleges and Universities in Anhui Province; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province)	This research project was sponsored by the Natural Science Research Project of Colleges and Universities in Anhui Province (No. KJ2015A036) and Natural Science Foundation of Anhui Province (1608085MH189).	Ab Mutalib NS, 2016, PEERJ, V4, DOI 10.7717/peerj.2119; Abooshahab Raziyeh, 2016, Asian Pac J Cancer Prev, V17, P3861; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; An HJ, 2018, J PATHOL TRANSL MED, V52, P9, DOI 10.4132/jptm.2017.07.26; Arcolia V, 2017, ONCOL LETT, V14, P4183, DOI 10.3892/ol.2017.6719; Arjumand W, 2018, METHODS MOL BIOL, V1699, P3, DOI 10.1007/978-1-4939-7435-1_1; Bobbili MR, 2017, ONCOTARGET, V8, P71206, DOI 10.18632/oncotarget.19331; Cao W, 2018, METHODS MOL BIOL, V1699, P67, DOI 10.1007/978-1-4939-7435-1_4; Chai YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159235; Chen SY, 2017, J CANCER, V8, P617, DOI 10.7150/jca.17394; Formiga MND, 2017, JAMA ONCOL, V3, P1400, DOI 10.1001/jamaoncol.2016.6389; Dal Maso L, 2017, EUR J CANCER, V77, P140, DOI 10.1016/j.ejca.2017.02.023; Delivanis DA, 2017, J CLIN ENDOCR METAB, V102, P2770, DOI 10.1210/jc.2017-00448; Dunderovic D, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0428-4; Gabalec F, 2016, ENDOKRYNOL POL, V67, P48, DOI 10.5603/EP.a2016.0022; Galusca B, 2005, VIRCHOWS ARCH, V447, P18, DOI 10.1007/s00428-005-1268-5; Gao C, 2014, NEOPLASMA, V61, P680, DOI 10.4149/neo_2014_083; Geller G, 2017, THYROID RES, V10, DOI 10.1186/s13044-017-0041-6; Hao MW, 2017, MOL MED REP, V15, P160, DOI 10.3892/mmr.2016.6020; Hoperia V, 2010, INT J PEDIATR ENDOCR, DOI 10.1155/2010/690108; Hou XY, 2013, MOL BIOL REP, V40, P3437, DOI 10.1007/s11033-012-2421-2; Khan NE, 2017, J CLIN ENDOCR METAB, V102, P1614, DOI 10.1210/jc.2016-2954; Kim SH, 2016, THYROID, V26, P1472, DOI 10.1089/thy.2016.0238; Kryvenko ON, 2017, VIRCHOWS ARCH, V470, P47, DOI 10.1007/s00428-016-2033-7; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee DY, 2016, THYROID, V26, P1259, DOI 10.1089/thy.2016.0147; Lee JS, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1928021; Li R, 2014, MOL BIOL REP, V41, P1977, DOI 10.1007/s11033-014-3045-5; Lmz M, 2017, ARCH ENDOCRIN METAB, V61, p398 , DOI [10.1590/2359-3997000000267, DOI 10.1590/2359-3997000000267]; Lococo F, 2017, TUMORI, V103, pE15, DOI 10.5301/tj.5000598; Pacella CM, 2013, J ENDOCRINOL INVEST, V36, P61, DOI 10.1007/BF03346744; Prasad ML, 2004, HISTOPATHOLOGY, V45, P39, DOI 10.1111/j.1365-2559.2004.01876.x; Ricciuti B, 2016, TUMORI S2, V102, DOI [10.5301/tj.5000514, DOI 10.5301/TJ.5000514]; Roman BR, 2017, CURR OPIN ENDOCRINOL, V24, P332, DOI 10.1097/MED.0000000000000359; Safranek J, 2016, ROZHL CHIR, V95, p394 ; Schmohl KA, 2017, THYROID, V27, P1534, DOI 10.1089/thy.2017.0290; Senfter Daniel, 2016, BioMolecular Concepts, V7, P311, DOI 10.1515/bmc-2016-0020; Sun J, 2015, ACTA U MED ANHUI; Tsai HF, 2016, J MOL MED, V94, P545, DOI 10.1007/s00109-015-1368-x; Uchino S, 2016, J CLIN ENDOCR METAB, V101, p2016 ; Vuong HG, 2017, HISTOPATHOLOGY, V71, P760, DOI 10.1111/his.13285; Wang Xin, 2017, Zhongguo Fei Ai Za Zhi, V20, P522, DOI 10.3779/j.issn.1009-3419.2017.08.04; Wang Y, 2018, INT J ONCOL, V52, P2130, DOI 10.3892/ijo.2018.4359; Wong KS, 2016, THYROID, V26, P911, DOI 10.1089/thy.2015.0644; Wu W, 2018, METHODS MOL BIOL, V1699, P91, DOI 10.1007/978-1-4939-7435-1_7; Xiao HB, 2015, ONCOTARGET, V6, P38005, DOI 10.18632/oncotarget.5357; Xu B, 2018, EJSO-EUR J SURG ONC, V44, P338, DOI 10.1016/j.ejso.2017.05.002; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Yoneyama K, 2015, ANTICANCER RES, V35, P1401; Zagzag J, 2013, SURGERY, V154, P1199, DOI 10.1016/j.surg.2013.06.020; Zhang J, 2013, INT J MED SCI, V10, P585, DOI 10.7150/ijms.5794; Zhang JS, 2017, ONCOL LETT, V14, P4983, DOI 10.3892/ol.2017.6769; Zhang Z, 2012, INT J MOL MED, V30, P856, DOI 10.3892/ijmm.2012.1059; Zhu J, 2018, METHODS MOL BIOL, V1699, P83, DOI 10.1007/978-1-4939-7435-1_6; Zhu XL, 2016, EXP MOL PATHOL, V100, P236, DOI 10.1016/j.yexmp.2016.01.004	55	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200290	10.1371/journal.pone.0200290	http://dx.doi.org/10.1371/journal.pone.0200290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005075	Green Published, gold, Green Submitted			2022-12-26	WOS:000438744200012
J	Donda, K; Zambrano, R; Moon, Y; Percival, J; Vaidya, R; Dapaah-Siakwan, F; Luo, SH; Duncan, MR; Bao, Y; Wang, LQ; Qin, L; Benny, M; Young, K; Wu, S				Donda, Keyur; Zambrano, Ronald; Moon, Younghye; Percival, Justin; Vaidya, Ruben; Dapaah-Siakwan, Fredrick; Luo, Shihua; Duncan, Matthew R.; Bao, Yong; Wang, Luqing; Qin, Ling; Benny, Merline; Young, Karen; Wu, Shu			Riociguat prevents hyperoxia-induced lung injury and pulmonary hypertension in neonatal rats without effects on long bone growth	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; INHALED NITRIC-OXIDE; BRONCHOPULMONARY DYSPLASIA; SILDENAFIL; EXPRESSION; THERAPY; INFANTS; CELLS; CGMP; ALVEOLARIZATION	Bronchopulmonary dysplasia (BPD) remains the most common and serious chronic lung disease of premature infants. Severe BPD complicated with pulmonary hypertension (PH) increases the mortality of these infants. Riociguat is an allosteric soluble guanylate cyclase stimulator and is approved by the FDA for treating PH in adults. However, it has not been approved for use in neonates due to concern for adverse effects on long bone growth. To address this concern we investigated if administration of riociguat is beneficial in preventing hyperoxia-induced lung injury and PH without side effects on long bone growth in newborn rats. Newborn rats were randomized to normoxia (21% O-2) or hyperoxia (85% O-2) exposure groups within 24 hours of birth, and received riociguat or placebo by once daily intraperitoneal injections during continuous normoxia or hyperoxia exposure for 9 days. In the hyperoxia control group, radial alveolar count, mean linear intercept and vascular density were significantly decreased, the pathological hallmarks of BPD, and these were accompanied by an increased inflammatory response. There was also significantly elevated vascular muscularization of peripheral pulmonary vessels, right ventricular systolic pressure and right ventricular hypertrophy indicating PH. However, administration of riociguat significantly decreased lung inflammation, improved alveolar and vascular development, and decreased PH during hyperoxia by inducing cGMP production. Additionally, riociguat did not affect long bone growth or structure. These data indicate that riociguat is beneficial in preventing hyperoxia-induced lung injury and PH without affecting long bone growth and structure and hence, suggests riociguat may be a potential novel agent for preventing BPD and PH in neonates.	[Donda, Keyur; Zambrano, Ronald; Vaidya, Ruben; Dapaah-Siakwan, Fredrick; Luo, Shihua; Duncan, Matthew R.; Bao, Yong; Benny, Merline; Young, Karen; Wu, Shu] Univ Miami, Sch Med, Pediat & Batchelor Childrens Res Inst, Miami, FL 33136 USA; [Moon, Younghye; Percival, Justin] Univ Miami, Miller Sch Med, Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Wang, Luqing; Qin, Ling] Univ Penn, Sch Med, Dept Orthoped Surg, Philadelphia, PA 19104 USA	University of Miami; University of Miami; University of Pennsylvania	Wu, S (corresponding author), Univ Miami, Sch Med, Pediat & Batchelor Childrens Res Inst, Miami, FL 33136 USA.	swu2@med.miami.edu	Vaidya, Ruben/ABE-5265-2020; DAPAAH-SIAKWAN, FREDRICK/AAD-9467-2020; Donda, Keyur/AAW-3193-2020	Vaidya, Ruben/0000-0001-6674-4692; DAPAAH-SIAKWAN, FREDRICK/0000-0002-0563-0437; Moon, Younghye/0000-0002-3737-0043; Donda, Keyur/0000-0002-0526-1176	University of Miami; March of Dimes Foundation; Batchelor Foundation	University of Miami; March of Dimes Foundation(March of Dimes); Batchelor Foundation	This work was supported by Project Newborn from the University of Miami, Grant from March of Dimes Foundation and Micah Batchelor Award from the Batchelor Foundation (SW).	Abman SH, 2013, AM J RESP CRIT CARE, V187, P572, DOI 10.1164/rccm.201210-1928PP; Ahluwalia A, 2004, P NATL ACAD SCI USA, V101, P1386, DOI 10.1073/pnas.0304264101; Alapati D, 2011, AM J RESP CELL MOL, V45, P1169, DOI 10.1165/rcmb.2011-0023OC; Ambalavanan N, 2016, J PERINATOL, V36, pS20, DOI 10.1038/jp.2016.45; Ambalavanan N, 2009, PEDIATRICS, V123, P1132, DOI 10.1542/peds.2008-0526; Bachiller PR, 2013, AM J PHYSIOL-LUNG C, V305, pL569, DOI 10.1152/ajplung.00401.2012; Berkelhamer SK, 2013, SEMIN PERINATOL, V37, P124, DOI 10.1053/j.semperi.2013.01.009; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Broderick KE, 2007, MOL ENDOCRINOL, V21, P1148, DOI 10.1210/me.2005-0389; Byrne AJ, 2016, TRENDS MOL MED, V22, P303, DOI 10.1016/j.molmed.2016.02.004; Chandra A, 2017, J BONE MINER RES, V32, P360, DOI 10.1002/jbmr.2996; Chen SY, 2011, AM J PHYSIOL-LUNG C, V300, pL330, DOI 10.1152/ajplung.00270.2010; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; Cole FS, 2011, PEDIATRICS, V127, P363, DOI 10.1542/peds.2010-3507; CRAWLEY DE, 1992, AM J PHYSIOL, V263, pL325, DOI 10.1152/ajplung.1992.263.3.L325; Czirok S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10125-3; Dasgupta A, 2014, CLIN PHARMACOL THER, V97, P88; del Visser YP, 2010, AM J RESP CRIT CARE, V182, P1239, DOI [10.1164/rccm.200909-1361OC, DOI 10.1164/RCCM.200909-1361OC]; Deruelle P, 2006, BIOL NEONATE, V90, P135, DOI 10.1159/000092518; Donohue PK, 2011, PEDIATRICS, V127, pE414, DOI 10.1542/peds.2010-3428; Eldredge LC, 2016, AM J RESP CELL MOL, V54, P273, DOI 10.1165/rcmb.2014-0395OC; Evaluation D., 1988, REVIEW, V9, P22; Farrow KN, 2008, CIRC RES, V102, P226, DOI 10.1161/CIRCRESAHA.107.161463; Fraccarollo D, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0421-1; Ghofrani HA, 2013, NEW ENGL J MED, V369, P330, DOI 10.1056/NEJMoa1209655; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Glynos C, 2015, AM J RESP CELL MOL, V52, P762, DOI 10.1165/rcmb.2014-0092OC; GRONECK P, 1994, PEDIATRICS, V93, P712; Guha M, 2013, NAT BIOTECHNOL, V31, P1064, DOI 10.1038/nbt1213-1064b; Herbert S, 2016, EARLY HUM DEV, V102, P21, DOI 10.1016/j.earlhumdev.2016.09.009; Homer BL, 2015, TOXICOL PATHOL, V43, P411, DOI 10.1177/0192623314546559; Hummler JK, 2017, NEONATOLOGY, V111, P280, DOI 10.1159/000450918; Hummler SC, 2013, AM J RESP CELL MOL, V48, P578, DOI 10.1165/rcmb.2012-0383OC; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kadmon G, 2017, PEDIATR PULM, V52, P77, DOI 10.1002/ppul.23508; Khemani E, 2007, PEDIATRICS, V120, P1260, DOI 10.1542/peds.2007-0971; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Lakshminrusimha S, 2016, SEMIN PERINATOL, V40, P160, DOI 10.1053/j.semperi.2015.12.004; Lang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043433; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee KJ, 2014, AM J RESP CELL MOL, V50, P369, DOI 10.1165/rcmb.2013-0118OC; Liao J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9977; Lin YJ, 2005, PEDIATR RES, V58, P22, DOI 10.1203/01.PDR.0000163378.94837.3E; Moon Y, 2017, ANTIOXID REDOX SIGN, V26, P966, DOI 10.1089/ars.2016.6630; Mourani PM, 2009, J PEDIATR-US, V154, P379, DOI 10.1016/j.jpeds.2008.09.021; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; NICHD, 1997, NEW ENGL J MED, V336, P597, DOI [10.1056/NEJM199702273360901, DOI 10.1056/NEJM199702273360901]; Nold MF, 2013, P NATL ACAD SCI USA, V110, P14384, DOI 10.1073/pnas.1306859110; Nyp M, 2012, J PERINATOL, V32, P64, DOI 10.1038/jp.2011.131; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Park HS, 2013, AM J RESP CELL MOL, V48, P105, DOI 10.1165/rcmb.2012-0043OC; Pradhan K, 2016, INT J CARDIOL, V216, P85, DOI 10.1016/j.ijcard.2016.04.098; Rieg AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066195; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; STEINHORN RH, 1995, AM J PHYSIOL-HEART C, V268, pH1483, DOI 10.1152/ajpheart.1995.268.4.H1483; Steinhorn RH, 2009, J PEDIATR-US, V155, P841, DOI 10.1016/j.jpeds.2009.06.012; Stenmark KR, 2005, ANNU REV PHYSIOL, V67, P623, DOI 10.1146/annurev.physiol.67.040403.102229; Syed MA, 2013, MEDIAT INFLAMM, V2013, P1; Tang JR, 2007, AM J PHYSIOL-LUNG C, V293, pL1271, DOI 10.1152/ajplung.00224.2007; Thebaud B, 2007, AM J RESP CRIT CARE, V175, P978, DOI 10.1164/rccm.200611-1660PP; Van Marter LJ, 2009, SEMIN FETAL NEONAT M, V14, P358, DOI 10.1016/j.siny.2009.08.007; Willis GR, 2018, AM J RESP CRIT CARE, V197, P104, DOI 10.1164/rccm.201705-0925OC; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhang RL, 2003, CIRC RES, V92, P308, DOI 10.1161/01.RES.0000056757.93432.8C; Zheng H, 2006, J BIOL CHEM, V281, P15809, DOI 10.1074/jbc.M513225200	67	13	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199927	10.1371/journal.pone.0199927	http://dx.doi.org/10.1371/journal.pone.0199927			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990355	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300020
J	Kerr, JR; Wilson, MS				Kerr, John R.; Wilson, Marc Stewart			Changes in perceived scientific consensus shift beliefs about climate change and GM food safety	PLOS ONE			English	Article							CULTURAL COGNITION; MEDIATION ANALYSIS; PUBLIC SUPPORT; FALSE BALANCE; PERCEPTIONS; SCIENCE; AGREEMENT; IMPACT	Despite an overwhelming scientific consensus, a sizable minority of people doubt that human activity is causing climate change. Communicating the existence of a scientific consensus has been suggested as a way to correct individuals' misperceptions about human-caused climate change and other scientific issues, though empirical support is mixed. We report an experiment in which psychology students were presented with consensus information about two issues, and subsequently reported their perception of the level of consensus and extent of their endorsement of those issues. We find that messages about scientific consensus on the reality of anthropogenic climate change and the safety of genetically modified food shift perceptions of scientific consensus. Using mediation models we also show that, for both these issues, high consensus messages also increase reported personal agreement with the scientific consensus, mediated by changes in perceptions of a scientific consensus. This confirms the role of perceived consensus in informing personal beliefs about climate change, though results indicate the impact of single, one-off messages may be limited.	[Kerr, John R.; Wilson, Marc Stewart] Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand	Victoria University Wellington	Kerr, JR (corresponding author), Victoria Univ Wellington, Sch Psychol, Wellington, New Zealand.	John.Kerr@vuw.ac.nz	Kerr, John/AAX-1806-2020	Kerr, John/0000-0002-6606-5507; Wilson, Marc/0000-0002-3009-5229				Aklin M, 2014, ENVIRON SCI POLICY, V38, P173, DOI 10.1016/j.envsci.2013.10.006; Allukian M, 2018, ANN EPIDEMIOL, V28, P401, DOI 10.1016/j.annepidem.2017.05.014; Almendrala A., 2016, HUFFINGTON POST; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bolsen T, 2017, 1 ANN RES ROUNDTABLE; Bolsen T, 2015, J COMMUN, V65, P745, DOI 10.1111/jcom.12171; Bolsen T, 2014, AM POLIT RES, V42, P65, DOI 10.1177/1532673X13484173; Brewer PR, 2017, ATL J COMMUN, V25, P166, DOI 10.1080/15456870.2017.1324453; CHAIKEN S, 1989, P212; Chikazhe TL, 2015, NZ PUBLIC ATTITUDES; Cohen P, 1999, MULTIVAR BEHAV RES, V34, P315, DOI 10.1207/S15327906MBR3403_2; Cook J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175799; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Cook J, 2016, TOP COGN SCI, V8, P160, DOI 10.1111/tops.12186; Deryugina T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151469; Dixon G, 2017, SCI COMMUN, V39, P520, DOI 10.1177/1075547017715473; Dixon G, 2016, J COMMUN, V66, P888, DOI 10.1111/jcom.12260; Dixon GN, 2015, J COMMUN, V65, P639, DOI 10.1111/jcom.12159; Dixon GN, 2013, SCI COMMUN, V35, P358, DOI 10.1177/1075547012458290; Dunlap R.E., 2011, OXFORD HDB CLIMATE C, P144; Dunwoody S, 2017, SCI COMMUN, V39, P338, DOI 10.1177/1075547017707765; Freedman DH, 2013, SCI AM, V309, P80, DOI 10.1038/scientificamerican0913-80; George D, 2003, SPSS WINDOWS STEP ST; Hamilton LC, 2016, SAGE OPEN, V6; Harker D., 2015, CREATING SCI CONTROV, DOI [10.1017/ CBO9781107706903, DOI 10.1017/CB09781107706903]; Hayes A. F., 2012, PROCESS VERSATILE CO; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; IPCC Climate Change, 2014, IPCC 5 ASS SYNTH REP; Johnson BB, 2018, PUBLIC UNDERST SCI, V27, P594, DOI 10.1177/0963662517706451; Jose P. E., 2013, DOING STAT MEDIATION; Kahan D, 2017, JCOM-J SCI COMMUN, V16; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kobayashi K, 2018, SCI COMMUN, V40, P63, DOI 10.1177/1075547017748948; Koehler DJ, 2016, J EXP PSYCHOL-APPL, V22, P24, DOI 10.1037/xap0000073; Kruglanski AW, 2005, HANDBOOK OF ATTITUDES, P323; Lang JT, 2016, WHATS SO CONTROVERSI; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; Leining C., 2015, FACT ACT NZ BELIEFS; Lewandowsky S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075637; Lewandowsky S, 2013, NAT CLIM CHANGE, V3, P399, DOI [10.1038/nclimate1720, 10.1038/NCLIMATE1720]; Maibach E, 2014, EARTHS FUTURE, V2, P295, DOI 10.1002/2013EF000226; Maibach EW, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/9/091003; McCright AM, 2013, CLIMATIC CHANGE, V119, P511, DOI 10.1007/s10584-013-0704-9; McFadden BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166140; Milfont TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174246; Myers TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120985; National Academies of Sciences Engineering and Medicine, 2017, COMMUNICATING SCI EF, DOI [10.17226/23674, DOI 10.17226/23674]; National Academies of Sciences Engineering and Medicine, 2016, GENETICALLY ENG CROP; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; O'Rourke HP, 2015, BEHAV RES METHODS, V47, P424, DOI 10.3758/s13428-014-0481-z; Oreskes N, 2010, MERCHANTS DOUBT; Pearce W, 2017, ENVIRON COMMUN, V11, P723, DOI 10.1080/17524032.2017.1333965; Petty R.E., 1986, COMMUN PERSUATION, P123; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Poulter S., 2013, DAILY MAIL; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Schwarz N., 2016, BEHAV SCI POLICY, V2, P85, DOI DOI 10.1353/BSP.2016.0009; Sjoberg L, 2004, EMBO REP, V5, pS47, DOI 10.1038/sj.embor.7400258; The Meningitis Foundation Aotearoa New Zealand, 2013, IMM HLTH REP; Tranter B, 2015, GLOBAL ENVIRON CHANG, V33, P154, DOI 10.1016/j.gloenvcha.2015.05.003; van der Linden S, 2017, JCOM-J SCI COMMUN, V16; van der Linden S, 2018, NAT HUM BEHAV, V2, P2, DOI 10.1038/s41562-017-0259-2; van der Linden S, 2017, GLOB CHALL, V1, DOI 10.1002/gch2.201600008; van der Linden S, 2015, PERS INDIV DIFFER, V87, P171, DOI 10.1016/j.paid.2015.07.045; van der Linden SL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2541-4; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; van der Linden SL, 2014, CLIMATIC CHANGE, V126, P255, DOI 10.1007/s10584-014-1190-4; Weaver K, 2007, J PERS SOC PSYCHOL, V92, P821, DOI 10.1037/0022-3514.92.5.821; Wilson MS, 2015, ANN C INT SOC POL PS	73	32	32	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200295	10.1371/journal.pone.0200295	http://dx.doi.org/10.1371/journal.pone.0200295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979762	gold, Green Published			2022-12-26	WOS:000437809500093
J	Lee, SM; Park, KH; Jung, EY; Kook, SY; Park, H; Jeon, SJ				Lee, Seung Mi; Park, Kyo Hoon; Jung, Eun Young; Kook, Song Yi; Park, Hyunsoo; Jeon, Se Jeong			Inflammatory proteins in maternal plasma, cervicovaginal and amniotic fluids as predictors of intra-amniotic infection in preterm premature rupture of membranes	PLOS ONE			English	Article							INTRAUTERINE INFECTION; MICROBIAL INVASION; MULTIPLE PROTEINS; WOMEN; INTERLEUKIN-6; SECRETIONS; PLACENTA; LESIONS; CAVITY; SERUM	Objective We aimed to assess the correlations among multiple cytokine concentrations in the maternal plasma, cervicovaginal fluid (CVF), and amniotic fluid (AF) compartments in women with preterm premature rupture of membranes (pPROM), and to develop a prediction model based on non-invasive measures, having better sensitivity and specificity for the identification of microbial invasion of amniotic cavity (MIAC). Method This retrospective study included 75 consecutive women with pPROM (20+0-34+0 weeks), who underwent amniocentesis. Both maternal plasma and CVF samples were collected at the time of amniocentesis. Stored AF, plasma and CVF samples were assayed for cytokine levels [interleukin (IL)-6, IL-8, monocyte chemotactic protein-1, macrophage inflammatory protein (MIP)-1 alpha, MIP-1 beta] using a multiplex immunoassay kit. Results Levels of inflammatory proteins measured in the CVF were significantly correlated with AF proteins levels, whereas none of the proteins in plasma correlated significantly with any in the AF or CVF. Proteins levels measured in the AF and CVF were significantly higher in women with MIAC compared to those without, whereas only high levels of IL-6 in plasma were significantly associated with MIAC. By using stepwise regression analysis, a non-invasive model (using clinical factors and CVF cytokine levels) for the prediction of MIAC was developed; the area under curve of this non-invasive model was similar to that of the invasive model (using clinical factors and AF cytokines). Conclusions The levels of inflammatory proteins in the CVF correlated with those in the AF, whereas those in the plasma showed no correlation. A non-invasive model using clinical factors and CVF cytokine levels predicted the risk of MIAC in women with pPROM.	[Lee, Seung Mi; Park, Kyo Hoon; Jung, Eun Young; Kook, Song Yi; Park, Hyunsoo; Jeon, Se Jeong] Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Lee, Seung Mi] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Kyo Hoon; Jung, Eun Young; Kook, Song Yi; Park, Hyunsoo; Jeon, Se Jeong] Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Dept Obstet & Gynecol, Bundang Hosp, Seongnam, South Korea.	pkh0419@snubh.org			Seoul National University Bundang Hospital Research Fund [13-2015-007]; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Seoul National University Bundang Hospital Research Fund; Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by the Seoul National University Bundang Hospital Research Fund (grant no. 13-2015-007), and by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. HI 14C1798).	Berger A, 2009, J PERINAT MED, V37, P72, DOI 10.1515/JPM.2009.016; Cobo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085277; Cobo T, 2013, ACTA OBSTET GYN SCAN, V92, P61, DOI 10.1111/aogs.12028; Combs CA, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.02.007; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; GIBBS RS, 1982, J INFECT DIS, V145, P1, DOI 10.1093/infdis/145.1.1; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Holst RM, 2011, BJOG-INT J OBSTET GY, V118, P240, DOI 10.1111/j.1471-0528.2010.02765.x; Jun JK, 2000, AM J OBSTET GYNECOL, V183, P868, DOI 10.1067/mob.2000.109034; Jung EY, 2017, REPROD SCI, V24, P142, DOI 10.1177/1933719116651149; Kacerovsky M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105882; KALTREIDER D F, 1980, Clinical Obstetrics and Gynecology, V23, P17, DOI 10.1097/00003081-198003000-00005; Kayem G, 2005, AM J OBSTET GYNECOL, V192, P140, DOI 10.1016/j.ajog.2004.07.015; Kim SA, 2016, YONSEI MED J, V57, P461, DOI 10.3349/ymj.2016.57.2.461; Lee SY, 2013, J KOREAN MED SCI, V28, P1226, DOI 10.3346/jkms.2013.28.8.1226; Leekha S, 2011, MAYO CLIN PROC, V86, P156, DOI 10.4065/mcp.2010.0639; Locatelli A, 2006, EUR J OBSTET GYN R B, V128, P97, DOI 10.1016/j.ejogrb.2006.02.003; Oh KJ, 2011, PLACENTA, V32, P732, DOI 10.1016/j.placenta.2011.07.080; Park KH, 2012, J PERINAT MED, V40, P151, DOI 10.1515/JPM.2011.124; Rizzo G, 1998, GYNECOL OBSTET INVES, V46, P91, DOI 10.1159/000010009; ROMERO R, 1993, AM J OBSTET GYNECOL, V169, P839, DOI 10.1016/0002-9378(93)90014-A; Ryu A, 2013, ACTA OBSTET GYN SCAN, V92, P517, DOI 10.1111/aogs.12073; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; YOON BH, 1995, AM J OBSTET GYNECOL, V172, P960, DOI 10.1016/0002-9378(95)90028-4	25	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200311	10.1371/journal.pone.0200311	http://dx.doi.org/10.1371/journal.pone.0200311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979758	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500095
J	Inoue, M; Matsuoka, H; Lesage, F; Harada, K				Inoue, Masumi; Matsuoka, Hidetada; Lesage, Florian; Harada, Keita			Lack of p11 expression facilitates acidity-sensing function of TASK1 channels in mouse adrenal medullary cells	FASEB JOURNAL			English	Article						chromaffin cell; trafficking; ER exit; K channel; pH	RECTIFYING K+ CHANNELS; POTASSIUM CHANNELS; CHROMAFFIN CELLS; CATECHOLAMINE SECRETION; MUSCARINIC RECEPTOR; BK CHANNELS; STIMULATION; INHIBITION; APAMIN; TASK-1/TASK-3	External acidity induces catecholamine secretion by inhibiting TASK1-like channels in rat adrenal medullary (AM) cells. TASK channels can function as a heteromer or homomer in the TASK subfamily. In this study, we elucidate the molecular identity of TASK1-like channels in mouse AM cells using gene knockout. Genetic deletion of TASK1, but not TASK3, abolished the depolarizing inward current and catecholamine secretion in response to acidity, whereas it did not affect the resting current level. Immunocytochemistry revealed that AM cells exhibited predominantly TASK1-like and little TASK3-like immunoreactivity. A proximity ligation assay showed that TASK1/3 heteromeric channels were not formed in AM cells or PC12 cells. However, the exogenous expression of p11 in PC12 cells resulted in the heteromeric formation of TASK isoforms, which were mainly located in the cytoplasm, and p11 was not expressed in rat adrenal medullae or PC12 cells. In AM cells, genetic deletion of TASK1 resulted in enhancement of the immunoreactivity of the TALK2 channel, but not TASK3. The results indicate that TASK1 homomeric channels function as acidity sensors in AM cells, and that function is facilitated by the lack of p11 expression.Inoue, M., Matsuoka, H., Lesage, F., Harada, K. Lack of p11 expression facilitates acidity-sensing function of TASK1 channels in mouse adrenal medullary cells.	[Inoue, Masumi; Matsuoka, Hidetada; Harada, Keita] Univ Occupat & Environm Hlth, Sch Med, Dept Cell & Syst Physiol, Kitakyushu, Fukuoka, Japan; [Lesage, Florian] Univ Cote Azur, Lab Excellence Ion Channel Sci & Therapeut LabEx, Inst Pharmacol Mol & Cellulaire, CNRS,INSERM, Valbonne, France	University of Occupational & Environmental Health - Japan; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Inoue, M (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Cell & Syst Physiol, Yahatanishi Ku, 1-1 Isseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	minoue@med.uoeh-u.ac.jp	Lesage, Florian/P-9780-2019; Lesage, Florian/D-5097-2011	Lesage, Florian/0000-0002-4406-7106; Lesage, Florian/0000-0002-4406-7106	Salt Science Foundation; Japan Society for the Promotion of Science [17K08555, 26460306]	Salt Science Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported, in part, by a grant from the Salt Science Foundation (to M.I.), and the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI; 17K08555 to M.I. and 26460306 to H.M.). The authors are grateful to Dr. W. Wisden for the generous gift of TASK1-KO and TASK3-KO mice, and to Dr. D. A. Bayliss (University of Virginia, Charlottesville, VA, USA) for that of GFP-TASK1 and GFP-TASK3 constructs. Thanks are also due to Dr. J. H. Steinbach (Washington University, St. Louis, MO, USA) for critically reading an early version of the manuscript. The authors declare no conflicts of interest.	Aller MI, 2005, J NEUROSCI, V25, P11455, DOI 10.1523/JNEUROSCI.3153-05.2005; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; Bournaud R, 2007, PFLUG ARCH EUR J PHY, V454, P83, DOI 10.1007/s00424-006-0185-z; BRANDT BL, 1976, J PHYSIOL-LONDON, V263, P417, DOI 10.1113/jphysiol.1976.sp011638; Brickley SG, 2007, J NEUROSCI, V27, P9329, DOI 10.1523/JNEUROSCI.1427-07.2007; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; CLAUSEN T, 1993, J PHYSIOL-LONDON, V472, P521, DOI 10.1113/jphysiol.1993.sp019960; CRYER PE, 1980, NEW ENGL J MED, V303, P436; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Feliciangeli S, 2015, J PHYSIOL-LONDON, V593, P2587, DOI 10.1113/jphysiol.2014.287268; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Guarina L, 2017, J PHYSIOL-LONDON, V595, P2587, DOI 10.1113/JP273735; Harada K, 2018, CELL TISSUE RES, V372, P457, DOI 10.1007/s00441-018-2809-y; Harada K, 2015, BRIT J PHARMACOL, V172, P1348, DOI 10.1111/bph.13011; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Inoue M, 2000, J PHYSIOL-LONDON, V528, P473, DOI 10.1111/j.1469-7793.2000.00473.x; INOUE M, 1995, BRIT J PHARMACOL, V114, P419, DOI 10.1111/j.1476-5381.1995.tb13243.x; Inoue M, 1997, AM J PHYSIOL-CELL PH, V273, pC137, DOI 10.1152/ajpcell.1997.273.1.C137; INOUE M, 1993, AM J PHYSIOL, V265, pC946, DOI 10.1152/ajpcell.1993.265.4.C946; Inoue M, 2018, PFLUG ARCH EUR J PHY, V470, P29, DOI 10.1007/s00424-017-2047-2; Inoue M, 2012, AM J PHYSIOL-CELL PH, V303, pC635, DOI 10.1152/ajpcell.00147.2012; Inoue M, 2008, J NEUROCHEM, V106, P1804, DOI 10.1111/j.1471-4159.2008.05521.x; Inoue S, 2017, FASEB J, V31; Ishii TM, 1997, J BIOL CHEM, V272, P23195, DOI 10.1074/jbc.272.37.23195; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kilisch M, 2015, PFLUG ARCH EUR J PHY, V467, P1105, DOI 10.1007/s00424-014-1672-2; Kim D, 2009, J PHYSIOL-LONDON, V587, P2963, DOI 10.1113/jphysiol.2009.171181; Lee J, 2000, PFLUG ARCH EUR J PHY, V439, P700, DOI 10.1007/s004240050995; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Lotshaw DP, 2007, CELL BIOCHEM BIOPHYS, V47, P209, DOI 10.1007/s12013-007-0007-8; Marcantoni A, 2010, J NEUROSCI, V30, P491, DOI 10.1523/JNEUROSCI.4961-09.2010; MASIAKOWSKI P, 1988, P NATL ACAD SCI USA, V85, P1277, DOI 10.1073/pnas.85.4.1277; Matsuoka H, 2017, J PHYSIOL-LONDON, V595, P6851, DOI 10.1113/JP275039; Matsuoka H, 2013, PFLUG ARCH EUR J PHY, V465, P1051, DOI 10.1007/s00424-013-1222-3; MEDBO JI, 1990, J PHYSIOL-LONDON, V421, P105, DOI 10.1113/jphysiol.1990.sp017935; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MONTIEL C, 1995, J PHYSIOL-LONDON, V486, P427, DOI 10.1113/jphysiol.1995.sp020823; Nagayama T, 2000, AM J PHYSIOL-REG I, V279, pR448, DOI 10.1152/ajpregu.2000.279.2.R448; NEELY A, 1992, J PHYSIOL-LONDON, V453, P97, DOI 10.1113/jphysiol.1992.sp019220; Renigunta V, 2006, TRAFFIC, V7, P168, DOI 10.1111/j.1600-0854.2005.00375.x; Rinne S, 2015, J MOL CELL CARDIOL, V81, P71, DOI 10.1016/j.yjmcc.2015.01.017; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOLARO CR, 1995, J NEUROSCI, V15, P6110; Streit AK, 2011, J BIOL CHEM, V286, P13977, DOI 10.1074/jbc.M111.227884; Suzuki Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186252; Thompson RJ, 1998, J PHYSIOL-LONDON, V512, P421, DOI 10.1111/j.1469-7793.1998.421be.x	51	7	8	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					455	468		10.1096/fj.201800407RR	http://dx.doi.org/10.1096/fj.201800407RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30001168	Bronze			2022-12-26	WOS:000457401500036
J	Li, N; Kong, M; Zeng, S; Hao, CZ; Li, M; Li, LY; Xu, Z; Zhu, M; Xu, Y				Li, Nan; Kong, Ming; Zeng, Sheng; Hao, Chenzhi; Li, Min; Li, Luyang; Xu, Zheng; Zhu, Min; Xu, Yong			Brahma related gene 1 (Brg1) contributes to liver regeneration by epigenetically activating the Wnt/-catenin pathway in mice	FASEB JOURNAL			English	Article						transcriptional regulation; epigenetics; Wnt signaling; chromatin remodeling protein; histone demethylase	TRANSCRIPTION FACTOR; BETA-CATENIN; C-MYC; SWI/SNF; CELLS; BRM; COMPLEXES; FIBROSIS; REQUIRES; PLAYS	Liver regeneration is a complicated pathophysiologic process that is regulated by a myriad of signaling pathways and transcription factors. The interaction among these pathways and factors, either cooperatively or antagonistically, may ultimately lead to recovery and restoration of liver function or permanent loss of liver function and liver failure. In the present study, we investigated the mechanism whereby the chromatin remodeling protein brahma related gene 1 (Brg1) regulates liver regeneration in mice. The Smarca4-Flox strain of mice was crossbred with the Alb-Cre strain to generate hepatocyte-specific Brg1 knockout mice. Liver injury was induced by partial hepatectomy (PHx). We report that Brg1 deletion in hepatocyte compromised liver regeneration and dampened survival after PHx in mice. Brg1 interacted with -catenin to potentiate Wnt signaling and promote hepatocyte proliferation. Mechanistically, Brg1 recruited lysine demethylase 4 (KDM4) to activate -catenin target genes. Our data suggest that Brg1 might play an essential role maintaining hepatic homeostasis and contributing to liver repair.Li, N., Kong, M., Zeng, S., Hao, C., Li, M., Li, L., Xu, Z., Zhu, M., Xu, Y. Brahma related gene 1 (Brg1) contributes to liver regeneration by epigenetically activating the Wnt/-catenin pathway in mice.	[Li, Nan; Kong, Ming; Zeng, Sheng; Hao, Chenzhi; Li, Min; Li, Luyang; Xu, Zheng; Xu, Yong] Nanjing Med Univ, Dept Pathophysiol, Key Lab Targeted Intervent Cardiovasc Dis, Collaborat Ctr Cardiovasc Translat Med, Nanjing, Jiangsu, Peoples R China; [Zhu, Min] Nanjing Med Univ, Dept Anat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zhu, M; Xu, Y (corresponding author), Nanjing Med Univ, 101 Longmian Ave, Nanjing 211166, Jiangsu, Peoples R China.	zhumin@njmu.edu.cn; yjxu@njmu.edu.cn			Natural Science Foundation of China [81725001, 81670223, 81401864]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grants 81725001, 81670223, and 81401864). The authors declare no conflicts of interest.	Berry WL, 2014, INT J ONCOL, V44, P1341, DOI 10.3892/ijo.2014.2279; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Endo M, 2013, LIVER INT, V33, P105, DOI 10.1111/liv.12005; Fan ZW, 2017, HEPATOLOGY, V65, P1904, DOI 10.1002/hep.29127; Fan ZW, 2015, BBA-GENE REGUL MECH, V1849, P1219, DOI 10.1016/j.bbagrm.2015.07.013; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Griffin CT, 2008, DEVELOPMENT, V135, P493, DOI 10.1242/dev.010090; Griffin CT, 2011, P NATL ACAD SCI USA, V108, P2282, DOI 10.1073/pnas.1013751108; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Itoh T, 2016, HEPATOLOGY, V64, P663, DOI 10.1002/hep.28661; Kaufmann B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180225; Kleger A, 2012, GASTROENTEROLOGY, V142, P907, DOI 10.1053/j.gastro.2012.01.004; Malouf GG, 2015, EPIGENETICS-US, V10, P872, DOI 10.1080/15592294.2015.1076955; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Oike T, 2013, JPN J CLIN ONCOL, V43, P849, DOI 10.1093/jjco/hyt101; Pedersen MT, 2016, EMBO J, V35, P1550, DOI 10.15252/embj.201593317; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sinha S, 2016, DNA CELL BIOL, V35, P373, DOI 10.1089/dna.2015.3155; Soeda J, 2014, HEPATOLOGY, V60, P1023, DOI 10.1002/hep.27266; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Stravitz RT, 2009, NAT REV GASTRO HEPAT, V6, P542, DOI 10.1038/nrgastro.2009.127; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Tian WF, 2016, INT J BIOCHEM CELL B, V71, P35, DOI 10.1016/j.biocel.2015.12.005; Tian WF, 2013, HEPATOLOGY, V58, P576, DOI 10.1002/hep.26207; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Weng XY, 2015, J MOL CELL CARDIOL, V82, P48, DOI 10.1016/j.yjmcc.2015.02.010; Wiley MM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001972; Willis MS, 2017, J MOL CELL CARDIOL, V105, P99, DOI 10.1016/j.yjmcc.2017.02.003; Wu JI, 2012, ACTA BIOCH BIOPH SIN, V44, P54, DOI 10.1093/abbs/gmr099; Xu HH, 2015, J AM SOC NEPHROL, V26, P1648, DOI 10.1681/ASN.2014070678; Xu Yong, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P141; Yamamoto S, 2013, CARCINOGENESIS, V34, P2380, DOI 10.1093/carcin/bgt174; Yang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14941; ZHONG R, 2014, SCI REP UK, V4; Zhou BS, 2016, BBA-MOL BASIS DIS, V1862, P1203, DOI 10.1016/j.bbadis.2016.02.002	36	40	39	4	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					327	338		10.1096/fj.201800197R	http://dx.doi.org/10.1096/fj.201800197R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30001167				2022-12-26	WOS:000457401500027
J	Ma, XL; Liu, K; Li, J; Li, HH; Li, J; Liu, YF; Yang, CL; Liang, HH				Ma, Xinli; Liu, Kai; Li, Jian; Li, Huanhuan; Li, Jun; Liu, Yingfang; Yang, Chonglin; Liang, Huanhuan			A non-canonical GTPase interaction enables ORP1L-Rab7-RILP complex formation and late endosome positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; trafficking; crystal structure; protein-protein interaction; GTPase; protein complex; cholesterol; ORP1L; Rab7; RILP; trafficking	RAB7 EFFECTOR; PROTEIN RILP; RECRUITMENT; BINDING; ORP1L; RAB7-RILP-P150(GLUED); TRANSPORT; BIOLOGY	Endosomal transport represents the primary mode for intracellular trafficking and signaling transduction and thus has to be tightly controlled. The molecular processes controlling the endosomal positioning utilize several large protein complexes, one of which contains the small GTPase Rab7, Rab-interacting lysosomal protein (RILP), and oxysterol-binding protein-related protein 1 (ORP1L). Rab7 is known to interact with RILP through a canonical binding site termed the effector-interacting switch region, but it is not clear how Rab7 interacts with ORP1L, limiting our understanding of the overall process. Here, we report structural and biochemical investigation of the Rab7-ORP1L interaction. We found that, contrary to prior studies, the interaction between Rab7 and the N-terminal ankyrin repeat domain (ARD(N)) of ORP1L is independent of Rab7's GTP- or GDP-binding state. Moreover, we show that Rab7 interacts with ORP1L ARD(N) via a unique region consisting of helix3 (3) and 3(10)-helix 2 (2). This architecture leaves the canonical effector-interacting switch regions available for RILP binding and thus allows formation of the ORP1L-Rab7-RILP tripartite complex. Mutational disruption of the interacting interface between ORP1L and Rab7 compromised the ability of ORP1L-Rab7-RILP to regulate the late endosome positioning. Collectively, our results again manifested the versatility in the interaction between GTPase and its effector.	[Ma, Xinli; Li, Jian; Li, Huanhuan; Li, Jun; Liu, Yingfang; Liang, Huanhuan] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Liu, Kai; Yang, Chonglin] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China; [Ma, Xinli; Liu, Kai; Li, Huanhuan] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China; [Liu, Kai; Yang, Chonglin] Yunnan Univ, State Key Lab Utilizat & Conservat Bioresources Y, Kunming 650500, Yunnan, Peoples R China; [Liu, Kai; Yang, Chonglin] Yunnan Univ, Life Sci Ctr, Kunming 650500, Yunnan, Peoples R China; [Liu, Kai; Yang, Chonglin] Yunnan Univ, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China; [Liu, Yingfang] Sun Yat Sen Univ, Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Liang, Huanhuan] Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Yunnan University; Yunnan University; Yunnan University; Sun Yat Sen University; Sun Yat Sen University	Liang, HH (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.; Yang, CL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Yang, CL (corresponding author), Yunnan Univ, State Key Lab Utilizat & Conservat Bioresources Y, Kunming 650500, Yunnan, Peoples R China.; Yang, CL (corresponding author), Yunnan Univ, Life Sci Ctr, Kunming 650500, Yunnan, Peoples R China.; Yang, CL (corresponding author), Yunnan Univ, Sch Life Sci, Kunming 650500, Yunnan, Peoples R China.; Liang, HH (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci Shenzhen, Guangzhou 510275, Guangdong, Peoples R China.	clyang@ynu.edu.cn; lianghh26@mail.sysu.edu.cn		Liu, Kai/0000-0002-8014-2310	National Natural Science Foundation of China [31530015, 31470744, 31000331]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31530015, 31470744, and 31000331. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Burke JE, 2014, SCIENCE, V344, P1035, DOI 10.1126/science.1253397; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Clark BS, 2011, DEV DYNAM, V240, P2452, DOI 10.1002/dvdy.22758; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hesketh GG, 2014, DEV CELL, V29, P591, DOI 10.1016/j.devcel.2014.04.010; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan AR, 2013, STRUCTURE, V21, P1284, DOI 10.1016/j.str.2013.06.016; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee MTG, 2009, TRAFFIC, V10, P1377, DOI 10.1111/j.1600-0854.2009.00942.x; Liu K, 2017, J CELL BIOL, V216, P3307, DOI 10.1083/jcb.201705151; Liu K, 2016, J CELL BIOL, V212, P181, DOI 10.1083/jcb.201506081; Mahmood T, 2012, N AM J MED SCI, V4, P429, DOI 10.4103/1947-2714.100998; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Vetter M, 2015, NAT STRUCT MOL BIOL, V22, P695, DOI 10.1038/nsmb.3065; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643	35	13	13	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14155	14164		10.1074/jbc.RA118.001854	http://dx.doi.org/10.1074/jbc.RA118.001854			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30012887	Green Published, hybrid			2022-12-26	WOS:000444070700036
J	Loyd, AL; Barnes, CW; Held, BW; Schink, MJ; Smith, ME; Smith, JA; Blanchette, RA				Loyd, A. L.; Barnes, C. W.; Held, B. W.; Schink, M. J.; Smith, M. E.; Smith, J. A.; Blanchette, R. A.			Elucidating "lucidum": Distinguishing the diverse laccate Ganoderma species of the United States	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; OIL PALM; IDENTIFICATION; MORPHOLOGY; TAXONOMY; CULTURES; MUSHROOMS; SEQUENCES; BONINENSE; NUCLEAR	Ganoderma is a large, diverse and globally-distributed genus in the Basidiomycota that includes species causing a white rot form of wood decay on a variety of tree species. For the past century, many studies of Ganoderma in North America and other regions of the world have used the name G. lucidum sensu lato for any laccate (shiny or varnished) Ganoderma species growing on hardwood trees or substrates. Molecular studies have established that G. lucidum sensu stricto (Curtis) Karst is native to Europe and some parts of China. To determine the species of the laccate Ganoderma that are present in the United States, we studied over 500 collections from recently collected samples and herbarium specimens from hardwoods, conifers, and monocots. A multilocus phylogeny using ITS, tef1 alpha, rpbl and rpb2 revealed three well-supported clades, similar to previously reported findings. From the U.S. collections, thirteen taxa representing twelve species were identified, including: G. curtisii, G. lucidum sensu stricto, G. martinicense, G. oregonense, G. polychromum, G. ravenelii, G. sessile, G. tsugae, G. tuberculosum, G. cf. weberianum, G. zonatum, and Tomophagus colossus (syn. G. colossus). The species G. meredithiae is synonymized with G. curtisii, and considered a physiological variant that specializes in decay of pines. The designation G. curtisii f.sp. meredithiae forma special is nov. is proposed. Species such as G. curtisii and G. sessile, once considered as G. lucidum sensu lato, were found to be divergent from one another, and highly divergent from G. lucidum sensu stricto. Morphological characteristics such as context tissue color and features (e.g. melanoid bands), basidiospore shape and size, geographic location, and host preference were found to aid in species identification. Surprisingly, G. lucidum sensu stricto was found in the U.S., but only in geographically restricted areas of northern Utah and California. These collections appear to have resulted from the introduction of this species into the United States possibly from mushroom growers producing G. lucidum outdoors. Overall, this study clarifies the chaotic taxonomy of the laccate Ganoderma in the United States, and will help to remove ambiguities from future studies focusing on the North American species of laccate Ganoderma.	[Loyd, A. L.; Smith, J. A.] Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA; [Loyd, A. L.] FA Bartlett Tree Experts Co, Charlotte, NC 28278 USA; [Barnes, C. W.] INAP, Dept Nacl Protect Vegetal, Quito, Ecuador; [Held, B. W.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Smith, M. E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida	Loyd, AL (corresponding author), Univ Florida, Sch Forest Resources & Conservat, Gainesville, FL 32611 USA.; Loyd, AL (corresponding author), FA Bartlett Tree Experts Co, Charlotte, NC 28278 USA.	aloyd@bartlett.com	Smith, Matthew E/A-8115-2012; Smith, Matthew E./ABC-3015-2020; Barnes, Charles W/AAC-8968-2022	Smith, Matthew E/0000-0002-0878-0932; Smith, Matthew E./0000-0002-0878-0932; Barnes, Charles W/0000-0001-5708-9091; Loyd, Andrew/0000-0002-6463-2635; Schink, Matthew/0000-0001-6660-6054; Blanchette, Robert A./0000-0003-2819-6511	F.A. Bartlett Tree Experts Company; International Society of Arboriculture-Florida Chapter; USDA National Institute of Food and Agriculture, Hatch [0022081]; Institute of Food and Agriculture Sciences at the University of Florida; National Institute of Food and Agriculture, USDA [FLAPLP-005289]; Mycological Society of America	F.A. Bartlett Tree Experts Company; International Society of Arboriculture-Florida Chapter; USDA National Institute of Food and Agriculture, Hatch; Institute of Food and Agriculture Sciences at the University of Florida; National Institute of Food and Agriculture, USDA(United States Department of Agriculture (USDA)); Mycological Society of America	This project was funded in part by the F.A. Bartlett Tree Experts Company and a research grant from the International Society of Arboriculture-Florida Chapter and was also supported in part by the USDA National Institute of Food and Agriculture, Hatch project 0022081. Matthew E. Smith's involvement in this project was made possible by the support of the Institute of Food and Agriculture Sciences at the University of Florida and by a grant from the National Institute of Food and Agriculture, USDA, under the grant #FLAPLP-005289. Finally, the herbarium studies were made possible by the Clark T. Rogerson research award from the Mycological Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The first author Andrew Loyd is employed by the F.A. Bartlett Tree Experts Company. F.A. Bartlett Tree Experts Company provided support in the form of salary for author AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ADASKAVEG JE, 1986, MYCOLOGIA, V78, P694, DOI 10.2307/3807513; ADASKAVEG JE, 1988, MYCOTAXON, V31, P251; ADASKAVEG JE, 1988, MYCOLOGIA, V80, P493, DOI 10.2307/3807851; Adaskaveg JE, 1986, THESIS; Anderson JB, 1980, EXPT MYCOLOGY, V4, P78, DOI DOI 10.1016/0147-5975({80)90053-5; [Anonymous], MYCOLOGIA; Atkinson GF, 1908, BOT GAZ, V46, P321, DOI 10.1086/329751; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BAZZALO ME, 1982, MYCOTAXON, V16, P293; Binder M, 2010, MYCOLOGIA, V102, P865, DOI 10.3852/09-288; Bivi MR, 2010, INT J AGRIC BIOL, V12, P833; Blanchette RA, 2016, FUNGAL ECOL, V23, P58, DOI 10.1016/j.funeco.2016.06.001; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cao Y, 2012, FUNGAL DIVERS, V56, P49, DOI 10.1007/s13225-012-0178-5; Elliott M. L., 2001, Palms, V45, P62; Elliott ML, 2018, MYCOLOGIA; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gazis R, 2011, MOL ECOL, V20, P3001, DOI 10.1111/j.1365-294X.2011.05110.x; Gilbertson R. L., 1986, North American polypores. Vol. I. Abortiporus-Lindtneria.; Torres-Torres MG, 2012, MYCOTAXON, V121, P93, DOI 10.5248/121.93; Gottlieb AM, 1999, MYCOL RES, V103, P661, DOI 10.1017/S0953756298007941; Gottlieb AM, 2000, MYCOL RES, V104, P1033, DOI 10.1017/S095375620000304X; HADDOW W. R., 1931, JOUR ARNOLD ARBORETUM, V12, P25; Hennicke F, 2016, PHYTOCHEMISTRY, V127, P29, DOI 10.1016/j.phytochem.2016.03.012; Hong SG, 2004, MYCOLOGIA, V96, P742, DOI 10.2307/3762108; Johnson B., 2017, NPDN NEWS; Karsten P.A., 1881, REV MYCOL TOULOUSE, V3, P16; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Loyd AL, 2018, FUNGAL BIOL-UK, V122, P254, DOI 10.1016/j.funbio.2018.01.006; MARX DH, 1976, CAN J MICROBIOL, V22, P338, DOI 10.1139/m76-051; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Matheny PB, 2002, AM J BOT, V89, P688, DOI 10.3732/ajb.89.4.688; McNeill J, 2012, INT CODE NOMENCLATUR; Moncalvo JM, 1995, MYCOL RES, V99, P1489, DOI 10.1016/S0953-7562(09)80798-3; Murrill WA., 1915, TROPICAL POLYPORES; Murrill WA, 1908, N AM FLORA, V9, P73; Murrill WA, 1902, B TORREY BOT CLUB, V29, P599, DOI DOI 10.2307/2478682; Murrill WA, 1922, MYCOLOGIA, V14, P332; NOBLES MK, 1948, CAN J RES C, V26, P281, DOI 10.1139/cjr48c-026; NOBLES MK, 1965, CAN J BOTANY, V43, P1097, DOI 10.1139/b65-126; Overholts LO, 1915, ANN MISSOURI BOTAN, V2, P667; Patouillard NT, 1889, BULL SOC MYCOL FR, V5, P64; Petersen RH, 1999, BIOSCIENCE, V49, P440, DOI 10.2307/1313552; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Ridgway R., 1912, COLOR STANDARDS COLO, DOI [10.3732/ajb.89.4.688, DOI 10.3732/AJB.89.4.688]; Ryvarden L, 2000, MYCOLOGIA, V92, P180, DOI 10.2307/3761462; Ryvarden L, 1991, SYNOP FUNGORUM, V5, P1; SARIAH M, 1994, PLANT PATHOL, V43, P507, DOI 10.1111/j.1365-3059.1994.tb01584.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEYAERT R L, 1980, Bulletin du Jardin Botanique National de Belgique, V50, P135, DOI 10.2307/3667780; Steyaert RL, 1972, PERSOONIA, V7, P55; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Torres-Torres Mabel Gisela, 2015, Rev. Mex. Mic, V41, P27; Wang DM, 2009, BOT STUD, V50, P451; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Welti S, 2010, FUNGAL DIVERS, V43, P103, DOI 10.1007/s13225-010-0036-2; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Le XT, 2012, MYCOL PROG, V11, P775, DOI 10.1007/s11557-011-0789-3; Zhou LW, 2015, PHYTOCHEMISTRY, V114, P7, DOI 10.1016/j.phytochem.2014.09.023	61	30	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199738	10.1371/journal.pone.0199738	http://dx.doi.org/10.1371/journal.pone.0199738			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020945	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400026
J	Chikkerur, J; Samanta, AK; Dhali, A; Kolte, AP; Roy, S; Maria, P				Chikkerur, Jayaram; Samanta, Ashis Kumar; Dhali, Arindam; Kolte, Atul Purushottam; Roy, Sohini; Maria, Pratheepa			In Silico evaluation and identification of fungi capable of producing endo-inulinase enzyme	PLOS ONE			English	Article							AIDED DRUG DESIGN; EXTRACELLULAR INULINASE; ASPERGILLUS-NIGER; SWISS-MODEL; MOLECULAR-CLONING; PROTEIN-STRUCTURE; PENICILLIUM-SUBRUBESCENS; 3-DIMENSIONAL STRUCTURES; MICROBIAL INULINASES; DIETARY MODULATION	The enzyme endo-inulinase hydrolyzes inulin to short chain fructooligosaccharides (FOS) that are potential prebiotics with many health promoting benefits. Although the raw materials for inulin production are inexpensive and readily available, commercial production of FOS from inulin is limited due to inadequate availability of the enzyme source. This study aimed to identify the fungi capable of producing endo-inulinase based on the in silico analysis of proteins retrieved from non-redundant protein sequence database. The endo-inulinase of Aspergillus ficuum was used as reference sequence. The amino acid sequences with >90% sequence coverage, belonging to different fungi were retrieved from the database and used for constructing three-dimensional (3D) protein models using SWISS-MODEL and Bagheerath H. The 3D models of comparable quality as that of the reference endo-inulinase were selected based on QMEAN Z score. The selected models were evaluated and validated for different structural and functional qualities using Pro-Q, ProSA, PSN-QA, VERIFY-3D, PROCHECK, PROTSAV metaserver, STRAP, molecular docking, and molecular dynamic simulation analyses. A total of 230 proteins belonging to 53 fungal species exhibited sequence coverage >90%. Sixty one protein sequences with >60% sequence identity were modeled as endo-inulinase with higher QMEAN Z Score. The evaluations and validations of these 61 selected models for different structural and functional qualities revealed that 60 models belonging to 22 fungal species exhibited native like structure and unique motifs and residues as that of the reference endo-inulinase. Further, these models also exhibited similar kind of interaction between the active site around the conserved glutamate residue and substrate as that of the reference endo-inulinase. In conclusion, based on the current study, 22 fungal species could be identified as endo-inulinase producer. Nevertheless, further biological assessment of their capability for producing endo-inulinase is imminent if they are to be used for commercial endo-inulinase production for application in FOS industry.	[Chikkerur, Jayaram; Samanta, Ashis Kumar; Kolte, Atul Purushottam; Roy, Sohini] ICAR Natl Inst Anim Nutr & Physiol, Anim Nutr Div, Bengaluru, Karnataka, India; [Chikkerur, Jayaram; Roy, Sohini] Jain Univ, Sch Sci, Dept Microbiol, Bengaluru, Karnataka, India; [Dhali, Arindam] ICAR Natl Inst Anim Nutr & Physiol, Bioenerget & Environm Sci Div, Bengaluru, Karnataka, India; [Maria, Pratheepa] ICAR Natl Bur Agr Insect Resources, Div Genom Resources, Bengaluru, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Jain University; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Animal Nutrition & Physiology; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Agricultural Insect Resources	Chikkerur, J (corresponding author), ICAR Natl Inst Anim Nutr & Physiol, Anim Nutr Div, Bengaluru, Karnataka, India.; Chikkerur, J (corresponding author), Jain Univ, Sch Sci, Dept Microbiol, Bengaluru, Karnataka, India.	ram.c.c80@gmail.com	Samanta, Ashis Kumar/AAE-6920-2019; nianp, Library/AAA-6956-2021; Chikkerur, Jayaram/ABI-5147-2020	Samanta, Ashis Kumar/0000-0003-1646-294X; M, Pratheepa/0000-0001-9129-1672; Roy, Sohini/0000-0001-6195-1262; Chikkerur, Jayaram/0000-0001-8575-7632	Council of Scientific and Industrial Research (CSIR); Ministry of Science and Technology, Government of India [09/1158(0002)2K17]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Science and Technology, Government of India(Ministry of Science and Technology, Government of India)	The authors gratefully acknowledge the Council of Scientific and Industrial Research (CSIR); (Sanctioned File No. 09/1158(0002)2K17), Ministry of Science and Technology, Government of India for the senior research fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the Council of Scientific and Industrial Research (CSIR); (Sanctioned File No. 09/1158(0002)2K17), Ministry of Science and Technology, Government of India for the senior research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors gratefully acknowledge the Director, ICAR-NBAIR, Bengaluru-560024 for providing the High Performance Super Computing facility under "Network Project on Agricultural Bioinformatics and Computational Biology" to carry out the molecular dynamic simulations.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Akimoto H, 2000, BIOSCI BIOTECH BIOCH, V64, P2328, DOI 10.1271/bbb.64.2328; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bonciu CN, 2012, LETT APPL MICROBIOL, V55, P195, DOI 10.1111/j.1472-765X.2012.03279.x; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Cogan DA, 2008, BIOORG MED CHEM LETT, V18, P3251, DOI 10.1016/j.bmcl.2008.04.043; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Flores AC, 2016, CRIT REV FOOD SCI, V56, P1893, DOI 10.1080/10408398.2013.807220; Flores-Gallegos AC, 2015, J BIOSCI BIOENG, V119, P421, DOI 10.1016/j.jbiosc.2014.09.020; Fructooligosaccharides (FOS), 2016, GRAND VIEW RES; Ghosh Soma, 2014, F1000Res, V3, P17, DOI 10.12688/f1000research.3-17.v1; Gibson GR, 1999, J NUTR, V129, p1438S, DOI 10.1093/jn/129.7.1438S; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gill PK, 2006, BIORESOURCE TECHNOL, V97, P355, DOI 10.1016/j.biortech.2005.02.038; Gille C, 2014, NUCLEIC ACIDS RES, V42, pW3, DOI 10.1093/nar/gku400; Goswami GK, 2015, BIOMED DATA MIN, V4, P112, DOI DOI 10.4172/2090-4924.1000112; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JACKSON RC, 1995, CURR OPIN BIOTECH, V6, P646, DOI 10.1016/0958-1669(95)80106-5; Jayaram B, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S7; Kango N, 2011, FOOD BIOTECHNOL, V25, P165, DOI 10.1080/08905436.2011.590763; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu GL, 2013, CRIT REV MICROBIOL, V39, P152, DOI 10.3109/1040841X.2012.694411; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mansouri S, 2013, ANTON LEEUW INT J G, V103, P1343, DOI 10.1007/s10482-013-9915-3; Martonak R, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.075503; Miao YZ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1658-2; Monsan P.F., 2009, PREBIOTICS PROBIOTIC, P293; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mutanda T, 2008, ENZYME MICROB TECH, V43, P362, DOI 10.1016/j.enzmictec.2008.06.005; Mutanda T, 2014, J IND MICROBIOL BIOT, V41, P893, DOI 10.1007/s10295-014-1452-1; Nakamura T, 1997, J FERMENT BIOENG, V84, P313, DOI 10.1016/S0922-338X(97)89250-1; Nguyen QD, 2013, FOOD TECHNOL BIOTECH, V51, P36; Ohta K, 2002, J BIOSCI BIOENG, V94, P78, DOI [10.1263/jbb.94.78, 10.1016/S1389-1723(02)80120-7]; Ohta K, 1998, BIOSCI BIOTECH BIOCH, V62, P1731, DOI 10.1271/bbb.62.1731; ONODERA S, 1988, AGR BIOL CHEM TOKYO, V52, P2569, DOI 10.1080/00021369.1988.10869080; Onodera S, 1996, BIOSCI BIOTECH BIOCH, V60, P1780, DOI 10.1271/bbb.60.1780; Pandey A, 1999, APPL BIOCHEM BIOTECH, V81, P35, DOI 10.1385/ABAB:81:1:35; Park H, 2008, J MOL MODEL, V14, P833, DOI 10.1007/s00894-008-0311-2; Peng M, 2017, J BIOTECHNOL, V246, P1, DOI 10.1016/j.jbiotec.2017.02.012; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pouyez J, 2012, BIOCHIMIE, V94, P2423, DOI 10.1016/j.biochi.2012.06.020; Rastall RA, 2015, CURR OPIN BIOTECH, V32, P42, DOI 10.1016/j.copbio.2014.11.002; Rawat HK, 2015, ANTON LEEUW INT J G, V107, P799, DOI 10.1007/s10482-014-0373-3; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Singh A, 2016, BBA-PROTEINS PROTEOM, V1864, P11, DOI 10.1016/j.bbapap.2015.10.004; Singh RS, 2016, INT J BIOL MACROMOL, V85, P565, DOI 10.1016/j.ijbiomac.2016.01.026; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Skowronek M, 2006, FOOD TECHNOL BIOTECH, V44, P53; Taft CA, 2008, J PHARM SCI-US, V97, P1089, DOI 10.1002/jps.21293; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Veselovsky A. V., 2003, Current Drug Targets - Infectious Disorders, V3, P33, DOI 10.2174/1568005033342145; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; XIAO R, 1989, J FERMENT BIOENG, V67, P244, DOI 10.1016/0922-338X(89)90226-2; Xu YB, 2016, J AGR FOOD CHEM, V64, P2612, DOI 10.1021/acs.jafc.5b05908; Yuan XL, 2006, MICROBIOL-SGM, V152, P3061, DOI 10.1099/mic.0.29051-0	68	4	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200607	10.1371/journal.pone.0200607	http://dx.doi.org/10.1371/journal.pone.0200607			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001376	Green Submitted, gold, Green Published			2022-12-26	WOS:000438457400087
J	Nyambura, LW; Jarmalavicius, S; Walden, P				Nyambura, Lydon Wainaina; Jarmalavicius, Saulius; Walden, Peter			Impact of Leishmania donovani infection on the HLA I self peptide repertoire of human macrophages	PLOS ONE			English	Article							HISTOCOMPATIBILITY COMPLEX I; THP-1 CELLS; MULTIPLE-SCLEROSIS; NITRIC-OXIDE; MECHANISMS; PROTEASOME; PREDICTION; INDUCTION; MOLECULES; PARASITES	Macrophages are specialized antigen-presenting cells that process and present self-antigens for induction of tolerance, and foreign antigens to initiate T cell-mediated immunity. Despite this, Leishmania donovani (LD) are able to parasitize the macrophages and persist. The impact of this parasitizing and persistence on antigen processing and presentation by macrophages remains poorly defined. To gain insight into this, we analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) and compared the HLA-I self-peptidomes, proteasome compositions, HLA expression and activation states of non-infected and LD-infected THP1-derived macrophages. We found that, though both HLA-I peptidomes were dominated by nonapeptides, they were heterogeneous and individualized, with differences in HLA binding affinities and anchor residues. Non-infected and LD-infected THP1 -derived macrophages were able to sample peptides from source proteins of almost all subcellular locations and involved in various cellular functions, but in different proportions. In the infected macrophages, there was increased sampling of plasma membrane and extracellular proteins, and those involved in immune responses, cell communication/ signal transduction and metabolism/energy pathways, and decreased sampling of nuclear and cytoplasmic proteins and those involved in protein metabolism, RNA binding and cell growth and/or maintenance. Though the activation state of infected macrophages was unchanged, their proteasome composition was altered.	[Nyambura, Lydon Wainaina; Jarmalavicius, Saulius; Walden, Peter] Charite Univ Med Berlin, Berlin, Germany; [Nyambura, Lydon Wainaina; Jarmalavicius, Saulius; Walden, Peter] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Nyambura, Lydon Wainaina; Jarmalavicius, Saulius; Walden, Peter] Berlin Inst Hlth, Dept Dermatol Venerol & Allergol, Clin Res Grp Tumor Immunol, Berlin, Germany; [Nyambura, Lydon Wainaina] Humboldt Univ, Lebenswissensch Fak, Inst Biol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Humboldt University of Berlin	Walden, P (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Walden, P (corresponding author), Humboldt Univ, Freie Univ Berlin, Berlin, Germany.; Walden, P (corresponding author), Berlin Inst Hlth, Dept Dermatol Venerol & Allergol, Clin Res Grp Tumor Immunol, Berlin, Germany.	peter.walden@charite.de		Walden, Peter/0000-0002-8986-3667; Nyambura, Lydon/0000-0003-2197-6048	Deutscher Akademischer Austauschdienst (DAAD); German Research Foundation (DFG); Open Access Publication Fund of Charite-Universitatsmedizin Berlin	Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of Charite-Universitatsmedizin Berlin	This work was supported by Deutscher Akademischer Austauschdienst (DAAD); German Research Foundation (DFG) and a Open Access Publication Fund of Charite-Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Biswas D, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-35; Bogdan C, 1999, PARASITOL TODAY, V15, P22, DOI 10.1016/S0169-4758(98)01362-3; Boucau J, 2018, MOL IMMUNOLOGY; Carrera L, 1996, J EXP MED, V183, P515, DOI 10.1084/jem.183.2.515; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Das A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005150; De Almeida MC, 2003, INT J PARASITOL, V33, P153, DOI 10.1016/S0020-7519(02)00266-7; de Verteuil D, 2010, MOL CELL PROTEOMICS, V9, P2034, DOI 10.1074/mcp.M900566-MCP200; Demine R, 2004, RAPID COMMUN MASS SP, V18, P907, DOI 10.1002/rcm.1420; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Desjeux P, 2001, T ROY SOC TROP MED H, V95, P239, DOI 10.1016/S0035-9203(01)90223-8; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869; Ebstein F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24032; Faria LO, 2008, EXP PARASITOL, V120, P261, DOI 10.1016/j.exppara.2008.08.003; Fissolo N, 2009, MOL CELL PROTEOMICS, V8, P2090, DOI 10.1074/mcp.M900001-MCP200; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Forget G, 2001, EUR J IMMUNOL, V31, P3185, DOI 10.1002/1521-4141(200111)31:11&lt;3185::AID-IMMU3185&gt;3.0.CO;2-J; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Jarmalavicius S, 2012, J BIOL CHEM, V287, P33401, DOI 10.1074/jbc.M112.358903; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Monge-Maillo B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003021; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; Niedermann G, 1996, P NATL ACAD SCI USA, V93, P8572, DOI 10.1073/pnas.93.16.8572; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nyambura LW, 2016, J IMMUNOL, V197, P2102, DOI 10.4049/jimmunol.1600762; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Prilliman KR, 1999, J IMMUNOL, V162, P7277; Pritchard Antonia L, 2015, Pigment Cell Melanoma Res, V28, P281, DOI 10.1111/pcmr.12357; PROUDFOOT L, 1995, EUR J IMMUNOL, V25, P745, DOI 10.1002/eji.1830250318; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; REINER NE, 1988, P NATL ACAD SCI USA, V85, P4330, DOI 10.1073/pnas.85.12.4330; REINER NE, 1987, J IMMUNOL, V138, P1919; Riedhammer C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00322; Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002; Rose SJ, 2014, INFECT IMMUN, V82, P405, DOI 10.1128/IAI.00820-13; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Schellens IMM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136417; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Singh AK, 2015, INFECT IMMUN, V83, P1853, DOI 10.1128/IAI.02833-14; Singh S, 2014, INT J INFECT DIS, V29, P103, DOI 10.1016/j.ijid.2014.07.011; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028	53	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200297	10.1371/journal.pone.0200297	http://dx.doi.org/10.1371/journal.pone.0200297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001391	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400043
J	Samano, R; Chico-Barba, G; Martinez-Rojano, H; Godinez, E; Rodriguez-Ventura, AL; Avila-Koury, G; Aguilar-Sanchez, K				Samano, Reyna; Chico-Barba, Gabriela; Martinez-Rojano, Hugo; Godinez, Estela; Lilia Rodriguez-Ventura, Ana; Avila-Koury, Gabriela; Aguilar-Sanchez, Karen			Pre-pregnancy body mass index classification and gestational weight gain on neonatal outcomes in adolescent mothers: A follow-up study	PLOS ONE			English	Article							PRETERM BIRTH; PREGNANCY; OBESITY; RATES; WOMEN	Introduction: Institute of Medicine gestational weight gain recommendations are based on body mass index (BMI) status using adult cut-off points for women of all ages, even though adolescents have specific criteria, like WHO and CDC, so adolescents can receive inadequate weight gain recommendations. Objectives: To estimate the proportion of classification disparity between the three criteria (WHO, CDC and IOM) of pre-pregnancy BMI status; and to analyze neonatal outcomes according to weight gain recommendation based on prepregnancy BMI using the three criteria. Methods: Follow-up study in pregnant adolescents 12-19 years. Sociodemographic, anthropometric and pregnancy data were obtained. Percentage of pre-pregnancy BMI classification disparity was calculated between three criteria. Gestational weight gain was categorized in adequate, low and high according to IOM. Regression models were used to analyze negative neonatal outcomes. Results: 601 pregnant adolescents were included, mean age was 16 +/- 1.4 years. For pre-pregnancy BMI classification, 28.5% had classification disparity using IOM vs WHO, and 14% when comparing IOM vs CDC. Greater classification disparity was observed as BMI increased. When using WHO categories, a high weight gain was associated with increased risk of having a low birth weight baby (OR: 1.91, CI95%: 1.03-3.53). For CDC criteria, a low weight gain was associated with increased risk of having a preterm baby (OR: 2.65; CI95%: 1.16-6.08) and a high weight gain was associated with low birth weight (OR: 2.10; CI95%: 1.10-4.01). For IOM criteria, a weight gain either low or high were associated with increased risk of low birth weight and preterm birth. Conclusion: There is pre-pregnancy BMI classification disparity using criteria for adolescents compared to adult criteria. Nevertheless, with WHO and CDC only a high gestational weight gain was a risk for negative neonatal outcome. It is important to have a BMI classification system for adolescents that better predicts neonatal outcomes.	[Samano, Reyna; Chico-Barba, Gabriela; Godinez, Estela; Lilia Rodriguez-Ventura, Ana] Inst Nacl Perinatol Isidro Espinosa de Los Reyes, Dept Nutr & Bioprogramac, Ciudad De Mexico, Mexico; [Chico-Barba, Gabriela] Univ Panamer, Fac Ciencias Salud, Escuela Enfermeria, Ciudad De Mexico, Mexico; [Martinez-Rojano, Hugo] Inst Politecn Nacl, Escuela Super Med, Secc Posgrad & Invest, Ciudad De Mexico, Mexico; [Martinez-Rojano, Hugo] Inst Diagnost & Referencia Epidemiol Manuel Marti, Coordinac Med Laboral, Ciudad De Mexico, Mexico; [Avila-Koury, Gabriela] Univ Iberoamer, Licenciatura Nutr & Ciencias Alimentos, Ciudad De Mexico, Mexico; [Aguilar-Sanchez, Karen] Inst Mexicano Seguro Social, Tlaxcala, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Iberoamericana Ciudad de Mexico; Instituto Mexicano del Seguro Social	Chico-Barba, G (corresponding author), Inst Nacl Perinatol Isidro Espinosa de Los Reyes, Dept Nutr & Bioprogramac, Ciudad De Mexico, Mexico.; Chico-Barba, G (corresponding author), Univ Panamer, Fac Ciencias Salud, Escuela Enfermeria, Ciudad De Mexico, Mexico.	gabyc3@gmail.com	Sámano, Reyna/AAU-7514-2020	Sámano, Reyna/0000-0001-5490-1363; Chico-Barba, Gabriela/0000-0002-5741-0241; Godinez-Martinez, Estela/0000-0002-8940-1729	Instituto Nacional de Perinatologoia [212250-49481]	Instituto Nacional de Perinatologoia	The Instituto Nacional de Perinatologoia (212250-49481) funded the study.	[Anonymous], 2006, CHILD GROWTH STANDAR; Arceo-Gomez Eva O, 2014, Lat. Am. J. Econ., V51, P109, DOI 10.7764/LAJE.51.1.109; Amaral JDA, 2015, MATERN CHILD NUTR, V11, P305, DOI 10.1111/mcn.12016; Bajos N, 2010, BMJ-BRIT MED J, V341, P84; Barros Denise Cavalcante de, 2014, Rev. bras. epidemiol., V17, P761, DOI 10.1590/1809-4503201400030015; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Blanquet-Garcia Jaime, 2016, Rev Med Inst Mex Seguro Soc, V54 Suppl 3, pS238; Boguszewski MCS, 2012, REV CHIL PEDIATR-CHI, V83, P620, DOI 10.4067/S0370-41062012000600014; de Castro F, 2013, SALUD PUBLICA MEXICO, V55, pS267; Fernandez ID, 2008, J AM DIET ASSOC, V108, P998, DOI 10.1016/j.jada.2008.03.012; Huerta SF, 2012, B MED HOSP INFANT M, V69, P30; Gordon L P., 2017, CLIN OBSTET GYNECOL, V3, P1; Groth SW, 2013, JOGNN-J OBST GYN NEO, V42, P541, DOI 10.1111/1552-6909.12230; Harper LM, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.053; Headen IE, 2012, ADV NUTR, V3, P83, DOI 10.3945/an.111.000984; Houde M, 2015, J PEDIATR ADOL GYNEC, V28, P502, DOI 10.1016/j.jpag.2015.03.003; Instituto Nacional de Estadistica y Geografia, 2016, EST PROP INT JUV; Jonas K, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0170-8; Kawakita T, 2016, J PEDIATR ADOL GYNEC, V29, P130, DOI 10.1016/j.jpag.2015.08.006; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Lohman T, 1988, HUMAN KINETICS; Martinez EZ, 2011, CAD SAUDE PUBLICA, V27, P855, DOI 10.1590/S0102-311X2011000500004; Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120; Matthews A, 2009, IMPLEMENTING GUIDELI; Minjares-Granillo RO, 2016, J PEDIATR ADOL GYNEC, V29, P304, DOI 10.1016/j.jpag.2015.11.005; Moll U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168543; Oviedo Cruz H, 2005, GINECOL OBS MEX, V73, P365; Pongcharoen T, 2016, ASIA PAC J CLIN NUTR, V25, P810, DOI 10.6133/apjcn.092015.41; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Taiwo A. A., 2014, African Journal of Biomedical Research, V17, P159; Tokmakidis SP, 2007, J ADOLESCENT HEALTH, V40, P305, DOI 10.1016/j.jadohealth.2006.10.001; Vivatkusol Y, 2017, INT J WOMENS HEALTH, V9, P347, DOI 10.2147/IJWH.S128941; Xiao LL, 2017, SCI REP-UK, V7, DOI 10.1038/srep41073	35	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200361	10.1371/journal.pone.0200361	http://dx.doi.org/10.1371/journal.pone.0200361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001386	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400050
J	Singh, JA; Cleveland, JD				Singh, Jasvinder A.; Cleveland, John D.			Gout and the risk of age-related macular degeneration in the elderly	PLOS ONE			English	Article							OXIDATIVE STRESS; EYE DISEASE; CARDIOVASCULAR-DISEASE; URIC-ACID; INFLAMMATION; PATHOGENESIS; HYPERTENSION; MACULOPATHY; ATHEROSCLEROSIS; ANTIOXIDANTS	Objective To assess whether gout is associated with incident age-related macular degeneration (AMD). Methods We used the 5% Medicare claims data from 2006-12 for all beneficiaries who were enrolled in Medicare fee-for-service (Parts A, B) and not enrolled in a Medicare Advantage Plan, and resided in the U.S. People were censored at the occurrence of new diagnosis of AMD, death or the end of study (12/31/2012), whichever occurred first. We used multivariable-adjusted Cox regression analyses to assess the association of gout with incident AMD, adjusted for demographics, comorbidity, and use of medications for cardiovascular disease and gout. Hazard ratios and 95% confidence intervals were calculated. Results In this observational cohort study, of the 1,684,314 eligible people, 116,097 developed incident AMD (6.9%). Incidence rates of AMD per 1,000 person-years were 20.1 for people with gout and 11.7 for people without gout. In multivariable-adjusted analyses, a diagnosis of gout was significantly associated with a higher risk of incident AMD with a hazard ratio of 1.39 (95% CI, 1.35, 1.43). This association was confirmed in sensitivity analyses that substituted Charlson-Romano comorbidity index continuous score with either a categorical Charlson-Romano comorbidity index score or individual Charlson-Romano index comorbidities plus hypertension, hyperlipidemia and coronary artery disease. Other covariates significantly associated with higher hazards of incident AMD were older age, female gender, White race/ethnicity, and higher Charlson-Romano comorbidity index score. Conclusions We noted a novel association of gout with AMD in the elderly. Future studies should investigate the pathways that mediate this association.	[Singh, Jasvinder A.] VA Med Ctr, Med Serv, Birmingham, AL 35233 USA; [Singh, Jasvinder A.; Cleveland, John D.] UAB, Dept Med, Sch Med, Birmingham, AL 35294 USA; [Singh, Jasvinder A.] UAB, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Singh, JA (corresponding author), VA Med Ctr, Med Serv, Birmingham, AL 35233 USA.; Singh, JA (corresponding author), UAB, Dept Med, Sch Med, Birmingham, AL 35294 USA.; Singh, JA (corresponding author), UAB, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.	Jasvinder.md@gmail.com	Singh, Jasvinder/R-6172-2019	Singh, Jasvinder/0000-0003-3485-0006	Division of Rheumatology at the University of Alabama at Birmingham	Division of Rheumatology at the University of Alabama at Birmingham	This material is the result of work supported by research funds from the Division of Rheumatology at the University of Alabama at Birmingham and the resources and use of facilities at the Birmingham VA Medical Center, Birmingham, Alabama, USA to JAS. The funding body did not play any role in design, in the collection, analysis, and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Anand R, 2000, OPHTHALMOLOGY, V107, P2224; [Anonymous], 2015, FACTS AG REL MAC DEG; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Beltowski J, 2005, TOXICOL MECH METHOD, V15, P61, DOI 10.1080/15376520590918766; Berry SD, 2010, J AM GERIATR SOC, V58, P783, DOI 10.1111/j.1532-5415.2010.02767.x; Betteridge DJ, 2000, METABOLISM, V49, P3, DOI 10.1016/S0026-0495(00)80077-3; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Bressler Neil M, 2004, JAMA, V291, P1900, DOI 10.1001/jama.291.15.1900; Bressler NM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1621; Buch H, 2005, OPHTHALMOLOGY, V112, P305, DOI 10.1016/j.ophtha.2004.08.025; Chaine G, 1998, BRIT J OPHTHALMOL, V82, P996, DOI 10.1136/bjo.82.9.996; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clemons TE, 2004, ARCH OPHTHALMOL-CHIC, V122, P716; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Curcio CA, 2017, JAMA OPHTHALMOL, V135, P843, DOI 10.1001/jamaophthalmol.2017.2008; Danulescu R, 2013, MED-SURG J, V117, P328; Doherty M, 2009, RHEUMATOLOGY, V48, P2, DOI 10.1093/rheumatology/kep086; Fauser S, 2015, ACTA OPHTHALMOL, V93, P734, DOI 10.1111/aos.12770; George J, 2006, CIRCULATION, V114, P2508, DOI 10.1161/CIRCULATIONAHA.106.651117; George Jacob, 2009, Ther Clin Risk Manag, V5, P799; George J, 2009, VASC HEALTH RISK MAN, V5, P265, DOI 10.2147/VHRM.S4265; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hyman L, 2000, ARCH OPHTHALMOL-CHIC, V118, P351, DOI 10.1001/archopht.118.3.351; Kalayoglu MV, 2007, CLIN EXP OPHTHALMOL, V35, P3, DOI 10.1111/j.1442-9071.2007.01432.x; Kanda A, 2008, BRIT J OPHTHALMOL, V92, P448, DOI 10.1136/bjo.2007.131581; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Katsi VK, 2015, J HYPERTENS, V33, P2382, DOI 10.1097/HJH.0000000000000766; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Keenan TDL, 2015, RETINA-J RET VIT DIS, V35, P2613, DOI 10.1097/IAE.0000000000000651; Kim SK, 2016, INFLAMMATION, V39, P473, DOI 10.1007/s10753-015-0271-5; KLEIN R, 1993, OPHTHALMOLOGY, V100, P406; Klein R, 2008, OPHTHALMOLOGY, V115, P1742, DOI 10.1016/j.ophtha.2008.03.021; Klein R, 2014, JAMA OPHTHALMOL, V132, P446, DOI 10.1001/jamaophthalmol.2013.7671; Krishnan E, 2010, RHEUMATOLOGY, V49, P1229, DOI 10.1093/rheumatology/keq037; Latkany Paul, 2010, J Ocul Biol Dis Infor, V3, P30, DOI 10.1007/s12177-010-9052-4; Liote Frederic, 2003, Curr Rheumatol Rep, V5, P227, DOI 10.1007/s11926-003-0072-y; Maguire MG, 1997, ARCH OPHTHALMOL-CHIC, V115, P741; Metelitsina TI, 2006, BRIT J OPHTHALMOL, V90, P342, DOI 10.1136/bjo.2005.082974; Moshfeghi DM, 2007, RETINA-J RET VIT DIS, V27, P269, DOI 10.1097/IAE.0b013e31802e3e9b; Neogi T, 2011, NEW ENGL J MED, V364, P443, DOI 10.1056/NEJMcp1001124; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Richer Stuart, 2004, Optometry, V75, P216, DOI 10.1016/S1529-1839(04)70049-4; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Shaw PX, 2016, AIMS MOL SCI, V3, P196, DOI 10.3934/molsci.2016.2.196; Singh JA, 2007, ARTHRIT RHEUM-ARTHR, V57, P822, DOI 10.1002/art.22767; Singh JA, 2015, JCR-J CLIN RHEUMATOL, V21, P225, DOI 10.1097/RHU.0000000000000246; Singh JA, 2014, J RHEUMATOL, V41, P615, DOI 10.3899/jrheum.131258; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Taylor H R, 2000, Trans Am Ophthalmol Soc, V98, P91; Taylor HR, 2000, T AM OPHTHAL SOC, V98, P6; Tokarz P, 2013, BIOGERONTOLOGY, V14, P461, DOI 10.1007/s10522-013-9463-2; U. S. Census Bureau, NAT POP PROJ 1 SUMM; VINGERLING JR, 1995, AM J EPIDEMIOL, V142, P404, DOI 10.1093/oxfordjournals.aje.a117648; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wortmann RL, 2002, CURR OPIN RHEUMATOL, V14, P281, DOI 10.1097/00002281-200205000-00015; Zamudio-Cuevas Y, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1012-3; Zhang JX, 2015, ENDOCRINE, V48, P135, DOI 10.1007/s12020-014-0239-5	60	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199562	10.1371/journal.pone.0199562	http://dx.doi.org/10.1371/journal.pone.0199562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001351	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400012
J	Gopinath, B; Liew, G; Craig, A; Pozzato, I; Meares, S; Burlutsky, G; Cameron, ID; Mitchell, P				Gopinath, Bamini; Liew, Gerald; Craig, Ashley; Pozzato, Ilaria; Meares, Susanne; Burlutsky, George; Cameron, Ian D.; Mitchell, Paul			Association between head injury and concussion with retinal vessel caliber	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; MICROVASCULAR NETWORK ALTERATIONS; RATE-VARIABILITY; SIGNS; ADULTS; RISK; VALIDATION; DIAMETERS; TOOL	The adverse long-term consequences following traumatic brain injury are poorly understood, particularly on the cerebral microvasculature. Retinal vessels are a surrogate marker of cerebral vascular changes. We therefore aimed to examine the cross-sectional association between serious head injury or being knocked unconscious, and/or concussion and retinal microvascular signs, specifically, mean retinal arteriolar and venular calibre, in older adults after accounting for potential confounders. This cohort study involved 2,624 adults with mean age of 66.9 (+/- 9.1) years who self-reported head injury and concussion parameters, and had gradable retinal photographs. Face-to-face interviews with trained interviewers allowed participants to report prior serious head injury or being knocked unconscious, and/or a previous diagnosis of concussion by a medical professional. Fundus photographs were taken and retinal vascular calibre measured using computer-assisted techniques and summarized. There were 25.9%, 15.3% and 10.1% who reported a prior serious head injury or being "knocked unconscious", concussion, and both, respectively. Participants in the first group compared to non-injured participants had significantly wider (similar to 2 mu m) mean retinal venular calibre (p = 0.02), after adjusting for age, sex, smoking, body mass index, mean arterial blood pressure, type 2 diabetes and fellow vessel calibre. No significant associations were observed in people reporting medically diagnosed concussion or with mean retinal arteriolar calibre. Our exploratory study suggests that head injury is independently associated with wider retinal venular caliber. These findings warrant further investigation in longitudinal cohort studies.	[Gopinath, Bamini; Liew, Gerald; Burlutsky, George; Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia; [Gopinath, Bamini; Liew, Gerald; Burlutsky, George; Mitchell, Paul] Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia; [Gopinath, Bamini; Craig, Ashley; Pozzato, Ilaria; Cameron, Ian D.] Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Med Sch, Kolling Med Res Inst, Sydney, NSW, Australia; [Meares, Susanne] Macquarie Univ, Dept Psychol, Sydney, NSW, Australia	University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Macquarie University	Gopinath, B (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Sydney, NSW, Australia.; Gopinath, B (corresponding author), Univ Sydney, Westmead Inst Med Res, Sydney, NSW, Australia.; Gopinath, B (corresponding author), Univ Sydney, John Walsh Ctr Rehabil Res, Sydney Med Sch, Kolling Med Res Inst, Sydney, NSW, Australia.	bamini.gopinath@sydney.edu.au	Gopinath, Bamini/K-4286-2019; Liew, Gerald/AAB-6870-2022	Gopinath, Bamini/0000-0003-3573-359X; Pozzato, Ilaria/0000-0002-8752-1460; Meares, Susanne/0000-0002-3859-9974	Australian National Health and Medical Research Council [974159, 991407, 211069, 262120]; HEARing CRC; Australian Government's Cooperative Research Centres Program; Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The Blue Mountains Eye and Hearing Studies were supported by the Australian National Health and Medical Research Council (Grant Nos. 974159, 991407, 211069, 262120) (PM). The authors also acknowledge financial support from the HEARing CRC, established and supported under the Australian Government's Cooperative Research Centres Program. IDC is funded by an Australian National Health and Medical Research Council Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung CYL, 2014, J STROKE CEREBROVASC, V23, P43, DOI 10.1016/j.jstrokecerebrovasdis.2012.09.002; Childs C, 2014, EUR J EMERG MED, V21, P388, DOI 10.1097/MEJ.0000000000000169; Conder RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00890; Debuc DC, 2017, AM J PHYSIOL-HEART C, V312, pH201, DOI 10.1152/ajpheart.00201.2016; Doubal FN, 2010, NEUROLOGY, V74, P1102, DOI 10.1212/WNL.0b013e3181d7d8b4; El Dabagh Y, 2017, INVEST OPHTH VIS SCI, V58, P5263, DOI 10.1167/iovs.17-22461; Erlanger DM, 2002, J HEAD TRAUMA REHAB, V17, P458, DOI 10.1097/00001199-200210000-00007; Foks KA, 2017, J NEUROTRAUM    1122, DOI DOI 10.1089/neu.2018.5979; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gopinath B, 2013, BRIT J NUTR, V110, P739, DOI 10.1017/S0007114512005491; Gopinath B, 2010, J HYPERTENS, V28, P1406, DOI 10.1097/HJH.0b013e3283395223; Gopinath B, 2009, AM J OPHTHALMOL, V148, P902, DOI 10.1016/j.ajo.2009.07.018; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Hilal S, 2014, NEUROSCI LETT, V577, P95, DOI 10.1016/j.neulet.2014.06.024; Ikram MK, 2010, AM J GERIAT PSYCHIAT, V18, P452, DOI 10.1097/JGP.0b013e3181d69250; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Ikram MK, 2010, PLOS GENET; Jennings JR, 2015, PSYCHOPHYSIOLOGY, V52, P214, DOI 10.1111/psyp.12319; Jensen RA, 2010, AM J EPIDEMIOL, V171, P522, DOI 10.1093/aje/kwp414; Kim DH, 2015, J AM GERIATR SOC, V63, P1886, DOI 10.1111/jgs.13594; Kim DH, 2011, STROKE, V42, P1589, DOI 10.1161/STROKEAHA.110.605261; Koval P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081536; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Liew G, 2011, REV ESP CARDIOL, V64, P515, DOI [10.1016/j.rec.2011.02.017, 10.1016/j.recesp.2011.02.014]; Mayer AR, 2017, NEUROLOGY, V89, P623, DOI 10.1212/WNL.0000000000004214; McGeechan K, 2009, AM J EPIDEMIOL, V170, P1323, DOI 10.1093/aje/kwp306; McGeechan K, 2009, ANN INTERN MED, V151, P404, DOI 10.7326/0003-4819-151-6-200909150-00005; Pozzato I, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016222; Rodrigues D, 2016, SPINAL CORD, V54, P292, DOI 10.1038/sc.2015.174; Shalev I, 2013, PSYCHOL SCI, V24, P1198, DOI 10.1177/0956797612470959; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; Wecht JM, 2013, J SPINAL CORD MED, V36, P74, DOI 10.1179/2045772312Y.0000000056; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wright S, 1934, ANN MATH STAT, V5, P161, DOI 10.1214/aoms/1177732676; Xing C, 2006, HYPERTENSION, V47, P797, DOI 10.1161/01.HYP.0000208330.68355.72; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200441	10.1371/journal.pone.0200441	http://dx.doi.org/10.1371/journal.pone.0200441			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM7QQ	29995951	gold, Green Submitted, Green Published			2022-12-26	WOS:000438388800066
J	Nan, YQ; Gao, YY				Nan, Yongqing; Gao, Yanyan			A machine learning method to monitor China's AIDS epidemics with data from Baidu trends	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; DISEASE	Background AIDS is a worrying public health issue in China and lacks timely and effective surveillance. With the diffusion and adoption of the Internet, the 'big data' aggregated from Internet search engines, which contain users' information on the concern or reality of their health status, provide a new opportunity for AIDS surveillance. This paper uses search engine data to monitor and forecast AIDS in China. Methods A machine learning method, artificial neural networks (ANNs), is used to forecast AIDS incidences and deaths. Search trend data related to AIDS from the largest Chinese search engine, Baidu. com, are collected and selected as the input variables of ANNs, and officially reported actual AIDS incidences and deaths are used as the output variable. Three criteria, the mean absolute percentage error, the root mean squared percentage error, and the index of agreement, are used to test the forecasting performance of the ANN method. Results Based on the monthly time series data from January 2011 to June 2017, this article finds that, under the three criteria, the ANN method can lead to satisfactory forecasting of AIDS incidences and deaths, regardless of the change in the number of search queries. Conclusions Despite the inability to self-detect HIV/AIDS through online searching, Internet-based data should be adopted as a timely, cost-effective complement to a traditional AIDS surveillance system.	[Nan, Yongqing; Gao, Yanyan] Southeast Univ, Sch Econ & Management, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Gao, YY (corresponding author), Southeast Univ, Sch Econ & Management, Nanjing, Jiangsu, Peoples R China.	yanyan_gao@seu.edu.cn	Gao, Yanyan/AAE-6607-2022; Gao, Yanyan/AAL-7187-2020	Gao, Yanyan/0000-0003-0326-504X; Gao, Yanyan/0000-0003-0326-504X	Key Project of China Social Science Foundation [15AJL004]; National Natural Science Foundation of China (CN) [71771052]; Youth project of MOE Humanity and Social Science Foundation (CN) [17YJC790040]; Basic Research Funds for China's Central Universities [2242017K40168]	Key Project of China Social Science Foundation; National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Youth project of MOE Humanity and Social Science Foundation (CN); Basic Research Funds for China's Central Universities	Funded by The Key Project of China Social Science Foundation, 15AJL004, Mr Yongqing Nan. National Natural Science Foundation of China (CN), 71771052, Dr Yanyan Gao. The Youth project of MOE Humanity and Social Science Foundation (CN), 17YJC790040, Dr Yanyan Gao. Basic Research Funds for China's Central Universities, 2242017K40168, Dr Yanyan Gao.	Brion GM, 2003, WATER SCI TECHNOL, V47, P235, DOI 10.2166/wst.2003.0201; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; CNNIC, 2015, STUD REP CHIN INT US; Dailey L, 2007, J AM MED INFORM ASSN, V14, P626, DOI 10.1197/jamia.M2328; Dickerson S, 2004, J AM MED INFORM ASSN, V11, P499, DOI 10.1197/jamia.M1460; Elliot AJ, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3403; Eysenbach G, 2006, AMIA, V244, P248; Fernando HJS, 2012, ENVIRON POLLUT, V163, P62, DOI 10.1016/j.envpol.2011.12.018; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gu YZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12649; Hecht-Nielsen R., 1987, IEEE First International Conference on Neural Networks, P11; Hecht-Nielsen R., 1989, NEURAL COMPUTERS, P445; Kang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079823; Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1145/44571.44572; Liu YF, 2010, INT J EPIDEMIOL, V39, pII90, DOI 10.1093/ije/dyq214; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Palmer A, 2006, TOURISM MANAGE, V27, P781, DOI 10.1016/j.tourman.2005.05.006; Pan B, 2012, J HOSP TOUR TECHNOL, V3, P196, DOI 10.1108/17579881211264486; Schmidt C. W., 2012, ENVIRON HEALTH PERSP, V120, pA31; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Tadeusiewicz R., 1995, CONTROL ENG PRACT, V3, P746, DOI DOI 10.1016/0967-0661(95)90080-2; Teng T, 2011, Adv Dent Res, V23, P10, DOI 10.1177/0022034511398871; Wilson K, 2009, CAN MED ASSOC J, V180, P829, DOI [10.1503/cmaj.090215, 10.1503/cmaj.1090215]; Witt S., 1992, MODELING FORECASTING; World Health Organisation, 2007, WHO CAS DEF HIV SURV; Yang Y, 2014, J TRAVEL RES, V53, P433, DOI 10.1177/0047287513500391; Yuan Luo, 2010, 2010 IEEE International Conference on Service Operations and Logistics and Informatics (SOLI 2010), P76, DOI 10.1109/SOLI.2010.5551614; Yuan QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064323; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0	30	13	13	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7								10.1371/journal.pone.0199697	http://dx.doi.org/10.1371/journal.pone.0199697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM7QQ	29995920	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800030
J	Graffmann, N; Ncube, A; Wruck, W; Adjaye, J				Graffmann, Nina; Ncube, Audrey; Wruck, Wasco; Adjaye, James			Cell fate decisions of human iPSC-derived bipotential hepatoblasts depend on cell density	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CHOLANGIOCYTE-LIKE CELLS; BILE-DUCT DEVELOPMENT; HEPATOCYTE-LIKE CELLS; DIRECTED DIFFERENTIATION; ALAGILLE-SYNDROME; LIVER DEVELOPMENT; BETA-CATENIN; STEM/PROGENITOR CELLS; HUMAN JAGGED1	During embryonic development bipotential hepatoblasts differentiate into hepatocytes and cholangiocytes- the two main cell types within the liver. Cell fate decision depends on elaborate interactions between distinct signalling pathways, namely Notch, WNT, TGF beta, and Hedgehog. Several in vitro protocols have been established to differentiate human pluripotent stem cells into either hepatocyte or cholangiocyte like cells (HLC/CLC) to enable disease modelling or drug screening. During HLC differentiation we observed the occurrence of epithelial cells with a phenotype divergent from the typical hepatic polygonal shape- we refer to these as endoderm derived epithelial cells (EDECs). These cells do not express the mature hepatocyte marker ALB or the progenitor marker AFP. However they express the cholangiocyte markers SOX9, OPN, CFTR as well as HNF4 alpha, CK18 and CK19. Interestingly, they express both E Cadherin and Vimentin, two markers that are mutually exclusive, except for cancer cells. EDECs grow spontaneously under low density cell culture conditions and their occurrence was unaffected by interfering with the above mentioned signalling pathways.	[Graffmann, Nina; Ncube, Audrey; Wruck, Wasco; Adjaye, James] Heinrich Heine Univ, Med Fac, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Adjaye, J (corresponding author), Heinrich Heine Univ, Med Fac, Inst Stem Cell Res & Regenerat Med, Dusseldorf, Germany.	James.Adjaye@med.uni-duesseldorf.de		Graffmann, Nina/0000-0002-1229-0792	Research commission of the Medical faculty of Heinrich Heine University Dusseldorf; Medical faculty of Heinrich Heine University Dusseldorf	Research commission of the Medical faculty of Heinrich Heine University Dusseldorf; Medical faculty of Heinrich Heine University Dusseldorf	N.G. acknowledges support from the Research commission of the Medical faculty of Heinrich Heine University Dusseldorf (www.medizin.hhu.de/dekanat/gremien-und-kommissionen/kommissionen/forschungskommission.html). J.A. acknowledges support from the Medical faculty of Heinrich Heine University Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript; Nina Graffmann acknowledges support from the Research commission of the Medical faculty of Heinrich Heine University Dusseldorf (http://www.medizin.hhu.de/dekanat/gremien-und-kommissionen/kommissionen/forschungskommission.html). James Adjaye acknowledges support from the Medical faculty of Heinrich Heine University Dusseldorf. We thank M. Bohndorf and S. Wehrmeyer for technical support.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Cameron K, 2015, STEM CELL REP, V5, P1250, DOI 10.1016/j.stemcr.2015.10.016; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Chaw SY, 2012, ORAL ONCOL, V48, P997, DOI 10.1016/j.oraloncology.2012.05.011; Cordi S, 2016, DIFFERENTIATION, V91, P42, DOI 10.1016/j.diff.2016.02.001; Dabeva MD, 2000, AM J PATHOL, V156, P2017, DOI 10.1016/S0002-9440(10)65074-2; Decaens T, 2008, HEPATOLOGY, V47, P247, DOI 10.1002/hep.21952; Dianat N, 2014, HEPATOLOGY, V60, P700, DOI 10.1002/hep.27165; Diehl AM, 1998, J BIOL CHEM, V273, P30843, DOI 10.1074/jbc.273.47.30843; Drews K, 2015, STEM CELL RES, V15, P712, DOI 10.1016/j.scr.2015.11.003; Fougere-Deschatrette C, 2006, STEM CELLS, V24, P2098, DOI 10.1634/stemcells.2006-0009; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Graffmann N, 2016, STEM CELLS DEV, V25, P1119, DOI 10.1089/scd.2015.0383; Hannan NRF, 2013, NAT PROTOC, V8, P430, DOI 10.1038/nprot.2012.153; Hussain SZ, 2004, EXP CELL RES, V292, P157, DOI 10.1016/j.yexcr.2003.08.020; Keitel V, 2013, CURR OPIN GASTROEN, V29, P299, DOI 10.1097/MOG.0b013e32835f3f14; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li ZY, 2009, J CLIN INVEST, V119, P1537, DOI 10.1172/JCI38201; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Ogawa M, 2015, NAT BIOTECHNOL, V33, P853, DOI 10.1038/nbt.3294; Omenetti A, 2011, CURR OPIN GASTROEN, V27, P268, DOI 10.1097/MOG.0b013e32834550b4; Ortica S, 2014, FASEB J, V28, P603, DOI 10.1096/fj.13-235903; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Sampaziotis F, 2017, NAT PROTOC, V12, P814, DOI 10.1038/nprot.2017.011; Sampaziotis F, 2015, NAT BIOTECHNOL, V33, P845, DOI 10.1038/nbt.3275; Seth A, 2014, DEVELOPMENT, V141, P538, DOI 10.1242/dev.099481; Siller R, 2015, STEM CELL REP, V4, P939, DOI 10.1016/j.stemcr.2015.04.001; Tan EH, 2007, CELL TISSUE RES, V330, P427, DOI 10.1007/s00441-007-0505-4; Tanimizu N, 2004, J CELL SCI, V117, P3165, DOI 10.1242/jcs.01169; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Wang Y, 2011, STEM CELL REV REP, V7, P331, DOI 10.1007/s12015-010-9209-3; Wilson AA, 2015, STEM CELL REP, V4, P873, DOI 10.1016/j.stemcr.2015.02.021; Wolfrum K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013703; Yamasaki H, 2006, DEVELOPMENT, V133, P4233, DOI 10.1242/dev.02591; Zong YW, 2011, INT J BIOCHEM CELL B, V43, P257, DOI 10.1016/j.biocel.2010.06.020; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	40	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200416	10.1371/journal.pone.0200416	http://dx.doi.org/10.1371/journal.pone.0200416			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990377	Green Submitted, gold, Green Published			2022-12-26	WOS:000438170300047
J	Kupfer, S; Winklhofer, S; Becker, AS; Distler, O; Chung, CB; Alkadhi, H; Finkenstaedt, T				Kupfer, Sivert; Winklhofer, Sebastian; Becker, Anton S.; Distler, Oliver; Chung, Christine B.; Alkadhi, Hatem; Finkenstaedt, Tim			Gouty arthritis: Can we avoid unnecessary dual-energy CT examinations using prior radiographs?	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; CRYSTAL-ARTHROPATHIES; TOPHACEOUS GOUT; DIAGNOSIS; IDENTIFICATION; EXTREMITIES; DEPOSITION; DISEASE; TOPHUS; JOINT	Objective The dual-energy CT (DECT) algorithm for urate detection is feasible only if hyperdense deposits are present. Based on our experience, around half of the performed DECT examinations show no such deposits and thus were useless for this indication. Our diagnostic accuracy study investigates whether conventional radiographs can serve as gatekeeper test prior to DECT for reliable exclusion of such radiopaque deposits. Materials and methods In this retrospective study, 77 clinically indicated DECT examinations of the hand (n = 29), foot (n = 36) and ankle (n = 12) of 55 patients (13 female, mean age 62 +/- 15 years) with suspected gouty arthritis were included. Two blinded readers independently evaluated DECT, gray-scale CT images (reference standard) and corresponding standardized radiographs for the presence/location of dense soft tissue deposits. Results Interreader agreement for detection of soft tissue deposits with DECT and radiographs was excellent (DECT: both readers, K = 1; radiographs: both readers, K = 0.94). DECT showed soft tissue deposits in 54/77 DECT (70%) scans. 30/54 scans (56%) showed deposits on the corresponding radiographs, while in 24 scans (44%) no deposits were seen on radiographs. Test performance of radiographs for soft tissue deposit detection: sensitivity 56%, specificity 100%, PPV 100%, NPV 48.9%, and accuracy 69%. Low density of the deposits was the main reasons for false-negative radiographs (19 cases, 79%), followed by superimposition of deposits by osseous structures (5 cases, 21%). Conclusion Conventional radiographs of the hand, foot and ankle cannot serve as a gatekeeper test for reliable exclusion of radiopaque soft tissue deposits prior to DECT.	[Kupfer, Sivert; Becker, Anton S.; Alkadhi, Hatem; Finkenstaedt, Tim] Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Winklhofer, Sebastian] Univ Zurich, Univ Hosp Zurich, Dept Neuroradiol, Zurich, Switzerland; [Distler, Oliver] Univ Zurich, Univ Hosp Zurich, Dept Rheumatol, Zurich, Switzerland; [Chung, Christine B.; Finkenstaedt, Tim] Univ Calif San Diego, Sch Med, Dept Radiol, San Diego, CA 92103 USA	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of California System; University of California San Diego	Finkenstaedt, T (corresponding author), Univ Zurich, Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland.; Finkenstaedt, T (corresponding author), Univ Calif San Diego, Sch Med, Dept Radiol, San Diego, CA 92103 USA.	tim.finkenstaedt@usz.ch	Winklhofer, Sebastian/AAB-8987-2022; Becker, Anton S./H-5416-2019; Distler, Oliver/AAE-6225-2019	Becker, Anton S./0000-0001-8372-6496; Distler, Oliver/0000-0002-0546-8310; Finkenstaedt, Tim/0000-0002-8807-7306				Abreu M, 2004, SKELETAL RADIOL, V33, P392, DOI 10.1007/s00256-004-0767-9; BARTHELEMY CR, 1984, SKELETAL RADIOL, V11, P1, DOI 10.1007/BF00361124; Bely M, 2016, STRUCTURAL CHEM; BLOCH C, 1980, AM J ROENTGENOL, V134, P781, DOI 10.2214/ajr.134.4.781; Bongartz T, 2015, ANN RHEUM DIS, V74, P1072, DOI 10.1136/annrheumdis-2013-205095; Chen J, 2017, Z RHEUMATOL, V76, P723, DOI 10.1007/s00393-016-0250-8; Cheng Jianguo, 2007, Tech Reg Anesth Pain Manag, V11, P141, DOI 10.1053/j.trap.2007.05.006; Choi HK, 2009, ANN RHEUM DIS, V68, P1609, DOI 10.1136/ard.2008.099713; Choi HK, 2012, ANN RHEUM DIS, V71, P1466, DOI 10.1136/annrheumdis-2011-200976; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Dalbeth N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0301-3; Dalbeth N, 2010, ARTHRITIS RHEUM-US, V62, P1549, DOI 10.1002/art.27356; Diekhoff T, 2018, INVEST RADIOL, V53, P6, DOI 10.1097/RLI.0000000000000402; Diekhoff T, 2015, INVEST RADIOL, V50, P255, DOI 10.1097/RLI.0000000000000099; DIEPPE PA, 1982, ANN RHEUM DIS, V41, P371, DOI 10.1136/ard.41.4.371; Finkenstaedt T, 2016, EUR RADIOL, V26, P3989, DOI 10.1007/s00330-016-4237-2; Gamala M, 2018, CLIN RHEUMATOL, V37, P1879, DOI 10.1007/s10067-018-3980-y; Gentili Amilcare, 2006, Curr Rheumatol Rep, V8, P231, DOI 10.1007/s11926-996-0030-6; Gerster JC, 2002, ANN RHEUM DIS, V61, P52, DOI 10.1136/ard.61.1.52; Gerster JC, 1996, ARTHRITIS RHEUM, V39, P1406, DOI 10.1002/art.1780390820; Girish G, 2013, ARTHRITIS, DOI 10.1155/2013/673401; Girish G, 2013, AM J ROENTGENOL, V201, P515, DOI 10.2214/AJR.13.10776; Glazebrook KN, 2011, RADIOLOGY, V261, P516, DOI 10.1148/radiol.11102485; Kiefer T, 2016, EUR J RADIOL, V85, P1829, DOI 10.1016/j.ejrad.2016.08.004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mallinson PI, 2014, SKELETAL RADIOL, V43, P277, DOI 10.1007/s00256-013-1771-8; Mallinson PI, 2014, AM J ROENTGENOL, V203, pW103, DOI 10.2214/AJR.13.11396; MARTEL W, 1981, RADIOLOGY, V141, P1; McQueen FM, 2014, RHEUM DIS CLIN N AM, V40, P231, DOI 10.1016/j.rdc.2014.01.004; Melzer R, 2014, SEMIN ARTHRITIS RHEU, V43, P662, DOI 10.1016/j.semarthrit.2013.11.002; Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237; Nicolaou S, 2010, AM J ROENTGENOL, V194, P1072, DOI 10.2214/AJR.09.2428; Pineda C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3223; RESNICK D, 1974, RADIOLOGY, V113, P633, DOI 10.1148/113.3.633; Sakellariou G, 2016, ANN RHEUM DIS, V75, P686, DOI 10.1136/annrheumdis-2016-eular.4747; Saltybaeva N, 2014, RADIOLOGY, V273, P153, DOI 10.1148/radiol.14132903; Schueller-Weidekamm C, 2007, EUR J RADIOL, V62, P437, DOI 10.1016/j.ejrad.2006.12.005; Segal JB, 1999, ARTHRIT CARE RES, V12, P376, DOI 10.1002/1529-0131(199912)12:6<376::AID-ART5>3.0.CO;2-5; Swan A, 2002, ANN RHEUM DIS, V61, P493, DOI 10.1136/ard.61.6.493; Thornton FJ, 2000, EUR J RADIOL, V36, P123, DOI 10.1016/S0720-048X(00)00214-X; Yin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095743	41	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200473	10.1371/journal.pone.0200473	http://dx.doi.org/10.1371/journal.pone.0200473			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990381	gold, Green Published			2022-12-26	WOS:000438170300053
J	Miettinen, HM; Gripentrog, JM; Lord, CI; Nagy, JO				Miettinen, Heini M.; Gripentrog, Jeannie M.; Lord, Connie I.; Nagy, Jon O.			CD177-mediated nanoparticle targeting of human and mouse neutrophils	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; C5A RECEPTOR ANTAGONIST; FORMYL PEPTIDE RECEPTOR; COMPLEMENT C5A; CARDIAC DYSFUNCTION; EXTRACELLULAR TRAPS; ANTIGEN NB1; C-TERMINUS; RAT MODEL; CD177	Neutrophils are the most abundant white blood cells, with a vital role in innate immune defense against bacterial and fungal pathogens. Although mostly associated with pathological processes directly related to immune defense, they can also play a detrimental role in inflammatory conditions and have been found to have a pro-metastatic role in the spread of cancer cells. Here, we explore ways to temporarily suppress these detrimental activities. We first examined the possibility of using siRNA and antisense oligonucleotides (ASOs) for transient knockdown of the human and mouse C5a receptor, an important chemoattractant receptor involved in neutrophil-mediated injury that is associated with myocardial infarction, sepsis, and neurodegenerative diseases. We found that siRNAs and ASOs transfected into cultured cell lines can eliminate 70-90% of C5a receptor mRNA and protein within 72 h of administration, a clinically relevant time frame after a cardiovascular event. Targeted drug delivery to specific cells or tissues of interest in a mammalian host, however, remains a major challenge. Here, using phage display technology, we have identified peptides that bind specifically to CD177, a neutrophil-specific surface molecule. We have attached these peptides to fluorescent, lipid-based nanoparticles and confirmed targeting and delivery to cultured cells ectopically presenting either human or mouse CD177. In addition, we have shown peptide-nanoparticle binding specifically to neutrophils in human and mouse blood. We anticipate that these or related tagged nanoparticles may be therapeutically useful for delivery of siRNAs or ASOs to neutrophils for transient knockdown of pro-inflammatory proteins such as the C5a receptor.	[Miettinen, Heini M.; Gripentrog, Jeannie M.; Lord, Connie I.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Nagy, Jon O.] NanoValent Pharmaceut Inc, Bozeman, MT USA	Montana State University System; Montana State University Bozeman	Miettinen, HM (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	heini@montana.edu		Miettinen, Heini/0000-0001-6249-8615	Innovative Science Award from the American Heart Association [12PILT1266001]	Innovative Science Award from the American Heart Association	This work was funded in part by an Innovative Science Award (12PILT1266001) to HMM, from the American Heart Association, which had no role in study design, data collection, analysis, decision to publish, or manuscript preparation. NanoValent Pharmaceuticals, Inc., provided nanoparticle samples, but provided no funding for work at Montana State University laboratories nor support for Montana State University investigators.	Arumugam TV, 2004, J HEPATOL, V40, P934, DOI 10.1016/j.jhep.2004.02.017; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Bahr SM, 2009, BIOTECHNOL BIOENG, V104, P1041, DOI 10.1002/bit.22452; Bai M, 2017, BLOOD, V130, P2092, DOI 10.1182/blood-2017-03-768507; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136; Boulay F, 1997, ANN NY ACAD SCI, V832, P69, DOI 10.1111/j.1749-6632.1997.tb46238.x; Bruehl RE, 2001, BIOCHEMISTRY-US, V40, P5964, DOI 10.1021/bi002921s; Buras JA, 2004, IMMUNOBIOLOGY, V209, P629, DOI 10.1016/j.imbio.2004.09.004; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chan JHP, 2006, CLIN EXP PHARMACOL P, V33, P533, DOI 10.1111/j.1440-1681.2006.04403.x; Chu DF, 2016, ADV HEALTHC MATER, V5, P1088, DOI 10.1002/adhm.201500998; Dominska M, 2010, J CELL SCI, V123, P1183, DOI 10.1242/jcs.066399; ECKHARDT H, 1986, J CHEM PHYS, V85, P4116, DOI 10.1063/1.450882; Federman Noah, 2012, Sarcoma, V2012, P126906, DOI 10.1155/2012/126906; Gohring K, 2004, BRIT J HAEMATOL, V126, P252, DOI 10.1111/j.1365-2141.2004.05027.x; GOLDSCHMEDING R, 1992, BRIT J HAEMATOL, V81, P336, DOI 10.1111/j.1365-2141.1992.tb08237.x; Gripentrog JM, 2003, J IMMUNOL, V171, P3187, DOI 10.4049/jimmunol.171.6.3187; Guo RF, 2003, FASEB J, V17, P1889, DOI 10.1096/fj.03-0009fje; Haimes J, 2014, DEMONSTRATION CALCUL; Hatakeyama H, 2009, J CONTROL RELEASE, V139, P127, DOI 10.1016/j.jconrel.2009.06.008; Heller T, 1999, J IMMUNOL, V163, P985; Hoesel LM, 2007, MOL IMMUNOL, V44, P95, DOI 10.1016/j.molimm.2006.06.009; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; Jaye DL, 2001, J IMMUNOL, V166, P7250, DOI 10.4049/jimmunol.166.12.7250; Jayne DRW, 2017, J AM SOC NEPHROL, V28, P2756, DOI 10.1681/ASN.2016111179; Jimenez-Alcazar M, 2017, SCIENCE, V358, P1202, DOI 10.1126/science.aam8897; Johswich K, 2009, INFLAMM BOWEL DIS, V15, P1812, DOI 10.1002/ibd.21012; Jorch SK, 2017, NAT MED, V23, P279, DOI 10.1038/nm.4294; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Karathanasis E, 2009, ANN BIOMED ENG, V37, P1984, DOI 10.1007/s10439-009-9702-5; Kauppinen Sakari, 2005, Drug Discov Today Technol, V2, P287, DOI 10.1016/j.ddtec.2005.08.012; Kissel K, 2001, EUR J IMMUNOL, V31, P1301, DOI 10.1002/1521-4141(200105)31:5<1301::AID-IMMU1301>3.0.CO;2-J; KLONER RA, 1993, J AM COLL CARDIOL, V21, P537, DOI 10.1016/0735-1097(93)90700-B; Kuckleburg CJ, 2012, J IMMUNOL, V188, P2419, DOI 10.4049/jimmunol.1102540; Li WJ, 2004, ADV DRUG DELIVER REV, V56, P967, DOI 10.1016/j.addr.2003.10.041; Liu SJ, 2001, ACTA PHARMACOL SIN, V22, P971; Lonn P, 2016, SCI REP-UK, V6, DOI 10.1038/srep32301; Mastrobattista E, 2002, J BIOL CHEM, V277, P27135, DOI 10.1074/jbc.M200429200; Matsuo K, 2000, TRANSFUSION, V40, P654, DOI 10.1046/j.1537-2995.2000.40060654.x; Mazzucchelli L, 1999, BLOOD, V93, P1738, DOI 10.1182/blood.V93.5.1738.405a18_1738_1748; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Moriconi A, 2014, P NATL ACAD SCI USA, V111, P16937, DOI 10.1073/pnas.1417365111; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Oliveira S, 2007, INT J PHARM, V331, P211, DOI 10.1016/j.ijpharm.2006.11.050; OLMSTED J, 1983, J PHYS CHEM-US, V87, P4790, DOI 10.1021/j150642a006; Perera MN, 2006, J CLIN NEUROSCI, V13, P1, DOI 10.1016/j.jocn.2005.07.005; Pillay J, 2010, BLOOD, V116, P625, DOI 10.1182/blood-2010-01-259028; PLANK C, 1994, J BIOL CHEM, V269, P12918; Proctor LM, 2004, BRIT J PHARMACOL, V142, P756, DOI 10.1038/sj.bjp.0705819; Riley RD, 2000, J THORAC CARDIOV SUR, V120, P350, DOI 10.1067/mtc.2000.107281; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Schnatbaum K, 2006, BIOORG MED CHEM LETT, V16, P5088, DOI 10.1016/j.bmcl.2006.07.036; Schwarz B, 2015, ACS NANO, V9, P9134, DOI 10.1021/acsnano.5b03360; Servid A, 2013, BIOMACROMOLECULES, V14, P2989, DOI 10.1021/bm400796c; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Stroncek DF, 2007, CURR OPIN HEMATOL, V14, P688, DOI 10.1097/MOH.0b013e3282efed9e; STRONCEK DF, 1993, TRANSFUSION, V33, P656, DOI 10.1046/j.1537-2995.1993.33893342747.x; Subramanian H, 2011, MOL PHARMACOL, V79, P1005, DOI 10.1124/mol.111.071472; Suvorova ES, 2005, TRAFFIC, V6, P100, DOI 10.1111/j.1600-0854.2004.00256.x; Tofukuji M, 2000, ANN THORAC SURG, V69, P799, DOI 10.1016/S0003-4975(99)01408-3; Uthayakumar S, 1995, CELL MOL BIOL RES, V41, P405; Varkouhi AK, 2011, J CONTROL RELEASE, V151, P220, DOI 10.1016/j.jconrel.2010.11.004; Wang ZJ, 2014, NAT NANOTECHNOL, V9, P204, DOI [10.1038/NNANO.2014.17, 10.1038/nnano.2014.17]; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wright HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058598; Wu ZP, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006067; Yamagami S, 1999, J LEUKOCYTE BIOL, V65, P744, DOI 10.1002/jlb.65.6.744; Zhang HM, 2007, BIOCHEM BIOPH RES CO, V357, P446, DOI 10.1016/j.bbrc.2007.03.152	72	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200444	10.1371/journal.pone.0200444	http://dx.doi.org/10.1371/journal.pone.0200444			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990379	Green Submitted, gold, Green Published			2022-12-26	WOS:000438170300051
J	Piasecki, P; Narloch, J; Brzozowski, K; Ziecina, P; Mazurek, A; Budzynska, A; Korniluk, J; Dziuk, M				Piasecki, Piotr; Narloch, Jerzy; Brzozowski, Krzysztof; Ziecina, Piotr; Mazurek, Andrzej; Budzynska, Anna; Korniluk, Jan; Dziuk, Miroslaw			The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after Y-90-radioembolization	PLOS ONE			English	Article							INTERNAL RADIATION-THERAPY; Y-90 RESIN MICROSPHERES; TC-99M-MACROAGGREGATED ALBUMIN; HEPATOCELLULAR-CARCINOMA; RADIOEMBOLIZATION; DOSIMETRY; SURVIVAL; CANCER; BLOOD	The aim of this study was to evaluate a modified method of calculating the Tc-99m/Y-90 tumor-to-normal-liver uptake ratio (mT/N) based on SPECT/CT imaging, for use in predicting the overall response of colorectal liver tumors after radioembolization. A modified phantom-based method of tumor-to-normal-liver ratio calculation was proposed and assessed. In contrast to the traditional method based on data gathered from the whole tumor, gamma counts are collected only from a 2D region of interest delineated in the SPECT/CT section with the longest tumor diameter (as specified in RECIST 1.1). The modified tumor-to-normal-liver ratio (mT/N1) and Y-90 predicted tumor absorbed dose (PAD) were obtained based on Tc-99m-MAA SPECT/CT, and similarly the modified tumor-to-normal-liver ratio (mT/N2) and Y-90 actual tumor absorbed dose (AAD) were calculated after Y-90-SPECT/CT. Tumor response was assessed on follow-up CTs. Using the newly proposed method, a total of 103 liver colorectal metastases in 21 patients who underwent radioembolization (between June 2009 and October 2015) were evaluated in pre-treatment CT scans and Tc-99m-MAA-SPECT/CT scans and compared with post-treatment Y-90-SPECT/CT scans and follow-up CT scans. The results showed that the mT/N1 ratio (p = 0.012), PAD (p < 0.001) and AAD (p < 0.001) were predictors of tumor response after radioembolization. The time to progression was significantly lengthened for tumors with mT/N1 higher than 1.7 or PAD higher than 70 Gy. The risk of progression for tumors with mT/N1 lower than 1.7 or PAD below 70 Gy was significantly higher. The mT/N2 ratio had no significant correlation with treatment results.	[Piasecki, Piotr; Narloch, Jerzy; Brzozowski, Krzysztof; Ziecina, Piotr] Mil Inst Med, Intervent Radiol Dept, Warsaw, Poland; [Mazurek, Andrzej; Budzynska, Anna; Dziuk, Miroslaw] Mil Inst Med, Nucl Med Dept, Warsaw, Poland; [Korniluk, Jan] Mil Inst Med, Oncol Dept, Warsaw, Poland	Military Institute of Aviation Medicine; Military Institute of Aviation Medicine; Military Institute of Aviation Medicine	Piasecki, P (corresponding author), Mil Inst Med, Intervent Radiol Dept, Warsaw, Poland.	piotr_piasecki@wp.pl	Narloch, Jerzy/AAS-2826-2020	Narloch, Jerzy/0000-0001-6856-111X; Brzozowski, Krzysztof/0000-0003-0663-8040				ACKERMAN NB, 1969, SURGERY, V66, P1067; ANDERSON JH, 1992, BRIT J CANCER, V66, P287, DOI 10.1038/bjc.1992.258; Bernardini M, 2014, PHYS MEDICA, V30, P752, DOI 10.1016/j.ejmp.2014.05.004; Campbell AM, 2000, PHYS MED BIOL, V45, P1023, DOI 10.1088/0031-9155/45/4/316; Dawson LA, 2001, SEMIN RADIAT ONCOL, V11, P240, DOI 10.1053/srao.2001.23485; Dhabuwala Atul, 2005, BMC Nucl Med, V5, P7, DOI 10.1186/1471-2385-5-7; Dieudonne A, 2011, J NUCL MED, V52, P1930, DOI 10.2967/jnumed.111.095232; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gales SL, 2015, J NUCL MED TECHNOL, V43, P220, DOI 10.2967/jnmt.114.151811; Garin E, 2012, J NUCL MED, V53, P255, DOI 10.2967/jnumed.111.094235; GRAY BN, 1990, INT J RADIAT ONCOL, V18, P619, DOI 10.1016/0360-3016(90)90069-V; Gulec SA, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-15; Gulec SA, 2006, J NUCL MED, V47, P1209; Ho S, 1996, EUR J NUCL MED, V23, P947, DOI 10.1007/BF01084369; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Kennedy A, 2007, INT J RADIAT ONCOL, V68, P13, DOI 10.1016/j.ijrobp.2006.11.060; Kennedy A, 2014, FUTURE ONCOL, V10, P77, DOI 10.2217/fon.14.230; Kennedy AS, 2004, INT J RADIAT ONCOL, V60, P1552, DOI 10.1016/j.ijrobp.2004.09.004; Knesaurek K, 2010, TECHNOL CANCER RES T, V9, P253, DOI 10.1177/153303461000900304; Lam MGEH, 2015, EUR J NUCL MED MOL I, V42, P1192, DOI 10.1007/s00259-015-3048-z; Lam MGEH, 2013, J NUCL MED, V54, P2192, DOI 10.2967/jnumed.113.132852; Lewandowski RJ, 2014, EUR J NUCL MED MOL I, V41, P1861, DOI 10.1007/s00259-014-2799-2; Salem R, 2011, J VASC INTERV RADIOL, V22, P265, DOI 10.1016/j.jvir.2010.10.029; Sarfaraz M, 2004, MED PHYS, V31, P2449, DOI 10.1118/1.1781332; Ulrich G, 2013, J NUCL MED, V54, P516, DOI 10.2967/jnumed.112.112508; van Hazel GA, 2016, J CLIN ONCOL, V34, P1723, DOI 10.1200/JCO.2015.66.1181; Wasan HS, 2017, LANCET ONCOL, V18, P1159, DOI 10.1016/S1470-2045(17)30457-6; Wondergem M, 2013, J NUCL MED, V54, P1294, DOI 10.2967/jnumed.112.117614	28	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200488	10.1371/journal.pone.0200488	http://dx.doi.org/10.1371/journal.pone.0200488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990342	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300055
J	Fukuda, M; Omodaka, K; Tatewaki, Y; Himori, N; Matsudaira, I; Nishiguchi, KM; Murata, T; Taki, Y; Nakazawa, T				Fukuda, Mana; Omodaka, Kazuko; Tatewaki, Yasuko; Himori, Noriko; Matsudaira, Izumi; Nishiguchi, Koji M.; Murata, Takaki; Taki, Yasuyuki; Nakazawa, Toru			Quantitative MRI evaluation of glaucomatous changes in the visual pathway	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; LATERAL GENICULATE-NUCLEUS; VOXEL-BASED MORPHOMETRY; OPTIC-NERVE; RETINOTOPIC ORGANIZATION; CORTICAL FUNCTION; HUMAN CORTEX; FIELD; PROGRESSION; JAPANESE	Background The aims of this study were to investigate glaucomatous morphological changes quantitatively in the visual cortex of the brain with voxel-based morphometry (VBM), a normalizing MRI technique, and to clarify the relationship between glaucomatous damage and regional changes in the visual cortex of patients with open-angle glaucoma (OAG). Methods Thirty-one patients with OAG (age: 55.9 +/- 10.7, male: female = 9: 22) and 20 age-matched controls (age: 54.9 +/- 9.8, male: female = 10: 10) were included in this study. The cross-sectional area (CSA) of the optic nerve was manually measured with T2-weighed MRI. Images of the visual cortex were acquired with T1-weighed 3D magnetization-prepared rapid acquisition with gradient echo (MPRAGE) sequencing, and the normalized regional visual cortex volume, i.e., gray matter density (GMD), in Brodmann areas (BA) 17, 18, and 19, was calculated with a normalizing technique based on statistic parametric mapping 8 (SPM8) analysis. We compared the regional GMD of the visual cortex in the control subjects and OAG patients. Spearman's rank correlation analysis was used to determine the relationship between optic nerve CSA and GMD in BA 17, 18, and 19. Results We found that the normal and OAG patients differed significantly in optic nerve CSA (p < 0.001) and visual cortex GMD in BA 17 (p = 0.030), BA 18 (p = 0.003), and BA 19 (p = 0.005). In addition, we found a significant correlation between optic nerve CSA and visual cortex GMD in BA 19 (r = 0.33, p = 0.023), but not in BA 17 (r = 0.17, p = 0.237) or BA 18 (r = 0.24, p = 0.099). Conclusion Quantitative MRI parametric evaluation of GMD can detect glaucoma-associated anatomical atrophy of the visual cortex in BA 17, 18, and 19. Furthermore, GMD in BA 19 was significantly correlated to the damage level of the optic nerve, as well as the retina, in patients with OAG. This is the first demonstration of an association between the cortex of the brain responsible for higher-order visual function and glaucoma severity. Evaluation of the visual cortex with MRI is thus a very promising potential method for objective examination in OAG.	[Fukuda, Mana; Omodaka, Kazuko; Himori, Noriko; Nakazawa, Toru] Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan; [Omodaka, Kazuko; Nakazawa, Toru] Tohoku Univ, Dept Ophthalm Imaging & Informat Analyt, Grad Sch Med, Sendai, Miyagi, Japan; [Tatewaki, Yasuko; Matsudaira, Izumi; Taki, Yasuyuki] Tohoku Univ, Inst Dev Aging & Canc, Grad Sch Med, Sendai, Miyagi, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi, Japan; [Murata, Takaki] Tohoku Univ, Diagnost Radiol, Grad Sch Med, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Ophthalmol, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Nakazawa, T (corresponding author), Tohoku Univ, Dept Ophthalmol, Grad Sch Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Dept Ophthalm Imaging & Informat Analyt, Grad Sch Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Dept Adv Ophthalm Med, Grad Sch Med, Sendai, Miyagi, Japan.; Nakazawa, T (corresponding author), Tohoku Univ, Ophthalmol, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi, Japan.	ntoru@oph.med.tohoku.ac.jp			Japan Science and Technology Agency grant from the Japan Society for the Promotion of Science KAKENHI [17H04349, 16K15730]; Japan Science and Technology Agency Center for Revitalization Promotion and KAKENHI [17K16957]; Public Trust Suda Memorial Fund for Glaucoma Research; Young Investigator Grant of Tohoku University Hospital; Japan Society for the Promotion of Science KAKENHI [26860971]; Project (Project to Promote Gender Equality and Female Researchers) of Tohoku University	Japan Science and Technology Agency grant from the Japan Society for the Promotion of Science KAKENHI; Japan Science and Technology Agency Center for Revitalization Promotion and KAKENHI; Public Trust Suda Memorial Fund for Glaucoma Research; Young Investigator Grant of Tohoku University Hospital; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Project (Project to Promote Gender Equality and Female Researchers) of Tohoku University	This paper was supported in part by a Japan Science and Technology Agency grant from the Japan Society for the Promotion of Science KAKENHI Grants-in-Aid for Scientific Research (B) (T.N. 17H04349) and for Exploratory Research (T.N. 16K15730), and by the Japan Science and Technology Agency Center for Revitalization Promotion and KAKENHI Grant-in-Aid for young scientists (B) (K0. 17K16957) and Public Trust Suda Memorial Fund for Glaucoma Research. This work was supported by a Young Investigator Grant of Tohoku University Hospital (Y.T.); ST grant from the Japan Society for the Promotion of Science KAKENHI Grants-in-Aid Young Investigator (B) (Y. T. 26860971); and TUMUG Support Project (Project to Promote Gender Equality and Female Researchers) of Tohoku University (Y.T.).	Anderson DR., 1999, AUTOMATED STATIC PER; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Boucard CC, 2009, BRAIN, V132, P1898, DOI 10.1093/brain/awp119; Braddick OJ, 2001, PERCEPTION, V30, P61, DOI 10.1068/p3048; Chen WW, 2013, INVEST OPHTH VIS SCI, V54, P545, DOI 10.1167/iovs.12-9893; Dieleman N, 2017, NEUROIMAGE-CLIN, V16, P507, DOI 10.1016/j.nicl.2017.09.002; Duncan RO, 2007, INVEST OPHTH VIS SCI, V48, P733, DOI 10.1167/iovs.06-0773; Duncan RO, 2007, PROG RETIN EYE RES, V26, P38, DOI 10.1016/j.preteyeres.2006.10.001; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Frezzotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105931; Garaci FG, 2009, RADIOLOGY, V252, P496, DOI 10.1148/radiol.2522081240; Gudmundsson LS, 2013, NEUROLOGY, V80, P2138, DOI 10.1212/WNL.0b013e318295d69e; Gupta N, 2006, BRIT J OPHTHALMOL, V90, P674, DOI 10.1136/bjo.2005.086769; Gupta N, 2009, BRIT J OPHTHALMOL, V93, P56, DOI 10.1136/bjo.2008.138172; Gupta N, 2007, CURR OPIN OPHTHALMOL, V18, P110, DOI 10.1097/ICU.0b013e3280895aea; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Kashiwagi K, 2004, J GLAUCOMA, V13, P189, DOI 10.1097/00061198-200406000-00003; Kashiwagi K, 2003, INVEST OPHTH VIS SCI, V44, P154, DOI 10.1167/iovs.02-0398; Lakshmanan Y, 2013, OPHTHAL PHYSL OPT, V33, P172, DOI 10.1111/opo.12021; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Li CY, 2012, CURR EYE RES, V37, P794, DOI 10.3109/02713683.2012.683506; McKendrick AM, 2005, INVEST OPHTH VIS SCI, V46, P3693, DOI 10.1167/iovs.04-1406; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nakazawa T, 2016, ASIA-PAC J OPHTHALMO, V5, P38, DOI 10.1097/APO.0000000000000183; Nucci C, 2013, CURR OPIN PHARMACOL, V13, P128, DOI 10.1016/j.coph.2012.08.004; Omodaka K, 2014, CLIN EXP OPHTHALMOL, V42, P360, DOI 10.1111/ceo.12237; Ramli NM, 2014, GRAEF ARCH CLIN EXP, V252, P995, DOI 10.1007/s00417-014-2622-6; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Wandell BA, 2005, PHILOS T R SOC B, V360, P693, DOI 10.1098/rstb.2005.1628; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Yokoyama Yu, 2015, BMC Res Notes, V8, P360, DOI 10.1186/s13104-015-1339-x; Yucel YH, 2008, CAN J OPHTHALMOL, V43, P342, DOI 10.3129/i08-059; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhou W, 2017, J GLAUCOMA, V26, P173, DOI 10.1097/IJG.0000000000000558	36	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0197027	10.1371/journal.pone.0197027	http://dx.doi.org/10.1371/journal.pone.0197027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985921	Green Submitted, gold, Green Published			2022-12-26	WOS:000438035500003
J	Loria, R; Laquintana, V; Bon, G; Trisciuoglio, D; Frapolli, R; Covello, R; Amoreo, CA; Ferraresi, V; Zoccali, C; Novello, M; Del Bufalo, D; Milella, M; Biagini, R; D'Incalci, M; Falcioni, R				Loria, Rossella; Laquintana, Valentina; Bon, Giulia; Trisciuoglio, Daniela; Frapolli, Roberta; Covello, Renato; Amoreo, Carla Azzurra; Ferraresi, Virginia; Zoccali, Carmine; Novello, Mariangela; Del Bufalo, Donatella; Milella, Michele; Biagini, Roberto; D'Incalci, Maurizio; Falcioni, Rita			HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance	ONCOGENE			English	Article							SOFT-TISSUE SARCOMA; NUCLEOTIDE-EXCISION-REPAIR; MESENCHYMAL TRANSITION; MYXOID LIPOSARCOMAS; COLON-CANCER; DNA-BINDING; KAPPA-B; ECTEINASCIDIN-743; EXPRESSION; GENE	Although the medical treatments of sarcoma have evolved in the last years, a significant portion of patients develops recurrence after therapies suggesting the need to identify novel targets to improve the treatments. By the use of patient derived and established cell lines from liposarcoma, as well as specimens from patient biopsies, we found that HMGA1 is involved in the progression of dedifferentiated and myxoid liposarcoma. The immunohistochemical and RT-PCR analyses of 68 liposarcoma specimens revealed a significant high expression of HMGA1, at the protein and RNA levels, both in myxoid and dedifferentiated liposarcoma subtypes compared with differentiated ones. Loss-and gain-of-function experiments by HMGA1-specific depletion and overexpression in dedifferentiated and myxoid liposarcoma cells showed the contribution of this oncogenic factor in cell proliferation, motility, invasion, and drug resistance. The in vitro and in vivo treatment of myxoid liposarcoma with trabectedin, a drug with a potent anti-tumor activity, revealed downregulation of HMGA1, E2F1, and its-downstream targets, vimentin and ZEB1, indicating a critical role of trabectedin in inhibiting the mesenchymal markers of these tumors through the HMGA1/E2F1 axis. These data were also confirmed in patients' tumor biopsies being HMGA1, E2F1, and vimentin expression significantly reduced upon trabectedin therapy, administered as neo-adjuvant chemotherapy. Furthermore, trabectedin treatment inhibits in vitro NFkB pathway in mixoyd liposarcoma sensitive but not in resistant counterparts, and the inhibition of NFkB pathway re-sensitizes the resistant cells to trabectedin treatment. These data support the rational for combining NFkB inhibitors with trabectedin in liposarcoma patients, who have become resistant to the drug.	[Loria, Rossella; Laquintana, Valentina; Bon, Giulia; Falcioni, Rita] IRCCS Regina Elena Natl Canc Inst, Cellular Network & Mol Therapeut Target Unit, Via Elio Chianesi 53, I-00144 Rome, Italy; [Trisciuoglio, Daniela; Del Bufalo, Donatella] IRCCS Regina Elena Natl Canc Inst, Preclin Models & New Therapeut Agents Unit, Via Elio Chianesi 53, I-00144 Rome, Italy; [Trisciuoglio, Daniela] Sapienza Univ Rome, Inst Mol Biol & Pathol, CNR Natl Res Council, I-00185 Rome, Italy; [Frapolli, Roberta; D'Incalci, Maurizio] IRCCS Ist Ric Farmacol Mario Negri, Dept Oncol, Via La Masa 19, Milan, Italy; [Covello, Renato; Amoreo, Carla Azzurra; Novello, Mariangela] IRCCS Regina Elena Natl Canc Inst, Pathol Unit, Dept Res Adv Diagnost & Technol Innovat, Via Elio Chianesi 53, I-00144 Rome, Italy; [Ferraresi, Virginia; Milella, Michele] IRCCS Regina Elena Natl Canc Inst, Med Oncol A, Via Elio Chianesi 53, I-00144 Rome, Italy; [Zoccali, Carmine; Biagini, Roberto] IRCCS Regina Elena Natl Canc Inst, Dept Expt Clin Oncol, Orthoped Surg, Via Elio Chianesi 53, I-00144 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Falcioni, R (corresponding author), IRCCS Regina Elena Natl Canc Inst, Cellular Network & Mol Therapeut Target Unit, Via Elio Chianesi 53, I-00144 Rome, Italy.	rita.falcioni@ifo.gov.it	Del Bufalo, Donatella/K-8673-2016; Milella, Michele/ABH-8606-2020; Zoccali, Carmine/AAR-4473-2020; Bon, Giulia/ABH-6498-2020; Loria, Rossella/ABH-7374-2020; Falcioni, Rita/H-8869-2017; Laquintana, Valentina/U-7577-2017; ferraresi, virginia/ABH-7898-2020; Frapolli, Roberta/AAA-6729-2020; trisciuoglio, daniela/AAL-4002-2021; Loria, Rossella/A-6139-2015; D'Incalci, Maurizio/AAA-9021-2020; Del Bufalo, Donatella/AAC-1594-2021; Trisciuoglio, Daniela/H-2131-2016	Del Bufalo, Donatella/0000-0002-3148-6096; Zoccali, Carmine/0000-0002-6616-1996; Bon, Giulia/0000-0002-5409-5864; Loria, Rossella/0000-0002-1305-2825; Falcioni, Rita/0000-0002-3745-4327; Laquintana, Valentina/0000-0002-7374-5279; ferraresi, virginia/0000-0001-6419-1668; Frapolli, Roberta/0000-0003-2907-273X; D'Incalci, Maurizio/0000-0001-8784-1360; Del Bufalo, Donatella/0000-0002-3148-6096; Trisciuoglio, Daniela/0000-0002-7007-7914	Ministero della Salute (DMT Sarcoma Group IRE); Italian Association for Cancer Research (AIRC) [IG 18622, IG 19189]; PharmaMar	Ministero della Salute (DMT Sarcoma Group IRE); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); PharmaMar	We thank PharmaMar for providing us trabectedin, Dr. Alessandra Verdina for her support, and Dr. Silvia Soddu for discussion. This work was supported by Ministero della Salute (DMT Sarcoma Group IRE) and PharmaMar to RF, and Italian Association for Cancer Research (AIRC) with a IG 18622 to M.M., and IG 19189 to MD	Allavena P, 2005, CANCER RES, V65, P2964, DOI 10.1158/0008-5472.CAN-04-4037; AMAN P, 1992, GENE CHROMOSOME CANC, V5, P278, DOI 10.1002/gcc.2870050403; ASHAR HR, 1995, CELL, V82, P57; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Belton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030034; Bon G, 2017, ONCOTARGET, V8, P108463, DOI 10.18632/oncotarget.11400; Bonfanti M, 1999, ANTI-CANCER DRUG DES, V14, P179; Carter NJ, 2010, DRUGS, V70, P355, DOI 10.2165/11202860-000000000-00000; Casali PG, 2010, CURR OPIN ONCOL, V22, P342, DOI 10.1097/CCO.0b013e32833aaac1; Chiappetta G, 1996, ONCOGENE, V13, P2439; Crago AM, 2011, CURR OPIN ONCOL, V23, P373, DOI 10.1097/CCO.0b013e32834796e6; D'Angelo D, 2013, EUR J CANCER, V49, P1142, DOI 10.1016/j.ejca.2012.10.014; D'Incalci M, 2010, MOL CANCER THER, V9, P2157, DOI 10.1158/1535-7163.MCT-10-0263; Damia G, 2001, INT J CANCER, V92, P583, DOI 10.1002/ijc.1221; Di Giandomenico S, 2014, ONCOGENE, V33, P5201, DOI 10.1038/onc.2013.462; Doyle LA, 2014, CANCER-AM CANCER SOC, V120, P1763, DOI 10.1002/cncr.28657; Fattore L, 2015, ONCOTARGET, V6, P24823, DOI 10.18632/oncotarget.4485; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; FLETCHER JA, 1992, CANCER RES, V52, P6224; Folgiero V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001592; Frapolli R, 2010, CLIN CANCER RES, V16, P4958, DOI 10.1158/1078-0432.CCR-10-0317; Frensing T, 2008, BBA-GENE REGUL MECH, V1779, P139, DOI 10.1016/j.bbagrm.2007.11.007; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Germano G, 2010, CANCER RES, V70, P2235, DOI 10.1158/0008-5472.CAN-09-2335; Gordon EM, 2016, ADV THER, V33, P1055, DOI 10.1007/s12325-016-0344-3; Gronchi A, 2017, LANCET ONCOL, V18, P812, DOI 10.1016/S1470-2045(17)30334-0; Guirouilh-Barbat J, 2008, MOL BIOL CELL, V19, P3969, DOI 10.1091/mbc.E08-02-0215; Kazmierczak B, 1998, GENE CHROMOSOME CANC, V23, P279, DOI 10.1002/(SICI)1098-2264(199812)23:4<279::AID-GCC1>3.0.CO;2-1; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Loria R, 2015, ONCOTARGET, V6, P2779, DOI 10.18632/oncotarget.2995; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Massimi I, 2013, MOL CARCINOGEN, V52, P526, DOI 10.1002/mc.21887; Merkhofer EC, 2010, ONCOGENE, V29, P1238, DOI 10.1038/onc.2009.410; Minuzzo M, 2000, P NATL ACAD SCI USA, V97, P6780, DOI 10.1073/pnas.97.12.6780; MORTON DL, 1978, AUST NZ J SURG, V48, P56, DOI 10.1111/j.1445-2197.1978.tb05806.x; Munshi N, 1998, MOL CELL, V2, P457, DOI 10.1016/S1097-2765(00)80145-8; PANAGOPOULOS I, 1994, CANCER RES, V54, P6500; Pegoraro S, 2013, ONCOTARGET, V4, P1293, DOI 10.18632/oncotarget.1136; Pentimalli F, 2008, EUR J CANCER, V44, P2668, DOI 10.1016/j.ejca.2008.07.033; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Singer S, 2003, ANN SURG, V238, P358, DOI 10.1097/01.sla.0000086542.11899.38; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Takebayashi Y, 1999, P NATL ACAD SCI USA, V96, P7196, DOI 10.1073/pnas.96.13.7196; Takebayashi Y, 2001, NAT MED, V7, P961, DOI 10.1038/91008; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Uboldi S, 2012, INT J CANCER, V131, P59, DOI 10.1002/ijc.26340; Valoti G, 1998, CLIN CANCER RES, V4, P1977; Zoi I, 2016, TRENDS MOL MED, V22, P839, DOI 10.1016/j.molmed.2016.07.009	50	19	19	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 8	2018	37	45					5926	5938		10.1038/s41388-018-0394-x	http://dx.doi.org/10.1038/s41388-018-0394-x			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GZ6PQ	29980789	Green Published, hybrid			2022-12-26	WOS:000449562500002
J	Sayeed, M; Gautam, S; Verma, DP; Afshan, T; Kumari, T; Srivastava, AK; Ghosh, JK				Sayeed, Mohd; Gautam, Sudeep; Verma, Devesh Pratap; Afshan, Tayyaba; Kumari, Tripti; Srivastava, Arvind Kumar; Ghosh, Jimut Kanti			A collagen domain-derived short adiponectin peptide activates APPL1 and AMPK signaling pathways and improves glucose and fatty acid metabolisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Type 2 diabetes; adiponectin; AMP-activated kinase (AMPK); cell signaling; peptide chemical synthesis; adiponectin collagen domain; APPL-1; fatty acid metabolism; oral glucose tolerance test (OGTT); peptide oligomerization	INDUCED INSULIN-RESISTANCE; PROTEIN-KINASE; SKELETAL-MUSCLE; L6 MYOTUBES; OB/OB MICE; ADIPOSE; CELLS; BONE; ADIPOGENESIS; HYPOADIPONECTINEMIA	Adiponectin is a fat tissue-derived adipokine with beneficial effects against diabetes, cardiovascular diseases, and cancer. Accordingly, adiponectin-mimetic molecules possess significant pharmacological potential. Oligomeric states of adiponectin appear to determine its biological activity. We identified a highly conserved, 13-residue segment (ADP-1) from adiponectin's collagen domain, which comprises GXXG motifs and has one asparagine and two histidine residues that assist in oligomeric protein assembly. We therefore hypothesized that ADP-1 promotes oligomeric assembly and thereby mediates potential metabolic effects. We observed here that ADP-1 is stable in human serum and oligomerizes in aqueous environments. We also found that ADP-1 activates AMP-activated protein kinase (AMPK) in an adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 (APPL1)-dependent pathway and stimulates glucose uptake in rat skeletal muscle cells (L6 myotubes). ADP-1-induced glucose transport coincided with ADP-1-induced biosynthesis of glucose transporter 4 and its translocation to the plasma membrane. ADP-1 induced an interaction between APPL1 and the small GTPase Rab5, resulting in AMPK phosphorylation, in turn leading to phosphorylation of p38 mitogen-activated protein kinase (MAPK), acetyl-CoA carboxylase, and peroxisome proliferator-activated receptor . Similar to adiponectin, ADP-1 increased the expression of the adiponectin receptor 1 (AdipoR1) gene. Of note, ADP-1 decreased blood glucose levels and enhanced insulin production in pancreatic cells in db/db mice. Further, ADP-1 beneficially affected lipid metabolism by enhancing lipid globule formation in mouse 3T3-L1 adipocytes. To our knowledge, this is the first report on identification of a short peptide from adiponectin with positive effects on glucose or fatty acid metabolism.	[Sayeed, Mohd; Verma, Devesh Pratap; Afshan, Tayyaba; Kumari, Tripti; Ghosh, Jimut Kanti] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Gautam, Sudeep; Srivastava, Arvind Kumar] Cent Drug Res Inst, CSIR, Biochem Div, Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ghosh, JK (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Jankipuram Extens,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	jk_ghosh@cdri.res.in			CSIR-network project [BSC 0120]; CSIR-Central Drug Research Institute [9716]	CSIR-network project(Council of Scientific & Industrial Research (CSIR) - India); CSIR-Central Drug Research Institute	This work was supported by CSIR-network project BSC 0120. The CSIR-Central Drug Research Institute communication number of this article is 9716. The authors declare that they have no conflicts of interest with the contents of this article.	Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Almer G., BIOLOGICS, V5, P95; Anhe GF, 2012, EUR J PHARMACOL, V689, P285, DOI 10.1016/j.ejphar.2012.06.007; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Benvenuti S, 2007, J ENDOCRINOL INVEST, V30, pRC26, DOI 10.1007/BF03350807; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Cheng HX, 2011, J PHOTOCH PHOTOBIO B, V105, P126, DOI 10.1016/j.jphotobiol.2011.07.004; Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Del Aguila LF, 1999, AM J PHYSIOL-ENDOC M, V276, pE849, DOI 10.1152/ajpendo.1999.276.5.E849; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gautam S, 2015, EUR J PHARMACOL, V762, P419, DOI 10.1016/j.ejphar.2015.05.021; Gautam S, 2014, APPL BIOCHEM BIOTECH, V174, P2446, DOI 10.1007/s12010-014-1192-8; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hindi L, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2248; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hui XY, 2012, BRIT J PHARMACOL, V165, P574, DOI 10.1111/j.1476-5381.2011.01395.x; Iwaniak Anna, 2008, Polish Journal of Food and Nutrition Sciences, V58, P289; Jakopitsch C, 2003, EUR J BIOCHEM, V270, P1006, DOI 10.1046/j.1432-1033.2003.03476.x; Ruiz-Ojeda FJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071040; Jiao HL, 2015, CURR OSTEOPOROS REP, V13, P327, DOI 10.1007/s11914-015-0286-8; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; KLIP A, 1987, BIOCHEM J, V242, P131, DOI 10.1042/bj2420131; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lecka-Czernik B, 2017, DIABETOLOGIA, V60, P1163, DOI 10.1007/s00125-017-4269-4; Liu ML, 2014, BEST PRACT RES CL EN, V28, P25, DOI 10.1016/j.beem.2013.06.003; Lorenzo M, 2008, J Anim Sci, V86, pE94; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; McFalls EO, 2004, AM J PHYSIOL-HEART C, V287, pH1328, DOI 10.1152/ajpheart.01188.2003; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Nayak AR, 2016, J STRUCT BIOL, V195, P129, DOI 10.1016/j.jsb.2016.02.020; Otvos L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-90; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ruan H, 2016, J MOL CELL BIOL, V8, P101, DOI 10.1093/jmcb/mjw014; Rubin MR, 2015, CURR OSTEOPOROS REP, V13, P186, DOI 10.1007/s11914-015-0265-0; Sawada K, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-36; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Sinha S, 2004, J BIOL CHEM, V279, P41294, DOI 10.1074/jbc.M406514200; Srivastava S, 2013, ANTIMICROB AGENTS CH, V57, P2457, DOI 10.1128/AAC.00169-13; Tanabe J., 2013, J ORAL TISSUE ENG, V11, P9, DOI [10.11223/jarde.11.9, DOI 10.11223/JARDE.11.9]; Varshney S, 2014, J LIPID RES, V55, P1019, DOI 10.1194/jlr.M039925; Vianna AGD, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0274-5; Wang HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19445; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yap A, 2007, CYTOTECHNOLOGY, V55, P103, DOI 10.1007/s10616-007-9107-y; Yonemitsu S, 2001, DIABETES, V50, P1093, DOI 10.2337/diabetes.50.5.1093; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Zhou LJ, 2009, J BIOL CHEM, V284, P22426, DOI 10.1074/jbc.M109.028357	56	17	19	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13509	13523		10.1074/jbc.RA118.001801	http://dx.doi.org/10.1074/jbc.RA118.001801			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991592	Green Published, hybrid			2022-12-26	WOS:000443375500013
J	Luhung, I; Wu, Y; Xu, SY; Yamamoto, N; Chang, VWC; Nazaroff, WW				Luhung, Irvan; Wu, Yan; Xu, Siyu; Yamamoto, Naomichi; Chang, Victor Wei-Chung; Nazaroff, William W.			Exploring temporal patterns of bacterial and fungal DNA accumulation on a ventilation system filter for a Singapore university library	PLOS ONE			English	Article							OUTDOOR ENVIRONMENTS; AIRBORNE FUNGI; UNITED-STATES; INDOOR; COMMUNITIES; BUILDINGS; PARTICLES; PROFILES; DUST; TOOL	Introduction Ventilation system filters process recirculated indoor air along with outdoor air. This function inspires the idea of using the filter as an indoor bioaerosol sampler. While promising, there remains a need to investigate several factors that could limit the accuracy of such a sampling approach. Among the important factors are the dynamics of microbial assemblages on filter surfaces over time and the differential influence of outdoor versus recirculated indoor air. Methods This study collected ventilation system filter samples from an air handling unit on a regular schedule over a 21-week period and analyzed the accumulation patterns of biological particles on the filter both quantitatively (using fluorometry and qPCR) and in terms of microbial diversity (using 16S rDNA and ITS sequencing). Results The quantitative result showed that total and bacterial DNA accumulated monotonically, rising to 41 ng/cm(2) for total DNA and to 2.8 ng/cm(2) for bacterial DNA over the 21-week period. The accumulation rate of bacterial DNA correlated with indoor occupancy level. Fungal DNA first rose to 4.0 ng/cm(2) before showing a dip to 1.4 ng/cm(2) between weeks 6 and 10. The dip indicated a possible artifact of this sampling approach for quantitative analysis as DNA may not be conserved on the filter over the months-long service period. The sequencing results indicate major contributions from outdoor air for fungi and from recirculated indoor air for bacteria. Despite the quantitative changes, the community structure of the microbial assemblages was stable throughout the 21-week sampling period, highlighting the robustness of this sampling method for microbial profiling. Conclusion This study supports the use of ventilation system filters as indoor bioaerosol samplers, but with caveats: 1) an outdoor reference is required to properly understand the contribution of outdoor bioaerosols; and 2) there is a need to better understand the persistence and durability of the targeted organisms on ventilation system filters.	[Luhung, Irvan; Wu, Yan; Chang, Victor Wei-Chung; Nazaroff, William W.] BEARS, SinBerBEST Program, Singapore, Singapore; [Luhung, Irvan] Nanyang Technol Univ, SCELSE, Singapore, Singapore; [Wu, Yan] Shandong Univ, Sch Environm Sci & Engn, Jinan, Shandong, Peoples R China; [Xu, Siyu; Yamamoto, Naomichi] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Environm Hlth Sci, Seoul, South Korea; [Chang, Victor Wei-Chung] Monash Univ, Dept Civil Engn, Clayton, Vic, Australia; [Nazaroff, William W.] Univ Calif Berkeley, Dept Civil & Environm Engn, Berkeley, CA 94720 USA	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Shandong University; Seoul National University (SNU); Monash University; University of California System; University of California Berkeley	Luhung, I (corresponding author), BEARS, SinBerBEST Program, Singapore, Singapore.; Luhung, I (corresponding author), Nanyang Technol Univ, SCELSE, Singapore, Singapore.	irva0003@ntu.edu.sg	Nazaroff, William/AAJ-7352-2021; Nazaroff, William W/C-4106-2008; Yamamoto, Naomichi/D-4099-2014; CHANG, Victor Wei-Chung/A-3796-2011	Nazaroff, William/0000-0001-5645-3357; Nazaroff, William W/0000-0001-5645-3357; Yamamoto, Naomichi/0000-0002-5969-5500; CHANG, Victor Wei-Chung/0000-0003-4683-1267	Republic of Singapore's National Research Foundation; Republic of Singapore's National Research Foundation [NRF-CRP8-2011-03]	Republic of Singapore's National Research Foundation; Republic of Singapore's National Research Foundation	This research is funded by the Republic of Singapore's National Research Foundation through a grant to the Berkeley Education Alliance for Research in Singapore (BEARS) for the Singapore Berkeley Building Efficiency and Sustainability in the Tropics (SinBerBEST) Program. BEARS has been established by the University of California, Berkeley as a center for intellectual excellence in research and education in Singapore. This research is also assisted by the Republic of Singapore's National Research Foundation through a grant number NRF-CRP8-2011-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azimi P, 2014, ATMOS ENVIRON, V98, P337, DOI 10.1016/j.atmosenv.2014.09.007; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dannemiller KC, 2014, J BASIC MICROB, V54, P315, DOI 10.1002/jobm.201200507; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goebes MD, 2011, AEROSOL SCI TECH, V45, P352, DOI 10.1080/02786826.2010.537712; Haaland D, 2017, INDOOR AIR, V27, P364, DOI 10.1111/ina.12319; Hoisington A, 2016, INDOOR AIR, V26, P857, DOI 10.1111/ina.12273; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Kembel SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087093; Liu CM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-255; Liu ZJ, 2015, ENERG BUILDINGS, V103, P166, DOI 10.1016/j.enbuild.2015.06.056; Luhung I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186295; Luhung I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141158; Meadow JF, 2014, INDOOR AIR, V24, P41, DOI 10.1111/ina.12047; Nilsson RH, 2009, SOURCE CODE BIOL MED, V4, DOI 10.1186/1751-0473-4-1; Noris F, 2011, ATMOS ENVIRON, V45, P338, DOI 10.1016/j.atmosenv.2010.10.017; Pigeot-Remy S, 2014, APPL CATAL B-ENVIRON, V144, P654, DOI 10.1016/j.apcatb.2013.07.036; Qian J, 2012, INDOOR AIR, V22, P339, DOI 10.1111/j.1600-0668.2012.00769.x; Sautour M, 2009, SCI TOTAL ENVIRON, V407, P3766, DOI 10.1016/j.scitotenv.2009.02.024; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shelton BG, 2002, APPL ENVIRON MICROB, V68, P1743, DOI 10.1128/AEM.68.4.1743-1753.2002; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yamamoto N, 2011, INDOOR AIR, V21, P521, DOI 10.1111/j.1600-0668.2011.00732.x; Yamamoto N, 2015, ENVIRON SCI TECHNOL, V49, P5098, DOI 10.1021/es506165z	30	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200820	10.1371/journal.pone.0200820	http://dx.doi.org/10.1371/journal.pone.0200820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020972	Green Published, gold			2022-12-26	WOS:000439022400079
J	Stringer, EM; Kendall, MA; Lockman, S; Campbell, TB; Nielsen-Saines, K; Sawe, F; Cu-uvin, S; Wu, XY; Currier, JS				Stringer, Elizabeth M.; Kendall, Michelle A.; Lockman, Shahin; Campbell, Thomas B.; Nielsen-Saines, Karin; Sawe, Fred; Cu-uvin, Susan; Wu, Xingye; Currier, Judith S.			Pregnancy outcomes among H IV-infected women who conceived on antiretroviral therapy	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; PRETERM DELIVERY; INCREASED RISK; HIV; PREVENTION	As antiretroviral therapy (ART) expands in resource-limited settings, understanding the impact of ART on pregnancy outcomes is critical. We analyzed women who became pregnant on ART while enrolled in a clinical trial (HPTN 052, ACTG A5208, and ACTG A5175); the majority of women were from Africa, with a median age of 29 years. Eligible women were on ART at conception and had a documented date of a last menstrual period and a pregnancy outcome. The primary outcome was non-live birth (stillbirth; spontaneous abortion; elective termination; or ectopic pregnancy) versus live birth. Preterm birth (<37 weeks completed gestation) was a secondary outcome. We used Cox proportional hazards regression models with time-varying covariates. 359 women became pregnant, of whom 253 (70%) met inclusion criteria: 127 (50%) were on NNRTI-based ART, 118 (47%) on PI-based ART, and 8 (3%) on 3-NRTIs at conception. There were 160 (63%) live births (76 term and 84 preterm), 11 (4%) stillbirths, 51 (20%) spontaneous abortions, 28 (11%) elective terminations, and 3 (1%) ectopic pregnancies. In multivariable analysis adjusted for region, parent study, and pre-pregnancy ART class, only older age was associated with increased hazard of preterm birth [HR: 2.49 for age 25-30 years; 95% CI: 1.18-5.26; p = 0.017]. Women conceiving on ART had high rates of preterm birth and other adverse pregnancy outcomes. Despite the benefits of ART, studies designed to investigate the effects of preconception ART on pregnancy outcomes are needed.	[Stringer, Elizabeth M.] Univ N Carolina, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC 27515 USA; [Kendall, Michelle A.; Wu, Xingye] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [Lockman, Shahin] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lockman, Shahin] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Campbell, Thomas B.] Univ Colorado, Sch Med, Dept Med, Div Infect Dis, Aurora, CO USA; [Nielsen-Saines, Karin] UCLA, David Geffen Sch Med, Dept Pediat, Div Infect Dis, Los Angeles, CA 90095 USA; [Sawe, Fred] USAMRD K, Kenya Med Res Inst KEMRI, HJFMRI, Kericho, Kenya; [Cu-uvin, Susan] Brown Univ, Providence Boston Ctr AIDS Res, Brown Global Hlth Initiat, Providence, RI USA; [Currier, Judith S.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Kenya Medical Research Institute; Brown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stringer, EM (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Div Maternal Fetal Med, Chapel Hill, NC 27515 USA.; Currier, JS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Los Angeles, CA 90095 USA.	Elizabeth_stringer@med.unc.edu; JSCurrier@mednet.ucla.edu	Kendall, Michelle A/B-7665-2016	Kendall, Michelle A/0000-0001-9160-4544; Stringer, Elizabeth/0000-0003-4210-381X	National Institutes of Health; AIDS Clinical Trials Group, and Division of Intramural Research; National Institute of Allergy and Infectious Diseases [U01-A1068619/UMI-A1068619, U01A1068636/A168634/A138838]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068634, U01AI068636, U01AI069424, UM1AI069432, UM1AI069412, UM1AI106716, UM1AI069424, UM1AI068636, UM1AI069456, UM1AI068619, P30AI050410, UM1AI106701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIDS Clinical Trials Group, and Division of Intramural Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institutes of Health grants to the HIV Prevention Trials Network as well as grants to the AIDS Clinical Trials Group, and Division of Intramural Research, National Institute of Allergy and Infectious Diseases, U01-A1068619/UMI-A1068619 and U01A1068636/A168634/A138838. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1479-1; CAMPBELL S, 1985, OBSTET GYNECOL, V65, P613; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Dellicour S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011088; Fowler MG, 2016, NEW ENGL J MED, V375, P1726, DOI 10.1056/NEJMoa1511691; GRAVETT MG, 2010, BMC PREGNANCY CHI S1, V10; Jabeen M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S6; Johnson KM, 2016, PREGNANCY HYPERTENS, V6, P418, DOI 10.1016/j.preghy.2016.10.002; Kourtis AP, 2007, AIDS, V21, P607, DOI 10.1097/QAD.0b013e32802ef2f6; Kourtis AP, 2011, J INFECT DIS, V204, P493, DOI 10.1093/infdis/jir318; Lambert JS, 2000, AIDS, V14, P1389, DOI 10.1097/00002030-200007070-00012; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lorenzi P, 1998, AIDS, V12, pF241, DOI 10.1097/00002030-199818000-00002; Luo CW, 2017, JAIDS-J ACQ IMM DEF, V75, pS7, DOI [10.1097/qai.0000000000001332, 10.1097/QAI.0000000000001332]; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Stringer EM, 2011, OBSTET GYNECOL, V117, P1151, DOI 10.1097/AOG.0b013e3182167627; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Tooke L, 2016, PREGNANCY HYPERTENS, V6, P266, DOI 10.1016/j.preghy.2016.04.006; Uthman OA, 2017, LANCET HIV, V4, pE21, DOI 10.1016/S2352-3018(16)30195-3; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 2015, GUID START ANT THER; Zash R, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2017.2222; Zash R, 2016, JAIDS-J ACQ IMM DEF, V71, P428, DOI 10.1097/QAI.0000000000000847	27	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199555	10.1371/journal.pone.0199555	http://dx.doi.org/10.1371/journal.pone.0199555			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020964	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400018
J	Wei, T; Liao, F; Wang, YW; Pan, C; Xiao, C; Huang, DX				Wei, Tian; Liao, Fei; Wang, Yaowu; Pan, Chao; Xiao, Chao; Huang, Daixin			A novel multiplex assay of SNP-STR markers for forensic purpose	PLOS ONE			English	Article							UNBALANCED DNA MIXTURES; SHORT TANDEM REPEATS; SEXUAL ASSAULT; DIP-STR; LASER MICRODISSECTION; EPITHELIAL-CELLS; SPERM CELLS; DIFFERENTIAL EXTRACTION; SIZE DISTRIBUTIONS; FLOW-CYTOMETRY	Like DIP-STR markers (deletion/insertion polymorphism-short tandem repeat combinations), SNP-STR markers (single nucleotide polymorphism-STR combinations) are also valuable in forensic DNA mixture analysis. In this study, eight SNP-STRs were selected, and a stable and sensitive multiplex polymerase chain reaction (PCR) assay was developed for amplifying these SNP-STRs and the Amelogenin gender marker according to the principle of amplification refractory mutation system (ARMS). This novel multiplex set allows detection of the minor DNA contributor in a DNA mixture of any gender and cellular origin with high resolution (beyond a DNA ratio of 1:20). In addition, SNP-STR haplotype frequencies were estimated based on a survey of 350 unrelated individuals from Chinese Han population, and the combined power of discrimination (PD) and power of exclusion (PE) of the eight SNP-STRs were calculated as 0.99999999965 and 0.9996, which were obviously higher than that of the eight STR loci: 0.9999999954 and 0.9989 respectively. The results indicated that the SNP-STR compound markers have higher application value in forensic identification compared to standard autosomal STRs, especially in the analysis of imbalanced DNA mixtures.	[Wei, Tian; Liao, Fei; Wang, Yaowu; Pan, Chao; Xiao, Chao; Huang, Daixin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Huang, DX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Forens Med, Wuhan, Hubei, Peoples R China.	huangdaixin@mails.tjmu.edu.cn	Xiao, Chao/HHS-6978-2022	Xiao, Chao/0000-0001-7070-3156; Huang, Daixin/0000-0001-8909-2375	National Natural Science Foundation of China [81373250]; Fundamental Research Funds for the Central Universities, HUST [2016YXZD025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (No. 81373250 to DH) and the Fundamental Research Funds for the Central Universities, HUST: No. 2016YXZD025 to DH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anslinger K, 2007, INT J LEGAL MED, V121, P54, DOI 10.1007/s00414-005-0065-7; Bienvenue JM, 2006, J FORENSIC SCI, V51, P266, DOI 10.1111/j.1556-4029.2006.00054.x; Bruck S, 2011, J FORENSIC SCI, V56, P176, DOI 10.1111/j.1556-4029.2010.01553.x; Budowle B, 2009, J FORENSIC SCI, V54, P810, DOI 10.1111/j.1556-4029.2009.01046.x; Castella V, 2013, HUM MUTAT, V34, P644, DOI 10.1002/humu.22280; Cereda G, 2014, FORENSIC SCI INT-GEN, V11, P229, DOI 10.1016/j.fsigen.2014.04.001; Cereda G, 2014, FORENSIC SCI INT-GEN, V8, P159, DOI 10.1016/j.fsigen.2013.09.001; Cerri N, 2003, CROAT MED J, V44, P289; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chen J, 1998, J FORENSIC SCI, V43, P114; Clayton T, 2005, FORENSIC DNA EVIDENCE INTERPRETATION, P217; Di Martino D, 2004, FORENSIC SCI INT, V146, pS155, DOI 10.1016/j.forsciint.2004.09.047; Di Nunno N, 2003, AM J FOREN MED PATH, V24, P254, DOI 10.1097/01.paf.0000070224.58005.ac; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Findlay I, 1997, NATURE, V389, P555, DOI 10.1038/39225; Geng T, 2014, ANAL CHEM, V86, P703, DOI 10.1021/ac403137h; GILL P, 1985, NATURE, V318, P577, DOI 10.1038/318577a0; Hall D, 2011, FORENS SCI INT-GEN S, V3, pE1, DOI 10.1016/j.fsigss.2011.08.065; Han JP, 2014, FORENSIC SCI INT-GEN, V13, P239, DOI 10.1016/j.fsigen.2014.08.012; Hill CR, 2008, J FORENSIC SCI, V53, P73, DOI 10.1111/j.1556-4029.2008.00595.x; Horsman KM, 2005, ANAL CHEM, V77, P742, DOI 10.1021/ac0486239; Kidd KK, 2015, INVESTIG GENET, V6, DOI 10.1186/s13323-014-0018-3; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Ladd C, 2001, CROAT MED J, V42, P244; Lynch L, 2015, FORENSIC SCI INT-GEN, V16, P1, DOI 10.1016/j.fsigen.2014.10.017; Mountain JL, 2002, GENOME RES, V12, P1766, DOI 10.1101/gr.238602; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Norris JV, 2009, ANAL CHEM, V81, P6089, DOI 10.1021/ac900439b; Oldoni F, 2015, FORENSIC SCI INT-GEN, V19, P156, DOI 10.1016/j.fsigen.2015.07.012; Pereira J, 2012, FORENSIC SCI INT-GEN, V6, P228, DOI 10.1016/j.fsigen.2011.05.005; Phillips C, 2016, FORENSIC SCI INT-GEN, V23, P19, DOI 10.1016/j.fsigen.2016.03.002; Schoell WMJ, 1999, OBSTET GYNECOL, V94, P623, DOI 10.1016/S0029-7844(99)00373-7; Tereba A., 1999, PROFILES DNA, V3, P14; van der Gaag KJ, 2016, FORENSIC SCI INT-GEN, V24, P86, DOI 10.1016/j.fsigen.2016.05.016; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wang L, 2015, FORENS SCI INT-GEN S, V5, pE598, DOI 10.1016/j.fsigss.2015.09.236; Wang L, 2013, FORENS SCI INT-GEN S, V4, pE206, DOI 10.1016/j.fsigss.2013.10.106; YOSHIDA K, 1995, FORENSIC SCI INT, V72, P25, DOI 10.1016/0379-0738(94)01668-U	39	13	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200700	10.1371/journal.pone.0200700	http://dx.doi.org/10.1371/journal.pone.0200700			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020969	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400065
J	Bozic, J; Stoka, V; Dolenc, I				Bozic, Janja; Stoka, Veronika; Dolenc, Iztok			Glucosamine prevents polarization of cytotoxic granules in NK-92 cells by disturbing FOXO1/ERK/paxillin phosphorylation	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MICROTUBULE-ORGANIZING CENTER; DIPEPTIDYL PEPTIDASE-I; HUMAN CATHEPSIN-C; ACTIVATION; APOPTOSIS; PERFORIN; KINASE; GLYCOSYLATION; TRANSLOCATION	Glucosamine (GlcN) is a naturally occurring derivative of glucose and an over-the-counter food additive. However, the mechanism underlying GlcN action on cells is unknown. In this study, we investigated the effect of GlcN on natural killer (NK) cells. We demonstrate that GlcN affects NK-92 cell cytotoxicity by altering the distribution of cathepsin C, a cysteine protease required for granzyme processing in cytotoxic granules. The relocation of cathepsin C due to GlcN was shown to be accompanied by a decrease in the intracellular enzyme activity and its extracellular secretion. Similarly, the relocation of endosomal aspartic cathepsin E was observed. Furthermore, we elucidated that repositioning of cathepsin C is a consequence of altered signaling pathways of cytotoxic granule movement. The inhibition of phosphorylation upstream and downstream of ERK by GlcN disturbed the polarized release of cytotoxic vesicles. Considerable changes in the ERK phosphorylation dynamics, but not in those of p38 kinase or JNK, were observed in the IL2-activated NK-92 cells. We found decreased phosphorylation of the transcription factor FOXO1 and simultaneous prolonged phosphorylation of ERK as well as its nuclear translocation. Additionally, a protein downstream of the ERK phosphorylation cascade, paxillin, was less phosphorylated, resulting in a diffuse distribution of cytotoxic granules. Taken together, our results suggest that dietary GlcN affects signaling pathway activation of NK-92 immune cells.	[Bozic, Janja; Stoka, Veronika; Dolenc, Iztok] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia; [Bozic, Janja; Stoka, Veronika] Int Postgrad Sch Jozef Stefan, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Stoka, V; Dolenc, I (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana, Slovenia.; Stoka, V (corresponding author), Int Postgrad Sch Jozef Stefan, Ljubljana, Slovenia.	veronika.stoka@ijs.si; iztok.dolenc@ijs.si	Stoka, Veronika/AAM-2283-2021	Bozic, PhD, Janja/0000-0002-0030-2071	Slovenian Research Agency [P1-0140]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This study was supported by grants from the Slovenian Research Agency research program P1-0140 lead by Dr. Boris Turk. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2005, FOOD CHEM TOXICOL, V43, P187, DOI 10.1016/j.fct.2004.11.006; BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535; Barrientos C, 2010, NUTR RES, V30, P791, DOI 10.1016/j.nutres.2010.10.008; BROWN GR, 1993, J IMMUNOL, V150, P4733; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; CHANG L, 1993, J IMMUNOL METHODS, V166, P45; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Chen X, 2006, P NATL ACAD SCI USA, V103, P10346, DOI 10.1073/pnas.0604236103; Chien MW, 2015, J BIOL CHEM, V290, P29329, DOI 10.1074/jbc.M115.674671; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; Dahl SW, 2001, BIOCHEMISTRY-US, V40, P1671, DOI 10.1021/bi001693z; Deng YC, 2015, IMMUNITY, V42, P457, DOI 10.1016/j.immuni.2015.02.006; Dolenc I, 1996, FEBS LETT, V392, P277, DOI 10.1016/0014-5793(96)00828-9; DOLENC I, 1995, J BIOL CHEM, V270, P21626, DOI 10.1074/jbc.270.37.21626; Fung MM, 2003, CELL SIGNAL, V15, P625, DOI 10.1016/S0898-6568(03)00003-2; Hwang JS, 2017, J BIOL CHEM, V292, P1724, DOI 10.1074/jbc.M116.737940; Hwang SY, 2010, GLIA, V58, P1881, DOI 10.1002/glia.21058; Ishibe S, 2003, MOL CELL, V12, P1275, DOI 10.1016/S1097-2765(03)00406-4; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Khaznadar Z, 2014, EUR J IMMUNOL, V44, P3068, DOI 10.1002/eji.201444500; Konjar S, 2010, IMMUNOLOGY, V131, P257, DOI 10.1111/j.1365-2567.2010.03299.x; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Li CL, 2008, P NATL ACAD SCI USA, V105, P3017, DOI 10.1073/pnas.0712310105; Ma LL, 2002, J BIOL CHEM, V277, P39343, DOI 10.1074/jbc.M204924200; Mace EM, 2014, IMMUNOL CELL BIOL, V92, P245, DOI 10.1038/icb.2013.96; MacNeil AJ, 2007, BIOCHEM BIOPH RES CO, V361, P146, DOI 10.1016/j.bbrc.2007.06.183; Metkar SS, 2015, CELL DEATH DIFFER, V22, P74, DOI 10.1038/cdd.2014.110; Mihelic M, 2006, FEBS LETT, V580, P4195, DOI 10.1016/j.febslet.2006.06.076; Nabbi Arash, 2015, Cold Spring Harb Protoc, V2015, P769, DOI 10.1101/pdb.prot083733; Nanut MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00616; Niwa Y, 2012, FEBS LETT, V586, P3601, DOI 10.1016/j.febslet.2012.08.001; Noursadeghi M, 2008, J IMMUNOL METHODS, V329, P194, DOI 10.1016/j.jim.2007.10.015; PARIS A, 1995, FEBS LETT, V369, P326, DOI 10.1016/0014-5793(95)00777-7; Puizdar V, 2012, BIOL CHEM, V393, P177, DOI 10.1515/hsz-2011-0219; QUASTEL JH, 1953, NATURE, V171, P252, DOI 10.1038/171252a0; Reichlin A, 2001, CURRENT PROTOCOLS IM; Robertson LK, 2005, J IMMUNOL, V175, P8138, DOI 10.4049/jimmunol.175.12.8138; Runhaar J, 2017, ANN RHEUM DIS, V76, P1862, DOI 10.1136/annrheumdis-2017-211149; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Simon RR, 2011, DIABETES-METAB RES, V27, P14, DOI 10.1002/dmrr.1150; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Smyth MJ, 2001, J LEUKOCYTE BIOL, V70, P18; Someya A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165158; Stoka V, 2001, J BIOL CHEM, V276, P3149, DOI 10.1074/jbc.M008944200; Stoka V, 2005, IUBMB LIFE, V57, P347, DOI 10.1080/15216540500154920; Stoka V, 2016, AGEING RES REV, V32, P22, DOI 10.1016/j.arr.2016.04.010; Sutton VR, 2007, J CELL BIOL, V176, P425, DOI 10.1083/jcb.200609077; Trotta R, 2000, J IMMUNOL, V165, P1782, DOI 10.4049/jimmunol.165.4.1782; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Turk B, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P1968, DOI 10.1016/B978-0-12-382219-2.00447-6; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wainstein E, 2016, CURR OPIN CELL BIOL, V39, P15, DOI 10.1016/j.ceb.2016.01.007; YAGITA M, 1989, CELL IMMUNOL, V122, P83, DOI 10.1016/0008-8749(89)90150-0; Yamamoto K, 2012, BBA-PROTEINS PROTEOM, V1824, P105, DOI 10.1016/j.bbapap.2011.05.022; Zeleznik TZ, 2015, BIOCHEM BIOPH RES CO, V465, P213, DOI 10.1016/j.bbrc.2015.07.155; Zhang GX, 2005, J IMMUNOL, V175, P7202, DOI 10.4049/jimmunol.175.11.7202	59	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200757	10.1371/journal.pone.0200757	http://dx.doi.org/10.1371/journal.pone.0200757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016365	gold, Green Published, Green Submitted			2022-12-26	WOS:000438866600041
J	Hagenauer, MH; Schulmann, A; Li, JZ; Vawter, MP; Walsh, DM; Thompson, RC; Turner, CA; Bunney, WE; Myers, RM; Barchas, JD; Schatzberg, AF; Watson, SJ; Akil, H				Hagenauer, Megan Hastings; Schulmann, Anton; Li, Jun Z.; Vawter, Marquis P.; Walsh, David M.; Thompson, Robert C.; Turner, Cortney A.; Bunney, William E.; Myers, Richard M.; Barchas, Jack D.; Schatzberg, Alan F.; Watson, Stanley J.; Akil, Huda			Inference of cell type content from human brain transcriptomic datasets illuminates the effects of age, manner of death, dissection, and psychiatric diagnosis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; SUPERIOR TEMPORAL CORTEX; GENE-EXPRESSION; PREFRONTAL CORTEX; INTRACELLULAR PH; MOLECULAR PROFILES; POSTMORTEM FACTORS; BIPOLAR DISORDER; QUALITY-CONTROL; NEURONS	Psychiatric illness is unlikely to arise from pathology occurring uniformly across all cell types in affected brain regions. Despite this, transcriptomic analyses of the human brain have typically been conducted using macro-dissected tissue due to the difficulty of performing single-cell type analyses with donated post-mortem brains. To address this issue statistically, we compiled a database of several thousand transcripts that were specifically-enriched in one of 10 primary cortical cell types in previous publications. Using this database, we predicted the relative cell type content for 833 human cortical samples using microarray or RNA-Seq data from the Pritzker Consortium (GSE92538) or publicly-available databases (GSE53987, GSE21935, GSE21138, CommonMind Consortium). These predictions were generated by averaging normalized expression levels across transcripts specific to each cell type using our R-package BrainInABlender (validated and publicly-released on github). Using this method, we found that the principal components of variation in the datasets strongly correlated with the predicted neuronal/glial content of the samples. This variability was not simply due to dissectionthe relative balance of brain cell types appeared to be influenced by a variety of demographic, pre- and post-mortem variables. Prolonged hypoxia around the time of death predicted increased astrocytic and endothelial gene expression, illustrating vascular upregulation. Aging was associated with decreased neuronal gene expression. Red blood cell gene expression was reduced in individuals who died following systemic blood loss. Subjects with Major Depressive Disorder had decreased astrocytic gene expression, mirroring previous morphometric observations. Subjects with Schizophrenia had reduced red blood cell gene expression, resembling the hypofrontality detected in fMRI experiments. Finally, in datasets containing samples with especially variable cell content, we found that controlling for predicted sample cell content while evaluating differential expression improved the detection of previously-identified psychiatric effects. We conclude that accounting for cell type can greatly improve the interpretability of transcriptomic data.	[Hagenauer, Megan Hastings; Thompson, Robert C.; Turner, Cortney A.; Watson, Stanley J.; Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Schulmann, Anton] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA; [Li, Jun Z.] Univ Michigan, Genet, Ann Arbor, MI 48109 USA; [Vawter, Marquis P.; Walsh, David M.; Bunney, William E.] Univ Calif Irvine, Irvine, CA USA; [Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Barchas, Jack D.] Stanford Univ, Palo Alto, CA 94304 USA; [Schatzberg, Alan F.] Cornell Univ, New York, NY 10021 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of California System; University of California Irvine; HudsonAlpha Institute for Biotechnology; Stanford University; Cornell University	Hagenauer, MH (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	hagenaue@umich.edu	Hagenauer, Megan/AAF-3544-2020	Turner, Cortney/0000-0003-3403-8843; Hagenauer, Megan/0000-0002-3715-9475; Schulmann, Anton/0000-0002-6323-4969	Pritzker Neuropsychiatric Research Consortium; National Institutes of Health [R01MH104261]; National Institute of Mental Health [P50 MH60398, R01MH085801, R21MH113177]; Office of Naval Research [N00014-12-1-0366, N00014-09-1-059]; Hope for Depression Research Foundation; William Lion Penzner Foundation; Della Martin Foundation; National Alliance for Research on Schizophrenia and Depression Abramson Family Foundation Investigator Award; International Mental Health Research Organization-Johnson & Johnson Rising Star Translational Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH104261, R01MH085801, R21MH113177] Funding Source: NIH RePORTER	Pritzker Neuropsychiatric Research Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of Naval Research(Office of Naval Research); Hope for Depression Research Foundation; William Lion Penzner Foundation; Della Martin Foundation; National Alliance for Research on Schizophrenia and Depression Abramson Family Foundation Investigator Award; International Mental Health Research Organization-Johnson & Johnson Rising Star Translational Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Pritzker Neuropsychiatric Research Consortium (https://pritzkerneuropsych.org/www/), as well as the National Institutes of Health (https://www.nih. gov, R01MH104261 to H.A. and S.J.W.), National Institute of Mental Health (https://www.nimh.nih.gov/index.shtml, Conte Center Grant P50 MH60398 to W.E.B., R01MH085801 and R21MH113177 to M.P.V.), Office of Naval Research (https://www.onr.navy.mil, N00014-12-1-0366, N00014-09-1-059, and N00014-12-1-0366 to H.A. and S.J.W.), and the Hope for Depression Research Foundation (https://www.hopefordepression.org, H.A. and S.J.W). W.E.B. was further supported by the William Lion Penzner Foundation and the Della Martin Foundation. J.Z.L. was further supported by a National Alliance for Research on Schizophrenia and Depression Abramson Family Foundation Investigator Award (https://www.bbrfoundation.org) and an International Mental Health Research Organization-Johnson & Johnson Rising Star Translational Research Award (http://imhro.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Amaral DG, 2007, PROG BRAIN RES, V163, P3, DOI 10.1016/S0079-6123(07)63001-5; [Anonymous], 2016, BIORXIV, DOI [DOI 10.1101/060012, 10.1101/060012]; Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171; Atlas Allen Brain, 2013, TECHN WHIT PAP CAS Q, V7; Atlas Allen Brain, 2013, TECHN WHIT PAP MICR, V7; Atz M, 2007, J NEUROSCI METH, V163, P295, DOI 10.1016/j.jneumeth.2007.03.022; Banasiak KJ, 1998, BRAIN RES, V797, P295, DOI 10.1016/S0006-8993(98)00286-8; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Barnes MR, 2011, J NEUROSCI RES, V89, P1218, DOI 10.1002/jnr.22647; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bowling K, 2016, BIORXIV, DOI [10.1101/061416, DOI 10.1101/061416]; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Capurro A, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00441; Carpenter M.B, 1991, CORE TEXT NEUROANATO; Chase KA, 2015, PSYCHIAT RES, V225, P208, DOI 10.1016/j.psychres.2014.11.007; CHESLER M, 1987, AM J PHYSIOL, V253, pR666, DOI 10.1152/ajpregu.1987.253.4.R666; Chikina M, 2015, BIOINFORMATICS, V31, P1584, DOI 10.1093/bioinformatics/btv015; Choi KH, 2011, BIOL PSYCHIAT, V69, P353, DOI 10.1016/j.biopsych.2010.09.042; Choi KH, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-87; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Doss JF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2156-2; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Evans SJ, 2004, P NATL ACAD SCI USA, V101, P15506, DOI 10.1073/pnas.0406788101; Fasold M, 2013, BIOINFORMATICS, V29, P129, DOI 10.1093/bioinformatics/bts629; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Gaujoux R, 2013, BIOINFORMATICS, V29, P2211, DOI 10.1093/bioinformatics/btt351; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Hamakawa H, 2004, PSYCHIAT CLIN NEUROS, V58, P82, DOI 10.1111/j.1440-1819.2004.01197.x; HAMBERGER A, 1963, J CELL BIOL, V16, P521, DOI 10.1083/jcb.16.3.521; Hashimoto T, 2003, J NEUROSCI, V23, P6315; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutchins DE, 2002, FUNDAMENTAL NEUROSCI, P15; Johnson CP, 2015, MOL PSYCHIATR, V20, P201, DOI 10.1038/mp.2014.157; Kato T, 1998, EUR ARCH PSY CLIN N, V248, P301, DOI 10.1007/s004060050054; Kuhn A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-610; Kuhn A, 2011, NAT METHODS, V8, P945, DOI [10.1038/NMETH.1710, 10.1038/nmeth.1710]; Lake BB, 2016, SCIENCE, V352, P1586, DOI 10.1126/science.aaf1204; Lanz TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121744; Lewis DA, 2009, J CLIN INVEST, V119, P706, DOI 10.1172/JCI37335; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Li JZ, 2004, HUM MOL GENET, V13, P609, DOI 10.1093/hmg/ddh065; Li LX, 2010, GLIA, V58, P1157, DOI 10.1002/glia.20995; Lynch JC, 2002, FUNDAMENTAL NEUROSCI, P505; Mancarci O, 2016, BIORXIV, DOI [10.1101/089219, DOI 10.1101/089219]; Mauney SA, 2015, SCHIZOPHR RES, V169, P374, DOI 10.1016/j.schres.2015.10.042; Medina A, 2016, J PSYCHIATR RES, V72, P15, DOI 10.1016/j.jpsychires.2015.10.010; Montano CM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r94; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morris HM, 2008, CEREB CORTEX, V18, P1575, DOI 10.1093/cercor/bhm186; Narayan S, 2008, BRAIN RES, V1239, P235, DOI 10.1016/j.brainres.2008.08.023; Pandey GN, 2002, AM J PSYCHIAT, V159, P419, DOI 10.1176/appi.ajp.159.3.419; Peters A, 2008, NEUROSCIENCE, V152, P970, DOI 10.1016/j.neuroscience.2007.07.014; Peters A, 2004, CEREB CORTEX, V14, P995, DOI 10.1093/cercor/bhh060; Peters A, 2010, J COMP NEUROL, V518, P3962, DOI 10.1002/cne.22434; Pietersen CY, 2014, J NEUROGENET, V28, P70, DOI 10.3109/01677063.2013.878339; Pollard KS, 2005, STAT BIOL HEALTH, P249; Ragland JD, 2007, INT REV PSYCHIATR, V19, P419, DOI 10.1080/09540260701486365; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Resnick SM, 2003, J NEUROSCI, V23, P3295; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Sequeira PA, 2012, NEUROBIOL DIS, V45, P23, DOI 10.1016/j.nbd.2011.03.001; Shen-Orr SS, 2013, CURR OPIN IMMUNOL, V25, P571, DOI 10.1016/j.coi.2013.09.015; Shepherd TM, 2009, NEUROIMAGE, V44, P820, DOI 10.1016/j.neuroimage.2008.09.054; Smith DE, 2004, J NEUROSCI, V24, P4373, DOI 10.1523/JNEUROSCI.4289-03.2004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Stranahan AM, 2012, J COMP NEUROL, V520, P1318, DOI 10.1002/cne.22790; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN N, 1993, J COMP NEUROL, V330, P381, DOI 10.1002/cne.903300308; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Turner CA, 2012, NEURON, V76, P160, DOI 10.1016/j.neuron.2012.08.037; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Volk DW, 2001, AM J PSYCHIAT, V158, P256, DOI 10.1176/appi.ajp.158.2.256; Volk DW, 2000, ARCH GEN PSYCHIAT, V57, P237, DOI 10.1001/archpsyc.57.3.237; Weis S, 2007, J NEUROSCI METH, V165, P198, DOI 10.1016/j.jneumeth.2007.06.001; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	84	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200003	10.1371/journal.pone.0200003	http://dx.doi.org/10.1371/journal.pone.0200003			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2XR	30016334	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600015
J	Higuchi, T; Nagami, T; Nakata, H; Kanosue, K				Higuchi, Takatoshi; Nagami, Tomoyuki; Nakata, Hiroki; Kanosue, Kazuyuki			Head-eye movement of collegiate baseball batters during fastball hitting	PLOS ONE			English	Article							BALL; MOTION; MODEL	Successful baseball hitting involves a combination of highly trained perceptual skills and forceful bat swing motions. The purpose of the present study was to quantify the horizontal movement of the head and eyes while baseball batters hit a fastball to clarify a visual strategy for this highly trained interceptive task. Six collegiate baseball players hit a fastball that was launched from a pitching machine. The ball speed was 31.9 ms(-1) for the Slow Ball Task and 40.3 ms(-1) for the Fast Ball Task. Horizontal head movements were analysed using images that were captured by two high-speed video cameras. The Horizontal eye movement was recorded with electrooculography. The angular speed of the horizontal head and eye movements during hitting were divided into four time periods (I-40 = 21-40% of total ball-flight, 1-60 = 41-60% of total ball-flight, I-80 = 61-80% of total ball-flight, I-100 = 81 100% of total ball-flight) and analysed using analysis of variance and a Tukey post-hoc multiple-comparison. In the Slow Ball Task, the horizontal angular velocity of the head during I-80 was significantly faster than that during I-40 (p < 0.05). In the Fast Ball Task, the horizontal angular velocity of the head during I-80 was significantly faster than that during I-40 and I-60 (p < 0.05). These results indicated that the tracking motion of the head became faster as the launched ball came close to the batters, but there was no change in the angular tracking motion of the eyes. Therefore, rapid eye movement may not be suitable to accurately estimate the ball's future location during fastball hitting based on the eye-centered coordinates. Our findings suggest that conventional vision training with a wide range of saccadic or smooth-pursuit eye movements does not reflect the characteristics of tracking strategies during baseball hitting.	[Higuchi, Takatoshi] Fukuoka Inst Technol, Fac Socioenvironm Studies, Fukuoka, Fukuoka, Japan; [Nagami, Tomoyuki] Kitasato Univ, Coll Liberal Arts & Sci, Sagamihara, Kanagawa, Japan; [Nakata, Hiroki] Nara Womens Univ, Fac Human Life & Environm, Nara, Japan; [Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Fukuoka Institute of Technology; Kitasato University; Nara Womens University; Waseda University	Higuchi, T (corresponding author), Fukuoka Inst Technol, Fac Socioenvironm Studies, Fukuoka, Fukuoka, Japan.	higuchi@fit.ac.jp			Japan Society for the Promotion on Science [16K16546]	Japan Society for the Promotion on Science	This work was supported by Japan Society for the Promotion on Science, Grant-in-Aid for Young Scientists (B) Grant Number 16K16546 to TH.	BAHILL AT, 1984, AM SCI, V72, P249; Brenner E, 2011, HUM MOVEMENT SCI, V30, P475, DOI 10.1016/j.humov.2010.12.007; Constable PA, 2017, DOC OPHTHALMOL, V134, P1, DOI 10.1007/s10633-017-9573-2; DeRenne C., 1992, J APPL SPORTS SCI RE, V6, P214, DOI 10.1519/00124278-199211000-00004; Dessing JC, 2005, J COGNITIVE NEUROSCI, V17, P668, DOI 10.1162/0898929053467604; Higuchi T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148498; Higuchi T, 2013, J APPL BIOMECH, V29, P279, DOI 10.1123/jab.29.3.279; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Pouget A, 2002, COGNITION, V83, pB1, DOI 10.1016/S0010-0277(01)00163-9; Sarpeshkar V, 2017, J EXP PSYCHOL HUMAN, V43, P1744, DOI 10.1037/xhp0000465; SCHALEN L, 1980, ACTA OTO-LARYNGOL, V90, P404, DOI 10.3109/00016488009131742; SHAFFER B, 1993, CLIN ORTHOP RELAT R, P285; SHANK MD, 1987, PERCEPT MOTOR SKILL, V64, P1191, DOI 10.2466/pms.1987.64.3c.1191; Spering M, 2011, J NEUROPHYSIOL, V105, P1756, DOI 10.1152/jn.00344.2010; Takeuchi T, 2009, PERCEPT MOTOR SKILL, V108, P971, DOI 10.2466/PMS.108.3.971-980; Uchida Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031530; Zago M, 2005, J NEURAL ENG, V2, DOI 10.1088/1741-2560/2/3/S04	20	8	8	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200443	10.1371/journal.pone.0200443	http://dx.doi.org/10.1371/journal.pone.0200443			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2XR	30016367	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600026
J	Wolf, CA; Young, HS; Zilliacus, KM; Wegmann, AS; McKown, M; Holmes, ND; Tershy, BR; Dirzo, R; Kropidlowski, S; Croll, DA				Wolf, Coral A.; Young, Hillary S.; Zilliacus, Kelly M.; Wegmann, Alexander S.; McKown, Matthew; Holmes, Nick D.; Tershy, Bernie R.; Dirzo, Rodolfo; Kropidlowski, Stefan; Croll, Donald A.			Invasive rat eradication strongly impacts plant recruitment on a tropical atoll	PLOS ONE			English	Article							NEW-ZEALAND; PALMYRA ATOLL; PISONIA-GRANDIS; SEED PREDATION; COCONUT PALM; PACIFIC RAT; LAND CRABS; ISLAND; FOREST; SEABIRDS	Rat eradication has become a common conservation intervention in island ecosystems and its effectiveness in protecting native vertebrates is increasingly well documented. Yet, the impacts of rat eradication on plant communities remain poorly understood. Here we compare native and non-native tree and palm seedling abundance before and after eradication of invasive rats (Rattus rattus) from Palmyra Atoll, Line Islands, Central Pacific Ocean. Overall, seedling recruitment increased for five of the six native trees species examined. While pre-eradication monitoring found no seedlings of Pisonia grandis, a dominant tree species that is important throughout the Pacific region, post-eradication monitoring documented a notable recruitment event immediately following eradication, with up to 688 individual P. grandis seedlings per 100m(2) recorded one month post-eradication. Two other locally rare native trees with no observed recruitment in pre-eradication surveys had recruitment post-rat eradication. However, we also found, by five years post-eradication, a 13-fold increase in recruitment of the naturalized and range-expanding coconut palm Cocos nucifera. Our results emphasize the strong effects that a rat eradication can have on tree recruitment with expected long-term effects on canopy composition. Rat eradication released non-native C. nucifera, likely with long-term implications for community composition, potentially necessitating future management interventions. Eradication, nevertheless, greatly benefitted recruitment of native tree species. If this pattern persists overtime, we expect long-term benefits for flora and fauna dependent on these native species.	[Wolf, Coral A.; Zilliacus, Kelly M.; McKown, Matthew; Tershy, Bernie R.; Croll, Donald A.] Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA; [Young, Hillary S.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Wegmann, Alexander S.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Wolf, Coral A.; Holmes, Nick D.] Isl Conservat, Santa Cruz, CA 95060 USA; [Dirzo, Rodolfo] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Kropidlowski, Stefan] US Fish & Wildlife Serv, Honolulu, HI USA; [Wegmann, Alexander S.] Nature Conservancy, Honolulu, HI USA; [McKown, Matthew] Conservat Metr, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Barbara; University of Hawaii System; University of Hawaii Manoa; Stanford University; United States Department of the Interior; US Fish & Wildlife Service; Nature Conservancy	Wolf, CA (corresponding author), Univ Calif Santa Cruz, Ecol & Evolutionary Biol Dept, Santa Cruz, CA 95064 USA.; Wolf, CA (corresponding author), Isl Conservat, Santa Cruz, CA 95060 USA.	coral.wolf@islandconversation.org		Wolf, Coral/0000-0001-6823-4311	Island Conservation; US Fish and Wildlife Service; National Fish and Wildlife Foundation; David and Lucile Packard Foundation; Moore Family Foundation; National Geographic Society; Nature Conservancy; National Science Foundation	Island Conservation; US Fish and Wildlife Service(US Fish & Wildlife Service); National Fish and Wildlife Foundation; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Moore Family Foundation; National Geographic Society(National Geographic Society); Nature Conservancy; National Science Foundation(National Science Foundation (NSF))	This research was funded by Island Conservation (https://www.islandconservation.org/; DC and BT), the US Fish and Wildlife Service (https://www.fws.gov/; NH and AW), National Fish and Wildlife Foundation (http://www.nfwf.org/Pages/default.aspx; NH), David and Lucile Packard Foundation (https://www.packard.org/; NH), Moore Family Foundation (NH), National Geographic Society (https://www.nationalgeographic.com/; RD and HY), The Nature Conservancy (https://www.nature.org/; AW), and the National Science Foundation (https://www.nsf.gov/; HY). The funding sources financially supported the data collection and writing of this report but did not have any other involvement in the study design data collection and analysis, decision to publish, or preparation of the manuscript. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the opinions or policies of the U.S. Government or the National Fish and Wildlife Foundation. Mention of trade names or commercial products does not constitute their endorsement by the U.S. Government or the National Fish and Wildlife Foundation.	ALLAWAY WG, 1984, MAR ECOL PROG SER, V19, P297, DOI 10.3354/meps019297; ALLEN RB, 1994, NEW ZEAL J BOT, V32, P429, DOI 10.1080/0028825X.1994.10412930; Atkinson I.A.E., 1985, International Council for Bird Preservation Technical Publication, P35; Auld TD, 2010, BIOL INVASIONS, V12, P3351, DOI 10.1007/s10530-010-9728-5; Bellingham PJ, 2010, NEW ZEAL J ECOL, V34, P115; Briggs AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041364; Brooke MD, 2018, ANIM CONSERV, V21, P3, DOI 10.1111/acv.12344; Burger AE, 2005, J TROP ECOL, V21, P263, DOI 10.1017/S0266467404002159; Burkill H.M., 1986, ECON BOT, V40, P176; Campbell DJ, 2002, BIOL CONSERV, V107, P19, DOI 10.1016/S0006-3207(02)00039-3; Campbell DJ, 2002, CHANGES NUMBERS WOOD; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Caut S, 2008, J APPL ECOL, V45, P428, DOI 10.1111/j.1365-2664.2007.01438.x; Chan E., 2006, SPECIES PROFILES PAC, V2, P1; Clayton RI, 2008, NEW ZEAL J ECOL, V32, P103; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; de Wit LA, 2017, AM J TROP MED HYG, V96, P749, DOI 10.4269/ajtmh.16-0573; Depkin CD, 2001, REPORT PALMYRA ATOLL; Doherty TS, 2016, P NATL ACAD SCI USA, V113, P11261, DOI 10.1073/pnas.1602480113; FALL MW, 1971, J MAMMAL, V52, P69, DOI 10.2307/1378432; Grant-Hoffman MN, 2010, BIOL INVASIONS, V12, P805, DOI 10.1007/s10530-009-9503-7; Grant-Hoffman MN, 2010, OECOLOGIA, V163, P449, DOI 10.1007/s00442-009-1523-6; Grant-Hoffman MN, 2010, OECOLOGIA, V162, P1005, DOI 10.1007/s00442-009-1500-0; Green PT, 1997, ECOLOGY, V78, P2474, DOI 10.1890/0012-9658(1997)078[2474:COSRBL]2.0.CO;2; Gunn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021143; Handler AT, 2007, PAC SCI, V61, P485, DOI 10.2984/1534-6188(2007)61[485:ASOPAL]2.0.CO;2; Hower LM, 2003, CARIBB J SCI, V39, P298; Hunt TL, 2007, J ARCHAEOL SCI, V34, P485, DOI 10.1016/j.jas.2006.10.003; Jackson W. B., 1967, Micronesica, V3, P5; Jones HP, 2008, CONSERV BIOL, V22, P16, DOI 10.1111/j.1523-1739.2007.00859.x; Jones HP, 2016, P NATL ACAD SCI USA, V113, P4033, DOI 10.1073/pnas.1521179113; Krauss KW, 2015, ECOHYDROLOGY, V8, P1514, DOI 10.1002/eco.1601; Le Corre M, 2015, BIOL CONSERV, V185, P85, DOI 10.1016/j.biocon.2014.12.015; Lei Simon A., 2010, Journal of the Arizona-Nevada Academy of Science, V42, P9, DOI 10.2181/036.042.0103; Lindquist ES, 2009, BIOL REV, V84, P203, DOI 10.1111/j.1469-185X.2008.00070.x; Lorvelec O, 2005, BIOL INVASIONS, V7, P135, DOI 10.1007/s10530-004-9643-8; Matisoo-Smith E, 2004, P NATL ACAD SCI USA, V101, P9167, DOI 10.1073/pnas.0403120101; McCauley DJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00409; McConkey KR, 2003, BIOL CONSERV, V109, P221, DOI 10.1016/S0006-3207(02)00149-0; Meyer JY, 2009, BIOL INVASIONS, V11, P1569, DOI 10.1007/s10530-008-9407-y; Monks JM, 2014, BIOL INVASIONS, V16, P167, DOI 10.1007/s10530-013-0511-2; Mueller-Dombois D, 1998, VEGETATION TROPICAL; Mulder CPH, 2009, BIOL INVASIONS, V11, P1671, DOI 10.1007/s10530-008-9396-x; Newton KM, 2016, J FISH WILDL MANAG, V7, P72, DOI 10.3996/082015-JFWM-073; Nigro KM, 2017, RESTOR ECOL, V25, P1015, DOI 10.1111/rec.12511; Pain D, 2000, EFFECTS BRODIFACOUM; Pender RJ, 2013, BIOL INVASIONS, V15, P213, DOI 10.1007/s10530-012-0280-3; Pitt WC, 2015, BIOL CONSERV, V185, P36, DOI 10.1016/j.biocon.2015.01.008; Russell JC, 2015, BIOL CONSERV, V185, P1, DOI 10.1016/j.biocon.2015.01.009; Schweizer D, 2016, PAC SCI, V70, P55, DOI 10.2984/70.1.5; Shiels AB, 2014, PAC SCI, V68, P145, DOI 10.2984/68.2.1; St Clair JJH, 2011, ANIM CONSERV, V14, P66, DOI 10.1111/j.1469-1795.2010.00391.x; St Clair JJH, 2011, BIOL CONSERV, V144, P68, DOI 10.1016/j.biocon.2010.10.006; Towns DR, 2006, BIOL INVASIONS, V8, P863, DOI 10.1007/s10530-005-0421-z; Traveset A, 2009, BIOL INVASIONS, V11, P1653, DOI 10.1007/s10530-008-9395-y; USEPA, 2006, INT RER EL DEC AZ ME; USFWS, 2011, PALM AT NAT WILDL RE; Walker TA, 1991, ATOLL RES B, P350; Wegmann A, 2012, P 25 VERT PEST C, P48; Wegmann A., 2009, LIMITATIONS TREE SEE; Whitworth DL, 2013, BIOL CONSERV, V162, P52, DOI 10.1016/j.biocon.2013.03.026; Yau KKW, 2003, BIOMETRICAL J, V45, P437, DOI 10.1002/bimj.200390024; Young HS, 2013, OECOLOGIA, V172, P857, DOI 10.1007/s00442-012-2542-2; Young HS, 2013, ECOLOGY, V94, P692, DOI 10.1890/12-0729.1; Young HS, 2010, J VEG SCI, V21, P1058, DOI 10.1111/j.1654-1103.2010.01219.x; Young HS, 2016, CAN J ZOOL, V95, P139; Zavaleta ES, 2001, TRENDS ECOL EVOL, V16, P454, DOI 10.1016/S0169-5347(01)02194-2	67	15	17	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200743	10.1371/journal.pone.0200743	http://dx.doi.org/10.1371/journal.pone.0200743			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016347	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600040
J	Koster, M; Itakura, S; Yovsi, R; Kartner, J				Koester, Moritz; Itakura, Shoji; Yovsi, Relindis; Kartner, Joscha			Visual attention in 5-year-olds from three different cultures	PLOS ONE			English	Article								Cognitive processes differ markedly between children from different cultures, with best evidence for attention to visual scenes and the activities of others. Children from urban Western cultures tend to focus on focal objects, whereas children from urban East-Asian cultures rather attend to contextual elements of a visual scene. Regarding the attention to others' activities, children from subsistence-based farming communities often observe several activities simultaneously, while children from urban Western contexts focus on activities sequentially. Here we assessed 144 5-year-old children from three prototypical cultural contexts (urban Germany, rural Cameroon, urban Japan) to investigate variations in attention across a variety of tasks. Attention to the elements of a visual scene was assessed in an optical illusion task, in picture descriptions and an eye-tracking paradigm. Attention to and learning from others' activities was assessed in a parallel action task and a rule-based game. Some tasks indicated higher context-sensitive attention in urban Japan, while other findings indicated higher context-sensitive attention in urban Germany. Levels of parallel attention and learning from others' activities were lower in rural Cameroonian children compared to the urban samples. Across tasks, the visual attention measures were unrelated. These findings substantiate that culture has a profound influence on early cognitive development, already in the preschool years. Furthermore, they raise critical questions about the early origins of cultural specificities in attention and the generalizability of attention phenomena beyond specific tasks and populations.	[Koester, Moritz; Kartner, Joscha] Univ Munster, Dept Psychol, Fliednerstr 21, Munster, Germany; [Koester, Moritz] Free Univ Berlin, Inst Psychol, Habelschwerdter Allee 45, Berlin, Germany; [Itakura, Shoji] Kyoto Univ, Grad Sch Letters, Dept Psychol, Sakyo Ku, Yoshida Honmachi, Kyoto, Japan	University of Munster; Free University of Berlin; Kyoto University	Koster, M (corresponding author), Univ Munster, Dept Psychol, Fliednerstr 21, Munster, Germany.; Koster, M (corresponding author), Free Univ Berlin, Inst Psychol, Habelschwerdter Allee 45, Berlin, Germany.	moritz.koester@fu-berlin.de	Kärtner, Joscha/AFF-7996-2022; Köster, Moritz/AAO-3276-2020; Kärtner, Joscha/AAE-9952-2022	Kärtner, Joscha/0000-0003-4139-5339; Köster, Moritz/0000-0002-0572-0061; Kärtner, Joscha/0000-0003-4139-5339; Koster, Moritz/0000-0002-9951-7741	DAAD fellowship (German Academic Exchange Service); Owen Aldis Award (International Society for Human Ethology); University of Munster; Open Access Publication Fund of University of Munster	DAAD fellowship (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Owen Aldis Award (International Society for Human Ethology); University of Munster; Open Access Publication Fund of University of Munster	The data assessment in Cameroon was partly funded by a DAAD fellowship (German Academic Exchange Service) to MK. The data assessment in Cameroon was partly funded by an Owen Aldis Award (International Society for Human Ethology) to MK. Ruth Baumann received a PROMOS stipend from the University of Munster. We received financial support by Open Access Publication Fund of University of Munster.	Bremner AJ, 2016, CHILD DEV, V87, P962, DOI 10.1111/cdev.12511; CHIU LH, 1972, INT J PSYCHOL, V7, P235, DOI 10.1080/00207597208246604; Chua HF, 2005, P NATL ACAD SCI USA, DOI [10.1073/pnas0506162102, DOI 10.1073/PNAS0506162102]; Cohen AS, 2015, COG SCI, DOI [10.1111/cogs12329, DOI 10.1111/C0GS12329]; Cole M., 1998, CULTURAL PSYCHOL ONC; Correa-Chavez M, 2005, CHILD DEV, DOI [10.1111/j1467-8624200500870x, DOI 10.1111/J1467-8624200500870X]; Correa-Chavez M, 2009, DEV PSYCHOL, V45, P630, DOI 10.1037/a0014144; Doherty MJ, 2008, PERCEPTION, V37, P1426, DOI 10.1068/p5946; Doherty MJ, 2010, DEVELOPMENTAL SCI, V13, P714, DOI 10.1111/j.1467-7687.2009.00931.x; Duffy S, 2009, J EXP CHILD PSYCHOL, DOI [10.1016/jjecp200806006, DOI 10.1016/JJECP200806006]; Gauthier I, 1997, VISION RES, DOI [10.1016/S0042-6989(96)00286-6, DOI 10.1016/S0042-6989(96)002866]; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Imada T, 2013, DEVELOPMENTAL SCI, DOI [10.1111/desc12016, DOI 10.1111/DESC12016]; Ji L, 2000, J PERS SOC PSYCHOL, DOI [10.1037/0022-3514785943, DOI 10.1037/0022-3514785943]; Kartner J, 2015, CHILD DEV, DOI [10.1111/cdev12377, DOI 10.1111/CDEV12377]; Kaspar K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021719; Keller H., 2013, ADV CULTURE PSYCHOL, P63, DOI [DOI 10.1093/ACPROF:OSO/9780199930449.003.0002, 10.1093/acprof:oso/9780199930449.003.0002]; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Koster M, 2017, NEUROIMAGE, V163, P413, DOI 10.1016/j.neuroimage.2017.08.008; Koster M, 2016, CHILD DEV, V87, P1727, DOI 10.1111/cdev.12636; Koster M, 2018, CONTEXT SENSITIVE AT; Koster M, 2015, HUMAN ETHOLOGY B; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masuda T, 2001, J PERS SOC PSYCHOL, DOI [10.1037/0022-3514815922, DOI 10.1037/0022-3514815922]; Mejia-Arauz R, 2007, CHILD DEV, DOI [10.1111/j1467-8624200701046x, DOI 10.1111/J1467-8624200701046X]; Mejia-Arauz R, 2005, INT J BEHAV DEV, DOI [10.1080/01650250444000342, DOI 10.1080/01650250444000342]; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Nisbett RE, 2003, P NATL ACAD SCI USA, DOI [10.1073/pnas1934527100, DOI 10.1073/PNAS1934527100]; Nisbett RE, 2001, PSYCHOL REV, DOI [10.1037/0033-295X1082291, DOI 10.1037/0033-295X1082291]; Rogoff B., 2007, HDB SOCIALIZATION TH, P490; Rogoff B, 2003, ANNU REV PSYCHOL, DOI [10.1146/annurevpsych54101601145118, DOI 10.1146/ANNUREVPSYCH54101601145118]; Rogoff B., 2003, CULTURAL NATURE HUMA; Rothbaum F, 2000, CHILD DEV, V71, P1121, DOI 10.1111/1467-8624.00214; Segall M.H., 1966, INFLUENCE CULTURE VI; Senzaki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147199; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481	36	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200239	10.1371/journal.pone.0200239	http://dx.doi.org/10.1371/journal.pone.0200239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2LQ	30011296	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800015
J	Palomino-Schatzlein, M; Simo, R; Hernandez, C; Ciudin, A; Mateos-Gregorio, P; Hernandez-Mijares, A; Pineda-Lucena, A; Herance, JR				Palomino-Schatzlein, Martina; Simo, Rafael; Hernandez, Cristina; Ciudin, Andreea; Mateos-Gregorio, Pablo; Hernandez-Mijares, Antonio; Pineda-Lucena, Antonio; Raul Herance, Jose			Metabolic fingerprint of insulin resistance in human polymorphonuclear leucocytes	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; ADIPONECTIN; OBESITY; PLASMA	The present study was aimed at determining the metabolic profile of PMNs in obese subjects, and to explore its potential relationship with insulin resistance (IR). To achieve this goal, a pilot clinical study was performed using PMNs from 17 patients with obesity and IR, and 17 lean controls without IR, which was validated in an additional smaller cohort (consisting of 10 patients and 10 controls). PMNs were isolated from peripheral blood and nuclear magnetic resonance was used to perform the metabolomic analysis. A total of 48 metabolites were quantified. The main metabolic change found in PMNs was a significant increase in 2-aminoisobutyric acid with a direct correlation with HOMA-IR (p<0.001), BMI (p<0.000001) and waist circumference (p<0.000001). By contrast, a decrease of 3-hydroxyisovalerate was observed with an inverse correlation with HOMA-IR (p = 0.001), BMI (p = 0.001) and waist circumference (p = 0.0001). Notably, the metabolic profile in plasma was different than that obtained in PMNs. In summary, our results suggest that the change in 3-hydroxyisovalerate and 2-aminoisobutyric is the key metabolic fingerprint in PMNs of obese subjects with IR. In addition, our methodology could be an easy and reliable tool for monitoring the effect of treatments in the setting of precision medicine.	[Palomino-Schatzlein, Martina; Mateos-Gregorio, Pablo; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia, Spain; [Simo, Rafael; Hernandez, Cristina; Ciudin, Andreea] Vail dHebron Res Inst, Diabet & Metab Res Unit, Barcelona, Spain; [Simo, Rafael; Hernandez, Cristina; Ciudin, Andreea] CIBERDEM Inst Salud Carlos III, Madrid, Spain; [Hernandez-Mijares, Antonio] Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Univ Hosp Doctor Peset, Serv Endocrinol, Valencia, Spain; [Pineda-Lucena, Antonio] Hosp Univ Politecn La Fe, Inst Invest Sanitaria La Fe, Drug Discovery Unit, Valencia, Spain; [Raul Herance, Jose] Vail dHebron Res Inst, CIBERbbn, CIBBIM Nanomed, Med Mol Imaging Res Grp, Barcelona, Spain	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Hospital Universitari i Politecnic La Fe; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Palomino-Schatzlein, M (corresponding author), Ctr Invest Principe Felipe, Struct Biochem Lab, Valencia, Spain.; Simo, R (corresponding author), Vail dHebron Res Inst, Diabet & Metab Res Unit, Barcelona, Spain.; Simo, R (corresponding author), CIBERDEM Inst Salud Carlos III, Madrid, Spain.; Herance, JR (corresponding author), Vail dHebron Res Inst, CIBERbbn, CIBBIM Nanomed, Med Mol Imaging Res Grp, Barcelona, Spain.	mpalomino@cipf.es; rafael.simo@vhir.org; raul.herance@vhir.org	Pineda-Lucena, Antonio/B-1320-2014; Camacho, José Raul Herance/Q-3416-2016; CIUDIN, ANDREEA/O-5250-2016; Palomino-Schätzlein, Martina/L-6260-2014	Pineda-Lucena, Antonio/0000-0002-3532-8781; Camacho, José Raul Herance/0000-0001-7178-3290; CIUDIN, ANDREEA/0000-0001-5622-0203; Simo Canonge, Rafael/0000-0003-0475-3096; Hernandez, Cristina/0000-0002-3109-1721; Palomino-Schatzlein, Martina/0000-0001-7303-0743	Carlos III Health Institute; European Regional Development Fund [PI16/02064, CP13/00252]; Spanish Ministerio de Economia y Competitividad [SAF2014-53977-R, RD12/0036/0025]; Ministry of Health of the Carlos III Health Institute	Carlos III Health Institute(Instituto de Salud Carlos III); European Regional Development Fund(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government); Ministry of Health of the Carlos III Health Institute	This work was supported by the Carlos III Health Institute and the European Regional Development Fund (PI16/02064, CP13/00252) to JRH and the Spanish Ministerio de Economia y Competitividad (SAF2014-53977-R and RD12/0036/0025) to MP. In addition, JRH is recipient of a contract from the Ministry of Health of the Carlos III Health Institute.	Agrawal M, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0917-9; Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Caimi G, 2000, ACTA DIABETOL, V37, P9, DOI 10.1007/s005920070029; Connelly MA, 2017, METAB SYNDR RELAT D, V15, P183, DOI 10.1089/met.2016.0145; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Fejfarova V, 2006, METABOLISM, V55, P811, DOI 10.1016/j.metabol.2006.02.007; Gonzalez-Muniesa P, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.34; Gowda GAN, 2015, ANAL CHEM, V87, P706, DOI 10.1021/ac503651e; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Jang C, 2016, NAT MED, V22, P421, DOI 10.1038/nm.4057; Karlikova R, 2016, J PROTEOME RES, V15, P3158, DOI 10.1021/acs.jproteome.6b00356; Kovacs H, 2005, PROG NUCL MAG RES SP, V46, P131, DOI 10.1016/j.pnmrs.2005.03.001; Lee CC, 2016, DIABETES CARE, V39, P582, DOI 10.2337/dc15-2284; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; Mayer-Scholl A, 2004, CURR OPIN MICROBIOL, V7, P62, DOI 10.1016/j.mib.2003.12.004; McShane LM, 2013, NATURE, V502, P317, DOI 10.1038/nature12564; Okekunle AP, 2017, DIABETES RES CLIN PR, V132, P45, DOI 10.1016/j.diabres.2017.07.023; Palomino-Schatzlein M, 2013, ANAL BIOANAL CHEM, V405, P8431, DOI 10.1007/s00216-013-7271-9; Palomino-Schatzlein M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182985; Park S, 2015, MOL CELLS, V38, P587, DOI 10.14348/molcells.2015.0126; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Rietman A, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2015.37; Seijkens T, 2014, DIABETES, V63, P3982, DOI 10.2337/db14-0272; Shin AC, 2014, CELL METAB, V20, P898, DOI 10.1016/j.cmet.2014.09.003; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Trellakis S, 2012, OBESITY FACTS, V5, P305, DOI 10.1159/000339452; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Walrand S, 2004, J LEUKOCYTE BIOL, V76, P1104, DOI 10.1189/jlb.0104050; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Zhao X, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2794591; Zhao X, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/8160545; Zheng P, 2016, J AFFECT DISORDERS, V195, P75, DOI 10.1016/j.jad.2016.02.008; Zilio S, 2016, VACCINES-BASEL, V4, DOI 10.3390/vaccines4030031	35	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0199351	10.1371/journal.pone.0199351	http://dx.doi.org/10.1371/journal.pone.0199351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005063	Green Submitted, Green Published, gold			2022-12-26	WOS:000438744200002
J	Hane, F; Augusta, C; Bai, O				Hane, Francis; Augusta, Carolyn; Bai, Owen			A hierarchical Bayesian model to predict APOE4 genotype and the age of Alzheimer's disease onset	PLOS ONE			English	Article							APOLIPOPROTEIN-E; RISK; ASSOCIATION; DEMENTIA; INJURY; SEX	In this work we use a hierarchical Bayesian paradigm to introduce a theoretical framework to determine an individual's Apolipoprotein epsilon 4 (APOE4) genotype, which heavily influences both the age of onset and probability of acquiring Alzheimer's disease (AD). This calculation is based solely on an individual's family history. This APOE4 genotype estimation is then combined with a number of known factors that influence AD onset to produce a function that estimates the onset of AD as a function of age. We disseminated our Alzheimer's predictive tool online at http://www.alzheimerspredictor.com.	[Hane, Francis] Lakehead Univ, Thunder Bay, ON, Canada; [Hane, Francis; Bai, Owen] Thunder Bay Reg Hlth Res Inst, Thunder Bay, ON, Canada; [Augusta, Carolyn] Univ Guelph, Guelph, ON, Canada	Lakehead University; Northern Ontario School of Medicine; University of Guelph	Hane, F (corresponding author), Lakehead Univ, Thunder Bay, ON, Canada.; Hane, F (corresponding author), Thunder Bay Reg Hlth Res Inst, Thunder Bay, ON, Canada.	fthane@uwaterloo.ca		Augusta, Carolyn/0000-0002-0201-9800	BrightFocus Foundation [A2015344F]	BrightFocus Foundation(BrightFocus Foundation)	The authors received no specific funding for this work. FH is supported by a post doctoral fellowship from the BrightFocus Foundation (A2015344F).	Arvanitakis Z, 2004, ARCH NEUROL-CHICAGO, V61, P661, DOI 10.1001/archneur.61.5.661; Bayes T., 1764, PHILOS T ROY SOC LON, V53, P370, DOI [10.1098/rstl.1763.0053, DOI 10.1098/RSTL.1763.0053]; Callahan BL, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0152-z; Centers for Disease Control and Prevention, 2014, NAT DIAB REP; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CROXSON SCM, 1995, AGE AGEING, V24, P421, DOI 10.1093/ageing/24.5.421; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Irie F, 2008, ARCH NEUROL-CHICAGO, V65, P89, DOI 10.1001/archneurol.2007.29; Khachaturian AS, 2011, ALZHEIMERS DEMENT, V7, P1, DOI 10.1016/j.jalz.2010.12.001; Letenneur L, 1999, J NEUROL NEUROSUR PS, V66, P177, DOI 10.1136/jnnp.66.2.177; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Macdonald A., 2000, ASTIN BULL, V30, P69, DOI [10.2143/AST.30.1.504627, DOI 10.2143/AST.30.1.504627]; Mendel G., 1901, J ROYAL HORTICULTURA, V26, P1; Mendel G. J., 1866, VERHANDLUNGEN NATURF, V4, P3; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; OTT A, 1995, BRIT MED J, V310, P970, DOI 10.1136/bmj.310.6985.970; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200263	10.1371/journal.pone.0200263	http://dx.doi.org/10.1371/journal.pone.0200263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001420	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400040
J	Mascalchi, M; Marzi, C; Giannelli, M; Ciulli, S; Bianchi, A; Ginestroni, A; Tessa, C; Nicolai, E; Aiello, M; Salvatore, E; Soricelli, A; Diciotti, S				Mascalchi, Mario; Marzi, Chiara; Giannelli, Marco; Ciulli, Stefano; Bianchi, Andrea; Ginestroni, Andrea; Tessa, Carlo; Nicolai, Emanuele; Aiello, Marco; Salvatore, Elena; Soricelli, Andrea; Diciotti, Stefano			Histogram analysis of DTI-derived indices reveals pontocerebellar degeneration and its progression in SCA2	PLOS ONE			English	Article							SPATIAL STATISTICS; HUNTINGTONS-DISEASE; DIFFUSION; ATAXIA; ROBUST; ATROPHY; MOTION; DAMAGE; MRI	Purpose To assess the potential of histogram metrics of diffusion-tensor imaging (DTI)-derived indices in revealing neurodegeneration and its progression in spinocerebellar ataxia type 2 (SCA2). Materials and methods Nine SCA2 patients and 16 age-matched healthy controls, were examined twice (SCA2 patients 3.6 +/- 0.7 years and controls 3.3 +/- 1.0 years apart) on the same 1.5T scanner by acquiring T-1-weighted and diffusion-weighted (b-value = 1000 s/mm(2)) images. Cerebrum and brainstem-cerebellum regions were segmented using FreeSurfer suite. Histogram analysis of DTI-derived indices, including mean diffusivity (MD), fractional anisotropy (FA), axial (AD) / radial (RD) diffusivity and mode of anisotropy (MO), was performed. Results At baseline, significant differences between SCA2 patients and controls were confined to brainstem-cerebellum. Median values of MD/AD/RD and FA/MO were significantly (p<0.001) higher and lower, respectively, in SCA2 patients (1.11/1.30/1.03x10(-3) mm(2)/s and 0.14/0.19) than in controls (0.80/1.00/0.70x10(-3) mm(2)/s and 0.20/0.41). Also, peak location values of MD/AD/RD and FA were significantly (p<0.001) higher and lower, respectively, in SCA2 patients (0.91/1.11/0.81x10(-3) mm(2)/s and 0.12) than in controls (0.71/0.91/0.63x10(-3) mm(2)/s and 0.18). Peak height values of FA and MD/AD/RD/MO were significantly (p<0.001) higher and lower, respectively, in SCA2 patients (0.20 and 0.07/0.06/0.07x10(-3) mm(2)/s/year 0.07) than in controls (0.15 and 0.14/0.11/0.12/x10(-3) mm(2)/s/year /0.09). The rate of change of MD median values was significantly (p<0.001) higher (i.e., increased) in SCA2 patients (0.010x10(-3) mm(2)/s/year) than in controls (-0.003x10(-3) mm(2)/s/year) in the brainstem-cerebellum, whereas no significant difference was found for other indices and in the cerebrum. Conclusion Histogram analysis of DTI-derived indices is a relatively straightforward approach which reveals microstructural changes associated with pontocerebellar degeneration in SCA2 and the median value of MD is capable to track its progression.	[Mascalchi, Mario; Ciulli, Stefano; Bianchi, Andrea] Univ Florence, Mario Serio Dept Expt & Clin Biomed Sci, Florence, Italy; [Marzi, Chiara; Diciotti, Stefano] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Cesena, Italy; [Giannelli, Marco] Pisa Univ Hosp Azienda Osped Univ Pisana, Unit Med Phys, Pisa, Italy; [Ginestroni, Andrea] Azienda Osped Univ Careggi, Neuroradiol Unit, Florence, Italy; [Tessa, Carlo] Versilia Hosp, Dept Radiol & Nucl Med, AUSL 12 Viareggio, Lido Di Camaiore, Lu, Italy; [Nicolai, Emanuele; Aiello, Marco] IRCSS Fondaz SDN, Naples, Italy; [Salvatore, Elena] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy; [Soricelli, Andrea] Univ Naples Parthenope, Naples, Italy	University of Florence; University of Bologna; University of Pisa; Azienda Ospedaliero Universitaria Pisana; University of Florence; Azienda Ospedaliero Universitaria Careggi; Ospedale Versilia; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); University of Naples Federico II; Parthenope University Naples	Mascalchi, M (corresponding author), Univ Florence, Mario Serio Dept Expt & Clin Biomed Sci, Florence, Italy.	m.mascalchi@dfc.unifi.it	Giannelli, Marco/AAO-5778-2020; Diciotti, Stefano/C-4167-2008; Aiello, Marco/K-3896-2016; Soricelli, Andrea/C-1133-2009	Diciotti, Stefano/0000-0001-8778-7819; Aiello, Marco/0000-0002-3676-0664; Giannelli, Marco/0000-0002-4061-0490; Ciulli, Stefano/0000-0002-9386-3088; Soricelli, Andrea/0000-0001-7011-7667; Mascalchi, Mario/0000-0002-5537-2982; Marzi, Chiara/0000-0002-1791-3573; SALVATORE, Elena/0000-0003-1493-5133				Auburger Georg W J, 2012, Handb Clin Neurol, V103, P423, DOI 10.1016/B978-0-444-51892-7.00026-7; Bach M, 2014, NEUROIMAGE, V100, P358, DOI 10.1016/j.neuroimage.2014.06.021; Baldarcara L, 2015, CEREBELLUM, V14, P175, DOI 10.1007/s12311-014-0610-3; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Cook PA, 2006, 14 SCI M INT SOC MAG, P2759; Della Nave R, 2008, NEUROIMAGE, V43, P10, DOI 10.1016/j.neuroimage.2008.06.036; Della Nave R, 2011, NEURORADIOLOGY, V53, P367, DOI 10.1007/s00234-010-0807-1; Ennis DB, 2006, MAGN RESON MED, V55, P136, DOI 10.1002/mrm.20741; FILLA A, 1990, J NEUROL, V237, P345, DOI 10.1007/BF00315657; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Focke NK, 2014, HUM BRAIN MAPP, V35, P3332, DOI 10.1002/hbm.22405; Goveas J, 2015, MAGN RESON IMAGING, V33, P853, DOI 10.1016/j.mri.2015.04.006; Hernandez-Castillo CR, 2016, J INT NEUROPSYCH SOC, V22, P486, DOI 10.1017/S1355617716000084; Hernandez-Castillo CR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135449; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jiang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112550; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045996; Kindlmann G, 2007, IEEE T MED IMAGING, V26, P1483, DOI 10.1109/TMI.2007.907277; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Madhyastha T, 2014, HUM BRAIN MAPP, V35, P4544, DOI 10.1002/hbm.22493; Mandelli ML, 2007, AM J NEURORADIOL, V28, P1996, DOI 10.3174/ajnr.A0716; Mascalchi M, 2015, AM J NEURORADIOL, V36, P1096, DOI 10.3174/ajnr.A4343; Mascalchi M., 2012, HDB CLIN NEUROL, P85, DOI [DOI 10.1016/B978-0-444-51892-7.00004-8, 10.1016/B978-0-444-51892-7.00004-8]; Mascalchi M, 2016, J NEUROIMAGING, V26, P197, DOI 10.1111/jon.12270; Mori S., 2013, INTRO DIFFUSION TENS; Odish OFF, 2015, HUM BRAIN MAPP, V36, P2061, DOI 10.1002/hbm.22756; Pareyson D, 1999, J NEUROL, V246, P389, DOI 10.1007/s004150050369; Pellecchia MT, 2011, MOVEMENT DISORD, V26, P1303, DOI 10.1002/mds.23601; Reetz K, 2013, BRAIN, V136, P905, DOI 10.1093/brain/aws369; Reginold W, 2014, PARKINSONISM RELAT D, V20, P222, DOI 10.1016/j.parkreldis.2013.10.002; Rosas HD, 2010, NEUROIMAGE, V49, P2995, DOI 10.1016/j.neuroimage.2009.10.015; Sakai T, 2002, ARCH NEUROL-CHICAGO, V59, P1044, DOI 10.1001/archneur.59.6.1044; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steens Stefan C A, 2004, Eur Radiol, V14, P425, DOI 10.1007/s00330-003-2121-3; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Zhang H, 2007, IEEE T MED IMAGING, V26, P1585, DOI 10.1109/TMI.2007.906784	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200258	10.1371/journal.pone.0200258	http://dx.doi.org/10.1371/journal.pone.0200258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001379	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400039
J	Yasuda-Yamahara, M; Rogg, M; Yamahara, K; Maier, JI; Huber, TB; Schell, C				Yasuda-Yamahara, Mako; Rogg, Manuel; Yamahara, Kosuke; Maier, Jasmin, I; Huber, Tobias B.; Schell, Christoph			AlF1L regulates actomyosin contractility and filopodial extensions in human podocytes	PLOS ONE			English	Article							INFLAMMATORY FACTOR-I; FOOT PROCESS EFFACEMENT; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIN-ASSOCIATED PROTEIN; LARGE GENE LISTS; AIF-1 EXPRESSION; PROLIFERATION; ACTIVATION; DISEASE; LAMELLIPODIA	Podocytes are highly-specialized epithelial cells essentially required for the generation and the maintenance of the kidney filtration barrier. This elementary function is directly based on an elaborated cytoskeletal apparatus establishing a complex network of primary and secondary processes. Here, we identify the actin-bundling protein allograft-inflammatory-inhibitor 1 like (AIF1L) as a selectively expressed podocyte protein in vivo. We describe the distinct subcellular localization of AIF1L to actin stress fibers, focal adhesion complexes and the nuclear compartment of podocytes in vitro. Genetic deletion of AIF1L in immortalized human podocytes resulted in an increased formation of filopodial extensions and decreased actomyosin contractility. By the use of SILAC based quantitative proteomics analysis we describe the podocyte specific AIF1L interactome and identify several components of the actomyosin machinery such as MYL9 and UNC45A as potential AIF1L interaction partners. Together, these findings indicate an involvement of AIF1L in the stabilization of podocyte morphology by titrating actomyosin contractility and membrane dynamics.	[Yasuda-Yamahara, Mako; Rogg, Manuel; Yamahara, Kosuke; Maier, Jasmin, I; Huber, Tobias B.; Schell, Christoph] Univ Freiburg, Fac Med, Med Ctr, Dept Med 4, Freiburg, Germany; [Yasuda-Yamahara, Mako; Yamahara, Kosuke] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Maier, Jasmin, I; Schell, Christoph] Univ Med Ctr Freiburg, Inst Surg Pathol, Freiburg, Germany; [Huber, Tobias B.] Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany; [Huber, Tobias B.] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany; [Schell, Christoph] Univ Freiburg, Fac Med, Berta Ottenstein Programme, Freiburg, Germany	University of Freiburg; Shiga University of Medical Science; University of Freiburg; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Huber, TB (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Dept Med 4, Freiburg, Germany.; Huber, TB (corresponding author), Albert Ludwigs Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.; Huber, TB (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med 3, Hamburg, Germany.	t.huber@uke.de		Huber, Tobias B./0000-0001-7175-5062; Rogg, Manuel/0000-0002-6658-9159; Maier, Jasmin Isabel/0000-0003-4158-2935	German Research Foundation (DFG) [CRC 1140, CRC 992, HU 1016/8-1]; European Research Council (ERC grant); H2020-IMI2 consortium BEAt-DKD [115974]; BMBF [STOP-FSGS 01GM1518C]; MSD Life Science Foundation; Public Interest Incorporated Foundation; Uehara Memorial Foundation; Excellence Initiative of the German Federal and State Governments; Freiburg Institute for Advanced Studies (FRIAS); German Society of Nephrology DGFN; Else KroEner Fresenius Stiftung, NAKSYS; Else Kroner-Fresenius-Stiftung [2018_A09]; Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg; Life Imaging Center (LIC) of the University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council (ERC grant)(European Research Council (ERC)); H2020-IMI2 consortium BEAt-DKD; BMBF(Federal Ministry of Education & Research (BMBF)); MSD Life Science Foundation; Public Interest Incorporated Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Excellence Initiative of the German Federal and State Governments; Freiburg Institute for Advanced Studies (FRIAS)(Fonds de la Recherche Scientifique - FNRS); German Society of Nephrology DGFN; Else KroEner Fresenius Stiftung, NAKSYS; Else Kroner-Fresenius-Stiftung; Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg; Life Imaging Center (LIC) of the University of Freiburg	This study was supported by the German Research Foundation (DFG): CRC 1140 (to TBH) and CRC 992 (to TBH), Heisenberg program (to TBH), and HU 1016/8-1 (to TBH); by the European Research Council (ERC grant to TBH) and by the H2020-IMI2 consortium BEAt-DKD (115974; to TBH); by the BMBF STOP-FSGS 01GM1518C (to TBH); by the MSD Life Science Foundation, Public Interest Incorporated Foundation and by the Uehara Memorial Foundation (to MY); by the Excellence Initiative of the German Federal and State Governments (BIOSS to TBH and CS) and the Freiburg Institute for Advanced Studies (FRIAS) (to TBH); the German Society of Nephrology DGFN (to CS), by the Else KroEner Fresenius Stiftung, NAKSYS (to MR, CS and TBH), Else Kroner-Fresenius-Stiftung-2018_A09 (to CS) and by the Berta-Ottenstein Programme, Faculty of Medicine, University of Freiburg (to CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Charlotte Meyer for expert technical assistance. In addition we would like to express our gratitude to all members of our laboratories and to the Life Imaging Center (LIC) of the University of Freiburg for helpful discussions and support.	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Autieri MV, 2003, CIRC RES, V92, P1107, DOI 10.1161/01.RES.0000074000.03562.CC; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Chew C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00011; Chinnasamy P, 2015, MOL MED, V21, P233, DOI 10.2119/molmed.2014.00264; Del Galdo F, 2006, ARTHRITIS RHEUM-US, V54, P2616, DOI 10.1002/art.22010; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Grahammer F, 2013, NAT REV NEPHROL, V9, P587, DOI 10.1038/nrneph.2013.169; Grgic I, 2014, KIDNEY INT, V86, P1116, DOI 10.1038/ki.2014.204; Hoffmann B, 2010, CELL ADHES MIGR, V4, P190, DOI 10.4161/cam.4.2.10899; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ichimura K, 2017, J CELL SCI, V130, P132, DOI 10.1242/jcs.187815; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Jacquemet G, 2015, CURR OPIN CELL BIOL, V37, P119, DOI 10.1016/j.ceb.2015.11.002; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kimura M, 2007, J IMMUNOL, V178, P3316, DOI 10.4049/jimmunol.178.5.3316; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Kuttner V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.17; Lee CF, 2014, INT REV CEL MOL BIO, V313, P103, DOI 10.1016/B978-0-12-800177-6.00004-9; Lehtimaki JI, 2017, J CELL BIOL, V216, P4053, DOI 10.1083/jcb.201703107; Lennon R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00160; Li T, 2012, BREAST CANCER RES TR, V131, P891, DOI 10.1007/s10549-011-1519-x; Liu S, 2008, CANCER SCI, V99, P952, DOI 10.1111/j.1349-7006.2008.00787.x; Lu YQ, 2017, KIDNEY INT, V92, P1119, DOI 10.1016/j.kint.2017.04.022; Ma H, 2010, J AM SOC NEPHROL, V21, P1145, DOI 10.1681/ASN.2009090991; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Murrell M, 2015, NAT REV MOL CELL BIO, V16, P486, DOI 10.1038/nrm4012; Perico L, 2016, NAT REV NEPHROL, V12, P692, DOI 10.1038/nrneph.2016.127; Rogg M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15844-1; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schell C, 2017, J AM SOC NEPHROL, V28, P3166, DOI 10.1681/ASN.2017020143; Schell C, 2017, P NATL ACAD SCI USA, V114, pE4621, DOI 10.1073/pnas.1617004114; Schulze JO, 2008, FEBS J, V275, P4627, DOI 10.1111/j.1742-4658.2008.06605.x; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen J, 2016, J PATHOL, V240, P149, DOI 10.1002/path.4764; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tan R, 2012, CELL ADHES MIGR, V6, P1, DOI 10.4161/cam.19809; Tian Y, 2006, AM J PHYSIOL-CELL PH, V290, pC1083, DOI 10.1152/ajpcell.00381.2005; Tsubata Y, 2006, KIDNEY INT, V70, P1948, DOI 10.1038/sj.ki.5001941; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yasuda-Yamahara M, 2018, MATRIX BIOL; Ye Y, 2014, ONCOL REP, V31, P828, DOI 10.3892/or.2013.2915; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhang Y, 2016, CANCER RES, V76, P4535, DOI 10.1158/0008-5472.CAN-15-2927; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12; Zhou Xinchun, 2011, Cardiovasc Pathol, V20, pe177, DOI 10.1016/j.carpath.2010.08.002	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200487	10.1371/journal.pone.0200487	http://dx.doi.org/10.1371/journal.pone.0200487			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001384	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400069
J	de Argolo, EGG; Reis, T; Fontes, DAT; Goncalves, EC; Giese, EG; Melo, FTD; dos Santos, JN; Furtado, AP				Gualberto de Argolo, Emanuelle Gabriela; Reis, Thais; Teixeira Fontes, Diego Ari; Goncalves, Evonnildo Costa; Giese, Elane Guerreiro; de Vasconcelos Melo, Francisco Tiago; dos Santos, Jeannie Nascimento; Furtado, Adriano Penha			Canine filariasis in the Amazon: Species diversity and epidemiology of these emergent and neglected zoonoses	PLOS ONE			English	Article							DIROFILARIA-IMMITIS; HEARTWORM DISEASE; DOMESTIC DOGS; MICROFILARIAE; INFECTION; PARASITES; ISLAND; BRAZIL	Dirofilaria immitis and Acanthocheilonema reconditum are common parasites in dogs but have also been reported parasitizing humans. The differential diagnosis and epidemiological evaluation of these zoonoses are important to the development of efficient public health policies and control strategies. The purpose of this study was to carry out an epidemiological survey by using molecular methods for the specific identification of filarid parasites of domestic dogs in the Marajo mesoregion, State of Para (PA), Brazil. A total of 418 canine blood samples from Marajo mesoregion (Northern Brazil) were collected, submitted to DNA extraction, polymerase chain reaction (PCR) with "pan filarial" primer, subsequent sequencing and sequence analysis using BLASTn software comparison with previously deposited sequences in GenBank. After that, a phylogenetic analysis by Maximum Parsimony was performed to aid the specific diagnosis. The obtained sequences showed the occurrence of 9 (2.15%) dogs infected with D. immitis and 30 (7.18%) by A. reconditum, with a confidence interval of 95%, there were no cases of co-infection. We observed that male dogs were more likely to D. immits and A. reconditum infection. However, age was not significant to both infections. This study reports for the first time the occurrence of A. reconditum in the northern region of Brazil and confirmed the presence of D. immitis in the Marajo mesoregion.	[Gualberto de Argolo, Emanuelle Gabriela; Reis, Thais; Teixeira Fontes, Diego Ari; de Vasconcelos Melo, Francisco Tiago; dos Santos, Jeannie Nascimento; Furtado, Adriano Penha] Univ Fed Para, Inst Ciencias Biol, Lab Biol Celular & Helmintol, Belem, Para, Brazil; [Goncalves, Evonnildo Costa] Univ Fed Para, Inst Ciencias Biol, Lab Tecnol Biomol, Belem, Para, Brazil; [Giese, Elane Guerreiro] Univ Fed Rural Amazonia, Inst Saude & Prod Anim, Lab Histol & Embriol Anim, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal do Para; Universidade Federal Rural da Amazonia (UFRA)	de Argolo, EGG (corresponding author), Univ Fed Para, Inst Ciencias Biol, Lab Biol Celular & Helmintol, Belem, Para, Brazil.	emanu_bielle@yahoo.com.br	Melo, Francisco Tiago V/I-2974-2015; Melo, Francisco Tiago V Vasconcelos/O-5419-2018; NASCIMENTO DOS SANTOS, JEANNIE/F-7130-2012	Melo, Francisco Tiago V/0000-0001-8935-2923; Melo, Francisco Tiago V Vasconcelos/0000-0001-8935-2923; NASCIMENTO DOS SANTOS, JEANNIE/0000-0002-6612-6410	Fundacao Amazonia de Amparo a Estudos e Pesquisas; Ministerio da Saude; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [023/2009 PPSUS-Marajo]; FAPESPA/MS/CNPq in Marcadores Epidemiologicos em Saude no Arquipelago do Marajo project; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Programa Pro-Amazonia - Biodiversidade e Sustentabilidade [047/2012]; Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica [032/2010]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Produtividade emPesquisa) [PQ/2016]; ProReitoria de Pesquisa e Pos-Graduacao de Universidade Federal do Para [02/2017-PROPESPPAPQ]; Para State Health Department (Secretaria de Saude do Estado Para - SESPA); Para State Health Department (Secretaria de Saude do Estado Para-SESPA)	Fundacao Amazonia de Amparo a Estudos e Pesquisas(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Ministerio da Saude; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESPA/MS/CNPq in Marcadores Epidemiologicos em Saude no Arquipelago do Marajo project; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Programa Pro-Amazonia - Biodiversidade e Sustentabilidade; Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Produtividade emPesquisa); ProReitoria de Pesquisa e Pos-Graduacao de Universidade Federal do Para; Para State Health Department (Secretaria de Saude do Estado Para - SESPA); Para State Health Department (Secretaria de Saude do Estado Para-SESPA)	This research has received several funding sources. All authors received investments from Fundacao Amazonia de Amparo a Estudos e Pesquisas (http://www.fapespa.pa.gov.br), Ministerio da Saude (http://portalsaude.saude.gov.br) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br) from Edital 023/2009 PPSUS-Marajo, FAPESPA/MS/CNPq in Marcadores Epidemiologicos em Saude no Arquipelago do Marajo project, for sample collection and equipment acquisition. JNS, EGG, FTVM, APF, EGGA, TR and DATF received investment from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br) from Programa Pro-Amazonia - Biodiversidade e Sustentabilidade (Edital 047/2012) and Programa Nacional de Incentivo a Pesquisa em Parasitologia Basica (Edital 032/2010), for reagents acquisition. Also, JNS receives Scholarship Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br) (Edital Produtividade emPesquisa- PQ/2016) and invests additional resources to reagents. APF received investment from ProReitoria de Pesquisa e Pos-Graduacao de Universidade Federal do Para (www.propesp.ufpa. br) from Edital 02/2017-PROPESPPAPQ 2017 for translation and revision of this paper. This work is part of the results of the Master's of Science thesis of EGGA, developed in the Biology of Infectious and Parasitic Agents Postgraduation Program, Federal University of Para (Universidade Federal do Para-UFPA). The Para State Health Department (Secretaria de Saude do Estado Para - SESPA) gave support to this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Rani PAM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-30; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson R.C., 2000, NEMATODE PARASITES V, Vsecond ed, P482; Anderson RC, 1976, KEYS NEMATODE PARASI, P59; Ayres M, 2007, BIOESTAT 50 APLICACE; Boonyapakorn Chaovalit, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P33; Brito AC, 2001, PREVALENCE CANINE FI, V17, P1497; Casiraghi M, 2006, VET PARASITOL, V141, P368, DOI 10.1016/j.vetpar.2006.06.006; CAVALLAZZI RODRIGO SILVA, 2002, J. Pneumologia, V28, P100, DOI 10.1590/S0102-35862002000200007; deCampos JRM, 1997, CHEST, V112, P729, DOI 10.1378/chest.112.3.729; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Furtado AP, 2009, PARASITOL RES, V105, P1509, DOI 10.1007/s00436-009-1584-9; Garcez LM, 2006, REV SOC BRAS MED TRO, V39, P333, DOI 10.1590/S0037-86822006000400003; Gomes LR, 2014, VETERINARIA NOTOCIAS, V18, P126; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Irwin PJ, 2004, TRENDS PARASITOL, V20, P27, DOI 10.1016/j.pt.2003.11.004; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Labarthe N, 2005, VET PARASITOL, V133, P149, DOI 10.1016/j.vetpar.2005.04.006; Leite LC, 2012, SEMIN-CIENC AGRAR, V33, P1149, DOI 10.5433/1679-0359.2012v33n3p1149; Magnis J, 2013, PARASITE VECTOR, V48, P25; Montoya JA, 2006, PARASITOL RES, V100, P103, DOI 10.1007/s00436-006-0257-1; Nei M, 2000, MOLECULAR EVOLUTION; Nuchprayoon S, 2005, AM J TROP MED HYG, V73, P895, DOI 10.4269/ajtmh.2005.73.895; Nzabanita E., 1982, California Veterinarian, V36, P24; Ogawa GM, 2013, REV BRAS PARASITOL V, V22, P559, DOI 10.1590/S1984-29612013000400017; Oge H, 2003, DEUT TIERARZTL WOCH, V110, P69; Otranto D, 2011, EMERG INFECT DIS, V17, P863, DOI 10.3201/eid1705.100916; Rishniw M, 2006, VET PARASITOL, V135, P303, DOI 10.1016/j.vetpar.2005.10.013; Rodrigues-Silva Rosângela, 2004, Rev. Soc. Bras. Med. Trop., V37, P56, DOI 10.1590/S0037-86822004000100015; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Simon F, 2012, CLIN MICROBIOL REV, V25, P507, DOI 10.1128/CMR.00012-12; Soares HS, 2014, REV BRAS PARASITOL V, V23, P473, DOI [10.1590/s1984-29612014093, 10.1590/S1984-29612014093]; Song Kun-Ho, 2002, Korean Journal of Parasitology, V40, P195, DOI 10.3347/kjp.2002.40.4.195; Souza N. F., 1997, Revista Brasileira de Parasitologia Veterinaria, V6, P83; Vicente Joaquim Julio, 1997, Revista Brasileira de Zoologia, V14, P1; XIE H, 1994, PARASITE, V1, P141, DOI 10.1051/parasite/1994012141	36	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200419	10.1371/journal.pone.0200419	http://dx.doi.org/10.1371/journal.pone.0200419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995959	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800064
J	Luna-Vital, DA; de Mejia, EG				Luna-Vital, Diego A.; de Mejia, Elvira Gonzalez			Anthocyanins from purple corn activate free fatty acid-receptor 1 and glucokinase enhancing in vitro insulin secretion and hepatic glucose uptake	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; DIETARY POLYPHENOLS; METABOLISM; EXTRACT; INGREDIENTS; ABSORPTION; MECHANISMS; EXPRESSION; PATHWAY; RISK	The objective of this study was to evaluate the ability of anthocyanins (ANC) present in purple corn to enhance insulin secretion and hepatic glucose uptake in pancreatic cells and hepatocytes, through activation of the free fatty acid receptor-1 (FFAR1) and glucokinase (GK), respectively. Using a dual-layer cell culture with Caco-2 cells, INS-1E or HepG2 cells were treated with an anthocyanin-rich extract from the pericarp of purple corn (PCW), as well as pure ANC cyanidin-3-O-glucoside (C3G), peonidin-3-O-glucoside, pelargonidin-3-O-glucoside. Delphinidin-3-O-glucoside (D3G) was used for comparative purposes. Semi-purified C3G (C3G-P) and condensed forms (CF-P) isolated from PCW were also used. At 100 mu M, the pure ANC enhanced glucose-stimulated insulin secretion (GSIS) in INS-1E cells ranging from 18% to 40% (p<0.05) compared to untreated cells. PCW increased GSIS by 51%. D3G was the most effective anthocyanin activating FFAR1 (EC50: 196.6 mu M). PCW had activating potential on FFAR1 (EC50: 77 mu g/mL). PCW, as well as C3G and D3G increased the expression of FFAR1, PLC, and phosphorylation of PKD, related to the FFAR1-dependent insulin secretory pathway. The treatment with 100 mu M of P3G and C3G increased (p<0.05) glucose uptake in HepG2 cells by 19% and 31%. PCW increased the glucose uptake in HepG2 cells by 48%. It was determined that CF-P was the most effective for activating GK (EC50: 39.9 mu M) and the PCW extracts had an efficacy of EC50: 44 mu g/mL. The ANC in purple corn also reduced AMPK phosphorylation and PEPCK expression in HepG2 cells, known to be related to reduction in gluconeogenesis. It is demonstrated for the first time that dietary ANC can enhance the activity of novel biomarkers FFAR1 and GK and potentially ameliorate type-2 diabetes comorbidities.	[Luna-Vital, Diego A.; de Mejia, Elvira Gonzalez] Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	de Mejia, EG (corresponding author), Univ Illinois, Dept Food Sci & Human Nutr, Urbana, IL 61801 USA.	edemejia@illinois.edu	Luna-Vital, Diego A./B-9634-2015	Luna-Vital, Diego A./0000-0001-7734-7975; DE MEJIA, ELVIRA/0000-0001-7426-9035	National Institute of Food and Agriculture [HATCH 703-6099-1010]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This research was supported by the National Institute of Food and Agriculture, HATCH 703-6099-1010 to EGDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatrach M, 2017, DIABETOLOGIA, V60, P1325, DOI 10.1007/s00125-017-4252-0; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; [Anonymous], 2017, DATA NATL DIABETES S; [Anonymous], 2018, DIABETES REPORT CARD; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Aune D, 2015, PHYSICAL ACTIVITY AN; Castell-Auvi A, 2010, PLANTA MED, V76, P1576, DOI 10.1055/s-0029-1241002; Castro-Acosta M, 2016, P NUTR SOC, V75; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Chen YF, 2016, J NUTR BIOCHEM, V31, P98, DOI 10.1016/j.jnutbio.2015.12.020; Chen ZQ, 2018, FOOD FUNCT, V9, P426, DOI [10.1039/c7fo00983f, 10.1039/C7FO00983F]; Choi YJ, 2014, ARCH PHARM RES, V37, P435, DOI 10.1007/s12272-013-0283-3; Chung SI, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100658; Cody RB, 2018, J MASS SPECTROM, V53, P58, DOI 10.1002/jms.4033; Cordero-Herrera I, 2014, FOOD CHEM TOXICOL, V64, P10, DOI 10.1016/j.fct.2013.11.014; Cremonini E, 2017, FOOD FUNCT, V8, P2915, DOI [10.1039/C7FO00625J, 10.1039/c7fo00625j]; Del Bo' C, 2016, EUR J NUTR, V55, P171, DOI 10.1007/s00394-015-0835-z; Deshpande AD, 2008, PHYS THER, V88, P1254, DOI 10.2522/ptj.20080020; Dhanesha N, 2012, PHARMACOL REP, V64, P140, DOI 10.1016/S1734-1140(12)70740-5; Esposito D, 2015, J AGR FOOD CHEM, V63, P6172, DOI 10.1021/acs.jafc.5b00963; Fernandes I, 2014, J FUNCT FOODS, V7, P54, DOI 10.1016/j.jff.2013.05.010; Gonzalez-Manzano S, 2008, J FOOD COMPOS ANAL, V21, P521, DOI 10.1016/j.jfca.2008.05.009; Gowd V, 2017, TRENDS FOOD SCI TECH, V68, P1, DOI 10.1016/j.tifs.2017.07.015; Guo X, 2016, EUR J CLIN NUTR, V70, P1360, DOI 10.1038/ejcn.2016.142; Haeusler RA, 2015, MOL METAB, V4, P222, DOI 10.1016/j.molmet.2014.12.007; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; He H, 2016, J AGR FOOD CHEM, V64, P2475, DOI 10.1021/acs.jafc.5b02823; Hidalgo J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040750; Ichimura A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00236; Imamura F, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3576; Johnson MH, 2016, J AGR FOOD CHEM, V64, P2569, DOI 10.1021/acs.jafc.6b00239; Kamiloglu S, 2015, INT J MOL SCI, V16, P21555, DOI 10.3390/ijms160921555; Kumar A, 2017, PHARMACOL REP, V69, P959, DOI 10.1016/j.pharep.2017.04.003; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Lu J, 2017, NAT STRUCT MOL BIOL, V24, P570, DOI 10.1038/nsmb.3417; Luna-Vital D, 2018, FOOD RES INT, V105, P169, DOI 10.1016/j.foodres.2017.11.009; Luna-Vital D, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700362; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Manzano S, 2010, MOL NUTR FOOD RES, V54, P1773, DOI 10.1002/mnfr.201000019; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matschnsky FM, 2011, DIABETES CARE, V34, pS236, DOI 10.2337/dc11-s236; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Moser S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070414; Muraki I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5001; Nam SJ, 2017, CEREAL CHEM, V94, P424, DOI [10.1094/CCHEM-04-16-0112-R, 10.1094/cchem-04-16-0112-r]; Noratto GD, 2017, FOOD CHEM, V227, P305, DOI 10.1016/j.foodchem.2017.01.097; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Somavat P, 2017, IND CROP PROD, V109, P92, DOI 10.1016/j.indcrop.2017.08.013; Sancho RAS, 2012, FOOD RES INT, V46, P378, DOI 10.1016/j.foodres.2011.11.021; Suantawee T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080814; Talagavadi V, 2016, J FUNCT FOODS, V21, P338, DOI 10.1016/j.jff.2015.12.007; Tsuda N, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.340; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Tsumura Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172252; Watterson KR, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00137; Williamson G, 2013, MOL NUTR FOOD RES, V57, P48, DOI 10.1002/mnfr.201200511; Xiao JB, 2015, CURR MED CHEM, V22, P23; Xu JY, 2017, BIOORG MED CHEM LETT, V27, P2063, DOI 10.1016/j.bmcl.2016.10.088; Yan FJ, 2016, FOOD FUNCT, V7, P425, DOI 10.1039/c5fo00841g; Zheng YC, 2016, J AGR FOOD CHEM, V64, P8763, DOI 10.1021/acs.jafc.6b03845	63	36	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200449	10.1371/journal.pone.0200449	http://dx.doi.org/10.1371/journal.pone.0200449			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995924	Green Submitted, gold, Green Published			2022-12-26	WOS:000438388800068
J	Rovere, M; Powers, AE; Patel, DS; Bartels, T				Rovere, Matteo; Powers, Alex Edward; Patel, Dushyant Shailesh; Bartels, Tim			pTSara-NatB, an improved N-terminal acetylation system for recombinant protein expression in E. coli	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; MOLECULAR-BASIS; ACETYLTRANSFERASE	N-terminal acetylation is one of the most common co- and post-translational modifications of the eukaryotic proteome and regulates numerous aspects of cellular physiology, such as protein folding, localization and turnover. In particular alpha-synuclein, whose dyshomeostasis has been tied to the pathogenesis of several neurodegenerative disorders, is completely N-alpha-acetylated in nervous tissue. In this work, building on previous reports, we develop and characterize a bacterial N-terminal acetylation system based on the expression of the yeast N-terminal acetyltransferase B (NatB) complex under the control of the P-BAD (L-arabinoseinducible) promoter. We show its functionality and the ability to completely N-alpha-acetylate our model substrate alpha-synuclein both upon induction of the construct with L-arabinose and also by only relying on the constitutive expression of the NatB genes.	[Rovere, Matteo; Powers, Alex Edward; Patel, Dushyant Shailesh; Bartels, Tim] Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA; [Rovere, Matteo; Powers, Alex Edward; Patel, Dushyant Shailesh; Bartels, Tim] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Bartels, T (corresponding author), Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, 75 Francis St, Boston, MA 02115 USA.; Bartels, T (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	tbartels@bwh.harvard.edu	Bartels, Tim/AAD-6128-2021; Rovere, Matteo/GQZ-6505-2022; Rovere, Matteo/AHC-1539-2022	Rovere, Matteo/0000-0002-3260-4955; Bartels, Tim/0000-0002-4071-5612; Powers, Alex/0000-0002-0732-3780	Parkinson's Foundation Stanley Fahn Award [PF-JFA-1884]	Parkinson's Foundation Stanley Fahn Award	Funded by Parkinson's Foundation Stanley Fahn Award PF-JFA-1884 (TB, http://parkinson.org/research/Grant-Opportunities/Fahn-Awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes H, 2016, TRENDS BIOCHEM SCI, V41, P746, DOI 10.1016/j.tibs.2016.07.005; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Bartels T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103727; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dikiy I, 2014, J BIOL CHEM, V289, P3652, DOI 10.1074/jbc.M113.512459; Drazic A, 2018, P NATL ACAD SCI USA, V115, P4399, DOI 10.1073/pnas.1718336115; Eastwood TA, 2017, FEBS LETT, V591, P833, DOI 10.1002/1873-3468.12597; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hong HY, 2017, STRUCTURE, V25, P641, DOI 10.1016/j.str.2017.03.003; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iyer A, 2016, J BIOL CHEM, V291, P21110, DOI 10.1074/jbc.M116.726612; Johnson Matthew, 2013, Methods Mol Biol, V981, P193, DOI 10.1007/978-1-62703-305-3_15; Johnson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015801; Jones JD, 2011, PROTEOMICS, V11, P3012, DOI 10.1002/pmic.201000812; Lautenschlager J, 2017, TRENDS CELL BIOL, V27, P468, DOI 10.1016/j.tcb.2017.02.002; Liszczak G, 2013, NAT STRUCT MOL BIOL, V20, P1098, DOI 10.1038/nsmb.2636; Polevoda B, 2003, J BIOL CHEM, V278, P30686, DOI 10.1074/jbc.M304690200; Polevoda B, 2008, J CELL BIOCHEM, V103, P492, DOI 10.1002/jcb.21418; Schleif R, 2010, FEMS MICROBIOL REV, V34, P779, DOI 10.1111/j.1574-6976.2010.00226.x; Selkoe D, 2014, NEURODEGENER DIS, V13, P114, DOI 10.1159/000355516; Shis DL, 2013, P NATL ACAD SCI USA, V110, P5028, DOI 10.1073/pnas.1220157110; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Starheim KK, 2008, BIOCHEM J, V415, P325, DOI 10.1042/BJ20080658; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Van Damme P, 2012, P NATL ACAD SCI USA, V109, P12449, DOI 10.1073/pnas.1210303109; Van Damme P, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004580; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314	30	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0198715	10.1371/journal.pone.0198715	http://dx.doi.org/10.1371/journal.pone.0198715			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995905	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800011
J	Gateau-Rey, L; Tanner, EVJ; Rapidel, B; Marelli, JP; Royaert, S				Gateau-Rey, Lauranne; Tanner, Edmund V. J.; Rapidel, Bruno; Marelli, Jean-Philippe; Royaert, Stefan			Climate change could threaten cocoa production: Effects of 2015-16 El Nino-related drought on cocoa agroforests in Bahia, Brazil	PLOS ONE			English	Article							ENSO-RELATED DROUGHT; THEOBROMA-CACAO; TREE MORTALITY; WEST-AFRICA; RAIN-FOREST; VEGETATION; VULNERABILITY; BIODIVERSITY; RESILIENCE; MANAGEMENT	Climate models predict a possible increase in the frequency of strong climate events such as El Nino-Southern Oscillation (ENSO), which in parts of the tropics are the cause of exceptional droughts, these threaten global food production. Agroforestry systems are often suggested as promising diversification options to increase farmers' resilience to extreme climatic events. In the Northeastern state of Bahia, where most Brazilian cocoa is grown in wildlife-friendly agroforests, ENSOs cause severe droughts which negatively affect forest and agriculture. Cocoa (Theobroma cacao) is described as being sensitive to drought but there are no field-studies of the effect of ENSO-related drought on adult cocoa trees in the America's; there is one study of an experimentally-imposed drought in Indonesia which resulted in 10 to 46% yield loss. In our study, in randomly chosen farms in Bahia, Brazil, we measured the effect of the 2015-16 severe ENSO, which caused an unprecedented drought in cocoa agroforests. We show that drought caused high cocoa tree mortality (15%) and severely decreased cocoa yield (89%); the drought also increased infection rate of the chronic fungal disease witches' broom (Moniliophthora perniciosa). Ours findings showed that Brazilian cocoa agroforests are at risk and that increasing frequency of strong droughts are likely to cause decreased cocoa yields in the coming decades. Furthermore, because cocoa, like many crops, is grown somewhat beyond its climatic limits, it and other crops could be the 'canaries in the coalmine' warning of forthcoming major drought effects on semi-natural and natural vegetation.	[Gateau-Rey, Lauranne; Tanner, Edmund V. J.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Rapidel, Bruno] CIRAD, UMR SYST, Montpellier, France; [Rapidel, Bruno] Univ Montpellier, CIRAD, INRA, UMR SYST,Montpellier SupAgro, Montpellier, France; [Marelli, Jean-Philippe] USDA, MARS, Cocoa Lab, Miami, FL USA; [Royaert, Stefan] MARS Ctr Cocoa Sci, Itajuipe, BA, Brazil	University of Cambridge; CIRAD; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; United States Department of Agriculture (USDA)	Gateau-Rey, L (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	lamg2@cam.ac.uk			MARS Inc.; Department of Plant Sciences, University of Cambridge [RG75058]	MARS Inc.; Department of Plant Sciences, University of Cambridge(University of Cambridge)	This study was funded by a MARS Inc. studentship for the Department of Plant Sciences, University of Cambridge (grant number: RG75058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the funding from MARS Inc. This study was conducted in the framework of the joint University of Cambridge-MARS-CIRAD PhD research project 'Optimising nutrient dynamic to increase yield and sustainability in traditional Brazilian cocoa agroforest in a climate change context'. We thank Wildson Farias, Jose Francisco de Assuncao Neto and their agronomy team for their assistance with the field work. We thank the MARS Center for Cocoa Sciences staff for logistic support; we also thank the Instituto Chico Mendes de Conservacao da Biodiversidade (ICMBio) for the research permit in Brazil.	Abdulai I, 2018, GLOBAL CHANGE BIOL, V24, P273, DOI 10.1111/gcb.13885; Abou Rajab Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149949; AIDE TM, 1990, ECOLOGY, V71, P1412, DOI 10.2307/1938278; ALI FM, 1969, EXP AGR, V5, P209, DOI 10.1017/S0014479700004452; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Allen JB, 1989, GEOGRAPHICAL VARIATI; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; Anderson W, 2017, AGR FOREST METEOROL, V239, P151, DOI 10.1016/j.agrformet.2017.03.008; [Anonymous], [No title captured]; Araujo P, 2011, P C CLIM CHANG DEV P; Araujo Q. R., 2013, J SUSTAINABLE FOREST, V32, P625; Awange JL, 2016, SCI TOTAL ENVIRON, V566, P1472, DOI 10.1016/j.scitotenv.2016.06.031; Bastide Ph., 2008, Tropicultura, V26, P33; Cai WJ, 2015, NAT CLIM CHANGE, V5, P849, DOI [10.1038/nclimate2743, 10.1038/NCLIMATE2743]; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Carr MKV, 2011, EXP AGR, V47, P653, DOI 10.1017/S0014479711000421; Cazorla I. M., 1995, Cocoa cycles: the economics of cocoa supply., P75; Chok D., 1998, COCOA DEV ITS ENV DI; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Chung CTY, 2016, CLIM DYNAM, V47, P1303, DOI 10.1007/s00382-015-2902-9; Clark JS, 2016, GLOBAL CHANGE BIOL, V22, P2317, DOI 10.1111/gcb.13252; Crowder DW, 2014, BIOL CONTROL, V75, P1, DOI 10.1016/j.biocontrol.2014.04.009; de Almeida A-AF, 2002, AGROTROPICA; Defries RS, 2000, GLOBAL CHANGE BIOL, V6, P247, DOI 10.1046/j.1365-2486.2000.00296.x; Dessay N, 2004, INT J REMOTE SENS, V25, P4063, DOI 10.1080/0143116031000101594; dos Santos IC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115746; Dunlop WR, 1925, NATURE, V115, P192, DOI 10.1038/115192a0; Getirana A, 2016, J HYDROMETEOROL, V17, P591, DOI 10.1175/JHM-D-15-0096.1; Gonsamo A, 2016, GLOBAL CHANGE BIOL, V22, P3414, DOI 10.1111/gcb.13258; Groeneveld JH, 2010, PERSPECT PLANT ECOL, V12, P183, DOI 10.1016/j.ppees.2010.02.005; Haggar J, 2011, DESK STUDY IMPACTS C; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; ICCO, 2010, IMP NIN NIN WEATH EV, P21; ICCO, 2015, MONTH REV MARK AUG 2; Jacobi J, 2015, RENEW AGR FOOD SYST, V30, P170, DOI 10.1017/S174217051300029X; Johns ND, 1999, ENVIRON MANAGE, V23, P31, DOI 10.1007/s002679900166; Keil A, 2008, CLIMATIC CHANGE, V86, P291, DOI 10.1007/s10584-007-9326-4; Keil A, 2009, CLIM RES, V38, P155, DOI 10.3354/cr00778; Kohler M, 2010, AGR FOREST METEOROL, V150, P1079, DOI 10.1016/j.agrformet.2010.04.005; Kogan F, 2017, INT J REMOTE SENS, V38, P161, DOI 10.1080/01431161.2016.1259679; Laderach P., 2011, PREDICTING IMPACT CL; Lawal J. O., 2014, Comunicata Scientiae, V5, P518; Lin BB, 2011, BIOSCIENCE, V61, P183, DOI 10.1525/bio.2011.61.3.4; Lobao D.E., 2004, AGROSSILVICULTURA, V1, P163; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; Norgrove L, 2018, GLOBAL CHANGE BIOL, V24, P559, DOI 10.1111/gcb.14012; Obeng EA, 2015, AGROFOREST SYST, V89, P19, DOI 10.1007/s10457-014-9739-9; Oliveira LMT, 2010, INT J REMOTE SENS, V31, P423, DOI 10.1080/01431160902893477; Papaioannou KJ, 2016, POLIT GEOGR, V50, P33, DOI 10.1016/j.polgeo.2015.07.001; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; Phillips OL, 2010, NEW PHYTOL, V187, P631, DOI 10.1111/j.1469-8137.2010.03359.x; Porter J. R, 2014, FOOD SECURITY FOOD P; Raes D., 2009, ETO CALCULATOR REF M, P3; Rodrigues RR, 2011, J CLIMATE, V24, P3402, DOI 10.1175/2011JCLI3983.1; Rojas Oscar, 2014, UNDERSTANDING DROUGH; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; Ruf F, 1995, BOOMS CRISES CACAO V; Ruf F, 2015, SUSTAIN SCI, V10, P101, DOI 10.1007/s11625-014-0282-4; SALAFSKY N, 1994, CLIMATIC CHANGE, V27, P373, DOI 10.1007/BF01096268; Schroth G, 2016, SCI TOTAL ENVIRON, V556, P231, DOI 10.1016/j.scitotenv.2016.03.024; Schwendenmann L, 2010, GLOBAL CHANGE BIOL, V16, P1515, DOI 10.1111/j.1365-2486.2009.02034.x; Setenta W, 2012, CONSERVACAO PRODUTIV; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Shimizu MH, 2017, INT J CLIMATOL, V37, P2977, DOI 10.1002/joc.4893; Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; TOXOPEUS H, 1970, Netherlands Journal of Agricultural Science, V18, P132; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; van Straaten O, 2010, BIOGEOSCIENCES, V7, P1223, DOI 10.5194/bg-7-1223-2010; Vicente-Serrano SM, 2010, J CLIMATE, V23, P1696, DOI 10.1175/2009JCLI2909.1; Vos R., 1999, ISS WORKING PAPER SE, V292, P1; Wanger TC, 2018, GLOBAL CHANGE BIOL, V24, P561, DOI 10.1111/gcb.14005; Wood G.A.R., 1987, COCOA, V4th ed; Zuidema PA, 2005, AGR SYST, V84, P195, DOI 10.1016/j.agsy.2004.06.015	75	37	39	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200454	10.1371/journal.pone.0200454	http://dx.doi.org/10.1371/journal.pone.0200454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990360	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300052
J	Ashfaq, M; Sabir, JSM; El-Ansary, HO; Perez, K; Levesque-Beaudin, V; Khan, AM; Rasool, A; Gallant, C; Addesi, J; Hebert, PDN				Ashfaq, Muhammad; Sabir, Jamal S. M.; El-Ansary, Hosam O.; Perez, Kate; Levesque-Beaudin, Valerie; Khan, Arif M.; Rasool, Akhtar; Gallant, Carlene; Addesi, Joseph; Hebert, Paul D. N.			Insect diversity in the Saharo-Arabian region: Revealing a little-studied fauna by DNA barcoding	PLOS ONE			English	Article							RAPID BIODIVERSITY ASSESSMENT; CONSERVATION; COMMUNITIES; INVENTORIES; ARTHROPODS; SYSTEM	Although insects dominate the terrestrial fauna, sampling constraints and the poor taxonomic knowledge of many groups have limited assessments of their diversity. Passive sampling techniques and DNA-based species assignments now make it possible to overcome these barriers. For example, Malaise traps collect specimens with minimal intervention while the Barcode Index Number (BIN) system automates taxonomic assignments. The present study employs Malaise traps and DNA barcoding to extend understanding of insect diversity in one of the least known zoogeographic regions, the Saharo-Arabian. Insects were collected at four sites in three countries (Egypt, Pakistan, Saudi Arabia) by deploying Malaise traps. The collected specimens were analyzed by sequencing 658 bp of cytochrome oxidase I (DNA barcode) and assigning BINs on the Barcode of Life Data Systems. The year-long deployment of a Malaise trap in Pakistan and briefer placements at two Egyptian sites and at one in Saudi Arabia collected 53,092 specimens. They belonged to 17 insect orders with Diptera and Hymenoptera dominating the catch. Barcode sequences were recovered from 44,432 (84%) of the specimens, revealing the occurrence of 3,682 BINs belonging to 254 families. Many of these taxa were uncommon as 25% of the families and 50% of the BINs from Pakistan were only present in one sample. Family and BIN counts varied significantly through the year, but diversity indices did not. Although more than 10,000 specimens were analyzed from each nation, just 2% of BINs were shared by Pakistan and Saudi Arabia, 4% by Egypt and Pakistan, and 7% by Egypt and Saudi Arabia. The present study demonstrates how the BIN system can circumvent the barriers imposed by limited access to taxonomic specialists and by the fact that many insect species in the Saharo-Arabian region are undescribed.	[Ashfaq, Muhammad; Perez, Kate; Levesque-Beaudin, Valerie; Gallant, Carlene; Addesi, Joseph; Hebert, Paul D. N.] Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada; [Sabir, Jamal S. M.] King Abdulaziz Univ, Dept Biol Sci, Biotechnol Res Grp, Jeddah, Saudi Arabia; [El-Ansary, Hosam O.] Alexandria Univ, Fac Agr El Shatby, Floriculture Ornamental Hort & Garden Design Dept, Alexandria, Egypt; [El-Ansary, Hosam O.] King Saud Univ, Coll Food & Agr Sci, Dept Plant Prod, Riyadh, Saudi Arabia; [Khan, Arif M.] Univ Sargodha, Dept Biotechnol, Sargodha, Pakistan; [Rasool, Akhtar] Univ Swat, Ctr Anim Sci & Fisheries, Mingora, Pakistan	University of Guelph; King Abdulaziz University; Egyptian Knowledge Bank (EKB); Alexandria University; King Saud University; University of Sargodha	Ashfaq, M (corresponding author), Univ Guelph, Ctr Biodivers Genom, Guelph, ON, Canada.	mashfaq@uoguelph.ca	Ashfaq, Muhammad/J-4723-2019; Elansary, Hosam O./E-3684-2019	Ashfaq, Muhammad/0000-0003-1351-4126; Elansary, Hosam O./0000-0002-4476-2408; Levesque-Beaudin, Valerie/0000-0002-6053-0949	Deanship of Scientific Research (DSR) at King Abdulaziz University [99-130-35-HiCi]; Ontario Ministry of Research, Innovation and Science; 'Food From Thought' program - Canada First Research Excellence Fund	Deanship of Scientific Research (DSR) at King Abdulaziz University; Ontario Ministry of Research, Innovation and Science; 'Food From Thought' program - Canada First Research Excellence Fund	This work was funded by the Deanship of Scientific Research (DSR) at King Abdulaziz University (grant number 99-130-35-HiCi); Ontario Ministry of Research, Innovation and Science; and 'Food From Thought' program supported by the Canada First Research Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Al-Ahmadi AZ, 1999, ENTOMOFAUNA SAUDI 1; Ashfaq M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174749; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P832, DOI 10.1111/1755-0998.12131; Azam I, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/942751; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Basset Y, 2012, SCIENCE, V338, P1481, DOI 10.1126/science.1226727; Brandon-Mong GJ, 2018, B ENTOMOL RES, V14, P1; Convention on Biological Diversity, 2014, PAK 5 NAT REP CBD; Cristescu ME, 2014, TRENDS ECOL EVOL, V29, P566, DOI 10.1016/j.tree.2014.08.001; El-Hawagry MS, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.274.4529; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gandhi KJK, 2007, ENVIRON REV, V15, P113, DOI 10.1139/A07-003; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Geiger MF, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e10671; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4611-3; Hebert PDN, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0333; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill D., 2005, HDB BIODIVERSITY MET; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Hutcheson J, 1999, FOREST ECOL MANAG, V118, P93, DOI 10.1016/S0378-1127(98)00495-2; Janzen DH, 2016, GENOME, V59, P641, DOI 10.1139/gen-2016-0005; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166; Lees DC, 2014, MOL ECOL RESOUR, V14, P286, DOI 10.1111/1755-0998.12178; Malik IU, 2014, J BIORES MANAG, V1, P21; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Miller S. E., 2002, CIMBEBASIA, V17, P197; Moreau CS, 2013, INVERTEBR SYST, V27, P81, DOI 10.1071/IS12067; Moriniere J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155497; Oliver I, 1996, ECOL APPL, V6, P594, DOI 10.2307/2269394; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Pentinsaari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108651; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Rafael JA, 2009, NEOTROP ENTOMOL, V38, P565, DOI 10.1590/S1519-566X2009000500001; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Russo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021079; Salem MM, 2017, INSECT FAUNA EGYPT C; SAMWAYS MJ, 1993, BIODIVERS CONSERV, V2, P258, DOI 10.1007/BF00056672; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Sing KW, 2016, GENOME, V59, P851, DOI [10.1139/gen-2015-0166, DOI 10.1139/GEN-2015-0166]; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stein ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051273; Steinke D, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001829; Telfer AC, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6313; von Harten A., 2008, ARTHROPOD FAUNA UAE, V1-5; Ward DF, 2004, NEW ZEAL J ECOL, V28, P151; Wilkie L, 2003, BIODIVERS CONSERV, V12, P121, DOI 10.1023/A:1021242329800; Wilson JJ, 2017, INSECT BIODIVERSITY, V1, DOI [10.1002/9781118945568, DOI 10.1002/9781118945568]; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zahiri R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178548	60	13	17	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0199965	10.1371/journal.pone.0199965	http://dx.doi.org/10.1371/journal.pone.0199965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985924	gold, Green Published			2022-12-26	WOS:000438035500016
J	Yang, JJ; Hu, L; Cai, TT; Chen, QL; Ma, Q; Yang, J; Meng, C; Hong, J				Yang, Juanjuan; Hu, Lei; Cai, Tiantian; Chen, Qiuluan; Ma, Qian; Yang, Jie; Meng, Chun; Hong, Jing			Purification and identification of two novel antioxidant peptides from perilla (Perilla frutescens L. Britton) seed protein hydrolysates	PLOS ONE			English	Article							DAMAGE	Proteins were extracted from perilla (Penile frutescens L. Britton) seed by-products and hydrolyzed with an alkaline protease. Antioxidant peptides were purified from the hydrolysate by size-exclusion chromatography and RP-HPLC. Two peptides with strong antioxidant activity were identified as Tyr-Leu (YL) and Phe-Tyr (FY) with the molecular mass of 294.33 Da and 328.33 Da, respectively. Synthesized YL and FY efficiently quenched free radicals (DPPH, ABTS and hydroxyl radicals) and showed high oxygen radical absorbance capacity. The two peptides also inhibited lipid peroxidation in the rat liver. Furthermore, YL and FY could protect HepG-2 cells against hydrogen peroxide-induced oxidative damage without cytotoxicity. Based on the structure-activity analysis, the Tyr residue was crucial for the antioxidant activity of YL and FY. The results indicate that the protein hydrolysate from perilla seed by-products possessed potent biological activity and can be utilized to develop health-related nutraceutical ingredients.	[Yang, Juanjuan; Hu, Lei; Cai, Tiantian; Chen, Qiuluan; Ma, Qian; Yang, Jie; Meng, Chun; Hong, Jing] Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou, Fujian, Peoples R China	Fuzhou University	Hong, J (corresponding author), Fuzhou Univ, Coll Biol Sci & Technol, Fuzhou, Fujian, Peoples R China.	jhong@fzu.edu.cn		Hong, Jing/0000-0001-7057-0074	National Natural Science Foundation of China [31000335, 31700656]; Fujian Province Natural Science Foundation [2013J05050, 2017J05050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Province Natural Science Foundation(Natural Science Foundation of Fujian Province)	This research was supported by grants from the National Natural Science Foundation of China, http://www.nsfc.gov.cn/english/site_1/Index.html (No. 31000335 (JH), No. 31700656 (JJY)). The National Natural Science Foundation of China played an important role in the study design, data collection and analysis, and decision to publish. This work was also supported by the Fujian Province Natural Science Foundation, http://xmgl.fjkjt.gov.cn/ (No.2013J05050 (JH), No. 2017J05050 (JJY)). The Fujian Province Natural Science Foundation played an important role in the study design, and data collection and analysis.	Abdel-Hamid M, 2016, INT DAIRY J; Asoodeh A, 2016, J FOOD DRUG ANAL, V24, P332, DOI 10.1016/j.jfda.2015.11.010; Chen TT, 2018, J FUNCT FOODS, V40, P606, DOI 10.1016/j.jff.2017.11.037; Chi CF, 2015, FOOD RES INT, V73, P124, DOI 10.1016/j.foodres.2014.08.038; Ghribi AM, 2015, J FUNCT FOODS, V12, P516, DOI 10.1016/j.jff.2014.12.011; Girgih AT, 2014, J FUNCT FOODS, V6, P384, DOI 10.1016/j.jff.2013.11.005; Guo H, 2009, FOOD CHEM, V113, P238, DOI 10.1016/j.foodchem.2008.06.081; Guo P, 2015, J FUNCT FOODS, V19, P394, DOI 10.1016/j.jff.2015.09.003; Hanada H, 2012, HEREDITAS, V149, P173, DOI 10.1111/j.1601-5223.2012.02260.x; Harnedy PA, 2017, FOOD RES INT; Harnedy PA, 2012, J FUNCT FOODS, V4, P6, DOI 10.1016/j.jff.2011.09.001; Hernandez-Ledesma B, 2005, J AGR FOOD CHEM, V53, P588, DOI 10.1021/jf048626m; Homayouni-Tabrizi M, 2016, INT J PEPT RES THER, V22, P187, DOI 10.1007/s10989-015-9497-1; Hong J, 2014, J FUNCT FOODS, V10, P144, DOI 10.1016/j.jff.2014.05.014; Igarashi M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/925342; Lee JH, 2017, J SCI FOOD AGR, V97, P4857, DOI 10.1002/jsfa.8356; Liu KL, 2015, FOOD CHEM, V187, P424, DOI 10.1016/j.foodchem.2015.04.086; Nkhili E, 2011, ANAL BIOANAL CHEM, V400, P1451, DOI 10.1007/s00216-011-4884-8; Park SY, 2016, J FUNCT FOODS, V20, P88, DOI 10.1016/j.jff.2015.10.023; Rajapakse N, 2005, J NUTR BIOCHEM, V16, P562, DOI 10.1016/j.jnutbio.2005.02.005; Samaraweera H, 2011, J FOOD SCI, V76, pR143, DOI 10.1111/j.1750-3841.2011.02291.x; Sarmadi BH, 2010, PEPTIDES, V31, P1949, DOI 10.1016/j.peptides.2010.06.020; Siow HL, 2016, J FUNCT FOODS, V22, P1, DOI 10.1016/j.jff.2016.01.011; Song NB, 2015, J KOREAN SOC APPL BI, V58, P83, DOI 10.1007/s13765-015-0031-0; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Wang B, 2016, J DAIRY SCI, V99, P2468, DOI 10.3168/jds.2015-10029; Wu HT, 2016, EUR FOOD RES TECHNOL, V242, P713, DOI 10.1007/s00217-015-2579-7; Yongvanit P, 2012, PARASITOL INT, V61, P130, DOI 10.1016/j.parint.2011.06.011; Zeng WC, 2015, PROCESS BIOCHEM, V50, P948, DOI 10.1016/j.procbio.2015.03.007; Zhang YF, 2012, PEPTIDES, V38, P13, DOI 10.1016/j.peptides.2012.08.014; Zou TB, 2016, MOLECULES, V21, DOI 10.3390/molecules21010072	31	33	34	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200021	10.1371/journal.pone.0200021	http://dx.doi.org/10.1371/journal.pone.0200021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985955	Green Submitted, gold, Green Published			2022-12-26	WOS:000438035500018
J	Spencer, NY; Yang, ZH; Sullivan, JC; Klein, T; Stanton, RC				Spencer, Netanya Y.; Yang, Zhihong; Sullivan, Jensyn Cone; Klein, Thomas; Stanton, Robert C.			Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes	PLOS ONE			English	Article							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; AMELIORATES OXIDATIVE STRESS; DPP-4 INHIBITION; DOUBLE-BLIND; NEPHROPATHY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; RATS; STREPTOZOTOCIN; DISEASE; HYPERGLYCEMIA	Background Dipeptidyl peptidase-4 (DPP-4) inhibitors may have protective effects on diabetic kidney disease (DKD) via specific antioxidant pathways. The DPP-4 inhibitor, linagliptin, was evaluated with the hypothesis that DPP-4 inhibition would ameliorate the development of DKD in a glucose-independent manner by altering specific antioxidant function. Methods DBA/2J mice (a well-characterized model of DKD) and glucose 6-phosphate dehydrogenase (G6PD) deficient mice (a model of impaired antioxidant function) were evaluated. Diabetes was induced by streptozotocin. Mice were divided into: diabetic (DM), diabetic+linagliptin (DM+Lina), and non-diabetic control and treated for 12 weeks. Results In DBA/2J mice, there was no difference in body weight and blood glucose between DM and DM+Lina groups. Linagliptin ameliorated albuminuria and kidney hypertrophy in DM DBA/2J mice and specifically increased the mRNA and protein levels for the antioxidants catalase and MnSOD. In G6PD deficient mice, however, increases in these mRNA levels did not occur and linagliptin renoprotection was not observed. Linagliptin also ameliorated histological trends toward mesangial expansion in wild-type mice but not in G6PD deficient mice. Conclusions Linagliptin renoprotection involved glucose-independent but antioxidant-enzyme-system-dependent increases in transcription (not just increased protein levels) of antioxidant proteins in wild-type mice. These studies demonstrate that an intact antioxidant system, in particular including transcription of catalase and MnSOD, is required for the renoprotective effects of linagliptin.	[Spencer, Netanya Y.; Yang, Zhihong; Stanton, Robert C.] Joslin Diabet Ctr, Boston, MA 02215 USA; [Spencer, Netanya Y.; Yang, Zhihong; Stanton, Robert C.] Harvard Med Sch, Boston, MA 02115 USA; [Sullivan, Jensyn Cone; Stanton, Robert C.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Klein, Thomas] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Boehringer Ingelheim	Stanton, RC (corresponding author), Joslin Diabet Ctr, Boston, MA 02215 USA.; Stanton, RC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Stanton, RC (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	robert.stanton@joslin.harvard.edu	Spencer, Netanya/AAS-7999-2020; Cone Sullivan, Jensyn/GPS-4753-2022; Stanton, Robert C/AAG-7584-2020	Spencer, Netanya/0000-0003-1010-5458; Stanton, Robert C/0000-0002-3056-1277	Boehringer-Ingelheim	Boehringer-Ingelheim(Boehringer Ingelheim)	TK is employed by a commercial company: Boehringer-Ingelheim. The funder (Boehringer-Ingelheim) provided support in the form of salaries for one author (TK) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author (TK) are articulated in the 'author contributions' section.	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Al-Rasheed NM, 2016, DRUG DES DEV THER, V10, P2095, DOI 10.2147/DDDT.S109287; Alkhalaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040427; Alkhalaf A, 2010, DIABETES CARE, V33, P1598, DOI 10.2337/dc09-2241; Alter ML, 2012, KIDNEY BLOOD PRESS R, V36, P119, DOI 10.1159/000341487; Avila DD, 2013, ARCH MED RES, V44, P194, DOI 10.1016/j.arcmed.2013.03.004; Bao W, 2014, J VASC SURG, V59, P1098, DOI 10.1016/j.jvs.2013.04.048; Chaykovska L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027861; Civantos E, 2017, DIABETES METAB SYNDR, V10, P207, DOI 10.2147/DMSO.S132537; Cooper ME, 2015, AM J KIDNEY DIS, V66, P441, DOI 10.1053/j.ajkd.2015.03.024; Dietrich N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167853; Duran-Salgado MB, 2014, WORLD J DIABETES, V5, P393, DOI 10.4239/wjd.v5.i3.393; Fujita H, 2009, J AM SOC NEPHROL, V20, P1303, DOI 10.1681/ASN.2008080844; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Groop PH, 2017, DIABETES OBES METAB, V19, P1610, DOI 10.1111/dom.13041; Gross ML, 2004, LAB INVEST, V84, P452, DOI 10.1038/labinvest.3700052; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hasan AA, 2017, J MOL ENDOCRINOL, V59, pR1, DOI 10.1530/JME-17-0005; Hattori S, 2011, ENDOCR J, V58, P69, DOI 10.1507/endocrj.K10E-382; Heise T, 2009, DIABETES OBES METAB, V11, P786, DOI 10.1111/j.1463-1326.2009.01046.x; Jain M, 2004, CIRCULATION, V109, P898, DOI 10.1161/01.CIR.0000112605.43318.CA; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; LEITER EH, 1982, P NATL ACAD SCI-BIOL, V79, P630, DOI 10.1073/pnas.79.2.630; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Nakashima S, 2014, HORM METAB RES, V46, P717, DOI 10.1055/s-0034-1371892; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; Pujadas G, 2017, ENDOCRINE, V56, P509, DOI 10.1007/s12020-016-1052-0; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; ROSSINI AA, 1977, DIABETES, V26, P916, DOI 10.2337/diabetes.26.10.916; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Spencer NY, 2014, BIOCHEMISTRY-US, V53, P1551, DOI 10.1021/bi401719r; Stanton RC, 2014, AM J KIDNEY DIS, V63, pS3, DOI 10.1053/j.ajkd.2013.10.050; Uchii M, 2016, EUR J PHARMACOL, V783, P56, DOI 10.1016/j.ejphar.2016.04.005; Waasdorp M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33030; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P952; Yoon SA, 2017, DIABETES OBES METAB, V19, P590, DOI 10.1111/dom.12863	44	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200249	10.1371/journal.pone.0200249	http://dx.doi.org/10.1371/journal.pone.0200249			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979777	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500083
J	Wustenhagen, E; Boukhallouk, F; Negwer, I; Rajalingam, K; Stubenrauch, F; Florin, L				Wuestenhagen, Elena; Boukhallouk, Fatima; Negwer, Inka; Rajalingam, Krishnaraj; Stubenrauch, Frank; Florin, Luise			The Myb-related protein MYPOP is a novel intrinsic host restriction factor of oncogenic human papillomaviruses	ONCOGENE			English	Article							MINOR CAPSID PROTEIN; TRANSCRIPTION FACTORS; HPV INFECTION; REPLICATION; L2; EXPRESSION; BINDING; E6; EPIDEMIOLOGY; ONCOPROTEINS	The skin represents a physical and chemical barrier against invading pathogens, which is additionally supported by restriction factors that provide intrinsic cellular immunity. These factors detect viruses to block their replication cycle. Here, we uncover the Myb-related transcription factor, partner of profilin (MYPOP) as a novel antiviral protein. It is highly expressed in the epithelium and binds to the minor capsid protein L2 and the DNA of human papillomaviruses (HPV), which are the primary causative agents of cervical cancer and other tumors. The early promoter activity and early gene expression of the oncogenic HPV types 16 and 18 is potently silenced by MYPOP. Cellular MYPOP-depletion relieves the restriction of HPV16 infection, demonstrating that MYPOP acts as a restriction factor. Interestingly, we found that MYPOP protein levels are significantly reduced in diverse HPV-transformed cell lines and in HPV-induced cervical cancer. Decades ago it became clear that the early oncoproteins E6 and E7 cooperate to immortalize keratinocytes by promoting degradation of tumor suppressor proteins. Our findings suggest that E7 stimulates MYPOP degradation. Moreover, overexpression of MYPOP blocks colony formation of HPV and non-virally transformed keratinocytes, suggesting that MYPOP exhibits tumor suppressor properties.	[Wuestenhagen, Elena; Boukhallouk, Fatima; Florin, Luise] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, Obere Zahlbacher Str 67, D-55131 Mainz, Germany; [Negwer, Inka] Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany; [Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Mol Signaling Unit, Mainz, Germany; [Stubenrauch, Frank] Univ Hosp, Inst Med Virol & Epidemiol Viral Dis, Div Expt Virol, Tubingen, Germany	Johannes Gutenberg University of Mainz; Max Planck Society; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Florin, L (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, Obere Zahlbacher Str 67, D-55131 Mainz, Germany.	lflorin@uni-mainz.de		Florin, Luise/0000-0003-4310-7329	Max Planck Graduate Center; Johannes Gutenberg-University Mainz (MPGC); Deutsche Forschungsgemeinschaft (DFG) [FL 696/2-1]	Max Planck Graduate Center(Max Planck Society); Johannes Gutenberg-University Mainz (MPGC); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We thank Dr. Hans-Jurgen Butt, Dr. Kaloian Koynov, and Dr. Ulrike Wieland for helpful discussion. We are grateful to Marc A. Schneider and Gilles Spoden for initial experiments (Y2H screening), Karl Sotlar for CIS sections, Claudia Simon for providing the E6 plasmid, Caroline Manicam and Monika Wied-mann for proofreading this manuscript. The skillful technical assistance in lentiviral RNAi system of Aleksandra Dimitrijevic is gratefully acknowledged. This work, including the efforts of Elena Wustenhagen and Inka Negwer, was funded by the Max Planck Graduate Center together with the Johannes Gutenberg-University Mainz (MPGC). Luise Florin receives research support from the Deutsche Forschungsgemeinschaft (DFG; FL 696/2-1).	Akgul B, 2003, VIROLOGY, V308, P279, DOI 10.1016/S0042-6822(02)00133-2; Baldwin Amy, 2007, Open Virol J, V1, P33, DOI 10.2174/1874357900701010033; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Bund T, 2014, CELL MICROBIOL, V16, P1179, DOI 10.1111/cmi.12271; Calton CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006200; Campos SK, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120370; Desaintes C, 1997, EMBO J, V16, P504, DOI 10.1093/emboj/16.3.504; Digiuseppe S, 2017, VIRUS RES, V231, P1, DOI 10.1016/j.virusres.2016.10.015; DiGiuseppe S, 2015, J VIROL, V89, P10442, DOI 10.1128/JVI.01588-15; DOLLARD SC, 1993, J VIROL, V67, P1721, DOI 10.1128/JVI.67.3.1721-1726.1993; Doorbar J, 2015, REV MED VIROL, V25, P2, DOI 10.1002/rmv.1822; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Dreer M, 2017, VIRUS RES, V231, P96, DOI 10.1016/j.virusres.2016.11.005; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Fast LA, 2017, BIOCHEM SOC T, V45, P489, DOI 10.1042/BST20160295; Florin L, 2012, MED MICROBIOL IMMUN, V201, P437, DOI 10.1007/s00430-012-0270-1; Grassel L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32337; HOPPESEYLER F, 1994, MOL CARCINOGEN, V10, P134, DOI 10.1002/mc.2940100304; HWANG ES, 1993, J VIROL, V67, P3720, DOI 10.1128/JVI.67.7.3720-3729.1993; ISHIJI T, 1992, EMBO J, V11, P2271, DOI 10.1002/j.1460-2075.1992.tb05286.x; Jackson J, 2001, BLOOD CELL MOL DIS, V27, P446, DOI 10.1006/bcmd.2001.0403; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kawamura T, 2014, J DERMATOL SCI, V75, P159, DOI 10.1016/j.jdermsci.2014.05.004; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; Leitz J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003957; Maglennon Gareth Adam, 2012, Open Virol J, V6, P190, DOI 10.2174/1874357901206010190; McBride AA, 2017, BIOL CHEM, V398, P919, DOI 10.1515/hsz-2017-0113; McBride AA, 2013, VIROLOGY, V445, P57, DOI 10.1016/j.virol.2013.06.006; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; MUNGER K, 1992, CANCER SURV, V12, P197; NURNBERG W, 1995, CANCER RES, V55, P4432; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Organista Nava J., 2016, J MOL GENET MED, V10, P1; Porter SS, 2017, VIRUS RES, V231, P10, DOI 10.1016/j.virusres.2016.11.014; Prouse MB, 2012, BBA-GENE REGUL MECH, V1819, P67, DOI 10.1016/j.bbagrm.2011.10.010; Raff AB, 2013, J VIROL, V87, P6062, DOI 10.1128/JVI.00330-13; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Scheffer KD, 2014, VIRUSES-BASEL, V6, P893, DOI 10.3390/v6020893; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Schneider MA, 2011, IDENTIFIZIERUNG CHAR, V16, P1; Schneider MA, 2013, J VIROL, V87, P4461, DOI 10.1128/JVI.01803-12; Schneider MA, 2011, CELL MICROBIOL, V13, P32, DOI 10.1111/j.1462-5822.2010.01515.x; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Soeda E, 2006, VIROLOGY, V351, P29, DOI 10.1016/j.virol.2006.03.016; Stanley M, 2010, GYNECOL ONCOL, V117, pS5, DOI [10.1016/j.ygyno.2010.01.024, 10.1016/j.ygyno.2010.04.002]; Stepp WH, 2013, MBIO, V4, DOI 10.1128/mBio.00845-13; Straub E, 2014, J VIROL, V88, P937, DOI 10.1128/JVI.02296-13; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Tomaic V, 2016, CANCERS, V8, DOI 10.3390/cancers8100095; Tota JE, 2011, PREV MED, V53, pS12, DOI 10.1016/j.ypmed.2011.08.017; Van Doorslaer K, 2017, MBIO, V8, DOI 10.1128/mBio.01758-17; Wang JW, 2013, VIROLOGY, V445, P175, DOI 10.1016/j.virol.2013.04.017; White EA, 2016, MBIO, V7, DOI 10.1128/mBio.01530-16; Wustenhagen E, 2016, J VIROL, V90, P10629, DOI 10.1128/JVI.01222-16; YEE C, 1985, AM J PATHOL, V119, P361; Yim Eun-Kyoung, 2005, Cancer Res Treat, V37, P319, DOI 10.4143/crt.2005.37.6.319; Zhou Y, 2011, FRONT BIOSCI-LANDMRK, V16, P1109, DOI 10.2741/3738	58	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 29	2018	37	48					6275	6284		10.1038/s41388-018-0398-6	http://dx.doi.org/10.1038/s41388-018-0398-6			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HC2HE	30018400	Green Published, hybrid			2022-12-26	WOS:000451622100006
J	Tsin, A; Betts-Obregon, B; Grigsby, J				Tsin, Andrew; Betts-Obregon, Brandi; Grigsby, Jeffery			Visual cycle proteins: Structure, function, and roles in human retinal disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BINDING PROTEIN; GENE-THERAPY; PIGMENT EPITHELIUM; IRBP PROMOTES; VITAMIN-A; RPE65; MUTATIONS; ISOMERASE; RELEASE; REGENERATION	Here, we seek to summarize the current understanding of the biochemical and molecular events mediated by visual cycle molecules in the eye. The structures and functions of selected visual cycle proteins and their roles in human retinal diseases are also highlighted. Genetic mutations and malfunctions of these proteins provide etiological evidence that many ocular diseases arise from anomalies of retinoid (vitamin A) metabolism and related visual processes. Genetic retinal disorders such as retinitis pigmentosa, Leber's congenital amaurosis, and Stargardt's disease are linked to structural changes in visual cycle proteins. Moreover, recent reports suggest that visual cycle proteins may also play a role in the development of diabetic retinopathy. Basic science has laid the groundwork for finding a cure for many of these blindness-causing afflictions, but much work remains. Some translational research projects have advanced to the clinical trial stage, while many others are still in progress, and more are at the ideas stage and remain yet to be tested. Some examples of these studies are discussed. Recent and future progress in our understanding of the visual cycle will inform intervention strategies to preserve human vision and prevent blindness.	[Tsin, Andrew; Betts-Obregon, Brandi] Univ Texas Rio Grande Valley Sch Med, Dept Biomed Sci, Edinburg, TX 78541 USA; [Grigsby, Jeffery] Vis Hlth Specialties, Midland, TX 79707 USA; [Grigsby, Jeffery] Univ Houston, Coll Optometry, Houston, TX 77204 USA; [Grigsby, Jeffery] Texas Tech Univ, Hlth Sci Ctr, Sch Hlth Profess, Dept Lab Sci & Primary Care, Midland, TX 79705 USA	University of Texas System; University of Texas Rio Grande Valley; University of Houston System; University of Houston; Texas Tech University System; Texas Tech University	Tsin, A (corresponding author), Univ Texas Rio Grande Valley Sch Med, Dept Biomed Sci, Edinburg, TX 78541 USA.	Andrew.Tsin@utrgv.edu			University of Texas Rio Grande Valley; University of Texas Rio Grande Valley School of Medicine	University of Texas Rio Grande Valley; University of Texas Rio Grande Valley School of Medicine	We thank the University of Texas Rio Grande Valley and University of Texas Rio Grande Valley School of Medicine for support of this work.	Ala-Laurila P, 2006, J GEN PHYSIOL, V128, P153, DOI 10.1085/jgp.200609557; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Betts-Obregon BS, 2014, INVEST OPHTH VIS SCI, V55, P6265, DOI 10.1167/iovs.14-14721; Cai X, 2009, OPHTHALMIC GENET, V30, P57, DOI 10.1080/13816810802626399; CARLSON A, 1992, BIOCHEMISTRY-US, V31, P9056, DOI 10.1021/bi00152a049; Chen Y, 2013, J CLIN INVEST, V123, P5119, DOI 10.1172/JCI69076; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; ELDER MJ, 1994, J PEDIATR OPHTHALMOL, V31, P38; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Garcia-Ramirez M, 2009, DIABETOLOGIA, V52, P2633, DOI 10.1007/s00125-009-1548-8; Garlipp MA, 2013, EXP EYE RES, V113, P192, DOI 10.1016/j.exer.2013.02.003; Gonzalez-Fernandez F, 2003, VISION RES, V43, P3021, DOI 10.1016/j.visres.2003.09.019; Gonzalez-Fernandez F, 2008, EXP EYE RES, V86, P169, DOI 10.1016/j.exer.2006.09.003; Gonzalez-Fernandez F, 2015, PHOTOCHEM PHOTOBIOL, V91, P371, DOI 10.1111/php.12416; Gonzalez-Fernandez F, 2014, EXP EYE RES, V120, P167, DOI 10.1016/j.exer.2014.01.002; Gonzalez-Fernandez Federico, 2012, J Ophthalmic Vis Res, V7, P100; Grigsby J. G., 2018, EARLY EVENTS DIABETI, P3; Grigsby JG, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/705783; Hareendran S, 2013, REV MED VIROL, V23, P399, DOI 10.1002/rmv.1762; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HO MTP, 1989, J BIOL CHEM, V264, P928; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Kashani AH, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4097; Kiser PD, 2016, ANNU REV VIS SCI, V2, P197, DOI 10.1146/annurev-vision-111815-114407; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; Kolesnikov AV, 2007, VISION RES, V47, P363, DOI 10.1016/j.visres.2006.08.024; Kumaran N, 2018, INVEST OPHTH VIS SCI, V59, P85, DOI 10.1167/iovs.17-22905; Lopez-Rubio S, 2018, MOL VIS, V24, P105; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Malechka VV, 2017, AM J PATHOL, V187, P2222, DOI 10.1016/j.ajpath.2017.06.007; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Muniz A, 2007, EXP EYE RES, V85, P175, DOI 10.1016/j.exer.2007.05.003; Muniz A, 2014, INVEST OPHTH VIS SCI, V55, P198, DOI 10.1167/iovs.13-11740; Muniz A, 2009, BIOCHEMISTRY-US, V48, P6854, DOI 10.1021/bi9002937; OKAJIMA TIL, 1990, P NATL ACAD SCI USA, V87, P6907, DOI 10.1073/pnas.87.17.6907; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Parker R, 2011, J NEUROSCI, V31, P4714, DOI 10.1523/JNEUROSCI.3722-10.2011; Parker RO, 2010, ADV EXP MED BIOL, V664, P141, DOI 10.1007/978-1-4419-1399-9_17; Parker RO, 2009, J NEUROSCI, V29, P4616, DOI 10.1523/JNEUROSCI.0063-09.2009; PEPPERBERG DR, 1993, MOL NEUROBIOL, V7, P61, DOI 10.1007/BF02780609; Qtaishat NM, 2005, EXP EYE RES, V81, P455, DOI 10.1016/j.exer.2005.03.005; Rayapudi S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008428.pub2; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Saari John C, 2016, Subcell Biochem, V81, P231; Schnedermann C, 2018, NAT CHEM, V10, P449, DOI 10.1038/s41557-018-0014-y; Sharma M. C., 2012, COLOR ATLAS SYNOPSIS, P228; Spark Therapeutics, 2017, LUXT INJ DRUG RAAV R; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Travis GH, 2010, METHODS MOL BIOL, V652, P329, DOI 10.1007/978-1-60327-325-1_19; Wang JS, 2011, PROG RETIN EYE RES, V30, P115, DOI 10.1016/j.preteyeres.2010.11.001; Westerfeld Corey, 2008, Semin Ophthalmol, V23, P59, DOI 10.1080/08820530701745249; Wiggs J. L., 2014, MOL GENETICS SELECTE, P9	58	17	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13016	13021		10.1074/jbc.AW118.003228	http://dx.doi.org/10.1074/jbc.AW118.003228			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	30002120	hybrid, Green Published			2022-12-26	WOS:000442730200004
J	Marizzi, C; Florio, A; Lee, M; Khalfan, M; Ghiban, C; Nash, B; Dorey, J; McKenzie, S; Mazza, C; Cellini, F; Baria, C; Bepat, R; Cosentino, L; Dvorak, A; Gacevic, A; Guzman-Moumtzis, C; Heller, F; Holt, NA; Horenstein, J; Joralemon, V; Kaur, M; Kaur, T; Khan, A; Kuppan, J; Laverty, S; Lock, C; Pena, M; Petrychyn, I; Puthenkalam, I; Ram, D; Ramos, A; Scoca, N; Sin, R; Gonzalez, I; Thakur, A; Usmanov, H; Han, K; Wu, AD; Zhu, T; Micklos, DA				Marizzi, Christine; Florio, Antonia; Lee, Melissa; Khalfan, Mohammed; Ghiban, Cornel; Nash, Bruce; Dorey, Jenna; McKenzie, Sean; Mazza, Christine; Cellini, Fabiana; Baria, Carlo; Bepat, Ron; Cosentino, Lena; Dvorak, Alexander; Gacevic, Amina; Guzman-Moumtzis, Cristina; Heller, Francesca; Holt, Nicholas Alexander; Horenstein, Jeffrey; Joralemon, Vincent; Kaur, Manveer; Kaur, Tanveer; Khan, Armani; Kuppan, Jessica; Laverty, Scott; Lock, Camila; Pena, Marianne; Petrychyn, Ilona; Puthenkalam, Indu; Ram, Daval; Ramos, Arlene; Scoca, Noelle; Sin, Rachel; Gonzalez, Izabel; Thakur, Akansha; Usmanov, Husan; Han, Karen; Wu, Andy; Zhu, Tiger; Micklos, David Andrew			DNA barcoding Brooklyn (New York): A first assessment of biodiversity in Marine Park by citizen scientists	PLOS ONE			English	Article							SPECIES IDENTIFICATION; ANT; HYMENOPTERA; PRIMERS; SPECIFICITY; DIVERSITY; HABITAT; TOOL	DNA barcoding is both an important research and science education tool. The technique allows for quick and accurate species identification using only minimal amounts of tissue samples taken from any organism at any developmental phase. DNA barcoding has many practical applications including furthering the study of taxonomy and monitoring biodiversity. In addition to these uses, DNA barcoding is a powerful tool to empower, engage, and educate students in the scientific method while conducting productive and creative research. The study presented here provides the first assessment of Marine Park (Brooklyn, New York, USA) biodiversity using DNA barcoding. New York City citizen scientists (high school students and their teachers) were trained to identify species using DNA barcoding during a two-week long institute. By performing NCBI GenBank BLAST searches, students taxonomically identified 187 samples (1 fungus, 70 animals and 116 plants) and also published 12 novel DNA barcodes on GenBank. Students also identified 7 ant species and demonstrated the potential of DNA barcoding for identification of this especially diverse group when coupled with traditional taxonomy using morphology. Here we outline how DNA barcoding allows citizen scientists to make preliminary taxonomic identifications and contribute to modern biodiversity research.	[Marizzi, Christine; Lee, Melissa; Ghiban, Cornel; Nash, Bruce; Dorey, Jenna; Micklos, David Andrew] DNA Learning Ctr, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Florio, Antonia] Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA; [Khalfan, Mohammed] NYU, New York, NY USA; [Dorey, Jenna] New York Bot Garden, Bronx, NY 10458 USA; [McKenzie, Sean] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Mazza, Christine; Cellini, Fabiana] New York City Dept Educ, Genovesi Environm Study Ctr, Brooklyn, NY USA; [Cosentino, Lena; Laverty, Scott] New York City Dept Educ, CSI Int Studies, Staten Isl, NY USA; [Bepat, Ron; Holt, Nicholas Alexander; Khan, Armani; Kuppan, Jessica; Ram, Daval; Han, Karen] New York City Dept Educ, High Sch Construct Trades Engn & Architecture, Queens, NY USA; [Dvorak, Alexander] New York City Dept Educ, Int High Sch Union Sq, New York, NY USA; [Gacevic, Amina; Kaur, Manveer; Kaur, Tanveer; Pena, Marianne; Ramos, Arlene; Gonzalez, Izabel] New York City Dept Educ, High Sch Hlth Profess & Human Serv, New York, NY USA; [Guzman-Moumtzis, Cristina; Joralemon, Vincent] New York City Dept Educ, Frank McCourt High Sch, New York, NY USA; [Heller, Francesca; Sin, Rachel; Usmanov, Husan; Wu, Andy] Franklin D Roosevelt High Sch, New York City Dept Educ, Brooklyn, NY USA; [Horenstein, Jeffrey; Zhu, Tiger] New York City Dept Educ, Stuyvesant High Sch, New York, NY USA; [Lock, Camila; Petrychyn, Ilona; Puthenkalam, Indu; Thakur, Akansha] New York City Dept Educ, Forest Hills High Sch, Queens, NY USA; [Scoca, Noelle] New York City Dept Educ, Brooklyn Int High Sch, Brooklyn, NY USA	Cold Spring Harbor Laboratory; American Museum of Natural History (AMNH); New York University; New York Botanical Garden; Rockefeller University	Marizzi, C (corresponding author), DNA Learning Ctr, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.	cmarizzi@cshl.edu	McKenzie, Sean K/AAD-8199-2020	McKenzie, Sean K/0000-0002-8238-4735	Alfred P. Sloan Foundation; National Science Foundation Plant Cyberinfrastructure Program [DBI-0735191, DBI-1265383]; NYCDOE	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Science Foundation Plant Cyberinfrastructure Program; NYCDOE	The inaugural Urban Barcode Project was funded by the Alfred P. Sloan Foundation (https://sloan.org/). DNA Subway was developed for the CyVerse (former iPlant) Collaborative, funded by a grant from the National Science Foundation Plant Cyberinfrastructure Program (#DBI-0735191, DBI-1265383, https://www.nsf.gov/). This study took place in collaboration with NYCDOE that funded the Urban Barcoding Project Institutes at the Genovesi Environmental Study Center (http://schools.nyc.gov/default.htm). Funding was received by David Andrew Micklos, CSHL, DNA Learning Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alden P., 1998, NATL AUDUBON SOC FIE; Auchincloss LC, 2014, CBE-LIFE SCI EDUC, V13, P29, DOI 10.1187/cbe.14-01-0004; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ballard HL, 2017, BIOL CONSERV, V208, P65, DOI 10.1016/j.biocon.2016.05.024; BERNARD EC, 1992, BIOL FERT SOILS, V14, P99, DOI 10.1007/BF00336257; Bowler I., 2015, COMM WORKSH RES ROCK; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; Clark LF, 2015, FOOD POLICY, V54, P85, DOI 10.1016/j.foodpol.2015.05.005; Day L., 2007, FIELD GUIDE NATURAL; DeSalle R, 1996, NATURE, V381, P197, DOI 10.1038/381197a0; Doukakis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040907; Eberhardt Ursula, 2012, Methods Mol Biol, V858, P183, DOI 10.1007/978-1-61779-591-6_9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Harris SE, 2013, SCIENCE, V342, P1462, DOI 10.1126/science.1230006; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henter HJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0340; Henter HJ, 2016, J COLL SCI TEACH, V46, P17, DOI DOI 10.2505/4/JCST16_; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hughes JB, 2000, CONSERV BIOL, V14, P1788, DOI 10.1111/j.1523-1739.2000.99187.x; Ivanov K, 2011, BIOL INVASIONS, V13, P1945, DOI 10.1007/s10530-011-0021-z; Jackson CJ, 1999, J CLIN MICROBIOL, V37, P931, DOI 10.1128/JCM.37.4.931-936.1999; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; Karsten L, 2006, CHILD YOUTH ENV, V16; King JR, 2004, INSECT SOC, V51, P197, DOI 10.1007/s00040-003-0709-x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress W John, 2012, Methods Mol Biol, V858, P3, DOI 10.1007/978-1-61779-591-6_1; Larsen BB, 2017, Q REV BIOL, V92, P229, DOI 10.1086/693564; Lehmitz R, 2017, EXP APPL ACAROL, V71, P259, DOI 10.1007/s10493-017-0126-x; Lindemann-Matthies P., 2002, J ENVIRON EDUC, V33, P22, DOI DOI 10.1080/00958960209600805; Little DP, 2014, GENOME, V57, P513, DOI 10.1139/gen-2014-0130; Little DP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03518; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Merchant N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002342; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Micklos D, 2011, SCIENCE, V334, P1657, DOI 10.1126/science.1197074; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; NYS Department of Environmental Conservation and NYS Department of Agriculture and Markets, 2014, NEW YORK STAT PROH R; Pecnikar ZF, 2014, J APPL GENET, V55, P43, DOI 10.1007/s13353-013-0180-y; Potter JW, 2003, CAN J SOIL SCI, V83, P289, DOI 10.4141/S01-064; Raja HA, 2017, FOOD CHEM, V214, P383, DOI 10.1016/j.foodchem.2016.07.052; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Santschi L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001471; Savage AM, 2015, INSECT CONSERV DIVER, V8, P216, DOI 10.1111/icad.12098; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Schwartz J., 2008, NY TIMES; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Shylla JA, 2013, PARASITOL RES, V112, P4239, DOI 10.1007/s00436-013-3616-8; Siddall ME, 2009, SYST BIOL, V58, P445, DOI 10.1093/sysbio/syp033; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Stoeckle MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043992; Stoeckle MY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00042; The Brooklyn Botanic Garden, 2013, INV ASS SCOR RANKS 1; Wetterer JK, 2011, FLA ENTOMOL, V94, P582, DOI 10.1653/024.094.0323; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Youngsteadt E, 2015, GLOBAL CHANGE BIOL, V21, P1103, DOI 10.1111/gcb.12791; Zheng H, 2006, BIOL CONTROL, V1, P160	63	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199015	10.1371/journal.pone.0199015	http://dx.doi.org/10.1371/journal.pone.0199015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020927	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400008
J	Ono, M; Lai, KKY; Wu, KJ; Nguyen, C; Lin, DP; Murali, R; Kahn, M				Ono, Masaya; Lai, Keane K. Y.; Wu, Kaijin; Cu Nguyen; Lin, David P.; Murali, Ramachandran; Kahn, Michael			Nuclear receptor/Wnt beta-caten in interactions are regulated via differential CBP/p300 coactivator usage	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; NEURONAL DIFFERENTIATION; SYNERGISTIC INDUCTION; BINDING-PROTEIN; GENE-EXPRESSION; P300; CBP; TRANSCRIPTION; PREDICTION; NARDILYSIN	Over 400 million years ago, the evolution of vertebrates gave rise to a life cycle in which the organism began to live longer particularly as an adult. To accommodate such a longer lifespan, the organism underwent adaptation, developing a mechanism for long-lived cellular homeostasis. This adaptation required a population of long-lived relatively quiescent somatic stem cells (SSCs) along with a more proliferative differentiated daughter cell population, and was necessary to safeguard the genetic attributes with which SSCs were endowed. Intriguingly, cAMP response element binding protein (CREB)-binding protein (CBP) and E1A-binding protein, 300 kDa (p300), the highly homologous Kat3 coactivators had diverged, through duplication of ancestral Kat3, immediately preceding the evolution of vertebrates, given that both CBP and p300 have been detected in nearly all vertebrates versus non-vertebrates. We now demonstrate that a relatively small, highly evolutionarily conserved, amino terminal 9 amino acid deletion in CBP versus p300, plays a critical role in allowing for both robust maintenance of genomic integrity in stem cells and the initiation of a feed-forward differentiation mechanism by tightly controlling the interaction of the nuclear receptor family with the Wnt signaling cascade in either an antagonistic or synergistic manner.	[Ono, Masaya] Natl Canc Ctr, Res Inst, Dept Clin Prote, Tokyo, Japan; [Lai, Keane K. Y.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Pathol, Duarte, CA USA; [Lai, Keane K. Y.; Cu Nguyen; Kahn, Michael] Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA; [Lai, Keane K. Y.; Lin, David P.] Univ Southern Calif, Dept Pathol, Los Angeles, CA 90007 USA; [Lai, Keane K. Y.; Lin, David P.] Univ Southern Calif, Southern Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90007 USA; [Wu, Kaijin; Cu Nguyen; Kahn, Michael] Univ Southern Calif, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90007 USA; [Wu, Kaijin; Kahn, Michael] Univ Southern Calif, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA; [Murali, Ramachandran] Cedars Sinai Med Ctr, Dept Biomed Sci, Res Div Immunol, Los Angeles, CA USA; [Kahn, Michael] Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA; [Kahn, Michael] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA; [Wu, Kaijin] Univ Southern Calif, Dept Med, Los Angeles, CA 90007 USA	National Cancer Center - Japan; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Cedars Sinai Medical Center; University of Southern California; University of Southern California; University of Southern California	Kahn, M (corresponding author), Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.; Kahn, M (corresponding author), Univ Southern Calif, Ctr Mol Pathways & Drug Discovery, Los Angeles, CA 90007 USA.; Kahn, M (corresponding author), Univ Southern Calif, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA.; Kahn, M (corresponding author), Univ Southern Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.; Kahn, M (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.	mkahn@coh.org	Murali, Ramachandran/D-1132-2009	Murali, Ramachandran/0000-0002-8384-2793	MEXT KAKENHI [JP17H06419]; USC Norris Comprehensive Cancer Center [NIH P30CA014089, NIH R01CA166161, R21NS074392, R21AI105057, R01HL112638]; NIH [K08AA025112]; Wright Foundation; STOP CANCER; NATIONAL CANCER INSTITUTE [R01CA166161, P30CA014089] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA025112] Funding Source: NIH RePORTER	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); USC Norris Comprehensive Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wright Foundation; STOP CANCER; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	M.O. was supported by MEXT KAKENHI Grant Number JP17H06419. M.K. was supported by USC Norris Comprehensive Cancer Center Support Grant NIH P30CA014089, and NIH R01CA166161, R21NS074392, R21AI105057, and R01HL112638. K.K.Y.L. has been supported by NIH K08AA025112, Wright Foundation, and STOP CANCER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M.O. was supported by MEXT KAKENHI Grant Number JP17H06419. M.K. was supported by USC Norris Comprehensive Cancer Center Support Grant NIH P30CA014089, and NIH R01CA166161, R21NS074392, R21AI105057, and R01HL112638. K.K.Y.L. has been supported by NIH K08AA025112, Wright Foundation, and STOP CANCER.	ALVER BH, 2017, NAT COMMUN, V8, DOI DOI 10.1371/JOURNAL.PONE.0075010; Angelov D, 2004, EMBO J, V23, P3815, DOI 10.1038/sj.emboj.7600400; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Bernstein HG, 2007, NEUROSCIENCE, V146, P1513, DOI 10.1016/j.neuroscience.2007.02.057; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; Boitard M, 2015, CELL REP, V10, P1349, DOI 10.1016/j.celrep.2015.01.061; BOUILLET P, 1995, DEV BIOL, V170, P420, DOI 10.1006/dbio.1995.1226; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Dillard AC, 2007, MOL CARCINOGEN, V46, P315, DOI 10.1002/mc.20280; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; FLEURIE A, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PGEN.1004074; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Higuchi Y, 2016, CURR MOL PHARMACOL, V9, P272, DOI 10.2174/1874467208666150526155146; Hong F, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000607; Kahn M, 2011, FUTURE MED CHEM, V3, P1745, DOI [10.4155/FMC.11.126, 10.4155/fmc.11.126]; Kamita M, 2015, PROTEOMICS, V15, P1622, DOI 10.1002/pmic.201400442; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kung AL, 2000, GENE DEV, V14, P272; Ma H, 2005, ONCOGENE, V24, P3619, DOI 10.1038/sj.onc.1208433; Magdeldin S, 2014, STEM CELL REV REP, V10, P561, DOI 10.1007/s12015-014-9517-0; Martins AHB, 2005, J BIOL CHEM, V280, P19576, DOI 10.1074/jbc.M502513200; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Mathieu J, 2017, DEVELOPMENT, V144, P541, DOI 10.1242/dev.128389; Matsubara J, 2009, J CLIN ONCOL, V27, P2261, DOI 10.1200/JCO.2008.19.9745; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; McMillan M, 2005, DRUG DISCOV TODAY, V10, P1467, DOI 10.1016/S1359-6446(05)03613-5; Metzler MA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120812; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Moayedi Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004055; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Ono Masaya, 2012, Int J Proteomics, V2012, P897412, DOI 10.1155/2012/897412; Ono M, 2009, J BIOL CHEM, V284, P29041, DOI 10.1074/jbc.M109.041749; Orsolits B, 2013, STEM CELLS DEV, V22, P2777, DOI 10.1089/scd.2012.0422; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Pirotte D, 2010, MOL CELL NEUROSCI, V43, P72, DOI 10.1016/j.mcn.2009.09.003; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Qu DB, 2015, J BIOL CHEM, V290, P30441, DOI 10.1074/jbc.M115.677815; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rieger ME, 2016, J BIOL CHEM, V291, P6569, DOI 10.1074/jbc.M115.706416; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sasaki T., 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0075010; Sasaki Tomoyo, 2014, Transl Respir Med, V2, P8, DOI 10.1186/s40247-014-0008-1; Son EY, 2014, AM J MED GENET C, V166, P333, DOI 10.1002/ajmg.c.31416; Szeto W, 2001, CANCER RES, V61, P4197; Tedesco M, 2009, J BIOL CHEM, V284, P35781, DOI 10.1074/jbc.M109.056481; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Thomas PD, 2016, CELL BIOL TOXICOL, V32, P61, DOI 10.1007/s10565-016-9318-0; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; Trosko James E, 2012, Int J Stem Cells, V5, P39; Weiske J, 2005, J CELL SCI, V118, P3117, DOI 10.1242/jcs.02437; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829; Yang WB, 2001, J BIOL CHEM, V276, P38341, DOI 10.1074/jbc.C100316200; Yip DJ, 2012, DEV CELL, V22, P871, DOI 10.1016/j.devcel.2012.01.020; Yoon WH, 2017, NEURON, V93, P115, DOI 10.1016/j.neuron.2016.11.038	58	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200714	10.1371/journal.pone.0200714	http://dx.doi.org/10.1371/journal.pone.0200714			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020971	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400067
J	Zhang, WQ; Hahn, AC; Cai, ZY; Lee, AJ; Holzleitner, IJ; DeBruine, LM; Jones, BC				Zhang, Weiqing; Hahn, Amanda C.; Cai, Ziyi; Lee, Anthony J.; Holzleitner, Iris J.; DeBruine, Lisa M.; Jones, Benedict C.			No evidence that facial width-to-height ratio (fWHR) is associated with women's sexual desire	PLOS ONE			English	Article							PERCEPTION	Facial width-to-height ratio (fWHR) has been linked to many different behavioral tendencies. However, not all of these correlations have replicated well across samples. Arnocky et al. (in press, Archives of Sexual Behavior) recently reported that sexual desire was correlated with fWHR. The current study aimed to test this relationship in a large sample of women. fWHR was measured from face images of 754 women. Each woman completed the Sexual Desire Inventory, which measures total, dyadic, and solitary sexual desire. Analyses revealed no significant correlations between fWHR and any of our measures of sexual desire. These null results do not support the hypothesis that fWHR is related to women's sexual desire. Additionally, we found no evidence that women's face-shape sexual dimorphism was related to their sociosexual orientation.	[Zhang, Weiqing; Cai, Ziyi; Lee, Anthony J.; Holzleitner, Iris J.; DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Hahn, Amanda C.] Humboldt State Univ, Dept Psychol, Arcata, CA 95521 USA	University of Glasgow; California State University System; California State Polytechnic University, Humboldt	Jones, BC (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	ben.jones@glasgow.ac.uk	Lee, Anthony J./I-8220-2012; DeBruine, Lisa M/A-6990-2008; Hahn, Amanda C/AAH-1106-2021; Jones, Benedict/A-7850-2008	Lee, Anthony J./0000-0001-8288-3393; DeBruine, Lisa M/0000-0002-7523-5539; Hahn, Amanda C/0000-0002-4555-7924; Jones, Benedict/0000-0001-7777-0220	ERC	ERC(European Research Council (ERC)European Commission)	This work was supported by ERC grants KINSHIP and OCMATE.; We thank Alex Jones, Brian Bird, Steven Arnocky, and Lynda Boothroyd for helpful comments and discussion. This work was funded by ERC grants to BCJ (OCMATE) and LMD (KINSHIP).	Arnocky S, 2018, ARCH SEX BEHAV, V47, P1375, DOI 10.1007/s10508-017-1070-x; Bird BM, 2016, EVOL HUM BEHAV, V37, P392, DOI 10.1016/j.evolhumbehav.2016.03.004; Campbell L, 2009, PERS INDIV DIFFER, V46, P509, DOI 10.1016/j.paid.2008.12.001; Geniole SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132726; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Hodges-Simeon CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153083; Holzleitner IJ, 2016, EVOL HUM BEHAV, V37, P217, DOI 10.1016/j.evolhumbehav.2015.11.004; Jones B. C., PSYCHONEUROENDOCRINO; Jones B. C., EVOLUTION HUMAN BEHA; Jones B. C., PSYCHOL SCI; Komori M, 2011, J EXP PSYCHOL HUMAN, V37, P626, DOI 10.1037/a0020369; Kosinski M, 2017, PSYCHOL SCI, V28, P1675, DOI 10.1177/0956797617716929; Kramer RSS, 2016, PEERJ, V4, DOI 10.7717/peerj.1801; Lee AJ, 2014, PSYCHOL SCI, V25, P476, DOI 10.1177/0956797613510724; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Trebicky V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149313; Welker KM, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01745; Whitehouse AJO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1351	21	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200308	10.1371/journal.pone.0200308	http://dx.doi.org/10.1371/journal.pone.0200308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020967	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000439022400046
J	Cruz-Lopez, D; Ramos, D; Castilloveitia, G; Schikorski, T				Cruz-Lopez, Didiana; Ramos, Dianne; Castilloveitia, Gloria; Schikorski, Thomas			Quintuple labeling in the electron microscope with genetically encoded enhanced horseradish peroxidase	PLOS ONE			English	Article							FUNCTIONAL EXPRESSION; VISUALIZATION	Genetic encoded multilabeling is essential for modern cell biology. In fluorescence microscopy this need has been satisfied by the development of numerous color-variants of the green fluorescent protein. In electron microscopy, however, true genetic encoded multilabeling is currently not possible. Here, we introduce combinatorial cell organelle type-specific labeling as a strategy for multilabeling. First, we created a reliable and high sensitive label by evolving the catalytic activity of horseradish peroxidase (HRP). We then built fusion proteins that targeted our new enhanced HRP (eHRP) to three cell organelles whose labeling pattern did not overlap with each other. The labeling of the endoplasmic reticulum, synaptic vesicles and the plasma membrane consequently allowed for triple labeling in the EM. The combinatorial expression of the three organelle-specific constructs increased the number of clearly distinguishable labels to seven. This strategy of multilabeling for EM closes a significant gap in our tool set and has a broad application range in cell biology.	[Cruz-Lopez, Didiana; Ramos, Dianne; Castilloveitia, Gloria; Schikorski, Thomas] Univ Cent Caribe, Dept Neurosci, Bayamon, PR 00960 USA; [Cruz-Lopez, Didiana] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Schikorski, T (corresponding author), Univ Cent Caribe, Dept Neurosci, Bayamon, PR 00960 USA.	ts.uccaribe@tutamail.com			NIH/NINDS [R21NS063208, R15NS095318]; NIH [SC1NS077776, 5R21NS063208, 1SC1NS077776, 1R15NS095318]; Vias RIMI Program at the Universidad del Este; VIAS RIMI Program at the Universidad del Este, Carolina, PR; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063208, SC1NS077776, R15NS095318] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vias RIMI Program at the Universidad del Este; VIAS RIMI Program at the Universidad del Este, Carolina, PR; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH/NINDS R21NS063208, NIH SC1NS077776, NIH/NINDS R15NS095318, Vias RIMI Program at the Universidad del Este.; This work was supported by the NIH grants 5R21NS063208, 1SC1NS077776, and 1R15NS095318 to T.S. Additional support for D.C.L. was obtained through the VIAS RIMI Program at the Universidad del Este, Carolina, PR.	Afuwape OAT, 2017, J PHYSIOL-LONDON, V595, P1223, DOI 10.1113/JP273115; Atasoy D, 2014, NAT NEUROSCI, V17, P1830, DOI 10.1038/nn.3854; CONNOLLY CN, 1994, J CELL BIOL, V127, P641, DOI 10.1083/jcb.127.3.641; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Gaietta G, 2001, P NATL ACAD SCI USA, V103, P17777; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Han S, 2018, CURR OPIN NEUROBIOL, V50, P17, DOI 10.1016/j.conb.2017.10.015; Hua ZL, 2011, NEURON, V71, P474, DOI 10.1016/j.neuron.2011.06.010; Joesch M, 2016, ELIFE, V5, DOI 10.7554/eLife.15015; Johnson E, 2015, SCI REP-UK, V5, DOI 10.1038/srep09583; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Leal-Ortiz S, 2008, J CELL BIOL, V181, P831, DOI 10.1083/jcb.200711167; Li J, 2010, NEURON, V69, P273, DOI [10.1083/jcb.200711167, DOI 10.1083/JCB.200711167]; Lin TY, 2016, J COMP NEUROL, V524, P213, DOI 10.1002/cne.23857; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Martell JD, 2016, NAT BIOTECHNOL, V34, P774, DOI 10.1038/nbt.3563; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; Morawski B, 2001, BIOTECHNOL BIOENG, V76, P99, DOI 10.1002/bit.1149; Morawski B, 2000, PROTEIN ENG, V13, P377, DOI 10.1093/protein/13.5.377; Ng J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38863; Norcott JP, 1996, J CELL BIOL, V134, P1229, DOI 10.1083/jcb.134.5.1229; Schikorski T, 2007, J NEUROSCI METH, V165, P210, DOI 10.1016/j.jneumeth.2007.06.004; Schikorski T, 2016, METHODS MOL BIOL, V1474, P327, DOI 10.1007/978-1-4939-6352-2_21; Schikorski T, 2010, METHODS MOL BIOL, V657, P315, DOI 10.1007/978-1-60761-783-9_25; Schirra RT, 2005, CURR PROTOC CYTOM, V70; Shigemoto R, 2017, WIRES DEV BIOL, V6, DOI 10.1002/wdev.288; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041	28	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200693	10.1371/journal.pone.0200693	http://dx.doi.org/10.1371/journal.pone.0200693			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011315	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800044
J	Oliveira, KMC; Pindur, L; Han, ZH; Bhavsar, MB; Barker, JH; Leppik, L				Oliveira, Karla M. C.; Pindur, Lukas; Han, Zhihua; Bhavsar, Mit B.; Barker, John H.; Leppik, Liudmila			Time course of traumatic neuroma development	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; LOWER-LIMB AMPUTATION; HUMAN LINGUAL NERVE; MOLECULAR-MECHANISMS; AXONAL DEGENERATION; SIGNALING PATHWAYS; NEUROPATHIC PAIN; IN-VIVO; INJURY; EXPRESSION	This study was designed to characterize morphologic stages during neuroma development post amputation with an eye toward developing better treatment strategies that intervene before neuromas are fully formed. Right forelimbs of 30 Sprague Dawley rats were amputated and limb stumps were collected at 3, 7, 28, 60 and 90 Days Post Amputation (DPA). Morphology of newly formed nerves and neuromas were assessed via general histology and neurofilament protein antibody staining. Analysis revealed six morphological characteristics during nerve and neuroma development; 1) normal nerve, 2) degenerating axons, 3) axonal sprouts, 4) unorganized bundles of axons, 5) unorganized axon growth into muscles, and 6) unorganized axon growth into fibrotic tissue (neuroma). At early stages (3 & 7 DPA) after amputation, normal nerves could be identified throughout the limb stump and small areas of axonal sprouts were present near the site of injury. Signs of degenerating axons were evident from 7 to 90 DPA. From day 28 on, variability of nerve characteristics with signs of unorganized axon growth into muscle and fibrotic tissue and neuroma formation became visible in multiple areas of stump tissue. These pathological features became more evident on days 60 and 90. At 90 DPA frank neuroma formation was present in all stump tissue. By following nerve regrowth and neuroma formation after amputation we were able to identify 6 separate histological stages of nerve regrowth and neuroma development. Axonal regrowth was observed as early as 3 DPA and signs of unorganized axonal growth and neuroma formation were evident by 28 DPA. Based on these observations we speculate that neuroma treatment and or prevention strategies might be more successful if targeted at the initial stages of development and not after 28 DPA.	[Oliveira, Karla M. C.; Pindur, Lukas; Han, Zhihua; Bhavsar, Mit B.; Barker, John H.; Leppik, Liudmila] Goethe Univ Frankfurt, Frankfurt Initiat Regenerat Med, Frankfurt, Germany	Goethe University Frankfurt	Leppik, L (corresponding author), Goethe Univ Frankfurt, Frankfurt Initiat Regenerat Med, Frankfurt, Germany.	Liudmila.Leppik@kgu.de		Costa Oliveira, Karla Mychellyne/0000-0002-3338-793X; Bhavsar, Mit/0000-0002-7400-1263; Han, Zhihua/0000-0003-3128-3077; Leppik, Liudmila/0000-0003-0362-4727	Friedrichsheim Foundation (Stiftung Friedrichsheim) based in Frankfurt/Main, Germany	Friedrichsheim Foundation (Stiftung Friedrichsheim) based in Frankfurt/Main, Germany	This study was supported in part by the Friedrichsheim Foundation (Stiftung Friedrichsheim) based in Frankfurt/Main, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe N, 2008, CURR OPIN NEUROBIOL, V18, P276, DOI 10.1016/j.conb.2008.06.005; ARGENYI ZB, 1990, J CUTAN PATHOL, V17, P329, DOI 10.1111/j.1600-0560.1990.tb00108.x; Ay Sadan, 2003, Tech Hand Up Extrem Surg, V7, P114, DOI 10.1097/00130911-200309000-00008; Buchheit T, 2016, PAIN MED, V17, P149, DOI 10.1111/pme.12848; Cai YQ, 2013, J PHARMACOL EXP THER, V345, P161, DOI 10.1124/jpet.112.202192; Chan KM, 2014, EXP NEUROL, V261, P826, DOI 10.1016/j.expneurol.2014.09.006; Dun XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119168; Economides JM, 2016, NEUROSURGERY, V79, P508, DOI 10.1227/NEU.0000000000001313; Egami S, 2016, J DERMATOL, V43, P836, DOI 10.1111/1346-8138.13297; Faroni A, 2015, ADV DRUG DELIVER REV, V82-83, P160, DOI 10.1016/j.addr.2014.11.010; Foltan R, 2008, MED HYPOTHESES, V71, P572, DOI 10.1016/j.mehy.2008.05.010; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gillen C, 1997, NEUROSCIENTIST, V3, P112, DOI 10.1177/107385849700300210; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Glenn TD, 2013, CURR OPIN NEUROBIOL, V23, P1041, DOI 10.1016/j.conb.2013.06.010; Helfand BT, 2003, MOL BIOL CELL, V14, P5069, DOI 10.1091/mbc.E03-06-0376; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hirose T, 2003, MODERN PATHOL, V16, P293, DOI 10.1097/01.MP.0000062654.83617.B7; Hisam A, 2016, JCPSP-J COLL PHYSICI, V26, P851; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; Hsu E, 2013, J PAIN RES, V6, P121, DOI 10.2147/JPR.S32299; Ismail HEA, 2017, J HAND MICROSURG, V9, P17, DOI 10.1055/s-0037-1602126; Kang J, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0990-6; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Khan Junad, 2017, Pathophysiology, V24, P155, DOI 10.1016/j.pathophys.2017.04.001; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Kryger GS, 2001, J HAND SURG-AM, V26A, P635, DOI 10.1053/jhsu.2001.26035; Leppik LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18353; Marcol W, 2007, NEUROSURG REV, V30, P235, DOI 10.1007/s10143-007-0085-5; Mavrogenis AF, 2008, INJURY, V39, pS43, DOI 10.1016/j.injury.2008.05.015; Mesfin MN, 2012, J NEUROTRAUM, V29, P1982, DOI 10.1089/neu.2011.2253; Michalski B, 2008, J NEUROCHEM, V105, P1244, DOI 10.1111/j.1471-4159.2008.05224.x; Namgung U, 2014, CELLS TISSUES ORGANS, V200, P6, DOI 10.1159/000370324; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nowalk JR, 2008, J HISTOTECHNOL, V31, P19; Pet MA, 2014, CLIN ORTHOP RELAT R, V472, P2991, DOI 10.1007/s11999-014-3602-1; Rainsbury JW, 2007, J LARYNGOL OTOL, V121, P601, DOI 10.1017/S0022215106004993; Rajput K, 2012, CLIN J PAIN, V28, P639, DOI 10.1097/AJP.0b013e31823d30a2; Stokvis A, 2010, J PLAST RECONSTR AES, V63, P1538, DOI 10.1016/j.bjps.2009.05.036; Thomsen L, 2013, CHIR MAIN, V32, P335, DOI 10.1016/j.main.2013.07.001; van der Avoort DJJC, 2013, J PLAST RECONSTR AES, V66, P1330, DOI 10.1016/j.bjps.2013.06.019; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Vora AR, 2007, ARCH ORAL BIOL, V52, P74, DOI 10.1016/j.archoralbio.2006.08.015; Vora AR, 2005, ORAL SURG ORAL MED O, V99, P395, DOI 10.1016/j.tripleo.2004.08.011; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Weng WD, 2016, SCI REP-UK, V6, DOI 10.1038/srep23828; Wood MD, 2015, EXP NEUROL, V265, P171, DOI 10.1016/j.expneurol.2015.02.001; Wu D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00055; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Yan HD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093973; Yan HD, 2012, J NEUROTRAUM, V29, P2791, DOI 10.1089/neu.2012.2502; Yao CL, 2017, ONCOTARGET, V8, P57670, DOI 10.18632/oncotarget.16917; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654	55	42	42	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200548	10.1371/journal.pone.0200548	http://dx.doi.org/10.1371/journal.pone.0200548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011306	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800026
J	Wang, YY; Zhang, YJ; Zhou, R; Dossa, K; Yu, JY; Li, DH; Liu, AL; Mmadi, MA; Zhang, XR; You, J				Wang, Yanyan; Zhang, Yujuan; Zhou, Rong; Dossa, Komivi; Yu, Jingyin; Li, Donghua; Liu, Aili; Mmadi, Marie Ali; Zhang, Xiurong; You, Jun			Identification and characterization of the bZIP transcription factor family and its expression in response to abiotic stresses in sesame	PLOS ONE			English	Article							DROUGHT TOLERANCE; SALT STRESS; ARABIDOPSIS; HETERODIMERIZATION; PROTEINS; QUALITY; ABA; ACTIVATION; ADAPTATION; DATABASE	Basic leucine zipper (bZIP) gene family is one of the largest transcription factor families in plants, and members of this family play important roles in multiple biological processes such as light signaling, seed maturation, flower development as well as abiotic and biotic stress responses. Nonetheless, genome-wide comprehensive analysis of the bZIP family is lacking in the important oil crop sesame. In the present study, 63 bZIP genes distributed on 14 linkage groups were identified in sesame, and denominated as SibZIP01-SibZIP63. Besides, all members of SibZIP family were divided into nine groups based on the phylogenetic relationship of Arabidopsis bZIPs, which was further supported by the analysis of their conserved motifs and gene structures. Promoter analysis showed that all SibZIP genes harbor cis-elements related to stress responsiveness in their promoter regions. Expression analyses of SibZIP genes based on transcriptome data showed that these genes have different expression patterns in different tissues. Additionally, we showed that a majority of SibZIPs (85.71%) exhibited significant transcriptional changes in responses to abiotic stresses, including drought, waterlogging, osmotic, salt, and cold, suggesting that SibZIPs may play a cardinal role in the regulation of stress responses in sesame. Together, these results provide new insights into stress-responsive SibZIP genes and pave the way for future studies of SibZ/Ps-mediated abiotic stress response in sesame.	[Wang, Yanyan; Zhang, Yujuan; Zhou, Rong; Dossa, Komivi; Yu, Jingyin; Li, Donghua; Liu, Aili; Mmadi, Marie Ali; Zhang, Xiurong; You, Jun] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China; [Zhang, Yujuan] Shandong Acad Agr Sci, Huanghuaihai Key Lab Cotton Genet Improvement & C, Minist Agr, Cotton Res Ctr, Jinan, Shandong, Peoples R China; [Dossa, Komivi; Mmadi, Marie Ali] CERAAS, Thies, Senegal	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Shandong Academy of Agricultural Sciences	You, J (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan, Hubei, Peoples R China.	junyou@caas.cn	Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yanbo/HFZ-8018-2022; Wang, Yin/HCI-9352-2022; wang, yan/GSE-6489-2022; Dossa, Komivi/O-8240-2016	You, Jun/0000-0001-8927-1015; Dossa, Komivi/0000-0003-4894-6279	China Agriculture Research System [CARS-14]; Agricultural Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences [CAAS-ASTIP-2013-OCRI]; National Infrastructure for Crop Germplasm Resources [NICGR2017-014]; Central Public-interest Scientific Institution Basal Research Fund [1610172018007]	China Agriculture Research System; Agricultural Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences; National Infrastructure for Crop Germplasm Resources; Central Public-interest Scientific Institution Basal Research Fund	This work was supported by China Agriculture Research System (CARS-14), the Agricultural Science and Technology Innovation Project of Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2013-OCRI), National Infrastructure for Crop Germplasm Resources (NICGR2017-014) and Central Public-interest Scientific Institution Basal Research Fund (1610172018007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alonso R, 2009, PLANT CELL, V21, P1747, DOI 10.1105/tpc.108.062968; Alvarez JM, 2014, PLANT J, V80, P1, DOI 10.1111/tpj.12618; Alves MS, 2013, INT J MOL SCI, V14, P7815, DOI 10.3390/ijms14047815; Assuncao AGL, 2010, P NATL ACAD SCI USA, V107, P10296, DOI 10.1073/pnas.1004788107; Burman N, 2018, PLANT PHYSIOL, V176, P1262, DOI 10.1104/pp.17.00478; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dietrich K, 2011, PLANT CELL, V23, P381, DOI 10.1105/tpc.110.075390; Dossa K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09397-6; Dossa K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01154; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Eskandari H, 2009, J FOOD AGRIC ENVIRON, V7, P339; FOSTER R, 1994, FASEB J, V8, P192, DOI 10.1096/fasebj.8.2.8119490; Fukao T, 2013, CURR OPIN PLANT BIOL, V16, P196, DOI 10.1016/j.pbi.2013.02.003; Gao HB, 2008, P NATL ACAD SCI USA, V105, P16398, DOI 10.1073/pnas.0808463105; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Hartmann L, 2015, PLANT CELL, V27, P2244, DOI 10.1105/tpc.15.00163; Hassanzadeh M., 2009, Research Journal of Environmental Sciences, V3, P116, DOI 10.3923/rjes.2009.116.121; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; Howe E, 2010, BIOMEDICAL INFORMATICS FOR CANCER RESEARCH, P267, DOI 10.1007/978-1-4419-5714-6_15; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kerr TCC, 2018, PLANT CELL ENVIRON, V41, P898, DOI 10.1111/pce.12906; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Li DY, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1990-6; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Liu JX, 2008, PLANT CELL ENVIRON, V31, P1735, DOI 10.1111/j.1365-3040.2008.01873.x; Liu JY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-281; Liu X, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1457-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Mair A, 2015, ELIFE, V4, DOI 10.7554/eLife.05828; Makinde FM, 2014, ACTA SCI POLON-TECHN, V13, P309, DOI 10.17306/J.AFS.2014.3.9; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Pedrotti L, 2018, PLANT CELL, V30, P495, DOI 10.1105/tpc.17.00414; Pourabed E, 2015, MOL BIOTECHNOL, V57, P12, DOI 10.1007/s12033-014-9797-2; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Van Leene J, 2016, J EXP BOT, V67, P5825, DOI 10.1093/jxb/erw347; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Wang JZ, 2011, J INTEGR PLANT BIOL, V53, P212, DOI 10.1111/j.1744-7909.2010.01017.x; Wang LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149912; Wang LH, 2015, PLANT CELL PHYSIOL, V56, DOI 10.1093/pcp/pcu175; Wang LH, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r39; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wei KF, 2012, DNA RES, V19, P463, DOI 10.1093/dnares/dss026; Wei LB, 2013, PLANTA, V237, P873, DOI 10.1007/s00425-012-1805-9; Wei WL, 2013, PLANT SCI, V208, P102, DOI 10.1016/j.plantsci.2013.03.014; Wei X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02586-3; Weltmeier F, 2006, EMBO J, V25, P3133, DOI 10.1038/sj.emboj.7601206; Xiang Y, 2008, PLANT PHYSIOL, V148, P1938, DOI 10.1104/pp.108.128199; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; You J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22585-2; Zhang M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4511-6; Zhong L, 2015, BIOCHEM BIOPH RES CO, V457, P433, DOI 10.1016/j.bbrc.2015.01.009; Zhou Y, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100288	66	40	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200850	10.1371/journal.pone.0200850	http://dx.doi.org/10.1371/journal.pone.0200850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011333	gold, Green Published, Green Submitted			2022-12-26	WOS:000438829800052
J	Li, XH; Yang, T; Liu, J; Qin, XQ; Yu, SW				Li, Xiuhai; Yang, Tao; Liu, Jian; Qin, Xiaoqing; Yu, Shaowei			Effects of vehicle gap changes on fuel economy and emission performance of the traffic flow in the ACC strategy	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; DIFFERENCE MODEL; DRIVING BEHAVIOR; DRIVER MEMORY; DYNAMICS; VELOCITY; CONSUMPTION; SYSTEMS; COMMUNICATION; CONGESTION	This paper focuses on the effects of vehicle gap changes on fuel and emission performance of the simulated traffic flow in the adaptive cruise control (ACC) strategy. Firstly, the close correlation of vehicle gap changes and the host car's behaviors was explored with the measured car-following data. Secondly, the correlation between the host car's velocity and vehicle gap changes with different memory steps was also explored to develop the nth car's optimal velocity function. Thirdly, a microscopic traffic simulation program was created for analyzing the traffic flow evolution process and approximately estimating the fuel consumptions and exhaust emissions. As a result, it was seen that vehicle gap changes with memory significantly affect fuel economy and emission performance of the simulated traffic flow in the ACC strategy, which can result in low fuel consumptions and exhaust emissions. This study is an incremental step forward for designing the control strategy of the ACC system.	[Li, Xiuhai; Yang, Tao; Liu, Jian; Qin, Xiaoqing] Shandong Yingcai Univ, Sch Business, Jinan, Shandong, Peoples R China; [Yu, Shaowei] Changan Univ, China Mobile Commun Corp, Minist Educ, Joint Lab Internet Vehicles, Xian, Shaanxi, Peoples R China	Chang'an University; China Mobile	Yu, SW (corresponding author), Changan Univ, China Mobile Commun Corp, Minist Educ, Joint Lab Internet Vehicles, Xian, Shaanxi, Peoples R China.	swyu2016@chd.edu.cn			Shandong Province Higher Educational Science and Technology Program [J18KA338]; National Natural Science Foundation [51278058]; Fundamental Research Funds for the Central Universities [300102248503]; Shandong Yingcai University Science Foundation [17YCZDZR04]; 111 Project on Information of Vehicle-Infrastructure Sensing and ITS [B14043]; China Postdoctoral Science Foundation [2016M602744]; Shaanxi Province Postdoctoral Science Foundation [2016BSHEDZZ132]; Shandong Province undergraduate teaching reform research project [2015M176]	Shandong Province Higher Educational Science and Technology Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Shandong Yingcai University Science Foundation; 111 Project on Information of Vehicle-Infrastructure Sensing and ITS; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shaanxi Province Postdoctoral Science Foundation; Shandong Province undergraduate teaching reform research project	The study has been funded by the Shandong Province Higher Educational Science and Technology Program (grant no. J18KA338), the National Natural Science Foundation (grant no. 51278058), the Fundamental Research Funds for the Central Universities (grant no. 300102248503), Shandong Yingcai University Science Foundation (grant no. 17YCZDZR04), The 111 Project on Information of Vehicle-Infrastructure Sensing and ITS (grant no. B14043), China Postdoctoral Science Foundation (grant no. 2016M602744) and Shaanxi Province Postdoctoral Science Foundation (grant no. 2016BSHEDZZ132), Shandong Province undergraduate teaching reform research project (grant no. 2015M176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study has been funded by the Shandong Province Higher Educational Science and Technology Program (Grant No. J18KA338), the National Natural Science Foundation (Grant No. 51278058), the Fundamental Research Funds for the Central Universities (Grant No. 300102248503), Shandong Yingcai University Science Foundation (Grant No. 17YCZDZR04), The 111 Project on Information of Vehicle-Infrastructure Sensing and ITS (Grant No. B14043), China Postdoctoral Science Foundation (Grant No. 2016M602744) and Shaanxi Province Postdoctoral Science Foundation (Grant No. 2016 BSHEDZZ132), Shandong Province undergraduate teaching reform research project (Grant No. 2015M176).	Ahn K, 2002, J TRANSP ENG, V128, P182, DOI 10.1061/(ASCE)0733-947X(2002)128:2(182); BANDO M, 1995, PHYS REV E, V51, P1035, DOI 10.1103/PhysRevE.51.1035; Bose A, 2003, IEEE T INTELL TRANSP, V4, P173, DOI 10.1109/TITS.2003.821340; Davis L. C., 2004, PHYS REV E, P69; Deng J., 1985, GRAY CONTROL SYSTEM, V2nd ed.; Ge JI, 2014, TRANSPORT RES C-EMER, V46, P46, DOI 10.1016/j.trc.2014.04.014; He ZB, 2015, TRANSPORT RES B-METH, V80, P185, DOI 10.1016/j.trb.2015.07.010; Helbing D, 1998, PHYS REV E, V58, P133, DOI 10.1103/PhysRevE.58.133; Jeong E, 2015, TRANSPORT RES D-TR E, V41, P106, DOI 10.1016/j.trd.2015.09.018; Jiang R., 2001, PHYS REV E, P64; Kesting A, 2008, TRANSPORT RES C-EMER, V16, P668, DOI 10.1016/j.trc.2007.12.004; LEE G, 1966, OPER RES, V14, P595, DOI 10.1287/opre.14.4.595; Ou H, 2018, PHYSICA A, V495, P260, DOI 10.1016/j.physa.2017.12.100; Patton M. Q., 1990, QUALITATIVE EVALUATI; Peng G. H., 2013, PHYSICA A, V392, P491; Sipahi Rifat, 2015, IFAC - Papers Online, V48, P376, DOI 10.1016/j.ifacol.2015.09.407; Tang TQ, 2010, PHYS LETT A, V374, P3951, DOI 10.1016/j.physleta.2010.07.062; Tang TQ, 2009, INT J MOD PHYS B, V23, P743, DOI 10.1142/S0217979209051966; Tang TQ, 2017, IET INTELL TRANSP SY, V11, P596, DOI 10.1049/iet-its.2017.0191; Tang TQ, 2015, TRANSPORT RES D-TR E, V41, P423, DOI 10.1016/j.trd.2015.10.016; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2013, SCI CHINA TECHNOL SC, V56, P1307, DOI 10.1007/s11431-013-5182-9; VARAIYA P, 1993, IEEE T AUTOMAT CONTR, V38, P195, DOI 10.1109/9.250509; Wu CX, 2011, TRANSPORT RES D-TR E, V16, P515, DOI 10.1016/j.trd.2011.06.002; Wu GY, 2010, TRANSPORT RES REC, P98, DOI 10.3141/2189-11; Yu L, 2008, COMMUN NONLINEAR SCI, V13, P2167, DOI 10.1016/j.cnsns.2007.07.008; Yu S, 2015, COMMUNICATIONS NONLI, V36, P319; Yu SW, 2018, NONLINEAR DYNAM, V91, P1415, DOI 10.1007/s11071-017-3953-8; Yu SW, 2016, PHYSICA A, V461, P613, DOI 10.1016/j.physa.2016.06.060; Yu SW, 2015, PHYSICA A, V428, P206, DOI 10.1016/j.physa.2015.01.064; Yu SW, 2015, PHYSICA A, V421, P1, DOI 10.1016/j.physa.2014.11.008; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Zhang HM, 2003, TRANSPORT RES B-METH, V37, P27, DOI 10.1016/S0191-2615(01)00043-1; Zhao X, 2005, EUR PHYS J B, V47, P145, DOI 10.1140/epjb/e2005-00304-3; Zhou T, 2014, COMMUN NONLINEAR SCI, V19, P3820, DOI 10.1016/j.cnsns.2014.03.012	35	14	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200110	10.1371/journal.pone.0200110	http://dx.doi.org/10.1371/journal.pone.0200110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001334	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400023
J	Morissette, O; Sirois, P; Lester, NP; Wilson, CC; Bernatchez, L				Morissette, Olivier; Sirois, Pascal; Lester, Nigel P.; Wilson, Chris C.; Bernatchez, Louis			Supplementation stocking of Lake Trout (Salvelinus namaycush) in small boreal lakes: Ecotypes influence on growth and condition	PLOS ONE			English	Article							DENSITY-DEPENDENT GROWTH; WILD POPULATIONS; ATLANTIC SALMON; GENETIC INTEGRITY; FISH STOCKING; NICHE SHIFTS; SIZE; HATCHERY; SURVIVAL; FITNESS	Supplementation stocking is a commonly used management tool to sustain exploited fish populations. Possible negative consequences of supplementation on local stocks are a concern for the conservation of wild fish populations. However, the direct impacts of supplementation on life history traits of local populations have rarely been investigated. In addition, intraspecific hybridization between contrasting ecotypes (planktivorous and piscivorous) has been seldom considered in supplementation plans. Here, we combined genetic (genotype-by-sequencing analysis) and life history traits to document the effects of supplementation on maximum length, growth rates, body condition and genetic admixture in stocked populations of two Lake Trout ecotypes from small boreal lakes in Quebec and Ontario, Canada. In both ecotypes, the length of stocked individuals was greater than local individuals and, in planktivorous-stocked populations, most stocked fish exhibited a planktivorous-like growth while 20% of fish exhibited piscivorous-like growth. The body condition index was positively related to the proportion of local genetic background, but this pattern was only observed in stocked planktivorous populations. We conclude that interactions and hybridization between contrasting ecotypes is a risk that could result in deleterious impacts and possible outbreeding depression. We discuss the implications of these findings for supplementation stocking.	[Morissette, Olivier; Bernatchez, Louis] Univ Laval, IBIS, Quebec City, PQ, Canada; [Sirois, Pascal] Univ Quebec Chicoutimi, Dept Sci Fondamentales, Lab Sci Aquat, Chaire Rech Especes Aquat Exploitees, Chicoutimi, PQ, Canada; [Lester, Nigel P.] Ontario Minist Nat Resources & Forestry, Aquat Res & Monitoring Sect, Peterborough, ON, Canada; [Wilson, Chris C.] Ontario Minist Nat Resources & Forestry, Aquat Res & Dev Sect, Peterborough, ON, Canada	Laval University; University of Quebec; University of Quebec Chicoutimi; Ministry of Natural Resources & Forestry; Ministry of Natural Resources & Forestry	Morissette, O (corresponding author), Univ Laval, IBIS, Quebec City, PQ, Canada.	olivier.morissette.1@ulaval.ca	Wilson, Chris C/J-4851-2012; Morissette, Olivier/ABA-9585-2020	Wilson, Chris C/0000-0002-9528-0652; Morissette, Olivier/0000-0002-5037-9093; Bernatchez, Louis/0000-0002-8085-9709	Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Research Chair in Genomics and Conservation of Aquatic Resources; Chaire de recherche sur les especes aquatiques exploitees; Fonds de recherche nature et technologies (FRQNT); NSERC Alexander Graham Bell doctoral scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Research Chair in Genomics and Conservation of Aquatic Resources; Chaire de recherche sur les especes aquatiques exploitees; Fonds de recherche nature et technologies (FRQNT); NSERC Alexander Graham Bell doctoral scholarship	This research was supported financially by a strategic project grant from the Natural Sciences and Engineering Research Council (NSERC, www.nserc-crsng.gc.ca/) of Canada to LB and PS, the Canadian Research Chair in Genomics and Conservation of Aquatic Resources to LB and the Chaire de recherche sur les especes aquatiques exploitees to PS. OM was supported by a doctoral scholarship of the Fonds de recherche nature et technologies (FRQNT, www.frqnt.gouv.qc.ca) (2014) and an NSERC Alexander Graham Bell doctoral scholarship (2015-2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Aprahamian MW, 2003, FISH RES, V62, P211, DOI 10.1016/S0165-7836(02)00163-7; Araki H, 2008, EVOL APPL, V1, P342, DOI 10.1111/j.1752-4571.2008.00026.x; Araki H, 2009, BIOL LETTERS, V5, P621, DOI 10.1098/rsbl.2009.0315; Barton NH, 2001, MOL ECOL, V10, P551, DOI 10.1046/j.1365-294x.2001.01216.x; Bernatchez S, 2016, MOL ECOL, V25, P4773, DOI 10.1111/mec.13795; Blackwell Brian G., 2000, Reviews in Fisheries Science, V8, P1, DOI 10.1080/10641260091129161; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; Brown ML, 1989, THESIS; Bystrom P, 1999, OIKOS, V86, P217, DOI 10.2307/3546440; CASSELMAN JM, 1992, CAN J FISH AQUAT SCI, V49, P102, DOI 10.1139/f92-305; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Christie MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10676; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Cowx I. G., 1994, Fisheries Management and Ecology, V1, P15; CRISP DT, 1993, J APPL ECOL, V30, P759, DOI 10.2307/2404254; Dillard, 1978, NEW APPROACHES MANAG, V5, P79; du Developpement Durable de l'Environnement de la Faune et des Parcs, 2013, OUT AID SEM PLANS EA, P12; Eby LA, 2006, TRENDS ECOL EVOL, V21, P576, DOI 10.1016/j.tree.2006.06.016; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Einum Sigurd, 2001, Nordic Journal of Freshwater Research, V75, P56; EVANS DO, 1991, CAN J FISH AQUAT SCI, V48, P134, DOI 10.1139/f91-312; Evans DO, 1991, EFFECTS EXPLOITATION; Finstad AG, 2006, OIKOS, V112, P73, DOI 10.1111/j.0030-1299.2006.13990.x; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; FRANCIS RICC, 1990, J FISH BIOL, V36, P883, DOI 10.1111/j.1095-8649.1990.tb05636.x; GALLUCCI VF, 1979, T AM FISH SOC, V108, P14, DOI 10.1577/1548-8659(1979)108<14:RFATAS>2.0.CO;2; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; GARDINER R, 1991, J FISH BIOL, V38, P691, DOI 10.1111/j.1095-8649.1991.tb03158.x; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Gompert Z, 2016, EVOL APPL, V9, P909, DOI 10.1111/eva.12380; Gow JL, 2011, EVOL APPL, V4, P763, DOI 10.1111/j.1752-4571.2011.00198.x; Hansen MJ, 2012, T AM FISH SOC, V141, P1492, DOI 10.1080/00028487.2012.711263; Harbicht AB, 2014, EVOLUTIONARY APPL, P1, DOI [10.1111/eva.12137, DOI 10.1111/EVA.12137]; Harvey AC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160152; Houde L, 2003, BIBLIOTHEQUE NATL QU, P25; Hunt TL, 2014, CAN J FISH AQUAT SCI, V71, P1554, DOI 10.1139/cjfas-2013-0517; Hutchings JA, 2014, J FISH BIOL, V85, P1907, DOI 10.1111/jfb.12545; HUTCHINGS JA, 1993, ECOLOGY, V74, P673, DOI 10.2307/1940795; Hutchings JA, 2001, J FISH BIOL, V59, P306, DOI 10.1006/jfbi.2001.1756; Keeley ER, 2001, CAN J FISH AQUAT SCI, V58, P1122, DOI 10.1139/cjfas-58-6-1122; Kerr SJ, 2001, PETERBOROUGH, P178; Kitada S, 2009, AQUACULTURE, V290, P69, DOI 10.1016/j.aquaculture.2009.02.011; Koops MA, 2004, FISH FISH, V5, P120, DOI 10.1111/j.1467-2979.2004.00149.x; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; Lamaze FC, 2013, EVOL APPL, V6, P393, DOI 10.1111/eva.12022; Lamaze FC, 2012, MOL ECOL, V21, P2877, DOI 10.1111/j.1365-294X.2012.05579.x; Le Luyer J, 2017, P NATL ACAD SCI USA, V114, P12964, DOI 10.1073/pnas.1711229114; Legler ND, 1977, THESIS; Letourneau J, 2018, EVOL APPL, V11, P577, DOI 10.1111/eva.12566; Mackenzie-Grieve JL, 2006, T AM FISH SOC, V135, P727, DOI 10.1577/T05-138.1; MACLEAN JA, 1981, CAN J FISH AQUAT SCI, V38, P1685, DOI 10.1139/f81-217; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martin NV, 1980, CHARRS SALMONIDS FIS; McCormish TS, 1971, THESIS; McDermid JL, 2010, T AM FISH SOC, V139, P21, DOI 10.1577/T08-130.1; McDermid JL, 2010, CAN J FISH AQUAT SCI, V67, P314, DOI 10.1139/F09-183; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; McGinnity P, 2009, P ROY SOC B-BIOL SCI, V276, P3601, DOI 10.1098/rspb.2009.0799; Muhlfeld CC, 2009, BIOL LETTERS, V5, P328, DOI 10.1098/rsbl.2009.0033; Muir AM, 2016, FISH FISH, V17, P1194, DOI 10.1111/faf.12114; Murphy B.R., 1996, FISHERIES TECHNIQUES, V2nd edition; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; Ogle D.H., 2021, R PACKAGE; Pazzia I, 2002, CAN J FISH AQUAT SCI, V59, P1593, DOI [10.1139/f02-128, 10.1139/F02-128]; PERSSON L, 1985, AM NAT, V126, P261, DOI 10.1086/284413; Piccolo Jack J., 1993, North American Journal of Fisheries Management, V13, P401, DOI 10.1577/1548-8675(1993)013<0401:SWEFLT>2.3.CO;2; Pister EP, 2001, ECOSYSTEMS, V4, P279, DOI 10.1007/s10021-001-0010-7; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; POST JR, 1989, CAN J FISH AQUAT SCI, V46, P1958, DOI 10.1139/f89-246; RASMUSSEN JB, 1990, CAN J FISH AQUAT SCI, V47, P2030, DOI 10.1139/f90-227; Reisenbichler R, 2008, ONCORHYNCHUS MYKISS, P371; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; Ryman N, 1995, CONSERV BIOL, V9, P1619, DOI 10.1046/j.1523-1739.1995.09061619.x; Shuter BJ, 1998, CAN J FISH AQUAT SCI, V55, P2161, DOI 10.1139/cjfas-55-9-2161; SIMARD A, 1972, Naturaliste Canadien (Quebec), V99, P561; Sogard SM, 1997, B MAR SCI, V60, P1129; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; Stafford CP, 2002, T AM FISH SOC, V131, P994, DOI 10.1577/1548-8659(2002)131&lt;0994:CILTGA&gt;2.0.CO;2; Tymchuk WE, 2006, T AM FISH SOC, V135, P442, DOI 10.1577/T05-181.1; Utter F, 2002, REV FISH BIOL FISHER, V12, P59, DOI 10.1023/A:1022644021870; Valiquette E, 2014, EVOL APPL, V7, P625, DOI 10.1111/eva.12160; Vander Zanden MJ, 2000, CAN J FISH AQUAT SCI, V57, P725, DOI 10.1139/cjfas-57-4-725; Vandersteen W, 2012, EVOL APPL, V5, P76, DOI 10.1111/j.1752-4571.2011.00210.x; WAPLES RS, 1991, CAN J FISH AQUAT SCI, V48, P124, DOI 10.1139/f91-311; Weber ED, 2003, CAN J FISH AQUAT SCI, V60, P1018, DOI 10.1139/F03-087; Wilson CC, 2004, IN ST WA MA, P21; Zimmerman MS, 2007, J GREAT LAKES RES, V33, P156, DOI 10.3394/0380-1330(2007)33[156:MAEDBS]2.0.CO;2; Zimmerman MS, 2009, CAN J FISH AQUAT SCI, V66, P1007, DOI 10.1139/F09-060	93	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200599	10.1371/journal.pone.0200599	http://dx.doi.org/10.1371/journal.pone.0200599			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001412	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400086
J	Ricci, F; Casiraghi, C; Storti, M; D'Alo, F; Catozzi, C; Ciccimarra, R; Ravanetti, F; Cacchioli, A; Villetti, G; Civelli, M; Murgia, X; Carnielli, V; Salomone, F				Ricci, Francesca; Casiraghi, Costanza; Storti, Matteo; D'Alo, Francesco; Catozzi, Chiara; Ciccimarra, Roberta; Ravanetti, Francesca; Cacchioli, Antonio; Villetti, Gino; Civelli, Maurizio; Murgia, Xabi; Carnielli, Virgilio; Salomone, Fabrizio			Surfactant replacement therapy in combination with different non-invasive ventilation techniques in spontaneously-breathing, surfactant-depleted adult rabbits	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; AIRWAY PRESSURE; RANDOMIZED-TRIAL; PRETERM INFANTS; TREATING APNEA; OPEN-LABEL; PREMATURITY; NEBULIZATION; EXTUBATION	Nasal intermittent positive pressure ventilation (NIPPV) holds great potential as a primary ventilation support method for Respiratory Distress Syndrome (RDS). The use of NIPPV may also be of great value combined with minimally invasive surfactant delivery. Our aim was to implement an in vivo model of RDS, which can be managed with different non-invasive ventilation (NIV) strategies, including non-synchronized NIPPV, synchronized NIPPV (SNIPPV), and nasal continuous positive airway pressure (NCPAP). Forty-two surfactant-depleted adult rabbits were allocated in six different groups: three groups of animals were treated with only NIV for three hours (NIPPV, SNIPPV, and NCPAP groups), while three other groups were treated with surfactant (SF) followed by NIV (NIPPV+SF, SNIPPV+SF, and NCPAP+SF groups). Arterial gas exchange, ventilation indices, and dynamic compliance were assessed. Post-mortem the lungs were sampled for histological evaluation. Surfactant depletion was successfully achieved by repeated broncho-alveolar lavages (BALs). After BALs, all animals developed a moderate respiratory distress, which could not be reverted by merely applying NIV. Conversely, surfactant administration followed by NIV induced a rapid improvement of arterial oxygenation in all surfactant-treated groups. Breath synchronization was associated with a significantly better response in terms of gas exchange and dynamic compliance compared to non-synchronized NIPPV, showing also the lowest injury scores after histological assessment. The proposed in vivo model of surfactant deficiency was successfully managed with NCPAP, NIPPV, or SNIPPV; this model resembles a moderate respiratory distress and it is suitable for the preclinical testing of less invasive surfactant administration techniques.	[Ricci, Francesca; Casiraghi, Costanza; Storti, Matteo; D'Alo, Francesco; Catozzi, Chiara; Villetti, Gino; Civelli, Maurizio; Salomone, Fabrizio] Chiesi Farmaceut, R&D Dept, Parma, Italy; [Ciccimarra, Roberta; Ravanetti, Francesca; Cacchioli, Antonio] Univ Parma, Dept Vet Sci, Parma, Italy; [Murgia, Xabi] Helmholtz Inst Pharmaceut Res Saarland, Dept Drug Delivery, Saarbrucken, Germany; [Carnielli, Virgilio] Polytech Univ Marche, Div Neonatol, Ancona, Italy; [Carnielli, Virgilio] Salesi Childrens Hosp, Ancona, Italy	Chiesi Pharmaceuticals Inc; University of Parma; Helmholtz Association; Helmholtz-Center for Infection Research; Marche Polytechnic University	Casiraghi, C (corresponding author), Chiesi Farmaceut, R&D Dept, Parma, Italy.	c.casiraghi@chiesi.com	Ciccimarra, Roberta/AAC-4086-2020	salomone, fabrizio/0000-0002-9083-3932; CASIRAGHI, COSTANZA/0000-0001-6225-5250; Ravanetti, Francesca/0000-0001-8729-3237; Ciccimarra, Roberta/0000-0001-9431-143X	Chiesi Farmaceutici	Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc)	Chiesi Farmaceutici has funded this study and provided support in the form of salaries for authors [FR, CC, MS, FDA, CC, GV, MC, FS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Barrington KJ, 2001, PEDIATRICS, V107, P638, DOI 10.1542/peds.107.4.638; Berggren E, 2000, ACTA PAEDIATR, V89, P460, DOI 10.1080/080352500750028195; Bhandari V, 2007, J PERINATOL, V27, P697, DOI 10.1038/sj.jp.7211805; Chang HY, 2011, PEDIATR RES, V69, P84, DOI 10.1203/PDR.0b013e3181ff6770; Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14483; Dargaville PA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3985; Dargaville PA, 2011, ARCH DIS CHILD-FETAL, V96, pF243, DOI 10.1136/adc.2010.192518; Davis Peter G, 2012, NEWBORN LUNG NEONATO, P265; Dijk PH, 1997, INTENS CARE MED, V23, P1077, DOI 10.1007/s001340050459; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; Finer NN, 2010, J AEROSOL MED PULM D, V23, P303, DOI 10.1089/jamp.2009.0758; Gizzi C, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/301818; Gizzi C, 2015, ARCH DIS CHILD-FETAL, V100, pF17, DOI 10.1136/archdischild-2013-305892; Gopel W, 2011, LANCET, V378, P1627, DOI 10.1016/S0140-6736(11)60986-0; Hayes D, 2010, RESPIRATION, V79, P425, DOI 10.1159/000242497; Hutten MC, 2015, PEDIATR RES, V78, P664, DOI 10.1038/pr.2015.165; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Jorch G, 1997, PEDIATR PULM, V24, P222, DOI 10.1002/(SICI)1099-0496(199709)24:3<222::AID-PPUL9>3.0.CO;2-O; KATTWINKEL J, 1975, J PEDIATR-US, V86, P588, DOI 10.1016/S0022-3476(75)80158-2; Khalaf MN, 2001, PEDIATRICS, V108, P13, DOI 10.1542/peds.108.1.13; Kishore MSS, 2009, ACTA PAEDIATR, V98, P1412, DOI 10.1111/j.1651-2227.2009.01348.x; Lin CH, 1998, PEDIATR PULM, V26, P349, DOI 10.1002/(SICI)1099-0496(199811)26:5<349::AID-PPUL8>3.0.CO;2-7; Mazela J, 2007, CURR OPIN PEDIATR, V19, P155, DOI 10.1097/MOP.0b013e32807fb013; Mazela J, 2011, EUR J PEDIATR, V170, P433, DOI 10.1007/s00431-010-1292-6; Moretti C, 2016, NEONATOLOGY, V109, P359, DOI 10.1159/000444898; MORLEY CJ, 1988, EARLY HUM DEV, V17, P41, DOI 10.1016/S0378-3782(88)80056-2; Mrozek JD, 1997, AM J RESP CRIT CARE, V156, P1058, DOI 10.1164/ajrccm.156.4.9610104; Nkadi PO, 2009, MOL GENET METAB, V97, P95, DOI 10.1016/j.ymgme.2009.01.015; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701; Owen LS, 2011, ARCH DIS CHILD-FETAL, V96, pF422, DOI 10.1136/adc.2010.205195; Owen LS, 2016, SEMIN FETAL NEONAT M, V21, P146, DOI 10.1016/j.siny.2016.01.003; Pedersen M, 1998, INHALATION AEROSOL N; Ricci F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169190; Roberts KD, 2010, PEDIATR RES, V68, P414, DOI 10.1203/PDR.0b013e3181ef7619; SAUNDERS RA, 1976, BIOL NEONATE, V29, P178; SPEER CP, 1992, PEDIATRICS, V89, P13; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sweet DG, 2016, NEONATOLOGY, P107, DOI [10.1159/000448985, DOI 10.1159/000448985]; Walsh BK, 2013, RESP CARE, V58, P367, DOI 10.4187/respcare.02189; Walther FJ, 2014, PEERJ, V2, DOI 10.7717/peerj.403; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2; Zimmermann AM, 2010, PEDIATR PULM, V45, P782, DOI 10.1002/ppul.21252; Zimmermann L J I, 2005, Biol Neonate, V87, P296, DOI 10.1159/000084877	43	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200542	10.1371/journal.pone.0200542	http://dx.doi.org/10.1371/journal.pone.0200542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001410	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400076
J	Wilson, J; Matejusova, I; McIntosh, RE; Carboni, S; Bekaert, M				Wilson, Joanna; Matejusova, Iveta; McIntosh, Rebecca E.; Carboni, Stefano; Bekaert, Michael			New diagnostic SNP molecular markers for the Mytilus species complex	PLOS ONE			English	Article							M-TROSSULUS; CUTTHROAT TROUT; SHELL SHAPE; GALLOPROVINCIALIS; EDULIS; HYBRIDIZATION; MUSSELS; POPULATIONS; HYBRIDS; INTROGRESSION	The development of diagnostic markers has been a long-standing interest of population geneticists as it allows clarification of taxonomic uncertainties. Historically, there has been much debate on the taxonomic status of species belonging to the Mytilus species complex (M. edulis, M. galloprovincialis and M. trossulus), and whether they are discrete species. We analysed reference pure specimens of M. edulis, M. galloprovincialis and M. trossulus, using Restriction site associated DNA (RAD) sequencing and identified over 6,000 SNP markers separating the three species unambiguously. We developed a panel of diagnostic SNP markers for the genotyping of Mytilus species complex as well as the identification of hybrids and interspecies introgression events in Mytilus species. We validated a panel of twelve diagnostic SNP markers which can be used for species genotyping. Being able to accurately identify species and hybrids within the Mytilus species complex is important for the selective mussel stock management, the exclusion of invasive species, basic physiology and bio-diversity studies.	[Wilson, Joanna; Carboni, Stefano; Bekaert, Michael] Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland; [Wilson, Joanna; Matejusova, Iveta; McIntosh, Rebecca E.] Marine Scotland Sci, Aberdeen, Scotland	University of Stirling; Marine Scotland Science (MSS)	Bekaert, M (corresponding author), Univ Stirling, Fac Nat Sci, Inst Aquaculture, Stirling, Scotland.	michael.bekaert@stir.ac.uk		Bekaert, Michael/0000-0002-1206-7654; Carboni, Stefano/0000-0002-1302-1068	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; Marine Scotland Science; University of Stirling	MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; Marine Scotland Science; University of Stirling	The authors acknowledge the support of the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) in the completion of this study. MASTS is funded by the Scottish Funding Council (grant reference HR09011) to JW and MB and contributing institutions. JW was also supported by Marine Scotland Science. Publication fees were coved by the University of Stirling to MB.	Andersen SH, 2008, EARLY HUMAN IMPACT M, P135; [Anonymous], 2021, LANG ENV STAT COMP; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beaumont AR, 2008, J EXP MAR BIOL ECOL, V367, P100, DOI 10.1016/j.jembe.2008.08.021; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Coghlan B, 2007, MAR BIOL, V150, P841, DOI 10.1007/s00227-006-0408-z; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Dias PJ, 2008, J EXP MAR BIOL ECOL, V367, P253, DOI 10.1016/j.jembe.2008.10.011; Dias PJ, 2011, HYDROBIOLOGIA, V670, P127, DOI 10.1007/s10750-011-0664-x; Doherty SD, 2009, J EXP MAR BIOL ECOL, V378, P1, DOI 10.1016/j.jembe.2009.04.022; Etter PD, 2011, METHODS MOL BIOL, V772, P157, DOI 10.1007/978-1-61779-228-1_9; Gosling E, 2008, J MAR BIOL ASSOC UK, V88, P341, DOI 10.1017/S0025315408000957; Hayden MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-80; HEPPER BT, 1957, J MAR BIOL ASSOC UK, V36, P33, DOI 10.1017/S0025315400017045; Hilbish TJ, 2002, MAR BIOL, V140, P137, DOI 10.1007/s002270100631; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Houston RD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-244; Innes DJ, 1999, MAR BIOL, V133, P691, DOI 10.1007/s002270050510; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; KOEHN RK, 1991, AQUACULTURE, V94, P125, DOI 10.1016/0044-8486(91)90114-M; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Linnen CR, 2009, COLD SH Q B, V74, P155, DOI 10.1101/sqb.2009.74.045; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; MCDONALD JH, 1991, MAR BIOL, V111, P323, DOI 10.1007/BF01319403; Michalek K, 2016, MAR GENOM, V27, P3, DOI 10.1016/j.margen.2016.04.008; Monfort MC, 2014, EUROPEAN MARKET MUSS; Penney RW, 2007, N AM J AQUACULT, V69, P281, DOI 10.1577/A06-044.1; Pritchard VL, 2007, CONSERV GENET, V8, P1311, DOI 10.1007/s10592-006-9280-0; Rawson PD, 1996, HEREDITY, V77, P599, DOI 10.1038/hdy.1996.187; Rawson PD, 1999, MAR BIOL, V134, P201, DOI 10.1007/s002270050538; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Riginos C, 2005, MOL ECOL, V14, P381, DOI 10.1111/j.1365-294X.2004.02379.x; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; SEED R, 1968, J MAR BIOL ASSOC UK, V48, P561, DOI 10.1017/S0025315400019159; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steffani CN, 2003, MAR ECOL PROG SER, V246, P197, DOI 10.3354/meps246197; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Suchanek TH, 1997, BIOL BULL, V193, P187, DOI 10.2307/1542764; Tremblay M. John, 2002, Proceedings of the Nova Scotian Institute of Science, V42, P101; Twyford AD, 2012, HEREDITY, V108, P179, DOI 10.1038/hdy.2011.68; Wenne R, 2016, POLAR BIOL, V39, P343, DOI 10.1007/s00300-015-1785-x; WIDDOWS J, 1988, MAR ECOL PROG SER, V46, P113, DOI 10.3354/meps046113; Wonham MJ, 2004, J SHELLFISH RES, V23, P535; Zbawicka M, 2012, MAR BIOL, V159, P1347, DOI 10.1007/s00227-012-1915-8; Zizek S, 2012, SLOV VET RES, V49, P149; Zuo Lingjun, 2014, Shanghai Arch Psychiatry, V26, P165, DOI 10.3969/j.issn.1002-0829.2014.03.009	49	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200654	10.1371/journal.pone.0200654	http://dx.doi.org/10.1371/journal.pone.0200654			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001394	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400092
J	Yepez, VA; Kremer, LS; Iuso, A; Gusic, M; Kopajtich, R; Konarikova, E; Nadel, A; Wachutka, L; Prokisch, H; Gagneur, J				Yepez, Vicente A.; Kremer, Laura S.; Iuso, Arcangela; Gusic, Mirjana; Kopajtich, Robert; Konarikova, Eliska; Nadel, Agnieszka; Wachutka, Leonhard; Prokisch, Holger; Gagneur, Julien			OCR-Stats: Robust estimation and statistical testing of mitochondrial respiration activities using Seahorse XF Analyzer	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; MUTATIONS CAUSE; CELLS; METABOLISM; DISEASE; DEFECT	The accurate quantification of cellular and mitochondrial bioenergetic activity is of great interest in medicine and biology. Mitochondrial stress tests performed with Seahorse Bioscience XF Analyzers allow the estimation of different bioenergetic measures by monitoring the oxygen consumption rates (OCR) of living cells in multi-well plates. However, studies of the statistical best practices for determining aggregated OCR measurements and comparisons have been lacking. Therefore, to understand how OCR behaves across different biological samples, wells, and plates, we performed mitochondrial stress tests in 126 96-well plates involving 203 fibroblast cell lines. We show that the noise of OCR is multiplicative, that outlier data points can concern individual measurements or all measurements of a well, and that the inter-plate variation is greater than the intra-plate variation. Based on these insights, we developed a novel statistical method, OCR-Stats, that: i) robustly estimates OCR levels modeling multiplicative noise and automatically identifying outlier data points and outlier wells; and ii) performs statistical testing between samples, taking into account the different magnitudes of the between- and within-plate variations. This led to a significant reduction of the coefficient of variation across plates of basal respiration by 45% and of maximal respiration by 29%. Moreover, using positive and negative controls, we show that our statistical test outperforms the existing methods, which suffer from an excess of either false positives (within-plate methods), or false negatives (between-plate methods). Altogether, this study provides statistical good practices to support experimentalists in designing, analyzing, testing, and reporting the results of mitochondrial stress tests using this high throughput platform.	[Yepez, Vicente A.; Wachutka, Leonhard; Gagneur, Julien] Tech Univ Munich, Dept Informat, Garching, Germany; [Yepez, Vicente A.; Gagneur, Julien] Ludwig Maximilians Univ Munchen, Dept Biochem, Gene Ctr, Quantitat Biosci Munich, Munich, Germany; [Kremer, Laura S.; Iuso, Arcangela; Gusic, Mirjana; Kopajtich, Robert; Konarikova, Eliska; Nadel, Agnieszka; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Kremer, Laura S.; Iuso, Arcangela; Gusic, Mirjana; Kopajtich, Robert; Konarikova, Eliska; Nadel, Agnieszka; Prokisch, Holger] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, Munich, Germany	Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Gagneur, J (corresponding author), Tech Univ Munich, Dept Informat, Garching, Germany.; Gagneur, J (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biochem, Gene Ctr, Quantitat Biosci Munich, Munich, Germany.	gagneur@in.tum.de	Koňaříková, Eliška/AAG-4073-2021	Koňaříková, Eliška/0000-0001-7365-5006; Kremer, Laura/0000-0002-1647-7538; Gagneur, Julien/0000-0002-8924-8365; Gusic, Mirjana/0000-0002-9350-291X; Nadel, Agnieszka/0000-0003-1561-9204; Prokisch, Holger/0000-0003-2379-6286; Yepez, Vicente A/0000-0001-7916-3643	German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET) [01GM1113C]; E-Rare project GENOMIT [01GM1207]; Juniorverbund in der Systemmedizin 'mitOmics' [FKZ 01ZX1405A]; DZHK (German Centre for Cardiovascular Research); German Research Foundation (DFG); Technical University of Munich (TUM); Graduate School of Quantitative Biosciences Munich (QBM); EU [317433, 633974]; Cell lines and DNA Bank of Pediatric Movement Disorders and Mitochondrial Diseases of the Telethon Genetic Biobank Network [GTB09003]	German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; Juniorverbund in der Systemmedizin 'mitOmics'; DZHK (German Centre for Cardiovascular Research); German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich (TUM); Graduate School of Quantitative Biosciences Munich (QBM); EU(European Commission); Cell lines and DNA Bank of Pediatric Movement Disorders and Mitochondrial Diseases of the Telethon Genetic Biobank Network(Fondazione Telethon)	This study was supported by the German Bundesministerium fur Bildung und Forschung (BMBF) through the German Network for mitochondrial disorders (mitoNET, 01GM1113C to HP), the E-Rare project GENOMIT (01GM1207 to HP), the Juniorverbund in der Systemmedizin 'mitOmics' (FKZ 01ZX1405A JG, LW and VAY), the DZHK (German Centre for Cardiovascular Research, LSK), the German Research Foundation (DFG) and the Technical University of Munich (TUM) in the framework of the Open Access Publishing Program. A Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM) supports VAY. HP is supported by EU FP7 Mitochondrial European Educational Training Project (317433). JG, VAY, LSK and RK and HP are supported by EU Horizon2020 Collaborative Research Project SOUND (633974). We thank the Cell lines and DNA Bank of Pediatric Movement Disorders and Mitochondrial Diseases of the Telethon Genetic Biobank Network (GTB09003).	Agilent Technologies, 2016, MULT XF REP GEN US G; Agilent Technologies, 2017, MIT STRESS TEST KIT; Almontashiri NAM, 2014, CELL REP, V7, P834, DOI 10.1016/j.celrep.2014.03.051; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Chacko BK, 2014, CLIN SCI, V127, P367, DOI 10.1042/CS20140101; Divakaruni AS, 2014, METHOD ENZYMOL, V547, P309, DOI 10.1016/B978-0-12-801415-8.00016-3; Dmitriev RI, 2012, CELL MOL LIFE SCI, V69, P2025, DOI 10.1007/s00018-011-0914-0; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Dunham-Snary KJ, 2014, REDOX BIOL, V2, P656, DOI 10.1016/j.redox.2014.04.005; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gorman GS, 2016, NAT REV DIS PRIM; Haack TB, 2013, J INHERIT METAB DIS, V36, P55, DOI 10.1007/s10545-012-9489-7; Hautakangas MR, 2016, MITOCHONDRION, V29, P53, DOI 10.1016/j.mito.2016.05.004; Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011; Hill BG, 2012, BIOL CHEM, V393, P1485, DOI 10.1515/hsz-2012-0198; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Koopman M, 2016, NAT PROTOC, V11, P1798, DOI 10.1038/nprot.2016.106; Kramer PA, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150161; Kremer LS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15824; Kremer LS, 2016, AM J HUM GENET, V98, P358, DOI 10.1016/j.ajhg.2015.12.009; Mitsopoulos P, 2015, MOL CELL BIOL, V35, P1838, DOI 10.1128/MCB.00047-15; Olahova M, 2015, BRAIN, V138, P3503, DOI 10.1093/brain/awv291; Powel CA, 2015, AM J HUM GENET, V97, P319, DOI 10.1016/j.ajhg.2015.06.011; Pronicka E, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0930-9; Ribeiro SM, 2015, METHODS MOL BIOL, V1241, P59, DOI 10.1007/978-1-4939-1875-1_6; Seahorse Bioscience, 2014, NORM XF MET DAT CELL; Shah-Simpson S, 2016, MOL BIOCHEM PARASIT, V208, P91, DOI 10.1016/j.molbiopara.2016.07.001; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sun N, 2016, MOL CELL, V61, P654, DOI 10.1016/j.molcel.2016.01.028; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weinberg SE, 2015, IMMUNITY, V42, P406, DOI 10.1016/j.immuni.2015.02.002; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zhang J, 2012, NAT PROTOC, P7, DOI [10.1038/nprot.2012.048.Measuring, DOI 10.1038/NPROT.2012.048.MEASURING]; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	44	28	28	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199938	10.1371/journal.pone.0199938	http://dx.doi.org/10.1371/journal.pone.0199938			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995917	Green Published, Green Submitted, gold			2022-12-26	WOS:000438388800037
J	Goszczynski, D; Molina, A; Teran, E; Morales-Durand, H; Ross, P; Cheng, H; Giovambattista, G; Demyda-Peyras, S				Goszczynski, Daniel; Molina, Antonio; Teran, Ester; Morales-Durand, Hernan; Ross, Pablo; Cheng, Hao; Giovambattista, Guillermo; Demyda-Peyras, Sebastian			Runs of homozygosity in a selected cattle population with extremely inbred bulls: Descriptive and functional analyses revealed highly variable patterns	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED GLYCOPROTEINS; INBREEDING DEPRESSION; DAIRY-CATTLE; GENETIC DIVERSITY; HOLSTEIN CATTLE; COMPUTER-PROGRAM; BEEF HEIFERS; MILK-YIELD; GENOME; COWS	The analysis of runs of homozygosity (ROH), using high throughput genomic data, has become a valuable and frequently used methodology to characterize the genomic and inbreeding variation of livestock and wildlife animal populations. However, this methodology has been scarcely used in highly inbred domestic animals. Here, we analyzed and characterized the occurrence of ROH fragments in highly inbred (HI; average pedigree-based inbreeding coefficient F-PED = 0.164; 0.103 to 0.306) and outbred Retinta bulls (LI; average F-PED = 0.008; 0 to 0.025). We studied the length of the fragments, their abundance, and genome distribution using high-density microarray data. The number of ROH was significantly higher in the HI group, especially for long fragments (>8Mb). In the LI group, the number of ROH continuously decreased with fragment length. Genome-wide distribution of ROH was highly variable between samples. Some chromosomes presented a larger number of fragments (BTA1, BTA19, BTA29), others had longer fragments (BTA4, BTA12, BTA17), while other ones showed an increased ROH accumulation over specific loci (BTA2, BTA7, BTA23, BTA29). Similar differences were observed in the analysis of 12 individuals produced by a similar inbred event (F-PED3 = 0.125). The correlation between the fraction of the genome covered by ROH (FROH) and F-PED was high (0.79), suggesting that ROH-based estimations are indicative of inbreeding levels. On the other hand, the correlation between F-PED and the microsatellite-based inbreeding coefficient (F-MIC) was only moderate (r = 0.44), suggesting that STR-based inbreeding estimations should be avoided. Similarly, we found a very low correlation (r = -0.0132) between recombination rate and ROH abundance across the genome. Finally, we performed functional annotation analyses of genome regions with significantly enriched ROH abundance. Results revealed gene clusters related to pregnancy-associated proteins and immune reaction. The same analysis performed for regions enriched with recently formed ROH (> 8 Mb) showed gene clusters related to flagellum assembly. In both cases, the processes were related to male and female reproductive functions, which may partially explain the reduced fertility associated with inbred populations.	[Goszczynski, Daniel; Teran, Ester; Morales-Durand, Hernan; Giovambattista, Guillermo; Demyda-Peyras, Sebastian] Fac Ciencias Vet UNLP, UNLP CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulouf, La Plata, Buenos Aires, Argentina; [Molina, Antonio; Giovambattista, Guillermo; Demyda-Peyras, Sebastian] Univ Cordoba, Dept Genet, Cordoba, Spain; [Ross, Pablo; Cheng, Hao; Giovambattista, Guillermo; Demyda-Peyras, Sebastian] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Giovambattista, Guillermo; Demyda-Peyras, Sebastian] Univ Nacl La Plata, Dept Prod & Anim, Fac Ciencias Vet, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Universidad de Cordoba; University of California System; University of California Davis; National University of La Plata	Demyda-Peyras, S (corresponding author), Fac Ciencias Vet UNLP, UNLP CONICET LA PLATA, IGEVET Inst Genet Vet Ing Fernando N Dulouf, La Plata, Buenos Aires, Argentina.; Demyda-Peyras, S (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.; Demyda-Peyras, S (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Demyda-Peyras, S (corresponding author), Univ Nacl La Plata, Dept Prod & Anim, Fac Ciencias Vet, La Plata, Buenos Aires, Argentina.	sdemyda@igevet.gob.ar	Molina, Antonio/E-4698-2010; Demyda-Peyrás, Sebastian/S-9151-2019; Goszczynski, Daniel/AAW-9365-2020	Molina, Antonio/0000-0002-9566-6600; Demyda-Peyrás, Sebastian/0000-0003-3286-2441; Goszczynski, Daniel/0000-0002-1419-6353; Cheng, Hao/0000-0001-5146-7231	Veterinary Genetics Diagnostic Laboratory (LDGV); Molecular and Applied Animal Cytogenetic Laboratory (MERAGEM Research Group) at the University of Cordoba (Spain); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) [PICT2016-4832]; CONICET	Veterinary Genetics Diagnostic Laboratory (LDGV); Molecular and Applied Animal Cytogenetic Laboratory (MERAGEM Research Group) at the University of Cordoba (Spain); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	National Association of Breeders of Select Retinta Cattle kindly supplied all the pedigree data and DNA samples. This work was funded by the Veterinary Genetics Diagnostic Laboratory (LDGV) and the Molecular and Applied Animal Cytogenetic Laboratory (MERAGEM Research Group) at the University of Cordoba (Spain) and by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina) (grant PICT2016-4832). Ester Teran is supported by a doctoral internal fellowship of CONICET.	Aken BL, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw093; Baumung R, 2003, GENET SEL EVOL, V35, P369, DOI 10.1051/gse:2003029; Beltman ME, 2013, REPROD FERT DEVELOP, V25, P966, DOI 10.1071/RD12232; Beltman ME, 2010, REPROD FERT DEVELOP, V22, P987, DOI 10.1071/RD09302; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Biscarini F, 2015, ARXIV150403802V1GBIO; Biscarini F, 2016, ARXIV160107062V1; Bjelland DW, 2015, J DAIRY SCI, V98, P4934, DOI 10.3168/jds.2014-9014; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; BUTLER JE, 1982, BIOL REPROD, V26, P925, DOI 10.1095/biolreprod26.5.925; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Cecchi F, 2012, LARGE ANIM REV, V18, P79; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Commun L, 2016, J VET DIAGN INVEST, V28, P207, DOI 10.1177/1040638716632815; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Curik I, 2017, REV BRAS ZOOTECN, V46, P773, DOI [10.1590/S1806-92902017000900010, 10.1590/s1806-92902017000900010]; de Roos APW, 2011, J DAIRY SCI, V94, P1559, DOI 10.3168/jds.2010-3354; Dorado J, 2017, REPROD FERT DEVELOP, V29, P712, DOI 10.1071/RD15324; ERCANBRACK SK, 1991, J ANIM SCI, V69, P4734, DOI 10.2527/1991.69124734x; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Ferencakovic M, 2017, J DAIRY SCI, V100, P4721, DOI 10.3168/jds.2016-12164; Ferencakovic M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-42; Ferencakovic Maja, 2011, Agriculturae Conspectus Scientificus, V76, P325; Fernandez J, 2006, MOL ECOL, V15, P1657, DOI 10.1111/j.1365-294X.2006.02873.x; FISHER RA, 1954, HEREDITY, V8, P187, DOI 10.1038/hdy.1954.17; FRANKLIN IR, 1977, THEOR POPUL BIOL, V11, P60, DOI 10.1016/0040-5809(77)90007-7; Garcia-Ispierto I, 2016, LIVEST SCI, V192, P44, DOI 10.1016/j.livsci.2016.09.003; Gatea AO, 2018, THERIOGENOLOGY, V108, P269, DOI 10.1016/j.theriogenology.2017.12.021; Gonzalez-Recio O, 2007, J DAIRY SCI, V90, P5744, DOI 10.3168/jds.2007-0203; Gurgul A, 2016, J APPL GENET, V57, P527, DOI 10.1007/s13353-016-0337-6; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P172, DOI 10.1111/j.1439-0388.2005.00512.x; Hansen LB, 2000, J DAIRY SCI, V83, P1145, DOI 10.3168/jds.S0022-0302(00)74980-0; Hockett ME, 2004, PROSTAG OTH LIPID M, V73, P227, DOI 10.1016/j.prostaglandins.2004.02.002; Hooshmandabbasi R, 2018, THERIOGENOLOGY, V105, P158, DOI 10.1016/j.theriogenology.2017.09.031; Howrigan DP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-460; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jimenez JM, 2007, PATRIMONIO GANADERO, VII, P9; Kardos M, 2015, HEREDITY, V115, P63, DOI 10.1038/hdy.2015.17; Kardos M, 2017, GENETICS, V205, P1319, DOI 10.1534/genetics.116.198861; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kim ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129967; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kosciuczuk EM, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0246-z; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kukuckova V, 2017, CONSERV GENET, V18, P893, DOI 10.1007/s10592-017-0935-9; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Leroy G, 2014, ANIM GENET, V45, P618, DOI 10.1111/age.12178; Liu L, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1854269; Ma L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005387; Macedo AA, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-79; Maignel L., 1996, INTERBULL B, V14, P49; Marras G, 2015, ANIM GENET, V46, P110, DOI 10.1111/age.12259; Mastrangelo S, 2016, ANIMAL, V10, P746, DOI 10.1017/S1751731115002943; Mastrangelo S, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0360-z; Mayo LM, 2016, J DAIRY SCI, V99, P7634, DOI 10.3168/jds.2016-11224; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mercadante PM, 2016, J DAIRY SCI, V99, P3031, DOI 10.3168/jds.2015-10595; Metzger J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1977-3; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Morales R, 2017, LIVEST SCI, V204, P115, DOI 10.1016/j.livsci.2017.08.014; Morales R, 2013, J ANIM BREED GENET, V130, P425, DOI 10.1111/jbg.12038; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Peripolli E, 2017, ANIM GENET, V48, P255, DOI 10.1111/age.12526; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Roberts JN, 2015, REPROD DOMEST ANIM, V50, P651, DOI 10.1111/rda.12546; Roth Z, 2016, REPROD FERT DEVELOP, V28, P1653, DOI 10.1071/RD14431; Roth Z, 2013, J DAIRY SCI, V96, P6499, DOI 10.3168/jds.2013-6903; Saura M, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-014-0081-5; Sewalem A, 2006, J DAIRY SCI, V89, P2210, DOI 10.3168/jds.S0022-0302(06)72291-3; Sha YW, 2017, FERTIL STERIL, V107, P1312, DOI 10.1016/j.fertnstert.2017.04.007; Snowder GD, 2005, J ANIM SCI, V83, P1247; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Szmatola T, 2016, LIVEST SCI, V188, P72, DOI 10.1016/j.livsci.2016.04.006; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Williams JL, 2016, ANIM GENET, V47, P19, DOI 10.1111/age.12376; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Zavarez LB, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00005; Zhang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057772; Zhang QQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1715-x; Zhang QQ, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0227-7; ZOLI AP, 1991, BIOL REPROD, V45, P1, DOI 10.1095/biolreprod45.1.1	85	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200069	10.1371/journal.pone.0200069	http://dx.doi.org/10.1371/journal.pone.0200069			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985951	Green Submitted, Green Published, gold			2022-12-26	WOS:000438035500021
J	Lin, ZX; Yang, Z; He, BH; Wang, DD; Gao, XY; Tam, SY; Wu, VWC				Lin, Zhixiong; Yang, Zhining; He, Binghui; Wang, Dangdang; Gao, Xiaoyin; Tam, Shing-yau; Wu, Vincent Wing Cheung			Pattern of radiation-induced thyroid gland changes in nasopharyngeal carcinoma patients in 48 months after radiotherapy	PLOS ONE			English	Article							NECK-CANCER PATIENTS; RETROSPECTIVE ANALYSIS; DOSIMETRIC PREDICTORS; HYPOTHYROIDISM; HEAD; THERAPY; DISORDERS; IRRADIATION; COHORT; RISK	Objectives Radiation-induced hypothyroidism is the most common thyroid disorder after radiotherapy in nasopharyngeal carcinoma (NPC) patients. This study evaluated the pattern of radiation-induced thyroid gland changes in 48 months after radiotherapy in NPC patients and the association of hypothyroidism incidence with thyroid dose. Methods Fifty-six NPC patients treated by intensity modulated radiotherapy in 2013 were recruited. All patients received baseline thyroid hormones (fT3, fT4 and TSH) tests and CT scan before radiotherapy. Repeated measures of the thyroid hormones and gland volume were performed at 3, 6, 12, 18, 24, 30, 36 and 48 months after treatment. Trend lines of the thyroid volume and hormone level changes against time were plotted. The incidence of hypothyroidism patients and its relationship with the dose were also evaluated. Results The mean thyroid volume followed a decreasing trend after radiotherapy, reaching a minimum (-39.8%) at 30 months and slightly increased afterward. The fT4 level followed a similar pattern with its mean value dropped by 21.5% at 30 months and became steady after 36 months. TSH level showed gradual rise from just after radiotherapy, reaching a peak at 24 months and became relatively steady after 36 months. The incidence of hypothyroidism increased to a maximum at 24 months (28.6%) and dropped afterwards. Thyroid D-mean and D-50 were significantly correlated with hypothyroidism incidence in 12 to 30 months (p > 0.40, p < 0.05). Conclusion The patterns of radiation induced thyroid volume shrinkage and fT4 level reduction were similar, with both of them showed decreasing trend from 0 to 30 months. The thyroid volume and function reached a relatively steady state after 36 months. The incidence of hypothyroidism increased up to 24 months and its frequency was associated with the thyroid dose.	[Lin, Zhixiong; Yang, Zhining; He, Binghui; Wang, Dangdang; Gao, Xiaoyin; Wu, Vincent Wing Cheung] Shantou Univ, Canc Hosp, Med Coll, Shantou, Peoples R China; [Tam, Shing-yau; Wu, Vincent Wing Cheung] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China	Shantou University; Hong Kong Polytechnic University	Wu, VWC (corresponding author), Shantou Univ, Canc Hosp, Med Coll, Shantou, Peoples R China.; Wu, VWC (corresponding author), Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Kowloon, Hong Kong, Peoples R China.	htvinwu@polyu.edu.hk	Tam, Shing Yau/AAZ-1345-2020; Tam, Shing Yau/AAN-4109-2020	Tam, Shing Yau/0000-0002-5899-1041; Lin, Zhixiong/0000-0003-4898-7441; WU, Wing Cheung Vincent/0000-0002-1257-4154	Hong Kong Polytechnic University [G-YN45]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This study was funded by Internal Central Research Grant of the Hong Kong Polytechnic University (Project code: G-YN45); Hong Kong Polytechnic University Internal Grant No: G-YN45	Alterio D, 2007, INT J RADIAT ONCOL, V67, P144, DOI 10.1016/j.ijrobp.2006.08.051; Bakhshandeh M, 2012, INT J RADIAT ONCOL, V83, P198, DOI 10.1016/j.ijrobp.2011.05.064; Berges O, 2010, CANCER RADIOTHER, V14, P307, DOI 10.1016/j.canrad.2010.03.005; Bhandare N, 2007, INT J RADIAT ONCOL, V68, P1131, DOI 10.1016/j.ijrobp.2007.01.029; CANNON CR, 1994, LARYNGOSCOPE, V104, P1, DOI 10.1288/00005537-199411001-00001; El-Shebiney M, 2016, DAN MED J, V63; Fan CY, 2017, RADIOTHER ONCOL, V123, P394, DOI 10.1016/j.radonc.2017.04.025; Fujiwara M, 2015, J RADIAT RES, V56, P577, DOI 10.1093/jrr/rrv006; Jereczek-Fossa BA, 2004, CANCER TREAT REV, V30, P369, DOI 10.1016/j.ctrv.2003.12.003; Khandelwal D, 2012, DRUGS, V72, P17, DOI 10.2165/11598070-000000000-00000; Lee V, 2016, CLIN ONCOL-UK, V28, pE52, DOI 10.1016/j.clon.2016.05.004; Lin Zhi-Xiong, 2009, Ai Zheng, V28, P1029; Lin ZX, 2014, HEAD NECK-J SCI SPEC, V36, P171, DOI 10.1002/hed.23285; Lin ZX, 2013, J MED IMAG RADIAT ON, V57, P713, DOI 10.1111/1754-9485.12074; Lin ZX, 2011, THYROID, V21, P19, DOI 10.1089/thy.2010.0229; Miller MC, 2009, CURR OPIN OTOLARYNGO, V17, P111, DOI 10.1097/MOO.0b013e328325a538; Nishiyama K, 1996, INT J RADIAT ONCOL, V34, P439, DOI 10.1016/0360-3016(95)02079-9; Ozawa H, 2007, AM J OTOLARYNG, V28, P46, DOI 10.1016/j.amjoto.2006.06.011; Siala W, 2011, ANN ENDOCRINOL-PARIS, V72, P19, DOI 10.1016/j.ando.2010.06.005; Sommat K, 2017, INT J RADIAT ONCOL, V98, P574, DOI 10.1016/j.ijrobp.2017.03.007; UY HL, 1995, AM J MED, V99, P173, DOI 10.1016/S0002-9343(99)80137-5; Wu YH, 2010, INT J RADIAT ONCOL, V76, P1133, DOI 10.1016/j.ijrobp.2009.03.011; Zhai RP, 2017, ORAL ONCOL, V68, P44, DOI 10.1016/j.oraloncology.2017.03.005	23	14	14	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200310	10.1371/journal.pone.0200310	http://dx.doi.org/10.1371/journal.pone.0200310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	29985952	gold, Green Published, Green Submitted			2022-12-26	WOS:000438035500031
J	Griet, M; de Valdez, GF; Gerez, CL; Rodriguez, AV				Griet, Milagros; Font de Valdez, Graciela; Gerez, Carla L.; Rodriguez, Ana V.			Two-step production of anti-inflammatory soluble factor by Lactobacillus reuteri CRL 1098	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; LACTIC-ACID BACTERIA; NUTRITIONAL-REQUIREMENTS; LACTOCOCCUS-LACTIS; BIOMASS PRODUCTION; GROWTH-PHASE; PH; OPTIMIZATION; FERMENTATION; CELLS	We have demonstrated previously that a soluble factor (LrS) produced by Lactobacillus (L.) reuteri CRL 1098 modulates the inflammatory response triggered by lipopolysaccharide. In this study, the production of LrS by L. reuteri CRL 1098 was realized through two steps: i) bacterial biomass production, ii) LrS production, where the bacterial biomass was able to live but did not proliferate. Therefore, the simultaneous evaluation of the effect of different factors on the growth and LrS production was performed. Biomass production was found to be dependent mainly on culture medium, while LrS production with anti-inflammatory activity depended on culture conditions of the biomass such as pH, agitation and growth phase. The L. reuteri CRL 1098 biomass and LrS production in the optimized culture media designed for this work reduced the complete process cost by approximately 95%, respectively to laboratory scale cost.	[Griet, Milagros; Font de Valdez, Graciela; Gerez, Carla L.; Rodriguez, Ana V.] Consejo Nacl Invest Cient & Tecn CONICET, Ctr Referencia Lactobacilos CERELA, San Miguel De Tucuman, Tucuman, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gerez, CL (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Ctr Referencia Lactobacilos CERELA, San Miguel De Tucuman, Tucuman, Argentina.	clugerez@cerela.org.ar		Gerez, Carla/0000-0001-5126-0281	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina [PIP 0512, PIP 0611]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The authors acknowledge the financial support of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 0512 and PIP 0611) from Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ezkauriatza EJ, 2010, BIORESOURCE TECHNOL, V101, P2837, DOI 10.1016/j.biortech.2009.10.047; Aguirre-Ezkauriatza EJ, 2008, J DAIRY SCI, V91, P4454, DOI 10.3168/jds.2008-1140; Aller K, 2014, APPL MICROBIOL BIOT, V98, P5871, DOI 10.1007/s00253-014-5641-7; Ashraf R, 2014, J DAIRY SCI, V97, P2542, DOI 10.3168/jds.2013-7459; Atilola OA, 2015, FOODS, V4, P318, DOI 10.3390/foods4030318; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Deepika G, 2009, J APPL MICROBIOL, V107, P1230, DOI 10.1111/j.1365-2672.2009.04306.x; Deepika G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-116; Degeest B, 2002, INT J FOOD MICROBIOL, V79, P161, DOI 10.1016/S0168-1605(02)00116-2; Ettinger G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168622; Farias ME, 2000, FEMS MICROBIOL LETT, V185, P263, DOI 10.1016/S0378-1097(00)00106-3; Finamore A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094891; Fong FLY, 2016, SCI REP-UK, V6, DOI 10.1038/srep22845; Fung WY, 2008, J AGR FOOD CHEM, V56, P7910, DOI 10.1021/jf801567j; Griet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110027; Guo SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124549; Guyot JP, 2000, J APPL MICROBIOL, V88, P176, DOI 10.1046/j.1365-2672.2000.00953.x; Guzman F, 2007, ELECTRON J BIOTECHN, V10, P279, DOI 10.2225/vol10-issue2-fulltext-13; Ha MY, 2003, J BIOSCI BIOENG, V96, P134, DOI 10.1263/jbb.96.134; Hebert EM, 2004, CURR MICROBIOL, V49, P341, DOI 10.1007/s00284-004-4357-9; Hevia A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/351204; Inic-Kanada A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157875; Tomas MSJ, 2010, PROBIOTICS ANTIMICRO, V2, P2, DOI 10.1007/s12602-010-9037-4; KANDLER O, 1986, BERGEYS MANUAL SYSTE; Kanmani P, 2011, PREP BIOCHEM BIOTECH, V41, P40, DOI 10.1080/10826068.2010.534221; Koscik RJE, 2018, REPROD SCI, V25, P239, DOI 10.1177/1933719117711259; Krzywonos M, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue2-fulltext-10; Laakso K, 2011, MICROB BIOTECHNOL, V4, P746, DOI 10.1111/j.1751-7915.2011.00275.x; Lazzi C, 2011, J FOOD SCI, V76, pM392, DOI 10.1111/j.1750-3841.2011.02212.x; LeBlanc JG, 2004, APPL MICROBIOL BIOT, V65, P119, DOI 10.1007/s00253-003-1532-z; Maassen CBM, 2003, VACCINE, V21, P2751, DOI 10.1016/S0264-410X(03)00220-2; Malheiros PS, 2015, BRAZ J MICROBIOL, V46, P825, DOI 10.1590/S1517-838246320140279; Manzoor A, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-017-0059-2; Mariman R, 2014, BRIT J NUTR, V112, P1088, DOI 10.1017/S000711451400169X; Mataragas M, 2004, ANTON LEEUW INT J G, V85, P191, DOI 10.1023/B:ANTO.0000020291.01957.a2; Matsusaki T, 2016, INT IMMUNOPHARMACOL, V39, P320, DOI 10.1016/j.intimp.2016.08.001; Mechoud MA, 2012, INT IMMUNOPHARMACOL, V14, P446, DOI 10.1016/j.intimp.2012.08.020; Meli F, 2014, CURR MICROBIOL, V68, P82, DOI 10.1007/s00284-013-0445-z; Moretro T, 1998, J APPL MICROBIOL, V85, P715, DOI 10.1111/j.1365-2672.1998.00583.x; NORTON S, 1994, ENZYME MICROB TECH, V16, P457, DOI 10.1016/0141-0229(94)90015-9; Pancheniak EDR, 2012, BRAZ J MICROBIOL, V43, P135, DOI [10.1590/S1517-83822012000100015, 10.1590/S1517-838220120001000015]; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Polak-Berecka M, 2011, BRAZ J MICROBIOL, V42, P1485, DOI [10.1590/S1517-83822011000400035, 10.1590/S1517-838220110004000035]; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649; Racine FM, 2007, PROCESS BIOCHEM, V42, P1609, DOI 10.1016/j.procbio.2007.09.001; Rault A, 2009, APPL ENVIRON MICROB, V75, P4374, DOI 10.1128/AEM.02725-08; RUSSELL JB, 1991, APPL ENVIRON MICROB, V57, P255, DOI 10.1128/AEM.57.1.255-259.1991; Saha BC, 2006, J IND MICROBIOL BIOT, V33, P887, DOI 10.1007/s10295-006-0140-1; Sanchez B, 2009, FEMS MICROBIOL LETT, V295, P226, DOI 10.1111/j.1574-6968.2009.01599.x; Savoie S, 2007, J APPL MICROBIOL, V103, P163, DOI 10.1111/j.1365-2672.2006.03219.x; Seenappanahalli Nanjundaiah Yashaswini, 2016, Biochem Biophys Rep, V6, P68, DOI 10.1016/j.bbrep.2016.03.003; Shahravy A, 2012, CHEM IND CHEM ENG Q, V18, P273, DOI 10.2298/CICEQ110709004S; Speranza B, 2017, J SCI FOOD AGR, V97, P2961, DOI 10.1002/jsfa.8135; Suzuki C, 2014, INFLAMMATION, V37, P1728, DOI 10.1007/s10753-014-9901-6; Todorov SD, 2006, MICROBIOL RES, V161, P102, DOI 10.1016/j.micres.2005.06.006; Wasko A, 2010, ACTA BIOL HUNG, V61, P344, DOI 10.1556/ABiol.61.2010.3.10; Wee YJ, 2009, BIORESOURCE TECHNOL, V100, P4262, DOI 10.1016/j.biortech.2009.03.074; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Zhang J, 2012, APPL BIOCHEM BIOTECH, V166, P1388, DOI 10.1007/s12010-011-9532-4; Zhang Y, 2014, J BIOSCI BIOENG, V118, P298, DOI 10.1016/j.jbiosc.2014.02.018	61	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200426	10.1371/journal.pone.0200426	http://dx.doi.org/10.1371/journal.pone.0200426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979794	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500108
J	Agrawal, M; Yeo, CR; Shabbir, A; Chhay, V; Silver, DL; Magkos, F; Vidal-Puig, A; Toh, SA				Agrawal, Madhur; Yeo, Chia Rou; Shabbir, Asim; Chhay, Vanna; Silver, David L.; Magkos, Faidon; Vidal-Puig, Antonio; Toh, Sue-Anne			Fat storage-inducing transmembrane protein 2 (FIT2) is less abundant in type 2 diabetes, and regulates triglyceride accumulation and insulin sensitivity in adipocytes	FASEB JOURNAL			English	Article						adipose function; lipid droplets; glucose uptake; ER stress	ENDOPLASMIC-RETICULUM STRESS; ADIPOSE-TISSUE EXPANDABILITY; PPAR-GAMMA; BETA-CELLS; TNF-ALPHA; PALMITATE; RESISTANCE; APOPTOSIS; OBESITY; PHOSPHORYLATION	Fat storage-inducing transmembrane protein 2 (FIT2) aids in partitioning of cellular triacylglycerol into lipid droplets. A genome-wide association study reported FITM2-R3H domain containing like-HNF4A locus to be associated with type 2 diabetes (T2DM) in East Asian populations. Mice with adipose tissue (AT)-specific FIT2 knockout exhibited lipodystrophic features, with reduced AT mass, insulin resistance, and greater inflammation in AT when fed a high-fat diet. The role of FIT2 in regulating human adipocyte function is not known. Here, we found FIT2 protein abundance is lower in subcutaneous and omental AT obtained from patients with T2DM compared with nondiabetic control subjects. Partial loss of FIT2 protein in primary human adipocytes attenuated their lipid storage capacity and induced insulin resistance. After palmitate treatment, triacylglycerol accumulation, insulin-induced Akt (Ser-473) phosphorylation, and insulin-stimulated glucose uptake were significantly reduced in FIT2 knockdown adipocytes compared with control cells. Gene expression of proinflammatory cytokines IL-18 and IL-6 and phosphorylation of the endoplasmic reticulum stress marker inositol-requiring enzyme 1 were greater in FIT2 knockdown adipocytes than in control cells. Our results show for the first time that FIT2 is associated with T2DM in humans and plays an integral role in maintaining metabolically healthy AT function.Agrawal, M., Yeo, C. R., Shabbir, A., Chhay, V., Silver, D. L., Magkos, F., Vidal-Puig, A., Toh, S.-A. Fat storage-inducing transmembrane protein 2 (FIT2) is less abundant in type 2 diabetes, and regulates triglyceride accumulation and insulin sensitivity in adipocytes.	[Agrawal, Madhur] Univ Kentucky, Dept Pharmacol & Nutr Sci, Lexington, KY USA; [Yeo, Chia Rou; Chhay, Vanna; Toh, Sue-Anne] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, 14 Med Dr, S-117599 Singapore, Singapore; [Magkos, Faidon] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Shabbir, Asim] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Silver, David L.] Duke Natl Univ Singapore, Med Sch, Signature Res Program Cardiovasc & Metab Disorder, Singapore, Singapore; [Magkos, Faidon] ASTAR, SICS, Singapore, Singapore; [Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge, England; [Vidal-Puig, Antonio] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Toh, Sue-Anne] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore	University of Kentucky; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; National University of Singapore	Toh, SA (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, 14 Med Dr, S-117599 Singapore, Singapore.	mdcsates@nus.edu.sg	Shabbir, Asim/W-3259-2017; Magkos, Faidon/CAA-9939-2022; Magkos, Faidon/B-4384-2010	Magkos, Faidon/0000-0002-1312-7364; Magkos, Faidon/0000-0002-1312-7364; Chhay, Vanna/0000-0003-1352-8384; Vidal-Puig, Antonio/0000-0003-4220-9577; Agrawal, Madhur/0000-0002-0966-8571	Singapore Ministry of Health's National Medical Research Council [NMRC/CSA/034/2012, NMRC/CIRG/1377/2013]; MRC [MC_UU_00014/2, G0400192, MC_UU_12012/2, G0600717, G0802051] Funding Source: UKRI	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.L.S. is thankfully acknowledged for providing the FIT2 antibody. Part of this work has been presented at the American Diabetes Association's 74th Scientific Sessions in 2014 as a guided audio poster (2014-A-4177-Diabetes). S.-A.T. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. This research is funded by the Singapore Ministry of Health's National Medical Research Council under its Clinician Scientist Award Grant (NMRC/CSA/034/2012) and Individual Research Grant (NMRC/CIRG/1377/2013). The authors declare no conflicts of interest.	Araki E, 2003, EXP BIOL MED, V228, P1213, DOI 10.1177/153537020322801018; Barneda D, 2017, CURR OPIN CELL BIOL, V47, P9, DOI 10.1016/j.ceb.2017.02.002; Boden G, 2014, DIABETES, V63, P912, DOI 10.2337/db13-0906; Boden G, 2011, METHOD ENZYMOL, V489, P67, DOI 10.1016/B978-0-12-385116-1.00004-2; Capel F, 2016, BBA-MOL CELL BIOL L, V1861, P2000, DOI 10.1016/j.bbalip.2016.10.002; Carobbio S, 2011, CURR OPIN CLIN NUTR, V14, P520, DOI 10.1097/MCO.0b013e32834ad966; Carswell KA, 2012, METHODS MOL BIOL, V806, P203, DOI 10.1007/978-1-61779-367-7_14; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choudhary V, 2015, J CELL BIOL, V211, P261, DOI 10.1083/jcb.201505067; Das SK, 2008, AM J PHYSIOL-ENDOC M, V295, pE393, DOI 10.1152/ajpendo.90355.2008; Gil-Campos M, 2004, INT J OBESITY, V28, pS75, DOI 10.1038/sj.ijo.0802806; Goh VJ, 2015, J BIOL CHEM, V290, P25686, DOI 10.1074/jbc.M115.676700; Gray SL, 2007, NUTR REV, V65, pS7, DOI [10.1111/j.1753-4887.2007.tb00331.x, 10.1301/nr.2007.jun.S7-S12]; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; Gu XM, 2010, LIFE SCI, V87, P724, DOI 10.1016/j.lfs.2010.10.012; Guo W, 2007, AM J PHYSIOL-ENDOC M, V293, pE576, DOI 10.1152/ajpendo.00523.2006; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Jung S, 2015, J CRANIO MAXILL SURG, V43, P2144, DOI 10.1016/j.jcms.2015.10.002; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kien CL, 2005, AM J CLIN NUTR, V82, P320, DOI 10.1093/ajcn/82.2.320; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170728; McCall KD, 2010, J ENDOCRINOL, V207, P343, DOI 10.1677/JOE-09-0370; Miranda DA, 2014, J BIOL CHEM, V289, P9560, DOI 10.1074/jbc.M114.547687; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Russo V, 2014, STEM CELL TRANSL MED, V3, P206, DOI 10.5966/sctm.2013-0125; Sabin MA, 2007, J CELL PHYSIOL, V211, P244, DOI 10.1002/jcp.20922; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Sovik O, 1996, ACTA PAEDIATR, V85, P29, DOI 10.1111/j.1651-2227.1996.tb14263.x; Summers LKM, 2002, DIABETOLOGIA, V45, P369, DOI 10.1007/s00125-001-0768-3; Talbot NA, 2014, MOL CELL ENDOCRINOL, V393, P129, DOI 10.1016/j.mce.2014.06.010; Tan CY, 2008, BIOCHEM SOC T, V36, P935, DOI 10.1042/BST0360935; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wood IS, 2005, BIOCHEM BIOPH RES CO, V337, P422, DOI 10.1016/j.bbrc.2005.09.068; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010	49	5	5	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					430	440		10.1096/fj.201701321RR	http://dx.doi.org/10.1096/fj.201701321RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	30020828				2022-12-26	WOS:000457401500034
J	Ashton, NN; Stewart, RJ				Ashton, Nicholas N.; Stewart, Russell J.			Aquatic caddisworm silk is solidified by environmental metal ions during the natural fiber-spinning process	FASEB JOURNAL			English	Article						bioadhesive; metallofibers; caddisfly; Trichoptera; Ca2+-phosphoserine complexes	AMINO-ACID-COMPOSITION; BOMBYX-MORI FIBROIN; SPIDER SILK; C-13 NMR; PH; PROTEIN; STATE; TRICHOPTERA; MECHANISM; CONSERVATION	Aquatic caddisfly larvae (caddisworms) wet-spin fibers to construct composite cases of silk and stone. The silk emerges from labial ducts as a nanofibrous fluid gel, flowing over the stone substrate and making intimate interfacial adhesive contacts before being drawn into tough fibers that rapidly solidify underwater to span gaps in the construction. Divalent metal ions are responsible for the unique mechanical properties of naturally spun silk fibers; however, when and where divalent metal ions are incorporated into the metallofibers and other aspects of the fiber solidification mechanism are poorly understood. To investigate, the elemental composition and secondary structure of silk precursors stored in the silk gland lumen were compared with naturally spun fibers by inductively coupled plasma optical emission spectroscopy and attenuated total reflection Fourier transform infrared spectroscopy. Naturally spun fibers contained near equimolar ratios of Ca2+ to P. In contrast, silk precursors stored in the silk gland lumen contained only traces of Ca2+ and other multivalent metal ions. Ca2+ was also undetectable in anterior lumenal silk using the histochemical Ca2+ indicator, alizarin S red. Addition of Ca2+ to isolated lumenal silk resulted in Ca2+ complexation by H-fibroin phosphoserines (pSs) and a shift in secondary structure from random coils to -structures, creating infrared spectra in the phosphate and amide I regions nearly equivalent to those found in naturally spun Ca2+-containing silk fibers. Light and electron microscopy within distinct regions of the silk gland suggested that posterior gland silk colloidal complexes transition into a nanofibrous morphology as they pass into the chitin-lined anterior lumen. Altogether, the results suggest that environmental Ca2+ absorbed from natural water triggers silk fiber solidification postdraw by complexing H-fibroin pSs, creating Ca2+-stabilized crystalline -nanodomains that cross-link and toughen the freshly drawn silk fibers.Ashton, N. N., Stewart, R. J. Aquatic caddisworm silk is solidified by environmental metal ions during the natural fiber-spinning process.	[Ashton, Nicholas N.; Stewart, Russell J.] Univ Utah, Dept Bioengn, 20 S 2030 East,Room 506C, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Stewart, RJ (corresponding author), Univ Utah, Dept Bioengn, 20 S 2030 East,Room 506C, Salt Lake City, UT 84112 USA.	russell.stewart@utah.edu			U.S. Army Research Office, Life Sciences Division [W911NF1310319]	U.S. Army Research Office, Life Sciences Division	The authors thank Daniel Taggert (University of Utah) for confocal images of the caddisworm silk glands. This work was funded by the U.S. Army Research Office, Life Sciences Division (W911NF1310319). The authors declare no conflicts of interest.	Addison JB, 2014, BIOMACROMOLECULES, V15, P1269, DOI 10.1021/bm401822p; Addison JB, 2013, BIOMACROMOLECULES, V14, P1140, DOI 10.1021/bm400019d; AKAI H, 1983, EXPERIENTIA, V39, P443, DOI 10.1007/BF01965158; Andersson M, 2017, NAT CHEM BIOL, V13, P262, DOI [10.1038/NCHEMBIO.2269, 10.1038/nchembio.2269]; Andersson M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001921; Asakura T, 2001, BIOPOLYMERS, V58, P521, DOI 10.1002/1097-0282(20010415)58:5&lt;521::AID-BIP1027&gt;3.0.CO;2-T; Ashton NN, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160067; Ashton NN, 2015, SOFT MATTER, V11, P1667, DOI 10.1039/c4sm02435d; Ashton NN, 2013, BIOMACROMOLECULES, V14, P3668, DOI 10.1021/bm401036z; Ashton NN, 2012, BIOPOLYMERS, V97, P432, DOI 10.1002/bip.21720; Chawla K, 1998, FIBROUS MAT; Collin MA, 2018, INT J BIOL MACROMOL, V113, P829, DOI 10.1016/j.ijbiomac.2018.02.032; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; Deng H, 1998, J PHYS CHEM B, V102, P3617, DOI 10.1021/jp973314q; Domigan LJ, 2015, INSECT BIOCHEM MOLEC, V65, P100, DOI 10.1016/j.ibmb.2015.09.001; Eisoldt L, 2012, BIOPOLYMERS, V97, P355, DOI 10.1002/bip.22006; ENGSTER MS, 1976, CELL TISSUE RES, V169, P77; Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7; He YX, 2012, J MOL BIOL, V418, P197, DOI 10.1016/j.jmb.2012.02.040; Heim M, 2009, ANGEW CHEM INT EDIT, V48, P3584, DOI 10.1002/anie.200803341; Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5; Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109; Jenkins JE, 2010, BIOMACROMOLECULES, V11, P192, DOI 10.1021/bm9010672; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; LAROCHE G, 1991, BIOCHEMISTRY-US, V30, P3105, DOI 10.1021/bi00226a018; LUCAS F, 1960, J MOL BIOL, V2, P339, DOI 10.1016/S0022-2836(60)80045-9; Naskar D, 2014, WOODH PUBL SER BIOM, V74, P3, DOI 10.1533/9780857097064.1.3; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; O'Brien JP, 1998, ADV MATER, V10, P1185, DOI 10.1002/(SICI)1521-4095(199810)10:15<1185::AID-ADMA1185>3.0.CO;2-T; Ochi A, 2002, BIOMACROMOLECULES, V3, P1187, DOI 10.1021/bm020056g; Ohkawa K, 2012, J FIBER BIOENG INF, V5, P125; Ohkawa K, 2013, BIOFOULING, V29, P357, DOI 10.1080/08927014.2013.774376; PARKER CR, 1985, CAN J ZOOL, V63, P2443, DOI 10.1139/z85-361; RUDALL KM, 1971, ANNU REV ENTOMOL, V16, P73, DOI 10.1146/annurev.en.16.010171.000445; SAITO H, 1984, MACROMOLECULES, V17, P1405, DOI 10.1021/ma00137a018; SANCHEZRUIZ JM, 1988, BIOCHEMISTRY-US, V27, P3338, DOI 10.1021/bi00409a033; Sandrin V, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-104; Stewart RJ, 2011, J POLYM SCI POL PHYS, V49, P757, DOI 10.1002/polb.22256; Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d; Strickland M, 2018, HEREDITY, V120, P574, DOI 10.1038/s41437-018-0050-9; Strzelecki JW, 2011, CENT EUR J PHYS, V9, P482, DOI 10.2478/s11534-010-0105-x; Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147; VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wallace JA, 2012, J PHYS CHEM LETT, V3, P658, DOI 10.1021/jz2016846; Wang CS, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0710; Wang CS, 2014, INSECT BIOCHEM MOLEC, V54, P69, DOI 10.1016/j.ibmb.2014.08.009; WARWICKER JO, 1960, J MOL BIOL, V2, P350, DOI 10.1016/S0022-2836(60)80046-0; Wiggens G. B., 2004, CADDISFLIES UNDERWAT; Wilding M. A., 1995, CHEM TEXTILES IND, P1; Woodings C., 2001, REGENERATED CELLULOS, V18; Yonemura N, 2009, J MOL EVOL, V68, P641, DOI 10.1007/s00239-009-9234-5; Yonemura N, 2006, BIOMACROMOLECULES, V7, P3370, DOI 10.1021/bm060663u; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078; Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i	56	10	10	2	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2019	33	1					572	583		10.1096/fj.201801029R	http://dx.doi.org/10.1096/fj.201801029R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HJ7TZ	29985645				2022-12-26	WOS:000457401500045
J	Dinkel, BA; Kremer, KN; Rollins, MR; Medlyn, MJ; Hedin, KE				Dinkel, Brittney A.; Kremer, Kimberly N.; Rollins, Meagan R.; Medlyn, Michael J.; Hedin, Karen E.			GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3K/PREX1 signaling and T cell cytokine secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CXC chemokine receptor type 4 (CXCR-4); G protein-coupled receptor (GPCR); T-cell receptor (TCR); fluorescence resonance energy transfer (FRET); cytokine; phosphorylation; G protein-coupled receptor kinase-2 (GRK2); IL-10; IL-2; PI3 kinase (PI3K); proximity ligation assay (PLA)	COUPLED RECEPTOR KINASE; NUCLEOTIDE EXCHANGE FACTOR; RHEUMATOID-ARTHRITIS; CHEMOKINE RECEPTORS; TYROSINE KINASE; IMMUNOLOGICAL SYNAPSE; PROTEIN-KINASE; BREAST-CANCER; FACTOR-I; PHOSPHORYLATION	The immune system includes abundant examples of biologically-relevant cross-regulation of signaling pathways by the T cell antigen receptor (TCR) and the G protein-coupled chemokine receptor, CXCR4. TCR ligation induces transactivation of CXCR4 and TCR-CXCR4 complex formation, permitting the TCR to signal via CXCR4 to activate a phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein (PREX1)-dependent signaling pathway that drives robust cytokine secretion by T cells. To understand this receptor heterodimer and its regulation, we characterized the molecular mechanisms required for TCR-mediated TCR-CXCR4 complex formation. We found that the cytoplasmic C-terminal domain of CXCR4 and specifically phosphorylation of Ser-339 within this region were required for TCR-CXCR4 complex formation. Interestingly, siRNA-mediated depletion of G protein-coupled receptor kinase-2 (GRK2) or inhibition by the GRK2-specific inhibitor, paroxetine, inhibited TCR-induced phosphorylation of CXCR4-Ser-339 and TCR-CXCR4 complex formation. Either GRK2 siRNA or paroxetine treatment of human T cells significantly reduced T cell cytokine production. Upstream, TCR-activated tyrosine kinases caused inducible tyrosine phosphorylation of GRK2 and were required for the GRK2-dependent events of CXCR4-Ser-339 phosphorylation and TCR-CXCR4 complex formation. Downstream of TCR-CXCR4 complex formation, we found that GRK2 and phosphatidylinositol 3-kinase (PI3K) were required for TCR-stimulated membrane recruitment of PREX1 and for stabilization of cytokine mRNAs and robust cytokine secretion. Together, our results identify a novel role for GRK2 as a target of TCR signaling that is responsible for TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that signals via PI3K/PREX1 to mediate cytokine production. Therapeutic regulation of GRK2 or PI3K may therefore be useful for limiting cytokines produced by T cell malignancies or autoimmune diseases.	[Dinkel, Brittney A.] Mayo Clin, Grad Sch Biomed Sci, Mayo IMM PhD Training Program, Rochester, MN 55905 USA; [Dinkel, Brittney A.; Kremer, Kimberly N.; Rollins, Meagan R.; Medlyn, Michael J.; Hedin, Karen E.] Mayo Clin, Dept Immunol, Coll Med & Sci, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Hedin, KE (corresponding author), Mayo Clin, Dept Immunol, Guggenheim Bldg,3rd Floor,200 First St Southwest, Rochester, MN 55905 USA.	hedin.karen@mayo.edu		Hedin, Karen/0000-0003-1010-923X	Mayo Clinic; National Institutes of Health from NIGMS [RO1 GM59763]; National Institutes of Health [R25 HL092621]; National Institutes of Health Ph.D. Training Grant in Basic Immunology from NIAID [T32 AI07425]; Mayo Clinic Graduate School of Biomedical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL092621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059763] Funding Source: NIH RePORTER	Mayo Clinic; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ph.D. Training Grant in Basic Immunology from NIAID; Mayo Clinic Graduate School of Biomedical Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Mayo Clinic and by National Institutes of Health Grant RO1 GM59763 from NIGMS (to K. E. H.) and Grant R25 HL092621 (to M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Ph.D. Training Grant in Basic Immunology T32 AI07425 from NIAID and the Mayo Clinic Graduate School of Biomedical Sciences.	Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Amara A, 1997, J EXP MED, V186, P139, DOI 10.1084/jem.186.1.139; Bird H, 2000, J RHEUMATOL, V27, P2791; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brault L, 2014, LEUKEMIA, V28, P566, DOI 10.1038/leu.2013.201; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cascio G, 2015, J IMMUNOL, V194, P5509, DOI 10.4049/jimmunol.1402419; Chen SS, 2016, LEUKEMIA, V30, P833, DOI 10.1038/leu.2015.316; Chernock RD, 2001, BLOOD, V97, P608, DOI 10.1182/blood.V97.3.608; Clift IC, 2014, MOL PHARMACOL, V85, P542, DOI 10.1124/mol.113.089714; DEBLASI A, 1995, J CLIN INVEST, V95, P203, DOI 10.1172/JCI117641; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; DeFord-Watts LM, 2007, J BIOL CHEM, V282, P16126, DOI 10.1074/jbc.M609418200; Delcourt N, 2007, TRENDS PHARMACOL SCI, V28, P602, DOI 10.1016/j.tips.2007.09.007; Gonzalez BR, 2016, CURR OPIN ONCOL, V28, P88, DOI 10.1097/CCO.0000000000000243; Gorentla Balachandra K, 2012, J Clin Cell Immunol, V2012, P5; Guccione M, 2016, J MED CHEM, V59, P9277, DOI 10.1021/acs.jmedchem.5b01939; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hawkins PT, 2015, BBA-MOL CELL BIOL L, V1851, P882, DOI 10.1016/j.bbalip.2014.12.006; Huang WS, 2015, J LEUKOCYTE BIOL, V97, P477, DOI 10.1189/jlb.1RI0614-293R; Isik N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003424; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kohler RE, 2008, BRAIN PATHOL, V18, P504, DOI 10.1111/j.1750-3639.2008.00154.x; Krasel C, 2001, J BIOL CHEM, V276, P1911, DOI 10.1074/jbc.M008773200; Kremer KN, 2007, J IMMUNOL, V178, P1581, DOI 10.4049/jimmunol.178.3.1581; Kremer KN, 2017, BLOOD, V130, P982, DOI 10.1182/blood-2017-03-770982; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Kumar A, 2009, METHOD ENZYMOL, V460, P379, DOI 10.1016/S0076-6879(09)05219-7; Launay O, 2013, VACCINE, V31, P3492, DOI 10.1016/j.vaccine.2013.05.095; Li X, 2006, BIOCHEM J, V394, P427, DOI 10.1042/BJ20051560; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Maekawa T, 2000, INTERNAL MED, V39, P90, DOI 10.2169/internalmedicine.39.90; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mueller W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064975; Murthy KS, 2008, AM J PHYSIOL-CELL PH, V294, pC477, DOI 10.1152/ajpcell.00229.2007; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Orsini MJ, 1999, J BIOL CHEM, V274, P31076, DOI 10.1074/jbc.274.43.31076; Pan DX, 2016, J BIOL CHEM, V291, P6359, DOI 10.1074/jbc.M115.686592; Patrussi L, 2007, BLOOD, V110, P1730, DOI 10.1182/blood-2007-01-068411; Patton DT, 2007, BIOCHEM SOC T, V35, P167, DOI 10.1042/BST0350167; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Przybyla JA, 2010, J PHARMACOL EXP THER, V332, P710, DOI 10.1124/jpet.109.162701; Pyne NJ, 2011, TRENDS PHARMACOL SCI, V32, P443, DOI 10.1016/j.tips.2011.04.002; Rocha-Perugini V, 2017, ADV EXP MED BIOL, V1006, P271, DOI 10.1007/978-4-431-56550-5_15; Rodriguez-Frade JM, 1999, J CELL BIOL, V144, P755, DOI 10.1083/jcb.144.4.755; Rodriguez-Frade JM, 1999, P NATL ACAD SCI USA, V96, P3628, DOI 10.1073/pnas.96.7.3628; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santio NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130340; Sarnago S, 1999, J BIOL CHEM, V274, P34411, DOI 10.1074/jbc.274.48.34411; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Smith X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004018; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Stark AK, 2015, CURR OPIN PHARMACOL, V23, P82, DOI 10.1016/j.coph.2015.05.017; Thal DM, 2012, ACS CHEM BIOL, V7, P1830, DOI 10.1021/cb3003013; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Wang QT, 2017, SCI REP-UK, V7, DOI 10.1038/srep45364; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Welch Heidi C E, 2015, Small GTPases, V6, P49, DOI 10.4161/21541248.2014.973770; Yang J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003519; Zuo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26812	70	19	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 7	2018	293	36					14022	14039		10.1074/jbc.RA118.003097	http://dx.doi.org/10.1074/jbc.RA118.003097			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS9TS	30018141	Green Published, hybrid			2022-12-26	WOS:000444070700026
J	Hutt, DM; Loguercio, S; Roth, DM; Su, AI; Balch, WE				Hutt, Darren M.; Loguercio, Salvatore; Roth, Daniela Martino; Su, Andrew I.; Balch, William E.			Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis transmembrane conductance regulator (CFTR); cystic fibrosis; proteostasis; eukaryotic translation initiation; translation initiation factor; eIF3a; eukaryotic translation initiation factor 3; F508del-CFTR; network hub; protein misfolding; protein translation	TRANSMEMBRANE CONDUCTANCE REGULATOR; RNA RECOGNITION MOTIF; CYSTIC-FIBROSIS; MESSENGER-RNA; IN-VITRO; BIOCHEMICAL-CHARACTERIZATION; PROFILING REVEALS; PROTEIN-SYNTHESIS; EIF3; CFTR	Inherited and somatic rare diseases result from >200,000 genetic variants leading to loss- or gain-of-toxic function, often caused by protein misfolding. Many of these misfolded variants fail to properly interact with other proteins. Understanding the link between factors mediating the transcription, translation, and protein folding of these disease-associated variants remains a major challenge in cell biology. Herein, we utilized the cystic fibrosis transmembrane conductance regulator (CFTR) protein as a model and performed a proteomics-based high-throughput screen (HTS) to identify pathways and components affecting the folding and function of the most common cystic fibrosis-associated mutation, the F508del variant of CFTR. Using a shortest-path algorithm we developed, we mapped HTS hits to the CFTR interactome to provide functional context to the targets and identified the eukaryotic translation initiation factor 3a (eIF3a) as a central hub for the biogenesis of CFTR. Of note, siRNA-mediated silencing of eIF3a reduced the polysome-to-monosome ratio in F508del-expressing cells, which, in turn, decreased the translation of CFTR variants, leading to increased CFTR stability, trafficking, and function at the cell surface. This finding suggested that eIF3a is involved in mediating the impact of genetic variations in CFTR on the folding of this protein. We posit that the number of ribosomes on a CFTR mRNA transcript is inversely correlated with the stability of the translated polypeptide. Polysome-based translation challenges the capacity of the proteostasis environment to balance message fidelity with protein folding, leading to disease. We suggest that this deficit can be corrected through control of translation initiation.	[Hutt, Darren M.; Loguercio, Salvatore; Roth, Daniela Martino; Balch, William E.] Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA; [Su, Andrew I.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Roth, Daniela Martino] Locana, 3210 Merryfield Row, San Diego, CA 92122 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Mol Med, La Jolla, CA 92037 USA.; Balch, WE (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	webalch@scripps.edu		Loguercio, Salvatore/0000-0002-7544-2992; Su, Andrew I./0000-0002-9859-4104	NHLBI NIH HHS [R01 HL095524] Funding Source: Medline; NIA NIH HHS [P01 AG049665] Funding Source: Medline; NIDDK NIH HHS [R01 DK051870] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG049665] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Ahner A, 2016, AM J PHYSIOL-CELL PH, V310, pC175, DOI 10.1152/ajpcell.00124.2015; Ahner A, 2013, MOL BIOL CELL, V24, P74, DOI 10.1091/mbc.E12-09-0678; Alanis-Lobato G, 2017, NUCLEIC ACIDS RES, V45, pD408, DOI 10.1093/nar/gkw985; Amaral MD, 2015, J CYST FIBROS, V14, P687, DOI 10.1016/j.jcf.2015.09.006; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Bagdany M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00444-4; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balch WE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004499; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; Berger B, 2013, NAT REV GENET, V14, P333, DOI 10.1038/nrg3433; Beznoskova P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003962; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Bouchecareilh M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404707; Brar GA, 2016, CELL, V167, P1681, DOI 10.1016/j.cell.2016.09.022; Brar GA, 2015, NAT REV MOL CELL BIO, V16, P651, DOI 10.1038/nrm4069; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Callebaut I, 2018, J CYST FIBROS, V17, pS5, DOI 10.1016/j.jcf.2017.08.008; Carter H, 2013, CURR OPIN GENET DEV, V23, P611, DOI 10.1016/j.gde.2013.10.003; Cate JHD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0176; Chadani Y, 2016, P NATL ACAD SCI USA, V113, pE829, DOI 10.1073/pnas.1520560113; Chaudhuri J, 1997, J BIOL CHEM, V272, P30975, DOI 10.1074/jbc.272.49.30975; Chiu WL, 2010, MOL CELL BIOL, V30, P4415, DOI 10.1128/MCB.00280-10; Churbanov A, 2005, NUCLEIC ACIDS RES, V33, P5512, DOI 10.1093/nar/gki847; Dacheux E, 2017, NUCLEIC ACIDS RES, V45, P6981, DOI 10.1093/nar/gkx430; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dong ZZ, 2003, MOL BIOL CELL, V14, P3942, DOI 10.1091/mbc.E02-12-0784; Faure G, 2016, NUCLEIC ACIDS RES, V44, P10898, DOI 10.1093/nar/gkw671; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Fernandes LD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17618-1; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gobet C, 2017, CURR OPIN GENET DEV, V43, P120, DOI 10.1016/j.gde.2017.03.005; Gong XY, 2016, J BIOL CHEM, V291, P2004, DOI 10.1074/jbc.M115.685628; Gradi A, 1998, MOL CELL BIOL, V18, P334, DOI 10.1128/MCB.18.1.334; Gross AM, 2015, NAT BIOTECHNOL, V33, P720, DOI 10.1038/nbt.3283; Hartl D, 2015, J CYST FIBROS, V14, P415, DOI 10.1016/j.jcf.2015.06.001; Hartl FU, 2017, ANNU REV BIOCHEM, V86, P21, DOI 10.1146/annurev-biochem-061516-044518; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Heyer EE, 2016, CELL, V164, P757, DOI 10.1016/j.cell.2016.01.003; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hinnebusch AG, 2017, TRENDS BIOCHEM SCI, V42, P589, DOI 10.1016/j.tibs.2017.03.004; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jia MW, 2006, BIOCHEM BIOPH RES CO, V343, P177, DOI 10.1016/j.bbrc.2006.02.135; Karczewski KJ, 2017, NUCLEIC ACIDS RES, V45, pD840, DOI 10.1093/nar/gkw971; Kim SJ, 2015, SCIENCE, V348, P444, DOI 10.1126/science.aaa3974; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lacerda R, 2017, CELL MOL LIFE SCI, V74, P1659, DOI 10.1007/s00018-016-2428-2; Lan A, 2011, NUCLEIC ACIDS RES, V39, pW424, DOI 10.1093/nar/gkr359; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lee ASY, 2015, NATURE, V522, P111, DOI 10.1038/nature14267; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li J, 2017, TRENDS CELL BIOL, V27, P895, DOI 10.1016/j.tcb.2017.08.002; Luck K, 2017, TRENDS BIOCHEM SCI, V42, P342, DOI 10.1016/j.tibs.2017.02.006; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McClure ML, 2016, AM J PHYSIOL-LUNG C, V311, pL719, DOI 10.1152/ajplung.00431.2015; Meriin AB, 2012, J BIOL CHEM, V287, P34264, DOI 10.1074/jbc.M112.397307; Mohammad MP, 2017, NUCLEIC ACIDS RES, V45, P2658, DOI 10.1093/nar/gkx049; Morgunov AS, 2014, NAT STRUCT MOL BIOL, V21, P1023, DOI 10.1038/nsmb.2926; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Pankow S, 2015, NATURE, V528, P510, DOI 10.1038/nature15729; Pavitt GD, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012278; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Perlmutter DH, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005801; Pisarev AV, 2007, CELL, V131, P286, DOI 10.1016/j.cell.2007.08.041; Quon BS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i859; Ratjen F, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.10; Raxwal VK, 2016, BBA-GENE REGUL MECH, V1859, P1538, DOI 10.1016/j.bbagrm.2016.09.001; Rodnina MV, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0182; Rodnina MV, 2016, J MOL BIOL, V428, P2165, DOI 10.1016/j.jmb.2016.03.022; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Roth DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001998; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Sala AJ, 2017, J CELL BIOL, V216, P1231, DOI 10.1083/jcb.201612111; Saletta F, 2010, BBA-REV CANCER, V1806, P275, DOI 10.1016/j.bbcan.2010.07.005; Saxena A, 2012, J BIOL CHEM, V287, P19158, DOI 10.1074/jbc.M111.297580; Schmidt BZ, 2009, J BIOL CHEM, V284, P4168, DOI 10.1074/jbc.M806485200; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sesen J, 2017, FRONT BIOSCI-LANDMRK, V22, P1, DOI 10.2741/4469; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Shabalina SA, 2013, NUCLEIC ACIDS RES, V41, P2073, DOI 10.1093/nar/gks1205; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Solomon GM, 2016, ANN AM THORAC SOC, V13, pS169, DOI 10.1513/AnnalsATS.201509-601KV; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Spielberg DR, 2016, ANNU REV GENOM HUM G, V17, P155, DOI 10.1146/annurev-genom-090314-050024; Steffen KK, 2016, CELL METAB, V23, P1004, DOI 10.1016/j.cmet.2016.05.013; Thommen M, 2017, CURR OPIN STRUC BIOL, V42, P83, DOI 10.1016/j.sbi.2016.11.020; Tran JR, 2011, J BIOL CHEM, V286, P5744, DOI 10.1074/jbc.M110.179259; Valasek L, 2001, EMBO J, V20, P891, DOI 10.1093/emboj/20.4.891; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wagner S, 2016, NUCLEIC ACIDS RES, V44, P10772, DOI 10.1093/nar/gkw972; Wagner S, 2014, MOL CELL BIOL, V34, P3041, DOI 10.1128/MCB.00663-14; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yu MK, 2016, CELL SYST, V2, P77, DOI 10.1016/j.cels.2016.02.003; Zhao F, 2017, NUCLEIC ACIDS RES, V45, P8484, DOI 10.1093/nar/gkx501; Zhou M, 2008, P NATL ACAD SCI USA, V105, P18139, DOI 10.1073/pnas.0801313105	110	12	13	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13477	13495		10.1074/jbc.RA118.003192	http://dx.doi.org/10.1074/jbc.RA118.003192			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30006345	Green Published, hybrid			2022-12-26	WOS:000443375500011
J	Hicks, SD; Khurana, N; Williams, J; Greene, CD; Uhlig, R; Middleton, FA				Hicks, Steven D.; Khurana, Neil; Williams, Jeremy; Greene, Cindy Dowd; Uhlig, Richard; Middleton, Frank A.			Diurnal oscillations in human salivary microRNA and microbial transcription: Implications for human health and disease	PLOS ONE			English	Article							GUT-BRAIN AXIS; CIRCADIAN-CLOCK; DISRUPTION; EXPRESSION; SPECTRUM; RHYTHM; SLEEP	The microbiome plays a vital role in human health and disease. Interaction between human hosts and the microbiome occurs through a number of mechanisms, including transcrip-tomic regulation by microRNA (miRNA). In animal models, circadian variations in miRNA and microbiome elements have been described, but patterns of co-expression and potential diurnal interaction in humans have not. We investigated daily oscillations in salivary miRNA and microbial RNA to explore relationships between these components of the gut-brain-axis and their implications in human health. Nine subjects provided 120 saliva samples at designated times, on repeated days. Samples were divided into three sets for exploration and cross-validation. Identification and quantification of host miRNA and microbial RNA was performed using next generation sequencing. Three stages of statistical analyses were used to identify circadian oscillators: 1) a two-way analysis of variance in the first two sample sets identified host miRNAs and microbial RNAs whose abundance varied with collection time (but not day); 2) multivariate modeling identified subsets of these miRNAs and microbial RNAs strongly-associated with collection time, and evaluated their predictive ability in an independent hold-out sample set; 3) regulation of circadian miRNAs and microbial RNAs was explored in data from autistic children with disordered sleep (n = 77), relative to autistic peers with typical sleep (n = 63). Eleven miRNAs and 11 microbial RNAs demonstrated consistent diurnal oscillation across sample sets and accurately predicted collection time in the hold-out set. Associations among five circadian miRNAs and four circadian microbial RNAs were observed. We termed the 11 miRNAs CircaMiRs. These CircaMiRs had 1,127 predicted gene targets, with enrichment for both circadian gene targets and metabolic signaling processes. Four CircaMiRs had "altered" expression patterns among children with disordered sleep. Thus, novel and correlated circadian oscillations in human miRNA and microbial RNA exist and may have distinct implications in human health and disease.	[Hicks, Steven D.] Penn State Univ, Hershey Med Ctr, Dept Pediat, Hershey, PA USA; [Khurana, Neil] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Khurana, Neil; Williams, Jeremy; Greene, Cindy Dowd; Uhlig, Richard] Quadrant Biosci Inc, Syracuse, NY USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA.	middletf@upstate.edu		Middleton, Frank/0000-0002-3107-7188; Hicks, Steven/0000-0002-9579-6798	Quadrant Biosciences Inc.; STTR; National Institutes of Mental Health [R41 MH111347]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002014, KL2TR002015] Funding Source: NIH RePORTER	Quadrant Biosciences Inc.; STTR; National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this study was provided by Quadrant Biosciences Inc. (formerly Motion Intelligence; https://quadrantbiosciences.com/) and an STTR grant to SUNY Upstate, Hershey Medical Center and Quadrant Biosciences from the National Institutes of Mental Health (R41 MH111347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth D, 2017, NUCLEIC ACIDS RES, V45, P1649, DOI 10.1093/nar/gkw1248; Gorostiza EA, 2014, CURR BIOL, V24, P2161, DOI 10.1016/j.cub.2014.07.063; Bendova Z, 2012, NEUROCHEM INT, V61, P43, DOI 10.1016/j.neuint.2012.04.016; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Carskadon MA, 1998, SLEEP, V21, P871, DOI 10.1093/sleep/21.8.871; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng Lesley, 2013, Frontiers in Genetics, V4, P150, DOI [10.3389/fgene.2013.00150, 10.3389/fimmu.2013.00388]; Cloutier F, 2015, J MOL NEUROSCI, V56, P102, DOI 10.1007/s12031-014-0471-8; Dalmasso G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019293, 10.1371/journal.pone.0023806]; Damdimopoulou P, 2011, J NUTR, V141, P1583, DOI 10.3945/jn.111.140277; de Kloet ER, 2009, BRAIN RES, V1293, P129, DOI 10.1016/j.brainres.2009.03.039; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dickson I., 2017, NATURE REV GASTROENT, V14; Figueroa KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008280; Freischmidt A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-42; Galimberti D, 2014, J ALZHEIMERS DIS, V42, P1261, DOI 10.3233/JAD-140756; Gallego JA, 2012, J MOL NEUROSCI, V47, P243, DOI 10.1007/s12031-012-9731-7; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Hansen KF, 2011, GENOME MED, V3, DOI 10.1186/gm224; Hanson JR, 2007, TERPENOIDS STEROIDS; Heegaard NHH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160577; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hicks SD, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00176; Hicks SD, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0586-x; Jasinska M, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/6373412; Jasinska M, 2015, EUR J NEUROSCI, V42, P2585, DOI 10.1111/ejn.13045; Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197; Ksiazek-Winiarek DJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/172351; Laudes M, 2010, HORM METAB RES, V42, P268, DOI 10.1055/s-0029-1243638; Li Q, 2016, NEUROSCIENCE, V324, P131, DOI 10.1016/j.neuroscience.2016.03.013; Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005; Masotti A, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00137; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reinke H, 2016, GASTROENTEROLOGY, V150, P574, DOI 10.1053/j.gastro.2015.11.043; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Song J, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00227; Stoicea N, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00011; Takeda N, 2016, HYPERTENS RES, V39, P383, DOI 10.1038/hr.2016.9; Videnovic A, 2015, SLEEP MED CLIN, V10, P469, DOI 10.1016/j.jsmc.2015.08.004; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wang Y, 2015, MOL NEUROENDOCRINOLO, P75; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Wulff K, 2010, NAT REV NEUROSCI, V11, P589, DOI 10.1038/nrn2868	47	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0198288	10.1371/journal.pone.0198288	http://dx.doi.org/10.1371/journal.pone.0198288			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020932	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400004
J	Lister, DL; Jones, H; Oliveira, HR; Petrie, CA; Liu, XY; Cockram, J; Kneale, CJ; Kovaleva, O; Jones, MK				Lister, Diane L.; Jones, Huw; Oliveira, Hugo R.; Petrie, Cameron A.; Liu, Xinyi; Cockram, James; Kneale, Catherine J.; Kovaleva, Olga; Jones, Martin K.			Barley heads east: Genetic analyses reveal routes of spread through diverse Eurasian landscapes	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; WINTER GROWTH HABIT; HORDEUM-VULGARE; BRONZE-AGE; POPULATION-STRUCTURE; TIBETAN PLATEAU; FLOWERING TIME; CULTIVATED BARLEY; FERTILE CRESCENT; 6-ROWED BARLEY	One of the world's most important crops, barley, was domesticated in the Near East around 11,000 years ago. Barley is a highly resilient crop, able to grown in varied and marginal environments, such as in regions of high altitude and latitude. Archaeobotanical evidence shows that barley had spread throughout Eurasia by 2,000 BC. To further elucidate the routes by which barley cultivation was spread through Eurasia, simple sequence repeat (SSR) analysis was used to determine genetic diversity and population structure in three extant barley taxa: domesticated barley (Hordeum vulgare L. subsp. vulgare), wild barley (H. vulgaresubsp. spontaneum) and a six-rowed brittle rachis form (H. vulgaresubsp. vulgare f. agriocrithon (Aberg) Bowd.). Analysis of data using the Bayesian clustering algorithm InStruct suggests a model with three ancestral genepools, which captures a major split in the data, with substantial additional resolution provided under a model with eight genepools. Our results indicate that H. vulgaresubsp. vulgaref. agriocrithon accessions and Tibetan Plateau H. vulgaresubsp. spontaneum are closely related to the H. vulgaresubsp. vulgare in their vicinity, and are therefore likely to be feral derivatives of H. vulgaresubsp. vulgare. Under the eight genepool model, cultivated barley is split into six ancestral genepools, each of which has a distinct distribution through Eurasia, along with distinct morphological features and flowering time phenotypes. The distribution of these genepools and their phenotypic characteristics is discussed together with archaeological evidence for the spread of barley eastwards across Eurasia.	[Lister, Diane L.; Kneale, Catherine J.] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Jones, Huw; Cockram, James] NIAB, John Bingham Lab, Cambridge, England; [Oliveira, Hugo R.] Univ Manchester, Manchester Inst Biotechnol, Sch Earth & Environm Sci, Manchester, Lancs, England; [Petrie, Cameron A.; Jones, Martin K.] Univ Cambridge, Dept Archaeol, Cambridge, England; [Liu, Xinyi] Washington Univ St Louis, Dept Anthropol, St Louis, MO 63130 USA; [Kovaleva, Olga] NI Vavilov Res Inst Plant Ind, St Petersburg, Russia	University of Cambridge; University of Manchester; University of Cambridge; Washington University (WUSTL); Vavilov All-Russian Institute of Plant Genetic Resources	Lister, DL (corresponding author), Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England.	dll1000@cam.ac.uk	liu, xinyi/GWZ-8739-2022; Petrie, Cameron/ABB-8528-2021	Petrie, Cameron/0000-0002-2926-7230; Cockram, James/0000-0002-1014-6463; Oliveira, Hugo/0000-0002-5038-073X	"Food Globalization in Prehistory" project (FOGLIP) [249642]; European Research Council - FP7-IDEAS-ERC - Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013); Vavilov Institute and Cambridge: insights from historic crop resources [JP101321]; Royal Society of London, International Joint Project [2010/R3]; BBSRC [BB/P027970/1] Funding Source: UKRI	"Food Globalization in Prehistory" project (FOGLIP); European Research Council - FP7-IDEAS-ERC - Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013); Vavilov Institute and Cambridge: insights from historic crop resources; Royal Society of London, International Joint Project(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding source 1. "Food Globalization in Prehistory" project (FOGLIP), grant number 249642, awarded to Martin Kenneth Jones; funded by the European Research Council - FP7-IDEAS-ERC - Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013), url: http://cordis.europa.eu/programme/rcn/845_en.html. Funding source 2: "The Vavilov Institute and Cambridge: insights from historic crop resources", grant number JP101321, awarded to Martin Kenneth Jones; funded by the Royal Society of London, International Joint Project 2010/R3 (Russia costshare), url: https://royalsociety.org/grants-schemes-awards/grants/international-exchanges/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2004, THEOR APPL GENET, V109, P588, DOI 10.1007/s00122-004-1657-1; Abebe TD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00813; Aberg E., 1938, ANN AGR COLL SWEDEN, V6, P159; Allaby RG, 2008, P NATL ACAD SCI USA, V105, P13982, DOI 10.1073/pnas.0803780105; Antolin F, 2015, J ARCHAEOL SCI, V61, P90, DOI 10.1016/j.jas.2015.05.007; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bellina B, 2014, CAMB ARCHAEOL J, V24, P345, DOI 10.1017/S0959774314000547; Bengtsson T, 2017, GENET RESOUR CROP EV, V64, P2021, DOI 10.1007/s10722-017-0493-5; Bjornstad A, 1997, THEOR APPL GENET, V94, P514, DOI 10.1007/s001220050445; Campana MG, 2011, MOL ECOL RESOUR, V11, P349, DOI 10.1111/j.1755-0998.2010.02917.x; Castillo CC, 2016, ANTIQUITY, V90, P1255, DOI 10.15184/aqy.2016.175; Chen FH, 2015, SCIENCE, V347, P248, DOI 10.1126/science.1259172; Christian D, 2000, J WORLD HIST, V11, P1, DOI 10.1353/jwh.2000.0004; Civan P, 2017, NEW PHYTOLOGIST; CLARK H. H., 1967, Agric. Hist. Rev., V15, P1; Cockram J, 2007, J EXP BOT, V58, P1231, DOI 10.1093/jxb/erm042; Cockram J, 2010, P NATL ACAD SCI USA, V107, P21611, DOI 10.1073/pnas.1010179107; Cockram J, 2009, CROP SCI, V49, P403, DOI 10.2135/cropsci2008.07.0398; Colledge S, 2004, CURR ANTHROPOL, V45, pS35, DOI 10.1086/422086; Costantini L., 2006, 1 FARMERS W PAKISTAN; Crawford GW, 2011, CURR ANTHROPOL, V52, pS331, DOI 10.1086/658369; Crawford GW, 2003, ANTIQUITY, V77, P87, DOI 10.1017/S0003598X00061378; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dawson IK, 2015, NEW PHYTOL, V206, P913, DOI 10.1111/nph.13266; Dodson JR, 2013, QUATERNARY SCI REV, V72, P108, DOI 10.1016/j.quascirev.2013.04.021; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frachetti MD, 2007, J FIELD ARCHAEOL, V32, P221, DOI 10.1179/009346907791071520; Frachetti MD, 2012, CURR ANTHROPOL, V53, P2, DOI 10.1086/663692; Frachetti MD, 2010, WORLD ARCHAEOL, V42, P622, DOI 10.1080/00438240903371270; Freisleben R., 1940, ZUCHTER, V12, P257, DOI 10.1007/BF01812425; Gao H, 2007, GENETICS, V176, P1635, DOI 10.1534/genetics.107.072371; Garazhian O., 2009, ANTIQUITY; Gross BL, 2014, P NATL ACAD SCI USA, V111, P6190, DOI 10.1073/pnas.1308942110; Guedes JAD, 2015, P NATL ACAD SCI USA, V112, P5625, DOI 10.1073/pnas.1423708112; Guedes JD, 2016, ARCHAEOL RES ASIA, V5, P16, DOI 10.1016/j.ara.2016.02.001; Habu J., 2014, CAMBRIDGE WORLD PREH, V3, P724; Helbuk H., 1969, PREHISTORY HUMAN ECO, P383; Hennig C, 2015, PRABCLUS FUNCTIONS C; Hillman G, 2001, HOLOCENE, V11, P383, DOI 10.1191/095968301678302823; Hillman G., 1975, P PREHIST SOC, V41, P70; Hunt HV, 2011, MOL ECOL, V20, P4756, DOI 10.1111/j.1365-294X.2011.05318.x; Jiao TL, 2016, QUATERN INT, V419, P54, DOI 10.1016/j.quaint.2015.06.060; Jones G, 2013, ANTIQUITY, V87, P701, DOI 10.1017/S0003598X00049401; Jones G, 2012, J ARCHAEOL SCI, V39, P3230, DOI 10.1016/j.jas.2012.05.014; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Jones H, 2016, QUATERN INT, V426, P26, DOI 10.1016/j.quaint.2016.02.029; Jones H, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-320; Kadowaki S, 2015, J ARCHAEOL SCI, V53, P408, DOI 10.1016/j.jas.2014.10.021; Karsai I, 2005, THEOR APPL GENET, V110, P1458, DOI 10.1007/s00122-005-1979-7; Knorzer KH, 2000, VEG HIST ARCHAEOBOT, V9, P219, DOI 10.1007/BF01294636; Knupffer H, 2003, DEV PL GEN, V7, P53, DOI 10.1016/S0168-7972(03)80006-3; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Larson G, 2013, TRENDS GENET, V29, P197, DOI 10.1016/j.tig.2013.01.003; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leipe C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174397; Lister DL, 2013, VEG HIST ARCHAEOBOT, V22, P439, DOI 10.1007/s00334-012-0376-9; Lister DL, 2009, J ARCHAEOL SCI, V36, P1092, DOI 10.1016/j.jas.2008.12.012; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187405; Liu XY, 2016, QUATERN INT, V426, P107, DOI 10.1016/j.quaint.2016.02.059; Matsui A, 2006, WORLD ARCHAEOL, V38, P259, DOI 10.1080/00438240600708295; Matuzeviciute GM, 2017, QUATERN INT, V437, P35, DOI 10.1016/j.quaint.2015.06.065; Molina-Cano JL, 2005, THEOR APPL GENET, V110, P613, DOI 10.1007/s00122-004-1878-3; Morales J, 2016, QUATERN INT, V412, P96, DOI 10.1016/j.quaint.2016.01.066; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Morrell PL, 2014, J HERED, V105, P253, DOI 10.1093/jhered/est083; Naumov I.V., 2006, HIST SIBERIA; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Poets AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0712-3; Pourkheirandish M, 2015, CELL, V162, P527, DOI 10.1016/j.cell.2015.07.002; Pritchard JK, 2000, GENETICS, V155, P945; Ren XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062700; Roustaei K, 2015, ANTIQUITY, V89, P573, DOI 10.15184/aqy.2015.26; Saisho D, 2007, GENETICS, V177, P1765, DOI 10.1534/genetics.107.079491; Saisho D, 2011, PLANT CELL PHYSIOL, V52, P775, DOI [10.1093/pcp/pcr046, 10.1093/pcp/pcr049]; Sjogren P, 2013, VEG HIST ARCHAEOBOT, V22, P1, DOI 10.1007/s00334-012-0346-2; Spengler R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3382; Spengler RN, 2016, HOLOCENE, V26, P1527, DOI 10.1177/0959683616641739; Spengler RN, 2015, J WORLD PREHIST, V28, P215, DOI 10.1007/s10963-015-9087-3; Spengler RN, 2014, QUATERN INT, V348, P147, DOI 10.1016/j.quaint.2014.03.039; Spengler RN, 2014, VEG HIST ARCHAEOBOT, V23, P805, DOI 10.1007/s00334-014-0448-0; Stevens CJ, 2016, HOLOCENE, V26, P1541, DOI 10.1177/0959683616650268; Tai TH, 1990, PLANT MOL BIOL REP, P8; Takezaki N, 1996, GENETICS, V144, P389; Tanno K, 2004, THEOR APPL GENET, V110, P145, DOI 10.1007/s00122-004-1816-4; Team RDC, 2007, R VERS 2 5 1; Tewari R, PRAGDHARA; Thornton CP, 2010, SANG E CHAKHMAQ; Tian D, 2018, ENVIRON ARCHAEOL, V23, P416, DOI 10.1080/14614103.2017.1415121; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; Warnes M.G.R., 2016, PACKAGE GPLOTS VARIO; Weiss E, 2004, P NATL ACAD SCI USA, V101, P9551, DOI 10.1073/pnas.0402362101; Wickham H., 2016, GGPLOT2 CREATE ELEGA; Yang J, 2010, CEREALS IN CHINA, P69; Zhao ZJ, 2009, CHIN ARCHAEOL, V9, P1	99	36	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0196652	10.1371/journal.pone.0196652	http://dx.doi.org/10.1371/journal.pone.0196652			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020920	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400001
J	Korsten, P; Mavropoulou, E; Wienbeck, S; Ellenberger, D; Patschan, D; Zeisberg, M; Vasko, R; Tampe, B; Muller, GA				Korsten, Peter; Mavropoulou, Eirini; Wienbeck, Susanne; Ellenberger, David; Patschan, Daniel; Zeisberg, Michael; Vasko, Radovan; Tampe, Bjoern; Mueller, Gerhard A.			The "rapid atrial swirl sign" for assessing central venous catheters: Performance by medical residents after limited training	PLOS ONE			English	Article							ULTRASONOGRAPHIC BUBBLE TEST; CHEST RADIOGRAPHY; SALINE FLUSH; PLACEMENT; CONFIRMATION; ULTRASOUND; ECHOCARDIOGRAPHY; LOCALIZATION; INSERTION; LANDMARK	Rationale Central venous catheter (CVC) placement is a standard procedure in critical care. Ultrasound guidance during placement is recommended by current guidelines, but there is no consensus on the best method for evaluating the correct CVC tip position. Recently, the "rapid atrial swirl sign" (RASS) has been investigated in a limited number of studies. Objectives We performed a prospective diagnostic accuracy study of focused echocardiography for the evaluation of CVC tip position in our medical ICU and IMC units. Methods We performed a prospective diagnostic accuracy study in 100 patients admitted to the Intensive Care Unit and Intermediate Care Unit at our center. The first 10 subjects were assessed by one staff physician investigator (reference cohort), the remaining 90 patients by different residents (test cohort). All patients received a post-procedural chest radiograph (CXR) as gold standard. CVC placement was assessed with focused echocardiography performed by residents after a short training session. A rapid opacification of the right atrium (RASS) after injection of 10 mL of normal saline was regarded as "positive", flush after more than two seconds was defined as "delayed", no flush was a "negative" test result. Measurements and main results Overall sensitivity of the RASS was 100% (95% CI 73.54-100%), specificity was 94.32% (CI 87.24-98.13%). Positive and negative predictive values were 70.59% (CI 44.04-89.09%) and 100% (CI 95.65-100%), respectively. Median time for echocardiographic testing was 5 minutes (1-28) in the whole cohort, CXRs were available after 49.5 minutes (13-254). Interrater agreement of the RASS was 0.77 (Cohen's kappa), Measurement of CVC tip position was not different between two observers. Test characteristics were similar among differently experienced residents. Conclusions Presence of the RASS by focused echocardiography showed excellent sensitivity and specificity and was equally performed by residents after minimal training. In patients with a positive RASS, routine CXR can be safely omitted, reducing time, costs and radiation exposure. A negative RASS should lead to a search for misplaced catheters.	[Korsten, Peter; Patschan, Daniel; Zeisberg, Michael; Vasko, Radovan; Tampe, Bjoern; Mueller, Gerhard A.] Univ Med Ctr Goettingen, Dept Nephrol & Rheumatol, Gottingen, Germany; [Mavropoulou, Eirini] Univ Med Ctr Goettingen, Dept Gastroenterol & Gastrointestinal Oncol, Gottingen, Germany; [Wienbeck, Susanne] Univ Med Ctr Goettingen, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Ellenberger, David] Univ Med Ctr Goettingen, Dept Med Stat, Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Korsten, P (corresponding author), Univ Med Ctr Goettingen, Dept Nephrol & Rheumatol, Gottingen, Germany.	peter.korsten@med.uni-goettingen.de	Korsten, med. Peter/H-3562-2019; Tampe, Björn/ABA-6091-2021	Korsten, med. Peter/0000-0001-6065-5680; Tampe, Björn/0000-0002-4357-9863; Ellenberger, David/0000-0002-2274-5025				Baviskar AS, 2015, INDIAN J CRIT CARE M, V19, P38, DOI 10.4103/0972-5229.148642; Bedel J, 2013, INTENS CARE MED, V39, P1932, DOI 10.1007/s00134-013-3097-3; Berrington de Gonzalez A, 2004, LANCET, V363, P345, DOI 10.1016/S0140-6736(04)15433-0; Duran-Gehring PE, 2015, AM J EMERG MED, V33, P315, DOI 10.1016/j.ajem.2014.10.010; Ender J, 2009, J CARDIOTHOR VASC AN, V23, P457, DOI 10.1053/j.jvca.2008.12.003; Farkas Josh, 2015, EMCRIT; Fletcher SJ, 2000, BRIT J ANAESTH, V85, P188; Fragou M, 2011, CRIT CARE MED, V39, P1607, DOI 10.1097/CCM.0b013e318218a1ae; Gekle R, 2015, J ULTRAS MED, V34, P1295, DOI 10.7863/ultra.34.7.1295; Horowitz R, 2014, ANN EMERG MED, V63, P678, DOI 10.1016/j.annemergmed.2013.12.020; Jenssen C, 2015, EFSUMB GUIDELINES 6, V1980, DOI [10.1055/s-0035-1553450, DOI 10.1055/S-0035-1553450]; Kaji AH, 2014, ANN EMERG MED, V64, P292, DOI 10.1016/j.annemergmed.2014.03.025; Lalu MM, 2015, CRIT CARE MED, V43, P1498, DOI 10.1097/CCM.0000000000000973; Lee JH, 2009, BRIT J ANAESTH, V102, P662, DOI 10.1093/bja/aep046; Martinez-Flores Favio, 2009, Rev Med Inst Mex Seguro Soc, V47, P665; Maury E, 2001, AM J RESP CRIT CARE, V164, P403, DOI 10.1164/ajrccm.164.3.2009042; Meggiolaro M, 2015, MINERVA ANESTESIOL, V81, P989; Prekker ME, 2010, ACAD EMERG MED, V17, pE85, DOI 10.1111/j.1553-2712.2010.00785.x; Vezzani A, 2010, CRIT CARE MED, V38, P533, DOI 10.1097/CCM.0b013e3181c0328f; Weekes AJ, 2016, EMERG MED J, V33, P176, DOI 10.1136/emermed-2015-205000; Weekes AJ, 2014, ACAD EMERG MED, V21, P65, DOI 10.1111/acem.12283	21	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199345	10.1371/journal.pone.0199345	http://dx.doi.org/10.1371/journal.pone.0199345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011285	Green Published, gold, Green Submitted			2022-12-26	WOS:000438829800003
J	Cespedes, MI; McGree, J; Drovandi, CC; Mengersen, K; Doecke, JD; Fripp, J				Cespedes, Marcela, I; McGree, James; Drovandi, Christopher C.; Mengersen, Kerrie; Doecke, James D.; Fripp, Jurgen		Alzheimers Dis Neuroimaging Initia	An efficient algorithm for estimating brain covariance networks	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; GRAPH-THEORETICAL ANALYSIS; CORTICAL NETWORKS; CLUSTER DETECTION; DISEASE; MODELS; ORGANIZATION; CONNECTIVITY; CONSISTENCY; CHALLENGES	Often derived from partial correlations or many pairwise analyses, covariance networks represent the inter-relationships among regions and can reveal important topological structures in brain measures from healthy and pathological subjects. However both approaches are not consistent network estimators and are sensitive to the value of the tuning parameters. Here, we propose a consistent covariance network estimator by maximising the network likelihood (MNL) which is robust to the tuning parameter. We validate the consistency of our algorithm theoretically and via a simulation study, and contrast these results against two well-known approaches: the graphical LASSO (gLASSO) and Pearson pairwise correlations (PPC) over a range of tuning parameters. The MNL algorithm had a specificity equal to and greater than 0.94 for all sample sizes in the simulation study, and the sensitivity was shown to increase as the sample size increased. The gLASSO and PPC demonstrated a specificity-sensitivity trade-off over a range of values of tuning parameters highlighting the discrepancy in the results for misspecified values. Application of the MNL algorithm to the case study data showed a loss of connections between healthy and impaired groups, and improved ability to identify between lobe connectivity in contrast to gLASSO networks. In this work, we propose the MNL algorithm as an effective approach to find covariance brain networks, which can inform the organisational features in brain-wide analyses, particularly for large sample sizes.	[Cespedes, Marcela, I; McGree, James; Drovandi, Christopher C.; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia; [Cespedes, Marcela, I; Doecke, James D.; Fripp, Jurgen] CSIRO, Hlth & Biosecur Australian E Hlth Res Ctr, Level 5,UQ Hlth Sci Bldg, Herston, Qld 4029, Australia	Queensland University of Technology (QUT); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cespedes, MI (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld, Australia.; Cespedes, MI (corresponding author), CSIRO, Hlth & Biosecur Australian E Hlth Res Ctr, Level 5,UQ Hlth Sci Bldg, Herston, Qld 4029, Australia.	Marcela.Cespedes@csiro.edu	Drovandi, Christopher/J-1051-2012; Fripp, Jurgen/A-8763-2011; Mengersen, Kerrie/AHC-4096-2022	Fripp, Jurgen/0000-0001-9705-0079; Drovandi, Christopher/0000-0001-9222-8763; Cespedes, Marcela/0000-0002-0997-1941	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defence) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; Research Training Program (RTP) doctoral scholarship by the Australian Government; Commonwealth Scientific and Industrial Research Organisation (CSIRO); CSIRO; Queensland University of Technology (QUT); QUT [FL150100150]; Australian Research Council (ARC) Laureate [FL150100150]; Australian Research Councils Discovery Early Career Researcher Award [DE160100741]; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defence); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Research Training Program (RTP) doctoral scholarship by the Australian Government; Commonwealth Scientific and Industrial Research Organisation (CSIRO)(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Queensland University of Technology (QUT); QUT; Australian Research Council (ARC) Laureate(Australian Research Council); Australian Research Councils Discovery Early Career Researcher Award(Australian Research Council); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defence award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MIC was funded by the Research Training Program (RTP) doctoral scholarship provided by the Australian Government and a top-up provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO). JDD is the Biostatistics Team Leader of the Australian eHealth Research Centre and is funded by the CSIRO. JF is the Acting Group leader in the Biomedical Informatics team at the Australian eHealth Research Centre and is funded by the CSIRO. JM is funded by the Queensland University of Technology (QUT) and is affiliated with the Australian Research Council and Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS). KM is jointly funded by QUT and the Australian Research Council (ARC) Laureate, project ID FL150100150 Bayesian Learning for Decision Making in the Big Data Era and is the Deputy Director of ACEMS. CCD is affiliated with QUT and ACEMS and was supported by an Australian Research Councils Discovery Early Career Researcher Award scheme DE160100741. The funders provided support in the form of salaries for the authors (MIC, JM, CCD, KM, JDD and JF), but did not have any additional role in the study design, decision to publish or preparation of the manuscript. The specific role of these authors are articulated in the author contributions section.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defence award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; BristolMyers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MIC was funded by the Research Training Program (RTP) doctoral scholarship provided by the Australian Government and a top-up provided by the Commonwealth Scientific and Industrial Research Organisation (CSIRO). JDD is the Biostatistics Team Leader of the Australian e-Health Research Centre and is funded by the CSIRO. JF is the Acting Group leader in the Biomedical Informatics team at the Australian e-Health Research Centre and is funded by the CSIRO. JM is funded by the Queensland University of Technology (QUT) and is affiliated with the Australian Research Council and Centre of Excellence for Mathematical and Statistical Frontiers (ACEMS). KM is jointly funded by QUT and the Australian Research Council (ARC) Laureate, project ID FL150100150 Bayesian Learning for Decision Making in the Big Data Era and is the Deputy Director of ACEMS. CCD is affiliated with QUT and ACEMS and was supported by an Australian Research Councils Discovery Early Career Researcher Award scheme DE160100741. The funders provided support in the form of salaries for the authors (MIC, JM, CCD, KM, JDD and JF), but did not have any additional role in the study design, decision to publish or preparation of the manuscript. The specific role of these authors are articulated in the author contributions section.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Acosta O, 2009, MED IMAGE ANAL, V13, P730, DOI 10.1016/j.media.2009.07.003; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Anderson C, 2016, SPAT SPATIO-TEMPORAL, V16, P11, DOI 10.1016/j.sste.2015.11.005; Anderson C, 2014, BIOSTATISTICS, V15, P457, DOI 10.1093/biostatistics/kxu005; Banerjee O, 2008, J MACH LEARN RES, V9, P485; Banerjee S., 2014, HIERARCHICAL MODELIN; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2017, NEUROSCIENTIST, V23, P499, DOI 10.1177/1073858416667720; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Betzel RF, 2016, NEUROIMAGE, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041; Bien J, 2011, BIOMETRIKA, V98, P807, DOI 10.1093/biomet/asr054; Bowman FD, 2008, NEUROIMAGE, V39, P146, DOI 10.1016/j.neuroimage.2007.08.012; Brier MR, 2014, NEUROBIOL AGING, V35, P757, DOI 10.1016/j.neurobiolaging.2013.10.081; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Caeyenberghs K, 2016, J NEUROSCI, V36, P4056, DOI 10.1523/JNEUROSCI.1973-15.2016; Casella G, 2002, STAT INFERENCE, V2; Cespedes MI, 2017, 112807 QUT; Chen ZJ, 2011, NEUROIMAGE, V56, P235, DOI 10.1016/j.neuroimage.2011.01.010; Cho H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13642-3; Fan JQ, 2009, ANN APPL STAT, V3, P521, DOI 10.1214/08-AOAS215; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fischi-Gomez E, 2016, NEUROIMAGE-CLIN, V11, P195, DOI 10.1016/j.nicl.2016.02.001; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gao X, 2012, STAT SINICA, V22, P1123, DOI 10.5705/ss.2009.210; Getis A, 2010, ADV SPAT SCI, P147, DOI 10.1007/978-3-642-01976-0_11; Goldstone A, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00285; Gossl C, 2001, BIOMETRICS, V57, P554, DOI 10.1111/j.0006-341X.2001.00554.x; Greene H., 2003, ECONOMETRIC ANAL; Griffa A, 2013, NEUROIMAGE, V80, P515, DOI 10.1016/j.neuroimage.2013.04.056; Hacking I, 2016, LOGIC STAT INFERENCE; Hart MG, 2016, BRIT J NEUROSURG, V30, P506, DOI 10.1080/02688697.2016.1208809; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Huang SA, 2010, NEUROIMAGE, V50, P935, DOI 10.1016/j.neuroimage.2009.12.120; Jalili M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29780; KIEFER J, 1956, ANN MATH STAT, V27, P887, DOI 10.1214/aoms/1177728066; Knopman DS, 2016, NEUROLOGY, V87, P691, DOI 10.1212/WNL.0000000000002979; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Leroux BG, 2000, STAT MODELS EPIDEMIO, P179, DOI [10.1007/978-1-4612-1284-3_4, DOI 10.1007/978-1-4612-1284-3]; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Liu Han, 2010, Adv Neural Inf Process Syst, V24, P1432; Mazumder R, 2012, ELECTRON J STAT, V6, P2125, DOI 10.1214/12-EJS740; Miller KL, 2016, NAT NEUROSCI, V19, P1523, DOI 10.1038/nn.4393; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; Pourahmadi M, 2000, BIOMETRIKA, V87, P425, DOI 10.1093/biomet/87.2.425; Rabinovici GD, 2015, J ALZHEIMERS ASS, V11, P263, DOI [10.1016/j.jalz.2015.07.341, DOI 10.1016/J.JALZ.2015.07.341]; Sanabria-Diaz G, 2010, NEUROIMAGE, V50, P1497, DOI 10.1016/j.neuroimage.2010.01.028; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Smith SM, 2018, NEURON, V97, P263, DOI 10.1016/j.neuron.2017.12.018; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Varoquaux G., 2010, ADV NEURAL INFORM PR, P2334; Wackerly D., 2007, MATH STAT APPL; WALD A, 1949, ANN MATH STAT, V20, P595, DOI 10.1214/aoms/1177729952; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085460; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Yang S, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1385, DOI 10.1145/2783258.2783391; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhang TL, 2009, BIOMETRICS, V65, P353, DOI 10.1111/j.1541-0420.2008.01069.x; Zhang YC, 2012, SCHIZOPHR RES, V141, P109, DOI 10.1016/j.schres.2012.08.021; Zhou LP, 2016, IEEE T PATTERN ANAL, V38, P2269, DOI 10.1109/TPAMI.2015.2511754	65	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0198583	10.1371/journal.pone.0198583	http://dx.doi.org/10.1371/journal.pone.0198583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001336	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400005
J	Medina, V; Sardoy, PM; Soria, M; Vay, CA; Gutkind, GO; Zavala, JA				Medina, Virginia; Sardoy, Pedro M.; Soria, Marcelo; Vay, Carlos A.; Gutkind, Gabriel O.; Zavala, Jorge A.			Characterized non-transient microbiota from stinkbug (Nezara viridula) midgut deactivates soybean chemical defenses	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; VERTICAL TRANSMISSION; GUT BACTERIA; PEST STATUS; BUG; SYMBIONT; DIVERSITY; EVOLUTION; HEMIPTERA; HOST	The Southern green stinkbug (N. viridula) feeds on developing soybean seeds in spite of their strong defenses against herbivory, making this pest one of the most harmful to soybean crops. To test the hypothesis that midgut bacterial community allows stinkbugs to tolerate chemical defenses of soybean developing seeds, we identified and characterized midgut microbiota of stinkbugs collected from soybean crops, different secondary plant hosts or insects at diapause on Eucalyptus trees. Our study demonstrated that while more than 54% of N. viridula adults collected in the field had no detectable bacteria in the V1-V3 midgut ventricles, the guts of the rest of stinkbugs were colonized by non-transient microbiota (NTM) and transient microbiota not present in stinkbugs at diapause. While transient microbiota Bacillus sp., Micrococcus sp., Streptomyces sp., Staphylococcus sp. and others had low abundance, NTM microbiota was represented by Yokenella sp., Pantoea sp. and Enterococcus sp. isolates. We found some isolates that showed in vitro P-glucosidase and raffinase activities plus the ability to degrade isoflavonoids and deactivate soybean protease inhibitors. Our results suggest that the stinkbugs' NTM microbiota may impact on nutrition, detoxification and deactivation of chemical defenses, and Enterococcus sp., Yokenella sp. and Pantoea sp. strains might help stinkbugs to feed on soybean developing seeds in spite of its chemical defenses.	[Medina, Virginia; Sardoy, Pedro M.; Zavala, Jorge A.] Univ Buenos Aires, Fac Agron, INBA,CONICET, Catedra Bioquim,Inst Invest Biociencias Agr & Amb, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Fac Agron, INBA,CONICET, Catedra Microbiol,Inst Invest Biociencias Agr & A, Buenos Aires, DF, Argentina; [Vay, Carlos A.; Gutkind, Gabriel O.] Univ Buenos Aires, Fac Farm & Bioquim, Buenos Aires, DF, Argentina; [Gutkind, Gabriel O.; Zavala, Jorge A.] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn Argentina, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Zavala, JA (corresponding author), Univ Buenos Aires, Fac Agron, INBA,CONICET, Catedra Bioquim,Inst Invest Biociencias Agr & Amb, Buenos Aires, DF, Argentina.; Zavala, JA (corresponding author), Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn Argentina, Buenos Aires, DF, Argentina.	zavala@agro.uba.ar	Gutkind, Gabriel/B-6673-2012	Gutkind, Gabriel/0000-0003-1999-9785; Zavala, Jorge/0000-0001-6265-0920	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP-2012-0136]; Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT) [PICT-2015-0684]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT)	This study was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), PIP-2012-0136, and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (MINCyT), PICT-2015-0684 to JAZ. The funders had no role in study design, data collection analysis, decision to publish, or preparation of the manuscript.	Al-Sheraji SH, 2013, J FUNCT FOODS, V5, P1542, DOI 10.1016/j.jff.2013.08.009; Andongma AA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09470; Antonino P., 1996, AgriScientia, V13, P13; Aragon JA, 1998, CULTIVO SOJA ARGENTI, P247; Bansal R, 2014, ENVIRON ENTOMOL, V43, P617, DOI 10.1603/EN13341; BARAMPAMA Z, 1994, J FOOD SCI, V59, P833, DOI 10.1111/j.1365-2621.1994.tb08139.x; Bergey D.H., 2000, BERGEYS MANUAL DETER; Bizzini A, 2011, J CLIN MICROBIOL, V49, P693, DOI 10.1128/JCM.01463-10; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Bredow C, 2015, GENET MOL RES, V14, P9703, DOI 10.4238/2015.August.19.3; Ceja-Navarro JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8618; Chu CC, 2013, P NATL ACAD SCI USA, V110, P11917, DOI 10.1073/pnas.1301886110; Chung SH, 2013, P NATL ACAD SCI USA, V110, P15728, DOI 10.1073/pnas.1308867110; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Correa-Ferreira BS, 2002, AGR FOREST ENTOMOL, V4, P145, DOI 10.1046/j.1461-9563.2002.00136.x; Curzi MJ, 2012, ECOL EVOL, V2, P2005, DOI 10.1002/ece3.331; da Graca JP, 2016, PHYTOCHEMISTRY, V131, P84, DOI 10.1016/j.phytochem.2016.08.013; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2015, ANNU REV ENTOMOL, V60, P17, DOI 10.1146/annurev-ento-010814-020822; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; FEHR W. R., 1977, STAGES SOYBEAN DEV; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; Geib SM, 2009, MICROB ECOL, V58, P199, DOI 10.1007/s00248-009-9501-4; Geib SM, 2009, ENVIRON ENTOMOL, V38, P686, DOI 10.1603/022.038.0320; Giacometti R, 2016, PEST MANAG SCI, V72, P1585, DOI 10.1002/ps.4192; Hirose E, 2006, ANN ENTOMOL SOC AM, V99, P91, DOI 10.1603/0013-8746(2006)099[0091:BITGOS]2.0.CO;2; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Humphrey PT, 2014, MOL ECOL, V23, P1497, DOI 10.1111/mec.12657; Itoh H, 2017, APPL ENTOMOL ZOOL, V52, P51, DOI 10.1007/s13355-016-0453-0; Kent AD, 2010, DNA CELL BIOL, V29, P509, DOI 10.1089/dna.2009.0988; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; KIMURA M, 1980, P NATL ACAD SCI-BIOL, V77, P522, DOI 10.1073/pnas.77.1.522; KOSAKO Y, 1984, JPN J MED SCI BIOL, V37, P117, DOI 10.7883/yoken1952.37.117; KOUKER G, 1987, APPL ENVIRON MICROB, V53, P211, DOI 10.1128/AEM.53.1.211-213.1987; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lehman R, 2009, MICROB ECOL, V57, P349, DOI 10.1007/s00248-008-9415-6; Lomate PR, 2016, SCI REP-UK, V6, DOI 10.1038/srep27587; Lundgren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010831; Medrano EG, 2009, CURR MICROBIOL, V59, P405, DOI 10.1007/s00284-009-9452-5; Musolin DL, 2003, ECOL ENTOMOL, V28, P694, DOI 10.1111/j.1365-2311.2003.00559.x; Musolin DL, 2012, PHYSIOL ENTOMOL, V37, P309, DOI 10.1111/j.1365-3032.2012.00846.x; Panizzi Antonio R., 2000, Anais da Sociedade Entomologica do Brasil, V29, P1, DOI 10.1590/S0301-80592000000100001; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Piubelli GC, 2003, J CHEM ECOL, V29, P1223, DOI 10.1023/A:1023889825129; Prado SS, 2006, ANN ENTOMOL SOC AM, V99, P577, DOI 10.1603/0013-8746(2006)99[577:VTOAPC]2.0.CO;2; Prado SS, 2009, ENVIRON ENTOMOL, V38, P103, DOI 10.1603/022.038.0112; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saulich A.K., 2012, ENTOMOL REV, V92, P1, DOI [10.1134/S0013873812010010, DOI 10.1134/S0013873812010010]; Sudakaran S, 2012, MOL ECOL, V21, P6134, DOI 10.1111/mec.12027; Sugio A, 2015, J EXP BOT, V66, P467, DOI 10.1093/jxb/eru435; Tada A, 2011, APPL ENTOMOL ZOOL, V46, P483, DOI 10.1007/s13355-011-0066-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090312; Temple JH, 2009, MIDSOUTH ENTOMOL, V2, P68; TODD JW, 1989, ANNU REV ENTOMOL, V34, P273, DOI 10.1146/annurev.en.34.010189.001421; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wang H, 2011, J APPL MICROBIOL, V110, P1390, DOI 10.1111/j.1365-2672.2011.05001.x; Weyland F, 2008, ECOL AUSTRAL, P357; Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zavala JA, 2008, P NATL ACAD SCI USA, V105, P5129, DOI 10.1073/pnas.0800568105; Zavala JA, 2015, PLANT CELL ENVIRON, V38, P920, DOI 10.1111/pce.12368; Zucchi Tiago D, 2012, BMC Microbiol, V12, P101, DOI 10.1186/1471-2180-12-101	67	17	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200161	10.1371/journal.pone.0200161	http://dx.doi.org/10.1371/journal.pone.0200161			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001328	Green Submitted, gold, Green Published			2022-12-26	WOS:000438457400030
J	Watts, TW; Gandhi, J; Ibrahim, DA; Masucci, MD; Raver, CC				Watts, Tyler W.; Gandhi, Jill; Ibrahim, Deanna A.; Masucci, Michael D.; Raver, C. Cybele			The Chicago School Readiness Project: Examining the long-term impacts of an early childhood intervention	PLOS ONE			English	Article							SELF-REGULATION; EXECUTIVE FUNCTION; COGNITIVE CONTROL; EFFORTFUL CONTROL; CONDUCT PROBLEMS; INCREDIBLE YEARS; RISK BEHAVIOR; EDUCATION; CHILDREN; PROGRAM	The current paper reports long-term treatment impact estimates for a randomized evaluation of an early childhood intervention designed to promote children's developmental outcomes and improve the quality of Head Start centers serving high-violence and high-crime areas in inner-city Chicago. Initial evaluations of end-of-preschool data reported that the program led to reductions in child behavioral problems and gains in measures of executive function and academic achievement. For this report, we analyzed adolescent follow-up data taken 10 to 11 years after program completion. We found evidence that the program had positive long-term effects on students' executive function and grades, though effects were somewhat imprecise and dependent on the inclusion of baseline covariates. Results also indicated that treated children had heightened sensitivity to emotional stimuli, and we found no evidence of long-run effects on measures of behavioral problems. These findings raise the possibility that developing programs that improve on the Head Start model could carry long-run benefits for affected children.	[Watts, Tyler W.; Gandhi, Jill; Ibrahim, Deanna A.; Raver, C. Cybele] NYU, Steinhardt Sch Culture Educ & Human Dev, 550 1St Ave, New York, NY 10003 USA; [Masucci, Michael D.] Columbia Univ, Med Ctr, Div Translat Imaging, New York State Psychiat Inst, New York, NY USA	New York University; Columbia University; New York State Psychiatry Institute	Watts, TW (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, 550 1St Ave, New York, NY 10003 USA.	tyler.watts@nyu.edu		Watts, Tyler/0000-0002-2741-0873; Masucci, Michael/0000-0002-9151-7253; Gandhi, Jill/0000-0003-1009-4912	Institute of Educational Sciences [R305A160176]; National Institute of Health [R01HD046160]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046160] Funding Source: NIH RePORTER	Institute of Educational Sciences; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was funded by the Institute of Educational Sciences [R305A160176; url: https://ies.ed.gov/] and the National Institute of Health [R01HD046160; url: https://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2015, INQUISIT 4; Arnett JJ, 1999, AM PSYCHOL, V54, P317, DOI 10.1037/0003-066X.54.5.317; Arnold DH, 1998, DEV PSYCHOL, V34, P276, DOI 10.1037/0012-1649.34.2.276; Bailey D, 2017, J RES EDUC EFF, V10, P7, DOI 10.1080/19345747.2016.1232459; Bailey DH, 2018, AM PSYCHOL, V73, P81, DOI 10.1037/amp0000146; Bailey MJ, 2011, WHITHER OPPORTUNITY?: RISING INEQUALITY, SCHOOLS, AND CHILDREN'S LIFE CHANCES, P117; Barnett WS, 2011, SCIENCE, V333, P975, DOI 10.1126/science.1204534; Barnett W. S., 2003, NIEER PRESCHOOL POLI; Barnett W. S., 2012, STATE PRESCHOOL 2012; Berenson AB, 2001, ARCH PEDIAT ADOL MED, V155, P1238, DOI 10.1001/archpedi.155.11.1238; Bierman KL, 2008, DEV PSYCHOPATHOL, V20, P821, DOI 10.1017/S0954579408000394; Blair C, 2002, AM PSYCHOL, V57, P111, DOI 10.1037//0003-066X.57.2.111; Blair C., 2011, HDB SELF REGULATION, P300; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Blair C, 2015, ANNU REV PSYCHOL, V66, P711, DOI 10.1146/annurev-psych-010814-015221; Brocki KC, 2014, INFANT CHILD DEV, V23, P588, DOI 10.1002/icd.1871; Browning CR, 2008, J HEALTH SOC BEHAV, V49, P269, DOI 10.1177/002214650804900303; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Camilli G, 2010, TEACH COLL REC, V112, P579; CAMPBELL FA, 2002, APPL DEVELOPMENTAL S, V0006; Capistrano CG, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01242; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Chen E, 1999, Ann N Y Acad Sci, V896, P417, DOI 10.1111/j.1749-6632.1999.tb08158.x; Curbow S, 2000, EARLY CHILD RES Q, V15, P515; Davidson MC, 2006, NEUROPSYCHOLOGIA, V44, P2037, DOI 10.1016/j.neuropsychologia.2006.02.006; de Boer MR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0162-z; Degol JL, 2015, EARLY CHILD RES Q, V31, P89, DOI 10.1016/j.ecresq.2015.01.002; Diamond A, 1996, DEV PSYCHOBIOL, V29, P315, DOI 10.1002/(SICI)1098-2302(199605)29:4<315::AID-DEV2>3.0.CO;2-T; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Diamond A, 2011, SCIENCE, V333, P959, DOI 10.1126/science.1204529; Duncan GJ, 1998, AM SOCIOL REV, V63, P406, DOI 10.2307/2657556; Duncan GJ, 2007, FUTURE CHILD, V17, P143, DOI 10.1353/foc.2007.0015; Duncan GJ, 2010, CHILD DEV, V81, P306, DOI 10.1111/j.1467-8624.2009.01396.x; Dunn L., 1986, PEABODY PICTURE VOCA; Dunn L.M., 1981, PEABODY PICTURE VOCA; Elango S., 2016, EC MEANS TESTED TRAN, V2, P235; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Flook L, 2013, MIND BRAIN EDUC, V7, P182, DOI 10.1111/mbe.12026; Foorman BR, 1998, J EDUC PSYCHOL, V90, P37, DOI 10.1037//0022-0663.90.2.235; Frede, 2010, AM EDUC, V34, P21, DOI DOI 10.2307/1602366; Frick PJ, 2004, J CLIN CHILD ADOLESC, V33, P54, DOI 10.1207/S15374424JCCP3301_6; Gilliam WS., 2005, PREKINDERGARTENERS L; Gormley WT, 2018, J POLICY ANAL MANAG, V37, P63, DOI 10.1002/pam.22023; Hare TA, 2008, BIOL PSYCHIAT, V63, P927, DOI 10.1016/j.biopsych.2008.03.015; Harms-Ringdahl L., 2003, P EUR SAF REL C ESRE; Heckman J, 2010, QUANT ECON, V1, P1, DOI 10.3982/QE8; Heckman JJ, 2011, DAEDALUS-US, V140, P70, DOI 10.1162/DAED_a_00078; Heckman JJ, 2010, REV ECON STAT, V92, P244, DOI 10.1162/rest.2010.12366; Heckman JJ, 2010, J PUBLIC ECON, V94, P114, DOI 10.1016/j.jpubeco.2009.11.001; Jones Stephanie, 2000, HDB INFANT MENTAL HL, P113; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kirkham NZ, 2003, DEVELOPMENTAL SCI, V6, P449, DOI 10.1111/1467-7687.00300; Krueger AB, 1999, Q J ECON, V114, P497, DOI 10.1162/003355399556052; La Paro KM, 2004, ELEM SCHOOL J, V104, P409, DOI 10.1086/499760; McCoy DC, 2018, DEV PSYCHOL, V54, P772, DOI 10.1037/dev0000457; McCoy DC, 2017, EDUC RESEARCHER, V46, P474, DOI 10.3102/0013189X17737739; McCoy DC, 2016, DEVELOPMENTAL SCI, V19, P164, DOI 10.1111/desc.12287; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Moylan CA, 2010, J FAM VIOLENCE, V25, P53, DOI 10.1007/s10896-009-9269-9; Murray KT, 2002, J ABNORM CHILD PSYCH, V30, P503, DOI 10.1023/A:1019821031523; Nagaoka J., 2013, VOICEURBAN ED, V38, P45; Oberle E, 2012, J EARLY ADOLESCENCE, V32, P565, DOI 10.1177/0272431611403741; Pas ET, 2012, J SCHOOL PSYCHOL, V50, P129, DOI 10.1016/j.jsp.2011.07.003; Puma M., 2012, 201245 OPRE ADM CHIL; Qi CH, 2003, TOP EARLY CHILD SPEC, V23, P188; Raver C. C., 2002, SOCIAL POLICY REPORT, V16, P3, DOI [DOI 10.1002/j.2379-3988.2002.tb00041.x, 10.1002/j.2379-3988.2002.tb00041.x]; Raver CC, 2008, EARLY CHILD RES Q, V23, P10, DOI 10.1016/j.ecresq.2007.09.001; Raver CC, 2011, CHILD DEV, V82, P362, DOI 10.1111/j.1467-8624.2010.01561.x; Raver CC, 2009, J CONSULT CLIN PSYCH, V77, P302, DOI 10.1037/a0015302; Raver CC, 2004, CHILD DEV, V75, P346, DOI 10.1111/j.1467-8624.2004.00676.x; Reynolds AJ, 2002, EDUC EVAL POLICY AN, V24, P267, DOI 10.3102/01623737024004267; Riesch SK, 2006, PUBLIC HEALTH NURS, V23, P366, DOI 10.1111/j.1525-1446.2006.00574.x; Ritchie S, 2003, J APPL DEV PSYCHOL, V24, P497, DOI 10.1016/S0193-3973(03)00028-5; Romer D, 2010, DEV PSYCHOBIOL, V52, P263, DOI 10.1002/dev.20442; Schweinhart L., 1993, MONOGRAPHS HIGH SCOP, V10; Schweinhart L. J., 2005, HIGHSCOPE PERRY PRES; Semega J.L., 2017, INCOME POVERTY US 20; Smith-Donald R, 2007, EARLY CHILD RES Q, V22, P173, DOI 10.1016/j.ecresq.2007.01.002; Somerville LH, 2011, J COGNITIVE NEUROSCI, V23, P2123, DOI 10.1162/jocn.2010.21572; StataCorp, 2017, STAT TAT SOFTW REL 1; Stetser MC, 2014, 2014391 NCES; Temple JA, 2007, ECON EDUC REV, V26, P126, DOI 10.1016/j.econedurev.2005.11.004; Tottenham N, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00039; Ursache A, 2012, CHILD DEV PERSPECT, V6, P122, DOI 10.1111/j.1750-8606.2011.00209.x; Watts TW, 2014, EDUC RESEARCHER, V43, P352, DOI 10.3102/0013189X14553660; Webster-Stratton C, 2001, Prev Sci, V2, P165, DOI 10.1023/A:1011510923900; Webster-Stratton C, 2004, J CLIN CHILD ADOLESC, V33, P105, DOI 10.1207/S15374424JCCP3301_11; Webster-Stratton C, 2008, J CHILD PSYCHOL PSYC, V49, P471, DOI 10.1111/j.1469-7610.2007.01861.x; Webster-Stratton C, 2010, J CHILD SERV, V5, P25, DOI 10.5042/jcs.2010.0115; WHITEHURST GJ, 1994, J EDUC PSYCHOL, V86, P542, DOI 10.1037/0022-0663.86.4.542; Whitehurst GJ, 2013, CAN WE BE HARDHEADED; Zelazo PD, 2012, CHILD DEV PERSPECT, V6, P354, DOI 10.1111/j.1750-8606.2012.00246.x; Zhai FH, 2012, CHILD YOUTH SERV REV, V34, P946, DOI 10.1016/j.childyouth.2012.01.026; Zill N., 2003, LETT NAMING TASK; Zill N., 2003, EARLY MATH SKILLS TE; Zill N, 1990, BEHAV PROBLEMS INDEX; Ziol-Guest KM, 2009, AM J PUBLIC HEALTH, V99, P527, DOI 10.2105/AJPH.2007.130575	98	38	38	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200144	10.1371/journal.pone.0200144	http://dx.doi.org/10.1371/journal.pone.0200144			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001339	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400028
J	Puig-Pons, V; Estruch, VD; Espinosa, V; de la Gandara, F; Melich, B; Cort, JL				Puig-Pons, Vicente; Domingo Estruch, Vicente; Espinosa, Victor; de la Gandara, Fernando; Melich, Begonya; Luis Cort, Jose			Relationship between weight and linear dimensions of Bluefin tuna (Thunnus thynnus) following fattening on western Mediterranean farms	PLOS ONE			English	Article							LINNAEUS; LENGTH; L.	This study presents various models based on formulae relating weight and dimensions (length, height and width) of Bluefin tuna, Thunnus thynnus (L.), fattened in captivity. The main aim of establishing these expressions is to design tools for indirectly predicting the weight of a Bluefin tuna from measurements of one or more dimensions obtained using non-invasive methods such as stereoscopic cameras. Measurements of maximum length, height and width following slaughter were taken of fish fattened in captivity (n = 2078). Different relationships drawn from the dimensions of the tuna against their weight are fitted with part of the data collection and later checked against a reserved sample set. The resulting formulae are compared with the formulae most commonly used in the case of wild tuna. The results of this study confirm that, for tuna fattened in cages, the availability of more than one dimension to estimate weight improves the predictive power of the model and reduces error in the estimate.	[Puig-Pons, Vicente; Domingo Estruch, Vicente; Espinosa, Victor] Univ Politecn Valencia, Inst Invest Gestio Integrada Zones Costaneres, Gandia, Valencia, Spain; [de la Gandara, Fernando] Ctr Oceanog Murcia, Inst Espanol Oceanog, Planta Cult Marinos, Puerto De Mazarron, Murcia, Spain; [Melich, Begonya] Grp Balfego, Lametlla De Mar, Tarragona, Spain; [Luis Cort, Jose] Ctr Oceanog Santander, Inst Espanol Oceanog, Fisheries Area, Santander, Cantabria, Spain	Universitat Politecnica de Valencia; Spanish Institute of Oceanography; Spanish Institute of Oceanography	Puig-Pons, V (corresponding author), Univ Politecn Valencia, Inst Invest Gestio Integrada Zones Costaneres, Gandia, Valencia, Spain.	vipuipon@upvnet.upv.es	Estruch, Vicente D./B-7825-2014; Puig-Pons, Vicente/GPX-0467-2022; Espinosa, Victor/G-4665-2011; Espinosa, Víctor/ABI-1185-2020; de la GÃndara, Fernando/ABC-4724-2020; de la Gandara, Fernando/H-5377-2017	Estruch, Vicente D./0000-0002-0365-6481; Puig-Pons, Vicente/0000-0002-8154-8259; Espinosa, Victor/0000-0001-8882-866X; Espinosa, Víctor/0000-0001-8882-866X; de la Gandara, Fernando/0000-0001-6045-7510	ACUSTUNA project [CTM2015-70446-R]	ACUSTUNA project	This work was supported by funding from ACUSTUNA project ref. CTM2015-70446-R (MINECO/ERDF, EU). The authors are grateful for the support provided by Grup Balfego. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by funding from ACUSTUNA project ref. CTM2015-70446-R (MINECO/ERDF, EU). The authors are grateful for the support provided by Grup Balfego.	Aguado-Gimenez F, 2005, AQUACULTURE, V249, P303, DOI 10.1016/j.aquaculture.2005.04.064; Aguado-Gimenez F, 2005, AQUAC RES, V36, P610, DOI 10.1111/j.1365-2109.2005.01210.x; Cort JL, 2015, REV FISH SCI AQUAC, V23, P23, DOI 10.1080/23308249.2015.1008625; Cort JL, 2013, REV FISH SCI, V21, P181, DOI 10.1080/10641262.2013.793284; Costa C, 2009, AQUACULTURE, V291, P161, DOI 10.1016/j.aquaculture.2009.02.013; Daniel W. W, 2014, BIOSTATISTICS FDN AN; Deguara S., SCRS2016189; Dela Gandara F., 2016, ADV TUNA AQUACULTURE; Farwell C.J., 2003, Cahiers Options Mediterraneennes, V60, P65; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Harvey E, 2003, FISH RES, V63, P315, DOI 10.1016/S0165-7836(03)00080-8; ICCAT, 2010, ICCAT MAN DESCR SPEC, P93; ICCAT, 2014, REC ICCAT AM REC 13; Katavic I., 2016, SCRS2015200, V72, P1848; Munoz-Benavent P, 2018, ICES J MAR SCI, V75, P390, DOI 10.1093/icesjms/fsx151; Ottolenghi F., 2008, FAO Fisheries Technical Paper, P169; Phillips K., 2009, 200844 BUR RUR SCI F; Puig V., 2012, COLLECTION VOLUME SC, V68, P284; Rodriguez-Marin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141478; StatPoint Technologies Inc, 2013, STATGRAPHICSCENTURIO; Torisawa S., 2001, AQUAT LIVING RESOUR, V24, P107; Vita R, 2004, AQUAC RES, V35, P1384, DOI 10.1111/j.1365-2109.2004.01155.x	22	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200406	10.1371/journal.pone.0200406	http://dx.doi.org/10.1371/journal.pone.0200406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990350	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300045
J	Troiani, F; Nikolic, K; Constandinou, TG				Troiani, Francesca; Nikolic, Konstantin; Constandinou, Timothy G.			Simulating optical coherence tomography for observing nerve activity: A finite difference time domain bi-dimensional model	PLOS ONE			English	Article							FULL-WAVE MODEL; LIGHT-SCATTERING; IMAGE-FORMATION; TISSUES	We present a finite difference time domain (FDTD) model for computation of A line scans in time domain optical coherence tomography (OCT). The OCT output signal is created using two different simulations for the reference and sample arms, with a successive computation of the interference signal with external software. In this paper we present the model applied to two different samples: a glass rod filled with water-sucrose solution at different concentrations and a peripheral nerve. This work aims to understand to what extent time domain OCT can be used for non-invasive, direct optical monitoring of peripheral nerve activity.	[Troiani, Francesca; Nikolic, Konstantin; Constandinou, Timothy G.] Imperial Coll London, Ctr Bioinspired Technol, London, England	Imperial College London	Troiani, F (corresponding author), Imperial Coll London, Ctr Bioinspired Technol, London, England.	f.troiani14@imperial.ac.uk		Constandinou, Timothy/0000-0001-9778-1162; Nikolic, Konstantin/0000-0002-6551-2977	Engineering and Physical Sciences Research Council [1507059]; BBSRC [BB/L018268/1] Funding Source: UKRI; EPSRC [EP/N002474/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work has been funded by the Engineering and Physical Sciences Research Council (award reference 1507059). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AD, 2006, OPT LETT, V31, P3459, DOI 10.1364/OL.31.003459; Akkin T, 2004, OPT EXPRESS, V12, P2377, DOI 10.1364/OPEX.12.002377; Akkin Taner, 2010, Front Neuroenergetics, V2, DOI 10.3389/fnene.2010.00022; Akkin T, 2009, J MEMBRANE BIOL, V231, P35, DOI 10.1007/s00232-009-9202-4; Barkmeier JM, 2000, J ANAT, V196, P85, DOI 10.1046/j.1469-7580.2000.19610085.x; Boppart SA, 1996, J NEUROSCI METH, V70, P65, DOI 10.1016/S0165-0270(96)00104-5; Boppart SA, 2003, PSYCHOPHYSIOLOGY, V40, P529, DOI 10.1111/1469-8986.00055; Chavannes N, 2003, IEEE ANTENN PROPAG M, V45, P52, DOI 10.1109/MAP.2003.1282180; Chen Y, 2009, J NEUROSCI METH, V178, P162, DOI 10.1016/j.jneumeth.2008.11.026; COHEN LB, 1968, NATURE, V218, P438, DOI 10.1038/218438a0; COHEN LB, 1972, J PHYSIOL-LONDON, V224, P701, DOI 10.1113/jphysiol.1972.sp009919; Converse M, 2004, IEEE T MICROW THEORY, V52, P1876, DOI 10.1109/TMTT.2004.832012; Davidson D. B., 2010, COMPUTATIONAL ELECTR; GILBERT DS, 1975, J PHYSIOL-LONDON, V253, P303, DOI 10.1113/jphysiol.1975.sp011191; Graf BW, 2009, OPT EXPRESS, V17, P13447, DOI 10.1364/OE.17.013447; HALE GM, 1973, APPL OPTICS, V12, P555, DOI 10.1364/AO.12.000555; HILL DK, 1949, J PHYSIOL-LONDON, V108, P278, DOI 10.1113/jphysiol.1949.sp004331; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Hubing T, 2008, SURVEY CURRENT COMPU; Kirillin M, 2010, OPT EXPRESS, V18, P21714, DOI 10.1364/OE.18.021714; Magnain C, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.1.015004; Morell P., 1999, BASIC NEUROCHEMISTRY, V6th ed.; Munro PRT, 2016, OPT EXPRESS, V24, P27016, DOI 10.1364/OE.24.027016; Munro PRT, 2015, OPT EXPRESS, V23, P2541, DOI 10.1364/OE.23.002541; Periyasamy V, 2016, APPL OPTICS, V55, P2921, DOI 10.1364/AO.55.002921; Schneider John B., 2010, UNDERSTANDING FINITE, V28; Taflove A., 2005, COMPUTATIONAL ELECTR, V3rd; Tanifuji T, 2002, IEEE T MED IMAGING, V21, P181, DOI 10.1109/42.993136; Tuchin V. V., 2015, TISSUE OPTICS LIGHT; WILSON BC, 1990, IEEE J QUANTUM ELECT, V26, P2186, DOI 10.1109/3.64355; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Yeh YJ, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035001	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200392	10.1371/journal.pone.0200392	http://dx.doi.org/10.1371/journal.pone.0200392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990346	Green Submitted, gold, Green Published			2022-12-26	WOS:000438170300044
J	Maiuthed, A; Bhummaphan, N; Luanpitpong, S; Mutirangura, A; Aporntewan, C; Meeprasert, A; Rungrotmongkol, T; Rojanasakul, Y; Chanvorachote, P				Maiuthed, Arnatchai; Bhummaphan, Narumol; Luanpitpong, Sudjit; Mutirangura, Apiwat; Aporntewan, Chatchawit; Meeprasert, Arthitaya; Rungrotmongkol, Thanyada; Rojanasakul, Yon; Chanvorachote, Pithi			Nitric oxide promotes cancer cell dedifferentiation by disrupting an Oct4:caveolin-1 complex: A new regulatory mechanism for cancer stem cell formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cancer stem cells; caveolin; cell signaling; lung cancer; proteasome; GSK3; OCT4; nitric oxide; caveolin-1; protein degradation; protein-protein interaction; differentiation; regulation	CAVEOLIN-1 EXPRESSION; MOLECULAR-DYNAMICS; EXTRINSIC CONTROL; OCT4; PROTEIN; GENE; SOX2; RESISTANCE; PATHWAY; WWP2	Cancer stem cells (CSCs) are unique populations of cells that can self-renew and generate different cancer cell lineages. Although CSCs are believed to be a promising target for novel therapies, the specific mechanisms by which these putative therapeutics could intervene are less clear. Nitric oxide (NO) is a biological mediator frequently up-regulated in tumors and has been linked to cancer aggressiveness. Here, we search for targets of NO that could explain its activity. We find that it directly affects the stability and function of octamer-binding transcription factor 4 (Oct4), known to drive the stemness of lung cancer cells. We demonstrated that NO promotes the CSC-regulatory activity of Oct4 through a mechanism that involves complex formation between Oct4 and the scaffolding protein caveolin-1 (Cav-1). In the absence of NO, Oct4 forms a molecular complex with Cav-1, which promotes the ubiquitin-mediated proteasomal degradation of Oct4. NO promotes Akt-dependent phosphorylation of Cav-1 at tyrosine 14, disrupting the Cav-1:Oct4 complex. Site-directed mutagenesis and computational modeling studies revealed that the hydroxyl moiety at tyrosine 14 of Cav-1 is crucial for its interaction with Oct4. Both removal of the hydroxyl via mutation to phenylalanine and phosphorylation lead to an increase in binding free energy (G(bind)) between Oct4 and Cav-1, destabilizing the complex. Together, these results unveiled a novel mechanism of CSC regulation through NO-mediated stabilization of Oct4, a key stem cell transcription factor, and point to new opportunities to design CSC-related therapeutics.	[Maiuthed, Arnatchai; Chanvorachote, Pithi] Chulalongkorn Univ, Dept Pharmacol & Physiol, Bangkok 10330, Thailand; [Maiuthed, Arnatchai; Bhummaphan, Narumol; Chanvorachote, Pithi] Chulalongkorn Univ, Fac Pharmaceut Sci, Cell Based Drug & Hlth Prod Dev Res Unit, Bangkok 10330, Thailand; [Aporntewan, Chatchawit] Chulalongkorn Univ, Dept Math & Comp Sci, Bangkok 10330, Thailand; [Rungrotmongkol, Thanyada] Chulalongkorn Univ, PhD Program Bioinformat & Computat Biol, Bangkok 10330, Thailand; [Meeprasert, Arthitaya; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Struct & Computat Biol Res Grp, Bangkok 10330, Thailand; [Meeprasert, Arthitaya; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok 10330, Thailand; [Mutirangura, Apiwat] Chulalongkorn Univ, Fac Med, Dept Anat, Ctr Excellence Mol Genet Canc & Human Dis, Bangkok 10330, Thailand; [Bhummaphan, Narumol] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok 10330, Thailand; [Luanpitpong, Sudjit] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Ctr Excellence Stem Cell Res, Bangkok 10700, Thailand; [Rojanasakul, Yon] West Virginia Univ, WVU Canc Inst, Morgantown, WV 26506 USA	Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Mahidol University; West Virginia University	Chanvorachote, P (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacol & Physiol, Bangkok 10330, Thailand.	pithi.ch@gmail.com	Luanpitpong, Sudjit/ABF-1962-2021	Maiuthed, Arnatchai/0000-0001-6528-7346; chanvorachote, pithi/0000-0002-3103-3249; Luanpitpong, Sudjit/0000-0002-1639-4935				Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Aporntewan C, 2011, ASIAN BIOMED, V5, P257, DOI 10.5372/1905-7415.0502.034; Belanger MM, 2004, CHEST, V125, p106S, DOI 10.1378/chest.125.5_suppl.106S; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Byrne DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044879; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Cassinelli G, 2013, CURR MED CHEM, V20, P1923, DOI 10.2174/09298673113209990106; Chang JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005541; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chanvorachote P, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-52; Chanvorachote P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/941359; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen SF, 2010, J CELL BIOCHEM, V109, P356, DOI 10.1002/jcb.22407; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cohen AW, 2005, DIABETES, V54, P679, DOI 10.2337/diabetes.54.3.679; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Diaz-Valdivia N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1477-5; Esch D, 2013, NAT CELL BIOL, V15, P295, DOI 10.1038/ncb2680; Felley-Bosco E, 2000, P NATL ACAD SCI USA, V97, P14334, DOI 10.1073/pnas.250406797; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; GABBERT H, 1985, CLIN EXP METASTAS, V3, P257, DOI 10.1007/BF01585081; Galbiati F, 2000, J BIOL CHEM, V275, P23368, DOI 10.1074/jbc.M002020200; GLENNEY JR, 1992, FEBS LETT, V314, P45, DOI 10.1016/0014-5793(92)81458-X; Golden BDO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076345; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hatefi N, 2012, IRAN J BASIC MED SCI, V15, P1154; Hayashi H, 2015, ONCOGENE, V34, P199, DOI 10.1038/onc.2013.547; Hirst DG, 2011, METHODS MOL BIOL, V704, P1, DOI 10.1007/978-1-61737-964-2_1; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Ju H, 1997, J BIOL CHEM, V272, P18522, DOI 10.1074/jbc.272.30.18522; Kai WC, 2001, AM J PATHOL, V159, P1635, DOI 10.1016/S0002-9440(10)63010-6; Kaiyawet N, 2013, J CHEM INF MODEL, V53, P1315, DOI 10.1021/ci400131y; Karoubi Golnaz, 2009, Interact Cardiovasc Thorac Surg, V8, P393, DOI 10.1510/icvts.2008.193995; Kato T, 2004, CANCER LETT, V214, P121, DOI 10.1016/j.canlet.2004.04.017; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kempfle JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23293; Kim BW, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-2015-1; Kobayashi I, 2016, BIOCHEM BIOPH RES CO, V473, P125, DOI 10.1016/j.bbrc.2016.03.064; Kogo H, 2004, J BIOL CHEM, V279, P25574, DOI 10.1074/jbc.M310807200; Kongsune P, 2012, MONATSH CHEM, V143, P853, DOI 10.1007/s00706-011-0690-4; Kosaka T, 2016, HUM PATHOL, V51, P1, DOI 10.1016/j.humpath.2015.12.008; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Liao B, 2010, CELL RES, V20, P332, DOI 10.1038/cr.2009.136; Liu AF, 2013, CHIN J CANCER, V32, P483, DOI 10.5732/cjc.012.10282; Liu CG, 2011, ANN SURG, V253, P1165, DOI 10.1097/SLA.0b013e318214c54e; Liu PF, 2018, CLIN RESPIR J, V12, P23, DOI 10.1111/crj.12471; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Masri F, 2010, ANN THORAC MED, V5, P123, DOI 10.4103/1817-1737.65036; Matsumoto A, 2003, SCIENCE, V301, P657, DOI 10.1126/science.1079319; Matsunaga T, 2014, FREE RADICAL RES, V48, P1371, DOI 10.3109/10715762.2014.957694; Meeprasert A, 2014, J CHEM INF MODEL, V54, P1208, DOI 10.1021/ci400605a; Meeprasert A, 2012, J MOL GRAPH MODEL, V38, P148, DOI 10.1016/j.jmgm.2012.06.007; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Powan P, 2014, MOL CELL BIOCHEM, V393, P237, DOI 10.1007/s11010-014-2066-7; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rao CV, 2004, MUTAT RES-FUND MOL M, V555, P107, DOI 10.1016/j.mrfmmm.2004.05.022; Ridnour LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044081; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Saisongkorh V, 2016, CELL ONCOL, V39, P449, DOI 10.1007/s13402-016-0287-3; Salcido CD, 2010, BRIT J CANCER, V102, P1636, DOI 10.1038/sj.bjc.6605668; Shackleton M, 2010, SEMIN CANCER BIOL, V20, P85, DOI 10.1016/j.semcancer.2010.04.002; Shi GL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt39; Shyamsunder P, 2013, GENE, V527, P521, DOI 10.1016/j.gene.2013.06.051; Sun MZ, 2012, BIOMED PHARMACOTHER, V66, P242, DOI 10.1016/j.biopha.2011.11.003; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAKEDA J, 1992, NUCLEIC ACIDS RES, V20, P4613, DOI 10.1093/nar/20.17.4613; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tantong S, 2016, PEPTIDES, V84, P7, DOI 10.1016/j.peptides.2016.07.005; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Tompkins DH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008248; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Villodre ES, 2016, CANCER TREAT REV, V51, P1, DOI 10.1016/j.ctrv.2016.10.003; Wang H, 2011, AM J PHYSIOL-ENDOC M, V300, pE134, DOI 10.1152/ajpendo.00498.2010; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yokomori H, 2003, J GASTROENTEROL, V38, P854, DOI 10.1007/s00535-003-1161-4; Yongsanguanchai N, 2015, AM J PHYSIOL-CELL PH, V308, pC89, DOI 10.1152/ajpcell.00187.2014; YORK DM, 1993, J CHEM PHYS, V99, P8345, DOI 10.1063/1.465608; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zeineddine D, 2014, AM J STEM CELLS, V3, P74; Zhao QW, 2015, ONCOL REP, V33, P1621, DOI 10.3892/or.2015.3752; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	92	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13534	13552		10.1074/jbc.RA117.000287	http://dx.doi.org/10.1074/jbc.RA117.000287			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29986880	hybrid, Green Published			2022-12-26	WOS:000443375500015
J	Praktiknjo, SD; Saad, F; Maier, D; Ip, P; Hipfner, DR				Praktiknjo, Samantha D.; Saad, Farah; Maier, Dominic; Ip, Pamela; Hipfner, David R.			Activation of Smoothened in the Hedgehog pathway unexpectedly increases G(s)-dependent cAMP levels in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hedgehog signaling pathway; heterotrimeric G protein; cyclic AMP (cAMP); G protein-coupled receptor (GPCR); Drosophila; G-protein-coupled receptor kinase; Smoothened	PROTEIN-KINASE-A; HETEROTRIMERIC G-PROTEINS; COUPLED RECEPTOR GPR161; SIGNAL-TRANSDUCTION; SONIC HEDGEHOG; CUBITUS INTERRUPTUS; LIMB DEVELOPMENT; PHOSPHORYLATION; MELANOGASTER; TRAFFICKING	Hedgehog (Hh) signaling plays a key role in the development and maintenance of animal tissues. This signaling is mediated by the atypical G protein-coupled receptor (GPCR) Smoothened (Smo). Smo activation leads to signaling through several well-characterized effectors to activate Hh target gene expression. Recent studies have implicated activation of the heterotrimeric G protein subunit G(i) and the subsequent decrease in cellular cAMP levels in promoting the Hh response in flies and mammals. Although Hh stimulation decreases cAMP levels in some insect cell lines, here using a bioluminescence resonance energy transfer (BRET)-based assay we found that this stimulation had no detectable effect in Drosophila S2-R+ cells. However, we observed an unexpected and significant G(s)-dependent increase in cAMP levels in response to strong Smo activation in Smo-transfected cells. This effect was mediated by Smo's broadly conserved core, and was specifically activated in response to phosphorylation of the Smo C-terminus by GPCR kinase 2 (Gprk2). Genetic analysis of heterotrimeric G protein function in the developing Drosophila wing revealed a positive role for cAMP in the endogenous Hh response. Specifically, we found that mutation or depletion of G(s) diminished low-threshold Hh responses in Drosophila, whereas depletion of G(i) potentiated them (in contrast to previous findings). Our analysis suggested that regulated cAMP production is important for controlling the sensitivity of cellular responses to Hh in Drosophila.	[Praktiknjo, Samantha D.; Saad, Farah; Maier, Dominic; Ip, Pamela; Hipfner, David R.] Inst Rech Clin Montreal, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada; [Praktiknjo, Samantha D.; Maier, Dominic; Ip, Pamela; Hipfner, David R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Saad, Farah; Hipfner, David R.] McGill Univ, Dept Biol, Montreal, PQ H3A 0C7, Canada; [Hipfner, David R.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Praktiknjo, Samantha D.] Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med Helmholtz Assoc, Syst Biol Gene Regulatory Elements, D-13125 Berlin, Germany	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; McGill University; Universite de Montreal; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hipfner, DR (corresponding author), Inst Rech Clin Montreal, 110 Pine Ave West, Montreal, PQ H2W 1R7, Canada.	david.hipfner@ircm.qc.ca	Praktiknjo, Samantha/AAI-9126-2020	Praktiknjo, Samantha/0000-0002-0186-5271; Hipfner, David/0000-0002-2265-5871	Canadian Institutes of Health Research (CIHR) [106426]; CIHR New Investigator Award; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Canadian Institutes of Health Research (CIHR) Grant 106426 (to D.R.H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a CIHR New Investigator Award.	Apionishev S, 2005, NAT CELL BIOL, V7, P86, DOI 10.1038/ncb1210; Ayers KL, 2010, TRENDS CELL BIOL, V20, P287, DOI 10.1016/j.tcb.2010.02.002; Baker JD, 2002, J EXP BIOL, V205, P2555; Belgacem YH, 2011, P NATL ACAD SCI USA, V108, P4482, DOI 10.1073/pnas.1018217108; Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Carbe CJ, 2014, AM J PHYSIOL-HEART C, V307, pH66, DOI 10.1152/ajpheart.00166.2014; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen YB, 2013, CELL RES, V23, P186, DOI 10.1038/cr.2013.10; Chen YB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001083; Chen YB, 2010, GENE DEV, V24, P2054, DOI 10.1101/gad.1948710; Cheng SF, 2012, DEVELOPMENT, V139, P85, DOI 10.1242/dev.068817; Cheng SF, 2010, DEV BIOL, V337, P99, DOI 10.1016/j.ydbio.2009.10.014; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; DANG DT, 1992, DEV GENET, V13, P367, DOI 10.1002/dvg.1020130507; DasGupta R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r203; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; FRASER SE, 1985, NATURE, V317, P533, DOI 10.1038/317533a0; He XL, 2014, NAT MED, V20, P1035, DOI 10.1038/nm.3666; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Li S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005414; Li S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001239; Li SX, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002481; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; Lum L, 2003, MOL CELL, V12, P1261, DOI 10.1016/S1097-2765(03)00426-X; Ma GQ, 2016, DEV CELL, V39, P438, DOI 10.1016/j.devcel.2016.09.014; Maier D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004399; Maier D, 2012, FLY, V6, P135, DOI 10.4161/fly.20245; Malpel S, 2007, DEV BIOL, V303, P121, DOI 10.1016/j.ydbio.2006.10.042; Marada S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005473; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Mukhopadhyay S, 2014, SEMIN CELL DEV BIOL, V33, P63, DOI 10.1016/j.semcdb.2014.05.002; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Niewiadomski P, 2013, CELL SIGNAL, V25, P2222, DOI 10.1016/j.cellsig.2013.07.012; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Ohlmeyer JT, 1997, GENE DEV, V11, P2250, DOI 10.1101/gad.11.17.2250; Pak E, 2016, DEV CELL, V38, P333, DOI 10.1016/j.devcel.2016.07.026; Pal K, 2016, J CELL BIOL, V212, P861, DOI 10.1083/jcb.201506132; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; PREAT T, 1993, GENETICS, V135, P1047; Pusapati GV, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao5749; Qi Y, 2016, DEV CELL, V39, P385, DOI 10.1016/j.devcel.2016.11.001; QUAN F, 1991, P NATL ACAD SCI USA, V88, P1898, DOI 10.1073/pnas.88.5.1898; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Ruel L, 2003, NAT CELL BIOL, V5, P907, DOI 10.1038/ncb1052; Sanial M, 2017, DEVELOPMENT, V144, P1841, DOI 10.1242/dev.144782; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Shi Q, 2011, DEVELOPMENT, V138, P4219, DOI 10.1242/dev.067959; Singh J, 2015, J BIOL CHEM, V290, P29663, DOI 10.1074/jbc.M115.665810; Tiecke E, 2007, DEV BIOL, V305, P312, DOI 10.1016/j.ydbio.2007.02.017; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/nchembio.1611, 10.1038/NCHEMBIO.1611]; Villanueva H, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa7355; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Xia RH, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001238; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225; Zhao ZH, 2016, EMBO REP, V17, P739, DOI 10.15252/embr.201541532; Zhou QH, 2006, GENETICS, V173, P2049, DOI 10.1534/genetics.106.061036; Zhou QH, 2011, DEV CELL, V20, P802, DOI 10.1016/j.devcel.2011.04.020	69	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13496	13508		10.1074/jbc.RA118.001953	http://dx.doi.org/10.1074/jbc.RA118.001953			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	30018136	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000443375500012
J	Liu, WS; Lai, YT; Chan, HL; Li, SY; Lin, CC; Liu, CK; Tsou, HH; Liu, TY				Liu, Wen-Sheng; Lai, Yen-Ting; Chan, Hsiang-Lin; Li, Szu-Yuan; Lin, Chih-Ching; Liu, Chih-Kuang; Tsou, Han-Hsing; Liu, Tsung-Yun			Associations between perfluorinated chemicals and serum biochemical markers and performance status in uremic patients under hemodialysis	PLOS ONE			English	Article							PERFLUOROOCTANE SULFONATE PFOS; PERSISTENT ORGANIC POLLUTANTS; CHRONIC KIDNEY-DISEASE; PERFLUOROALKYL CHEMICALS; GLUCOSE-HOMEOSTASIS; US ADULTS; ACID; EXPOSURE; ADOLESCENTS; CHILDREN	Perfluorooctanesulfonate (PFOS) and perfluorooctanoic acid (PFOA) are commonly used perfluorinated chemicals (PFCs). PFCs are mainly excreted by urine. Uremic patients tend to accumulate toxins in their body and have poor functional status. We investigated the associations between PFCs and the clinical profile of uremic patients under hemodialysis (HD). Liquid chromatography tandem mass spectrometry coupled with isotope dilution was used to quantify PFOA and PFOS. We enrolled 126 patients under regular HD. Compared with previous research, the concentration of PFOA was lower, but that of PFOS was higher in uremic patients than in the general population. The levels of PFOA and PFOS in uremic patients before dialysis were 0.52 (ng/ml) and 21.84 (ng/ml) respectively. The PFOA level remained unchanged but that of PFOS decreased to 1.85 ng/mL after dialysis. PFOS can be removed by HD. Patients using hypertensive medication had a lower PFOS then those who did not. The PFOS level was negatively correlated with the duration of the HD session and patient performance status, but positively correlated with levels of cholesterol, chloride (an indicator of acidemia), ferritin, and total protein. (p < 0.05). The association with serum protein may explain the long half-life of PFCs in humans. This is the first study which investigated PFCs in uremic patients and showed PFCs are associated with adverse effects in this population.	[Liu, Wen-Sheng] Taipei City Hosp, Dept Med, Div Nephrol, Zhongxing Branch, Taipei, Taiwan; [Liu, Wen-Sheng; Li, Szu-Yuan; Lin, Chih-Ching] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Liu, Wen-Sheng] Fu Jen Catholic Univ, Coll Sci & Engn, New Taipei, Taiwan; [Liu, Wen-Sheng; Tsou, Han-Hsing; Liu, Tsung-Yun] Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan; [Lai, Yen-Ting] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Hsin Chu Branch, Hsinchu, Taiwan; [Lai, Yen-Ting] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan; [Chan, Hsiang-Lin] Chang Gung Mem Hosp & Univ, Dept Child Psychiat, Taoyuan, Taiwan; [Li, Szu-Yuan; Lin, Chih-Ching] Taipei Vet Gen Hosp, Div Nephrol, Taipei, Taiwan; [Li, Szu-Yuan; Lin, Chih-Ching] Taipei Vet Gen Hosp, Dept Med, Taipei, Taiwan; [Liu, Chih-Kuang] Fu Jen Catholic Univ, Coll Med, New Taipei, Taiwan; [Liu, Chih-Kuang] Fu Jen Catholic Univ, Grad Inst Business Adm, New Taipei, Taiwan; [Liu, Tsung-Yun] Natl Yang Ming Univ, Inst Food Safety & Hlth Risk Assessment, Taipei, Taiwan	Taipei City Hospital; National Yang Ming Chiao Tung University; Fu Jen Catholic University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Fu Jen Catholic University; Fu Jen Catholic University; National Yang Ming Chiao Tung University	Liu, TY (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Environm & Occupat Hlth Sci, Taipei, Taiwan.; Liu, TY (corresponding author), Natl Yang Ming Univ, Inst Food Safety & Hlth Risk Assessment, Taipei, Taiwan.	tyliu@ym.edu.tw	liu, wen/HGE-3071-2022	Tsou, HanHsing/0000-0002-8542-0201; Liu, Tsung-Yun/0000-0003-1641-7866; Lai, Yen-Ting/0000-0001-8043-5183	Taipei Veteran General Hospital [201010007IC]; Taipei City Hospital [TPCH-103-028, 10401-62-039]	Taipei Veteran General Hospital; Taipei City Hospital	This study was supported by Taipei Veteran General Hospital (Grant No 201010007IC) and Taipei City Hospital (Grant No TPCH-103-028 & 10401-62-039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334; Bao J, 2014, ENVIRON SCI POLLUT R, V21, P7650, DOI 10.1007/s11356-014-2594-4; Barton CA, 2006, J AIR WASTE MANAGE, V56, P48, DOI 10.1080/10473289.2006.10464429; Butenhoff JL, 2004, TOXICOL SCI, V82, P394, DOI 10.1093/toxsci/kfh302; Chen MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042474; Dallaire R, 2009, ENVIRON HEALTH PERSP, V117, P1380, DOI 10.1289/ehp.0900633; Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008; Holzer J, 2008, ENVIRON HEALTH PERSP, V116, P651, DOI 10.1289/ehp.11064; Hsu JY, 2013, CHEMOSPHERE, V93, P532, DOI 10.1016/j.chemosphere.2013.06.047; Hsu TW, 2014, JAMA INTERN MED, V174, P347, DOI 10.1001/jamainternmed.2013.12700; Jensen AA, 2008, INT J ANDROL, V31, P161, DOI 10.1111/j.1365-2605.2008.00870.x; Joensen UN, 2009, ENVIRON HEALTH PERSP, V117, P923, DOI 10.1289/ehp.0800517; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Kemper RA, 2005, DRUG CHEM TOXICOL, V28, P281, DOI 10.1081/DCT-200064468; Lee JH, 2017, INT J HYG ENVIR HEAL, V220, P1046, DOI 10.1016/j.ijheh.2017.06.005; Li SY, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-89; Lin AYC, 2009, ENVIRON POLLUT, V157, P1365, DOI 10.1016/j.envpol.2008.11.033; Lin CY, 2013, INT J CARDIOL, V168, P3309, DOI 10.1016/j.ijcard.2013.04.042; Lin CY, 2010, AM J GASTROENTEROL, V105, P1354, DOI 10.1038/ajg.2009.707; Lin CY, 2009, DIABETES CARE, V32, P702, DOI 10.2337/dc08-1816; Lin LY, 2014, J CLIN ENDOCR METAB, V99, P2173, DOI 10.1210/jc.2013-3409; Liu WS, 2016, CLIN EXP PHARMACOL P, V43, P875, DOI 10.1111/1440-1681.12618; Liu WS, 2016, ENVIRON TOXICOL PHAR, V45, P108, DOI 10.1016/j.etap.2016.05.021; Liu WS, 2012, SCI WORLD J, P1, DOI 10.1100/2012/157437; Lopez-Espinosa MJ, 2012, REPROD TOXICOL, V33, P552, DOI 10.1016/j.reprotox.2011.04.002; Magulova K, 2016, ENVIRON POLLUT, V217, P82, DOI 10.1016/j.envpol.2016.01.022; Meng D, 2017, J ENVIRON SCI HEAL B, V52, P690, DOI 10.1080/03601234.2017.1331672; Modesto AP, 2018, PERITON DIALYSIS INT, V38, P24, DOI 10.3747/pdi.2015.00241; Naruse S, 1984, Neurol Res, V6, P169; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; SCHNEEBERGER EE, 1988, BIOMATER ARTIF CELL, V16, P565, DOI 10.3109/10731198809132611; Shankar Anoop, 2011, Clin Epidemiol, V3, P251, DOI 10.2147/CLEP.S21677; Shankar A, 2011, AM J EPIDEMIOL, V174, P893, DOI 10.1093/aje/kwr171; Watkins DJ, 2014, ENVIRON INT, V63, P71, DOI 10.1016/j.envint.2013.10.018; Wu LL, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-31; Yan S, 2015, SCI REP-UK, V5, DOI [10.1038/srep15917, 10.1038/srep11029]; Yang YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137914; Zhang Y, 2013, NANOSCALE RES LETT, V8, DOI [10.1186/1556-276X-8-471, 10.1186/1556-276X-8-544]	38	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200271	10.1371/journal.pone.0200271	http://dx.doi.org/10.1371/journal.pone.0200271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016344	gold, Green Published, Green Submitted			2022-12-26	WOS:000438866600019
J	Wei, B; Kang, M				Wei, Bai; Kang, Min			In vitro activity of fosfomycin against Campylobacter isolates from poultry and wild birds	PLOS ONE			English	Article							MULTIDRUG-RESISTANT CAMPYLOBACTER; ANTIBIOTIC-RESISTANCE; SOUTH-KOREA; ANTIMICROBIAL AGENTS; JEJUNI; COLI; SUSCEPTIBILITIES; PATHOGENS; STRAINS	Fosfomycin is a broad-spectrum antibiotic with the activity against both Gram-positive and Gram-negative pathogens by inhibiting the bacterial cell wall synthesis. Given the potential therapeutic efficacy of fosfomycin against Campylobacterspp., the aim of the present study was to determine the in vitro fosfomycin susceptibility of Campylobacter isolates from avian sources including poultry and wild birds. A total of eight (1.8%) strains of Campylobacter including five C. jejuni strains isolated from ducks and three C. coli strains isolated from chickens and duck showed resistance to fosfomycin, with MICs ranging from 64 to > 256 mu g/mL. The extent of fosfomycin resistance was 0%, 0.9% and 3.9% in wild birds, chicken and ducks respectively. The MIC50, MIC90, and MIC100 values were 8, 32, and 32 mu g/mL respectively in wild bird, 32, 32, and 64 mu g/mL respectively in chicken, and 32, 32, and >= 256 mu g/mL respectively in ducks. All eight fosfomycin-resistant Campylobacter strains were multidrug resistant; six were also resistant to fluoroquinolones, ampicillin, and tetracycline, and two were also resistant to fluoroquinolones, ampicillin, tetracycline, and macrolides. However, the fosfomycin resistance gene fosX(CC) was not detected in the eight fosfomycin-resistant strains. Because food animals can harbor fosfomycin-resistant Campylobacter and transmit them to humans, greater efforts are needed to monitor the prevalence of fosfomycin resistance in Campylobacter strains isolated from such animals.	[Kang, Min] Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea; Chonbuk Natl Univ, Ctr Poultry Dis Control, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Kang, M (corresponding author), Chonbuk Natl Univ, Dept Vet Infect Dis & Avian Dis, Coll Vet Med, Iksan, South Korea.	vet.minkang@gmail.com	WEI, BAI/L-3736-2019		Korea Institute of Planning and Evaluation for technology in Food, Agriculture, Forestry and Fisheries [716002-7, 315035-5]; NRF - Ministry of Education [2017R1D1A1B03030883]; Research of Animal and Plant Quarantine Agency, South Korea [Z-1543073-2015-16-01]	Korea Institute of Planning and Evaluation for technology in Food, Agriculture, Forestry and Fisheries; NRF - Ministry of Education; Research of Animal and Plant Quarantine Agency, South Korea	This work was supported by Korea Institute of Planning and Evaluation for technology in Food, Agriculture, Forestry and Fisheries (716002-7, 315035-5), Basic Science Research Program through the NRF funded by the Ministry of Education (2017R1D1A1B03030883), and Research of Animal and Plant Quarantine Agency (Z-1543073-2015-16-01), South Korea.	Aguilar-Company J, 2016, ANTIMICROB AGENTS CH, V60, P4398, DOI 10.1128/AAC.00447-16; ECUAST, 2017, BREAKP TABL INT MICS; Engberg J, 2004, EMERG INFECT DIS, V10, P1056, DOI 10.3201/eid1006.030669; European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5182; Fuchigami T, 1983, Jpn J Antibiot, V36, P2849; Gaudreau C, 2015, CLIN INFECT DIS, V61, P1549, DOI 10.1093/cid/civ570; GOMEZGARCES JL, 1995, ANTIMICROB AGENTS CH, V39, P542, DOI 10.1128/AAC.39.2.542; Kim JS, 2016, ZOONOSES PUBLIC HLTH, V63, P545, DOI 10.1111/zph.12262; Kurekci C, 2013, INT J FOOD MICROBIOL, V166, P450, DOI 10.1016/j.ijfoodmicro.2013.08.014; Kurincic M, 2012, INT J ANTIMICROB AG, V40, P467, DOI 10.1016/j.ijantimicag.2012.07.015; Lehtopolku M, 2010, ANTIMICROB AGENTS CH, V54, P1232, DOI 10.1128/AAC.00898-09; McMahon MAS, 2007, APPL ENVIRON MICROB, V73, P211, DOI 10.1128/AEM.00578-06; National Antimicrobial Resistance Monitoring System (NARMS), 2011, NARM RET ANN REP 201; NOGAWA T, 1984, Japanese Journal of Antibiotics, V37, P1620; Osterblad M, 2001, NATURE, V409, P37, DOI 10.1038/35051173; Sackey BA, 2001, INT J FOOD MICROBIOL, V71, P21, DOI 10.1016/S0168-1605(01)00595-5; Schwaiger K, 2008, ZOONOSES PUBLIC HLTH, V55, P331, DOI 10.1111/j.1863-2378.2008.01151.x; Sharma A, 2017, J ANTIMICROB CHEMOTH, V72, P68, DOI 10.1093/jac/dkw382; Shin E, 2015, ANTIMICROB AGENTS CH, V59, P6670, DOI 10.1128/AAC.01395-15; Silver LL, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025262; Sorlozano-Puerto A, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02317-16; Tribble DR, 2017, J TRAVEL MED, V24, pS6, DOI 10.1093/jtm/taw090; Van Hoang K, 2011, APPL ENVIRON MICROB, V77, P2309, DOI 10.1128/AEM.02094-10; Wang Y, 2015, J ANTIMICROB CHEMOTH, V70, P1261, DOI 10.1093/jac/dku488; Wei B, 2016, FOOD CONTROL, V62, P63, DOI 10.1016/j.foodcont.2015.10.013; Wei B, 2015, INT J ANTIMICROB AG, V45, P197, DOI 10.1016/j.ijantimicag.2014.10.007; Wei B, 2014, APPL ENVIRON MICROB, V80, P7604, DOI 10.1128/AEM.02469-14; Xu HW, 2014, CURR TOP MED CHEM, V14, P21; Zhou J, 2015, INT J BIOL SCI, V11, P1016, DOI 10.7150/ijbs.11751	29	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200853	10.1371/journal.pone.0200853	http://dx.doi.org/10.1371/journal.pone.0200853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016352	gold, Green Published, Green Submitted			2022-12-26	WOS:000438866600048
J	Song, K; Im, SH; Yoon, YJ; Kim, HM; Lee, HJ; Park, GS				Song, Kiwon; Im, Sang Hyeon; Yoon, Yeo Jun; Kim, Hui Min; Lee, Hae June; Park, Gwan Soo			A 60 Hz uniform electromagnetic field promotes human cell proliferation by decreasing intracellular reactive oxygen species levels	PLOS ONE			English	Article							FREQUENCY MAGNETIC-FIELDS; HUMAN-DIPLOID FIBROBLASTS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; NEURONAL DIFFERENTIATION; INTERMITTENT EXPOSURE; CHILDHOOD-CANCER; OXIDATIVE STRESS; STEM-CELLS; IN-VITRO	Previously, we showed that exposure of human normal and cancer cells to a 6 mT, 60 Hz gradient electromagnetic field (EMF) induced genotoxicity. Here, we investigated the cellular effects of a uniform EMF. Single or repetitive exposure to a 6 mT, 60 Hz uniform EMF neither induced DNA damage nor affected cell viability in HeLa and primary IMR-90 fibroblasts. However, continuous exposure of these cells to an EMF promoted cell proliferation. Cell viability increased 24.4% for HeLa and 15.2% for IMR-90 cells after a total 168 h exposure by subculture. This increase in cell proliferation was directly correlated with EMF strength and exposure time. When further incubated without EMF, cell proliferation slowed down to that of unexposed cells, suggesting that the proliferative effect is reversible. The expression of cell cycle markers increased in cells continuously exposed to an EMF as expected, but the distribution of cells in each stage of the cell cycle did not change. Notably, intracellular reactive oxygen species levels decreased and phosphorylation of Akt and Erk1/2 increased in cells exposed to an EMF, suggesting that reduced levels of intracellular reactive oxygen species play a role in increased proliferation. These results demonstrate that EMF uniformity at an extremely low frequency (ELF) is an important factor in the cellular effects of ELF-EMF.	[Song, Kiwon; Yoon, Yeo Jun] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea; [Im, Sang Hyeon; Kim, Hui Min; Lee, Hae June; Park, Gwan Soo] Pusan Natl Univ, Dept Elect Engn, Pusan, South Korea	Yonsei University; Pusan National University	Song, K (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul, South Korea.; Park, GS (corresponding author), Pusan Natl Univ, Dept Elect Engn, Pusan, South Korea.	bc5012@yonsei.ac.kr; gspark@pusan.ac.kr			National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning [NRF-2016M3A9C6918275]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning	This research was supported by a grant from the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3A9C6918275) (KS).; We are grateful to Prof. Sang Won Kang (Ewha Womans University, Korea) for providing glucose oxidase and technical support. This work was supported by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning [No. NRF-2016M3A9C6918275].	Ahmadian S, 2006, BIOTECHNOL APPL BIOC, V43, P71, DOI 10.1042/BA20050086; Martinez MA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040510; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Baek S, 2014, ACS NANO, V8, P10125, DOI 10.1021/nn502923s; BOWMAN JD, 1995, BIOELECTROMAGNETICS, V16, P48, DOI 10.1002/bem.2250160111; CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508; Duong CN, 2016, INT J RADIAT BIOL, V92, P195, DOI 10.3109/09553002.2016.1136851; CLEARY SF, 1993, AM IND HYG ASSOC J, V54, P178, DOI 10.1202/0002-8894(1993)054<0178:AROIVS>2.0.CO;2; Costin GE, 2012, CURR MOL MED, V12, P14, DOI 10.2174/156652412798376143; Ding GR, 2004, INT J RADIAT BIOL, V80, P317, DOI 10.1080/09553000410001679802; FEYCHTING M, 1993, AM J EPIDEMIOL, V138, P467, DOI 10.1093/oxfordjournals.aje.a116881; Frahm J, 2010, TOXICOL LETT, V192, P330, DOI 10.1016/j.toxlet.2009.11.010; Gow AJ, 1999, AM J PHYSIOL-LUNG C, V277, pL271, DOI 10.1152/ajplung.1999.277.2.L271; Hong MN, 2012, J RADIAT RES, V53, P79, DOI 10.1269/jrr.11049; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Jin YB, 2014, RADIAT ENVIRON BIOPH, V53, P93, DOI 10.1007/s00411-013-0506-5; Khavari BAA, 2015, RAZI J MED SCI, V22; Khavari B, 2011, CLIN BIOCHEM, V44, pS165, DOI 10.1016/j.clinbiochem.2011.08.416; Kim J, 2012, BIOELECTROMAGNETICS, V33, P383, DOI 10.1002/bem.21697; Kim J, 2010, BIOCHEM BIOPH RES CO, V400, P739, DOI 10.1016/j.bbrc.2010.08.140; Kim YW, 2009, BIOELECTROMAGNETICS, V30, P66, DOI 10.1002/bem.20448; Kirson ED, 2007, P NATL ACAD SCI USA, V104, P10152, DOI 10.1073/pnas.0702916104; Lai H, 1997, BIOELECTROMAGNETICS, V18, P156, DOI 10.1002/(SICI)1521-186X(1997)18:2<156::AID-BEM8>3.0.CO;2-1; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Luukkonen J, 2016, INT J RADIAT BIOL, P1; Maredziak M, 2017, ELECTROMAGN BIOL MED, V36, P45, DOI 10.3109/15368378.2016.1149860; McNamee JP, 2005, RADIAT RES, V164, P791, DOI 10.1667/RR3465.1; Mezei G, 2001, J EXPO ANAL ENV EPID, V11, P41, DOI 10.1038/sj.jea.7500145; Moriyama K, 2005, BIOELECTROMAGNETICS, V26, P238, DOI 10.1002/bem.20099; Nie K, 2003, J CELL BIOCHEM, V90, P1197, DOI 10.1002/jcb.10704; Panieri E, 2013, FREE RADICAL BIO MED, V57, P176, DOI 10.1016/j.freeradbiomed.2012.12.024; Pasi F, 2016, ELECTROMAGN BIOL MED, V35, P343, DOI 10.3109/15368378.2016.1138123; Patruno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139644; Polaniak R, 2010, INT J TOXICOL, V29, P221, DOI 10.1177/1091581809352011; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; SAVITZ DA, 1988, AM J EPIDEMIOL, V128, P21, DOI 10.1093/oxfordjournals.aje.a114943; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Seong Y, 2014, LIFE SCI, V102, P16, DOI 10.1016/j.lfs.2014.02.022; Song J, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/426069; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Ulrich-Merzenich G, 2007, EUR J NUTR, V46, P87, DOI 10.1007/s00394-006-0636-5; Urnukhsaikhan E, 2016, LIFE SCI, V151, P130, DOI 10.1016/j.lfs.2016.02.066; VISTICA DT, 1991, CANCER RES, V51, P2515; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Winker R, 2005, MUTAT RES-GEN TOX EN, V585, P43, DOI 10.1016/j.mrgentox.2005.04.013; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Zhang MS, 2013, BIOELECTROMAGNETICS, V34, P74, DOI 10.1002/bem.21747	47	27	27	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0199753	10.1371/journal.pone.0199753	http://dx.doi.org/10.1371/journal.pone.0199753			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011321	Green Submitted, Green Published, gold			2022-12-26	WOS:000438829800005
J	Gruszczynska, K; Likus, W; Onyszczuk, M; Wawruszczak, R; Goldyn, K; Olczak, Z; Machnikowska-Sokolowska, M; Mandera, M; Baron, J				Gruszczynska, Katarzyna; Likus, Wirginia; Onyszczuk, Magdalena; Wawruszczak, Rita; Goldyn, Kamila; Olczak, Zbigniew; Machnikowska-Sokolowska, Magdalena; Mandera, Marek; Baron, Jan			How does nonsyndromic craniosynostosis affect on bone width of nasal cavity in children? - Computed tomography study	PLOS ONE			English	Article							SAGITTAL SYNOSTOSIS; INDEX; ACCURACY; VOLUME	Craniosynostosis is caused by premature fusion of one or more cranial sutures, restricting skull, brain and face growth. Nonsyndromic craniosynostosis could disturb the proportions of face. Although morphometric diameters of nasal cavity in healthy children are already known, they have not been established yet in children with nonsyndromic craniosynostosis. The aim our study was to check whether diameters of bone structures of nasal cavity in children with nonsyndromic craniosynostosis measured in CT are within normal range. 249 children aged 0-36 months (96 with clinical diagnosis of nonsyndromic craniosynostosis and 153 in control group) were included into the study. The following diameters were measured on head CT scans: anterior bony width (ABW), bony choanal aperture width (BCAW), right and left posterior bony width (between bone sidewall and nasal cavity septum-RPBW and LPBW). The study group has been divided into 4 categories, depending on child's age. The dimensions measured between bone structures of nasal cavity were statistically significantly lower in comparison to the control group. They did not depend on the sex for ABW, nor on age in groups 7-12 months and < 2 years for BCAW, RPBW and LPBW. The measured dimensions increased with age. In children with nonsyndromic craniosynostosis the diameter of pyriform aperture and bony choanal aperture were lower than in controls, what may be described as fronto-orbital anomalies. Morphometric measurements of anthropometric indicators on CT scans could be used as standards in the clinical identification of craniosynostosis type and may help in planning surgical procedures, particularly in the facial skeleton in children.	[Gruszczynska, Katarzyna; Machnikowska-Sokolowska, Magdalena] Med Univ Silesia, Sch Med Katowice, Dept Diagnost Imaging, Katowice, Poland; [Likus, Wirginia] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Anat, Katowice, Poland; [Onyszczuk, Magdalena] Megrez Sp Zoo, Reg Specialist Hosp Tychy, Tychy, Poland; [Wawruszczak, Rita; Goldyn, Kamila] Med Univ Silesia, Sch Med Katowice, Dept Radiol & Nucl Med, Students Sci Org, Katowice, Poland; [Olczak, Zbigniew] Med Univ Silesia, John Paul Upper Silesian Child Hlth Ctr 2, Dept Diagnost Imaging & Intervent Radiol, Independent Publ Clin Hosp 6, Katowice, Poland; [Mandera, Marek] Med Univ Silesia, Sch Publ Hlth Bytom, Dept Emergency Med & Pediat Neurosurg, Katowice, Poland; [Baron, Jan] Med Univ Silesia, Sch Med Katowice, Dept Radiodiagnost & Invas Radiol, Katowice, Poland; [Onyszczuk, Magdalena] Med Univ Silesia, Div Dent Zabrze, Sch Med, Chair & Dept Pathol, Katowice, Poland	Medical University Silesia; Medical University Silesia; Medical University Silesia; Medical University Silesia; Medical University Silesia; Medical University Silesia; Medical University Silesia	Likus, W (corresponding author), Med Univ Silesia, Sch Hlth Sci Katowice, Dept Anat, Katowice, Poland.	wirginia.likus@gmail.com		Baron, Jan/0000-0001-5216-4961; Likus, Wirginia/0000-0002-4738-6102; Mandera, Marek/0000-0003-2141-7932; Gruszczynska, Katarzyna/0000-0002-0863-4492; Chrabanska (Onyszczuk), Magdalena/0000-0001-7704-1124; Machnikowska-Sokolowska, Magdalena/0000-0001-8807-5899				Aviv RI, 2002, CLIN RADIOL, V57, P93, DOI 10.1053/crad.2001.0836; Bannink N, 2011, J DEV BEHAV PEDIATR, V32, P233, DOI 10.1097/DBP.0b013e318206d5e3; Bonfield CM, 2014, J CRANIO MAXILL SURG, V42, P1095, DOI 10.1016/j.jcms.2014.01.036; de Water VR, 2014, J ORAL MAXIL SURG, V72, P139, DOI 10.1016/j.joms.2013.07.034; Djupesland PG, 2014, THER DELIV, V5, P709, DOI [10.4155/tde.14.41, 10.4155/TDE.14.41]; Djupesland PG, 1998, ACTA OTO-LARYNGOL, V118, P852, DOI 10.1080/00016489850182576; FARKAS LG, 1985, CLEFT PALATE J, V22, P253; Forte AJ, 2014, PLAST RECONSTR SURG, V134, P285, DOI 10.1097/PRS.0000000000000360; Garza Rebecca M, 2012, Semin Plast Surg, V26, P53, DOI 10.1055/s-0032-1320063; Gasparini G, 2013, CHILD NERV SYST, V29, P665, DOI 10.1007/s00381-012-2002-7; Governale LS, 2015, PEDIATR NEUROL, V53, P394, DOI 10.1016/j.pediatrneurol.2015.07.006; Heller JB, 2008, PLAST RECONSTR SURG, V121, P187, DOI 10.1097/01.prs.0000293762.71115.c5; Heuze Y, 2010, J ANAT, V217, P85, DOI 10.1111/j.1469-7580.2010.01258.x; Iyer RR, 2018, CHILD NERV SYST, V34, P137, DOI 10.1007/s00381-017-3601-0; Kawlewska E, 2017, ADV INTELLIGENT SYST, P132; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Liew YT, 2017, AURIS NASUS LARYNX, V44, P635, DOI 10.1016/j.anl.2016.10.001; Likus W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/125810; McEwan TW, 2016, CLEFT PALATE-CRAN J, V53, pE95, DOI 10.1597/14-310; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; OTTO A W, 1830, LEHRBUCH PATHOLOGISC, V1; Persing John A, 2008, Plast Reconstr Surg, V121, P1, DOI 10.1097/01.prs.0000305929.40363.bf; POSNICK JC, 1993, CLEFT PALATE-CRAN J, V30, P251; Roberts W.E., 2004, SEMIN ORTHOD, V10, P100; Shin JH, 2007, GRABB SMITHS PLASTIC, V6th, P226; Smartt JM, 2011, PLAST RECONSTR SURG, V127, P303, DOI 10.1097/PRS.0b013e3181f95cd8; Stamper BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026557; van Lindert EJ, 2013, CHILD NERV SYST, V29, P1007, DOI 10.1007/s00381-013-2059-y; WAITZMAN AA, 1992, CLEFT PALATE-CRAN J, V29, P112, DOI 10.1597/1545-1569(1992)029<0112:CSMBOC>2.3.CO;2; Wilbrand JF, 2012, J PEDIATR-US, V161, P1120, DOI 10.1016/j.jpeds.2012.05.023	31	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200282	10.1371/journal.pone.0200282	http://dx.doi.org/10.1371/journal.pone.0200282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005068	Green Submitted, Green Published, gold			2022-12-26	WOS:000438744200011
J	Hooi, DJ; Lissenberg-Witte, BI; Kenter, G; de Koning, MNC; Bravio, IG; Ardts, K; Kleinmoedig, S; Benita, E; Pinedo, HM; Berkhof, J; Quint, WGV; Meijer, CJLM				Hooi, Desiree J.; Lissenberg-Witte, Birgit, I; Kenter, Gemma; de Koning, Maurits N. C.; Bravio, Igor Gomes; Ardts, Kim; Kleinmoedig, Suhaina; Benita, Edlyn; Pinedo, Herbert M.; Berkhof, Johannes; Quint, Wim G., V; Meijer, Chris J. L. M.			Human papillomavirus (HPV) prevalence and associated risk factors in women from Curacao	PLOS ONE			English	Article							CYTOLOGY; CANCER	Background In the Caribbean region, a notable difference in HPV-prevalence and genotypes distribution between the islands is observed. Recently we found in Curacao a low incidence of HPV16 and 18 in cervical cancer compared to the standard world population. We aimed to determine HPV-prevalence, HPV-genotype distribution and associated risk-factors in women from Curacao. Methods 5000 women aged 25-65 years were randomly selected from the national Population Register. HPV was detected by means of GP5+/6+PCR EIA and GP 5+/6+amplimers from HPV-positive samples were genotyped with a reverse hybridisation assay. We also collected personal data and data on risk-factors. Results 1075 women were enrolled in the study. Overall HPV-prevalence was 19.7%. Most frequent genotypes were HPV16 (2.3%), 35 (2.1%) and 52 (1.8%). Twenty-seven women detected with abnormal cytology (i.e.>= ASC-US) were referred for biopsy. In women with normal cytology (n = 1048), HPV-prevalence was 17.9% and the most common high-risk HPV (hrHPV)types were HPV35 (2.0%), 18 (1.8%), 16 (1.5%) and 52 (1.5%). The highest HPV-prevalence (32.8%) was found in the age-group: 25-34 (n = 247). HPV positive women started sex at a younger age (p = 0.032). Conclusions HPV-prevalence in the overall population is high and HPV16 was the most common genotype followed by 35 and 18. In women with normal cytology HPV35 is the most common genotype followed by HPV18, 52 and 16. The high HPV-prevalence (32.8%) in women of 25-34 years argue for introduction of cervical cancer prevention strategies. HPV-type distribution found in Curacao should be taken into account when considering the choice for prophylactic vaccination.	[Hooi, Desiree J.; Meijer, Chris J. L. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Lissenberg-Witte, Birgit, I; Berkhof, Johannes] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Kenter, Gemma] Vrije Univ Amsterdam Med Ctr, Dept Gynaecol & Oncol, Amsterdam, Netherlands; [de Koning, Maurits N. C.; Quint, Wim G., V] DDL Diagnost Lab, Rijswijk, Netherlands; [Bravio, Igor Gomes; Ardts, Kim; Pinedo, Herbert M.] Fundashon Prevenshon, Willemstad, Curacao; [Kleinmoedig, Suhaina; Benita, Edlyn] ADC, Dept Pathol, Willemstad, Curacao	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; DDL Diagnostic Laboratory	Hooi, DJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands.	d.hooi@vumc.nl			Fundashon Prevenshon grant [2015-01]	Fundashon Prevenshon grant	This work was supported by Fundashon Prevenshon grant number 2015-01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andall-Brereton GM, 2011, REV PANAM SALUD PUBL, V29, P220; Bulk S, 2006, BRIT J CANCER, V94, P171, DOI 10.1038/sj.bjc.6602915; Bulk S, 2004, J CLIN PATHOL, V57, P388, DOI 10.1136/jcp.2003.011841; Burchell AN, 2006, VACCINE, V24, P52, DOI 10.1016/j.vaccine.2006.05.031; Consedine NS, 2015, J IMMIGR MINOR HEALT, V17, P905, DOI 10.1007/s10903-014-9991-0; Cordel N, 2015, INT J INFECT DIS, V41, P13, DOI 10.1016/j.ijid.2015.10.012; Doorbar J, 2012, VACCINE, V30, pF55, DOI 10.1016/j.vaccine.2012.06.083; Garland SM, 2016, CLIN INFECT DIS, V356; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; Hooi Desiree J., 2017, SEX TRANSM INFECT, P1, DOI [10.1136/sextrans-2017-053109, DOI 10.1136/SEXTRANS-2017-053109]; Lewis-Bell K, 2013, REV PANAM SALUD PUBL, V33, P159, DOI 10.1590/S1020-49892013000300001; Moscicki AB, 2006, VACCINE, V24, P42, DOI 10.1016/j.vaccine.2006.06.018; Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013; Premdas R, 1996, 234 KELL I; Serrano B., 2021, HUMAN PAPILLOMAVIRUS; Sunassee A., WHO CLASSIFICATION C; Walmer DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076110; Watt Angela, 2009, Infect Agent Cancer, V4 Suppl 1, pS11, DOI 10.1186/1750-9378-4-S1-S11	18	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0199624	10.1371/journal.pone.0199624	http://dx.doi.org/10.1371/journal.pone.0199624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005066	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200004
J	Stefler, D; Hu, YY; Malyutina, S; Pajak, A; Kubinova, R; Peasey, A; Pikhart, H; Rodriguez-Artalejo, F; Bobak, M				Stefler, Denes; Hu, Yaoyue; Malyutina, Sofia; Pajak, Andrzej; Kubinova, Ruzena; Peasey, Anne; Pikhart, Hynek; Rodriguez-Artalejo, Fernando; Bobak, Martin			Mediterranean diet and physical functioning trajectories in Eastern Europe: Findings from the HAPIEE study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; FOLLOW-UP; PATTERNS; DECLINE; DISABILITY; ADHERENCE; COUNTRIES; INDICATORS; DEMENTIA; HEALTH	Background Unhealthy diet may increase the risk of impaired physical functioning in older age. Although poor diet and limited physical functioning both seem to be particularly common in Eastern Europe, no previous study has assessed the relationship between these two factors in this region. The current analysis examined the association between overall diet quality and physical functioning in Eastern European populations. Methods We used data on 25,504 persons (aged 45-69 years at baseline) who participated in the Health Alcohol and Psychosocial factors in Eastern Europe (HAPIEE) study. Dietary assessment at baseline used food frequency questionnaire, and the overall diet quality was evaluated by the Mediterranean diet score (MDS). Physical functioning (PF) was measured by the physical functioning subscale (PF-10) of the 36-item Short-Form Health Survey at baseline and three subsequent occasions over a 10-year period. The cross-sectional and longitudinal relationships between the MDS and PF were examined simultaneously using growth curve models. Results Men and women with higher adherence to the Mediterranean diet had significantly better PF at baseline; after multivariable adjustment, the regression coefficient per 1-unit increase in the MDS was 0.39 (95% CI: 0.25, 0.52) in men and 0.50 (0.36, 0.64) in women. However, we found no statistically significant link between baseline MDS and the subsequent slope of PF decline in neither gender; the coefficients were -0.02 (-0.04, 0.00) in men and -0.01 (-0.03, 0.02) in women. Discussion Our results do not support the hypothesis that the Mediterranean diet has a substantial impact on the trajectories of physical functioning, although the differences existing at baseline may be related to dietary habits in earlier life.	[Stefler, Denes; Hu, Yaoyue; Peasey, Anne; Pikhart, Hynek; Bobak, Martin] UCL, Dept Epidemiol & Publ Hlth, London, England; [Hu, Yaoyue] Max Planck Inst Demog Res, Rostock, Germany; [Malyutina, Sofia] Russian Acad Med Sci, Inst Internal & Prevent Med, Siberian Branch, Novosibirsk, Russia; [Pajak, Andrzej] Jagiellonian Univ, Dept Epidemiol & Populat Studies, Coll Med, Krakow, Poland; [Kubinova, Ruzena] Natl Inst Publ Hlth, Prague, Czech Republic; [Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, Dept Prevent Med & Publ Hlth, Sch Med, IdiPaz, Madrid, Spain; [Rodriguez-Artalejo, Fernando] CIBERESP, Madrid, Spain	University of London; University College London; Max Planck Society; Russian Academy of Medical Sciences; Russian Academy of Sciences; Jagiellonian University; Collegium Medicum Jagiellonian University; National Institute of Public Health (SZU) - Czech Republic; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Stefler, D (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	denes.stefler@ucl.ac.uk	Pikhart, Hynek/E-3074-2010; Malyutina, Sofia/J-1651-2018; Stefler, Denes/H-5394-2019	Pikhart, Hynek/0000-0001-5277-4049; Malyutina, Sofia/0000-0001-6539-0466; Stefler, Denes/0000-0002-4482-148X; Hu, Yaoyue/0000-0001-6517-1503; Bobak, Martin/0000-0002-2633-6851	Wellcome Trust [WT064947, WT081081]; US National Institute of Aging [1R01AG23522]; MacArthur Foundation Initiative on Social Upheaval and Health; Russian Scientific Foundation [14-45-00030]; ATHLOS Project, a European Union Horizon 2020 Research and Innovation Program [635316]; Russian Science Foundation [17-45-00002] Funding Source: Russian Science Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); US National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MacArthur Foundation Initiative on Social Upheaval and Health; Russian Scientific Foundation(Russian Science Foundation (RSF)); ATHLOS Project, a European Union Horizon 2020 Research and Innovation Program; Russian Science Foundation(Russian Science Foundation (RSF))	The HAPIEE study was supported by the Wellcome Trust [grant numbers WT064947, WT081081], the US National Institute of Aging [grant number 1R01AG23522] and the MacArthur Foundation Initiative on Social Upheaval and Health. The current analysis was partly supported by the Russian Scientific Foundation [grant number 14-45-00030]. This work was also supported by the ATHLOS Project, a European Union Horizon 2020 Research and Innovation Program [grant number 635316]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artaud F, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4240; Barrea L, 2018, CLIN NUTR; Bloomfield HE, 2016, ANN INTERN MED, V165, P491, DOI 10.7326/M16-0361; Bobak M, 2004, J EPIDEMIOL COMMUN H, V58, P238, DOI 10.1136/jech.2003.011825; Bobak M, 2004, BRIT MED J, V329, P767, DOI 10.1136/bmj.38202.667130.55; Boylan S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-439; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cosco TD, 2014, INT PSYCHOGERIATR, V26, P373, DOI 10.1017/S1041610213002287; Estruch R, 2018, NEW ENGL J MED, V378, DOI [10.1056/NEJMoa1800389, 10.1056/nejmoa1800389]; European Food Safety Authority (EFSA), 2011, 215 EFSA; Feart C, 2011, EUR J EPIDEMIOL, V26, P747, DOI 10.1007/s10654-011-9611-4; Gilmore A, 2004, AM J PUBLIC HEALTH, V94, P2177, DOI 10.2105/AJPH.94.12.2177; Ginter E, 1998, NUTRITION, V14, P452, DOI 10.1016/S0899-9007(98)00017-3; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Hagan KA, 2016, J NUTR, V146, P1341, DOI 10.3945/jn.115.227900; Houston DK, 2005, AM J CLIN NUTR, V81, P515; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hu YY, 2016, J GERONTOL A-BIOL, V71, P1063, DOI 10.1093/gerona/glv233; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kojima G, 2018, J AM GERIATR SOC, V66, P783, DOI 10.1111/jgs.15251; Lourida I, 2013, EPIDEMIOLOGY, V24, P479, DOI 10.1097/EDE.0b013e3182944410; Milaneschi Y, 2011, EXP GERONTOL, V46, P303, DOI 10.1016/j.exger.2010.11.030; Milaneschi Y, 2010, CURR OPIN CLIN NUTR, V13, P625, DOI 10.1097/MCO.0b013e32833e337d; Mirowsky J, 2008, RES AGING, V30, P93, DOI 10.1177/0164027507309649; Mirowsky J, 2007, SOCIOL METHOD RES, V35, P497, DOI 10.1177/0049124106296015; Peasey A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-255; Perez-Tasigchana RF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151596; Pomerleau J, 2006, PUBLIC HEALTH NUTR, V9, P575, DOI 10.1079/PHN2005910; Raczek AE, 1998, J CLIN EPIDEMIOL, V51, P1203, DOI 10.1016/S0895-4356(98)00112-7; Semba RD, 2003, AGING CLIN EXP RES, V15, P482, DOI 10.1007/BF03327377; Shahar DR, 2012, J AM GERIATR SOC, V60, P1881, DOI 10.1111/j.1532-5415.2012.04167.x; Singer JD, 2005, ENCY STAT BEHAV SCI; Slattery ML, 2010, APPL PHYSIOL NUTR ME, V35, P207, DOI 10.1139/H10-006; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Stefler D, 2017, EUR J NUTR, V56, P421, DOI 10.1007/s00394-015-1092-x; Stoel RD., 2003, METODOLOGIA CIENCIAS, V5, P21; Struijk EA, 2018, J GERONTOL A-BIOL, V73, P333, DOI 10.1093/gerona/glw208; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Tomkins S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030274; Trichopoulou A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-112; Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010; van de Rest O, 2015, ADV NUTR, V6, P154, DOI 10.3945/an.114.007617; Vercambre MN, 2009, BRIT J NUTR, V102, P419, DOI 10.1017/S0007114508201959; WA, 2011, ANN AGR ENV MED, V18, P194; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu W, 2009, PSYCHOL METHODS, V14, P183, DOI 10.1037/a0015858; Zbeida M, 2014, J NUTR HEALTH AGING, V18, P411, DOI 10.1007/s12603-014-0003-9	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200460	10.1371/journal.pone.0200460	http://dx.doi.org/10.1371/journal.pone.0200460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001406	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400059
J	Fiorillo, A; Petrosino, M; Ilari, A; Pasquo, A; Cipollone, A; Maggio, M; Chiaraluce, R; Consalvi, V				Fiorillo, Annarita; Petrosino, Maria; Ilari, Andrea; Pasquo, Alessandra; Cipollone, Alessandra; Maggio, Maristella; Chiaraluce, Roberta; Consalvi, Valerio			The phosphoglycerate kinase 1 variants found in carcinoma cells display different catalytic activity and conformational stability compared to the native enzyme	PLOS ONE			English	Article							GLYCOLYSIS; DISEASE; PGK1; OVEREXPRESSION; METABOLISM; MECHANISM; SEQUENCE	Cancer cells are able to survive in difficult conditions, reprogramming their metabolism according to their requirements. Under hypoxic conditions they shift from oxidative phosphorylation to aerobic glycolysis, a behavior known as Warburg effect. In the last years, glycolytic enzymes have been identified as potential targets for alternative anticancer therapies. Recently, phosphoglycerate kinase 1 (PGK1), an ubiquitous enzyme expressed in all somatic cells that catalyzes the seventh step of glycolysis which consists of the reversible phosphotransfer reaction from 1,3-bisphosphoglycerate to ADP, has been discovered to be overexpressed in many cancer types. Moreover, several somatic variants of PGK1 have been identified in tumors. In this study we analyzed the effect of the single nucleotide variants found in cancer tissues on the PGK1 structure and function. Our results clearly show that the variants display a decreased catalytic efficiency and/or thermodynamic stability and an altered local tertiary structure, as shown by the solved X-ray structures. The changes in the catalytic properties and in the stability of the PGK1 variants, mainly due to the local changes evidenced by the X-ray structures, suggest also changes in the functional role of PGK to support the biosynthetic need of the growing and proliferating tumour cells.	[Fiorillo, Annarita; Petrosino, Maria; Cipollone, Alessandra; Chiaraluce, Roberta; Consalvi, Valerio] Sapienza Univ Rome, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Ilari, Andrea] CNR, Inst Mol Biol & Pathol, Rome, Italy; [Pasquo, Alessandra] ENEA CR Frascati, Diagnost & Metrol Lab, FSN TECFIS DIM, Frascati, Italy; [Maggio, Maristella] Univ Pavia, Dept Mol Med, Unit Immunol & Gen Pathol, Pavia, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Italian National Agency New Technical Energy & Sustainable Economics Development; University of Pavia	Fiorillo, A; Chiaraluce, R (corresponding author), Sapienza Univ Rome, Dept Biochem Sci A Rossi Fanelli, Rome, Italy.	annarita.fiorillo@uniroma1.it; roberta.chiaraluce@uniroma1.it	consalvi, valerio/F-1918-2011; Ilari, Andrea/T-5501-2017; Maggi, Maristella/P-2896-2019; Maggi, Maristella/O-6759-2014; Ilari, Andrea/AAC-7670-2022	Ilari, Andrea/0000-0002-7754-399X; Maggi, Maristella/0000-0002-9075-8143; Maggi, Maristella/0000-0002-9075-8143; Ilari, Andrea/0000-0002-7754-399X; CHIARALUCE, Roberta/0000-0001-7748-2237; FIORILLO, Annarita/0000-0002-8966-8554	Regione Lazio [FILAS-RU-2014-1020]	Regione Lazio(Regione Lazio)	This study was supported by Prot. FILAS-RU-2014-1020 Regione Lazio, Grant recipient: Valerio Consalvi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SS, 2013, INT J ONCOL, V43, P586, DOI 10.3892/ijo.2013.1971; Ai JZ, 2011, CELL PHYSIOL BIOCHEM, V27, P207, DOI 10.1159/000327946; Ariosa AR, 2017, AUTOPHAGY, V13, P1091, DOI 10.1080/15548627.2017.1321723; Auton M, 2007, P NATL ACAD SCI USA, V104, P15317, DOI 10.1073/pnas.0706251104; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Beutler E, 2007, BRIT J HAEMATOL, V136, P3, DOI 10.1111/j.1365-2141.2006.06351.x; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Butera D, 2014, J BIOL CHEM, V289, P2992, DOI 10.1074/jbc.M113.539924; Casadio R, 2011, HUM MUTAT, V32, P1161, DOI 10.1002/humu.21555; Chen XP, 2015, NAT CHEM BIOL, V11, P19, DOI 10.1038/nchembio.1657; Chiarelli LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032065; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Cliff MJ, 2010, J AM CHEM SOC, V132, P6507, DOI 10.1021/ja100974t; Daly EB, 2004, BBA-MOL CELL RES, V1691, P17, DOI 10.1016/j.bbamcr.2003.11.004; Duan Z, 2002, ANTICANCER RES, V22, P1933; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gondeau C, 2008, NUCLEIC ACIDS RES, V36, P3620, DOI 10.1093/nar/gkn212; Hwang TL, 2006, PROTEOMICS, V6, P2259, DOI 10.1002/pmic.200500345; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karki R, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0115-z; Kiss RS, 2003, J BIOL CHEM, V278, P21952, DOI 10.1074/jbc.M302676200; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Li XJ, 2016, MOL CELL, V61, P705, DOI 10.1016/j.molcel.2016.02.009; Lim SO, 2016, CANCER RES, V76, P1284, DOI 10.1158/0008-5472.CAN-15-2478; Lori C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064824; Lori L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159180; Lu ZM, 2018, TRENDS BIOCHEM SCI, V43, P301, DOI 10.1016/j.tibs.2018.01.006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Pasquo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032555; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Petrosino M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020361; Petukh M, 2015, HUM MUTAT, V36, P524, DOI 10.1002/humu.22770; Qian X, 2017, MOL CELL, V65, P917, DOI 10.1016/j.molcel.2017.01.027; Rodriguez-Enriquez S, 2014, ARCH TOXICOL, V88, P1327, DOI 10.1007/s00204-014-1246-2; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sheng HM, 2016, RECENT PAT ANTI-CANC, V11, P297, DOI 10.2174/1574892811666160415160104; SHERMAN MA, 1992, PROTEIN SCI, V1, P752, DOI 10.1002/pro.5560010607; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun S, 2015, BRIT J CANCER, V112, P1332, DOI 10.1038/bjc.2015.114; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vas M, 2010, CURR PROTEIN PEPT SC, V11, P118, DOI 10.2174/138920310790848403; Wang JH, 2007, CANCER RES, V67, P149, DOI 10.1158/0008-5472.CAN-06-2971; Yu X, 2017, ONCOGENE, V36, P2629, DOI 10.1038/onc.2016.410; Zerrad L, 2011, J BIOL CHEM, V286, P14040, DOI 10.1074/jbc.M110.206813; Zieker D, 2010, INT J CANCER, V126, P1513, DOI 10.1002/ijc.24835	53	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199191	10.1371/journal.pone.0199191	http://dx.doi.org/10.1371/journal.pone.0199191			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995887	gold, Green Published, Green Submitted			2022-12-26	WOS:000438388800019
J	Noll, E; Diemunsch, S; Pottecher, J; Rameaux, JP; Diana, M; Sauleau, E; Ruetzler, K; Diemunsch, P				Noll, Eric; Diemunsch, Sophie; Pottecher, Julien; Rameaux, Jean-Pierre; Diana, Michele; Sauleau, Eric; Ruetzler, Kurt; Diemunsch, Pierre			Prevention of laparoscopic surgery induced hypothermia with warmed humidified insufflation: Is the experimental combination of a warming blanket synergistic?	PLOS ONE			English	Article							OPEN ABDOMINAL-SURGERY; FORCED-AIR; INTRAOPERATIVE HYPOTHERMIA; HEAT-LOSS; CARBON-DIOXIDE; TEMPERATURE; NORMOTHERMIA; SYSTEM; MAINTENANCE; HUMANS	Introduction Maintaining normothermia during anesthesia is imperative to provide quality patient care and to prevent adverse outcomes. Prolonged laparoscopic procedures have been identified as a potential risk factor for hypothermia, due to continuous insufflation of cold and dry carbon dioxide. Perioperative hypothermia is associated with increased hospital cost and many complications including; impaired drug metabolism, impaired immune function, cardiac morbidity, shivering, coagulopathy. Methods In this experimental study, four pigs underwent four interventions each, resulting in 16 total trials. Using standardized general anesthesia in a randomized Latin-square sequence the four interventions include: 1. Control group without an administered pneumoperitoneum, 2. Administered standard pneumoperitoneum using 21 degrees C insufflated gas and under-body forced-air warming, 3. Administered pneumoperitoneum with insufflation of warmed/humidified carbon dioxide, 4. Administered pneumoperitoneum with insufflation of warmed/humidified carbon dioxide and under-body forced-air warming. The primary outcome was distal esophageal temperature change 4 hours after trocar insertion. Results Four hours after trocar insertion, pigs in the control group lost 2.1 +/- 0.4 degrees C; pigs with warmed and humidified insufflation lost 1.8 +/- 0.4 degrees C; pigs with forced-air warming group lost 1.3 +/- 0.9 degrees C; and pigs exposed to a combination of warmed and humidified insufflation with forcedair warming increased by 0.3 +/- 0.2 degrees C. Conclusion This experimental animal study provides evidence that a combination of warmed and humidified insufflation of carbon dioxide (CO2) in conjunction with forced-air warming is an effective strategy in the prevention of perioperative hypothermia. Further clinical trials investigating humans are therefore indicated.	[Noll, Eric; Diemunsch, Sophie; Pottecher, Julien; Rameaux, Jean-Pierre; Diemunsch, Pierre] Hop Univ, Serv Anesthesie Reanimat Chirurg, Strasbourg, France; [Diana, Michele] Inst Hosp Univ Strasbourg, Strasbourg, France; [Sauleau, Eric] CHU Strasbourg, Dept Bio Stat, Strasbourg, France; [Ruetzler, Kurt] Cleveland Clin, Dept Outcomes Res, Anesthesiol Inst, Cleveland, OH 44106 USA	CHU Strasbourg; CHU Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cleveland Clinic Foundation	Diemunsch, P (corresponding author), Hop Univ, Serv Anesthesie Reanimat Chirurg, Strasbourg, France.	pierre.diemunsch@chru-strasbourg.fr	Ruetzler, Kurt/W-2596-2017; Ruetzler, Kurt/P-7101-2019; Pottecher, Julien/AAH-1572-2020	Ruetzler, Kurt/0000-0003-0467-1736; Ruetzler, Kurt/0000-0003-0467-1736; 	Fisher Paykel	Fisher Paykel	Laparoscopic Humigard insufflators were provided for free by Fisher & Paykel HealthCare. Pierre Diemunsch reported his participation in a research meeting sponsored by Fisher & Paykel in 2013. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CAMUS Y, 1995, J CLIN ANESTH, V7, P384, DOI 10.1016/0952-8180(95)00051-I; CHENG C, 1995, ANESTHESIOLOGY, V82, P1160, DOI 10.1097/00000542-199505000-00011; Diana M, 2014, ANN SURG, V259, P700, DOI 10.1097/SLA.0b013e31828d4ab3; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Grocott HP, 2004, ANESTH ANALG, V98, P298, DOI [10.1213/01.ANE.0000096242.06561.C0, 10.1213/01.ANE.0000096212.06561.C0]; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hynson J M, 1992, J Clin Anesth, V4, P194, DOI 10.1016/0952-8180(92)90064-8; HYNSON JM, 1993, ANESTHESIOLOGY, V79, P219, DOI 10.1097/00000542-199308000-00005; Jacobs VR, 1999, J AM ASSOC GYN LAP, V6, P289, DOI 10.1016/S1074-3804(99)80063-2; Janicki PK, 2001, ANESTHESIOLOGY, V95, P868, DOI 10.1097/00000542-200110000-00014; John M, 2016, BRIT J ANAESTH, V116, P249, DOI 10.1093/bja/aev412; JUST B, 1993, ANESTHESIOLOGY, V79, P214, DOI 10.1097/00000542-199308000-00004; KURZ A, 1993, ANESTH ANALG, V77, P89; Lenhardt R, 1997, ANESTHESIOLOGY, V87, P1318, DOI 10.1097/00000542-199712000-00009; MICHELSON AD, 1994, THROMB HAEMOSTASIS, V71, P633; MONAGLE J, 1993, AUST NZ J SURG, V63, P186, DOI 10.1111/j.1445-2197.1993.tb00515.x; Noll E, 2012, SURG ENDOSC, V26, P3622, DOI 10.1007/s00464-012-2385-2; Ruetzler K, 2011, ANESTH ANALG, V112, P608, DOI 10.1213/ANE.0b013e3181e7cc20; Schlotterbeck H, 2008, SURG ENDOSC, V22, P2616, DOI 10.1007/s00464-008-9841-z; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2016, LANCET, V387, P2655, DOI 10.1016/S0140-6736(15)00981-2; Sessler DI, 2009, LANCET, V374, P1049, DOI 10.1016/S0140-6736(09)61686-X; SESSLER DI, 1993, ANESTH ANALG, V77, P73; Wenisch C, 1996, ANESTH ANALG, V82, P810, DOI 10.1097/00000539-199604000-00023	24	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199369	10.1371/journal.pone.0199369	http://dx.doi.org/10.1371/journal.pone.0199369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995891	Green Published, gold, Green Submitted			2022-12-26	WOS:000438388800020
J	dos Santos, CF; Otesbelgue, A; Blochtein, B				dos Santos, Charles Fernando; Otesbelgue, Alex; Blochtein, Betina			The dilemma of agricultural pollination in Brazil: Beekeeping growth and insecticide use	PLOS ONE			English	Article							CHALLENGES; MANAGEMENT; PESTS	Pollination by bees improves agricultural crop yields and improves the financial outlook of beekeepers because it increases honey production and hive rental revenues. However, in Brazil, with a few exceptions, these benefits have been neglected in recent years because beekeepers are more interested in honey production than in agricultural pollination. The excessive and indiscriminate use of insecticides on agricultural fields in Brazil appears to be one of the principal obstacles preventing partnership between farmers and beekeepers. The goal of this study was therefore to evaluate the most recent situation in Brazil in relation to the use of insecticides, agriculture and to honey production in comparison with other countries. Our results show that Brazil is the largest consumer of insecticides in the world and that consumption has increased by > 150% over 15 years. While countries with a high Human Development Index (i.e., a measure that can also be used to question national policy choices) are reducing their levels of insecticide use in agriculture, Brazil is going in the opposite direction. It is highly likely the increase seen in other countries is a result of alternative methods for pest control rather than a result of the amount of area under agricultural cultivation and their capability to shift their economies from agriculture to other sectors. The number of hives (23%) and the volume of honey production (72%) in Brazil have, however, increased over the same period, raising Brazil to the ninth highest honey producer in the world. Although the data on apiculture are promising, the growth in use of insecticides in Brazil is a cause for concern because they leave residuals on bee products, on crops, and in the environment. Civil society and government in Brazil should encourage reductions in insecticide use and better relations between agricultural farmers and beekeepers.	[dos Santos, Charles Fernando; Otesbelgue, Alex; Blochtein, Betina] Pontificia Univ Catolia Rio Grande Sul, Escola Ciencias, Dept Biodiversidade & Ecol, Porto Alegre, RS, Brazil; [Blochtein, Betina] Pontificia Univ Catolia Rio Grande Sul, Inst Meio Ambiente, Porto Alegre, RS, Brazil		dos Santos, CF; Blochtein, B (corresponding author), Pontificia Univ Catolia Rio Grande Sul, Escola Ciencias, Dept Biodiversidade & Ecol, Porto Alegre, RS, Brazil.; Blochtein, B (corresponding author), Pontificia Univ Catolia Rio Grande Sul, Inst Meio Ambiente, Porto Alegre, RS, Brazil.	charles.santos@pucrs.br; betinabl@pucrs.br	dos Santos, Charles Fernando/AAD-2347-2020; Blochtein, Betina/B-9412-2014; dos Santos, Charles Fernando/F-8617-2012	Blochtein, Betina/0000-0001-8452-1716; dos Santos, Charles Fernando/0000-0001-5181-2461; Otesbelgue, Alex/0000-0002-8832-1241	Programa de Bolsas Pesquisa Alunos da PUCRS/BPA [01/2017]	Programa de Bolsas Pesquisa Alunos da PUCRS/BPA	CFS is grateful to the Programa Nacional de Pos-Doutorado (PNPD) from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). AO is grateful to the Programa de Bolsas Pesquisa Alunos da PUCRS/BPA (No 01/2017). BB is grateful to the Produtividade em Pesquisa do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the committee of the VI Simposio de Biodiversidade of the Universidade Federal de Santa Maria, especially to Andressa Paladini PhD, whose invitation to CFS for a talk about bee extinction led to the development of this manuscript. CFS is grateful to the Programa Nacional de Pos-Doutorado (PNPD) from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). AO is grateful to the Programa de Bolsas Pesquisa Alunos da PUCRS/BPA (No 01/2017). BB is grateful to the Produtividade em Pesquisa do Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Barbosa WF, 2015, ENVIRON TOXICOL CHEM, V34, P2149, DOI 10.1002/etc.3053; BELLOTTI A C, 1990, Journal of Agricultural Entomology, V7, P191; Brazil, 2010, PEST REL PROD COMM B; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Cerqueira A, 2017, ACTA BRAS, V1, P17, DOI 10.22571/Actabra13201754; Cham K de O, 2017, MANUAL AVALIACAO RIS; Ciereszko A, 2017, APIDOLOGIE, V48, P211, DOI 10.1007/s13592-016-0466-2; Cullen E. M., 2008, American Entomologist, V54, P170; Dasgupta S, 2001, ENVIRON DEV ECON, V6, P459, DOI 10.1017/S1355770X01000262; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devkota K., 2016, Agriculture and Food Security, V5; Dorneles AL, 2017, APIDOLOGIE, V48, P612, DOI 10.1007/s13592-017-0502-x; dos Santos CF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31605; FAO, 2017, DATA; Fathy KH., 2012, INSECTICIDES ADV INT, P17, DOI [DOI 10.5772/27852, 10.5772/27852]; Fox J., 2018, R COMPANION APPL REG, VThird; FREITAS B. M., 2012, POLINIZADORES NO BRA, P103; Giannini TC, 2015, J ECON ENTOMOL, V108, P849, DOI 10.1093/jee/tov093; Gianquitto T, 2014, AMERICA'S DARWIN: DARWINIAN THEORY AND U.S. LITERARY CULTURE, P1, DOI 10.1007/s13592-014-0316-z; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Halinski R, 2015, REV BRAS ENTOMOL, V59, P222, DOI 10.1016/j.rbe.2015.07.001; Hamerschlag K., 2007, MORE INTEGRATED PEST; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Jaffe R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121157; Klatt B.K., 2014, AGR FOOD SEC, V3, P14, DOI [10.1186/2048-7010-3-14, DOI 10.1186/2048-7010-3-14]; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Lundin O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136928; Mamun M. S. A., 2011, The Journal of Plant Protection Sciences, V3, P1; MAPA, 2020, MAPA MINISTERIO AGRI; Mitchell EAD, 2017, SCIENCE, V358, P109, DOI 10.1126/science.aan3684; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morais MM, 2012, POLINIZADORES BRASIL, P488; Novais SMA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167292; Oliveira CM, 2014, CROP PROT, V56, P50, DOI 10.1016/j.cropro.2013.10.022; Oliver TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10122; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; R Core Team, 2021, R LANGUAGE ENV STAT; Rebek EJ, 2012, INSECTICIDES BASIC O, P171, DOI DOI 10.5772/29887; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Scott-Dupree C., 1995, GUIDE MANAGING BEES; Sgolastra F, 2017, PEST MANAG SCI, V73, P1236, DOI 10.1002/ps.4449; Spurgeon D., 2016, EFSA SUPPORT PUBL, V13, P66, DOI [10.2903/sp.efsa.2016.EN-1076, DOI 10.2903/SP.EFSA.2016.EN-1076]; Thompson HM, 2005, ECOTOXICOLOGY, V14, P757, DOI 10.1007/s10646-005-0024-6; Tosi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1711; Tosi S, 2018, SCI TOTAL ENVIRON, V615, P208, DOI 10.1016/j.scitotenv.2017.09.226; Urban D., 2007, CATALOGUE BEES HYMEN; Venturieri GC, 2012, POLINIZAODRES BRASIL, P488; Willer H., 2018, WORLD ORGANIC AGR ST, DOI [10.4324/9781849775991, DOI 10.4324/9781849775991]; Woodcock BA, 2014, J APPL ECOL, V51, P142, DOI 10.1111/1365-2664.12171; Woodcock T.S., 2012, POLLINATION AGR LAND; Zotti MJ, 2015, NEOTROP ENTOMOL, V44, P197, DOI 10.1007/s13744-015-0291-8	60	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200286	10.1371/journal.pone.0200286	http://dx.doi.org/10.1371/journal.pone.0200286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM1FJ	29979763	Green Published, Green Submitted, gold			2022-12-26	WOS:000437809500091
J	Best, SA; Harapas, CR; Kersbergen, A; Rathi, V; Asselin-Labat, ML; Sutherland, KD				Best, Sarah A.; Harapas, Cassandra R.; Kersbergen, Ariena; Rathi, Vivek; Asselin-Labat, Marie-Liesse; Sutherland, Kate D.			FGFR3-TACC3 is an oncogenic fusion protein in respiratory epithelium	ONCOGENE			English	Article							CELL LUNG-CANCER; MEDIATED GENE-TRANSFER; MOUSE MODEL; STEM-CELLS; TUMOR-SUPPRESSOR; OF-ORIGIN; IN-VIVO; ADENOCARCINOMA; IDENTIFICATION; CARCINOMA	Structural rearrangements of the genome can drive lung tumorigenesis through the generation of fusion genes with oncogenic properties. Advanced genomic approaches have identified the presence of a genetic fusion between fibroblast growth factor receptor 3 (FGFR3) and transforming acidic coiled-coil 3 (TACC3) in non-small cell lung cancer (NSCLC), providing a novel target for FGFR inhibition. To interrogate the functional consequences of the FGFR3-TACC3 fusion in the transformation of lung epithelial cells, we generated a novel transgenic mouse model that expresses FGFR3-TACC3 concomitant with loss of the p53 tumor suppressor gene. Intranasal delivery of an Ad5-CMV-Cre virus promoted seromucinous glandular transformation of olfactory cells lining the nasal cavities of FGFR3-TACC3 (LSL-F3T3) mice, which was further accelerated upon loss of p53 (LSL-F3T3/p53). Surprisingly, lung tumors failed to develop in intranasally infected LSL-F3T3 and LSL-F3T3/p53 mice. In line with these observations, we demonstrated that intranasal delivery of Ad5-CMV-Cre induces widespread Cre-mediated recombination in the olfactory epithelium. Intra-tracheal delivery of Ad5-CMV-Cre into the lungs of LSL-F3T3 and LSL-F3T3/p53 mice, however, resulted in the development of lung adenocarcinomas. Taken together, these findings provide in vivo evidence for an oncogenic function of FGFR3-TACC3 in respiratory epithelium.	[Best, Sarah A.; Harapas, Cassandra R.; Kersbergen, Ariena; Asselin-Labat, Marie-Liesse; Sutherland, Kate D.] Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia; [Best, Sarah A.; Asselin-Labat, Marie-Liesse; Sutherland, Kate D.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Rathi, Vivek] Univ Melbourne, St Vincents Hosp, Dept Anat Pathol, Fitzroy, Vic 3065, Australia	Walter & Eliza Hall Institute; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Sutherland, KD (corresponding author), Walter & Eliza Hall Inst Med Res, ACRF Stem Cells & Canc Div, Parkville, Vic 3052, Australia.; Sutherland, KD (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	sutherland.k@wehi.edu.au	Rathi, Vivek/AAD-5983-2021	Best, Sarah/0000-0002-4232-9432; Sutherland, Kate/0000-0002-7453-3366	Worldwide Cancer Research Project Grant [14-0433]; Victorian Cancer Agency (VCA) Early Career Seed Grant [ECSG16001]; Viertel Foundation Senior Medical Research Fellowship; Peter and Julie Alston Centenary Fellowship	Worldwide Cancer Research Project Grant; Victorian Cancer Agency (VCA) Early Career Seed Grant; Viertel Foundation Senior Medical Research Fellowship; Peter and Julie Alston Centenary Fellowship	We are grateful to C. Alvarado, L. Scott, H. Johnson, K. Birchall, and L. Mackiewicz for animal husbandry, E. Tsui and C. Tsui in the WEHI Histology Facility for expert support and P. Maltezos for preparation of the nasal cavity graphic image. The authors thank T. Wilson, J. Mighall, and J. Pasquet for technical support and W. Alexander for useful discussions and critically reading the manuscript. This work was supported in part by a Worldwide Cancer Research Project Grant [14-0433]. SAB is supported by a Victorian Cancer Agency (VCA) Early Career Seed Grant (ECSG16001); M-LA-L is supported by a Viertel Foundation Senior Medical Research Fellowship; KDS is supported by the Peter and Julie Alston Centenary Fellowship. This work was made possible through Victorian Government Operational Infrastructure Support and Australian Government.	[Anonymous], 2016, CANC FACTS FIG 2016; Arimoto Y, 2002, ACTA OTO-LARYNGOL, V122, P627, DOI 10.1080/000164802320396303; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Best SA, 2018, CELL METAB, V27, P935, DOI 10.1016/j.cmet.2018.02.006; Best SA, 2018, METHODS MOL BIOL, V1725, P15, DOI 10.1007/978-1-4939-7568-6_2; Best SA, 2017, J INVEST DERMATOL, V137, P506, DOI 10.1016/j.jid.2016.09.027; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Capelletti M, 2014, CLIN CANCER RES, V20, P6551, DOI 10.1158/1078-0432.CCR-14-1337; Carneiro BA, 2015, GYNECOL ONCOL REP, V13, P53, DOI 10.1016/j.gore.2015.06.005; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Daly C, 2017, ONCOGENE, V36, P471, DOI 10.1038/onc.2016.216; Damjanovic Daniela, 2008, Genet Vaccines Ther, V6, P5, DOI 10.1186/1479-0556-6-5; Doi K, 2005, ANN OTO RHINOL LARYN, V114, P629, DOI 10.1177/000348940511400808; Duggan CD, 2007, NAT NEUROSCI, V10, P673, DOI 10.1038/nn0607-673; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; George J, 2015, NATURE, V524, P47, DOI 10.1038/nature14664; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hatch TF, 1964, PULM DEP RET INH AER; Huijbers IJ, 2014, EMBO MOL MED, V6, P212, DOI 10.1002/emmm.201303297; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Johnson VJ, 2007, J IMMUNOL, V179, P1864, DOI 10.4049/jimmunol.179.3.1864; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Leong HS, 2013, CANCER RES, V73, P1591, DOI 10.1158/0008-5472.CAN-12-3019; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Majewski IJ, 2013, J PATHOL, V230, P270, DOI 10.1002/path.4209; Mollaoglu G, 2017, CANCER CELL, V31, P270, DOI 10.1016/j.ccell.2016.12.005; Mukhopadhyay A, 2014, CELL REP, V8, P40, DOI 10.1016/j.celrep.2014.05.036; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nelson KN, 2016, MOL CANCER RES, V14, P458, DOI 10.1158/1541-7786.MCR-15-0497; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Parker BC, 2013, J CLIN INVEST, V123, P855, DOI 10.1172/JCI67144; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Sharpless NE, 2006, NAT REV DRUG DISCOV, V5, P741, DOI 10.1038/nrd2110; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soda M, 2008, P NATL ACAD SCI USA, V105, P19893, DOI 10.1073/pnas.0805381105; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Sutherland KD, 2010, MOL ONCOL, V4, P397, DOI 10.1016/j.molonc.2010.05.002; Weeden CE, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000731; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xu CX, 2014, CANCER CELL, V25, P590, DOI 10.1016/j.ccr.2014.03.033; Yin YJ, 2013, CANCER RES, V73, P5730, DOI 10.1158/0008-5472.CAN-13-0495; Yuan L, 2014, CANCER BIOL THER, V15, P1613, DOI 10.4161/15384047.2014.961874; Zehir A, 2017, NAT MED, V23, P703, DOI 10.1038/nm.4333; Zhao HQ, 1996, J NEUROBIOL, V30, P521, DOI 10.1002/(SICI)1097-4695(199608)30:4<521::AID-NEU7>3.0.CO;2-5	58	6	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 15	2018	37	46					6096	6104		10.1038/s41388-018-0399-5	http://dx.doi.org/10.1038/s41388-018-0399-5			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HA3SQ	29991799	Green Accepted			2022-12-26	WOS:000450175900007
J	Domingues, MN; Souza, FHM; Vieira, PS; de Morais, MAB; Zanphorlin, LM; dos Santos, CR; Pirolla, RAS; Honorato, RV; de Oliveira, PSL; Gozzo, FC; Murakami, MT				Domingues, Mariane Noronha; Moreira Souza, Flavio Henrique; Vieira, Plinio Salmazo; Bueno de Morais, Mariana Abrahao; Zanphorlin, Leticia Maria; dos Santos, Camila Ramos; Siqueira Pirolla, Renan Augusto; Honorato, Rodrigo Vargas; Lopes de Oliveira, Paulo Sergio; Gozzo, Fabio Cesar; Murakami, Mario Tyago			Structural basis of exo--mannanase activity in the GH2 family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; enzyme; enzyme catalysis; protein structure; protein conformation; site-directed mutagenesis; exo--mannanase; GH2 family; molecular mechanism; Xanthomonas axonopodis pv; citri	BIOLOGICAL MACROMOLECULES; STRUCTURE REFINEMENT; SOLUTION SCATTERING; BETA-GALACTOSIDASE; MOLECULAR GRAPHICS; CRYSTAL-STRUCTURE; GUAR GUM; SPECIFICITY; MANNOSIDASE; RESOLUTION	The classical microbial strategy for depolymerization of -mannan polysaccharides involves the synergistic action of at least two enzymes, endo-1,4--mannanases and -mannosidases. In this work, we describe the first exo--mannanase from the GH2 family, isolated from Xanthomonas axonopodis pv. citri (XacMan2A), which can efficiently hydrolyze both manno-oligosaccharides and -mannan into mannose. It represents a valuable process simplification in the microbial carbon uptake that could be of potential industrial interest. Biochemical assays revealed a progressive increase in the hydrolysis rates from mannobiose to mannohexaose, which distinguishes XacMan2A from the known GH2 -mannosidases. Crystallographic analysis indicates that the active-site topology of XacMan2A underwent profound structural changes at the positive-subsite region, by the removal of the physical barrier canonically observed in GH2 -mannosidases, generating a more open and accessible active site with additional productive positive subsites. Besides that, XacMan2A contains two residue substitutions in relation to typical GH2 -mannosidases, Gly(439) and Gly(556), which alter the active site volume and are essential to its mode of action. Interestingly, the only other mechanistically characterized mannose-releasing exo--mannanase so far is from the GH5 family, and its mode of action was attributed to the emergence of a blocking loop at the negative-subsite region of a cleft-like active site, whereas in XacMan2A, the same activity can be explained by the removal of steric barriers at the positive-subsite region in an originally pocket-like active site. Therefore, the GH2 exo--mannanase represents a distinct molecular route to this rare activity, expanding our knowledge about functional convergence mechanisms in carbohydrate-active enzymes.	[Bueno de Morais, Mariana Abrahao; Zanphorlin, Leticia Maria; dos Santos, Camila Ramos; Murakami, Mario Tyago] Brazilian Bioethanol Sci & Technol Lab, BR-13083970 Campinas, SP, Brazil; [Honorato, Rodrigo Vargas; Lopes de Oliveira, Paulo Sergio] Brazilian Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Gozzo, Fabio Cesar] Univ Estadual Campinas, Dalton Mass Spectrometry Lab, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas	Murakami, MT (corresponding author), Brazilian Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@ctbe.cnpem.br	Oliveira, Paulo S/K-5588-2013; Murakami, Mario T/F-5640-2016; Santos, Camila Ramos dos/F-7095-2013; Vargas Honorato, Rodrigo/H-9773-2013	Murakami, Mario T/0000-0002-0405-8010; Santos, Camila Ramos dos/0000-0003-0652-4211; Domingues, Mariane/0000-0003-0229-8261; Morais, Mariana Abrahao Bueno de/0000-0003-1012-1394; Pirolla, Renan/0000-0002-0949-8875; Vargas Honorato, Rodrigo/0000-0001-5267-3002	Sao Paulo Research Foundation (FAPESP) [2015/26982-0]; FAPESP [2013/24622-0, 2016/06509-0, 2016/19995-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) Grant 2015/26982-0 (to M. T. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ardevol A, 2015, J AM CHEM SOC, V137, P7528, DOI 10.1021/jacs.5b01156; BETTIOL JLP, 2000, Patent No. 1059351; Brett C. T., 1996, TOPICS PLANT FUNCTIO; Capek P, 2000, CARBOHYD RES, V329, P635, DOI 10.1016/S0008-6215(00)00210-X; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Chauhan PS, 2014, BIOPROC BIOSYST ENG, V37, P1459, DOI 10.1007/s00449-013-1118-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Dias FMV, 2004, J BIOL CHEM, V279, P25517, DOI 10.1074/jbc.M401647200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Cairo JPLF, 2013, INSECT BIOCHEM MOLEC, V43, P970, DOI 10.1016/j.ibmb.2013.07.007; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Ge X, 2001, ANAL CHEM, V73, P5078, DOI 10.1021/ac0105890; Guillotin L, 2017, BIOCHIMIE, V137, P190, DOI 10.1016/j.biochi.2017.03.020; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Hashimoto H, 2006, CELL MOL LIFE SCI, V63, P2954, DOI 10.1007/s00018-006-6195-3; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lavoie J. M., 2011, BIOFUELS ENG PROCESS, V29, P307; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Malgas S, 2015, WORLD J MICROB BIOT, V31, P1167, DOI 10.1007/s11274-015-1878-2; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mussini F. J., 2011, International Journal of Poultry Science, V10, P778; Naran R, 2007, PLANT J, V50, P95, DOI 10.1111/j.1365-313X.2007.03033.x; Nascimento AS, 2014, FEBS J, V281, P4165, DOI 10.1111/febs.12894; Nunes FM, 2006, J AGR FOOD CHEM, V54, P3428, DOI 10.1021/jf052971+; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pangsri P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1565-7; Parisi GC, 2002, DIGEST DIS SCI, V47, P1697, DOI 10.1023/A:1016419906546; Pee V, 2002, Patent, Patent No. [EP0871596, 0871596]; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SANDIN RL, 1987, J MED MICROBIOL, V24, P145, DOI 10.1099/00222615-24-2-145; Santos CR, 2014, J BIOL CHEM, V289, P7362, DOI 10.1074/jbc.M113.537167; Santos CR, 2014, J BIOL CHEM, V289, P32186, DOI 10.1074/jbc.M114.605105; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Skalova T, 2005, J MOL BIOL, V353, P282, DOI 10.1016/j.jmb.2005.08.028; Srivastava PK, 2014, PREP BIOCHEM BIOTECH, V44, P392, DOI 10.1080/10826068.2013.833108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tailford LE, 2008, NAT CHEM BIOL, V4, P306, DOI 10.1038/nchembio.81; Tailford LE, 2007, J BIOL CHEM, V282, P11291, DOI 10.1074/jbc.M610964200; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Zyl WH, 2010, PROCESS BIOCHEM, V45, P1203, DOI 10.1016/j.procbio.2010.05.011; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Yamabhai M, 2016, CRIT REV BIOTECHNOL, V36, P32, DOI 10.3109/07388551.2014.923372	61	11	11	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13636	13649		10.1074/jbc.RA118.002374	http://dx.doi.org/10.1074/jbc.RA118.002374			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29997257	hybrid, Green Published			2022-12-26	WOS:000443375500023
J	Luczkowiak, J; Matamoros, T; Menendez-Arias, L				Luczkowiak, Joanna; Matamoros, Tania; Menendez-Arias, Luis			Template-primer binding affinity and RNase H cleavage specificity contribute to the strand transfer efficiency of HIV-1 reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						reverse transcription; human immunodeficiency virus (HIV); DNA synthesis; retrovirus; ribonuclease; RNase H; strand transfer; template-primer binding	NONTEMPLATED NUCLEOTIDE ADDITION; COPY-CHOICE RECOMBINATION; NUCLEOCAPSID PROTEIN; DNA-SYNTHESIS; LIBRARY CONSTRUCTION; STEADY-STATE; FREQUENCY; FIDELITY; REPLICATION; MUTATIONS	During reverse transcription of the HIV-1 genome, two strand-transfer events occur. Both events rely on the RNase H cleavage activity of reverse transcriptases (RTs) and template homology. Using a panel of mutants of HIV-1(BH10) (group M/subtype B) and HIV-1(ESP49) (group O) RTs and in vitro assays, we demonstrate that there is a strong correlation between RT minus-strand transfer efficiency and template-primer binding affinity. The highest strand transfer efficiencies were obtained with HIV-1(ESP49) RT mutants containing the substitutions K358R/A359G/S360A, alone or in combination with V148I or T355A/Q357M. These HIV-1(ESP49) RT mutants had been previously engineered to increase their DNA polymerase activity at high temperatures. Now, we found that RTs containing RNase H-inactivating mutations (D443N or E478Q) were devoid of strand transfer activity, whereas enzymes containing F61A or L92P had very low strand transfer activity. The strand transfer defect produced by L92P was attributed to a loss of template-primer binding affinity and, more specifically, to the higher dissociation rate constants (k(off)) shown by RTs bearing this substitution. Although L92P also deleteriously affected the RT's nontemplated nucleotide addition activity, neither nontemplated nucleotide addition activity nor the RT's clamp activities contributed to increased template switching when all tested mutant and WT RTs were considered. Interestingly, our results also revealed an association between efficient strand transfer and the generation of secondary cleavages in the donor RNA, consistent with the creation of invasion sites. Exposure of the elongated DNA at these sites facilitate acceptor (RNA or DNA) binding and promote template switching.	CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain; Univ Autonoma Madrid, C Nicolas Cabrera 1,Campus Cantoblanco, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Menendez-Arias, L (corresponding author), Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1,Campus Cantoblanco, Madrid 28049, Spain.	lmenendez@cbm.csic.es	Luczkowiak, Joanna/H-3912-2014; Menendez Arias, Luis/N-7447-2016	Luczkowiak, Joanna/0000-0001-6950-9372; Menendez Arias, Luis/0000-0002-1251-6640				Agopian A, 2007, J MOL BIOL, V373, P127, DOI 10.1016/j.jmb.2007.07.044; Alvarez M, 2009, J MOL BIOL, V392, P872, DOI 10.1016/j.jmb.2009.07.081; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Berkhout B, 2001, RNA, V7, P1097, DOI 10.1017/S1355838201002035; Betancor G, 2010, ANTIMICROB AGENTS CH, V54, P4799, DOI 10.1128/AAC.00716-10; Boretto J, 2001, ANAL BIOCHEM, V292, P139, DOI 10.1006/abio.2001.5045; Brincat JL, 2002, J VIROL, V76, P88, DOI 10.1128/JVI.76.1.88-95.2002; Cameron CE, 1997, P NATL ACAD SCI USA, V94, P6700, DOI 10.1073/pnas.94.13.6700; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Darlix JL, 2011, J MOL BIOL, V410, P565, DOI 10.1016/j.jmb.2011.03.037; Delviks-Frankenberry K, 2011, VIRUSES-BASEL, V3, P1650, DOI 10.3390/v3091650; Derebail SS, 2003, J BIOL CHEM, V278, P15702, DOI 10.1074/jbc.M211701200; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Fisher TS, 2003, J MOL BIOL, V325, P443, DOI 10.1016/S0022-2836(02)01225-1; Fisher TS, 2002, J BIOL CHEM, V277, P22345, DOI 10.1074/jbc.M200282200; Golinelli MP, 2002, BIOCHEMISTRY-US, V41, P5894, DOI 10.1021/bi0160415; Golinelli MP, 2002, VIROLOGY, V294, P122, DOI 10.1006/viro.2001.1322; Hanson MN, 2006, J MOL BIOL, V363, P878, DOI 10.1016/j.jmb.2006.08.068; Head SR, 2014, BIOTECHNIQUES, V56, P61, DOI 10.2144/000114133; Herzig E, 2015, J VIROL, V89, P8119, DOI 10.1128/JVI.00809-15; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P12209, DOI 10.1073/pnas.221289898; KATI WM, 1992, J BIOL CHEM, V267, P25988; Langevin SA, 2013, RNA BIOL, V10, P502, DOI 10.4161/rna.24284; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Levin JG, 2010, RNA BIOL, V7, P754, DOI 10.4161/rna.7.6.14115; Liu SX, 2008, SCIENCE, V322, P1092, DOI 10.1126/science.1163108; Matamoros T, 2005, J MOL BIOL, V349, P451, DOI 10.1016/j.jmb.2005.04.004; Matamoros T, 2013, BIOCHEMISTRY-US, V52, P9318, DOI 10.1021/bi401390x; Menendez-Arias L, 1998, BIOCHEMISTRY-US, V37, P16636, DOI 10.1021/bi981830g; Menendez-Arias L, 2001, J BIOL CHEM, V276, P27470, DOI 10.1074/jbc.M104342200; Menendez-Arias L, 2017, VIRUS RES, V234, P153, DOI 10.1016/j.virusres.2016.12.019; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; Moumen A, 2001, NUCLEIC ACIDS RES, V29, P3814, DOI 10.1093/nar/29.18.3814; Muchiri JM, 2011, J MOL BIOL, V412, P354, DOI 10.1016/j.jmb.2011.07.055; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Nguyen LA, 2012, J MOL BIOL, V415, P248, DOI 10.1016/j.jmb.2011.11.014; Nikolenko GN, 2004, J VIROL, V78, P8761, DOI 10.1128/JVI.78.16.8761-8770.2004; Ohtsubo Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41769; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Operario DJ, 2006, J BIOL CHEM, V281, P32113, DOI 10.1074/jbc.M604665200; Oz-Gleenberg I, 2011, NUCLEIC ACIDS RES, V39, P1042, DOI 10.1093/nar/gkq786; Piekna-Przybylska D, 2011, RNA BIOL, V8, P230, DOI 10.4161/rna.8.2.14802; Purohit V, 2005, J BIOL CHEM, V280, P40534, DOI 10.1074/jbc.M507839200; REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013; Schlub TE, 2014, J VIROL, V88, P3837, DOI 10.1128/JVI.03136-13; Simon-Loriere E, 2011, RNA BIOL, V8, P280, DOI 10.4161/rna.8.2.15193; Svarovskaia ES, 2000, J VIROL, V74, P7171, DOI 10.1128/JVI.74.15.7171-7178.2000; TANESE N, 1991, J VIROL, V65, P4387, DOI 10.1128/JVI.65.8.4387-4397.1991; Vo MN, 2006, J MOL BIOL, V363, P244, DOI 10.1016/j.jmb.2006.08.039; Vuilleumier S, 2015, CURR OPIN HIV AIDS, V10, P84, DOI 10.1097/COH.0000000000000137; Warrilow D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013229; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02	54	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 31	2018	293	35					13351	13363		10.1074/jbc.RA118.004324	http://dx.doi.org/10.1074/jbc.RA118.004324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GS2JV	29991591	Green Published, hybrid			2022-12-26	WOS:000443375500001
J	Rosling, JEO; Ridgway, MC; Summers, RL; Kirk, K; Lehane, AM				Rosling, James E. O.; Ridgway, Melanie C.; Summers, Robert L.; Kirk, Kiaran; Lehane, Adele M.			Biochemical characterization and chemical inhibition o PfATP4-associated Na+-ATPase activity in Plasmodium falciparum membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; MALARIA-INFECTED ERYTHROCYTES; X-RAY-MICROANALYSIS; SPIROINDOLONE ANTIMALARIALS; PARASITE; PFATP4; TRANSPORT; CHANNEL; TARGET; HOMEOSTASIS	The antimalarial activity of chemically diverse compounds, including the clinical candidate cipargamin, has been linked to the ATPase PfATP4 in the malaria-causing parasite Plasmodium falciparum. The characterization of PfATP4 has been hampered by the inability thus far to achieve its functional expression in a heterologous system. Here, we optimized a membrane ATPase assay to probe the function of PfATP4 and its chemical sensitivity. We found that cipargamin inhibited the Na+-dependent ATPase activity present in P. falciparum membranes from WT parasites and that its potency was reduced in cipargamin-resistant PfATP4-mutant parasites. The cipargamin-sensitive fraction of membrane ATPase activity was inhibited by all 28 of the compounds in the "Malaria Box" shown previously to disrupt ion regulation in P. falciparum in a cipargamin-like manner. This is consistent with PfATP4 being the direct target of these compounds. Characterization of the cipargamin-sensitive ATPase activity yielded data consistent with PfATP4 being a Na+ transporter that is sensitive to physiologically relevant perturbations of pH, but not of [K+] or [Ce2+]. With an apparent K-m for ATP of 0.2 mm and an apparent K-m for Na+ of 16 -17 mm, the protein is predicted to operate at below its half-maximal rate under normal physiological conditions, allowing the rate of Na+ efflux to increase in response to an increase in cytosolic [Na+]. In membranes from a cipargamin-resistant PfATP4-mutant line, the apparent K-m for Na+ is slightly elevated. Our study provides new insights into the biochemical properties and chemical sensitivity of an important new antimalarial drug target.	[Rosling, James E. O.; Ridgway, Melanie C.; Summers, Robert L.; Kirk, Kiaran; Lehane, Adele M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia	Australian National University	Kirk, K; Lehane, AM (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia.	kiaran.kirk@anu.edu.au; adele.lehane@anu.edu.au	Summers, Robert L/E-8982-2012; Lehane, Adele M/B-4127-2012; Kirk, Kiaran/C-8299-2009	Summers, Robert L/0000-0003-0840-1784; Lehane, Adele M/0000-0002-0050-9101; Kirk, Kiaran/0000-0002-5613-2622; Ridgway, Melanie/0000-0002-6763-2366	Australian Research Council [DE160101035, LP150101226]; National Health and Medical Research Council [1042272]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council Discovery Early Career Researcher Award (DE160101035 to A. M. L.), an Australian Research Council Linkage Project Grant (LP150101226 to K. K.), and a National Health and Medical Research Council Project Grant (1042272 to K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Allen RJW, 2010, MOL BIOCHEM PARASIT, V169, P63, DOI 10.1016/j.molbiopara.2009.09.005; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; de Almeida-Amaral EE, 2008, EXP PARASITOL, V118, P165, DOI 10.1016/j.exppara.2007.07.001; Dennis ASM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26819-1; Dennis ASM, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00087-18, 10.1128/aac.00087-18]; Desai SA, 1997, P NATL ACAD SCI USA, V94, P2045, DOI 10.1073/pnas.94.5.2045; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Ernst Orna, 2010, J Vis Exp, DOI 10.3791/1918; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; Goldgof GM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27806; Hapuarachchi SV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006180; Hewitt SN, 2017, ACS INFECT DIS, V3, P34, DOI 10.1021/acsinfecdis.6b00078; KIRK K, 1994, J BIOL CHEM, V269, P3339; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LEE P, 1988, AM J TROP MED HYG, V39, P157, DOI 10.4269/ajtmh.1988.39.157; Lehane AM, 2014, MOL MICROBIOL, V94, P327, DOI 10.1111/mmi.12765; Mauritz JMA, 2011, BIOPHYS J, V100, P1438, DOI 10.1016/j.bpj.2011.02.007; ROBINSON JD, 1981, J NEUROCHEM, V37, P140, DOI 10.1111/j.1471-4159.1981.tb05301.x; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Saliba KJ, 1999, J BIOL CHEM, V274, P33213, DOI 10.1074/jbc.274.47.33213; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Spry C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054974; Staines HM, 2001, AM J PHYSIOL-CELL PH, V280, pC1576, DOI 10.1152/ajpcell.2001.280.6.C1576; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WINKLER BS, 1980, INVEST OPHTH VIS SCI, V19, P562; Winterberg M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29241; Zahler R, 1997, J GEN PHYSIOL, V110, P201, DOI 10.1085/jgp.110.2.201	37	20	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 24	2018	293	34					13327	13337		10.1074/jbc.RA118.003640	http://dx.doi.org/10.1074/jbc.RA118.003640			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GR6BO	29986883	Green Published, hybrid			2022-12-26	WOS:000442730200029
J	Craig, JW; Mina, MJ; Crombie, JL; LaCasce, AS; Weinstock, DM; Pinkus, GS; Pozdnyakova, O				Craig, Jeffrey W.; Mina, Michael J.; Crombie, Jennifer L.; LaCasce, Ann S.; Weinstock, David M.; Pinkus, Geraldine S.; Pozdnyakova, Olga			Assessment of CD52 expression in "double-hit" and "double-expressor" lymphomas: Implications for clinical trial eligibility	PLOS ONE			English	Article							B-CELL LYMPHOMA; RITUXIMAB PLUS CYCLOPHOSPHAMIDE; HEMATOLOGIC NEOPLASMS; ANTIBODY THERAPIES; T-CELLS; CLASSIFICATION; MACROPHAGES; VINCRISTINE; INVOLVEMENT; DOXORUBICIN	"Double-hit" and "double-expressor" lymphomas represent distinct but overlapping subsets of aggressive B-cell non-Hodgkin lymphoma. The high rates of bone marrow involvement by these lymphomas pose a major therapeutic challenge due to the chemotherapy-resistant nature of the bone marrow microenvironment and the limited utility of rituximab-based salvage regimens in patients with relapsed/refractory disease. Preclinical studies utilizing highdose cyclophosphamide in combination with the anti-CD52 monoclonal antibody alemtuzumab have recently shown promise in the treatment of intramedullary disease, and a Phase I human trial is now underway. In support of such efforts, here we perform CD52 target validation on a series of double-hit (n = 40) and double-expressor (n = 58) lymphomas using immunohistochemistry. CD52 expression levels varied considerably across samples, however positive staining was observed in 75% of both double-hit and double-expressor lymphomas. Similarly, high levels of CD52 expression were seen in patients whose disease was associated with high-risk clinical features, including primary refractory status (73%), higher IPI score (76%), and bone marrow involvement (74%). CD52 expression was not significantly correlated with diagnostically relevant pathologic features such as morphology, cytogenetic findings or other immunophenotypic features, but was notably present in all cases lacking CD20 expression (n = 6). We propose that CD52 expression status be evaluated on a case-by-case basis to guide eligibility for clinical trial enrollment.	[Craig, Jeffrey W.; Mina, Michael J.; Pinkus, Geraldine S.; Pozdnyakova, Olga] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Craig, Jeffrey W.; Mina, Michael J.; Crombie, Jennifer L.; LaCasce, Ann S.; Pinkus, Geraldine S.; Pozdnyakova, Olga] Harvard Med Sch, Boston, MA 02115 USA; [Crombie, Jennifer L.; LaCasce, Ann S.; Weinstock, David M.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Weinstock, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA USA; [Pozdnyakova, Olga] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pozdnyakova, O (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.; Pozdnyakova, O (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Pozdnyakova, O (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.	opozdnyakova@bwh.harvard.edu		Craig, Jeffrey William/0000-0003-1295-3258	Ann LaCasce - Seattle Genetics; BMS; Forty Seven	Ann LaCasce - Seattle Genetics; BMS(Bristol-Myers Squibb); Forty Seven	Ann LaCasce - Seattle Genetics: Consultancy, Research Funding; BMS: Consultancy; Forty Seven: Consultancy, Membership on an entity's Board of Directors or advisory committees. The funder provided support in the form of salaries for author (ASL), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bertram HC, 2001, AM J CLIN PATHOL, V116, P191; Bonavida B, 2014, SEMIN ONCOL, V41, P667, DOI 10.1053/j.seminoncol.2014.08.006; Cao WQ, 2008, AM J CLIN PATHOL, V129, P926, DOI 10.1309/8UVF7YQ1D4D4ETQV; Coiffier B, 2016, AM SOC HEMATOL ED PR, V2016, P366, DOI DOI 10.1182/ASHEDUCATI0N-2016.1.366; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Cuccuini W, 2012, BLOOD, V119, P4619, DOI 10.1182/blood-2012-01-406033; Ginaldi L, 1998, LEUKEMIA RES, V22, P185, DOI 10.1016/S0145-2126(97)00158-6; Green TM, 2012, J CLIN ONCOL, V30, P3460, DOI 10.1200/JCO.2011.41.4342; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hiraga J, 2009, BLOOD, V113, P4885, DOI 10.1182/blood-2008-08-175208; Johnson NA, 2012, J CLIN ONCOL, V30, P3452, DOI 10.1200/JCO.2011.41.0985; Kang BW, 2013, CANCER RES TREAT, V45, P112, DOI 10.4143/crt.2013.45.2.112; Kennedy GA, 2002, BRIT J HAEMATOL, V119, P412, DOI 10.1046/j.1365-2141.2002.03843.x; Krause DS, 2015, HAEMATOLOGICA, V100, P1376, DOI 10.3324/haematol.2014.113852; Ku M, 2017, BLOOD REV, V31, P23, DOI 10.1016/j.blre.2016.08.001; Leskov I, 2013, ONCOGENE, V32, P1066, DOI 10.1038/onc.2012.117; Lossos C, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.47.47; Lu CS, 2015, LEUKEMIA LYMPHOMA, V56, P2047, DOI 10.3109/10428194.2014.982636; Mantovani A, 2015, J EXP MED, V212, P435, DOI 10.1084/jem.20150295; Oki Y, 2014, BRIT J HAEMATOL, V166, P891, DOI 10.1111/bjh.12982; Pallasch CP, 2014, CELL, V156, P590, DOI 10.1016/j.cell.2013.12.041; Rao SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039416; Rodig SJ, 2006, CLIN CANCER RES, V12, P7174, DOI 10.1158/1078-0432.CCR-06-1275; Rosenthal A, 2017, BLOOD REV, V31, P37, DOI 10.1016/j.blre.2016.09.004; Salles G, 2017, ADV THER, V34, P2232, DOI 10.1007/s12325-017-0612-x; Sarkozy Clementine, 2015, Lancet Oncol, V16, pe555, DOI 10.1016/S1470-2045(15)00005-4; Sarkozy C, 2015, CURR OPIN ONCOL, V27, P377, DOI 10.1097/CCO.0000000000000209; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Swerdlow SH., 2017, WHO CLASSIFICATION T, V2, P453; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tarella C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106745; Teo ECY, 2016, CRIT REV ONCOL HEMAT, V97, P72, DOI 10.1016/j.critrevonc.2015.08.014; Watanabe T, 2006, CLIN IMMUNOL, V120, P247, DOI 10.1016/j.clim.2006.05.006; Weiskopf K, 2015, MABS-AUSTIN, V7, P303, DOI 10.1080/19420862.2015.1011450; Yao Z, 2018, LEUKEMIA, V32, P353, DOI 10.1038/leu.2017.222; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199708	10.1371/journal.pone.0199708	http://dx.doi.org/10.1371/journal.pone.0199708			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020951	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400025
J	Hachul, ACL; Boldarine, VT; Neto, NIP; Moreno, MF; Ribeiro, EB; do Nascimento, CMO; Oyama, LM				Hachul, Ana C. L.; Boldarine, Valter T.; Neto, Nelson I. P.; Moreno, Mayara F.; Ribeiro, Eliane B.; do Nascimento, Claudia M. O.; Oyama, Lila M.			Maternal consumption of green tea extract during pregnancy and lactation alters offspring's metabolism in rats	PLOS ONE			English	Article							HIGH-FAT-DIET; TOLL-LIKE RECEPTOR; INDUCED OBESITY; GUT MICROBIOTA; INSULIN-RESISTANCE; POLYPHENOL EPIGALLOCATECHIN-3-GALLATE; GLUCOSE-TOLERANCE; PREVENTS OBESITY; ADIPOSE-TISSUE; INFLAMMATION	Introduction Green tea extract has anti-inflammatory and antioxidant effects which improve dyslipidemia and decrease adipose tissue depots associated with hyperlipidic diet consumption. Objective To evaluate the effect of green tea extract consumption by rats during pregnancy and lactation on the metabolism of their offspring that received control or high-fat diet with water during 10 weeks after weaning. Methods Wistar rats received water (W) or green tea extract diluted in water (G) (400 mg/kg body weight/day), and control diet (10 animals in W and G groups) during pregnancy and lactation. After weaning, offspring received water and a control (CW) or a high-fat diet (HW), for 10 weeks. One week before the end of treatment, oral glucose tolerance test was performed. The animals were euthanized and the samples were collected for biochemical, hormonal and antioxidant enzymes activity analyses. In addition, IL-10, TNF-alpha, IL-6, and IL-1 beta were quantified by ELISA while p-NF-kappa Bp50 was analyzed by Western Blotting. Repeated Measures ANOVA, followed by Tukey's test were used to find differences between data (p < 0.05). Results The consumption of high-fat diet by rats for 10 weeks after weaning promoted hyperglycemia and hyperinsulinemia, and increased fat depots. The ingestion of a high-fat diet by the offspring of mothers who consumed green tea extract during pregnancy and lactation decreased the inflammatory cytokines in adipose tissue, while the ingestion of a control diet increased the same cytokines. Conclusion Our results demonstrate that prenatal consumption of green tea associated with consumption of high-fat diet by offspring after weaning prevented inflammation. However, maternal consumption of the green tea extract induced a pro-inflammatory status in the adipose tissue of the adult offspring that received the control diet after weaning.	[Hachul, Ana C. L.; Boldarine, Valter T.; Neto, Nelson I. P.; Moreno, Mayara F.; Ribeiro, Eliane B.; do Nascimento, Claudia M. O.; Oyama, Lila M.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Fisiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Oyama, LM (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Dept Fisiol, Sao Paulo, Brazil.	lmoyama@gmail.com	Nascimento, Claudia Maria Oller do/T-4151-2019; Oyama, Lila M/B-7609-2012; Hachul, Ana C. L./N-4082-2017; Ribeiro, Eliane B/C-8124-2012; Neto, Nelson Inácio Pinto NIP/N-3269-2018; Moreno, Mayara F/N-4433-2017; Boldarine, Valter/AAC-9086-2020; Moreno, Mayara Franzoi/AAB-6151-2020	Nascimento, Claudia Maria Oller do/0000-0001-5755-3392; Hachul, Ana C. L./0000-0003-4044-9382; Ribeiro, Eliane B/0000-0002-3071-9134; Moreno, Mayara F/0000-0001-9078-2795; Moreno, Mayara Franzoi/0000-0001-9078-2795; Inacio Pinto Neto, Nelson/0000-0003-2634-359X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/19508-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo 2014/19508-7-grant to: Dr Lila Missae Oyama and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-grant to: Ana Claudia Losinskas Hachul. EBR, CMON and LMO are recipientes of CNPq fellowships.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Berk ES, 2005, OBES RES, V13, P1566, DOI 10.1038/oby.2005.192; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byun EH, 2010, J IMMUNOL, V185, P33, DOI 10.4049/jimmunol.0903742; Byun EB, 2012, BIOCHEM BIOPH RES CO, V426, P480, DOI 10.1016/j.bbrc.2012.08.096; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cano P, 2009, OBESITY, V17, P1866, DOI 10.1038/oby.2009.200; Champ M, 2009, CURR OPIN CLIN NUTR, V12, P565, DOI 10.1097/MCO.0b013e328331b4aa; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Chen ZY, 2001, J AGR FOOD CHEM, V49, P477, DOI 10.1021/jf000877h; Choo JJ, 2003, J NUTR BIOCHEM, V14, P671, DOI 10.1016/j.jnutbio.2003.08.005; Cunha CA, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/635470; Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040; FRAYN KN, 1995, AM J CLIN NUTR, V62, p250S, DOI 10.1093/ajcn/62.1.250S; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; Jang HJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE1444, DOI 10.1152/ajpendo.00434.2013; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926; Li JL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-161; Loche E, 2016, CURR OPIN LIPIDOL, V27, P449, DOI 10.1097/MOL.0000000000000338; Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x; Machado MV, 2012, ANN HEPATOL, V11, P440, DOI 10.1016/S1665-2681(19)31457-7; del Bas JM, 2015, J NUTR BIOCHEM, V26, P1670, DOI 10.1016/j.jnutbio.2015.08.015; Maron DJ, 2003, ARCH INTERN MED, V163, P1448, DOI 10.1001/archinte.163.12.1448; Moreno MF, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-84; Mukai Y, 2013, NUTRITION, V29, P291, DOI 10.1016/j.nut.2012.06.005; Muralimanoharan S, 2017, J MOL CELL CARDIOL, V108, P181, DOI 10.1016/j.yjmcc.2017.06.006; Nakamura YK, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-60; Okuda MH, 2014, J NUTR BIOCHEM, V25, P1084, DOI 10.1016/j.jnutbio.2014.05.012; Phillips LK, 2008, CURR HYPERTENS REP, V10, P156, DOI 10.1007/s11906-008-0029-7; Batista GDP, 2009, ARQ BRAS CARDIOL, V93, P121; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; Santamarina AB, 2015, J NUTR BIOCHEM, V26, P1348, DOI 10.1016/j.jnutbio.2015.07.002; Santana A, 2015, J NUTR BIOCHEM, V26, P893, DOI 10.1016/j.jnutbio.2015.03.001; Sato S, 2013, NUTRITION, V29, P1152, DOI 10.1016/j.nut.2013.03.021; Shen CL, 2011, OSTEOPOROSIS INT, V22, P327, DOI 10.1007/s00198-010-1209-2; Shen CL, 2010, J NUTR BIOCHEM, V21, P968, DOI 10.1016/j.jnutbio.2009.08.002; Singh DP, 2017, PHARMACOL RES, V123, P103, DOI 10.1016/j.phrs.2017.06.015; TRUSWELL AS, 1994, AM J CLIN NUTR, V59, p710S, DOI 10.1093/ajcn/59.3.710S; Tsukumo DM, 2015, ARCH ENDOCRIN METAB, V59, P154, DOI 10.1590/2359-3997000000029; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Venables MC, 2008, AM J CLIN NUTR, V87, P778, DOI 10.1093/ajcn/87.3.778; Voshol PJ, 2009, BBA-MOL CELL BIOL L, V1791, P479, DOI 10.1016/j.bbalip.2008.12.015; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178; Yamashita AS, 2010, CYTOKINE, V52, P168, DOI 10.1016/j.cyto.2010.07.006; Youn HS, 2006, BIOCHEM PHARMACOL, V72, P850, DOI 10.1016/j.bcp.2006.06.021; Zou TD, 2017, J PHYSIOL-LONDON, V595, P1547, DOI 10.1113/JP273478; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	57	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199969	10.1371/journal.pone.0199969	http://dx.doi.org/10.1371/journal.pone.0199969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020947	Green Published, gold, Green Submitted			2022-12-26	WOS:000439022400033
J	Etchegaray, JP; Mostoslavsky, R				Etchegaray, Jean-Pierre; Mostoslavsky, Raul			A sirtuin's role in preventing senescence by protecting ribosomal DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							YEAST; SIR2	Ribosomes are encoded by many copies of ribosomal DNA (rDNA) packed into the nucleolus. High rates of transcription combined with highly repetitive sequences render rDNA loci particularly vulnerable to genomic instability, a proposed underlying cause of cellular senescence. The molecular mechanisms that maintain rDNA stability have remained unclear. A new paper elucidates a sirtuin-dependent mechanism that protects rDNA loci from genomic instability and prevents cellular senescence via heterochromatin silencing mediated by the chromatin remodeler SNF2H. This finding extends our understanding of chromatin dynamics within rDNA regions and offers new mechanistic insights into aging-related pathologies associated with genomic instability.	[Etchegaray, Jean-Pierre; Mostoslavsky, Raul] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Etchegaray, Jean-Pierre; Mostoslavsky, Raul] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Mostoslavsky, Raul] Broad Inst Harvard & Massachusetts Inst Technol, Boston, MA 02113 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mostoslavsky, R (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.; Mostoslavsky, R (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.; Mostoslavsky, R (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Boston, MA 02113 USA.	rmostoslavsky@mgh.harvard.edu						Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Paredes S, 2018, J BIOL CHEM, V293, P11242, DOI 10.1074/jbc.AC118.003325; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 1997, SCIENCE, V277, P1313, DOI 10.1126/science.277.5330.1313; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018	10	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 13	2018	293	28					11251	11252		10.1074/jbc.H118.004040	http://dx.doi.org/10.1074/jbc.H118.004040			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GN3DD	30006387	Green Published, hybrid			2022-12-26	WOS:000438882800036
J	Heim, JB; McDonald, CA; Wyles, SP; Sominidi-Damodaran, S; Squirewel, EJ; Li, M; Motsonelidze, C; Bottcher, RT; van Deursen, J; Meves, A				Heim, Joel B.; McDonald, Cera A.; Wyles, Saranya P.; Sominidi-Damodaran, Sindhuja; Squirewel, Edwin J.; Li, Ming; Motsonelidze, Catherine; Boettcher, Ralph T.; van Deursen, Jan; Meves, Alexander			FAK auto-phosphorylation site tyrosine 397 is required for development but dispensable for normal skin homeostasis	PLOS ONE			English	Article							FOCAL ADHESION KINASE; VASCULAR DEVELOPMENT; MOUSE EMBRYOS; CANCER; FIBRONECTIN; CELLS; REVEALS; PHOSPHORYLATION; PROGRESSION; EXPRESSION	Focal adhesion kinase (FAK) is an intensely studied non-receptor tyrosine kinase with roles in cancer and other common human diseases. Despite the large interest in FAK, the in vivo contribution of FAK auto-phosphorylation site tyrosine (Y) 397 to FAK function is incompletely understood. To study FAK Y397 in vivo we analyzed mice with 'non-phosphorylatable' Y-to-phenylalanine (F) and `phospho-mimicking' Y-to-glutamate (E) mutations in the germline. We found that FAK Y397F mice die early during embryogenesis with abnormal angiogenesis like FAK kinase-dead mice. When Y397 is mutated to a glutamate mice survive beyond mid-gestation like mice where Y397 is lost by deletion of FAK exon 15. In culture, defects in proliferation, invasion and gene expression were more severe with the FAK Y397F than with the FAK Y397E mutation despite the inability of FAK Y397E to bind SRC. Conditional expression of FAK Y397F or Y397E in unchallenged avascular epidermis, however, resulted in no appreciable phenotype. We conclude that FAK Y397 is required for the highly dynamic tissue remodeling during development but dispensable for normal homeostasis of avascular epidermis. In contrast to the Y397F mutation, FAK Y397E retains sufficient biological activity to allow for development beyond mid-gestation.	[Heim, Joel B.; McDonald, Cera A.; Wyles, Saranya P.; Sominidi-Damodaran, Sindhuja; Squirewel, Edwin J.; Li, Ming; Motsonelidze, Catherine; Meves, Alexander] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA; [Boettcher, Ralph T.] Max Planck Inst Biochem, Dept Mol Med, Martinsried, Germany; [Boettcher, Ralph T.] German Ctr Cardiovasc Res Munich Partner Site, Munich, Germany; [van Deursen, Jan; Meves, Alexander] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [van Deursen, Jan] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA; [van Deursen, Jan; Meves, Alexander] Mayo Clin, Canc Ctr, Rochester, MN 55905 USA; [Heim, Joel B.] Univ Oslo, Dept Chem, Oslo, Norway	Mayo Clinic; Max Planck Society; German Centre for Cardiovascular Research; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Oslo	Meves, A (corresponding author), Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA.; Meves, A (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.; Meves, A (corresponding author), Mayo Clin, Canc Ctr, Rochester, MN 55905 USA.	meves.alexander@mayo.edu	Heim, Joel Benjamin/K-3615-2016	Heim, Joel Benjamin/0000-0001-9702-9480; McDonald, Cera Alexandra/0000-0002-9651-1993	Mayo Clinic Lucille and Smith Gibson Research Fellowship; Foundation for the National Institutes of Health [CA215105]; NATIONAL CANCER INSTITUTE [K08CA215105] Funding Source: NIH RePORTER	Mayo Clinic Lucille and Smith Gibson Research Fellowship; Foundation for the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Mayo Clinic Lucille and Smith Gibson Research Fellowship to JBH and SSD and also the Foundation for the National Institutes of Health (CA215105 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2014, ANTICANCER RES, V34, P3969; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Ceccarelli DFJ, 2006, J BIOL CHEM, V281, P252, DOI 10.1074/jbc.M509188200; Coolen NA, 2010, ARCH DERMATOL RES, V302, P47, DOI 10.1007/s00403-009-0989-8; Corsi JM, 2009, J BIOL CHEM, V284, P34769, DOI 10.1074/jbc.M109.067280; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Golubovskaya VM, 2014, FRONT BIOSCI-LANDMRK, V19, P687, DOI 10.2741/4236; Hamidi H, 2016, BRIT J CANCER, V115, P1017, DOI 10.1038/bjc.2016.312; Heim JB, 2017, P NATL ACAD SCI USA, V114, P3933, DOI 10.1073/pnas.1614894114; Horton ER, 2016, J CELL BIOL, V212, P349, DOI 10.1083/jcb.201508080; Ilic D, 2004, J CELL SCI, V117, P177, DOI 10.1242/jcs.00845; ILLC D, 1995, NATURE, V377, P539; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Lim ST, 2008, CELL CYCLE, V7, P2306, DOI 10.4161/cc.6367; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Meves A, 2015, J CLIN ONCOL, V33, P2509, DOI 10.1200/JCO.2014.60.7002; Meves A, 2011, P NATL ACAD SCI USA, V108, P15213, DOI 10.1073/pnas.1105689108; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Owen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016457; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Schiller HB, 2011, EMBO REP, V12, P259, DOI 10.1038/embor.2011.5; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Yokomizo T, 2012, NAT PROTOC, V7, P421, DOI 10.1038/nprot.2011.441; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200558	10.1371/journal.pone.0200558	http://dx.doi.org/10.1371/journal.pone.0200558			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001432	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400077
J	Narazaki, T; Isojunno, S; Nowacek, DP; Swift, R; Friedlaender, AS; Ramp, C; Smout, S; Aoki, K; Deecke, VB; Sato, K; Miller, PJO				Narazaki, Tomoko; Isojunno, Saana; Nowacek, Douglas P.; Swift, Rene; Friedlaender, Ari S.; Ramp, Christian; Smout, Sophie; Aoki, Kagari; Deecke, Volker B.; Sato, Katsufumi; Miller, Patrick J. O.			Body density of humpback whales (Megaptera novaengliae) in feeding aggregations estimated from hydrodynamic gliding performance	PLOS ONE			English	Article							DOLPHINS TURSIOPS-TRUNCATUS; SOUTHERN ELEPHANT SEALS; ATLANTIC FIN WHALES; NORTH-ATLANTIC; BALAENOPTERA-PHYSALUS; EUBALAENA-GLACIALIS; STROKING PATTERNS; DIVING BEHAVIOR; MARINE MAMMALS; GREY SEALS	Many baleen whales undertake annual fasting and feeding cycles, resulting in substantial changes in their body condition, an important factor affecting fitness. As a measure of lipid-store body condition, tissue density of a few deep diving marine mammals has been estimated using a hydrodynamic glide model of drag and buoyancy forces. Here, we applied the method to shallow-diving humpback whales (Megaptera novaeangliae) in North Atlantic and Antarctic feeding aggregations. High-resolution 3-axis acceleration, depth and speed data were collected from 24 whales. Measured values of acceleration during 5 s glides were fitted to a hydrodynamic glide model to estimate unknown parameters (tissue density, drag term and diving gas volume) in a Bayesian framework. Estimated species-average tissue density (1031.6 +/- 2.1 kg m(-3), +/- 95% credible interval) indicates that humpback whale tissue is typically negatively buoyant although there was a large inter-individual variation ranging from 1025.2 to 1043.1 kg m(-3). The precision of the individual estimates was substantially finer than the variation across different individual whales, demonstrating a progressive decrease in tissue density throughout the feeding season and comparably high lipid-store in pregnant females. The drag term (CDAm-1) was estimated to be relatively high, indicating a large effect of lift-related induced drag for humpback whales. Our results show that tissue density of shallow diving baleen whales can be estimated using the hydrodynamic gliding model, although cross-validation with other techniques is an essential next step. This method for estimating body condition is likely to be broadly applicable across a range of aquatic animals and environments.	[Narazaki, Tomoko; Isojunno, Saana; Swift, Rene; Ramp, Christian; Smout, Sophie; Aoki, Kagari; Miller, Patrick J. O.] Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Narazaki, Tomoko; Aoki, Kagari; Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Nowacek, Douglas P.] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Nowacek, Douglas P.] Duke Univ, Marine Lab, Pratt Sch Engn, Beaufort, NC 28516 USA; [Friedlaender, Ari S.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Ramp, Christian] Mingan Isl Cetacean Study, Longue Pointe De Mingan, PQ, Canada; [Deecke, Volker B.] Univ Cumbria, Dept Sci Nat Resources & Outdoor Studies, Ambleside, Cumbria, England	University of St Andrews; University of Tokyo; Duke University; Duke University; University of California System; University of California Santa Cruz; University of Cumbria	Narazaki, T (corresponding author), Univ St Andrews, Sea Mammal Res Unit, St Andrews, Fife, Scotland.; Narazaki, T (corresponding author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan.	naratomoz@gmail.com		Narazaki, Tomoko/0000-0003-4513-3432; isojunno, saana/0000-0002-2212-2135; Ramp, Christian/0000-0001-5528-1733	Strategic Environmental Research and Development Program [RC-2337]; Core Research for Evolutional Science and Technology by Japan Science and Technology Agency [JPMJCR1685]; Japan Society for the Promotion of Science; SERDP award [RC-2337]; JST [CREST JPMJCR1685]; JSPS Bilateral Open Partnership Joint Research Projects	Strategic Environmental Research and Development Program; Core Research for Evolutional Science and Technology by Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); SERDP award; JST(Japan Science & Technology Agency (JST)); JSPS Bilateral Open Partnership Joint Research Projects	This study was funded by Strategic Environmental Research and Development Program (https://www.serdp-estcp.org; grant number RC-2337). In addition, the study was partly supported by Core Research for Evolutional Science and Technology by Japan Science and Technology Agency (http://www.jst.go.jp/kisoken/crest/en/index.html, grant number JPMJCR1685) and Bilateral Open Partnership Joint Research Projects by Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-bilat/index.html; no specific grant number).; This study was funded by SERDP award RC-2337, and was partly supported by JST (CREST JPMJCR1685) and JSPS Bilateral Open Partnership Joint Research Projects. We would like to thank to all staffs and volunteers in Mingan Island Cetacean Study for field data collection. We also thank the scientific and technical staff on the Antarctic cruises, particularly those involved with tagging and tag data processing: Alison Stimpert, Ann Allen.	AGUILAR A, 1990, J MAMMAL, V71, P544, DOI 10.2307/1381793; Andersen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103072; Aoki K, 2017, J EXP BIOL, V220, P3802, DOI 10.1242/jeb.158287; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Bety J, 2003, AM NAT, V162, P110, DOI 10.1086/375680; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Biuw M, 2003, J EXP BIOL, V206, P3405, DOI 10.1242/jeb.00583; BOSE N, 1989, PROC R SOC SER B-BIO, V237, P175, DOI 10.1098/rspb.1989.0043; Bradford AL, 2012, J MAMMAL, V93, P251, DOI 10.1644/11-MAMM-A-091.1; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Christiansen F, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1468; Christiansen F, 2014, FUNCT ECOL, V28, P579, DOI 10.1111/1365-2435.12200; Christiansen F, 2013, J EXP BIOL, V216, P427, DOI 10.1242/jeb.074518; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Crossin GT, 2013, PHYSIOL BIOCHEM ZOOL, V86, P761, DOI 10.1086/673755; Durban JW, 2016, MAR MAMMAL SCI, V32, P1510, DOI 10.1111/mms.12328; FISH FE, 1993, J EXP BIOL, V185, P179; FISH FE, 1995, J MORPHOL, V225, P51, DOI 10.1002/jmor.1052250105; Friedlaender AS, 2013, MAR ECOL PROG SER, V494, P281, DOI 10.3354/meps10541; Friedlaender AS, 2016, P SOC OPEN SCI, V3; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; HAIN JHW, 1982, FISH B-NOAA, V80, P259; Hall AJ, 2001, J ANIM ECOL, V70, P138; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kasuya T, 1995, DEV MAR BIO, V4, P481; Konishi Kenji, 2006, Mammal Study, V31, P15, DOI 10.3106/1348-6160(2006)31[15:COBDAB]2.0.CO;2; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; LEITH D, 1972, FED PROC, V31, pA335; LOCKYER C, 1986, CAN J FISH AQUAT SCI, V43, P142, DOI 10.1139/f86-015; LOCKYER C, 1976, J CONSEIL, V36, P259, DOI 10.1093/icesjms/36.3.259; Lockyer C.H., 1987, APPROACHES MARINE MA, P183; LOCKYER CH, 1985, CAN J ZOOL, V63, P2328, DOI 10.1139/z85-345; McMahon CR, 2000, ANTARCT SCI, V12, P149, DOI 10.1017/S0954102000000195; Miklosovic DS, 2004, PHYS FLUIDS, V16, pL39, DOI 10.1063/1.1688341; Miller CA, 2012, MAR ECOL PROG SER, V459, P135, DOI 10.3354/meps09675; Miller CA, 2011, MAR ECOL PROG SER, V438, P267, DOI 10.3354/meps09174; Miller P, 2016, J EXP BIOL, V219, P2458, DOI 10.1242/jeb.137349; Miller PJO, 2004, J EXP BIOL, V207, P1953, DOI 10.1242/jeb.00993; Moya-Larano J, 2008, J ANIM ECOL, V77, P1099, DOI 10.1111/j.1365-2656.2008.01433.x; Naess A, 1998, SARSIA, V83, P211; National Research Council (NRC), 2017, APPR UND CUM EFF STR; Nowacek DP, 2001, P ROY SOC B-BIOL SCI, V268, P1811, DOI 10.1098/rspb.2001.1730; Page B, 2005, MAR ECOL PROG SER, V304, P249, DOI 10.3354/meps304249; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Piscitelli MA, 2013, J MORPHOL, V274, P1425, DOI 10.1002/jmor.20192; Piscitelli MA, 2010, J MORPHOL, V271, P654, DOI 10.1002/jmor.10823; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; Ponganis PJ, 2011, COMPR PHYSIOL, V1, P447, DOI 10.1002/cphy.c091003; Ramp C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121374; REILLY JJ, 1990, J APPL PHYSIOL, V69, P885, DOI 10.1152/jappl.1990.69.3.885; Richard G, 2014, J EXP BIOL, V217, P2609, DOI 10.1242/jeb.088542; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; Ryan C, 2013, MAR MAMMAL SCI, V29, P542, DOI 10.1111/j.1748-7692.2012.00578.x; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2002, J EXP BIOL, V205, P1189; Scholander P. F., 1940, Hvalradets Skrifter, Vno. 22, P1; Segre PS, 2017, CURR BIOL, V27, pR636, DOI 10.1016/j.cub.2017.05.063; Shiomi K, 2010, AQUAT BIOL, V8, P299, DOI 10.3354/ab00239; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Skrovan RC, 1999, J EXP BIOL, V202, P2749; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; TYACK P, 1983, BEHAVIOUR, V83, P132, DOI 10.1163/156853982X00067; Vikingsson G.A., 1990, International Whaling Commission Report of the Commission, V40, P365; Vikingsson GA, 1995, DEV MAR BIO, V4, P361; Watanabe Y, 2006, J EXP BIOL, V209, P3269, DOI 10.1242/jeb.02402; Weinstein BG, 2017, OECOLOGIA, V185, P427, DOI 10.1007/s00442-017-3949-6; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Williams R, 2013, ICES J MAR SCI, V70, P1273, DOI 10.1093/icesjms/fst059; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Woodward BL, 2006, J MORPHOL, V267, P1284, DOI 10.1002/jmor.10474	72	20	22	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200287	10.1371/journal.pone.0200287	http://dx.doi.org/10.1371/journal.pone.0200287			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001369	Green Accepted, gold, Green Published			2022-12-26	WOS:000438457400042
J	Pettian, MS; Plepis, AMD; Martins, VDA; dos Santos, GR; Pinto, CAL; Galdeano, EA; Calegari, ARA; de Moraes, CA; da Cunha, MR				Pettian, Mariane Silva; de Guzzi Plepis, Ana Maria; Amaro Martins, Virginia da Conceicao; dos Santos, Geovane Ribeiro; Lopes Pinto, Clovis Antonio; Galdeano, Ewerton Alexandre; Alves Calegari, Amanda Regina; de Moraes, Carlos Alberto; da Cunha, Marcelo Rodrigues			Use of an anionic collagen matrix made from bovine intestinal serosa for in vivo repair of cranial defects	PLOS ONE			English	Article							POLYANIONIC COLLAGEN; BONE DEFECTS; TISSUE; SUBMUCOSA; BIOCOMPATIBILITY; BIOMATERIALS; REGENERATION; IMPLANTS; SCAFFOLDS; MEMBRANES	Polymeric biomaterials composed of extracellular matrix components possess osteoconductive capacity that is essential for bone healing. The presence of collagen and the ability to undergo physicochemical modifications render these materials a suitable alternative in bone regenerative therapies. The objective of this study was to evaluate the osteogenic capacity of collagen-based matrices (native and anionic after alkaline hydrolysis) made from bovine intestinal serosa (MBIS). Twenty-five animals underwent surgery to create a cranial defect to be filled with native and anionic collagen matrixes, mmineralized and non mineralized. The animals were killed painlessly 6 weeks after surgery and samples of the wound area were submitted to routine histology and morphometric analysis. In the surgical area there was new bone formation projecting from the margins to the center of the defect. More marked bone neoformation occurred in the anionic matrices groups in such a way that permitted union of the opposite margins of the bone defect. The newly formed bone matrix exhibited good optical density of type I collagen fibers. Immunoexpression of osteocalcin by osteocytes was observed in the newly formed bone. Morphometric analysis showed a greater bone volume in the groups receiving the anionic matrices compared to the native membranes. Mineralization of the biomaterial did not increase its osteoregenerative capacity. In conclusion, the anionic matrix exhibits osteoregenerative capacity and is suitable for bone reconstruction therapies.	[Pettian, Mariane Silva; dos Santos, Geovane Ribeiro; Lopes Pinto, Clovis Antonio; Galdeano, Ewerton Alexandre; Alves Calegari, Amanda Regina; de Moraes, Carlos Alberto; da Cunha, Marcelo Rodrigues] Fac Med Jundiai, Dept Morphol & Pathol, Jundiai, SP, Brazil; [de Guzzi Plepis, Ana Maria; da Cunha, Marcelo Rodrigues] Univ Sao Paulo, Interunit Postgrad Program Bioengn, Sao Carlos, SP, Brazil; [de Guzzi Plepis, Ana Maria; Amaro Martins, Virginia da Conceicao] Univ Sao Paulo, Inst Chem Sao Carlos, Sao Carlos, SP, Brazil; [Lopes Pinto, Clovis Antonio] AC Camargo Canc Ctr, Dept Anat Pathol, Sao Paulo, SP, Brazil	Faculdade de Medicina de Jundiai; Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center	da Cunha, MR (corresponding author), Fac Med Jundiai, Dept Morphol & Pathol, Jundiai, SP, Brazil.; da Cunha, MR (corresponding author), Univ Sao Paulo, Interunit Postgrad Program Bioengn, Sao Carlos, SP, Brazil.	cunhamr@hotmail.com	Martins, Virginia C. A./H-5832-2012; Plepis, Ana/J-2559-2012	Martins, Virginia C. A./0000-0001-7565-9641; Plepis, Ana/0000-0002-4360-8433	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/02767-4]; Nucleo de Apoio a Pesquisa e a Docencia/Faculdade de Medicina de Jundiai (NAPED/FMJ); A.C. Camargo Cancer Center - Sao Paulo/SP; Department of Anatomical Pathology, A.C. Camargo Cancer Center, Sao Paulo, SP	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Nucleo de Apoio a Pesquisa e a Docencia/Faculdade de Medicina de Jundiai (NAPED/FMJ); A.C. Camargo Cancer Center - Sao Paulo/SP; Department of Anatomical Pathology, A.C. Camargo Cancer Center, Sao Paulo, SP	This work was funded by (Pettian MS) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), processo 2012/02767-4. Financing in the purchase of consumer material and scholarship grant postgraduate. (Pinto CAL) Department of Anatomical Pathology, A.C. Camargo Cancer Center, Sao Paulo, SP. Data analysis. (Cunha MR) Nucleo de Apoio a Pesquisa e a Docencia/Faculdade de Medicina de Jundiai (NAPED/FMJ). Financing in the purchase of consumer material.r Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), processo 2012/02767-4. A.C. Camargo Cancer Center - Sao Paulo/SP. Nucleo de Apoio a Pesquisa e a Docencia/Faculdade de Medicina de Jundiai (NAPED/FMJ).	Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Bauer AJP, 2014, SOFT MATER, V12, P359, DOI 10.1080/1539445X.2014.925474; Benavidez TE, 2016, TISSUE ENG PART C-ME, V22, P69, DOI [10.1089/ten.tec.2015.0315, 10.1089/ten.TEC.2015.0315]; Bernales Diego M, 2004, Rev Cubana Invest Bioméd, V23, P65; Bouler JM, 2017, ACTA BIOMATER, V53, P1, DOI 10.1016/j.actbio.2017.01.076; Campana V, 2014, J MATER SCI-MATER M, V25, P2445, DOI 10.1007/s10856-014-5240-2; Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019; Cardoso AKMV, 2006, CELLS TISSUES ORGANS, V184, P128, DOI 10.1159/000099619; Bolanos MAC, 2017, MAT SCI ENG C-MATER, V72, P519, DOI 10.1016/j.msec.2016.11.113; Chang CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153412; Chattopadhyay S, 2014, BIOPOLYMERS, V101, P821, DOI 10.1002/bip.22486; Chen S, 2017, COMPUT METHOD BIOMEC, V20, P905, DOI 10.1080/10255842.2017.1314468; Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4; Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y; da Cunha MR, 2017, MATER RES-IBERO-AM J, V20, P819, DOI [10.1590/1980-5373-mr-2016-1112, 10.1590/1980-5373-MR-2016-1112]; de Batista TM, 2009, J THERM ANAL CALORIM, V95, P945, DOI 10.1007/s10973-007-8897-7; DELMAS PD, 1990, J BONE MINER RES, V5, P5, DOI 10.1002/jbmr.5650050104; Dimitriou R, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-81; Farbod K, 2014, TISSUE ENG PART B-RE, V20, P173, DOI [10.1089/ten.teb.2013.0221, 10.1089/ten.TEB.2013.0221]; Forti FL, 2011, J MATER SCI-MATER M, V22, P1901, DOI 10.1007/s10856-011-4358-8; Ghanaati S, 2010, BIOMED MAT, V7; Girardi RCG, 2005, THESIS; Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210; GROESSNERSCHREIBER B, 1991, CALCIFIED TISSUE INT, V48, P335, DOI 10.1007/BF02556153; Gutierres M., 2006, ARQ MED, V19, P153; Hamada H, 2010, BIOL PHARM B; Hirata HH, 2015, INJURY, V46, P1215, DOI 10.1016/j.injury.2015.03.039; Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209; Horn MM, 2009, CARBOHYD POLYM, V77, P239, DOI 10.1016/j.carbpol.2008.12.039; Ishikawa K, 1999, J BIOMED MATER RES, V47, P111, DOI 10.1002/(SICI)1097-4636(199911)47:2<111::AID-JBM1>3.0.CO;2-0; Keskin M, 2008, PLAST RECONSTR SURG, V122, P400, DOI 10.1097/PRS.0b013e31817d6206; Khan Ruby, 2013, J Indian Soc Periodontol, V17, P539, DOI 10.4103/0972-124X.118333; Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020; Konig Jr B., 2010, IMPLANTOLOGIA OSTEOI, P337; Lee CH, 2001, INT J PHARMACEUT, V221, P1, DOI 10.1016/S0378-5173(01)00691-3; Lee M, 2008, J SURG RES, V147, P168, DOI 10.1016/j.jss.2008.03.012; Li Hua, 2006, Shanghai Kou Qiang Yi Xue, V15, P167; Li M, 2017, MAT SCI ENG C-MATER, V75, P149, DOI 10.1016/j.msec.2017.02.042; Ma X, 2006, ZHONGGUO XIU FU CHON, V20, P1062; Machado EG, 2015, ACTA HISTOCHEM, V117, P288, DOI 10.1016/j.acthis.2015.03.006; MANDARIMDELACER.CA, 1999, BRAZ J MORPHOL SCI, V16, P131; Issa JPM, 2012, MICROSC RES TECHNIQ, V75, P145, DOI 10.1002/jemt.21037; Miguel FB, 2013, J MATER SCI-MATER M, V24, P2567, DOI 10.1007/s10856-013-4980-8; Moore DC, 2004, J BIOMED MATER RES A, V69A, P259, DOI 10.1002/jbm.a.20123; Moreira PD, 2013, J BIOMED MATER RES B, V101B, P18, DOI 10.1002/jbm.b.32804; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Pearlin, 2018, CURR OSTEOPOROS REP, V16, P169, DOI 10.1007/s11914-018-0428-x; Peel SAF, 1998, TISSUE ENG, V4, P143, DOI 10.1089/ten.1998.4.143; Plepis AMD, 1996, POLYM ENG SCI, V36, P2932; Rasmussen CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145389; Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0; Rong JJ, 2015, INT J CLIN EXP PATHO, V8, P1282; Soccol Andréa Thomaz, 2006, Rev. Bras. Otorrinolaringol., V72, P195, DOI 10.1590/S0034-72992006000200008; SPECTOR M, 1979, J BIOMED MATER RES, V13, P677, DOI 10.1002/jbm.820130502; Trebacz H, 2005, INT J BIOL MACROMOL, V37, P257, DOI 10.1016/j.ijbiomac.2005.04.007; Ungureanu D.N., 2011, INT J BIOL BIOMED EN, V5, P57; Walmsley GG, 2016, STEM CELL REV REP, V12, P524, DOI 10.1007/s12015-016-9665-5; Walsh WR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168883; WEINANS H, 1993, J ORTHOPAED RES, V11, P500, DOI 10.1002/jor.1100110405; Yamamura K, 2005, J BIOMEDICAL MAT RES, V29, P1249; Zhang Cangyu, 2014, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V28, P384; Zhao L, 2011, J BIOMED MATER RES B, V97B, P1, DOI 10.1002/jbm.b.31768; Zhao L, 2008, STRATEG TRAUMA LIMB, V3, P57, DOI 10.1007/s11751-008-0034-z	64	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0197806	10.1371/journal.pone.0197806	http://dx.doi.org/10.1371/journal.pone.0197806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001321	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400002
J	Golreihan, A; Steuwe, C; Woelders, L; Deprez, A; Fujita, Y; Vellekoop, J; Swennen, R; Roeffaers, MBJ				Golreihan, Asefeh; Steuwe, Christian; Woelders, Lineke; Deprez, Arne; Fujita, Yasuhiko; Vellekoop, Johan; Swennen, Rudy; Roeffaers, Maarten B. J.			Improving preservation state assessment of carbonate microfossils in paleontological research using label-free stimulated Raman imaging	PLOS ONE			English	Article							PLANKTONIC-FORAMINIFERA; DISSOLUTION; CALCIFICATION; CALIBRATION; TOMOGRAPHY; CLIMATE; TESTS; BONES; MG/CA	In micropaleontological and paleoclimatological studies based on microfossil morphology and geochemistry, assessing the preservation state of fossils is of the highest importance, as diagenetic alteration invalidates textural features and compromises the correct interpretation of stable isotope and trace elemental analysis. In this paper, we present a novel noninvasive and label-free tomographic approach to reconstruct the three-dimensional architecture of microfossils with submicron resolution based on stimulated Raman scattering (SRS). Furthermore, this technique allows deciphering the three-dimensional (3D) distribution of the minerals within these fossils in a chemically sensitive manner. Our method, therefore, allows to identify microfossils, to chemically map their internal structure and eventually to determine their preservation state. We demonstrate the effectiveness of this method by analyzing several benthic and planktonic foraminifera, obtaining full 3D distributions of carbonate, iron oxide and porosity for each specimen. Subsequently, the preservation state of each microfossil can be assessed using these 3D compositional maps. The technique is highly sensitive, non-destructive, time-efficient and avoids the need for sample pretreatment. Therefore, its predestined application is the final check of the state of microfossils before applying subsequent geochemical analyses.	[Golreihan, Asefeh; Woelders, Lineke; Deprez, Arne; Vellekoop, Johan; Swennen, Rudy] Katholieke Univ Leuven, Div Geol, Dept Earth & Environm Sci, Heverlee, Belgium; [Steuwe, Christian; Roeffaers, Maarten B. J.] Katholieke Univ Leuven, Dept Chem, Ctr Surface Chem & Catalysis, Heverlee, Belgium; [Fujita, Yasuhiko] Katholieke Univ Leuven, Dept Chem, Mol Imaging & Photon, Heverlee, Belgium	KU Leuven; KU Leuven; KU Leuven	Golreihan, A (corresponding author), Katholieke Univ Leuven, Div Geol, Dept Earth & Environm Sci, Heverlee, Belgium.; Roeffaers, MBJ (corresponding author), Katholieke Univ Leuven, Dept Chem, Ctr Surface Chem & Catalysis, Heverlee, Belgium.	asefeh.golreihan@kuleuvan.be; maarten.roeffaers@kuleuven.be	Roeffaers, Maarten/AAB-8874-2020; Vellekoop, Johan/L-1805-2019; Fujita, Yasuhiko/F-8172-2019; Roeffaers, Maarten/D-9328-2011	Vellekoop, Johan/0000-0001-6977-693X; Roeffaers, Maarten/0000-0001-6582-6514	Fonds Wetenschappelijk Onderzoek [12R6315N, 12Z6618N]; Fond Wetenschappelijk Onderzoek [AKUL/15/15]; KU Leuven Research Fund [C14/15/053]	Fonds Wetenschappelijk Onderzoek(FWO); Fond Wetenschappelijk Onderzoek; KU Leuven Research Fund(KU Leuven)	Christian Steuwe and Johan Vellekoop are supported by postdoctoral Fonds Wetenschappelijk Onderzoek fellowships 12R6315N and 12Z6618N, respectively. www.fwo.be. The authors also thank Fond Wetenschappelijk Onderzoek for the investment in SRS microscopy (AKUL/15/15). www.fwo.be. Maarten Roeffaers acknowledges financial support from the KU Leuven Research Fund (C14/15/053). www.kuleuven.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel RL, 2012, PALAEONTOL ELECTRON, V15, P1, DOI DOI 10.26879/284; ADELSECK CG, 1977, DEEP-SEA RES, V24, P1167, DOI 10.1016/0146-6291(77)90520-3; Brasier MD, 2015, P NATL ACAD SCI USA, V112, P4859, DOI 10.1073/pnas.1405338111; Brown SJ, 1996, PALEOCEANOGRAPHY, V11, P543, DOI 10.1029/96PA01491; De La Pierre M, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871900; DHondt S, 1996, SCIENCE, V271, P1838, DOI 10.1126/science.271.5257.1838; Dodd J.R., 1990, PALEOECOLOGY CONCEPT; dos Anjos-Zerfass GD, 2011, REV MEX CIENC GEOL, V28, P92; Folk R.L., 1965, SOC ECON PALEONTOLOG, V13, P14, DOI DOI 10.2110/PEC.65.07.0014; Freudiger CW, 2008, SCIENCE, V322, P1857, DOI 10.1126/science.1165758; Gehler A, 2011, PALAEOGEOGR PALAEOCL, V310, P84, DOI 10.1016/j.palaeo.2011.04.014; Grauel AL, 2013, GEOCHIM COSMOCHIM AC, V108, P125, DOI 10.1016/j.gca.2012.12.049; Gunasekaran S, 2006, J RAMAN SPECTROSC, V37, P892, DOI 10.1002/jrs.1518; Harper D, 2009, INTRO PALEOBIOLOGY F; Hoppe KA, 2003, INT J OSTEOARCHAEOL, V13, P20, DOI 10.1002/oa.663; Liu KL, 2014, ACS NANO, V8, P12650, DOI 10.1021/nn505576p; LOHMANN GP, 1995, PALEOCEANOGRAPHY, V10, P445, DOI 10.1029/95PA00059; Masschaele BC, 2007, NUCL INSTRUM METH A, V580, P266, DOI 10.1016/j.nima.2007.05.099; Milsom C, 2013, FOSSILS AT A GLANCE; Min W, 2011, ANNU REV PHYS CHEM, V62, P507, DOI 10.1146/annurev.physchem.012809.103512; Nehrke G, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003996; Nestler K, 2003, J MOL STRUCT, V661, P357, DOI 10.1016/j.molstruc.2003.09.020; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Sadekov AY, 2010, EARTH PLANET SC LETT, V292, P312, DOI 10.1016/j.epsl.2010.01.039; Schopf JW, 2007, PRECAMBRIAN RES, V158, P141, DOI 10.1016/j.precamres.2007.04.009; Schopf JW, 2005, ASTROBIOLOGY, V5, P333, DOI 10.1089/ast.2005.5.333; Sexton PF, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001291; Shieh YT, 2002, J ASIAN EARTH SCI, V21, P1, DOI 10.1016/S1367-9120(01)00083-9; Speijer RP, 2008, GEOSPHERE, V4, P760, DOI 10.1130/GES00176.1; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; UREY HC, 1951, GEOL SOC AM BULL, V62, P399, DOI 10.1130/0016-7606(1951)62[399:MOPATO]2.0.CO;2; Wei L, 2012, ANAL BIOANAL CHEM, V403, P2197, DOI 10.1007/s00216-012-5890-1; Williams M, 2007, GEOBIOS-LYON, V40, P861, DOI 10.1016/j.geobios.2007.02.007	34	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0199695	10.1371/journal.pone.0199695	http://dx.doi.org/10.1371/journal.pone.0199695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995961	Green Submitted, gold, Green Published			2022-12-26	WOS:000438388800029
J	Besomi, M; Leppe, J; Di Silvestre, MC; Setchell, J				Besomi, Manuela; Leppe, Jaime; Cristina Di Silvestre, Maria; Setchell, Jenny			SeRUN (R) study: Development of running profiles using a mixed methods analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RECREATIONAL RUNNERS; NOVICE RUNNERS; MUSCULOSKELETAL INJURIES; TRAINING CHARACTERISTICS; RISK-FACTORS; DISTANCE; PROGRAM; METAANALYSIS; ASSOCIATION	Objective To determine profiles of urban runners based on socio-demographic, health, motivational, training characteristics and running-related beliefs and behaviours. Methods Mixed, exploratory, sequential study with two stages: 1) quantitative, using an online survey; and 2) qualitative, using semi-structured interviews with runners from the previous stage. Participants were recruited via: running routes commonly attended by runners, eight races, previous databases and social media networks. The survey collected information on six dimensions: (1) socio-demographic; (2) health; (3) motivations; (4) training characteristics; (5) running-related behaviour; and (6) beliefs and perceptions about health. Profiles were identified using a two-step hierarchical clustering analysis. Subsequently, 15 interviews were conducted with participating runners across each of the identified profiles. Qualitative analysis complemented the profiles characterization, explaining motivations to start and continue running, beliefs about risk factors and injury prevention, and the physical therapist's role in rehabilitation. Statistical analysis from stage one was conducted using SPSS 22 with a confidence level of 5%. Qualitative data were analysed using thematic and content analyses. Results A total of 821 surveys were analysed (46% female), mean aged 36.6 +/- 10.0 years. Cluster analysis delineated four profiles (n = 752) according to years of running experience, weekly running volume and hours of weekly training. Profiles were named "Beginner" (n = 163); "Basic" (n = 164); "Middle" (n = 160) and "Advanced" (n = 265). Profiles were statistically different according to sex, age, years of running experience, training characteristics, previous injuries and use of technological devices (p<0.05). There were identified motivations to start and continue running. Beliefs about risk factors vary among stretching, footwear, training surface and overload. Runners identified the physical therapist as a specialist, involved in the rehabilitation process and showing empathy towards the patient. The identification of these profiles allows the generation of future prospective studies and clinical trials to evaluate risk and prognostic factors targeting specific populations of runners, with the ultimate aim of reducing running-related injury.	[Besomi, Manuela; Leppe, Jaime; Cristina Di Silvestre, Maria] Univ Desarrollo, Sch Phys Therapy, Santiago, Chile; [Besomi, Manuela; Setchell, Jenny] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia	Universidad del Desarrollo; University of Queensland	Besomi, M (corresponding author), Univ Desarrollo, Sch Phys Therapy, Santiago, Chile.; Besomi, M (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia.	mbesomim@udd.cl	Besomi, Manuela/M-4623-2017; Besomi, Manuela/AFM-1217-2022; Leppe Zamora, Jaime/G-4837-2016	Besomi, Manuela/0000-0001-8880-4561; Besomi, Manuela/0000-0001-8880-4561; Leppe Zamora, Jaime/0000-0002-8663-1182	Internal Funding Program at Universidad del Desarrollo (UDD), Chile [20151014181017582294]; School of Physical Therapy at the Universidad del Desarrollo, Chile	Internal Funding Program at Universidad del Desarrollo (UDD), Chile; School of Physical Therapy at the Universidad del Desarrollo, Chile	This research was funded by an Internal Funding Program at Universidad del Desarrollo (UDD), Chile #20151014181017582294 awarded to Manuela Besomi [MB], http://www.udd.cl/wp-content/uploads/2014/07/Bases-Concurso-Interno-20151.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to School of Physical Therapy at the Universidad del Desarrollo, Chile, for their support during the study development process.	Ardern CL, 2016, BRIT J SPORT MED, V50, P853, DOI 10.1136/bjsports-2016-096278; Ardern CL, 2013, BRIT J SPORT MED, V47, P1120, DOI 10.1136/bjsports-2012-091203; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bredeweg SW, 2012, BRIT J SPORT MED, V46, P865, DOI 10.1136/bjsports-2012-091397; Buist I, 2008, AM J SPORT MED, V36, P35, DOI 10.1177/0363546507307505; Carvalho NB, 2015, FOOD RES INT, V77, P400, DOI 10.1016/j.foodres.2015.10.013; Damsted Camma, 2017, Inj Epidemiol, V4, P30, DOI 10.1186/s40621-017-0124-9; Dideriksen M, 2016, J STRENGTH COND RES, V30, P1592, DOI 10.1519/JSC.0000000000001244; Gallant JL, 2014, J AM PODIAT MED ASSN, V104, P211, DOI 10.7547/0003-0538-104.2.211; Giddings Lynne S, 2006, Contemp Nurse, V23, P3; Hair J.F., 2005, ESSENTIALS BUSINESS; Heiderscheit B, 2014, J ORTHOP SPORT PHYS, V44, P724, DOI 10.2519/jospt.2014.0113; Hespanhol LC, 2012, BRAZ J PHYS THER, V16, P46, DOI 10.1590/S1413-35552012000100009; Hespanhol LC, 2013, J PHYSIOTHER, V59, P263, DOI 10.1016/S1836-9553(13)70203-0; Hespanhol LC, 2016, J SCI MED SPORT, V19, P800, DOI 10.1016/j.jsams.2015.12.004; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hulme A, 2017, THEOR ISS ERGON SCI, V18, P338, DOI 10.1080/1463922X.2016.1274455; Hulme A, 2011, INJURY EPIDEMIOLOGY, V2, P1; Hulme A, 2016, J SPORT HEALTH SCI, V5, P172, DOI 10.1016/j.jshs.2016.01.023; Kingdom FAA, 2016, MODEL COMP, P247; Kluitenberg B, 2015, SPORTS MED, V45, P1143, DOI 10.1007/s40279-015-0331-x; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; Malisoux L, 2015, J SCI MED SPORT, V18, P523, DOI 10.1016/j.jsams.2014.07.014; Masters K. S., 1995, Journal of Sport Behavior, V18, P69; Ministerio del Deporte Chile, 2016, NAT SURV PHYS ACT SP; Nielsen RO, 2012, INT J SPORTS PHYS TH, V7, P58; Nielsen RO, 2014, INT J SPORTS PHYS TH, V9, P338; Nielsen RO, 2014, J ORTHOP SPORT PHYS, V44, P739, DOI 10.2519/jospt.2014.5164; Nigg BM, 2015, BRIT J SPORT MED, V49, P1290, DOI 10.1136/bjsports-2015-095054; OGLES BM, 1995, INT J SPORT PSYCHOL, V26, P233; Ooms L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-697; Rasmussen CH, 2013, INT J SPORTS PHYS TH, V8, P111; Sallade J R, 1992, J Athl Train, V27, P50; Saragiotto BT, 2014, J ORTHOP SPORT PHYS, V44, P733, DOI 10.2519/jospt.2014.5710; Saragiotto BT, 2014, SPORTS MED, V44, P1153, DOI 10.1007/s40279-014-0194-6; Tariq Shema, 2013, JRSM Short Rep, V4, p2042533313479197, DOI 10.1177/2042533313479197; Thompson CG, 2017, BASIC APPL SOC PSYCH, V39, P81, DOI 10.1080/01973533.2016.1277529; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; VANMECHELEN W, 1993, AM J SPORT MED, V21, P711, DOI 10.1177/036354659302100513; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6; Videbaek S, 2015, SPORTS MED, V45, P1017, DOI 10.1007/s40279-015-0333-8; Yamato TP, 2015, J ORTHOP SPORT PHYS, V45, P375, DOI 10.2519/jospt.2015.5741; Yeung EW, 2001, BRIT J SPORT MED, V35, P383, DOI 10.1136/bjsm.35.6.383; Sancho AZ, 2012, UNIV PSYCHOL, V11, P895	44	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200389	10.1371/journal.pone.0200389	http://dx.doi.org/10.1371/journal.pone.0200389			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990334	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300043
J	Miotto, N; Mendes, LC; Zanaga, LP; Lazarini, MSK; Goncales, ESL; Pedro, MN; Goncales, FL; Stucchi, RSB; Vigani, AG				Miotto, Noelle; Mendes, Leandro Cesar; Zanaga, Leticia Pisoni; Kroll Lazarini, Maria Silvia; Lopes Goncales, Eduardo Sellan; Pedro, Marcelo Nardi; Goncales, Fernando Lopes, Jr.; Bello Stucchi, Raquel Silveira; Vigani, Aline Gonzalez			All-oral direct antiviral treatment for hepatitis C chronic infection in a real-life cohort: The role of cirrhosis and comorbidities in treatment response	PLOS ONE			English	Article							DACLATASVIR PLUS SOFOSBUVIR; ADVANCED LIVER-DISEASE; GENOTYPE 3 INFECTION; VIRUS; HCV; SIMEPREVIR; RIBAVIRIN; SAFETY; AGENTS; EPIDEMIOLOGY	Background Hepatitis C virus (HCV) infection is the major cause of end-stage liver disease (LD) worldwide. The aim of this study was to assess sustained virological response (SVR) rates in a real-world cohort of patients with HCV infection treated with interferon-free direct antiviral agents (DAA). Patients and methods All patients with genotypes 1, 2 or 3 HCV infection who started interferon-free treatment at a university hospital from December 2015 through July 2017 were included. The primary outcome was SVR at post-treatment week 12 by intention-to-treat (ITT) and modified ITT (mITT) analysis. Results Five hundred twenty seven patients were enrolled, 51.6% with cirrhosis. Most patients received sofosbuvir + daclatasvir + ribavirin (60.7%) and sofosbuvir + simeprevir (25.6%). Overall SVR rates were 90.5% for ITT and 96% for mITT. SVR rates were higher in non-cirrhotic (94.2% in ITT and 96.8% in mITT) versus cirrhotic patients (87.1% in ITT and 95.2% in mITT). In ITT and mITT assessments, SVR rates were higher in patients with Child-Pugh A (n = 222, 88.7% and 95.7%, respectively) versus Child-Pugh B or C (n = 40, 80% and 90%, respectively); SVR rates were higher in patients with genotype 1 (n = 405, 92.1% and 98.2%), followed by genotype 2 (n = 13, 84.6% and 92.7%) and genotype 3 (n = 109, 84.4% and 88.4%). Lower comorbidity index (p = 0.0014) and absence of cirrhosis (p = 0.0071) were associated with SVR. Among cirrhotic patients, lower Model for End-Stage Liver Disease (p = 0.0258), higher albumin (p = 0.0015), and higher glomerular filtration rate (p = 0.0366) were related to SVR. Twenty-two cirrhotic patients (8%) had clinical liver decompensation during treatment. Complications of advanced LD were responsible for discontinuation of treatment and death in 12 and 7 patients, respectively. Conclusion Treatment with all-oral DAA achieved high SVR rates, particularly in patients without cirrhosis and few comorbidities. Advanced LD is associated to poor outcome, such as treatment failure and death.	[Miotto, Noelle; Mendes, Leandro Cesar; Zanaga, Leticia Pisoni; Kroll Lazarini, Maria Silvia; Lopes Goncales, Eduardo Sellan; Pedro, Marcelo Nardi; Goncales, Fernando Lopes, Jr.; Bello Stucchi, Raquel Silveira; Vigani, Aline Gonzalez] Univ Estadual Campinas, Fac Med, Infect Dis Div, Internal Med Dept, Campinas, SP, Brazil	Universidade Estadual de Campinas	Miotto, N (corresponding author), Univ Estadual Campinas, Fac Med, Infect Dis Div, Internal Med Dept, Campinas, SP, Brazil.	miotto.noelle@gmail.com		Sellan Lopes Goncales, Eduardo/0000-0002-0180-4292; Zanaga, Leticia/0000-0002-9806-3899; Miotto, Noelle/0000-0002-1172-8481				Alonso S, 2017, J VIRAL HEPATITIS, V24, P304, DOI 10.1111/jvh.12648; Alonso S, 2016, GUT, V65, P2060, DOI [10.1136/gutjnl-2016-312444, DOI 10.1136/GUTJNL-2016-312444]; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; BEDOSSA P, 1993, ANN PATHOL, V13, P260; Bruggmann P, 2014, J VIRAL HEPATITIS, V21, P5, DOI 10.1111/jvh.12247; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Cheinquer HH, 2017, J HEPATOL, V66, pS508, DOI 10.1016/S0168-8278(17)31417-4; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Conti F, 2017, J VIRAL HEPATITIS, V24, P454, DOI 10.1111/jvh.12663; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Fontana RJ, 2010, GASTROENTEROLOGY, V138, P2321, DOI 10.1053/j.gastro.2010.02.058; Foster GR, 2016, J HEPATOL, V64, P1224, DOI 10.1016/j.jhep.2016.01.029; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hezode C, 2016, HEPATOLOGY, V63, P1809, DOI 10.1002/hep.28491; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kutala BK, 2017, HEPATIC MED-EVID RES, V9, P67, DOI 10.2147/HMER.S149578; Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Leroy V, 2016, HEPATOLOGY, V63, P1430, DOI 10.1002/hep.28473; LEVEY AS, 1993, J AM SOC NEPHROL, V4, P1159; Maan R, 2016, CLIN GASTROENTEROL H, V14, P1821, DOI 10.1016/j.cgh.2016.07.001; Mendes LC, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165432; Miotto N, 2017, EUR J GASTROEN HEPAT, V29, P1149, DOI 10.1097/MEG.0000000000000944; Nagaty A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184654; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pol S, 2017, J HEPATOL, V66, P39, DOI 10.1016/j.jhep.2016.08.021; Pugh RN, 1976, BRIT J SURG, V60, P646; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rockey DC, 2006, HEPATOLOGY, V43, pS113, DOI 10.1002/hep.21046; Rodriguez-Osorio I, 2017, J CLIN VIROL, V88, P58, DOI 10.1016/j.jcv.2017.01.003; Sulkowski MS, 2016, GASTROENTEROLOGY, V150, P419, DOI 10.1053/j.gastro.2015.10.013; Sulkowski MS, 2014, NEW ENGL J MED, V370, P1469, DOI 10.1056/NEJMx140017; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Welzel TM, 2016, GUT, V65, P1861, DOI 10.1136/gutjnl-2016-312444; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; World Health Organization, GLOBAL HEPATITIS REP	37	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199941	10.1371/journal.pone.0199941	http://dx.doi.org/10.1371/journal.pone.0199941			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990371	Green Submitted, Green Published, gold			2022-12-26	WOS:000438170300021
J	Obmann, VC; Mertineit, N; Berzigotti, A; Marx, C; Ebner, L; Kreis, R; Vermathen, P; Heverhagen, JT; Christe, A; Huber, AT				Obmann, Verena C.; Mertineit, Nando; Berzigotti, Annalisa; Marx, Christina; Ebner, Lukas; Kreis, Roland; Vermathen, Peter; Heverhagen, Johannes T.; Christe, Andreas; Huber, Adrian T.			CT predicts liver fibrosis: Prospective evaluation of morphology- and attenuation- based quantitative scores in routine portal venous abdominal scans	PLOS ONE			English	Article							UNITED-STATES; HEPATIC-FIBROSIS; MR ELASTOGRAPHY; PERFUSION CT; DISEASE; POPULATION; CIRRHOSIS; PREVALENCE; EXPERIENCE; BURDEN	Objectives Our aim was to prospectively determine whether quantitative computed tomography (CT) scores, consisting of simplified indices for liver remodeling and attenuation, may predict liver fibrosis in abdominal CT scans. Materials and methods This cross-sectional, prospective study was approved by the local IRB (Kantonale Ethik-kommission Bern). Written informed consent was given from all patients undergoing study MR exams. Between 02/16 and 05/17, four different liver fibrosis scores (CRL-R = caudateright-lobe ratio, LIMV-, LIMA- and LIMVA-fibrosis score, with "LIM" for liver imaging morphology, "V" for liver vein diameter and "A" for attenuation) were calculated in 1534 consecutive abdominal CT scans, excluding patients with prior liver surgery and liver metastasis. Patients were invited to undergo magnetic resonance (MR) elastography as the non-invasive gold standard to evaluate liver fibrosis. MR elastography shear modulus >2.8 kPa was defined as beginning liver fibrosis, while >= 3.5 kPa was defined as significant liver fibrosis (which would correspond to fibrosis stage F2 or higher in histology). Cutoff values, sensitivities and specificities obtained from the receiver operating characteristics (ROC) analysis were then calculated in 141 patients who followed the invitation for MR elastography. To mitigate selection bias, prevalence was estimated in the screened total population (n = 1534) by applying the cutoff values with sensitivities and specificities calculated in the MR elastography sub-group. Positive predictive values (PPV) and negative predictive values (NPV) were then calculated. Results Fibrosis scores including liver vein attenuation LIMA-FS and LIMVA-FS showed higher areas under the ROC curves (0.96-0.97) than CRL-R (0.82) to detect significant liver fibrosis, while LIMV-FS showed good performance as well (0.92). The prevalence-corrected PPV were 29% for CRL-R, 70% for LIMV-FS, 76% for LIMA-FS and 82% for LIMVA-FS. Conclusion CT fibrosis scores, notably LIMA-FS and LIMVA-FS, may predict significant liver fibrosis on routine abdominal CT scans.	[Obmann, Verena C.; Mertineit, Nando; Marx, Christina; Ebner, Lukas; Kreis, Roland; Vermathen, Peter; Heverhagen, Johannes T.; Christe, Andreas; Huber, Adrian T.] Univ Bern, Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland; [Berzigotti, Annalisa] Univ Hosp Bern, Univ Bern, Inselspital, Dept Visceral Surg & Med,Hepatol, Bern, Switzerland; [Kreis, Roland; Vermathen, Peter] Univ Bern, Unit Magnet Resonance Spect & Methodol, Dept BioMed Res, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Huber, AT (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, Bern, Switzerland.	adrian.huber@insel.ch	Berzigotti, Annalisa/AGJ-9475-2022; Huber, Adrian/ABA-2766-2020; Vermathen, P./J-5789-2012; Kreis, Roland/F-2550-2010; Berzigotti, Annalisa/AAB-8999-2019	Vermathen, P./0000-0001-8649-1098; Kreis, Roland/0000-0002-8618-6875; Berzigotti, Annalisa/0000-0003-4562-9016; Heverhagen, Johannes/0000-0002-5416-6650; Obmann, Verena/0000-0001-6572-9968; Huber, Adrian Thomas/0000-0001-6146-8238; Ebner, Lukas/0000-0001-5117-6047	Swiss National Science Foundation Research Equipment (R'Equip Grant); University of Bern; Swiss foundation to fight against cancer	Swiss National Science Foundation Research Equipment (R'Equip Grant); University of Bern; Swiss foundation to fight against cancer	This work was supported by the Swiss National Science Foundation Research Equipment (R'Equip Grant) and Matching Fund from the University of Bern as well as the Swiss foundation to fight against cancer.	Adrian H, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13923; Anderson GF, 2000, HEALTH AFFAIR, V19, P191, DOI 10.1377/hlthaff.19.3.191; [Anonymous], NATL VITAL STAT SYST, V66, P1; Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Awaya H, 2002, RADIOLOGY, V224, P769, DOI 10.1148/radiol.2243011495; Babu AS, 2016, RADIOGRAPHICS, V36, P1987, DOI 10.1148/rg.2016160042; Bell BP, 2008, AM J GASTROENTEROL, V103, P2727, DOI 10.1111/j.1572-0241.2008.02071.x; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Brancatelli G, 2007, EUR J RADIOL, V61, P57, DOI 10.1016/j.ejrad.2006.11.003; Castera L, 2012, GASTROENTEROLOGY, V142, P1293, DOI 10.1053/j.gastro.2012.02.017; Chahal HS, 2016, JAMA INTERN MED, V176, P65, DOI 10.1001/jamainternmed.2015.6011; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Daginawala N, 2016, EUR J RADIOL, V85, P511, DOI 10.1016/j.ejrad.2015.12.009; Ellis EL, 2012, J HEPATOL, V56, P1171, DOI 10.1016/j.jhep.2011.09.024; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Guan S, 2005, WORLD J GASTROENTERO, V11, P3465, DOI 10.3748/wjg.v11.i22.3465; Hagiwara M, 2008, RADIOLOGY, V246, P926, DOI 10.1148/radiol.2463070077; Horowitz JM, 2017, ABDOM RADIOL NY; Jeffery RW, 2003, OBES RES, V11, p12S, DOI 10.1038/oby.2003.221; Kuhn JP, 2017, RADIOLOGY, V284, P706, DOI 10.1148/radiol.2017161228; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Pickhardt PJ, 2016, EUR RADIOL; Ronot M, 2010, RADIOLOGY, V256, P135, DOI 10.1148/radiol.10091295; Roulot D, 2011, GUT, V60, P977, DOI 10.1136/gut.2010.221382; Singh S, 2015, CLIN GASTROENTEROL H, V13, P440, DOI 10.1016/j.cgh.2014.09.046; Smith AD, 2016, RADIOLOGY, V280, P771, DOI 10.1148/radiol.2016151542; Team R. C., 2000, R LANG DEF; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667, DOI 10.2214/ajr.176.3.1760667; Walser Eric M, 2005, Semin Intervent Radiol, V22, P271, DOI 10.1055/s-2005-925553; Wang FS, 2014, HEPATOLOGY, V60, P2099, DOI 10.1002/hep.27406; Wang LH, 2015, INT J CLIN EXP MED, V8, P15276; Wong VWS, 2012, GUT, V61, P409, DOI 10.1136/gutjnl-2011-300342; Xiao GQ, 2017, HEPATOLOGY, V66, P1486, DOI 10.1002/hep.29302; Yin M, 2016, RADIOLOGY, V278, P114, DOI 10.1148/radiol.2015142141; Yoshimitsu K, 2016, EUR RADIOL, V26, P656, DOI 10.1007/s00330-015-3863-4; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhang Y, 2009, J MAGN RESON IMAGING, V29, P1085, DOI 10.1002/jmri.21718; Zois CD, 2010, WORLD J GASTROENTERO, V16, P3944, DOI 10.3748/wjg.v16.i31.3944	39	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199611	10.1371/journal.pone.0199611	http://dx.doi.org/10.1371/journal.pone.0199611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990333	Green Published, Green Submitted, gold			2022-12-26	WOS:000438170300014
J	Okolie, O; Irvin, DM; Bago, JR; Sheets, K; Satterlee, A; Carey-Ewend, AG; Lettry, V; Dumitru, R; Elton, S; Ewend, MG; Miller, CR; Hingtgen, SD				Okolie, Onyinyechukwu; Irvin, David M.; Bago, Juli R.; Sheets, Kevin; Satterlee, Andrew; Carey-Ewend, Abigail G.; Lettry, Vivien; Dumitru, Raluca; Elton, Scott; Ewend, Matthew G.; Miller, C. Ryan; Hingtgen, Shawn D.			Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection	PLOS ONE			English	Article							ALLOGENEIC TRANSPLANTATION; MOLECULAR SUBGROUPS; MOUSE MODEL; CHEMOTHERAPY; CANCER; BRAIN; GLIOBLASTOMA; FIBROBLASTS; EFFICACY; RADIOTHERAPY	Background Cytotoxic neural stem cells (NSCs) have emerged as a promising treatment for Medulloblastoma (MB), the most common malignant primary pediatric brain tumor. The lack of accurate pre-clinical models incorporating surgical resection and tumor recurrence limits advancement in post-surgical MB treatments. Using cell lines from two of the 5 distinct MB molecular sub-groups, in this study, we developed an image-guided mouse model of MB surgical resection and investigate intra-cavity NSC therapy for post-operative MB. Methods Using D283 and Daoy human MB cells engineered to express multi-modality optical reporters, we created the first image-guided resection model of orthotopic MB. Brain-derived NSCs and novel induced NSCs (iNSCs) generated from pediatric skin were engineered to express the pro-drug/enzyme therapy thymidine kinase/ganciclovir, seeded into the postoperative cavity, and used to investigate intra-cavity therapy for post-surgical MB. Results We found that surgery reduced MB volumes by 92%, and the rate of post-operative MB regrowth increased 3-fold compared to pre-resection growth. Real-time imaging showed NSCs rapidly homed to MB, migrating 1.6-fold faster and 2-fold farther in the presence of tumors, and co-localized with MB present in the contra-lateral hemisphere. Seeding of cytotoxic NSCs into the post-operative surgical cavity decreased MB volumes 15-fold and extended median survival 133%. As an initial step towards novel autologous therapy in human MB patients, we found skin-derived iNSCs homed to MB cells, while intra-cavity iNSC therapy suppressed post-surgical tumor growth and prolonged survival of MB-bearing mice by 123%. Conclusions We report a novel image-guided model of MB resection/recurrence and provide new evidence of cytotoxic NSCs/iNSCs delivered into the surgical cavity effectively target residual MB foci.	[Okolie, Onyinyechukwu; Bago, Juli R.; Sheets, Kevin; Satterlee, Andrew; Carey-Ewend, Abigail G.; Lettry, Vivien; Hingtgen, Shawn D.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27515 USA; [Irvin, David M.; Ewend, Matthew G.; Miller, C. Ryan; Hingtgen, Shawn D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Irvin, David M.; Miller, C. Ryan] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Div Neuropathol, Chapel Hill, NC 27515 USA; [Irvin, David M.; Miller, C. Ryan] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA; [Irvin, David M.; Miller, C. Ryan] Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27515 USA; [Dumitru, Raluca] Univ N Carolina, Sch Med, Dept Genet, Human Pluripotent Stem Cell Core, Chapel Hill, NC 27515 USA; [Elton, Scott; Ewend, Matthew G.] Univ N Carolina, Dept Neurosurg, Chapel Hill, NC 27515 USA; [Miller, C. Ryan; Hingtgen, Shawn D.] Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27515 USA; [Hingtgen, Shawn D.] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Hingtgen, SD (corresponding author), Univ N Carolina, Eshelman Sch Pharm, Div Pharmacoengn & Mol Pharmaceut, Chapel Hill, NC 27515 USA.; Hingtgen, SD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Hingtgen, SD (corresponding author), Univ N Carolina, Sch Med, Neurosci Ctr, Chapel Hill, NC 27515 USA.; Hingtgen, SD (corresponding author), Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC 27515 USA.	hingtgen@email.unc.edu	Miller, Ryan/B-9365-2008; Stem Cell Core, Human Pluripotent/AFY-9750-2022; , Pathology Services Core/CEZ-2246-2022; BAGO, JULI R/M-3526-2018	Miller, Ryan/0000-0002-0096-8762; BAGO, JULI R/0000-0002-2862-4048; Satterlee, Andrew/0000-0001-6952-5823	UNC Eshelman Institute for Innovation; UNC Translational and Clinical Science Institute; UNC University Cancer Research Fund; National Cancer Institute [P30CA016086]; University Cancer Research Fund; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002489] Funding Source: NIH RePORTER	UNC Eshelman Institute for Innovation; UNC Translational and Clinical Science Institute; UNC University Cancer Research Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by a grant from the UNC Eshelman Institute for Innovation (S.D.H.), the UNC Translational and Clinical Science Institute TL1 Pre-doctoral Translational Research Fellowship (O.O.), the UNC University Cancer Research Fund (C.R.M.). The UNC Translational Pathology Laboratory is supported by the National Cancer Institute (P30CA016086) and University Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the UNC-Olympus Imaging Research Center for microscope usage. We would also like to that Kathryn Pietrosimone for her expert review of the manuscript. This work was supported by a grant from the UNC Eshelman Institute for Innovation (S.D.H.), the UNC Translational and Clinical Science Institute TL1 Pre-doctoral Translational Research Fellowship (O.O.), the UNC University Cancer Research Fund (C.R.M.). The UNC Translational Pathology Laboratory is supported by the National Cancer Institute (P30CA016086) and University Cancer Research Fund.	Aboody KS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005365; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Ahmed AU, 2010, CURR OPIN MOL THER, V12, P546; Bago JR, 2015, METHODS, DOI [10.1016/j.ymeth.2015.08, DOI 10.1016/J.YMETH.2015.08]; Bago JR, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6510; Bago JR, 2016, BIOMATERIALS, V90, P116, DOI 10.1016/j.biomaterials.2016.03.008; Bago JR, 2016, BIOMATERIALS, V84, P42, DOI 10.1016/j.biomaterials.2016.01.007; Bago JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10593; Bai RY, 2015, NEURO-ONCOLOGY, V17, P545, DOI 10.1093/neuonc/nou234; Beck C, 1995, HUM GENE THER, V6, P1525, DOI 10.1089/hum.1995.6.12-1525; Duebgen M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju090; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Genovesi LA, 2013, P NATL ACAD SCI USA, V110, pE4325, DOI 10.1073/pnas.1318639110; Giordana MT, 1999, INT J CANCER, V80, P689, DOI 10.1002/(SICI)1097-0215(19990301)80:5<689::AID-IJC10>3.0.CO;2-G; Gutova M, 2013, GENE THER, V20, P143, DOI 10.1038/gt.2012.12; Hingtgen S, 2013, J NEURO-ONCOL, V111, P153, DOI 10.1007/s11060-012-1008-z; Hingtgen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040234; Hingtgen S, 2008, MOL CANCER THER, V7, P3575, DOI 10.1158/1535-7163.MCT-08-0640; Hingtgen SD, 2010, STEM CELLS, V28, P832, DOI 10.1002/stem.313; Kauer TM, 2012, NAT NEUROSCI, V15, P197, DOI 10.1038/nn.3019; Kawauchi D, 2012, CANCER CELL, V21, P168, DOI 10.1016/j.ccr.2011.12.023; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim SK, 2006, CLIN CANCER RES, V12, P5550, DOI 10.1158/1078-0432.CCR-05-2508; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lujan E, 2012, CURR OPIN GENET DEV, V22, P517, DOI 10.1016/j.gde.2012.07.002; Martinez-Quintanilla J, 2015, MOL THER, V23, P108, DOI 10.1038/mt.2014.204; Matsui T, 2012, STEM CELLS, V30, P1109, DOI 10.1002/stem.1091; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Muraoka K, 2006, EXP NEUROL, V199, P311, DOI 10.1016/j.expneurol.2005.12.004; Northcott PA, 2012, NAT REV CANCER, V12, P818, DOI 10.1038/nrc3410; Okolie O, 2016, NEURO-ONCOLOGY, V18, P1622, DOI 10.1093/neuonc/now117; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; Packer RJ, 2006, J CLIN ONCOL, V24, P4202, DOI 10.1200/JCO.2006.06.4980; PATRICE SJ, 1995, PEDIATR NEUROSURG, V22, P197, DOI 10.1159/000120901; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Ramaswamy V, 2013, LANCET ONCOL, V14, P1200, DOI 10.1016/S1470-2045(13)70449-2; Redjal N, 2015, STEM CELLS, V33, P101, DOI 10.1002/stem.1834; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Rutkowski Stefan, 2006, Expert Rev Neurother, V6, P1211, DOI 10.1586/14737175.6.8.1211; Shah K, 2016, NEURO-ONCOLOGY, V18, P1066, DOI 10.1093/neuonc/now096; Stuckey DW, 2015, STEM CELLS, V33, P589, DOI 10.1002/stem.1874; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; Taylor RE, 2003, J CLIN ONCOL, V21, P1581, DOI 10.1200/JCO.2003.05.116; Tobias AL, 2013, STEM CELL TRANSL MED, V2, P655, DOI 10.5966/sctm.2013-0039; Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886	48	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0198596	10.1371/journal.pone.0198596	http://dx.doi.org/10.1371/journal.pone.0198596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990322	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300003
J	Hyncicova, E; Kalina, A; Vyhnalek, M; Nikolai, T; Martinkovic, L; Lisy, J; Hort, J; Meluzinova, E; Laczo, J				Hyncicova, Eva; Kalina, Adam; Vyhnalek, Martin; Nikolai, Tomas; Martinkovic, Lukas; Lisy, Jiri; Hort, Jakub; Meluzinova, Eva; Laczo, Jan			Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; PHYSICAL-DISABILITY; FATIGUE; ANXIETY; ROBUST; OPTIMIZATION; REGISTRATION; INVENTORY	Background Neuropsychiatric symptoms and reduced health-related quality of life (HRQoL) are frequent in multiple sclerosis, where are associated with structural brain changes, but have been less studied in clinically isolated syndrome (CIS). Objective To characterize HRQoL, neuropsychiatric symptoms (depressive symptoms, anxiety, apathy and fatigue), their interrelations and associations with structural brain changes in CIS. Methods Patients with CIS (n = 67) and demographically matched healthy controls (n = 46) underwent neurological and psychological examinations including assessment of HRQoL, neuropsychiatric symptoms and cognitive functioning, and MRI brain scan with global, regional and lesion load volume measurement. Results The CIS group had more, mostly mild, depressive symptoms and anxiety, and lower HRQoL physical and social subscores (p <= 0.037). Neuropsychiatric symptoms were associated with most HRQoL subscores (beta <=-0.34, p <= 0.005). Cognitive functioning unlike clinical disability was associated with depressive symptoms and lower HRQoL emotional subscores (beta <=-0.29, p <= 0.019). Depressive symptoms and apathy were associated with right temporal, left insular and right occipital lesion load (beta >= 0.29, p >= 0.032). Anxiety was associated with lower white matter volume (beta = -0.25, p = 0.045). Conclusion Mild depressive symptoms and anxiety with decreased HRQoL are present in patients with CIS. Neuropsychiatric symptoms contributing to decreased HRQoL are the result of structural brain changes and require complex therapeutic approach in patients with CIS.	[Hyncicova, Eva; Kalina, Adam; Vyhnalek, Martin; Nikolai, Tomas; Martinkovic, Lukas; Hort, Jakub; Meluzinova, Eva; Laczo, Jan] Charles Univ Prague, Dept Neurol, Fac Med 2, Motol Univ Hosp, Prague, Czech Republic; [Lisy, Jiri] Charles Univ Prague, Dept Radiol, Fac Med 2, Motol Univ Hosp, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague; Motol University Hospital	Laczo, J (corresponding author), Charles Univ Prague, Dept Neurol, Fac Med 2, Motol Univ Hosp, Prague, Czech Republic.	jan.laczo@lfmotol.cuni.cz	Kalina, Adam/C-2987-2019; Nikolai, Tomas/AAL-6666-2021; Vyhnalek, Martin/R-3515-2019; Nikolai, Tomas/G-4883-2017; Hort, Jakub/M-4011-2016; Kalina, Adam/AGQ-7742-2022; Martinkovic, Lukas/AAR-9847-2021	Kalina, Adam/0000-0002-7316-364X; Nikolai, Tomas/0000-0002-0104-7228; Vyhnalek, Martin/0000-0002-5976-4932; Nikolai, Tomas/0000-0002-0104-7228; Hort, Jakub/0000-0002-1080-3726; Kalina, Adam/0000-0002-7316-364X; Martinkovic, Lukas/0000-0001-9117-2737	GAUK (Charles University Grant Agency) [546317]; MH CZ-IGA (Ministry of Health, Czech Republic, Internal Grant Agancy) [NT/12385-5, NR/9445-3]; MH CZ-DRO (Ministry of Health, Czech Republic-Dconceptual development of research organization, Motol University Hospital, Prague, Czech Republic) [00064203]; IPE (Institutional Support of Excellence, 2nd Faculty of Medicine, Charles University) [6990122]	GAUK (Charles University Grant Agency); MH CZ-IGA (Ministry of Health, Czech Republic, Internal Grant Agancy); MH CZ-DRO (Ministry of Health, Czech Republic-Dconceptual development of research organization, Motol University Hospital, Prague, Czech Republic); IPE (Institutional Support of Excellence, 2nd Faculty of Medicine, Charles University)	This work received support from GAUK (Charles University Grant Agency), Grant No. 546317, http://www.cuni.cz/UK-33.html, recipient: Lukas Martinkovic; MH CZ-IGA (Ministry of Health, Czech Republic, Internal Grant Agancy) Grant Nos. NT/12385-5 and NR/9445-3, https://www.mzcr.cz/obsah/veda-a-vyzkum-iga-mz_2203_1.html, recipient: Eva Meluzinova; MH CZ-DRO (Ministry of Health, Czech Republic-Dconceptual development of research organization, Motol University Hospital, Prague, Czech Republic) Grant No. 00064203, https://www.mzcr.cz/dokumenty/ institucionalni-podporadedikace_7615_978_3. html, recipient: Jan Laczo; and IPE (Institutional Support of Excellence, 2nd Faculty of Medicine, Charles University) Grant No. 6990122, https:// www.lf2.cuni.cz/aktuality/vyhlaseni-programu-ipe-institucionalni-podpory-excelence, recipient: Jakub Hort. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anhoque CF, 2013, CLIN NEUROL NEUROSUR, V115, P1032, DOI 10.1016/j.clineuro.2012.10.025; Anhoque CF, 2013, ARQ NEURO-PSIQUIAT, V71, P74, DOI 10.1590/S0004-282X2013005000004; Anhoque CF, 2011, ARQ NEURO-PSIQUIAT, V69, P882, DOI 10.1590/S0004-282X2011000700006; Audoin B, 2010, J NEUROL NEUROSUR PS, V81, P690, DOI 10.1136/jnnp.2009.188748; Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Benedict RHB, 2004, MULT SCLER J, V10, P675, DOI 10.1191/1352458504ms1098oa; Berg D, 2000, MULT SCLER J, V6, P156, DOI 10.1191/135245800701566016; D'Alisa S, 2006, DISABIL REHABIL, V28, P307, DOI 10.1080/09638280500191753; Damasceno A, 2016, MULT SCLER J, V22, P822, DOI 10.1177/1352458515599451; Di Legge S, 2003, MULT SCLER J, V9, P302, DOI 10.1191/1352458503ms921oa; Dufek M, 2014, NEUROL PRAXI, V15, P31; Feinstein A, 2002, J NEUROL, V249, P815, DOI 10.1007/s00415-002-0725-0; Figved N, 2005, ACTA PSYCHIAT SCAND, V112, P463, DOI 10.1111/j.1600-0447.2005.00624.x; Gavelova M, 2015, DISABIL HEALTH J, V8, P372, DOI 10.1016/j.dhjo.2015.02.006; Ghajarzadeh M, 2013, ACTA NEUROL BELG, V113, P411, DOI 10.1007/s13760-013-0198-2; Hynicova E, 2017, J NEUROL, V264, P482, DOI 10.1007/s00415-016-8368-9; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klevan G, 2014, ACTA NEUROL SCAND, V129, P21, DOI 10.1111/ane.12142; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Langdon DW, 2013, EUR NEUROL, V69, P346, DOI 10.1159/000345698; Lynch SG, 2001, MULT SCLER J, V7, P411, DOI 10.1191/135245801701566998; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Mohr DC, 1999, ARCH NEUROL-CHICAGO, V56, P1263, DOI 10.1001/archneur.56.10.1263; Nourbakhsh B, 2016, EUR J NEUROL, V23, P1482, DOI 10.1111/ene.13102; Nygaard GO, 2015, MULT SCLER J, V21, P402, DOI 10.1177/1352458514543811; Pandey K, 2009, CURR TREAT OPTION NE, V11, P193, DOI 10.1007/s11940-009-0023-7; Parmenter BA, 2007, MULT SCLER J, V13, P52, DOI 10.1177/1352458506070750; Patel Viral P, 2016, Mult Scler J Exp Transl Clin, V2, p2055217316653150, DOI 10.1177/2055217316653150; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pujol J, 2000, PSYCHIAT RES-NEUROIM, V99, P151, DOI 10.1016/S0925-4927(00)00061-5; Putzki N, 2009, EUR J NEUROL, V16, P713, DOI 10.1111/j.1468-1331.2009.02572.x; Rao SM, 2014, MULT SCLER INT, V2014, DOI [10.1155/2014/975803, DOI 10.1155/2014/975803]; Runia TF, 2015, J NEUROL NEUROSUR PS, V86, P543, DOI 10.1136/jnnp-2014-308374; Simioni S, 2007, SWISS MED WKLY, V137, P496; Smith A., 1982, SYMBOL DIGIT MODALIT; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Stuke H, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00622; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zorzon M, 2002, EUR J NEUROL, V9, P491, DOI 10.1046/j.1468-1331.2002.00442.x	43	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0200254	10.1371/journal.pone.0200254	http://dx.doi.org/10.1371/journal.pone.0200254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979757	gold, Green Submitted, Green Published			2022-12-26	WOS:000437809500085
J	Cervera-Torres, S; Fernandez, SR; Lachmair, M; Gerjets, P				Cervera-Torres, Sergio; Ruiz Fernandez, Susana; Lachmair, Martin; Gerjets, Peter			Valence-space associations in touchscreen interactions: Valence match between emotional pictures and their vertical touch location leads to pictures' positive evaluation	PLOS ONE			English	Article								Embodied cognition research suggests that bodily experiences might ground mental representations of emotional valence in the vertical dimension of space (i.e., positive is up and negative is down). Accordingly, recent studies show that upward and downward arm movements may also influence the evaluation of valence-laden stimuli, suggesting that upward (downwards) movements lead to more positive (negative) evaluations. Interestingly, these studies typically did not investigate paradigms that require a direct hand interaction with the stimuli. With the advent of touchscreen devices and their use for experimental environments, however, a direct and more natural hand interaction with the stimuli has come to the fore. In this regard, the goal of the present study is to examine how direct hand interaction with valence-laden stimuli on a touchscreen monitor affects their perceived valence. To do so, participants evaluated emotional pictures after touching and moving them either upwards or downwards across a vertically mounted touchscreen. In contrast to previous findings, the results suggest that positive pictures were evaluated as more positive after downward movements while negative pictures were evaluated as less negative following upward movements. This finding may indicate that a matching between the pictures' valence and the valence associated with their vertical touch location leads to more positive evaluations. Thus, the present study extends earlier results by an important point: Touching the emotional pictures during movement may influence their valence processing.	[Cervera-Torres, Sergio; Ruiz Fernandez, Susana; Lachmair, Martin; Gerjets, Peter] Leibniz Inst Wissensmedien, Tubingen, Germany; [Cervera-Torres, Sergio; Ruiz Fernandez, Susana; Gerjets, Peter] Univ Tubingen, LEAD Grad Sch & Res Network, Tubingen, Germany; [Ruiz Fernandez, Susana] FOM Hsch Oekon & Management, Stuttgart, Germany	Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen	Cervera-Torres, S (corresponding author), Leibniz Inst Wissensmedien, Tubingen, Germany.; Cervera-Torres, S (corresponding author), Univ Tubingen, LEAD Grad Sch & Res Network, Tubingen, Germany.	s.cervera-torres@iwm-tuebingen.de	Cervera-Torres, Sergio/AAC-7168-2020; Lachmair, Martin/HCH-2667-2022; Gerjets, Peter/AAD-2017-2020	Cervera-Torres, Sergio/0000-0003-1689-4654; Lachmair, Martin/0000-0002-0469-9168				Abrams RA, 2008, COGNITION, V107, P1035, DOI 10.1016/j.cognition.2007.09.006; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barsalou L.W., 2012, CAMBRIDGE HDB PSYCHO, P239, DOI [10.1017/CBO9781139029377.017, DOI 10.1017/CBO9781139029377.017]; Brookshire G, 2010, P 32 ANN C COGN SCI, P1940; Brucker B., 2016, P EARLI SPEC INT GRO, P48; Carr EW, 2016, EMOTION, V16, P540, DOI 10.1037/emo0000146; Torres SC, 2020, PSYCHOL RES-PSYCH FO, V84, P23, DOI 10.1007/s00426-018-0971-1; Dudschig C, 2015, ACTA PSYCHOL, V156, P143, DOI 10.1016/j.actpsy.2014.09.015; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Koch SC, 2011, SOC PSYCHOL-GERMANY, V42, P214, DOI 10.1027/1864-9335/a000065; Lakoff G, 2008, METAPHORS WE LIVE BY; Lang P.J., 2008, A8 U FLOR; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Marmolejo-Ramos F, 2017, PSYCHOL RES-PSYCH FO, V81, P750, DOI 10.1007/s00426-016-0787-9; Meier BP, 2005, METAPHOR SYMBOL, V20, P239, DOI 10.1207/s15327868ms2004_1; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Nair S, 2015, HEALTH PSYCHOL, V34, P632, DOI 10.1037/hea0000146; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PRASAD S, 2015, COGENT PSYCHOL, V2, DOI DOI 10.1080/23311908.2015.1079945; Reed CL, 2006, J EXP PSYCHOL HUMAN, V32, P166, DOI 10.1037/0096-1523.32.1.166; SALMASO D, 1985, CORTEX, V21, P533, DOI 10.1016/S0010-9452(58)80003-9; Sasaki K, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.0690; Schnall S, 2006, P 26 ANN M COGN SCI; Steegen S, 2016, PERSPECT PSYCHOL SCI, V11, P702, DOI 10.1177/1745691616658637; STEPPER S, 1993, J PERS SOC PSYCHOL, V64, P211, DOI 10.1037/0022-3514.64.2.211; Tseng P, 2011, EXP BRAIN RES, V209, P257, DOI 10.1007/s00221-011-2544-z; West B. T., 2014, LINEAR MIXED MODELS; Wigdor D, 2011, BRAVE NUI WORLD: DESIGNING NATURAL USER INTERFACES FOR TOUCH AND GESTURE, P1; Winkielman P, 2001, J PERS SOC PSYCHOL, V81, P989, DOI 10.1037//0022-3514.81.6.989	30	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0199972	10.1371/journal.pone.0199972	http://dx.doi.org/10.1371/journal.pone.0199972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN4SJ	30020949	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400034
J	Maeda, T; Hashizume, H; Yoshimura, N; Oka, H; Ishimoto, Y; Nagata, K; Takami, M; Tsutsui, S; Iwasaki, H; Minamide, A; Nakagawa, Y; Yukawa, Y; Muraki, S; Tanaka, S; Yamada, H; Yoshida, M				Maeda, Takahiro; Hashizume, Hiroshi; Yoshimura, Noriko; Oka, Hiroyuki; Ishimoto, Yuyu; Nagata, Keiji; Takami, Masanari; Tsutsui, Shunji; Iwasaki, Hiroshi; Minamide, Akihito; Nakagawa, Yukihiro; Yukawa, Yasutsugu; Muraki, Shigeyuki; Tanaka, Sakae; Yamada, Hiroshi; Yoshida, Munehito			Factors associated with lumbar spinal stenosis in a large-scale, population-based cohort: The Wakayama Spine Study	PLOS ONE			English	Article							OLDER-ADULTS; PREVALENCE; COMPLICATIONS; SURGERY; TRENDS; PAIN	Objective Patients with lumbar spinal stenosis (LSS) who have radiographically similar degrees of stenosis may not necessarily exhibit equivalent symptoms. As part of a cross-sectional study, we examined factors associated with symptomatic LSS (sLSS) in the general population of Japan. Methods We evaluated 968 participants (men, 319; women, 649) between 2008 and 2010. Orthopedic surgery specialists diagnosed sLSS using interview results, medical examinations, and imaging findings. LSS was radiographically graded using a 4-level scale. Additionally, we examined basic anthropometry, smoking habits, alcohol consumption, ankle-brachial index values (ABI), and glycosylated hemoglobin (HbA1c) levels. We grouped patients with moderate and severe radiographic LSS, and compared the indicated factors on the basis of the presence/absence of sLSS. Data were evaluated using multiple logistic regression analyses. Results Radiographically, 451 participants had moderate and 288 severe stenosis. Clinically, 92 participants were diagnosed with sLSS, including 36 with moderate and 52 with severe stenosis. In the moderate stenosis group, participants with sLSS had significantly higher rates of diabetes mellitus (DM) and lower ABIs than did non-LSS participants. Although sLSS participants tended to be older (p = 0.19), there were no significant differences in the sex distribution, body mass index values, or in the percentages of participants who were drinkers/smokers. In the severe stenosis group, there were no differences in any of the evaluated factors. Multiple logistic regression showed that DM (odds ratio [OR], 3.92; 95% confidence interval [CI], 1.52-9.34]) and low ABI (1 SD = 0.09; OR, 1.36; 95% CI, 1.04-1.81) were significantly associated with LSS in the moderate stenosis group. Conclusions DM and low ABIs are significantly associated with sLSS in patients with moderate radiographic stenosis. Neither factor is associated with sLSS in patients with severe stenosis. Notably, the effects of intrinsic factors on symptomology may be masked when anatomic stenosis is severe.	[Maeda, Takahiro; Hashizume, Hiroshi; Ishimoto, Yuyu; Nagata, Keiji; Takami, Masanari; Tsutsui, Shunji; Iwasaki, Hiroshi; Minamide, Akihito; Nakagawa, Yukihiro; Yukawa, Yasutsugu; Yamada, Hiroshi; Yoshida, Munehito] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Wakayama, Japan; [Yoshimura, Noriko; Muraki, Shigeyuki] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Prevent Med Locomot Organ Disorders,Bunkyo K, Tokyo, Japan; [Oka, Hiroyuki] Univ Tokyo, Fac Med, 22nd Century Med & Res Ctr, Dept Med Res & Management Musculoskeletal Pain,Bu, Tokyo, Japan; [Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan; [Yoshida, Munehito] Sumiya Orthopaed Hosp, Dept Orthopaed Surg, Wakayama, Wakayama, Japan	Wakayama Medical University; University of Tokyo; University of Tokyo; University of Tokyo	Hashizume, H (corresponding author), Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Wakayama, Japan.	hashizum@wakayama-med.ac.jp	Hashizume, Hiroshi/V-6888-2019; Tanaka, Sakae/Y-3061-2019; Tanaka, Shinya/D-3586-2011	Hashizume, Hiroshi/0000-0002-9064-0284; Tanaka, Sakae/0000-0001-9210-9414; 	Ministry of Health, Labor and Welfare [H-25-Choujyu-007, H25-Nanchitou (Men)-005, 201417014A, H22-Choujyu-Wakate-007]; Japan Society for the Promotion of Science KAKENHI grant [15K15219, 26670307, 24659666]; Ministry of Education, Culture, Sports, Science and Technology in Japan [NSF 08033011-00262];  [B26293139];  [B23390172];  [B2629333];  [C20591774];  [C26462249];  [C16K10834];  [C25462305];  [B25860448]	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; ; ; ; 	This study was supported by: H-25-Choujyu-007 (Director, Noriko Yoshimura), H25-Nanchitou (Men)-005 (Director, Sakae Tanaka), 201417014A (Director, Noriko Yoshimura), and H22-Choujyu-Wakate-007 (Director, Shigeyuki Muraki) from the Ministry of Health, Labor and Welfare (http://www.mhlw.go.jp); a Grant-in-Aid for Scientific Research (B26293139, B23390172 to Noriko Yoshimura, B2629333, C20591774 to Shigeyuki Muraki, C26462249 to Hiroshi Hashizume, C16K10834, C25462305 to Hiroshi Yamada); a Grant-in-Aid for Young Researchers (B25860448 to Yuyu Ishimoto); a Grant-in-Aid for Challenging Exploratory Research (15K15219 to Noriko Yoshimura, 26670307 to Shigeyuki Muraki, 24659666 to Hiroyuki Oka) of Japan Society for the Promotion of Science KAKENHI grant (https://www.jsps.go.jp/j- grantsinaid/); and Collaborating Research with NSF 08033011-00262 (Director, Noriko Yoshimura) from the Ministry of Education, Culture, Sports, Science and Technology in Japan (http://www.mext.go.jp/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anekstein Y, 2010, ISR MED ASSOC J, V12, P16; Asadian L, 2016, CLIN MED INSIGHTS-EN, V9, DOI 10.4137/CMED.S39035; Cadogan MP, 2011, J GERONTOL NURS, V37, P8, DOI 10.3928/00989134-20110503-07; Ciol MA, 1996, J AM GERIATR SOC, V44, P285, DOI 10.1111/j.1532-5415.1996.tb00915.x; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Fardon D F, 2001, Spine (Phila Pa 1976), V26, pE93, DOI 10.1097/00007632-200103010-00006; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; HAMANISHI C, 1994, J SPINAL DISORD, V7, P388; Ishimoto Y, 2013, OSTEOARTHR CARTILAGE, V21, P783, DOI 10.1016/j.joca.2013.02.656; Ishimoto Y, 2012, OSTEOARTHR CARTILAGE, V20, P1103, DOI 10.1016/j.joca.2012.06.018; Japan Atherosclerosis Society, 2007, J Atheroscler Thromb, P5; Japan diabetes Society, 2007, TREATM GUID DIAB 200; Katz JN, 2008, NEW ENGL J MED, V358, P818, DOI 10.1056/NEJMcp0708097; Lotan R, 2008, J SPINAL DISORD TECH, V21, P247, DOI 10.1097/BSD.0b013e31813707af; Lurie JD, 2008, SPINE, V33, P1605, DOI 10.1097/BRS.0b013e3181791af3; Matsudaira K, 2009, SPINE, V34, P115, DOI 10.1097/BRS.0b013e31818f924d; Ministry of Health Labour and Welfare, 2005, REP NAT HLTH NUTR SU; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Muraki S, 2009, ANN RHEUM DIS, V68, P1401, DOI 10.1136/ard.2007.087296; North American Spine Society, 2011, DIAGN TREATM DEG LUM; Orchard TJ, 1992, CIRCULATION, V88; Sekiguchi M, 2015, EUR SPINE J, V24, P2288, DOI 10.1007/s00586-015-4002-2; Sirvanci M, 2008, EUR SPINE J, V17, P679, DOI 10.1007/s00586-008-0646-5; Suri P, 2010, JAMA-J AM MED ASSOC, V304, P2628, DOI 10.1001/jama.2010.1833; Uesugi K, 2013, SPINE, V38, pE540, DOI 10.1097/BRS.0b013e31828a2517; Yoshihara H, 2016, PAIN PRACT, V16, P245, DOI 10.1111/papr.12272; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8	28	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200208	10.1371/journal.pone.0200208	http://dx.doi.org/10.1371/journal.pone.0200208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020970	Green Published, Green Submitted, gold			2022-12-26	WOS:000439022400042
J	Adachi, S; Honma, T; Yasaka, R; Ohshima, K; Tokuda, M				Adachi, Shuhei; Honma, Tomoki; Yasaka, Ryosuke; Ohshima, Kazusato; Tokuda, Makoto			Effects of infection by Turnip mosaic virus on the population growth of generalist and specialist aphid vectors on turnip plants	PLOS ONE			English	Article							RECOMBINATION; TRANSMISSION; PERFORMANCE	Recent studies have revealed that relationships between plant pathogens and their vectors differ depending on species, strains and associated host plants. Turnip mosaic virus (TuMV) is one of the most important plant viruses worldwide and is transmitted by at least 89 aphid species in a non-persistent manner. TuMV is fundamentally divided into six phylogenetic groups; among which Asian-BR, basal-BR and world-B groups are known to occur in Japan. In Kyushu Japan, basal-BR has invaded approximately 2000 and immediately replaced the predominant world-B virus group. To clarify the relationships between TuMV and vector aphids, we examined the effects of the TuMV phylogenetic group on the population growth of aphid vectors in turnip plants. The population growth of a generalist aphid, Myzus persicae, was not significantly different between non-infected and TuMV-infected treatments. The population growth of a specialist aphid, Lipaphis erysimi, was higher in TuMV-infected plants than non-infected ones. Similar results were obtained in experiments using world-B and basal-BR groups of TuMV. Therefore, we conclude that L. erysimi is more mutualistic with TuMV than M. persicae, and differences in TuMV phylogenetic groups do not affect the growth of aphid vectors on turnip plants.	[Adachi, Shuhei] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan; [Adachi, Shuhei; Honma, Tomoki; Tokuda, Makoto] Saga Univ, Fac Agr, Lab Syst Ecol, Saga, Japan; [Yasaka, Ryosuke; Ohshima, Kazusato] Saga Univ, Fac Agr, Lab Plant Virol, Saga, Japan	Kagoshima University; Saga University; Saga University	Adachi, S (corresponding author), Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima, Japan.; Adachi, S (corresponding author), Saga Univ, Fac Agr, Lab Syst Ecol, Saga, Japan.	aphidtennis@gmail.com		Adachi, Shuhei/0000-0002-7314-4676				Andret-Link P, 2005, J PLANT PATHOL, V87, P153; Bak A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14493; Blackman RL, 2017, APHIDS WORLDS PLANTS; Casteel CL, 2015, PLANT PHYSIOL, V169, P209, DOI 10.1104/pp.15.00332; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Kersch-Becker MF, 2014, OECOLOGIA, V174, P883, DOI 10.1007/s00442-013-2812-7; Kluth S, 2002, OECOLOGIA, V133, P193, DOI 10.1007/s00442-002-1016-3; Li M, 2011, INSECT SCI, V18, P40, DOI 10.1111/j.1744-7917.2010.01354.x; Liu J, 2010, J ZHEJIANG UNIV-SC B, V11, P30, DOI 10.1631/jzus.B0900213; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Moritsu M., 1983, APHIDS JAPAN COLORS; Ng JCK, 2004, MOL PLANT PATHOL, V5, P505, DOI [10.1111/j.1364-3703.2004.00240.x, 10.1111/J.1364-3703.2004.00240.X]; Nishi Y., 1963, B KYUSHU AGR EXP STA, V8, P355; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Ohshima K, 2007, J GEN VIROL, V88, P298, DOI 10.1099/vir.0.82335-0; Ohshima Kazusato, 2012, Uirusu, V62, P151; PAN HP, 2013, SCI REP UK, V3; Pinheiro PV, 2017, MOL CELL PROTEOMICS, V16, pS230, DOI [10.1074/mcp.M116.063495, 10.1074/mcp.m116.063495]; SANO Y, 1989, Annals of the Phytopathological Society of Japan, V55, P296, DOI 10.3186/jjphytopath.55.296; Shattuck V. I., 1992, Horticultural Reviews, V14, P199; Tomimura K, 2004, VIROLOGY, V330, P408, DOI 10.1016/j.virol.2004.09.040; Tomitaka Y, 2006, MOL ECOL, V15, P4437, DOI 10.1111/j.1365-294X.2006.03094.x; TOMLINSON JA, 1987, ANN APPL BIOL, V110, P661, DOI 10.1111/j.1744-7348.1987.tb04187.x; Tsuchizaki T, 1981, RES B HOKKAIDO NATL, V131, P71; Walsh JA, 2002, MOL PLANT PATHOL, V3, P289, DOI 10.1046/j.1364-3703.2002.00132.x; Yasaka R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01934-7	26	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200784	10.1371/journal.pone.0200784	http://dx.doi.org/10.1371/journal.pone.0200784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016354	Green Published, gold, Green Submitted			2022-12-26	WOS:000438866600042
J	Franca, DDD; Alves Del-Rios, NHA; Carneiro, MAD; Guimaraes, RA; Caetano, KAA; Reis, MND; Martins, RMB; Motta-Castro, ARC; Stefani, MMD; Teles, SA				da Silva Franca, Divania Dias; Alves Del-Rios, Native Helena; dos Santos Carneiro, Megmar Aparecida; Guimaraes, Rafael Alves; Amorim Caetano, Karlla Antonieta; da Guarda Reis, Monica Nogueira; Bringel Martins, Regina Maria; Coimbra Motta-Castro, Ana Rita; de Araujo Stefani, Mariane Martins; Teles, Sheila Araujo			HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: Prevalence and molecular characteristics	PLOS ONE			English	Article							SEXUAL RISK BEHAVIORS; INJECTION-DRUG USE; TRANSMISSION; PREVENTION; SALVADOR; DISEASE; IMPACT	Brazil has the largest cocaine market in South America, and crack cocaine use is closely associated with HIV-1 infection. This study investigated the prevalence, risk factors, and HIV-1 subtypes, including recombinant forms and mutations associated with drug resistance, among crack cocaine users in Central-West Brazil. We recruited 600 crack cocaine users admitted to a referral hospital in Goiania for psychiatric disorders. The participants were interviewed; blood samples were collected for anti-HIV-1/2 serological screening. HIV-1 pol gene sequences (entire protease [PR] and partial reverse transcriptase [RT]) were obtained from plasma RNA. HIV-1 subtypes, recombinant viruses, transmitted drug resistance (TDR), and secondary drug resistance mutations were investigated. The median participant age was 30 years (range, 18-68 years); most were male, single, unemployed, and of mixed races. Among them, 2.8% (17/600) were HIV-1 positive: 2.2% of men (11/507) and 6.5% of women (6/93). The main predictors of HIV-1 seropositivity were a sexual partner with HIV infection, irregular condom use, and previous homelessness. HIV-1 pol sequences (12/17) indicated the predominance of subtype B (n = 7), followed by recombinant forms F-PR/B-RT (n = 1) and B-PR/F-RT (n = 2) and subtypes F1 (n = 1) and C (n = 1). TDR prevalence was 58.3% (7/12). Isolates from two participants showed mutations associated with resistance to nucleoside reverse transcriptase inhibitors (NRTI) only (M41L, T125C, T125F, M184V), while an isolate from one patient who had received antiretroviral therapy (ART) since 2008 had a mutation associated with resistance to non-NRTI (G190S). Five isolates had secondary mutations to protease inhibitors (K20M, L10V, L33I, A71T, A71V). In conclusion, the findings of HIV-1 circulation, TDR to NRTI, and secondary mutations to protease inhibitors in ART-naive crack cocaine users support the importance of monitoring this population in regions far from the epicenter of the HIV epidemic.	[da Silva Franca, Divania Dias] Municipal Secretary Hlth Goiania, Dept Epidemiol, Goiania, Go, Brazil; [Alves Del-Rios, Native Helena; dos Santos Carneiro, Megmar Aparecida; da Guarda Reis, Monica Nogueira; Bringel Martins, Regina Maria; de Araujo Stefani, Mariane Martins] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Guimaraes, Rafael Alves; Amorim Caetano, Karlla Antonieta; Teles, Sheila Araujo] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil; [Coimbra Motta-Castro, Ana Rita] Univ Fed Mato Grosso do Sul, Ctr Biol & Hlth Sci, Campo Grande, MS, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Mato Grosso do Sul	Teles, SA (corresponding author), Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil.	Sheila.fen@gmail.com	Teles, Sheila Araujo/D-8837-2015; Caetano, Karlla Antonieta A/M-4025-2016; TELES, SHEILA/X-7998-2019; Carneiro, Megmar/O-6482-2018	Teles, Sheila Araujo/0000-0003-4030-6947; Caetano, Karlla Antonieta A/0000-0003-4818-4753; TELES, SHEILA/0000-0002-7059-4241; Carneiro, Megmar/0000-0003-0569-477X; Motta-Castro, Ana Rita/0000-0003-3070-1337	Brazilian National Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico in portuguese - CNPq); Foundation for Research Support of Goias State (Fundacao de Amparo a Pesquisa do Estado de Goias in Portuguese - FAPEG); FUNDECT/CNPq PRONEM - MS [074/2015]	Brazilian National Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico in portuguese - CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of Goias State (Fundacao de Amparo a Pesquisa do Estado de Goias in Portuguese - FAPEG); FUNDECT/CNPq PRONEM - MS(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	The authors express their gratitude to Brazilian National Research Council (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico in portuguese - CNPq) and Foundation for Research Support of Goias State (Fundacao de Amparo a Pesquisa do Estado de Goias in Portuguese - FAPEG) for funding. The authors also received funding from FUNDECT/CNPq PRONEM - MS. Process no 074/2015.	Abdalla RR, 2014, ADDICT BEHAV, V39, P297, DOI 10.1016/j.addbeh.2013.10.019; Aldous JL, 2012, CLIN INFECT DIS, V55, P1135, DOI 10.1093/cid/cis612; [Anonymous], 2009, RELATORIO BRASILEIRO; Atkinson JS, 2010, AIDS BEHAV, V14, P48, DOI 10.1007/s10461-007-9346-0; Bastos FI, 2014, PESQUISA NACL USO CR; Baum MK, 2009, JAIDS-J ACQ IMM DEF, V50, P93, DOI 10.1097/QAI.0b013e3181900129; Bertoni N, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0070-x; Brenner B, 2013, AIDS, V27, P1045, DOI 10.1097/QAD.0b013e32835cffd9; Cruz M, 2014, SUBST ABUSE TREAT PR, V9, DOI 10.1186/1747-597X-9-2; Cruz MS, 2013, INT J DRUG POLICY, V24, P432, DOI 10.1016/j.drugpo.2013.03.012; de Carvalho HB, 2009, CLINICS, V64, P857, DOI 10.1590/S1807-59322009000900006; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Departamento de DST AeHV, 2014, B EP HIV AIDS, P77; Dickson-Gomez J, 2012, SUBST USE MISUSE, V47, P265, DOI 10.3109/10826084.2011.635325; Diehl A, 2014, ADICCIONES, V26, P208, DOI 10.20882/adicciones.2; Duailibi Lígia Bonacim, 2008, Cad. Saúde Pública, V24, ps545, DOI 10.1590/S0102-311X2008001600007; Duff P, 2013, HARM REDUCT J, V10, DOI 10.1186/1477-7517-10-29; EDLIN BR, 1994, NEW ENGL J MED, V331, P1422, DOI 10.1056/NEJM199411243312106; Fischer B, 2013, INT J DRUG POLICY, V24, P631, DOI 10.1016/j.drugpo.2013.09.003; Frost SDW, 2015, J INFECT DIS, V211, P856, DOI 10.1093/infdis/jiu563; Gomez MP, 2002, SEX TRANSM DIS, V29, P259, DOI 10.1097/00007435-200205000-00002; Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610; Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372; Hwang LY, 2000, CLIN INFECT DIS, V31, P920, DOI 10.1086/318131; Khan MR, 2013, AIDS BEHAV, V17, P1185, DOI 10.1007/s10461-012-0276-0; Malta Monica, 2008, Rev. Saúde Pública, V42, P830, DOI 10.1590/S0034-89102008000500007; McCoy CB, 2004, ANN EPIDEMIOL, V14, P535, DOI 10.1016/j.annepidem.2003.10.001; Narvaez JCM, 2014, SOC PSYCH PSYCH EPID, V49, P1249, DOI 10.1007/s00127-014-0830-3; Narvaez JCM, 2014, COMPR PSYCHIAT, V55, P1369, DOI 10.1016/j.comppsych.2014.04.021; Nunes CLX, 2007, BRAZ J INFECT DIS, V11, P561, DOI 10.1590/S1413-86702007000600007; Perez AO, 2015, EUR ADDICT RES, V21, P53, DOI 10.1159/000363737; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Poon AFY, 2015, J INFECT DIS, V211, P926, DOI 10.1093/infdis/jiu560; Prevention CDC, 2017, DET INV RESP HIV TRA, P57; Ribeiro M, 2006, REV BRAS PSIQUIATR, V28, P196, DOI 10.1590/S1516-44462006000300010; UNODC, 2015, UNITED NATIONS PUBL, P162; Cardoso LPV, 2011, AIDS RES HUM RETROV, V27, P1349, DOI 10.1089/aid.2011.0153; Cardoso LPV, 2009, J CLIN VIROL, V46, P134, DOI 10.1016/j.jcv.2009.07.009; von Diemen L, 2010, ARCH WOMEN MENT HLTH, V13, P185, DOI 10.1007/s00737-009-0089-y; Wertheim JO, 2014, J INFECT DIS, V209, P304, DOI 10.1093/infdis/jit524	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0199606	10.1371/journal.pone.0199606	http://dx.doi.org/10.1371/journal.pone.0199606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2XR	30016324	Green Submitted, Green Published, gold			2022-12-26	WOS:000438866600010
J	Mayhugh, RE; Laurienti, PJ; Fanning, J; Gauvin, L; Heilman, KJ; Porges, SW; Rejeski, WJ				Mayhugh, Rhiannon E.; Laurienti, Paul J.; Fanning, Jason; Gauvin, Lise; Heilman, Keri J.; Porges, Stephen W.; Rejeski, W. Jack			Cardiac vagal dysfunction moderates patterns of craving across the day in moderate to heavy consumers of alcohol	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RESPIRATORY SINUS ARRHYTHMIA; AUTONOMIC REGULATION; BEHAVIOR PROBLEMS; ATTENTIONAL BIAS; SELF-REGULATION; CUE-REACTIVITY; STRESS; RELAPSE; INDEX	Background Alcohol craving, a known correlate of vulnerability to Alcohol Use Disorder (AUD), has been found to be inversely related to cardiac vagal tone (CVT). Here we examine how resting CVT, CVT reactivity to a postural challenge, and their interaction influence craving during imposed alcohol abstinence and their usual drinking among moderate to heavy drinkers. Methods Participants were recruited from the local community (final n = 29) and assessed for CVT functioning via respiratory sinus arrhythmia (RSA) at rest (RSA-rest) and during a postural challenge (RSA-react). Craving intensity was assessed throughout the day during 3-day periods of imposed alcohol abstinence (abstained days) and drinking as usual (normal days) via Ecological Momentary Assessment (EMA). Multilevel statistical modeling assessed relationships between patterns of CVT and diurnal craving. The primary hypothesis of interest was that the interaction of RSA-rest with RSA-react would be significantly associated with increased craving across the day. Results Overall, craving increased throughout the day and significantly decreased after drinking (p < 0.001). There was a significant interaction between RSA-rest and RSA-react with plots revealing that this effect was driven by an aberrant craving pattern among participants with higher RSA-rest and a sluggish vagal brake in response to a postural shiftatypical RSA-react. Conclusion Although additional research is needed to corroborate these findings, our results suggest that moderate-heavy drinkers characterized by higher RSA-rest and atypical RSA-react exhibit aberrant patterns of craving across the day that may represent a risk factor for AUD.	[Mayhugh, Rhiannon E.; Laurienti, Paul J.] Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA; [Mayhugh, Rhiannon E.] Wake Forest Sch Med, Neurosci Program, Winston Salem, NC USA; [Laurienti, Paul J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27101 USA; [Laurienti, Paul J.; Rejeski, W. Jack] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Fanning, Jason; Rejeski, W. Jack] Wake Forest Univ, Dept Geriatr Med, Winston Salem, NC 27109 USA; [Gauvin, Lise] Univ Montreal, Ecole Sante Publ, CRCHUM, Montreal, PQ, Canada; [Gauvin, Lise] Univ Montreal, Ecole Sante Publ, Dept Med Sociale & Prevent, Montreal, PQ, Canada; [Heilman, Keri J.; Porges, Stephen W.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Universite de Montreal; Universite de Montreal; University of North Carolina; University of North Carolina Chapel Hill; Wake Forest University	Laurienti, PJ (corresponding author), Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA.; Laurienti, PJ (corresponding author), Wake Forest Sch Med, Dept Radiol, Winston Salem, NC 27101 USA.; Laurienti, PJ (corresponding author), Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA.	plaurien@wakehealth.edu	Ghiami, Zeinab/G-5492-2016	Gauvin, Lise/0000-0002-1562-1307	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [T32AA007565, P01AA021099, P50AA026117]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007565, P01AA021099, P50AA026117] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under Award Number T32AA007565, P01AA021099, and P50AA026117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aiken L. S., 1991, MULTIPLE REGRESSION; Ashare RL, 2012, PSYCHOPHARMACOLOGY, V220, P259, DOI 10.1007/s00213-011-2473-3; Balzarotti S, 2017, BIOL PSYCHOL, V130, P54, DOI 10.1016/j.biopsycho.2017.10.008; Beauchaine TP, 2007, BIOL PSYCHOL, V74, P174, DOI 10.1016/j.biopsycho.2005.08.008; Beauchaine TP, 2015, INT J PSYCHOPHYSIOL, V98, P338, DOI 10.1016/j.ijpsycho.2015.08.004; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Breese GR, 2005, ALCOHOL CLIN EXP RES, V29, P185, DOI 10.1097/01.ALC.0000153544.83656.3C; Bujarski S, 2014, DRUG ALCOHOL DEPEN, V140, P161, DOI 10.1016/j.drugalcdep.2014.04.015; Byrne EA, 1996, J APPL PHYSIOL, V81, P743, DOI 10.1152/jappl.1996.81.2.743; Cribbet MR, 2011, EMOTION, V11, P188, DOI 10.1037/a0021789; Culbertson C, 2010, PHARMACOL BIOCHEM BE, V96, P454, DOI 10.1016/j.pbb.2010.07.005; Dale LP, 2011, INFANT MENT HEALTH J, V32, P473, DOI 10.1002/imhj.20306; de Bruijn C, 2004, J NERV MENT DIS, V192, P494, DOI 10.1097/01.nmd.0000131912.71344.e4; Evans BE, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00066; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fazzino TL, 2013, ALCOHOL CLIN EXP RES, V37, P2161, DOI 10.1111/acer.12191; Garland EL, 2012, PSYCHOPHARMACOLOGY, V222, P17, DOI 10.1007/s00213-011-2618-4; Garland EL, 2012, EXP CLIN PSYCHOPHARM, V20, P225, DOI 10.1037/a0027199; Geisler FCM, 2013, BIOL PSYCHOL, V93, P279, DOI 10.1016/j.biopsycho.2013.02.013; Heilman KJ, 2012, DEV PSYCHOPATHOL, V24, P241, DOI 10.1017/S0954579411000800; Heilman KJ, 2011, DEV PSYCHOBIOL, V53, P785, DOI 10.1002/dev.20551; Hinnant JB, 2009, J ABNORM CHILD PSYCH, V37, P1049, DOI 10.1007/s10802-009-9341-1; Karpyak VM, 2014, ALCOHOL CLIN EXP RES, V38, P9, DOI 10.1111/acer.12270; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Lewis GF, 2012, BIOL PSYCHOL, V89, P349, DOI 10.1016/j.biopsycho.2011.11.009; Mayhugh RE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195063; Miranda R, 2016, ADDICT BIOL, V21, P171, DOI 10.1111/adb.12192; Moos RH, 2006, ADDICTION, V101, P212, DOI 10.1111/j.1360-0443.2006.01310.x; Naqvi NH, 2014, ANN NY ACAD SCI, V1316, P53, DOI 10.1111/nyas.12415; Porges S. W., 1985, METHOD APPARATUS EVA, V4, P944; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; PORGES SW, 1995, NEUROSCI BIOBEHAV R, V19, P225, DOI 10.1016/0149-7634(94)00066-A; Porges SW, 1996, DEV PSYCHOBIOL, V29, P697, DOI 10.1002/(SICI)1098-2302(199612)29:8<697::AID-DEV5>3.0.CO;2-O; PORGES SW, 1992, BIOL PSYCHOL, V34, P93, DOI 10.1016/0301-0511(92)90012-J; Quintana DS, 2013, PSYCHOPHYSIOLOGY, V50, P1202, DOI 10.1111/psyp.12134; Quintana DS, 2013, DRUG ALCOHOL DEPEN, V132, P395, DOI 10.1016/j.drugalcdep.2013.02.025; Rajan I, 1998, BIOL PSYCHIAT, V43, P544, DOI 10.1016/S0006-3223(97)00399-5; Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Riniolo T, 1997, PSYCHOPHYSIOLOGY, V34, P613, DOI 10.1111/j.1469-8986.1997.tb01748.x; Seo D, 2015, ALCOHOL RES-CURR REV, V37, P143; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sinha R, 2009, NEUROPSYCHOPHARMACOL, V34, P1198, DOI 10.1038/npp.2008.78; Sinha R, 2011, ARCH GEN PSYCHIAT, V68, P942, DOI 10.1001/archgenpsychiatry.2011.49; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Umhau JC, 2002, PSYCHOPHYSIOLOGY, V39, P117, DOI 10.1017/S0048577201392016; Vakili S, 2008, ADDICT BEHAV, V33, P1123, DOI 10.1016/j.addbeh.2008.03.009; WANG MQ, 1992, PHARMACOL BIOCHEM BE, V43, P641; Yaroslavsky I, 2014, DEV PSYCHOPATHOL, V26, P1337, DOI 10.1017/S0954579414001060; Yaroslavsky I, 2013, BIOL PSYCHOL, V94, P272, DOI 10.1016/j.biopsycho.2013.06.008	52	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0200424	10.1371/journal.pone.0200424	http://dx.doi.org/10.1371/journal.pone.0200424			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2XR	30016350	Green Published, Green Submitted, gold			2022-12-26	WOS:000438866600025
J	Fraser, H; Parker, T; Nakagawa, S; Barnett, A; Fidler, F				Fraser, Hannah; Parker, Tim; Nakagawa, Shinichi; Barnett, Ashley; Fidler, Fiona			Questionable research practices in ecology and evolution	PLOS ONE			English	Article							PUBLICATION BIAS	We surveyed 807 researchers (494 ecologists and 313 evolutionary biologists) about their use of Questionable Research Practices (QRPs), including cherry picking statistically significant results, p hacking, and hypothesising after the results are known (HARKing). We also asked them to estimate the proportion of their colleagues that use each of these QRPs. Several of the QRPs were prevalent within the ecology and evolution research community. Across the two groups, we found 64% of surveyed researchers reported they had at least once failed to report results because they were not statistically significant (cherry picking); 42% had collected more data after inspecting whether results were statistically significant (a form of p hacking) and 51% had reported an unexpected finding as though it had been hypothesised from the start (HARKing). Such practices have been directly implicated in the low rates of reproducible results uncovered by recent large scale replication studies in psychology and other disciplines. The rates of QRPs found in this study are comparable with the rates seen in psychology, indicating that the reproducibility problems discovered in psychology are also likely to be present in ecology and evolution.	[Fraser, Hannah; Barnett, Ashley; Fidler, Fiona] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Parker, Tim] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA; [Nakagawa, Shinichi] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Fidler, Fiona] Univ Melbourne, Sch Hist & Philosoph Studies, Parkville, Vic, Australia	University of Melbourne; Whitman College; University of New South Wales Sydney; University of Melbourne	Fraser, H (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.	hannahsfraser@gmail.com	Nakagawa, Shinichi/B-5571-2011; Parker, Timothy/B-6895-2009	Nakagawa, Shinichi/0000-0002-7765-5182; Fidler, Fiona/0000-0002-2700-2562; Fraser, Hannah/0000-0003-2443-4463; Parker, Timothy/0000-0003-2995-5284	Australian Research Council Future Fellowship [FT150100297]; Whitman College	Australian Research Council Future Fellowship(Australian Research Council); Whitman College	Fiona Fidler is supported by an Australian Research Council Future Fellowship (FT150100297). T. Parker was supported by a sabbatical provided by Whitman College and was hosted by S. Griffith at Macquarie University.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Agnoli F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172792; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS451, DOI 10.1098/rsbl.2004.0218; Csada RD, 1996, OIKOS, V76, P591, DOI 10.2307/3546355; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010068; Fidler F, 2017, BIOSCIENCE, V67, P282, DOI 10.1093/biosci/biw159; Fiedler K, 2016, SOC PSYCHOL PERS SCI, V7, P45, DOI 10.1177/1948550615612150; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Fraser H, 2017, PREREGISTRATION QUES, DOI [10.17605/OSF.IO/RG2NQ, DOI 10.17605/OSF.I0/RG2NQ]; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Ihle M, 2017, BEHAV ECOL, V28, P348, DOI 10.1093/beheco/arx003; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jennions MD, 2002, BIOL REV, V77, P211, DOI 10.1017/S1464793101005875; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Kelly CD, 2006, Q REV BIOL, V81, P221, DOI 10.1086/506236; Kerr N L, 1998, Pers Soc Psychol Rev, V2, P196, DOI 10.1207/s15327957pspr0203_4; Lebel EP, 2013, PERSPECT PSYCHOL SCI, V8, P424, DOI 10.1177/1745691613491437; Mellor D, 2017, PREREGISTRATION INCR, DOI [10.17605/OSF.IO/XSFAM, DOI 10.17605/OSF.IO/XSFAM]; Mills JA, 2015, TRENDS ECOL EVOL, V30, P581, DOI 10.1016/j.tree.2015.07.006; Mislan KAS, 2016, TRENDS ECOL EVOL, V31, P4, DOI 10.1016/j.tree.2015.11.006; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0196-3; Nosek BA, 2018, P NATL ACAD SCI USA, V115, P2600, DOI 10.1073/pnas.1708274114; O'Boyle EH, 2017, J MANAGE, V43, P376, DOI 10.1177/0149206314527133; Parker TH, NAT ECOL EVOL; Parker TH, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00076; Parker TH, 2016, TRENDS ECOL EVOL, V31, P711, DOI 10.1016/j.tree.2016.07.002; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; R Core Team, 2021, R LANGUAGE ENV STAT; Reuters T, 2013, T REUTERS RES ANAL U; Roche DG, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002295; Schneider G, 2017, NONPARAMETRIC STAT M; Schnitzer SA, 2016, BIOSCIENCE, V66, P98, DOI 10.1093/biosci/biv176; Schwab A, 2011, ORGAN SCI, V22, P1105, DOI 10.1287/orsc.1100.0557; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Smaldino PE, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160384; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Whitlock MC, 2011, TRENDS ECOL EVOL, V26, P61, DOI 10.1016/j.tree.2010.11.006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	42	117	117	8	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200303	10.1371/journal.pone.0200303	http://dx.doi.org/10.1371/journal.pone.0200303			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GN2LQ	30011289	Green Published, Green Submitted, gold			2022-12-26	WOS:000438829800017
J	Shin, SW; Jeon, JH; Jeong, SA; Kim, JA; Park, DS; Shin, Y; Oh, HW				Shin, Sang Woon; Jeon, Jun Hyoung; Jeong, Seon Ah; Kim, Ji-Ae; Park, Doo-Sang; Shin, Yunhee; Oh, Hyun-Woo			A plant diterpene counteracts juvenile hormone-mediated gene regulation during Drosophila melanogaster larval development	PLOS ONE			English	Article							MALE ACCESSORY-GLANDS; RED FLOUR BEETLE; METHOPRENE-TOLERANT; PROTEIN-SYNTHESIS; METAMORPHOSIS; TRANSCRIPTION; EXPRESSION; RECEPTOR; MET; KRUPPEL-HOMOLOG-1	Many plant species possess compounds with juvenile hormone disruptor (JHD) activity. In some plant species, such activity has been attributed to diterpene secondary metabolites. Plant JHD diterpenes disrupt insect development by interfering with the juvenile hormone (JH)-mediated formation of JH receptor complexes. Here, we demonstrate that a plant extract and a diterpene from Lindera erythrocarpa (methyl lucidone) interfere with the formation of both methoprene-tolerant (Met)/Taiman and Germ cell-expressed (GCE)/Taiman heterodimer complexes in yeast two-hybrid assays in vitro. In addition to the in vitro JHD activity, the diterpene and the plant extract from L. erythrocarpa also disrupt the development of larvae and pupae in Drosophila melanogaster. Comparing the transcriptomes of juvenile hormone analog (JHA, methoprene)- and JHD (methyl lucidone)-fed wandering third-instar larvae revealed a large number of genes that were coregulated by JHA and JHD. Moreover, most (83%) of the genes that were repressed by methyl lucidone were significantly activated by methoprene, indicating that JHDs and JHAs have opposing effects on the transcriptional regulation of many JH-dependent genes. Gene ontology analysis also suggested that some of the genes activated-by-JHA/repressed-by-JHD play roles in spermatogenesis. Affymetrix microarray-based analysis indicated that the expression of genes activated-by-JHA/repressed-by-JHD was testis-specific. Together, these results suggest that JH is involved in testis-specific gene expression and that plant JHD diterpenes function as JH antagonists in such JHA-mediated gene regulation.	[Shin, Sang Woon; Kim, Ji-Ae; Oh, Hyun-Woo] Korea Res Inst Biosci & Biotechnol, Core Facil Management Ctr, Daejeon, South Korea; [Jeon, Jun Hyoung; Jeong, Seon Ah; Park, Doo-Sang] Korea Res Inst Biosci & Biotechnol, Biol Resource Ctr, Jeongeup, South Korea; [Shin, Yunhee] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California Berkeley	Shin, SW; Oh, HW (corresponding author), Korea Res Inst Biosci & Biotechnol, Core Facil Management Ctr, Daejeon, South Korea.	shinwoongg@gmail.com; hwoh@kribb.re.kr		Shin, Sang Woon/0000-0001-9467-0803	KRIBB Research Initiative Program [KGM4981814]; National Research Foundation of Korea [2016M3A9A5919255]	KRIBB Research Initiative Program; National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the KRIBB Research Initiative Program (KGM4981814), awarded to H.O., and the National Research Foundation of Korea (2016M3A9A5919255), awarded to DP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026772; Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Barry J, 2008, INSECT BIOCHEM MOLEC, V38, P346, DOI 10.1016/j.ibmb.2007.12.001; Baumann A, 2010, J INSECT PHYSIOL, V56, P1445, DOI 10.1016/j.jinsphys.2010.05.001; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; CHEN PS, 1984, ANNU REV ENTOMOL, V29, P233, DOI 10.1146/annurev.en.29.010184.001313; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; COUCHE GA, 1985, CAN J ZOOL, V63, P2789, DOI 10.1139/z85-417; Davey K.G., 1985, P1; Godlewski J, 2006, BIOCHEM BIOPH RES CO, V342, P1305, DOI 10.1016/j.bbrc.2006.02.097; GOLD SMW, 1989, INSECT BIOCHEM, V19, P139, DOI 10.1016/0020-1790(89)90084-X; Hempel LU, 2006, DEV DYNAM, V235, P1053, DOI 10.1002/dvdy.20698; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kayukawa T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01570; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lee SH, 2015, P NATL ACAD SCI USA, V112, P1733, DOI 10.1073/pnas.1424386112; LEOPOLD RA, 1976, ANNU REV ENTOMOL, V21, P199, DOI 10.1146/annurev.en.21.010176.001215; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; Lozano J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00163; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Oh HW, 2017, J CHEM ECOL, V43, P703, DOI 10.1007/s10886-017-0861-9; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; REGIS L, 1985, INSECT SCI APPL, V6, P579, DOI 10.1017/S1742758400009139; RIDDIFORD LM, 1994, J NEUROBIOL, V25, P819, DOI 10.1002/neu.480250707; RIDDIFORD LM, 1991, GEN COMP ENDOCR, V82, P172, DOI 10.1016/0016-6480(91)90181-5; Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141; SHEMSHEDINI L, 1990, J BIOL CHEM, V265, P1913; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang SL, 2007, J INSECT PHYSIOL, V53, P246, DOI 10.1016/j.jinsphys.2006.07.011; White-Cooper H, 1998, DEVELOPMENT, V125, P125; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007; YAMAMOTO K, 1988, SCIENCE, V239, P916, DOI 10.1126/science.3124270; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	48	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2018	13	7							e0200706	10.1371/journal.pone.0200706	http://dx.doi.org/10.1371/journal.pone.0200706			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2LQ	30011330	Green Submitted, gold, Green Published			2022-12-26	WOS:000438829800046
J	Fleming, NH; Grade, MM; Bendavid, E				Fleming, Nathaniel H.; Grade, Madeline M.; Bendavid, Eran			Impact of primary care provider density on detection and diagnosis of cutaneous melanoma	PLOS ONE			English	Article							CANCER; LESIONS; US; OVERDIAGNOSIS; PREVALENCE; PHYSICIANS; EPIDEMIC; OUTCOMES	Introduction Early diagnosis of cutaneous melanoma is critical in preventing melanoma-associated deaths, but the role of primary care providers (PCPs) in diagnosing melanoma is underexplored. We aimed to explore the association of PCP density with melanoma incidence and mortality. Methods All cases of cutaneous melanoma diagnosed in the United States from 2008-2012 and reported in the Surveillance, Epidemiology, and End Results (SEER) database were analyzed in 2016. County-level primary care physician density was obtained from the Area Health Resources File (AHRF). We conducted multivariate linear regression using 1) average annual melanoma incidence or 2) average annual melanoma mortality by county as primary outcomes, adjusting for demographic confounders and dermatologist density. Cox proportional hazard regression was conducted using individual outcome data from SEER with the same covariates. Results Across 611 counties, 167,305 cases of melanoma were analyzed. Per 100,000 people, an additional 10 PCPs per county was associated with 1.62 additional cases of melanoma per year (95% CI 1.06-2.18, p<0.001). This increased incidence occurred disproportionally in early-stage melanoma (Stage 0: 0.69 cases (0.38-1.00), p<0.001; Stage I: 0.63 cases (0.37-0.89), p<0.001; Stage II: 0.11 cases (0.03-0.19), p = 0.005). There was no statistically significant association between PCP density and incidence of stage III or IV melanoma, or with melanoma-specific mortality. Survival analysis demonstrated elimination of 5-year post-diagnosis mortality risk in medically underserved counties after adjusting stage. Conclusions Higher densities of PCPs may be linked to increased diagnosis of early-stage melanoma without corresponding decreases in late-stage diagnoses or melanoma-associated mortality.	[Fleming, Nathaniel H.; Grade, Madeline M.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Dept Med, Div Primary Care & Populat Hlth, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Fleming, NH (corresponding author), Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA.	nfleming@stanford.edu	Fleming, Nathaniel/AAU-2017-2021	Grade, Madeline/0000-0003-4888-360X	National Institute on Minority Health and Health Disparities [U54MD010724] Funding Source: NIH RePORTER; NIMHD NIH HHS [U54 MD010724] Funding Source: Medline	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Ananthakrishnan AN, 2010, J GEN INTERN MED, V25, P1164, DOI 10.1007/s11606-010-1457-z; [Anonymous], 2015, CURR MED RES OPIN; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P429, DOI 10.1001/jama.2016.8465; Boniol M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008158; Breitbart EW, 2012, J AM ACAD DERMATOL, V66, P201, DOI 10.1016/j.jaad.2010.11.016; Brochez L, 2002, J PATHOL, V196, P459, DOI 10.1002/path.1061; Chen SC, 2006, J GEN INTERN MED, V21, P678, DOI 10.1111/j.1525-1497.2006.00462.x; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; Coups EJ, 2010, AM J MED, V123, P439, DOI 10.1016/j.amjmed.2009.10.014; Curiel-Lewandrowski C, 2016, CANCER-AM CANCER SOC, V122, P3102, DOI 10.1002/cncr.30194; Economic Research Service, 2015, RUR URB CONT COD; Eide MJ, 2013, J AM BOARD FAM MED, V26, P648, DOI 10.3122/jabfm.2013.06.130108; Ferris LK, 2017, JAMA ONCOL, V3, P1112, DOI 10.1001/jamaoncol.2016.6779; Frangos JE, 2012, J AM ACAD DERMATOL, V67, P387, DOI 10.1016/j.jaad.2011.10.026; Geller AC, 2004, J AM BOARD FAM PRACT, V17, P416, DOI 10.3122/jabfm.17.6.416; Guy GP, 2015, AM J PREV MED, V48, P183, DOI 10.1016/j.amepre.2014.08.036; Levell NJ, 2009, BRIT J DERMATOL, V161, P630, DOI 10.1111/j.1365-2133.2009.09299.x; Lin MJ, 2014, J AM ACAD DERMATOL, V71, P691, DOI 10.1016/j.jaad.2014.04.068; Moore MM, 2006, ARCH DERMATOL, V142, P439, DOI 10.1001/archderm.142.4.439; Roetzheim RG, 2013, J AM BOARD FAM MED, V26, P637, DOI 10.3122/jabfm.2013.06.130042; Screening W., 2012, DOES SKIN CANC SCREE, P5395, DOI [10.1002/cncr.27566PMID:22517033, DOI 10.1002/CNCR.27566]; Swetter SM, 2017, JAMA DERMATOL, V153, P797, DOI 10.1001/jamadermatol.2017.1324; US Department of Health and Human Services, 2015, LISTS DES PRIM MED C; Weinstock MA, 2016, CANCER-AM CANCER SOC, V122, P3152, DOI 10.1002/cncr.30177; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099; Welch HG, 2005, BRIT MED J, V331, P481, DOI 10.1136/bmj.38516.649537.E0; Weyers W, 2012, J CUTAN PATHOL, V39, P9, DOI 10.1111/j.1600-0560.2011.01831.x	28	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200097	10.1371/journal.pone.0200097	http://dx.doi.org/10.1371/journal.pone.0200097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005065	Green Published, Green Submitted, gold			2022-12-26	WOS:000438744200007
J	Lim, JU; Yeo, CD; Kang, HS; Park, CK; Kim, JS; Kim, JW; Kim, SJ; Lee, SH				Lim, Jeong Uk; Yeo, Chang Dong; Kang, Hye Seon; Park, Chan Kwon; Kim, Ju Sang; Kim, Jin Woo; Kim, Seung Joon; Lee, Sang Haak			Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion	PLOS ONE			English	Article							PLATINUM-BASED CHEMOTHERAPY; PREOPERATIVE NEUTROPHIL; POSTOPERATIVE SURVIVAL; COLORECTAL-CANCER; TUMOR PROGRESSION; USEFUL PREDICTOR; POOR SURVIVAL; ADENOCARCINOMA; THROMBOCYTOSIS; METASTASIS	Introduction A combination of platelet and lymphocyte to monocyte ratio (LMR) (abbreviated as COP-LMR) has been recently evaluated as systemic inflammatory marker for prognostication in lung cancer. While previous study on COP-LMR has evaluated its prognostic value in NSCLC patients who underwent curative resections, the combination of these two markers has not been evaluated in advanced NSCLC yet. Objectives In this study, we evaluated the prognostic value of COP-LMR in stage IV NSCLC with malignant pleural effusion under active anticancer treatment. Methods Between January 2012 and July 2016, 217 patients with stage IV NSCLC and MPE undergoing active anticancer treatment were selected for evaluation. If patients had both low LMR (< 2.47) and increased platelet (> 30.0 x 10(4) mm-3), they were assigned to COP-LMR group 2. Patients with one parameter were assigned to COP-LMR group 1. If none, patients were assigned to COP-LMR group 0. Results Median overall survival (OS) (P < 0.001), progression free survival (PFS) (P < 0.001) and histological feature (P = 0.003) showed significant differences among COP-LMR groups. For COP-LMR groups 0, 1 and 2, median survival times were 35.9, 14.7 and 7.4 months, respectively, while median progression free times were 19.2, 13.3 and 7.4 months, respectively. Older age, male, low albumin, high CRP and high COP-LMR (0 vs 1, P = 0.021, hazard ratio (HR): 1.822, 95% confidence interval (CI): 1.096-3.027 and 0 vs 2, P = 0.003, HR: 2.464, 95% CI: 1.373-4.421) were independent predictive factors for shorter OS. Age, sex, histology, albumin, or CRP had no significant influence on PFS. High COP-LMR was the significant factor in predicting shorter PFS (0 vs 1, P = 0.116 and 0 vs 2, P = 0.007, HR: 1.902, 95% CI: 1.194-3.028). Conclusions A combination of pretreatment LMR and platelet levels can be used to predict short survival in stage IV NSCLC patients who underwent active anticancer treatment.	[Lim, Jeong Uk; Yeo, Chang Dong; Kang, Hye Seon; Park, Chan Kwon; Kim, Ju Sang; Kim, Jin Woo; Kim, Seung Joon; Lee, Sang Haak] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea	Catholic University of Korea	Yeo, CD (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Pulmonol, Seoul, South Korea.	brainyeo@catholic.ac.kr	KIM, JUSANG/AAB-3748-2019; Lim, Jeong Uk/AAI-7281-2020	KIM, JUSANG/0000-0002-4433-231X; Lim, Jeong Uk/0000-0001-8364-2380				Absenger G, 2013, ANTICANCER RES, V33, P4591; Aerts JG, 2013, CANCER RES, V73, P2381, DOI 10.1158/0008-5472.CAN-12-3932; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; BELLOC C, 1995, INT J CANCER, V60, P413, DOI 10.1002/ijc.2910600324; Cedres S, 2012, CLIN TRANSL ONCOL, V14, P864, DOI 10.1007/s12094-012-0872-5; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; D'Angelo SP, 2011, J CLIN ONCOL, V29, P2066, DOI 10.1200/JCO.2010.32.6181; Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Guruvayoorappan C, 2008, INTEGR CANCER THER, V7, P90, DOI 10.1177/1534735408319060; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Holgersson G, 2017, NEOPLASMA, V64, P909, DOI 10.4149/neo_2017_614; Hu PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108062; Ishizuka M, 2013, BRIT J CANCER, V109, P401, DOI 10.1038/bjc.2013.350; Ishizuka M, 2014, J SURG ONCOL, V110, P935, DOI 10.1002/jso.23753; Ishizuka M, 2012, J SURG ONCOL, V106, P887, DOI 10.1002/jso.23163; Jing XY, 2015, INT J CLIN EXP MED, V8, P10633; Jurasz P, 2004, BRIT J PHARMACOL, V143, P819, DOI 10.1038/sj.bjp.0706013; Kasapoglu US, 2016, CLIN RESPIR J, V10, P791, DOI 10.1111/crj.12292; Kim KH, 2014, J KOREAN MED SCI, V29, P507, DOI 10.3346/jkms.2014.29.4.507; Kim SH, 2016, ONCOTARGET, V7, P36198, DOI 10.18632/oncotarget.8809; Labelle M, 2011, CANCER CELL, V20, P576, DOI 10.1016/j.ccr.2011.09.009; Lin GN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0070-0; Liu HB, 2013, NEOPLASMA, V60, P203, DOI 10.4149/neo_2013_027; Liu W, 2017, ONCOTARGET, V8, P73198, DOI 10.18632/oncotarget.18336; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moro-Sibilot D, 2015, LUNG CANCER, V88, P215, DOI 10.1016/j.lungcan.2015.02.011; O'Callaghan DS, 2010, J THORAC ONCOL, V5, P2024, DOI 10.1097/JTO.0b013e3181f387e4; SARACH MA, 1993, INT J EXP PATHOL, V74, P511; Sharma D, 2014, J CELL PHYSIOL, V229, P1005, DOI 10.1002/jcp.24539; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Siveen KS, 2009, IMMUNOL LETT, V123, P97, DOI 10.1016/j.imlet.2009.02.011; Smith RA, 2009, AM J SURG, V197, P466, DOI 10.1016/j.amjsurg.2007.12.057; Toda M, 2018, THORAC CANCER, V9, P112, DOI 10.1111/1759-7714.12547; Tomita M, 2012, ANTICANCER RES, V32, P3535; Tomita M, 2011, ANTICANCER RES, V31, P2995; Tomita M, 2009, ANTICANCER RES, V29, P2687; Wang YQ, 2017, ONCOL LETT, V14, P4331, DOI 10.3892/ol.2017.6660; Wu YL, 2007, J THORAC ONCOL, V2, P430, DOI 10.1097/01.JTO.0000268677.87496.4c; Yang HB, 2016, ONCOTARGET, V7, P76769, DOI 10.18632/oncotarget.12526; Yao YW, 2013, CANCER IMMUNOL IMMUN, V62, P471, DOI 10.1007/s00262-012-1347-9; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126496	44	23	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2018	13	7							e0200341	10.1371/journal.pone.0200341	http://dx.doi.org/10.1371/journal.pone.0200341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1IZ	30005083	Green Submitted, Green Published, gold			2022-12-26	WOS:000438744200015
J	Amparo, ACB; Jayme, SI; Roces, MCR; Quizon, MCL; Villalon, EES; Quiambao, BP; Baquilod, MS; Hernandez, LM; Taylor, LH; Nel, LH				Amparo, Anna Charinna B.; Jayme, Sarah, I; Roces, Maria Concepcion R.; Quizon, Maria Consorcia L.; Villalon, Ernesto E. S., III; Quiambao, Beatriz P.; Baquilod, Mario S.; Hernandez, Leda M.; Taylor, Louise H.; Nel, Louis H.			The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective	PLOS ONE			English	Article								Background The Philippine government has an extensive network of 513 Animal Bite Treatment Centers (ABTCs) to supply rabies post exposure prophylaxis (PEP), reaching over 1 million bite victims in 2016. The network was evaluated using a review of existing national and provincial data, key informant interviews and surveys in sample ABTCs to determine the cost-effectiveness of this network in preventing human rabies deaths. Methodology and principal findings One urban and one rural ABTC in each of three selected provinces were studied in more detail. PEP delivery generally followed national guidance based on best practices, but there was evidence of operational challenges in supplying all ABTCs with adequate biologics and recently trained staff. Funding was contributed by different levels of government and in some clinics, patients paid for a significant fraction of the total cost. From a health provider perspective including both fixed and variable costs, the average PEP course delivered cost USD 32.91/patient across urban ABTCs (with higher patient throughput) and USD 57.21/patient across rural ABTCs. These costs suggests that PEP provision in the Philippines cost USD 37.6 million in 2016, with a cost per life saved of USD 8,290. An analysis of the 2,239 suspected rabies deaths from 2008 to 2016 showed no significant decline, and from 2014-16 an average of 8,534 years of life were lost annually. The incidence of rabies deaths from 2014-16 was not clearly related to the provision of ABTCs (per 100,000 population) or human population density, but deaths were more common in higher income provinces. Conclusions/Significance In the context of comprehensive rabies control (including dog vaccination and public awareness) ways to reduce this high expenditure on PEP should be explored, to most cost-effectively reach the elimination of human rabies deaths. This paper is accompanied by another containing data on the operation of ABTCs network from a patient perspective.	[Amparo, Anna Charinna B.; Jayme, Sarah, I] Global Alliance Rabies Control, Sta Rosa City, Philippines; [Roces, Maria Concepcion R.; Quizon, Maria Consorcia L.] South Asia Field Epidemiol & Technol Network SAFE, Quezon City, Philippines; [Villalon, Ernesto E. S., III; Baquilod, Mario S.; Hernandez, Leda M.] Dis Prevent & Control Bur, Dept Hlth, Manila, Philippines; [Quiambao, Beatriz P.] Res Inst Trop Med, Dept Hlth, Muntinlupa, Philippines; [Taylor, Louise H.; Nel, Louis H.] Global Alliance Rabies Control, New York, NY USA; [Nel, Louis H.] Univ Pretoria, Pretoria, South Africa	Philippine Department Health; Philippine Department Health; Research Institute for Tropical Medicine - Philippines; University of Pretoria	Amparo, ACB (corresponding author), Global Alliance Rabies Control, Sta Rosa City, Philippines.	chari.amparo@rabiesalliance.org	Nel, Louis H/F-1001-2012	Nel, Louis H/0000-0001-8963-0153; Roces, Maria Concepcion/0000-0003-3047-9529; Amparo, Anna Charinna/0000-0002-9358-3983	GlaxoSmithKline Biologicals SA (Belgium)	GlaxoSmithKline Biologicals SA (Belgium)(GlaxoSmithKline)	The Global Alliance for Rabies Control (USA) received funds from GlaxoSmithKline Biologicals SA (Belgium) to undertake the study. ACBA, SIJ, LHT, MCR, and MCLQ were funded proportionate to their time spent on the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDC, 2017, RAB EXP DOM AN; Commission on Macroeconomics and Health, 2001, MACR HLTH INV HLTH D; De Silva AP, 2017, B WORLD HEALTH ORGAN, V95, P646, DOI 10.2471/BLT.16.188060; Department of Labor and Employment National Wages and Productivty Commission, 2017, SUMM CURR REG DAIL M; Elio-Villa LP, EPIDEMIOLOGICAL STUD; Government of the Philippines, 2016, FREE ANT RAB VACC 20; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Philippines Department of Health Philippines Department of Agriculture, 2011, GUID MAN RAB EXP SEC; Philippines Department of Health Philippines Department of Education, 2012, NAT RAB PREV CONTR P; Public Health Agency of Canada, 2017, CAN IMM GUID 4 D ACT; Shim E, 2009, VACCINE, V27, P7167, DOI 10.1016/j.vaccine.2009.09.027; Undurraga EA, 2017, AM J TROP MED HYG, V96, P1307, DOI 10.4269/ajtmh.16-0785; WHO, 2017, BACKGR PAP PROP REV; World Bank Group, 2017, DATABANK GDP CAP CUR	14	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199186	10.1371/journal.pone.0199186	http://dx.doi.org/10.1371/journal.pone.0199186			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001378	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400006
J	Flegr, J; Sebankova, B; Priplatova, L; Chvatalova, V; Kankova, S				Flegr, Jaroslav; Sebankova, Blanka; Priplatova, Lenka; Chvatalova, Veronika; Kankova, Sarka			Lower performance of Toxoplasma-infected, Rh-negative subjects in the weight holding and hand-grip tests	PLOS ONE			English	Article							GONDII ANTIBODY-TITERS; LATENT TOXOPLASMOSIS; TESTOSTERONE CONCENTRATION; SUICIDE ATTEMPTS; HEALTH-STATUS; SCHIZOPHRENIA; BEHAVIOR; SEROPOSITIVITY; MANIPULATION; ASSOCIATION	Background Toxoplasma, a protozoan parasite of cats, infects many species of intermediate and paratenic hosts, including about one-third of humans worldwide. After a short phase of acute infection, the tissue cysts containing slowly dividing bradyzoites are formed in various organs and toxoplasmosis proceeds spontaneously in its latent form. In immunocompetent subjects, latent toxoplasmosis was considered asymptomatic. However, dozens of studies performed on animals and humans in the past twenty years have shown that it is accompanied by a broad spectrum of specific behavioural, physiological and even morphological changes. In human hosts, the changes often go in the opposite direction in men and women, and are mostly weaker or non-existent in Rh-positive subjects. Methods Here, we searched for the indices of lower endurance of the infected subjects by examining the performance of nearly five hundred university students tested for toxoplasmosis and Rh phenotype in two tests, a weight holding test and a grip test. Results The results confirmed the existence of a negative association of latent toxoplasmosis with the performance of students, especially Rh-negative men, in these tests. Surprisingly, but in an accordance with some already published data, Toxoplasma-infected, Rh-positive subjects expressed a higher, rather than lower, performance in our endurance tests. Discussion Therefore, the results only partly support the hypothesis for the lower endurance of Toxoplasma infected subjects as the performance of Rh-positive subjects (representing majority of population) correlated positively with the Toxoplasma infection.	[Flegr, Jaroslav; Sebankova, Blanka; Priplatova, Lenka; Chvatalova, Veronika; Kankova, Sarka] Charles Univ Prague, Fac Sci, Div Biol, Prague, Vinicna, Czech Republic	Charles University Prague	Flegr, J (corresponding author), Charles Univ Prague, Fac Sci, Div Biol, Prague, Vinicna, Czech Republic.	flegr@cesnet.cz	Flegr, Jaroslav/A-1564-2008; Chvatalova, Veronika/Z-4109-2019; Šebánková, Blanka/GQH-0803-2022; Flegr, Jaroslav/AAG-7568-2021; Šárka, Kaňková/F-8514-2019	Flegr, Jaroslav/0000-0002-0822-0126; Chvatalova, Veronika/0000-0002-9601-492X; Flegr, Jaroslav/0000-0002-0822-0126; Šárka, Kaňková/0000-0002-3087-7538; Priplatova, Lenka/0000-0002-2860-3853	Czech Science Foundation [18-13692S]; Charles University Research Centre program [204056]	Czech Science Foundation(Grant Agency of the Czech Republic); Charles University Research Centre program	This work has been supported by Czech Science Foundation 18-13692S and Charles University Research Centre program No. 204056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Charlie Lotterman for his help with the final version of the paper. This work has been supported by Czech Science Fundation 18-13692S and Charles University Research Centre program No. 204056.	Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Arling TA, 2009, J NERV MENT DIS, V197, P905, DOI 10.1097/NMD.0b013e3181c29a23; Bohannon RW, 2001, PERCEPT MOTOR SKILL, V93, P323, DOI 10.2466/PMS.93.5.323-328; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Dickerson F, 2014, J NERV MENT DIS, V202, P589, DOI 10.1097/NMD.0000000000000166; Ferreira EC, 2013, T ROY SOC TROP MED H, V107, P390, DOI 10.1093/trstmh/trt026; Flegr J, 1996, PARASITOLOGY, V113, P49, DOI 10.1017/S0031182000066269; Flegr J, 2003, BIOL PSYCHOL, V63, P253, DOI 10.1016/S0301-0511(03)00075-9; Flegr J, 2000, BIOL PSYCHOL, V53, P57, DOI 10.1016/S0301-0511(00)00034-X; FLEGR J, 1994, FOLIA PARASIT, V41, P122; Flegr J, 2008, PARASITOLOGY, V135, P427, DOI 10.1017/S0031182007004064; Flegr J, 2016, PARASITOLOGY, V143, P1974, DOI 10.1017/S0031182016001785; Flegr J, 2014, PLOS ONE, V9, DOI [10.1017/S0031182016001785, DOI 10.1017/S0031182016001785]; Flegr J, 2013, PLOS ONE, V8; Flegr J, 2008, AM J PHYS ANTHROPOL, V137, P479, DOI 10.1002/ajpa.20888; Flegr J, 2008, NEUROENDOCRINOL LETT, V29, P475; Flegr J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147955; Flegr J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141362; Flegr J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049478; Flegr J, 2012, FOLIA PARASIT, V59, P253, DOI 10.14411/fp.2012.035; Flegr J, 2010, FOLIA PARASIT, V57, P143, DOI 10.14411/fp.2010.018; Flegr J, 2010, FOLIA PARASIT, V57, P81, DOI 10.14411/fp.2010.010; Havlicek J, 2001, PARASITOLOGY, V122, P515, DOI 10.1017/S0031182001007624; HOBFOLL SE, 1994, AM J COMMUN PSYCHOL, V22, P49, DOI 10.1007/BF02506817; Hodkova H, 2007, PARASITOLOGY, V134, P1329, DOI 10.1017/S0031182007002673; Kankova S, 2010, PARASITOLOGY, V137, P1773, DOI 10.1017/S0031182010000661; Kankova S, 2011, EXP PARASITOL, V128, P181, DOI 10.1016/j.exppara.2011.03.014; Lim A, 2013, MOL ECOL, V22, P102, DOI 10.1111/mec.12042; Lindova J, 2006, INT J PARASITOL, V36, P1485, DOI 10.1016/j.ijpara.2006.07.008; Lindova J, 2010, FOLIA PARASIT, V57, P136, DOI 10.14411/fp.2010.017; Ling VJ, 2011, J NERV MENT DIS, V199, P440, DOI 10.1097/NMD.0b013e318221416e; Mafi P, 2012, Open Orthop J, V6, P95, DOI 10.2174/1874325001206010095; Novotna M, 2008, PARASITOLOGY, V135, P1253, DOI 10.1017/S003118200800485X; Okusaga O, 2011, SCHIZOPHR RES, V133, P150, DOI 10.1016/j.schres.2011.08.006; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Pearce BD, 2014, SOC PSYCH PSYCH EPID, V49, P1001, DOI 10.1007/s00127-014-0820-5; Pearce BD, 2013, SCHIZOPHR RES, V150, P258, DOI 10.1016/j.schres.2013.07.028; Sebankova B, 2017, FRONT ECOL EVOL, V5, DOI 10.3389/fevo.2017.00144; Stock AK, 2014, BRAIN BEHAV IMMUN, V37, P103, DOI 10.1016/j.bbi.2013.11.004; Tamres LK, 2002, PERS SOC PSYCHOL REV, V6, P2, DOI 10.1207/S15327957PSPR0601_1; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Vyas A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004935; Vyas A, 2010, FOLIA PARASIT, V57, P88, DOI 10.14411/fp.2010.011; Webster JP, 2001, MICROBES INFECT, V3, P1037, DOI 10.1016/S1286-4579(01)01459-9; Yagmur F, 2010, FORENSIC SCI INT, V199, P15, DOI 10.1016/j.forsciint.2010.02.020; Zhang YF, 2012, J CLIN PSYCHIAT, V73, P1069, DOI 10.4088/JCP.11m07532	46	4	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200346	10.1371/journal.pone.0200346	http://dx.doi.org/10.1371/journal.pone.0200346			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001377	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400048
J	Hagiwara, H; Nakajima, Y; Ikegami, T; Kinno, Y; Kumada, M				Hagiwara, Hiroaki; Nakajima, Yoshito; Ikegami, Tadashi; Kinno, Yoshinori; Kumada, Megumi			Hemilaterally masked arterial spin labeling by intentional magnetic field changes in the labeling area due to placement of material with high susceptibility	PLOS ONE			English	Article							COLLATERAL CIRCULATION; TERRITORIES; ARTIFACT	Background and purpose Arterial spin labeling(ASL)with magnetic resonance imaging (MRI) is an effective method for estimating cerebral blood flow (CBF). Furthermore, assessing perfusion territories of arteries is useful for determining the treatment strategy of patients with carotid artery stenosis. ASL with selective vessel labeling is an effective method to obtain perfusion mapping, however, the application for selective labeling is not installed on all MR scanners. The purpose of this study is to establish a method to selectively mask in the labeling area using material with high susceptibility instead of selectively labeling to obtain a partial perfusion image. Materials and methods ASL perfusion images were performed in five volunteers. Masking was applied by placing a stainless-steel bolt and nuts on the neck. The area of artifacts extended to the carotid artery was confirmed by the localizer image. In the obtained masked ASL blood flow of the left and right cerebrum and cerebellum was measured and compared with control ASL without masking. By subtracting masked ASL from the control ASL, the perfusion territory of the carotid artery on the masked side was identified. Results Mean CBF which was 39.6 ml/(100 g x min) in control ASL decreased to 16.1 ml/(100 g x min) in masked ASL, and the masking ratio was 59.6%. There were no significant differences in the CBF of non-masked areas under the control ASL condition (39.6 +/- 5.2 m1/[100 g x min]) between that under the masked ASL condition (39.4 +/- 7.0 ml/[100 g x min]). By subtracting masked ASL from control ASL, we successfully visualized the hemilateral carotid artery's perfusion territory. Conclusion Intentional susceptibility artifacts with non-magnetic metals on the neck can mask spin labeling of the carotid artery. Furthermore, hemilateral carotid artery perfusion territories can be visualized in hemilaterally masked ASL.	[Hagiwara, Hiroaki; Nakajima, Yoshito; Ikegami, Tadashi; Kinno, Yoshinori; Kumada, Megumi] Yokohama Minamikyosai Hosp, Dept Radiol, Yokohama, Kanagawa, Japan; [Ikegami, Tadashi] Kanagawa Dent Univ, Dept Diagnost Imaging, Yokosuka, Kanagawa, Japan	Kanagawa Dental College	Hagiwara, H (corresponding author), Yokohama Minamikyosai Hosp, Dept Radiol, Yokohama, Kanagawa, Japan.	hhagi1936@gmail.com		HAGIWARA, Hiroaki/0000-0001-9818-0959				Ahmad FU, 2013, J NEUROSURG-SPINE, V19, P629, DOI 10.3171/2013.7.SPINE1359; Amukotuwa SA, 2016, J MAGN RESON IMAGING, V43, P11, DOI 10.1002/jmri.24873; Brott TG, 2011, STROKE, V42, pE420, DOI 10.1161/STR.0b013e3182112d08; Chng SM, 2008, STROKE, V39, P3248, DOI 10.1161/STROKEAHA.108.520593; CHO ZH, 1992, MAGNET RESON MED, V23, P193, DOI 10.1002/mrm.1910230120; Davies NP, 2003, MAGNET RESON MED, V49, P1133, DOI 10.1002/mrm.10475; Hartkamp NS, 2016, J NEUROL NEUROSUR PS, V87, P1084, DOI 10.1136/jnnp-2015-312906; Hartkamp NS, 2014, MAGN RESON MED, V71, P2059, DOI 10.1002/mrm.24872; Helle M, 2010, MAGN RESON MED, V64, P777, DOI 10.1002/mrm.22451; Hendrikse J, 2010, RADIOLOGY, V254, P867, DOI 10.1148/radiol.09090284; Krabbe-Hartkamp MJ, 1998, RADIOLOGY, V207, P103, DOI 10.1148/radiology.207.1.9530305; Liebeskind DS, 2003, STROKE, V34, P2279, DOI 10.1161/01.STR.0000086465.41263.06; Maurea S, 2006, RADIOL MED, V111, P674, DOI 10.1007/s11547-006-0065-9; Pollock JM, 2009, MAGN RESON IMAGING C, V17, P315, DOI 10.1016/j.mric.2009.01.008; VANDERZWAN A, 1991, STROKE, V22, P1078, DOI 10.1161/01.STR.22.8.1078; Wong EC, 2007, MAGN RESON MED, V58, P1086, DOI 10.1002/mrm.21293; Yamazaki Masaru, 2016, Nihon Hoshasen Gijutsu Gakkai Zasshi, V72, P480, DOI 10.6009/jjrt.2016_JSRT_72.6.480	17	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200648	10.1371/journal.pone.0200648	http://dx.doi.org/10.1371/journal.pone.0200648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001396	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400090
J	Jones, JAB; Lenart, A; Baudisch, A				Jones, Julia A. Berthold; Lenart, Adam; Baudisch, Annette			Complexity of the relationship between life expectancy and overlap of lifespans	PLOS ONE			English	Article							EVOLUTION; MORTALITY; TRANSFERS; MODEL	Longevity has long been recognised as a key facilitator of reciprocal altruism because repeated cooperation of partners hinges on mutual survival. Although demographic tools can be used to quantify mutual survival and expected overlapping lifespans, studies on the evolutionary theory of cooperation take only limited advantage of demography. Overlap of lifespans depends on variation in survival across ages and can be high or low independently of high or low life expectancies. Here we develop formal demographic measures to study the complex relationships between shared life expectancy of two birth cohort peers, the proportion of their lives that they can expect to overlap, and longevity. We simulate age-specific mortality schedules using a Siler model to reveal how infant and senescent mortality, along with age-independent mortality, affect the relationship between the proportion of life shared and life expectancy. We find that while the proportion of life shared can vary vastly for similar life expectancies, almost all changes to mortality schedules that result in higher life expectancies also result in higher proportions of life shared. A distinct exception occurs if life expectancy increases due to lowering the rate of senescence. In this case the proportion of life shared decreases. Our work shows that almost all selective pressures that result in higher life expectancies also result in a larger proportion of life shared. Therefore, selective forces that extend life also improve the chances that a cooperative system would be stable in terms of reciprocal interactions. Since reciprocal interactions may also reduce mortality and result in a feedback loop with the evolution of longevity, our measures and findings can be used for future cross-species comparisons that aim to disentangle predecessor and successor in the evolution of longevity and cooperation.	[Jones, Julia A. Berthold; Lenart, Adam; Baudisch, Annette] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark; [Jones, Julia A. Berthold; Lenart, Adam; Baudisch, Annette] Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark; [Jones, Julia A. Berthold; Baudisch, Annette] Univ Southern Denmark, Dept Biol, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark	Jones, JAB (corresponding author), Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense, Denmark.; Jones, JAB (corresponding author), Univ Southern Denmark, Dept Publ Hlth, Odense, Denmark.; Jones, JAB (corresponding author), Univ Southern Denmark, Dept Biol, Odense, Denmark.	juliajones@biology.sdu.dk	Baudisch, Annette/ABA-2290-2020	Baudisch, Annette/0000-0002-4202-089X				Arnold KE, 1998, P ROY SOC B-BIOL SCI, V265, P739, DOI 10.1098/rspb.1998.0355; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Baudisch A, 2011, METHODS ECOL EVOL, V2, P375, DOI 10.1111/j.2041-210X.2010.00087.x; Burger O, 2012, P NATL ACAD SCI USA, V109, P18210, DOI 10.1073/pnas.1215627109; Chapais B, 2001, INT J PRIMATOL, V22, P203, DOI 10.1023/A:1005619430744; Downing PA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1663; Dugatkin L.A., 1997, COOPERATION ANIMALS; Ebensperger LA, 2012, J ANIM ECOL, V81, P1013, DOI 10.1111/j.1365-2656.2012.01973.x; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gillespie DOS, 2014, DEMOGRAPHY, V51, P1003, DOI 10.1007/s13524-014-0287-8; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Jones OR, 2014, NATURE, V505, P169, DOI 10.1038/nature12789; Lee RD, 2003, P NATL ACAD SCI USA, V100, P9637, DOI 10.1073/pnas.1530303100; Lee R, 2008, P NATL ACAD SCI USA, V105, P7124, DOI 10.1073/pnas.0710234105; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Makeham W.M., 1860, J I ACTUAR, V8, P301, DOI DOI 10.1017/S204616580000126X; Nemeth L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185702; NOWAK MA, 1994, J THEOR BIOL, V168, P219, DOI 10.1006/jtbi.1994.1101; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Pen I, 2000, P ROY SOC B-BIOL SCI, V267, P2411, DOI 10.1098/rspb.2000.1299; Preston S, 2000, DEMOGRAPHY MEASURING; PROMISLOW DEL, 1990, J ZOOL, V220, P417, DOI 10.1111/j.1469-7998.1990.tb04316.x; R Core Team, 2013, R LANG ENV STAT COMP; Rau R, 2008, POPUL DEV REV, V34, P747, DOI 10.1111/j.1728-4457.2008.00249.x; Ridley J, 2005, BEHAV ECOL, V16, P358, DOI 10.1093/beheco/arh170; Ross C, 2015, J THEOR BIOL, V369, P85, DOI 10.1016/j.jtbi.2015.01.020; Shkolnikov V.M., 2003, DEMOGR RES, V8, P305, DOI [DOI 10.4054/DEMRES.2003.8.11, 10.4054/DemRes.2003.8.11]; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; Smits J, 2009, SOC SCI MED, V68, P1114, DOI 10.1016/j.socscimed.2008.12.034; Stearns S.C., 1992, pi; van Raalte AA, 2014, DEMOGRAPHY, V51, P73, DOI 10.1007/s13524-013-0253-x; Vaupel JW, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000128; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; Wrycza TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119163; Wrycza TF, 2014, DEMOGR RES, V30, P1571, DOI 10.4054/DemRes.2014.30.57	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0197985	10.1371/journal.pone.0197985	http://dx.doi.org/10.1371/journal.pone.0197985			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001385	Green Published, gold, Green Submitted			2022-12-26	WOS:000438457400004
J	Yang, X; Jiang, YK; Zhou, SB; Guo, RJ; Han, G; Wang, B				Yang, Xi; Jiang, Yongkang; Zhou, Shengbo; Guo, Ruiji; Han, Gang; Wang, Bin			Morphological and neurophysiological impairment of the nerve in type II macrodactyly	PLOS ONE			English	Article							NEURAL FIBROLIPOMA; ANASTOMOSES; HAMARTOMA; MUTATIONS; PIK3CA; ULNAR; HAND	Background Macrodactyly is a congenital malformation characterized by aggressive overgrowth of multiple tissues, including subcutaneous fat, nerves, and bones in digits or limbs. In type II macrodactyly, the peripheral nerve is enlarged; however, the morphological and functional characteristics of the affected peripheral nerves have rarely been evaluated. Methods In this research, six macrodactyly patients and three polydactyly patients (control) were studied. Pre-operative sensory nerve action potential and intra-operative nerve action potential tests were performed. The microstructure and ultrastructure of the enlarged nerves were observed and neurofilament (NF) expression was evaluated using immunofluorescent staining. Results Axon impairment of the digital nerves originating from the median nerve (MN) was observed. A compensatory reinnervation from the ulnar nerve (UN) was found in two of the six patients, and significant morphological changes were observed in the enlarged nerve. The myelinated nerve fibers decreased, the lamellar structure of the myelin sheath changed, and the density of the NFs of the unmyelinated fibers decreased. There was aberrant distribution of NFs in the macrodactylous nerve tissues. In patients with compensatory UN reinnervation, the number of myelinated and unmyelinated fibers increased to normal levels; however, the diameter of the myelinated fibers apparently decreased. Conclusions The morphology and function of the macrodactylous enlarged nerve was impaired in type II macrodactyly patients; however, the unaffected UN partially compensated for the lost function of the affected MN under specific situations. Electrophysiological tests should be performed to determine the function of the affected nerve and surgical treatment for type II macrodactyly could be refined.	[Yang, Xi; Jiang, Yongkang; Zhou, Shengbo; Guo, Ruiji; Han, Gang; Wang, Bin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Wang, B (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, Sch Med, Shanghai, Peoples R China.	wangbin1766@163.com		Jiang, Yongkang/0000-0003-4865-3417; Wang, Bin/0000-0002-7940-1223	National Natural Science Foundation of China [81772115, 81571930, 81401530]; Top Priority Clinical Medical Center of Shanghai Municipal Commission of Health and Family Planning	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Top Priority Clinical Medical Center of Shanghai Municipal Commission of Health and Family Planning	Funding was received from the National Natural Science Foundation of China (81772115, 81571930, and 81401530), Top Priority Clinical Medical Center of Shanghai Municipal Commission of Health and Family Planning. The authors have no conflicts of interest to disclose.	Ahadi Tannaz, 2016, Med J Islam Repub Iran, V30, P324; Avci G, 2010, J PLAST SURG HAND SU, V44, P219, DOI 10.3109/02844310902749380; Boland RA, 2007, CLIN NEUROPHYSIOL, V118, P770, DOI 10.1016/j.clinph.2006.12.009; Cerrato F, 2013, J HAND SURG-AM, V38A, P2112, DOI 10.1016/j.jhsa.2013.08.095; Fatemi MJ, 2010, J PLAST RECONSTR AES, V63, P565, DOI 10.1016/j.bjps.2008.08.059; Fransen BL, 2014, FOOT ANKLE SURG, V20, pE47, DOI 10.1016/j.fas.2014.05.002; Hardwicke J, 2013, J HAND SURG-EUR VOL, V38E, P297, DOI 10.1177/1753193412451232; Kini JR, 2018, TURK J PATHOL, V34, P87, DOI 10.5146/tjpath.2014.01282; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Liao ML, 2016, J COMP NEUROL, V524, P3810, DOI 10.1002/cne.24033; Maclellan RA, 2014, PLAST RECONSTR SURG, V133, p12E, DOI 10.1097/01.prs.0000436822.26709.7c; Mahipathy SRRV, 2015, J CLIN DIAGN RES, V9, pPD22, DOI 10.7860/JCDR/2015/14525.6528; Miura A, 2016, J ANESTH, V30, P961, DOI 10.1007/s00540-016-2247-5; Paraskevas G, 2010, CHIRURGIA-BUCHAREST, V105, P839; Patzig J, 2016, SEPTIN ANILLIN FILAM, V5, DOI [10.7554/eLife.17119, DOI 10.7554/ELIFE.17119]; Plaza JA, 2014, J AM ACAD DERMATOL, V70, P736, DOI 10.1016/j.jaad.2013.10.002; Rios JJ, 2013, HUM MOL GENET, V22, P444, DOI 10.1093/hmg/dds440; Ronchi G, 2014, J PERIPHER NERV SYST, V19, P224, DOI 10.1111/jns.12090; Roy J, 2016, MUSCLE NERVE, V54, P36, DOI 10.1002/mus.24993; Venkatesh K, 2009, J CUTAN PATHOL, V36, P594, DOI 10.1111/j.1600-0560.2008.01088.x; Zolin SD, 2014, ACTA ORTOP BRAS, V22, P34, DOI 10.1590/S1413-78522014000100006	21	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200183	10.1371/journal.pone.0200183	http://dx.doi.org/10.1371/journal.pone.0200183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001338	gold, Green Submitted, Green Published			2022-12-26	WOS:000438457400034
J	Ketoh, GK; Ahadji-Dabla, KM; Chabi, J; Amoudji, AD; Apetogbo, GY; Awokou, F; Glitho, IA				Ketoh, Guillaume K.; Ahadji-Dabla, Koffi M.; Chabi, Joseph; Amoudji, Adjovi D.; Apetogbo, Georges Y.; Awokou, Fantche; Glitho, Isabelle A.			Efficacy of two PBO long lasting insecticidal nets against natural populations of Anopheles gambiae s.l. in experimental huts, Kolokope, Togo	PLOS ONE			English	Article							RESISTANCE; PYRETHROIDS	LLINs containing an insecticide plus the synergist, piperonyl butoxide (PBO) have been designed for increased efficacy against pyrethroid-resistant malaria vectors. In this study, two LLINs with PBO, PermaNet (R) 3.0 and Olyset (R) Plus, and a pyrethroid-only LLIN, Yorkool (R), were evaluated in experimental huts against a free-flying, wild population of Anopheles gambiae s.l in Kolokope, a cotton cultivated area of Togo. WHO susceptibility tube tests and subsequent molecular assays determine the An. gambiae s.l populations to be resistant to pyrethroids and DDT with both target site kdr and metabolic resistance mechanisms involved in the resistance observed. Anopheles gambiae s.s. and An. coluzzi were present in sympatry though the kdr(L1014F) mutation was observed at a higher frequency in An. gambiae s.s. The experimental hut results showed that both PermaNet (R) 3.0 and Olyset (R) Plus nets induced similar levels of deterrence, exophily, and reduced blood feeding rate against wild An. gambiae s.l in contrast to the pyrethroid only LLIN, Yorkool (R). The proportion of wild An. gambiae s.l killed by unwashed PermaNet (R) 3.0 was significantly higher than unwashed Olyset (R) Plus (corrected mortality 80.5% compared to 66.6%). Similar blood feeding inhibition rates were observed for unwashed PermaNet (R) 3.0 and Olyset (R) Plus; however, PermaNet (R) 3.0 washed 20 times demonstrated significantly higher blood feeding inhibition rate than Olyset (R) Plus washed 20 times (91.1% compared with 85.6% respectively). Yorkool (R) performed the worst for all the parameters evaluated. In an area of pyrethroid resistance of An. gambiae s.l involving kdr target site and metabolic resistance mechanisms, LLINs with PBO can provide additional protection in terms of reduction in blood feeding and increase in mosquito mortality compared to a pyrethroid-only net, and should be considered in malaria vector control strategies.	[Ketoh, Guillaume K.; Ahadji-Dabla, Koffi M.; Amoudji, Adjovi D.; Apetogbo, Georges Y.; Glitho, Isabelle A.] Univ Lome, Fac Sci, Unite Rech Ecotoxicol URET, LEA,Insect Pest & Insect Vector Management Ecotox, Lome, Togo; [Chabi, Joseph] Univ Ghana, NMIMR, Legon, Accra, Ghana; [Awokou, Fantche] Minist Sante, PNLP, Lome, Togo	University of Ghana	Ahadji-Dabla, KM (corresponding author), Univ Lome, Fac Sci, Unite Rech Ecotoxicol URET, LEA,Insect Pest & Insect Vector Management Ecotox, Lome, Togo.	km.ahadjidabia@gmail.com	Chabi, Joseph/AAM-8321-2021	AHADJI-DABLA, Koffi Mensah/0000-0002-1097-5325				Ahadji-Dabla K. M., 2014, International Journal of Biological and Chemical Sciences, V8, P314; Aizoun N, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-147; [Anonymous], 2013, WHOHTMNTDWHOPES2013; [Anonymous], 2006, PESTICIDES THEIR APP; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x; Chouaibou M, 2014, ACTA TROP, V130, P108, DOI 10.1016/j.actatropica.2013.10.020; Corbel V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-113; CRASH, 2012, RAPP D ACT; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Dabire RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101484; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Edi CV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004236; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; Ketoh KG, 2005, JRECH SCI UNIVLOME A, V7, p13 ; Koudou BG, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-172; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Pennetier C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075134; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; TUNGU P, 2010, TANZANIA MALAR J, V9, DOI DOI 10.1186/1475-2875-9-21; WHO, 2009, 13 WHOP WORK GROUP M; WHO, 2009, 12 WHOPES WORK GROUP; World Health Organization, 2012, 15 WHOPES WORK GROUP; World Health Organization, 2016, 19 WHOPES WORK GROUP; World Health Organization, 2013, TEST PROC INS RES MO, P40	26	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0192492	10.1371/journal.pone.0192492	http://dx.doi.org/10.1371/journal.pone.0192492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995894	Green Submitted, gold, Green Published			2022-12-26	WOS:000438388800002
J	Mahapatra, S; Ying, LH; Ho, PPK; Kurnellas, M; Rothbard, J; Steinman, L; Cornfield, DN				Mahapatra, Sidharth; Ying, Lihua; Ho, Peggy Pui-Kay; Kurnellas, Michael; Rothbard, Jonathan; Steinman, Lawrence; Cornfield, David N.			An amyloidogenic hexapeptide derived from amylin attenuates inflammation and acute lung injury in murine sepsis	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHAPERONE-LIKE ACTIVITY; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; BRAIN DISEASE; CELLS; MICE; APOPTOSIS; PROTEINS	Although the accumulation of amyloidogenic proteins in neuroinflammatory conditions is generally considered pathologic, in a murine model of multiple sclerosis, amyloid-forming fibrils, comprised of hexapeptides, are anti-inflammatory. Whether these molecules modulate systemic inflammatory conditions remains unknown. We hypothesized that an amylin hexapeptide that forms fibrils can attenuate the systemic inflammatory response in a murine model of sepsis. To test this hypothesis, mice were pre-treated with either vehicle or amylin hexapeptide (20 mu g) at 12 hours and 6 hours prior to intraperitoneal (i.p.) lipopolysaccharide (LPS, 20 mg/kg) administration. Illness severity and survival were monitored every 6 hours for 3 days. Levels of pro- (IL-6, TNF-alpha, IFN-gamma) and anti-inflammatory (IL-10) cytokines were measured via ELISA at 1, 3, 6, 12, and 24 hours after LPS (i.p.). As a metric of lung injury, pulmonary artery endothelial cell (PAEC) barrier function was tested 24 hours after LPS administration by comparing lung wet-to-dry ratios, Evan's blue dye (EBD) extravasation, lung histology and caspase-3 activity. Compared to controls, pretreatment with amylin hexapeptide significantly reduced mortality (p<0.05 at 72 h), illness severity (p<0.05), and pro-inflammatory cytokine levels, while IL-10 levels were elevated (p<0.05). Amylin pretreatment attenuated LPS-induced lung injury, as demonstrated by decreased lung water and caspase-3 activity (p<0.05, versus PBS). Hence, in a murine model of systemic inflammation, pretreatment with amylin hexapeptide reduced mortality, disease severity, and preserved lung barrier function. Amylin hexapeptide may represent a novel therapeutic tool to mitigate sepsis severity and lung injury.	[Mahapatra, Sidharth] Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA; [Ying, Lihua; Cornfield, David N.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Ho, Peggy Pui-Kay; Rothbard, Jonathan; Steinman, Lawrence] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Kurnellas, Michael] Alector, San Francisco, CA USA	University of Nebraska System; University of Nebraska Medical Center; Stanford University; Stanford University	Mahapatra, S (corresponding author), Univ Nebraska Med Ctr, Dept Pediat, Omaha, NE 68198 USA.	sidharth.mahapatra@unmc.edu	Mahapatra, Sidharth/H-4697-2019	Mahapatra, Sidharth/0000-0002-2483-0610; Steinman, Lawrence/0000-0002-2437-2250; /0000-0002-6848-318X	National Multiple Sclerosis Society Grant [NMSS SPO 112677]	National Multiple Sclerosis Society Grant(National Multiple Sclerosis Society)	The work in this manuscript was supported by the National Multiple Sclerosis Society Grant (NMSS SPO 112677) to Lawrence Steinman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Bhattacharyya J, 2006, BIOCHEMISTRY-US, V45, P3069, DOI 10.1021/bi0518141; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; FREUDENBERG M A, 1990, International Reviews of Immunology, V6, P207, DOI 10.3109/08830189009056632; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Gourdain P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-25; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; GRIFFIN WST, 1989, P NATL ACAD SCI USA, V86, P7611; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hoff J, 2000, LAB ANIMAL, V29, P47; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Ji Z, 2012, IMMUNOL CELL BIOL, V90, P388, DOI 10.1038/icb.2011.51; Kitamura Y, 2001, AM J RESP CRIT CARE, V163, P762, DOI 10.1164/ajrccm.163.3.2003065; Kurnellas MP, 2014, J EXP MED, V211, P1847, DOI 10.1084/jem.20140107; Kurnellas MP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005681; Kurnellas MP, 2012, J BIOL CHEM, V287, P36423, DOI 10.1074/jbc.M112.371229; Kurnellas MP, 2015, P NATL ACAD SCI USA, V112, P15016, DOI 10.1073/pnas.1521206112; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Maseda D, 2013, J IMMUNOL, V191, P2780, DOI 10.4049/jimmunol.1300649; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mehta D, 2014, AM J PHYSIOL-LUNG C, V307, pL924, DOI 10.1152/ajplung.00318.2014; Moitra J, 2007, TRANSL RES, V150, P253, DOI 10.1016/j.trsl.2007.03.013; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pangratz-Fuehrer S, 2011, EYE, V25, P809, DOI 10.1038/eye.2011.42; Penaloza HF, 2015, IMMUNOLOGY, V146, P100, DOI 10.1111/imm.12486; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rothbard JB, 2012, J BIOL CHEM, V287, P9708, DOI 10.1074/jbc.M111.337691; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Shrum Bradly, 2014, BMC Res Notes, V7, P233, DOI 10.1186/1756-0500-7-233; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Skelly CL, 2007, P NATL ACAD SCI USA, V104, P12474, DOI 10.1073/pnas.0705429104; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Tedder TF, 2010, J ALLERGY CLIN IMMUN, V125, P1125, DOI 10.1016/j.jaci.2010.03.024; Velotta JB, 2011, ANN THORAC SURG, V91, P1907, DOI 10.1016/j.athoracsur.2011.02.072; Weinger JG, 2012, J NEUROPATH EXP NEUR, V71, P422, DOI 10.1097/NEN.0b013e3182540d2e; Wekerle H, 2005, NEUROL SCI, V26, pS1, DOI 10.1007/s10072-005-0386-9; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Yanai H, 2013, P NATL ACAD SCI USA, V110, P20699, DOI 10.1073/pnas.1320808110	42	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0199206	10.1371/journal.pone.0199206	http://dx.doi.org/10.1371/journal.pone.0199206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990318	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300007
J	Mudie, LI; Varadaraj, V; Gajwani, P; Munoz, B; Ramulu, P; Lin, FR; Swenor, BK; Friedman, DS; Zebardast, N				Mudie, Lucy I.; Varadaraj, Varshini; Gajwani, Prateek; Munoz, Beatriz; Ramulu, Pradeep; Lin, Frank R.; Swenor, Bonnielin K.; Friedman, David S.; Zebardast, Nazlee			Dual sensory impairment: The association between glaucomatous vision loss and hearing impairment and function	PLOS ONE			English	Article							SALISBURY-EYE-EVALUATION; MINI-MENTAL-STATE; QUALITY-OF-LIFE; VISUAL IMPAIRMENT; OLDER-ADULTS; UNITED-STATES; COGNITIVE DECLINE; PRIMARY CARE; PREVALENCE; POPULATION	Background Hearing impairment, vision impairment, and dual impairment (both hearing and vision impairment), have been independently associated with functional and cognitive decline. In prior studies of dual impairment, vision impairment is generally not defined or defined by visual acuity alone. Glaucoma is a leading cause of blindness and does not affect visual acuity until late in the disease; instead, visual field loss is used to measure vision impairment from glaucoma. Objective To examine the effect of glaucomatous visual field loss and hearing impairment on function. Design Cross-sectional. Setting Hospital-based clinic in Baltimore, Maryland. Subjects 220 adults, >= 55 years presenting to the glaucoma clinic. Methods Vision impairment was defined as mean deviation on visual field testing worse than -5 decibels in the better eye, and hearing impairment was defined as pure tone average worse than 25 decibels on threshold audiometry testing in the better ear. Standardized questionnaires were used to assess functional status. Results Five participants were excluded for incomplete testing, leaving 32 with vision impairment only, 63 with hearing impairment only, 42 with dual impairment, and 78 controls with no hearing impairment or vision impairment. Participants with dual impairment were more likely to be older and non-White. Dual impairment was associated with significantly more severe driving limitation and more difficulty with communication compared to those without sensory impairment when adjusted for age, race, gender and number of comorbidities. Conclusion Older individuals with glaucoma and hearing loss seem to have generally poorer functioning than those with single sensory loss. Health professionals should consider visual field loss as a type of vision impairment when managing patients with dual impairment.	[Mudie, Lucy I.; Varadaraj, Varshini; Gajwani, Prateek; Munoz, Beatriz; Ramulu, Pradeep; Lin, Frank R.; Swenor, Bonnielin K.; Friedman, David S.; Zebardast, Nazlee] Johns Hopkins Univ, Baltimore, MD 21218 USA	Johns Hopkins University	Friedman, DS (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	david.friedman@jhu.edu	Swenor, Bonnie/ABH-1542-2021; Mudie, Lucy/C-2372-2017	Swenor, Bonnie/0000-0002-6044-0951; Friedman, David/0000-0002-2055-5797; Mudie, Lucy/0000-0003-2780-4079	NIA NIH HHS [K01 AG052640] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG052640] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1997, WHO CLASSIFICATION F; Busse A, 2002, J CLIN EPIDEMIOL, V55, P909, DOI 10.1016/S0895-4356(02)00449-3; Chen DS, 2015, J GERONTOL A-BIOL, V70, P654, DOI 10.1093/gerona/glu207; Chou KL, 2004, INT J GERIATR PSYCH, V19, P825, DOI 10.1002/gps.1174; Cohen S, 1997, JAMA-J AM MED ASSOC, V277, P1940; Crews JE, 2004, AM J PUBLIC HEALTH, V94, P823, DOI 10.2105/AJPH.94.5.823; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman EE, 2008, OPHTHALMOLOGY, V115, P233, DOI 10.1016/j.ophtha.2007.04.050; GAASTERLAND DE, 1994, OPHTHALMOLOGY, V101, P1445; Green KA, 2013, J AM GERIATR SOC, V61, P252, DOI 10.1111/jgs.12091; Huddle MG, 2016, J AM GERIATR SOC, V64, P1735, DOI 10.1111/jgs.14210; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; KLEIN R, 1995, ARCH OPHTHALMOL-CHIC, V113, P333, DOI 10.1001/archopht.1995.01100030089026; LICHTENSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V259, P2875, DOI 10.1001/jama.259.19.2875; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, ARCH INTERN MED, V171, P1851, DOI 10.1001/archinternmed.2011.506; Loprinzi PD, 2013, MAYO CLIN P; Mitoku K, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0286-2; Munoz B, 2000, ARCH OPHTHALMOL-CHIC, V118, P819, DOI 10.1001/archopht.118.6.819; Olusanya BO, 2014, B WORLD HEALTH ORGAN, V92, P367, DOI 10.2471/BLT.13.128728; Pascolini D, 2011, BR J OPHTHALMOL; Ramulu PY, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.01.037; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; Reischies FM, 1997, BRIT J PSYCHIAT, V171, P449, DOI 10.1192/bjp.171.5.449; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; SALIVE ME, 1994, J AM GERIATR SOC, V42, P287, DOI 10.1111/j.1532-5415.1994.tb01753.x; Schneider JM, 2011, J AGING HEALTH; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Swenor BK, 2013, JAMA INTERN MED, V173, P312, DOI 10.1001/jamainternmed.2013.1880; TULEY MR, 1990, EAR HEARING, V11, P56, DOI 10.1097/00003446-199002000-00011; United States Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics, 1994, NAT HLTH INT SURV 19; Vitale S, 2006, JAMA-J AM MED ASSOC, V295, P2158, DOI 10.1001/jama.295.18.2158; West SK, 1997, INVEST OPHTH VIS SCI, V38, P72; Yamada Y, 2016, J GERONTOL A-BIOL, V71, P117, DOI 10.1093/gerona/glv036; Yamasoba T, 2013, HEARING RES, V303, P30, DOI 10.1016/j.heares.2013.01.021	37	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2018	13	7							e0199889	10.1371/journal.pone.0199889	http://dx.doi.org/10.1371/journal.pone.0199889			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM1FJ	29979753	Green Submitted, Green Published, gold			2022-12-26	WOS:000437809500039
J	Shahid, F; Rahmat, NA; Lip, GYH; Shantsila, E				Shahid, Farhan; Rahmat, Nur A.; Lip, Gregory Y. H.; Shantsila, Eduard			Prognostic implication of monocytes in atrial fibrillation: The West Birmingham Atrial Fibrillation Project	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; PLASMINOGEN-ACTIVATOR; BLOOD MONOCYTES; DISEASE; MARKERS; FIBRINOLYSIS; INFLAMMATION; MECHANISMS; EXPRESSION; THROMBUS	Background and objectives High monocyte counts are related to adverse outcomes in cardiovascular disease. Their role in prognostication in patients with atrial fibrillation (AF) is unknown. We investigated whether monocyte counts are useful as a marker of prognosis in patients with AF. Methods Monocyte counts were obtained from blood samples in 881 AF patients. Study outcomes were (i) all-cause death; (ii) major adverse cardiovascular events; (iii) stroke, TIA or other systemic embolism (SSE); and (iv) major bleeding. Results Median follow up was 7.2 years; 44% of patients died, 48% developed MACE; 9% had SSE and 5% had major bleeding. On Cox regression, after adjustment for CHA(2)DS(2)-VASc score, the highest quartile of monocyte counts (i.e., >= 580 mu L vs. other quartiles) was associated with increased risk of death (hazard ratio [HR] 1.64, 95% confidence interval [CI] 1.31-2.05, p<0.001) and MACE (HR 1.58, 95% CI 1.28-1.96, p<0.001). Persistent monocyte levels >= 580 per mu L during follow up were associated with further increase in risk of death (HR 1.52, 95% CI 1.10-2.11, p = 0.01) and MACE (HR 1.54, 95% CI 1.13-2.09, p = 0.006). Persistent monocyte levels >= 580 per mu L during were associated with a significant increase in major bleeding events (HR 2.77, 95% CI 1.36-5.67, p = 0.005, after adjustment for HAS-BLED score). Conclusion High monocyte counts independently predict the occurrence of MACE, major bleeding and mortality, but not SSE. Understanding the pathophysiological mechanisms involved would help understand the relationships between monocytes, and adverse thrombotic and bleeding outcomes in AF patients.	[Shahid, Farhan; Rahmat, Nur A.; Lip, Gregory Y. H.; Shantsila, Eduard] Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England	University of Birmingham	Shantsila, E (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Birmingham, W Midlands, England.	shantsila@gmail.com		Shantsila, Eduard/0000-0002-2429-6980				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Campbell CL, 2011, J THROMB THROMBOLYS, V31, P139, DOI 10.1007/s11239-010-0513-1; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Ganne F, 2000, THROMB HAEMOSTASIS, V84, P680, DOI 10.1055/s-0037-1614087; Kervinen H, 2004, AM J CARDIOL, V94, P993, DOI 10.1016/j.amjcard.2004.06.052; Maekawa Y, 2002, J AM COLL CARDIOL, V39, P241, DOI 10.1016/S0735-1097(01)01721-1; NORTHEAST ADR, 1995, J VASC SURG, V22, P573, DOI 10.1016/S0741-5214(95)70041-2; Shantsila E, 2014, ATHEROSCLEROSIS, V234, P4, DOI 10.1016/j.atherosclerosis.2014.02.009; Shantsila E, 2009, THROMB HAEMOSTASIS, V102, P916, DOI 10.1160/TH09-01-0023; Singh I, 2003, CIRCULATION, V107, P869, DOI 10.1161/01.CIR.0000050149.22928.39; Speidl WS, 2004, FASEB J, V18, P603, DOI 10.1096/fj.03-0454fje; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Weber C, 2016, THROMB HAEMOSTASIS, V116, P626, DOI 10.1160/TH16-02-0091; Wrigley BJ, 2013, EUR J CLIN INVEST, V43, P121, DOI 10.1111/eci.12023	15	4	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 18	2018	13	7							e0200373	10.1371/journal.pone.0200373	http://dx.doi.org/10.1371/journal.pone.0200373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN4SJ	30020950	Green Submitted, Green Published, gold			2022-12-26	WOS:000439022400047
J	Seo, KH; Lee, JY; Yoon, K; Do, JG; Park, HJ; Lee, SY; Park, YS; Lee, YT				Seo, Kyoung-Ho; Lee, Joon-Youn; Yoon, Kyungjae; Do, Jong Geol; Park, Hee-Jin; Lee, So-Yeon; Park, Young Sook; Lee, Yong-Taek			Long-term outcome of low-energy extracorporeal shockwave therapy on gluteal tendinopathy documented by magnetic resonance imaging	PLOS ONE			English	Article							TROCHANTERIC-PAIN-SYNDROME; MEDIUS TENDON TEARS; GREATER TROCHANTER; WAVE THERAPY; MRI; HIP; MANAGEMENT; PATHOLOGY	Background Previous outcome studies for extracorporeal Shockwave therapy (ESWT) have included clinically diagnosed greater trochanteric pain syndrome (GTPS). The purpose of this study is to investigate outcome of ESWT on GTPS with gluteal tendinopathy documented by magnetic resonance imaging (MRI). Methods Medical records of 38 consecutive patients were retrospectively reviewed, who underwent ESWT for GTPS with MRI-documented gluteal tendinopathy (> 6 months). ESWT was conducted (1/week) when the Roles-Maudsley score (RMS) showed "Poor" or "Fair" grade after conservative treatment until RMS had reached "Good" or "Excellent" grade (treatment success) or until 12 treatments had been applied. Numeric rating scale (NRS) and RMS were evaluated before, 1 week after (immediate follow-up) and mean 27 months after ESWT program (long-term follow-up). Success rate was calculated at each follow-up point. Results Initial NRS (5.9 +/- 1.6) significantly decreased at immediate (2.5 +/- 1.5, p < 0.01) and long-term follow-up (3.3 +/- 3.0, p < 0.01), respectively. Success rates were 83.3% (immediate) and 55.6% (long-term), respectively. There was no correlation among age, symptom duration and NRS. Conclusion Low-energy ESWT can be an effective treatment for pain relief in chronic GTPS with MRI-documented gluteal tendinopathy. However, its long-term effect appears to decrease with time.	[Seo, Kyoung-Ho] Hallym Univ, Dongtan Sacred Heart Hosp, Dept Phys Med & Rehabil, Coll Med, Hwaseong Si, Gyeonggi Do, South Korea; [Lee, Joon-Youn; Yoon, Kyungjae; Do, Jong Geol; Lee, Yong-Taek] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Sch Med, Seoul, South Korea; [Park, Hee-Jin; Lee, So-Yeon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiol, Sch Med, Seoul, South Korea; [Park, Young Sook] Sungkyunkwan Univ, Samsung Changwon Hosp, Dept Phys & Rehabil Med, Sch Med, Changwon Si, Gyeongsangnam D, South Korea	Hallym University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, YT (corresponding author), Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Phys & Rehabil Med, Sch Med, Seoul, South Korea.	yongtaek1.lee@gmail.com	Lee, Yong-Taek/ABB-3200-2020	Lee, Yong-Taek/0000-0001-6611-0999; Kyoung-Ho, Seo/0000-0002-9139-1638				Barratt PA, 2017, BRIT J SPORT MED, V51, P97, DOI 10.1136/bjsports-2015-095858; Bird PA, 2001, ARTHRITIS RHEUM, V44, P2138, DOI 10.1002/1529-0131(200109)44:9<2138::AID-ART367>3.0.CO;2-M; Blankenbaker DG, 2008, SKELETAL RADIOL, V37, P903, DOI 10.1007/s00256-008-0514-8; Chowdhury R, 2014, POSTGRAD MED J, V90, P576, DOI 10.1136/postgradmedj-2013-131828; Chung CB, 1999, AM J ROENTGENOL, V173, P351, DOI 10.2214/ajr.173.2.10430134; Cvitanic O, 2004, AM J ROENTGENOL, V182, P137, DOI 10.2214/ajr.182.1.1820137; Del Buono A, 2012, BRIT MED BULL, V102, P115, DOI 10.1093/bmb/ldr038; Farr D, 2007, ARTHROSCOPY, V23, DOI 10.1016/j.arthro.2006.10.021; Fearon AM, 2010, CLIN ORTHOP RELAT R, V468, P1838, DOI 10.1007/s11999-009-1174-2; Furia JP, 2009, AM J SPORT MED, V37, P1806, DOI 10.1177/0363546509333014; Grimaldi A, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-096175; Haliloglu N, 2010, EUR J RADIOL, V75, P64, DOI 10.1016/j.ejrad.2009.03.039; Klontzas ME, 2014, EUR J RADIOL, V83, P1850, DOI 10.1016/j.ejrad.2014.06.009; Kong A, 2007, EUR RADIOL, V17, P1772, DOI 10.1007/s00330-006-0485-x; Korakakis V, 2018, BRIT J SPORT MED, V52, P387, DOI 10.1136/bjsports-2016-097347; Lee JY, 2017, ANN REHABIL MED-ARM, V41, P42, DOI 10.5535/arm.2017.41.1.42; Mani-Babu S, 2015, AM J SPORT MED, V43, P752, DOI 10.1177/0363546514531911; Ozcakar L, 2004, CLIN RHEUMATOL, V23, P464, DOI 10.1007/s10067-004-0917-4; Peters J, 2004, SKELETAL RADIOL, V33, P712, DOI 10.1007/s00256-004-0849-8; Pfirrmann CWA, 2001, RADIOLOGY, V221, P469, DOI 10.1148/radiol.2211001634; Rompe JD, 2009, AM J SPORT MED, V37, P1981, DOI 10.1177/0363546509334374; Rompe JD, 1998, J BONE JOINT SURG BR, V80B, P546, DOI 10.1302/0301-620X.80B3.8434; Sayegh Fares, 2004, Acta Orthop Belg, V70, P423; Tortolani P Justin, 2002, Spine J, V2, P251, DOI 10.1016/S1529-9430(02)00198-5; Wilson SA, 2014, INT J RHEUM DIS, V17, P621, DOI 10.1111/1756-185X.12250	25	10	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 17	2018	13	7							e0197460	10.1371/journal.pone.0197460	http://dx.doi.org/10.1371/journal.pone.0197460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN2XR	30016333	Green Submitted, gold, Green Published			2022-12-26	WOS:000438866600002
J	Kamnerdsiri, WA; Martinez, JER; Fox, C; Weiss, P				Kamnerdsiri, Watcharaphol Alexandre; Rodriguez Martinez, Jesus Eugenio; Fox, Christopher; Weiss, Petr			Clinical correlation between erectile function and ejaculatory function in the Czech male population	PLOS ONE			English	Article							69 YEARS OLD; PREMATURE-EJACULATION; SEXUAL SATISFACTION; INTERNATIONAL INDEX; MEN 40; DYSFUNCTION; ANXIETY; PREVALENCE; DEPRESSION; EPIDEMIOLOGY	Introduction This study explores the relationship between erectile function and ejaculatory function, to inform the clinical psychosexological and sexual medicine practice treatment protocols. Materials and methods A total of 1,004 Czech males aged between 15 and 84 years (m = 42.8 yrs; sd = 17.6 years) completed a sexual behavior questionnaire. A cross-sectional design was adopted. Erectile function was measured with the International Index of Erectile Function (IIEF-5) and ejaculatory function measured using self-report intravaginal ejaculation latency time and the Index of Premature Ejaculation (IPE). Linear regression analyses were used to explore the relationships between premature ejaculation and erectile dysfunction. Results The sample mean self-reported intravaginal ejaculatory latency time was 9.34 minutes. The overall mean on the IPE was 19.44 (sd= 2.368). The Control domain mean was 81.13 (sd= 17.22); Sexual Satisfaction domain mean 78.60 (sd = 20.59); and the Distress domain mean was 86.86 (sd= 18.32). The mean score on the IIEF-5 was 19.28 (sd= 2.53). The results indicate a relationship between premature ejaculation and erectile dysfunction. With age significantly associated with all measures. Conclusions Higher levels of erectile function are associated with a better control and sexual satisfaction, and less distress about ejaculation. This association supports the consideration of this relationship in the development of new clinical practice guidelines for erectile dysfunction and premature ejaculation.	[Kamnerdsiri, Watcharaphol Alexandre] Charles Univ Prague, Fac Med 1, Dept Psychiat, Prague, Czech Republic; [Rodriguez Martinez, Jesus Eugenio] Murcian Inst Sexol, Murcia, Spain; [Fox, Christopher] Univ Sydney, Fac Med & Hlth, Westmead Clin Sch, Sydney, NSW, Australia; [Weiss, Petr] Charles Univ Prague, Fac Med 1, Inst Sexol, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; University of Sydney; Charles University Prague	Kamnerdsiri, WA (corresponding author), Charles Univ Prague, Fac Med 1, Dept Psychiat, Prague, Czech Republic.	Kamnerdsiri@gmail.com	MARTINEZ, JESUS EUGENIO RODRIGUEZ/AAS-8187-2021; Kamnerdsiri, Watcharaphol/ABH-8940-2020	MARTINEZ, JESUS EUGENIO RODRIGUEZ/0000-0001-8404-1413; Kamnerdsiri, Watcharaphol/0000-0003-2032-0063; Fox, Christopher/0000-0001-9342-8839				Althof S, 2006, J SEX MED, V3, P465, DOI 10.1111/j.1743-6109.2006.00239.x; BECK JG, 1986, BEHAV RES THER, V24, P9, DOI 10.1016/0005-7967(86)90144-0; Braun M, 2000, INT J IMPOT RES, V12, P305, DOI 10.1038/sj.ijir.3900622; Brody S, 2015, J SEX MED, V12, P398, DOI 10.1111/jsm.12738; Brody S, 2010, J SEX MED, V7, P1336, DOI 10.1111/j.1743-6109.2009.01677.x; Cabello F, 2002, MANUAL MED TERAPIA S; Cappelleri JC, 2000, UROLOGY, V56, P477, DOI 10.1016/S0090-4295(00)00697-X; Corona G, 2006, J ANDROL, V27, P86, DOI 10.2164/jandrol.05070; Corona G, 2004, EUR UROL, V46, P615, DOI 10.1016/j.eururo.2004.07.001; Corona G, 2015, J SEX MED, V12, P2291, DOI 10.1111/jsm.13041; Corretti G, 2006, J SEX MARITAL THER, V32, P183, DOI 10.1080/00926230500442342; FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1; Giuliano F, 2008, EUR UROL, V53, P1048, DOI 10.1016/j.eururo.2007.10.015; HaavioMannila E, 1997, ARCH SEX BEHAV, V26, P399, DOI 10.1023/A:1024591318836; Hatzimouratidis K, 2010, EUR UROL, V57, P804, DOI 10.1016/j.eururo.2010.02.020; Jannini EA, 2005, INT J ANDROL, V28, P40, DOI 10.1111/j.1365-2605.2005.00593.x; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Klapilova K, 2015, J SEX MED, V12, P667, DOI 10.1111/jsm.12766; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Lavoisier P, 2014, PHYS THER, V94, P1731, DOI 10.2522/ptj.20130354; McMahon CG, 2013, J SEX MED, V10, P204, DOI 10.1111/j.1743-6109.2012.02824.x; MEISLER AW, 1991, ARCH SEX BEHAV, V20, P541, DOI 10.1007/BF01550953; Moreira ED, 2003, UROLOGY, V61, P431, DOI 10.1016/S0090-4295(02)02158-1; Mourikis I, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0074-y; Nicolosi A, 2004, J AFFECT DISORDERS, V82, P235, DOI 10.1016/j.jad.2003.12.008; Nicolosi A, 2003, UROLOGY, V61, P201, DOI 10.1016/S0090-4295(02)02102-7; Nowosielski K, 2010, J SEX MED, V7, P3589, DOI 10.1111/j.1743-6109.2010.01927.x; Okulate G, 2003, GEN HOSP PSYCHIAT, V25, P209, DOI 10.1016/S0163-8343(03)00015-X; PALACE EM, 1990, J ABNORM PSYCHOL, V99, P403, DOI 10.1037/0021-843X.99.4.403; Patrick DL, 2005, J SEX MED, V2, P358, DOI 10.1111/j.1743-6109.2005.20353.x; Porst H, 2007, EUR UROL, V51, P816, DOI 10.1016/j.eururo.2006.07.004; Pujols Y, 2010, J SEX MED, V7, P905, DOI 10.1111/j.1743-6109.2009.01604.x; Rajkumar RP, 2015, COMPR PSYCHIAT, V60, P114, DOI 10.1016/j.comppsych.2015.03.001; Rosen R C, 2000, Curr Psychiatry Rep, V2, P189, DOI 10.1007/s11920-996-0006-2; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Serefoglu EC, 2014, SEX MED-UK, V2, P41, DOI 10.1002/sm2.27; Serefoglu EC, 2014, J SEX MED, V11, P1423, DOI 10.1111/jsm.12524; Tao P, 2011, J SEX MED, V8, P455, DOI 10.1111/j.1743-6109.2010.02129.x; Waldinger MD, 2005, J SEX MED, V2, P498, DOI 10.1111/j.1743-6109.2005.00069.x; Weiss P, 2011, J SEX MED, V8, P1404, DOI 10.1111/j.1743-6109.2011.02214.x	41	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0199588	10.1371/journal.pone.0199588	http://dx.doi.org/10.1371/journal.pone.0199588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001388	Green Published, Green Submitted, gold			2022-12-26	WOS:000438457400013
J	Kunzmann, S; Ottensmeier, B; Speer, CP; Fehrholz, M				Kunzmann, Steffen; Ottensmeier, Barbara; Speer, Christian P.; Fehrholz, Markus			Effect of progesterone on Smad signaling and TGF-beta/Smad-regulated genes in lung epithelial cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; PRETERM INFANTS; EXPRESSION; ESTRADIOL; PREGNANCY; ESTROGEN; PLASMA; BIRTH; REPLACEMENT	The effect of endogenous progesterone and/or exogenous pre- or postnatal progesterone application on lung function of preterm infants is poorly defined. While prenatal progesterone substitution may prevent preterm birth, in vitro and in vivo data suggest a benefit of postnatal progesterone replacement on the incidence and severity of bronchopulmonary dysplasia (BPD). However, the molecular mechanisms responsible for progesterone's effects are undefined. Numerous factors are involved in lung development, airway inflammation, and airway remodeling: the transforming growth factor beta (TGF-beta)/mothers against decapentaplegic homolog (Smad) signaling pathway and TGF-beta-regulated genes, such as connective tissue growth factor (CTGF), transgelin (TAGLN), and plasminogen activator inhibitor-1 (PAI-1). These processes contribute to the development of BPD. The aim of the present study was to clarify whether progesterone could affect TGF-beta 1-activated Smad signaling and CTGF/transgelin/PAI-1 expression in lung epithelial cells. The pharmacological effect of progesterone on Smad signaling was investigated using a TGF-beta 1-inducible luciferase reporter and western blotting analysis of phosphorylated Smad2/3 in A549 lung epithelial cells. The regulation of CTGF, transgelin, and PAI-1 expression by progesterone was studied using a promoter-based luciferase reporter, quantitative real-time PCR, and western blotting in the same cell line. While progesterone alone had no direct effect on Smad signaling in lung epithelial cells, it dose-dependently inhibited TGF-beta 1-induced Smad3 phosphorylation, as shown by luciferase assays and western blotting analysis. Progesterone also antagonized the TGF-beta 1/Smad-induced upregulation of CTGF, transgelin, and PAI-1 at the promoter, mRNA, and/or protein levels. The present study highlights possible new molecular mechanisms involving progesterone, including inhibition of TGF-beta 1-activated Smad signaling and TGF-beta 1-regulated genes involved in BPD pathogenesis, which are likely to attenuate the development of BPD by inhibiting TGF-beta 1-mediated airway remodeling. Understanding these mechanisms might help to explain the effects of pre- or postnatal application of progesterone on lung diseases of preterm infants.	[Kunzmann, Steffen] Buergerhosp Frankfurt Main, Clin Neonatol, Frankfurt, Germany; [Ottensmeier, Barbara; Speer, Christian P.; Fehrholz, Markus] Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Fehrholz, M (corresponding author), Univ Wurzburg, Univ Childrens Hosp, Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de			DFG (German research foundation) [DFG-KU1403/6-1]	DFG (German research foundation)(German Research Foundation (DFG))	This work was supported by DFG (German research foundation; grant DFG-KU1403/6-1 (SK); http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by DFG (German research foundation; grant DFG-KU1403/6-1; http://www.dfg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are grateful to Dr. S. Itoh (Research Laboratories, Kyowa Hakko Kogyo, Tokyo, Japan) for providing pGL3ti(CAGA) 12 and p3TP-vector. The anti-Smad2/3-P antibody was a gift from Dr. C.-H. Heldin (Ludwig Institute for Cancer Research, Uppsala, Sweden).	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Akinnusi Morohunfolu E., 2007, Inflammation & Allergy Drug Targets, V6, P201; Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; BEDWANI JR, 1975, BRIT J PHARMACOL, V53, P547, DOI 10.1111/j.1476-5381.1975.tb07393.x; Beyer C, 2003, BIOL NEONATE, V84, P59, DOI 10.1159/000071445; Bosse R, 1997, MOL BRAIN RES, V46, P343, DOI 10.1016/S0169-328X(97)00082-X; Cederqvist K, 2006, PEDIATRICS, V117, P1226, DOI 10.1542/peds.2005-0870; Chen TH, 1996, LIFE SCI, V58, P983, DOI 10.1016/0024-3205(96)00046-X; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; CONLY PW, 1970, PEDIATR RES, V4, P76, DOI 10.1203/00006450-197001000-00009; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DVORACSEK E, 1990, ACTA PHYSIOL HUNG, V76, P151; Fehrholz M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184556; Fehrholz M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097357; Fehrholz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051575; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Goodnight W, 2016, AM J PERINAT, V33, P253, DOI 10.1055/s-0035-1570378; Hemauer SJ, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.065; HERCZ P, 1985, ACTA MED HUNG, V42, P29; Ishii H, 2007, NEUROSCIENTIST, V13, P323, DOI 10.1177/10738584070130040601; Ito I, 2010, J BIOL CHEM, V285, P14747, DOI 10.1074/jbc.M109.093039; JOENSUU H, 1981, BIOL NEONATE, V40, P183; Kunzmann S, 2007, AM J PHYSIOL-LUNG C, V292, pL223, DOI 10.1152/ajplung.00159.2006; Kunzmann S, 2011, AM J RESP CELL MOL, V45, P969, DOI 10.1165/rcmb.2010-0519OC; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Philip AGS, 2012, NEONATOLOGY, V102, P1, DOI 10.1159/000336030; Rageh MAE, 2001, J CLIN PATHOL-MOL PA, V54, P338, DOI 10.1136/mp.54.5.338; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; SCOMMEGNA A, 1972, AM J OBSTET GYNECOL, V113, P60, DOI 10.1016/0002-9378(72)90452-8; Shields AD, 2005, AM J OBSTET GYNECOL, V193, P1144, DOI 10.1016/j.ajog.2005.05.046; SIPPELL WG, 1978, J STEROID BIOCHEM, V9, P63, DOI 10.1016/0022-4731(78)90104-8; Speer Christian P, 2009, Neonatology, V95, P353, DOI 10.1159/000209301; Trotter A, 2007, ARCH DIS CHILD-FETAL, V92, pF94, DOI 10.1136/adc.2006.097170; Trotter A, 2006, PEDIATR RES, V60, P60, DOI 10.1203/01.pdr.0000220360.77567.d8; Trotter A, 2001, Paediatr Drugs, V3, P629, DOI 10.2165/00128072-200103090-00001; Trotter A, 2000, ANN MED, V32, P608, DOI 10.3109/07853890009002031; Trotter A, 1999, J CLIN ENDOCR METAB, V84, P4531, DOI 10.1210/jc.84.12.4531; Trotter A, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/170491; Watson Cheryl S, 2006, J Mol Signal, V1, P5, DOI 10.1186/1750-2187-1-5; Xie MX, 2013, ONCOL REP, V29, P1873, DOI 10.3892/or.2013.2336; Yan B, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028064; Zhang RF, 2014, AM J PHYSIOL-LUNG C, V306, pL574, DOI 10.1152/ajplung.00327.2013	47	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200661	10.1371/journal.pone.0200661	http://dx.doi.org/10.1371/journal.pone.0200661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001393	gold, Green Published, Green Submitted			2022-12-26	WOS:000438457400094
J	Lee, WJ; Peng, LN; Liang, CK; Loh, CH; Chen, LK				Lee, Wei-Ju; Peng, Li-Ning; Liang, Chih-Kuang; Loh, Ching-Hui; Chen, Liang-Kung			Cognitive frailty predicting all-cause mortality among community-living older adults in Taiwan: A 4-year nationwide population-based cohort study	PLOS ONE			English	Article							MENTAL STATUS QUESTIONNAIRE; ADVERSE HEALTH OUTCOMES; IMPAIRMENT; ASSOCIATION; PREVALENCE; PHENOTYPE; PEOPLE	Background Cognitive frailty (CF) featured as frailty plus cognitive impairment was deemed to be a novel target for dementia and disable prevention. The study was intended to investigate the epidemiology of CF and the association between CF and all-cause mortality. Methods The national representative cohort study was comprised of 1,103 community-living middle-aged and older adults. CF was defined as the co-existence of dynapenia (weakness and/or slowness) and cognitive impairment (1.5 standard deviations below the age-, sex- and education-matched norms in cognitive tests) without known neurodegenerative diseases. Dynapenia was defined by the Asian Working Group for Sarcopenia and cognitive function was assessed by the Short Portable Mental Status Questionnaire. Results The prevalence of CF was 8.6% in this study. Subjects with CF were older, more likely to be women, having less regular exercise, fewer educational years, more depressive symptoms and greater multimorbidity. Compared to robust individuals, CF was significantly associated with all-cause mortality (HR: 3.1, 95% CI:1.3-7.7, p = 0.012). Conclusion Dynapenia and cognitive impairment synergistically contribute to the mortality risk for the participants in this study. Further study is needed to explore the underlying pathophysiology and the reversibility of CF.	[Lee, Wei-Ju; Peng, Li-Ning; Liang, Chih-Kuang; Loh, Ching-Hui; Chen, Liang-Kung] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan; [Lee, Wei-Ju; Peng, Li-Ning; Liang, Chih-Kuang; Loh, Ching-Hui; Chen, Liang-Kung] Natl Yang Ming Univ, Sch Med, Dept Geriatr, Taipei, Taiwan; [Lee, Wei-Ju] Taipei Vet Gen Hosp, Yuanshan Branch, Dept Family Med, Yi Land, Taiwan; [Peng, Li-Ning; Chen, Liang-Kung] Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan; [Liang, Chih-Kuang] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Loh, Ching-Hui] Hualien Tzu Chi Hosp Buddhist Tzu Chi Med Fdn, Ctr Hlth & Aging, Hualien, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Kaohsiung Veterans General Hospital	Loh, CH; Chen, LK (corresponding author), Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei, Taiwan.; Loh, CH; Chen, LK (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Geriatr, Taipei, Taiwan.; Chen, LK (corresponding author), Taipei Vet Gen Hosp, Ctr Geriatr & Gerontol, Taipei, Taiwan.; Loh, CH (corresponding author), Hualien Tzu Chi Hosp Buddhist Tzu Chi Med Fdn, Ctr Hlth & Aging, Hualien, Taiwan.	Twdoc1960@gmail.com; lkchen2@vghtpe.gov.tw	peng, li/GQH-5153-2022; Liang, Chih-Kuang/AAJ-5235-2020; Lee, Wei-Ju/AAK-1549-2021	Liang, Chih-Kuang/0000-0003-1604-1600; Lee, Wei-Ju/0000-0003-4326-333X; Chen, Liang-Kung/0000-0002-2387-8508	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital; Ministry of Science and Technology of Taiwan [MOST 105-3011-B-010-001, MOST107-2634-F-010-001]	Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 105-3011-B-010-001 and MOST107-2634-F-010-001).; The authors express their gratitude to the staff from Health Promotion Administration, Ministry of Health and Welfare, Taiwan for data collection and to all the participants for their assistance. This study was supported by the Aging and Health Research Center, National Yang Ming University; Center for Geriatrics and Gerontology, Taipei Veterans General Hospital, as well as the Ministry of Science and Technology of Taiwan (MOST 105-3011-B-010-001).	Aisen PS, 2008, NEUROLOGY, V70, P2020, DOI 10.1212/01.wnl.0000313380.89894.54; Avila-Funes JA, 2009, J AM GERIATR SOC, V57, P453, DOI 10.1111/j.1532-5415.2008.02136.x; Canevelli M, 2017, J AM MED DIRECTORS A; Canevelli M, 2017, J AM MED DIR ASSOC, V18, P816, DOI 10.1016/j.jamda.2017.07.004; Cano C, 2012, J NUTR HEALTH AGING, V16, P142, DOI 10.1007/s12603-011-0104-7; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chen WT, 2015, HUM BRAIN MAPP, V36, P3666, DOI 10.1002/hbm.22870; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Cornman JC, 2014, INT J EPIDEMIOL; Cortina-Borja Mario, 2009, BMC Res Notes, V2, P105, DOI 10.1186/1756-0500-2-105; Dubois B, 2010, LANCET NEUROL, V9, P1118, DOI 10.1016/S1474-4422(10)70223-4; Feng L, 2017, J AM MED DIR ASSOC, V18, P252, DOI 10.1016/j.jamda.2016.09.015; Ganguli M, 2010, AM J GERIAT PSYCHIAT, V18, P674, DOI 10.1097/JGP.0b013e3181cdee4f; Huang CY, 2016, REJUV RES, V19, P71, DOI 10.1089/rej.2015.1710; Hwang AC, 2015, REJUV RES, V18, P564, DOI 10.1089/rej.2015.1699; Jessen F, 2014, ALZHEIMERS DEMENT, V10, P844, DOI 10.1016/j.jalz.2014.01.001; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kelaiditi E, 2013, J NUTR HEALTH AGING, V17, P726, DOI 10.1007/s12603-013-0367-2; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee WJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40427; Lee Y, 2018, MATURITAS, V107, P50, DOI 10.1016/j.maturitas.2017.10.006; Liu LK, 2018, REJUV RES, V21, P510, DOI 10.1089/rej.2017.2038; Liu LK, 2017, SCI REP-UK, V7, DOI 10.1038/srep46417; Lohman MC, 2013, J AM GERIATR SOC, V61, P474, DOI 10.1111/jgs.12138; Malhotra C, 2013, ANN ACAD MED SINGAP, V42, P315; Panza F, 2015, J ALZHEIMERS DIS, V47, P793, DOI 10.3233/JAD-150358; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; Roppolo M, 2017, J NUTR HEALTH AGING, V21, P631, DOI 10.1007/s12603-016-0828-5; Ruan QW, 2015, AGEING RES REV, V20, P1, DOI 10.1016/j.arr.2014.12.004; Shimada H, 2016, J NUTR HEALTH AGING, V20, P729, DOI 10.1007/s12603-016-0685-2; Solfrizzi V, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.10.012; St John PD, 2017, INT PSYCHOGERIATR, V29, P535, DOI 10.1017/S1041610216002088; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Xue QL, 2008, J GERONTOL A-BIOL, V63, P984, DOI 10.1093/gerona/63.9.984; Zhang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040793	36	37	46	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200447	10.1371/journal.pone.0200447	http://dx.doi.org/10.1371/journal.pone.0200447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GM8FT	30001354	Green Submitted, gold, Green Published			2022-12-26	WOS:000438457400056
J	Ng, KYB; Simpson, NAB; Cade, JE; Greenwood, DC; Mcardle, HJ; Ciantar, E; Alwan, NA				Ng, Ka Ying Bonnie; Simpson, Nigel A. B.; Cade, Janet E.; Greenwood, Darren C.; Mcardle, Harry J.; Ciantar, Etienne; Alwan, Nisreen A.			!Is infant arterial stiffness associated with maternal blood pressure in pregnancy? Findings from a UK birth cohort (Baby VIP study)	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; IRON STATUS; HYPERTENSION; WEIGHT; MORTALITY; CHILDREN; DISEASE; GROWTH; AMPLIFICATION; PREECLAMPSIA	Background In adults, arterial stiffness measured by pulse wave velocity (PWV) is regarded as a predictor of cardiovascular disease. Infant vascular development depends on factors related to pregnancy, including maternal blood pressure (BP). This study assessed the association between maternal BP in pregnancy and infant brachio-femoral PWV at age 2-6 weeks. Methods The Baby Vascular health and Iron in Pregnancy (Baby VIP) study is a birth cohort which measured PWV and heart rate (HR) in 284 babies in Leeds, UK, at 2-6 weeks after birth. Maternal BP measurements at 12 and 36 weeks gestation was collected from antenatal clinical records. Multivariable linear regression models assessed associations between maternal systolic and diastolic BPs, and BP change from booking to 36 weeks, with infant PWV adjusting for covariables at both mother and baby level. Results There was no evidence of an association between infant PWV and maternal systolic BP at booking (adjusted regression coefficient -0.01 m/s per 10mmHg, 95% CI -0.11, 0.14, p = 0.84) or at 36 weeks (adjusted regression coefficient 0.00 m/s per 10mmHg, 95% CI -0.12, 0.11, p = 0.95). Change between 12 and 36 weeks gestation of more than 30 mmHg in systolic BP or 15 mmHg in diastolic BP was also not associated with infant PWV. There was an inverse relationship between infant HR and infant PWV (regression coefficient -0.14 m/s per 10 bpm, 95% CI -0.22, -0.05, p<0.01). Conclusions This study has shown no evidence of association between infant PWV at 2-6 weeks of age and maternal BP in early or late pregnancy. Infant HR was inversely associated with infant PWV. Further studies are required to determine the predictors of infant PWV as well as the importance and long term implications of PWV measurements in infants.	[Ng, Ka Ying Bonnie] Univ Southampton, Human Dev & Hlth Acad Unit, Fac Med, Southampton, Hants, England; [Ng, Ka Ying Bonnie] Princess Anne Hosp, Dept Obstet & Gynaecol, Southampton, Hants, England; [Simpson, Nigel A. B.; Ciantar, Etienne] Univ Leeds, Dept Womens & Childrens Hlth, Leeds, W Yorkshire, England; [Cade, Janet E.] Univ Leeds, Sch Food Sci & Nutr, Nutr Epidemiol Grp, Leeds, W Yorkshire, England; [Greenwood, Darren C.] Univ Leeds, Sch Med, Div Epidemiol & Biostat, Leeds, W Yorkshire, England; [Mcardle, Harry J.] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland; [Alwan, Nisreen A.] Univ Southampton, Southampton Gen Hosp, Acad Unit Primary Care & Populat Sci, Fac Med, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alwan, Nisreen A.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England	University of Southampton; University of Leeds; University of Leeds; University of Leeds; University of Aberdeen; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Alwan, NA (corresponding author), Univ Southampton, Southampton Gen Hosp, Acad Unit Primary Care & Populat Sci, Fac Med, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.; Alwan, NA (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.	N.A.Alwan@soton.ac.uk	Alwan, Nisreen A./AFP-0662-2022; Cade, Janet/G-4250-2016	Alwan, Nisreen A./0000-0002-4134-8463; Ng, Ka Ying Bonnie/0000-0002-2770-6148; Cade, Janet/0000-0003-3421-0121	Wellcome Trust (GB) Research Training Fellowship [WT87789]	Wellcome Trust (GB) Research Training Fellowship	This work was supported by the Wellcome Trust (GB) Research Training Fellowship grant no. WT87789 to NAA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are sincerely grateful to all study participants. Our thanks go to Angela Wray, Julie Grindey and Viv Dolby for data collection; Stephen Greenwald for advice on PWV measurement and Michael Mahmoudi for reviewing the manuscript. The Baby VIP study was supported by a Wellcome Trust Research Training Fellowship to NAA (Reference: WT87789).	Alwan NA, 2014, ARCH DIS CHILD-FETAL, pA153, DOI [10.1161/01.HYP.0000250434.73119.7a, DOI 10.1161/01.HYP.0000250434.73119.7A]; Alwan NA, 2015, BRIT J NUTR, V113, P1985, DOI 10.1017/S0007114515001166; Alwan NA, 2015, NEONATOLOGY, V107, P297, DOI 10.1159/000377618; [Anonymous], 2010, HYP PREGN DIAGN MAN; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Beevers G, 2001, BRIT MED J, V322, P912, DOI 10.1136/bmj.322.7291.912; BOUTOUYRIE P, 1995, HYPERTENSION, V25, P651, DOI 10.1161/01.HYP.25.4.651; Bramham K, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2301; Chen S, 2015, NEONATOLOGY, V107, P20, DOI 10.1159/000366467; Cheung Yiu-Fai, 2010, Korean Circ J, V40, P153, DOI 10.4070/kcj.2010.40.4.153; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; FRIEDMAN EA, 1978, JAMA-J AM MED ASSOC, V239, P2249; Gillman MW, 2004, J PEDIATR-US, V144, P240, DOI 10.1016/j.jpeds.2003.10.064; HIMMELMANN A, 1994, J INTERN MED, V235, P347, DOI 10.1111/j.1365-2796.1994.tb01085.x; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; IBSEN KK, 1980, ACTA PAEDIATR SCAND, V69, P109, DOI 10.1111/j.1651-2227.1980.tb07040.x; James PR, 2004, HEART, V90, P1499, DOI 10.1136/hrt.2004.035444; Keehn L, 2014, J HYPERTENS, V32, P1464, DOI 10.1097/HJH.0000000000000203; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Koudsi A, 2007, HYPERTENSION, V49, P225, DOI 10.1161/01.HYP.0000250434.73119.7a; Laogun A A, 1982, Clin Phys Physiol Meas, V3, P201, DOI 10.1088/0143-0815/3/3/004; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Law CM, 1996, J HYPERTENS, V14, P935; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Lurbe E, 2003, HYPERTENSION, V41, P646, DOI 10.1161/01.HYP.0000048341.52293.7C; Lurbe E, 1996, AM J HYPERTENS, V9, P787, DOI 10.1016/0895-7061(96)00058-1; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; O'Rourke MF, 2004, J HYPERTENS, V22, P1633, DOI 10.1097/01.hjh.0000125473.35523.3f; Park BJ, 2010, ARCH CARDIOVASC DIS, V103, P246, DOI 10.1016/j.acvd.2010.03.004; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; SEIDMAN DS, 1991, BRIT J OBSTET GYNAEC, V98, P1009, DOI 10.1111/j.1471-0528.1991.tb15339.x; Shahin Y, 2013, HYPERTENS RES, V36, P208, DOI 10.1038/hr.2012.144; Steer PJ, 2004, BRIT MED J, V329, P1312, DOI 10.1136/bmj.38258.566262.7C; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; van der Meer RW, 2007, J CARDIOVASC MAGN R, V9, P645, DOI 10.1080/10976640601093703; van Leeuwen-Segarceanu EM, 2010, J HYPERTENS, V28, P1687, DOI 10.1097/HJH.0b013e32833a8b83; Vatten LJ, 2003, OBSTET GYNECOL, V101, P529, DOI 10.1016/S0029-7844(02)02718-7; Verbeke F, 2005, HYPERTENSION, V46, P244, DOI 10.1161/01.HYP.0000166723.07809.7e; ZINNER SH, 1980, HYPERTENSION, V2, pI99, DOI 10.1161/01.HYP.2.4_Pt_2.I99	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200159	10.1371/journal.pone.0200159	http://dx.doi.org/10.1371/journal.pone.0200159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001353	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000438457400029
J	Pugliese, M; Matic, S; Prethi, S; Gisi, U; Gullino, ML				Pugliese, Massimo; Matic, Slavica; Prethi, Sanila; Gisi, Ulrich; Gullino, Maria Lodovica			Molecular characterization and sensitivity to demethylation inhibitor fungicides of Aspergillus fumigatus from orange-based compost	PLOS ONE			English	Article							MYCOSPHAERELLA-GRAMINICOLA; AZOLE FUNGICIDES; RESISTANCE; TR46/Y121F/T289A; SUSCEPTIBILITY; AGRICULTURE; POPULATIONS; DIVERSITY; TR34/L98H; DENMARK	Aspergillus fumigatus, the causal agent of human aspergilloses, is known to be non-pathogenic in plants. It is present as saprophyte in different types of organic matter and develops rapidly during the high-temperature phase of the composting process. Aspergilloses are treated with demethylation inhibitor (DMI) fungicides and resistant isolates have been recently reported. The present study aims to estimate the abundance, genetic diversity and DMI sensitivity of A. fumigatus during the composting process of orange fruits. Composting of orange fruits resulted in a 100-fold increase in A. fumigatus frequency already after 1 week, demonstrating that the degradation of orange fruits favoured the growth of A. fumigatus in compost. Most of A. fumigatus isolates belonged to mating type 2, including those initially isolated from the orange peel, whereas mating type 1 evolved towards the end of the composting process. None of the A. fumigatus isolates expressed simultaneously both mating types. The 52 investigated isolates exhibited moderate SSR polymorphisms by formation of one major (47 isolates) and one minor cluster (5 isolates). The latter included mating type 1 isolates from the last sampling and the DMI-resistant reference strains. Only few isolates showed cyp51A polymorphisms but were sensitive to DMIs as all the other isolates. None of the A. fumigatus isolates owned any of the mutations associated with DMI resistance. This study documents a high reproduction rate of A. fumigatus during the composting process of orange fruits, requesting specific safety precautions in compost handling. Furthermore, azole residue concentrations in orange-based compost were not sufficient to select A. fumigatus resistant genotypes.	[Pugliese, Massimo; Matic, Slavica; Gisi, Ulrich; Gullino, Maria Lodovica] Turin Univ, AGROINNOVA Ctr Competence Innovat Agroenvironm Se, Largo P Braccini 2, Turin, Italy; [Pugliese, Massimo; Gullino, Maria Lodovica] Turin Univ, Agr Forestry & Food Sci Dept DISAFA, Largo P Braccini 2, Turin, Italy; [Prethi, Sanila] Alexander Technol Inst Thessaloniki, Thessaloniki, Greece	University of Turin; University of Turin	Matic, S (corresponding author), Turin Univ, AGROINNOVA Ctr Competence Innovat Agroenvironm Se, Largo P Braccini 2, Turin, Italy.	slavica.matic@unito.it	Matić, Slavica/L-6810-2017; PUGLIESE, MASSIMO/B-3576-2018	Matić, Slavica/0000-0002-0885-8744; PUGLIESE, MASSIMO/0000-0002-2271-3429	Giuseppe Boccuzzi Memorial Project	Giuseppe Boccuzzi Memorial Project	The research leading to these results has received funding from the Giuseppe Boccuzzi Memorial Project.The authors thank also the Erasmus+ for Traineeship programme 2016/2017 for supporting the mobility of Sanila Prethi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2013, INT J AGRIC BIOL, V15, P1283; Alvarez-Perez S, 2010, MED MYCOL, V48, P273, DOI [10.3109/13693780903095414, 10.1080/13693780903095414]; Astvad KMT, 2014, ANTIMICROB AGENTS CH, V58, P5096, DOI 10.1128/AAC.02855-14; Berger S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01024; Bukar A., 2009, BAYERO J PURE APPL S, V2, P122, DOI [DOI 10.4314/BAJOPAS.V2I1.73454, 10.4314/bajopas.v2i1.73454]; Chowdhary A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052871; Coppola L, 2011, NEW BIOTECHNOL, V29, P99, DOI 10.1016/j.nbt.2011.03.005; de Valk HA, 2005, J CLIN MICROBIOL, V43, P4112, DOI 10.1128/JCM.43.8.4112-4120.2005; Denning DW, 1997, ANTIMICROB AGENTS CH, V41, P1364, DOI 10.1128/AAC.41.6.1364; Fraaije BA, 2007, MOL PLANT PATHOL, V8, P245, DOI [10.1111/j.1364-3703.2007.00388.x, 10.1111/j.1364-3703.2007.00388.X]; Franceschini S, 2016, COMPOST SCI UTIL, V24, P20, DOI 10.1080/1065657X.2015.1046612; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gisi U, 1997, PESTIC SCI, V51, P290, DOI 10.1002/(SICI)1096-9063(199711)51:3&lt;290::AID-PS637&gt;3.0.CO;2-H; Gisi U, 2014, PEST MANAG SCI, V70, P352, DOI 10.1002/ps.3664; Hollomon D, 2017, PEST MANAG SCI, V73, P1987, DOI 10.1002/ps.4607; Jeanvoine A, 2017, J APPL MICROBIOL, V123, P172, DOI 10.1111/jam.13488; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kupper T, 2008, BIORESOURCE TECHNOL, V99, P7988, DOI 10.1016/j.biortech.2008.03.052; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Lass-Florl C, 2006, MED MYCOL, V44, pS319, DOI 10.1080/13693780600779401; Mellado E, 2005, ANTIMICROB AGENTS CH, V49, P2536, DOI 10.1128/AAC.49.6.2536-2538.2005; Millner P, 1994, BIOAEROSOLS ASS COMP; Mortensen KL, 2010, ANTIMICROB AGENTS CH, V54, P4545, DOI 10.1128/AAC.00692-10; Motulsky H, GRAPHPAD PRISM REGRE; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Paoletti M, 2005, CURR BIOL, V15, P1242, DOI 10.1016/j.cub.2005.05.045; Pavel AB, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-9; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Prigitano A, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.12.20747; Recer G.M., 2001, AEROBIOLOGIA, V17, P99, DOI DOI 10.1023/A:1010816114787; Riat A, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02088-17, 10.1128/aac.02088-17]; Santoro K, 2017, PEST MANAG SCI, V73, P2481, DOI 10.1002/ps.4642; Saveyn H., 2014, END WASTE CRITERIA B; Snelders E, 2010, ANTIMICROB AGENTS CH, V54, P2425, DOI 10.1128/AAC.01599-09; Snelders E, 2009, APPL ENVIRON MICROB, V75, P4053, DOI 10.1128/AEM.00231-09; Spadaro D, 2015, J APPL MICROBIOL, V119, P510, DOI 10.1111/jam.12852; Stensvold CR, 2012, CURR FUNGAL INFECT R, V6, P178, DOI 10.1007/s12281-012-0097-7; Stentiford E. I., 1996, The science of composting: part 1., P49; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomazin R, 2017, 27 EUR C CLIN MICR I; Tournas VH, 2005, INT J FOOD MICROBIOL, V105, P11, DOI 10.1016/j.ijfoodmicro.2005.05.002; Turner, 2015, PESTICIDE MANUAL; Vaezi A, 2018, J MYCOL MED, V28, P59, DOI 10.1016/j.mycmed.2017.12.007; van der Linden JWM, 2013, CLIN INFECT DIS, V57, P513, DOI 10.1093/cid/cit320; van Ingen J, 2015, J ANTIMICROB CHEMOTH, V70, P178, DOI 10.1093/jac/dku364; Varga J, 2003, INFECT GENET EVOL, V3, P3, DOI 10.1016/S1567-1348(02)00156-9; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Wheeler P. A., 2001, P1E315TR ENV AG R D; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhang JH, 2017, MBIO, V8, DOI [10.1128/mBio.00791-17, 10.1128/mbio.00791-17]	51	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2018	13	7							e0200569	10.1371/journal.pone.0200569	http://dx.doi.org/10.1371/journal.pone.0200569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM8FT	30001414	Green Submitted, Green Published, gold			2022-12-26	WOS:000438457400082
J	Gupta, P; Uner, OE; Nayak, S; Grant, GR; Kalb, RG				Gupta, Preetika; Uner, Ogul E.; Nayak, Soumyashant; Grant, Gregory R.; Kalb, Robert G.			SAP97 regulates behavior and expression of schizophrenia risk enriched gene sets in mouse hippocampus	PLOS ONE			English	Article							NMDA RECEPTOR; MICE LACKING; AUTISM; PSD-95; ISOFORMS; BINDING; PROTEIN; SHANK3; ASSOCIATION; NEUROSERPIN	Synapse associated protein of 97KDa (SAP97) belongs to a family of scaffolding proteins, the membrane-associated guanylate kinases (MAGUKs), that are highly enriched in the postsynaptic density of synapses and play an important role in organizing protein complexes necessary for synaptic development and plasticity. The Dlg-MAGUK family of proteins are structurally very similar, and an effort has been made to parse apart the unique function of each Dlg-MAGUK protein by characterization of knockout mice. Knockout mice have been generated and characterized for PSD-95, PSD-93, and SAP102, however SAP97 knockout mice have been impossible to study because the SAP97 null mice die soon after birth due to a craniofacial defect. We studied the transcriptomic and behavioral consequences of a brain-specific conditional knockout of SAP97 (SAP97-cKO). RNA sequencing from hippocampi from control and SAP97-cKO male animals identified 67 SAP97 regulated transcripts. As large-scale genetic studies have implicated MAGUKs in neuropsychiatric disorders such as intellectual disability, autism spectrum disorders, and schizophrenia (SCZ), we analyzed our differentially expressed gene (DEG) set for enrichment of disease risk-associated genes, and found our DEG set to be specifically enriched for SCZ-related genes. Subjecting SAP97-cKO mice to a battery of behavioral tests revealed a subtle male-specific cognitive deficit and female-specific motor deficit, while other behaviors were largely unaffected. These data suggest that loss of SAP97 may have a modest contribution to organismal behavior. The SAP97-cKO mouse serves as a stepping stone for understanding the unique role of SAP97 in biology.	[Gupta, Preetika] Univ Penn, Dept Neurosci, Neurosci Grad Grp, Philadelphia, PA 19104 USA; [Uner, Ogul E.] Univ Penn, Dept Biol, Sch Arts & Sci, Philadelphia, PA 19104 USA; [Nayak, Soumyashant; Grant, Gregory R.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Grant, Gregory R.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Kalb, Robert G.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Northwestern University; Feinberg School of Medicine	Gupta, P (corresponding author), Univ Penn, Dept Neurosci, Neurosci Grad Grp, Philadelphia, PA 19104 USA.	preetika@pennmedicine.upenn.edu	Grant, Gregory Robert/I-3599-2019	Grant, Gregory Robert/0000-0002-0139-7658; Uner, Ogul/0000-0002-8730-6859	Public Health Service grants [NS095746, NS093439]; NIH training grant [5T32MH017168-33]; National Center for Advancing Translational Sciences grant [5UL1TR000003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS096746] Funding Source: NIH RePORTER	Public Health Service grants(United States Department of Health & Human ServicesUnited States Public Health Service); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grants NS095746 and NS093439 (to R.G.K.), the NIH training grant 5T32MH017168-33 (to P.G.), and by The National Center for Advancing Translational Sciences grant 5UL1TR000003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allswede DM, 2017, COMPLEMENT GENE EXPR, P1, DOI [10.1038/npp.2017.164, DOI 10.1038/NPP.2017.164]; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Borges VM, 2010, J NEUROSCI RES, V88, P2610, DOI 10.1002/jnr.22428; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chang X, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.154; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; David S, 2005, FEBS LETT, V579, P1534, DOI 10.1016/j.febslet.2005.01.040; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Delluc A, 2014, BRIT J HAEMATOL, V164, P272, DOI 10.1111/bjh.12627; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860; Feyder M, 2010, AM J PSYCHIAT, V167, P1508, DOI 10.1176/appi.ajp.2010.10040484; Fombonne E., 2003, JAMA-J AM MED ASSOC, V289, P1; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Funk AJ, 2009, NEUROREPORT, V20, P1019, DOI 10.1097/WNR.0b013e32832d30d9; Ghosh A, 2013, NAT REV DRUG DISCOV, V12, P777, DOI 10.1038/nrd4102; Giannone G, 2013, CELL REP, V3, P1996, DOI 10.1016/j.celrep.2013.05.013; Grabrucker S, 2014, EXP NEUROL, V253, P126, DOI 10.1016/j.expneurol.2013.12.015; Gris JC, 2015, THROMB RES, V135, pS56, DOI 10.1016/S0049-3848(15)50445-3; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Halacheva K, 2009, PSYCHIAT RES, V169, P51, DOI 10.1016/j.psychres.2008.05.011; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; Hoirisch-Clapauch S, 2015, DYSFUNCTION COAGULAT, V6, pe704, DOI [10.1038/tp.2015.204, DOI 10.1038/TP.2015.204]; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Kessler RC, 2008, J CLIN PSYCHIAT, P1; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; Kokras N, 2014, BRIT J PHARMACOL, V171, P1, DOI [10.1111/bph.12291, DOI 10.1111/BPH.12291]; Kouser M, 2013, J NEUROSCI, V33, P18448, DOI 10.1523/JNEUROSCI.3017-13.2013; Kristiansen LV, 2006, MOL PSYCHIATR, V11, P737, DOI 10.1038/sj.mp.4001844; Kulkarni J, 2013, INT J ENDOCRINOL MET, V11, P1, DOI [10.5812/ijem.7963, DOI 10.5812/IJEM.7963]; Law CW, 2014, VOOM PRECISION WEIGH, P1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madani R, 2003, MOL CELL NEUROSCI, V23, P473, DOI 10.1016/S1044-7431(03)00077-0; Migaud M, 1998, ENHANCED LONG TERM P, P1; Migaud M, ENHANCED LONG TERM P; Mojsilovic-Petrovic J, 2006, J NEUROSCI, V26, P9250, DOI 10.1523/JNEUROSCI.1856-06.2006; Mondin M, 2011, J NEUROSCI, V31, P13500, DOI 10.1523/JNEUROSCI.6439-10.2011; Mulle JG, 2015, MOL PSYCHIATR, V20, P1028, DOI 10.1038/mp.2015.76; Patel S, 2015, BMC BIOINFORMATICS, P1, DOI [10.1186/s12859-014-0430-y, DOI 10.1186/S12859-014-0430-Y]; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Quintero-Rivera F, 2010, AM J MED GENET A, V152A, P2459, DOI 10.1002/ajmg.a.33573; Reumann R, 2017, LEARN MEMORY, V24, P650, DOI 10.1101/lm.045864.117; Rezende SM, 2004, BLOOD, V103, P1192, DOI 10.1182/blood-2003-05-1551; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saetre P, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-46; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Song XQ, 2014, SCHIZOPHR RES, V159, P51, DOI 10.1016/j.schres.2014.07.033; Toyooka K, 2002, SELECTIVE REDUCTION, P1; Uchino S, 2013, BRAIN DEV-JPN, V35, P106, DOI 10.1016/j.braindev.2012.05.013; Uezato A, 2015, REDUCED CORTICAL EXP, V5, pe654, DOI [10.1038/tp.2015.154, DOI 10.1038/TP.2015.154]; Uezato A, 2017, AM J MED GENET B, V174, P798, DOI 10.1002/ajmg.b.32595; Uezato A, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-2; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Wang XM, 2011, HUM MOL GENET, V20, P3093, DOI 10.1093/hmg/ddr212; Winkler D, 2018, BEHAV BRAIN RES, V352, P35, DOI 10.1016/j.bbr.2017.02.011; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Xing J, 2016, RESEQUENCING ASS ANA, P1, DOI [10.1038/srep27491, DOI 10.1038/SREP27491]; Zhang L, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0175-17.2017; Zhao Z, 2015, MOL PSYCHIATR, V20, P563, DOI 10.1038/mp.2014.82; Zhou WG, 2008, J NEUROSCI, V28, P10220, DOI 10.1523/JNEUROSCI.3434-08.2008	61	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2018	13	7							e0200477	10.1371/journal.pone.0200477	http://dx.doi.org/10.1371/journal.pone.0200477			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM7QQ	29995933	Green Submitted, Green Published, gold			2022-12-26	WOS:000438388800071
J	Gonzalez-Machado, C; Capita, R; Riesco-Pelaez, F; Alonso-Calleja, C				Gonzalez-Machado, Camino; Capita, Rosa; Riesco-Pelaez, Felix; Alonso-Calleja, Carlos			Visualization and quantification of the cellular and extracellular components of Salmonella Agona biofilms at different stages of development	PLOS ONE			English	Article							LASER-SCANNING MICROSCOPY; FORM BIOFILMS; ABILITY; ARCHITECTURE; VIABILITY; BIOCIDES; STRAINS; CLSM	Salmonella is a major food-borne pathogen able to persist in food processing environments because of its ability to form biofilms. A Salmonella enterica serotype Agona isolate from poultry (S24) was grown at 37 degrees C in biofilms for up to 144 hours (H144) in attachment to polystyrene surfaces. Biofilm structures were examined at different stages in their development (H3, H24, H48, H72, H96 and H144) using confocal laser scanning microscopy (CLSM) in conjunction with fluorescent dyes for live cells (SYTO 9), dead cells (propidium iodide), proteins (fluorescein isothiocyanate isomer I), lipids (DiD'oil), alpha-polysaccharides (concanavalin A, tetramethylrhodamine conjugate), and beta-polysaccharides (calcofluor white M2R). Strain S24 developed a robust biofilm at H72 (biovolume of 166,852.5 +/- 13,681.8 mu m(3) in the observation field of 16,078.2 mu m(2)). The largest biovolume of live cells was also detected at H72 (128,110.3 +/- 4,969.1 mu m(3)), decreasing thereafter, which was probably owing to the detachment of cells prior to a new phase of colonization. The percentage of dead cells with regard to total cells in the biofilms increased throughout the incubation, ranging from 2.3 +/- 1.1% (H24) to 44.2 +/- 11.0% (H144). Proteins showed the greatest biovolume among the extracellular components within the biofilms, with values ranging from 1,295.1 +/- 1,294.9 mu m(3)(H3) to 19,186.2 +/- 8,536.0 mu m(3) (H96). Maximum biovolume values of 15,171.9 +/- 660.7 mu m(3) (H48), 7,055.3 +/- 4,415.2 mu m(3) (H144), and 2,548.6 +/- 1,597.5 mu m(3) (H72) were observed for beta-polysaccharides, alpha-polysaccharides and lipids, respectively. A strong (P < 0.01) positive correlation was found between the total biovolume of biofilm and the biovolume of live cells, proteins and beta-polysaccharides, which may serve as useful markers of biofilm formation. The present work provides new insights into the formation of S. Agona biofilms. Our findings may contribute to the designing of reliable strategies for preventing and removing these bacterial communities.	[Gonzalez-Machado, Camino; Capita, Rosa; Alonso-Calleja, Carlos] Univ Leon, Dept Food Hyg & Technol, Leon, Spain; [Gonzalez-Machado, Camino; Capita, Rosa; Alonso-Calleja, Carlos] Univ Leon, Inst Food Sci & Technol, Leon, Spain; [Riesco-Pelaez, Felix] Univ Leon, Dept Elect Engn & Syst Engn & Automat Control, Leon, Spain	Universidad de Leon; Universidad de Leon; Universidad de Leon	Alonso-Calleja, C (corresponding author), Univ Leon, Dept Food Hyg & Technol, Leon, Spain.; Alonso-Calleja, C (corresponding author), Univ Leon, Inst Food Sci & Technol, Leon, Spain.	carlos.alonso.calleja@unileon.es	Alonso-Calleja, Carlos/B-8189-2017; González-Machado, Camino/E-4873-2019; Capita, Rosa/B-8192-2017; Riesco-Peláez, Félix/R-1052-2017	Alonso-Calleja, Carlos/0000-0002-8688-0912; González-Machado, Camino/0000-0002-6444-8408; Capita, Rosa/0000-0001-9584-0755; Riesco-Peláez, Félix/0000-0001-6082-5432	Spanish Ministry of Economy, Industry and Competitiveness (INIA) [RTA2014-00045-C03-02]; Regional Government of Castile and Leon (Operational Programme for Youth Employment, European Social Fund and Youth Employment Initiative)	Spanish Ministry of Economy, Industry and Competitiveness (INIA); Regional Government of Castile and Leon (Operational Programme for Youth Employment, European Social Fund and Youth Employment Initiative)	This research was supported by the Spanish Ministry of Economy, Industry and Competitiveness (INIA; RTA2014-00045-C03-02). Camino GonzaAlez-Machado was beneficiary of a fellowship of the Regional Government of Castile and Leon (Operational Programme for Youth Employment, European Social Fund and Youth Employment Initiative). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Spanish Ministry of Economy, Industry and Competitiveness (INIA; RTA2014-00045-C03-02). Camino Gonza A lez-Machado was beneficiary of a fellowship of the Regional Government of Castile and Leon (Operational Programme for Youth Employment, European Social Fund and Youth Employment Initiative).	Arciola CR, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00007; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Buzon-Duran L, 2017, FOOD MICROBIOL, V65, P294, DOI 10.1016/j.fm.2017.01.003; Capita R, 2017, FOODBORNE PATHOG DIS, V14, P350, DOI 10.1089/fpd.2016.2241; Castelijn GAA, 2012, BIOFOULING, V28, P51, DOI 10.1080/08927014.2011.648927; Chavant P, 2002, APPL ENVIRON MICROB, V68, P728, DOI 10.1128/AEM.68.2.728-737.2002; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Diez-Garcia M, 2012, FOOD MICROBIOL, V31, P173, DOI 10.1016/j.fm.2012.03.012; European Food Safety Authority, 2017, EFSA J, V15, DOI 10.2903/j.efsa.2017.5077; Fish KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115824; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Guilbaud M, 2015, APPL ENVIRON MICROB, V81, P1804, DOI 10.1128/AEM.03173-14; Houari A, 2013, BIOFOULING, V29, P109, DOI 10.1080/08927014.2012.752464; Kamjunke N, 2012, INT BIODETER BIODEGR, V69, P17, DOI 10.1016/j.ibiod.2011.11.015; MacKenzie KD, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00138; Marshall JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089243; Midelet G, 2004, J APPL MICROBIOL, V97, P262, DOI 10.1111/j.1365-2672.2004.02296.x; Mohle RB, 2007, BIOTECHNOL BIOENG, V98, P747, DOI 10.1002/bit.21448; Mohammed MMA, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.20015; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; MURGA R, 1995, BIOTECHNOL BIOENG, V45, P503, DOI 10.1002/bit.260450607; Petrova OE, 2016, CURR OPIN MICROBIOL, V30, P67, DOI 10.1016/j.mib.2016.01.004; Simoes M, 2005, WATER RES, V39, P5142, DOI 10.1016/j.watres.2005.09.028; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vestby LK, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-20; Vogeleer P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00317; Wagner M, 2009, WATER RES, V43, P63, DOI 10.1016/j.watres.2008.10.034; Wang HH, 2013, INT J FOOD MICROBIOL, V167, P293, DOI 10.1016/j.ijfoodmicro.2013.10.005; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Zhang T, 2001, BIOTECHNOL LETT, V23, P405, DOI 10.1023/A:1005620730265	31	30	37	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0200011	10.1371/journal.pone.0200011	http://dx.doi.org/10.1371/journal.pone.0200011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990340	gold, Green Published, Green Submitted			2022-12-26	WOS:000438170300023
J	Olugbenga, I; Taiwo, O; Laverty, M; Ngige, E; Anyaike, C; Bakare, R; Ogunleye, V; Maddox, BLP; Newman, DR; Gliddon, HD; Ofondu, E; Nurse-Findlay, S; Taylor, MM				Olugbenga, Ijaodola; Taiwo, Oyelade; Laverty, Maura; Ngige, Evelyn; Anyaike, Chukwuma; Bakare, Rasheed; Ogunleye, Veronica; Maddox, Brandy L. Peterson; Newman, Daniel R.; Gliddon, Harriet D.; Ofondu, Eugenia; Nurse-Findlay, Stephen; Taylor, Melanie M.			Clinic-based evaluation study of the diagnostic accuracy of a dual rapid test for the screening of HIV and syphilis in pregnant women in Nigeria	PLOS ONE			English	Article								Background Screening pregnant women for HIV and syphilis is recommended by WHO in order to reduce mother-to-child transmission. We evaluated the field performance, feasibility, and acceptability of a dual rapid diagnostic test (RDT) for HIV and syphilis test in antenatal clinic settings in Nigeria. Methods and findings Participants were recruited at 12 antenatal clinic sites in three states of Nigeria. All consenting individuals were tested according to the national HIV testing algorithm, as well as a dual RDT, the SD BIOLINE HIV/Syphilis Duo Test (Alere, USA), in the clinic. To determine sensitivity, specificity and concordance, whole blood samples were obtained for repeat RDT performance in the laboratory, as well as reference tests for HIV and syphilis. Dual test acceptability and operational characteristics were assessed among participants and clinic staff. The prevalence of HIV among the 4,551 enrollees was 3.0% (138/4551) using the national clinic-based HIV testing algorithm. Positive and negative percent agreement of the HIV component of the dual RDT were 100.0% (95% CI 99.7-100.0) and 99.9% (95% CI 99.7-100.0) respectively, when compared with the national rapid testing algorithm. The prevalence of syphilis, using TPHA as the reference test, was low at 0.09% (4/4550). The sensitivity of the syphilis component of the dual RDT could not be calculated as no positive results were observed for patients that were positive for syphilis by TPHA. Each of the only four TPHA-positive specimens had RPR titers of 1:1 (neat), indicative of non-active syphilis. The specificity of the syphilis component of the dual RDT was 99.9% (95% CI 99.8-100.0). The dual RDT received favorable feasibility ratings among antenatal care clinic staff. Acceptability among study participants was high with most women reporting preference for rapid dual HIV/syphilis testing. Conclusions The SD BIOLINE HIV/Syphilis Duo Test showed a high overall diagnostic accuracy for HIV and a high specificity for syphilis diagnosis in antenatal clinic settings. This study adds to a growing body of evidence that supports the clinic-based use of dual tests for HIV and syphilis among pregnant women.	[Olugbenga, Ijaodola; Ngige, Evelyn; Anyaike, Chukwuma] Fed Minist Hlth Nigeria, Natl AIDS & STIs Control Programme, Fct Abuja, Nigeria; [Taiwo, Oyelade] WHO Reg Off Africa, Brazzaville, Rep Congo; [Laverty, Maura; Gliddon, Harriet D.; Nurse-Findlay, Stephen; Taylor, Melanie M.] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland; [Bakare, Rasheed; Ogunleye, Veronica] Univ Coll Hosp Ibadan, Dept Microbiol, Ibadan, Nigeria; [Maddox, Brandy L. Peterson; Newman, Daniel R.; Taylor, Melanie M.] Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div STD Prevent, Atlanta, GA 30333 USA; [Gliddon, Harriet D.] UCL, London Ctr Nanotechnol, London, England; [Ofondu, Eugenia] Fed Med Ctr Owerri, Dermatol & Venereol Dept, Owerri, Nigeria	World Health Organization; University of Ibadan; University College Hospital, Ibadan; Centers for Disease Control & Prevention - USA; University of London; University College London	Taylor, MM (corresponding author), World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.; Taylor, MM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Div STD Prevent, Atlanta, GA 30333 USA.	mtaylor@who.int		Gliddon, Harriet/0000-0002-9623-4252; Oyelade, Taiwo/0000-0002-3452-975X	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)	This work was funded by the UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), a cosponsored program executed by the World Health Organization (WHO). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, ELIMINATION MOTHER T; [Anonymous], 2021, LANG ENV STAT COMP; Black V, 2016, SEX TRANSM INFECT, V92, P495, DOI 10.1136/sextrans-2015-052474; Bristow CC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1574-3; Bristow CC, 2016, SEX TRANSM INFECT, V92, P182, DOI 10.1136/sextrans-2015-052326; Gliddon HD, 2017, SEX TRANSM INFECT, V93, pS3, DOI 10.1136/sextrans-2016-053069; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hess KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112190; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Rotondi MA, 2009, ELEMENTARY EPIDEMIOL; Taylor M, 2018, LANCET GLOB HEALTH, V6, pE26, DOI 10.1016/S2214-109X(17)30422-9; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2016, GLOB AIDS MON 2017; UNICEF, 2016, MAT NEWB HLTH DISP N; WHO, 2016, GLOB HLTH SECT HIV 2; WHO, 2020, WHO INF NOT US DUAL; WHO, 2015, RREP GLOB SEX TRANSM; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2015, WHO PREQ IN VITR DIA; World Health Organization, 2014, GLOB GUID CRIT PROC; Yin Yue-Ping, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS22, DOI 10.1016/j.ijgo.2015.04.004	22	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2018	13	7							e0198698	10.1371/journal.pone.0198698	http://dx.doi.org/10.1371/journal.pone.0198698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM5IS	29990336	Green Published, gold, Green Submitted			2022-12-26	WOS:000438170300004
